PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lu, ZG; Xu, J; Wang, Q; Pan, YX				Lu, Zhigang; Xu, Jin; Wang, Qian; Pan, Ying-Xian			Morphine modulates the expression of mu-opioid receptor exon 5-associated full-length C-terminal splice variants by upregulating miR-378a-3p	FASEB JOURNAL			English	Article						microRNA; morphine; opioid; OPRM1; splicing	MESSENGER-RNA; GENE; TOLERANCE; MICRORNAS; IDENTIFICATION; ASSOCIATION; REGION; MOR1	The mu-opioid receptor gene, OPRM1, undergoes extensive alternative splicing, creating an array of splice variants that are conserved from rodent to human. Both mouse and human OPRM1 have five exon 5-associated seven transmembrane full-length carboxyl terminal variants, MOR-1B1, MOR-1B2, MOR-1B3, MOR-1B4, and MOR-1B5, all of which are derived from alternative 3 ' splicing from exon 3 to alternative sites within exon 5. The functional relevance of these exon 5-associated MOR-1Bs has been demonstrated in mu agonist-induced G protein coupling, adenylyl cyclase activity, receptor internalization and desensitization, and post-endocytic sorting, as well as region-specific expression at the mRNA level. In the present study, we mapped a polyadenylation site for both mouse and human MOR-1Bs that defines the 3 '-untranslated regions (3 '-UTR) of MOR-1Bs and stabilizes mMOR-1Bs mRNAs. We identified a conserved miR378a-3p sequence in the 3 '-UTR of both mouse and human MOR-1B(S) transcripts through which miR-378a-3p can regulate the expression of MOR-1Bs at the mRNA level. Chronic morphine treatment significantly increased the miR-378-3p level in Be(2)C cells and the brainstem of the morphine tolerant mice, contributing to the decreased expression of the mouse and human MOR-1B3 and MOR-1B4. Our study provides new insights into the role of miRNAs and Oprm1 splice variants in morphine tolerance.	[Lu, Zhigang] Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Peoples R China; [Lu, Zhigang] Nanjing Univ Chinese Med, Affiliated Hosp, Coll Clin Med 1, Nanjing, Peoples R China; [Lu, Zhigang] Nanjing Univ Chinese Med, Minist Educ, Key Lab Acupuncture & Med Res, Nanjing, Peoples R China; [Xu, Jin; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10065 USA; [Xu, Jin; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, 1275 York Ave, New York, NY 10021 USA; [Wang, Qian] Nanjing Univ Chinese Med, Int Educ Coll, Nanjing, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Nanjing University of Chinese Medicine	Lu, ZG (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Peoples R China.; Pan, YX (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10065 USA.	luzg@njucm.edu.cn; pany@mskcc.org			HHS \ NIH \ National Institute on Drug Abuse (NIDA) [DA042888, DA046714, DA007242]; Mayday Foundation; Peter F. McManus Charitable Trust; NSFC \ National Natural Science Foundation of China [81673412]; HHS \ NIH \ National Cancer Institute (NCI) [CA08748]	HHS \ NIH \ National Institute on Drug Abuse (NIDA); Mayday Foundation; Peter F. McManus Charitable Trust; NSFC \ National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); HHS \ NIH \ National Cancer Institute (NCI)	HHS vertical bar NIH vertical bar National Institute on Drug Abuse (NIDA), Grant/Award Number: DA042888, DA046714 and DA007242; The Mayday Foundation; The Peter F. McManus Charitable Trust; NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 81673412; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: CA08748	Allo M, 2014, P NATL ACAD SCI USA, V111, P15622, DOI 10.1073/pnas.1416858111; Barbierato M, 2015, CNS NEUROL DISORD-DR, V14, P239, DOI 10.2174/1871527314666150116123932; Ding NX, 2018, INT J MOL MED, V42, P381, DOI 10.3892/ijmm.2018.3639; Dreyer JL, 2010, GENOME MED, V2, DOI 10.1186/gm213; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Havens MA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004312; He Ying, 2012, Frontiers in Genetics, V3, P110, DOI 10.3389/fgene.2012.00110; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Hu XM, 2016, MOL PAIN, V12, DOI 10.1177/1744806916666283; Hwang CK, 2012, J NEUROIMMUNE PHARM, V7, P808, DOI 10.1007/s11481-011-9323-2; Hyun J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10993; Ide S, 2005, GENE, V364, P139, DOI 10.1016/j.gene.2005.05.040; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; KOLESNIKOV YA, 1993, P NATL ACAD SCI USA, V90, P5162, DOI 10.1073/pnas.90.11.5162; Krist B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/281756; Kucherenko MM, 2018, J CELL SCI, V131, DOI 10.1242/jcs.202002; Li H, 2014, EUR J CANCER, V50, P1207, DOI 10.1016/j.ejca.2013.12.010; Lu ZG, 2015, J CLIN INVEST, V125, P2626, DOI 10.1172/JCI81070; Lu ZG, 2014, MOL PHARMACOL, V85, P368, DOI 10.1124/mol.113.089292; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Pan L, 2005, NEUROSCIENCE, V133, P209, DOI 10.1016/j.neuroscience.2004.12.033; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pan YX, 2005, MOL PHARMACOL, V68, P866, DOI 10.1124/mol.105.011858; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Rodriguez Raquel E., 2012, Frontiers in Genetics, V3, P223, DOI 10.3389/fgene.2012.00223; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; Tapocik JD, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00020; Tapocik JD, 2013, ADDICT BIOL, V18, P480, DOI 10.1111/j.1369-1600.2012.00470.x; Wei XF, 2016, RNA BIOL, V13, P1300, DOI 10.1080/15476286.2016.1239008; Wu QF, 2005, MOL PHARMACOL, V68, P279, DOI 10.1124/mol.105.012567; Wu QF, 2013, FASEB J, V27, P522, DOI 10.1096/fj.12-213439; Wu QF, 2009, MOL PHARMACOL, V75, P744, DOI 10.1124/mol.108.053462; Wu QF, 2008, FASEB J, V22, P4085, DOI 10.1096/fj.08-108175; Xu JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087078; Xu J, 2015, P NATL ACAD SCI USA, V112, P279, DOI 10.1073/pnas.1419183112; Zhang YH, 2006, BRAIN RES, V1099, P33, DOI 10.1016/j.brainres.2006.04.133	37	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4540	4556		10.1096/fj.201901879RR	http://dx.doi.org/10.1096/fj.201901879RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31999011	Green Accepted			2022-12-28	WOS:000510165500001
J	Lee, DH; Kim, GW; Jeon, YH; Yoo, J; Lee, SW; Kwon, SH				Lee, Dong Hoon; Kim, Go Woon; Jeon, Yu Hyun; Yoo, Jung; Lee, Sang Wu; Kwon, So Hee			Advances in histone demethylase KDM4 as cancer therapeutic targets	FASEB JOURNAL			English	Review						anticancer agent; epigenetic agent; KDM4; KDM4 inhibitor	ACUTE MYELOID-LEUKEMIA; EPITHELIAL-MESENCHYMAL TRANSITION; LYSINE 9 TRIMETHYLATION; REGULATES CELL-GROWTH; DOMAIN-CONTAINING 2A; DNA-DAMAGE RESPONSE; ANDROGEN RECEPTOR; JMJD2 FAMILY; GENETIC ALTERATIONS; DOWN-REGULATION	The KDM4 subfamily H3K9 histone demethylases are epigenetic regulators that control chromatin structure and gene expression by demethylating histone H3K9, H3K36, and H1.4K26. The KDM4 subfamily mainly consists of four proteins (KDM4A-D), all harboring the Jumonji C domain (JmjC) but with differential substrate specificities. KDM4A-C proteins also possess the double PHD and Tudor domains, whereas KDM4D lacks these domains. KDM4 proteins are overexpressed or deregulated in multiple cancers, cardiovascular diseases, and mental retardation and are thus potential therapeutic targets. Despite extensive efforts, however, there are very few KDM4-selective inhibitors. Defining the exact physiological and oncogenic functions of KDM4 demethylase will provide the foundation for the discovery of novel potent inhibitors. In this review, we focus on recent studies highlighting the oncogenic functions of KDM4s and the interplay between KDM4-mediated epigenetic and metabolic pathways in cancer. We also review currently available KDM4 inhibitors and discuss their potential as therapeutic agents for cancer treatment.	[Lee, Dong Hoon; Kim, Go Woon; Jeon, Yu Hyun; Yoo, Jung; Lee, Sang Wu; Kwon, So Hee] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, 85 Songdogwahak Ro, Incheon 21983, South Korea; [Kwon, So Hee] Yonsei Univ, Dept Integrated OMICS Biomed Sci, Seoul, South Korea	Yonsei University; Yonsei University	Kwon, SH (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, 85 Songdogwahak Ro, Incheon 21983, South Korea.	soheekwon@yonsei.ac.kr	Kwon, So/AAG-8971-2020	Lee, Dong Hoon/0000-0001-9718-3955	National Research Foundation of Korea [2016R1D1A1A02937071, 2018R1A6A1A03023718, 2019R1A2C1008619, 2019R1I1A1A01058601]	National Research Foundation of Korea(National Research Foundation of Korea)	National Research Foundation of Korea, Grant/Award Number: 2016R1D1A1A02937071, 2018R1A6A1A03023718, 2019R1A2C1008619 and 2019R1I1A1A01058601	Agger K, 2016, GENE DEV, V30, P1278, DOI 10.1101/gad.280495.116; Antonoff MB, 2010, J SURG RES, V163, P72, DOI 10.1016/j.jss.2010.04.047; Bavetsias V, 2016, J MED CHEM, V59, P1388, DOI 10.1021/acs.jmedchem.5b01635; Berdel B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-516; Berry WL, 2014, INT J ONCOL, V44, P1341, DOI 10.3892/ijo.2014.2279; Berry WL, 2013, CANCER RES, V73, P2936, DOI 10.1158/0008-5472.CAN-12-4300; Berry WL, 2012, INT J ONCOL, V41, P1701, DOI 10.3892/ijo.2012.1618; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Black JC, 2016, J BIOL CHEM, V291, P4862, DOI 10.1074/jbc.M115.711648; Black JC, 2015, GENE DEV, V29, P1018, DOI 10.1101/gad.259796.115; Black JC, 2013, CELL, V154, P541, DOI 10.1016/j.cell.2013.06.051; Bur H, 2016, ANTICANCER RES, V36, P4677, DOI 10.21873/anticanres.11020; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Cao HH, 2015, ONCOTARGET, V6, P5435, DOI 10.18632/oncotarget.3102; Carter BZ, 2006, BLOOD, V108, P630, DOI 10.1182/blood-2005-09-3898; Cascella B, 2017, CHEM COMMUN, V53, P2174, DOI 10.1039/c6cc09882g; Castellini L, 2017, NUCLEIC ACIDS RES, V45, P3674, DOI 10.1093/nar/gkw1281; Chen L, 2014, BRIT J CANCER, V110, P1014, DOI 10.1038/bjc.2013.808; Chen Z, 2017, ONCOTARGET, V8, P17712, DOI 10.18632/oncotarget.10832; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chen ZZ, 2007, P NATL ACAD SCI USA, V104, P10818, DOI 10.1073/pnas.0704525104; Cheung N, 2016, CANCER CELL, V29, P32, DOI 10.1016/j.ccell.2015.12.007; Chin YW, 2015, EXPERT OPIN THER PAT, V25, P135, DOI 10.1517/13543776.2014.991310; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Chong PSY, 2014, CANCER RES, V74, P3043, DOI 10.1158/0008-5472.CAN-13-2321; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Chu CH, 2014, J MED CHEM, V57, P5975, DOI 10.1021/jm500249n; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Coffey K, 2013, NUCLEIC ACIDS RES, V41, P4433, DOI 10.1093/nar/gkt106; Crea F, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-52; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Deng WW, 2018, MOL CELL BIOCHEM, V449, P81, DOI 10.1007/s11010-018-3345-5; Ding XM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003884; Duan LL, 2015, CHEM BIOL, V22, P1185, DOI 10.1016/j.chembiol.2015.08.007; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Franci G, 2017, EPIGENETICS-US, V12, P198, DOI 10.1080/15592294.2016.1249089; Franci Gianluigi, 2014, Biomol Concepts, V5, P209, DOI 10.1515/bmc-2014-0010; Fu LN, 2018, ONCOGENE, V37, P389, DOI 10.1038/onc.2017.345; Fu LN, 2012, CARCINOGENESIS, V33, P1664, DOI 10.1093/carcin/bgs217; Garcia J, 2018, BREAST CANCER-BASIC, V12, DOI 10.1177/1178223418773075; Garcia J, 2016, BREAST CANCER-BASIC, V10, P169, DOI 10.4137/BCBCR.S40182; Gaughan L, 2013, NUCLEIC ACIDS RES, V41, P6892, DOI 10.1093/nar/gkt469; Giri NC, 2013, BIOCHEMISTRY-US, V52, P4168, DOI 10.1021/bi400274v; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Gupta V, 2014, CURR PHARM DESIGN, V20, P1706, DOI 10.2174/13816128113199990536; Hamada S, 2010, J MED CHEM, V53, P5629, DOI 10.1021/jm1003655; Hamada S, 2009, BIOORG MED CHEM LETT, V19, P2852, DOI 10.1016/j.bmcl.2009.03.098; Han FJ, 2016, ONCOTARGET, V7, P38626, DOI 10.18632/oncotarget.9573; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; Helias C, 2008, CANCER GENET CYTOGEN, V180, P51, DOI 10.1016/j.cancergencyto.2007.09.010; Hensen EF, 2011, FAM CANCER, V10, P355, DOI 10.1007/s10689-010-9402-1; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Hofmann JJ, 2007, GENE EXPR PATTERNS, V7, P461, DOI 10.1016/j.modgep.2006.11.002; Hong Q, 2014, ONCOTARGET, V5, P4779, DOI 10.18632/oncotarget.2029; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Hu CE, 2014, BIOCHEM BIOPH RES CO, V449, P1, DOI 10.1016/j.bbrc.2014.04.126; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Hui Zeng, 2015, FEBS Lett, V589, P812, DOI 10.1016/j.febslet.2015.02.014; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; Italiano A, 2006, CANCER GENET CYTOGEN, V167, P122, DOI 10.1016/j.cancergencyto.2006.01.004; Itoh Y, 2013, MOL BIOSYST, V9, P873, DOI 10.1039/c3mb25410k; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Jin CY, 2014, P NATL ACAD SCI USA, V111, P9235, DOI 10.1073/pnas.1404303111; Jing JC, 2019, J CELL BIOCHEM, V120, P7897, DOI 10.1002/jcb.28065; Katoh M, 2004, INT J ONCOL, V24, P1623; Kauffman EC, 2011, MOL CARCINOGEN, V50, P931, DOI 10.1002/mc.20758; Kawamura A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14773; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Kim JG, 2012, BBA-GENE REGUL MECH, V1819, P1200, DOI 10.1016/j.bbagrm.2012.10.001; Kim TD, 2016, ONCOL REP, V35, P3679, DOI 10.3892/or.2016.4747; Kim TD, 2016, J CLIN INVEST, V126, P706, DOI 10.1172/JCI78132; Kim TD, 2014, AM J TRANSL RES, V6, P236; Kim TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034618; King ONF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015535; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Kogure M, 2013, CANCER LETT, V336, P76, DOI 10.1016/j.canlet.2013.04.009; Krishnan S, 2013, STRUCTURE, V21, P98, DOI 10.1016/j.str.2012.10.018; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Labbe RM, 2014, AM J TRANSL RES, V6, P1; Lee HY, 2013, CARCINOGENESIS, V34, P2706, DOI 10.1093/carcin/bgt256; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Leurs U, 2014, ACS CHEM BIOL, V9, P2131, DOI 10.1021/cb500374f; Levin May, 2018, Oncotarget, V9, P16861, DOI 10.18632/oncotarget.24717; Li AH, 2011, AM J PATHOL, V178, P1340, DOI 10.1016/j.ajpath.2010.11.058; Li BX, 2013, INDIAN J EXP BIOL, V51, P208; Li BX, 2012, EXP THER MED, V4, P755, DOI 10.3892/etm.2012.662; Li HJ, 2016, ONCOTARGET, V7, P57866, DOI 10.18632/oncotarget.11077; Li LL, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3667; Li LL, 2014, BREAST CANCER RES TR, V147, P487, DOI 10.1007/s10549-014-3083-7; Li N, 2017, BIOMED PHARMACOTHER, V89, P305, DOI 10.1016/j.biopha.2017.02.014; Li S, 2015, ACTA BIOCH BIOPH SIN, V47, P997, DOI 10.1093/abbs/gmv107; Li WJ, 2011, BIOCHEM BIOPH RES CO, V416, P372, DOI 10.1016/j.bbrc.2011.11.045; Li XJ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0503-4; Liang Y, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005145; Lin HZ, 2018, J ENZYM INHIB MED CH, V33, P777, DOI 10.1080/14756366.2018.1455676; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Liu L, 2010, TOXICOLOGY, V271, P57, DOI 10.1016/j.tox.2010.03.004; Liu YX, 2013, GUT, V62, P571, DOI 10.1136/gutjnl-2011-301059; Lohse B, 2011, ANGEW CHEM INT EDIT, V50, P9100, DOI 10.1002/anie.201101849; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lu JW, 2015, ACTA HISTOCHEM, V117, P14, DOI 10.1016/j.acthis.2014.10.002; Luo WB, 2012, P NATL ACAD SCI USA, V109, pE3367, DOI 10.1073/pnas.1217394109; Luo XL, 2011, J AM CHEM SOC, V133, P9451, DOI 10.1021/ja201597b; Maes T, 2015, CURR OPIN PHARMACOL, V23, P52, DOI 10.1016/j.coph.2015.05.009; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Marvalim C, 2017, PHARMACOGENET GENOM, V27, P120, DOI 10.1097/FPC.0000000000000266; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Menter T, 2019, VIRCHOWS ARCH, V474, P497, DOI 10.1007/s00428-018-2438-6; Min DJ, 2010, CANCER CELL, V18, P539, DOI 10.1016/j.ccr.2010.11.032; Mu HQ, 2019, J CELL BIOCHEM, V120, P4987, DOI 10.1002/jcb.27774; Neault M, 2016, CELL REP, V14, P1966, DOI 10.1016/j.celrep.2016.01.068; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Nilsson EM, 2015, ONCOTARGET, V6, P35710, DOI 10.18632/oncotarget.5958; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Ozaki Y, 2015, MAMM GENOME, V26, P591, DOI 10.1007/s00335-015-9592-9; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Patani N, 2011, ANTICANCER RES, V31, P4115; Pedersen MT, 2016, EMBO J, V35, P1550, DOI 10.15252/embj.201593317; Peng KS, 2019, GASTROENTEROLOGY, V156, P1112, DOI 10.1053/j.gastro.2018.11.036; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Pollard PJ, 2003, ANN MED, V35, P632, DOI 10.1080/07853890310018458; Qiu MT, 2015, ONCOTARGET, V6, P31702, DOI 10.18632/oncotarget.5165; Rai G, 2010, PROBE REPORTS NIH MO; Ratovitski EA, 2014, CELL CYCLE, V13, P749, DOI 10.4161/cc.27676; Richarson AD, 2016, ELIFE, V5, DOI 10.7554/eLife.10860; Ricketts CJ, 2012, J UROLOGY, V188, P2063, DOI 10.1016/j.juro.2012.08.030; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Rose NR, 2008, J MED CHEM, V51, P7053, DOI 10.1021/jm800936s; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Ruger N, 2015, CHEMMEDCHEM, V10, P1875, DOI 10.1002/cmdc.201500335; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Scott LM, 2015, BLOOD REV, V29, P405, DOI 10.1016/j.blre.2015.06.002; Sekirnik R, 2009, CHEM COMMUN, P6376, DOI 10.1039/b916357c; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shmakova A, 2014, BIOCHEM J, V462, P385, DOI 10.1042/BJ20140754; Slee RB, 2012, ONCOGENE, V31, P3244, DOI 10.1038/onc.2011.502; Soini Y, 2015, INT J CLIN EXP PATHO, V8, P12922; Suikki HE, 2010, PROSTATE, V70, P889, DOI 10.1002/pros.21123; Sun BB, 2014, J DIGEST DIS, V15, P491, DOI 10.1111/1751-2980.12166; Sun LL, 2013, AM J CANCER RES, V3, P509; Tausendschon M, 2011, CYTOKINE, V53, P256, DOI 10.1016/j.cyto.2010.11.002; Terndrup M, 2014, MOL CELL BIOL, V34, P1031, DOI 10.1128/MCB.00864-13; Thalhammer A, 2011, ORG BIOMOL CHEM, V9, P127, DOI 10.1039/c0ob00592d; Toro JR, 2003, AM J HUM GENET, V73, P95, DOI 10.1086/376435; Toyokawa G, 2016, ANTICANCER RES, V36, P4841, DOI 10.21873/anticanres.11046; Toyokawa G, 2011, CANCER PREV RES, V4, P2051, DOI 10.1158/1940-6207.CAPR-11-0290; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Uimonen K, 2014, HISTOL HISTOPATHOL, V29, P797, DOI 10.14670/HH-29.797; Upadhyay AK, 2018, BIOORG MED CHEM LETT, V28, P1708, DOI 10.1016/j.bmcl.2018.04.050; van den Hoogen C, 2011, AM J PATHOL, V179, P2559, DOI 10.1016/j.ajpath.2011.07.011; van der Horst G, 2011, NEOPLASIA, V13, P516, DOI 10.1593/neo.11122; Van Rechem C, 2015, CANCER DISCOV, V5, P245, DOI 10.1158/2159-8290.CD-14-1159; Van Rechem C, 2015, CANCER DISCOV, V5, P255, DOI 10.1158/2159-8290.CD-14-1326; Venneti S, 2013, J NEUROPATH EXP NEUR, V72, P298, DOI 10.1097/NEN.0b013e3182898113; Vieira FQ, 2014, ENDOCR-RELAT CANCER, V21, P51, DOI 10.1530/ERC-13-0375; Vinatzer U, 2008, CLIN CANCER RES, V14, P6426, DOI 10.1158/1078-0432.CCR-08-0702; Wagner EK, 2012, BIOCHEMISTRY-US, V51, P8293, DOI 10.1021/bi3009278; Walsh CA, 2014, CANCER RES, V74, P2533, DOI 10.1158/0008-5472.CAN-13-2133; Wang B, 2016, J MOL NEUROSCI, V60, P137, DOI 10.1007/s12031-016-0796-6; Wang DY, 2015, EXP MOL PATHOL, V99, P399, DOI 10.1016/j.yexmp.2015.08.020; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Wang HL, 2014, ASIAN PAC J CANCER P, V15, P3051, DOI 10.7314/APJCP.2014.15.7.3051; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wein F, 2015, HAEMATOLOGICA, V100, P1320, DOI 10.3324/haematol.2015.127498; Wen L, 2012, ACTA PHARMACOL SIN, V33, P109, DOI 10.1038/aps.2011.145; West DC, 2016, MOL CANCER RES, V14, P707, DOI 10.1158/1541-7786.MCR-15-0433; Westaway SM, 2016, J MED CHEM, V59, P1370, DOI 10.1021/acs.jmedchem.5b01538; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wilson C, 2017, ONCOGENE, V36, P2565, DOI 10.1038/onc.2016.412; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wong CC, 2017, ONCOGENE, V36, P3359, DOI 10.1038/onc.2016.485; Woon ECY, 2012, ANGEW CHEM INT EDIT, V51, P1631, DOI 10.1002/anie.201107833; Wu J, 2012, ONCOGENE, V31, P333, DOI 10.1038/onc.2011.227; Wu MC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1305-y; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu WH, 2016, ONCOL REP, V35, P352, DOI 10.3892/or.2015.4349; Xu WH, 2015, BIOL CHEM, V396, P929, DOI 10.1515/hsz-2014-0284; Yamamoto S, 2013, CARCINOGENESIS, V34, P2380, DOI 10.1093/carcin/bgt174; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang J, 2017, CANCER RES, V77, P4626, DOI [10.1158/0008-5472.CAN-16-0826, 10.1158/0008-5472.can-16-0826]; Yang J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv080; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yang ZQ, 2001, JPN J CANCER RES, V92, P423, DOI 10.1111/j.1349-7006.2001.tb01112.x; Yang ZQ, 2000, CANCER RES, V60, P4735; Ye Q, 2015, AM J CANCER RES, V5, P1519; Young LC, 2013, BIOCHEM CELL BIOL, V91, P369, DOI 10.1139/bcb-2012-0054; Young LC, 2013, J BIOL CHEM, V288, P21376, DOI 10.1074/jbc.M113.491514; Yuan X, 2016, NEOPLASIA, V18, P594, DOI 10.1016/j.neo.2016.08.005; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005; Zhang JW, 2016, EXP CELL RES, V349, P77, DOI 10.1016/j.yexcr.2016.09.023; Zhang JJ, 2018, AM J TRANSL RES, V10, P525; Zhao L, 2013, CLIN CANCER RES, V19, P6419, DOI 10.1158/1078-0432.CCR-13-0254; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zheng H, 2014, ONCOGENE, V33, P734, DOI 10.1038/onc.2013.6; Zhou B, 2010, BIOORG MED CHEM LETT, V20, P6217, DOI 10.1016/j.bmcl.2010.08.106; Zhu S, 2012, J CELL BIOCHEM, V113, P2375, DOI 10.1002/jcb.24109	210	45	46	8	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3461	3484		10.1096/fj.201902584R	http://dx.doi.org/10.1096/fj.201902584R		JAN 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31961018	Bronze			2022-12-28	WOS:000508664100001
J	Yang, WL; Chi, YJ; Meng, YH; Chen, ZZ; Xiang, R; Yan, H; Yang, JC				Yang, Weili; Chi, Yujing; Meng, Yuhong; Chen, Zhenzhen; Xiang, Rui; Yan, Han; Yang, Jichun			FAM3A plays crucial roles in controlling PDX1 and insulin expressions in pancreatic beta cells	FASEB JOURNAL			English	Article						FAM3A; FOXA2; mitochondria; pancreatic beta cells; PDX1	MITOCHONDRIAL DYSFUNCTION; HEPATIC GLUCONEOGENESIS; FOXA2; GENE; SECRETION; DIFFERENTIATION; TRANSCRIPTION; MAFA; ATP; PROLIFERATION	So far, the mechanism that links mitochondrial dysfunction to PDX1 inhibition in the pathogenesis of pancreatic beta cell dysfunction under diabetic condition remains largely unclear. This study determined the role of mitochondrial protein FAM3A in regulating PDX1 expression in pancreatic beta cells using gain- and loss-of function methods in vitro and in vivo. Within pancreas, FAM3A is highly expressed in beta, alpha, delta, and pp cells of islets. Islet FAM3A expression was correlated with insulin expression under physiological and diabetic conditions. Mice with specific knockout of FAM3A in islet beta cells exhibited markedly blunted insulin secretion and glucose intolerance. FAM3A-deficient islets showed significant decrease in PDX1 expression, and insulin expression and secretion. FAM3A overexpression upregulated PDX1 and insulin expressions, and augmented insulin secretion in cultured islets and beta cells. Mechanistically, FAM3A enhanced ATP production to elevate cellular Ca2+ level and promote insulin secretion. Furthermore, FAM3A-induced ATP release activated CaM to function as a co-activator of FOXA2, stimulating PDX1 gene transcription. In conclusion, FAM3A plays crucial roles in controlling PDX1 and insulin expressions in pancreatic beta cells. Inhibition of FAM3A will trigger mitochondrial dysfunction to repress PDX1 and insulin expressions.	[Yang, Weili; Meng, Yuhong; Xiang, Rui; Yan, Han; Yang, Jichun] Peking Univ, Sch Basic Med Sci, Ctr Noncoding RNA Med,Dept Physiol & Pathophysiol, Hlth Sci Ctr,Key Lab Mol Cardiovasc Sci,Minist Ed, Beijing, Peoples R China; [Yang, Weili] Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China; [Chi, Yujing] Peking Univ, Peoples Hosp, Dept Cent Lab, Beijing, Peoples R China; [Chi, Yujing] Peking Univ, Peoples Hosp, Inst Clin Mol Biol, Beijing, Peoples R China; [Chen, Zhenzhen] Chinese Acad Med Sci & Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Hypertens Ctr, Fuwai Hosp,State Key Lab Cardiovasc Dis, Beijing, Peoples R China	Peking University; Capital Medical University; Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Yang, JC (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Hlth Sci Ctr, Beijing 100191, Peoples R China.	yangj@bjmu.edu.cn		Chen, Zhenzhen/0000-0001-9919-3997; Xiang, Rui/0000-0002-1473-3235	National Key Research Program of China [2016YFC0903000/2017YFC0909600]; National Natural Science Foundation of China [81670748, 81471035, 81870551, 81670787]; Beijing Natural Science Foundation [7171006]; State Key Laboratory of Cardiovascular Disease Grant [2018fk-02]; Innovative Fund for Doctoral Students [89100226570405007]	National Key Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); State Key Laboratory of Cardiovascular Disease Grant; Innovative Fund for Doctoral Students	National Key Research Program of China, Grant/Award Number: 2016YFC0903000/2017YFC0909600; National Natural Science Foundation of China, Grant/Award Number: 81670748, 81471035, 81870551 and 81670787; Beijing Natural Science Foundation, Grant/Award Number: 7171006; State Key Laboratory of Cardiovascular Disease Grant, Grant/Award Number: 2018fk-02; Innovative Fund for Doctoral Students, Grant/Award Number: 89100226570405007	Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE678, DOI 10.1152/ajpendo.90287.2008; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Arnes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052026; Bastidas-Ponce A, 2017, MOL METAB, V6, P524, DOI 10.1016/j.molmet.2017.03.007; Bonnavion R, 2017, J PATHOL, V242, P90, DOI 10.1002/path.4885; Cai EP, 2012, DIABETES, V61, P1708, DOI 10.2337/db11-1344; Cantley J, 2019, DIABETOLOGIA, V62, P99, DOI 10.1007/s00125-018-4743-7; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chen ACH, 2017, CELL TISSUE RES, V368, P563, DOI 10.1007/s00441-017-2583-2; Chen ZZ, 2017, ONCOTARGET, V8, P49882, DOI 10.18632/oncotarget.17805; Chi YJ, 2017, ONCOTARGET, V8, P45862, DOI 10.18632/oncotarget.17578; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Choudhury AI, 2005, J CLIN INVEST, V115, P940; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891; Fogarty MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004633; Pacheco PAF, 2013, CURR DIABETES REV, V9, P228, DOI 10.2174/1573399811309030004; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Han SI, 2016, ACTA DIABETOL, V53, P651, DOI 10.1007/s00592-016-0853-1; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hoang M, 2019, ENDOCRINOLOGY, V160, P2825, DOI 10.1210/en.2018-00936; Hou WF, 1998, ANTISENSE NUCLEIC A, V8, P295, DOI 10.1089/oli.1.1998.8.295; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; Jang I, 2019, ELIFE, V8, DOI 10.7554/eLife.44528; Jia S, 2014, J MOL CELL CARDIOL, V74, P173, DOI 10.1016/j.yjmcc.2014.05.011; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Kaviani M, 2016, CELL BIOL INT, V40, P1248, DOI 10.1002/cbin.10691; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Li XM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11740; Millership SJ, 2018, J CLIN INVEST, V128, P3369, DOI 10.1172/JCI120115; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Ni QC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15755; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Osman MAA, 2019, J CELL MOL MED, V23, P4653, DOI 10.1111/jcmm.14216; Palomer X, 2018, TRENDS ENDOCRIN MET, V29, P178, DOI 10.1016/j.tem.2017.11.009; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qin Y, 2015, GENET MOL RES, V14, P8892, DOI 10.4238/2015.August.3.12; Richards-Williams C, 2008, PURINERG SIGNAL, V4, P393, DOI 10.1007/s11302-008-9126-y; Robert-Cooperman CE, 2010, DIABETES, V59, P2209, DOI 10.2337/db09-1552; Sargsyan E, 2016, BBA-MOL CELL BIOL L, V1861, P1151, DOI 10.1016/j.bbalip.2016.06.012; Song Q, 2016, NEUROCHEM INT, V94, P82, DOI 10.1016/j.neuint.2016.02.010; Song Q, 2015, CELL PHYSIOL BIOCHEM, V37, P1431, DOI 10.1159/000438512; Tamura Y, 2007, DIABETOLOGIA, V50, P131, DOI 10.1007/s00125-006-0467-1; Taylor R, 2013, DIABETIC MED, V30, P267, DOI 10.1111/dme.12039; Wang CJ, 2014, HEPATOLOGY, V59, P1779, DOI 10.1002/hep.26945; Wang CJ, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/515136; Wang HY, 2002, J BIOL CHEM, V277, P17564, DOI 10.1074/jbc.M111037200; Wang JP, 2018, DIABETES, V67, P581, DOI 10.2337/db17-0799; Wang YQ, 2019, DIABETES, V68, P1950, DOI 10.2337/db19-0166; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wu L, 2004, J BIOL CHEM, V279, P12126, DOI 10.1074/jbc.M307097200; Yang JC, 2004, J BIOL CHEM, V279, P53915, DOI 10.1074/jbc.M405309200; Yang JC, 2010, NUTR REV, V68, P270, DOI 10.1111/j.1753-4887.2010.00282.x; Yang JC, 2009, FEBS LETT, V583, P3009, DOI 10.1016/j.febslet.2009.08.008; Yang WL, 2017, DIABETES, V66, P1819, DOI 10.2337/db16-1172; Yang Z, 2011, ARCH MED SCI, V7, P665, DOI 10.5114/aoms.2011.24137; Yu X, 2018, MOL MED REP, V17, P7931, DOI 10.3892/mmr.2018.8813; Zhang XY, 2018, METABOLISM, V81, P71, DOI 10.1016/j.metabol.2017.12.001; Zhang Y, 2012, GASTROENTEROLOGY, V142, P1571, DOI 10.1053/j.gastro.2012.02.043; Zhou YL, 2013, BBA-GEN SUBJECTS, V1830, P4160, DOI 10.1016/j.bbagen.2013.03.029; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816; Zhu YX, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0694-z	70	5	5	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3915	3931		10.1096/fj.201902368RR	http://dx.doi.org/10.1096/fj.201902368RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944392	hybrid			2022-12-28	WOS:000507593700001
J	Konishi, HA; Yoshimura, SH				Konishi, Hide A.; Yoshimura, Shige H.			Interactions between non-structured domains of FG- and non-FG-nucleoporins coordinate the ordered assembly of the nuclear pore complex in mitosis	FASEB JOURNAL			English	Article						intrinsically disordered region; molecular crowding; nuclear pore complex; self-assembly	PHASE-TRANSITIONS; PHOSPHORYLATION; ORGANIZATION; HYDROGEL; PROLINE	In this study, we examined how channel-forming subunits of the nuclear pore complex (NPC) are assembled into a selective channel within a highly structured scaffold ring during postmitotic assembly. We focused on non-structured domains of the scaffold Nups and performed in vitro self-assembled particle assays with those derived from channel-forming FG-Nups. We found that non-structured domains of ELYS and Nup35N interacted with channel-forming FG-Nups to form a self-assembled particle. Sequential addition of FG-Nups into the scaffold particle revealed that ELYS, which initiates postmitotic NPC reassembly, interacts with early assembling FG-Nups (Nups98 and 153) but not middle stage-assembling FG-Nups (Nups58 and 62). Nup35, which assembles between the early and middle stages, facilitated the assembly of Nup62 into the early assembling Nups both in vitro and in vivo. These results demonstrate that ELYS and Nup35 have a role of facilitator in the ordered assembly of channel-forming FG-Nups during mitosis.	[Konishi, Hide A.; Yoshimura, Shige H.] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Kyoto, Japan; [Konishi, Hide A.] Rockefeller Univ, Lab Chromosome & Cell Biol, 1230 York Ave, New York, NY 10021 USA	Kyoto University; Rockefeller University	Yoshimura, SH (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Sakyo Ku, Kyoto 6068501, Japan.	yoshimura@lif.kyoto-u.ac.jp	Yoshimura, Shige H./AAF-5463-2019	Yoshimura, Shige H./0000-0001-6033-1301; Konishi, Hide/0000-0001-9529-9321	MEXT | Japan Society for the Promotion of Science (JSPS) [LS076]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: LS076	Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; Chug H, 2015, SCIENCE, V350, P106, DOI 10.1126/science.aac7420; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Eibauer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8532; Elad N, 2009, CURR OPIN STRUC BIOL, V19, P226, DOI 10.1016/j.sbi.2009.02.009; Fischer J, 2015, NAT STRUCT MOL BIOL, V22, P774, DOI 10.1038/nsmb.3084; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Iwashita K, 2018, INT J BIOL MACROMOL, V120, P10, DOI 10.1016/j.ijbiomac.2018.08.063; Kim SJ, 2018, NATURE, V555, P475, DOI 10.1038/nature26003; Konishi HA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05959-w; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Linder MI, 2017, DEV CELL, V43, P141, DOI 10.1016/j.devcel.2017.08.020; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Otsuka S, 2018, FEBS LETT, V592, P475, DOI 10.1002/1873-3468.12905; Otsuka S, 2014, METHOD CELL BIOL, V122, P219, DOI 10.1016/B978-0-12-417160-2.00010-2; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; PIELA L, 1987, BIOPOLYMERS, V26, P1587, DOI 10.1002/bip.360260910; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Ullman KS, 2015, SCIENCE, V350, P33, DOI 10.1126/science.aad3797; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Woodruff JB, 2015, SCIENCE, V348, P808, DOI 10.1126/science.aaa3923	31	3	3	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1532	1545		10.1096/fj.201901669R	http://dx.doi.org/10.1096/fj.201901669R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914646	Green Submitted			2022-12-28	WOS:000507308900101
J	Sulser, P; Pickel, C; Gunter, J; Leissing, TM; Crean, D; Schofield, CJ; Wenger, RH; Scholz, CC				Sulser, Pascale; Pickel, Christina; Gunter, Julia; Leissing, Thomas M.; Crean, Daniel; Schofield, Christopher J.; Wenger, Roland H.; Scholz, Carsten C.			HIF hydroxylase inhibitors decrease cellular oxygen consumption depending on their selectivity	FASEB JOURNAL			English	Article						anemia; hypoxia; 2-oxoglutarate oxygenase inhibitor; prolyl hydroxylase inhibitor; Roxadustat	NF-KAPPA-B; PHARMACOLOGICAL INHIBITION; ASPARAGINYL HYDROXYLASE; HYPOXIA; PROLYL; EXPRESSION; PROTEIN; HIF-1-ALPHA; ACTIVATION; ADAPTATION	Pharmacologic HIF hydroxylase inhibitors (HIs) are effective for the treatment of anemia in chronic kidney disease patients and may also be beneficial for the treatment of diseases such as chronic inflammation and ischemia-reperfusion injury. The selectivities of many HIs for HIF hydroxylases and possible off-target effects in cellulo are unclear, delaying the translation from preclinical studies to clinical trials. We developed a novel assay that discriminates between the inhibition of HIF-alpha prolyl-4-hydroxylase domain (PHD) enzymes and HIF-alpha asparagine hydroxylase factor inhibiting HIF (FIH). We characterized 15 clinical and preclinical HIs, categorizing them into pan-HIF-alpha hydroxylase (broad spectrum), PHD-selective, and FIH-selective inhibitors, and investigated their effects on HIF-dependent transcriptional regulation, erythropoietin production, and cellular energy metabolism. While energy homeostasis was generally maintained following HI treatment, the pan-HIs led to a stronger increase in pericellular pO(2) than the PHD/FIH-selective HIs. Combined knockdown of FIH and PHD-selective inhibition did not further increase pericellular pO(2). Hence, the additional increase in pericellular pO(2) by pan- over PHD-selective HIs likely reflects HIF hydroxylase independent off-target effects. Overall, these analyses demonstrate that HIs can lead to oxygen redistribution within the cellular microenvironment, which should be considered as a possible contributor to HI effects in the treatment of hypoxia-associated diseases.	[Sulser, Pascale; Pickel, Christina; Gunter, Julia; Wenger, Roland H.; Scholz, Carsten C.] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Gunter, Julia; Wenger, Roland H.; Scholz, Carsten C.] Natl Ctr Competence Res Kidney, Zurich, Switzerland; [Leissing, Thomas M.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Crean, Daniel] Univ Coll Dublin, Conway Inst, Sch Vet Med, Dublin, Ireland; [Crean, Daniel] Univ Coll Dublin, Conway Inst, UCI Diabet Complicat Res Ctr, Dublin, Ireland	University of Zurich; University of Oxford; University College Dublin; University College Dublin	Wenger, RH; Scholz, CC (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	roland.wenger@access.uzh.ch; carsten.scholz@uzh.ch	Scholz, Carsten C./P-3185-2019; Wenger, Roland/B-7953-2009	Scholz, Carsten C./0000-0001-6579-8015; Pickel, Christina/0000-0001-7476-2954; Wenger, Roland/0000-0001-7592-4839	SNSF [002031003A_165679]; Forschungskredit of the University of Zurich [FK-15-046]; Junior Grant of the NCCR Kidney.CH; BBSRC [BB/R000344/1] Funding Source: UKRI	SNSF(Swiss National Science Foundation (SNSF)); Forschungskredit of the University of Zurich; Junior Grant of the NCCR Kidney.CH; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SNSF, Grant/Award Number: 002031003A_165679; Forschungskredit of the University of Zurich, Grant/Award Number: FK-15-046; Junior Grant of the NCCR Kidney.CH, Grant/Award Number: Junior Grant	Agbor TA, 2011, J BIOL CHEM, V286, P4718, DOI 10.1074/jbc.M110.115931; Ariazi JL, 2017, J PHARMACOL EXP THER, V363, P336, DOI 10.1124/jpet.117.242503; Barrett TD, 2011, MOL PHARMACOL, V79, P910, DOI 10.1124/mol.110.070508; Beck H, 2018, CHEMMEDCHEM, V13, P988, DOI 10.1002/cmdc.201700783; Bonnici J, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0071; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUSTOVETSKY NN, 1993, FEBS LETT, V315, P233, DOI 10.1016/0014-5793(93)81170-5; Chan MC, 2016, J BIOL CHEM, V291, P20661, DOI 10.1074/jbc.M116.749291; Chan MC, 2016, MOL ASPECTS MED, V47-48, P54, DOI 10.1016/j.mam.2016.01.001; Cho EA, 2013, J CELL BIOCHEM, V114, P864, DOI 10.1002/jcb.24423; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cosin-Roger J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00213-3; Crean D, 2015, TOXICOL IN VITRO, V30, P128, DOI 10.1016/j.tiv.2014.11.015; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Debenham JS, 2016, J MED CHEM, V59, P11039, DOI 10.1021/acs.jmedchem.6b01242; Dhillon S, 2019, DRUGS, V79, P563, DOI 10.1007/s40265-019-01077-1; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Flamme I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111838; Gutsche K, 2016, FREE RADICAL BIO MED, V101, P129, DOI 10.1016/j.freeradbiomed.2016.10.002; Haase VH, 2017, EXP CELL RES, V356, P160, DOI 10.1016/j.yexcr.2017.05.004; Hampton-Smith RJ, 2009, ANN NY ACAD SCI, V1177, P19, DOI 10.1111/j.1749-6632.2009.05035.x; Imeri F, 2019, KIDNEY INT, V95, P375, DOI 10.1016/j.kint.2018.08.043; Islam MS, 2018, ANNU REV BIOCHEM, V87, P585, DOI 10.1146/annurev-biochem-061516-044724; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Madsen CD, 2015, EMBO REP, V16, P1394, DOI 10.15252/embr.201540107; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; McMurray F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121829; Nolan KA, 2018, CURR OPIN NEPHROL HY, V27, P277, DOI 10.1097/MNH.0000000000000420; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pickel C, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101265; Pickel C, 2018, METHODS MOL BIOL, V1742, P1, DOI 10.1007/978-1-4939-7665-2_1; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Roatsch M, 2019, ACS CHEM BIOL, V14, P1737, DOI 10.1021/acschembio.9b00289; Rodriguez J, 2016, CELL REP, V14, P2745, DOI 10.1016/j.celrep.2016.02.043; Schley G, 2012, AM J PATHOL, V181, P1595, DOI 10.1016/j.ajpath.2012.07.010; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scholz CC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002347; Scholz CC, 2013, P NATL ACAD SCI USA, V110, P18490, DOI 10.1073/pnas.1309718110; Scholz CC, 2013, BIOL CHEM, V394, P479, DOI 10.1515/hsz-2012-0338; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2019, ANNU REV PHARMACOL, V59, P379, DOI 10.1146/annurev-pharmtox-010818-021637; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Signorelli S, 2010, CELL PHYSIOL BIOCHEM, V25, P135, DOI 10.1159/000272066; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Taylor CT, 2017, NAT REV IMMUNOL, V17, P774, DOI 10.1038/nri.2017.103; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Van Welden S, 2017, NAT REV GASTRO HEPAT, V14, P596, DOI 10.1038/nrgastro.2017.101; Vogler M, 2015, PFLUG ARCH EUR J PHY, V467, P2141, DOI 10.1007/s00424-014-1667-z; Wang J, 2002, FEBS LETT, V529, P309, DOI 10.1016/S0014-5793(02)03389-6; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Wenger RH, 2015, HYPOXIA, V3, P35, DOI 10.2147/HP.S92198; Yeh TL, 2017, CHEM SCI, V8, P7651, DOI 10.1039/c7sc02103h; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zhdanov AV, 2015, BBA-BIOENERGETICS, V1847, P1254, DOI 10.1016/j.bbabio.2015.06.016	71	18	18	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2344	2358		10.1096/fj.201902240R	http://dx.doi.org/10.1096/fj.201902240R		DEC 2019	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908020				2022-12-28	WOS:000503399600001
J	Ambhore, NS; Kalidhindi, RSR; Pabelick, CM; Hawse, JR; Prakash, YS; Sathish, V				Ambhore, Nilesh Sudhakar; Kalidhindi, Rama Satyanarayana Raju; Pabelick, Christina M.; Hawse, John R.; Prakash, Y. S.; Sathish, Venkatachalem			Differential estrogen-receptor activation regulates extracellular matrix deposition in human airway smooth muscle remodeling via NF-kappa B pathway	FASEB JOURNAL			English	Article						sex difference; sex steroids; asthma; TNF-alpha; PDGF	TISSUE GROWTH-FACTOR; NEUROTROPHIC FACTOR; SEX STEROIDS; INTRACELLULAR CA2+; CIGARETTE-SMOKE; LUNG; EXPRESSION; PROLIFERATION; INFLAMMATION; DISEASE	Altered airway smooth muscle (ASM) mass and extracellular matrix (ECM) deposition in airways are characteristic features of remodeling in asthma. Increased ECM production modulates ASM cell proliferation and leads to airway remodeling. Our previous studies showed that ASM from patients with asthma exhibited increased expression of estrogen receptor (ER)-beta, which upon activation down-regulated ASM proliferation, implicating an important role for estrogen signaling in airway physiology. There is no current information on the effect of differential ER activation on ECM production. In this study, we evaluated the effect of ER-alpha vs. ER-beta activation on ECM production, deposition, and underlying pathways. Primary human ASM cells isolated from asthmatics and nonasthmatics were treated with E-2, an ER-alpha agonist [propylpyrazoletriol (PPT)], and an ER-beta agonist [WAY-200070 (WAY)] with TNF-alpha or platelet-derived growth factor (PDGF) followed by evaluation of ECM production and deposition. Expression of proteins and genes corresponding to ECM were measured using Western blotting and quantitative RT-PCR with subsequent matrix metalloproteinase (MMP) activity. Molecular mechanisms of ER activation in regulating ECM were evaluated by luciferase reporter assays for activator protein 1 (AP-1) and NF-kappa B. TNF-alpha or PDGF significantly (P < 0.001) increased ECM deposition and MMP activity in human ASM cells, which was significantly reduced with WAY treatment but not with PPT. Furthermore, TNF-alpha- or PDGF-induced ECM gene expression in ASM cells was significantly reduced with WAY (P < 0.001). Moreover, WAY significantly down-regulated the activation of NF-kappa B (P < 0.001) and AP-1 (P < 0.01, P < 0.05) in ASM cells from asthmatics and nonasthmatics. Overall, we demonstrate differential ER signaling in controlling ECM production and deposition. Activation of ER-beta diminishes ECM deposition via suppressing the NF-kappa B pathway activity and might serve as a novel target to blunt airway remodeling.	[Ambhore, Nilesh Sudhakar; Kalidhindi, Rama Satyanarayana Raju; Sathish, Venkatachalem] North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND USA; [Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA; [Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Hawse, John R.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	North Dakota State University Fargo; Mayo Clinic; Mayo Clinic; Mayo Clinic	Sathish, V (corresponding author), North Dakota State Univ, Sch Pharm, Dept Pharmaceut Sci, 1401 Albrecht Blvd,Sudro Hall,Room 203, Fargo, ND 58108 USA.	s.venkatachalem@ndsu.edu	Ambhore, Nilesh Sudhakar/AEK-8110-2022	Ambhore, Nilesh Sudhakar/0000-0002-9293-6062; venkatachalem, sathish/0000-0001-9770-8299; Prakash, Y S/0000-0002-2968-224X	U.S. National Institutes of Health/Heart, Lung, and Blood Institute [R01-HL123494, R01-HL123494-02S1, R01-HL088029, R01-HL142061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL142061] Funding Source: NIH RePORTER	U.S. National Institutes of Health/Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Jagadish Loganathan (North Dakota State University) for providing technical support in the completion of this study. This study was supported by U.S. National Institutes of Health/Heart, Lung, and Blood Institute Grants R01-HL123494 and R01-HL123494-02S1 (to V.S.), R01-HL088029 (to Y.S.P.), and R01-HL142061 (to C.M.P. and Y.S.P.). The authors declare no conflicts of interest.	Abcejo AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044343; Agarwal AK, 1997, J ASTHMA, V34, P539, DOI 10.3109/02770909709055398; Ambhore NS, 2019, AM J RESP CELL MOL, V61, P469, DOI 10.1165/rcmb.2018-0321OC; Ambhore NS, 2018, MOL CELL ENDOCRINOL, V476, P37, DOI 10.1016/j.mce.2018.04.007; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Aravamudan B, 2017, J CELL PHYSIOL, V232, P1754, DOI 10.1002/jcp.25674; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Bai TR, 2000, AM J RESP CRIT CARE, V162, P663, DOI 10.1164/ajrccm.162.2.9907151; Balzano G, 2001, ALLERGY, V56, P13, DOI 10.1034/j.1398-9995.2001.00128.x; Barton M, 2018, J STEROID BIOCHEM, V176, P4, DOI 10.1016/j.jsbmb.2017.03.021; Bjornson C L, 2000, J Gend Specif Med, V3, P57; Black JL, 2003, RESP PHYSIOL NEUROBI, V137, P339, DOI 10.1016/S1569-9048(03)00157-5; Black JL, 2001, AM J RESP CRIT CARE, V164, pS63, DOI 10.1164/ajrccm.164.supplement_2.2106059; Bosse Ynuk, 2008, Proc Am Thorac Soc, V5, P62, DOI 10.1513/pats.200705-056VS; Boulet LP, 2000, AM J RESP CRIT CARE, V162, P1308, DOI 10.1164/ajrccm.162.4.9910051; Britt RD, 2015, J CELL PHYSIOL, V230, P1189, DOI 10.1002/jcp.24814; Burgess JK, 2009, PHARMACOL THERAPEUT, V122, P19, DOI 10.1016/j.pharmthera.2008.12.002; Burgess JK, 2005, CLIN EXP PHARMACOL P, V32, P988, DOI 10.1111/j.1440-1681.2005.04296.x; Burgess JK, 2003, AM J RESP CRIT CARE, V167, P71, DOI 10.1164/rccm.200205-416OC; Burgess JK, 2010, MINERVA PNEUMOL, V49, P219; Caracta CF, 2003, MT SINAI J MED, V70, P215; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Carey MA, 2007, AM J PHYSIOL-LUNG C, V293, pL272, DOI 10.1152/ajplung.00174.2007; Chen YJ, 2015, BBA-GENE REGUL MECH, V1849, P1248, DOI 10.1016/j.bbagrm.2015.07.016; Cho JY, 2006, J ALLERGY CLIN IMMUN, V117, P618, DOI 10.1016/j.jaci.2005.12.1324; COLVILLENASH PR, 1995, J PHARMACOL EXP THER, V274, P1463; Coraux Christelle, 2008, Proc Am Thorac Soc, V5, P689, DOI 10.1513/pats.200801-010AW; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Dagnell C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-156; Dekkers BGJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1405, DOI 10.1152/ajplung.00331.2006; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Elshaw SR, 2004, BRIT J PHARMACOL, V142, P1318, DOI 10.1038/sj.bjp.0705883; Freeman MR, 2017, AM J PHYSIOL-LUNG C, V313, pL360, DOI 10.1152/ajplung.00580.2016; Harkness LM, 2017, J CELL MOL MED, V21, P3288, DOI 10.1111/jcmm.13232; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Jensen-Jarolim E, 2008, ALLERGY, V63, P610, DOI 10.1111/j.1398-9995.2008.01645.x; Jia M, 2015, BEST PRACT RES CL EN, V29, P557, DOI 10.1016/j.beem.2015.04.008; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; KALIDHINDI R, 2019, AM J RESP CRIT CARE, V199; KALIDHINDI R, 2018, AM J RESP CRIT CARE, V197; Kalidhindi Rama Satyanarayana Raju, 2019, Cell Physiol Biochem, V53, P215, DOI 10.33594/000000131; Karakiulakis G, 2007, J BIOL CHEM, V282, P908, DOI 10.1074/jbc.M602178200; Koziol-White CJ, 2011, EXPERT REV RESP MED, V5, P767, DOI [10.1586/ERS.11.77, 10.1586/ers.11.77]; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lau JY, 2010, RESPIROLOGY, V15, P303, DOI 10.1111/j.1440-1843.2009.01683.x; Laudet V., 2002, NUCL RECEPTORS FACTB; Lewis CC, 2005, J ALLERGY CLIN IMMUN, V115, P534, DOI 10.1016/j.jaci.2004.11.051; Loganathan J, 2019, CELL TISSUE RES, V376, P425, DOI 10.1007/s00441-019-02995-y; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Matteis M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-108; Melgert BN, 2007, CURR ALLERGY ASTHM R, V7, P143, DOI 10.1007/s11882-007-0012-4; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Oldenburger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031574; Parameswaran K, 2006, CELL BIOCHEM BIOPHYS, V44, P139, DOI 10.1385/CBB:44:1:139; Parks WC, 2001, RESP RES, V2, P10, DOI 10.1186/rr33; Prakash YS, 2016, AM J PHYSIOL-LUNG C, V311, pL1113, DOI 10.1152/ajplung.00370.2016; Prakash YS, 2013, AM J PHYSIOL-LUNG C, V305, pL912, DOI 10.1152/ajplung.00259.2013; Prakash YS, 1997, AM J PHYSIOL-CELL PH, V272, pC966, DOI 10.1152/ajpcell.1997.272.3.C966; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Pupo M, 2016, METHODS MOL BIOL, V1366, P471, DOI 10.1007/978-1-4939-3127-9_37; Raju KRS, 2014, PULM PHARMACOL THER, V29, P209, DOI 10.1016/j.pupt.2014.07.007; Raju KRS, 2016, MED HYPOTHESES, V87, P75, DOI 10.1016/j.mehy.2015.11.020; Robert S, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160107; ROCHE WR, 1989, LANCET, V1, P520; Roscioni S. S., 2010, AM J RESP CRIT CARE, V181, pA2142; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; Rydell-Tormanen K, 2012, LAB INVEST, V92, P917, DOI 10.1038/labinvest.2012.57; Sathish V, 2016, SEX DIFFERENCES IN PHYSIOLOGY, P89, DOI 10.1016/B978-0-12-802388-4.00006-9; Sathish V, 2015, CELL PHYSIOL BIOCHEM, V36, P1101, DOI 10.1159/000430282; Sathish V, 2015, PHARMACOL THERAPEUT, V150, P94, DOI 10.1016/j.pharmthera.2015.01.007; Sathish V, 2011, AM J PHYSIOL-LUNG C, V301, pL607, DOI 10.1152/ajplung.00019.2011; Shah R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02997; Townsend EA, 2012, AM J PHYSIOL-LUNG C, V303, pL923, DOI 10.1152/ajplung.00023.2012; Townsend EA, 2012, ENDOCR REV, V33, P1, DOI 10.1210/er.2010-0031; Townsend EA, 2010, AM J PHYSIOL-LUNG C, V298, pL521, DOI 10.1152/ajplung.00287.2009; Triebner K, 2019, MATURITAS, V120, P29, DOI 10.1016/j.maturitas.2018.11.007; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Vogel ER, 2017, PEDIATR RES, V81, P376, DOI 10.1038/pr.2016.218; Vogel ER, 2014, AM J PHYSIOL-LUNG C, V307, pL978, DOI 10.1152/ajplung.00111.2014; Vohra PK, 2013, BBA-MOL CELL RES, V1833, P2953, DOI 10.1016/j.bbamcr.2013.07.019; Wang SY, 2016, J CELL PHYSIOL, V231, P1586, DOI 10.1002/jcp.25254; Wang ZY, 2018, MOL MED REP, V18, P3143, DOI 10.3892/mmr.2018.9320	88	12	14	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13935	13950		10.1096/fj.201901340R	http://dx.doi.org/10.1096/fj.201901340R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31638834	Green Published			2022-12-28	WOS:000507466100068
J	Benetos, A; Verhulst, S; Labat, C; Lai, TP; Girerd, N; Toupance, S; Zannad, F; Rossignol, P; Aviv, A				Benetos, Athanase; Verhulst, Simon; Labat, Carlos; Lai, Tsung-Po; Girerd, Nicolas; Toupance, Simon; Zannad, Faiez; Rossignol, Patrick; Aviv, Abraham			Telomere length tracking in children and their parents: implications for adult onset diseases	FASEB JOURNAL			English	Article						aging; telomere attrition; leukocytes; terminal restriction fragments	ASSOCIATION; CANCER; RISK; DNA	Adults with comparatively short or long leukocyte telomere length (LTL) typically continue to display comparatively short or long LTL throughout life. This LTL tracking stems from the inability of person-to-person variation in age-dependent LTL shortening during adulthood to offset the wide interindividual LTL variation established prior to adult life. However, LTL tracking in children is unstudied. This study aimed to examine LTL shortening rates and tracking in children and their parents. Longitudinal study in children (n = 67) and their parents (n = 99), whose ages at baseline were 11.4 +/- 0.3 and 43.4 +/- 0.4 yr, respectively. LTL was measured by Southern blotting at baseline and similar to 14 yr thereafter. LTL displayed tracking in both children [intraclass correlation coefficient (ICC) = 0.905, P < 0.001] and their parents (ICC = 0.856, P < 0.001). The children's rate of LTL shortening was twice that of their parents (40.7 +/- 2.5 bp/yr; 20.3 +/- 2.1 bp/yr, respectively; P < 0.0001). LTL tracking applies not only to adulthood but also to the second decade of life. Coupled with previous work showing that the interindividual variation in LTL across newborns is as wide as in their parents, these findings support the thesis that the LTL-adult disease connection is principally determined before the second decade of life, perhaps mainly at birth.	[Benetos, Athanase; Labat, Carlos; Girerd, Nicolas; Toupance, Simon; Zannad, Faiez; Rossignol, Patrick] Univ Lorraine, CHRU Plurithemat Nancy, INSERM, DCAC,UMR S 1116, Nancy, France; [Benetos, Athanase; Toupance, Simon] Univ Lorraine, CHRU Plurithemat Nancy, INSERM, Dept Geriatr Med,UMR S 1116, Nancy, France; [Verhulst, Simon] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Lai, Tsung-Po; Aviv, Abraham] State Univ New Jersey, Rutgers New Jersey Med Sch, Ctr Human Dev & Aging, Newark, NJ USA; [Girerd, Nicolas; Zannad, Faiez; Rossignol, Patrick] CHRU Nancy, INSERM, CIC P 14 33, Nancy, France; [Girerd, Nicolas; Zannad, Faiez; Rossignol, Patrick] Invest Network Initiat Cardiovasc & Renal Clin Tr, Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Groningen; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm)	Benetos, A (corresponding author), Univ Lorraine, Univ Hosp Nancy, Dept Geriatr, F-54511 Nancy, France.	a.benetos@chru-nancy.fr	GIRERD, Nicolas/D-5493-2011	Girerd, Nicolas/0000-0002-3278-2057; Toupance, Simon/0000-0001-7441-567X; Verhulst, Simon/0000-0002-1143-6868	regional project Contrats de Plan Etat-Region (CPER)-Innovations Technologiques, Modelisation et Medecine Personnalisee (ITM2P); French PIA Project Lorraine Universite d'Excellence [ANR-15-IDEX-04-LUE]; Investments for the Future Program [ANR-15-RHU-0004]; Nancy Centre Hospitalier Regional Universitaire (CHRU); Universite de Lorraine; U.S. National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute) [R01HL116446, R01HL13840]; U.S. National Institutes of Health (NIH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development) [R01HD071180]; Norwegian Institute of Public Health [262700, 262043]	regional project Contrats de Plan Etat-Region (CPER)-Innovations Technologiques, Modelisation et Medecine Personnalisee (ITM2P); French PIA Project Lorraine Universite d'Excellence; Investments for the Future Program; Nancy Centre Hospitalier Regional Universitaire (CHRU); Universite de Lorraine; U.S. National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. National Institutes of Health (NIH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development); Norwegian Institute of Public Health	This work was supported by the regional project Contrats de Plan Etat-Region (CPER)-Innovations Technologiques, Modelisation et Medecine Personnalisee (ITM2P) 2015-2020, the French PIA Project Lorraine Universite d'Excellence (ANR-15-IDEX-04-LUE), and the Investments for the Future Program under Grant ANR-15-RHU-0004. The Suivi Temporaire Annuel Non-Invasif de la Sante des Lorrains Assures Sociaux (STANISLAS) study was sponsored by Nancy Centre Hospitalier Regional Universitaire (CHRU), Universite de Lorraine. Abraham Aviv research was supported by U.S. National Institutes of Health (NIH) Grants R01HL116446 and R01HL13840 (National Heart, Lung, and Blood Institute), R01HD071180 (Eunice Kennedy Shriver National Institute of Child Health and Human Development), and Norwegian Institute of Public Health Grants 262700 and 262043. The STANISLAS cohort study is declared on ClinicalTrials.gov under the identifier NCT01391442. The authors declare no conflicts of interest.	Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aviv A, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0436; Benetos A, 2018, CIRC RES, V122, P616, DOI 10.1161/CIRCRESAHA.117.311751; Benetos A, 2013, AGING CELL, V12, P615, DOI 10.1111/acel.12086; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Caini S, 2015, J DERMATOL SCI, V80, P168, DOI 10.1016/j.jdermsci.2015.08.003; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Factor-Litvak P, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3927; Ferreira JP, 2018, INT J EPIDEMIOL, V47, P395, DOI 10.1093/ije/dyx240; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Hjelmborg JB, 2015, J MED GENET, V52, P297, DOI 10.1136/jmedgenet-2014-102736; Hunt SC, 2015, CIRC-CARDIOVASC GENE, V8, P4, DOI 10.1161/CIRCGENETICS.114.000964; Iles MM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju267; Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; R Core Team, 2015, R LANGUAGE ENV STAT; Seow WJ, 2014, CANCER RES, V74, P4090, DOI 10.1158/0008-5472.CAN-14-0459; Sidorov I, 2009, EXP HEMATOL, V37, P514, DOI 10.1016/j.exphem.2008.11.009; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Steenstrup T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt370; Verhulst S, 2015, INT J EPIDEMIOL, V44, P1683, DOI 10.1093/ije/dyv166; Zhan YQ, 2017, CIRC RES, V121, P214, DOI 10.1161/CIRCRESAHA.116.310517	27	20	21	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14248	14253		10.1096/fj.201901275R	http://dx.doi.org/10.1096/fj.201901275R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31652401	Green Published, Green Submitted			2022-12-28	WOS:000507466100092
J	Hartz, AMS; Rempe, RG; Soldner, ELB; Pekcec, A; Schlichtiger, J; Kryscio, R; Bauer, B				Hartz, Anika M. S.; Rempe, Ralf G.; Soldner, Emma L. B.; Pekcec, Anton; Schlichtiger, Juli; Kryscio, Richard; Bauer, Bjoern			Cytosolic phospholipase A2 is a key regulator of blood-brain barrier function in epilepsy	FASEB JOURNAL			English	Article						P-glycoprotein; seizures; BCRP; neurovascular unit	CANCER RESISTANCE PROTEIN; GLYCOPROTEIN-MEDIATED TRANSPORT; INDUCED UP-REGULATION; MAJOR VAULT PROTEIN; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; ANTIEPILEPTIC DRUGS; CENTELLA-ASIATICA; ABC TRANSPORTERS; CYCLOOXYGENASE 2	Blood brain barrier dysfunction in epilepsy contributes to seizures and resistance to antiseizure drugs. Reports show that seizures increase brain glutamate levels, leading to barrier dysfunction. One component of barrier dysfunction is overexpression of the drug efflux transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). Based on our previous studies, we hypothesized that glutamate released during seizures activates cytosolic phospholipase A2 (cPLA2), resulting in P-gp and BCRP overexpression. We exposed isolated rat brain capillaries to glutamate ex vivo and used an in vivo ex vivo approach of isolating brain capillaries from rats after status epilepticus (SE) and in chronic epileptic (CE) rats. Glutamate increased cPLA2, P-gp, and BCRP protein and activity levels in isolated brain capillaries. We confirmed the role of cPLA2 in the signaling pathway in brain capillaries from male and female mice lacking cPLA2. We also demonstrated, in vivo, that cPLA2 inhibition prevents overexpression of P-gp and BCRP at the blood brain barrier in rats after status epilepticus and in CE rats. Our data support the hypothesis that glutamate signals cPLA2 activation, resulting in overexpression of blood brain barrier P-gp and BCRP.	[Hartz, Anika M. S.; Kryscio, Richard] Univ Kentucky, Coll Pharm, Sanders Brown Ctr Aging, Lexington, KY USA; [Hartz, Anika M. S.] Univ Kentucky, Coll Pharm, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Rempe, Ralf G.; Bauer, Bjoern] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 333 Sanders Brown Ctr Aging,800 S Limestone St, Lexington, KY 40536 USA; [Kryscio, Richard] Univ Kentucky, Dept Stat, Lexington, KY USA; [Bauer, Bjoern] Univ Kentucky, Epilepsy Ctr, Lexington, KY USA; [Soldner, Emma L. B.; Pekcec, Anton; Schlichtiger, Juli] Univ Minnesota, Coll Pharm, Dept Pharm Practice & Pharmaceut Sci, Duluth, MN 55812 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Minnesota System; University of Minnesota Duluth	Bauer, B (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 333 Sanders Brown Ctr Aging,800 S Limestone St, Lexington, KY 40536 USA.	bjoern.bauer@uky.edu			U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [1R01NS079507]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079507] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Joseph V. Bonventre (Brighan and Women's Hospital, Harvard Medical School, Boston, MA, USA) for cPLA2 breeding pairs and Eileen O'Leary (Brigham and Women's Hospital, Boston, MA, USA) for advice on breeding and genotyping. The authors also thank Britt Johnson and Kevin Viken (both from University of Minnesota), Stephanie Edelmann and Samantha Mullins (both from University of Kentucky) for technical assistance, breeding, and genotyping, respectively, and all members of the B.B. and A.M.S.H. laboratories for proof reading the manuscript. This project was supported by Grant 1R01NS079507 from the U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (to B.B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the NIH. The authors declare no conflicts of interest.	Andras IE, 2007, J CEREBR BLOOD F MET, V27, P1431, DOI 10.1038/sj.jcbfm.9600445; Anfuso CD, 2007, J LIPID RES, V48, P782, DOI 10.1194/jlr.M600489-JLR200; Aronica E, 2005, EPILEPSIA, V46, P849, DOI 10.1111/j.1528-1167.2005.66604.x; Bankstahl JP, 2008, NEUROPHARMACOLOGY, V54, P1006, DOI 10.1016/j.neuropharm.2008.02.008; Barbosa NR, 2008, PHYTOMEDICINE, V15, P896, DOI 10.1016/j.phymed.2008.02.007; Bauer B, 2008, MOL PHARMACOL, V73, P1444, DOI 10.1124/mol.107.041210; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Boulton DW, 2002, LIFE SCI, V71, P163, DOI 10.1016/S0024-3205(02)01680-6; Chen H., 2018, CARDIOVASC PHARM OPE, V7, P246; Cui LL, 2010, BRAIN RES, V1325, P164, DOI 10.1016/j.brainres.2010.02.036; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Dharmapuri G, 2015, LEUKEMIA RES, V39, P696, DOI 10.1016/j.leukres.2015.02.013; Dixit AB, 2017, SEIZURE-EUR J EPILEP, V47, P9, DOI 10.1016/j.seizure.2017.02.014; Doran A, 2005, DRUG METAB DISPOS, V33, P165, DOI 10.1124/dmd.104.001230; Gidal BE, 2014, EPILEPSY CURR, V14, P136, DOI 10.5698/1535-7597-14.3.136; Gu KS, 2012, ASIAN PAC J CANCER P, V13, P2379, DOI 10.7314/APJCP.2012.13.5.2379; Gu YY, 2013, MOL BIOSYST, V9, P467, DOI 10.1039/c2mb25528f; Gupta YK, 2003, PHARMACOL BIOCHEM BE, V74, P579, DOI 10.1016/S0091-3057(02)01044-4; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Hartz AMS, 2004, MOL PHARMACOL, V66, P387, DOI 10.1124/mol.104.001503; Hartz AMS, 2017, MOL PHARMACEUT, V14, P999, DOI 10.1021/acs.molpharmaceut.6b00770; Hartz AMS, 2016, J NEUROSCI, V36, P1930, DOI 10.1523/JNEUROSCI.0350-15.2016; Hartz AMS, 2010, J CEREBR BLOOD F MET, V30, P1742, DOI 10.1038/jcbfm.2010.36; Holtman L, 2010, EPILEPSY RES, V91, P49, DOI 10.1016/j.eplepsyres.2010.06.011; Kajiwara K, 1996, BIOCHEM BIOPH RES CO, V219, P795, DOI 10.1006/bbrc.1996.0313; Kwan P, 2010, LANCET NEUROL, V9, P27, DOI 10.1016/S1474-4422(09)70304-7; Lazarowski A, 2007, EPILEPSIA, V48, P140, DOI 10.1111/j.1528-1167.2007.01302.x; Luna-Tortos C, 2008, NEUROPHARMACOLOGY, V55, P1364, DOI 10.1016/j.neuropharm.2008.08.032; Marchi N, 2005, EPILEPSIA, V46, P1613, DOI 10.1111/j.1528-1167.2005.00265.x; Nakanishi H, 2013, EUR J PHARMACOL, V710, P20, DOI 10.1016/j.ejphar.2013.03.049; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Nito C, 2008, J CEREBR BLOOD F MET, V28, P1686, DOI 10.1038/jcbfm.2008.60; Pagliarulo V, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-47; Pekcec A, 2009, J PHARMACOL EXP THER, V330, P939, DOI 10.1124/jpet.109.152520; Potschka H, 2002, NEUROSCI LETT, V327, P173, DOI 10.1016/S0304-3940(02)00423-8; Potschka H, 2001, EPILEPSIA, V42, P1231, DOI 10.1046/j.1528-1157.2001.01901.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rambeck B, 2006, EPILEPSIA, V47, P681, DOI 10.1111/j.1528-1167.2006.00504.x; Rempe RG, 2018, J NEUROSCI, V38, P4301, DOI 10.1523/JNEUROSCI.2751-17.2018; REYNOLDS LJ, 1994, ANAL BIOCHEM, V217, P25, DOI 10.1006/abio.1994.1079; Rizzi M, 2002, J NEUROSCI, V22, P5833, DOI 10.1523/jneurosci.22-14-05833.2002; Romermann K, 2015, NEUROPHARMACOLOGY, V93, P7, DOI 10.1016/j.neuropharm.2015.01.015; Salvamoser JD, 2015, MOL PHARMACEUT, V12, P2049, DOI 10.1021/mp500841w; Schlichtiger J, 2010, BRIT J PHARMACOL, V160, P1062, DOI 10.1111/j.1476-5381.2010.00765.x; SCHRAMM U, 1995, AM J PHYSIOL-RENAL, V268, pF46, DOI 10.1152/ajprenal.1995.268.1.F46; Sharp CD, 2005, AM J PHYSIOL-HEART C, V288, pH1893, DOI 10.1152/ajpheart.01110.2003; Shukla S, 2011, MOL PHARMACEUT, V8, P1292, DOI 10.1021/mp2001022; Sisodiya SM, 2006, NEUROPATH APPL NEURO, V32, P51, DOI 10.1111/j.1365-2990.2005.00699.x; Sui H, 2014, CHIN J INTEGR MED, V20, P610, DOI 10.1007/s11655-013-1452-4; Surowiak P, 2008, ANTICANCER RES, V28, P2967; Tang F, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00301; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; van Vliet EA, 2006, EPILEPSIA, V47, P672, DOI 10.1111/j.1528-1167.2006.00496.x; van Vliet EA, 2005, EPILEPSIA, V46, P1569, DOI 10.1111/j.1528-1167.2005.00250.x; van Vliet EA, 2010, NEUROPHARMACOLOGY, V58, P404, DOI 10.1016/j.neuropharm.2009.09.012; VISIOLI F, 1994, METAB BRAIN DIS, V9, P161, DOI 10.1007/BF01999769; Weidner LD, 2018, EPILEPSIA, V59, P1507, DOI 10.1111/epi.14505; Zatelli MC, 2009, CELL ONCOL, V31, P457, DOI 10.3233/CLO-2009-0490; Zhang CB, 2010, LIFE SCI, V86, P899, DOI 10.1016/j.lfs.2010.04.008; Zhou L, 2018, J NEUROSCI, V38, P3346, DOI 10.1523/JNEUROSCI.3245-17.2018; Zibell G, 2009, NEUROPHARMACOLOGY, V56, P849, DOI 10.1016/j.neuropharm.2009.01.009	61	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14281	14295		10.1096/fj.201901369RR	http://dx.doi.org/10.1096/fj.201901369RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31661303	Green Published, Bronze			2022-12-28	WOS:000507466100095
J	Jiang, YP; Quan, J; Chen, Y; Liao, XH; Dai, Q; Lu, R; Yu, Y; Hu, GY; Li, QB; Meng, J; Xie, YY; Peng, ZZ; Tao, LJ				Jiang, YuPeng; Quan, Jiao; Chen, Yang; Liao, Xiaohua; Dai, Qin; Lu, Rong; Yu, Yue; Hu, Gaoyun; Li, Qianbin; Meng, Jie; Xie, Yanyun; Peng, Zhangzhe; Tao, Lijian			Fluorofenidone protects against acute kidney injury	FASEB JOURNAL			English	Article						cisplatin; ischemia reperfusion injury; lipopolysaccharide	CISPLATIN-INDUCED NEPHROTOXICITY; OXIDATIVE STRESS; CELL-DEATH; INFLAMMATION; MAPK; DEFICIENCY; MECHANISMS; APOPTOSIS; MICE; MITOCHONDRIAL	Cisplatin (CP) is one of the most effective chemotherapeutics in the treatment of human cancers. However, the beneficial effects of CP are limited by the toxic effects, especially nephrotoxicity. Fluorofenidone (AKFPD) is a promising multifunctional antifibrosis pyridinone drug discovered by our group. But there is no evidence of its protective effects against acute kidney injury (AKI). Therefore, we investigated the protective effects of AKFPD on CP-induced AKI in vivo and in vitro. Compared with the model group, treatment with AKFPD effectively ameliorated kidney damages. In order to elucidate the mechanisms, we discovered that AKFPD treatment notably alleviated generation of reactive oxygen species, reduced the phosphorylation levels of MAPKs (ERK1 and 2, JNKs, and p38), suppressed inflammatory response, inhibited apoptosis, and abated the expression of CP transporters (organic cation transporter 2 and copper transport protein 1) compared with the model group. Moreover, because renal ischemia reperfusion injury (IRI)-induced AKI and LPS-induced AKI are the major models representative of renal transplantation-correlated AKI and sepsis-related AKI, which are also the main causes of AKI, we have also proved the effectiveness of AKFPD on these models. In conclusion, these findings suggest that AKFPD is a potent drug for CP-, IRI-, and LPS-caused AKI and elucidate the underlying mechanism.	[Jiang, YuPeng; Chen, Yang; Liao, Xiaohua; Dai, Qin; Lu, Rong; Yu, Yue; Xie, Yanyun; Peng, Zhangzhe; Tao, Lijian] Cent South Univ, Xiangya Hosp, Dept Nephrol, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Quan, Jiao] Cent South Univ, Xiangya Hosp, Dept Nutriol, Changsha, Peoples R China; [Meng, Jie] Cent South Univ, Xiangya Hosp, Dept Respirol, Changsha, Peoples R China; [Hu, Gaoyun; Li, Qianbin] Cent South Univ, Sch Pharmaceut Sci, Dept Pharmaceut Chem, Changsha, Peoples R China	Central South University; Central South University; Central South University; Central South University	Peng, ZZ; Tao, LJ (corresponding author), Cent South Univ, Xiangya Hosp, Dept Nephrol, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	pengzhangzhe@csu.edu.cn; taolj@csu.edu.cn	TAO, Li/HIR-4254-2022	Jiang, Yupeng/0000-0001-8971-2079	National Natural Science Foundation of China [81673499]; Natural Science Foundation of Hunan Province [2017SK2051, 2018JJ3835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This study was supported by the National Natural Science Foundation of China (81673499) and Natural Science Foundation of Hunan Province (2017SK2051 and 2018JJ3835). The authors declare no conflicts of interest.	Bai J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27217-3; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bouchard J, 2016, KIDNEY DIS-BASEL, V2, P103, DOI 10.1159/000445091; Deng B, 2017, KIDNEY INT, V92, P89, DOI 10.1016/j.kint.2017.01.009; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Esposito V, 2013, AM J PHYSIOL-RENAL, V304, pF440, DOI 10.1152/ajprenal.00487.2011; Guo SX, 2015, MAR DRUGS, V13, P2105, DOI 10.3390/md13042105; Han SJ, 2017, J AM SOC NEPHROL, V28, P1200, DOI 10.1681/ASN.2016030349; Huang YC, 2017, TOXICOL APPL PHARM, V329, P128, DOI 10.1016/j.taap.2017.05.034; Islam MS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061412; Jin XG, 2013, KIDNEY INT, V83, P604, DOI 10.1038/ki.2012.408; Khajevand-Khazaei MR, 2019, INT IMMUNOPHARMACOL, V69, P19, DOI 10.1016/j.intimp.2019.01.026; Kidir V, 2016, RENAL FAILURE, V38, P372, DOI 10.3109/0886022X.2015.1135468; Kim JH, 2010, NEPHROL DIAL TRANSPL, V25, P1435, DOI 10.1093/ndt/gfp659; Kimura A, 2012, KIDNEY INT, V82, P1093, DOI 10.1038/ki.2012.240; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Li J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20934; Li ZC, 2018, KIDNEY INT, V93, P881, DOI 10.1016/j.kint.2017.10.021; Liang H, 2017, INFLAMM RES, V66, P399, DOI 10.1007/s00011-017-1023-9; Liu J, 2018, KIDNEY INT, V93, P303, DOI 10.1016/j.kint.2017.09.031; Liu X, 2018, CELL, V174, P187, DOI 10.1016/j.cell.2018.04.017; Ma XB, 2015, INT IMMUNOPHARMACOL, V28, P399, DOI 10.1016/j.intimp.2015.06.020; Malik S, 2016, LAB INVEST, V96, P853, DOI 10.1038/labinvest.2016.60; Manohar S, 2018, J NEPHROL, V31, P15, DOI 10.1007/s40620-017-0392-z; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Meng J, 2012, SHOCK, V38, P567, DOI 10.1097/SHK.0b013e31826fe992; Meng XM, 2018, LAB INVEST, V98, P63, DOI 10.1038/labinvest.2017.120; Miyasato Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24257-7; Molitoris BA, 2014, J CLIN INVEST, V124, P2355, DOI 10.1172/JCI72269; Nezu M, 2017, KIDNEY INT, V91, P387, DOI 10.1016/j.kint.2016.08.023; Ni J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1725-8; Ni J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1589-y; Ning WB, 2011, INT IMMUNOPHARMACOL, V11, P1327, DOI 10.1016/j.intimp.2011.04.016; Ozkok A, 2016, TOXICOL LETT, V240, P105, DOI 10.1016/j.toxlet.2015.10.028; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Peng Y, 2013, EUR J CLIN INVEST, V43, P358, DOI 10.1111/eci.12053; Peng ZZ, 2009, NEPHROLOGY, V14, P565, DOI 10.1111/j.1440-1797.2009.01129.x; Privratsky JR, 2018, AM J PHYSIOL-RENAL, V315, pF682, DOI 10.1152/ajprenal.00104.2018; Sahu BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134139; Sakai K, 2019, LAB INVEST, V99, P671, DOI 10.1038/s41374-018-0162-0; Santos A, 2018, MICRON, V114, P1, DOI 10.1016/j.micron.2018.07.002; Shingu C, 2010, J ANESTH, V24, P569, DOI 10.1007/s00540-010-0942-1; Singbartl K, 2019, SEMIN NEPHROL, V39, P96, DOI 10.1016/j.semnephrol.2018.10.007; Soetikno V, 2019, DRUG RES, V69, P75, DOI 10.1055/a-0641-5148; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Tan RZ, 2019, PHYTOMEDICINE, V52, P284, DOI 10.1016/j.phymed.2018.09.210; Tomar A, 2017, PHYTOMEDICINE, V34, P154, DOI 10.1016/j.phymed.2017.05.007; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Wu Y, 2015, INT J MED SCI, V12, P655, DOI 10.7150/ijms.12460; Xiao YD, 2017, ACTA CIR BRAS, V32, P429, DOI 10.1590/s0102-865020170060000003; Xu ZH, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0590-5; Yuan QJ, 2011, AM J NEPHROL, V34, P181, DOI 10.1159/000329080; Zhou J, 2018, J CELL MOL MED, V22, P2908, DOI 10.1111/jcmm.13585	55	10	10	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14325	14336		10.1096/fj.201901468RR	http://dx.doi.org/10.1096/fj.201901468RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31661638	Bronze			2022-12-28	WOS:000507466100098
J	Krys, D; Hamann, I; Wuest, M; Wuest, F				Krys, Daniel; Hamann, Ingrit; Wuest, Melinda; Wuest, Frank			Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer	FASEB JOURNAL			English	Article						thymidine kinase 1; [F-18]FLT; positron emission tomography	POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; MORTALITY; DILAZEP; ANALOGS; PROTEIN; SLC28; ENT1	Elevated proliferation rates in cancer can be visualized with positron emission tomography (PET) using 3'-deoxy-3'-L-[F-18]fluorothymidine ([F-18]FLT). This study investigates whether [F-18]FLT transport proteins are regulated through hypoxia. Expression and function of human equilibrative nucleoside transporter (hENT)-1, hENT2, and thymidine kinase 1 (TK1) were studied under normoxic and hypoxic conditions, and assessed with [F-18] FLT-PET in estrogen receptor positive (ER+)-MCF7, triple-negative MDA-MB231 breast cancer (BC) cells, and MCF10A cells (human mammary epithelial cells). Functional involvement of hENT2 [F-18]FLT transport was demonstrated in all cell lines. In vitro [F-18]FLT uptake was higher in MDA-MB231 than in MCF7: 242 +/- 9 vs. 147 +/- 18% radioactivity/mg protein after 60 min under normoxia. Hypoxia showed no significant change in radiotracer uptake. Protein analysis revealed increased hENT1 (P<0.0963) in MDA-MB231. Hypoxia did not change expression of either hENT1, hENT2, or TK1. In vitro inhibition experiments suggested involvement of hENT1, hENT2, and human concentrative nucleoside transporters during [F-18]FLT uptake into all cell lines. In vivo PET imaging revealed comparable tumor uptake in MCF7 and MDA-MB231 tumors over 60 min, reaching standardized uptake values of 0.96 +/- 0.05 vs. 0.89 +/- 0.08 (n = 3). Higher hENT1 expression in MDA-MB231 seems to drive nucleoside transport, whereas TK1 expression in MCF7 seems responsible for comparable [F-18]FLT retention in ER+ tumors. Our study demonstrates that hypoxia does not significantly affect nucleoside transport as tested with [F-18]FLT in BC.	[Krys, Daniel; Hamann, Ingrit; Wuest, Melinda; Wuest, Frank] Univ Alberta, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada; [Wuest, Melinda; Wuest, Frank] Univ Alberta, Canc Res Inst Northern Alberta, Edmonton, AB, Canada	University of Alberta; University of Alberta	Wuest, F (corresponding author), Univ Alberta, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	wuest@ualberta.ca			Alberta Cancer Foundation; Cancer Research Institute of Northern Alberta (CRINA); Dianne and Irving Kipnes Foundation	Alberta Cancer Foundation; Cancer Research Institute of Northern Alberta (CRINA); Dianne and Irving Kipnes Foundation	The authors thank Dr. John Wilson, David Clendening, and Blake Lazurko (Edmonton Radiopharmaceutical Center, Edmonton, AB, Canada) for <SUP>18</SUP>F production. The authors also thank Ali Akbari and Cody Bergman (Department of Oncology, University of Alberta) for preparation of [<SUP>18</SUP>F]FLT, and Dr. John Mackey and Kathrin Graham (Department of Oncology and Cross Cancer Institute, Edmonton, AB, Canada) for help with the analysis of the patient mRNA samples for the Canadian Breast Cancer Foundation Tumor Bank (Northern Alberta Study Center, Edmonton, AB, Canada). The authors are grateful to Dan McGinn (Vivarium of the Cross Cancer Institute, Edmonton, AB, Canada) for supporting the animal work, Dr. Hans-Soenke Jans (University of Alberta) for technical help and support of the PET imaging experiments, and Dr. Jatinder Kaur (University of Alberta) for supporting the additional flow cytometry experiments. Additionally, the authors thank Dr. Xuejun Sun and Geraldine Barron of the Cell Imaging Facility of Department of Oncology for their help with the cell imaging experiments. D.K. thanks the Alberta Cancer Foundation for a Graduate Student Scholarship and the Cancer Research Institute of Northern Alberta (CRINA) for a La Vie en Rose Scholarship for Breast Cancer Research. The authors also gratefully acknowledge the Dianne and Irving Kipnes Foundation for supporting this work. The authors declare no conflicts of interest.	Adejolu M, 2012, AM J ROENTGENOL, V198, pW304, DOI 10.2214/AJR.11.7130; Alvarez JV, 2014, CANCER RES, V74, P7583, DOI 10.1158/0008-5472.CAN-14-1235; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Bychkovsky BL, 2017, BREAST, V31, P318, DOI 10.1016/j.breast.2016.06.017; Casanello P, 2005, CIRC RES, V97, P16, DOI 10.1161/01.RES.0000172568.49367.f8; Dehdashti F, 2003, INT J RADIAT ONCOL, V55, P1233, DOI 10.1016/S0360-3016(02)04477-2; DeSantis CE, 2017, CA-CANCER J CLIN, V67, P439, DOI 10.3322/caac.21412; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; Groheux D, 2016, J NUCL MED, V57, p17S, DOI 10.2967/jnumed.115.157859; Hamann I, 2018, FASEB J, V32, P5104, DOI 10.1096/fj.201800360R; Inic Z, 2014, CLIN MED INSIGHTS-ON, V8, P107, DOI 10.4137/CMO.S18006; Kabat GC, 2017, J RACIAL ETHN HEALTH, V4, P1181, DOI 10.1007/s40615-016-0324-y; Kubota K, 2017, SEMIN NUCL MED, V47, P408, DOI 10.1053/j.semnuclmed.2017.02.005; Kumar H, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/584758; Lee KE, 2015, CELL, V163, P1288, DOI 10.1016/j.cell.2015.11.011; Liao GJ, 2016, J NUCL MED, V57, P1269, DOI 10.2967/jnumed.116.175596; Machulla HJ, 2000, J RADIOANAL NUCL CH, V243, P843, DOI 10.1023/A:1010684101509; Mackey JR, 2002, CLIN CANCER RES, V8, P110; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; MCGUIRE AH, 1991, J NUCL MED, V32, P1526; Molina-Arcas M, 2006, BIOCHEM PHARMACOL, V72, P1646, DOI 10.1016/j.bcp.2006.07.036; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Paproski RJ, 2010, J NUCL MED, V51, P1447, DOI 10.2967/jnumed.110.076356; Pastor-Anglada M, 2008, XENOBIOTICA, V38, P972, DOI 10.1080/00498250802069096 ; Pastor-Anglada M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00013; Playa H, 2014, BIOORG MED CHEM LETT, V24, P5801, DOI 10.1016/j.bmcl.2014.10.026; Plotnik DA, 2011, NUCL MED BIOL, V38, P979, DOI 10.1016/j.nucmedbio.2011.03.009; Robertson S, 2018, J CLIN PATHOL, V71, P787, DOI 10.1136/jclinpath-2017-204976; Robins MJ, 2010, J MED CHEM, V53, P6040, DOI 10.1021/jm100432w; Salman S, 2018, ADV EXP MED BIOL, V1071, P43, DOI 10.1007/978-3-319-91137-3_5; Santini D, 2010, J CELL PHYSIOL, V223, P384, DOI 10.1002/jcp.22045; SEMENZA GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI DOI 10.1016/J.BBAMCR.2015.05.036; Shen BZ, 2017, ONCOTARGET, V8, P43536, DOI 10.18632/oncotarget.16647; Sun Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136015; Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819; Toyohara J, 2002, NUCL MED BIOL, V29, P281, DOI 10.1016/S0969-8051(02)00286-X; Vavere AL, 2007, DALTON T, P4893, DOI 10.1039/b705989b; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Wuest M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0609-9; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007	42	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13837	13851		10.1096/fj.201900870RR	http://dx.doi.org/10.1096/fj.201900870RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31601121	Bronze			2022-12-28	WOS:000507466100061
J	Fang, Y; Tschulakow, A; Taubitz, T; Illing, B; Biesemeier, A; Julien-Schraermeyer, S; Radu, RA; Jiang, ZC; Schraermeyer, U				Fang, Yuan; Tschulakow, Alexander; Taubitz, Tatjana; Illing, Barbara; Biesemeier, Antje; Julien-Schraermeyer, Sylvie; Radu, Roxana A.; Jiang, Zhichun; Schraermeyer, Ulrich			Fundus autofluorescence, spectral-domain optical coherence tomography, and histology correlations in a Stargardt disease mouse model	FASEB JOURNAL			English	Article						ABCA4; blue light damage; fundus autofluorescence; lipofuscin; mouse model; Stargardt disease	LIGHT-INDUCED RETINOPATHY; LIPOFUSCIN FLUOROPHORE; INDUCED DAMAGE; OCULAR FUNDUS; HUMAN RPE; PIGMENT; CELLS; ABCR; A2E; PHOTORECEPTORS	Stargardt disease (STGD1), known as inherited retinal dystrophy, is caused by ABCA4 mutations. The pigmented Abca4(-/-) mouse strain only reflects the early stage of STGD1 since it is devoid of retinal degeneration. This blue light-illuminated pigmented Abca4(-/-) mouse model presented retinal pigment epithelium (RPE) and photoreceptor degeneration which was similar to the advanced STGD1 phenotype. In contrast, wild-type mice showed no RPE degeneration after blue light illumination. In Abca4(-/-) mice, the acute blue light diminished the mean autofluorescence (AF) intensity in both fundus short-wavelength autofluorescence (SW-AF) and near-infrared autofluorescence (NIR-AF) modalities correlating with reduced levels of bisretinoid-fluorophores. Blue light-induced RPE cellular damage preceded the photoreceptors loss. In late-stage STGD1-like patient and blue light-illuminated Abca4(-/-) mice, lipofuscin and melanolipofuscin granules were found to contribute to NIR-AF, indicated by the colocalization of lipofuscin-AF and NIR-AF under the fluorescence microscope. In this mouse model, the correlation between in vivo and ex vivo assessments revealed histological characteristics of fundus AF abnormalities. The flecks which are hyper AF in both SW-AF and NIR-AF corresponded to the subretinal macrophages fully packed with pigment granules (lipofuscin, melanin, and melanolipofuscin). This mouse model, which has the phenotype of advanced STGD1, is important to understand the histopathology of Stargardt disease.	[Fang, Yuan; Tschulakow, Alexander; Taubitz, Tatjana; Illing, Barbara; Biesemeier, Antje; Julien-Schraermeyer, Sylvie; Schraermeyer, Ulrich] Univ Tubingen, Div Expt Vitreoretinal Surg, Inst Ophthalm Res, Ctr Ophthalmol, Schleichstr 12, D-72076 Tubingen, Germany; [Tschulakow, Alexander; Julien-Schraermeyer, Sylvie; Schraermeyer, Ulrich] STZ Ocutox, Preclin Drug Assessment, Hechingen, Germany; [Radu, Roxana A.; Jiang, Zhichun] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Stein Eye Inst, Los Angeles, CA 90095 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schraermeyer, U (corresponding author), Univ Tubingen, Div Expt Vitreoretinal Surg, Inst Ophthalm Res, Ctr Ophthalmol, Schleichstr 12, D-72076 Tubingen, Germany.	ulrich.schraermeyer@med.uni-tuebingen.de	Taubitz, Tatjana/AAA-2941-2021	Taubitz, Tatjana/0000-0002-6747-4484; Julien-Schraermeyer, Sylvie/0000-0002-2322-511X; Biesemeier, Antje/0000-0002-3462-8803; Radu, Roxana/0000-0002-5064-6403	NEI NIH HHS [P30 EY000331] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Blacharski P.A., 1988, RETINAL DYSTROPHY DE, P135; Bonilha VL, 2016, OPHTHALMIC GENET, V37, P150, DOI 10.3109/13816810.2014.958861; BOULTON M, 1990, VISION RES, V30, P1291, DOI 10.1016/0042-6989(90)90003-4; Ciccone L, 2018, RETINA-J RET VIT DIS, V38, P2214, DOI 10.1097/IAE.0000000000001841; Cideciyan AV, 2015, INVEST OPHTH VIS SCI, V56, P5946, DOI 10.1167/iovs.15-17698; Cideciyan AV, 2004, HUM MOL GENET, V13, P525, DOI 10.1093/hmg/ddh048; Cukras CA, 2012, ARCH OPHTHALMOL-CHIC, V130, P171, DOI 10.1001/archophthalmol.2011.332; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; Dontsov AE, 2017, BIOCHEMISTRY-MOSCOW+, V82, P916, DOI 10.1134/S0006297917080065; Duncker T, 2015, INVEST OPHTH VIS SCI, V56, P3159, DOI 10.1167/iovs.14-16343; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fujinami K, 2015, OPHTHALMOLOGY, V122, P326, DOI 10.1016/j.ophtha.2014.08.012; GELISKEN O, 1985, INT OPHTHALMOL, V8, P225, DOI 10.1007/BF00137651; Grey AC, 2011, INVEST OPHTH VIS SCI, V52, P3926, DOI 10.1167/iovs.10-7020; HAM WT, 1978, INVEST OPHTH VIS SCI, V17, P1029; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Issa PC, 2013, INVEST OPHTH VIS SCI, V54, P5602, DOI 10.1167/iovs.13-11688; Issa PC, 2012, INVEST OPHTH VIS SCI, V53, P1066, DOI 10.1167/iovs.11-8767; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Katz ML, 2005, MECH AGEING DEV, V126, P513, DOI 10.1016/j.mad.2004.11.004; Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122; Kellner S, 2009, AM J OPHTHALMOL, V147, P895, DOI 10.1016/j.ajo.2008.12.023; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Kumar V, 2017, GRAEF ARCH CLIN EXP, V255, P1917, DOI 10.1007/s00417-017-3736-4; Lambertus S, 2015, OPHTHALMOLOGY, V122, P335, DOI 10.1016/j.ophtha.2014.08.032; Lei L, 2012, MOL VIS, V18, P103; Lenis TL, 2018, P NATL ACAD SCI USA, V115, pE11120, DOI 10.1073/pnas.1802519115; Lenis TL, 2017, P NATL ACAD SCI USA, V114, P3987, DOI 10.1073/pnas.1620299114; Lin CH, 2017, TOXICOL SCI, V157, P196, DOI 10.1093/toxsci/kfx030; Lu B, 2017, OPHTHALMIC RES, V57, P252, DOI 10.1159/000452282; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Marie M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0331-5; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Nakamura M, 2018, EXP EYE RES, V177, P1, DOI 10.1016/j.exer.2018.07.022; Oguchi Y, 2018, JPN J OPHTHALMOL, V62, P605, DOI 10.1007/s10384-018-0614-5; Paavo M, 2018, J NEUROSCI RES, V97, P1; Parodi MB, 2019, GRAEF ARCH CLIN EXP, V257, P41, DOI 10.1007/s00417-018-4167-6; Parodi MB, 2015, BRIT J OPHTHALMOL, V99, P1354, DOI 10.1136/bjophthalmol-2014-306237; Polosa A, 2017, CURR EYE RES, V42, P924, DOI 10.1080/02713683.2016.1255336; Quazi F, 2014, P NATL ACAD SCI USA, V111, P5024, DOI 10.1073/pnas.1400780111; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Rapp LM, 1980, EFFECTS CONSTANT LIG, P133; Rotenstreich Y, 2003, OPHTHALMOLOGY, V110, P1151, DOI 10.1016/S0161-6420(03)00333-6; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Rudolf M, 2013, OPHTHALMOLOGY, V120, P821, DOI 10.1016/j.ophtha.2012.10.007; Sarna T, 2003, EXP EYE RES, V76, P89, DOI 10.1016/S0014-4835(02)00247-6; Sears AE, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.5.6; Shamsi FA, 2001, INVEST OPHTH VIS SCI, V42, P3041; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Strauss RW, 2017, JAMA OPHTHALMOL, V135, P1232, DOI 10.1001/jamaophthalmol.2017.4152; Taubit T, 2018, PEERJ, V6, DOI 10.7717/peerj.5215; Taubitz T, 2019, EBIOMEDICINE, V48, P592, DOI 10.1016/j.ebiom.2019.09.048; Teussink MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172635; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; van der Burght Barbro W, 2013, Acta Ophthalmol, V91, pe537, DOI 10.1111/aos.12146; Voigt M, 2010, AM J OPHTHALMOL, V150, P330, DOI 10.1016/j.ajo.2010.04.001; Wajer SD, 2000, MICROVASC RES, V60, P281, DOI 10.1006/mvre.2000.2270; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P474, DOI 10.1562/2005-10-21-RA-725; Warburton S, 2007, MOL VIS, V13, P318; Wassell J, 1999, J BIOL CHEM, V274, P23828, DOI 10.1074/jbc.274.34.23828; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wolock CJ, 2019, GENET MED, V21, P2336, DOI 10.1038/s41436-019-0495-0; Wu L, 2014, INVEST OPHTH VIS SCI, V55, P1910, DOI 10.1167/iovs.14-13867; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	71	8	7	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3693	3714		10.1096/fj.201901784RR	http://dx.doi.org/10.1096/fj.201901784RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31989709	hybrid			2022-12-28	WOS:000519218400018
J	Weng, QY; Chen, MJ; Yang, WB; Li, J; Fan, K; Xu, M; Weng, W; Lv, XL; Fang, SJ; Zheng, LY; Song, JJ; Zhao, ZW; Fan, XX; Ji, JS				Weng, Qiaoyou; Chen, Minjiang; Yang, Weibin; Li, Jie; Fan, Kai; Xu, Min; Weng, Wei; Lv, Xiuling; Fang, Shiji; Zheng, Liyun; Song, Jingjing; Zhao, Zhongwei; Fan, Xiaoxi; Ji, Jiansong			Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma	FASEB JOURNAL			English	Article						hepatocellular carcinoma; MAGI3; miR-34c-3p; Warburg effect	TUMOR-SUPPRESSOR; MICRORNAS; PROGRESSION; EXPRESSION	Activated oncogenes and loss of tumor suppressors contribute to reprogrammed energy metabolism and induce aerobic glycolysis, also known as Warburg effect. MicroRNAs are profoundly implicated in human malignancies by inhibiting translation of multiple mRNA targets. Using hepatocellular carcinoma (HCC) molecular profiles from The Cancer Genome Atlas (TCGA), we identified a handful of dysregulated microRNA in HCC glycolysis, especially miR-34c-3p. Antagonization of miR-34c-3p inhibited the lactate production, glucose consumption, extracellular acidification rate (ECAR), and aggressive proliferation in HCC cells. Hijacking glycolysis by 2-deoxy-d-glucose or galactose largely abrogated the suppressive effects of miR-34c-3p inhibition in HCC. Membrane associated guanylate kinase, WW, and PDZ domain containing 3 (MAGI3) is then identified as a direct functional target of miR-34c-3p in regulating HCC glycolysis and oncogenic activities. Mechanistically, MAGI3 physically interacted with beta-catenin to regulate its transcriptional activity and c-Myc expression, which further facilitates the Warburg effect by increasing expression of glycolytic genes including HK2, PFKL, and LDHA. Moreover, overexpressed miR-34c-3p and reduced MAGI3 predicted poor clinical outcome and was closely associated with the maximum standard uptake value (SUVmax) in HCC patients who received preoperative F-18-FDG PET/CT. Our findings elucidate critical several microRNAs implicated in HCC glycolysis and reveal a novel function of miR-34c-3p/MAGI3 axis in Warburg effect through regulating beta-catenin activity.	[Weng, Qiaoyou; Chen, Minjiang; Yang, Weibin; Li, Jie; Fan, Kai; Xu, Min; Weng, Wei; Lv, Xiuling; Fang, Shiji; Zheng, Liyun; Song, Jingjing; Zhao, Zhongwei; Fan, Xiaoxi; Ji, Jiansong] Zhejiang Univ, Lishui Hosp, Key Lab Imaging Diag & Minimally Invas Intervent, Sch Med, Lishui, Peoples R China; [Weng, Qiaoyou; Chen, Minjiang; Yang, Weibin; Li, Jie; Fan, Kai; Xu, Min; Weng, Wei; Lv, Xiuling; Fang, Shiji; Zheng, Liyun; Song, Jingjing; Zhao, Zhongwei; Fan, Xiaoxi; Ji, Jiansong] Wenzhou Med Univ, Dept Radiol, Affiliated Hosp 5, Wenzhou, Peoples R China; [Weng, Qiaoyou; Chen, Minjiang; Yang, Weibin; Li, Jie; Fan, Kai; Xu, Min; Weng, Wei; Lv, Xiuling; Fang, Shiji; Zheng, Liyun; Song, Jingjing; Zhao, Zhongwei; Fan, Xiaoxi; Ji, Jiansong] Zhejiang Univ, Cent Hosp Zhejiang Lishui, Affiliated Lishui Hosp, Lishui, Peoples R China	Zhejiang University; Wenzhou Medical University; Zhejiang University	Fan, XX; Ji, JS (corresponding author), Zhejiang Univ, Dept Radiol, Affiliated Lishui Hosp, Lishui 323000, Peoples R China.; Fan, XX; Ji, JS (corresponding author), Wenzhou Med Univ, Affiliated Hosp 5, Cent Hosp Zhejiang Lishui, Wenzhou, Peoples R China.	21968108@qq.com; lschrjjs@163.com		, Jiansong/0000-0001-6975-620X	National Key Research and Development projects intergovernmental cooperation in science and technology of China [2018YFE0126900]; National Natural Science Foundation of China [81803778]; Key Research and development Project of Zhejiang Province [2018C03024]; Public Welfare Project of Zhejiang Province [2018KY197, 2018KY932, 2017C33216]	National Key Research and Development projects intergovernmental cooperation in science and technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and development Project of Zhejiang Province; Public Welfare Project of Zhejiang Province	National Key Research and Development projects intergovernmental cooperation in science and technology of China, Grant/Award Number: 2018YFE0126900; National Natural Science Foundation of China, Grant/Award Number: 81803778; The Key Research and development Project of Zhejiang Province, Grant/Award Number: 2018C03024; The Public Welfare Project of Zhejiang Province, Grant/Award Number: 2018KY197, 2018KY932 and 2017C33216	Chang J, 2002, CANCER LETT, V182, P193, DOI 10.1016/S0304-3835(02)00083-6; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Du WF, 2018, ANTI-CANCER DRUG, V29, P975, DOI 10.1097/CAD.0000000000000674; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gambari R, 2016, INT J ONCOL, V49, P5, DOI 10.3892/ijo.2016.3503; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hua SN, 2018, ONCOGENE, V37, P1624, DOI 10.1038/s41388-017-0057-3; Jiang SH, 2017, GASTROENTEROLOGY, V153, P277, DOI 10.1053/j.gastro.2017.03.008; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Katoh H, 2006, AM J PATHOL, V168, P1375, DOI 10.2353/ajpath.2006.050989; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Li ZM, 2016, ONCOTARGET, V7, P52781, DOI 10.18632/oncotarget.10947; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu F, 2015, CELL PROLIFERAT, V48, P582, DOI 10.1111/cpr.12201; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu JR, 2015, CANCER LETT, V356, P156, DOI 10.1016/j.canlet.2014.04.001; Ma Q, 2015, ONCOTARGET, V6, P35851, DOI 10.18632/oncotarget.5323; Ni TK, 2016, ELIFE, V5, DOI 10.7554/eLife.14730; Pogribny IP, 2014, CANCER LETT, V342, P223, DOI 10.1016/j.canlet.2012.01.038; Song JJ, 2015, INT J CLIN EXP PATHO, V8, P12728; Streba LAM, 2015, WORLD J GASTROENTERO, V21, P4103, DOI 10.3748/wjg.v21.i14.4103; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wu J, 2017, BIOCHEM BIOPH RES CO, V483, P10, DOI 10.1016/j.bbrc.2017.01.023; Xiao CZ, 2017, J CANCER RES CLIN, V143, P263, DOI 10.1007/s00432-016-2280-7; Zhong XP, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1603-4	31	13	14	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5420	5434		10.1096/fj.201902895R	http://dx.doi.org/10.1096/fj.201902895R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32080912	hybrid			2022-12-28	WOS:000515257100001
J	Dasgupta, A; Chen, KH; Wu, DC; Hoskin, V; Mewburn, J; Lima, PDA; Parlow, LRG; Hindmarch, CCT; Martin, A; Sykes, EA; Tayade, C; Lightbody, ED; Madarnas, Y; SenGupta, SK; Elliott, BE; Nicol, CJB; Archer, SL				Dasgupta, Asish; Chen, Kuang-Hueih; Wu, Danchen; Hoskin, Victoria; Mewburn, Jeffrey; Lima, Patricia D. A.; Parlow, Leah R. G.; Hindmarch, Charles C. T.; Martin, Ashley; Sykes, Edward A.; Tayade, Chandrakant; Lightbody, Elizabeth D.; Madarnas, Yolanda; SenGupta, Sandip K.; Elliott, Bruce E.; Nicol, Christopher J. B.; Archer, Stephen L.			An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications	FASEB JOURNAL			English	Article						Akt; breast cancer; Hyperion; microRNA-34a-3p; MiD49; MiD51; mitotic mitochondrial fission; non-small cell lung cancer	MITOFUSIN 2; INDUCED DRP1; PHOSPHORYLATION; FUSION; ACTIVATION; PROLIFERATION; INHIBITION; APOPTOSIS; P21(CIP1); SIGNALS	Excessive proliferation and apoptosis-resistance are hallmarks of cancer. Increased dynamin-related protein 1 (Drp1)-mediated mitochondrial fission is one of the mediators of this phenotype. Mitochondrial fission that accompanies the nuclear division is called mitotic fission and occurs when activated Drp1 binds partner proteins on the outer mitochondrial membrane. We examine the role of Drp1-binding partners, mitochondrial dynamics protein of 49 and 51 kDa (MiD49 and MiD51), as drivers of cell proliferation and apoptosis-resistance in non-small cell lung cancer (NSCLC) and invasive breast carcinoma (IBC). We also evaluate whether inhibiting MiDs can be therapeutically exploited to regress cancer. We show that MiD levels are pathologically elevated in NSCLC and IBC by an epigenetic mechanism (decreased microRNA-34a-3p expression). MiDs silencing causes cell cycle arrest through (a) increased expression of cell cycle inhibitors, p27(Kip1) and p21(Waf1), (b) inhibition of Drp1, and (c) inhibition of the Akt-mTOR-p70S6K pathway. Silencing MiDs leads to mitochondrial fusion, cell cycle arrest, increased apoptosis, and tumor regression in a xenotransplant NSCLC model. There are positive correlations between MiD expression and tumor size and grade in breast cancer patients and inverse correlations with survival in NSCLC patients. The microRNA-34a-3p-MiDs axis is important to cancer pathogenesis and constitutes a new therapeutic target.	[Dasgupta, Asish; Chen, Kuang-Hueih; Wu, Danchen; Mewburn, Jeffrey; Parlow, Leah R. G.; Martin, Ashley; Sykes, Edward A.; Archer, Stephen L.] Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada; [Hoskin, Victoria; Lightbody, Elizabeth D.; SenGupta, Sandip K.; Elliott, Bruce E.; Nicol, Christopher J. B.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Lima, Patricia D. A.; Hindmarch, Charles C. T.] Queens Univ, Dept Med, Translat Inst Med TIME, Queens Cardiopulm Unit QCPU, Kingston, ON, Canada; [Tayade, Chandrakant; Nicol, Christopher J. B.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Madarnas, Yolanda; SenGupta, Sandip K.] Kingston Hlth Sci Ctr, Kingston, ON, Canada	Queens University - Canada; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Archer, SL (corresponding author), Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada.	stephen.archer@queensu.ca	Hindmarch, Charles/AAM-3385-2021; Wu, Danchen/W-4727-2019; wu, danchen/Y-8493-2019	Wu, Danchen/0000-0003-3901-5907; 	Breast Cancer Action Kingston; Queen'sCardiopulmonary Unit (QCPU)	Breast Cancer Action Kingston; Queen'sCardiopulmonary Unit (QCPU)	SLAand his researchare supported byQueen'sCardiopulmonary Unit (QCPU). The authors thank Dr Mamoru Ito (Central Institute for Experimental Animals, Kawasaki, Japan), for providing the BALB/c-Rag2-/-IL2R.c-/-mice. The authors also wish to thank Dr Lois Shepherd (CCT Division, Queen's Cancer Research Institute; Kingston, Canada) and Mr Shakeel Virk (Queen's Laboratory for Molecular Pathology, Kingston, Canada) for their valuable contributions of the NSCLC patient data. The authors also wish to thank the Breast Cancer Action Kingston for the funding of the construction of the breast can-cer cohort and TMAs.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cass Jamaica D, 2012, Cancers (Basel), V4, P725, DOI 10.3390/cancers4030725; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen KH, 2018, CIRCULATION, V138, P287, DOI 10.1161/CIRCULATIONAHA.117.031258; Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7; Dasgupta A, 2015, J IMMUNOL, V195, P5780, DOI 10.4049/jimmunol.1501023; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Ghaffari A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0438-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong ZG, 2013, CIRC RES, V112, P802, DOI 10.1161/CIRCRESAHA.111.300285; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kim DI, 2016, BBA-MOL CELL RES, V1863, P2820, DOI 10.1016/j.bbamcr.2016.09.003; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Flores JM, 2014, CELL CYCLE, V13, DOI 10.4161/cc.29147; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113; Prieto J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11124; Prins KW, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006195; Ray A, 2009, MOL CELL BIOL, V29, P986, DOI 10.1128/MCB.00898-08; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Shimura T, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.12; Skildum AJ, 2002, J BIOL CHEM, V277, P5145, DOI 10.1074/jbc.M109179200; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tian L, 2017, J MOL MED, V95, P381, DOI 10.1007/s00109-017-1522-8; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zorzano A, 2015, ANTIOXID REDOX SIGN, V22, P1020, DOI 10.1089/ars.2014.6208	47	7	7	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5106	5127		10.1096/fj.201903117R	http://dx.doi.org/10.1096/fj.201903117R		FEB 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32068312				2022-12-28	WOS:000515251900001
J	Liu, Y; Chen, X; Choi, YJ; Yang, N; Song, ZY; Snedecor, ER; Liang, W; Leung, ELH; Zhang, LF; Qin, C; Chen, J				Liu, Ying; Chen, Xi; Choi, Yeon Ja; Yang, Ning; Song, Zhongya; Snedecor, Elizabeth R.; Liang, Wei; Leung, Elaine Lai-Han; Zhang, Lianfeng; Qin, Chuan; Chen, Jiang			GORAB promotes embryonic lung maturation through antagonizing AKT phosphorylation, versican expression, and mesenchymal cell migration	FASEB JOURNAL			English	Article						co-culture; fibroblast; morphogenesis; PDGF; signaling; VCAN	SMOOTH-MUSCLE; PDGF-A; TRANSCRIPTIONAL CONTROL; GROWTH; ALPHA; SCYL1BP1; PROTEOGLYCAN; DEGRADATION; APOPTOSIS; MICE	Embryonic development of the alveolar sac of the lung is dependent upon multiple signaling pathways to coordinate cell growth, migration, and the formation of the extracellular matrix. Here, we identify GORAB as a regulator of embryonic alveolar sac formation as genetically disrupting the Gorab gene in mice resulted in fatal saccular maturation defects characterized by a thickened lung mesenchyme. This abnormality is not associated with impairments in cellular proliferation and death, but aberrantly increased protein kinase B (AKT) phosphorylation, elevated Vcan transcription, and enhanced migration of mesenchymal fibroblasts. Genetically augmenting PDGFR alpha, a potent activator of AKT in lung mesenchymal cells, recapitulated the alveolar phenotypes, whereas disrupting PDGFR alpha partially rescued alveolar phenotypes in Gorab-deficient mice. Overexpressing or suppressing Vcan in primary embryonic lung fibroblasts could, respectively, mimic or attenuate alveolar sac-like phenotypes in a co-culture model. These findings suggest a role of GORAB in negatively regulating AKT phosphorylation, the expression of Vcan, and the migration of lung mesenchyme fibroblasts, and suggest that alveolar sac formation resembles a patterning event that is orchestrated by molecular signaling and the extracellular matrix in the mesenchyme.	[Liu, Ying; Liang, Wei; Zhang, Lianfeng; Qin, Chuan; Chen, Jiang] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Beijing, Peoples R China; [Liu, Ying; Liang, Wei; Zhang, Lianfeng; Qin, Chuan; Chen, Jiang] Minist Hlth, Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China; [Liu, Ying; Liang, Wei; Zhang, Lianfeng; Qin, Chuan; Chen, Jiang] Minist Hlth, Key Lab Human Dis Comparat Med, Beijing, Peoples R China; [Chen, Xi; Choi, Yeon Ja; Yang, Ning; Song, Zhongya; Snedecor, Elizabeth R.; Chen, Jiang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Chen, Xi; Leung, Elaine Lai-Han] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Song, Zhongya] Peking Univ First Hosp, Dept Dermatol, Beijing, Peoples R China; [Chen, Jiang] SUNY Stony Brook, Dept Dermatol, Stony Brook, NY 11794 USA; [Choi, Yeon Ja] Dongguk Univ Gyeongju, Coll Sci & Technol, Dept Biopharmaceut Engn, Gyeongju, South Korea	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Macau University of Science & Technology; Peking University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Dongguk University	Chen, J (corresponding author), SUNY Stony Brook, Renaissance Sch Med, Dept Pathol, Stony Brook, NY 11794 USA.; Qin, C (corresponding author), CAMS, PUMC, Comparat Med Ctr, Inst Lab Anim Sci, Beijing 100021, Peoples R China.	qinchuan@pumc.edu.cn; jiang.chen@stonybrook.edu	Chen, Xi/AAI-1665-2021; qin, chuan/ABG-4508-2020	Chen, Xi/0000-0001-8072-6335; 	Stony Brook University; China Scholarship Council [201706010325]; CAMS initiative for Innovative Medicine [2016-12M-2-006]; Macau Science and Technology Development Fund [0096/2018/A3]; Natural Science Foundation of China [31301928, 81472899, 81773308]; National Institute of Health of the United States of America [AR061485, AR071573]	Stony Brook University; China Scholarship Council(China Scholarship Council); CAMS initiative for Innovative Medicine; Macau Science and Technology Development Fund; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Jason Shieh for discussion and Adam Naqvi for assistance. We would also like to thank Dr. Lorin Olson for sharing the Pdgfr alpha/J mouse models, Dr. Uwe Kornak for sharing the Gorab conditional knockout mouse models, and the flow cytometry core facility of Stony Brook University for support. Zhongya Song was supported by the China Scholarship Council (No. 201706010325). This work was supported by CAMS initiative for Innovative Medicine (2016-12M-2-006), Macau Science and Technology Development Fund (Project No: 0096/2018/A3), and research grants from the Natural Science Foundation of China (31301928, 81472899, and 81773308) and the National Institute of Health of the United States of America (AR061485 and AR071573). The funders had no role in study design, data collection, data analysis, decision to publish, and preparation of the manuscript.	Andersson-Sjoland A, 2015, GLYCOBIOLOGY, V25, P243, DOI 10.1093/glycob/cwu120; Andersson-Sjoland A, 2011, J HEART LUNG TRANSPL, V30, P945, DOI 10.1016/j.healun.2011.04.006; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Benjamin JT, 2009, DEV BIOL, V335, P407, DOI 10.1016/j.ydbio.2009.09.021; Bird AD, 2014, AM J RESP CELL MOL, V50, P419, DOI 10.1165/rcmb.2013-0169OC; Bostrom H, 2002, DEV DYNAM, V223, P155, DOI 10.1002/dvdy.1225.abs; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Chan WL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007242; Chao CM, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00027; Chen J, 2015, J INVEST DERMATOL, V135, P701, DOI 10.1038/jid.2014.483; Dieperink HI, 2006, PEDIATR RES, V59, P185, DOI 10.1203/01.pdr.0000196371.85945.3a; Dutt S, 2006, THESCIENTIFICWORLDJO, V6, P1114, DOI 10.1100/tsw.2006.219; Egerer J, 2015, J INVEST DERMATOL, V135, P2368, DOI 10.1038/jid.2015.192; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Faggian J, 2007, AM J PHYSIOL-REG I, V293, pR784, DOI 10.1152/ajpregu.00801.2006; Gouveia L, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161976; Gouveia L, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13092; Greer RM, 2014, ORGANOGENESIS, V10, P340, DOI 10.4161/org.29198; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hsu HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14612-5; Hu L, 2012, CARCINOGENESIS, V33, P1581, DOI 10.1093/carcin/bgs162; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; Kresch MJ, 1998, PEDIATR RES, V43, P426, DOI 10.1203/00006450-199803000-00020; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Kugler MC, 2017, AM J RESP CELL MOL, V57, P280, DOI 10.1165/rcmb.2016-0268OC; Kugler MC, 2015, AM J RESP CELL MOL, V52, P1, DOI 10.1165/rcmb.2014-0132TR; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Li J, 2001, DEV BIOL, V239, P338, DOI 10.1006/dbio.2001.0441; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Liu Y, 2016, J INVEST DERMATOL, V136, P378, DOI 10.1016/j.jid.2015.10.067; Liu YH, 2012, MOL BIOL CELL, V23, P4506, DOI 10.1091/mbc.E12-05-0362; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; McCulley D, 2015, CURR OPIN GENET DEV, V32, P98, DOI 10.1016/j.gde.2015.01.011; McGowan SE, 2013, AM J PHYSIOL-LUNG C, V305, P1229, DOI 10.1152/ajplung.00011.2013; McGowan SE, 2008, ANAT REC, V291, P1649, DOI 10.1002/ar.20764; Noskovicova N, 2015, AM J RESP CELL MOL, V52, P263, DOI 10.1165/rcmb.2014-0294TR; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Osman N, 2014, CELL SIGNAL, V26, P912, DOI 10.1016/j.cellsig.2014.01.019; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Rajab A, 2008, AM J MED GENET A, V146A, P965, DOI 10.1002/ajmg.a.32143; Saito S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186615; Sani FV, 2010, EUR J ORAL SCI, V118, P221, DOI 10.1111/j.1600-0722.2010.00732.x; Scavo LM, 1998, AM J RESP CELL MOL, V18, P21, DOI 10.1165/ajrcmb.18.1.2744; Schittny JC, 2017, CELL TISSUE RES, V367, P427, DOI 10.1007/s00441-016-2545-0; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Snyder JM, 2015, J HISTOCHEM CYTOCHEM, V63, P952, DOI 10.1369/0022155415610383; Sun T, 2000, DEVELOPMENT, V127, P4519; Szabo A, 2016, J CELL BIOL, V213, P543, DOI 10.1083/jcb.201602083; Theocharis AD, 2008, CONNECT TISSUE RES, V49, P230, DOI 10.1080/03008200802147571; Tiedemann K, 1997, MATRIX BIOL, V15, P469, DOI 10.1016/S0945-053X(97)90020-2; Volckaert T, 2015, DEV DYNAM, V244, P342, DOI 10.1002/dvdy.24234; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yan J, 2010, FEBS LETT, V584, P3275, DOI 10.1016/j.febslet.2010.06.027; Yang ZP, 2014, ASIAN PAC J CANCER P, V15, P7467, DOI 10.7314/APJCP.2014.15.17.7467; Zhang WD, 2016, MOL NEUROBIOL, V53, P6342, DOI 10.1007/s12035-015-9531-5; Zhang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22597; Zhuo Y, 2006, TRANSGENIC RES, V15, P543, DOI 10.1007/s11248-006-9007-5	64	0	0	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4918	4933		10.1096/fj.201902075R	http://dx.doi.org/10.1096/fj.201902075R		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067289	Green Accepted			2022-12-28	WOS:000515251000001
J	Song, CC; Cao, J; Lei, YS; Chi, H; Kong, PY; Chen, GH; Yu, TL; Li, JN; Prajapati, RK; Xia, JJ; Yan, JL				Song, Chengchao; Cao, Jing; Lei, Yongsheng; Chi, Hui; Kong, Pengyu; Chen, Guanghua; Yu, Tailong; Li, Jianan; Prajapati, Ravi Kumar; Xia, Jingjun; Yan, Jinglong			Nuciferine prevents bone loss by disrupting multinucleated osteoclast formation and promoting type H vessel formation	FASEB JOURNAL			English	Article						CD31; Emcn; PDGF-BB; preosteoclast	DC-STAMP; ANGIOGENESIS; DIFFERENTIATION; CELLS; OSTEOGENESIS; INHIBITION; PRECURSORS; PATHWAY	Recently, type H vessels were reported to couple angiogenesis and osteogenesis during osteoclastogenesis, and tartrate-resistant acid phosphatase (Trap)(+) preosteoclasts were found to secrete increased PDGF-BB to promote type H vessel formation. Therefore, utilization of type H vessels may be a strategy to treat diseases involving bone loss. In the present study, we found that nuciferine, a natural bioactive compound, has various effects, including inhibiting osteoclastogenesis and promoting type H vessel formation. Nuciferine inhibited osteoclastogenesis and bone resorption but increased the relative number of Trap(+) preosteoclasts. Nuciferine restrained the expression of osteoclast-specific genes and proteins, promoted PDGF-BB production and potentiated related angiogenic activities by inhibiting the MAPK and NF-kappa B signaling pathways in vitro. We confirmed the bone-protective effects of nuciferine in ovariectomized mice and found that nuciferine treatment increased the PDGF-BB concentration and the number of type H vessels in the femur. In conclusion, our results demonstrated that nuciferine can decrease multinucleated osteoclast formation and promote type H vessel formation through preservation of Trap(+) preosteoclasts via inhibition of the MAPK and NF-kappa B signaling pathways and may be an excellent agent for the treatment of diseases involving bone loss.	[Song, Chengchao; Lei, Yongsheng; Chi, Hui; Kong, Pengyu; Chen, Guanghua; Yu, Tailong; Prajapati, Ravi Kumar; Xia, Jingjun; Yan, Jinglong] Harbin Med Univ, Affiliated Hosp 2, Dept Orthoped, Harbin 150086, Heilongjiang, Peoples R China; [Song, Chengchao; Cao, Jing; Lei, Yongsheng; Chi, Hui] Harbin Med Univ, Minist Educ, Key Lab Myocardial Ischemia, Harbin, Peoples R China; [Cao, Jing] Harbin Med Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, Harbin, Peoples R China; [Li, Jianan] Heilongjiang Prov Hosp, Dept Orthoped, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Yan, JL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Orthoped, Harbin 150086, Heilongjiang, Peoples R China.	yjlhmu@163.com	Xu, Ping/I-1910-2013; Chen, Guanghua/X-2001-2018	Xu, Ping/0000-0002-1516-4986; Chen, Guanghua/0000-0003-1388-5584	National Natural Science Foundation of China [81472107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China, Grant/Award Number: 81472107	An YA, 2019, FASEB J, V33, P12515, DOI 10.1096/fj.201802805RR; Arai A, 2012, J CELL SCI, V125, P2910, DOI 10.1242/jcs.099986; Binkley N, 1998, J BONE MINER RES, V13, P1775, DOI 10.1359/jbmr.1998.13.11.1775; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chang EJ, 2008, J CELL SCI, V121, P2555, DOI 10.1242/jcs.028217; Chen H, 2019, I-PERCEPTION, V10, DOI 10.1177/2041669519864971; Chen X, 2017, FASEB J, V31, P4855, DOI 10.1096/fj.201700316R; Dou C, 2018, ADV SCI, V5, DOI 10.1002/advs.201700578; Gao B, 2019, J CLIN INVEST, V129, P2578, DOI 10.1172/JCI98857; Hadji P, 2019, OSTEOPOROSIS INT, V30, P2391, DOI 10.1007/s00198-019-05103-6; Hotokezaka H, 2007, J CELL BIOCHEM, V101, P122, DOI 10.1002/jcb.21167; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Huang J, 2018, THERANOSTICS, V8, P2435, DOI 10.7150/thno.22144; Imam B, 2019, CUREUS, V11, DOI 10.7759/cureus.5328; Kim JY, 2014, J BONE MINER RES, V29, P1541, DOI 10.1002/jbmr.2183; Kim MJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040431; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Li MJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42484; Liu CM, 2014, MOLECULES, V19, P17829, DOI 10.3390/molecules191117829; Liu W, 2015, J ETHNOPHARMACOL, V165, P83, DOI 10.1016/j.jep.2015.02.015; Liu Y, 2017, DRUG DELIV, V24, P443, DOI 10.1080/10717544.2016.1261381; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; Rahman MM, 2015, BIOCHEM BIOPH RES CO, V462, P159, DOI 10.1016/j.bbrc.2015.04.115; Ramasamy SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13601; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Romeo SG, 2019, NAT CELL BIOL, V21, P430, DOI 10.1038/s41556-019-0304-7; Russell LA, 2018, BEST PRACT RES CL RH, V32, P835, DOI 10.1016/j.berh.2019.04.002; Sakagami N, 2005, MICRON, V36, P688, DOI 10.1016/j.micron.2005.06.008; Stegen S, 2015, BONE, V70, P19, DOI 10.1016/j.bone.2014.09.017; Sun XY, 2019, THERANOSTICS, V9, P5183, DOI 10.7150/thno.33376; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Wang L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.36; Wisitrasameewong W, 2017, J DENT RES, V96, P685, DOI 10.1177/0022034517690490; Wu HC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00939; Wu HB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0540-y; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Xu R, 2018, NAT MED, V24, P823, DOI 10.1038/s41591-018-0020-z; Yang M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16003	41	10	15	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4798	4811		10.1096/fj.201902551R	http://dx.doi.org/10.1096/fj.201902551R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32039519				2022-12-28	WOS:000512568800001
J	Draijer, C; Speth, JM; Penke, LRK; Zaslona, Z; Bazzill, JD; Lugogo, N; Huang, YJ; Moon, JJ; Peters-Golden, M				Draijer, Christina; Speth, Jennifer M.; Penke, Loka R. K.; Zaslona, Zbigniew; Bazzill, Joseph D.; Lugogo, Njira; Huang, Yvonne J.; Moon, James J.; Peters-Golden, Marc			Resident alveolar macrophage-derived vesicular SOCS3 dampens allergic airway inflammation	FASEB JOURNAL			English	Article						allergic airway inflammation; alveolar macrophages; extracellular vesicles; epithelial cells; liposomes; suppressor of cytokine signaling 3	CYTOKINE SIGNALING 3; LUNG INFLAMMATION; STAT PATHWAY; CELL; EPITHELIUM; ASTHMA; SUPPRESSOR; SECRETION; MODEL; MICE	Resident alveolar macrophages (AMs) suppress allergic inflammation in murine asthma models. Previously we reported that resident AMs can blunt inflammatory signaling in alveolar epithelial cells (ECs) by transcellular delivery of suppressor of cytokine signaling 3 (SOCS3) within extracellular vesicles (EVs). Here we examined the role of vesicular SOCS3 secretion as a mechanism by which AMs restrain allergic inflammatory responses in airway ECs. Bronchoalveolar lavage fluid (BALF) levels of SOCS3 were reduced in asthmatics and in allergen-challenged mice. Ex vivo SOCS3 secretion was reduced in AMs from challenged mice and this defect was mimicked by exposing normal AMs to cytokines associated with allergic inflammation. Both AM-derived EVs and synthetic SOCS3 liposomes inhibited the activation of STAT3 and STAT6 as well as cytokine gene expression in ECs challenged with IL-4/IL-13 and house dust mite (HDM) extract. This suppressive effect of EVs was lost when they were obtained from AMs exposed to allergic inflammation-associated cytokines. Finally, inflammatory cell recruitment and cytokine generation in the lungs of OVA-challenged mice were attenuated by intrapulmonary pretreatment with SOCS3 liposomes. Overall, AM secretion of SOCS3 within EVs serves as a brake on airway EC responses during allergic inflammation, but is impaired in asthma. Synthetic liposomes encapsulating SOCS3 can rescue this defect and may serve as a framework for novel therapeutic approaches targeting airway inflammation.	[Draijer, Christina; Speth, Jennifer M.; Penke, Loka R. K.; Zaslona, Zbigniew; Lugogo, Njira; Huang, Yvonne J.; Peters-Golden, Marc] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Med Sch, 6301 MSRB 3,1150 Med Ctr Dr, Ann Arbor, MI 48109 USA; [Bazzill, Joseph D.; Moon, James J.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Moon, James J.; Peters-Golden, Marc] Univ Michigan, Grad Program Immunol, Med Sch, Ann Arbor, MI 48109 USA; [Moon, James J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Peters-Golden, M (corresponding author), Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Med Sch, 6301 MSRB 3,1150 Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	PENKE, LOKA RAGHU KUMAR/L-7255-2016; Moon, James J/ABE-4429-2021	Moon, James J/0000-0003-2238-2372; Huang, Yvonne/0000-0002-7497-6597; PENKE, LOKA RAGHU KUMAR/0000-0002-2780-7950; Zaslona, Zbigniew/0000-0003-3361-4140; Speth, Jennifer/0000-0002-7724-6995	National Institutes of Health [R01 HL 12555, R35 H144979]; NIH [T32 HL 7749-23]; American Cancer Society; AHA	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); AHA(American Heart Association)	National Institutes of Health, Grant/Award Number: R01 HL 12555 and R35 H144979; NIH Training, Grant/Award Number: T32 HL 7749-23; American Cancer Society, Grant/Award Number: J.M.S.; AHA, Grant/Award Number: L.R.P	Ashino S, 2014, J ALLERGY CLIN IMMUN, V133, P1162, DOI 10.1016/j.jaci.2013.10.036; Banerjee S, 2017, DRUGS, V77, P521, DOI 10.1007/s40265-017-0701-9; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Calbet M, 2019, J PHARMACOL EXP THER, V370, P137, DOI 10.1124/jpet.119.256263; Careau E, 2004, AM J RESP CELL MOL, V31, P22, DOI 10.1165/rcmb.2003-0229OC; Chung S, 2016, ONCOTARGET, V7, P17532, DOI 10.18632/oncotarget.8162; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; de Oliveira JR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/178369; Draijer C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/632049; Draijer C, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0681-6; Fricker M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00196-2017; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kubo M, 2006, CURR ALLERGY ASTHM R, V6, P32, DOI 10.1007/s11882-006-0007-6; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lee YG, 2015, AM J RESP CELL MOL, V52, P772, DOI 10.1165/rcmb.2014-0255OC; Li RF, 2018, EUR REV MED PHARMACO, V22, P835, DOI 10.26355/eurrev_201802_14320; Matsunaga Y, 2011, BIOCHEM BIOPH RES CO, V404, P261, DOI 10.1016/j.bbrc.2010.11.104; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; Melgert BN, 2010, AM J RESP CELL MOL, V42, P595, DOI 10.1165/rcmb.2009-0016OC; Melgert BN, 2005, CLIN EXP ALLERGY, V35, P1496, DOI 10.1111/j.1365-2222.2005.02362.x; Nasreen N, 2012, INT IMMUNOPHARMACOL, V12, P217, DOI 10.1016/j.intimp.2011.11.014; Zafra MP, 2015, INT J MOL SCI, V16, P5434, DOI 10.3390/ijms16035434; Peters-Golden M, 2004, AM J RESP CELL MOL, V31, P3, DOI 10.1165/rcmb.f279; Salama N, 2013, ARCH ITAL UROL ANDRO, V85, P118, DOI 10.4081/aiua.2013.3.118; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Schneider DJ, 2017, J BIOL CHEM, V292, P20897, DOI 10.1074/jbc.M117.792416; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Speth JM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131340; Speth JM, 2016, J IMMUNOL, V196, P5112, DOI 10.4049/jimmunol.1502153; Spinelli C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1490144; THEPEN T, 1994, ANN NY ACAD SCI, V725, P200, DOI 10.1111/j.1749-6632.1994.tb39802.x; Vale K, 2016, FUTURE MED CHEM, V8, P405, DOI 10.4155/fmc.16.4; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Yoshimura A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028571; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580; Zaslona Z, 2014, J ALLERGY CLIN IMMUN, V133, P379, DOI 10.1016/j.jaci.2013.07.037; Zhou HW, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-7	42	19	20	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4718	4731		10.1096/fj.201903089R	http://dx.doi.org/10.1096/fj.201903089R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030817	Green Published, Green Accepted			2022-12-28	WOS:000512331900001
J	Kang, JH; Jung, MY; Choudhury, M; Leof, EB				Kang, Jeong-Han; Jung, Mi-Yeon; Choudhury, Malay; Leof, Edward B.			Transforming growth factor beta induces fibroblasts to express and release the immunomodulatory protein PD-L1 into extracellular vesicles	FASEB JOURNAL			English	Article						fibroblast; checkpoint inhibitor; extracellular vesicles; signaling	IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; MESENCHYMAL TRANSITION; LUNG FIBROSIS; B7 FAMILY; CELLS; INHIBITION; RECEPTOR; KINASE; ACTIVATION	Transforming growth factor-beta (TGF beta) is an enigmatic protein with various roles in healthy tissue homeostasis/development as well as the development or progression of cancer, wound healing, fibrotic disorders, and immune modulation, to name a few. As TGF beta is causal to various fibroproliferative disorders featuring localized or systemic tissue/organ fibrosis as well as the activated stroma observed in various malignancies, characterizing the pathways and players mediating its action is fundamental. In the current study, we found that TGF beta induces the expression of the immunoinhibitory molecule Programed death-ligand 1 (PD-L1) in human and murine fibroblasts in a Smad2/3- and YAP/TAZ-dependent manner. Furthermore, PD-L1 knockdown decreased the TGF beta-dependent induction of extracellular matrix proteins, including collagen I alpha 1 (colI alpha 1) and alpha-smooth muscle actin (alpha-SMA), and cell migration/wound healing. In addition to an endogenous role for PD-L1 in profibrotic TGF beta signaling, TGF beta stimulated-human lung fibroblast-derived PD-L1 into extracellular vesicles (EVs) capable of inhibiting T cell proliferation in response to T cell receptor stimulation and mediating fibroblast cell migration. These findings provide new insights and potential targets for a variety of fibrotic and malignant diseases.	[Kang, Jeong-Han; Jung, Mi-Yeon; Choudhury, Malay; Leof, Edward B.] Mayo Clin Coll Med, Dept Biochem,Div Pulm,Thorac Dis Res Unit, Crit Care Med,Mol Biol, Rochester, MN USA; Mayo Clin Coll Med, 200 Second St, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Kang, JH (corresponding author), Mayo Clin Coll Med, Dept Biochem,Div Pulm,Thorac Dis Res Unit, Crit Care Med,Mol Biol, Rochester, MN USA.	kang.jeonghan@mayo.edu	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Choudhury, Malay/0000-0003-3051-9084	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R37-GM055816, R01-GM054200] Funding Source: Medline	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Antoniou KM, 2015, CURR OPIN PULM MED, V21, P626, DOI 10.1097/MCP.0000000000000217; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Bernard K, 2018, J BIOL CHEM, V293, P1218, DOI 10.1074/jbc.RA117.000444; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Celada LJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar8356; Chanda D, 2019, AM J RESP CELL MOL, V60, P279, DOI 10.1165/rcmb.2018-0062OC; Chen M, 2019, ACM T INTERNET TECHN, V19, DOI 10.1145/3239565; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Crane CA, 2009, ONCOGENE, V28, P306, DOI 10.1038/onc.2008.384; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Dezutter-Dambuyant C, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1091146; Dong HD, 1999, NAT MED, V5, P1365; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; Feng JS, 2017, NANO ENERGY, V36, P1, DOI 10.1016/j.nanoen.2017.04.010; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Futakuchi A, 2018, INVEST OPHTH VIS SCI, V59, P3069, DOI 10.1167/iovs.18-24258; Geng Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125326; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hong M, 2011, J BIOL CHEM, V286, P17841, DOI 10.1074/jbc.M111.233676; Jung MY, 2018, FASEB J, V32, P3803, DOI 10.1096/fj.201701187R; Kang JH, 2017, J CLIN INVEST, V127, P2541, DOI 10.1172/JCI88696; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim MH, 2018, CANCER IMMUNOL RES, V6, P255, DOI 10.1158/2326-6066.CIR-17-0320; Kim S, 2016, HUM PATHOL, V58, P7, DOI 10.1016/j.humpath.2016.07.007; Koo JH, 2018, CELL METAB, V28, P196, DOI 10.1016/j.cmet.2018.07.010; Kouidhi S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00353; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lasky JA, 2000, ENVIRON HEALTH PERSP, V108, P751, DOI 10.2307/3454412; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; Li YY, 2018, J CELL PHYSIOL, V233, P2590, DOI 10.1002/jcp.26134; Lim S, 2017, CANCER RES, V77, P1245, DOI 10.1158/0008-5472.CAN-16-1647; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Maia J, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00018; Martin-Medina A, 2018, AM J RESP CRIT CARE, V198, P1527, DOI 10.1164/rccm.201708-1580OC; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miao J, 2017, ONCOTARGET, V8, P89802, DOI 10.18632/oncotarget.21155; Miranda MZ, 2017, J BIOL CHEM, V292, P14902, DOI 10.1074/jbc.M117.780502; Nana-Sinkam SP, 2017, AM J RESP CRIT CARE, V196, P1510, DOI 10.1164/rccm.201612-2457PP; Neuzillet C, 2014, ONCOTARGET, V5, P78, DOI 10.18632/oncotarget.1569; Ni K, 2018, AM J RESP CELL MOL, V58, P684, DOI 10.1165/rcmb.2017-0326OC; Ou JN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00295; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ricklefs FL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2766; Ryu JH, 2014, MAYO CLIN PROC, V89, P1130, DOI 10.1016/j.mayocp.2014.03.016; Santarpia M, 2015, TRANSL LUNG CANCER R, V4, P728, DOI 10.3978/j.issn.2218-6751.2015.12.04; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soukupova J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12837-y; Starke A, 2007, NEPHRON EXP NEPHROL, V107, pE22, DOI 10.1159/000106506; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Szul T, 2016, AM J RESP CELL MOL, V54, P359, DOI 10.1165/rcmb.2015-0108OC; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van Rensburg HJJ, 2018, CANCER RES, V78, P1457, DOI 10.1158/0008-5472.CAN-17-3139; Vancheri C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0478-1; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wang LT, 2017, CANCER RES, V77, P4065, DOI 10.1158/0008-5472.CAN-17-0090; Wangpaichitr M, 2017, CELL DEV BIOL, V6, P1; Watanabe R, 2017, J CLIN INVEST, V127, P2725, DOI 10.1172/JCI92167; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zank DC, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00010	80	37	37	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2213	2226		10.1096/fj.201902354R	http://dx.doi.org/10.1096/fj.201902354R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907984				2022-12-28	WOS:000514663600020
J	Omeragic, A; Saikali, MF; Currier, S; Volsky, DJ; Cummins, CL; Bendayan, R				Omeragic, Amila; Saikali, Michael F.; Currier, Sydney; Volsky, David J.; Cummins, Carolyn L.; Bendayan, Reina			Selective peroxisome proliferator-activated receptor-gamma modulator, INT131 exhibits anti-inflammatory effects in an EcoHIV mouse model	FASEB JOURNAL			English	Article						HAND; HIV-1; glial cells; neuroinflammation; PPARgamma	IMMUNODEFICIENCY-VIRUS TYPE-1; NEUROCOGNITIVE DISORDER; ANTIRETROVIRAL THERAPY; P-GLYCOPROTEIN; FUNCTIONAL EXPRESSION; HIV-1 DNA; BRAIN; ASTROCYTES; PATHOGENESIS; INFECTION	Despite the use of antiretroviral therapy for the treatment of HIV-1 infection, cognitive impairments, that is, HIV-1-associated neurocognitive disorders remain prevalent potentially due to persistent viral replication, production of viral proteins, associated brain inflammation or in certain instances, antiretroviral neurotoxicity. Cellular targets in the brain include microglia which in response to infection release inflammatory markers and viral proteins. Evidence suggests that PPAR gamma agonists exert anti-inflammatory properties in neurological disorders. However, these agonists namely, thiazolidinediones have limited use in the clinic due to reported adverse side effects. INT131 is a novel non-thiazolidinedione compound that belongs to a new class of drugs known as selective PPAR gamma modulators. INT131 is considered to have a safer profile; however, its neuroprotective role in vivo is not known.The goal of this study was to examine the effect of INT131 in the context of EcoHIV-induced inflammation in vitro, in primary cultures of mouse glial cells and in vivo, in a mouse model of EcoHIV-associated brain inflammation, as well as characterize its pharmacokinetic properties and brain penetration. In primary cultures of glial cells and in the in vivo mouse model, EcoHIV exposure resulted in a significant elevation of inflammatory markers such as TNF alpha, IL-1 beta, CCL3, and C3 which were attenuated with INT131 treatment. Pharmacokinetic analyses revealed that INT131 penetrates into the brain with a brain to blood partition ratio Kp value of 8.5%. Overall, this is the first report to demonstrate that INT131 could be a potential candidate for the treatment of HIV-1-associated brain inflammation.	[Omeragic, Amila; Saikali, Michael F.; Currier, Sydney; Cummins, Carolyn L.; Bendayan, Reina] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sciences, Toronto, ON, Canada; [Volsky, David J.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY USA; Univ Toronto, Toronto, ON M5S 3M2, Canada	University of Toronto; Icahn School of Medicine at Mount Sinai; University of Toronto	Bendayan, R (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sciences, Toronto, ON, Canada.	r.bendayan@utoronto.ca		Cummins, Carolyn/0000-0001-7603-6577				An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; Anderson CE, 2003, NEUROPATH APPL NEURO, V29, P378, DOI 10.1046/j.1365-2990.2003.00475.x; Asahchop EL, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0370-5; Ashraf T, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-91; Ashraf T, 2011, J NEUROSCI RES, V89, P1773, DOI 10.1002/jnr.22720; Bernardo A, 2008, PPAR RES, V2008, DOI 10.1155/2008/864140; Bertoldi A, 2017, NEW MICROBIOL, V40, P1; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Carvallo L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179882; Cavalcante GIT, 2010, INT J NEUROSCI, V120, P739, DOI 10.3109/00207454.2010.520541; Chang KL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09000; Churchill MJ, 2015, J NEUROVIROL, V21, P290, DOI 10.1007/s13365-014-0271-5; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Cotto B, 2019, J NEUROVIROL, V25, P722, DOI 10.1007/s13365-019-00721-6; DePaoli AM, 2014, DIABETES CARE, V37, P1918, DOI 10.2337/dc13-2480; Dunn FL, 2011, J DIABETES COMPLICAT, V25, P151, DOI 10.1016/j.jdiacomp.2010.06.006; Eggers C, 2017, J NEUROL, V264, P1715, DOI 10.1007/s00415-017-8503-2; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Godoy JA, 2017, BIOCHEM BIOPH RES CO, V490, P955, DOI 10.1016/j.bbrc.2017.06.146; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Gu CJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007061; Guha D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-138; Hadas E, 2007, AIDS, V21, P905, DOI 10.1097/QAD.0b013e3281574549; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Higgins LS, 2008, PPAR RES, V2008, DOI 10.1155/2008/936906; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Huang W, 2014, J CEREBR BLOOD F MET, V34, P646, DOI 10.1038/jcbfm.2013.240; Huang W, 2011, FASEB J, V25, P3979, DOI 10.1096/fj.11-188607; Jones LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151702; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kaplan J, 2007, SHOCK, V28, P722, DOI 10.1097/shk.0b013e318055683a; Kelschenbach J, 2019, MBIO, V10, DOI 10.1128/mBio.00591-19; Kelschenbach JL, 2012, J NEUROIMMUNE PHARM, V7, P380, DOI 10.1007/s11481-011-9316-1; Langford D, 2004, J NEUROPATH EXP NEUR, V63, P1038, DOI 10.1093/jnen/63.10.1038; Le Douce V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-32; Lee DH, 2012, AM J PHYSIOL-ENDOC M, V302, pE552, DOI 10.1152/ajpendo.00569.2011; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li GH, 2016, CURR HIV RES, V14, P373, DOI 10.2174/1570162X14666161006121455; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1007/BF03206645; Maschke M, 2000, J NEUROL NEUROSUR PS, V69, P376, DOI 10.1136/jnnp.69.3.376; McRae M, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1143543; Moidunny S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0613-8; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Muscarella LA, 2014, J NEUROPATH EXP NEUR, V73, P50, DOI [10.1097/NEN.0000000000000026, 10.1097/NEN.0000000000000024]; Nakatsumi H, 2017, CELL REP, V21, P2471, DOI 10.1016/j.celrep.2017.11.014; Nedelcovych MT, 2017, J MED CHEM, V60, P7186, DOI 10.1021/acs.jmedchem.7b00966; Nwogu JN, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/2587094; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Omeragic A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45878-6; Omeragic A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0957-8; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Piacenti FJ, 2006, PHARMACOTHERAPY, V26, P1111, DOI 10.1592/phco.26.8.1111; Potula R, 2008, AIDS, V22, P1539, DOI 10.1097/QAD.0b013e3283081e08; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Robillard KR, 2014, ANTIMICROB AGENTS CH, V58, P1713, DOI 10.1128/AAC.02031-13; Ronaldson PT, 2008, GLIA, V56, P1711, DOI 10.1002/glia.20725; Ronaldson PT, 2008, J NEUROCHEM, V106, P1298, DOI 10.1111/j.1471-4159.2008.05479.x; Ronaldson PT, 2006, MOL PHARMACOL, V70, P1087, DOI 10.1124/mol.106.025973; Russell RA, 2017, CELL REP, V18, P1473, DOI 10.1016/j.celrep.2017.01.027; Sahebkar A, 2014, EXPERT OPIN PHARMACO, V15, P493, DOI 10.1517/14656566.2014.876992; Saylor D, 2018, INFECT NEUROINFECTIO, V24, P1397, DOI DOI 10.1212/C0N.0000000000000647; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Schildge S., 2013, JOVE-J VIS EXP, P1; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Sillman Brady, 2018, Handb Clin Neurol, V152, P21, DOI 10.1016/B978-0-444-63849-6.00003-7; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; Weber SM, 2004, AM J ENDOCRINOL META, V63104, P329; Xie X, 2017, MBIO, V8, P1	74	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1996	2010		10.1096/fj.201901874R	http://dx.doi.org/10.1096/fj.201901874R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907999				2022-12-28	WOS:000514663600007
J	Volkening, L; Vatselia, A; Asgedom, G; Bastians, H; Lavin, M; Schindler, D; Schambach, A; Bousset, K; Dork, T				Voelkening, Lea; Vatselia, Anna; Asgedom, Girmay; Bastians, Holger; Lavin, Martin; Schindler, Detlev; Schambach, Axel; Bousset, Kristine; Doerk, Thilo			RAD50 regulates mitotic progression independent of DNA repair functions	FASEB JOURNAL			English	Article						ATR; cell division; mitotic delay; MRN complex; RAD50 phosphorylation	DAMAGE RESPONSE; ATM; PHOSPHORYLATION; REPLICATION; PROMOTES; PATHWAY; MITOSIS	The Mre11A/RAD50/NBN complex (MRN) is an essential regulator of the cellular damage response after DNA double-strand breaks (DSBs). More recent work has indicated that MRN may also impact on the duration of mitosis. We show here that RAD50-deficient fibroblasts exhibit a marked delay in mitotic progression that can be rescued by lentiviral transduction of RAD50. The delay was observed throughout all mitotic phases in live cell imaging using GFP-labeled H2B as a fluorescent marker. In complementation assays with RAD50 phosphorylation mutants, modifications at Ser635 had little effect on mitotic progression. By contrast with RAD50, fibroblast strains deficient in ATM or NBN did not show a significant slowing of mitotic progression. Ataxia-telangiectasia-like disorder (ATLD) fibroblasts with nuclease-deficient MRE11A (p.W210C) tended to show slower mitosis, though by far not as significant as RAD50-deficient cells. Inhibitor studies indicated that ATM kinase activity might not grossly impact on mitotic progression, while treatment with MRE11A inhibitor PFM39 modestly prolonged mitosis. Inhibition of ATR kinase significantly prolonged mitosis but this effect was mostly independent of RAD50 status. Taken together, our data unravel a mitotic role of RAD50 that can be separated from its known functions in DNA repair.	[Voelkening, Lea; Vatselia, Anna; Bousset, Kristine; Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, D-30625 Hannover, Germany; [Asgedom, Girmay; Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Bastians, Holger] Univ Med Gottingen, Inst Mol Oncol, Gottingen, Germany; [Lavin, Martin] Queensland Inst Med Res, Brisbane, Qld, Australia; [Schindler, Detlev] Univ Wurzburg, Inst Human Genet, Bioctr, Wurzburg, Germany; [Schambach, Axel] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Hannover Medical School; Hannover Medical School; University of Gottingen; QIMR Berghofer Medical Research Institute; University of Wurzburg; Harvard University; Boston Children's Hospital; Harvard Medical School	Dork, T (corresponding author), Hannover Med Sch, Gynaecol Res Unit, D-30625 Hannover, Germany.	doerk.thilo@mh-hannover.de	Schambach, Axel/C-5491-2011; Dörk, Thilo/J-8620-2012; Lavin, Martin/F-5961-2014	Dörk, Thilo/0000-0002-9458-0282; Lavin, Martin/0000-0002-5940-4769				Aze A, 2016, NAT CELL BIOL, V18, P684, DOI 10.1038/ncb3344; Bakhoum SF, 2017, TRENDS CANCER, V3, P225, DOI 10.1016/j.trecan.2017.02.001; Eliezer Y, 2014, J BIOL CHEM, V289, P8182, DOI 10.1074/jbc.M113.532739; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Gatei M, 2014, HUM MOL GENET, V23, P4232, DOI 10.1093/hmg/ddu141; Gatei M, 2011, J BIOL CHEM, V286, P31542, DOI 10.1074/jbc.M111.258152; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jones GN, 2018, BRIT J CANCER, V119, P1233, DOI 10.1038/s41416-018-0286-4; Jullien D, 2002, J CELL SCI, V115, P71; Kabeche L, 2018, SCIENCE, V359, P108, DOI 10.1126/science.aan6490; Laulier C, 2011, NUCLEIC ACIDS RES, V39, P5935, DOI 10.1093/nar/gkr187; Lemmens B, 2018, MOL CELL, V71, P117, DOI 10.1016/j.molcel.2018.05.026; Li J, 2018, BIOCHEM J, V475, P981, DOI 10.1042/BCJ20170520; Li ZG, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00595-16; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Oricchio E, 2006, CELL CYCLE, V5, P88, DOI 10.4161/cc.5.1.2269; Palazzo L, 2014, CELL CYCLE, V13, P1091, DOI 10.4161/cc.27945; Reynolds JJ, 2013, DNA REPAIR, V12, P588, DOI 10.1016/j.dnarep.2013.04.011; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rozier L, 2013, MOL CELL, V49, P1097, DOI 10.1016/j.molcel.2013.01.023; Schroder-Heurich B, 2014, FASEB J, V28, P1331, DOI 10.1096/fj.13-236984; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Syed A, 2018, ANNU REV BIOCHEM, V87, P263, DOI 10.1146/annurev-biochem-062917-012415; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Xu R, 2018, P NATL ACAD SCI USA, V115, pE10079, DOI 10.1073/pnas.1806665115; Yang CY, 2014, CARCINOGENESIS, V35, P2007, DOI 10.1093/carcin/bgu087; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016	31	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2812	2820		10.1096/fj.201902318R	http://dx.doi.org/10.1096/fj.201902318R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908056				2022-12-28	WOS:000514663600060
J	Taniguchi, M; Ueda, Y; Matsushita, M; Nagaya, S; Hashizume, C; Arai, K; Kabayama, K; Fukase, K; Watanabe, K; Wardhani, LO; Hayashi, K; Okazaki, T				Taniguchi, Makoto; Ueda, Yoshibumi; Matsushita, Michiko; Nagaya, Shingo; Hashizume, Chieko; Arai, Kenta; Kabayama, Kazuya; Fukase, Koichi; Watanabe, Ken; Wardhani, Lusi Oka; Hayashi, Kazuhiko; Okazaki, Toshiro			Deficiency of sphingomyelin synthase 2 prolongs survival by the inhibition of lymphoma infiltration through ICAM-1 reduction	FASEB JOURNAL			English	Article						ICAM-1; infiltration; malignant lymphoma; SMS2; sphingomyelin	LUNG EPITHELIAL-CELLS; TUMOR MICROENVIRONMENT; CIRCULATING MARKERS; SMS2 DEFICIENCY; FATTY LIVER; EXPRESSION; METASTASIS; ADHESION; SPHINGOLIPIDS; INFLAMMATION	The tumor microenvironment (TME) formation involving host cells and cancer cells through cell adhesion molecules (CAMs) is essential for the multiple steps of cancer metastasis and growth. Sphingomyelin synthase 2 (SMS2) is involved in inflammatory diseases such as obesity and diabetes mellitus by regulation of the SM/ceramide balance. However, the involvement of SMS2 in TME formation and metastasis is largely unknown. Here, we report that SMS2-deficient (SMS2-KO) mice show suppressed the EL4 cell infiltration to liver and prolonged survival time. ICAM-1 was identified as a candidate for the inhibition of TME formation in immortalized mouse embryonic fibroblasts (tMEFs) from mRNA array analysis for CAMs. Reduced SM/ceramide balance in SMS2-KO tMEFs suppressed the attachment of EL4 cells through transcriptional reduction of ICAM-1 by the inhibition of NF-kappa B activation. TNF-alpha-induced NF-kappa B activation and subsequent induction of ICAM-1 were suppressed in SMS2-KO tMEFs but restored by SMS2 re-introduction. In the EL4 cell infiltration mouse model, EL4 injection increased ICAM-1 expression in WT liver but not in SMS2-KO mouse liver. Therefore, inhibition of SMS2 may be a therapeutic target to suppress the infiltration of malignant lymphoma.	[Taniguchi, Makoto] Kanazawa Med Univ, Med Res Inst, Dept Life Sci, Kahoku, Ishikawa, Japan; [Ueda, Yoshibumi; Nagaya, Shingo; Hashizume, Chieko; Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol & Immunol, Fac Med, 1-1 Daigaku, Kahoku, Ishikawa 9200293, Japan; [Ueda, Yoshibumi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Matsushita, Michiko] Univ Tottori, Sch Hlth Sci, Dept Pathobiol Sci & Technol, Tottori, Japan; [Arai, Kenta; Kabayama, Kazuya; Fukase, Koichi] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka, Japan; [Kabayama, Kazuya; Fukase, Koichi] Osaka Univ, Grad Sch Sci, Project Res Ctr, Osaka, Japan; [Watanabe, Ken] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Japan; [Wardhani, Lusi Oka; Hayashi, Kazuhiko] Tottori Univ, Dept Pathol & Microbiol, Fac Med, Div Mol Pathol, Tottori, Japan; [Okazaki, Toshiro] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Kahoku, Ishikawa, Japan	Kanazawa Medical University; Kanazawa Medical University; University of Tokyo; Tottori University; Osaka University; Osaka University; National Center for Geriatrics & Gerontology; Tottori University; Kanazawa Medical University	Okazaki, T (corresponding author), Kanazawa Med Univ, Dept Hematol & Immunol, Fac Med, 1-1 Daigaku, Kahoku, Ishikawa 9200293, Japan.	toshiroo@mbox.kyoto-inet.or.jp	Ueda, Yoshibumi/AHA-4956-2022; Watanabe, Ken/I-3960-2013; Kabayama, Kazuya/ABD-5748-2020; Taniguchi, Makoto/L-5757-2019	Ueda, Yoshibumi/0000-0003-1500-3469; Watanabe, Ken/0000-0003-0664-3915; Kabayama, Kazuya/0000-0002-7583-5454; Taniguchi, Makoto/0000-0001-5920-8285; Hashizume, Chieko/0000-0002-5937-3915; Wardhani, Lusi Oka/0000-0002-9895-9038	Kanazawa Medical University; JSPS KAKENHI [17K18205, 18H02697]; Takeda Science Foundation; Shalome Co., Ltd; ONO Pharmaceutical Co., Ltd; Strategic Research Foundation [S1201004, H2012-16]	Kanazawa Medical University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Shalome Co., Ltd; ONO Pharmaceutical Co., Ltd(Ono Pharmaceutical Co Ltd); Strategic Research Foundation	Kanazawa Medical University; JSPS KAKENHI, Grant/Award Number: 17K18205 and 18H02697; Takeda Science Foundation; Shalome Co., Ltd; ONO Pharmaceutical Co., Ltd; Strategic Research Foundation, Grant/Award Number: S1201004 and H2012-16	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Aoudjit F, 1998, J IMMUNOL, V161, P2333; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Benedicto A, 2017, ONCOL LETT, V14, P3883, DOI 10.3892/ol.2017.6700; Bertolino P, 2005, HEPATOLOGY, V42, P1063, DOI 10.1002/hep.20885; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BurkeGaffney A, 1996, BRIT J PHARMACOL, V119, P1149, DOI 10.1111/j.1476-5381.1996.tb16017.x; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Ding L, 2001, BRIT J CANCER, V85, P431, DOI 10.1054/bjoc.2001.1911; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; Fernandez-Garcia P, 2019, CANCERS, V11, DOI 10.3390/cancers11010088; Gowda S, 2011, AM J PHYSIOL-LUNG C, V300, pL430, DOI 10.1152/ajplung.00208.2010; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harjunpaa H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01078; Hui LL, 2015, CANCER LETT, V368, P7, DOI 10.1016/j.canlet.2015.07.039; Iyengar NM, 2016, J CLIN ONCOL, V34, P4270, DOI 10.1200/JCO.2016.67.4283; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kanwar JR, 2003, CANCER GENE THER, V10, P468, DOI 10.1038/sj.cgt.7700590; Kitatani K, 2015, MOL CELLS, V38, P482, DOI 10.14348/molcells.2015.0118; Kotteas EA, 2014, ANTICANCER RES, V34, P4665; Lee IT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/791231; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Lind L, 2003, ATHEROSCLEROSIS, V169, P203, DOI 10.1016/S0021-9150(03)00012-1; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Matsumoto T, 2016, ANTICANCER RES, V36, P1473; Matsumoto T, 2015, ANTICANCER RES, V35, P4647; Matsuura K, 2019, ANTICANCER RES, V39, P4061, DOI 10.21873/anticanres.13562; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nakamura M, 2017, ANTICANCER RES, V37, P3429, DOI 10.21873/anticanres.11710; Ogiso H, 2015, J LIPID RES, V56, P1594, DOI 10.1194/jlr.M059972; Ohnishi T, 2017, FASEB J, V31, P3816, DOI 10.1096/fj.201601225RR; Roma-Rodrigues C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040840; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sakamoto H, 2017, BIOCHEM BIOPH RES CO, V482, P202, DOI 10.1016/j.bbrc.2016.11.041; Shakor ABA, 2011, J BIOL CHEM, V286, P36053, DOI 10.1074/jbc.M111.228593; Taniguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37829; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Taniguchi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416552; Trayssac M, 2018, J CLIN INVEST, V128, P2702, DOI 10.1172/JCI97949; Ueda Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22399-2; Woo CH, 2005, AM J PHYSIOL-LUNG C, V288, pL307, DOI 10.1152/ajplung.00105.2004; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Zhang Y, 2011, BIOCHEM PHARMACOL, V82, P287, DOI 10.1016/j.bcp.2011.04.009; Zhang ZH, 2011, CLIN EXP METASTAS, V28, P551, DOI 10.1007/s10585-011-9391-y	49	9	9	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3838	3854		10.1096/fj.201901783RR	http://dx.doi.org/10.1096/fj.201901783RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31970839	Bronze			2022-12-28	WOS:000508877000001
J	Kim, BS; Tilstam, PV; Arnke, K; Leng, L; Ruhl, T; Piecychna, M; Schulte, W; Sauler, M; Frueh, FS; Storti, G; Lindenblatt, N; Giovanoli, P; Pallua, N; Bernhagen, J; Bucala, R				Kim, Bong-Sung; Tilstam, Pathricia V.; Arnke, Kevin; Leng, Lin; Ruhl, Tim; Piecychna, Marta; Schulte, Wibke; Sauler, Maor; Frueh, Florian S.; Storti, Gabriele; Lindenblatt, Nicole; Giovanoli, Pietro; Pallua, Norbert; Bernhagen, Juergen; Bucala, Richard			Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF-2 in adipose tissue during endotoxemia	FASEB JOURNAL			English	Article						adipose tissue; D-DT; inflammation; macrophage; macrophage polarization; MIF; MIF-2; sepsis; wound healing	MIGRATION INHIBITORY FACTOR; D-DOPACHROME TAUTOMERASE; INSULIN-RESISTANCE; SEPTIC SHOCK; T-CELLS; INFLAMMATION; SEPSIS; EXPRESSION; HOMOLOG	Sepsis is a leading cause of death worldwide and recent studies have shown white adipose tissue (WAT) to be an important regulator in septic conditions. In the present study, the role of the inflammatory cytokine macrophage migration inhibitory factor (MIF) and its structural homolog D-dopachrome tautomerase (D-DT/MIF-2) were investigated in WAT in a murine endotoxemia model. Both MIF and MIF-2 levels were increased in the peritoneal fluid of LPS-challenged wild-type mice, yet, in visceral WAT, the proteins were differentially regulated, with elevated MIF but downregulated MIF-2 expression in adipocytes. Mif gene deletion polarized adipose tissue macrophages (ATM) toward an anti-inflammatory phenotype while Mif-2 gene knockout drove ATMs toward a pro-inflammatory phenotype and Mif-deficiency was found to increase fibroblast viability. Additionally, we observed the same differential regulation of these two MIF family proteins in human adipose tissue in septic vs healthy patients. Taken together, these data suggest an inverse relationship between adipocyte MIF and MIF-2 expression during systemic inflammation, with the downregulation of MIF-2 in fat tissue potentially increasing pro-inflammatory macrophage polarization to further drive adipose inflammation.	[Kim, Bong-Sung; Tilstam, Pathricia V.; Leng, Lin; Piecychna, Marta; Schulte, Wibke; Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, POB 208031,300 Cedar St, New Haven, CT 06510 USA; [Kim, Bong-Sung; Ruhl, Tim; Pallua, Norbert] Rhein Westfal TH Aachen, Dept Plast Reconstruct & Hand Surg, Aachen, Germany; [Arnke, Kevin; Lindenblatt, Nicole; Giovanoli, Pietro] Univ Hosp Zurich, Dept Plast Surg & Hand Surg, Zurich, Switzerland; [Schulte, Wibke] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Schulte, Wibke] Charite Univ Med Berlin, Campus Charite Mitte I, Campus Virchow Klinikum, Dept Surg, Berlin, Germany; [Schulte, Wibke] BIH, Berlin, Germany; [Sauler, Maor] Yale Univ, Sch Med, Dept Pulm Crit Care & Sleep Med, New Haven, CT USA; [Storti, Gabriele] Univ Roma Tor Vergata, Unit Plast & Reconstruct Surg, Rome, Italy; [Bernhagen, Juergen] Ludwig Maximilians Univ Munchen, Inst Stroke & Dementia Res, Dept Vasc Biol, Munich, Germany; [Bernhagen, Juergen] Munich Cluster Syst Neurol, Munich, Germany	Yale University; RWTH Aachen University; University of Zurich; University Zurich Hospital; Yale University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Yale University; University of Rome Tor Vergata; University of Munich	Tilstam, PV (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208031,300 Cedar St, New Haven, CT 06510 USA.; Kim, BS (corresponding author), Univ Spital Zurich, Klin Plast Chirurg & Handchirurg, Ramistr 100, CH-8091 Zurich, Switzerland.	bong-sung.kim@usz.ch; pathricia.tilstam@yale.edu	Kim, Bong-Sung/AAR-3802-2021; Lindenblatt, Nicole/O-6708-2016; Frueh, Florian S./R-5012-2019; Storti, Gabriele/AAA-6683-2022	Lindenblatt, Nicole/0000-0003-0293-1004; Frueh, Florian S./0000-0003-0904-9591; Storti, Gabriele/0000-0001-7147-9854; Leng, Lin/0000-0002-0605-358X; Kim, Bong-Sung/0000-0002-0493-3196	Deutsche Forschungsgemeinschaft [SCHU2851/1-1, KI1973/1-1, KI1973/2-1, SFB 1123/A03, BE1977/7-1, BE1977/11-1]; START program [AR049610, HL130669]; Arthritis Foundation [548970]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); START program(Austrian Science Fund (FWF)); Arthritis Foundation	Deutsche Forschungsgemeinschaft, Grant/Award Number: SCHU2851/1-1, KI1973/1-1, KI1973/2-1, SFB 1123/A03, BE1977/7-1 and BE1977/11-1; START program, Grant/Award Number: AR049610 and HL130669; Arthritis Foundation, Grant/Award Number: 548970	Atri C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061801; Ayala A, 1996, SHOCK, V6, pS27, DOI 10.1097/00024382-199610001-00007; Bainbridge P, 2013, J WOUND CARE, V22, P407; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Campbell L, 2013, J INVEST DERMATOL, V133, P2461, DOI 10.1038/jid.2013.164; Cassado AD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00225; Cho KW, 2014, METHOD ENZYMOL, V537, P297, DOI 10.1016/B978-0-12-411619-1.00016-1; Dickerson RN, 2013, CRIT CARE, V17, DOI 10.1186/cc12715; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Finucane OM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113369; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Gabhann JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085834; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Hecker A, 2019, LANGENBECK ARCH SURG, V404, P257, DOI 10.1007/s00423-019-01752-7; Heinrichs D, 2014, FASEB J, V28, P5136, DOI 10.1096/fj.14-256776; Hillenbrand A, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-26; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Ishimoto K, 2012, CYTOKINE, V60, P772, DOI 10.1016/j.cyto.2012.07.037; Italiani P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087680; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Iwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033402; Kim BS, 2017, J CELL MOL MED, V21, P35, DOI 10.1111/jcmm.12936; Kim BS, 2016, BURNS, V42, P1265, DOI 10.1016/j.burns.2016.02.005; Kim BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137366; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.26; Kolyva AS, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.34; Koskela M, 2009, CRIT CARE, V13, DOI 10.1186/cc7932; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Moustaid N, 1996, J NUTR, V126, P865, DOI 10.1093/jn/126.4.865; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pepper DJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1360-z; Pierpont Yvonne N, 2014, ISRN Obes, V2014, P638936, DOI 10.1155/2014/638936; Qi DK, 2014, J CLIN INVEST, V124, P3540, DOI 10.1172/JCI73061; Rico RM, 2002, J SURG RES, V102, P193, DOI 10.1006/jsre.2001.6316; Roger T, 2001, J ENDOTOXIN RES, V7, P456, DOI 10.1177/09680519010070061101; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Sommer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073992; Van Cromphaut SJ, 2008, CURR PHARM DESIGN, V14, P1887, DOI 10.2174/138161208784980563; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wang SC, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0405-4; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080	57	14	14	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4219	4233		10.1096/fj.201901511R	http://dx.doi.org/10.1096/fj.201901511R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31961019	Bronze, Green Accepted			2022-12-28	WOS:000508663100001
J	Jiang, SH; Dong, FY; Da, LT; Yang, XM; Wang, XX; Weng, JY; Feng, L; Zhu, LL; Zhang, YL; Zhang, ZG; Sun, YW; Li, J; Xu, MJ				Jiang, Shu-Heng; Dong, Fang-Yuan; Da, Lin-Tai; Yang, Xiao-Mei; Wang, Xiao-Xue; Weng, Jing-Yi; Feng, Lei; Zhu, Li-Li; Zhang, Yan-Li; Zhang, Zhi-Gang; Sun, Yong-Wei; Li, Jun; Xu, Min-Juan			Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2	FASEB JOURNAL			English	Article						chemosensitivity; hexokinase; pancreatic cancer; Streptomyces; Warburg effect	STREPTOMYCES XIAMENENSIS 318; METABOLIC REQUIREMENTS; 2-DEOXY-D-GLUCOSE; TUMORS	Mangrove-derived actinobacteria strains are well-known for producing novel secondary metabolites. The polycyclic tetramate macrolactam (PTM), ikarugamycin (IKA) isolated from Streptomyces xiamenensis 318, exhibits antiproliferative activities against pancreatic ductal adenocarcinoma (PDAC) in vitro. However, the protein target for bioactive IKA is unclear. In this study, whole transcriptome-based profiling revealed that the glycolysis pathway is significantly affected by IKA. Metabolomic studies demonstrated that IKA treatment induces a significant drop in glucose-6-phosphate and a slight increase in intracellular glucose level. Analysis of glucose consumption, lactate production, and the extracellular acidification rate confirmed the inhibitory role of IKA on the glycolytic flux in PDAC cells. Surface plasmon resonance (SPR) experiments and docking studies identified the key enzyme of glycolysis, hexokinase 2 (HK2), as a molecular target of IKA. Moreover, IKA reduced tumor size without overt cytotoxicity in mice with PDAC xenografts and increased chemotherapy response to gemcitabine in PDAC cells in vitro. Taken together, IKA can block glycolysis in pancreatic cancer by targeting HK2, which may be a potential drug candidate for PDAC treatment.	[Jiang, Shu-Heng; Da, Lin-Tai; Weng, Jing-Yi; Xu, Min-Juan] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Jiang, Shu-Heng; Yang, Xiao-Mei; Zhu, Li-Li; Zhang, Yan-Li; Zhang, Zhi-Gang; Li, Jun] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Dong, Fang-Yuan] Fudan Univ, Huadong Hosp, Shanghai Key Lab Clin Geriatr Med, Dept Gastroenterol, Shanghai, Peoples R China; [Wang, Xiao-Xue; Feng, Lei] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai, Peoples R China; [Sun, Yong-Wei] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Biliary Pancreat Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, MJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.; Li, J (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	junli@shsci.org; minjuanxu@sjtu.edu.cn		Xu, Min-Juan/0000-0003-1768-208X	National Natural Science Foundation of China (NSFC) [81502382, 81473105]; National Natural Science Foundation of China; Shanghai Jiao Tong University; Fudan University;  [2019YFC0312501];  [19YF1445700];  [ZH2018ZDB08]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University; Fudan University; ; ; 	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81473105; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81502382; Research and Development, Grant/Award Number: 2019YFC0312501, 81502382, 19YF1445700 and ZH2018ZDB08; National Natural Science Foundation of China; Shanghai Jiao Tong University; Fudan University	Antosch J, 2014, ANGEW CHEM INT EDIT, V53, P3011, DOI 10.1002/anie.201310641; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Boeck S, 2017, LANCET, V390, P847, DOI 10.1016/S0140-6736(17)31806-8; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; Du Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10982; Elkin SR, 2016, TRAFFIC, V17, P1139, DOI 10.1111/tra.12425; Futamura Y, 2013, MOL BIOSYST, V9, P897, DOI 10.1039/c2mb25468a; Gandham SK, 2015, INT J NANOMED, V10, P4405, DOI 10.2147/IJN.S82818; Gordon-Dseagu VL, 2018, INT J EPIDEMIOL, V47, P427, DOI 10.1093/ije/dyx232; Habrook CJ, 2017, CANCER CELL, V31, P5, DOI 10.1016/j.ccell.2016.12.006; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HASUMI K, 1992, EUR J BIOCHEM, V205, P841, DOI 10.1111/j.1432-1033.1992.tb16848.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang SH, 2017, GASTROENTEROLOGY, V153, P277, DOI 10.1053/j.gastro.2017.03.008; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Lacret R, 2015, MAR DRUGS, V13, P128, DOI 10.3390/md13010128; Li W, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0530-4; Lin H, 2016, ACS MED CHEM LETT, V7, P217, DOI 10.1021/acsmedchemlett.5b00214; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo TC, 2001, J VIROL, V75, P2488, DOI 10.1128/JVI.75.5.2488-2492.2001; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nath K, 2016, BBA-REV CANCER, V1866, P151, DOI 10.1016/j.bbcan.2016.08.001; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Popescu R, 2011, MUTAT RES-FUND MOL M, V709-10, P60, DOI 10.1016/j.mrfmmm.2011.03.001; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Ros S, 2013, CANCER DISCOV, V3, P1105, DOI 10.1158/2159-8290.CD-13-0565; Salani B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02070; Schug ZT, 2016, CELL METAB, V23, P391, DOI 10.1016/j.cmet.2016.02.016; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18977; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yu HL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40689; Zhang GT, 2014, ANGEW CHEM INT EDIT, V53, P4840, DOI 10.1002/anie.201402078; Zhang XD, 2006, ANTICANCER RES, V26, P3561; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	42	13	13	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3943	3955		10.1096/fj.201901237R	http://dx.doi.org/10.1096/fj.201901237R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944405	Bronze			2022-12-28	WOS:000507596900001
J	Li, J; Deng, ZY; Zhang, X; Liu, F; Yang, CZ; Shi, GP				Li, Jie; Deng, Zhiyong; Zhang, Xian; Liu, Feng; Yang, Chongzhe; Shi, Guo-Ping			Deficiency of immunoglobulin E protects mice from experimental abdominal aortic aneurysms	FASEB JOURNAL			English	Article						abdominal aortic aneurysm; Fc epsilon R1; IgE; IL6; MAPK; neutrophil	HIGH-AFFINITY RECEPTOR; NEUTROPHIL RECRUITMENT; CELL SURVIVAL; MAST-CELLS; IGE; ACTIVATION; EXPRESSION; JNK; PATHOGENESIS; P38	Allergic asthma with high plasma IgE levels is a significant risk factor of human abdominal aortic aneurysm (AAA). This study tests a direct role of IgE in angiotensin-II (Ang-II) perfusion- and peri-aortic CaCl2 injury-induced AAA in mice. In both models, IgE-deficiency in Apoe(-/-)Ige(-/-) mice blunts AAA growth and reduces lesion accumulation of macrophages, CD4(+) and CD8(+) T cells, and lesion MHC class-II expression, CD31(+) microvessel growth, and media smooth muscle cell loss, compared with those from Apoe(-/-) control mice. Real time-PCR reveals significant reductions in expression of neutrophil chemoattractants MIP-2 alpha and CXCL5 in AAA lesions or macrophages from Apoe(-/-)Ige(-/-) mice, along with reduced lesion Ly6G(+) neutrophil accumulation. Consistent with reduced lesion inflammatory cell accumulation, we find significant reductions of plasma and AAA lesion IL6 expression in Apoe(-/-)Ige(-/-) mice. Immunofluorescent staining and FACS analysis show that AAA lesion neutrophils express Fc epsilon R1. Mechanistic study demonstrates that IgE induces neutrophil Fc epsilon R1 expression, activates MAPK signaling, and promotes IL6 production. This study supports a direct role of IgE in AAA by promoting lesion chemokine expression, inflammatory cell accumulation, MAPK signaling, and cytokine expression. IgE inhibition may represent a novel therapeutic approach in AAA management.	[Li, Jie; Liu, Feng; Yang, Chongzhe] South China Univ Technol, Sch Med, Guangzhou First Peoples Hosp, Natl Key Clin Specialty,Dept Geriatr, Guangzhou, Guangdong, Peoples R China; [Li, Jie; Deng, Zhiyong; Zhang, Xian; Yang, Chongzhe; Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Li, Jie; Deng, Zhiyong; Zhang, Xian; Yang, Chongzhe; Shi, Guo-Ping] Harvard Med Sch, Boston, MA 02115 USA; [Deng, Zhiyong; Yang, Chongzhe] Guangzhou Med Univ, Guangzhou First Peoples Hosp, Dept Geriatr, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Guangzhou Medical University; South China University of Technology	Shi, GP (corresponding author), Brigham & Womens Hosp, Cardiovasc Med, 77 Ave Louis Pasteur,NRB 7, Boston, MA 02115 USA.; Yang, CZ (corresponding author), Guangzhou First Peoples Hosp, Dept Geriatr, 1 Panfu Rd,Pansong Bldg 7, Guangzhou 510180, Guangdong, Peoples R China.	eyyangchongzhe@scut.edu.cn; gshi@bwh.harvard.edu		Zhang, Xian/0000-0002-6055-0130; Yang, Chongzhe/0000-0002-0338-8245	National Natural Science Foundation of China [81300176]; Fundamental Research Funds for the Central Universities, SCUT [D2180650]; Science Foundation of Guangzhou First People's Hospital [2019]; National Institutes of Health [HL123568, HL60942, AG058670]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities); Science Foundation of Guangzhou First People's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Natural Science Foundation of China, Grant/Award Number: 81300176; Fundamental Research Funds for the Central Universities, SCUT, Grant/Award Number: D2180650; Science Foundation of Guangzhou First People's Hospital, Grant/Award Number: 2019; National Institutes of Health, Grant/Award Number: HL123568, HL60942 and AG058670	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Alphonse MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001921; Anzai A, 2015, CIRC RES, V116, P612, DOI 10.1161/CIRCRESAHA.116.304918; APPELBERG R, 1992, J LEUKOCYTE BIOL, V52, P303, DOI 10.1002/jlb.52.3.303; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Dale MA, 2015, ARTERIOSCL THROM VAS, V35, P1746, DOI 10.1161/ATVBAHA.115.305269; de Oliveira S, 2015, J IMMUNOL, V194, P1523, DOI 10.4049/jimmunol.1402386; Disteldorf EM, 2015, J AM SOC NEPHROL, V26, P55, DOI 10.1681/ASN.2013101061; Eliason JL, 2005, CIRCULATION, V112, P232, DOI 10.1161/CIRCULATIONAHA.104.517391; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; Golledge J, 2019, NAT REV CARDIOL, V16, P225, DOI 10.1038/s41569-018-0114-9; Gounni AS, 2001, FASEB J, V15, P940, DOI 10.1096/fj.00-0378com; Gray RD, 2018, THORAX, V73, P134, DOI 10.1136/thoraxjnl-2017-210134; Rosa SIG, 2016, PHYTOMEDICINE, V23, P9, DOI 10.1016/j.phymed.2015.11.003; Guo WJ, 2019, AGING DIS, V10, P699, DOI 10.14336/AD.2018.1128; Hannawa KK, 2005, CIRCULATION, V112, P241, DOI 10.1161/CIRCULATIONAHA.105.535625; He L, 2018, ARTERIOSCL THROM VAS, V38, P1616, DOI 10.1161/ATVBAHA.118.311289; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Kasper B, 2006, BLOOD, V107, P1768, DOI 10.1182/blood-2005-06-2501; Keeling W Brent, 2005, Vasc Endovascular Surg, V39, P457, DOI 10.1177/153857440503900601; Kelly BT, 2016, ANN ALLERG ASTHMA IM, V116, P183, DOI 10.1016/j.anai.2015.10.026; Kim HW, 2017, AM J PHYSIOL-HEART C, V313, pH1168, DOI 10.1152/ajpheart.00296.2017; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kothari P, 2014, J IMMUNOL, V192, P349, DOI 10.4049/jimmunol.1301906; Lai CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146565; Liu CL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11983-3; Liu CL, 2018, NAT REV CARDIOL, V15, P351, DOI 10.1038/s41569-018-0002-3; Liu CL, 2016, ARTERIOSCL THROM VAS, V36, P69, DOI 10.1161/ATVBAHA.115.305911; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Monteseirin J, 2001, CLIN EXP ALLERGY, V31, P889, DOI 10.1046/j.1365-2222.2001.01083.x; Monteseirin J, 2007, J IMMUNOL, V179, P2634, DOI 10.4049/jimmunol.179.4.2634; Moxon JV, 2010, CURR PROB CARDIOLOGY, V35, P512, DOI 10.1016/j.cpcardiol.2010.08.004; Nishi H, 2017, J CLIN INVEST, V127, P3810, DOI 10.1172/JCI94039; Pagano MB, 2007, P NATL ACAD SCI USA, V104, P2855, DOI 10.1073/pnas.0606091104; Porcherie A, 2011, J EXP MED, V208, P2225, DOI 10.1084/jem.20110845; Qin ZX, 2015, J MOL CELL CARDIOL, V87, P160, DOI 10.1016/j.yjmcc.2015.08.014; Ramos-Mozo P, 2012, ATHEROSCLEROSIS, V220, P552, DOI 10.1016/j.atherosclerosis.2011.11.023; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Sampson UKA, 2014, GLOB HEART, V9, P171, DOI 10.1016/j.gheart.2013.12.010; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Spinosa M, 2018, J VASC SURG, V68, p93S, DOI 10.1016/j.jvs.2018.05.253; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Swamydas M., 2015, CURR PROTOC IMMUNOL, V110, P21; Tsai SH, 2013, CARDIOVASC RES, V100, P501, DOI 10.1093/cvr/cvt230; Wang J, 2015, J VASC SURG, V62, P1615, DOI 10.1016/j.jvs.2014.06.004; Wang J, 2014, EMBO MOL MED, V6, P952, DOI 10.15252/emmm.201303811; Wang J, 2011, J CLIN INVEST, V121, P3564, DOI 10.1172/JCI46028; Watanabe K, 2012, AM J PHYSIOL-HEART C, V302, pH95, DOI 10.1152/ajpheart.00695.2011; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Yamaguchi T, 2008, J CELL PHYSIOL, V217, P423, DOI 10.1002/jcp.21517; Yan HM, 2016, ARTERIOSCL THROM VAS, V36, P1660, DOI 10.1161/ATVBAHA.116.307786; Yang LL, 2017, CELL PHYSIOL BIOCHEM, V43, P2074, DOI 10.1159/000484192; Yi YH, 2009, J BIOL CHEM, V284, P3855, DOI 10.1074/jbc.M804334200; Zhang XJ, 2015, VASC PHARMACOL, V73, P86, DOI 10.1016/j.vph.2015.04.003	59	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3091	3104		10.1096/fj.201902095RR	http://dx.doi.org/10.1096/fj.201902095RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909541	Green Accepted			2022-12-28	WOS:000505525200001
J	Pirozzi, C; Lama, A; Annunziata, C; Cavaliere, G; De Caro, C; Citraro, R; Russo, E; Tallarico, M; Iannone, M; Ferrante, MC; Mollica, MP; Raso, GM; De Sarro, G; Calignano, A; Meli, R				Pirozzi, Claudio; Lama, Adriano; Annunziata, Chiara; Cavaliere, Gina; De Caro, Carmen; Citraro, Rita; Russo, Emilio; Tallarico, Martina; Iannone, Michelangelo; Ferrante, Maria Carmela; Mollica, Maria Pina; Mattace Raso, Giuseppina; De Sarro, Giovambattista; Calignano, Antonio; Meli, Rosaria			Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence	FASEB JOURNAL			English	Article						antiepileptic drug; hepatotoxicity; lipid metabolism; mitochondrial dysfunction; oxidative stress; short-chain fatty acid	ACTIVATED RECEPTOR-ALPHA; SPIKE-WAVE DISCHARGES; SODIUM VALPROATE; OXIDATIVE STRESS; ABSENCE EPILEPSY; ANTIEPILEPTIC DRUGS; ACID-METABOLISM; WAG/RIJ; TOXICITY; HEPATOTOXICITY	Sodium valproate (VPA), an antiepileptic drug, may cause dose- and time-dependent hepatotoxicity. However, its iatrogenic molecular mechanism and the rescue therapy are disregarded. Recently, it has been demonstrated that sodium butyrate (NaB) reduces hepatic steatosis, improving respiratory capacity and mitochondrial dysfunction in obese mice. Here, we investigated the protective effect of NaB in counteracting VPA-induced hepatotoxicity using in vitro and in vivo models. Human HepG2 cells and primary rat hepatocytes were exposed to high VPA concentration and treated with NaB. Mitochondrial function, lipid metabolism, and oxidative stress were evaluated, using Seahorse analyzer, spectrophotometric, and biochemical determinations. Liver protection by NaB was also evaluated in VPA-treated epileptic WAG/Rij rats, receiving NaB for 6 months. NaB prevented VPA toxicity, limiting cell oxidative and mitochondrial damage (ROS, malondialdehyde, SOD activity, mitochondrial bioenergetics), and restoring fatty acid oxidation (peroxisome proliferator-activated receptor alpha expression and carnitine palmitoyl-transferase activity) in HepG2 cells, primary hepatocytes, and isolated mitochondria. In vivo, NaB confirmed its activity normalizing hepatic biomarkers, fatty acid metabolism, and reducing inflammation and fibrosis induced by VPA. These data support the protective potential of NaB on VPA-induced liver injury, indicating it as valid therapeutic approach in counteracting this common side effect due to VPA chronic treatment.	[Pirozzi, Claudio; Lama, Adriano; Annunziata, Chiara; Mattace Raso, Giuseppina; Calignano, Antonio; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Via Domenico Montesano 49, I-80131 Naples, Italy; [Cavaliere, Gina; Mollica, Maria Pina] Univ Naples Federico II, Dept Biol, Naples, Italy; [De Caro, Carmen; Citraro, Rita; Russo, Emilio; De Sarro, Giovambattista] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy; [Tallarico, Martina; Iannone, Michelangelo] CNR, Inst Neurol Sci, Pharmacol Sect, Catanzaro, Italy; [Ferrante, Maria Carmela] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); University of Naples Federico II	Raso, GM; Meli, R (corresponding author), Univ Naples Federico II, Dept Pharm, Via Domenico Montesano 49, I-80131 Naples, Italy.	mattace@unina.it; meli@unina.it	Lama, Adriano/AAC-1964-2020; Tallarico, Martina/AAC-5167-2022; Pirozzi, Claudio/S-2760-2016; Russo, Emilio/G-5241-2010; De, Carmen/AAH-2150-2019	Lama, Adriano/0000-0002-5816-1400; Russo, Emilio/0000-0002-1279-8123; Mollica, Maria Pina/0000-0003-2726-7779; Mattace Raso, Giuseppina/0000-0002-5254-139X; Pirozzi, Claudio/0000-0002-3409-5744; Annunziata, Chiara/0000-0003-2784-8004; DE CARO, Carmen/0000-0003-3549-5958	Italian Ministry of Research (MIUR) [2015XSZ9A2]	Italian Ministry of Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research project was partially financed by the Italian Ministry of Research (MIUR; prot. 2015XSZ9A2)	Aires CCP, 2010, BIOCHEM PHARMACOL, V79, P792, DOI 10.1016/j.bcp.2009.10.011; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Bai XP, 2017, TOXICOL APPL PHARM, V324, P12, DOI 10.1016/j.taap.2017.03.022; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Behrends V, 2019, ARCH TOXICOL, V93, P341, DOI 10.1007/s00204-018-2371-0; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Garcia-Canaveras JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27239; Chang TKH, 2006, DRUG METAB REV, V38, P627, DOI 10.1080/03602530600959433; Chen MJ, 2015, J HEPATOL, V63, P503, DOI 10.1016/j.jhep.2015.04.016; Church RJ, 2019, HEPATOLOGY, V69, P760, DOI 10.1002/hep.29802; Citraro R, 2020, MOL NEUROBIOL, V57, P408, DOI 10.1007/s12035-019-01712-8; Citraro R, 2017, CURR PHARM DESIGN, V23, P5546, DOI 10.2174/1381612823666171024130001; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Gayam V, 2018, J COMMUNITY HOSP INT, V8, P311, DOI 10.1080/20009666.2018.1514933; Gong Y, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-44; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Ikura Y, 2010, HEPATOLOGY, V51, P2227, DOI 10.1002/hep.23688; Jafarian I, 2013, TOXICOL MECH METHOD, V23, P617, DOI 10.3109/15376516.2013.821567; Ji QLL, 2010, TOXICOL IN VITRO, V24, P1086, DOI 10.1016/j.tiv.2010.03.014; Kiang TKL, 2010, TOXICOL SCI, V118, P501, DOI 10.1093/toxsci/kfq294; Kim SM, 2017, ONCOTARGET, V8, P46273, DOI 10.18632/oncotarget.17695; Komulainen T, 2015, TOXICOLOGY, V331, P47, DOI 10.1016/j.tox.2015.03.001; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kovacs Z, 2014, BRAIN RES BULL, V104, P7, DOI 10.1016/j.brainresbull.2014.03.003; Kovacs Z, 2011, BRAIN RES BULL, V85, P410, DOI 10.1016/j.brainresbull.2011.05.003; Lama A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41295-x; Lama A, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600418; Lee MS, 2009, ARCH PHARM RES, V32, P1029, DOI 10.1007/s12272-009-1708-x; Leo A, 2017, NEUROTHERAPEUTICS, V14, P1134, DOI 10.1007/s13311-017-0550-y; LEWIS JH, 1982, HEPATOLOGY, V2, P870, DOI 10.1002/hep.1840020622; Lheureux PER, 2005, CRIT CARE, V9, P431, DOI 10.1186/cc3742; Lheureux PER, 2009, CLIN TOXICOL, V47, P101, DOI 10.1080/15563650902752376; Li SS, 2018, MOL MED REP, V18, P799, DOI 10.3892/mmr.2018.9048; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Luef G, 2009, EPILEPSY RES, V86, P42, DOI 10.1016/j.eplepsyres.2009.04.004; Ma X, 2012, J ANIM SCI, V90, P266, DOI 10.2527/jas.50965; Mancuso M, 2012, EXPERT OPIN PHARMACO, V13, P527, DOI 10.1517/14656566.2012.657177; Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Ong MMK, 2006, FREE RADICAL BIO MED, V40, P420, DOI 10.1016/j.freeradbiomed.2005.08.038; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; POWELLJACKSON PR, 1984, GUT, V25, P673, DOI 10.1136/gut.25.6.673; Rabinowich L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168905; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Raso GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068626; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Roma-Giannikou E, 1999, CELL MOL LIFE SCI, V56, P363, DOI 10.1007/s000180050437; Ruoss M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020347; Russo E, 2008, EPILEPSY BEHAV, V13, P295, DOI 10.1016/j.yebeh.2008.04.018; Russo E, 2016, NEUROSCI BIOBEHAV R, V71, P388, DOI 10.1016/j.neubiorev.2016.09.017; Russo E, 2014, BRAIN BEHAV IMMUN, V42, P157, DOI 10.1016/j.bbi.2014.06.016; Russo E, 2013, PHARMACOL RES, V70, P1, DOI 10.1016/j.phrs.2012.12.002; Russo R, 2016, PHARMACOL RES, V103, P279, DOI 10.1016/j.phrs.2015.11.026; Sato K, 2005, VIRCHOWS ARCH, V447, P996, DOI 10.1007/s00428-005-0042-z; Schmid MM, 2013, PHARMACOPSYCHIATRY, V46, P63, DOI 10.1055/s-0032-1323671; Schumacher JD, 2015, TOXICOL APPL PHARM, V289, P40, DOI 10.1016/j.taap.2015.08.022; Shen Ling, 2012, J Vis Exp, DOI 10.3791/3917; Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x; Silva MFB, 2001, ANAL BIOCHEM, V290, P60, DOI 10.1006/abio.2000.4947; Szyf M, 2015, EUR NEUROPSYCHOPHARM, V25, P682, DOI 10.1016/j.euroneuro.2014.01.009; TAKEUCHI T, 1988, NEUROPEDIATRICS, V19, P158, DOI 10.1055/s-2008-1052421; Taniura H, 2006, HISTOL HISTOPATHOL, V21, P785, DOI 10.14670/HH-21.785; Tham NTT, 2019, J VET SCI, V20, P34, DOI 10.4142/jvs.2019.20.1.34; Tolosa L, 2018, ARCH TOXICOL, V92, P383, DOI 10.1007/s00204-017-2036-4; Tong V, 2005, TOXICOL SCI, V86, P436, DOI 10.1093/toxsci/kfi185; Tong V, 2005, TOXICOL SCI, V86, P427, DOI 10.1093/toxsci/kfi184; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; van Breda SGJ, 2018, TOXICOLOGY, V393, P160, DOI 10.1016/j.tox.2017.11.013; van Luijtelaar G, 2012, INT J PSYCHOPHYSIOL, V85, P49, DOI 10.1016/j.ijpsycho.2011.09.010; van Rijn CM, 2004, EPILEPSY RES, V59, P181, DOI 10.1016/j.eplepsyres.2004.04.003; Vidaurre J, 2017, PEDIATR NEUROL, V77, P23, DOI 10.1016/j.pediatrneurol.2017.09.013; Vitins AP, 2014, ARCH TOXICOL, V88, P1573, DOI 10.1007/s00204-014-1211-0; Wang W, 2012, HUM EXP TOXICOL, V31, P1092, DOI 10.1177/0960327112444477; Wu JL, 2017, IMMUNOL LETT, V190, P169, DOI 10.1016/j.imlet.2017.08.005; Zhou D, 2017, WORLD J GASTROENTERO, V23, P60, DOI 10.3748/wjg.v23.i1.60	77	24	26	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					676	690		10.1096/fj.201900927RR	http://dx.doi.org/10.1096/fj.201900927RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914696				2022-12-28	WOS:000507308900047
J	Rymut, N; Heinz, J; Sadhu, S; Hosseini, Z; Riley, CO; Marinello, M; Maloney, J; MacNamara, KC; Spite, M; Fredman, G				Rymut, Nicholas; Heinz, Justin; Sadhu, Sudeshna; Hosseini, Zeinab; Riley, Colin O.; Marinello, Michael; Maloney, Jackson; MacNamara, Katherine C.; Spite, Matthew; Fredman, Gabrielle			Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage	FASEB JOURNAL			English	Article						efferocytosis; inflammation-resolution; MerTK; resolvin; SASP	APOPTOTIC CELLS; PLAQUE NECROSIS; RESOLUTION; INFLAMMATION; MACROPHAGES; CLEARANCE; RECEPTOR; REDUCTION; LIPOXIN	Inflammation-resolution is mediated by the balance between specialized pro-resolving mediators (SPMs) like resolvin D1 (RvD1) and pro-inflammatory factors, like leukotriene B-4 (LTB4). A key cellular process of inflammation-resolution is efferocytosis. Aging is associated with defective inflammation-resolution and the accumulation of pro-inflammatory senescent cells (SCs). Therefore, understanding mechanism(s) that underpin this impairment is a critical gap. Here, using a model of hind limb ischemia-reperfusion (I/R) remote lung injury, we present evidence that aging is associated with heightened inflammation, impaired SPM:LT ratio, defective efferocytosis, and a decrease in MerTK levels in injured lungs. Treatment with RvD1 mitigated I/R lung injury in aging, promoted efferocytosis, and prevented the decrease of MerTK in injured lungs from old mice. Old MerTK cleavage-resistant mice (MerTK(CR)) exhibited less neutrophils or polymorpho nuclear cells infiltration and had improved efferocytosis compared with old WT controls. Mechanistically, macrophages that were treated with conditioned media (CM) from senescent cells had increased MerTK cleavage, impaired efferocytosis, and a defective RvD1:LTB4 ratio. Macrophages from MerTK(CR) mice were resistant to CM-induced efferocytosis defects and had an improved RvD1:LTB4 ratio. RvD1-stimulated macrophages prevented CM-induced MerTK cleavage and promoted efferocytosis. Together, these data suggest a new mechanism and a potential therapy to promote inflammation-resolution and efferocytosis in aging.	[Rymut, Nicholas; Heinz, Justin; Sadhu, Sudeshna; Hosseini, Zeinab; Marinello, Michael; Fredman, Gabrielle] Albany Med Coll, Dept Mol & Cellular Physiol, ME403, Albany, NY 12208 USA; [Riley, Colin O.; Spite, Matthew] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA; [Riley, Colin O.; Spite, Matthew] Harvard Med Sch, Boston, MA 02115 USA; [Maloney, Jackson; MacNamara, Katherine C.] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Albany Medical College	Fredman, G (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, ME403, Albany, NY 12208 USA.	fredmag@amc.edu			American Federation for Aging (AFAR) Research grant [A16034]; NIH [HL119587, HL141127, HL106173, GM095467, GM105949]	American Federation for Aging (AFAR) Research grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an American Federation for Aging (AFAR) Research grant A16034 (GF), NIH grants HL119587 (GF), HL141127 (GF), HL106173 (MS), GM095467 (MS; Core B), and GM105949 (KCM)	Aprahamian T, 2008, CLIN EXP IMMUNOL, V152, P448, DOI 10.1111/j.1365-2249.2008.03658.x; Aprahamian T, 2004, J EXP MED, V199, P1121, DOI 10.1084/jem.20031557; Arnardottir HH, 2014, J IMMUNOL, V193, P4235, DOI 10.4049/jimmunol.1401313; Cai B, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar3721; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; DeBerge M, 2017, CIRC RES, V121, P930, DOI 10.1161/CIRCRESAHA.117.311327; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Fredman G, 2010, ARTERIOSCL THROM VAS, V30, P2005, DOI 10.1161/ATVBAHA.110.209908; Frisch BJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124213; Gangemi S, 2005, EXP GERONTOL, V40, P612, DOI 10.1016/j.exger.2005.04.004; HIGASHIMOTO Y, 1993, MECH AGEING DEV, V69, P207, DOI 10.1016/0047-6374(93)90024-L; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Kline KA, 2016, CURR OPIN MICROBIOL, V29, P63, DOI 10.1016/j.mib.2015.11.003; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; McPhillips K, 2007, J IMMUNOL, V178, P8117, DOI 10.4049/jimmunol.178.12.8117; Proto JD, 2018, IMMUNITY, V49, P666, DOI 10.1016/j.immuni.2018.07.015; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Qiu FH, 2000, P NATL ACAD SCI USA, V97, P4267, DOI 10.1073/pnas.97.8.4267; Rodier Francis, 2013, Methods Mol Biol, V965, P165, DOI 10.1007/978-1-62703-239-1_10; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SEEKAMP A, 1993, AGENT ACTION SUPPL, V41, P137; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shinohara M, 2014, AM J PHYSIOL-LUNG C, V307, pL746, DOI 10.1152/ajplung.00166.2014; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Whittington RA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01464; Wong CK, 2017, J IMMUNOL, V199, P1060, DOI 10.4049/jimmunol.1700397; Wongrakpanich S, 2018, AGING DIS, V9, P143, DOI 10.14336/AD.2017.0306; Yang B, 2016, BR J ANAESTH S2, V117, pii32	42	32	32	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					597	609		10.1096/fj.201902126R	http://dx.doi.org/10.1096/fj.201902126R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914705	Green Accepted, Bronze			2022-12-28	WOS:000507308900041
J	Su, H; Ye, C; Lei, CT; Tang, H; Zeng, JY; Yi, F; Zhang, C				Su, Hua; Ye, Chen; Lei, Chun-Tao; Tang, Hui; Zeng, Jie-Yu; Yi, Fan; Zhang, Chun			Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure	FASEB JOURNAL			English	Article						cell cycle; integrin beta 8; MDM2 membrane translocation; p53; TGF-beta 1	ACUTE-RENAL-FAILURE; FIBROSIS; ACTIVATION; BINDING; REPAIR; CELLS; BETA	Acute kidney injury (AKI) is the leading cause of renal failure, and quite a few patients will advance to chronic kidney disease (CKD) in the long term. Here, we explore the roles and mechanisms of tubular epithelial cells (TECs) during repeated cisplatin (CP) induced AKI to CKD transition (AKI-CKD). Previously, we reported that murine double minute 2 (MDM2), an E3-ubiquitin ligase, is involved in tubulointerstitial fibrosis. However, whether tubular MDM2 is implicated in AKI-CKD is undefined. Currently, we confirmed that during AKI-CKD, MDM2 shifts from nucleus to cell membrane in TECs both in vivo and in vitro. Whereas regulating MDM2 distribution chemically or genetically has a prominent impact on tubular disorders. And then we investigated the mechanisms of the above findings. First, in the nucleus, repeated CP administration leads to MDM2 reduction with escalated p53 and cell cycle G2/M arrest. On the other hand, multiple CP treatment increases the level of membranous MDM2 with ensuing integrin beta 8 degradation and TGF-beta 1 activation. More interestingly, anchoring MDM2 on cell membranes can mimic the reduction of integrin beta 8 arousing by repeated CP exposure. Collectively, our findings provided the evidence that tubular MDM2 subcellular shuttling is involved in AKI-CKD through p53-G2/M arrest and integrin beta 8 mediated TGF-beta 1 activation.	[Su, Hua; Ye, Chen; Lei, Chun-Tao; Tang, Hui; Zeng, Jie-Yu; Zhang, Chun] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nephrol, Union Hosp, Wuhan 430022, Hubei, Peoples R China; [Yi, Fan] Shandong Univ, Sch Basic Med Sci, Dept Pharmacol, Key Lab Infect & Immun Shandong Prov, Jinan, Peoples R China	Huazhong University of Science & Technology; Shandong University	Zhang, C (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nephrol, Union Hosp, Wuhan 430022, Hubei, Peoples R China.	drzhangchun@hust.edu.cn			Program for HUST Academic Frontier Youth Team [2017QYTD20]; National Natural Science Foundation of China [81570671, 81873602, 81770711]	Program for HUST Academic Frontier Youth Team; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Program for HUST Academic Frontier Youth Team, Grant/Award Number: 2017QYTD20; National Natural Science Foundation of China, Grant/Award Number: 81570671, 81873602 and 81770711	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9; Jadot I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183604; Jiang CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36698; Khan S, 2011, AM J PATHOL, V178, P609, DOI 10.1016/j.ajpath.2010.10.031; Lakhe-Reddy S, 2006, J BIOL CHEM, V281, P19688, DOI 10.1074/jbc.M601110200; Le Clef N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152153; Lei CT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10927-5; Little MH, 2017, J AM SOC NEPHROL, V28, P34, DOI 10.1681/ASN.2016070748; MOYLE M, 1991, J BIOL CHEM, V266, P19650; Mulay SR, 2016, AM J PATHOL, V186, P1442, DOI 10.1016/j.ajpath.2016.01.017; Mulay SR, 2013, J PATHOL, V230, P322, DOI 10.1002/path.4193; Mulay SR, 2012, KIDNEY INT, V81, P1199, DOI 10.1038/ki.2011.482; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Sarafraz-Yazdi E, 2010, P NATL ACAD SCI USA, V107, P1918, DOI 10.1073/pnas.0909364107; Sharp CN, 2016, AM J PHYSIOL-RENAL, V310, pF560, DOI 10.1152/ajprenal.00512.2015; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Strous G J, 2001, Sci STKE, V2001, ppe41, DOI 10.1126/stke.2001.110.pe41; Tang H, 2017, J CELL MOL MED, V21, P3435, DOI 10.1111/jcmm.13253; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Venkatachalam MA, 2015, J AM SOC NEPHROL, V26, P1765, DOI 10.1681/ASN.2015010006; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wang SM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026245; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Ye C, 2017, AM J PHYSIOL-RENAL, V312, pF760, DOI 10.1152/ajprenal.00528.2016	35	6	6	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1620	1636		10.1096/fj.201901412R	http://dx.doi.org/10.1096/fj.201901412R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914692	Bronze			2022-12-28	WOS:000507308900107
J	Tran, PHT; Malmgaard-Clausen, NM; Puggaard, RS; Svensson, RB; Nybing, JD; Hansen, P; Schjerling, P; Zinglersen, AH; Couppe, C; Boesen, M; Magnusson, SP; Kjaer, M				Tran, Peter H. T.; Malmgaard-Clausen, Nikolaj M.; Puggaard, Rikke S.; Svensson, Rene B.; Nybing, Janus D.; Hansen, Philip; Schjerling, Peter; Zinglersen, Amanda H.; Couppe, Christian; Boesen, Mikael; Magnusson, S. Peter; Kjaer, Michael			Early development of tendinopathy in humans: Sequence of pathological changes in structure and tissue turnover signaling	FASEB JOURNAL			English	Article						clinical; inflammation; mRNA; tendinopathy; ultrasound	HUMAN PATELLAR TENDON; VISA-A QUESTIONNAIRE; MECHANICAL-PROPERTIES; ACHILLES TENDINOSIS; COLLAGEN FIBRILS; GENE-EXPRESSION; SUBSTANCE-P; NEOVASCULARIZATION; IMMOBILIZATION; INFLAMMATION	Overloading of tendon tissue with resulting chronic pain (tendinopathy) is a common disorder in occupational-, leisure- and sports-activity, but its pathogenesis remains poorly understood. To investigate the very early phase of tendinopathy, Achilles and patellar tendons were investigated in 200 physically active patients and 50 healthy control persons. Patients were divided into three groups: symptoms for 0-1 months (T1), 1-2 months (T2) or 2-3 months (T3). Tendinopathic Achilles tendon cross-sectional area determined by ultrasonography (US) was similar to 25% larger than in healthy control persons. Both Achilles and patellar anterior-posterior diameter were elevated in tendinopathy, and only later in Achilles was the width increased. Increased tendon size was accompanied by an increase in hypervascularization (US Doppler flow) without any change in mRNA for angiogenic factors. From patellar biopsies taken bilaterally, mRNA for most growth factors and tendon components remained unchanged (except for TGF-beta1 and substance-P) in early tendinopathy. Tendon stiffness remained unaltered over the first three months of tendinopathy and was similar to the asymptomatic contra-lateral tendon. In conclusion, this suggests that tendinopathy pathogenesis represents a disturbed tissue homeostasis with fluid accumulation. The disturbance is likely induced by repeated mechanical overloading rather than a partial rupture of the tendon.	[Tran, Peter H. T.; Malmgaard-Clausen, Nikolaj M.; Puggaard, Rikke S.; Svensson, Rene B.; Schjerling, Peter; Zinglersen, Amanda H.; Couppe, Christian; Magnusson, S. Peter; Kjaer, Michael] Bispebjerg Hosp, Inst Sports Med Copenhagen, Dept Orthopaed Surg M, Bldg 8,Nielsine Nielsens Vej 11, DK-2400 Copenhagen NV, Denmark; [Tran, Peter H. T.; Malmgaard-Clausen, Nikolaj M.; Puggaard, Rikke S.; Svensson, Rene B.; Schjerling, Peter; Zinglersen, Amanda H.; Kjaer, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Couppe, Christian; Magnusson, S. Peter] Bispebjerg Hosp, Dept Phys & Occupat Therapy, Copenhagen, Denmark; [Nybing, Janus D.; Hansen, Philip; Boesen, Mikael] Bispebjerg Frederiksberg Hosp, Dept Radiol, Frederiksberg, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital	Tran, PHT (corresponding author), Bispebjerg Hosp, Inst Sports Med Copenhagen, Dept Orthopaed Surg M, Bldg 8,Nielsine Nielsens Vej 11, DK-2400 Copenhagen NV, Denmark.	tranenpeter@gmail.com	Magnusson, Peter/AAN-1631-2020; Kjaer, Michael/W-6842-2019; Magnusson, S. Peter/AAD-5903-2022; Zinglersen, Amanda Hempel/ABH-2482-2020; Svensson, Rene B./AGZ-3181-2022; Schjerling, Peter/F-6194-2011	Kjaer, Michael/0000-0002-4582-8755; Magnusson, S. Peter/0000-0002-4308-5484; Svensson, Rene B./0000-0002-1607-5379; Schjerling, Peter/0000-0001-7138-3211; Zinglersen, Amanda Hempel/0000-0003-2880-1638; Hansen, Philip/0000-0002-6972-7852	Lundbeck Foundation [R198-2015-207]; Nordea Foundation; Augustinus Foundation [17-3727]; Novo Nordisk Foundation [NNF16-0C0022846]; Ministry of Culture [FPK-2016-0069]; Danish Rheumatism Association [R150-A4500]	Lundbeck Foundation(Lundbeckfonden); Nordea Foundation; Augustinus Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ministry of Culture; Danish Rheumatism Association	Lundbeck Foundation, Grant/Award Number: R198-2015-207; Nordea Foundation; Augustinus Foundation, Grant/Award Number: 17-3727; Novo Nordisk Foundation, Grant/Award Number: NNF16-0C0022846; Ministry of Culture, Grant/Award Number: FPK-2016-0069; The Danish Rheumatism Association, Grant/Award Number: R150-A4500	Ackermann PW, 2003, J ORTHOP RES, V21, P432, DOI 10.1016/S0736-0266(02)00207-3; Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Backman LJ, 2011, J MUSCULOSKEL NEURON, V11, P133; Beyer R, 2018, TRANSL SPORTS MED, V1, P79, DOI 10.1002/tsm2.19; Boesen AP, 2014, J APPL PHYSIOL, V116, P192, DOI 10.1152/japplphysiol.01077.2013; Child S, 2010, AM J SPORT MED, V38, P1885, DOI 10.1177/0363546510366234; Couppe C, 2013, SCAND J MED SCI SPOR, V23, pe89, DOI 10.1111/sms.12023; Couppe C, 2012, CLIN BIOMECH, V27, P949, DOI 10.1016/j.clinbiomech.2012.06.003; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; de Boer MD, 2007, J PHYSIOL-LONDON, V583, P1079, DOI 10.1113/jphysiol.2007.135392; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; Gardin A, 2016, J MAGN RESON IMAGING, V43, P1417, DOI 10.1002/jmri.25104; Gotoh M, 1998, J ORTHOP RES, V16, P618, DOI 10.1002/jor.1100160515; Hansen P, 2006, CLIN BIOMECH, V21, P54, DOI 10.1016/j.clinbiomech.2005.07.008; Heinemeier KM, 2016, J APPL PHYSIOL, V120, P1000, DOI 10.1152/japplphysiol.00870.2015; Heinemeier KM, 2017, J APPL PHYSIOL, V123, P1397, DOI 10.1152/japplphysiol.00281.2017; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Hullfish TJ, 2018, J APPL PHYSIOL, V125, P453, DOI 10.1152/japplphysiol.00012.2018; Iversen JV, 2016, SCAND J MED SCI SPOR, V26, P1423, DOI 10.1111/sms.12576; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Kjaer M, 2013, J APPL PHYSIOL, V115, P879, DOI 10.1152/japplphysiol.00120.2013; Kongsgaard M, 2010, AM J SPORT MED, V38, P749, DOI 10.1177/0363546509350915; Leppilahti J, 1996, ACTA ORTHOP SCAND, V67, P277, DOI 10.3109/17453679608994688; Lopes AD, 2012, SPORTS MED, V42, P891, DOI [10.2165/11631170-000000000-00000, 10.1007/BF03262301]; Maganaris CN, 2003, P ROY SOC B-BIOL SCI, V270, pS39, DOI 10.1098/rsbl.2003.0004; Magnusson SP, 2010, NAT REV RHEUMATOL, V6, P262, DOI 10.1038/nrrheum.2010.43; Magnusson SP, 2018, J PHYSL, V597, P1283; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Nadeau MJ, 2016, J FOOT ANKLE RES, V9, DOI 10.1186/s13047-016-0164-3; Ohberg L, 2001, KNEE SURG SPORT TR A, V9, P233, DOI 10.1007/s001670000189; Parkinson J, 2010, ARTHRITIS RHEUM-US, V62, P3028, DOI 10.1002/art.27587; Pingel J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-53; Pingel J, 2014, J ANAT, V224, P548, DOI 10.1111/joa.12164; Pingel J, 2013, EUR J APPL PHYSIOL, V113, P2101, DOI 10.1007/s00421-013-2638-3; Pufe T, 2001, VIRCHOWS ARCH, V439, P579, DOI 10.1007/s004280100422; Rigozzi S, 2011, J STRUCT BIOL, V176, P9, DOI 10.1016/j.jsb.2011.07.002; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Svensson RB, 2017, ACTA BIOMATER, V50, P293, DOI 10.1016/j.actbio.2017.01.006; Svensson RB, 2016, J APPL PHYSIOL, V121, DOI 10.1152/japplphysiol.00328.2016; VISSER JJ, 1990, EUR J APPL PHYSIOL O, V61, P453, DOI 10.1007/BF00236067; Zanetti M, 2003, RADIOLOGY, V227, P556, DOI 10.1148/radiol.2272012069; Zheng W, 2001, AM J PHYSIOL-HEART C, V280, pH909, DOI 10.1152/ajpheart.2001.280.2.H909	43	33	33	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					776	788		10.1096/fj.201901309R	http://dx.doi.org/10.1096/fj.201901309R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914656				2022-12-28	WOS:000507308900053
J	Zhou, C; Zhang, JC; Zhang, M; Wang, DB; Ma, Y; Wang, Y; Wang, YZ; Huang, YM; Zhang, Y				Zhou, Chuan; Zhang, Jingcheng; Zhang, Min; Wang, Debao; Ma, Yi; Wang, Yong; Wang, Yizhi; Huang, Yuemeng; Zhang, Yong			Transcriptional memory inherited from donor cells is a developmental defect of bovine cloned embryos	FASEB JOURNAL			English	Article						Transcriptional memory gene; somatic cell nuclear transfer reprogramming; bovine	PLURIPOTENT STEM-CELLS; EPIGENETIC MEMORY; GENE-EXPRESSION; NUCLEAR; METHYLATION; IDENTIFICATION; FIBROBLASTS; PROTEIN-1; OOCYTES; FETAL	Studies on the effects of transcriptional memory on clone reprogramming in mammals are limited. In the present study, we observed higher levels of active histone H3 lysine 4 trimethylation (H3K4me3 and 5-hydroxymethylcytosine) and repressive (5-methylcytosine) epigenetic modifications in bovine early cloned embryos than in in vitro fertilized embryos. We hypothesized that aberrant epigenetic modification may result in transcriptional disorders in bovine somatic cell nuclear transfer (SCNT) embryos. RNA sequencing results confirmed that both abnormal transcriptional silencing and transcriptional activation are involved in bovine SCNT reprogramming. The cloned embryos exhibited excessive transcription in RNA processing- and translation-related genes as well as transcriptional defects in reproduction-related genes whose transcriptional profiles were similar to those in donor cells. These results demonstrated the existence of active and silent memory genes inherited from donor cells in early bovine SCNT embryos. Further, H3K4me3-specific demethylase 5B (KDM5B) mRNA was injected into the reconstructed embryos to reduce the increased H3K4me3 modification. KDM5B overexpression not only reduced the transcriptional level of active memory genes, but also promoted the expression of silent memory genes; in particular, it rescued the expression of multiple development-related genes. These results showed that transcriptional memory acts as a reprogramming barrier and KDM5B improves SCNT reprogramming via bidirectional regulation effects on transcriptional memory genes in bovines.	[Zhou, Chuan; Zhang, Jingcheng; Zhang, Min; Wang, Debao; Wang, Yong; Wang, Yizhi; Huang, Yuemeng; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China; [Zhou, Chuan; Zhang, Jingcheng; Zhang, Min; Wang, Debao; Wang, Yong; Wang, Yizhi; Huang, Yuemeng; Zhang, Yong] Engn Ctr Anim Embryo Technol, Yangling, Shaanxi, Peoples R China; [Zhou, Chuan; Zhang, Jingcheng; Zhang, Min; Wang, Debao; Wang, Yong; Wang, Yizhi; Huang, Yuemeng; Zhang, Yong] Northwest A&F Univ, Lab Embryo Technol Livestock, Yangling, Shaanxi, Peoples R China; [Ma, Yi] Tianjin Inst Anim Sci & Vet, Tianjin, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	zhangyong1956@nwsuaf.edu.cn			National Natural Science Foundation of China [31772603]; National Major Project for Production of Transgenic Breeding [2016ZX08007-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Production of Transgenic Breeding	National Natural Science Foundation of China, Grant/Award Number: 31772603; National Major Project for Production of Transgenic Breeding, Grant/Award Number: 2016ZX08007-003	Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Cao ZB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144897; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Gao R, 2018, CELL STEM CELL, V23, P426, DOI 10.1016/j.stem.2018.07.017; GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779; Han J, 2018, THERIOGENOLOGY, V108, P46, DOI 10.1016/j.theriogenology.2017.11.029; Hormanseder E, 2017, CELL STEM CELL, V21, P135, DOI 10.1016/j.stem.2017.03.003; Hu JJ, 2010, DEV DYNAM, V239, P407, DOI 10.1002/dvdy.22170; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang ZL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-756; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Khaw SL, 2015, CELL REP, V12, P1080, DOI 10.1016/j.celrep.2015.07.032; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu WQ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.10; Liu X, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158261; Liu Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5091-1; Lonergan P, 2007, THERIOGENOLOGY, V68, P1128, DOI 10.1016/j.theriogenology.2007.08.012; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Nishimura K, 2017, STEM CELL REP, V8, P787, DOI 10.1016/j.stemcr.2017.01.026; Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rissi VB, 2019, REPRODUCTION, V157, P123, DOI 10.1530/REP-18-0366; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Singh SK, 2018, CELL STEM CELL, V23, P252, DOI 10.1016/j.stem.2018.06.001; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Su JM, 2015, J PINEAL RES, V59, P455, DOI 10.1111/jpi.12275; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xie BT, 2016, REPRODUCTION, V151, P9, DOI 10.1530/REP-15-0338; Xu Y, 2016, AM J HUM GENET, V99, P744, DOI 10.1016/j.ajhg.2016.06.024; Yang L, 2018, EMBO REP, V19, DOI 10.15252/embr.201846240; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yang XG, 2016, CANCER RES, V76, P4124, DOI 10.1158/0008-5472.CAN-15-2973; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zhang JC, 2017, J BIOL CHEM, V292, P15916, DOI 10.1074/jbc.M117.796771; Zhang ZR, 2018, CELL PHYSIOL BIOCHEM, V45, P1529, DOI 10.1159/000487579; Zhou C, 2019, FASEB J, V33, P4638, DOI 10.1096/fj.201801887R	52	25	26	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1637	1651		10.1096/fj.201900578RR	http://dx.doi.org/10.1096/fj.201900578RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914649				2022-12-28	WOS:000507308900108
J	Nunez, FJ; Johnstone, TB; Corpuz, ML; Kazarian, AG; Mohajer, NN; Tliba, O; Panettieri, RA; Koziol-White, C; Roosan, MR; Ostrom, RS				Nunez, Francisco J.; Johnstone, Timothy B.; Corpuz, Maia L.; Kazarian, Austin G.; Mohajer, Nicole N.; Tliba, Omar; Panettieri, Reynold A.; Koziol-White, Cynthia; Roosan, Moom R.; Ostrom, Rennolds S.			Glucocorticoids rapidly activate cAMP production via G(alpha s) to initiate non-genomic signaling that contributes to one-third of their canonical genomic effects	FASEB JOURNAL			English	Article						airway smooth muscle; corticosteroids; G protein-coupled receptors; membrane glucocorticoid receptor; RNA sequencing	RNA-SEQ DATA; INHALED CORTICOSTEROIDS; SINGLE INHALER; RECEPTOR; BUDESONIDE/FORMOTEROL; EXPRESSION; BIOCONDUCTOR; PROGESTERONE; MAINTENANCE; EFFICACY	Glucocorticoids are widely used for the suppression of inflammation, but evidence is growing that they can have rapid, non-genomic actions that have been unappreciated. Diverse cell signaling effects have been reported for glucocorticoids, leading us to hypothesize that glucocorticoids alone can swiftly increase the 3 ',5 '-cyclic adenosine monophosphate (cAMP) production. We found that prednisone, fluticasone, budesonide, and progesterone each increased cAMP levels within 3 minutes without phosphodiesterase inhibitors by measuring real-time cAMP dynamics using the cAMP difference detector in situ assay in a variety of immortalized cell lines and primary human airway smooth muscle (HASM) cells. A membrane- impermeable glucocorticoid showed similarly rapid stimulation of cAMP, implying that responses are initiated at the cell surface. siRNA knockdown of G(alpha s) virtually eliminated glucocorticoid-stimulated cAMP responses, suggesting that these drugs activate the cAMP production via a G protein-coupled receptor. Estradiol had small effects on cAMP levels but G protein estrogen receptor antagonists had little effect on responses to any of the glucocorticoids tested. The genomic and non-genomic actions of budesonide were analyzed by RNA-Seq analysis of 24 hours treated HASM, with and without knockdown of G(alpha s). A 140-gene budesonide signature was identified, of which 48 genes represent a non-genomic signature that requires G(alpha s) signaling. Collectively, this non-genomic cAMP signaling modality contributes to one-third of the gene expression changes induced by glucocorticoid treatment and shifts the view of how this important class of drugs exerts its effects.	[Nunez, Francisco J.; Johnstone, Timothy B.; Corpuz, Maia L.; Kazarian, Austin G.; Mohajer, Nicole N.; Ostrom, Rennolds S.] Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, 9401 Jeronimo Rd, Irvine, CA 92618 USA; [Tliba, Omar] Long Isl Univ, Coll Vet Med, Dept Biomed Sci, Brookville, NY USA; [Panettieri, Reynold A.; Koziol-White, Cynthia] Rutgers State Univ, Inst Child Hlth, Rutgers Inst Translat Med & Sci, New Brunswick, NJ USA; [Roosan, Moom R.] Chapman Univ, Sch Pharm, Dept Pharm Practice, Irvine, CA USA	Chapman University System; Chapman University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Chapman University System; Chapman University	Ostrom, RS (corresponding author), Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, 9401 Jeronimo Rd, Irvine, CA 92618 USA.	rostrom@chapman.edu		Roosan, Moom/0000-0002-5318-5120	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [GM107094]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [P01HL11447, HL111541]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM107094; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: P01HL11447 and HL111541	Buttgereit F, 1997, BIOCHEM J, V326, P329, DOI 10.1042/bj3260329; COLLINS S, 1988, J BIOL CHEM, V263, P9067; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Flaherty RL, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0823-8; Gai MN, 2005, J CHROMATOGR SCI, V43, P201, DOI 10.1093/chromsci/43.4.201; Garcia-Murillas I, 2014, ONCOGENE, V33, P2478, DOI 10.1038/onc.2013.202; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han JZ, 2005, ACTA PHARMACOL SIN, V26, P199, DOI 10.1111/j.1745-7254.2005.00539.x; Himes BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099625; Horvath G, 2011, PULM PHARMACOL THER, V24, P654, DOI 10.1016/j.pupt.2011.08.002; Ishimoto H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003843; Johnstone TB, 2018, AM J RESP CELL MOL, V58, P530, DOI 10.1165/rcmb.2017-0294OC; Kan MY, 2019, AM J RESP CELL MOL, V61, P110, DOI 10.1165/rcmb.2018-0385OC; Koziol-White C, 2019, AM J PHYSL LUN UNPUB; Lemanske Robert F. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS502; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindsey SH, 2014, STEROIDS, V81, P99, DOI 10.1016/j.steroids.2013.10.017; Liu XQ, 2010, AM J PHYSIOL-LUNG C, V298, pL819, DOI 10.1152/ajplung.00429.2009; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; MOORE FL, 1994, HORM BEHAV, V28, P512, DOI 10.1006/hbeh.1994.1049; Newton R, 2016, BRIT J PHARMACOL, V173, P3405, DOI 10.1111/bph.13628; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri RA, 2019, TRENDS PHARMACOL SCI, V40, P38, DOI 10.1016/j.tips.2018.11.002; Rabe KF, 2006, CHEST, V129, P246, DOI 10.1378/chest.129.2.246; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scicchitano R, 2004, CURR MED RES OPIN, V20, P1403, DOI 10.1185/030079904X2051; Shen Y, 2015, BIOINFORMATICS, V31, P1745, DOI 10.1093/bioinformatics/btv031; Smit P, 2012, J EUR ACAD DERMATOL, V26, P1197, DOI 10.1111/j.1468-3083.2012.04449.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Song IH, 2006, MOL CELL ENDOCRINOL, V246, P142, DOI 10.1016/j.mce.2005.11.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Timmermans S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01545; Urbach V, 2006, STEROIDS, V71, P323, DOI 10.1016/j.steroids.2005.09.014; Urbach V, 2001, J PHYSIOL-LONDON, V537, P267, DOI 10.1111/j.1469-7793.2001.0267k.x; Vernocchi S, 2013, MOL CELL PROTEOMICS, V12, P1764, DOI 10.1074/mcp.M112.022947; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Yu T, 2017, ONCOGENE, V36, P2131, DOI 10.1038/onc.2016.370; Yu X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191418; Yu X, 2014, AM J PHYSIOL-ENDOC M, V307, pE398, DOI 10.1152/ajpendo.00534.2013; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang SM, 2007, STEROIDS, V72, P600, DOI 10.1016/j.steroids.2007.03.012; Zhang YM, 2012, AM J PHYSIOL-ENDOC M, V302, pE747, DOI 10.1152/ajpendo.00302.2011	47	15	16	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2882	2895		10.1096/fj.201902521R	http://dx.doi.org/10.1096/fj.201902521R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908022	hybrid, Green Published			2022-12-28	WOS:000504677500001
J	Shen, WY; Luo, C; Hurtado, PR; Hurtado-Perez, E; Luo, RY; Hu, ZL; Li, H; Xu, JM; Zhou, XF; Dai, RP				Shen, Wei-Yun; Luo, Cong; Reinaldo Hurtado, Plinio; Hurtado-Perez, Ernesto; Luo, Ru-Yi; Hu, Zhao-Lan; Li, Hui; Xu, Jun-Mei; Zhou, Xin-Fu; Dai, Ru-Ping			The regulatory role of ProBDNF in monocyte function: Implications in Stanford type-A aortic dissection disease	FASEB JOURNAL			English	Article						inflammatory disease; monocytes; proBDNF; Stanford type-A acute aortic dissection	NERVOUS-SYSTEM; BDNF; P75(NTR); INFLAMMATION; BLOOD; POLARIZATION; INJURY; CELLS	Brain-derived neurotrophic factor precursor (proBDNF) has been reported to strengthen the dysfunction of monocytes/macrophages in animal studies. However, it is still unknown the roles of proBDNF in the dysfunction of monocytes in the inflammatory diseases in humans. In the present study, we showed that proBDNF and pan neurotrophic receptor p75 were significantly upregulated in monocytes from healthy donors (HD) after lipopolysaccharide treatment. Exogenous proBDNF treatment upregulated CD40 and proinflammatory cytokines expression in monocytes including interleukin (IL)-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha. In Stanford type-A acute aortic dissection (AAD) patients, proBDNF was upregulated in CD14(+)CD163(+)CX3CR1(+) M2- but not CD14(+)CD68(+)CCR2(+)M1-like monocytes. In addition, sera from AAD patients activated gene expression of proinflammatory cytokines in cultured PBMCs from HD, which was attenuated by proBDNF monoclonal antibody (Ab-proB) treatment. These findings suggested that upregulation of proBDNF in M2-like monocytes may contribute to the proinflammatory response in the AAD.	[Shen, Wei-Yun; Luo, Cong; Luo, Ru-Yi; Hu, Zhao-Lan; Li, Hui; Xu, Jun-Mei; Dai, Ru-Ping] Cent South Univ, Xiangya Hosp 2, Dept Anesthesiol, 139 Ren Min Cent Rd, Changsha 410011, Hunan, Peoples R China; [Shen, Wei-Yun; Luo, Cong; Luo, Ru-Yi; Hu, Zhao-Lan; Li, Hui; Xu, Jun-Mei; Dai, Ru-Ping] Cent South Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China; [Reinaldo Hurtado, Plinio; Hurtado-Perez, Ernesto] Royal Adelaide Hosp, Dept Renal Med, Adelaide, SA, Australia; [Zhou, Xin-Fu] Univ South Australia, Div Hlth Sci, Sch Pharm & Med Sci, Adelaide, SA, Australia	Central South University; Central South University; Royal Adelaide Hospital; University of South Australia	Luo, C; Dai, RP (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Anesthesiol, 139 Ren Min Cent Rd, Changsha 410011, Hunan, Peoples R China.	Luocong1988@csu.edu.cn; xyeyyrupingdai@csu.edu.cn	Hu, Zhaolan/GYU-4213-2022		National Natural Science Foundation of China [81773154, 81471106, 81873770]; National Key R&D Program of China [2018YFC2001902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	National Natural Science Foundation of China, Grant/Award Number: 81773154, 81471106 and 81873770; National Key R&D Program of China, Grant/Award Number: 2018YFC2001902	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Azoulay D, 2008, J NEUROIMMUNOL, V195, P186, DOI 10.1016/j.jneuroim.2008.01.010; Blochl A, 2007, J NEUROCHEM, V102, P289, DOI 10.1111/j.1471-4159.2007.04496.x; Bonizzi G, 2004, TRENDS IMMUNOL, V35, P270; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Cai DQ, 2006, PHYSIOL GENOMICS, V24, P191, DOI 10.1152/physiolgenomics.00165.2005; Cifani N, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/9782594; Cordova ZM, 2016, ONCOTARGET, V7, P54392, DOI 10.18632/oncotarget.11106; Del Porto F, 2010, ANN MED, V42, P622, DOI 10.3109/07853890.2010.518156; Dusedau HP, 2019, GLIA, V67, P193, DOI 10.1002/glia.23553; Erbel Raimund, 2014, Kardiol Pol, V72, P1169, DOI 10.5603/KP.2014.0225; Fadini GP, 2013, DIABETOLOGIA, V56, P1856, DOI 10.1007/s00125-013-2918-9; Fadini GP, 2014, ATHEROSCLEROSIS, V237, P805, DOI 10.1016/j.atherosclerosis.2014.10.106; Fleitas C, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0411-6; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Fukui S, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01958; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Jiang YM, 2008, MOL IMMUNOL, V45, P1557, DOI 10.1016/j.molimm.2007.10.008; Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644; Kaess BM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001544; Lansac G, 2006, J NEUROIMMUNOL, V171, P57, DOI 10.1016/j.jneuroim.2005.09.019; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Lim Y, 2015, J NEUROCHEM, V134, P75, DOI 10.1111/jnc.13108; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Luo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27171; Luo F, 2009, AGEING RES REV, V8, P31, DOI 10.1016/j.arr.2008.08.001; Morimura S, 2016, J DERMATOL SCI, V82, P175, DOI 10.1016/j.jdermsci.2016.03.004; Nienaber CA, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.71, 10.1038/nrdp.2016.53]; Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu203; Rost B, 2005, REGUL PEPTIDES, V124, P19, DOI 10.1016/j.regpep.2004.06.024; Schulte-Herbruggen O, 2005, J NEUROIMMUNOL, V160, P204, DOI 10.1016/j.jneuroim.2004.10.026; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; Tasci I, 2012, ANADOLU KARDIYOL DER, V12, P684, DOI 10.5152/akd.2012.221; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; van Diepen JA, 2016, CELL MOL LIFE SCI, V73, P4675, DOI 10.1007/s00018-016-2316-9; Weber C, 2016, THROMB HAEMOSTASIS, V116, P626, DOI 10.1160/TH16-02-0091; Wong I, 2010, BRAIN BEHAV IMMUN, V24, P585, DOI 10.1016/j.bbi.2010.01.001; Zhao GQ, 2017, MOL NEUROBIOL, V54, P5573, DOI 10.1007/s12035-016-0098-6; Zhou L, 2018, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0015-4; Zhou L, 2013, J AFFECT DISORDERS, V150, P776, DOI 10.1016/j.jad.2013.03.002; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x	43	10	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2541	2553		10.1096/fj.201901905RR	http://dx.doi.org/10.1096/fj.201901905RR		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908023	Bronze			2022-12-28	WOS:000504090300001
J	Zhang, L; Liu, LM; Bai, M; Liu, MN; Wei, L; Yang, Z; Qian, Q; Ning, XX; Sun, SR				Zhang, Lei; Liu, Limin; Bai, Ming; Liu, Minna; Wei, Lei; Yang, Zhen; Qian, Qi; Ning, Xiaoxuan; Sun, Shiren			Hypoxia-induced HE4 in tubular epithelial cells promotes extracellular matrix accumulation and renal fibrosis via NF-kappa B	FASEB JOURNAL			English	Article						chronic hypoxia; extracellular matrix; human epididymis secretory protein 4; NF-kappa B; renal fibrosis	EPIDIDYMIS PROTEIN 4; KIDNEY-DISEASE; ACTIVATION; EXPRESSION; FIBROGENESIS; PROGRESSION; ADENOSINE; BIOMARKER; INVASION; MCP-1	Hypoxia-induced extracellular matrix (ECM) deposition is an important cause of renal fibrosis that is triggered by unknown mechanisms. Human epididymis secretory protein 4 (HE4) is a newly discovered key molecule that causes ECM deposition. We used the unilateral ureteral obstruction (UUO) mouse model to investigate the expression and mechanisms of HE4 in the pathogenesis of renal fibrosis. Results were confirmed in the HK2 cell line and in human donors of kidney tissue with chronic kidney disease. Hypoxia significantly increased HE4 in renal tubular epithelial cells. HE4 overexpression activated the NF-kappa B pathway through the NF-kappa B transcription-activating group P65 by phosphorylation and nuclear translocation. NF-kappa B upregulated tissue inhibitor metalloproteinases 1, which may inhibit ECM degradation through inhibition of matrix metallopeptidase 2 activity. Silencing HE4 inhibited hypoxia-induced ECM deposition and alleviated fibrosis in UUO mice in vivo and blocked NF-kappa B activation in vitro. Expression of HE4 in the tubulointerstitium was positively correlated with tubulointerstitial fibrosis in tissue samples from patients with chronic kidney disease. Our results suggest that hypoxia induces renal fibrosis by upregulating HE4 and activating the HIF-1 alpha/HE4/NF-kappa B signaling pathway. Uncovering the molecular mechanisms and function of HE4 overexpression in hypoxia-induced renal fibrosis will provide important insights into understanding renal fibrosis and antifibrotic strategies.	[Zhang, Lei; Liu, Limin; Bai, Ming; Liu, Minna; Wei, Lei; Yang, Zhen; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian, Shaanxi, Peoples R China; [Zhang, Lei] PLA Joint Logist Support Force, Hosp 987, Dept Nephrol, Xian, Shaanxi, Peoples R China; [Liu, Limin] Xian PeiHua Univ, Sch Med, Xian, Shaanxi, Peoples R China; [Bai, Ming; Liu, Minna; Wei, Lei; Yang, Zhen; Ning, Xiaoxuan; Sun, Shiren] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Qian, Qi] Mayo Clin, Dept Med, Coll Med, Rochester, MN USA; [Qian, Qi] Mayo Grad Sch, Rochester, MN USA; [Ning, Xiaoxuan] Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Mayo Clinic; Mayo Clinic; Air Force Military Medical University	Ning, XX; Sun, SR (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Nephrol, 15 Chang West Rd, Xian 710032, Shaanxi, Peoples R China.	ningxx01@fmmu.edu.cn; sunshiren@medmail.com.cn	liu, li/HGC-0900-2022; Liu, Minna/AAV-1609-2020		National Natural Science Foundation of China [81670655, 81700584]; National Natural Science Foundation of Shaanxi Province [2019JQ-036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shaanxi Province	National Natural Science Foundation of China, Grant/Award Number: 81670655 and 81700584; National Natural Science Foundation of Shaanxi Province, Grant/Award Number: 2019JQ-036	Choi JY, 2011, J BREAST CANCER, V14, P88, DOI 10.4048/jbc.2011.14.2.88; Chuang PY, 2013, J MOL MED, V91, P549, DOI 10.1007/s00109-012-0983-z; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Escudero JM, 2011, CLIN CHEM, V57, P1534, DOI 10.1373/clinchem.2010.157073; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Higgins DF, 2008, CELL CYCLE, V7, P1128, DOI 10.4161/cc.7.9.5804; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Jia QQ, 2013, MOLECULES, V18, P13061, DOI 10.3390/molecules181013061; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; Krishnamachary B, 2003, CANCER RES, V63, P1138; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Ma YG, 2012, J CARDIOVASC TRANSL, V5, P848, DOI 10.1007/s12265-012-9398-z; Moore L, 2012, HEART FAIL REV, V17, P693, DOI 10.1007/s10741-011-9266-y; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nagy B, 2016, CHEST, V150, P661, DOI 10.1016/j.chest.2016.04.006; Nakamura A, 2004, J AM SOC NEPHROL, V15, P316, DOI 10.1097/01.ASN.0000111247.76908.59; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Ronco P, 2008, KIDNEY INT, V74, P873, DOI 10.1038/ki.2008.349; Sato Y, 2017, INFLAMM REGEN, V37, DOI 10.1186/s41232-017-0048-3; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Tanaka T, 2017, MED MOL MORPHOL, V50, P1, DOI 10.1007/s00795-016-0146-3; Wan JX, 2016, ONCOTARGET, V7, P67748, DOI 10.18632/oncotarget.11682; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang XQ, 2016, J RECEPT SIG TRANSD, V36, P152, DOI 10.3109/10799893.2015.1061002; Yang ZX, 2016, J CLIN LAB ANAL, V30, P897, DOI 10.1002/jcla.21954	28	28	28	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2554	2567		10.1096/fj.201901950R	http://dx.doi.org/10.1096/fj.201901950R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909536	Bronze			2022-12-28	WOS:000503399900001
J	Graves, JP; Bradbury, JA; Gruzdev, A; Li, H; Duval, C; Lih, FB; Edin, ML; Zeldin, DC				Graves, Joan P.; Bradbury, J. Alyce; Gruzdev, Artiom; Li, Hong; Duval, Caroline; Lih, Fred B.; Edin, Matthew L.; Zeldin, Darryl C.			Expression of Cyp2c/Cyp2j subfamily members and oxylipin levels during LPS-induced inflammation and resolution in mice	FASEB JOURNAL			English	Article						cytochromes P450; ipopolysaccharide; gene expression; fatty acids; eicosanoids	SOLUBLE EPOXIDE HYDROLASE; CYTOCHROME-P450 ENZYMES; EPOXYEICOSATRIENOIC ACIDS; TISSUE DISTRIBUTION; THERAPEUTIC TARGET; QUANTITATIVE PCR; GENE; LIPOPOLYSACCHARIDE; BIOACTIVATION; ARACHIDONATE	Inflammatory stimuli, such as bacterial LPS, alter the expression of many cytochromes P450. CYP2C and CYP2J subfamily members actively metabolize fatty acids to bioactive eicosanoids, which exhibit potent anti-inflammatory effects. Herein, we examined mRNA levels of the 15 mouse Cyp2c and 7 mouse Cyp2j isoforms in liver, kidney, duodenum, and brain over a 96-h time course of LPS-induced inflammation and resolution. Plasma and liver eicosanoid levels were also measured by liquid chromatography with tandem mass spectrometry. Expression changes in Cyp2c and Cyp2j isoforms were both isoform and tissue specific. Total liver Cyp2c and Cyp2j mRNA content was reduced by 80% 24 h after LPS but recovered to baseline levels by 96 h. Total Cyp2c and Cyp2j mRNA in kidney (-19%) and duodenum (-64%) were reduced 24 h after LPS but recovered above baseline by 72 h. Total Cyp2c and Cyp2j mRNA content in brain was elevated at all time points after LPS dosing. Plasma eicosanoids transiently increased 3-6 h after administration of LPS. In liver, esterified oxylipin levels decreased during acute inflammation and before recovering. The biphasic suppression and recovery of mouse Cyp2c and Cyp2j isoforms and associated changes in eicosanoid levels during LPS-induced inflammation and resolution may have important physiologic consequences.	[Graves, Joan P.; Bradbury, J. Alyce; Gruzdev, Artiom; Li, Hong; Duval, Caroline; Lih, Fred B.; Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, 111 TW Alexander Dr,Bldg 101,Room A214, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zeldin, DC (corresponding author), NIEHS, Div Intramural Res, NIH, 111 TW Alexander Dr,Bldg 101,Room A214, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Li, Hong/ABE-3959-2021; Zeldin, Darryl/Y-7091-2018	Zeldin, Darryl/0000-0002-2087-7307; Edin, Matthew/0000-0002-7042-500X	Division of Intramural Research, NIEHS/NIH [Z01 ES025034]	Division of Intramural Research, NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Lois Wyrick [National Institute of Environmental Health Sciences (NIEHS), U.S. National Institutes of Health (NIH); contractor] for graphic arts assistance. This work was supported by the Division of Intramural Research, NIEHS/NIH, (Z01 ES025034 to D.C.Z.). The authors declare no conflicts of interest.	Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Askari A, 2013, PROSTAG OTH LIPID M, V107, P56, DOI 10.1016/j.prostaglandins.2013.02.003; Askari AA, 2014, BIOCHEM BIOPH RES CO, V446, P633, DOI 10.1016/j.bbrc.2014.03.020; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Capdevila JH, 2000, J LIPID RES, V41, P163; Cheng PY, 2003, J PHARMACOL EXP THER, V307, P1205, DOI 10.1124/jpet.103.057174; Deng BQ, 2017, P NATL ACAD SCI USA, V114, P12608, DOI 10.1073/pnas.1705615114; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Duval C, 2017, ENVIRON HEALTH PERSP, V125, P428, DOI 10.1289/EHP316; Edin ML, 2018, J BIOL CHEM, V293, P3281, DOI 10.1074/jbc.RA117.000298; Falck JR, 2011, J MED CHEM, V54, P4109, DOI 10.1021/jm200132q; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Graves JP, 2017, DRUG METAB DISPOS, V45, P807, DOI 10.1124/dmd.117.075697; Graves JP, 2015, DRUG METAB DISPOS, V43, P1169, DOI 10.1124/dmd.115.064139; Grkovich A, 2009, BBA-MOL CELL BIOL L, V1791, P975, DOI 10.1016/j.bbalip.2009.02.002; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Imig JD, 2016, ADV PHARMACOL, V77, P105, DOI 10.1016/bs.apha.2016.04.003; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Kinney Jefferson W, 2018, Alzheimers Dement (N Y), V4, P575, DOI 10.1016/j.trci.2018.06.014; Klett Eric L, 2013, J Biol Chem, V288, P21618, DOI 10.1074/jbc.M113.481077; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Ma JX, 2002, BIOCHEM PHARMACOL, V64, P1447, DOI 10.1016/S0006-2952(02)01393-X; Ma M, 2019, P NATL ACAD SCI USA, V116, P7083, DOI 10.1073/pnas.1819234116; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Moriya N, 2012, BIOL PHARM BULL, V35, P473, DOI 10.1248/bpb.35.473; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seemann S, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0370-8; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Temesvari M, 2012, J PHARMACOL EXP THER, V341, P294, DOI 10.1124/jpet.111.189597; Theken KN, 2011, DRUG METAB DISPOS, V39, P22, DOI 10.1124/dmd.110.035287; Tyden E, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0069-8; Zhang WY, 2012, DIGEST DIS SCI, V57, P2580, DOI 10.1007/s10620-012-2217-1	46	7	7	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14784	14797		10.1096/fj.201901872R	http://dx.doi.org/10.1096/fj.201901872R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690125	Green Published, Bronze			2022-12-28	WOS:000507466100132
J	Huang, HP; Kolibabka, M; Eshwaran, R; Chatterjee, A; Schlotterer, A; Willer, H; Bieback, K; Hammes, HP; Feng, YX				Huang, Hongpeng; Kolibabka, Matthias; Eshwaran, Rachana; Chatterjee, Anupriya; Schlotterer, Andrea; Willer, Helene; Bieback, Karen; Hammes, Hans-Peter; Feng, Yuxi			Intravitreal injection of mesenchymal stem cells evokes retinal vascular damage in rats	FASEB JOURNAL			English	Article						retina; inflammation; vessels	BONE-MARROW; DIABETIC-RETINOPATHY; STROMAL CELLS; DEGENERATION; PHENOTYPE; PERICYTES	The aim of this study is to investigate the vascular outcome after intravitreal mesenchymal stem cell (MSC) administration in rats without or with damage to the neurovascular unit [transgenic (TGR) rats]. Male Sprague-Dawley (SD) and TGR rats received an intravitreal injection of 2 x 10(4) rat bone marrow-derived MSCs (BMSCs) or human adipose-derived stem cells (ASCs) at postnatal d 30. After 4 wk, vasculature, neuronal function, and gene expression in the retinas were evaluated using retinal morphometry, electroretinography, immunofluorescence, Western blot, and quantitative PCR. Intravitreal administration of rat BMSCs and human ASCs in both SD and TGR eyes induced cataract, loss of pericytes, and increased formation of acellular capillaries. BMSCs remained in the vitreous cavity and did not migrate into the retinas. Intravitreal administration of BMSCs impacted retinal neuronal function in neither SD nor TGR rats. Retinal glial activation, elevation of IL-1 beta, C3, arginase 1, and heat shock protein 90 were detected in BMSC-injected SD rats. Intravitreal administration of MSCs induces cataract, retinal vasoregression, activation of retinal glial cells, and inflammatory response in rat eyes.	[Huang, Hongpeng; Eshwaran, Rachana; Chatterjee, Anupriya; Feng, Yuxi] Heidelberg Univ, Med Fac Mannheim, Expt Pharmacol, Ludolf Krehl Str 13-17, D-68167 Mannheim, Germany; [Kolibabka, Matthias; Schlotterer, Andrea; Hammes, Hans-Peter] Heidelberg Univ, Med Fac Mannheim, Med Clin 5, Mannheim, Germany; [Willer, Helene; Bieback, Karen] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, Mannheim, Germany; [Hammes, Hans-Peter; Feng, Yuxi] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Feng, YX (corresponding author), Heidelberg Univ, Med Fac Mannheim, Expt Pharmacol, Ludolf Krehl Str 13-17, D-68167 Mannheim, Germany.	yuxi.feng@medma.uni-heidelberg.de	Schlotterer, Andrea/GWC-7442-2022		Deutsche Forschungsgemeinschaft (DFG) [FE 969/2-1, HA 1755/10-1, IRTG 1874 DIAMICOM-SP2]; Deutsche Diabetes Gesellschaft (DDG); European Foundation for the Study of Diabetes (EFSD); Novartis	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Diabetes Gesellschaft (DDG); European Foundation for the Study of Diabetes (EFSD); Novartis(Novartis)	The authors thank Ulrike Kaiser (Fifth Medical Clinic), Susanne Elvers-Hornung (Institute of Transfusion Medicine and Immunology), Nadine Dietrich (Fifth Medical Clinic), and Heike Rauscher (Experimental Pharmacology) for their excellent technical assistance. This research was funded by the Deutsche Forschungsgemeinschaft (DFG; FE 969/2-1 to Y.F., HA 1755/10-1 to H.-P.H., IRTG 1874 DIAMICOM-SP2 to Y.F., SP5 to H.-P.H., and SP6 to K.B.), the Deutsche Diabetes Gesellschaft (DDG), and the European Foundation for the Study of Diabetes (EFSD; Novartis-2014 to Y.F.). The funders had no role in the design of the study, the collection, analyses, or interpretation of data, writing of the manuscript, or the decision to publish the results. The authors declare no conflicts of interest.	Abcouwer SF, 2017, DIABETES, V66, P261, DOI 10.2337/dbi16-0047; Aguila M, 2016, ADV EXP MED BIOL, V854, P161, DOI 10.1007/978-3-319-17121-0_22; Altmann C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010110; BARNETT NL, 1995, EXP EYE RES, V61, P83, DOI 10.1016/S0014-4835(95)80061-1; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bieback K, 2012, CYTOTHERAPY, V14, P570, DOI 10.3109/14653249.2011.652809; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chakravarthy H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146829; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Dutescu RM, 2013, INVEST OPHTH VIS SCI, V54, P2582, DOI 10.1167/iovs.12-11446; Elshaer SL, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1059-y; Ezquer M, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0299-y; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; GUREVICH L, 1993, VISION RES, V33, P2431, DOI 10.1016/0042-6989(93)90122-D; Hammes HP, 2018, DIABETOLOGIA, V61, P29, DOI 10.1007/s00125-017-4435-8; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ikwegbue PC, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010002; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kuriyan AE, 2017, NEW ENGL J MED, V376, P1047, DOI 10.1056/NEJMoa1609583; Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y; Mendel TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065691; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Otani A, 2004, J CLIN INVEST, V114, P765, DOI 10.1172/JCI200421686; Perdiguero EG, 2011, J BIOL CHEM, V286, P36841, DOI 10.1074/jbc.M111.220061; Qiu Y, 2016, ACTA DIABETOL, V53, P81, DOI 10.1007/s00592-015-0752-x; Rajashekhar G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00059; Rajashekhar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084671; Rangasamy S, 2012, MIDDLE EAST AFR J OP, V19, P52, DOI 10.4103/0974-9233.92116; Satarian Leila, 2017, J Ophthalmic Vis Res, V12, P58, DOI 10.4103/2008-322X.200164; Siqueira RC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0020-6; Terlizzi V, 2018, STEM CELLS, V36, P240, DOI 10.1002/stem.2726; Tomita M, 2002, STEM CELLS, V20, P279, DOI 10.1634/stemcells.20-4-279; Urbak Larke, 2010, Int J Proteomics, V2010, P479571, DOI 10.1155/2010/479571; Wang JD, 2017, ACTA OPHTHALMOL, V95, pE453, DOI 10.1111/aos.13154; Zhang Y, 2017, MOL VIS, V23, P228; Zhang Y, 2010, INVEST OPHTH VIS SCI, V51, P3742, DOI 10.1167/iovs.08-3314	44	11	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14668	14679		10.1096/fj.201901500R	http://dx.doi.org/10.1096/fj.201901500R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690119	Bronze			2022-12-28	WOS:000507466100123
J	Lei, X; Liu, LL; Terrillion, CE; Karuppagounder, SS; Cisternas, P; Lay, M; Martinelli, DC; Aja, S; Dong, XZ; Pletnikov, MV; Wong, GW				Lei, Xia; Liu, Lili; Terrillion, Chantelle E.; Karuppagounder, Senthilkumar S.; Cisternas, Pedro; Lay, Mark; Martinelli, David C.; Aja, Susan; Dong, Xinzhong; Pletnikov, Mikhail, V; Wong, G. William			FAM19A1, a brain-enriched and metabolically responsive neurokine, regulates food intake patterns and mouse behaviors	FASEB JOURNAL			English	Article						chemokine-like; dopamine; locomotor hyperactivity; TAFA1	CEREBELLAR INTERPOSITUS NUCLEAR; SENSORIMOTOR GATING DEFICITS; PREPULSE INHIBITION; INSULIN SENSITIVITY; SECRETED PROTEIN; EXPRESSION; MICE; DOPAMINE; NEURONS; HYPOTHALAMUS	Cytokines and chemokines play diverse roles in different organ systems. Family with sequence similarity 19, member A1-5 (FAM19A1-A5; also known as TAFA1-5) is a group of conserved chemokine-like proteins enriched in the CNS of mice and humans. Their functions are only beginning to emerge. Here, we show that the expression of Fam19a1-a5 in different mouse brain regions are induced or suppressed by unfed and refed states. The striking nutritional regulation of Fam19a family members in the brain suggests a potential central role in regulating metabolism. Using a knockout (KO) mouse model, we show that loss of FAM19A1 results in sexually dimorphic phenotypes. In male mice, FAM19A1 deficiency alters food intake patterns during the light and dark cycle. Fam19a1 KO mice are hyperactive, and locomotor hyperactivity is more pronounced in female KO mice. Behavior tests indicate that Fam19a1 KO female mice have reduced anxiety and sensitivity to pain. Spatial learning and exploration, however, is preserved in Fam19a1 KO mice. Altered behaviors are associated with elevated norepinephrine and dopamine turnover in the striatum. Our results establish an in vivo function of FAM19A1 and highlight central roles for this family of neurokines in modulating animal physiology and behavior.	[Lei, Xia; Liu, Lili; Cisternas, Pedro; Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA; [Lei, Xia; Liu, Lili; Aja, Susan; Wong, G. William] Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, Baltimore, MD 21205 USA; [Terrillion, Chantelle E.; Pletnikov, Mikhail, V] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD 21205 USA; [Karuppagounder, Senthilkumar S.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21205 USA; [Karuppagounder, Senthilkumar S.] Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21205 USA; [Lay, Mark; Aja, Susan; Dong, Xinzhong; Pletnikov, Mikhail, V] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA; [Liu, Lili] Hunan Univ Sci & Technol, Coll Life Sci, Changsha, Hunan, Peoples R China; [Cisternas, Pedro] Pontificia Univ Catolica Chile, Ctr Envejecimiento & Regenerac CARE UC, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Martinelli, David C.] Univ Connecticut, Hlth Ctr, Dept Neurosci, Farmington, CT USA; [Dong, Xinzhong] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Hunan University of Science & Technology; Pontificia Universidad Catolica de Chile; University of Connecticut; Howard Hughes Medical Institute; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Liu, Lili/HHC-6357-2022; Karuppagounder, Senthilkumar/I-6752-2013	Karuppagounder, Senthilkumar/0000-0002-3281-9913; Lei, Xia/0000-0003-4241-6576; Martinelli, David/0000-0002-8318-3986	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK084171]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Valina Dawson and Ted Dawson (Johns Hopkins University School of Medicine) for providing resources to measure brain monoamine levels. This work was supported by a grant from the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (DK084171 to G.W.W.). The authors declare no conflicts of interest.	Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Ahmari SE, 2012, NEUROPSYCHOPHARMACOL, V37, P1216, DOI 10.1038/npp.2011.308; Allison KC, 2010, INT J EAT DISORDER, V43, P241, DOI 10.1002/eat.20693; Andermann ML, 2017, NEURON, V95, P757, DOI 10.1016/j.neuron.2017.06.014; Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; BENINGER RJ, 1983, BRAIN RES REV, V6, P173, DOI 10.1016/0165-0173(83)90038-3; Berman SM, 2013, CEREBELLUM, V12, P59, DOI 10.1007/s12311-012-0360-z; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Delfini MC, 2013, CELL REP, V5, P378, DOI 10.1016/j.celrep.2013.09.013; Dong XT, 2018, NEURON, V98, P482, DOI 10.1016/j.neuron.2018.03.023; El Messari S, 1998, J COMP NEUROL, V399, P492, DOI 10.1002/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X; Geyer MA, 1999, PSYCHOPHARMACOLOGY, V147, P11, DOI 10.1007/s002130051130; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Guan XM, 1997, MOL CELL ENDOCRINOL, V133, P1, DOI 10.1016/S0303-7207(97)00138-X; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; Jafari A, 2019, STEM CELLS, V37, P407, DOI 10.1002/stem.2955; Jones MD, 2003, PHARMACOL BIOCHEM BE, V75, P209, DOI 10.1016/S0091-3057(03)00073-X; Kambrun C, 2018, CELL REP, V22, P2886, DOI 10.1016/j.celrep.2018.02.068; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karuppagounder SS, 2016, J CHEM NEUROANAT, V76, P90, DOI 10.1016/j.jchemneu.2016.01.007; Koebis M, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0437-4; Koros C, 2009, NUTRITION, V25, P85, DOI 10.1016/j.nut.2008.06.033; Li B, 2009, NEUROSIGNALS, V17, P132, DOI 10.1159/000197913; Little HC, 2018, MOL CELL PROTEOMICS, V17, P1546, DOI 10.1074/mcp.RA118.000794; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundgren JD, 2013, EAT BEHAV, V14, P447, DOI 10.1016/j.eatbeh.2013.08.006; MAHLER P, 1993, PHYSIOL BEHAV, V54, P1063, DOI 10.1016/0031-9384(93)90325-A; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Miller LR, 2017, FASEB J, V31, P29, DOI 10.1096/fj.201600781R; Miller VM, 2014, AM J PHYSIOL-HEART C, V306, pH781, DOI 10.1152/ajpheart.00994.2013; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Ouagazzal AM, 2001, PSYCHOPHARMACOLOGY, V156, P273, DOI 10.1007/s002130100763; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Park MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15586-0; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Petersen PS, 2014, AM J PHYSIOL-REG I, V307, pR1458, DOI 10.1152/ajpregu.00335.2014; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Schuske K, 2007, NAT NEUROSCI, V10, P846, DOI 10.1038/nn1920; Schwartz DM, 2016, NAT REV RHEUMATOL, V12, P25, DOI 10.1038/nrrheum.2015.167; Shao YK, 2015, FEBS LETT, V589, P467, DOI 10.1016/j.febslet.2015.01.003; Song CH, 2012, J NEUROPHYSIOL, V107, P3397, DOI 10.1152/jn.00692.2011; Swerdlow NR, 2016, CURR TOP BEHAV NEURO, V28, P305, DOI 10.1007/7854_2015_5012; Tang YT, 2004, GENOMICS, V83, P727, DOI 10.1016/j.ygeno.2003.10.006; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Terrillion CE, 2017, NEUROPSYCHOPHARMACOL, V42, P2242, DOI 10.1038/npp.2017.129; Tiveron MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157052; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Varlamov Oleg, 2014, Front Endocrinol (Lausanne), V5, P241, DOI 10.3389/fendo.2014.00241; Walford GA, 2016, DIABETES, V65, P3200, DOI 10.2337/db16-0199; Wang WY, 2015, CELL MOL IMMUNOL, V12, P615, DOI 10.1038/cmi.2014.61; Wang XY, 2018, ACTA BIOCH BIOPH SIN, V50, P984, DOI 10.1093/abbs/gmy097; Wang YB, 2018, CIRCULATION, V138, P48, DOI 10.1161/CIRCULATIONAHA.117.032398; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wen YQ, 2004, NEUROSCI LETT, V370, P25, DOI 10.1016/j.neulet.2004.07.072; Zheng C., 2018, FASEB J; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zhu JN, 2008, CELL MOL NEUROBIOL, V28, P469, DOI 10.1007/s10571-007-9236-z; Zhu JN, 2006, J NEUROSCI RES, V84, P1597, DOI 10.1002/jnr.21059; Zhu JN, 2004, NEUROSCI RES, V48, P405, DOI 10.1016/j.neures.2003.12.009; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	66	10	10	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14734	14747		10.1096/fj.201901232RR	http://dx.doi.org/10.1096/fj.201901232RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689372	Bronze, Green Published			2022-12-28	WOS:000507466100128
J	Pan, L; Wang, H; Luo, JH; Zeng, J; Pi, J; Liu, HJ; Liu, C; Ba, XQ; Qu, XP; Xiang, Y; Boldogh, I; Qin, XQ				Pan, Lang; Wang, Hui; Luo, Jinhua; Zeng, Ji; Pi, Jiao; Liu, Huijun; Liu, Chi; Ba, Xueqing; Qu, Xiangping; Xiang, Yang; Boldogh, Istvan; Qin, Xiaoqun			Epigenetic regulation of TIMP1 expression by 8-oxoguanine DNA glycosylase-1 binding to DNA:RNA hybrid	FASEB JOURNAL			English	Article						oxidative stress; DNA damage and repair; transcriptional modulation	BASE-EXCISION-REPAIR; PROINFLAMMATORY GENE-EXPRESSION; R-LOOPS; LUNG INJURY; PROTEIN-A; TRANSCRIPTION; OGG1; DAMAGE; DYNAMICS; MATRIX	8-Oxoguanine DNA glycosylase-1 (OGG1)-initiated base excision repair pathway is primarily responsible for 7, 8-dihydro-8-oxoguanine (8-oxoG) removal from DNA. Recent studies, however, have shown that 8-oxoG in gene regulatory elements may serve as an epigenetic mark, and OGG1 has distinct functions in modulating gene expression. Genome-wide mapping of oxidative stress-induced OGG1 enrichment within introns was documented, but its significance has not yet been fully characterized. Here, we explored whether OGG1 recruited to intron 1 of tissue inhibitor of metalloproteinase-1 (TIMP1) gene and modulated its expression. Using chromatin and DNA:RNA hybrid immunoprecipitation assays, we report recruitment of OGG1 to the DNA:RNA hybrid in intron 1, where it increases nascent RNA but lowers mRNA levels in O-3-exposed human airway epithelial cells and mouse lungs. Decrease in TIMP1 expression is alleviated by antioxidant administration, small interfering RNA depletion, or inhibition of OGG1 binding to its genomic substrate. In vitro studies revealed direct interaction between OGG1 and 8-oxoG containing DNA:RNA hybrid, without excision of its substrate. Inhibition of OGG1 binding to DNA:RNA hybrid translated into an increase in TIMP1 expression and a decrease in oxidant-induced lung inflammatory responses as well as airway remodeling. Data documented here reveal a novel molecular link between OGG1 at damaged sites and transcription dynamics that may contribute to oxidative stress-induced cellular and tissue responses.	[Pan, Lang; Wang, Hui; Luo, Jinhua; Zeng, Ji; Pi, Jiao; Liu, Huijun; Liu, Chi; Qu, Xiangping; Xiang, Yang; Qin, Xiaoqun] Cent South Univ, Xiangya Med Sch, Sch Basic Med, Dept Physiol, 110 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Ba, Xueqing] Northeast Normal Univ, Inst Cytol & Genet, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China; [Boldogh, Istvan] Univ Texas Med Branch, Sch Med, Dept Microbiol & Immunol, Galveston, TX 77555 USA	Central South University; Northeast Normal University - China; University of Texas System; University of Texas Medical Branch Galveston	Xiang, Y; Qin, XQ (corresponding author), Cent South Univ, Xiangya Med Sch, Sch Basic Med, Dept Physiol, 110 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	xiangyang@csu.edu.cn; qinxiaoqun@csu.edu.cn		Pan, Lang/0000-0003-2324-2144	National Natural Science Foundation of China [31671188, 81970033, 81670002, 31900424]; U.S. National Institutes of Health, National Institute of Allergic and Infectious Diseases [AI062885]; Central South University [140050006]; Natural Science Foundation Xiang of Hunan Province [2019JJ50760]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Institute of Allergic and Infectious Diseases; Central South University; Natural Science Foundation Xiang of Hunan Province; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Dr. S. Haller (University of Texas Medical Branch at Galveston) for English editing of the manuscript. This study was supported by grants from the National Natural Science Foundation of China (31671188 and 81970033 to X.Q., 81670002 to Y.X., and 31900424 to L.P.), the U.S. National Institutes of Health, National Institute of Allergic and Infectious Diseases (AI062885 to I.B.), Postdoctoral Initial Research Funding from Central South University (140050006 to L.P.), and the Natural Science Foundation Xiang of Hunan Province (2019JJ50760 to L.P.). The authors declare no conflicts of interest.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Aguilera-Aguirre L, 2017, AM J PHYSIOL-LUNG C, V313, pL1058, DOI 10.1152/ajplung.00141.2017; Aguilera-Aguirre L, 2015, FREE RADICAL BIO MED, V89, P20, DOI 10.1016/j.freeradbiomed.2015.07.007; Allgayer J, 2016, NUCLEIC ACIDS RES, V44, P7267, DOI 10.1093/nar/gkw473; Ba XQ, 2018, REDOX BIOL, V14, P669, DOI 10.1016/j.redox.2017.11.008; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Bacsi A, 2013, DNA REPAIR, V12, P18, DOI 10.1016/j.dnarep.2012.10.002; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; Bonnet A, 2017, MOL CELL, V67, P608, DOI 10.1016/j.molcel.2017.07.002; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Connor AJ, 2012, EXP MOL PATHOL, V92, P229, DOI 10.1016/j.yexmp.2012.01.004; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Dantzer F, 2002, NUCLEIC ACIDS RES, V30, P2349, DOI 10.1093/nar/30.11.2349; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dean G, 2000, J BIOL CHEM, V275, P32664, DOI 10.1074/jbc.275.42.32664; Fleming AM, 2017, DNA REPAIR, V56, P75, DOI 10.1016/j.dnarep.2017.06.009; Fleming AM, 2017, P NATL ACAD SCI USA, V114, P2604, DOI 10.1073/pnas.1619809114; FLENNIKEN AM, 1990, GENE DEV, V4, P1094, DOI 10.1101/gad.4.7.1094; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Grainge CL, 2013, CHEST, V144, P1906, DOI 10.1378/chest.12-1944; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hao WJ, 2018, REDOX BIOL, V18, P43, DOI 10.1016/j.redox.2018.06.002; Haque R, 2007, TOXICOL APPL PHARM, V220, P72, DOI 10.1016/j.taap.2006.12.017; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hu JP, 2005, NUCLEIC ACIDS RES, V33, P3271, DOI 10.1093/nar/gki636; Ivanov AI, 2013, INT REV CEL MOL BIO, V303, P27, DOI 10.1016/B978-0-12-407697-6.00002-7; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; Khobta A, 2012, MUTAT RES-FUND MOL M, V736, P5, DOI 10.1016/j.mrfmmm.2011.07.014; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Komakula SSB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33151-1; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Michaudel C, 2018, J ALLERGY CLIN IMMUN, V142, P942, DOI 10.1016/j.jaci.2017.11.044; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Mitra S, 1997, MOL CELLS, V7, P305; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pan L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43297; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Pastukh V, 2007, FREE RADICAL BIO MED, V43, P1616, DOI 10.1016/j.freeradbiomed.2007.08.027; Pastukh V, 2015, AM J PHYSIOL-LUNG C, V309, pL1367, DOI 10.1152/ajplung.00236.2015; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Raha D., 2010, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb2119s91, DOI 10.1002/0471142727.MB2119S91]; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Roy D, 2009, MOL CELL BIOL, V29, P3124, DOI 10.1128/MCB.00139-09; Sampath H, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102667; Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697; Samson LD, 2018, SCIENCE, V362, P748, DOI 10.1126/science.aav4744; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Seifermann M, 2017, DNA REPAIR, V58, P13, DOI 10.1016/j.dnarep.2017.08.005; Seifermann M, 2017, FREE RADICAL BIO MED, V107, P258, DOI 10.1016/j.freeradbiomed.2016.11.018; Shah A, 2018, CIRCULATION, V138, P1446, DOI 10.1161/CIRCULATIONAHA.117.033249; Sridhara SC, 2017, CELL REP, V18, P334, DOI 10.1016/j.celrep.2016.12.050; Sunil VR, 2013, TOXICOL SCI, V133, P309, DOI 10.1093/toxsci/kft071; Tahara YK, 2018, J AM CHEM SOC, V140, P2105, DOI 10.1021/jacs.7b09316; Teng YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06586-3; Touati E, 2006, HELICOBACTER, V11, P494, DOI 10.1111/j.1523-5378.2006.00442.x; van der Kemp PA, 2004, NUCLEIC ACIDS RES, V32, P570, DOI 10.1093/nar/gkh224; Visnes T, 2018, SCIENCE, V362, P834, DOI 10.1126/science.aar8048; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Xiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031158	75	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14159	14170		10.1096/fj.201900993RR	http://dx.doi.org/10.1096/fj.201900993RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31652414	Green Published			2022-12-28	WOS:000507466100085
J	Zhang, T; Du, XH; Zhao, LH; He, MN; Lin, L; Guo, CH; Zhang, XR; Han, J; Yan, H; Huang, K; Sun, GH; Yan, L; Zhou, B; Xia, GL; Qin, YY; Wang, C				Zhang, Tuo; Du, Xinhua; Zhao, Lihua; He, Meina; Lin, Lin; Guo, Chuanhui; Zhang, Xinran; Han, Jun; Yan, Hao; Huang, Kun; Sun, Guanghong; Yan, Lei; Zhou, Bo; Xia, Guoliang; Qin, YingYing; Wang, Chao			SIRT1 facilitates primordial follicle recruitment independent of deacetylase activity through directly modulating Akt1 and mTOR transcription	FASEB JOURNAL			English	Article						primordial follicle activation; ovary; in vitro activation; resveratrol	IN-VITRO ACTIVATION; PRIMARY OVARIAN INSUFFICIENCY; OOCYTES; STIMULATION; INFERTILITY; DISRUPTION; MATURATION; FERTILITY; INTERACTS; GROWTH	In female mammals, the majority of primordial follicles (PFs) are physiologically quiescent, and only a few of them are activated and enter the growing follicle pool. Specific molecules, such as mammalian target of rapamycin (mTOR) and the serine/threonine kinase Akt (AKT), have been proven to be important for PF activation. However, how the transcription of these genes is regulated is not clear. Although activators of mTOR or AKT have been successfully used to rescue the fertility of patients with premature ovarian insufficiency, the low efficacy and unclear safety profile of these drugs hinder their clinical use in the in vitro activation (IVA) of PFs. Here, sirtuin 1 (SIRT1), an NAD-dependent deacetylase, was demonstrated to activate mouse PFs independent of its deacetylase activity. SIRT1 was prominently expressed in pregranulosa cells (pGCs) and oocytes, and its expression was increased during PF activation. PF activation was achieved by either up-regulating SIRT1 with a specific activator or overexpressing SIRT1. Moreover, SIRT1 knockdown in oocytes or pGCs could significantly suppress PF activation. Further studies demonstrated that SIRT1 enhanced both Aka and mTOR expression by acting more as a transcription cofactor, directly binding to the respective gene promoters, than as a deacetylase. Importantly, we explored the potential clinical applications of targeting SIRT1 in IVA via short-term treatment of cultured ovaries from mice and human ovarian tissues to activate PFs by applying the SIRT1 activator resveratrol. RSV-induced IVA could be a candidate strategy to develop more efficient procedures for future clinical treatment of infertility.	[Zhang, Tuo; Du, Xinhua; Zhao, Lihua; He, Meina; Lin, Lin; Guo, Chuanhui; Zhang, Xinran; Han, Jun; Yan, Hao; Huang, Kun; Sun, Guanghong; Zhou, Bo; Xia, Guoliang; Wang, Chao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Zhao, Lihua] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Pathol & Hepatol, Beijing, Peoples R China; [Yan, Lei; Qin, YingYing] Shandong Univ, Ctr Reprod Med, Shandong Prov Hosp, Jinan 250021, Peoples R China; [Yan, Lei; Qin, YingYing] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Yan, Lei; Qin, YingYing] Shandong Univ, Key Lab Reprod Endocrinol, Minist Educ, Jinan, Peoples R China; [Yan, Lei; Qin, YingYing] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China; [Xia, Guoliang] Ningxia Univ, Western China Coll Life Sci, Minist Educ Conservat & Utilizat Special Biol Res, Key Lab, Yinchuan, Peoples R China	China Agricultural University; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Ningxia University	Wang, C (corresponding author), China Agr Univ, Ctr Life Sci, 2 Yuan Ming Yuan West Rd, Beijing 100193, Peoples R China.	qinyingying1006@163.com; wangcam@126.com		Yan, Hao/0000-0003-1468-6165	National Key Research and Developmental Program of China [2017YFC1001100]; National Basic Research Program of China [2014CB943202, 2013CB945501, 2014CB138503]; National Natural Science Foundation of China [31872792, 31371448, 31571540]; Beijing Natural Science Foundation [5182015, 7182090]; Project of State Key Laboratory of Agrobiotechnology [2015SKLAB4-1, 2016SKLAB-1]; Institution of Higher Education Projects of Building First-Class Discipline Construction in Ningxia Region (Biology) [NXYLXK2017B05]	National Key Research and Developmental Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Project of State Key Laboratory of Agrobiotechnology; Institution of Higher Education Projects of Building First-Class Discipline Construction in Ningxia Region (Biology)	The authors thank each member of the G.X. Laboratory for their valuable discussions, and Nature Research Editing Service for language revision. This study was supported by the National Key Research and Developmental Program of China (Grant 2017YFC1001100 to G.X.); the National Basic Research Pro-gram of China (Grants 2014CB943202 to C.W., 2013CB945501 to G.X., and 2014CB138503 to B.Z.); the National Natural Science Foundation of China (Grants 31872792 to C.W. and 31371448 and 31571540 to G.X.); the Beijing Natural Science Foundation (Grants 5182015 to C.W. and 7182090 to G.X.); the Project of State Key Laboratory of Agrobiotechnology (Grants 2015SKLAB4-1 to C.W. and 2016SKLAB-1 to G.X.); and the Institution of Higher Education Projects of Building First-Class Discipline Construction in Ningxia Region (Biology) (Grant NXYLXK2017B05 to G.X.). The authors declare no conflicts of interest.	Adhikari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039034; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Bell EL, 2014, DEVELOPMENT, V141, P3495, DOI 10.1242/dev.110627; Bezerra MES, 2018, REPROD DOMEST ANIM, V53, P1298, DOI 10.1111/rda.13274; Bidet M, 2011, J CLIN ENDOCR METAB, V96, P3864, DOI 10.1210/jc.2011-1038; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Cordeiro CN, 2016, REPROD SCI, V23, P429, DOI 10.1177/1933719115625842; Gorre N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110491; Guo J, 2018, P NATL ACAD SCI USA, V115, pE5326, DOI 10.1073/pnas.1800352115; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Kawamura K, 2016, CURR OPIN OBSTET GYN, V28, P217, DOI 10.1097/GCO.0000000000000268; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Ladanyi C, 2017, J ASSIST REPROD GEN, V34, P709, DOI 10.1007/s10815-017-0899-1; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Liu C, 2017, DEVELOPMENT, V144, P441, DOI 10.1242/dev.147074; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Liu MJ, 2018, FERTIL STERIL, V109, P900, DOI 10.1016/j.fertnstert.2018.01.020; Liu MY, 2013, HUM REPROD, V28, P707, DOI 10.1093/humrep/des437; Liu WJ, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0114-8; Long GY, 2019, GENE, V686, P194, DOI 10.1016/j.gene.2018.10.040; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; PEDERSEN T, 1970, J REPROD FERTIL, V21, P81, DOI 10.1530/jrf.0.0210081; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Qin YY, 2015, HUM REPROD UPDATE, V21, P787, DOI 10.1093/humupd/dmv036; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sun XH, 2015, CELL CYCLE, V14, P721, DOI 10.1080/15384101.2014.995496; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Suzuki S, 2018, MOL CELL ENDOCRINOL, V461, P178, DOI 10.1016/j.mce.2017.09.012; Tatone C, 2018, HUM REPROD UPDATE, V24, P267, DOI 10.1093/humupd/dmy003; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang C, 2017, CELL MOL LIFE SCI, V74, P2547, DOI 10.1007/s00018-017-2480-6; Wang XQ, 2016, WOMENS HEALTH, V12, P275, DOI 10.2217/whe-2016-0019; Yan H, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0541-4; Yin O, 2016, J CLIN ENDOCR METAB, V101, P3568, DOI 10.1210/jc.2016-2837; Zhai J, 2016, J CLIN ENDOCR METAB, V101, P4405, DOI 10.1210/jc.2016-1589; Zhang H, 2015, HUM REPROD UPDATE, V21, P779, DOI 10.1093/humupd/dmv037; Zhang H, 2014, CURR BIOL, V24, P2501, DOI 10.1016/j.cub.2014.09.023; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang M, 2017, FRONT IMMUNOL, V8, P1, DOI 10.3389/fimmu.2017.00942; Zhou XL, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0097-z	49	20	25	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14703	14716		10.1096/fj.201900782R	http://dx.doi.org/10.1096/fj.201900782R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31693862	Bronze			2022-12-28	WOS:000507466100126
J	Antonioli, L; D'Antongiovanni, V; Pellegrini, C; Fornai, M; Benvenuti, L; di Carlo, A; van den Wijngaard, R; Caputi, V; Cerantola, S; Giron, MC; Nemeth, ZH; Hasko, G; Blandizzi, C; Colucci, R				Antonioli, Luca; D'Antongiovanni, Vanessa; Pellegrini, Carolina; Fornai, Matteo; Benvenuti, Laura; di Carlo, Alma; van den Wijngaard, Rene; Caputi, Valentina; Cerantola, Silvia; Giron, Maria Cecilia; Nemeth, Zoltan H.; Hasko, Gyorgy; Blandizzi, Corrado; Colucci, Rocchina			Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia	FASEB JOURNAL			English	Article						colonic motor dysfunction; enteric glia; inflammation; obesity; substance P	GASTROINTESTINAL MOTILITY; GUT MICROBIOTA; S100B PROTEIN; DISORDERS; NEURONS; TRANSIT; DISEASE; CELLS; MOTOR; ACID	The present study was designed to examine the role of enteric glial cells (EGCs) in colonic neuromuscular dysfunctions in a mouse model of high-fat diet (HFD)-induced obesity. C57BL/6J mice were fed with HFD or standard diet (SD) for 1, 2, or 8 weeks. Colonic interleukin (IL)-1 beta, IL-6, and malondialdehyde (MDA) levels were measured. Expression of occludin in colonic tissues was examined by western blot. Substance P (SP), S100 beta, GFAP, and phosphorylated mitogen-activated protein kinase 1 (pERK) were assessed in whole mount specimens of colonic plexus by immunohistochemistry. Colonic tachykininergic contractions, elicited by electrical stimulation or exogenous SP, were recorded in the presence or absence of fluorocitrate (FC). To mimic exposure to HFD, cultured EGCs were incubated with palmitate (PA) and/or lipopolysaccharide (LPS). SP and IL-1 beta levels were assayed in the culture medium by ELISA. HFD mice displayed an increase in colonic IL-1 beta and MDA, and a reduction of occludin at week 2. These changes occurred to a greater extent at week 8. In vitro electrically evoked tachykininergic contractions were enhanced in HFD mice after 2 or 8 weeks, and they were blunted by FC. Colonic IL-6 levels as well as substance P and S100 beta density in myenteric ganglia of HFD mice were increased at week 8, but not at week 1 or 2. In cultured EGCs, co-incubation with palmitate plus LPS led to a significant increase in both SP and IL-1 beta release. HFD-induced obesity is characterized by a hyperactivation of EGCs and is involved in the development of enteric motor disorders through an increase in tachykininergic activity and release of pro-inflammatory mediators.	[Antonioli, Luca; D'Antongiovanni, Vanessa; Fornai, Matteo; Benvenuti, Laura; di Carlo, Alma; Blandizzi, Corrado] Univ Pisa, Dept Clin & Expt Med, Via Roma 55, I-56126 Pisa, Italy; [Pellegrini, Carolina] Univ Pisa, Dept Pharm, Pisa, Italy; [Fornai, Matteo; van den Wijngaard, Rene] Acad Med Ctr, Dept Gastroenterol & Hepatol, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [Caputi, Valentina; Cerantola, Silvia; Giron, Maria Cecilia; Colucci, Rocchina] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Caputi, Valentina] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland; [Nemeth, Zoltan H.; Hasko, Gyorgy] Columbia Univ, Dept Anesthesiol, New York, NY USA; [Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ USA	University of Pisa; University of Pisa; University of Amsterdam; Academic Medical Center Amsterdam; University of Padua; University College Cork; Columbia University; Atlantic Health System	Fornai, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Via Roma 55, I-56126 Pisa, Italy.; Fornai, M (corresponding author), Acad Med Ctr, Dept Gastroenterol & Hepatol, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.	mfornai74@gmail.com	Giron, Maria Cecilia/AAL-4438-2021; Pellegrini, Carolina/ABE-3462-2021	Giron, Maria Cecilia/0000-0002-0825-7965; Pellegrini, Carolina/0000-0003-2644-5430; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; D'ANTONGIOVANNI, Vanessa/0000-0002-3303-0674; FORNAI, MATTEO/0000-0002-0812-3959; BLANDIZZI, CORRADO/0000-0001-9927-5386				Anitha M, 2016, CELL MOL GASTROENTER, V2, P328, DOI 10.1016/j.jcmgh.2015.12.008; Antonioli L, 2019, INT J OBESITY, V43, P331, DOI 10.1038/s41366-018-0166-2; Antonioli L, 2017, PURINERG SIGNAL, V13, P497, DOI 10.1007/s11302-017-9577-0; Barajon I, 2009, J HISTOCHEM CYTOCHEM, V57, P1013, DOI 10.1369/jhc.2009.953539; Bassotti G, 2014, UNITED EUR GASTROENT, V2, P457, DOI 10.1177/2050640614548096; Bassotti G, 2014, WORLD J GASTROENTERO, V20, P37, DOI 10.3748/wjg.v20.i1.37; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Caputi V, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00350; Chandrasekharan B, 2019, GASTROENTEROLOGY, V157, P179, DOI 10.1053/j.gastro.2019.03.045; Chassaing B, 2014, GUT, V63, P1069, DOI 10.1136/gutjnl-2013-304909; Chow AK, 2017, AM J PHYSIOL-GASTR L, V312, pG145, DOI 10.1152/ajpgi.00384.2016; Christofi FL, 2018, CELL MOL GASTROENTER, V6, P354, DOI 10.1016/j.jcmgh.2018.06.011; Cirillo C, 2011, WORLD J GASTROENTERO, V17, P1261, DOI 10.3748/wjg.v17.i10.1261; Cossais F, 2019, J CLIN GASTROENTEROL, V53, P449, DOI 10.1097/MCG.0000000000001011; Dai XJ, 2015, CELL STRESS CHAPERON, V20, P321, DOI 10.1007/s12192-014-0552-1; DAMETO MC, 1991, COMP BIOCHEM PHYS A, V99, P651, DOI 10.1016/0300-9629(91)90145-3; Delgado-Aros S, 2004, AM J GASTROENTEROL, V99, P1801, DOI 10.1111/j.1572-0241.2004.30887.x; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; France M, 2012, NEUROGASTROENT MOTIL, V24, pe450, DOI 10.1111/j.1365-2982.2012.01981.x; Fysekidis M, 2012, OBES SURG, V22, P403, DOI 10.1007/s11695-011-0396-z; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gougeon PY, 2013, J NEUROSCI, V33, P3339, DOI 10.1523/JNEUROSCI.3564-12.2013; Gulbransen BD, 2018, GASTROENTEROLOGY, V155, P245, DOI 10.1053/j.gastro.2018.06.050; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Herder C, 2015, TRENDS ENDOCRIN MET, V26, P551, DOI 10.1016/j.tem.2015.08.001; Ho Wayne, 2008, Gastroenterol Hepatol (N Y), V4, P572; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Jarolimova J., 2013, PRIM CARE COMPANION, V15, P5; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kindt S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01414.x; Konig J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.54; Kunisawa J, 2014, J IMMUNOL, V193, P1666, DOI 10.4049/jimmunol.1302944; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Le Pluart D, 2015, ALIMENT PHARM THER, V41, P758, DOI 10.1111/apt.13143; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; McMenamin CA, 2018, NEUROSCIENCE, V393, P369, DOI 10.1016/j.neuroscience.2018.09.033; Murakami M, 2009, J NEUROSCI RES, V87, P2095, DOI 10.1002/jnr.22036; Murphy EA, 2015, CURR OPIN CLIN NUTR, V18, P515, DOI 10.1097/MCO.0000000000000209; Nasser Y, 2006, AM J PHYSIOL-GASTR L, V291, pG912, DOI 10.1152/ajpgi.00067.2006; Nezami BG, 2014, GASTROENTEROLOGY, V146, P473, DOI 10.1053/j.gastro.2013.10.053; Nyavor Y, 2019, CELL TISSUE RES, V376, P325, DOI 10.1007/s00441-019-03002-0; Ochoa-Cortes F, 2016, INFLAMM BOWEL DIS, V22, P433, DOI 10.1097/MIB.0000000000000667; Phatak UP, 2014, INT J OBESITY, V38, P1324, DOI 10.1038/ijo.2014.67; Pochard C, 2018, AM J PHYSIOL-GASTR L, V315, pG1, DOI 10.1152/ajpgi.00016.2018; Pochard C, 2016, GASTROENTEROLOGY, V150, P168, DOI 10.1053/j.gastro.2015.09.038; Rajindrajith S, 2014, J NEUROGASTROENTEROL, V20, P414, DOI 10.5056/jnm14067; Rao M, 2017, GASTROENTEROLOGY, V153, P1068, DOI 10.1053/j.gastro.2017.07.002; Raybould HE, 2012, J PHYSIOL-LONDON, V590, P441, DOI 10.1113/jphysiol.2011.222133; Reichardt F, 2017, J PHYSIOL-LONDON, V595, P1831, DOI 10.1113/JP273269; Richter S, 2018, CELL TISSUE RES, V374, P473, DOI 10.1007/s00441-018-2907-x; Ridha M, 2015, HYPERTENSION, V65, P949, DOI 10.1161/HYPERTENSIONAHA.114.04926; Sharkey KA, 2015, J CLIN INVEST, V125, P918, DOI 10.1172/JCI76303; Stenkamp-Strahm C, 2013, AUTON NEUROSCI-BASIC, V177, P199, DOI 10.1016/j.autneu.2013.04.014; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Tambucci R, 2019, J PEDIATR GASTR NUTR, V68, P517, DOI 10.1097/MPG.0000000000002208; Turco F, 2014, GUT, V63, P105, DOI 10.1136/gutjnl-2012-302090; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Voss U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081413; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm2	63	19	19	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5512	5524		10.1096/fj.201901844R	http://dx.doi.org/10.1096/fj.201901844R		FEB 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086846	Bronze, Green Published			2022-12-28	WOS:000515257600001
J	Ruscitto, A; Morel, MM; Shawber, CJ; Reeve, G; Lecholop, MK; Bonthius, D; Yao, H; Embree, MC				Ruscitto, Angela; Morel, Mallory M.; Shawber, Carrie J.; Reeve, Gwendolyn; Lecholop, Michael K.; Bonthius, Daniel; Yao, Hai; Embree, Mildred C.			Evidence of vasculature and chondrocyte to osteoblast transdifferentiation in craniofacial synovial joints: Implications for osteoarthritis diagnosis and therapy	FASEB JOURNAL			English	Article						angiogenesis; cartilage; chondrogenesis; miniature pigs; osteoarthritis; osteogenesis; temporomandibular joint; transdifferentiation	TEMPOROMANDIBULAR-JOINT; CONDYLAR CARTILAGE; ENDOTHELIAL-CELL; ARTICULAR-CARTILAGE; GROWTH-FACTOR; MIDDLE-EAR; PATHOGENESIS; EXPRESSION; MOUSE; DIFFERENTIATION	Temporomandibular joint osteoarthritis (TMJ OA) leads to permanent cartilage destruction, jaw dysfunction, and compromises the quality of life. However, the pathological mechanisms governing TMJ OA are poorly understood. Unlike appendicular articular cartilage, the TMJ has two distinct functions as the synovial joint of the craniofacial complex and also as the site for endochondral jaw bone growth. The established dogma of endochondral bone ossification is that hypertrophic chondrocytes undergo apoptosis, while invading vasculature with osteoprogenitors replace cartilage with bone. However, contemporary murine genetic studies support the direct differentiation of chondrocytes into osteoblasts and osteocytes in the TMJ. Here we sought to characterize putative vasculature and cartilage to bone transdifferentiation using healthy and diseased TMJ tissues from miniature pigs and humans. During endochondral ossification, the presence of fully formed vasculature expressing CD31(+) endothelial cells and alpha-SMA(+) vascular smooth muscle cells were detected within all cellular zones in growing miniature pigs. Arterial, endothelial, venous, angiogenic, and mural cell markers were significantly upregulated in miniature pig TMJ tissues relative to donor matched knee meniscus fibrocartilage tissue. Upon surgically creating TMJ OA in miniature pigs, we discovered increased vasculature and putative chondrocyte to osteoblast transformation dually marked by COL2 and BSP or RUNX2 within the vascular bundles. Pathological human TMJ tissues also exhibited increased vasculature, while isolated diseased human TMJ cells exhibited marked increased in vasculature markers relative to control 293T cells. Our study provides evidence to suggest that the TMJ in higher order species are in fact vascularized. There have been no reports of cartilage to bone transdifferentiation or vasculature in human-relevant TMJ OA large animal models or in human TMJ tissues and cells. Therefore, these findings may potentially alter the clinical management of TMJ OA by defining new drugs that target angiogenesis or block the cartilage to bone transformation.	[Ruscitto, Angela; Morel, Mallory M.; Embree, Mildred C.] Columbia Univ, Coll Dent Med, Cartilage Biol & Regenerat Med Lab, Irving Med Ctr, New York, NY 10027 USA; [Shawber, Carrie J.] Columbia Univ, Coll Phys & Surg, Dept OB GYN, Div Reprod Sci,Irving Med Ctr, New York, NY USA; [Reeve, Gwendolyn] New York Presbyterian Weill Cornell Med Ctr, Div Oral & Maxillofacial Surg, New York, NY USA; [Lecholop, Michael K.] Med Univ South Carolina, Dept Oral & Maxillofacial Surg, Coll Dent Med, Charleston, SC 29425 USA; [Bonthius, Daniel; Yao, Hai] Clemson Univ, Clemson MUSC Bioengn Program, Dept Bioengn, Greenville, SC USA; [Yao, Hai] Med Univ South Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Medical University of South Carolina; Clemson University; Medical University of South Carolina; Medical University of South Carolina	Embree, MC (corresponding author), Columbia Univ, Coll Dent Med, Cartilage Biol & Regenerat Med Lab, Irving Med Ctr, New York, NY 10027 USA.	mce2123@cumc.columbia.edu			NIH [5R00DE0220660, R01DE021134, P20GM121342]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: 5R00DE0220660, R01DE021134 and P20GM121342	Aigner T, 2002, CURR OPIN RHEUMATOL, V14, P578, DOI 10.1097/00002281-200209000-00018; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Almarza AJ, 2018, TISSUE ENG PART B-RE, V24, P171, DOI [10.1089/ten.teb.2017.0341, 10.1089/ten.TEB.2017.0341]; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205; ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305; Aurich M, 2005, ARTHRITIS RHEUM-US, V52, P112, DOI 10.1002/art.20740; BENJAMIN M, 1990, J ANAT, V171, P1; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; BERMEJO A, 1993, ORAL SURG ORAL MED O, V75, P18, DOI 10.1016/0030-4220(93)90399-O; Bharathi SC, 2014, J INT SOC PREV COMMU, V4, P67, DOI 10.4103/2231-0762.127853; BORA FW, 1987, HAND CLIN, V3, P325; de Moraes LOC, 2015, EUR J HISTOCHEM, V59, P263, DOI 10.4081/ejh.2015.2569; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Decker RS, 2014, MATRIX BIOL, V39, P5, DOI 10.1016/j.matbio.2014.08.006; Delaire J., 1998, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V99, P3; Di Giancamillo A, 2017, J CELL MOL MED, V21, P3066, DOI 10.1111/jcmm.13218; DONES M, 1959, Oral Surg Oral Med Oral Pathol, V12, P1433, DOI 10.1016/0030-4220(59)90262-2; Duan XC, 2016, MATRIX BIOL, V52-54, P127, DOI 10.1016/j.matbio.2016.02.005; DURKIN JF, 1973, ORAL SCI REV, V2, P29; Eisenmann D. R., 1980, ORAL HISTOLOGY DEV S, P194; EISENSTEIN R, 1973, AM J PATHOL, V73, P765; Embree MC, 2015, OSTEOARTHR CARTILAGE, V23, P629, DOI 10.1016/j.joca.2014.12.015; Embree MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13073; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gill M, 2001, CIRC RES, V88, P167; Gray JC, 1999, J ORTHOP SPORT PHYS, V29, P23, DOI 10.2519/jospt.1999.29.1.23; Gu SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101000; Hall AC, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0837-6; Heinemeier KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8335; Herring SW, 2002, ANAT RECORD, V266, P152, DOI 10.1002/ar.10049; HERRING SW, 1976, ARCH ORAL BIOL, V21, P473, DOI 10.1016/0003-9969(76)90105-9; Hinton RJ, 2017, J DENT RES, V96, P23, DOI 10.1177/0022034516668321; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hu DP, 2017, DEVELOPMENT, V144, P221, DOI 10.1242/dev.130807; Huang GTJ, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P1, DOI 10.1002/9781118498026; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; Jing Y, 2015, J DENT RES, V94, P1668, DOI 10.1177/0022034515598135; Jing Y, 2018, INT J BIOL SCI, V14, P1, DOI 10.7150/ijbs.23165; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KERMACK KA, 1972, P ROY SOC MED, V65, P389, DOI 10.1177/003591577206500439; KESSEL L J, 1969, British Journal of Oral Surgery, V7, P124; Kim YH, 2008, DEVELOPMENT, V135, P3755, DOI 10.1242/dev.022475; Kobayashi T, 2014, METHODS MOL BIOL, V1130, P3, DOI 10.1007/978-1-62703-989-5_1; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Kronenberg HM, 2007, ANN NY ACAD SCI, V1116, P59, DOI 10.1196/annals.1402.059; Kume T, 2010, HISTOL HISTOPATHOL, V25, P637, DOI 10.14670/HH-25.637; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lamy S, 2010, VASC PHARMACOL, V53, P200, DOI 10.1016/j.vph.2010.08.002; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Lautenschlager S, 2018, NATURE, V561, P533, DOI 10.1038/s41586-018-0521-4; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lin AW, 2018, J COMP PATHOL, V161, P55, DOI 10.1016/j.jcpa.2018.05.001; Long FX, 1998, DEVELOPMENT, V125, P1067; Mair KH, 2014, DEV COMP IMMUNOL, V45, P321, DOI 10.1016/j.dci.2014.03.022; Mei H, 2014, J BIOL CHEM, V289, P20836, DOI 10.1074/jbc.M114.557454; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miyake T, 1997, J ANAT, V190, P239, DOI 10.1046/j.1469-7580.1997.19020239.x; MORIMOTO K, 1987, J PROSTHET DENT, V57, P723, DOI 10.1016/0022-3913(87)90372-6; Nathan J, 2018, J DENT RES, V97, P329, DOI 10.1177/0022034517735094; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Owtad P, 2013, J DENT RES, V92, P315, DOI 10.1177/0022034513476302; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Park J, 2015, BIOL OPEN, V4, P608, DOI 10.1242/bio.201411031; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Poole A R, 1993, Agents Actions Suppl, V39, P3; Purcell P, 2012, J DENT RES, V91, P387, DOI 10.1177/0022034512438401; Purcell P, 2009, P NATL ACAD SCI USA, V106, P18297, DOI 10.1073/pnas.0908836106; Rotter A, 2017, J DTSCH DERMATOL GES, V15, P1185, DOI 10.1111/ddg.13365; Schneider RA, 2015, CURR TOP DEV BIOL, V115, P271, DOI 10.1016/bs.ctdb.2015.08.002; Schomberg DT, 2016, TOXICOL PATHOL, V44, P299, DOI 10.1177/0192623315618292; Scrivani SJ, 2008, NEW ENGL J MED, V359, P2693, DOI 10.1056/NEJMra0802472; Shen G, 2005, Orthod Craniofac Res, V8, P114; Shen G, 2006, ARCH ORAL BIOL, V51, P315, DOI 10.1016/j.archoralbio.2005.08.004; Shen G, 2005, J DENT RES, V84, P691, DOI 10.1177/154405910508400802; Sherwood J, 2019, OSTEOARTHR CARTILAGE, V27, P365, DOI 10.1016/j.joca.2018.10.005; Shibata S, 2008, J ANAT, V213, P274, DOI 10.1111/j.1469-7580.2008.00934.x; Shibukawa Y, 2007, DEV DYNAM, V236, P426, DOI 10.1002/dvdy.21036; Sindelar BJ, 2005, CELLS TISSUES ORGANS, V180, P36, DOI 10.1159/000086197; Singh P, 2019, ANN NY ACAD SCI, V1442, P17, DOI 10.1111/nyas.13930; Squires GR, 2003, ARTHRITIS RHEUM-US, V48, P1261, DOI 10.1002/art.10976; STROM D, 1986, ARCH ORAL BIOL, V31, P763, DOI 10.1016/0003-9969(86)90009-9; Sun ZY, 2002, ARCH ORAL BIOL, V47, P293, DOI 10.1016/S0003-9969(02)00004-3; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tripathi Tulika, 2019, J Clin Orthod, V53, P29; Vapniarsky N, 2017, TISSUE ENG PART C-ME, V23, P700, DOI [10.1089/ten.tec.2017.0149, 10.1089/ten.TEC.2017.0149]; Wadhwa S, 2005, OSTEOARTHR CARTILAGE, V13, P817, DOI 10.1016/j.joca.2005.04.016; Wang XD, 2015, J DENT RES, V94, P666, DOI 10.1177/0022034515574770; Wang Y, 2011, DEV DYNAM, V240, P2466, DOI 10.1002/dvdy.22748; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820; Zou HX, 2013, CARDIOVASC PATHOL, V22, P203, DOI 10.1016/j.carpath.2012.10.001	96	17	17	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4445	4461		10.1096/fj.201902287R	http://dx.doi.org/10.1096/fj.201902287R		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030828	Green Accepted, hybrid			2022-12-28	WOS:000512333200001
J	Zhou, YX; Qiu, LY; Wang, HY; Chen, XM				Zhou, Yuxin; Qiu, Liyan; Wang, Haiying; Chen, Xuanmao			Induction of activity synchronization among primed hippocampal neurons out of random dynamics is key for trace memory formation and retrieval	FASEB JOURNAL			English	Article						calcium imaging in freely behaving animals; declarative memory; GCaMP6; memory consolidation; right-skewed lognormal distribution; synaptic plasticity	BIDIRECTIONAL SYNAPTIC PLASTICITY; TIMING-DEPENDENT PLASTICITY; IN-VIVO; ADENYLYL CYCLASES; CALCIUM SIGNALS; BRAIN; EXCITABILITY; AMYGDALA; CREB; ORGANIZATION	Memory is thought to be encoded by sparsely distributed neuronal ensembles in memory-related regions. However, it is unclear how memory-eligible neurons react during learning to encode trace fear memory and how they retrieve a memory. We implemented a fiber-optic confocal fluorescence endomicroscope to directly visualize calcium dynamics of hippocampal CA1 neurons in freely behaving mice subjected to trace fear conditioning. Here we report that the overall activity levels of CA1 neurons showed a right-skewed lognormal distribution, with a small portion of highly active neurons (termed Primed Neurons) filling the long-tail. Repetitive training induced Primed Neurons to shift from random activity to well-tuned synchronization. The emergence of activity synchronization coincided with the appearance of mouse freezing behaviors. In recall, a partial synchronization among the same subset of Primed Neurons was induced from random dynamics, which also coincided with mouse freezing behaviors. Additionally, training-induced synchronization facilitated robust calcium entry into Primed Neurons. In contrast, most CA1 neurons did not respond to tone and foot shock throughout the training and recall cycles. In conclusion, Primed Neurons are preferably recruited to encode trace fear memory and induction of activity synchronization among Primed Neurons out of random dynamics is critical for trace memory formation and retrieval.	[Zhou, Yuxin; Qiu, Liyan; Chen, Xuanmao] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Wang, Haiying] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA	University System Of New Hampshire; University of New Hampshire; University of Connecticut	Chen, XM (corresponding author), Univ New Hampshire, Coll Life Sci & Agr, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA.	Xuanmao.Chen@unh.edu		Chen, Xuanmao/0000-0002-0057-8510	National Institutes of Health [MH105746, AG054729, GM113131-7006]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: MH105746, AG054729 and GM113131-7006	AIKA Y, 1994, EXP BRAIN RES, V99, P267; Andersen P., 2007, HIPPOCAMPUS BOOK; Asok A, 2019, TRENDS NEUROSCI, V42, P14, DOI 10.1016/j.tins.2018.10.005; Bakkum DJ, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00193; Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Buonomano DV, 2009, NEURON, V63, P423, DOI 10.1016/j.neuron.2009.08.003; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Chen CP, 2006, BIOSYSTEMS, V85, P137, DOI 10.1016/j.biosystems.2005.12.006; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XM, 2016, BIOL PSYCHIAT, V80, P836, DOI 10.1016/j.biopsych.2015.12.012; Chen XM, 2015, J NEUROSCI, V35, P339, DOI 10.1523/JNEUROSCI.2478-14.2015; Clark RE, 2002, TRENDS COGN SCI, V6, P524, DOI 10.1016/S1364-6613(02)02041-7; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Frankland PW, 2015, NEUROPSYCHOPHARMACOL, V40, P243, DOI 10.1038/npp.2014.234; Ghandour K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10683-2; Golomb D, 2006, J NEUROPHYSIOL, V95, P1049, DOI 10.1152/jn.00932.2005; Gore BB, 2014, LEARN MEMORY, V21, P575, DOI 10.1101/lm.036079.114; Gorski JA, 2002, J NEUROSCI, V22, P6309; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Josselyn SA, 2004, NEUROBIOL LEARN MEM, V82, P159, DOI 10.1016/j.nlm.2004.05.008; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kim J, 2014, NAT NEUROSCI, V17, P65, DOI 10.1038/nn.3592; Kim J, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00044; Kochli DE, 2015, LEARN MEMORY, V22, P92, DOI 10.1101/lm.034918.114; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Le Duigou C, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00262; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; Mizuseki K, 2013, CELL REP, V4, P1010, DOI 10.1016/j.celrep.2013.07.039; Pang KKL, 2019, P NATL ACAD SCI USA, V116, P5737, DOI 10.1073/pnas.1817643116; Park S, 2016, NEUROPSYCHOPHARMACOL, V41, P2987, DOI 10.1038/npp.2016.73; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Roy DS, 2017, CELL, V170, P1000, DOI 10.1016/j.cell.2017.07.013; Russell JT, 2011, BRIT J PHARMACOL, V163, P1605, DOI 10.1111/j.1476-5381.2010.00988.x; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Schultz SR., 2007, SCHOLARPEDIA, V2, P2046, DOI 10.4249/scholarpedia.2046; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Semon R.W., 1921, THE MNEME; Song CH, 2015, J NEUROSCI, V35, P13511, DOI 10.1523/JNEUROSCI.2329-15.2015; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tanaka KZ, 2018, SCIENCE, V361, P392, DOI 10.1126/science.aat5397; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tonegawa S, 2018, NAT REV NEUROSCI, V19, P485, DOI 10.1038/s41583-018-0031-2; Tonegawa S, 2015, CURR OPIN NEUROBIOL, V35, P101, DOI 10.1016/j.conb.2015.07.009; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Vincent P, 2006, EMBO REP, V7, P1154, DOI 10.1038/sj.embor.7400801; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Wang HB, 2012, REV NEUROSCIENCE, V23, P67, DOI 10.1515/revneuro-2011-0063; Wang ZH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00697-5; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yada Y, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00028; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012; Yang SG, 2014, P NATL ACAD SCI USA, V111, P12919, DOI 10.1073/pnas.1405468111; Yang WJ, 2017, NAT METHODS, V14, P349, DOI 10.1038/nmeth.4230; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Zhang L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219152; Zhang M, 2011, J NEUROSCI, V31, P10174, DOI 10.1523/JNEUROSCI.0009-11.2011; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	69	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3658	3676		10.1096/fj.201902274R	http://dx.doi.org/10.1096/fj.201902274R		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944374	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000507592600001
J	Agha, NH; Mehta, SK; Rooney, BV; Laughlin, MS; Markofski, MM; Pierson, DL; Katsanis, E; Crucian, BE; Simpson, RJ				Agha, Nadia H.; Mehta, Satish K.; Rooney, Bridgette V.; Laughlin, Mitzi S.; Markofski, Melissa M.; Pierson, Duane L.; Katsanis, Emmanuel; Crucian, Brian E.; Simpson, Richard J.			Exercise as a countermeasure for latent viral reactivation during long duration space flight	FASEB JOURNAL			English	Article						astronauts; cytomegalovirus (CMV); Epstein-Barr virus (EBV); functional fitness tests; immune dysregulation; varicella zoster virus (VZV); (V) over dotO(2max)	EPSTEIN-BARR-VIRUS; IMMUNE DYSREGULATION; STRESS; INTERVENTIONS; HEALTH; IMPACT; CELLS	Latent viral reactivation is a commonly reported manifestation of immune system dysregulation during spaceflight. As physical fitness and exercise training have been shown to benefit multiple arms of the immune system, we hypothesized that higher levels of preflight physical fitness and/or maintaining fitness during a mission would protect astronauts from latent viral reactivation. Standardized tests of maximal strength, muscular endurance, flexibility, and cardiorespiratory fitness (CRF) were performed in 22 international space station (ISS) crewmembers before and after a similar to 6-month mission. Reactivation of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and varicella zoster virus (VZV) was determined in crewmembers and ground-based controls before, during, and after spaceflight. Crewmembers with higher CRF before spaceflight had a 29% reduced risk of latent viral reactivation compared to crew with lower CRF. Higher preflight upper body muscular endurance was associated with a 39% reduced risk of viral reactivation, a longer time to viral reactivation, and lower peak viral DNA concentrations, particularly for EBV and VZV. Latent viral reactivation rates were highest in crew with lower preflight CRF and higher levels of CRF deconditioning on return to Earth. We conclude that physical fitness may protect astronauts from latent viral reactivation during long duration spaceflight missions.	[Agha, Nadia H.; Rooney, Bridgette V.; Laughlin, Mitzi S.; Markofski, Melissa M.; Simpson, Richard J.] Univ Houston, Lab Integrated Physiol, Dept Hlth & Human Performance, Houston, TX USA; [Mehta, Satish K.] NASA, JesTech, Johnson Space Ctr, Houston, TX USA; [Rooney, Bridgette V.] NASA, GeoControl Syst Inc, Johnson Space Ctr, Houston, TX USA; [Pierson, Duane L.; Crucian, Brian E.] NASA, Johnson Space Ctr, Houston, TX USA; [Simpson, Richard J.] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA; [Simpson, Richard J.] Univ Arizona, Dept Nutr Sci, 1177 E Fourth St Shantz Bldg Room 308, Tucson, AZ 85721 USA; [Katsanis, Emmanuel; Simpson, Richard J.] Univ Arizona, Dept Pediat, 1177 E Fourth St Shantz Bldg Room 308, Tucson, AZ 85721 USA; [Katsanis, Emmanuel; Simpson, Richard J.] Univ Arizona, Dept Immunobiol, 1177 E Fourth St Shantz Bldg Room 308, Tucson, AZ 85721 USA	University of Houston System; University of Houston; National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); University of Texas System; UTMD Anderson Cancer Center; University of Arizona; University of Arizona; University of Arizona	Simpson, RJ (corresponding author), Univ Arizona, Dept Nutr Sci, 1177 E Fourth St Shantz Bldg Room 308, Tucson, AZ 85721 USA.; Simpson, RJ (corresponding author), Univ Arizona, Dept Pediat, 1177 E Fourth St Shantz Bldg Room 308, Tucson, AZ 85721 USA.; Simpson, RJ (corresponding author), Univ Arizona, Dept Immunobiol, 1177 E Fourth St Shantz Bldg Room 308, Tucson, AZ 85721 USA.	rjsimpson@email.arizona.edu	Katsanis, Emmanuel/D-9600-2011; Markofski, Melissa M/Q-6372-2016	Katsanis, Emmanuel/0000-0003-1466-6965; Markofski, Melissa M/0000-0003-0214-4246; Simpson, Richard/0000-0002-7064-6881	National Aeronautics and Space Administration (NASA) [NNX12AB48G, NNX16AB29G, NNX16AG02G]; American College of Sports Medicine (ACSM)	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); American College of Sports Medicine (ACSM)	National Aeronautics and Space Administration (NASA), Grant/Award Number: NNX12AB48G, NNX16AB29G and NNX16AG02G; American College of Sports Medicine (ACSM)	ABELN V, 2012, STRESS CHALLENGES IM, P373; Abeln V, 2020, STRESS CHALLENGES AND IMMUNITY IN SPACE: FROM MECHANISMS TO MONITORING AND PREVENTIVE STRATEGIES, 2ND EDITION, P577, DOI 10.1007/978-3-030-16996-1_32; Alfano CA, 2018, ACTA ASTRONAUT, V142, P289, DOI 10.1016/j.actaastro.2017.11.009; *AM COLL SPORTS ME, 2018, ACSMS GUIDELINES EXE, P472; BAKER FL, 2016, INT SOC EXERCISE IMM, P116; Bigley AB, 2019, J APPL PHYSIOL, V126, P842, DOI 10.1152/japplphysiol.00761.2018; Bigley AB, 2014, BRAIN BEHAV IMMUN, V39, P160, DOI 10.1016/j.bbi.2013.10.030; Campbell JP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00648; Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188; Crucian B, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.13; Crucian B, 2014, BRAIN BEHAV IMMUN, V39, P23, DOI 10.1016/j.bbi.2014.01.011; Crucian BE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01437; Dhabhar FS, 2014, IMMUNOL RES, V58, P193, DOI 10.1007/s12026-014-8517-0; Duggal NA, 2019, NAT REV IMMUNOL, V19, P563, DOI 10.1038/s41577-019-0177-9; GLASER R, 1991, BRAIN BEHAV IMMUN, V5, P219, DOI 10.1016/0889-1591(91)90018-6; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; GLASER R, 1995, NEUROENDOCRINOLOGY, V62, P356, DOI 10.1159/000127025; GLASER R, 1994, PSYCHONEUROENDOCRINO, V19, P765, DOI 10.1016/0306-4530(94)90023-X; Glaser R, 1999, BRAIN BEHAV IMMUN, V13, P240, DOI 10.1006/brbi.1999.0566; Gleeson M, 2002, MED SCI SPORT EXER, V34, P411, DOI 10.1097/00005768-200203000-00005; Godbout JP, 2006, J NEUROIMMUNE PHARM, V1, P421, DOI 10.1007/s11481-006-9036-0; Graff RM, 2018, BRAIN BEHAV IMMUN, V74, P143, DOI 10.1016/j.bbi.2018.08.017; Konda NN, 2019, NPJ MICROGRAVITY, V5, DOI 10.1038/s41526-019-0073-4; Kunz HE, 2018, PHYSIOL BEHAV, V194, P56, DOI 10.1016/j.physbeh.2018.04.035; Laughlin MS, 2015, AEROSP MED HUM PERF, V86, pA87, DOI 10.3357/AMHP.EC11.2015; Mehta SK, 2014, BRAIN BEHAV IMMUN, V41, P210, DOI 10.1016/j.bbi.2014.05.014; Mehta SK, 2013, CYTOKINE, V61, P205, DOI 10.1016/j.cyto.2012.09.019; Mehta SK, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0015-y; Mehta SK, 2000, J MED VIROL, V61, P235, DOI 10.1002/(SICI)1096-9071(200006)61:2&lt;235::AID-JMV10&gt;3.0.CO;2-4; *NASA, 2015, NAS SPAC FLIGHT HUM, P83; Nieman DC, 2019, J SPORT HEALTH SCI, V8, P201, DOI 10.1016/j.jshs.2018.09.009; Pascoe AR, 2014, BRAIN BEHAV IMMUN, V39, P33, DOI 10.1016/j.bbi.2013.10.003; Petersen N, 2016, EXTREME PHYSIOL MED, V5, DOI 10.1186/s13728-016-0050-4; Rooney BV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00016; Simpson RJ, 2015, PROG MOL BIOL TRANSL, V135, P355, DOI 10.1016/bs.pmbts.2015.08.001; Simpson RJ, 2014, BRAIN BEHAV IMMUN, V39, P1, DOI 10.1016/j.bbi.2014.03.006; Simpson RJ, 2012, AGEING RES REV, V11, P404, DOI 10.1016/j.arr.2012.03.003; Spielmann G, 2019, J APPL PHYSIOL, V126, P469, DOI 10.1152/japplphysiol.00789.2018; Spielmann G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25852; Spielmann G, 2014, BRAIN BEHAV IMMUN, V39, P142, DOI 10.1016/j.bbi.2013.05.003; Spielmann G, 2011, BRAIN BEHAV IMMUN, V25, P1521, DOI 10.1016/j.bbi.2011.07.226	41	17	18	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2869	2881		10.1096/fj.201902327R	http://dx.doi.org/10.1096/fj.201902327R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908052	Green Accepted, Bronze			2022-12-28	WOS:000505686700001
J	Annunziata, C; Lama, A; Pirozzi, C; Cavaliere, G; Trinchese, G; Di Guida, F; Izzo, AN; Cimmino, F; Paciello, O; De Biase, D; Murru, E; Banni, S; Calignano, A; Mollica, MP; Raso, GM; Meli, R				Annunziata, Chiara; Lama, Adriano; Pirozzi, Claudio; Cavaliere, Gina; Trinchese, Giovanna; Di Guida, Francesca; Nitrato Izzo, Allegra; Cimmino, Fabiano; Paciello, Orlando; De Biase, Davide; Murru, Elisabetta; Banni, Sebastiano; Calignano, Antonio; Mollica, Maria Pina; Mattace Raso, Giuseppina; Meli, Rosaria			Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice	FASEB JOURNAL			English	Article						adenosine monophosphate-activated protein kinase (AMPK); high-fat diet; metabolic flexibility; mitochondrial dysfunction; oxidative stress; peroxisome proliferator-activated receptor (PPAR)-alpha	ACTIVATED PROTEIN-KINASE; IMPROVES INSULIN SENSITIVITY; FATTY LIVER-DISEASE; ADIPOSE-TISSUE; IN-VITRO; FLEXIBILITY; AMPK; OVEREXPRESSION; INFLAMMATION; RESISTANCE	Peroxisome proliferator-activated receptor (PPAR)-alpha activation controls hepatic lipid homeostasis, stimulating fatty acid oxidation, and adapting the metabolic response to lipid overload and storage. Here, we investigate the effect of palmitoylethanolamide (PEA), an endogenous PPAR-alpha ligand, in counteracting hepatic metabolic inflexibility and mitochondrial dysfunction induced by high-fat diet (HFD) in mice. Long-term PEA administration (30 mg/kg/die per os) in HFD mice limited hepatic lipid accumulation, increased energy expenditure, and markedly reduced insulin resistance. In isolated liver mitochondria, we have demonstrated PEA capability to modulate mitochondrial oxidative capacity and energy efficiency, leading to the reduction of intracellular lipid accumulation and oxidative stress. Moreover, we have evaluated the effect of PEA on mitochondrial bioenergetics of palmitate-challenged HepG2 cells, using Seahorse analyzer. In vitro data showed that PEA recovered mitochondrial dysfunction and reduced lipid accumulation in insulin-resistant HepG2 cells, increasing fatty acid oxidation. Mechanistic studies showed that PEA effect on lipid metabolism was limited by AMP-activated protein kinase (AMPK) inhibition, providing evidence for a pivotal role of AMPK in PEA-induced adaptive metabolic setting. All these findings identify PEA as a modulator of hepatic lipid and glucose homeostasis, limiting metabolic inflexibility induced by nutrient overload.	[Annunziata, Chiara; Lama, Adriano; Pirozzi, Claudio; Di Guida, Francesca; Nitrato Izzo, Allegra; Calignano, Antonio; Mattace Raso, Giuseppina; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Cavaliere, Gina; Trinchese, Giovanna; Cimmino, Fabiano; Mollica, Maria Pina] Univ Naples Federico II, Dept Biol, Complesso Univ Monte St Angelo, I-80126 Naples, Italy; [Paciello, Orlando; De Biase, Davide] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Murru, Elisabetta; Banni, Sebastiano] Univ Cagliari, Cittadella Univ Monserrato, Dept Biomed Sci, Cagliari, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Cagliari	Mollica, MP (corresponding author), Univ Naples Federico II, Dept Biol, Complesso Univ Monte St Angelo, I-80126 Naples, Italy.	mariapia.mollica@unina.it	Pirozzi, Claudio/S-2760-2016; Murru, Elisabetta/AAW-4909-2021; Giovanna, Trinchese/AAC-5995-2022; CIMMINO, FABIANO/AIA-1152-2022; Lama, Adriano/AAC-1964-2020	Giovanna, Trinchese/0000-0002-4096-6876; CIMMINO, FABIANO/0000-0001-5239-4329; Lama, Adriano/0000-0002-5816-1400; Mattace Raso, Giuseppina/0000-0002-5254-139X; Annunziata, Chiara/0000-0003-2784-8004; Mollica, Maria Pina/0000-0003-2726-7779; Murru, Maria Elisabetta/0000-0002-7394-5780; Pirozzi, Claudio/0000-0002-3409-5744				Abdulnour J, 2014, OBESITY, V22, P211, DOI 10.1002/oby.20498; AEBI H, 1984, METHOD ENZYMOL, V105, P121; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P1632, DOI 10.1016/j.drudis.2014.06.007; Battaglia GM, 2012, AM J PHYSIOL-ENDOC M, V303, pE1440, DOI 10.1152/ajpendo.00355.2012; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bergamo P, 2007, FREE RADICAL BIO MED, V43, P71, DOI 10.1016/j.freeradbiomed.2007.03.023; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cairns CB, 1998, AM J PHYSIOL-REG I, V274, pR1376, DOI 10.1152/ajpregu.1998.274.5.R1376; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Carta G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00902; Cavaliere G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149033; D'Agostino G, 2015, MOL METAB, V4, P528, DOI 10.1016/j.molmet.2015.04.005; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Dominguez JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006790; Fanelli F, 2018, MOL METAB, V14, P82, DOI 10.1016/j.molmet.2018.06.002; Ferrante MC, 2014, TOXICOL APPL PHARM, V279, P401, DOI 10.1016/j.taap.2014.06.016; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Franko A, 2016, DIABETES, V65, P2540, DOI 10.2337/db15-1670; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Gross B, 2017, NAT REV ENDOCRINOL, V13, P36, DOI 10.1038/nrendo.2016.135; Harriman G, 2016, P NATL ACAD SCI USA, V113, pE1796, DOI 10.1073/pnas.1520686113; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Khan RS, 2019, HEPATOLOGY, V70, P711, DOI 10.1002/hep.30429; Kim K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071522; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Konrad D, 2014, PHYSIOLOGY, V29, P304, DOI 10.1152/physiol.00014.2014; Lama A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41295-x; Lama A, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600418; Lihn AS, 2008, MOL CELL ENDOCRINOL, V292, P36, DOI 10.1016/j.mce.2008.06.004; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; Oriente F, 2013, DIABETOLOGIA, V56, P2713, DOI 10.1007/s00125-013-3053-3; Petrosino S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00249; Petrosino S, 2017, BRIT J PHARMACOL, V174, P1349, DOI 10.1111/bph.13580; Piscitelli F, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-51; Raso GM, 2014, ENDOCRINOLOGY, V155, P1291, DOI 10.1210/en.2013-1823; Raso GM, 2014, PHARMACOL RES, V86, P32, DOI 10.1016/j.phrs.2014.05.006; Russo R, 2018, CURR MED CHEM, V25, P3930, DOI 10.2174/0929867324666170216113756; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Seo E, 2009, KOREAN J PHYSIOL PHA, V13, P449, DOI 10.4196/kjpp.2009.13.6.449; Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211; Tanaka N, 2017, PHARMACOL THERAPEUT, V179, P142, DOI 10.1016/j.pharmthera.2017.05.011; Theurey P, 2017, TRENDS ENDOCRIN MET, V28, P32, DOI 10.1016/j.tem.2016.09.002; Wallenius K, 2013, PPAR RES, V2013, DOI 10.1155/2013/305347; Wu D, 2014, INT J MOL MED, V34, P1706, DOI 10.3892/ijmm.2014.1942; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Zhang HA, 2016, BIOCHEM BIOPH RES CO, V474, P364, DOI 10.1016/j.bbrc.2016.04.111	61	20	20	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					350	364		10.1096/fj.201901510RR	http://dx.doi.org/10.1096/fj.201901510RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914699	Green Published			2022-12-28	WOS:000507308900025
J	Arnaud, AP; Rome, V; Richard, M; Formal, M; David-Le Gall, S; Boudry, G				Arnaud, Alexis Pierre; Rome, Veronique; Richard, Marion; Formal, Michele; David-Le Gall, Sandrine; Boudry, Gaelle			Post-natal co-development of the microbiota and gut barrier function follows different paths in the small and large intestine in piglets	FASEB JOURNAL			English	Article						intestinal permeability; neonate; short-chain fatty acid; toll-like receptors	GERM-FREE; MILK; INFLAMMATION; EXPRESSION; SECRETION; PROFILES; GRADIENT; VIRUSES; HEALTH; MODEL	Gut microbiota and intestinal barrier co-develop after birth, establishing a homeostatic state whereby mucosal cells cohabit with commensal bacteria. We hypothesized that this post-natal co-development follows different timings depending on the intestinal site considered. Jejunal, ileal, and colonic luminal contents and mucosa were sampled in suckling piglets at post-natal day (PND) 0, 2, 7, 14, and 28. Jejunal, ileal, and colonic luminal microbiota (evaluated by 16S DNA sequencing followed by beta-diversity analysis) clustered at PND2 but colonic microbiota diverge afterwards (P < .05). Mucosal permeability, evaluated in Ussing chambers, increased with age in the jejunum and ileum (P < .05) but not the colon. Expression of pattern recognition receptor (PRR) exhibited different patterns (gradual or sharp increase, decrease, or no change with age, P < .05) depending on PRR and intestinal site considered. Principal component analysis of mucosa data revealed clear clustering of colonic samples, irrespective of the age and clustering of jejunal and ileal samples, with gradual changes with age. Correlation analysis highlighted three families correlating with mucosal parameters: Enterobacteriaceae in the jejunum, Peptostreptococcaceae in the ileum, and Micrococcaceae in the colon. In conclusion, small and large intestine display close microbiota composition early in life but distinct mucosal phenotype and follow very different post-natal development.	[Arnaud, Alexis Pierre; Rome, Veronique; Richard, Marion; Formal, Michele; David-Le Gall, Sandrine; Boudry, Gaelle] Univ Rennes, INSERM, INRA, Inst NuMeCan, St Gilles, France; [Arnaud, Alexis Pierre] Univ Rennes 1, CHU Rennes, Serv Chirurg Pediat, Rennes, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Rennes	Boudry, G (corresponding author), Univ Rennes 1, INRA, INSERM, Inst NuMeCan, F-35590 St Gilles, France.	Gaelle.Boudry@inra.fr	Arnaud, Alexis/AGT-6845-2022; Boudry, Gaelle/ABG-8836-2020	Arnaud, Alexis/0000-0003-4378-3570; Boudry, Gaelle/0000-0002-5287-571X; LE GALL-DAVID, Sandrine/0000-0001-5493-3429				Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Bhattarai Y, 2016, METHODS MOL BIOL, V1438, P123, DOI 10.1007/978-1-4939-3661-8_8; Boudry G, 2008, J PHYSIOL PHARMACOL, V59, P543; Buddington RK, 2011, J ANIM SCI, V89, P1506, DOI 10.2527/jas.2010-3705; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; Chen L, 2018, PEERJ, V6, DOI 10.7717/peerj.4600; Chen NH, 2017, IUBMB LIFE, V69, P297, DOI 10.1002/iub.1625; Chen X, 2018, ANAEROBE, V49, P30, DOI 10.1016/j.anaerobe.2017.12.002; Choteau L, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0158-0; Desaldeleer C, 2014, J NUTR BIOCHEM, V25, P1090, DOI 10.1016/j.jnutbio.2014.05.014; DUCKER DA, 1980, GUT, V21, P133, DOI 10.1136/gut.21.2.133; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Gebbers JO, 2004, ANN NY ACAD SCI, V1029, P337, DOI 10.1196/annals.1309.015; Goulet O, 2015, NUTR REV, V73, P32, DOI 10.1093/nutrit/nuv039; Gourbeyre P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12225; Alvarez-Mercado AI, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030068; Kerr CA, 2015, CRIT REV MICROBIOL, V41, P326, DOI 10.3109/1040841X.2013.837863; KLOBASA F, 1987, J ANIM SCI, V64, P1458, DOI 10.2527/jas1987.6451458x; Kraiczy J, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/7242415; Kraiczy J, 2019, GUT, V68, P49, DOI 10.1136/gutjnl-2017-314817; Le Bourgot C, 2019, FASEB J, V33, P301, DOI 10.1096/fj.201800108R; Le Bourgot C, 2017, BRIT J NUTR, V117, P83, DOI 10.1017/S0007114516004268; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Li N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01798; Liu Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40235-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; Maradiaga N, 2018, MICROB PATHOGENESIS, V121, P27, DOI 10.1016/j.micpath.2018.05.007; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Pacheco AR, 2015, ANNU REV ANIM BIOSCI, V3, P419, DOI 10.1146/annurev-animal-022114-111112; Price AE, 2018, IMMUNITY, V49, P560, DOI 10.1016/j.immuni.2018.07.016; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reid CJ, 1998, GUT, V42, P220, DOI 10.1136/gut.42.2.220; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rokhsefat S, 2016, DIGEST DIS SCI, V61, P1473, DOI 10.1007/s10620-016-4032-6; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Salcedo J, 2016, J DAIRY SCI, V99, P7733, DOI 10.3168/jds.2016-10966; Shulman RJ, 1998, PEDIATR RES, V44, P519, DOI 10.1203/00006450-199810000-00009; Smirnov KS, 2016, INT J MED MICROBIOL, V306, P266, DOI 10.1016/j.ijmm.2016.03.006; Sun J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29093-3; Tomas J, 2015, ISME J, V9, P46, DOI 10.1038/ismej.2014.111; Walker RW, 2017, PEDIATR OBES, V12, P3, DOI 10.1111/ijpo.12217; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009	51	12	12	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1430	1446		10.1096/fj.201902514R	http://dx.doi.org/10.1096/fj.201902514R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914707	Bronze			2022-12-28	WOS:000507308900095
J	Fierro-Fernandez, M; Miguel, V; Marquez-Exposito, L; Nuevo-Tapioles, C; Herrero, JI; Blanco-Ruiz, E; Tituana, J; Castillo, C; Cannata, P; Monsalve, M; Ruiz-Ortega, M; Ramos, R; Lamas, S				Fierro-Fernandez, Marta; Miguel, Veronica; Marquez-Exposito, Laura; Nuevo-Tapioles, Cristina; Herrero, J. Ignacio; Blanco-Ruiz, Eva; Tituana, Jessica; Castillo, Carolina; Cannata, Pablo; Monsalve, Maria; Ruiz-Ortega, Marta; Ramos, Ricardo; Lamas, Santiago			MiR-9-5p protects from kidney fibrosis by metabolic reprogramming	FASEB JOURNAL			English	Article						chronic kidney disease; fatty acid oxidation; fibrosis; metabolism; microRNAs; mitochondria	PROMOTES RENAL FIBROSIS; FIBROGENIC TRANSFORMATION; TUBULE INJURY; UP-REGULATION; EXPRESSION; MICRORNAS; TARGET; NEPHROPATHY; PGC-1-ALPHA; MECHANISMS	MicroRNAs (miRNAs) regulate gene expression posttranscriptionally and control biological processes (BPs), including fibrogenesis. Kidney fibrosis remains a clinical challenge and miRNAs may represent a valid therapeutic avenue. We show that miR-9-5p protected from renal fibrosis in the mouse model of unilateral ureteral obstruction (UUO). This was reflected in reduced expression of pro-fibrotic markers, decreased number of infiltrating monocytes/macrophages, and diminished tubular epithelial cell injury and transforming growth factor-beta 1 (TGF-beta 1)-dependent de-differentiation in human kidney proximal tubular (HKC-8) cells. RNA-sequencing (RNA-Seq) studies in the UUO model revealed that treatment with miR-9-5p prevented the downregulation of genes related to key metabolic pathways, including mitochondrial function, oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and glycolysis. Studies in human tubular epithelial cells demonstrated that miR-9-5p impeded TGF-beta 1-induced bioenergetics derangement. The expression of the FAO-related axis peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha)-peroxisome proliferator-activated receptor alpha (PPAR alpha) was reduced by UUO, although preserved by the administration of miR-9-5p. We found that in mice null for the mitochondrial master regulator PGC-1 alpha, miR-9-5p was unable to promote a protective effect in the UUO model. We propose that miR-9-5p elicits a protective response to chronic kidney injury and renal fibrosis by inducing reprogramming of the metabolic derangement and mitochondrial dysfunction affecting tubular epithelial cells.	[Fierro-Fernandez, Marta; Miguel, Veronica; Nuevo-Tapioles, Cristina; Herrero, J. Ignacio; Blanco-Ruiz, Eva; Tituana, Jessica; Lamas, Santiago] Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Cell Biol & Immunol, Madrid, Spain; [Marquez-Exposito, Laura; Cannata, Pablo; Ruiz-Ortega, Marta] Fdn Jimenez Diaz (UAM), Inst Invest Sanitaria, Madrid, Spain; [Castillo, Carolina] Hosp Univ Principe Asturias, Madrid, Spain; [Monsalve, Maria] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Ramos, Ricardo] Fdn Parque Cient Madrid, Serv Genom, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Prince of Asturias University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Lamas, S (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Cell Biol & Immunol, Madrid, Spain.	slamas@cbm.csic.es	Nuevo-Tapioles, Cristina/AAT-5772-2021; Miguel, Veronica/AAA-3645-2021; Monsalve, Maria/K-4416-2014; Ruiz-Ortega, Marta/D-3584-2012; Nuevo-Tapioles, Cristina/F-5970-2016; Lamas, Santiago/G-7308-2015; ramos-ruiz, ricardo/Q-2237-2016	Monsalve, Maria/0000-0003-2796-1453; Ruiz-Ortega, Marta/0000-0002-1495-6535; Nuevo-Tapioles, Cristina/0000-0001-5809-2030; Lamas, Santiago/0000-0001-5166-4155; Miguel, Veronica/0000-0001-9863-0710; Blanco-Ruiz, Eva/0000-0001-5940-1827; TITUANA FAJARDO, JESSICA/0000-0002-3337-8363; ramos-ruiz, ricardo/0000-0002-6331-9786	Ministerio de Economia y Competitividad (MINECO) [SAF2015-66107-R, SAF 2012-31388, SAF2015-63904-R, BES-2013-065986, BES-2014-068929]; MINECO Instituto de Salud Carlos III (ISCIII) [RD12/0021/0009, RD16/0009/0016, PI17/00119]; Comunidad de Madrid [B2017/BMD-3751]; FRIAT Fundacion Renal Inigo Alvarez de Toledo; Fundacion Ramon Areces (Ramon Areces Foundation)	Ministerio de Economia y Competitividad (MINECO); MINECO Instituto de Salud Carlos III (ISCIII); Comunidad de Madrid(Comunidad de Madrid); FRIAT Fundacion Renal Inigo Alvarez de Toledo; Fundacion Ramon Areces (Ramon Areces Foundation)	Ministerio de Economia y Competitividad (MINECO), Grant/Award Number: SAF2015-66107-R, SAF 2012-31388, SAF2015-63904-R, BES-2013-065986 and BES-2014-068929; MINECO Instituto de Salud Carlos III (ISCIII), Grant/Award Number: RD12/0021/0009, RD16/0009/0016 and PI17/00119; Comunidad de Madrid, Grant/Award Number: B2017/BMD-3751; FRIAT Fundacion Renal Inigo Alvarez de Toledo; Fundacion Ramon Areces (Ramon Areces Foundation)	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt K, 2016, AM J PHYSIOL-RENAL, V310, pF109, DOI 10.1152/ajprenal.00387.2015; Bonventre JV, 2014, KIDNEY INT SUPPL, V4, P39, DOI 10.1038/kisup.2014.8; Breyer MD, 2016, NAT REV DRUG DISCOV, V15, P568, DOI 10.1038/nrd.2016.67; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chang-Panesso M, 2017, NAT REV NEPHROL, V13, P39, DOI 10.1038/nrneph.2016.169; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Cheng CJ, 2015, NATURE, V518, P107, DOI 10.1038/nature13905; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chung ACK, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00050; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; de Rie D, 2017, NAT BIOTECHNOL, V35, P872, DOI 10.1038/nbt.3947; Dennis G, 2003, GENOME BIOL, V4; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Espinosa-Diez C, 2015, ANTIOXID REDOX SIGN, V23, P1092, DOI 10.1089/ars.2014.6025; Fierro-Fernandez M, 2016, REDOX BIOL, V7, P58, DOI 10.1016/j.redox.2015.11.006; Fierro-Fernandez M, 2015, EMBO REP, V16, P1358, DOI 10.15252/embr.201540750; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Gomez IG, 2016, AM J PHYSIOL-RENAL, V310, pP931, DOI 10.1152/ajprenal.00523.2015; Gomez IG, 2015, J CLIN INVEST, V125, P141, DOI 10.1172/JCI75852; Han SH, 2017, J AM SOC NEPHROL, V28, P3312, DOI 10.1681/ASN.2017020130; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Lavoz C, 2015, J PATHOL, V236, P407, DOI 10.1002/path.4537; Leaf IA, 2017, NEPHROL DIAL TRANSPL, V32, P89, DOI 10.1093/ndt/gfw388; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li R, 2013, KIDNEY INT, V84, P1129, DOI 10.1038/ki.2013.272; Li SY, 2018, SEMIN NEPHROL, V38, P121, DOI 10.1016/j.semnephrol.2018.01.003; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Lynch MR, 2018, AM J PHYSIOL-RENAL, V314, pF1, DOI 10.1152/ajprenal.00263.2017; Macconi D, 2012, J AM SOC NEPHROL, V23, P1496, DOI 10.1681/ASN.2011121144; MacKinnon M, 2006, AM J KIDNEY DIS, V48, P8, DOI 10.1053/j.ajkd.2006.04.077; Maheshwari R, 2017, NANOMEDICINE-UK, V12, P2653, DOI 10.2217/nnm-2017-0210; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Miguel V, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0044-2; O'Reilly S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0929-x; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Pottier N, 2014, TRENDS PHARMACOL SCI, V35, P119, DOI 10.1016/j.tips.2014.01.003; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Ralto KM, 2016, SEMIN NEPHROL, V36, P8, DOI 10.1016/j.semnephrol.2016.01.005; Remuzzi A, 2016, J AM SOC NEPHROL, V27, P699, DOI 10.1681/ASN.2014100971; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Shihab FS, 2007, CLIN J AM SOC NEPHRO, V2, P876, DOI 10.2215/CJN.02660707; Simon N, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00052; Smeets B, 2013, J PATHOL, V229, P645, DOI 10.1002/path.4125; Stadler K, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0611-8; Szeto HH, 2017, J AM SOC NEPHROL, V28, P2856, DOI 10.1681/ASN.2017030247; Tang PMK, 2019, NAT REV NEPHROL, V15, P144, DOI 10.1038/s41581-019-0110-2; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202; Trzpis M, 2008, J PATHOL, V216, P201, DOI 10.1002/path.2396; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang JY, 2016, J DIABETES COMPLICAT, V30, P406, DOI 10.1016/j.jdiacomp.2015.12.011; Wang JY, 2013, CELL BIOCHEM BIOPHYS, V67, P537, DOI 10.1007/s12013-013-9539-2; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zhang F, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0771-9; Zhao H, 2019, CLIN CHIM ACTA, V491, P59, DOI 10.1016/j.cca.2019.01.008; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC	76	32	35	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					410	431		10.1096/fj.201901599RR	http://dx.doi.org/10.1096/fj.201901599RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914684	Green Published, Green Submitted			2022-12-28	WOS:000507308900029
J	Khan, YA; Maurya, SK; Kulkarni, C; Tiwari, MC; Nagar, GK; Chattopadhyay, N				Khan, Yasir Akhtar; Maurya, Shailendra Kumar; Kulkarni, Chirag; Tiwari, Mahesh Chandra; Nagar, Geet Kumar; Chattopadhyay, Naibedya			Fasciola helminth defense molecule-1 protects against experimental arthritis by inhibiting osteoclast formation and function without modulating the systemic immune response	FASEB JOURNAL			English	Article						bone; cartilage; collagen-induced arthritis; helminth defense molecule; lysosome; osteoclast	RHEUMATOID-ARTHRITIS; BONE LOSS; T-CELLS; H+-ATPASE; PATHOGENESIS; DESTRUCTION; CYTOKINES; ACIDIFICATION; DEGENERATION; MACROPHAGES	An inverse correlation between helminth infection and the autoimmune disease appears to be contributed by the anti-inflammatory factors produced by these organisms. Suppressing osteoclast function without affecting the systemic immunological response is an emerging therapeutic strategy for rheumatoid arthritis (RA). We observed that a synthetic peptide corresponding to 34 amino acids of C-terminal sequence of Fasciola helminth defense molecule-1 (C-FhHDM-1) inhibited RANKL-induced osteoclast formation and lysosomal acidification with an attendant upregulation of sequestome1/p62, a negative regulator of NF-kappa B expression. C-FhHDM-1 also suppressed RANKL production from osteoblasts. Macrophages are the major inflammatory cells in the joints of RA and C-FhHDM-1 suppressed ICAM-1 (an inflammatory surrogate) expression in these cells. In a murine model of collagen II-induced arthritis (CIA), C-FhHDM-1 improved clinical score, protected against cartilage destruction, and maintained bone mass and bone architecture of joints compared with the CIA group. C-FhHDM-1 suppressed the CIA-induced expression of TNF, IL-17, and IFN-gamma in joints but not their serum levels. The peptide also had no effect on the CIA-induced suppression of T regulatory response. We conclude that C-FhHDM-1 has a joint-specific protective effect in experimental arthritis without mitigating systemic inflammation, and thus could become an adjuvant anti-arthritis therapy to prevent RA-induced osteopenia.	[Khan, Yasir Akhtar; Maurya, Shailendra Kumar; Kulkarni, Chirag; Tiwari, Mahesh Chandra; Nagar, Geet Kumar; Chattopadhyay, Naibedya] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India; [Khan, Yasir Akhtar] Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh 202002, Uttar Pradesh, India; [Kulkarni, Chirag; Chattopadhyay, Naibedya] CSIR Cent Drug Res Inst, Acad Sci & Innovat Res, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Aligarh Muslim University; Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Chattopadhyay, N (corresponding author), CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India.; Khan, YA (corresponding author), Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh 202002, Uttar Pradesh, India.	yasirkhanakhtar@gmail.com; n_chattopadhyay@cdri.res.in	Chattopadhyay, Naibedya/AAQ-3213-2021	Chattopadhyay, Naibedya/0000-0003-2473-0246	Department of Science and Technology-Science and Engineering Research Board, Government of India [PDF/2015/000790]; Department of Science and Technology, Government of India [SB/SO/HS/048/2014]	Department of Science and Technology-Science and Engineering Research Board, Government of India; Department of Science and Technology, Government of India(Department of Science & Technology (India))	Department of Science and Technology-Science and Engineering Research Board, Government of India, Grant/Award Number: PDF/2015/000790; Department of Science and Technology, Government of India, Grant/Award Number: SB/SO/HS/048/2014	Alvarado R, 2017, FASEB J, V31, P85, DOI 10.1096/fj.201500093R; Alves CH, 2016, CLIN REV ALLERG IMMU, V51, P27, DOI 10.1007/s12016-015-8522-7; Amarasekara DS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e8; Bonnet CS, 2015, ANN RHEUM DIS, V74, P242, DOI 10.1136/annrheumdis-2013-203670; Boraschi-Diaz I, 2016, CYTOTECHNOLOGY, V68, P105, DOI 10.1007/s10616-014-9759-3; Boyce Brendan F, 2007, Curr Osteoporos Rep, V5, P98; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Chen YM, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1763-0; Cummings SR, 2018, J BONE MINER RES, V33, P190, DOI 10.1002/jbmr.3337; Garimella MG, 2015, J IMMUNOL, V195, P5136, DOI 10.4049/jimmunol.1500332; Garrood T, 2006, RHEUMATOLOGY, V45, P250, DOI 10.1093/rheumatology/kei207; Gelman A, 2011, DEV CELL, V21, P808, DOI 10.1016/j.devcel.2011.10.021; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gu W., 2017, ONCOTARGET, V8; Heidari B, 2011, CASP J INTERN MED, V2, P161; Hengartner NE, 2013, MOL MED, V19, P36, DOI 10.2119/molmed.2012.00058; Henriksen K, 2006, J BONE MINER RES, V21, P58, DOI 10.1359/JBMR.050905; Hubbard AK, 2000, INFLAMMATION, V24, P115, DOI 10.1023/A:1007029409521; Jung SM, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/263625; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kato G, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0753-8; Kelchtermans H, 2009, ANN RHEUM DIS, V68, P744, DOI 10.1136/ard.2007.086066; Kelly C, 2002, Eur J Intern Med, V13, P423, DOI 10.1016/S0953-6205(02)00129-2; Khan YA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126429; Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#; Kour S, 2016, J IMMUNOL, V196, P5024, DOI 10.4049/jimmunol.1500907; Kumar RA, 2018, INT IMMUNOPHARMACOL, V65, P348, DOI 10.1016/j.intimp.2018.10.016; Lacombe J, 2013, CELL CYCLE, V12, P2744, DOI 10.4161/cc.25825; Langdon K, 2019, INT IMMUNOPHARMACOL, V66, P366, DOI 10.1016/j.intimp.2018.11.034; Li J, 2012, CURR RHEUMATOL REP, V14, P445, DOI 10.1007/s11926-012-0272-4; Lund ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep37789; Matsumoto N, 2019, BIOCHEM BIOPH RES CO, V510, P421, DOI 10.1016/j.bbrc.2019.01.118; Matsumoto N, 2014, BBA-BIOENERGETICS, V1837, P744, DOI 10.1016/j.bbabio.2014.02.011; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Meyer PWA, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/158514; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Nakamichi Y, 2012, P NATL ACAD SCI USA, V109, P10006, DOI 10.1073/pnas.1207361109; Niikura K, 2007, BONE, V40, P888, DOI 10.1016/j.bone.2006.10.015; Pal S, 2019, J ETHNOPHARMACOL, V235, P8, DOI 10.1016/j.jep.2019.01.029; Pal S, 2016, TOXICOL APPL PHARM, V295, P12, DOI 10.1016/j.taap.2016.02.002; Pereira M, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216267; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sato W, 2012, J IMMUNOL, V189, P5057, DOI 10.4049/jimmunol.1202026; Smallwood TB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00453; Srivastava RK, 2011, J IMMUNOL, V186, P2262, DOI 10.4049/jimmunol.1002691; Swarnkar G, 2012, BRIT J PHARMACOL, V165, P1526, DOI 10.1111/j.1476-5381.2011.01637.x; SZEKANECZ Z, 1994, ARTHRITIS RHEUM, V37, P221, DOI 10.1002/art.1780370211; Takeuchi T, 2016, ANN RHEUM DIS, V75, P983, DOI 10.1136/annrheumdis-2015-208052; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Tripathi JK, 2015, BIOMATERIALS, V56, P92, DOI 10.1016/j.biomaterials.2015.03.046; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; Vomero M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01577; Wang CQ, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-6; Wei S, 2008, PATHOL RES PRACT, V204, P695, DOI 10.1016/j.prp.2008.07.002; Xu SQ, 2012, RHEUMATOL INT, V32, P3397, DOI 10.1007/s00296-011-2175-5; Zhu SP, 2016, J CELL BIOCHEM, V117, P1464, DOI 10.1002/jcb.25442	58	6	6	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1091	1106		10.1096/fj.201901480RR	http://dx.doi.org/10.1096/fj.201901480RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914677				2022-12-28	WOS:000507308900074
J	Sochaj-Gregorczyk, A; Ksiazek, M; Waligorska, I; Straczek, A; Benedyk, M; Mizgalska, D; Thogersen, IB; Enghild, JJ; Potempa, J				Sochaj-Gregorczyk, Alicja; Ksiazek, Miroslaw; Waligorska, Irena; Straczek, Anna; Benedyk, Malgorzata; Mizgalska, Danuta; Thogersen, Ida B.; Enghild, Jan J.; Potempa, Jan			Plasmin inhibition by bacterial serpin: Implications in gum disease	FASEB JOURNAL			English	Article						fibrinolysis; plasmin; periodontitis; serpin; Tannerella forsythia	STAPHYLOCOCCUS-AUREUS; TANNERELLA-FORSYTHIA; PERIODONTAL-DISEASE; DEFICIENCY; COMPLEX; RANGE; MODEL; UPA	Tannerella forsythia is a periodontopathogen that expresses miropin, a protease inhibitor in the serpin superfamily. In this study, we show that miropin is also a specific and efficient inhibitor of plasmin; thus, it represents the first proteinaceous plasmin inhibitor of prokaryotic origin described to date. Miropin inhibits plasmin through the formation of a stable covalent complex triggered by cleavage of the Lys(368)-Thr(369) (P2-P1) reactive site bond with a stoichiometry of inhibition of 3.8 and an association rate constant (k(ass)) of 3.3 x 10(5) M(-1)s(-1). The inhibition of the fibrinolytic activity of plasmin was nearly as effective as that exerted by alpha(2)-antiplasmin. Miropin also acted in vivo by reducing blood loss in a mice tail bleeding assay. Importantly, intact T. forsythia cells or outer membrane vesicles, both of which carry surface-associated miropin, strongly inhibited plasmin. In intact bacterial cells, the antiplasmin activity of miropin protects envelope proteins from plasmin-mediated degradation. In summary, in the environment of periodontal pockets, which are bathed in gingival crevicular fluid consisting of 70% of blood plasma, an abundance of T. forsythia in the bacterial biofilm can cause local inhibition of fibrinolysis, which could have possible deleterious effects on the tooth-supporting structures of the periodontium.	[Sochaj-Gregorczyk, Alicja; Ksiazek, Miroslaw] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland; [Ksiazek, Miroslaw; Waligorska, Irena; Straczek, Anna; Benedyk, Malgorzata; Mizgalska, Danuta; Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland; [Ksiazek, Miroslaw; Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Thogersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark	Jagiellonian University; Jagiellonian University; University of Louisville; Aarhus University	Ksiazek, M (corresponding author), Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	ksiazek.miroslaw@gmail.com	Potempa, Jan/AAA-6850-2021		National Science Center (Krakow, Poland) [UMO-2015/17/B/NZ1/00666, UMO-2016/21/B/NZ1/00292]; NIH/NIDCR [R21DE026280]; Ministry of Science and Higher Education [1306/MOB/IV/2015/0]	National Science Center (Krakow, Poland)(National Science Centre, Poland); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	National Science Center (Krakow, Poland), Grant/Award Number: UMO-2015/17/B/NZ1/00666 and UMO-2016/21/B/NZ1/00292; NIH/NIDCR, Grant/Award Number: R21DE026280; Ministry of Science and Higher Education, Grant/Award Number: 1306/MOB/IV/2015/0	Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Benedyk M, 2016, J INNATE IMMUN, V8, P185, DOI 10.1159/000441724; BRAUN V, 1969, EUR J BIOCHEM, V10, P426, DOI 10.1111/j.1432-1033.1969.tb00707.x; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Celkan T, 2017, J THROMB THROMBOLYS, V43, P132, DOI 10.1007/s11239-016-1416-6; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Collen D, 1980, J Clin Pathol Suppl (R Coll Pathol), V14, P24; Cortes-Vieyra R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1396106; Darenfed H, 1999, INFECT IMMUN, V67, P6439; DeCarlo AA, 2007, J PERIODONTAL RES, V42, P305, DOI 10.1111/j.1600-0765.2006.00949.x; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Eckert M, 2018, MOL ORAL MICROBIOL, V33, P240, DOI 10.1111/omi.12220; Friedrich V, 2015, MOL ORAL MICROBIOL, V30, P451, DOI 10.1111/omi.12104; Goulas T, 2017, J BIOL CHEM, V292, P10883, DOI 10.1074/jbc.M117.786533; Guo YZ, 2008, ARTHRITIS RHEUM, V58, P764, DOI 10.1002/art.23263; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hienz SA, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/615486; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Imamura T, 2001, J BIOL CHEM, V276, P18984, DOI 10.1074/jbc.M006760200; Ioannidou E, 2011, J DENT RES, V90, P1411, DOI 10.1177/0022034511423394; Kanno Y, 2016, INT J BIOL SCI, V12, P63, DOI 10.7150/ijbs.12690; Khoshhal K, 2003, J PEDIATR ORTHOPED, V23, P661, DOI 10.1097/01241398-200309000-00017; Krafts KP, 2010, ORGANOGENESIS, V6, P225, DOI 10.4161/org.6.4.12555; Ksiazek M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00312; Ksiazek M, 2015, J BIOL CHEM, V290, P658, DOI 10.1074/jbc.M114.601716; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lam RS, 2015, IMMUNOL CELL BIOL, V93, P705, DOI 10.1038/icb.2015.25; Lasica AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37708; Liesenborghs L, 2018, J THROMB HAEMOST, V16, P441, DOI 10.1111/jth.13928; Nazir Muhammad Ashraf, 2017, Int J Health Sci (Qassim), V11, P72; Neilands J, 2016, ARCH ORAL BIOL, V70, P1, DOI 10.1016/j.archoralbio.2016.05.016; Peetermans M, 2016, CRIT REV MICROBIOL, V42, P866, DOI 10.3109/1040841X.2015.1080214; Persson RE, 2003, J CLIN PERIODONTOL, V30, P207, DOI 10.1034/j.1600-051X.2003.00237.x; Potempa J, 2017, NAT REV RHEUMATOL, V13, P606, DOI 10.1038/nrrheum.2017.132; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scully C, 2001, ORAL SURG ORAL MED O, V91, P334, DOI 10.1067/moe.2001.112158; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Srinivas SK, 2012, J WOMENS HEALTH, V21, P121, DOI 10.1089/jwh.2011.3023; Sulniute R, 2011, AM J PATHOL, V179, P819, DOI 10.1016/j.ajpath.2011.05.003; Suzuki J, 2010, EXPERT OPIN THER TAR, V14, P1023, DOI 10.1517/14728222.2010.511616; Tefs K, 2006, BLOOD, V108, P3021, DOI 10.1182/blood-2006-04-017350; UETE T, 1975, CLIN CHEM, V21, P1632; Ulisse S, 2011, ENCY CANC, P2904; Vieira ML, 2016, CRIT REV MICROBIOL, V42, P573, DOI 10.3109/1040841X.2014.972336; Wara-aswapati N, 2009, ORAL DIS, V15, P354, DOI 10.1111/j.1601-0825.2009.01562.x; Waschulewski IK, 2016, ARCH ORAL BIOL, V72, P75, DOI 10.1016/j.archoralbio.2016.07.013; Zeng XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046508	49	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					619	630		10.1096/fj.201901490RR	http://dx.doi.org/10.1096/fj.201901490RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914706	Green Accepted			2022-12-28	WOS:000507308900043
J	Sun, XY; Gao, XQ; Deng, ZH; Zhang, LL; McGilvray, K; Gadomski, BC; Amra, S; Bao, G; Huard, J				Sun, Xuying; Gao, Xueqin; Deng, Zhenhan; Zhang, Linlin; McGilvray, Kirk; Gadomski, Benjamin C.; Amra, Sarah; Bao, Gang; Huard, Johnny			High bone microarchitecture, strength, and resistance to bone loss in MRL/MpJ mice correlates with activation of different signaling pathways and systemic factors	FASEB JOURNAL			English	Article						MRL; MpJ mice; osteoblasts; osteoclasts; ovariectomy; tibia fracture	MESENCHYMAL STEM-CELLS; MINERAL DENSITY; ARTICULAR-CARTILAGE; DIGIT TIP; MRL MICE; IGF-I; REGENERATION; FRACTURE; EXPRESSION; DENOSUMAB	The MRL/MpJ mice have demonstrated an enhanced tissue regeneration capacity for various tissues. In the present study, we systematically characterized bone microarchitecture and found that MRL/MpJ mice exhibit higher bone microarchitecture and strength compared to both C57BL/10J and C57BL/6J WT mice at 2, 4, and 10 months of age. The higher bone mass in MRL/MpJ mice was correlated to increased osteoblasts, decreased osteoclasts, higher cell proliferation, and bone formation, and enhanced pSMAD5 signaling earlier during postnatal development (2-month old) in the spine trabecular bone, and lower bone resorption rate at later age. Furthermore, these mice exhibit accelerated fracture healing via enhanced pSMAD5, pAKT and p-P38MAPK pathways compared to control groups. Moreover, MRL/MpJ mice demonstrated resistance to ovariectomy-induced bone loss as evidenced by maintaining higher bone volume/tissue volume (BV/TV) and lower percentage of bone loss later after ovariectomy. The consistently higher serum IGF1 level and lower RANKL level in MRL/MpJ mice may contribute to the maintenance of high bone mass in uninjured and injured bone. In conclusion, our results indicate that enhanced pSMAD5, pAKT, and p-P38MAPK signaling, higher serum IGF-1, and lower RANKL level contribute to the higher bone microarchitecture and strength, accelerated healing, and resistance to osteoporosis in MRL/MpJ mice.	[Sun, Xuying; Gao, Xueqin; Deng, Zhenhan; Amra, Sarah; Huard, Johnny] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Brown Fdn Inst Mol Med, Dept Orthopaed Surg, 1881 East Rd,Room 3SCR6-3607, Houston, TX 77054 USA; [Gao, Xueqin; Huard, Johnny] Steadman Philippon Res Inst, Ctr Regenerat Sports Med, 181 West Meadow Dr,Suite 1000, Vail, CO 81657 USA; [Zhang, Linlin; Bao, Gang] Rice Univ, Dept Biomed Engn, Houston, TX USA; [McGilvray, Kirk; Gadomski, Benjamin C.] Colorado State Univ, Dept Mech Engn, Orthopaed Bioengn Res Lab, Ft Collins, CO 80523 USA; [McGilvray, Kirk; Gadomski, Benjamin C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	University of Texas System; University of Texas Health Science Center Houston; Steadman Philippon Research Institute; Rice University; Colorado State University; Colorado State University	Gao, XQ; Huard, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Brown Fdn Inst Mol Med, Dept Orthopaed Surg, 1881 East Rd,Room 3SCR6-3607, Houston, TX 77054 USA.; Gao, XQ; Huard, J (corresponding author), Steadman Philippon Res Inst, Ctr Regenerat Sports Med, 181 West Meadow Dr,Suite 1000, Vail, CO 81657 USA.	Xueqin.Gao@uth.tmc.edu; jhuard@sprivail.org	Deng, Zhenhan/AAB-4968-2021; Deng, Zhenhan/AAR-2420-2021	Deng, Zhenhan/0000-0003-0522-8269; Zhang, Linlin/0000-0003-3240-1215; McGilvray, Kirk/0000-0003-1302-9307; Gao, Xueqin/0000-0001-5833-1548	University of Texas Health Science Center at Houston (UTHealth); Steadman Philippon Research Institute (SPRI)	University of Texas Health Science Center at Houston (UTHealth); Steadman Philippon Research Institute (SPRI)	University of Texas Health Science Center at Houston (UTHealth); Steadman Philippon Research Institute (SPRI)	Anagnostis P, 2018, HAEMOPHILIA, V24, P316, DOI 10.1111/hae.13384; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Beederman Maureen, 2013, J Biomed Sci Eng, V6, P32; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Buckley G, 2011, J ANAT, V218, P163, DOI 10.1111/j.1469-7580.2010.01313.x; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Christians JK, 2019, GROWTH HORM IGF RES, V44, P6, DOI 10.1016/j.ghir.2018.10.006; de Souza KSC, 2016, DIABETES-METAB RES, V32, P589, DOI 10.1002/dmrr.2772; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dempster DW, 2012, CLIN THER, V34, P521, DOI 10.1016/j.clinthera.2012.02.002; Deng ZH, 2019, FASEB J, V33, P8809, DOI 10.1096/fj.201802132RR; Eastell R, 2011, J BONE MINER RES, V26, P530, DOI 10.1002/jbmr.251; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Esapa Christopher T, 2012, Curr Protoc Mouse Biol, V2, P365, DOI 10.1002/9780470942390.mo120124; Fitzgerald J, 2008, OSTEOARTHR CARTILAGE, V16, P1319, DOI 10.1016/j.joca.2008.03.014; Fornari R, 2018, EAT WEIGHT DISORD-ST, V23, P375, DOI 10.1007/s40519-017-0362-4; Gao XQ, 2016, HUM MOL GENET, V25, P3216, DOI 10.1093/hmg/ddw172; Gao XQ, 2014, FASEB J, V28, P3792, DOI 10.1096/fj.13-247965; Gao XQ, 2014, BIOMATERIALS, V35, P6859, DOI 10.1016/j.biomaterials.2014.04.113; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Hinton RJ, 2017, J DENT RES, V96, P23, DOI 10.1177/0022034516668321; Hu DP, 2017, DEVELOPMENT, V144, P221, DOI 10.1242/dev.130807; Ibrahim MM, 2014, WOUND REPAIR REGEN, V22, P755, DOI 10.1111/wrr.12238; Idris AI, 2012, METHODS MOL BIOL, V816, P545, DOI 10.1007/978-1-61779-415-5_34; Jilka RL, 2013, J GERONTOL A-BIOL, V68, P1209, DOI 10.1093/gerona/glt046; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; KELLER TS, 1994, J BIOMECH, V27, P1159, DOI 10.1016/0021-9290(94)90056-6; Kendler DL, 2010, J BONE MINER RES, V25, P72, DOI 10.1359/jbmr.090716; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kwiatkowski A, 2016, BIOCHEM BIOPH RES CO, V473, P907, DOI 10.1016/j.bbrc.2016.03.149; Langdahl B, 2016, THER ADV MUSCULOSKEL, V8, P225, DOI 10.1177/1759720X16670154; Lau KHW, 2016, BONE, V92, P18, DOI 10.1016/j.bone.2016.08.005; Laurent P, 2012, INT ENDOD J, V45, P439, DOI 10.1111/j.1365-2591.2011.01995.x; Lee Y, 2013, BONE, V56, P383, DOI 10.1016/j.bone.2013.07.007; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; LEVAME M, 1987, PATHOL BIOL, V35, P1183; Li GY, 2017, BBA-MOL BASIS DIS, V1863, P2848, DOI 10.1016/j.bbadis.2017.07.036; Mak J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23076; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Naseem RH, 2007, PHYSIOL GENOMICS, V30, P44, DOI 10.1152/physiolgenomics.00070.2006; Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091; Paccou J, 2012, JOINT BONE SPINE, V79, P78, DOI 10.1016/j.jbspin.2011.06.002; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; Rai MF, 2014, MATRIX BIOL, V39, P50, DOI 10.1016/j.matbio.2014.08.011; Rai MF, 2012, ARTHRITIS RHEUM-US, V64, P2300, DOI 10.1002/art.34396; Ramcharan MA, 2017, OSTEOPOROSIS INT, V28, P1133, DOI 10.1007/s00198-016-3801-6; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Sankaran JS, 2017, MAMM GENOME, V28, P476, DOI 10.1007/s00335-017-9717-4; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Selvamurugan N, 2004, J BIOL CHEM, V279, P19327, DOI 10.1074/jbc.M314048200; Simintiriadis D, 2013, SCAND J CLIN LAB INV, V73, P34, DOI 10.3109/00365513.2012.733409; Sims NA, 2014, CURR OSTEOPOROS REP, V12, P98, DOI 10.1007/s11914-014-0196-1; Sinha KM, 2019, FASEB J, V33, P8321, DOI 10.1096/fj.201801794R; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thuret S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030904; Tsai JN, 2017, BONE, V95, P20, DOI 10.1016/j.bone.2016.11.009; Tseng C, 2019, STEM CELLS, V37, P357, DOI 10.1002/stem.2957; Turner NJ, 2013, J TISSUE ENG REGEN M, V7, P139, DOI 10.1002/term.508; Tuzcu S, 2017, Z RHEUMATOL, V76, P716, DOI 10.1007/s00393-016-0171-6; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Ward BD, 2008, ARTHRITIS RHEUM-US, V58, P744, DOI 10.1002/art.23288; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yen ML, 2005, MOL PHARMACOL, V68, P1061, DOI 10.1124/mol.104.010082; Yuan YY, 2008, OSTEOPOROSIS INT, V19, P625, DOI 10.1007/s00198-007-0509-7	68	2	2	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					789	806		10.1096/fj.201901229RR	http://dx.doi.org/10.1096/fj.201901229RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914651				2022-12-28	WOS:000507308900054
J	Wu, DC; Dasgupta, A; Chen, KH; Neuber-Hess, M; Patel, J; Hurst, TE; Mewburn, JD; Lima, PDA; Alizadeh, E; Martin, A; Wells, M; Snieckus, V; Archer, SL				Wu, Danchen; Dasgupta, Asish; Chen, Kuang-Hueih; Neuber-Hess, Monica; Patel, Jignesh; Hurst, Timothy E.; Mewburn, Jeffrey D.; Lima, Patricia D. A.; Alizadeh, Elahe; Martin, Ashley; Wells, Michael; Snieckus, Victor; Archer, Stephen L.			Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: Therapeutic potential of Drpitor1 and Drpitor1a in cancer and cardiac ischemia-reperfusion injury	FASEB JOURNAL			English	Article						breast cancer; ellipticine; lung cancer; mitochondrial dynamics; mitochondrial division inhibitor 1 (mdivi-1); mitochondrial fission; right ventricle	MITOCHONDRIAL DYNAMICS; FISSION; DIVISION; DYSFUNCTION; MDIVI-1; INJURY	Mitochondrial fission is important in physiological processes, including coordination of mitochondrial and nuclear division during mitosis, and pathologic processes, such as the production of reactive oxygen species (ROS) during cardiac ischemia-reperfusion injury (IR). Mitochondrial fission is mainly mediated by dynamin-related protein 1 (Drp1), a large GTPase. The GTPase activity of Drp1 is essential for its fissogenic activity. Therefore, we aimed to identify Drp1 inhibitors and evaluate their anti-neoplastic and cardioprotective properties in five cancer cell lines (A549, SK-MES-1, SK-LU-1, SW 900, and MCF7) and an experimental cardiac IR injury model. Virtual screening of a chemical library revealed 17 compounds with high predicted affinity to the GTPase domain of Drp1. In silico screening identified an ellipticine compound, Drpitor1, as a putative, potent Drp1 inhibitor. We also synthesized a congener of Drpitor1 to remove the methoxymethyl group and reduce hydrolytic lability (Drpitor1a). Drpitor1 and Drpitor1a inhibited the GTPase activity of Drp1 without inhibiting the GTPase of dynamin 1. Drpitor1 and Drpitor1a have greater potency than the current standard Drp1 GTPase inhibitor, mdivi-1, (IC50 for mitochondrial fragmentation are 0.09, 0.06, and 10 mu M, respectively). Both Drpitors reduced proliferation and induced apoptosis in cancer cells. Drpitor1a suppressed lung cancer tumor growth in a mouse xenograft model. Drpitor1a also inhibited mitochondrial ROS production, prevented mitochondrial fission, and improved right ventricular diastolic dysfunction during IR injury. In conclusion, Drpitors are useful tools for understanding mitochondrial dynamics and have therapeutic potential in treating cancer and cardiac IR injury.	[Wu, Danchen; Dasgupta, Asish; Chen, Kuang-Hueih; Neuber-Hess, Monica; Mewburn, Jeffrey D.; Martin, Ashley; Archer, Stephen L.] Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada; [Patel, Jignesh; Hurst, Timothy E.; Snieckus, Victor] Queens Univ, Dept Chem, Kingston, ON, Canada; [Lima, Patricia D. A.; Alizadeh, Elahe] Queens Univ, Dept Med, Translat Inst Med TIME, Queens Cardiopulm Unit QCPU, Kingston, ON, Canada; [Wells, Michael] Queens Univ, Off Partnerships & Innovat, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada	Archer, SL (corresponding author), Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada.	stephen.archer@queensu.ca	Wu, Danchen/W-4727-2019; wu, danchen/Y-8493-2019	Wu, Danchen/0000-0003-3901-5907; Alizadeh, Elahe/0000-0003-4046-1226	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR); HHS | National Institutes of Health (NIH) [NIH-R01-HL071115, 1RC1HL099462]; Canada Research Chairs (Chaires de recherche du Canada) [950-229252]; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Vascular Network	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chairs (Chaires de recherche du Canada)(Canada Research Chairs); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Vascular Network	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR); HHS | National Institutes of Health (NIH), Grant/Award Number: NIH-R01-HL071115; HHS | National Institutes of Health (NIH), Grant/Award Number: 1RC1HL099462; Canada Research Chairs (Chaires de recherche du Canada), Grant/Award Number: 950-229252; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Vascular Network	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bernardo PH, 2004, J MED CHEM, V47, P4958, DOI 10.1021/jm049625o; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen KH, 2018, CIRCULATION, V138, P287, DOI 10.1161/CIRCULATIONAHA.117.031258; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Maneechote C, 2017, J CELL MOL MED, V21, P2643, DOI 10.1111/jcmm.13330; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Nishiyama T, 2017, EUR J MED CHEM, V136, P1, DOI 10.1016/j.ejmech.2017.04.071; Peiris-Pages Maria, 2018, Oncotarget, V9, P13254, DOI 10.18632/oncotarget.24285; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Ruiz A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00003; Sharp Willard W, 2015, Crit Care Med, V43, pe38, DOI 10.1097/CCM.0000000000000817; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Sumida M, 2015, J AM SOC NEPHROL, V26, P2378, DOI 10.1681/ASN.2014080750; Thenappan T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5492; Tian L, 2017, J MOL MED, V95, P381, DOI 10.1007/s00109-017-1522-8; WATANABE M, 1980, J AM CHEM SOC, V102, P1457, DOI 10.1021/ja00524a059; Wenger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071835; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894	26	41	42	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1447	1464		10.1096/fj.201901467R	http://dx.doi.org/10.1096/fj.201901467R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914641	Bronze			2022-12-28	WOS:000507308900096
J	Dizin, E; Olivier, V; Maire, C; Komarynets, O; Sassi, A; Roth, I; Loffing, J; de Seigneux, S; Maillard, M; Rutkowski, JM; Edwards, A; Feraille, E				Dizin, Eva; Olivier, Valerie; Maire, Charline; Komarynets, Olga; Sassi, Ali; Roth, Isabelle; Loffing, Johannes; de Seigneux, Sophie; Maillard, Marc; Rutkowski, Joseph M.; Edwards, Aurelie; Feraille, Eric			Time-course of sodium transport along the nephron in nephrotic syndrome: The role of potassium	FASEB JOURNAL			English	Article						aldosterone paradox; edema; ENaC; hyperkalemia; proteinuria; SRAA	EPITHELIAL NA+ CHANNEL; INCREASED EXPRESSION; SURFACE EXPRESSION; ANGIOTENSIN-II; ALDOSTERONE; KIDNEY; COTRANSPORTER; ENAC; ACTIVATION; MECHANISMS	The mechanism of sodium retention and its location in kidney tubules may vary with time in nephrotic syndrome (NS). We studied the mechanisms of sodium retention in transgenic POD-ATTAC mice, which display an inducible podocyte-specific apoptosis. At day 2 after the induction of NS, the increased abundance of NHE3 and phosphorylated NCC in nephrotic mice compared with controls suggest that early sodium retention occurs mainly in the proximal and distal tubules. At day 3, the abundance of NHE3 normalized, phosphorylated NCC levels decreased, and cleavage and apical localization of gamma-ENaC increased in nephrotic mice. These findings indicate that sodium retention shifted from the proximal and distal tubules to the collecting system. Increased cleavage and apical localization of gamma-ENaC persisted at day 5 in nephrotic mice when hypovolemia resolved and steady-state was reached. Sodium retention and gamma-ENaC cleavage were independent of the increased plasma levels of aldosterone. Nephrotic mice displayed decreased glomerular filtration rate and urinary potassium excretion associated with hyperkaliemia at day 3. Feeding nephrotic mice with a low potassium diet prevented hyperkaliemia, gamma-ENaC cleavage, and led to persistent increased phosphorylation of NCC. These results suggest that potassium homeostasis is a major determinant of the tubular site of sodium retention in nephrotic mice.	[Dizin, Eva; Olivier, Valerie; Maire, Charline; Komarynets, Olga; Sassi, Ali; Roth, Isabelle; de Seigneux, Sophie; Feraille, Eric] Univ Geneva, Dept Cellular Physiol & Metab, CMU, Geneva, Switzerland; [Dizin, Eva; Olivier, Valerie; Maire, Charline; Roth, Isabelle; Loffing, Johannes; de Seigneux, Sophie; Feraille, Eric] Natl Ctr Competence Res Kidney Ch, Zurich, Switzerland; [Loffing, Johannes] Univ Zurich, Inst Anat, Zurich, Switzerland; [Maillard, Marc] CHU Vaudois, Serv Nephrol, Lausanne, Switzerland; [Rutkowski, Joseph M.] Texas A&M Univ, Dept Med Physiol, Hlth Sci Ctr, Bryan, TX USA; [Edwards, Aurelie] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of Geneva; University of Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Boston University	Feraille, E (corresponding author), Univ Geneva, Dept Cellular Physiol & Metab, Fac Med, CMU, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@unige.ch	Maillard, Marc/AAY-8604-2020; Loffing, Johannes/ABG-9973-2020	Feraille, Eric/0000-0003-1656-8365; SASSI, ALI/0000-0002-3194-777X; Loffing, Johannes/0000-0002-9415-6588	Swiss National Science Foundation [310030_143929/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Grant/Award Number: 31003A_156736/1; Swiss National Science Foundation, Grant/Award Number: 310030_143929/1	Amlal H, 2001, AM J PHYSIOL-RENAL, V280, pF513, DOI 10.1152/ajprenal.2001.280.3.F513; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; Bohnert BN, 2018, KIDNEY INT, V93, P159, DOI 10.1016/j.kint.2017.07.023; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; de Seigneux S, 2006, AM J PHYSIOL-RENAL, V291, pF208, DOI 10.1152/ajprenal.00399.2005; Dechenes G, 2000, J AM SOC NEPHROL, V11, P604, DOI 10.1681/ASN.V114604; Frindt G, 2008, J GEN PHYSIOL, V131, P617, DOI 10.1085/jgp.200809989; Frindt G, 2015, AM J PHYSIOL-RENAL, V308, pF572, DOI 10.1152/ajprenal.00585.2014; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Hasler U, 2003, J BIOL CHEM, V278, P21639, DOI 10.1074/jbc.M212388200; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Houillier P, 1996, KIDNEY INT, V50, P1496, DOI 10.1038/ki.1996.464; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; HUMPHREYS MH, 1994, KIDNEY INT, V45, P266, DOI 10.1038/ki.1994.33; ICHIKAWA I, 1983, J CLIN INVEST, V71, P91, DOI 10.1172/JCI110756; Jarvie BC, 2017, NAT NEUROSCI, V20, P167, DOI 10.1038/nn.4451; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; KIM JK, 1990, KIDNEY INT, V38, P818, DOI 10.1038/ki.1990.276; Kim SW, 2004, AM J PHYSIOL-RENAL, V286, pF922, DOI 10.1152/ajprenal.00277.2003; Koizumi M, 2019, HYPERTENSION, V74, P509, DOI 10.1161/HYPERTENSIONAHA.118.12352; Layton AT, 2016, AM J PHYSIOL-RENAL, V310, pF1269, DOI 10.1152/ajprenal.00543.2015; Lourdel S, 2005, J AM SOC NEPHROL, V16, P3642, DOI 10.1681/ASN.2005040363; Mollet G, 2009, J AM SOC NEPHROL, V20, P2181, DOI 10.1681/ASN.2009040379; Motoyoshi Y, 2008, KIDNEY INT, V74, P1262, DOI 10.1038/ki.2008.405; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Arroyo JP, 2011, PHYSIOLOGY, V26, P115, DOI 10.1152/physiol.00049.2010; Pfister MF, 1997, J BIOL CHEM, V272, P20125, DOI 10.1074/jbc.272.32.20125; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Rutkowski JM, 2013, J AM SOC NEPHROL, V24, P268, DOI 10.1681/ASN.2012040414; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Siddall EC, 2012, KIDNEY INT, V82, P635, DOI 10.1038/ki.2012.180; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Terker AS, 2016, J AM SOC NEPHROL, V27, P2436, DOI 10.1681/ASN.2015070815; Terker AS, 2016, KIDNEY INT, V89, P127, DOI 10.1038/ki.2015.289; Udwan K, 2017, J PHYSIOL-LONDON, V595, P6905, DOI 10.1113/JP274927; Volk KA, 2005, J BIOL CHEM, V280, P18348, DOI 10.1074/jbc.M413689200; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wang YB, 2014, J AM SOC NEPHROL, V25, P250, DOI 10.1681/ASN.2013040429; Youn JH, 2013, SEMIN NEPHROL, V33, P248, DOI 10.1016/j.semnephrol.2013.04.005	43	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2408	2424		10.1096/fj.201901345R	http://dx.doi.org/10.1096/fj.201901345R		DEC 2019	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908015	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000504855000001
J	Yoo, SM; Yamashita, S; Kim, H; Na, D; Lee, H; Kim, SJ; Cho, DH; Kanki, T; Jung, YK				Yoo, Seung-Min; Yamashita, Shun-ichi; Kim, Hyunjoo; Na, DoHyeong; Lee, Haneul; Kim, Seo Jin; Cho, Dong-Hyung; Kanki, Tomotake; Jung, Yong-Keun			FKBP8 LIRL-dependent mitochondrial fragmentation facilitates mitophagy under stress conditions	FASEB JOURNAL			English	Article						FKBP8; mitochondria fission; mitophagy; OPA1; stress	AUTOPHAGOSOME FORMATION; CELL-DEATH; FISSION; DEGRADATION; PROTEIN; REQUIRES; PARKIN; DRP1; OPA1; RECRUITMENT	Mitochondrial quality control maintains mitochondrial function by regulating mitochondrial dynamics and mitophagy. Despite the identification of mitochondrial quality control factors, little is known about the crucial regulators coordinating both mitochondrial fission and mitophagy. Through a cell-based functional screening assay, FK506 binding protein 8 (FKBP8) was identified to target microtubule-associated protein 1 light chain 3 (LC3) to the mitochondria and to change mitochondrial morphology. Microscopy analysis revealed that the formation of tubular and enlarged mitochondria was observed in FKBP8 knockdown HeLa cells and the cortex of Fkbp8 heterozygote-knockout mouse embryos. Under iron depletion-induced stress, FKBP8 was recruited to the site of mitochondrial division through budding and colocalized with LC3. FKBP8 was also found to be required for mitochondrial fragmentation and mitophagy under hypoxic stress. Conversely, FKBP8 overexpression induced mitochondrial fragmentation in HeLa cells, human fibroblasts and mouse embryo fibroblasts (MEFs), and this fragmentation occurred in Drp1 knockout MEF cells, FIP200 knockout HeLa cells and BNIP3/NIX double knockout HeLa cells, but not in Opa1 knockout MEFs. Interestingly, we found an LIR motif-like sequence (LIRL), as well as an LIR motif, at the N-terminus of FKBP8 and LIRL was essential for both inducing mitochondrial fragmentation and binding of FKBP8 to OPA1. Together, we suggest that FKBP8 plays an essential role in mitochondrial fragmentation through LIRL during mitophagy and this activity of FKBP8 together with LIR is required for mitophagy under stress conditions.	[Yoo, Seung-Min; Kim, Hyunjoo; Na, DoHyeong; Lee, Haneul; Kim, Seo Jin; Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 08826, South Korea; [Yamashita, Shun-ichi; Kanki, Tomotake] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cellular Physiol, Niigata, Japan; [Cho, Dong-Hyung] Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea	Seoul National University (SNU); Niigata University; Kyungpook National University	Jung, YK (corresponding author), Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 08826, South Korea.	ykjung@snu.ac.kr	Kanki, Tomotake/H-7250-2012	Kanki, Tomotake/0000-0001-9646-5379; Jung, Yong-Keun/0000-0002-9686-3120	CRI grant [NRF-2019R1A2B5B03070352]; Bio & Medical Technology Development Program of the National Research Foundation [NRF-2017M3A9G7073521]; Japan's Society for the Promotion of Science [KAKENHI 19H05712]	CRI grant; Bio & Medical Technology Development Program of the National Research Foundation; Japan's Society for the Promotion of Science	CRI grant, Grant/Award Number: NRF-2019R1A2B5B03070352; Bio & Medical Technology Development Program of the National Research Foundation, Grant/Award Number: NRF-2017M3A9G7073521; Japan's Society for the Promotion of Science, Grant/Award Number: KAKENHI 19H05712	Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Frezza Christian, 2007, Methods Mol Biol, V372, P405, DOI 10.1007/978-1-59745-365-3_29; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Li WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32933; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Nah J, 2017, COMPR PHYSIOL, V7, P1407, DOI 10.1002/cphy.c170005; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Oettinghaus B, 2016, BBA-BIOENERGETICS, V1857, P1267, DOI 10.1016/j.bbabio.2016.03.016; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Padgett ME, 2016, JOVE-J VIS EXP, DOI 10.3791/54166; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Saita S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2400; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wong RLY, 2008, HUM MOL GENET, V17, P587, DOI 10.1093/hmg/ddm333; Wu WX, 2016, EMBO J, V35, P1368, DOI 10.15252/embj.201593102; Yamashita S, 2016, J CELL BIOL, V215, P649, DOI 10.1083/jcb.201605093; Yoo SM, 2018, MOL CELLS, V41, P18, DOI 10.14348/molcells.2018.2277	47	19	19	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2944	2957		10.1096/fj.201901735R	http://dx.doi.org/10.1096/fj.201901735R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908024				2022-12-28	WOS:000504668100001
J	Kliewe, F; Kaling, S; Lotzsch, H; Artelt, N; Schindler, M; Rogge, H; Schroder, S; Scharf, C; Amann, K; Daniel, C; Lindenmeyer, MT; Cohen, CD; Endlich, K; Endlich, N				Kliewe, Felix; Kaling, Soeren; Loetzsch, Henriette; Artelt, Nadine; Schindler, Maximilian; Rogge, Henrik; Schroeder, Sindy; Scharf, Christian; Amann, Kerstin; Daniel, Christoph; Lindenmeyer, Maja T.; Cohen, Clemens D.; Endlich, Karlhans; Endlich, Nicole			Fibronectin is up-regulated in podocytes by mechanical stress	FASEB JOURNAL			English	Article						Fn1; extracellular matrix; hypertension; mechanical load; diabetic nephropathy	SHARED TRANSCRIPTIONAL NETWORKS; DIABETIC-NEPHROPATHY; INTEGRIN BINDING; GENE-EXPRESSION; GLOMERULOPATHY; GLOMERULOSCLEROSIS; IDENTIFICATION; MUTATIONS; MATRIX; KIDNEY	Hypertension is one of the central causes of kidney damage. In the past it was shown that glomerular hypertension leads to morphologic changes of podocytes and effacement and is responsible for detachment of these postmitotic cells. Because we have shown that podocytes are mechanosensitive and respond to mechanical stress by reorganization of the actin cytoskeleton in vitro, we look for mechanotransducers in podocytes. In this study, we demonstrate that the extracellular matrix protein fibronectin (Fn1) might be a potential candidate. The present study shows that Fn1 is essential for the attachment of podocytes during mechanical stress. By real-time quantitative PCR as well as by liquid chromatography-mass spectrometry, we found a significant up-regulation of Fn1 caused by mechanical stretch (3 d, 0.5 Hz, and 5% extension). To study the role of Fn1 in cultured podocytes under mechanical stress, Fn1 was knocked down (Fn1 KD) by a specific small interfering RNA. Additionally, we established a Fn1 knockout (KO) podocyte cell line (Fn1 KO) by clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9). During mechanical stress, a significant loss of podocytes (>80%) was observed in Fn1 KD as well as Fn1 KO podocytes compared with control cells. Furthermore, Fn1 KO podocytes showed a significant down-regulation of the focal adhesion proteins talin, vinculin, and paxillin and a reduced cell spreading, indicating an important role of Fn1 in adhesion. Analyses of kidney sections from patients with diabetic nephropathy have shown a significant up-regulation of FN1 in contrast to control biopsies. In summary, we show that Fn1 plays an important role in the adaptation of podocytes to mechanical stress.	[Kliewe, Felix; Kaling, Soeren; Loetzsch, Henriette; Artelt, Nadine; Schindler, Maximilian; Rogge, Henrik; Schroeder, Sindy; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Scharf, Christian] Univ Med Greifswald, Dept Ear Nose & Throat Dis, Greifswald, Germany; [Amann, Kerstin; Daniel, Christoph] Univ Med Erlangen, Dept Nephropathol, Erlangen, Germany; [Lindenmeyer, Maja T.] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Hamburg, Germany; [Cohen, Clemens D.] Univ Munich, Med Clin & Policlin 4, Nephrol Ctr, Munich, Germany	Greifswald Medical School; Greifswald Medical School; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Endlich, N (corresponding author), Univ Med Greifswald, Inst Anat & Zellbiol, Friedrich Loeffler Str 23c, D-17489 Greifswald, Germany.	nicole.endlich@uni-greifswald.de	Scharf, Christian/A-7931-2011; Daniel, Christoph/AAK-2136-2021	Scharf, Christian/0000-0001-6806-6450; Endlich, Karlhans/0000-0001-6052-6061; Schindler, Maximilian/0000-0001-8549-510X; Lindenmeyer, Maja/0000-0003-4162-9107	Domagk scholarship from the University Medicine Greifswald; Else Kroener Fresenius Foundation; Emerging Fields Initiative (EFI) for Cell Cycle in Disease and Regeneration (CYDER) from the FriedrichAlexander-Universitat Erlangen-Nurnberg (FAU)	Domagk scholarship from the University Medicine Greifswald; Else Kroener Fresenius Foundation; Emerging Fields Initiative (EFI) for Cell Cycle in Disease and Regeneration (CYDER) from the FriedrichAlexander-Universitat Erlangen-Nurnberg (FAU)	The authors thank Mandy Weise (Department of Anatomy and Cell Biology, University Medicine Greifswald) for her excellent technical assistance. The authors also thank all participating centres of the European Renal cDNA Bank-Kroener-Fresenius Biopsy Bank (ERCB-KFB) and their partners for their cooperation. Active members at the time of the study are listed in Martini et al. (33). S.K. was supported by a Domagk scholarship from the University Medicine Greifswald. C.D.C. and M.T.L. were supported by the Else Kroener Fresenius Foundation. Part of this work was also supported by an Emerging Fields Initiative (EFI) for Cell Cycle in Disease and Regeneration (CYDER) from the FriedrichAlexander-Universitat Erlangen-Nurnberg (FAU). The authors declare no conflicts of interest.	Albrecht T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44492; Aslam N, 2019, HUM GENOME VAR, V6, DOI 10.1038/s41439-019-0042-1; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Baydar DE, 2013, AM J KIDNEY DIS, V61, P514, DOI 10.1053/j.ajkd.2012.08.050; Blumenthal A, 2015, AM J PHYSIOL-RENAL, V308, pF602, DOI 10.1152/ajprenal.00190.2014; Castelletti F, 2008, P NATL ACAD SCI USA, V105, P2538, DOI 10.1073/pnas.0707730105; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; Craig D, 2001, P NATL ACAD SCI USA, V98, P5590, DOI 10.1073/pnas.101582198; Endlich K, 2017, PFLUG ARCH EUR J PHY, V469, P937, DOI 10.1007/s00424-017-2025-8; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Endlich N, 2002, FASEB J, V16, P1850, DOI 10.1096/fj.02-0125fje; Endlich N, 2012, SEMIN NEPHROL, V32, P327, DOI 10.1016/j.semnephrol.2012.06.004; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gee EPS, 2013, J BIOL CHEM, V288, P21329, DOI 10.1074/jbc.M113.462077; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gruden G, 2000, DIABETES, V49, P655, DOI 10.2337/diabetes.49.4.655; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; Jia Z., 2012, J NEPHROL THERAPEUTI, V2, P112, DOI DOI 10.4172/2161-0959.1000112; Ju WJ, 2013, GENOME RES, V23, P1862, DOI 10.1101/gr.155697.113; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kliewe F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10116-4; Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351; Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; KRETZLER M, 1994, VIRCHOWS ARCH, V425, P181; Kriz W, 1998, NEPHROL DIAL TRANSPL, V13, P2781, DOI 10.1093/ndt/13.11.2781; Kubow KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9026; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Lennon R, 2014, J AM SOC NEPHROL, V25, P939, DOI 10.1681/ASN.2013030233; Liu S, 2007, AM J PHYSIOL-RENAL, V293, pF1727, DOI 10.1152/ajprenal.00316.2007; Lutz R, 2010, J CELL SCI, V123, P1511, DOI 10.1242/jcs.060905; Martini S, 2014, J AM SOC NEPHROL, V25, P2559, DOI 10.1681/ASN.2013080906; Nicolaou N, 2012, J CLIN INVEST, V122, P4375, DOI 10.1172/JCI64100; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Ohtsubo H, 2016, PEDIATR NEPHROL, V31, P1459, DOI 10.1007/s00467-016-3368-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Roy S, 2003, DIABETES, V52, P1229, DOI 10.2337/diabetes.52.5.1229; Sawada K, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9265074; Schordan S, 2013, AM J PHYSIOL-RENAL, V304, pF1458, DOI 10.1152/ajprenal.00615.2012; Schordan S, 2011, AM J PHYSIOL-RENAL, V300, pF119, DOI 10.1152/ajprenal.00143.2010; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; SIMONS JL, 1993, J AM SOC NEPHROL, V3, P1775; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Thallas-Bonke V, 2008, DIABETES, V57, P460, DOI 10.2337/db07-1119; Tomasini-Johansson BR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205360; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Dokkum RPE, 1999, AM J PHYSIOL-REG I, V276, pR855, DOI 10.1152/ajpregu.1999.276.3.R855; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wu J, 2017, CHINESE MED J-PEKING, V130, P2261, DOI 10.4103/0366-6999.213970; Zbyszynski P, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-018-2412-7; Zhang MZ, 2012, DIABETES, V61, P2575, DOI 10.2337/db12-0046	59	11	11	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14450	14460		10.1096/fj.201900978RR	http://dx.doi.org/10.1096/fj.201900978RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31675484	Bronze			2022-12-28	WOS:000507466100107
J	Lai, TKY; Zhai, DX; Su, P; Jiang, AL; Boychuk, J; Liu, F				Lai, Terence K. Y.; Zhai, Dongxu; Su, Ping; Jiang, Anlong; Boychuk, Jay; Liu, Fang			The receptor-receptor interaction between mGluR1 receptor and NMDA receptor: a potential therapeutic target for protection against ischemic stroke	FASEB JOURNAL			English	Article						glutamate; excitotoxicity; peptide treatment; tMCAO	METABOTROPIC GLUTAMATE RECEPTORS; CEREBRAL-ARTERY OCCLUSION; TYROSINE PHOSPHORYLATION; GROUP-I; SELECTIVE BLOCKADE; NEURONAL INJURY; CLINICAL-TRIALS; NR2A SUBUNIT; ASPARTATE; ANTAGONIST	Ischemic stroke is one of the leading causes of long-term disability worldwide. It arises when the blood flow to the brain is severely impaired, causing brain infarction. The current therapies for ischemic stroke are tissue plasminogen activator and mechanical thrombectomy, which re-establishes blood circulation to the brain but offers no neuroprotective effects. Excitotoxicity, particularly through the N-methyl-D-aspartate receptor (NMDAR), has been heavily implicated in the pathophysiology of brain infarction resulting from ischemic stroke. Here we investigated the interaction between NMDAR and metabotropic glutamate receptor 1 (mGluR1) as a novel target to develop potential neuroprotective agents for ischemic stroke. Through coimmunoprecipitation and affinity binding assay, we revealed that the interaction is mediated through 2 distinct sites on the mGluR1 C terminus. We then found that the disruption of mGluR1-G1uN2A subunit of NMDAR (G1uN2A) protected the primary mouse hippocampal neurons against NMDAR-mediated excitotoxicity and reversed the NMDAR-mediated regulation of ERK1/2 in rat hippocampal slices. The same protection was also observed in an animal model of ischemic stroke, alleviating brain infarction and yielding better motor recovery. These findings confirmed the existence of a receptor-receptor interaction between NMDAR and mGluR1, implicating this interconnection as a potential treatment target site for ischemic stroke.	[Lai, Terence K. Y.; Zhai, Dongxu; Su, Ping; Jiang, Anlong; Boychuk, Jay; Liu, Fang] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, 250 Coll St, Toronto, ON M5T 1R8, Canada; [Lai, Terence K. Y.; Jiang, Anlong; Boychuk, Jay; Liu, Fang] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Liu, Fang] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Liu, Fang] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto	Liu, F (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, 250 Coll St, Toronto, ON M5T 1R8, Canada.	fang.liu@camh.ca	Su, Ping/AGY-4522-2022	Su, Ping/0000-0001-6807-8443				ALBERS GW, 1995, STROKE, V26, P254, DOI 10.1161/01.STR.26.2.254; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Asano S, 2016, CURR OPIN PHARMACOL, V26, P80, DOI 10.1016/j.coph.2015.10.004; Battaglia G, 2001, MOL CELL NEUROSCI, V17, P1071, DOI 10.1006/mcne.2001.0992; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bertaso F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009755; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Brown V, 2014, NEUROPSYCHOPHARMACOL, V39, P2131, DOI 10.1038/npp.2014.61; Bruno V, 1999, NEUROPHARMACOLOGY, V38, P199, DOI 10.1016/S0028-3908(98)00159-2; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; CHANDLER LJ, 1993, J NEUROCHEM, V60, P1578, DOI 10.1111/j.1471-4159.1993.tb03326.x; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Cousins SL, 2012, J BIOL CHEM, V287, P13465, DOI 10.1074/jbc.M111.292862; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; Delaney AJ, 2013, J NEUROPHYSIOL, V109, P1391, DOI 10.1152/jn.00176.2012; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; EIMERL S, 1994, J NEUROCHEM, V62, P1223; Enz R, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00052; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; FIX AS, 1993, EXP NEUROL, V123, P204, DOI 10.1006/exnr.1993.1153; Flint AC, 1997, J NEUROSCI, V17, P2469; Gerriets T, 2004, STROKE, V35, P2372, DOI 10.1161/01.STR.0000142134.37512.a7; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; GROTTA J, 1995, STROKE, V26, P602, DOI 10.1161/01.STR.26.4.602; Grupke S, 2015, CLIN NEUROL NEUROSUR, V129, P1, DOI 10.1016/j.clineuro.2014.11.013; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; ITO K, 1995, NEUROSCI LETT, V183, P112, DOI 10.1016/0304-3940(94)11127-5; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kohara A, 2008, BRAIN RES, V1191, P168, DOI 10.1016/j.brainres.2007.11.035; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lai TKY, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0409-0; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Liu XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114623; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Matsumoto S, 2002, J CEREBR BLOOD F MET, V22, P1107, DOI 10.1097/00004647-200209000-00008; Meli E, 2002, PHARMACOL BIOCHEM BE, V73, P439, DOI 10.1016/S0091-3057(02)00834-1; Morikawa E, 1998, J NEUROSCI, V18, P9727; Moutin E, 2012, J CELL BIOL, V198, P251, DOI 10.1083/jcb.201110101; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Murotomi K, 2008, J NEUROCHEM, V105, P1625, DOI 10.1111/j.1471-4159.2008.05260.x; Ohtani Y, 2014, J NEUROSCI, V34, P2702, DOI 10.1523/JNEUROSCI.3542-13.2014; Onwuekwe IO, 2012, ANN MED HEALTH SCI R, V2, P186, DOI 10.4103/2141-9248.105669; Orlando LR, 2001, EXP NEUROL, V167, P196, DOI 10.1006/exnr.2000.7542; Patel RAG, 2017, PROG CARDIOVASC DIS, V59, P542, DOI 10.1016/j.pcad.2017.04.005; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Pellegrini-Giampietro DE, 1999, EUR J NEUROSCI, V11, P3637, DOI 10.1046/j.1460-9568.1999.00786.x; Pellegrini-Giampietro DE, 1999, NEUROPHARMACOLOGY, V38, P1607, DOI 10.1016/S0028-3908(99)00097-0; Peng XP, 2019, INT J MOL MED, V44, P227, DOI 10.3892/ijmm.2019.4195; Perroy J, 2008, J BIOL CHEM, V283, P6799, DOI 10.1074/jbc.M705661200; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Sasaki Masanori, 2009, V549, P187, DOI 10.1007/978-1-60327-931-4_13; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Segura T, 2008, EXPERT OPIN PHARMACO, V9, P1071, DOI [10.1517/14656566.9.7.1071, 10.1517/14656560802049322]; Sigoillot SM, 2010, J NEUROSCI, V30, P13, DOI 10.1523/JNEUROSCI.4374-09.2010; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Strasser U, 1998, EUR J NEUROSCI, V10, P2848, DOI 10.1111/j.1460-9568.1998.00291.x; Su P, 2014, NEURON, V84, P1302, DOI 10.1016/j.neuron.2014.11.007; Takagi N, 2003, J NEUROCHEM, V84, P67, DOI 10.1046/j.1471-4159.2003.01500.x; Takagi N, 1997, J NEUROCHEM, V69, P1060; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4289, DOI 10.2174/138161212802481200; Vidale S, 2018, J CLIN NEUROL, V14, P407, DOI 10.3988/jcn.2018.14.3.407; Watkins JC, 2000, BIOCHEM SOC T, V28, P297, DOI 10.1042/0300-5127:0280297; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao L, 2011, J BIOL CHEM, V286, P20175, DOI 10.1074/jbc.M110.188854; Xu WW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20095-9; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Zamzow DR, 2013, J NEUROSCI, V33, P12300, DOI 10.1523/JNEUROSCI.0312-13.2013; Zhai DX, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-20; Zhai DX, 2013, NEUROBIOL DIS, V54, P392, DOI 10.1016/j.nbd.2013.01.013; Zhang F, 2013, STROKE, V44, P170, DOI 10.1161/STROKEAHA.112.667253; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82; Zhou XJ, 2013, J BIOL CHEM, V288, P24151, DOI 10.1074/jbc.M113.482000; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	87	13	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14423	14439		10.1096/fj.201900417R	http://dx.doi.org/10.1096/fj.201900417R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31670972				2022-12-28	WOS:000507466100105
J	Tu-Sekine, B; Padhi, A; Jin, S; Kalyan, S; Singh, K; Apperson, M; Kapania, R; Hur, SC; Nain, A; Kim, SF				Tu-Sekine, Becky; Padhi, Abinash; Jin, Sunghee; Kalyan, Srivathsan; Singh, Karanpreet; Apperson, Matthew; Kapania, Rakesh; Hur, Soojung Claire; Nain, Amrinder; Kim, Sangwon F.			Inositol polyphosphate multikinase is a metformin target that regulates cell migration	FASEB JOURNAL			English	Article						integrin; adhesion; focal adhesion kinase; nanonet force microscopy; extracellular matrix	NANONET FORCE MICROSCOPY; ACTIVATED PROTEIN-KINASE; FOCAL ADHESION KINASE; HEXAKISPHOSPHATE KINASE; SINGLE; PROLIFERATION; INTEGRINS; IPMK	Metformin has been shown to alter cell adhesion protein expression, which is thought to play a role in its observed antitumor properties. We found that metformin treatment down-regulated integrin beta 1 concomitant with the loss of inositol polyphosphate multikinase (IPMK) in murine myocytes, adipocytes, and hepatocytes. To determine if IPMK was upstream of integrin beta 1 expression, we examined IPMK-/- mouse embryonic fibroblast cells and found that integrins beta 1 and beta 3 gene expression was reduced by half, relative to wild-type cells, whereas focal adhesion kinase (FAK) activity and Rho/Rac/Cdc42 protein levels were increased, resulting in migration defects. Using nanonet force microscopy, we determined that cell:extracellular matrix adhesion and cell contractility forces were decreased, confirming the functional relevance of integrin and Rho protein dysregulation. Pharmacological studies showed that inhibition of both FAK1 and proline-rich tyrosine kinase 2 partially restored integrin beta 1 expression, suggesting negative regulation of integrin beta 1 by FAK. Together our data indicate that IPMK participates in the regulation of cell migration and provides a potential link between metformin and wound healing impairment.	[Tu-Sekine, Becky; Jin, Sunghee; Kim, Sangwon F.] Johns Hopkins Univ, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA; [Kalyan, Srivathsan; Hur, Soojung Claire] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Padhi, Abinash; Apperson, Matthew; Nain, Amrinder] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA; [Singh, Karanpreet; Kapania, Rakesh] Virginia Polytech Inst & State Univ, Dept Aerosp & Ocean Engn, Blacksburg, VA 24061 USA	Johns Hopkins University; Johns Hopkins University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Kim, SF (corresponding author), Johns Hopkins Univ, Dept Endocrinol Diabet & Metab, Ctr Asthma & Allergy, 5501 Hopkins Bayview Cir,Room 2A 44, Baltimore, MD 21224 USA.	skim132@jhmi.edu	singh, Karanpreet/AAT-5185-2020	Kapania, Rakesh/0000-0001-7294-4703	U.S. National Institutes of Health (NIH) [DA568921]; American Heart Association [17SFRN33610014]; National Science Foundation (NSF) [1437101, 1462916]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	The authors thank Jade West for assisting with cell tracking analyses, and Angie Chan for assisting with quantitative RT-PCR experiments (both from Johns Hopkins University). This work was supported by U.S. National Institutes of Health (NIH) Grant DA568921 (to S.F.K.), American Heart Association Grant 17SFRN33610014 (to S.F.K.), and National Science Foundation (NSF) Grants 1437101 and 1462916 (to A.N.). The authors declare no conflicts of interest.	Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Bang S, 2014, MOL ENDOCRINOL, V28, P1186, DOI 10.1210/me.2014-1134; Bang S, 2012, P NATL ACAD SCI USA, V109, P616, DOI 10.1073/pnas.1119751109; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chalfoun J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04567-y; Fesseha BK, 2018, DIABETES CARE, V41, P1478, DOI 10.2337/dc17-1683; Fu CL, 2017, P NATL ACAD SCI USA, V114, P2036, DOI 10.1073/pnas.1700165114; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hall A, 2017, MOL BIOL CELL, V28, P1894, DOI 10.1091/mbc.E17-01-0053; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37468; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Jadav RS, 2016, CELL SIGNAL, V28, P1124, DOI 10.1016/j.cellsig.2016.04.011; Jang SY, 2014, ANTICANCER RES, V34, P4127; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Koivisto L, 2014, ADV WOUND CARE, V3, P762, DOI 10.1089/wound.2013.0436; Koons B, 2017, ACS NANO, V11, P12037, DOI 10.1021/acsnano.7b04567; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li X, 1999, J BIOL CHEM, V274, P8917, DOI 10.1074/jbc.274.13.8917; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Maag D, 2011, P NATL ACAD SCI USA, V108, P1391, DOI 10.1073/pnas.1017831108; Malabanan MM, 2016, BIOCHEM SOC T, V44, P279, DOI 10.1042/BST20150225; Murphy James M, 2016, [Frontiers in Biology, 生物学前沿], V11, P1; Nain AS, 2013, POLYM J, V45, P695, DOI 10.1038/pj.2013.1; Nain AS, 2009, MACROMOL RAPID COMM, V30, P1406, DOI 10.1002/marc.200900204; Ochoa-Gonzalez F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150900; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Piccinini F, 2016, BIOINFORMATICS, V32, P955, DOI 10.1093/bioinformatics/btv686; Qiang P, 2019, EUR REV MED PHARMACO, V23, P1778, DOI 10.26355/eurrev_201902_17140; Reig G, 2014, DEVELOPMENT, V141, P1999, DOI 10.1242/dev.101451; Resnick AC, 2005, P NATL ACAD SCI USA, V102, P12783, DOI 10.1073/pnas.0506184102; Scherer PC, 2016, P NATL ACAD SCI USA, V113, P3503, DOI 10.1073/pnas.1525580113; Schexnayder C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113692; Sheets K, 2016, BIOPHYS J, V111, P197, DOI 10.1016/j.bpj.2016.05.031; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Welf ES, 2012, J CELL BIOL, V197, P105, DOI 10.1083/jcb.201108152; Xu RS, 2013, P NATL ACAD SCI USA, V110, P16181, DOI 10.1073/pnas.1315551110; Yi Y, 2017, J BIOL CHEM, V292, P5253, DOI 10.1074/jbc.M116.769141; Yu T, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.28	43	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14137	14146		10.1096/fj.201900717RR	http://dx.doi.org/10.1096/fj.201900717RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31657647	Green Published, Bronze			2022-12-28	WOS:000507466100083
J	Peng, LL; Ming, Y; Zhang, L; Zhou, J; Xiang, W; Zeng, S; He, HP; Chen, LG				Peng, Lilei; Ming, Yang; Zhang, Ling; Zhou, Jie; Xiang, Wei; Zeng, Shan; He, Haiping; Chen, Ligang			MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway	FASEB JOURNAL			English	Article						Akt signaling pathway; colony-formation ability; Ecto-5 '-nucleotidase; glioma stem cells; microRNA-30a; orthotopic tumor growth; proliferation; self-renewal; sphere-formation ability	TUMOR-GROWTH; EXPRESSION; CD73; PROLIFERATION; BIOMARKER; TARGET	Over the past decade, increasing researches have demonstrated the implication of microRNAs (miRNAs or miRs) in tumorigenicity of glioma stem cells (GSCs). The regulatory functions of miRNAs in GSCs have emerged as potential therapeutic candidates for glioma treatment. Herein, we aim to investigate the role of miR-30a in the proliferation and self-renewal of GSCs and the possible mechanism in relation to ecto-5 '-nucleotidase (NT5E)-dependent Akt signaling pathway. RT-qPCR and Western blot analysis were performed to determine the expression of miR-30a and NT5E in glioma tissues and cell lines. GSCs were isolated from glioma cells and identified using flow cytometry. The relationship between miR-30a and NT5E was determined by dual-luciferase reporter gene assay. Gain- and loss-of-function experiments were performed to examine the effects of miR-30a and NT5E on sphere formation, colony formation, and proliferation of GSCs in vitro, as well as orthotopic tumor growth of GSCs in nude mice. Additionally, the Akt signaling pathway was blocked with an Akt inhibitor, LY294002, to investigate its involvement in the regulatory effect of miR30a. miR-30a was poorly expressed in glioma tissues and cell lines as well as GSCs. NT5E, highly expressed in GSCs, was identified as a target of miR-30a. In addition, miR-30a upregulation or NT5E silencing could reduce GSC sphere formation, clone formation, proliferation, and orthotopic tumor growth in nude mice. Moreover, miR-30a inhibited the activation of the Akt signaling pathway by targeting NT5E, and ultimately suppressing the self-renewal and orthotopic tumor growth of GSCs. Our results demonstrate that miR-30a targets NT5E to inhibit the Akt signaling pathway, by which could suppress the self-renewal and orthotopic tumor growth of GSCs. Those findings may provide theoretical basis of miR-30a as a therapeutic target to suppress the glioma progression.	[Peng, Lilei; Ming, Yang; Zhang, Ling; Zhou, Jie; Xiang, Wei; Zeng, Shan; He, Haiping; Chen, Ligang] Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China; [Peng, Lilei; Ming, Yang; Zhang, Ling; Zhou, Jie; Xiang, Wei; Zeng, Shan; He, Haiping; Chen, Ligang] Neurosurg Clin Res Ctr Sichuan Prov, Luzhou 646000, Sichuan, Peoples R China	Southwest Medical University	Chen, LG (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China.; Chen, LG (corresponding author), Neurosurg Clin Res Ctr Sichuan Prov, Luzhou 646000, Sichuan, Peoples R China.	ligangchen_lgc@163.com			Science and Technology Department of Sichuan Province [2013SZZ002, 2018JY0404]; Health Commission of Sichuan Province [16PJ557]; government of Luzhou [14ZC0071-LH09, 2016LZXNYD-G03]; Southwest Medical University [2013ZRQN068]; Project Program of Neurosurgical Clinical Research Center of Sichuan Province [17082]	Science and Technology Department of Sichuan Province; Health Commission of Sichuan Province; government of Luzhou; Southwest Medical University; Project Program of Neurosurgical Clinical Research Center of Sichuan Province	This study was supported by the Science and Technology Department of Sichuan Province (grant nos. 2013SZZ002 and 2018JY0404), the Health Commission of Sichuan Province (grant no. 16PJ557), the government of Luzhou (grant nos. 14ZC0071-LH09 and 2016LZXNYD-G03), the Southwest Medical University (grant no. 2013ZRQN068) and the Project Program of Neurosurgical Clinical Research Center of Sichuan Province (grant no. 17082).	Allard B, 2014, INT J CANCER, V134, P1466, DOI 10.1002/ijc.28456; Azambuja JH, 2019, MOL NEUROBIOL, V56, P3260, DOI 10.1007/s12035-018-1240-4; Binello E, 2011, CANCER SCI, V102, P1958, DOI 10.1111/j.1349-7006.2011.02064.x; Cage TA, 2012, NEUROSURG CLIN N AM, V23, P515, DOI 10.1016/j.nec.2012.04.007; Cheng WJ, 2018, LIFE SCI, V208, P96, DOI 10.1016/j.lfs.2018.07.016; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Conti A, 2016, TUMOR BIOL, V37, P14035, DOI 10.1007/s13277-016-5273-x; Egan KM, 2011, J NEURO-ONCOL, V104, P535, DOI 10.1007/s11060-010-0506-0; Gao ZW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/460654; Hong J, 2019, CURR PROB CANCER, V43, P236, DOI 10.1016/j.currproblcancer.2018.07.007; Hua L, 2018, THERANOSTICS, V8, P5088, DOI 10.7150/thno.26225; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Katakowski M, 2013, CANCER LETT, V335, P201, DOI 10.1016/j.canlet.2013.02.019; Katsuta E, 2016, INT J ONCOL, V48, P657, DOI 10.3892/ijo.2015.3299; Kong BH, 2013, CHILD NERV SYST, V29, P217, DOI 10.1007/s00381-012-1964-9; Liu J, 2018, HISTOL HISTOPATHOL, V33, P987, DOI 10.14670/HH-11-995; Liu LM, 2016, HEPATOLOGY, V64, P814, DOI 10.1002/hep.28690; Liu Y, 2018, BIOMED PHARMACOTHER, V108, P845, DOI 10.1016/j.biopha.2018.09.068; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2014, CANCER LETT, V355, P85, DOI 10.1016/j.canlet.2014.09.012; Mahmood A, 2012, STEM CELLS DEV, V21, P3114, DOI 10.1089/scd.2012.0035; Peng D, 2019, IUBMB LIFE, V71, P113, DOI 10.1002/iub.1942; Peruzzi P, 2013, NEURO-ONCOLOGY, V15, P1212, DOI 10.1093/neuonc/not055; Rathod SS, 2014, FEBS OPEN BIO, V4, P485, DOI 10.1016/j.fob.2014.05.002; Relier S, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0277-6; Ruan P, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171027; Singh SV, 2017, BIOCHEM BIOPH RES CO, V491, P946, DOI 10.1016/j.bbrc.2017.07.140; Song L, 2017, ONCOTARGET, V8, P31977, DOI 10.18632/oncotarget.16667; Wang W, 2013, NEOPLASMA, V60, P274, DOI 10.4149/neo_2013_036; Wang Y, 2017, ONCOTARGET, V8, P59417, DOI 10.18632/oncotarget.19727; Wang ZJ, 2018, NANOSCALE, V10, P13106, DOI 10.1039/c8nr02708k; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Wu F, 2016, ONCOTARGET, V7, P61619, DOI 10.18632/oncotarget.11423; Wu XR, 2012, J SURG ONCOL, V106, P130, DOI 10.1002/jso.23056; Yao YL, 2015, CNS NEUROSCI THER, V21, P40, DOI 10.1111/cns.12321; Yu JG, 2017, IN VITRO CELL DEV-AN, V53, P132, DOI 10.1007/s11626-016-0089-y; Zhang YH, 2017, ONCOL REP, V38, P1156, DOI 10.3892/or.2017.5728; Zhao B, 2014, J CELL PHYSIOL, V229, P1141, DOI 10.1002/jcp.24540; Zhou JB, 2018, BIOMED PHARMACOTHER, V107, P1705, DOI 10.1016/j.biopha.2018.08.157; Zhu JJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0591-1; Zhu KP, 2017, ONCOTARGET, V8, P71881, DOI 10.18632/oncotarget.17985	41	8	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5128	5143		10.1096/fj.201802629RR	http://dx.doi.org/10.1096/fj.201802629RR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067282				2022-12-28	WOS:000515250300001
J	Hoppstadter, J; Perez, JVV; Linnenberger, R; Dahlem, C; Legroux, TM; Hecksteden, A; Tse, WKF; Flamini, S; Andreas, A; Herrmann, J; Herr, C; Muller, R; Meyer, T; Bals, R; Riccardi, C; Bruscoli, S; Kiemer, AK				Hoppstaedter, Jessica; Perez, Jenny Vanessa Valbuena; Linnenberger, Rebecca; Dahlem, Charlotte; Legroux, Thierry M.; Hecksteden, Anne; Tse, William K. F.; Flamini, Sara; Andreas, Anastasia; Herrmann, Jennifer; Herr, Christian; Mueller, Rolf; Meyer, Tim; Bals, Robert; Riccardi, Carlo; Bruscoli, Stefano; Kiemer, Alexandra K.			The glucocorticoid-induced leucine zipper mediates statin-induced muscle damage	FASEB JOURNAL			English	Article						flexor digitorum brevis; HMG-CoA; muscle wasting; statin-associated muscle symptoms; Tsc22d3	MYOBLAST CELLS; GILZ; PROTEIN; DIFFERENTIATION; SIMVASTATIN; INHIBITION; PATHWAY; RAT; GERANYLGERANYLATION; MYOTOXICITY	Statins, the most prescribed class of drugs for the treatment of hypercholesterolemia, can cause muscle-related adverse effects. It has been shown that the glucocorticoid-induced leucine zipper (GILZ) plays a key role in the anti-myogenic action of dexamethasone. In the present study, we aimed to evaluate the role of GILZ in statin-induced myopathy. Statins induced GILZ expression in C2C12 cells, primary murine myoblasts/myotubes, primary human myoblasts, and in vivo in zebrafish embryos and human quadriceps femoris muscle. Gilz induction was mediated by FOXO3 activation and binding to the Gilz promoter, and could be reversed by the addition of geranylgeranyl, but not farnesyl, pyrophosphate. Atorvastatin decreased Akt phosphorylation and increased cleaved caspase-3 levels in myoblasts. This effect was reversed in myoblasts from GILZ knockout mice. Similarly, myofibers isolated from knockout animals were more resistant toward statin-induced cell death than their wild-type counterparts. Statins also impaired myoblast differentiation, and this effect was accompanied by GILZ induction. The in vivo relevance of our findings was supported by the observation that gilz overexpression in zebrafish embryos led to impaired embryonic muscle development. Taken together, our data point toward GILZ as an essential mediator of the molecular mechanisms leading to statin-induced muscle damage.	[Hoppstaedter, Jessica; Perez, Jenny Vanessa Valbuena; Linnenberger, Rebecca; Dahlem, Charlotte; Legroux, Thierry M.; Kiemer, Alexandra K.] Saarland Univ, Dept Pharm, Pharmaceut Biol, Saarbrucken, Germany; [Hoppstaedter, Jessica; Flamini, Sara; Riccardi, Carlo; Bruscoli, Stefano] Univ Perugia, Dept Med, Sect Pharmacol, Perugia, Italy; [Hecksteden, Anne; Meyer, Tim] Saarland Univ, Inst Sports & Prevent Med, Saarbrucken, Germany; [Tse, William K. F.] Kyushu Univ, Fac Agr, Ctr Promot Int Educ & Res, Fukuoka, Japan; [Andreas, Anastasia; Herrmann, Jennifer; Mueller, Rolf] Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, Saarbrucken, Germany; [Herr, Christian; Bals, Robert] Saarland Univ, Dept Internal Med Pulmonol Allergol & Crit Care 5, Homburg, Germany	Saarland University; University of Perugia; Saarland University; Kyushu University; Helmholtz Association; Universitatsklinikum des Saarlandes	Kiemer, AK (corresponding author), Saarland Univ, Pharmaceut Biol, D-66123 Saarbrucken, Germany.	pharm.bio.kiemer@mx.uni-saarland.de	Hoppstädter, Jessica/AAM-2548-2020; Herr, Christian/AAH-5291-2021; Kiemer, Alexandra K./I-9300-2012; TSE, KA FAI WILLIAM/C-9384-2012; Dahlem, Charlotte/Z-3729-2019; Muller, Rolf/B-1559-2008	Kiemer, Alexandra K./0000-0002-7224-9900; TSE, KA FAI WILLIAM/0000-0002-3738-0460; Dahlem, Charlotte/0000-0001-9983-0802; Herr, Christian/0000-0001-9422-6569; Riccardi, Carlo/0000-0001-9257-3997; Muller, Rolf/0000-0002-1042-5665; Herrmann, Jennifer/0000-0003-3398-9938; Hoppstadter, Jessica/0000-0001-8758-1554				Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Asfour HA, 2018, EXP BIOL MED, V243, P118, DOI 10.1177/1535370217749494; Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Baba TT, 2008, J MUSCLE RES CELL M, V29, P127, DOI 10.1007/s10974-008-9146-9; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bereshchenko O, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00308; Bonifacio A, 2015, BBA-MOL CELL RES, V1853, P1841, DOI 10.1016/j.bbamcr.2015.04.010; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bruscoli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01720; Bruscoli S, 2012, J BIOL CHEM, V287, P1242, DOI 10.1074/jbc.M111.316372; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Campos LM, 2016, EXP BIOL MED, V241, P1950, DOI 10.1177/1535370216659944; Campos LM, 2015, J HISTOCHEM CYTOCHEM, V63, P427, DOI 10.1369/0022155415580396; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cao PR, 2009, FASEB J, V23, P2844, DOI 10.1096/fj.08-128843; Czepukojc B, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00179; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; du Souich P, 2017, PHARMACOL THERAPEUT, V175, P1, DOI 10.1016/j.pharmthera.2017.02.029; Espinasse MA, 2016, J INNATE IMMUN, V8, P81, DOI 10.1159/000439052; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Heller DJ, 2017, CIRCULATION, V136, P1087, DOI 10.1161/CIRCULATIONAHA.117.027067; Hoppstadter J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01634; Hoppstadter J, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03111; Hoppstadter J, 2016, J BIOL CHEM, V291, P22949, DOI 10.1074/jbc.M116.733253; Joha S, 2012, ONCOGENE, V31, P1419, DOI 10.1038/onc.2011.328; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Keire Paul, 2013, Methods Mol Biol, V946, P431, DOI 10.1007/978-1-62703-128-8_28; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Laufs U, 2017, ATHEROSCLEROSIS SUPP, V26, P45, DOI 10.1016/S1567-5688(17)30024-7; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mosshammer D, 2014, BRIT J CLIN PHARMACO, V78, P454, DOI 10.1111/bcp.12360; Needham M, 2014, NEUROMUSCULAR DISORD, V24, P4, DOI 10.1016/j.nmd.2013.09.011; Nolte Ellen, 2011, Rand Health Q, V1, P4; Ogura Takeharu, 2007, Journal of Toxicological Sciences, V32, P57, DOI 10.2131/jts.32.57; Osaki Y, 2015, BIOCHEM BIOPH RES CO, V466, P536, DOI 10.1016/j.bbrc.2015.09.065; Park KH, 2014, JOVE-J VIS EXP, DOI 10.3791/50898; Pasha R, 2017, ENVIRON TOXICOL PHAR, V52, P150, DOI 10.1016/j.etap.2017.03.021; Rashmi P, 2017, KIDNEY INT, V91, P1159, DOI 10.1016/j.kint.2016.10.038; Ravenscroft G, 2007, CELL MOTIL CYTOSKEL, V64, P727, DOI 10.1002/cm.20223; Sakamoto K, 2007, FASEB J, V21, P4087, DOI 10.1096/fj.07-8713com; Sakamoto K, 2013, J PHARMACOL SCI, V123, P289, DOI 10.1254/jphs.13R06CP; Sakamoto K, 2011, J PHARMACOL EXP THER, V338, P62, DOI 10.1124/jpet.111.179762; Salami JA, 2017, JAMA CARDIOL, V2, P56, DOI 10.1001/jamacardio.2016.4700; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Sirtori CR, 2014, PHARMACOL RES, V88, P3, DOI 10.1016/j.phrs.2014.03.002; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Trapani L, 2012, J CELL BIOCHEM, V113, P2057, DOI 10.1002/jcb.24077; Tse WKF, 2013, BBA-GEN SUBJECTS, V1830, P4584, DOI 10.1016/j.bbagen.2013.05.006; Vancheri F, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010500; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Ward NC, 2019, CIRC RES, V124, P328, DOI 10.1161/CIRCRESAHA.118.312782; Xie XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024469; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]	64	16	17	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4684	4701		10.1096/fj.201902557RRR	http://dx.doi.org/10.1096/fj.201902557RRR		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030813	Green Published, hybrid			2022-12-28	WOS:000512334100001
J	Kang, K; Quan, KT; Byun, HS; Lee, SR; Piao, X; Ju, E; Park, KA; Sohn, KC; Shen, HM; Na, M; Hur, GM				Kang, Kidong; Quan, Khong Trong; Byun, Hee Sun; Lee, So-Ra; Piao, Xuezhe; Ju, Eunjin; Park, Kyeong Ah; Sohn, Kyung-Cheol; Shen, Han-Ming; Na, MinKyun; Hur, Gang Min			3-O-acetylrubianol C (3AR-C) induces RIPK1-dependent programmed cell death by selective inhibition of IKK beta	FASEB JOURNAL			English	Article						apoptosis; IKK beta; necroptosis; phosphorylation; RIPK1; TNF; 3AR-C	NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; TNF; KINASE; ACTIVATION; ALPHA; RIPK1; UBIQUITINATION; INFLAMMATION; APOPTOSIS	In tumor necrosis factor (TNF) signaling, phosphorylation and activation of receptor interacting protein kinase 1 (RIPK1) by upstream kinases is an essential checkpoint in the suppression of TNF-induced cell death. Thus, discovery of pharmacological agents targeting RIPK1 may provide new strategies for improving the therapeutic efficacy of TNF. In this study, we found that 3-O-acetylrubianol C (3AR-C), an arborinane triterpenoid isolated from Rubia philippinesis, promoted TNF-induced apoptotic and necroptotic cell death. To identify the molecular mechanism, we found that in mouse embryonic fibroblasts, 3AR-C drastically upregulated RIPK1 kinase activity by selectively inhibiting IKK beta. Notably, 3AR-C did not interfere with IKK alpha or affect the formation of the TNF receptor1 (TNFR1) complex-I. Moreover, in human cancer cells, 3AR-C was only sufficient to sensitize TNF-induced cell death when c-FLIPL expression was downregulated to facilitate the formation of TNFR1 complex-II and necrosome. Taken together, our study identified a novel arborinane triterpenoid 3AR-C as a potent activator of TNF-induced cell death via inhibition of IKK beta phosphorylation and promotion of the cytotoxic potential of RIPK1, thus providing a rationale for further development of 3AR-C as a selective IKK beta inhibitor to overcome TNF resistance in cancer therpay.	[Kang, Kidong; Byun, Hee Sun; Lee, So-Ra; Piao, Xuezhe; Ju, Eunjin; Park, Kyeong Ah; Sohn, Kyung-Cheol; Hur, Gang Min] Chungnam Natl Univ, Dept Pharmacol, Coll Med, 266 Munhwa Ro, Daejeon 35015, South Korea; [Kang, Kidong; Byun, Hee Sun; Lee, So-Ra; Piao, Xuezhe; Ju, Eunjin; Park, Kyeong Ah; Sohn, Kyung-Cheol; Hur, Gang Min] Chungnam Natl Univ, Dept Med Sci, Coll Med, 266 Munhwa Ro, Daejeon 35015, South Korea; [Quan, Khong Trong; Na, MinKyun] Chungnam Natl Univ, Coll Pharm, Daejeon 34134, South Korea; [Shen, Han-Ming] Univ Macau, Fac Hlth Sci, Macau, Peoples R China; [Shen, Han-Ming] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore, Singapore	Chungnam National University; Chungnam National University; Chungnam National University; University of Macau; National University of Singapore	Hur, GM (corresponding author), Chungnam Natl Univ, Dept Pharmacol, Coll Med, 266 Munhwa Ro, Daejeon 35015, South Korea.; Hur, GM (corresponding author), Chungnam Natl Univ, Dept Med Sci, Coll Med, 266 Munhwa Ro, Daejeon 35015, South Korea.; Na, M (corresponding author), Chungnam Natl Univ, Coll Pharm, Daejeon 34134, South Korea.	mkna@cnu.ac.kr; gmhur@cnu.ac.kr	Hur, Gang-min/ABF-9263-2021	Hur, Gang-min/0000-0003-4870-6574; Khong, Quan T./0000-0003-2630-1031; Shen, Han-Ming/0000-0001-7369-5227	National Research Foundation of Korea (NRF) [2017R1A2A1A05001225, 2017R1A5A2015385, 2017R1A2A2A05001340]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2017R1A2A1A05001225, 2017R1A5A2015385 and 2017R1A2A2A05001340	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Annibaldi A, 2018, TRENDS MOL MED, V24, P49, DOI 10.1016/j.molmed.2017.11.002; Bajpai VK, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2253-2; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Carafa V, 2018, CLIN CANCER RES, V24, P2886, DOI 10.1158/1078-0432.CCR-17-3081; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dillon CP, 2016, CYTOKINE, V78, P47, DOI 10.1016/j.cyto.2015.10.014; Dondelinger Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09690-0; Dondelinger Y, 2017, NAT CELL BIOL, V19, P1237, DOI 10.1038/ncb3608; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fritsch J, 2017, BBA-MOL CELL RES, V1864, P2138, DOI 10.1016/j.bbamcr.2017.07.017; Fritsch J, 2014, MOL CELL BIOL, V34, P3214, DOI 10.1128/MCB.00048-14; Geng JF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00406-w; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gill BS, 2016, MOL BIOL REP, V43, P881, DOI 10.1007/s11033-016-4032-9; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Quan KT, 2016, J NAT PROD, V79, P2559, DOI 10.1021/acs.jnatprod.6b00489; Klingbeil O, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.271; Lafont E, 2018, NAT CELL BIOL, V20, P1389, DOI 10.1038/s41556-018-0229-6; Li CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-73; Li QT, 2000, GENE DEV, V14, P1729; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Liu X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.197; Menon MB, 2018, TRENDS BIOCHEM SCI, V43, P170, DOI 10.1016/j.tibs.2017.12.002; Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Newton K, 2015, TRENDS CELL BIOL, V25, P347, DOI 10.1016/j.tcb.2015.01.001; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Patlolla JMR, 2012, CURR PHARM BIOTECHNO, V13, P147; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Pratheeshkumar P, 2011, J ENVIRON PATHOL TOX, V30, P21, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i1.30; Salvador JAR, 2017, EUR J MED CHEM, V142, P95, DOI 10.1016/j.ejmech.2017.07.013; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Shi JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01849; Silke J, 2011, CURR OPIN IMMUNOL, V23, P620, DOI 10.1016/j.coi.2011.08.002; Smart Brian A, 2014, Pediatrics, V134 Suppl 3, pS181, DOI 10.1542/peds.2014-1817EEEE; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Ting AT, 2016, TRENDS IMMUNOL, V37, P535, DOI 10.1016/j.it.2016.06.002; Totzke J, 2017, CELL CHEM BIOL, V24, P1029, DOI 10.1016/j.chembiol.2017.07.011; Vlantis K, 2016, IMMUNITY, V44, P553, DOI 10.1016/j.immuni.2016.02.020; Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x; Wegner KW, 2017, TRENDS PHARMACOL SCI, V38, P202, DOI 10.1016/j.tips.2016.12.005; Wertz IE, 2014, CURR OPIN CHEM BIOL, V23, P71, DOI 10.1016/j.cbpa.2014.10.011; Won M, 2016, ARCH PHARM RES, V39, P1075, DOI 10.1007/s12272-016-0772-2; Yan J, 2013, CELL, V152, P304, DOI 10.1016/j.cell.2012.12.021; Yao WL, 2015, ONCOTARGET, V6, P34669, DOI 10.18632/oncotarget.5785; Zhang DW, 2011, CELL RES, V21, P368, DOI 10.1038/cr.2011.3; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444; Zhang YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14329	57	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4369	4383		10.1096/fj.201902547R	http://dx.doi.org/10.1096/fj.201902547R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32027418				2022-12-28	WOS:000512081500001
J	Bratengeier, C; Liszka, A; Hoffman, J; Bakker, AD; Fahlgren, A				Bratengeier, Cornelia; Liszka, Aneta; Hoffman, Johan; Bakker, Astrid D.; Fahlgren, Anna			High shear stress amplitude in combination with prolonged stimulus duration determine induction of osteoclast formation by hematopoietic progenitor cells	FASEB JOURNAL			English	Article						aseptic loosening; bone marrow; Piezo1; SERCA2; viscoelastic	NITRIC-OXIDE; VISCOELASTIC PROPERTIES; LIPID-BILAYERS; CA2+ INFLUX; FLUID-FLOW; STEM-CELLS; BONE; PIEZO1; FREQUENCY; PRESSURE	To date, it is unclear how fluid dynamics stimulate mechanosensory cells to induce an osteoprotective or osteodestructive response. We investigated how murine hematopoietic progenitor cells respond to 2 minutes of dynamic fluid flow stimulation with a precisely controlled sequence of fluid shear stresses. The response was quantified by measuring extracellular adenosine triphosphate (ATP), immunocytochemistry of Piezo1, and sarcoplasmic/endoplasmic Ca2+ reticulum ATPase 2 (SERCA2), and by the ability of soluble factors produced by mechanically stimulated cells to modulate osteoclast differentiation. We rejected our initial hypothesis that peak wall shear stress rate determines the response of hematopoietic progenitor cells to dynamic fluid shear stress, as it had only a minor correlation with the abovementioned parameters. Low stimulus amplitudes corresponded to activation of Piezo1, SERCA2, low concentrations of extracellular ATP, and inhibition of osteoclastogenesis and resorption area, while high amplitudes generally corresponded to osteodestructive responses. At a given amplitude (3 Pa) and waveform (square), the duration of individual stimuli (duty cycle) showed a strong correlation with the release of ATP and osteoclast number and resorption area. Collectively, our data suggest that hematopoietic progenitor cells respond in a viscoelastic manner to loading, since a combination of high shear stress amplitude and prolonged duty cycle is needed to trigger an osteodestructive response. Plain Language Summary In case of painful joints or missing teeth, the current intervention is to replace them with an implant to keep a high-quality lifestyle. When exercising or chewing, the cells in the bone around the implant experience mechanical loading. This loading generally supports bone formation to strengthen the bone and prevent breaking, but can also stimulate bone loss when the mechanical loading becomes too high around orthopedic and dental implants. We still do not fully understand how cells in the bone can distinguish between mechanical loading that strengthens or weakens the bone. We cultured cells derived from the bone marrow in the laboratory to test whether the bone loss response depends on (i) how fast a mechanical load is applied (rate), (ii) how intense the mechanical load is (amplitude), or (iii) how long each individual loading stimulus is applied (duration). We mimicked mechanical loading as it occurs in the body, by applying very precisely controlled flow of fluid over the cells. We found that a mechanosensitive receptor Piezo1 was activated by a low amplitude stimulus, which usually strengthens the bone. The potential inhibitor of Piezo1, namely SERCA2, was only activated by a low amplitude stimulus. This happened regardless of the rate of application. At a constant high amplitude, a longer duration of the stimulus enhanced the bone-weakening response. Based on these results we deduce that a high loading amplitude tends to be bone weakening, and the longer this high amplitude persists, the worse it is for the bone.	[Bratengeier, Cornelia; Liszka, Aneta; Fahlgren, Anna] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, S-58185 Linkoping, Sweden; [Bakker, Astrid D.] Univ Amsterdam, ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [Bakker, Astrid D.] Vrije Univ Amsterdam, Amsterdam Movement Sci, Amsterdam, Netherlands; [Hoffman, Johan] KTH Royal Inst Technol, Dept Computat Sci & Technol, Stockholm, Sweden	Linkoping University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Royal Institute of Technology	Bratengeier, C (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, S-58185 Linkoping, Sweden.	cornelia.bratengeier@liu.se	Bakker, Astrid Diana/AAD-1286-2019; Hoffman, Johan/F-6540-2014	Hoffman, Johan/0000-0003-4256-0463; Bratengeier, Cornelia/0000-0001-9302-0710; Liszka, Aneta/0000-0002-7252-6736	Vetenskapsradet (Swedish Research Council Formas) [2016-01822, 2016-06097, 521-20132593]; VINNOVA (Swedish Governmental Agency for Innovation Systems) [2012-04409]	Vetenskapsradet (Swedish Research Council Formas); VINNOVA (Swedish Governmental Agency for Innovation Systems)(Vinnova)	Vetenskapsradet (Swedish Research Council Formas), Grant/Award Number: 2016-01822, 2016-06097, 521-20132593; VINNOVA (Swedish Governmental Agency for Innovation Systems), Grant/Award Number: 2012-04409	Bacabac RG, 2005, ANN BIOMED ENG, V33, P104, DOI 10.1007/s10439-005-8968-5; Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138; Balleza D, 2012, CHANNELS, V6, P220, DOI 10.4161/chan.21085; BANES AJ, 1990, AM BIOTECHNOL LAB, V8, P12; Bartlett GE, 2009, ACTA ORTHOP, V80, P139, DOI 10.3109/17453670902947382; BEYER EC, 1991, J BIOL CHEM, V266, P7971; Bratengeier C, 2019, J CELL PHYSIOL, V234, P13057, DOI 10.1002/jcp.27976; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Chow JWM, 1998, J BONE MINER RES, V13, P1039, DOI 10.1359/jbmr.1998.13.6.1039; Cinar E, 2015, P NATL ACAD SCI USA, V112, P11783, DOI 10.1073/pnas.1507309112; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; Delaunay C, 2013, CLIN ORTHOP RELAT R, V471, P3863, DOI 10.1007/s11999-013-2935-5; Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227; Fahlgren A, 2018, J ORTHOP RES, V36, P1425, DOI 10.1002/jor.23780; Fahlgren A, 2010, ACTA ORTHOP, V81, P508, DOI 10.3109/17453674.2010.504610; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Frangos J. A., 1993, PHYS FORCES MAMMALIA; Fretwurst T, 2018, J DENT RES, V97, P259, DOI 10.1177/0022034517740560; Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gwam CU, 2017, J ARTHROPLASTY, V32, P2088, DOI 10.1016/j.arth.2017.02.046; Hatami J, 2013, EXP MECH, V53, P1291, DOI 10.1007/s11340-013-9744-3; Hoebertz A, 2000, BONE, V27, P503, DOI 10.1016/S8756-3282(00)00351-3; Hsieh YF, 2001, J BONE MINER RES, V16, P918, DOI 10.1359/jbmr.2001.16.5.918; Hu JJ, 2018, J MECH BEHAV BIOMED, V86, P1, DOI 10.1016/j.jmbbm.2018.05.038; Jafarabadi MR, 2016, LASER MED SCI, V31, P1827, DOI 10.1007/s10103-016-2058-9; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Jorgensen NR, 2013, J OSTEOPOROS, V2013, DOI 10.1155/2013/673684; KARRHOLM J, 1994, J BONE JOINT SURG BR, V76B, P912, DOI 10.1302/0301-620X.76B6.7983118; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; Kumar A, 2016, METHODS APPL FLUORES, V4, DOI [10.1088/2050-6120/4/4044008, 10.1088/2050-6120/4/4/044008]; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; Lenneras M, 2018, J TISSUE ENG REGEN M, V12, P1728, DOI 10.1002/term.2700; Lewis AH, 2017, CELL REP, V19, P2572, DOI 10.1016/j.celrep.2017.05.079; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Lim CG, 2018, BMB REP, V51, P623, DOI 10.5483/BMBRep.2018.51.12.237; Lloyd SA, 2014, J BONE MINER RES, V29, P275, DOI 10.1002/jbmr.2165; Mahmmoud YA, 2008, J BIOL CHEM, V283, P21418, DOI 10.1074/jbc.M803654200; Maneshi MM, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00069; Mann KA, 2014, COMPUT METHOD BIOMEC, V17, P1809, DOI 10.1080/10255842.2013.767336; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Morse A, 2014, J BONE MINER RES, V29, P2456, DOI 10.1002/jbmr.2278; Nagaraja Mamta Patel, 2014, Life-Basel, V4, P117, DOI 10.3390/life4020117; NAVAB M, 1991, J CLIN INVEST, V87, P1763, DOI 10.1172/JCI115195; Nilsson KG, 1996, J BONE JOINT SURG BR, V78B, P1; Praetorius HA, 2015, AM J PHYSIOL-CELL PH, V308, pC198, DOI 10.1152/ajpcell.00336.2014; Qiang YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28503-w; Roe AT, 2019, CARDIOVASC RES, V115, P752, DOI 10.1093/cvr/cvy257; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; RUBIN CT, 1994, CLIN ORTHOP RELAT R, P165; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shibamoto A, 2018, INT J ORAL SCI, V10, DOI 10.1038/s41368-018-0009-y; Singh M, 2016, EXP HEMATOL, V44, P1181, DOI 10.1016/j.exphem.2016.08.009; Skripitz R, 2000, J ORTHOPAED RES, V18, P481, DOI 10.1002/jor.1100180322; Su S, 2013, NAT METHODS, V10, P1105, DOI [10.1038/NMETH.2647, 10.1038/nmeth.2647]; Tamai N, 2013, HIGH PRESSURE RES, V33, P271, DOI 10.1080/08957959.2013.767900; Teng JF, 2015, PFLUG ARCH EUR J PHY, V467, P27, DOI 10.1007/s00424-014-1530-2; Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5; Uline MJ, 2012, BIOPHYS J, V102, P517, DOI 10.1016/j.bpj.2011.12.050; Vainionpaa A, 2006, OSTEOPOROSIS INT, V17, P455, DOI 10.1007/s00198-005-0005-x; van der Meer AD, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3366720; Vanleene M, 2013, BONE, V53, P507, DOI 10.1016/j.bone.2013.01.023; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Wall M, 2018, J ORTHOP RES, V36, P605, DOI 10.1002/jor.23707; Wang YB, 2018, J PHYSIOL-LONDON, V596, P969, DOI 10.1113/JP274404; Watanabe N, 2006, BIOPHYS J, V91, P1984, DOI 10.1529/biophysj.105.060236; Wechalekar MD, 2014, WORLD J ORTHOP, V5, P566, DOI 10.5312/wjo.v5.i5.566; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135; Wu J, 2017, CELL REP, V21, P2357, DOI 10.1016/j.celrep.2017.10.120; Zhang TX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01712-z; Zheng WJ, 2017, PROTEINS, V85, P2198, DOI 10.1002/prot.25384	80	8	8	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3755	3772		10.1096/fj.201901458R	http://dx.doi.org/10.1096/fj.201901458R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957079	Green Published			2022-12-28	WOS:000508136200001
J	Omsland, M; Andresen, V; Gullaksen, SE; Ayuda-Duran, P; Popa, M; Hovland, R; Brendehaug, A; Enserink, J; McCormack, E; Gjertsen, BT				Omsland, Maria; Andresen, Viheke; Gullaksen, Stein-Erik; Ayuda-Duran, Pilar; Popa, Mihacla; Hovland, Randi; Brendehaug, Atle; Enserink, Jorrit; McCormack, Emmet; Gjertsen, Bjorn Tore			Tyrosine kinase inhibitors and interferon-alpha increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines	FASEB JOURNAL			English	Article						cell adhesion; chronic myeloid leukemia; interferon-alpha; tunneling nanotubes; tyrosine kinase inhibitors	CHRONIC MYELOGENOUS LEUKEMIA; BONE-MARROW MICROENVIRONMENT; INTEGRIN-MEDIATED ADHESION; BCR-ABL EXPRESSION; MEMBRANE NANOTUBES; PROGENITOR CELLS; VALPROIC ACID; CUTTING EDGE; STEM-CELLS; T-CELLS	Chronic myeloid leukemia (CML) is a stem cell disease of the bone marrow where mechanisms of inter-leukemic communication and cell-to-cell interactions are proposed to be important for optimal therapy response. Tunneling nanotubes (TNTs) are novel intercellular communication structures transporting different cargos with potential implications in therapy resistance. Here, we have investigated TNTs in CML cells and following treatment with the highly effective CML therapeutics tyrosine kinase inhibitors (TKIs) and interferon-alpha (IFN alpha). CML cells from chronic phase CML patients as well as the blast crisis phase cell lines, Kcl-22 and K562, formed few or no TNTs. Treatment with imatinib increased TNT formation in both Kcl-22 and K562 cells, while nilotinib or IFN alpha increased TNTs in Kcl-22 cells only where the TNT increase was associated with adherence to fibronectin-coated surfaces, altered morphology, and reduced movement involving beta 1integrin. Ex vivo treated cells from chronic phase CML patients showed limited changes in TNT formation similarly to bone marrow cells from healthy individuals. Interestingly, in vivo nilotinib treatment in a Kcl-22 subcutaneous mouse model resulted in morphological changes and TNT-like structures in the tumor-derived Kcl-22 cells. Our results demonstrate that CML cells express low levels of TNTs, but CML therapeutics increase TNT formation in designated cell models indicating TNT functionality in bone marrow derived malignancies and their microenvironment.	[Omsland, Maria; Andresen, Viheke; Gullaksen, Stein-Erik; McCormack, Emmet; Gjertsen, Bjorn Tore] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Sci, N-5021 Bergen, Norway; [Omsland, Maria] NCI, Anim Models & Retroviral Vaccines Sect, Vaccine Branch, NIH, Bethesda, MD 20892 USA; [Andresen, Viheke; Gullaksen, Stein-Erik; Popa, Mihacla; Gjertsen, Bjorn Tore] Haukeland Hosp, Dept Internal Med, Hematol Sect, Bergen, Norway; [Ayuda-Duran, Pilar; Enserink, Jorrit] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Popa, Mihacla] KinN Therapeut, Bergen, Norway; [Hovland, Randi; Brendehaug, Atle] Haukeland Hosp, Dept Med Genet, Bergen, Norway	University of Bergen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bergen; Haukeland University Hospital; University of Oslo; University of Bergen; Haukeland University Hospital	Gjertsen, BT (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Sci, N-5021 Bergen, Norway.	bjorn.gjertsen@uib.no	Ayuda-Durán, Pilar/ABA-2373-2020; Gjertsen, Bjorn T/O-1542-2015; Gjertsen, Bjørn T/AAP-3281-2020; Ayuda-Durán, Pilar/AAR-6755-2021; Cormack, Emmet Mc/D-2922-2012; Gullaksen, Stein-Erik/AAD-4344-2021	Ayuda-Durán, Pilar/0000-0002-9799-3680; Gjertsen, Bjorn T/0000-0001-9358-9704; Gjertsen, Bjørn T/0000-0001-9358-9704; Ayuda-Durán, Pilar/0000-0002-9799-3680; Cormack, Emmet Mc/0000-0002-7621-4625; 	University of Bergen; Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; Melzer Hoyskolefond; Bergen Forskningsstiftelse (Bergen Research Foundation); Trond Mohn Foundation; Helse Bergen HF [911809, 911852, 912171, 240222]; Norwegian Research Council of Norway through its Centers of excellence funding scheme [223250, 262652]; Norwegian Research Council [294916]; Helse Vest RHF; Norwegian Cancer Society [205729, 182524]	University of Bergen; Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melzer Hoyskolefond; Bergen Forskningsstiftelse (Bergen Research Foundation); Trond Mohn Foundation; Helse Bergen HF; Norwegian Research Council of Norway through its Centers of excellence funding scheme; Norwegian Research Council(Research Council of NorwayEuropean Commission); Helse Vest RHF; Norwegian Cancer Society(Norwegian Cancer Society)	University of Bergen; Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; Norwegian Cancer Society with Solveig & Ole Lunds Legacy and Oyvinn Molbach-Petersens Fond for Clinical Research (BTG); Melzer Hoyskolefond (BTG); Bergen Forskningsstiftelse (Bergen Research Foundation); Trond Mohn Foundation (VA); Helse Vest RHF; Helse Bergen HF, Grant/Award Number: 911809, 911852, 912171 and 240222; Norwegian Cancer Society, Grant/Award Number: 205729 and 182524; Norwegian Research Council of Norway through its Centers of excellence funding scheme, Grant/Award Number: 223250 and 262652; Norwegian Research Council, Grant/Award Number: 294916	Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279; Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Andresen V, 2013, CELL DEATH DIFFER, V20, P1124, DOI 10.1038/cdd.2013.61; Apperley JF, 2015, LANCET, V385, P1447, DOI 10.1016/S0140-6736(13)62120-0; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Bewry NN, 2008, MOL CANCER THER, V7, P3169, DOI 10.1158/1535-7163.MCT-08-0314; BHATIA R, 1995, BLOOD, V85, P3636, DOI 10.1182/blood.V85.12.3636.bloodjournal85123636; Bhatia R, 1998, LEUKEMIA LYMPHOMA, V28, P241, DOI 10.3109/10428199809092680; Bhatia R, 1998, BLOOD, V91, P3414, DOI 10.1182/blood.V91.9.3414.3414_3414_3422; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Bruck O, 2018, LEUKEMIA, V32, P1643, DOI 10.1038/s41375-018-0175-0; Bruserud O, 2001, STEM CELLS, V19, P1, DOI 10.1634/stemcells.19-1-1; Burt R, 2019, BLOOD, V134, P1415, DOI 10.1182/blood.2019001398; Caponetti GC, 2019, SEMIN HEMATOL, V56, P7, DOI 10.1053/j.seminhematol.2018.05.004; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chauveau A, 2010, P NATL ACAD SCI USA, V107, P5545, DOI 10.1073/pnas.0910074107; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Delannoy A, 1997, J NATL CANCER I, V89, P1616; Desir S, 2019, CANCERS, V11, DOI 10.3390/cancers11070892; Desir S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27649-x; DOWDING C, 1993, LEUKEMIA LYMPHOMA, V11, P185, DOI 10.3109/10428199309047884; DOWDING C, 1991, BLOOD, V78, P499; Duarte D, 2018, BLOOD, V131, P1507, DOI 10.1182/blood-2017-12-784132; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Eiring AM, 2015, LEUKEMIA, V29, P586, DOI 10.1038/leu.2014.245; Forthun RB, 2019, J CANCER RES CLIN, V145, P1729, DOI 10.1007/s00432-019-02931-1; GORDON MY, 1987, NATURE, V328, P342, DOI 10.1038/328342a0; Gousset K, 2013, J CELL SCI, V126, P4424, DOI 10.1242/jcs.129239; Gratwohl A, 2003, LEUKEMIA, V17, P941, DOI 10.1038/sj.leu.2402896; Griessinger E, 2017, TRENDS CANCER, V3, P828, DOI 10.1016/j.trecan.2017.10.003; Gullaksen SE, 2017, HAEMATOLOGICA, V102, P1361, DOI 10.3324/haematol.2017.167080; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Hanna SJ, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223321; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Hehlmann R, 2012, BLOOD, V120, P737, DOI 10.1182/blood-2012-03-380147; Hjorth-Hansen H, 2016, LEUKEMIA, V30, P1853, DOI 10.1038/leu.2016.121; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2017, NEW ENGL J MED, V376, P917, DOI 10.1056/NEJMoa1609324; Houshmand M, 2019, LEUKEMIA, V33, P1543, DOI 10.1038/s41375-019-0490-0; Hurley A, 2013, J INFECT DIS, V207, P638, DOI 10.1093/infdis/jis730; Jabbour E, 2018, AM J HEMATOL, V93, P442, DOI 10.1002/ajh.25011; Jash E, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0281-7; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; Kolba MD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2045-8; Krause DS, 2015, HAEMATOLOGICA, V100, P1376, DOI 10.3324/haematol.2014.113852; Kretschmer A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44346-5; Kumar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10373-3; LEE JC, 1982, J IMMUNOL, V128, P2393; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Lundell BI, 1996, BLOOD, V87, P2450, DOI 10.1182/blood.V87.6.2450.bloodjournal8762450; Matula Z, 2016, STEM CELLS DEV, V25, P1818, DOI 10.1089/scd.2016.0086; McCormack E, 2012, LEUKEMIA, V26, P910, DOI 10.1038/leu.2011.315; McCormack E, 2013, BLOOD, V121, pE34, DOI 10.1182/blood-2012-05-429555; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Mitchell R, 2018, JNCI-J NATL CANCER I, V110, P467, DOI 10.1093/jnci/djx236; Mittal R, 2019, J CELL PHYSIOL, V234, P1130, DOI 10.1002/jcp.27072; Obr A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107367; Omsland M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29391-w; Omsland M, 2017, ONCOTARGET, V8, P7946, DOI 10.18632/oncotarget.13853; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Osteikoetxea-Molnar A, 2016, CELL MOL LIFE SCI, V73, P4531, DOI 10.1007/s00018-016-2233-y; Panasiuk M, 2018, J VIROL, V92, DOI [10.1128/jvi.00090-18, 10.1128/JVI.00090-18]; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Pemovska T, 2015, NATURE, V519, P102, DOI 10.1038/nature14119; Perrotti D, 2017, CURR DRUG TARGETS, V18, P377, DOI 10.2174/1389450117666160615074120; Pietarinen PO, 2017, ONCOTARGET, V8, P22606, DOI 10.18632/oncotarget.15146; Podszywalow-Bartnicka P, 2016, ONCOTARGET, V7, P79692, DOI 10.18632/oncotarget.12941; Polak R, 2015, BLOOD, V126, P2404, DOI 10.1182/blood-2015-03-634238; Radich JP, 2018, J NATL COMPR CANC NE, V16, P1108, DOI 10.6004/jnccn.2018.0071; Rainy N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.245; Reichert D, 2016, EXP HEMATOL, V44, P1092, DOI 10.1016/j.exphem.2016.07.006; Reikvam H, 2018, CASE REP HEMATOL, V2018, DOI 10.1155/2018/2045985; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Seyed-Razavi Y, 2013, IMMUNOL CELL BIOL, V91, P89, DOI 10.1038/icb.2012.52; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Silden E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056276; Simonsson B, 2011, BLOOD, V118, P3228, DOI 10.1182/blood-2011-02-336685; Souriant S, 2019, CELL REP, V26, P3586, DOI 10.1016/j.celrep.2019.02.091; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Talpaz M, 2013, LEUKEMIA, V27, P803, DOI 10.1038/leu.2012.313; TALPAZ M, 1987, BLOOD, V69, P1280; TALPAZ M, 1986, NEW ENGL J MED, V314, P1065, DOI 10.1056/NEJM198604243141701; Valent P, 2019, SEMIN CANC BIOL; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Verfaillie CM, 1998, J LAB CLIN MED, V131, P163, DOI 10.1016/S0022-2143(98)90159-7; VERFAILLIE CM, 1992, J CLIN INVEST, V90, P1232, DOI 10.1172/JCI115985; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2008, MOL CANCER THER, V7, P1121, DOI 10.1158/1535-7163.MCT-07-2331; Wertheim JA, 2003, BLOOD, V102, P2220, DOI 10.1182/blood-2003-01-0062; Zaccard CR, 2016, J LEUKOCYTE BIOL, V100, P81, DOI 10.1189/jlb.4VMR0915-395R; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	96	10	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3773	3791		10.1096/fj.201802061RR	http://dx.doi.org/10.1096/fj.201802061RR		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31945226	Green Published, hybrid			2022-12-28	WOS:000507597400001
J	Vidal, E; Fernandez-Borges, N; Erana, H; Parra, B; Pintado, B; Sanchez-Martin, MA; Charco, JM; Ordonez, M; Perez-Castro, MA; Pumarola, M; Mathiason, CK; Mayoral, T; Castilla, J				Vidal, Enric; Fernandez-Borges, Natalia; Erana, Hasier; Parra, Beatriz; Pintado, Belen; Sanchez-Martin, Manuel A.; Charco, Jorge M.; Ordonez, Montserrat; Perez-Castro, Miguel A.; Pumarola, Marti; Mathiason, Candace K.; Mayoral, Tomas; Castilla, Joaquin			Dogs are resistant to prion infection, due to the presence of asparagine at position 163 of their prion protein	FASEB JOURNAL			English	Article						canids; canine; dog; interspecies transmission; prion infection; prion susceptibility; scrapie; transgenic mouse models; transmission barrier; transmissible spongiform encephalopathy	BOVINE SPONGIFORM ENCEPHALOPATHY; BSE; SCRAPIE; DISEASE; TRANSMISSION; AGENT; CATS; DEGENERATION; REPLICATION; PRPRES	Unlike other species, prion disease has never been described in dogs even though they were similarly exposed to the bovine spongiform encephalopathy (BSE) agent. This resistance prompted a thorough analysis of the canine PRNP gene and the presence of a negatively charged amino acid residue in position 163 was readily identified as potentially fundamental as it differed from all known susceptible species. In the present study, the first transgenic mouse model expressing dog prion protein (PrP) was generated and challenged intracerebrally with a panel of prion isolates, none of which could infect them. The brains of these mice were subjected to in vitro prion amplification and failed to find even minimal amounts of misfolded prions providing definitive experimental evidence that dogs are resistant to prion disease. Subsequently, a second transgenic model was generated in which aspartic acid in position 163 was substituted for asparagine (the most common in prion susceptible species) resulting in susceptibility to BSE-derived isolates. These findings strongly support the hypothesis that the amino acid residue at position 163 of canine cellular prion protein (PrP (c)) is a major determinant of the exceptional resistance of the canidae family to prion infection and establish this as a promising therapeutic target for prion diseases.	[Vidal, Enric; Ordonez, Montserrat] Univ Autonoma Barcelona, IRTA, Ctr Recerca Sanit Anim, CReSA, Barcelona, Spain; [Fernandez-Borges, Natalia; Erana, Hasier; Charco, Jorge M.; Perez-Castro, Miguel A.; Castilla, Joaquin] CIC BioGUNE, Parque Tecnol Bizkaia, Derio 48160, Bizkaia, Spain; [Parra, Beatriz; Mayoral, Tomas] LCV, Madrid, Spain; [Pintado, Belen] Ctr Nacl Biotecnol, Madrid, Spain; [Sanchez-Martin, Manuel A.] Univ Salamanca, Serv Transgenesis, Nucleus, Salamanca, Spain; [Sanchez-Martin, Manuel A.] Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain; [Pumarola, Marti] UAB, Fac Vet, Dept Med & Cirurgia Anim, Barcelona, Spain; [Mathiason, Candace K.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Castilla, Joaquin] Ikerbasque, Basque Fdn Sci, Bilbao, Spain	Autonomous University of Barcelona; IRTA; CIC bioGUNE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Autonomous University of Barcelona; Colorado State University; Basque Foundation for Science	Castilla, J (corresponding author), CIC BioGUNE, Parque Tecnol Bizkaia, Derio 48160, Bizkaia, Spain.	castilla@joaquincastilla.com	Castilla, Joaquín/J-8414-2019; Pérez-Castro, Miguel A./AGW-9540-2022; Fernández-Borges, Natalia/H-1875-2012; Sanchez-Martin, Manuel/N-5327-2016; Vidal, Enric/P-2901-2019; Vidal, Enric/I-1679-2014	Castilla, Joaquín/0000-0002-2216-1361; Pérez-Castro, Miguel A./0000-0003-2850-3470; Sanchez-Martin, Manuel/0000-0001-8370-1336; Vidal, Enric/0000-0002-4965-3286; Vidal, Enric/0000-0002-4965-3286; Pumarola Batlle, Marti/0000-0002-0935-7941; M. Charco, Jorge/0000-0003-3476-1855	Ikerbasque foundation	Ikerbasque foundation	The authors would like to thank the following for their support: Ikerbasque foundation, vivarium, and maintenance from CIC bioGUNE and Patricia Pineiro for technical support. Sierra Espinar, Marta Valle, and Mariano Moreno for technical support, and IRTA-CReSA's biocontainment unit staff for care and maintenance of the animals. Olivier Andreoletti, Jean Jewell, and Fabrizio Tagliavini for the sheep-BSE, CWD, and BSE-L brain tissue samples, respectively. Glenn Telling and Jifeng Bian for the plasmid phgPrP-MCS. Dr. Mark P. Dagleish (Moredun Research Institute) for useful discussion and advice.	ALDHOUS P, 1990, NATURE, V345, P194; Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Bian JF, 2017, P NATL ACAD SCI USA, V114, P1141, DOI 10.1073/pnas.1611891114; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, FEBS LETT, V579, P6237, DOI 10.1016/j.febslet.2005.09.099; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Chianini F, 2012, P NATL ACAD SCI USA, V109, P5080, DOI 10.1073/pnas.1120076109; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; David M, 2012, OR 09 CANINE SPONGIF; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Erana H, 2017, J VIROL, V91, DOI 10.1128/JVI.01543-17; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Fernandez-Borges N, 2018, PRION, V2018, P1; Fernandez-Borges N, 2018, ACTA NEUROPATHOL, V135, P179, DOI 10.1007/s00401-017-1782-y; Fernandez-Borges N, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006716; Fernandez-Borges N, 2012, PRION, V6, DOI 10.4161/pri.22057; FRASER H, 1994, VET REC, V134, P449, DOI 10.1136/vr.134.17.449; GOURMELON P, 1987, BRAIN RES, V411, P391, DOI 10.1016/0006-8993(87)91093-6; Greenwood AD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-44; Hedman C, 2016, VET RES, V47, DOI 10.1186/s13567-015-0295-8; Kortz GD, 1997, VET PATHOL, V34, P296, DOI 10.1177/030098589703400405; Leclerc E, 2003, J MOL BIOL, V326, P475, DOI 10.1016/S0022-2836(02)01365-7; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Mathiason CK, 2013, J VIROL, V87, P1947, DOI 10.1128/JVI.02592-12; Otero A, 2017, MOL NEUROBIOL, V2017, P1; Otero A, 2019, MOL NEUROBIOL, V55, P6182; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Piccardo P, 2012, J COMP PATHOL, V147, P84, DOI 10.1016/j.jcpa.2011.09.004; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Sanchez-Garcia J, 2016, NEUROBIOL DIS, V95, P204, DOI 10.1016/j.nbd.2016.07.025; Sanchez-Garcia J, 2018, NEUROBIOL DIS, V119, P1, DOI 10.1016/j.nbd.2018.07.011; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Sigurdson CJ, 2008, J COMP PATHOL, V138, P189, DOI 10.1016/j.jcpa.2008.01.004; Sigurdson CJ, 2003, BRIT MED BULL, V66, P199, DOI 10.1093/bmb/66.1.199; Siso S, 2004, VET REC, V155, P524, DOI 10.1136/vr.155.17.524; Stewart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050623; Torres JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089722; Vidal E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004977; Vidal E, 2013, PRION, V7, P443, DOI 10.4161/pri.27014; Vidal E, 2013, J NEUROSCI, V33, P7778, DOI 10.1523/JNEUROSCI.0244-13.2013; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Windl Otto, 2012, Subcell Biochem, V65, P497, DOI 10.1007/978-94-007-5416-4_18; WYATT JM, 1991, VET REC, V129, P233, DOI 10.1136/vr.129.11.233; Zanusso G, 1998, LANCET, V352, P1116, DOI 10.1016/S0140-6736(05)79756-7	52	16	16	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3969	3982		10.1096/fj.201902646R	http://dx.doi.org/10.1096/fj.201902646R		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944411	Green Published			2022-12-28	WOS:000507590900001
J	Atack, JM; Guo, CY; Yang, L; Zhou, YQ; Jennings, MP				Atack, John M.; Guo, Chengying; Yang, Long; Zhou, Yaoqi; Jennings, Michael P.			DNA sequence repeats identify numerous Type I restriction-modification systems that are potential epigenetic regulators controlling phase-variable regulons; phasevarions	FASEB JOURNAL			English	Article						bacterial pathogenesis; epigenetics; phase variation; phasevarion; R-M systems	FUSOBACTERIUM-NUCLEATUM; PSEUDOMONAS-AERUGINOSA; NEISSERIA-MENINGITIDIS; MODIFICATION ENZYMES; RECOGNITION DOMAINS; DAM METHYLATION; GENES; EXPRESSION; RECOMBINATION; SPECIFICITY	Over recent years several examples of randomly switching methyltransferases, associated with Type III restriction-modification (R-M) systems, have been described in pathogenic bacteria. In every case examined, changes in simple DNA sequence repeats result in variable methyltransferase expression and result in global changes in gene expression, and differentiation of the bacterial cell into distinct phenotypes. These epigenetic regulatory systems are called phasevarions, phase-variable regulons, and are widespread in bacteria, with 17.4% of Type III R-M system containing simple DNA sequence repeats. A distinct, recombination-driven random switching system has also been described in Streptococci in Type I R-M systems that also regulate gene expression. Here, we interrogate the most extensive and well-curated database of R-M systems, REBASE, by searching for all possible simple DNA sequence repeats in the hsdRMS genes that encode Type I R-M systems. We report that 7.9% of hsdS, 2% of hsdM, and of 4.3% of hsdR genes contain simple sequence repeats that are capable of mediating phase variation. Phase variation of both hsdM and hsdS genes will lead to differential methyltransferase expression or specificity, and thereby the potential to control phasevarions. These data suggest that in addition to well characterized phasevarions controlled by Type III mod genes, and the previously described Streptococcal Type I R-M systems that switch via recombination, approximately 10% of all Type I R-M systems surveyed herein have independently evolved the ability to randomly switch expression via simple DNA sequence repeats.	[Atack, John M.; Zhou, Yaoqi; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld 4215, Australia; [Guo, Chengying; Yang, Long] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China	Griffith University; Shandong Agricultural University	Jennings, MP (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld 4215, Australia.	m.jennings@griffith.edu.au	Zhou, Yaoqi/B-3284-2009; Jennings, Michael P/G-4822-2013; Zhou, Yaoqi/ABD-1125-2020	Zhou, Yaoqi/0000-0002-9958-5699; Jennings, Michael P/0000-0002-1027-4684; Yang, Long/0000-0002-9990-8398	Department of Health \ National Health and Medical Research Council (NHMRC) [1071659, 1138466, 1099279, 1121629]; Department of Education and Training \ Australian Research Council (ARC) [170104691, 180100976, 180102060]	Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Department of Education and Training \ Australian Research Council (ARC)	Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: 1071659, 1138466, 1099279 and 1121629; Department of Education and Training vertical bar Australian Research Council (ARC), Grant/Award Number: 170104691, 180100976 and 180102060	Adamczyk-Poplawska M, 2011, J BACTERIOL, V193, P6750, DOI 10.1128/JB.05672-11; An RS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-19; Atack JM, 2018, TRENDS MICROBIOL, V26, P715, DOI 10.1016/j.tim.2018.01.008; Atack JM, 2018, NUCLEIC ACIDS RES, V46, P3532, DOI 10.1093/nar/gky192; Atack JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8828; Atack JM, 2015, J INFECT DIS, V212, P645, DOI 10.1093/infdis/jiv103; Bayliss CD, 2012, NUCLEIC ACIDS RES, V40, P5876, DOI 10.1093/nar/gks246; Blakeway LV, 2014, FASEB J, V28, P5197, DOI 10.1096/fj.14-256578; BLYN LB, 1990, EMBO J, V9, P4045, DOI 10.1002/j.1460-2075.1990.tb07626.x; Boyle B, 2012, J BACTERIOL, V194, P529, DOI 10.1128/JB.06246-11; Brocchi M, 2007, GENET MOL BIOL, V30, P236, DOI 10.1590/S1415-47572007000200011; BULLAS LR, 1976, J GEN MICROBIOL, V95, P166, DOI 10.1099/00221287-95-1-166; COWAN GM, 1989, CELL, V56, P103, DOI 10.1016/0092-8674(89)90988-4; COX EC, 1976, ANNU REV GENET, V10, P135, DOI 10.1146/annurev.ge.10.120176.001031; Dawid S, 1999, P NATL ACAD SCI USA, V96, P1077, DOI 10.1073/pnas.96.3.1077; De Ste Croix M, 2017, FEMS MICROBIOL REV, V41, pS3, DOI 10.1093/femsre/fux025; Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; Fox KL, 2007, MOL MICROBIOL, V65, P1375, DOI 10.1111/j.1365-2958.2007.05873.x; Fox KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090505; Frey J, 2011, VET MICROBIOL, V153, P51, DOI 10.1016/j.vetmic.2011.05.018; FULLERPACE FV, 1984, P NATL ACAD SCI-BIOL, V81, P6095, DOI 10.1073/pnas.81.19.6095; Furi L, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00370-19; GANN AAF, 1987, MOL MICROBIOL, V1, P13, DOI 10.1111/j.1365-2958.1987.tb00521.x; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3; GUBLER M, 1992, EMBO J, V11, P233, DOI 10.1002/j.1460-2075.1992.tb05046.x; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Highlander SK, 1996, GENE, V178, P89, DOI 10.1016/0378-1119(96)00340-X; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Hu YM, 2016, INFECT IMMUN, V84, P2243, DOI 10.1128/IAI.00324-16; Huo WW, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02174-18; Jen FEC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003377; Jeraldo P, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01154-15; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Lai QL, 2011, INT J SYST EVOL MICR, V61, P295, DOI 10.1099/ijs.0.022962-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Loimaranta V, 2009, J BIOL CHEM, V284, P18614, DOI 10.1074/jbc.M900581200; MacWilliams MP, 1996, EMBO J, V15, P4775, DOI 10.1002/j.1460-2075.1996.tb00855.x; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Mei-Dan O, 2008, KNEE SURG SPORT TR A, V16, P15, DOI 10.1007/s00167-007-0379-8; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; NAGARAJA V, 1985, NATURE, V316, P371, DOI 10.1038/316371a0; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; Oliver MB, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00386-17; Poole J, 2013, J INFECT DIS, V208, P720, DOI 10.1093/infdis/jit240; Power PM, 2009, INFECT GENET EVOL, V9, P216, DOI 10.1016/j.meegid.2008.11.006; PRICE C, 1989, J MOL BIOL, V205, P115, DOI 10.1016/0022-2836(89)90369-0; PRICE C, 1987, EMBO J, V6, P1493, DOI 10.1002/j.1460-2075.1987.tb02391.x; Rao DN, 2014, NUCLEIC ACIDS RES, V42, P45, DOI 10.1093/nar/gkt616; Reinert K, 2015, ANNU REV GENOM HUM G, V16, P133, DOI 10.1146/annurev-genom-090413-025358; Ren Z, 1999, J BACTERIOL, V181, P5865, DOI 10.1128/JB.181.18.5865-5870.1999; Richardson AR, 1999, J BACTERIOL, V181, P2067, DOI 10.1128/JB.181.7.2067-2074.1999; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Seib KL, 2015, NUCLEIC ACIDS RES, V43, P4150, DOI 10.1093/nar/gkv219; Seib KL, 2011, FASEB J, V25, P3622, DOI 10.1096/fj.11-183590; Seib KL, 2002, FEMS IMMUNOL MED MIC, V32, P159; Shang FM, 2018, WORLD J GASTRO ONCOL, V10, P71, DOI 10.4251/wjgo.v10.i3.71; Sitaraman R, 1997, MOL MICROBIOL, V26, P109, DOI 10.1046/j.1365-2958.1997.5571938.x; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00319-17; Srikhanta YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027569; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; van Belkum A, 2015, MBIO, V6, DOI 10.1128/mBio.01796-15; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Zaleski P, 2005, MICROBIOL-SGM, V151, P3361, DOI 10.1099/mic.0.28184-0; Zhou K, 2014, FEMS MICROBIOL REV, V38, P119, DOI 10.1111/1574-6976.12036	76	12	12	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1038	1051		10.1096/fj.201901536RR	http://dx.doi.org/10.1096/fj.201901536RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914596	Green Published, hybrid			2022-12-28	WOS:000507308900070
J	Gwon, MG; An, HJ; Kim, JY; Kim, WH; Gu, H; Kim, HJ; Leem, J; Jung, HJ; Park, KK				Gwon, Mi-Gyeong; An, Hyun-Jin; Kim, Jung-Yeon; Kim, Woon-Hae; Gu, Hyemin; Kim, Hyun-Ju; Leem, Jaechan; Jung, Hyun Jin; Park, Kwan-Kyu			Anti-fibrotic effects of synthetic TGF-beta 1 and Smad oligodeoxynucleotide on kidney fibrosis in vivo and in vitro through inhibition of both epithelial dedifferentiation and endothelial-mesenchymal transitions	FASEB JOURNAL			English	Article						EndoMT; epithelial dedifferentiation; kidney fibrosis; TGF-beta 1; Smad oligodeoxynucleotide; UUO	GROWTH-FACTOR-BETA; RENAL INTERSTITIAL FIBROSIS; TRANSCRIPTION FACTOR SNAIL; TGF-BETA; URETERAL OBSTRUCTION; MECHANISMS; INJURY; MYOFIBROBLAST; FIBROBLASTS; EXPRESSION	Kidney fibrosis is a common process of various kidney diseases leading to end-stage renal failure irrespective of etiology. Myofibroblasts are crucial mediators in kidney fibrosis through production of extracellular matrix (ECM), but their origin has not been clearly identified. Many study proposed that epithelial and endothelial cells become myofibroblasts by epithelial dedifferentiation and endothelial-mesenchymal transition (EndoMT). TGF-beta 1/Smad signaling plays a crucial role in partly epithelial-mensencymal transition (EMT) and EndoMT. Thus, we designed the TGF-beta 1/Smad oligodeoxynucleotide (ODN), a synthetic short DNA containing complementary sequence for Smad transcription factor and TGF-beta 1 mRNA. Therefore, this study investigated the anti-fibrotic effect of synthetic TGF-beta 1/Smad ODN on UUO-induced kidney fibrosis in vivo model and TGF-beta 1-induced in vitro model. To examine the effect of TGF-beta 1/Smad ODN, we performed various experiments to evaluate kidney fibrosis. The results showed that UUO induced inflammation, ECM accumulation, epithelial dedifferentiation and EndoMT processes, and tubular atrophy. However, synthetic TGF-beta 1/Smad ODN significantly suppressed UUO-induced fibrosis. Furthermore, synthetic ODN attenuated TGF-beta 1-induced epithelial dedifferentiation and EndoMT program via blocking TGF-beta 1/Smad signaling. In conclusion, this study demonstrated that administration of synthetic TGF-beta 1/Smad ODN attenuates kidney fibrosis, epithelial dedifferentiation, and EndoMT processes. The findings propose the possibility of synthetic ODN as a new effective therapeutic tool for kidney fibrosis.	[Gwon, Mi-Gyeong; An, Hyun-Jin; Gu, Hyemin; Kim, Hyun-Ju; Park, Kwan-Kyu] Catholic Univ Daegu, Sch Med, Dept Pathol, 33,Duryugongwon Ro 17 Gil, Daegu 42472, South Korea; [Kim, Jung-Yeon; Leem, Jaechan] Catholic Univ Daegu, Sch Med, Dept Immunol, Daegu, South Korea; [Kim, Woon-Hae] DGIST, Dept New Biol, Daegu, South Korea; [Jung, Hyun Jin] Catholic Univ Daegu, Sch Med, Dept Urol, Daegu, South Korea	Catholic University of Daegu; Catholic University of Daegu; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Catholic University of Daegu	Park, KK (corresponding author), Catholic Univ Daegu, Sch Med, Dept Pathol, 33,Duryugongwon Ro 17 Gil, Daegu 42472, South Korea.	kkpark@cu.ac.kr	Leem, Jaechan/AAQ-6648-2020; Kim, Woon-Hae/AAS-9817-2021	Kim, Woon-Hae/0000-0002-1536-5374; Leem, Jaechan/0000-0003-2329-4374	National Research Foundation of Korea (NRF) [NRF-2019R1F1A1061019]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2019R1F1A1061019	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Cai GY, 2008, NEPHROL DIAL TRANSPL, V23, P1861, DOI 10.1093/ndt/gfm666; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheng X, 2019, NEPHROL DIAL TRANSPL, V34, P242, DOI 10.1093/ndt/gfy107; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Choi BM, 1996, IMMUNOL CELL BIOL, V74, P144, DOI 10.1038/icb.1996.19; Collins AJ, 2009, AM J KIDNEY DIS, V55, pS1; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Gerarduzzi C, 2017, INFLAMM RES, V66, P451, DOI 10.1007/s00011-016-1019-x; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245; Haller H, 1998, KIDNEY INT, V53, P1550, DOI 10.1046/j.1523-1755.1998.00927.x; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Higashi AY, 2019, J AM SOC NEPHROL, V30, P80, DOI 10.1681/ASN.2018060644; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hu BA, 2013, CURR OPIN RHEUMATOL, V25, P71, DOI 10.1097/BOR.0b013e32835b1352; Hung TW, 2016, CELL PHYSIOL BIOCHEM, V40, P1029, DOI 10.1159/000453159; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kim KH, 2013, J MOL MED, V91, P573, DOI 10.1007/s00109-012-0972-2; Kim WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17873-2; Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Li YJ, 2012, KIDNEY INT, V81, P880, DOI 10.1038/ki.2011.469; Liang M, 2015, AM J PATHOL, V185, P1234, DOI 10.1016/j.ajpath.2015.01.027; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Lyman J L, 1986, Emerg Med Clin North Am, V4, P223; Ma FY, 2011, AM J PHYSIOL-RENAL, V300, pF1410, DOI 10.1152/ajprenal.00018.2011; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Overstreet JM, 2017, FASEB J, V31, P4407, DOI 10.1096/fj.201601359RR; Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045; Ramseyer VD, 2013, AM J PHYSIOL-RENAL, V304, pF1231, DOI 10.1152/ajprenal.00557.2012; Riedel K, 2008, IN VIVO, V22, P1; Rockey DC, 2015, NEW ENGL J MED, V373, P96, DOI 10.1056/NEJMc1504848; Seo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31931; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sung WJ, 2013, EXP MOL PATHOL, V95, P136, DOI 10.1016/j.yexmp.2013.06.008; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Wang YQ, 2015, BASIC CLIN PHARMACOL, V117, P164, DOI 10.1111/bcpt.12383; Wang ZJ, 2017, J CELL MOL MED, V21, P2359, DOI 10.1111/jcmm.13157; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wilmer WA, 1997, J BIOL CHEM, V272, P10877; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu CG, 2016, MOL MED REP, V13, P901, DOI 10.3892/mmr.2015.4631; Xu J, 2016, CLIN SCI, V130, P349, DOI 10.1042/CS20150385; Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yasar A, 2013, KAOHSIUNG J MED SCI, V29, P19, DOI 10.1016/j.kjms.2012.08.003; Yhee JY, 2008, J VET DIAGN INVEST, V20, P585, DOI 10.1177/104063870802000508; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2001, CURR OPIN NEPHROL HY, V10, P315, DOI 10.1097/00041552-200105000-00004; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang LJ, 2015, DRUG DES DEV THER, V9, P4669, DOI [10.2147/DDDT.S66770, 10.2147/DDDT.S86770]	70	17	19	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					333	349		10.1096/fj.201901307RR	http://dx.doi.org/10.1096/fj.201901307RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914629				2022-12-28	WOS:000507308900024
J	Penrad-Mobayed, M; Perrin, C; Herman, L; Todeschini, AL; Nigon, F; Cosson, B; Caburet, S; Veitia, RA				Penrad-Mobayed, May; Perrin, Caroline; Herman, Laetitia; Todeschini, Anne-Laure; Nigon, Fabienne; Cosson, Bertrand; Caburet, Sandrine; Veitia, Reiner A.			Conventional and unconventional interactions of the transcription factor FOXL2 uncovered by a proteome-wide analysis	FASEB JOURNAL			English	Article						DNA recombination and repair; protein-protein interaction; proteomics; mRNA splicing; RNA processing	GONADOTROPIN-RELEASING-HORMONE; GRANULOSA-CELL TUMORS; FORKHEAD TRANSCRIPTION; U2 SNRNP; GENE; EXPRESSION; BINDING; MOUSE; DEMETHYLATION; MITOCHONDRIA	Beyond the study of its transcriptional target genes, the identification of the various interactors of a transcription factor (TF) is crucial to understand its diverse cellular roles. We focused on FOXL2, a winged-helix forkhead TF important for ovarian development and maintenance. FOXL2 has been implicated in diverse cellular processes, including apoptosis, the control of cell cycle or the regulation of steroid hormone synthesis. To reliably identify partners of endogenous FOXL2, we performed a proteome-wide analysis using co-immunoprecipitation in the murine granulosa cell-derived AT29c and the pituitary-derived alpha-T3 cell lines, using three antibodies targeting different parts of the protein. Following a stringent selection of mass spectrometry data on the basis of identification reliability and protein enrichment, we identified a core set of 255 partners common to both cell lines. Their analysis showed that we could co-precipitate several complexes involved in mRNA processing, chromatin remodeling and DNA replication and repair. We further validated (direct and/or indirect) interactions with selected partners, suggesting an unexpected role for FOXL2 in those processes. Overall, this comprehensive analysis of the endogenous FOXL2 interactome sheds light on its numerous and diverse interactors and unconventional cellular roles.	[Penrad-Mobayed, May; Perrin, Caroline; Herman, Laetitia; Todeschini, Anne-Laure; Caburet, Sandrine; Veitia, Reiner A.] Univ Paris, CNRS, Inst Jacques Monod, UMR7592, 15 Rue Helene Brion, F-75013 Paris, France; [Nigon, Fabienne; Cosson, Bertrand] Univ Paris, CNRS, Epigenet & Cell Fate, UMR7216, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Caburet, S; Veitia, RA (corresponding author), Univ Paris, CNRS, Inst Jacques Monod, UMR7592, 15 Rue Helene Brion, F-75013 Paris, France.	sandrine.caburet@ijm.fr; reiner.veitia@ijm.fr	Caburet, Sandrine/AAH-3435-2019		Universite de Paris; Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale (FRM)	Universite de Paris; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	Universite de Paris; Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale (FRM)	Alemasova EE, 2017, ACTA NATURAE, V9, P4, DOI 10.32607/20758251-2017-9-2-4-16; Alves-Fernandes DK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133153; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Boulanger L, 2014, CURR BIOL, V24, P404, DOI 10.1016/j.cub.2013.12.039; BROSI R, 1993, SCIENCE, V262, P102, DOI 10.1126/science.8211112; Burg JM, 2016, BIOCHEMISTRY-US, V55, P1652, DOI 10.1021/acs.biochem.5b01135; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Curmi F, 2018, BIOCHEM SOC T, V46, P329, DOI 10.1042/BST20180016; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; Dutertre M, 2001, ENDOCRINOLOGY, V142, P4040, DOI 10.1210/en.142.9.4040; El Marabti E, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00080; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Elzaiat M, 2019, MOL CELL PROTEOMICS, V18, P1307, DOI 10.1074/mcp.RA119.001461; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Fong YW, 2013, MOL CELL, V52, P291, DOI 10.1016/j.molcel.2013.10.018; Fujiyama-Nakamura S, 2009, MOL CELL PROTEOMICS, V8, P1552, DOI 10.1074/mcp.M900147-MCP200; Galganski L, 2017, NUCLEIC ACIDS RES, V45, P10350, DOI 10.1093/nar/gkx759; Gandoura S, 2013, J HEPATOL, V58, P936, DOI 10.1016/j.jhep.2012.12.025; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Giurgiu M, 2019, NUCLEIC ACIDS RES, V47, pD559, DOI 10.1093/nar/gky973; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Justice NJ, 2011, MOL ENDOCRINOL, V25, P1404, DOI 10.1210/me.2011-0093; Kim KH, 2014, CANCER GENET-NY, V207, P365, DOI 10.1016/j.cancergen.2014.04.004; Kim SY, 2009, ENDOCRINOLOGY, V150, P5085, DOI 10.1210/en.2009-0313; Kim S, 2017, J BIOENERG BIOMEMBR, V49, P335, DOI 10.1007/s10863-017-9705-0; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; L'Hote D, 2012, HUM MOL GENET, V21, P3264, DOI 10.1093/hmg/dds170; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Lesnik C, 2015, RNA BIOL, V12, P801, DOI 10.1080/15476286.2015.1058686; Lettieri-Barbato D, 2019, METABOLISM, V95, P84, DOI 10.1016/j.metabol.2019.04.006; Li X, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145504; Li YL, 2018, AM J CANCER RES, V8, P1343; Liu XR, 2019, BBA-REV CANCER, V1871, P179, DOI 10.1016/j.bbcan.2018.12.007; MacDonald CC, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1526; Madabhushi R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071917; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Marongiu M, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0072-y; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Noli L, 2015, STEM CELL REP, V5, P946, DOI 10.1016/j.stemcr.2015.10.006; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Park M, 2010, MOL ENDOCRINOL, V24, P1024, DOI 10.1210/me.2009-0375; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Peserico A, 2013, CELL MOL LIFE SCI, V70, P2015, DOI 10.1007/s00018-012-1244-6; Pisarska MD, 2010, AM J PHYSIOL-ENDOC M, V299, pE101, DOI 10.1152/ajpendo.00534.2009; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Rahmoun M, 2017, NUCLEIC ACIDS RES, V45, P7191, DOI 10.1093/nar/gkx328; Rambout X, 2018, CHEM REV, V118, P4339, DOI 10.1021/acs.chemrev.7b00470; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shiomi Y, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020052; Sperling J, 2017, METHODS, V125, P70, DOI 10.1016/j.ymeth.2017.04.005; Thore S, 2019, BIOCHIMIE, V164, P105, DOI 10.1016/j.biochi.2019.03.016; Ting NSY, 2005, NUCLEIC ACIDS RES, V33, P2090, DOI 10.1093/nar/gki342; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022; Wang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051266	78	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					571	587		10.1096/fj.201901573R	http://dx.doi.org/10.1096/fj.201901573R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914586				2022-12-28	WOS:000507308900039
J	Tibaldi, E; Brocca, A; Sticca, A; Gola, E; Pizzi, M; Bordin, L; Pagano, MA; Mazzorana, M; Dona, G; Violi, P; Marin, O; Romano, A; Angeli, P; Carraro, A; Brunati, AM				Tibaldi, Elena; Brocca, Alessandra; Sticca, Antonietta; Gola, Elisabetta; Pizzi, Marco; Bordin, Luciana; Pagano, Mario Angelo; Mazzorana, Marco; Dona, Gabriella; Violi, Paola; Marin, Oriano; Romano, Antonella; Angeli, Paolo; Carraro, Amedeo; Brunati, Anna Maria			Fam20C-mediated phosphorylation of osteopontin is critical for its secretion but dispensable for its action as a cytokine in the activation of hepatic stellate cells in liver fibrogenesis	FASEB JOURNAL			English	Article						bile duct ligation; Golgi apparatus; hepatic stellate cells; osteopontin; phosphorylation	POSTTRANSLATIONAL MODIFICATIONS; CASEIN KINASE; FIBROSIS; INFLAMMATION; INHIBITION; BINDING; INJURY	Osteopontin (OPN) is a phosphoglycoprotein secreted into the extracellular matrix upon liver injury, acting as a cytokine stimulates the deposition of fibrillary collagen in liver fibrogenesis. In livers of mice subjected to bile duct ligation (BDL) and in cultured activated hepatic stellate cells (HSCs), we show that OPN, besides being overexpressed, is substantially phosphorylated by family with sequence similarity 20, member C (Fam20C), formerly known as Golgi casein kinase (G-CK), which is exclusively resident in the Golgi apparatus. In both experimental models, Fam20C becomes overactive when associated with a 500-kDa multiprotein complex, as compared with the negligible activity in livers of sham-operated rats and in quiescent HSCs. Fam20C knockdown not only confirmed the role of Fam20C itself in OPN phosphorylation, but also revealed that phosphorylation was essential for OPN secretion. However, OPN acts as a fibrogenic factor independently of its phosphorylation state, as demonstrated by the increased expression of Collagen-I by HSCs incubated with either a phosphorylated or nonphosphorylated form of recombinant OPN. Collectively, our results confirm that OPN promotes liver fibrosis and highlight Fam20C as a novel factor driving this process by favoring OPN secretion from HSCs, opening new avenues for deciphering yet unidentified mechanisms underlying liver fibrogenesis.	[Tibaldi, Elena; Bordin, Luciana; Pagano, Mario Angelo; Dona, Gabriella; Brunati, Anna Maria] Univ Padua, Dept Mol Med, Viale G Colombo 3, I-35131 Padua, Italy; [Brocca, Alessandra; Sticca, Antonietta; Gola, Elisabetta; Romano, Antonella; Angeli, Paolo] Univ Padua, Dept Med DIMED, Via Giustiniani 2, I-35128 Padua, Italy; [Pizzi, Marco] Univ Padua, Dept Med DIMED, Gen Pathol & Cytopathol Unit, Padua, Italy; [Mazzorana, Marco] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Violi, Paola; Carraro, Amedeo] Univ Hosp Verona, Dept Gen Surg & Odontoiatr, Liver Transplant Unit, Verona, Italy; [Marin, Oriano] Univ Padua, Dept Biomed Sci, Padua, Italy	University of Padua; University of Padua; University of Padua; Diamond Light Source; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Padua	Pagano, MA (corresponding author), Univ Padua, Dept Mol Med, Viale G Colombo 3, I-35131 Padua, Italy.; Angeli, P (corresponding author), Univ Padua, Dept Med DIMED, Via Giustiniani 2, I-35128 Padua, Italy.	mario.pagano@unipd.it; pangeli@unipd.it	Bordin, Luciana/I-6972-2019; Pizzi, Marco/H-6273-2016	Bordin, Luciana/0000-0003-4238-3153; Carraro, Amedeo/0000-0001-6449-4597; Pagano, Mario Angelo/0000-0003-4186-7658; Pizzi, Marco/0000-0003-4006-7317	DOR; University of Padova	DOR; University of Padova	DOR; University of Padova	Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Arriazu E, 2017, GUT, V66, P1123, DOI 10.1136/gutjnl-2015-310752; Brunati AM, 2000, BIOCHEM J, V351, P765, DOI 10.1042/0264-6021:3510765; Brunati AM, 2000, FEBS LETT, V471, P151, DOI 10.1016/S0014-5793(00)01378-8; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Chen Q, 2014, STEM CELLS, V32, P327, DOI 10.1002/stem.1567; Chen YH, 2018, EXP CELL RES, V362, P343, DOI 10.1016/j.yexcr.2017.11.035; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Cordero-Espinoza L, 2018, J CLIN INVEST, V128, P85, DOI 10.1172/JCI93562; Cui JX, 2017, ELIFE, V6, DOI 10.7554/eLife.23990; Cui JX, 2015, ELIFE, V4, DOI 10.7554/eLife.06120; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Greuter T, 2016, J GASTROENTEROL, V51, P511, DOI 10.1007/s00535-016-1190-4; Gringeri E, 2010, BIOCHEM J, V425, P401, DOI 10.1042/BJ20090902; Haghgoo SM, 2019, CLIN CHEM LAB MED, V57, P577, DOI 10.1515/cclm-2018-0357; Hui T, 2015, MATRIX BIOL, V41, P19, DOI 10.1016/j.matbio.2014.11.005; Icer MA, 2018, CLIN BIOCHEM, V59, P17, DOI 10.1016/j.clinbiochem.2018.07.003; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Klaning E, 2015, BBA-PROTEINS PROTEOM, V1854, P930, DOI 10.1016/j.bbapap.2015.03.008; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Leung TM, 2013, LAB INVEST, V93, P1082, DOI 10.1038/labinvest.2013.104; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Ohyama Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27784; Oyama M, 2018, BIOCHEM J, V475, P1583, DOI 10.1042/BCJ20170205; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Pinzani M, 2011, BEST PRACT RES CL GA, V25, P281, DOI 10.1016/j.bpg.2011.02.009; Pritchett J, 2012, HEPATOLOGY, V56, P1108, DOI 10.1002/hep.25758; Procino G, 2003, FASEB J, V17, P1886, DOI 10.1096/fj.02-0870fje; RUZZENE M, 1999, PROTEIN PHOSPHORYLAT, P221; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tibaldi E, 2006, CELL MOL LIFE SCI, V63, P378, DOI 10.1007/s00018-005-5506-4; Tibaldi E, 2014, BBA-MOL CELL RES, V1843, P288, DOI 10.1016/j.bbamcr.2013.10.010; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701; Wang XD, 2014, GUT, V63, P1805, DOI 10.1136/gutjnl-2013-306373; Wen YK, 2016, INT J BIOL SCI, V12, P1121, DOI 10.7150/ijbs.16445; Whyte MP, 2017, J BONE MINER RES, V32, P757, DOI 10.1002/jbmr.3034; Yang M, 2014, TOXICOL LETT, V224, P186, DOI 10.1016/j.toxlet.2013.10.030; Yanguas SC, 2016, ARCH TOXICOL, V90, P1025, DOI 10.1007/s00204-015-1543-4; Zhang JC, 2018, EMBO J, V37, DOI 10.15252/embj.201798699; Zhao HL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0391-6	49	4	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1122	1135		10.1096/fj.201900880R	http://dx.doi.org/10.1096/fj.201900880R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914633				2022-12-28	WOS:000507308900076
J	Liu, XY; Li, W; Cai, J; Yan, ZD; Shao, X; Xie, KN; Guo, XE; Luo, EP; Jing, D				Liu, Xiyu; Li, Wei; Cai, Jing; Yan, Zedong; Shao, Xi; Xie, Kangning; Guo, X. Edward; Luo, Erping; Jing, Da			Spatiotemporal characterization of microdamage accumulation and its targeted remodeling mechanisms in diabetic fatigued bone	FASEB JOURNAL			English	Article						bone remodeling; diffuse microdamage; fatigue loading; linear microcracks; type 1 diabetes mellitus (T1DM)	STRUCTURAL-PROPERTIES; MATRIX MICRODAMAGE; TYPE-1; STREPTOZOTOCIN; DAMAGE; MODEL; MICROCRACKS; DEGRADATION; OSTEOCYTES; INSULITIS	The skeleton of type 1 diabetes mellitus (T1DM) has deteriorated mechanical integrity and increased fragility, whereas the mechanisms are not fully understood. Load-induced microdamage naturally occurs in bone matrix and can be removed by initiating endogenous targeted bone remodeling. However, the microdamage accumulation in diabetic skeleton and the corresponding bone remodeling mechanisms remain poorly understood. Herein, streptozotocin-induced T1DM rats and age-matched non-diabetic rats were subjected to daily uniaxial ulnar loading for 1, 4, 7, and 10 days, respectively. The SPECT/CT and basic fuchsin staining revealed significant higher-density spatial accumulation of linear and diffuse microdamage in diabetic ulnae than non-diabetic ulnae. Linear microcracks increased within 10-day loading in diabetic bone, whereas peaked at Day 7 in non-diabetic bone. Moreover, diabetic fatigued ulnae had more severe disruptions of osteocyte canaliculi around linear microcracks. Immunostaining results revealed that diabetes impaired targeted remodeling in fatigued bone at every key stage, including increased apoptosis of bystander osteocytes, decreased RANKL secretion, reduced osteoclast recruitment and bone resorption, and impaired osteoblast-mediated bone formation. This study characterizes microdamage accumulation and abnormal remodeling mechanisms in the diabetic skeleton, which advances our etiologic understanding of diabetic bone deterioration and increased fragility from the aspect of microdamage accumulation and bone remodeling.	[Liu, Xiyu; Li, Wei; Yan, Zedong; Shao, Xi; Xie, Kangning; Luo, Erping; Jing, Da] Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Cai, Jing] Shaanxi Univ Chinese Med, Coll Basic Med, Xianyang, Peoples R China; [Guo, X. Edward] Columbia Univ, Dept Biomed Engn, Bone Bioengn Lab, New York, NY USA	Air Force Military Medical University; Shaanxi University of Chinese Medicine; Columbia University	Luo, EP; Jing, D (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.	luoerping@fmmu.edu.cn; jingdaasq@126.com	Xie, Kangning/AAQ-1496-2020	Xie, Kangning/0000-0002-6031-8489	National Natural Science Foundation of China (NSFC) [31500760, 51777211, 31670953]; Young Talent Supporting Project in Military Technology of China [17-JCJQ-QT-038]; Shaanxi Provincial Natural Science Foundation of China [2018JQ8056]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Young Talent Supporting Project in Military Technology of China; Shaanxi Provincial Natural Science Foundation of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: No. 31500760, 51777211 and 31670953; Young Talent Supporting Project in Military Technology of China, Grant/Award Number: No. 17-JCJQ-QT-038; Shaanxi Provincial Natural Science Foundation of China, Grant/Award Number: No. 2018JQ8056	Alexopoulou O, 2006, DIABETES METAB, V32, P453, DOI 10.1016/S1262-3636(07)70303-8; BELL RC, 1994, ENDOCRINOLOGY, V135, P2681, DOI 10.1210/en.135.6.2681; Brondum E, 2005, HORM METAB RES, V37, pS56, DOI 10.1055/s-2005-861370; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1995, BONE, V17, P431, DOI 10.1016/S8756-3282(95)00241-3; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6; BURR DB, 1990, CLIN ORTHOP RELAT R, P305, DOI 10.1097/00003086-199011000-00047; CHAUDHURI TK, 1983, SEMIN NUCL MED, V13, P75; Chen J, 2015, MOL IMAGING BIOL, V17, P337, DOI 10.1007/s11307-014-0787-3; Cheung WY, 2016, J BONE MINER RES, V31, P890, DOI 10.1002/jbmr.2740; Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Danielson KK, 2009, OSTEOPOROSIS INT, V20, P923, DOI 10.1007/s00198-008-0763-3; Danova NA, 2003, BONE, V33, P197, DOI 10.1016/S8756-3282(03)00155-8; Farlay D, 2016, J BONE MINER RES, V31, P190, DOI 10.1002/jbmr.2607; Farr JN, 2016, BONE, V82, P28, DOI 10.1016/j.bone.2015.07.027; Forsen L, 1999, DIABETOLOGIA, V42, P920, DOI 10.1007/s001250051248; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Herman BC, 2010, BONE, V47, P766, DOI 10.1016/j.bone.2010.07.006; Horcajada-Molteni MN, 2001, J BONE MINER RES, V16, P958, DOI 10.1359/jbmr.2001.16.5.958; Jing D, 2011, OSTEOPOROSIS INT, V22, P1885, DOI 10.1007/s00198-010-1447-3; Jing D, 2018, BONE, V106, P11, DOI 10.1016/j.bone.2017.10.001; Kalaitzoglou E, 2016, CURR OSTEOPOROS REP, V14, P310, DOI 10.1007/s11914-016-0329-9; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Kerschnitzki M, 2013, J BONE MINER RES, V28, P1837, DOI 10.1002/jbmr.1927; Kim AR, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1681-6; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; Li ZC, 2011, J NUCL MED, V52, P769, DOI 10.2967/jnumed.110.085456; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Lynch JA, 2008, BONE, V42, P942, DOI 10.1016/j.bone.2008.01.004; Macione J, 2011, J MECH BEHAV BIOMED, V4, P841, DOI 10.1016/j.jmbbm.2011.03.010; Mastrandrea LD, 2008, DIABETES CARE, V31, P1729, DOI 10.2337/dc07-2426; Mueller RJ, 2004, J MATER SCI-MATER M, V15, P367, DOI 10.1023/B:JMSM.0000021103.39114.cd; Muir P, 2007, BONE, V40, P948, DOI 10.1016/j.bone.2006.11.012; Nicodemus KK, 2001, DIABETES CARE, V24, P1192, DOI 10.2337/diacare.24.7.1192; O'Brien FJ, 2000, J ANAT, V197, P413, DOI 10.1046/j.1469-7580.2000.19730413.x; Ogasawara A, 2008, BONE, V43, P832, DOI 10.1016/j.bone.2008.07.246; Ohbayashi Y, 2017, ODONTOLOGY, V105, P382, DOI 10.1007/s10266-016-0279-9; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Papaccio G, 2000, J CELL BIOCHEM, V77, P82, DOI 10.1002/(SICI)1097-4644(20000401)77:1<82::AID-JCB9>3.3.CO;2-M; Parajuli A, 2015, BONE, V81, P152, DOI 10.1016/j.bone.2015.07.012; Pattin CA, 1996, J BIOMECH, V29, P69, DOI 10.1016/0021-9290(94)00156-1; Rubin MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154700; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0; Seref-Ferlengez Z, 2014, J BONE MINER RES, V29, P2537, DOI 10.1002/jbmr.2309; Silva MJ, 2009, J BONE MINER RES, V24, P1618, DOI [10.1359/jbmr.090316, 10.1359/JBMR.090316]; Thrailkill KM, 2005, DIABETES, V54, P2875, DOI 10.2337/diabetes.54.10.2875; Uthgenannt BA, 2007, J BONE MINER RES, V22, P1548, DOI 10.1359/JBMR.0070614; van der Jagt OP, 2011, J BONE JOINT SURG AM, V93A, P38, DOI 10.2106/JBJS.I.01535; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; WANG ZY, 1993, DIABETES, V42, P420, DOI 10.2337/diabetes.42.3.420; Weber DR, 2016, CURR OSTEOPOROSIS RE, V14, P1; Wong KK, 2013, J NUCL MED, V54, P590, DOI 10.2967/jnumed.112.114298; Yan YH, 2014, TOXICOL APPL PHARM, V281, P211, DOI 10.1016/j.taap.2014.10.005; Zhang XH, 2018, BONE, V108, P156, DOI 10.1016/j.bone.2018.01.011; ZIOUPOS P, 1994, J MATER SCI, V29, P978, DOI 10.1007/BF00351420; Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024; ZWAS ST, 1987, J NUCL MED, V28, P452	62	6	6	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2579	2594		10.1096/fj.201902011RR	http://dx.doi.org/10.1096/fj.201902011RR		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908007	Bronze			2022-12-28	WOS:000504089200001
J	Fearing, BV; Jing, LF; Barcellona, MN; Witte, SE; Buchowski, JM; Zebala, LP; Kelly, MP; Luhmann, S; Gupta, MC; Pathak, A; Setton, LA				Fearing, Bailey V.; Jing, Liufang; Barcellona, Marcos N.; Witte, Savannah Est; Buchowski, Jacob M.; Zebala, Lukas P.; Kelly, Michael P.; Luhmann, Scott; Gupta, Munish C.; Pathak, Amit; Setton, Lori A.			Mechanosensitive transcriptional coactivators MRTF-A and YAP/TAZ regulate nucleus pulposus cell phenotype through cell shape	FASEB JOURNAL			English	Article						intervertebral disc; mechanotransduction; F-actin; SRF; TEAD	SERUM RESPONSE FACTOR; TISSUE-GROWTH-FACTOR; EXTRACELLULAR-MATRIX; NOTOCHORDAL CELLS; GENE-EXPRESSION; YAP; DEGENERATION; LAMININ; ACTIN; MYOCARDIN	Cells of the adult nucleus pulposus (NP) are critically important in maintaining overall disc health and function. NP cells reside in a soft, gelatinous matrix that dehydrates and becomes increasingly fibrotic with age. Such changes result in physical cues of matrix stiffness that may be potent regulators of NP cell phenotype and may contribute to a transition toward a senescent and fibroblastic NP cell with a limited capacity for repair. Here, we investigate the mechanosignaling cues generated from changes in matrix stiffness in directing NP cell phenotype and identify mechanisms that can potentially preserve a biosynthetically active, juvenile NP cell phenotype. Using a laminin-functionalized polyethylene glycol hydrogel, we show that when NP cells form rounded, multicell clusters, they are able to maintain cytosolic localization of myocardin-related transcription factor (MRTF)-A, a coactivator of serum-response factor (SRF), known to promote fibroblast-like behaviors in many cells. Upon preservation of a rounded shape, human NP cells similarly showed cytosolic retention of transcriptional coactivator Yes-associated protein (YAP) and its paralogue PDZ-binding motif (TAZ) with associated decline in activation of its transcription factor TEA domain family member binding domain (TEAD). When changes in cell shape occur, leading to a more spread, fibrotic morphology associated with stronger F-actin alignment, SRF and TEAD are up-regulated. However, targeted deletion of either cofactor was not sufficient to overcome shape-mediated changes observed in transcriptional activation of SRF or TEAD. Findings show that substrate stiffness-induced promotion of F-actin alignment occurs concomitantly with a flattened, spread morphology, decreased NP marker expression, and reduced biosynthetic activity. This work indicates cell shape is a stronger indicator of SRF and TEAD mechanosignaling pathways than coactivators MRTF-A and YAP/TAZ, respectively, and may play a role in the degeneration-associated loss of NP cellularity and phenotype.	[Fearing, Bailey V.; Jing, Liufang; Barcellona, Marcos N.; Witte, Savannah Est; Setton, Lori A.] Washington Univ, Dept Biomed Engn, One Brookings Dr,Campus Box 1097, St Louis, MO 63130 USA; [Buchowski, Jacob M.; Zebala, Lukas P.; Kelly, Michael P.; Luhmann, Scott; Gupta, Munish C.; Setton, Lori A.] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Pathak, Amit] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Setton, LA (corresponding author), Washington Univ, Dept Biomed Engn, One Brookings Dr,Campus Box 1097, St Louis, MO 63130 USA.	setton@wustl.edu	Kelly, Michael P/CAE-8607-2022	Kelly, Michael P/0000-0001-6221-7406; Est-Witte, Savannah/0000-0003-3751-0760; Setton, Lori/0000-0001-5992-4206	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [F32 AR070579, R01 AR070975, R01 AR069588]; NIH National Institute of General Medical Sciences (NIGMS) [R35 GM128764]; National Science Foundation (NSF) [DGE-1143954]; Hope Center Viral Vectors Core at Washington University School of Medicine; AO Spine; OMeGA; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069588, R01AR070975, F32AR070579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM128764] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Hope Center Viral Vectors Core at Washington University School of Medicine; AO Spine; OMeGA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding support for this research was provided by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Grants F32 AR070579, R01 AR070975, and R01 AR069588; NIH National Institute of General Medical Sciences (NIGMS) Grant R35 GM128764; and the National Science Foundation (NSF; DGE-1143954). This work was also supported by the Hope Center Viral Vectors Core at Washington University School of Medicine. The work of B.V.F. and A.P. was funded by the NIH. J.M.B. received royalties from Globus, Wolters Kluwer, and K2M, and has received fellowship funding from AO Spine and OMeGA. M.C.G. received royalties from DePuy and Innomed, and holds personal stock of Johnson & Johnson and Procter & Gamble. M.C.G. also served as an advisor, consultant, and conducted travel for DePuy and Medtronic, and received fellowship funding from AO Spine and OMeGA. The work of L.A.S. was funded by the NIH, and has financial holdings in Cytex Therapeutics and Phasebio Pharmaceuticals that have interests that do not overlap with the subject of this publication. The remaining authors declare no potential conflicts of interest.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Bian Q, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.8; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Bridgen DT, 2013, J ORTHOP RES, V31, P1661, DOI 10.1002/jor.22395; Bridgen DT, 2017, ACTA BIOMATER, V55, P100, DOI 10.1016/j.actbio.2017.04.019; Chen HH, 2004, GENESIS, V39, P273, DOI 10.1002/gene.20055; Chen HH, 2004, J BIOL CHEM, V279, P30800, DOI 10.1074/jbc.M400154200; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ellis K, 2013, J CELL BIOL, V200, P667, DOI 10.1083/jcb.201212095; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Fearing BV, 2018, JOR SPINE, V1, DOI 10.1002/jsp2.1026; Foster CT, 2017, GENE DEV, V31, P2361, DOI 10.1101/gad.304501.117; Francisco AT, 2014, ACTA BIOMATER, V10, P1102, DOI 10.1016/j.actbio.2013.11.013; Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038; Fujita N, 2014, FASEB J, V28, P2455, DOI 10.1096/fj.13-243741; Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39; Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343; Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170; GOTZ W, 1995, J ANAT, V186, P111; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gualdrini F, 2016, MOL CELL, V64, P1048, DOI 10.1016/j.molcel.2016.10.016; Gunther S, 2004, NUCLEIC ACIDS RES, V32, P791, DOI 10.1093/nar/gkh248; Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Humphreys MD, 2018, JOR SPINE, V1, DOI 10.1002/jsp2.1028; Hwang PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28038; Hwang PY, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026360; Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009; Iatridis JC, 1997, J ORTHOP RES, V15, P318, DOI 10.1002/jor.1100150224; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Jing LF, 2012, J ORTHOP RES, V30, P1923, DOI 10.1002/jor.22158; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kim T, 2017, EMBO J, V36, P520, DOI 10.15252/embj.201695137; Kim T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10186; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; LATINKIC BV, 1991, NUCLEIC ACIDS RES, V19, P3261, DOI 10.1093/nar/19.12.3261; Le Maitre CL, 2009, ARTHRITIS RHEUM-US, V60, P460, DOI 10.1002/art.24248; Leitner L, 2011, J CELL SCI, V124, P4318, DOI 10.1242/jcs.092791; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Liu XF, 2016, CELL REP, V14, P1169, DOI 10.1016/j.celrep.2015.12.104; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Mendez MG, 2012, INT J BIOCHEM CELL B, V44, P728, DOI 10.1016/j.biocel.2012.02.003; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morin S, 2001, MOL CELL BIOL, V21, P1036, DOI 10.1128/MCB.21.4.1036-1044.2001; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nardone G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15321; Nettles DL, 2004, J ANAT, V204, P515, DOI 10.1111/j.0021-8782.2004.00306.x; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peng BG, 2009, SPINE, V34, pE178, DOI 10.1097/BRS.0b013e3181908ab3; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Richardson SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01567-w; Risbud MV, 2015, J ORTHOP RES, V33, P283, DOI 10.1002/jor.22789; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Row S, 2016, J CELL SCI, V129, P2950, DOI 10.1242/jcs.183772; Rubin DI, 2007, NEUROL CLIN, V25, P353, DOI 10.1016/j.ncl.2007.01.004; Sepulveda JL, 2002, J BIOL CHEM, V277, P25775, DOI 10.1074/jbc.M203122200; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Speight P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11642; Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306; Tran CM, 2010, ARTHRITIS RHEUM-US, V62, P1983, DOI 10.1002/art.27445; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Winkler T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098444; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108	87	29	29	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14022	14035		10.1096/fj.201802725RRR	http://dx.doi.org/10.1096/fj.201802725RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31638828	Green Published, hybrid			2022-12-28	WOS:000507466100074
J	Okuno, T; Koutsogiannaki, S; Hou, LF; Bu, WM; Ohto, U; Eckenhoff, RG; Yokomizo, T; Yuki, K				Okuno, Toshiaki; Koutsogiannaki, Sophia; Hou, Lifei; Bu, Weiming; Ohto, Umeharu; Eckenhoff, Roderic G.; Yokomizo, Takehiko; Yuki, Koichi			Volatile anesthetics isoflurane and sevoflurane directly target and attenuate Toll-like receptor 4 system	FASEB JOURNAL			English	Article						anesthesia; TLR4; sepsis	INNATE IMMUNE; SEVERE SEPSIS; INTRAVENOUS ANESTHESIA; INFLAMMATORY RESPONSE; STRUCTURAL BASIS; CECAL LIGATION; LIPOPOLYSACCHARIDE; NEUTROPHILS; CELLS; LPS	General anesthesia has been the requisite component of surgical procedures for over 150 yr. Although immunomodulatory effects of volatile anesthetics have been growingly appreciated, the molecular mechanism has not been understood. In septic mice, the commonly used volatile anesthetic isoflurane attenuated the production of 5-lipoxygenase products and IL-10 and reduced CD11b and intercellular adhesion molecule-1 expression on neutrophils, suggesting the attenuation of TLR4 signaling. We confirmed the attenuation of TLR4 signaling in vitro and their direct binding to TLR4-myeloid differentiation-2 (MD-2) complex by photolabeling experiments. The binding sites of volatile anesthetics isoflurane and sevoflurane were located near critical residues for TLR4-MD-2 complex formation and TLR4-MD-2-LPS dimerization. Additionally, TLR4 activation was not attenuated by intravenous anesthetics, except for a high concentration of propofol. Considering the important role of TLR4 system in the perioperative settings, these findings suggest the possibility that anesthetic choice may modulate the outcome in patients or surgical cases in which TLR4 activation is expected.	[Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Koutsogiannaki, Sophia; Hou, Lifei; Yuki, Koichi] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Koutsogiannaki, Sophia; Hou, Lifei; Yuki, Koichi] Harvard Med Sch, Dept Anesthesia, Boston, MA 02115 USA; [Bu, Weiming; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA; [Ohto, Umeharu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	Juntendo University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; University of Tokyo	Yuki, K (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Cardiac Anesthesia Div, 300 Longwood Ave, Boston, MA 02115 USA.	koichi.yuki@childrens.harvard.edu		Koutsogiannaki, Sophia/0000-0003-3555-1681	Children's Hospital Medical Center (CHMC) Anesthesia Foundation; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [R01GM118277]; Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science (MEXT/JSPS) Kakenhi [15KK0320, 16K08596, 19K07357, 15H05904, 15H04708, 18H02627]; NIH/NIGMS [P01GM55896]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118277] Funding Source: NIH RePORTER	Children's Hospital Medical Center (CHMC) Anesthesia Foundation; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science (MEXT/JSPS) Kakenhi; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Kyoko Yasuda (Juntendo University) and Dr. Hasan Badazada (University of Pennsylvania) for technical support. The authors also thank Dr. Yusuke Mitsui (Boston Children's Hospital) for technical help. This work was supported, in part, by the Children's Hospital Medical Center (CHMC) Anesthesia Foundation (to K.Y.), U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Grant R01GM118277 (to K.Y.). Research was also supported by the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science (MEXT/JSPS) Kakenhi Grants 15KK0320, 16K08596, and 19K07357 (to T.O.), 15H05904, 15H04708, and 18H02627 (to T.Y.) as well as NIH/NIGMS Grant P01GM55896 (to R.G.E.). The authors declare no conflicts of interest.	Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Anderson MR, 2000, CRIT CARE MED, V28, P3762, DOI 10.1097/00003246-200011000-00047; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Aronoff DM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/696897; Bandyopadhaya A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01211; Bedirli N, 2012, J SURG RES, V178, pE17, DOI 10.1016/j.jss.2011.12.037; Bedirli N, 2012, J NEUROSURG ANESTH, V24, P336, DOI 10.1097/ANA.0b013e318266791e; Benjamim CF, 2005, J IMMUNOL, V174, P1616, DOI 10.4049/jimmunol.174.3.1616; Boost KA, 2009, INT J MOL MED, V23, P665, DOI 10.3892/ijmm_00000178; Chaudhry H, 2013, IN VIVO, V27, P669; De Conno E, 2009, ANESTHESIOLOGY, V110, P1316, DOI 10.1097/ALN.0b013e3181a10731; De Hert S, 2009, ANAESTHESIA, V64, P953, DOI 10.1111/j.1365-2044.2009.06008.x; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; DOERFLER ME, 1989, J CLIN INVEST, V83, P970, DOI 10.1172/JCI113983; Dorward DA, 2015, AM J PATHOL, V185, P1172, DOI 10.1016/j.ajpath.2015.01.020; Eckenhoff RG, 2010, ACS CHEM NEUROSCI, V1, P139, DOI 10.1021/cn900014m; Fink MP, 2001, AM J PHYSIOL-LUNG C, V281, pL534, DOI 10.1152/ajplung.2001.281.3.L534; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Haeggstrom JZ, 2018, J CLIN INVEST, V128, P2680, DOI 10.1172/JCI97945; Haque A, 2011, INT HEART J, V52, P170, DOI 10.1536/ihj.52.170; Harizi H, 2005, TISSUE ANTIGENS, V65, P507, DOI 10.1111/j.1399-0039.2005.00394.x; Herrmann IK, 2013, ANESTHESIOLOGY, V119, P901, DOI 10.1097/ALN.0b013e3182a2a38c; Hofstetter C, 2007, ACTA ANAESTH SCAND, V51, P893, DOI 10.1111/j.1399-6576.2007.01353.x; Hoshino K, 1999, J IMMUNOL, V162, P3749; HYDE SR, 1990, INFECT IMMUN, V58, P619, DOI 10.1128/IAI.58.3.619-624.1990; Jerath A, 2017, ANESTH ANALG, V124, P1190, DOI 10.1213/ANE.0000000000001634; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Kennedy JI, 2010, CRIT CARE MED, V38, P1925; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Koutsogiannaki S, 2017, TOXICOL SCI, V156, P402, DOI 10.1093/toxsci/kfw261; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; L'Her E, 2008, RESP CARE, V53, P1295; Landoni G, 2019, NEW ENGL J MED, V380, P1214, DOI 10.1056/NEJMoa1816476; Leventhal JS, 2012, KIDNEY INT, V81, P826, DOI 10.1038/ki.2011.498; Lewkowicz N, 2016, MUCOSAL IMMUNOL, V9, P364, DOI 10.1038/mi.2015.66; Li JT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/108928; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Likhvantsev VV, 2016, J CARDIOTHOR VASC AN, V30, P1221, DOI 10.1053/j.jvca.2016.02.030; Lorenz E, 2002, PEDIATR RES, V52, P373, DOI 10.1203/01.PDR.0000025342.83436.53; Ma Xiaojing, 2015, F1000Res, V4, DOI 10.12688/f1000research.7010.1; Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Minou AF, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/930487; Molteni M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6978936; Mu JL, 2010, SHOCK, V34, P183, DOI 10.1097/SHK.0b013e3181cffc3f; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Okuno T, 2017, FASEB J, V31, P1584, DOI 10.1096/fj.201601095R; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Rodriguez-Gonzalez R, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-87; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Sasaki F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185133; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schilling T, 2011, ANESTHESIOLOGY, V115, P65, DOI 10.1097/ALN.0b013e318214b9de; Schorr CA, 2014, TRENDS MOL MED, V20, P192, DOI 10.1016/j.molmed.2014.02.001; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Smith WL, 2019, J BIOL CHEM, V294, P1697, DOI 10.1074/jbc.TM118.006295; SURETTE ME, 1993, J EXP MED, V178, P1347, DOI 10.1084/jem.178.4.1347; Tidswell M, 2010, CRIT CARE MED, V38, P72, DOI 10.1097/CCM.0b013e3181b07b78; Tse MT, 2013, NAT REV DRUG DISCOV, V12, P334, DOI 10.1038/nrd4016; Uhlig C, 2016, ANESTHESIOLOGY, V124, P1230, DOI 10.1097/ALN.0000000000001120; Wang H, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/851692; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Yue T, 2008, EUR RESPIR J, V31, P118, DOI 10.1183/09031936.00046307; Yuki K, 2012, FASEB J, V26, P4408, DOI 10.1096/fj.12-212746; Yuki K, 2011, ANESTH ANALG, V112, P830, DOI 10.1213/ANE.0b013e31820dcabb; Yuki K, 2010, ANESTHESIOLOGY, V113, P600, DOI 10.1097/ALN.0b013e3181e89a77; Yuki K, 2008, FASEB J, V22, P4109, DOI 10.1096/fj.08-113324; Zha H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216163	78	16	17	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14528	14541		10.1096/fj.201901570R	http://dx.doi.org/10.1096/fj.201901570R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31675483	Green Published			2022-12-28	WOS:000507466100113
J	Yang, DC; Li, JM; Xu, JH; Oldham, J; Phan, SH; Last, JA; Wu, R; Chen, CH				Yang, David C.; Li, Ji-Min; Xu, Jihao; Oldham, Justin; Phan, Sem H.; Last, Jerold A.; Wu, Reen; Chen, Ching-Hsien			Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression	FASEB JOURNAL			English	Article						pulmonary fibrosis; drug efficacy; AKT signaling; nintedanib; phospholipids	IDIOPATHIC PULMONARY-FIBROSIS; C-KINASE SUBSTRATE; MESENCHYMAL CELLS; LUNG FIBROSIS; DOUBLE-BLIND; TGF-BETA; CANCER; PHOSPHORYLATION; PIRFENIDONE; NINTEDANIB	Targeting activated fibroblasts, including myofibroblast differentiation, has emerged as a key therapeutic strategy in patients with idiopathic pulmonary fibrosis (IPF). However, there is no available therapy capable of selectively eradicating myofibroblasts or limiting their genesis. Through an integrative analysis of the regulator genes that are responsible for the activation of IPF fibroblasts, we noticed the phosphatidylinositol 4,5-bisphosphate (PIP2)-binding protein, myristoylated alanine-rich C-kinase substrate (MARCKS), as a potential target molecule for IPF. Herein, we have employed a 25-mer novel peptide, MARCKS phosphorylation site domain sequence (MPS), to determine if MARCKS inhibition reduces pulmonary fibrosis through the inactivation of PI3K/protein kinase B (AKT) signaling in fibroblast cells. We first observed that higher levels of MARCKS phosphorylation and the myofibroblast marker a-smooth muscle actin (alpha-SMA) were notably overexpressed in all tested IPF lung tissues and fibroblast cells. Treatment with the MPS peptide suppressed levels of MARCKS phosphorylation in primary IPF fibroblasts. A kinetic assay confirmed that this peptide binds to phospholipids, particularly PIP2, with a dissociation constant of 17.64 nM. As expected, a decrease of phosphatidylinositol (3,4,5)-trisphosphate pools and AKT activity occurred in MPS-treated IPF fibroblast cells. MPS peptide was demonstrated to impair cell proliferation, invasion, and migration in multiple IPF fibroblast cells in vitro as well as to reduce pulmonary fibrosis in bleomycin-treated mice in vivo. Surprisingly, we found that MPS peptide decreases a-SMA expression and synergistically interacts with nintedanib treatment in IPF fibroblasts. Our data suggest MARCKS as a druggable target in pulmonary fibrosis and also provide a promising antifibrotic agent that may lead to effective IPF treatments.	[Yang, David C.; Last, Jerold A.; Wu, Reen] Univ Calif Davis, Div Pulm & Crit Care Med, Davis, CA 95616 USA; [Yang, David C.; Li, Ji-Min; Xu, Jihao; Chen, Ching-Hsien] Univ Calif Davis, Div Nephrol, Dept Internal Med, 451 East Hlth Sci Dr,GBSF 6311, Davis, CA 95616 USA; [Yang, David C.; Oldham, Justin; Last, Jerold A.; Wu, Reen] Univ Calif Davis, Ctr Comparat Resp Biol & Med, Dept Internal Med, Davis, CA 95616 USA; [Phan, Sem H.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Michigan System; University of Michigan	Chen, CH (corresponding author), Univ Calif Davis, Div Nephrol, Dept Internal Med, 451 East Hlth Sci Dr,GBSF 6311, Davis, CA 95616 USA.	jchchen@ucdavis.edu		Yang, David/0000-0003-2657-745X	California University of California Office of the President (UCOP) Tobacco-Related Disease Research Program [TRDRP 27KT-0004, 28IR-0061]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL146802]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL146802] Funding Source: NIH RePORTER	California University of California Office of the President (UCOP) Tobacco-Related Disease Research Program; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Richart Harper and Dr, Angela Linderholm [University of California-Davis (UC Davis)] for collection of lung tissue samples, and Lisa Franzi and Cameron Larson (UC Davis) for assistance with the experiments, as well as the UC Davis Comprehensive Cancer Center for pathology support. This work was supported by the California University of California Office of the President (UCOP) Tobacco-Related Disease Research Program (Grants TRDRP 27KT-0004 and 28IR-0061) and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant R01HL146802. The authors declare no conflicts of interest.	Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Behr J, 2016, LANCET RESP MED, V4, P445, DOI 10.1016/S2213-2600(16)30044-3; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; CHEN B, 1992, J CLIN INVEST, V90, P1778, DOI 10.1172/JCI116052; Chen CH, 2014, ONCOGENE, V33, P3696, DOI 10.1038/onc.2013.336; Chen CH, 2015, ONCOTARGET, V6, P15194, DOI 10.18632/oncotarget.3827; Chen CH, 2014, AM J RESP CRIT CARE, V190, P1127, DOI 10.1164/rccm.201408-1505OC; Chen CH, 2014, AM J RESP CRIT CARE, V189, P1002, DOI 10.1164/rccm.201401-0053LE; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Conte E, 2013, LAB INVEST, V93, P566, DOI 10.1038/labinvest.2013.6; Conte E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024663; Eckert RE, 2010, AM J RESP CELL MOL, V42, P586, DOI 10.1165/rcmb.2008-0394OC; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Green TD, 2011, BBA-GEN SUBJECTS, V1810, P1110, DOI 10.1016/j.bbagen.2011.01.009; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; JORDANA M, 1988, AM REV RESPIR DIS, V137, P579, DOI 10.1164/ajrccm/137.3.579; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; KUHN C, 1991, AM J PATHOL, V138, P1257; Kuo TC, 2013, J CLIN INVEST, V123, P1082, DOI 10.1172/JCI64044; Lepparanta O, 2012, CELL TISSUE RES, V348, P491, DOI 10.1007/s00441-012-1385-9; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Limjunyawong N, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.249; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Martinez FJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.74; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Myllarniemi M, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.26385; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Park JA, 2007, AM J PATHOL, V171, P1822, DOI 10.2353/ajpath.2007.070318; Phan Sem H, 2008, Proc Am Thorac Soc, V5, P334, DOI 10.1513/pats.200708-146DR; RAGHU G, 1988, AM REV RESPIR DIS, V138, P703, DOI 10.1164/ajrccm/138.3.703; Raghu G, 2017, RESP MED, V129, P24, DOI 10.1016/j.rmed.2017.05.017; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rangarajan S, 2016, DRUGS, V76, P291, DOI 10.1007/s40265-015-0523-6; Rangarajan S, 2016, AM J RESP CELL MOL, V54, P51, DOI 10.1165/rcmb.2014-0445OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Sakamoto S, 2015, RESPIROLOGY, V20, P445, DOI 10.1111/resp.12477; Sanders YY, 2007, AM J RESP CELL MOL, V36, P226, DOI 10.1165/rcmb.2006-0178OC; Selman M, 2011, EXPERT OPIN EMERG DR, V16, P341, DOI 10.1517/14728214.2011.565049; Skold CM, 2017, J INTERN MED, V281, P149, DOI 10.1111/joim.12571; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Tzouvelekis A, 2015, THER CLIN RISK MANAG, V11, P359, DOI 10.2147/TCRM.S69716; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Wollin L, 2015, EUR RESPIR J, V45, P1434, DOI 10.1183/09031936.00174914; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Zhao J, 2017, CELL PHYSIOL BIOCHEM, V43, P697, DOI 10.1159/000480655; Ziemba BP, 2016, BIOPHYS J, V110, P1811, DOI 10.1016/j.bpj.2016.03.001	54	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14354	14369		10.1096/fj.201901705R	http://dx.doi.org/10.1096/fj.201901705R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31661644	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000507466100100
J	Naruse, C; Abe, K; Yoshihara, T; Kato, T; Nishiuchi, T; Asano, M				Naruse, Chie; Abe, Kanae; Yoshihara, Toru; Kato, Tomoaki; Nishiuchi, Takumi; Asano, Masahide			Heterochromatin protein 1 gamma deficiency decreases histone H3K27 methylation in mouse neurosphere neuronal genes	FASEB JOURNAL			English	Article						HP1 gamma; JMJD3; neurosphere; UTX	H3 LYSINE-9 METHYLATION; DNA METHYLATION; GENOME-WIDE; HP1; CELLS; CHROMODOMAIN; DOMAIN; MARKS; METHYLTRANSFERASE; DIFFERENTIATION	Heterochromatin protein (HP) 1 gamma, a component of heterochromatin in eukaryotes, is involved in H3K9 methylation. Although HP1 gamma is expressed strongly in neural tissues and neural stem cells, its functions are unclear. To elucidate the roles of HP1 gamma, we analyzed HP1 gamma -deficient (HP1 gamma KO) mouse embryonic neurospheres and determined that HP1 gamma KO neurospheres tended to differentiate after quaternary culture. Several genes normally expressed in neuronal cells were upregulated in HP1 gamma KO undifferentiated neurospheres, but not in the wild type (WT). Compared to that in the control neurospheres, the occupancy of H3K27me3 was lower around the transcription start sites (TSSs) of these genes in HP1 gamma KO neurospheres, while H3K9me2/3, H3K4me3, and H3K27ac amounts remained unchanged. Moreover, amounts of the H3K27me2/3 demethylases, UTX, and JMJD3, were increased around the TSSs of these genes. Treatment with GSK-J4, an inhibitor of H3K27 demethylases, decreased the expression of genes upregulated in HP1 gamma KO neurospheres, along with an increase of H3K27me3 amounts. Therefore, in murine neurospheres, HP1 gamma protected the promoter sites of differentiated cell-specific genes against H3K27 demethylases to repress the expression of these genes. A better understanding of central cellular processes such as histone methylation will help elucidate critical events such as cell-specific gene expression, epigenetics, and differentiation.	[Naruse, Chie; Yoshihara, Toru; Asano, Masahide] Kyoto Univ, Inst Lab Anim, Grad Sch Med, Kyoto, Japan; [Abe, Kanae] Kanazawa Univ, Div Transgen Anim Sci, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Kato, Tomoaki; Nishiuchi, Takumi] Kanazawa Univ, Div Funct Genom, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan	Kyoto University; Kanazawa University; Kanazawa University	Asano, M (corresponding author), Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	asano@anim.med.kyoto-u.ac.jp		Nishiuchi, Takumi/0000-0001-9429-5396	MEXT | Japan Society for the Promotion of Science (JSPS) [25430085, 25290031]; Kyoto University Research Development Program ISHIZUE [FY2016]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto University Research Development Program ISHIZUE	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 25430085 and 25290031; Kyoto University Research Development Program ISHIZUE, Grant/Award Number: FY2016	Abe K, 2011, BIOL REPROD, V85, P1013, DOI 10.1095/biolreprod.111.091512; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Aldiri I, 2012, DEV BIOL, V367, P91, DOI 10.1016/j.ydbio.2012.04.030; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Aydin E, 2015, J BIOSCIENCES, V40, P325, DOI 10.1007/s12038-015-9520-x; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Becker JS, 2017, MOL CELL, V68, P1023, DOI 10.1016/j.molcel.2017.11.030; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boros J, 2014, MOL CELL BIOL, V34, P3662, DOI 10.1128/MCB.00205-14; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Cheng TL, 2014, DEV CELL, V28, P547, DOI 10.1016/j.devcel.2014.01.032; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; Estaras C, 2012, DEVELOPMENT, V139, P2681, DOI 10.1242/dev.078345; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Juan AH, 2016, CELL REP, V17, P1369, DOI 10.1016/j.celrep.2016.09.087; Kim MY, 2010, NEUROSCIENCE, V170, P8, DOI 10.1016/j.neuroscience.2010.07.020; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li L, 2015, INT J MOL SCI, V16, P5125, DOI 10.3390/ijms16035125; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Naruse C, 2007, BIOCHEM BIOPH RES CO, V361, P109, DOI 10.1016/j.bbrc.2007.06.161; Naruse C, 2017, FASEB J, V31, P2252, DOI 10.1096/fj.201600642R; Ha N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00271; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohno R, 2013, DEVELOPMENT, V140, P2892, DOI 10.1242/dev.093229; Oshiro H, 2015, GENES CELLS, V20, P108, DOI 10.1111/gtc.12205; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Rube HT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11025; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Sudo G, 2016, GENES CELLS, V21, P218, DOI 10.1111/gtc.12331; Takada Y, 2011, DEVELOPMENT, V138, P4207, DOI 10.1242/dev.064444; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tan SL, 2012, DEVELOPMENT, V139, P3806, DOI 10.1242/dev.082198; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002	53	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3956	3968		10.1096/fj.201900139R	http://dx.doi.org/10.1096/fj.201900139R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31961023	Bronze			2022-12-28	WOS:000508663800001
J	Khan, N; Halcrow, PW; Lakpa, KL; Afghah, Z; Miller, NM; Dowdy, SF; Geiger, JD; Chen, XS				Khan, Nabab; Halcrow, Peter W.; Lakpa, Koffi L.; Afghah, Zahra; Miller, Nicole M.; Dowdy, Steven F.; Geiger, Jonathan D.; Chen, Xuesong			Two-pore channels regulate Tat endolysosome escape and Tat-mediated HIV-1 LTR transactivation	FASEB JOURNAL			English	Article						HIV-1 LTR transactivation; HIV-1 Tat; Tat endolysosome escape; two-pore channels	LYSOSOMAL MEMBRANE PERMEABILIZATION; ARGININE-RICH PEPTIDES; CENTRAL-NERVOUS-SYSTEM; CELLULAR UPTAKE; ANTIRETROVIRAL THERAPY; CALCIUM DYSREGULATION; MOLECULAR-MECHANISMS; ENTERS CELLS; VIRUS; PROTEIN	HIV-1 Tat is essential for HIV-1 replication and appears to play an important role in the pathogenesis of HIV-associated neurological complications. Secreted from infected or transfected cells, Tat has the extraordinary ability to cross the plasma membrane. In the brain, Tat can be taken up by CNS cells via receptor-mediated endocytosis. Following endocytosis and its internalization into endolysosomes, Tat must be released in order for it to activate the HIV-1 LTR promoter and facilitate HIV-1 viral replication in the nucleus. However, the underlying mechanisms whereby Tat escapes endolysosomes remain unclear. Because Tat disrupts intracellular calcium homeostasis, we investigated the involvement of calcium in Tat endolysosome escape and subsequent LTR transactivation. We demonstrated that chelating endolysosome calcium with high-affinity rhodamine-dextran or chelating cytosolic calcium with BAPTA-AM attenuated Tat endolysosome escape and LTR transactivation. Significantly, we demonstrated that pharmacologically blocking and knocking down the endolysosome-resident two-pore channels (TPCs) attenuated Tat endolysosome escape and LTR transactivation. This calcium-mediated effect appears to be selective for TPCs because knocking down TRPML1 calcium channels was without effect. Our findings suggest that calcium released from TPCs is involved in Tat endolysosome escape and subsequent LTR transactivation. TPCs might represent a novel therapeutic target against HIV-1 infection and HIV-associated neurological complications.	[Khan, Nabab; Halcrow, Peter W.; Lakpa, Koffi L.; Afghah, Zahra; Miller, Nicole M.; Geiger, Jonathan D.; Chen, Xuesong] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, 504 Hamline St, Grand Forks, ND 58203 USA; [Dowdy, Steven F.] UCSD, Dept Cellular & Mol Med, Sch Med, La Jolla, CA USA	University of North Dakota Grand Forks; University of California System; University of California San Diego	Chen, XS (corresponding author), Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, 504 Hamline St, Grand Forks, ND 58203 USA.	xuesong.chen@und.edu			HHS \ NIH \ National Institute of Mental Health (NIMH) [R01MH100972, R01MH105329]; HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS) [R01NS065957]; HHS \ NIH \ National Institute on Drug Abuse (NIDA) [R01DA032444]	HHS \ NIH \ National Institute of Mental Health (NIMH); HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS); HHS \ NIH \ National Institute on Drug Abuse (NIDA)	HHS vertical bar NIH vertical bar National Institute of Mental Health (NIMH), Grant/Award Number: R01MH100972 and R01MH105329; HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS065957; HHS vertical bar NIH vertical bar National Institute on Drug Abuse (NIDA), Grant/Award Number: R01DA032444	Agostini S, 2017, EBIOMEDICINE, V21, P170, DOI 10.1016/j.ebiom.2017.06.011; Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Aits S, 2015, METHOD CELL BIOL, V126, P261, DOI 10.1016/bs.mcb.2014.10.032; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI 10.1038/nchembio.1522; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Castonguay J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10607-4; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chauhan A, 2015, MICROB PATHOGENESIS, V78, P1, DOI 10.1016/j.micpath.2014.11.003; Chauhan A, 2014, VIROLOGY, V456, P1, DOI 10.1016/j.virol.2014.03.002; Cheng JJ, 2006, J MED CHEM, V49, P6522, DOI 10.1021/jm060736s; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Christensen KA, 2002, J CELL SCI, V115, P599; Churchill MJ, 2006, J NEUROVIROL, V12, P146, DOI 10.1080/13550280600748946; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Clark E, 2017, ONCOTARGET, V8, P27569, DOI 10.18632/oncotarget.15174; Cossart P, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016972; Datta G, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00329; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gaskill PJ, 2017, NEUROBIOL DIS, V105, P51, DOI 10.1016/j.nbd.2017.04.015; Glogau R, 2012, J DRUGS DERMATOL, V11, P38; Gray LR, 2014, CURR OPIN HIV AIDS, V9, P552, DOI 10.1097/COH.0000000000000108; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Grim CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01587; Gunaratne GS, 2018, CELL CALCIUM, V75, P30, DOI 10.1016/j.ceca.2018.08.003; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Haughey NJ, 2001, J NEUROCHEM, V78, P457, DOI 10.1046/j.1471-4159.2001.00396.x; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hu XT, 2016, CURR DRUG TARGETS, V17, P4, DOI 10.2174/1389450116666150531162212; Hui L, 2015, CELL CALCIUM, V58, P617, DOI 10.1016/j.ceca.2015.10.001; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Khan N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48777-y; Khan N, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1129-1; Kintzer AF, 2018, FEBS J, V285, P233, DOI 10.1111/febs.14154; KOLSON DL, 1994, J GEN VIROL, V75, P1927, DOI 10.1099/0022-1317-75-8-1927; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Lagostena L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43900; Li GH, 2012, FASEB J, V26, P2824, DOI 10.1096/fj.11-203315; Li SH, 2015, 2015 INTERNATIONAL CONFERENCE ON OPTOELECTRONICS AND MICROELECTRONICS (ICOM), P47, DOI 10.1109/ICoOM.2015.7398767; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2016, J CELL BIOL, V212, P755, DOI 10.1083/jcb.201603037; Lonn P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32301; Lonn P, 2015, EXPERT OPIN DRUG DEL, V12, P1627, DOI 10.1517/17425247.2015.1046431; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marban C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00397; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; Marchant JS, 2015, BIOCHEM SOC T, V43, P434, DOI 10.1042/BST20140303; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2013, MOL BIOSYST, V9, P855, DOI 10.1039/c2mb25467k; Nath A, 2000, ANN NEUROL, V47, P186, DOI 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V; Norman JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003731; Peng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034646; Rahman T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005450; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Ruas Margarida, 2015, Messenger (Los Angel), V4, P4; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Sakurai Yasuteru, 2015, Virus (Nagoya), V65, P71, DOI 10.2222/jsv.65.71; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; SLICE LW, 1992, BIOCHEMISTRY-US, V31, P12062, DOI 10.1021/bi00163a014; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120; Staring J, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216259; Sterea AM, 2018, CELL CALCIUM, V72, P91, DOI 10.1016/j.ceca.2018.02.006; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vijaykumar TS, 2008, VIROLOGY, V381, P1, DOI 10.1016/j.virol.2008.07.039; Vives E, 2003, J MOL RECOGNIT, V16, P265, DOI 10.1002/jmr.636; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang WY, 2015, P NATL ACAD SCI USA, V112, pE1373, DOI 10.1073/pnas.1419669112; Wenzel ED, 2017, J NEUROIMMUNE PHARM, V12, P492, DOI 10.1007/s11481-017-9739-4; Wolfram J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14221-2; Wong VKW, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00351; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Xiong J, 2016, SCI CHINA LIFE SCI, V59, P777, DOI 10.1007/s11427-016-5090-x; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685; Zhang XH, 2003, J GENE MED, V5, P209, DOI 10.1002/jgm.340; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938; Zhong XZ, 2017, CELL CALCIUM, V64, P20, DOI 10.1016/j.ceca.2016.12.001; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	108	24	24	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4147	4162		10.1096/fj.201902534R	http://dx.doi.org/10.1096/fj.201902534R		JAN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31950548	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000507915900001
J	Zhang, Q; Liu, N; Bai, JJ; Zhou, Q; Mao, J; Xu, L; Liu, J; Wei, HB; Ren, CC; Wu, XY; Wang, M; Zhao, B; Cong, YS				Zhang, Qian; Liu, Ning; Bai, Junjie; Zhou, Qi; Mao, Jian; Xu, Lu; Liu, Jiang; Wei, Haibin; Ren, Chengcheng; Wu, Xiaoying; Wang, Miao; Zhao, Bin; Cong, Yu-Sheng			Human telomerase reverse transcriptase is a novel target of Hippo-YAP pathway	FASEB JOURNAL			English	Article						Hippo pathway; hTERT; TEAD; telomere; YAP	ORGAN SIZE; BINDING; ROLES; CELLS; TAZ	Telomerase plays a pivotal role in tumorigenesis by maintaining telomere homeostasis, a hallmark of cancer. However, the mechanisms by which telomerase is reactivated or upregulated during tumorigenesis remain incompletely understood. Here, we report that the Hippo pathway effector Yes-associated protein (YAP) regulates the expression of human telomerase reverse transcriptase (hTERT). Ectopic expression or physiological activation of YAP increases hTERT expression, whereas knockdown of YAP decreases the expression of hTERT. YAP binds to the hTERT promoter through interaction with the TEA domain family transcription factors and activates hTERT transcription. Furthermore, sustained YAP hyperactivation promotes telomerase activity and extends telomere length, with increased hTERT expression. In addition, we show that hTERT expression is positively correlated with YAP activation in human liver cancer tissues. Together, our results demonstrate that YAP promotes hTERT expression, which could contribute to tumor progression.	[Zhang, Qian; Bai, Junjie; Mao, Jian; Xu, Lu; Liu, Jiang; Ren, Chengcheng; Wu, Xiaoying; Wang, Miao; Cong, Yu-Sheng] Hangzhou Normal Univ, Inst Aging Res, Key Lab Aging & Canc Biol Zhejiang Prov, Sch Med, 2318 Yuhangtang Rd, Hangzhou, Zhejiang, Peoples R China; [Liu, Ning] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Zhou, Qi; Zhao, Bin] Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Qi; Zhao, Bin] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Life Sci Inst, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Wei, Haibin] Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Hangzhou, Peoples R China	Hangzhou Normal University; Shanghai Ocean University; Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital	Cong, YS (corresponding author), Hangzhou Normal Univ, Inst Aging Res, Key Lab Aging & Canc Biol Zhejiang Prov, Sch Med, 2318 Yuhangtang Rd, Hangzhou, Zhejiang, Peoples R China.; Zhao, B (corresponding author), Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Zhao, B (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Network, Life Sci Inst, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	binzhao@zju.cdu.cn; yscong@hznu.edu.cn	Mao, Jianhua/GOK-2713-2022	Liu, Ning/0000-0002-7009-9187	National Natural Science Foundation of China [31571409, 31730020, 31801155]; Major Science and Technology Innovation Program of Hangzhou, Science and Technology Bureau of Hangzhou [20182014B01]; National Key R&D Program of China, Ministry of Science and Technology of China [2017YFA0504502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Innovation Program of Hangzhou, Science and Technology Bureau of Hangzhou; National Key R&D Program of China, Ministry of Science and Technology of China	National Natural Science Foundation of China, Grant/Award Number: 31571409, 31730020 and 31801155; Major Science and Technology Innovation Program of Hangzhou, Science and Technology Bureau of Hangzhou, Grant/Award Number: 20182014B01; National Key R&D Program of China, Ministry of Science and Technology of China, Grant/Award Number: 2017YFA0504502	Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Colebatch AJ, 2019, J CLIN PATHOL, V72, P281, DOI 10.1136/jclinpath-2018-205653; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Ding DQ, 2013, FASEB J, V27, P4375, DOI 10.1096/fj.13-230904; Ding DQ, 2013, FEBS J, V280, P3205, DOI 10.1111/febs.12258; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Jiang SW, 2000, DNA CELL BIOL, V19, P507, DOI 10.1089/10445490050128430; Koh CM, 2015, J CLIN INVEST, V125, P2109, DOI 10.1172/JCI79134; Liu H, 2018, EMBO REP, V19, DOI 10.15252/embr.201745180; Liu N, 2016, NUCLEIC ACIDS RES, V44, P8693, DOI 10.1093/nar/gkw549; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Low KC, 2013, TRENDS BIOCHEM SCI, V38, P426, DOI 10.1016/j.tibs.2013.07.001; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park JH, 2018, MOL CELLS, V41, P83, DOI 10.14348/molcells.2018.2242; Rausch V, 2019, CURR BIOL, V29, P242, DOI 10.1016/j.cub.2018.11.066; Reddy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073763; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Wong MS, 2014, TRENDS GENET, V30, P430, DOI 10.1016/j.tig.2014.07.006; Wright WE, 1996, DEV GENET, V18, P173; Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370; Xu LF, 2013, ANNU REV PATHOL-MECH, V8, P49, DOI 10.1146/annurev-pathol-020712-164030; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan XT, 2019, ONCOGENE, V38, P6172, DOI 10.1038/s41388-019-0872-9; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep19852; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou JZ, 2014, AGING CELL, V13, P197, DOI 10.1111/acel.12161; Zuo QP, 2011, EUR J PHARMACOL, V672, P113, DOI 10.1016/j.ejphar.2011.09.187	44	5	5	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4178	4188		10.1096/fj.201902147R	http://dx.doi.org/10.1096/fj.201902147R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31950551	hybrid			2022-12-28	WOS:000507916800001
J	Hollenhorst, MI; Jurastow, I; Nandigama, R; Appenzeller, S; Li, L; Vogel, J; Wiederhold, S; Althaus, M; Empting, M; Altmuller, J; Hirsch, AKH; Flockerzi, V; Canning, BJ; Saliba, AE; Krasteva-Christ, G				Hollenhorst, Monika I.; Jurastow, Innokentij; Nandigama, Rajender; Appenzeller, Silke; Li, Lei; Vogel, Joerg; Wiederhold, Stephanie; Althaus, Mike; Empting, Martin; Altmueller, Janine; Hirsch, Anna K. H.; Flockerzi, Veit; Canning, Brendan J.; Saliba, Antoine-Emmanuel; Krasteva-Christ, Gabriela			Tracheal brush cells release acetylcholine in response to bitter tastants for paracrine and autocrine signaling	FASEB JOURNAL			English	Article						acetylcholine; brush cells; mucociliary clearance; single-cell RNA-seq; taste	CHOLINERGIC CHEMOSENSORY CELLS; TUFT CELLS; TASTE; RECEPTORS; MECHANISM; TRIGGERS; IMMUNITY; CILIA; MICE	For protection from inhaled pathogens many strategies have evolved in the airways such as mucociliary clearance and cough. We have previously shown that protective respiratory reflexes to locally released bacterial bitter "taste" substances are most probably initiated by tracheal brush cells (BC). Our single-cell RNA-seq analysis of murine BC revealed high expression levels of cholinergic and bitter taste signaling transcripts (Tas2r108, Gnat3, Trpm5). We directly demonstrate the secretion of acetylcholine (ACh) from BC upon stimulation with the Tas2R agonist denatonium. Inhibition of the taste transduction cascade abolished the increase in [Ca2+](i) in BC and subsequent ACh-release. ACh-release is regulated in an autocrine manner. While the muscarinic ACh-receptors M3R and M1R are activating, M2R is inhibitory. Paracrine effects of ACh released in response to denatonium included increased [Ca2+](i) in ciliated cells. Stimulation by denatonium or with Pseudomonas quinolone signaling molecules led to an increase in mucociliary clearance in explanted tracheae that was Trpm5- and M3R-mediated. We show that ACh-release from BC via the bitter taste cascade leads to immediate paracrine protective responses that can be boosted in an autocrine manner. This mechanism represents the initial step for the activation of innate immune responses against pathogens in the airways.	[Hollenhorst, Monika I.; Krasteva-Christ, Gabriela] Saarland Univ, Inst Anat & Cell Biol, Homburg, Germany; [Jurastow, Innokentij; Wiederhold, Stephanie] Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany; [Jurastow, Innokentij] Humboldt Univ, Univ Hosp Charite, Dept Anesthesiol & Intens Care Med CS, Berlin, Germany; [Nandigama, Rajender] Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany; [Appenzeller, Silke] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Li, Lei] Univ Wurzburg, Core Unit SysMed, Wurzburg, Germany; [Vogel, Joerg; Saliba, Antoine-Emmanuel] Helmholtz Ctr Infect Res HZI, Helmholtz Inst RNA Based Infect Res HIRI, Wurzburg, Germany; [Althaus, Mike] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Empting, Martin; Hirsch, Anna K. H.] Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat DDOP, Saarbrucken, Germany; [Empting, Martin; Hirsch, Anna K. H.] Saarland Univ, Dept Pharm, Saarbrucken, Germany; [Empting, Martin; Hirsch, Anna K. H.] German Ctr Infect Res DZIF, Saarbrucken, Germany; [Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Flockerzi, Veit] Saarland Univ, Inst Expt & Clin Pharmacol & Toxicol PZMS, Homburg, Germany; [Canning, Brendan J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA	Universitatsklinikum des Saarlandes; Justus Liebig University Giessen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; University of Wurzburg; University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Newcastle University - UK; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; German Center for Infection Research; University of Cologne; Universitatsklinikum des Saarlandes; Johns Hopkins University	Krasteva-Christ, G (corresponding author), Saarland Univ, Inst Anat & Cell Biol, UKS, Gebaude 61, D-66421 Homburg, Germany.	Gabriela.Krasteva-Christ@uks.eu	Canning, Brendan/ABE-5261-2020; Vogel, Jörg/D-5574-2011; Canning, Brendan/AAM-9404-2021; Krasteva-Christ, Gabriela/CAI-9036-2022; Saliba, Antoine-Emmanuel/AAC-1252-2022	Vogel, Jörg/0000-0003-2220-1404; Canning, Brendan/0000-0003-4197-5560; Krasteva-Christ, Gabriela/0000-0002-0113-521X; Jurastow, Innokentij/0000-0002-5946-3363; Althaus, Mike/0000-0002-3554-7538; Empting, Martin/0000-0002-0503-5830; Altmuller, Janine/0000-0003-4372-1521; Nandigama, Rajender/0000-0002-7344-4732; Appenzeller, Silke/0000-0002-5472-8692	German Research Society [DFG SFB TRR 152]; Helmholtz Association's Initiative and Networking Fund	German Research Society(German Research Foundation (DFG)); Helmholtz Association's Initiative and Networking Fund	German Research Society, Grant/Award Number: DFG SFB TRR 152; Helmholtz Association's Initiative and Networking Fund	Allegretta G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00924; Bakshani CR, 2018, NPJ BIOFILMS MICROBI, V4, DOI 10.1038/s41522-018-0057-2; Bankova LG, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9453; Carey RM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092017; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; Dando R, 2012, J PHYSIOL-LONDON, V590, P3009, DOI 10.1113/jphysiol.2012.232009; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Droguett K, 2017, J PHYSIOL-LONDON, V595, P4755, DOI 10.1113/JP273996; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Finger TE, 2011, F1000 BIOL REP, V3, P1; Freund JR, 2018, J BIOL CHEM, V293, P9824, DOI 10.1074/jbc.RA117.001005; FRYER AD, 1993, LIFE SCI, V52, P529, DOI 10.1016/0024-3205(93)90311-P; Fu ZY, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00071; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Hecker A, 2015, J IMMUNOL, V195, P2325, DOI 10.4049/jimmunol.1400974; Hollenhorst MI, 2012, BRIT J PHARMACOL, V166, P1388, DOI 10.1111/j.1476-5381.2012.01883.x; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Klein MK, 2009, EUR RESPIR J, V33, P1113, DOI 10.1183/09031936.00015108; Konig P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004938; Krasteva G, 2012, LIFE SCI, V91, P992, DOI 10.1016/j.lfs.2012.06.014; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Krasteva-Christ G, 2015, INT IMMUNOPHARMACOL, V29, P158, DOI 10.1016/j.intimp.2015.05.028; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Liu SY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00739; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; LUCIANO L, 1968, Z ZELLFORSCH MIK ANA, V85, P350, DOI 10.1007/BF00328847; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Ogura T, 2011, J NEUROPHYSIOL, V106, P1274, DOI 10.1152/jn.00186.2011; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Richter K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28660; Richter K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01604; Roper SD, 2017, NAT REV NEUROSCI, V18, P485, DOI 10.1038/nrn.2017.68; Runer T, 1998, OTOLARYNG HEAD NECK, V119, P278, DOI 10.1016/S0194-5998(98)70063-4; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Schmid A, 2011, BIOL CELL, V103, P159, DOI 10.1042/BC20100120; Schutz B, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00087; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yamashita J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189340; Yan CH, 2017, AM J RHINOL ALLERGY, V31, P85, DOI 10.2500/ajra.2017.31.4424; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003	52	24	24	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					316	332		10.1096/fj.201901314RR	http://dx.doi.org/10.1096/fj.201901314RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914675	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000507308900023
J	Li, SP; Wen, HS; Du, SJ				Li, Siping; Wen, Haishen; Du, Shaojun			Defective sarcomere organization and reduced larval locomotion and fish survival in slow muscle heavy chain 1 (smyhc1) mutants	FASEB JOURNAL			English	Article						knockout; sarcomere; slow fibers; smyhc1; zebrafish	MESSENGER-RNA DECAY; SHELDON-SYNDROME; MYOSIN ISOFORMS; FIBER TYPES; IN-VIVO; SKELETAL; ZEBRAFISH; EXPRESSION; MUTATION; HEDGEHOG	Zebrafish skeletal muscles are broadly divided into slow-twitch and fast-twitch muscle fibers. The slow fibers, which express a slow fiber-specific myosin heavy chain 1 (Smyhc1), are the first group of muscle fibers formed during myogenesis. To uncover Smyhc1 function in muscle growth, we generated three mutant alleles with reading frame shift mutations in the zebrafish smyhc1 gene using CRISPR. The mutants showed shortened sarcomeres with no thick filaments and M-lines in slow fibers of the mutant embryos. However, the formation of slow muscle precursors and expression of other slow muscle genes were not affected and fast muscles appeared normal. The smyhc1 mutant embryos and larvae showed reduced locomotion and food intake. The mutant larvae exhibited increased lethality of incomplete penetrance. Approximately 2/5 of the homozygous mutants were viable and grew into reproductive adults. These adult mutants displayed a typical pattern of slow and fast muscle fiber distribution, and regained normal slow muscle formation. Together, our studies indicate that Smyhc1 is essential for myogenesis in embryonic slow muscles, and loss of Smyhc1 results in defective sarcomere assembly, reduces larval motility and fish survival, but has no visible impact on muscle growth in juvenile and adult zebrafish that escape the larval lethality.	[Li, Siping; Du, Shaojun] Univ Maryland, Sch Med, Inst Marine & Environm Technol, Dept Biochem & Mol Biol, 701 East Pratt St, Baltimore, MD 21202 USA; [Li, Siping; Wen, Haishen] Ocean Univ China, Fishery Coll, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Ocean University of China	Du, SJ (corresponding author), Univ Maryland, Sch Med, Inst Marine & Environm Technol, Dept Biochem & Mol Biol, 701 East Pratt St, Baltimore, MD 21202 USA.	sdu@som.umaryland.edu			National Institutes of Health [R01AR072703]; China Scholarship Council; National Institutes of Health SIG [1S10RR26870-1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Institutes of Health SIG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R01AR072703; China Scholarship Council; National Institutes of Health SIG, Grant/Award Number: 1S10RR26870-1	AcakpoSatchivi LJR, 1997, J CELL BIOL, V139, P1219, DOI 10.1083/jcb.139.5.1219; Agarkova I, 2005, TRENDS CELL BIOL, V15, P477, DOI 10.1016/j.tcb.2005.07.001; Ali AM, 2017, CASE REPORTS GENETIC, V2017, P1; Allen DL, 2000, MICROSC RES TECHNIQ, V50, P492, DOI 10.1002/1097-0029(20000915)50:6<492::AID-JEMT6>3.3.CO;2-A; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Barresi MJF, 2001, CURR BIOL, V11, P1432, DOI 10.1016/S0960-9822(01)00428-6; Berger J, 2017, HUM MOL GENET, V26, P1146, DOI 10.1093/hmg/ddx025; Bottinelli R, 2001, PFLUG ARCH EUR J PHY, V443, P6, DOI 10.1007/s004240100700; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Budde BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001362; Cai MX, 2018, MAR BIOTECHNOL, V20, P168, DOI 10.1007/s10126-018-9794-8; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Codina M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008416; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Du SJ, 2001, DIFFERENTIATION, V67, P84, DOI 10.1046/j.1432-0436.2001.067003084.x; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Ehler E, 1999, J CELL SCI, V112, P1529; Ehler E, 2008, ADV EXP MED BIOL, V642, P1; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Fenix AM, 2018, ELIFE, V7, DOI 10.7554/eLife.42144; Gautel M, 2016, J EXP BIOL, V219, P135, DOI 10.1242/jeb.124941; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Gurung R, 2017, GENETICS, V205, P725, DOI 10.1534/genetics.116.192864; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Holtzer H, 1997, CELL STRUCT FUNCT, V22, P83, DOI 10.1247/csf.22.83; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Lamont PJ, 2014, HUM MUTAT, V35, P868, DOI 10.1002/humu.22553; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; McGuigan K, 2004, MOL BIOL EVOL, V21, P1042, DOI 10.1093/molbev/msh103; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nord H, 2014, MOL BIOL CELL, V25, P1384, DOI 10.1091/mbc.E13-08-0486; Ortolano S, 2011, NEUROMUSCULAR DISORD, V21, P254, DOI 10.1016/j.nmd.2010.12.011; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Racca AW, 2015, HUM MOL GENET, V24, P3348, DOI 10.1093/hmg/ddv084; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; RHEE D, 1994, CELL MOTIL CYTOSKEL, V28, P1, DOI 10.1002/cm.970280102; Ruggiero L, 2015, BIOCHEM BIOPH RES CO, V457, P262, DOI 10.1016/j.bbrc.2014.12.098; Rui YN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001208; Rutland CS, 2011, DEVELOPMENT, V138, P3955, DOI 10.1242/dev.059063; Sanger JW, 2005, J MUSCLE RES CELL M, V26, P343, DOI 10.1007/s10974-005-9016-7; Sanger JW, 2017, HANDB EXP PHARMACOL, V235, P39, DOI 10.1007/164_2016_53; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Schiaffino S, 2015, SKELET MUSCLE, V15, P5; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Sharma A, 2019, BIORXIV261685; Shimada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052549; STARON RS, 1993, COMP BIOCHEM PHYS B, V106, P463, DOI 10.1016/0305-0491(93)90120-T; Tajsharghi H, 2014, EUR J HUM GENET, V22, P801, DOI 10.1038/ejhg.2013.250; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Toydemir RM, 2006, AM J MED GENET A, V140A, P2387, DOI 10.1002/ajmg.a.31495; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Velten BP, 2014, AM J PHYSIOL-REG I, V306, pR845, DOI 10.1152/ajpregu.00041.2014; Walklate J, 2016, J BIOL CHEM, V291, P10318, DOI 10.1074/jbc.M115.707489; Walsh R, 2010, CARDIOLOGY, V115, P49, DOI 10.1159/000252808; Weiss S, 2001, J BIOL CHEM, V276, P45902, DOI 10.1074/jbc.M107434200; Xu J, 2012, J GENET GENOMICS, V39, P69, DOI 10.1016/j.jgg.2012.01.005	62	5	5	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1378	1397		10.1096/fj.201900935RR	http://dx.doi.org/10.1096/fj.201900935RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914689	Green Accepted			2022-12-28	WOS:000507308900092
J	Matsuhisa, K; Saito, A; Cai, LJ; Kaneko, M; Okamoto, T; Sakaue, F; Asada, R; Urano, F; Yanagida, K; Okochi, M; Kudo, Y; Matsumoto, M; Nakayama, KI; Imaizumi, K				Matsuhisa, Koji; Saito, Atsushi; Cai, Longjie; Kaneko, Masayuki; Okamoto, Takumi; Sakaue, Fumika; Asada, Rie; Urano, Fumihiko; Yanagida, Kanta; Okochi, Masayasu; Kudo, Yukitsuka; Matsumoto, Masaki; Nakayama, Keiichi I.; Imaizumi, Kazunori			Production of BBF2H7-derived small peptide fragments via endoplasmic reticulum stress-dependent regulated intramembrane proteolysis	FASEB JOURNAL			English	Article						endoplasmic reticulum stress; regulated intramembrane proteolysis; site-2 protease; transmembrane transcription factor	ALZHEIMERS GAMMA-SECRETASE; BZIP TRANSCRIPTION FACTOR; ER STRESS; SITE-1 PROTEASE; LUMINAL DOMAIN; CLEAVAGE; PROTEINS; SUBSTRATE; MECHANISM; PATHWAY	Intramembrane cleavage of transmembrane proteins is a fundamental cellular process to produce important signals that elicit biological responses. These proteolytic events are known as regulated intramembrane proteolysis (RIP). ATF6 and BBF2H7 are transmembrane basic leucine zipper transcription factors and are subjected to RIP by site-1 protease (S1P) and site-2 protease (S2P) sequentially in response to endoplasmic reticulum (ER) stress. However, the detailed mechanisms responsible for RIP of the transcription factors, including the precise cutting sites, are still unknown. In this study, we demonstrated that S1P cleaves BBF2H7 just before the RXXL S1P recognition motif. Conversely, S2P cut at least three different sites in the membrane (next to Leu380, Met381, and Leu385), indicating that S2P cleaves the substrates at variable sites or via a multistep process. Interestingly, we found BBF2H7-derived small peptide (BSP) fragments located between the S1P and S2P cleavage sites in cells exposed to ER stress. Major type of BSP fragments was composed of 45 amino acid including partial transmembrane and luminal regions and easily aggregates like amyloid beta (A beta) protein. These results advance the understanding of poorly characterized ER stress-dependent RIP. Furthermore, the aggregable peptides produced by ER stress could link to the pathophysiology of neurodegenerative disorders.	[Matsuhisa, Koji; Saito, Atsushi; Cai, Longjie; Kaneko, Masayuki; Okamoto, Takumi; Sakaue, Fumika; Asada, Rie; Imaizumi, Kazunori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Hiroshima, Japan; [Matsuhisa, Koji; Saito, Atsushi; Sakaue, Fumika] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Stress Prot Proc, Hiroshima, Japan; [Asada, Rie; Urano, Fumihiko] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Yanagida, Kanta; Okochi, Masayasu] Osaka Univ, Grad Sch Med, Dept Integrated Med, Neuropsychiat,Div Internal Med, Osaka, Japan; [Kudo, Yukitsuka] Tohoku Univ, Inst Dev Aging & Canc, Dept Gerontol & Geriatr, Sendai, Miyagi, Japan; [Matsumoto, Masaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka, Fukuoka, Japan	Hiroshima University; Hiroshima University; Washington University (WUSTL); Osaka University; Tohoku University; Kyushu University	Imaizumi, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	imaizumi@hiroshima-u.ac.jp	Urano, Fumihiko/AAF-4492-2020; Kaneko, Masayuki/F-9302-2011	Kaneko, Masayuki/0000-0002-0477-0171; Matsumoto, Masaki/0000-0002-6987-0288; Sakaue, Fumika/0000-0003-1364-8730; Kitamura, Rie/0000-0001-8347-6909; Matsuhisa, Koji/0000-0003-0707-9025	Japan Society for the Promotion of Science KAKENHI [JP16K18395, JP17H01424, JP17H06416]; Japan Intractable Diseases Research Foundation; Uehara Memorial Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Terumo Foundation for Life Sciences and Arts; Sumitomo Electric Industries Group Corporate Social Responsibility Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Intractable Diseases Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Terumo Foundation for Life Sciences and Arts; Sumitomo Electric Industries Group Corporate Social Responsibility Foundation	Japan Society for the Promotion of Science KAKENHI, Grant/Award Number: JP16K18395, JP17H01424 and JP17H06416; Japan Intractable Diseases Research Foundation; The Uehara Memorial Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Terumo Foundation for Life Sciences and Arts; Sumitomo Electric Industries Group Corporate Social Responsibility Foundation	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cathcart JM, 2015, FRONT BIOSCI-LANDMRK, V20, P1164, DOI 10.2741/4365; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Close W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03164-5; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Gerakis Y, 2018, FEBS J, V285, P995, DOI 10.1111/febs.14332; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hale JE, 1996, AMINO ACIDS, V10, P243, DOI 10.1007/BF00807326; Hanna A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0509-3; Iadanza MG, 2018, NAT REV MOL CELL BIO, V19, P755, DOI 10.1038/s41580-018-0060-8; Iwamoto H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125982; Kanemoto S, 2015, J CELL SCI, V128, P4353, DOI 10.1242/jcs.176057; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Koide K, 2008, J BIOL CHEM, V283, P9562, DOI 10.1074/jbc.M709984200; Kondo S, 2012, CELL DEATH DIFFER, V19, P1939, DOI 10.1038/cdd.2012.77; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Makioka K, 2010, J NEUROL SCI, V297, P60, DOI 10.1016/j.jns.2010.06.019; Manolaridis I, 2013, NATURE, V504, P301, DOI 10.1038/nature12754; Mercado G, 2016, BRAIN RES, V1648, P626, DOI 10.1016/j.brainres.2016.04.042; Morishima-Kawashima M, 2014, FRONT PHYSIOL, P5; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Peer E, 2019, CANCERS, V11, DOI 10.3390/cancers11040538; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 2013, BBA-BIOMEMBRANES, V1828, P2801, DOI 10.1016/j.bbamem.2013.03.031; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Saito A, 2014, MOL CELL, V53, P127, DOI 10.1016/j.molcel.2013.11.008; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Shen JS, 2004, J BIOL CHEM, V279, P43046, DOI 10.1074/jbc.M408466200; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	53	2	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					865	880		10.1096/fj.201901748R	http://dx.doi.org/10.1096/fj.201901748R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914686	hybrid			2022-12-28	WOS:000507308900059
J	Okuyama, Y; Nagashima, H; Ushio-Fukai, M; Croft, M; Ishii, N; So, T				Okuyama, Yuko; Nagashima, Hiroyuki; Ushio-Fukai, Masuko; Croft, Michael; Ishii, Naoto; So, Takanori			IQGAP1 restrains T-cell cosignaling mediated by OX40	FASEB JOURNAL			English	Article						autoimmunity; CD4(+) T cells; cosignaling; T-cell inflammation; TNFRSF	LIGAND INTERACTION; COSTIMULATORY MOLECULE; PROTEINS; CDC42; AMELIORATION; GENERATION; BLOCKADE; IMMUNITY; BIOLOGY; MEMBERS	A costimulatory signal from the tumor necrosis factor receptor (TNFR) family molecule OX40 (CD134), which is induced on activated T cells, is important for T-cell immunity. Aberrant OX40 cosignaling has been implicated in autoimmune and inflammatory disorders. However, the molecular mechanism by which the OX40 cosignaling regulates the T-cell response remains obscure. We found that OX40 associated with a scaffold protein, IQ motif-containing GTPase-activating protein 1 (IQGAP1) after ligation by its ligand OX40L. Naive CD4(+) T cells from Iqgap1(-/-) mice displayed enhanced proliferation and cytokine secretion upon receiving OX40 cosignaling. A C-terminal IQGAP1 region was responsible for its association with OX40, and TNFR-associated factor 2 (TRAF2) bridged these two proteins. The enhanced cytokine response in Iqgap1(-/-) T cells was restored by the expression of the C-terminal IQGAP1. Thus, the IQGAP1 binding limits the OX40 cosignaling. Disease severity of experimental autoimmune encephalomyelitis (EAE) was significantly exacerbated in Iqgap1(-/-) mice as compared to wild-type mice. Additionally, recipient mice with Iqgap1(-/-) donor CD4(+) T cells exhibited significantly higher EAE scores than those with their wild-type counterparts, and OX40 blockade led to a significant reduction in the EAE severity. Thus, our study defines an important component of the OX40 cosignaling that restricts inflammation driven by antigen-activated T cells.	[Okuyama, Yuko; Nagashima, Hiroyuki; Ishii, Naoto; So, Takanori] Tohoku Univ, Dept Microbiol & Immunol, Grad Sch Med, Sendai, Miyagi, Japan; [Ushio-Fukai, Masuko] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA; [Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA; [So, Takanori] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Mol Cell Biol Lab, 2630 Sugitani, Toyama, Toyama 9300194, Japan	Tohoku University; University System of Georgia; Augusta University; La Jolla Institute for Immunology; University of Toyama	So, T (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Mol Cell Biol Lab, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	tso@pha.u-toyama.ac.jp	So, Takanori/R-6175-2019; Nagashima, Hiroyuki/AAL-3128-2021	So, Takanori/0000-0003-3004-8526; Ishii, Naoto/0000-0002-0549-8245; Nagashima, Hiroyuki/0000-0001-8405-6746	Takeda Scientific Foundation; Suzuken Memorial Foundation; SENSHIN Medical Research Foundation; Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science [JP15K19123, JP14J06157, JP24590571, JP15H04640, JP18H02572, JP24390118, JP15H04742]	Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Takeda Scientific Foundation; The Suzuken Memorial Foundation; The SENSHIN Medical Research Foundation; The Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science, Grant/Award Number: JP15K19123, JP14J06157, JP24590571, JP15H04640, JP18H02572, JP24390118 and JP15H04742	Bahou WF, 2004, J BIOL CHEM, V279, P22571, DOI 10.1074/jbc.M402561200; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Carboni S, 2003, J NEUROIMMUNOL, V145, P1, DOI 10.1016/j.jneuroim.2003.07.001; Choi S, 2016, NAT CELL BIOL, V18, P1324, DOI 10.1038/ncb3441; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Gorman JA, 2012, J IMMUNOL, V188, P6135, DOI 10.4049/jimmunol.1103487; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ishii N, 2010, ADV IMMUNOL, V105, P63, DOI 10.1016/S0065-2776(10)05003-0; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Linch SN, 2016, P NATL ACAD SCI USA, V113, pE319, DOI 10.1073/pnas.1510518113; Liu CS, 2013, J CLIN INVEST, V123, P1138, DOI 10.1172/JCI63836; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Murata K, 2002, J IMMUNOL, V169, P4628, DOI 10.4049/jimmunol.169.8.4628; Nagashima H, 2016, J IMMUNOL, V196, P4082, DOI 10.4049/jimmunol.1501610; Ndhlovu LC, 2001, J IMMUNOL, V167, P2991, DOI 10.4049/jimmunol.167.5.2991; Nohara C, 2001, J IMMUNOL, V166, P2108, DOI 10.4049/jimmunol.166.3.2108; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pelikan-Conchaudron A, 2011, J BIOL CHEM, V286, P35119, DOI 10.1074/jbc.M111.258772; Prell RA, 2003, J IMMUNOL, V171, P5997, DOI 10.4049/jimmunol.171.11.5997; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sagiv-Barfi I, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4488; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; So T, 2011, P NATL ACAD SCI USA, V108, P2903, DOI 10.1073/pnas.1008765108; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Sugamura K, 2004, NAT REV IMMUNOL, V4, P420, DOI 10.1038/nri1371; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Webb GJ, 2016, CLIN REV ALLERG IMMU, V50, P312, DOI 10.1007/s12016-015-8498-3; Weinberg AD, 1999, J IMMUNOL, V162, P1818; Weinberg AD, 2011, IMMUNOL REV, V244, P218, DOI 10.1111/j.1600-065X.2011.01069.x; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7	45	5	5	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					540	554		10.1096/fj.201900879RR	http://dx.doi.org/10.1096/fj.201900879RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914585	hybrid			2022-12-28	WOS:000507308900037
J	Qin, Y; Li, AQ; Liu, BL; Jiang, WT; Gao, M; Tian, XG; Gong, GH				Qin, Yuan; Li, Anqi; Liu, Bilin; Jiang, Wenting; Gao, Meng; Tian, Xiangang; Gong, Guohua			Mitochondrial fusion mediated by fusion promotion and fission inhibition directs adult mouse heart function toward a different direction	FASEB JOURNAL			English	Article						adult heart; cardiac function; mitochondrial dynamics; mitochondrial fitness; therapeutic target	ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; MITOFUSIN 2; MITOPHAGY; DYNAMICS; CA2+; DYSFUNCTION; AUTOPHAGY; ISCHEMIA; PROTECTS	Mitochondrial fusion and fission are essential for heart function. Abrogating mitochondrial dynamism leads to cardiomyopathy. Excessive mitochondrial fragmentation is involved in most heart diseases, thus enhancing mitochondrial fusion will be a potential therapeutic strategy. To understand the effects of promoting mitochondrial fusion in adult cardiac, we investigated mice hearts, and cultured murine embryonic fibroblasts (MEFs), in which mitofusin 2 (Mfn2) overexpressed or dynamin-related protein 1 (Drp1) was abrogated concomitantly forcing mitochondrial fusion. Parallel studies revealed that fission-defective Drp1 knockout hearts and MEFs evoked stronger mitochondrial enlargement, enhanced mitophagy with mitochondrial volume decrease and increased mitochondrial calcium uptake, superoxide production, and permeability transition pore opening, contributed to cardiomyocyte apoptosis and dilated cardiomyopathy. Mfn2 overexpression in the adult heart is comparable with the control except for slight mitochondrial enlargement and mitochondrial volume increase, but without mitophagy induction. Moreover, Mfn2 overexpression increases mitochondrial biogenesis and fusion could protect against mitochondrial fragmentation and Drp1 deletion evoking mitophagy in MEFs. Our findings indicate that mitochondrial fusion provoked by fusion promotion and fission inhibition direct the different fate of heart, Mfn2 upregulation other than Drp1 downregulation well maintains heart mitochondrial function is a more safe strategy for correcting excessive mitochondrial fragmentation in hearts.	[Qin, Yuan; Li, Anqi; Liu, Bilin; Jiang, Wenting; Gao, Meng; Gong, Guohua] Tongji Univ, Shanghai East Hosp, Inst Regenerat Med, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China; [Qin, Yuan] Tongji Univ, Shanghai East Hosp, Dept Pharm, Shanghai, Peoples R China; [Tian, Xiangang] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China	Tongji University; Tongji University; Army Medical University	Gong, GH (corresponding author), Tongji Univ, Shanghai East Hosp, Inst Regenerat Med, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China.	guohgong@tongji.edu.cn			Ministry of Science and Technology of the People's Republic of China (MOST) [2017YFA0105601]; National Natural Science Foundation of China (NSFC) [31771524]; Shanghai Municipal Education Commission [TP2017036]; Science and Technology Commission of Shanghai Municipality (STCSM) [17PJ1409600]	Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Science and Technology Commission of Shanghai Municipality (STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM))	Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2018YFA0107102; Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2017YFA0105601; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771524; Shanghai Municipal Education Commission, Grant/Award Number: TP2017036; Science and Technology Commission of Shanghai Municipality (STCSM), Grant/Award Number: 17PJ1409600	Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Bi JB, 2019, REDOX BIOL, V20, P296, DOI 10.1016/j.redox.2018.10.019; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2015, J CELL BIOL, V211, P795, DOI 10.1083/jcb.201507035; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen L, 2017, METHOD ENZYMOL, V588, P187, DOI 10.1016/bs.mie.2016.10.038; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Diaz-Trelles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12088; Dorn GW, 2015, EMBO MOL MED, V7, P865, DOI 10.15252/emmm.201404575; Dorn GW, 2015, CIRC RES, V116, P167, DOI 10.1161/CIRCRESAHA.116.303554; Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459; Gong GH, 2014, J MOL CELL CARDIOL, V76, P235, DOI 10.1016/j.yjmcc.2014.09.012; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Hansford RG, 1999, BIOCHEM SOC SYMP, V66, P141, DOI 10.1042/bss0660141; Joshi AU, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708166; Kim YY, 2018, ACTA BIOCH BIOPH SIN, V50, P209, DOI 10.1093/abbs/gmx137; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174; Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113; Oliveira JMA, 2010, EMBO MOL MED, V2, P487, DOI 10.1002/emmm.201000104; Ong SB, 2015, THROMB HAEMOSTASIS, V113, P513, DOI 10.1160/TH14-07-0592; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Park SJ, 2012, FEBS LETT, V586, P4303, DOI 10.1016/j.febslet.2012.10.035; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Qin Y, 2018, BIOCHEM BIOPH RES CO, V503, P729, DOI 10.1016/j.bbrc.2018.06.068; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Sebastian D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023; Song MS, 2014, CIRC RES, V115, P348, DOI 10.1161/CIRCRESAHA.115.304384; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang W, 2016, ANTIOXID REDOX SIGN, V25, P534, DOI 10.1089/ars.2016.6739; Yan QW, 2019, NEUROSCI LETT, V701, P84, DOI 10.1016/j.neulet.2019.02.030; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang J, 2017, CHIN AUTOM CONGR, P1; Zhang J, 2017, DYN GAMES APPL, V7, P112, DOI 10.1007/s13235-015-0165-z; Zhou YQ, 2019, J CLIN INVEST, V129, P1756, DOI 10.1172/JCI124194; Zhu TT, 2017, EUR J PHARMACOL, V809, P42, DOI 10.1016/j.ejphar.2017.05.003	47	18	20	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					663	675		10.1096/fj.201901671R	http://dx.doi.org/10.1096/fj.201901671R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914595				2022-12-28	WOS:000507308900046
J	Zhang, SS; Xu, XX; Xiang, WW; Zhang, HH; Lin, HL; Shen, LE; Lin, Q; Lin, F; Zhou, ZY				Zhang, Si-Si; Xu, Xin-Xin; Xiang, Wei-Wei; Zhang, Hui-Heng; Lin, Hui-Long; Shen, Lai-En; Lin, Qi; Lin, Feng; Zhou, Zhi-Yang			Using 17 beta-estradiol heparin-poloxamer thermosensitive hydrogel to enhance the endometrial regeneration and functional recovery of intrauterine adhesions in a rat model	FASEB JOURNAL			English	Article						17 beta-estradiol; apoptosis; heparin-poloxamer hydrogel; intrauterine adhesions; kisspeptin; regeneration	IN-VITRO; STEM/PROGENITOR CELLS; ASHERMANS-SYNDROME; STEM-CELLS; KISSPEPTIN; TRANSPLANTATION; IMPLANTATION; RECEPTIVITY; EXPRESSION; RECEPTORS	Mechanical damage or infection to the endometrium can lead to the formation of adhesions in the uterine cavity, which may result in reduced reproductive outcome and/or pregnancy complications. The prognosis of this disease is poor due to few effective treatments and the complex environment of endometrium. Heparin-Poloxamer Hydrogel (HP hydrogel) is a nontoxic and biodegradable biomaterial, which has been commonly used as a sustained-release delivery system. In this study, we applied a mini-endometrial curette to scrape the endometrium of rats to mimic the process of curettage in patients. After the establishment of IUA model in rats, we injected the thermo-sensitive hydrogel(E-2-HP hydrogel) into the injured uterine cavity and evaluated the therapeutic effect of E-2-HP hydrogel on the recovery of IUA. Our results showed that E-2-HP hydrogel can significantly facilitate the regeneration of injured endometrium along with inhibiting the cell apoptosis in IUA model. Furthermore, we revealed that E-2-HP hydrogel on the recovery of IUA was closely associated with the upregulation of kisspeptin through activating the ERK1/2 and MAPKs p38 pathways. In conclusion, E-2-HP hydrogel can effectively transfer E-2 into the injured endometrium and it can be considered as a promising therapeutic method for the women with intrauterine adhesions.	[Zhang, Si-Si; Lin, Hui-Long; Shen, Lai-En; Lin, Qi; Lin, Feng; Zhou, Zhi-Yang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gynaecol, Wenzhou 325035, Zhejiang, Peoples R China; [Xu, Xin-Xin] Zhejiang Univ, Womens Hosp, Sch Med, Dept Gynaecol, Hangzhou, Zhejiang, Peoples R China; [Xiang, Wei-Wei] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurol, Shanghai, Peoples R China; [Zhang, Hui-Heng] Wenzhou Med Univ, Sch Clin Med Sci 2, Wenzhou, Peoples R China; [Zhou, Zhi-Yang] Shanghai Jiao Tong Univ, Int Peace Maternal & Child Hlth Hosp, Sch Med, Shanghai, Peoples R China; [Zhou, Zhi-Yang] Shanghai Key Lab Embryo Original Dis, Shanghai, Peoples R China	Wenzhou Medical University; Zhejiang University; Shanghai Jiao Tong University; Wenzhou Medical University; Shanghai Jiao Tong University	Lin, F; Zhou, ZY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gynaecol, Wenzhou 325035, Zhejiang, Peoples R China.	23489067@qq.com; zhouzhiyang.19@hotmail.com			Zhejiang Provincal Administration of traditional Chinese Medicine [2016ZB079]; Medicine Grant from Wenzhou Bureau of Science and Technology [Y20180018]; National Natural Science Foundation of China [81803781]; Natural Science Foundation of Zhejiang Province, China [LQ18H280007]	Zhejiang Provincal Administration of traditional Chinese Medicine; Medicine Grant from Wenzhou Bureau of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	Zhejiang Provincal Administration of traditional Chinese Medicine, Grant/Award Number: 2016ZB079; Medicine Grant from Wenzhou Bureau of Science and Technology, Grant/Award Number: Y20180018; National Natural Science Foundation of China, Grant/Award Number: 81803781; Natural Science Foundation of Zhejiang Province, China, Grant/Award Number: LQ18H280007	Abomaray FM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5184601; Aghajanova L, 2018, J ASSIST REPROD GEN, V35, P757, DOI 10.1007/s10815-018-1130-8; Cai HH, 2016, REPROD SCI, V23, P1208, DOI 10.1177/1933719116632923; Calder M, 2014, ENDOCRINOLOGY, V155, P3065, DOI 10.1210/en.2013-1916; Roman AC, 2012, FERTIL STERIL, V97, P1213, DOI 10.1016/j.fertnstert.2012.02.021; Clarkson J, 2013, FRONT NEUROENDOCRIN, V34, P120, DOI 10.1016/j.yfrne.2013.02.002; Ding LJ, 2014, BIOMATERIALS, V35, P4888, DOI 10.1016/j.biomaterials.2014.02.046; Evans-Hoeker EA, 2014, SEMIN REPROD MED, V32, P392, DOI 10.1055/s-0034-1376358; Fayazi M, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0105-1; Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051; Gilman AR, 2016, J OBSTET GYNAECOL CA, V38, P453, DOI 10.1016/j.jogc.2016.03.003; Jamil Z, 2017, REPROD BIOMED ONLINE, V34, P147, DOI 10.1016/j.rbmo.2016.11.004; Johary J, 2014, J MINIM INVAS GYN, V21, P44, DOI 10.1016/j.jmig.2013.07.018; Liu AZ, 2016, GYNECOL ENDOCRINOL, V32, P737, DOI 10.3109/09513590.2016.1160375; Miravet-Valenciano JA, 2015, CURR OPIN OBSTET GYN, V27, P187, DOI 10.1097/GCO.0000000000000173; Mittelman-Smith MA, 2015, ENDOCRINOLOGY, V156, P2162, DOI 10.1210/en.2014-1803; Quinn CE, 2009, HUM REPROD UPDATE, V15, P229, DOI 10.1093/humupd/dmn052; Salazar CA, 2017, CURR OPIN OBSTET GYN, V29, P249, DOI 10.1097/GCO.0000000000000378; Salma U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/589296; Santamaria X, 2016, HUM REPROD, V31, P1087, DOI 10.1093/humrep/dew042; Sardo AD, 2016, EUR J OBSTET GYN R B, V203, P182, DOI 10.1016/j.ejogrb.2016.05.050; Tan JC, 2016, HUM REPROD, V31, P2723, DOI 10.1093/humrep/dew235; Taylor J, 2014, MOL REPROD DEV, V81, P42, DOI 10.1002/mrd.22279; Wahab F, 2016, NAT REV UROL, V13, P21, DOI 10.1038/nrurol.2015.277; Wei P, 2004, MOL REPROD DEV, V68, P456, DOI 10.1002/mrd.20104; Wiater J, 2018, REPROD DOMEST ANIM, V53, P333, DOI 10.1111/rda.13109; Xiao B, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801455; Xu HL, 2017, DRUG DELIV, V24, P867, DOI 10.1080/10717544.2017.1333173; Yoo MK, 2005, DRUG DEV IND PHARM, V31, P455, DOI 10.1080/03639040500214688; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097647; Zhang S, 2018, REPROD DOMEST ANIM, V53, P143, DOI 10.1111/rda.13083; Zhang SS, 2017, INT J NANOMED, V12, P5643, DOI 10.2147/IJN.S137237; Zhang SW, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1155-7; Zhu XX, 2019, CURR STEM CELL RES T, V14, P293, DOI 10.2174/1574888X14666181205120110; Zhu Y, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.896028	35	21	24	7	36	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					446	457		10.1096/fj.201901603RR	http://dx.doi.org/10.1096/fj.201901603RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914682				2022-12-28	WOS:000507308900031
J	Di, WD; Gasser, RB; He, L; Li, FF; Liu, XF; Zhou, CX; Zhou, YQ; Fang, R; Zhao, JL; Hu, M				Di, Wenda; Gasser, Robin B.; He, Li; Li, Fangfang; Liu, Xiaofang; Zhou, Caixian; Zhou, Yanqin; Fang, Rui; Zhao, Junlong; Hu, Min			A serine/threonine-specific protein kinase of Haemonchus contortus with a role in the development	FASEB JOURNAL			English	Article						akt-1; expression; functional genomics; kinase; signaling	STRONGYLOIDES-STERCORALIS; RNA INTERFERENCE; IN-VITRO; GENE; EXPRESSION; LONGEVITY; ELEGANS; AKT; REPRODUCTION; INHIBITORS	In the free-living nematode Caenorhabditis elegans, the serine/threonine-specific protein kinase, AKT, is known to play a key role in dauer formation, life-span, and stress-resistance through the insulin-like signaling pathway. Although the structure and function of AKT-coding genes of C. elegans are understood, this is not the case for homologous genes in parasitic nematodes. In the present study, we explored a C. elegans akt-1 gene homolog in the parasitic nematode Haemonchus contortus, investigated its transcript isoforms (Hc-akt-1a and Hc-akt-1b), and studied expression and function using both homologous and heterologous functional genomic tools. In C. elegans, we showed that the predicted promoter of Hc-akt-1 drives substantial expression in ASJ neurons of the N2 (wild-type) strain. In H. contortus (Haecon-5 stain), RNAi (soaking) led to a significantly decreased transcript abundance for both Hc-akt-1a and Hc-akt-1b, and reduced larval development in larval stages in vitro. Chemical inhibition was also shown to block larval development. Taken together, the evidence from this study points to a key functional role for Hc-akt-1 in H. contortus.	[Di, Wenda; Gasser, Robin B.; He, Li; Li, Fangfang; Liu, Xiaofang; Zhou, Caixian; Zhou, Yanqin; Fang, Rui; Zhao, Junlong; Hu, Min] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Key Lab Dev Vet Prod,Minist Agr, Wuhan 430070, Hubei, Peoples R China; [Gasser, Robin B.] Univ Melbourne, Dept Vet Biosci, Fac Vet & Agr Sci, Parkville, Vic, Australia	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; University of Melbourne	Gasser, RB; Hu, M (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Key Lab Dev Vet Prod,Minist Agr, Wuhan 430070, Hubei, Peoples R China.	robinbg@unimelb.edu.au; mhu@mail.hzau.edu.cn	Gasser, Robin/ABH-6185-2020	Gasser, Robin/0000-0002-4423-1690; , Wenda Di/0000-0003-1037-0286	NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [31172310]; National Key Basic Research Program (973 program) of China [2015CB150300]; Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation) [2017CFA020]; Huazhong Agricultural University Scientific & Technological Self Innovation Foundation [2015RC005]	NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); National Key Basic Research Program (973 program) of China(National Basic Research Program of China); Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation); Huazhong Agricultural University Scientific & Technological Self Innovation Foundation	NSFC vertical bar National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 31172310; National Key Basic Research Program (973 program) of China, Grant/Award Number: 2015CB150300; Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation), Grant/Award Number: 2017CFA020; Huazhong Agricultural University Scientific & Technological Self Innovation Foundation, Grant/Award Number: 2015RC005	Addie M, 2013, J MED CHEM, V56, P2059, DOI 10.1021/jm301762v; Ailion M, 2003, GENETICS, V165, P127; Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; Ashton FT, 2007, EXP PARASITOL, V115, P92, DOI 10.1016/j.exppara.2006.08.010; Ashton FT, 1999, VET PARASITOL, V84, P297, DOI 10.1016/S0304-4017(99)00037-0; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Ding HJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1991-1; FRANKE TF, 1994, ONCOGENE, V9, P141; Gems D, 1998, GENETICS, V150, P129; He L, 2018, INT J PARASITOL, V48, P1023, DOI 10.1016/j.ijpara.2018.06.005; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kotze AC, 2006, MOL BIOCHEM PARASIT, V145, P101, DOI 10.1016/j.molbiopara.2005.09.012; Lei WQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07991-2; Li FC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1351-6; Li FC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0498-2; Li FC, 2014, INT J PARASITOL, V44, P485, DOI 10.1016/j.ijpara.2014.03.005; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MAPES CJ, 1969, PARASITOLOGY, V59, P215, DOI 10.1017/S0031182000069961; Massey HC, 2013, INT J PARASITOL, V43, P515, DOI 10.1016/j.ijpara.2013.01.008; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mohandas N, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1341-8; Morel M, 2014, INT J PARASITOL-DRUG, V4, P256, DOI 10.1016/j.ijpddr.2014.09.004; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy Coleen T, 2013, WormBook, P1, DOI 10.1895/wormbook.1.164.1; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preston S, 2015, INT J PARASITOL, V45, P333, DOI 10.1016/j.ijpara.2015.01.007; Riehle MA, 2003, INSECT MOL BIOL, V12, P225, DOI 10.1046/j.1365-2583.2003.00405.x; SOMMERVILLE RI, 1966, J PARASITOL, V52, P127, DOI 10.2307/3276403; Stecher G, 2014, BIOINFORMATICS, V30, P1305, DOI 10.1093/bioinformatics/btu018; Stoltzfus JD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001854; Stoltzfus JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038587; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tissenbaum HA, 1998, GENETICS, V148, P703; Zawadzki JL, 2012, PARASITOLOGY, V139, P613, DOI 10.1017/S0031182012000121	38	6	7	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2075	2086		10.1096/fj.201900888RR	http://dx.doi.org/10.1096/fj.201900888RR		DEC 2019	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907982				2022-12-28	WOS:000504677400001
J	Dwivedi, SKD; Shameer, K; Dey, A; Mustafi, SB; Xiong, XH; Bhattacharya, U; Neizer-Ashun, F; Rao, G; Wang, Y; Ivan, C; Yang, D; Dudley, JT; Xu, C; Wren, JD; Mukherjee, P; Bhattacharya, R				Dwivedi, Shailendra Kumar Dhar; Shameer, Khader; Dey, Anindya; Mustafi, Soumyajit Banerjee; Xiong, Xunhao; Bhattacharya, Udayan; Neizer-Ashun, Fiifi; Rao, Geeta; Wang, Yue; Ivan, Cristina; Yang, Da; Dudley, Joel T.; Xu, Chao; Wren, Jonathan D.; Mukherjee, Priyabrata; Bhattacharya, Resham			KRCC1: A potential therapeutic target in ovarian cancer	FASEB JOURNAL			English	Article						KRCC1; ovarian cancer; systems biology	PROTEIN PHOSPHATASE-1; COMPLEXES; CHROMATIN; NETWORK; INHIBITOR; CELLS	Using a systems biology approach to prioritize potential points of intervention in ovarian cancer, we identified the lysine rich coiled-coil 1 (KRCC1), as a potential target. High-grade serous ovarian cancer patient tumors and cells express significantly higher levels of KRCC1 which correlates with poor overall survival and chemoresistance. We demonstrate that KRCC1 is predominantly present in the chromatin-bound nuclear fraction, interacts with HDAC1, HDAC2, and with the serine-threonine phosphatase PP1CC. Silencing KRCC1 inhibits cellular plasticity, invasive properties, and potentiates apoptosis resulting in reduced tumor growth. These phenotypes are associated with increased acetylation of histones and with increased phosphorylation of H2AX and CHK1, suggesting the modulation of transcription and DNA damage that may be mediated by the action of HDAC and PP1CC, respectively. Hence, we address an urgent need to develop new targets in cancer.	[Dwivedi, Shailendra Kumar Dhar; Dey, Anindya; Bhattacharya, Udayan; Neizer-Ashun, Fiifi; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Shameer, Khader; Dudley, Joel T.] Mt Sinai Hlth Syst, Dept Genet & Genom Sci, Icahn Inst Data Sci & Genom Technol, Inst Next Generat Healthcare INGH, New York, NY USA; [Mustafi, Soumyajit Banerjee] Burst Biol Smart Surg Inc, Res & Dev, 3501 W Elder St, Boise, ID USA; [Xiong, Xunhao; Rao, Geeta; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Wang, Yue; Yang, Da] Univ Pittsburgh, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA USA; [Ivan, Cristina] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Ivan, Cristina] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Xu, Chao] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Wren, Jonathan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Wren, Jonathan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Oklahoma City, OK USA; [Mukherjee, Priyabrata; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Icahn School of Medicine at Mount Sinai; University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bhattacharya, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Dept Obstet & Gynecol, 975 NE 10th St,BRC 1409B, Oklahoma City, OK 73104 USA.	Resham-Bhattacharya@ouhsc.edu	Xu, Chao/AAN-6427-2020; Bhattacharya, Udayan/ABG-5402-2021	Xu, Chao/0000-0002-3821-6187; Bhattacharya, Udayan/0000-0001-5380-7498	HHS \ National Institutes of Health (NIH) [CA157481, UL1TR000067, 5U54GM104938]; University of Oklahoma; National Institute of General Medical Sciences; Core; National Center for Advancing Translational Sciences	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Oklahoma; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Core(Luxembourg National Research Fund); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: CA157481, UL1TR000067 and 5U54GM104938; University of Oklahoma; National Institute of General Medical Sciences; Core; National Center for Advancing Translational Sciences	Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bazzi M, 2010, MOL CELL BIOL, V30, P131, DOI 10.1128/MCB.01000-09; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Chien J, 2008, ONCOGENE, V27, P7223, DOI 10.1038/onc.2008.360; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Cohen PTW, 2002, J CELL SCI, V115, P241; Cortez AJ, 2018, CANCER CHEMOTH PHARM, V81, P17, DOI 10.1007/s00280-017-3501-8; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; de Castro IJ, 2017, CELL CYCLE, V16, P2011, DOI 10.1080/15384101.2017.1371883; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dwivedi SKD, 2016, ONCOTARGET, V7, P15093, DOI 10.18632/oncotarget.7618; Eckschlager T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071414; Fardilha M, 2011, BIOCHEM PHARMACOL, V82, P1403, DOI 10.1016/j.bcp.2011.02.018; Freeman AK, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-27; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Giri K, 2014, BIOCONJUGATE CHEM, V25, P1078, DOI 10.1021/bc500084f; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang X, 2019, CANCER MANAG RES, V11, P4371, DOI 10.2147/CMAR.S200524; Ju JH, 2009, ORG LETT, V11, P1639, DOI 10.1021/ol900293j; Klymenko Y, 2017, CANCERS, V9, DOI 10.3390/cancers9080104; Krzyzosiak A, 2018, CELL, V174, P1216, DOI 10.1016/j.cell.2018.06.030; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mistry D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187091; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Mustafi SB, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0617-8; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Peters LA, 2017, NAT GENET, V49, P1437, DOI 10.1038/ng.3947; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Saha S, 2016, ACS NANO, V10, P10636, DOI 10.1021/acsnano.6b02231; Saxena M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00327; Seidel C, 2012, BIOCHIMIE, V94, P2264, DOI 10.1016/j.biochi.2012.05.012; Shan WW, 2012, CELL CYCLE, V11, P2107, DOI 10.4161/cc.20544; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tang HM, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.41; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Vagnarelli P, 2018, CELL, V174, P1049, DOI 10.1016/j.cell.2018.08.007; Verheyen T, 2015, NUCLEIC ACIDS RES, V43, P5771, DOI 10.1093/nar/gkv500; Wang FF, 2019, CANCER RES, V79, P2526, DOI 10.1158/0008-5472.CAN-18-1673; Winkler C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214932; Winkler C, 2015, J CELL SCI, V128, P4526, DOI 10.1242/jcs.175588; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yadav BS, 2018, CURR TOP MED CHEM, V18, P1737, DOI 10.2174/1568026618666181025112344; Yao YL, 2005, CURR CANCER DRUG TAR, V5, P595, DOI 10.2174/156800905774932815; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	56	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2287	2300		10.1096/fj.201902259R	http://dx.doi.org/10.1096/fj.201902259R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908025	Green Accepted, Bronze			2022-12-28	WOS:000504091300001
J	Inoue, K; Hu, XY; Zhao, BH				Inoue, Kazuki; Hu, Xiaoyu; Zhao, Baohong			Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption	FASEB JOURNAL			English	Article						inflammatory bone resorption; osteoclast; osteoimmunology; rheumatoid arthritis	NF-KAPPA-B; CALCIUM-SENSING RECEPTOR; RBP-J; RHEUMATOID-ARTHRITIS; INDUCED OSTEOCLASTOGENESIS; NOTCH; TNF; TRANSCRIPTION; EXPRESSION; MIR-182	Bone resorption is a severe consequence of inflammatory diseases associated with osteolysis, such as rheumatoid arthritis (RA), often leading to disability in patients. In physiological conditions, the differentiation of bone-resorbing osteoclasts is delicately regulated by the balance between osteoclastogenic and anti-osteoclastogenic mechanisms. Inflammation has complex impact on osteoclastogenesis and bone destruction, and the underlying mechanisms of which, especially feedback inhibition, are underexplored. Here, we identify a novel regulatory network mediated by RBP-J/NFATc1-miR182 in TNF-induced osteoclastogenesis and inflammatory bone resorption. This network includes negative regulator RBP-J and positive regulators, NFATc1 and miR182, of osteoclast differentiation. In this network, miR182 is a direct target of both RBP-J and NFATc1. RBP-J represses, while NFATc1 activates miR182 expression through binding to specific open chromatin regions in the miR182 promoter. Inhibition of miR182 by RBP-J servers as a critical mechanism that limits TNF-induced osteoclast differentiation and inflammatory bone resorption. Inflammation, such as that which occurs in RA, shifts the expression levels of the components in this network mediated by RBP-J/NFATc1-miR182-FoxO3/PKR (previously identified miR182 targets) towards more osteoclastogenic, rather than healthy conditions. Treatment with TNF inhibitors in RA patients reverses the expression changes of the network components and osteoclastogenic potential. Thus, this network controls the balance between activating and repressive signals that determine the extent of osteoclastogenesis. These findings collectively highlight the biological significance and translational implication of this newly identified intrinsic regulatory network in inflammatory osteoclastogenesis and osteolysis.	[Inoue, Kazuki; Zhao, Baohong] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Inoue, Kazuki; Zhao, Baohong] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Inoue, Kazuki; Zhao, Baohong] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Hu, Xiaoyu] Tsinghua Univ, Inst Immunol, Beijing, Peoples R China; [Hu, Xiaoyu] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Zhao, Baohong] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Cell & Dev Biol, New York, NY 10021 USA	Cornell University; Tsinghua University; Tsinghua University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Zhao, BH (corresponding author), Hosp Special Surg, Res Inst R804,535 East 70th St, New York, NY 10021 USA.	zhaob@hss.edu	Inoue, Kazuki/GRY-3245-2022; Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR062047, AR068970, AR071463]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR062047; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR068970; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR071463	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bao QW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02705-0; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Binder N, 2017, J IMMUNOL, V198, P3436, DOI 10.4049/jimmunol.1601716; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Feng X, 2013, BONE RES, V1, DOI 10.4248/BR201301003; Foldi J, 2016, PROTEIN CELL, V7, P201, DOI 10.1007/s13238-016-0248-7; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Gregersen PK, 2013, CELL, V155, P11, DOI 10.1016/j.cell.2013.08.050; Hayward SD, 2004, SEMIN CANCER BIOL, V14, P387, DOI 10.1016/j.semcancer.2004.04.018; Hendy GN, 2016, SEMIN CELL DEV BIOL, V49, P37, DOI 10.1016/j.semcdb.2015.11.006; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Inoue K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06446-0; Ivashkiv LB, 2003, ARTHRITIS RHEUM, V48, P2092, DOI 10.1002/art.11095; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Kitaura H, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/181849; Klein GL, 2016, SEMIN CELL DEV BIOL, V49, P52, DOI 10.1016/j.semcdb.2015.08.006; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; Miller CH, 2016, J IMMUNOL, V196, P4977, DOI 10.4049/jimmunol.1502044; Nakashima T, 2011, ANN NY ACAD SCI, V1240, pE13, DOI 10.1111/j.1749-6632.2011.06373.x; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Olive V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005813; Orozco G, 2014, ARTHRITIS RHEUMATOL, V66, P24, DOI 10.1002/art.38196; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Royce BF, 2007, ANN NY ACAD SCI, V1116, P245, DOI 10.1196/annals.1402.084; Sachdeva M, 2014, J CLIN INVEST, V124, P4305, DOI 10.1172/JCI77116; Sato K, 2006, CURR OPIN RHEUMATOL, V18, P419, DOI 10.1097/01.bor.0000231912.24740.a5; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schett G, 2009, J BONE MINER RES, V24, P1142, DOI 10.1359/jbmr.090533; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shang YL, 2016, PROTEIN CELL, V7, P159, DOI 10.1007/s13238-016-0250-0; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Sokhi UK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03081-7; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Swarnkar G, 2015, P NATL ACAD SCI USA, V112, P154, DOI 10.1073/pnas.1415213112; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Wang Y, 2015, J IMMUNOL, V194, P2878, DOI 10.4049/jimmunol.1402211; Weitzmann MN, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/125705; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yarilina A, 2011, P NATL ACAD SCI USA, V108, P1573, DOI 10.1073/pnas.1010030108; Zhang YH, 2001, J BIOL CHEM, V276, P563, DOI 10.1074/jbc.M008198200; Zhao BH, 2017, CURR OSTEOPOROS REP, V15, P126, DOI 10.1007/s11914-017-0358-z; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	60	8	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2392	2407		10.1096/fj.201902227R	http://dx.doi.org/10.1096/fj.201902227R		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908034	Bronze, Green Accepted			2022-12-28	WOS:000504093800001
J	Bai, LL; Sato, H; Kubo, Y; Wada, S; Aida, Y				Bai, Lanlan; Sato, Hirotaka; Kubo, Yoshinao; Wada, Satoshi; Aida, Yoko			CAT1/SLC7A1 acts as a cellular receptor for bovine leukemia virus infection	FASEB JOURNAL			English	Article						BLV envelope; binding ability; colocalization; syncytium formation	RETROVIRUS RECEPTOR; ENVELOPE PROTEIN; BINDING DOMAIN; SUSCEPTIBILITY; CELLS; ENTRY; BLV; ESTABLISHMENT; SEQUENCES; SUBUNIT	Bovine leukemia virus (BLV) is the causative agent of enzootic bovine leukosis, the most common neoplastic disease of cattle, which is closely related to human T-cell leukemia viruses. BLV has spread worldwide and causes a serious problem for the cattle industry. The cellular receptor specifically binds with viral envelope glycoprotein (Env), and this attachment mediates cell fusion to lead virus entry. BLV Env reportedly binds to cationic amino acid transporter 1 (CAT1)/solute carrier family 7 member 1 (SLC7A1), but whether the CAT1/SLC7A1 is an actual receptor for BLV remains unknown. Here, we showed that CAT1 functioned as an infection receptor, interacting with BLV particles. Cells expressing undetectable CAT1 levels were resistant to BLV infection but became highly susceptible upon CAT1 overexpression. CAT1 exhibited specific binding to BLV particles on the cell surface and colocalized with the Env in endomembrane compartments and membrane. Knockdown of CAT1 in permissive cells significantly reduced binding to BLV particles and BLV infection. Expression of CAT1 from various species demonstrated no species specificity for BLV infection, implicating CAT1 as a functional BLV receptor responsible for its broad host range. These findings provide insights for BLV infection and for developing new strategies for treating BLV and preventing its spread.	[Bai, Lanlan; Sato, Hirotaka; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Bai, Lanlan; Wada, Satoshi] RIKEN, Ctr Adv Photon, Photon Control Technol Team, Wako, Saitama, Japan; [Sato, Hirotaka; Aida, Yoko] RIKEN, Cluster Sci Technol & Innovat Hub, Nakamura Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Kubo, Yoshinao] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan	RIKEN; RIKEN; RIKEN; Nagasaki University	Aida, Y (corresponding author), RIKEN, Cluster Sci Technol & Innovat Hub, Nakamura Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	aida@riken.jp		Sato, Hirotaka/0000-0002-8321-9731; BAI, Lanlan/0000-0002-2414-3247	Japan Society for the Promotion of Science (JSPS) [16H02590]; Project of the National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution (the special scheme project on regional developing strategy) [16817983]; Project of the NARO Bio-oriented Technology Research Advancement Institution (the special scheme project on vitalizing management entities of agriculture, forestry, and fisheries) [16930548]; JSPS Postdoctoral Fellowship [16F16404]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Project of the National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution (the special scheme project on regional developing strategy); Project of the NARO Bio-oriented Technology Research Advancement Institution (the special scheme project on vitalizing management entities of agriculture, forestry, and fisheries); JSPS Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank the members of the Viral Infectious Disease Unit (RIKEN) for technical assistance and helpful suggestions, and the Support Unit for Biomaterial Analysis [RIKEN Brain Science Institute (BSI) Research Resources Center] for help with sequence analysis. This work was supported by Grants-in-Aid for Scientific Research [A (16H02590)] from the Japan Society for the Promotion of Science (JSPS), a grant from the Project of the National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution (the special scheme project on regional developing strategy; Grant 16817983), a grant from the Project of the NARO Bio-oriented Technology Research Advancement Institution (the special scheme project on vitalizing management entities of agriculture, forestry, and fisheries; Grant 16930548), and by the JSPS Postdoctoral Fellowship (Grant 16F16404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	AIDA Y, 1989, AM J VET RES, V50, P1946; Aida Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00328; ALBRITTON LM, 1993, J VIROL, V67, P2091, DOI 10.1128/JVI.67.4.2091-2096.1993; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; ALTANEROVA V, 1989, J GEN VIROL, V70, P1929, DOI 10.1099/0022-1317-70-7-1929; ALTANEROVA V, 1990, Archiv fuer Geschwulstforschung, V60, P89; ALTANEROVA V, 1989, AIDS, V3, P755, DOI 10.1097/00002030-198911000-00012; Animal and Plant Health Inspection Service, 2008, BOV LEUK VIR BLV US; Bae EH, 2006, J MICROBIOL, V44, P447; BAN J, 1993, J VIROL, V67, P1050, DOI 10.1128/JVI.67.2.1050-1057.1993; BAN J, 1994, ARCH VIROL, V138, P379, DOI 10.1007/BF01379141; BRUCK C, 1982, VIROLOGY, V122, P342, DOI 10.1016/0042-6822(82)90234-3; Buehring GC, 2003, AIDS RES HUM RETROV, V19, P1105, DOI 10.1089/088922203771881202; Buehring GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179367; Buehring GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134304; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; CALLEBAUT I, 1993, J VIROL, V67, P5321, DOI 10.1128/JVI.67.9.5321-5327.1993; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Ghez D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-99; Ghezzi P. C., 1997, Revista Argentina de Microbiologia, V29, P137; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Hunter E., 1997, P71; Inabe K, 1999, J VIROL, V73, P1293, DOI 10.1128/JVI.73.2.1293-1301.1999; Inabe K, 1998, VIROLOGY, V245, P53, DOI 10.1006/viro.1998.9140; Johnston ER, 2000, J VIROL, V74, P2930, DOI 10.1128/JVI.74.6.2930-2935.2000; Jones KS, 2011, VIRUSES-BASEL, V3, P794, DOI 10.3390/v3060794; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Kakoki K, 2014, VIRUS GENES, V48, P448, DOI 10.1007/s11262-014-1036-1; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; Kubo Y, 2002, VIROLOGY, V303, P338, DOI 10.1006/viro.2002.1641; MAMMERICKX M, 1981, ZBL VET MED B, V28, P69; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; MILLER JM, 1969, JNCI-J NATL CANCER I, V43, P1297; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Nagaoka Y, 1999, CANCER RES, V59, P975; OLSON C, 1981, J NATL CANCER I, V67, P671; ONUMA M, 1986, LEUKEMIA RES, V10, P689, DOI 10.1016/0145-2126(86)90274-2; Orlik O, 1997, J VIROL, V71, P3263, DOI 10.1128/JVI.71.4.3263-3267.1997; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; Polat M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0876-4; SAGATA N, 1984, EMBO J, V3, P3231, DOI 10.1002/j.1460-2075.1984.tb02283.x; Sato H, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1172-2; Sato H, 2018, ARCH VIROL, V163, P1519, DOI 10.1007/s00705-018-3744-7; Sommerfelt MA, 1999, J GEN VIROL, V80, P3049, DOI 10.1099/0022-1317-80-12-3049; Suzuki T, 1998, J VIROL, V72, P593, DOI 10.1128/JVI.72.1.593-599.1998; Van Der Maaten M J, 1975, Bibl Haematol, P360; WANG H, 1991, NATURE, V352, P729, DOI 10.1038/352729a0; Webster R. G., 1994, ENCY VIROLOGY; WEISS RA, 1995, CELL, V82, P531, DOI 10.1016/0092-8674(95)90024-1; YOSHIMOTO T, 1993, J VIROL, V67, P1310, DOI 10.1128/JVI.67.3.1310-1314.1993	51	15	17	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14516	14527		10.1096/fj.201901528R	http://dx.doi.org/10.1096/fj.201901528R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31648581	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000507466100112
J	Kucirek, M; Bagherpoor, AJ; Jaros, J; Hampl, A; Stros, M				Kucirek, Martin; Bagherpoor, Alireza J.; Jaros, Josef; Hampl, Ales; Stros, Michal			HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells	FASEB JOURNAL			English	Article						HMGB1; hESCs; neuroectodermal cells; telomeres	MOBILITY GROUP BOX; CHROMATIN PROTEIN HMGB2; REVERSE-TRANSCRIPTASE HTERT; ARTICULAR-CARTILAGE; DOWN-REGULATION; NONCODING RNA; BREAST-CANCER; TERRA; DNA; EXPRESSION	High-mobility group box (HMGB)1 and HMGB2 proteins are the subject of intensive research because of their involvement in DNA replication, repair, transcription, differentiation, proliferation, cell signaling, inflammation, and tumor migration. Using inducible, stably transfected human embryonic stem cells (hESCs) capable of the short hairpin RNA-mediated knockdown (KD) of HMGB1 and HMGB2, we provide evidence that deregulation of HMGB1 or HMGB2 expression in hESCs and their differentiated derivatives (neuroectodermal cells) results in distinct modulation of telomere homeostasis. Whereas HMGB1 enhances telomerase activity, HMGB2 acts as a negative regulator of telomerase activity in the cell. Stimulation of telomerase activity in the HMGB2-deficient cells may be related to activation of the PI3K/protein kinase B/ glycogen synthase kinase-313/ I3-catenin signaling pathways by HMGB1, augmented TERT/telomerase RNA subunit transcription, and possibly also because of changes in telomeric repeat-containing RNA (TERRA) and TERRA-polyA(+) transcription. The impact of HMGB1/2 KD on telomerase transcriptional regulation observed in neuroectodermal cells is partially masked in hESCs by their pluripotent state. Our findings on differential roles of HMGB1 and HMGB2 proteins in regulation of telomerase activity may suggest another possible outcome of HMGB1 targeting in cells, which is currently a promising approach aiming at increasing the anticancer activity of cytotoxic agents.	[Kucirek, Martin; Bagherpoor, Alireza J.; Stros, Michal] Czech Acad Sci, Inst Biophys, Dept Cell Biol & Radiobiol, Lab Anal Chromosomal Proteins, Brno, Czech Republic; [Jaros, Josef; Hampl, Ales] Masaryk Univ, Dept Histol & Embryol, Fac Med, Brno, Czech Republic; [Jaros, Josef; Hampl, Ales] St Annes Univ Hosp, Cell & Tissue Regenerat, Int Clin Res Ctr, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Stros, M (corresponding author), Czech Acad Sci, Inst Biophys, Kralovopolska 135, Brno 61200, Czech Republic.	stros@ibp.cz	Jaros, Josef/AAH-3332-2020	Jaros, Josef/0000-0001-7559-2344; Kucirek, Martin/0000-0003-1297-8631	Grant Agency of the Czech Republic [P305-15-01354S]; Internal Research Support Program of the Institute of Biophysics (Czech Academy of Sciences) [IBP CAS 68081707]; Ministry of Health of the Czech Republic [16-31501A]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Internal Research Support Program of the Institute of Biophysics (Czech Academy of Sciences); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The authors thank Thomas R. Cech (University of Colorado, Boulder, CO, USA) for plasmid phTR, and Maty Tzukerman (Technion-Israel Institute of Technology, Haifa, Israel) for plasmid hTERT(283-bp)-Luc. The authors also thank Radek Fedr [Institute of Biophysics (IBP), Czech Academy of Sciences (CAS)] for advice on confocal microscopy, and Petr Vanhara (Masaryk University) for the gift of PI3K/b-catenin antibodies. Financial support for this research was provided through the Grant Agency of the Czech Republic (Grant P305-15-01354S to M..S.) and the Internal Research Support Program of the Institute of Biophysics (Czech Academy of Sciences, IBP CAS 68081707 to M..S.), and Ministry of Health of the Czech Republic (Grant 16-31501A to A.H.). The authors declare no conflicts of interest.	Abraham AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084838; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Aird KM, 2016, J CELL BIOL, V215, P325, DOI 10.1083/jcb.201608026; Bagherpoor AJ, 2017, STEM CELLS DEV, V26, P328, DOI 10.1089/scd.2016.0274; Bandaria JN, 2016, CELL, V164, P735, DOI 10.1016/j.cell.2016.01.036; Barreiro-Alonso A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5845061; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bianchi ME, 2017, IMMUNOL REV, V280, P74, DOI 10.1111/imr.12601; Biniossek ML, 2013, J PROTEOMICS, V91, P515, DOI 10.1016/j.jprot.2013.08.007; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Cai X, 2017, ACTA BIOCH BIOPH SIN, V49, P119, DOI 10.1093/abbs/gmw124; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Campbell PA, 2013, STEM CELLS, V31, P1107, DOI 10.1002/stem.1365; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chang JT, 2006, BRIT J CANCER, V94, P870, DOI 10.1038/sj.bjc.6603008; Chen RJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.333; Cui GF, 2019, HUM PATHOL, V84, P133, DOI 10.1016/j.humpath.2018.09.017; Fajkus J, 2003, BIOTECHNIQUES, V35, P912; Feretzaki M, 2017, METHODS, V114, P39, DOI 10.1016/j.ymeth.2016.08.004; Fu DY, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0219-0; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; He SJ, 2017, ONCOTARGET, V8, P64534, DOI 10.18632/oncotarget.17885; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Montero JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12534; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Ke SB, 2015, INT J ONCOL, V46, P1051, DOI 10.3892/ijo.2014.2793; Khattar E, 2017, FRONT CELL DEV BIOL, V5, DOI [10.3389/fcell.2017.00007, 10.3389/fcell.2017.00001]; Kim HK, 2018, MOL CELLS, V41, P362, DOI 10.14348/molcells.2018.2291; Kimura A, 2018, DEV DYNAM, V247, P229, DOI 10.1002/dvdy.24559; Koch L, 2017, NAT REV GENET, V18, P453, DOI 10.1038/nrg.2017.58; Koh CM, 2013, METHOD ENZYMOL, V529, P161, DOI 10.1016/B978-0-12-418687-3.00013-6; Kong DM, 2007, ANAL BIOANAL CHEM, V388, P699, DOI 10.1007/s00216-007-1247-6; Laurent B, 2010, BLOOD, V115, P687, DOI 10.1182/blood-2009-06-230094; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; MacNeil DE, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090064; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mansour FH, 2013, ANAL BIOCHEM, V441, P18, DOI 10.1016/j.ab.2013.06.008; Mender Ilgen, 2015, Bio Protoc, V5; Meneghini V, 2013, J NEUROSCI, V33, P6047, DOI 10.1523/JNEUROSCI.2052-12.2013; Moravec M, 2016, EMBO REP, V17, P999, DOI 10.15252/embr.201541708; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Nakanishi A, 2014, INT J ONCOL, V44, P1813, DOI 10.3892/ijo.2014.2377; Pagano B, 2015, CHEM COMMUN, V51, P2964, DOI 10.1039/c4cc07231f; Polanska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089070; Polanska E, 2012, CHROMOSOMA, V121, P419, DOI 10.1007/s00412-012-0373-x; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Redon S, 2010, NUCLEIC ACIDS RES, V38, P5797, DOI 10.1093/nar/gkq296; Reeves R, 2015, DNA REPAIR, V36, P122, DOI 10.1016/j.dnarep.2015.09.015; Ronfani L, 2001, DEVELOPMENT, V128, P1265; Saleh S, 2008, PATHOLOGY, V40, P25, DOI 10.1080/00313020701716425; Sasaki T, 2013, PATHOBIOLOGY, V81, P36, DOI 10.1159/000351721; Sato M, 2019, CIRC J, V83, P368, DOI 10.1253/circj.CJ-18-0925; Scheibe M, 2013, GENOME RES, V23, P2149, DOI 10.1101/gr.151878.112; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Shay JW, 2019, NAT REV GENET, V20, P299, DOI 10.1038/s41576-019-0099-1; Shin YJ, 2013, CANCER BIOL THER, V14, P213, DOI 10.4161/cbt.23292; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Stros M, 2018, BBA-GENE REGUL MECH, V1861, P200, DOI 10.1016/j.bbagrm.2018.02.002; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tang DL, 2010, AUTOPHAGY, V6, P1181, DOI 10.4161/auto.6.8.13367; Taniguchi N, 2011, J BIOL CHEM, V286, P41489, DOI 10.1074/jbc.M111.236984; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P16817, DOI 10.1073/pnas.0904414106; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P1181, DOI 10.1073/pnas.0806062106; Trotman LC, 2003, CANCER CELL, V3, P97, DOI 10.1016/S1535-6108(03)00022-9; Wang CQ, 2015, INT J BIOL SCI, V11, P316, DOI 10.7150/ijbs.10528; Wang F, 2016, INT J MOL MED, V37, P1421, DOI 10.3892/ijmm.2016.2518; Wang LM, 2014, MOL CANCER RES, V12, P190, DOI 10.1158/1541-7786.MCR-13-0411; Wang S, 2019, CANCER MANAG RES, V11, P3111, DOI 10.2147/CMAR.S200566; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu RA, 2017, ANNU REV BIOCHEM, V86, P439, DOI 10.1146/annurev-biochem-061516-045019; Wu S, 2014, EUR UROL, V65, P274, DOI 10.1016/j.eururo.2013.10.038; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282; Zhao YL, 2017, HEPATOL COMMUN, V1, P816, DOI 10.1002/hep4.1086; Zhou XY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/743879	86	6	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14307	14324		10.1096/fj.201901465RRR	http://dx.doi.org/10.1096/fj.201901465RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31661640	Bronze			2022-12-28	WOS:000507466100097
J	Wang, YB; Yang, XD; Jiang, A; Wang, W; Li, J; Wen, JM				Wang, Yanbin; Yang, Xudong; Jiang, An; Wang, Wei; Li, Jian; Wen, Junmin			Methylation-dependent transcriptional repression of RUNX3 by KCNQ1OT1 regulates mouse cardiac microvascular endothelial cell viability and inflammatory response following myocardial infarction	FASEB JOURNAL			English	Article						DNMT1; MI; CMECs	LONG NONCODING RNAS; GENE-EXPRESSION; MESENCHYMAL TRANSITION; RISK	Myocardial infarction (MI) is a major contributor to death and disability throughout the world. Increasing evidence shows that long noncoding RNAs (lncRNAs) are involved in the progression of MI. Here, we hypothesized that lncRNA potassium voltage-gated channel subfamily q member 1 overlapping transcript 1 (KCNQ1OT1) could affect the development of MI via regulation of Runt-related transcription factor (RUNX)3 by methylation. Initially, by ligation of the left anterior descending coronary artery, an acute MI (AMI) mouse model was established to collect the cardiac microvascular endothelial cells (CMECs), which revealed a high KCNQ1OT1 expression and a low RUNX3 expression with its high methylation. After that, KCNQ1OT1 knockdown or RUNX3 overexpression were transduced into the CMECs in order to detect their role in CMEC proliferation, apoptosis, and inflammatory response. Moreover, we assessed their interaction with the inflammatory Notch pathway, by determining the expression of Jagged 1, Hey1, Hes1, Notch intracellular domain, and Notch1. It was observed that after KCNQ1OT1 knockdown, the proliferation of AMI-CMECs was promoted, whereas their apoptosis was inhibited, accompanied by reduced level of inflammatory factors. These trends could also be achieved by RUNX3 overexpression via the Notch pathway. Finally, the regulation of DNA methyltransferase (DNMT)1 dependent methylation in RUNX3 by KCNQ1OT1 was determined, suggesting that KCNQ1OT1 could result in down-regulated RUNX3 expression through promoted RUNX3 methylation caused by recruiting DNMT1. Overall, this study demonstrates that KCNQ1OT1 silencing inhibits RUNX3 methylation, thereby offering protection against CMEC injury and inflammatory response in AMI, which may serve as a promising target for the disease treatment.	[Wang, Yanbin; Wang, Wei; Li, Jian] Chinese Acad Med Sci, Fuwai Hosp, Dept Anesthesia, Shenzhen, Peoples R China; [Wen, Junmin] Chinese Acad Med Sci, Fuwai Hosp, Dept Intens Care Med, Shenzhen, Peoples R China; [Yang, Xudong] Xi An Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Xian, Peoples R China; [Jiang, An] Xi An Jiao Tong Univ, Affiliated Hosp 2, Gen Surg Dept Cadres Ward, Xian, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Xi'an Jiaotong University; Xi'an Jiaotong University	Wen, JM (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Dept Intens Care Med, 167 N Lishi Rd, Beijing 100037, Peoples R China.	wenjunmin2018@163.com						Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Cai M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28250; Chen B, 2018, MOL MED REP, V18, P16, DOI 10.3892/mmr.2018.8987; Chen WC, 2010, J GASTROEN HEPATOL, V25, P823, DOI 10.1111/j.1440-1746.2009.06191.x; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Gao J, 2010, EXP CELL RES, V316, P149, DOI 10.1016/j.yexcr.2009.09.025; Gao Nan, 2008, Zhonghua Zhongliu Zazhi, V30, P361; Harati H., 2015, INT J HIGH RISK BEHA, V4; Homma N, 2006, CANCER SCI, V97, P51, DOI 10.1111/j.1349-7006.2005.00133.x; Hu H, 2018, BIOMED PHARMACOTHER, V106, P738, DOI 10.1016/j.biopha.2018.06.122; Li H, 2017, INT J ONCOL, V50, P2059, DOI 10.3892/ijo.2017.3988; Li L, 2018, EUR REV MED PHARMACO, V22, P4332, DOI 10.26355/eurrev_201807_15430; Li M, 2018, MED SCI MONITOR, V24, P5064, DOI 10.12659/MSM.909348; Li X, 2017, J ELECTR COMPUT ENG, V2017, P1, DOI 10.1155/2017/5232507; Liang ZG, 2018, INT J MOL MED, V42, P975, DOI 10.3892/ijmm.2018.3695; Liu YH, 2017, INT J MOL MED, V40, P65, DOI 10.3892/ijmm.2017.2998; Lotem J, 2015, BBA-REV CANCER, V1855, P131, DOI 10.1016/j.bbcan.2015.01.004; Mathy NW, 2017, J BIOL CHEM, V292, P12375, DOI 10.1074/jbc.R116.760884; Mohammad F, 2010, DEVELOPMENT, V137, P2493, DOI 10.1242/dev.048181; Radecke CE, 2015, THROMB HAEMOSTASIS, V113, P605, DOI 10.1160/TH14-02-0151; Reed GW, 2017, LANCET, V389, P197, DOI 10.1016/S0140-6736(16)30677-8; Saddic LA, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001534; Silva JP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29993-4; Smid M, 2011, J THROMB HAEMOST, V9, P450, DOI 10.1111/j.1538-7836.2010.04162.x; Vausort M, 2014, CIRC RES, V115, P668, DOI 10.1161/CIRCRESAHA.115.303836; Wada M, 2004, ONCOGENE, V23, P2401, DOI 10.1038/sj.onc.1207395; Wan J, 2013, DNA CELL BIOL, V32, P628, DOI 10.1089/dna.2013.2118; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Xian Y, 2015, CIRCULATION, V132, P174, DOI 10.1161/CIRCULATIONAHA.114.014992; Xue J, 2017, ASIAN PAC J TROP MED, V10, P94, DOI 10.1016/j.apjtm.2016.11.010; Yang KP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00728; Yao XP, 2015, BIOMATERIALS, V60, P130, DOI 10.1016/j.biomaterials.2015.04.046; Zhang J, 2014, J CARDIOVASC PHARM, V64, P127, DOI 10.1097/FJC.0000000000000096; Zhou T, 2017, J CELL PHYSL, V234, P8659; Zhou XY, 2017, EXP THER MED, V14, P2695, DOI 10.3892/etm.2017.4812; Zhu YT, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0239-x	37	21	23	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13145	13160		10.1096/fj.201900310R	http://dx.doi.org/10.1096/fj.201900310R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31625414	Green Published, Bronze			2022-12-28	WOS:000507466100010
J	Wu, BL; Shang, HT; Liang, XT; Sun, YX; Jing, H; Han, X; Cheng, W				Wu, Bolin; Shang, Haitao; Liang, Xitian; Sun, Yixin; Jing, Hui; Han, Xue; Cheng, Wen			Preparation of novel targeting nanobubbles conjugated with small interfering RNA for concurrent molecular imaging and gene therapy in vivo	FASEB JOURNAL			English	Article						hepatocellular carcinoma; Balc/c nude mice; low-frequency ultrasound; NET-1; SMMC-7721	OVARIAN-CANCER; ULTRASOUND; MICROBUBBLES; EXPRESSION; TRANSFECTION; INHIBITION; GLYPICAN-3; INDUCTION; APOPTOSIS; NET-1	The aim of this study was to establish a novel targeting nanobubble (TNB) conjugated with small interfering RNA (siRNA)-cyanine 5 (Cy5) and to validate its theranostic ability in vivo. The TNB conjugated with neuroepithelial transforming gene 1 (NET-1) siRNA-Cy5 was prepared by thin-film hydration and mechanical sonication method. A hepatocellular carcinoma (HCC) xenograft model was established by subcutaneously injecting SMMC-7721 cells in BALB/c nude mice. The NET-1 siRNA-conjugated TNB was utilized for accurate contrast-enhanced ultrasound in vivo imaging, which was enabled by the target ligand GPC-3 antibody and specific gene transfection with the aid of low-frequency ultrasound (LFUS) irradiation. BALB/c nude mice bearing tumors were randomized into 5 groups and irradiated with LFUS for 5 min after TNB administration; mice were treated twice a week for a total of 60 d. The mean particle size of TNB was <500 nm. Mice treated with NET-1 siRNA-conjugated TNB showed a significant decrease in tumor growth and the highest survival rate. Our findings offer an effective and safe gene vehicle and probe for molecular imaging in vivo. It may improve the early diagnosis and treatment effects of HCC.	[Wu, Bolin; Shang, Haitao; Liang, Xitian; Sun, Yixin; Jing, Hui; Han, Xue; Cheng, Wen] Harbin Med Univ, Canc Hosp, Dept Ultrasound, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China	Harbin Medical University	Cheng, W (corresponding author), Harbin Med Univ, Canc Hosp, Dept Ultrasound, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China.	chengwen69@yahoo.com	Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-8389-8252	Natural Science Foundation of China [81571682, 81371568]; Fundamental Research Funds for the Provincial Universities [2017LCZX91]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Provincial Universities	The SMMC-7721 cells were a generous gift from the Institute of Cancer Research affiliated with Harbin Medical University. This research was supported by the Natural Science Foundation of China (Grants 81571682 and 81371568) and the Fundamental Research Funds for the Provincial Universities (Grant 2017LCZX91). The authors declare no conflicts of interest.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Chang SF, 2013, ULTRASON SONOCHEM, V20, P171, DOI 10.1016/j.ultsonch.2012.06.015; Chen L, 2007, INT J SURG PATHOL, V15, P346, DOI 10.1177/1066896907306083; Cosgrove D, 2006, EUR J RADIOL, V60, P324, DOI 10.1016/j.ejrad.2006.06.022; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Ferrara KW, 2009, ACCOUNTS CHEM RES, V42, P881, DOI 10.1021/ar8002442; Gao Y, 2017, NANOMED-NANOTECHNOL, V13, P2159, DOI 10.1016/j.nano.2017.06.001; Geis NA, 2012, CURR PHARM DESIGN, V18, P2166, DOI 10.2174/138161212800099946; Ji ZJ, 2015, ONCOL REP, V34, P811, DOI 10.3892/or.2015.4062; Jing H, 2015, ARCH MED SCI, V11, P292, DOI 10.5114/aoms.2015.50963; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Marmottant P, 2003, NATURE, V423, P153, DOI 10.1038/nature01613; Serru V, 2000, BBA-PROTEIN STRUCT M, V1478, P159, DOI 10.1016/S0167-4838(00)00022-4; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Tatiparti K, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7040077; The White House, PRECISION MED INITIA; Tian YH, 2018, ONCOTARGETS THER, V11, P4785, DOI 10.2147/OTT.S170786; Torchilin Vladimir P, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00477-3_1; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; WILLIAMS AR, 1973, J CELL SCI, V12, P875; Wu BL, 2016, TUMOR BIOL, V37, P12113, DOI 10.1007/s13277-016-5082-2; Wu J, 2008, ADV DRUG DELIVER REV, V60, P1103, DOI 10.1016/j.addr.2008.03.009; Yan F, 2011, ULTRASOUND MED BIOL, V37, P768, DOI 10.1016/j.ultrasmedbio.2011.02.006; Zarnitsyn V, 2008, BIOPHYS J, V95, P4124, DOI 10.1529/biophysj.108.131664; Zhu ZW, 2001, GUT, V48, P558, DOI 10.1136/gut.48.4.558	28	11	13	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14129	14136		10.1096/fj.201900716RR	http://dx.doi.org/10.1096/fj.201900716RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31657628				2022-12-28	WOS:000507466100082
J	Zhou, LL; Li, QJ; Chen, A; Liu, N; Chen, N; Chen, XJ; Zhu, L; Xia, BZ; Gong, YQ; Chen, XD				Zhou, Lulu; Li, Qinjin; Chen, Ao; Liu, Na; Chen, Ning; Chen, Xiaojun; Zhu, Lin; Xia, Benzeng; Gong, Yuqing; Chen, Xiaodong			KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondria! dysfunction via NF-kappa B-FGF21 or SREBP1c-FGF21 pathway	FASEB JOURNAL			English	Article						promoter; mitochondria; NAFLD; endoplasmic reticulum stress	GROWTH-FACTOR 21; FATTY LIVER-DISEASE; ER STRESS; PROTEIN; INSULIN; NASH; PATHOGENESIS; LIPOGENESIS; ACTIVATION; EXPRESSION	Twist-related protein 2 (TWIST2) is identified as a basic helix-loop-helix (b-HLH) transcription repressor by dimerizing with other b-HLH proteins. The significance of TWIST2 has been emphasized in various tumors; however, few studies report its functions in metabolism and metabolic diseases. Here we aimed to explore the novel role and regulation mechanism of TWIST2 in hepatic steatosis. Our results showed that Twist2 knockdown caused mice obesity, insulin resistance, and hepatic steatosis, which were accompanied with inflammation, endoplasmic reticulum stress, and mitochondrial dysfunction. In vitro, TWIST2 overexpression ameliorated hepatocellular steatosis, inhibited inflammation, and improved mitochondrial content and function with a fibroblast growth factor 21 (FGF21) dependent pattern. NF-kappa B negatively regulated FGF21 transcription by directly binding to FGF21 promoter DNA, which was eliminated by TWIST2 overexpression by inhibiting NF-kappa B expression and translocation to nucleus. TWIST2 overexpression decreased intracellular reactive oxygen species level, increased mitochondrial DNA and biogenesis, and enhanced ATP production and antioxidation ability. Additionally, TWIST2 expression was repressed by insulin-targeting sterol regulatory element binding protein 1c (SREBP1c) and forkhead box protein O1 and was enhanced by dexamethasone targeting Kriippel-like factor 15, which directly interacted with Twist2 promoter DNA. Together, our studies identify an important role and regulation mechanism of TWIST2 in maintaining hepatic homeostasis by ameliorating steatosis, inflammation, and oxidative stress via the NF-kappa B FGF21 or SREBP1c-FGF21 pathway, which may provide a new therapeutic scheme for nonalcoholic fatty liver disease.	[Zhou, Lulu; Li, Qinjin; Chen, Ao; Chen, Ning; Chen, Xiaodong] Huazhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; [Zhou, Lulu; Li, Qinjin; Chen, Ao; Chen, Ning; Chen, Xiaodong] Huazhong Agr Univ, Coll Vet Med, Shizishan St 1, Wuhan 430070, Peoples R China; [Zhou, Lulu; Li, Qinjin; Liu, Na; Chen, Xiaojun; Zhu, Lin; Xia, Benzeng; Gong, Yuqing; Chen, Xiaodong] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Chen, Ao] Wuhan Univ Sci & Technol, Coll Life Sci & Hlth, Inst Biol & Med, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Wuhan University of Science & Technology	Chen, XD (corresponding author), Huazhong Agr Univ, Coll Vet Med, Shizishan St 1, Wuhan 430070, Peoples R China.; Chen, XD (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Shizishan St 1, Wuhan 430070, Peoples R China.	chenxd@mail.hzau.edu.cn			National Key Research and Development Program of China [2017YFA010320-01, 2018YFD0500401-03]; Natural Science Foundation of China [31572382]; Fundamental Research Funds for the Central Universities [2662018PY020, 2662017JC034]	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Research and Development Program of China (2017YFA010320-01 and 2018YFD0500401-03), the Natural Science Foundation of China (31572382), and the Fundamental Research Funds for the Central Universities (2662018PY020 and 2662017JC034). The authors declare no conflicts of interest.	Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7; Arrese M, 2016, DIGEST DIS SCI, V61, P1294, DOI 10.1007/s10620-016-4049-x; Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; BonDurant LD, 2018, ANNU REV NUTR, V38, P173, DOI 10.1146/annurev-nutr-071816-064800; Canbay A, 2007, Z GASTROENTEROL, V45, P35, DOI 10.1055/s-2006-927368; Chen A, 2018, BBA-MOL CELL BIOL L, V1863, P538, DOI 10.1016/j.bbalip.2018.02.003; Cheng ZY, 2015, TRENDS ENDOCRIN MET, V26, P402, DOI 10.1016/j.tem.2015.06.006; Chichger H, 2015, FASEB J, V29, P868, DOI 10.1096/fj.14-257212; Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009; El Ghouzzi V, 2001, FEBS LETT, V492, P112, DOI 10.1016/S0014-5793(01)02238-4; Engin A, 2017, ADV EXP MED BIOL, V960, P443, DOI 10.1007/978-3-319-48382-5_19; Fabbrini E, 2015, NUTRIENTS, V7, P4995, DOI 10.3390/nu7064995; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Hamborg M, 2013, PHARM RES-DORDR, V30, P140, DOI 10.1007/s11095-012-0856-8; Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsieh PN, 2019, ENDOCR REV, V40, P137, DOI 10.1210/er.2018-00151; Jakobsen MU, 2007, EPIDEMIOL REV, V29, P77, DOI 10.1093/epirev/mxm002; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim OK, 2015, ANN NUTR METAB, V67, P218, DOI 10.1159/000440905; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Lee YS, 2003, NUCLEIC ACIDS RES, V31, P7165, DOI 10.1093/nar/gkg934; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liu J, 2015, METABOLISM, V64, P380, DOI 10.1016/j.metabol.2014.11.009; Maiers JL, 2019, SEMIN LIVER DIS, V39, P235, DOI 10.1055/s-0039-1681032; Maratos-Flier E, 2017, EXP CELL RES, V360, P2, DOI 10.1016/j.yexcr.2017.05.006; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pettersson AT, 2010, DIABETES, V59, P564, DOI 10.2337/db09-0997; Ren R, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0361-x; Sakamoto M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08226-2; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Spahis S, 2017, ANTIOXID REDOX SIGN, V26, P519, DOI 10.1089/ars.2016.6776; Wishahi Mohamed, 2018, Open Access Maced J Med Sci, V6, P1017, DOI 10.3889/oamjms.2018.165; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yilmaz E, 2017, ADV EXP MED BIOL, V960, P261, DOI 10.1007/978-3-319-48382-5_11; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zhang Y, 2011, MOL CELL ENDOCRINOL, V342, P41, DOI 10.1016/j.mce.2011.05.003; Zhao Chengxiao, 2015, Yichuan, V37, P17, DOI 10.16288/j.yczz.2015.01.003; Zhou L, 2013, HEPATOLOGY, V57, P1384, DOI 10.1002/hep.26167	51	11	11	13	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14254	14269		10.1096/fj.201901347RR	http://dx.doi.org/10.1096/fj.201901347RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31648561	Bronze			2022-12-28	WOS:000507466100093
J	Majumdar, G; Yadav, G; Hamaide, J; Coussement, L; De Meyer, T; Verhoye, M; Vanden Berghe, W; Van der Linden, A; Balthazart, J				Majumdar, Gaurav; Yadav, Garima; Hamaide, Julie; Coussement, Louis; De Meyer, Tim; Verhoye, Marleen; Vanden Berghe, Wim; Van der Linden, Annemie; Balthazart, Jacques			Molecular correlates of hypothalamic development in songbird ontogeny in comparison with the telencephalon	FASEB JOURNAL			English	Article						hormones; hypothalamus; ontogeny; sexual dimorphism; telencephalon; zebra finch	TESTOSTERONE-METABOLIZING ENZYMES; RECEPTOR MESSENGER-RNA; FEMALE ZEBRA FINCHES; SEXUAL-DIFFERENTIATION; THYROID-HORMONE; GENE-EXPRESSION; BRAIN NUCLEI; AROMATASE; BEHAVIOR; ORGANIZATION	Development of the songbird brain provides an excellent experimental model for understanding the regulation of sex differences in ontogeny. Considering the regulatory role of the hypothalamus in endocrine, in particular reproductive, physiology, we measured the structural (volume) and molecular correlates of hypothalamic development during ontogeny of male and female zebra finches. We quantified by relative quantitative polymerase chain reaction (rqPCR) the expression of 14 genes related to thyroid and steroid hormones actions as well as 12 genes related to brain plasticity at four specific time points during ontogeny and compared these expression patterns with the expression of the same genes as detected by transcriptomics in the telencephalon. These two different methodological approaches detected specific changes with age and demonstrated that in a substantial number of cases changes observed in both brain regions are nearly identical. Other genes however had a tissue-specific developmental pattern. Sex differences or interactions of sex by age were detected in the expression of a subset of genes, more in hypothalamus than telencephalon. These results correlate with multiple known aspects of the developmental and reproductive physiology but also raise a number of new functional questions.	[Majumdar, Gaurav; Yadav, Garima; Hamaide, Julie; Verhoye, Marleen; Van der Linden, Annemie] Univ Antwerp, Dept Biomed Sci, Bioimaging Lab, B-2000 Antwerp, Belgium; [Coussement, Louis; De Meyer, Tim] Univ Ghent, Dept Data Anal & Math Modelling, Biobix Lab Bioinformat & Computat Genom, Ghent, Belgium; [Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signaling PPES, Antwerp, Belgium; [Balthazart, Jacques] Univ Liege, GIGA Neurosci, Lab Behav Neuroendocrinol, Liege, Belgium	University of Antwerp; Ghent University; University of Antwerp; University of Liege	Majumdar, G (corresponding author), Univ Antwerp, Dept Biomed Sci, Bioimaging Lab, B-2000 Antwerp, Belgium.	Gaurav.majumdar@uantwerpen.be	Vanden Berghe, Wim/HGE-4696-2022; Berghe, Wim Vanden/S-6425-2018	Berghe, Wim Vanden/0000-0003-0161-7355; majumdar, gaurav/0000-0002-4238-3404	NINDS NIH HHS [RO1NS104008] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham U, 2003, CHRONOBIOL INT, V20, P657, DOI 10.1081/CBI-120022414; ADKINSREGAN E, 1994, J NEUROBIOL, V25, P865, DOI 10.1002/neu.480250710; ADKINSREGAN E, 1987, ANIM BEHAV, V35, P1100, DOI 10.1016/S0003-3472(87)80167-7; ADKINSREGAN E, 1990, HORM BEHAV, V24, P114, DOI 10.1016/0018-506X(90)90031-R; Agate RJ, 2003, P NATL ACAD SCI USA, V100, P4873, DOI 10.1073/pnas.0636925100; ARNOLD AP, 1988, FRONT NEUROENDOCRIN, V10, P185; BALTHAZART J, 1992, HORM BEHAV, V26, P179, DOI 10.1016/0018-506X(92)90041-S; BALTHAZART J, 1992, BRAIN RES, V574, P280, DOI 10.1016/0006-8993(92)90828-W; Balthazart J, 2007, FRONT NEUROENDOCRIN, V28, P161, DOI 10.1016/j.yfrne.2007.05.003; Balthazart J, 2017, HORMONES, BRAIN AND BEHAVIOR, VOL 5: DEVELOPMENT OF HORMONE-BEHAVIOR RELATIONSHIPS, 3RD EDITION, P185, DOI 10.1016/B978-0-12-803592-4.00101-2; Balthazart J, 2017, HORM BEHAV, V93, P137, DOI 10.1016/j.yhbeh.2017.05.017; Bardet SM, 2012, J COMP NEUROL, V520, P4226, DOI 10.1002/cne.23153; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; BOTTJER SW, 1985, J NEUROSCI, V5, P1556, DOI 10.1523/jneurosci.05-06-01556.1985; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Breazile James E., 1993, Publications of the Nuttall Ornithological Club, V23, P493; Burbridge S, 2016, COMPR PHYSIOL, V6, P623, DOI 10.1002/cphy.c150023; Cao J, 2002, BRAIN RES, V943, P80, DOI 10.1016/S0006-8993(02)02537-4; Chao A, 2015, DEV NEUROBIOL, V75, P271, DOI 10.1002/dneu.22228; Chen G, 2006, J NEUROBIOL, V66, P537, DOI 10.1002/neu.20247; Cornez G, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0849; de Vries G.J., 2002, HORMONES BRAIN BEHAV, P137, DOI [10.1016/B978, DOI 10.1016/B978-012532104-4/50066-4]; Ernst DK, 2016, J EXP BIOL, V219, P783, DOI 10.1242/jeb.126987; Felling RJ, 2015, EXP NEUROL, V268, P37, DOI 10.1016/j.expneurol.2014.09.017; Gahr M, 2004, ANN NY ACAD SCI, V1016, P684, DOI 10.1196/annals.1298.025; GURNEY ME, 1980, SCIENCE, V208, P1380, DOI 10.1126/science.208.4450.1380; Hamaide J, 2018, NEUROIMAGE, V181, P190, DOI 10.1016/j.neuroimage.2018.07.010; Hayase S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006537; Hernandez A, 2012, ENDOCRINOLOGY, V153, P2919, DOI 10.1210/en.2011-1905; Islam MM, 2015, BBA-GENE REGUL MECH, V1849, P210, DOI 10.1016/j.bbagrm.2014.06.001; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Johnen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058751; Kim YH, 2004, J COMP NEUROL, V469, P535, DOI 10.1002/cne.11033; Kinne A, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S7; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; KUENZEL WJ, 1982, J COMP NEUROL, V206, P293, DOI 10.1002/cne.902060309; Leng G., 2018, HEART BRAIN HYPOTHAL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London SE, 2007, J COMP NEUROL, V502, P507, DOI 10.1002/cne.21335; MacDougall-Shackleton SA, 1999, TRENDS NEUROSCI, V22, P432, DOI 10.1016/S0166-2236(99)01434-4; Majumdar G, 2015, MOL CELL ENDOCRINOL, V399, P110, DOI 10.1016/j.mce.2014.09.020; Markakis EA, 2002, FRONT NEUROENDOCRIN, V23, P257, DOI 10.1016/S0091-3022(02)00003-1; MATHEWS GA, 1990, GEN COMP ENDOCR, V80, P48, DOI 10.1016/0016-6480(90)90147-E; McNabb FMA, 2006, GEN COMP ENDOCR, V147, P93, DOI 10.1016/j.ygcen.2005.12.011; Metzdorf R, 1999, J COMP NEUROL, V407, P115; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Mishra I, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12627; Mouriec K, 2013, BRAIN RES, V1516, P20, DOI 10.1016/j.brainres.2013.04.034; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; NICHOLLS TJ, 1988, PHYSIOL REV, V68, P133, DOI 10.1152/physrev.1988.68.1.133; NixdorfBergweiler BE, 1996, J COMP NEUROL, V375, P445, DOI 10.1002/(SICI)1096-9861(19961118)375:3<445::AID-CNE7>3.0.CO;2-2; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; Peterson RS, 2005, P ROY SOC B-BIOL SCI, V272, P2089, DOI 10.1098/rspb.2005.3181; Pfaff D.W, 2017, HORMONES BRAIN BEHAV; Plant TM, 2015, KNOBIL NEILLS PHYSL; POHLAPEL G, 1984, Z TIERPSYCHOL, V64, P330; Prove I., 1983, P368; Raymaekers SR, 2017, GEN COMP ENDOCR, V240, P91, DOI 10.1016/j.ygcen.2016.09.016; Rhinn M, 1999, DEVELOPMENT, V126, P4295; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; SCHLINGER BA, 1992, ENDOCRINOLOGY, V130, P289, DOI 10.1210/en.130.1.289; Schlinger BA, 2001, TRENDS NEUROSCI, V24, P429, DOI 10.1016/S0166-2236(00)01855-5; Schlinger BA, 2017, HORMONES, BRAIN AND BEHAVIOR, VOL 2: NON-MAMMALIAN HORMONE-BEHAVIOR SYSTEMS, 3RD EDITION, P255, DOI 10.1016/B978-0-12-803592-4.00030-4; Shaughnessy DW, 2019, J COMP NEUROL, V527, P843, DOI 10.1002/cne.24569; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; Shinkai T, 1999, EXP GERONTOL, V34, P267, DOI 10.1016/S0531-5565(98)00074-6; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; SIMPSON HB, 1991, J NEUROBIOL, V22, P755, DOI 10.1002/neu.480220710; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Tobet S.A., 1992, HDB BEHAV NEUROBIOLO, V11, P41; Ubuka T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00038; Van Herck SLJ, 2013, GEN COMP ENDOCR, V190, P96, DOI 10.1016/j.ygcen.2013.05.003; VOCKEL A, 1990, J NEUROBIOL, V21, P808, DOI 10.1002/neu.480210514; VOCKEL A, 1990, BRAIN RES, V511, P291, DOI 10.1016/0006-8993(90)90174-A; WADE J, 1994, BRAIN RES, V639, P347, DOI 10.1016/0006-8993(94)91752-3; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; Xie YY, 2017, DEVELOPMENT, V144, P1588, DOI 10.1242/dev.139055; Yoshimura T, 2013, FRONT NEUROENDOCRIN, V34, P157, DOI 10.1016/j.yfrne.2013.04.002	84	0	0	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4997	5015		10.1096/fj.201902477R	http://dx.doi.org/10.1096/fj.201902477R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052887	Green Submitted			2022-12-28	WOS:000530242100014
J	Mihalas, BP; Redgrove, KA; Bernstein, IR; Robertson, MJ; McCluskey, A; Nixon, B; Holt, JE; McLaughlin, EA; Sutherland, JM				Mihalas, Bettina P.; Redgrove, Kate A.; Bernstein, Ilana R.; Robertson, Mark J.; McCluskey, Adam; Nixon, Brett; Holt, Janet E.; McLaughlin, Eileen A.; Sutherland, Jessie M.			Dynamin 2-dependent endocytosis is essential for mouse oocyte development and fertility	FASEB JOURNAL			English	Article						dynamin; endocytosis; folliculogenesis; oocyte; oogenesis	RIBONUCLEIC-ACID EXPRESSION; MAMMALIAN OOCYTES; FOLLICULAR DEVELOPMENT; MECHANISMS; GRANULOSA; ACTIN; MATURATION; GROWTH; ACTIVATION; ISOFORMS	During folliculogenesis, oocytes are dependent on metabolic and molecular support from surrounding somatic cells. Here, we examined the role of the dynamin (DNM) family of mechanoenzymes in mediating endocytotic uptake into growing follicular oocytes. We found DNM1 and DNM2 to be highly expressed in growing follicular oocytes as well as in mature germinal vesicle (GV) and metaphase II (MII) stage oocytes. Moreover, oocyte-specific conditional knockout (cKO) of DNM2 (DNM2 Delta) led to complete sterility, with follicles arresting at the preantral stage of development. In addition, DNM2 Delta ovaries were characterized by disrupted follicular growth as well as oocyte and follicle apoptosis. Further, the loss of DNM activity, either through DNM2 cKO or through pharmacological inhibition (Dyngo 6a) led to the impairment of endocytotic pathways in preantral oocytes as well as in mature GV and MII oocytes, respectively. Loss of DNM activity resulted in the redistribution of endosomes and the misslocalization of clathrin and actin, suggesting dysfunctional endocytosis. Notably, there was no observable effect on the fertility of DNM1 Delta females. Our study has provided new insight into the complex and dynamic nature of oocyte growth during folliculogenesis, suggesting a role for DNM2 in mediating the endocytotic events that are essential for oocyte development.	[Mihalas, Bettina P.; Redgrove, Kate A.; Bernstein, Ilana R.; Robertson, Mark J.; McCluskey, Adam; Nixon, Brett; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Mihalas, Bettina P.; Redgrove, Kate A.; Bernstein, Ilana R.; Nixon, Brett; Holt, Janet E.; McLaughlin, Eileen A.; Sutherland, Jessie M.] Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [Mihalas, Bettina P.; Redgrove, Kate A.; Bernstein, Ilana R.; Nixon, Brett; McLaughlin, Eileen A.; Sutherland, Jessie M.] Hunter Medial Res Inst, Pregnancy & Reprod Program, New Lambton Hts, NSW, Australia; [Robertson, Mark J.; McCluskey, Adam] Univ Newcastle, Prior Res Ctr Chem Biol, Callaghan, NSW, Australia; [Holt, Janet E.; Sutherland, Jessie M.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [McLaughlin, Eileen A.] Western Sydney Univ, Sch Sci, Penrith, NSW, Australia; [McLaughlin, Eileen A.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand	University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle; Western Sydney University; University of Auckland	Mihalas, BP (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Prior Res Ctr Reprod Sci, Univ Dr, Callaghan, NSW 2308, Australia.	Bettina.Mihalas@uon.edu.au	McLaughlin, Eileen/AAF-5588-2021; Robertson, Mark/E-9173-2014	Robertson, Mark/0000-0002-2140-2717; Mihalas, Bettina/0000-0002-6006-8475; Sutherland, Jessie/0000-0001-9672-2371; McLaughlin, Eileen/0000-0002-5837-3876				Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Palma GA, 2012, SCI WORLD J, DOI 10.1100/2012/938138; Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; Camlin NJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170650; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carabatsos MJ, 2000, DEV BIOL, V226, P167, DOI 10.1006/dbio.2000.9863; COLONNA R, 1983, BIOL REPROD, V28, P797, DOI 10.1095/biolreprod28.4.797; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DONAHUE RP, 1968, J REPROD FERTIL, V17, P395, DOI 10.1530/jrf.0.0170395; El-Hayek S, 2018, CURR BIOL, V28, P1124, DOI 10.1016/j.cub.2018.02.039; Elkin SR, 2016, WIEN MED WOCHENSCHR, V166, P196, DOI 10.1007/s10354-016-0432-7; EPPIG JJ, 1991, BIOESSAYS, V13, P569, DOI 10.1002/bies.950131105; Eppig JJ, 2018, CURR BIOL, V28, pR354, DOI 10.1016/j.cub.2018.03.005; Fair T, 2003, ANIM REPROD SCI, V78, P203, DOI 10.1016/S0378-4320(03)00091-5; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gittens JEI, 2005, J CELL SCI, V118, P5071, DOI 10.1242/jcs.02624; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; HIROBE S, 1992, ENDOCRINOLOGY, V131, P854, DOI 10.1210/en.131.2.854; Holt JE, 2012, MOL BIOL CELL, V23, P3970, DOI 10.1091/mbc.E12-05-0352; Jimah JR, 2019, TRENDS CELL BIOL, V29, P257, DOI 10.1016/j.tcb.2018.11.003; Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132; Kaur G, 2018, ADV EXP MED BIOL, V1074, P335, DOI 10.1007/978-3-319-75402-4_41; LEESE HJ, 1985, J EXP ZOOL, V234, P231, DOI 10.1002/jez.1402340208; Lowther KM, 2011, REPRODUCTION, V141, P737, DOI 10.1530/REP-10-0461; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; McLaughlin EA, 2009, REPRODUCTION, V137, P1, DOI 10.1530/REP-08-0118; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 2005, NAT GENET, V37, P215, DOI 10.1038/ng0305-215; Mihalas BP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06372-z; Mihalas BP, 2015, REPRODUCTION, V150, P485, DOI 10.1530/REP-14-0585; Monniaux D, 2016, THERIOGENOLOGY, V86, P41, DOI 10.1016/j.theriogenology.2016.04.017; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; NAKATA T, 1991, NEURON, V7, P461, DOI 10.1016/0896-6273(91)90298-E; Nixon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135605; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Ramachandran R, 2018, CURR BIOL, V28, pR411, DOI 10.1016/j.cub.2017.12.013; Redgrove KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35084; Reid AT, 2015, FASEB J, V29, P2872, DOI 10.1096/fj.14-265553; Reid AT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392803; Rimon-Dahari N, 2016, RESULTS PROBL CELL D, V58, P167, DOI 10.1007/978-3-319-31973-5_7; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Sundborger Anna C, 2014, F1000Prime Rep, V6, P85, DOI 10.12703/P6-85; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Vaid KS, 2007, J CELL PHYSIOL, V210, P644, DOI 10.1002/jcp.20855; van den Hurk R, 2005, THERIOGENOLOGY, V63, P1717, DOI 10.1016/j.theriogenology.2004.08.005; Wang QC, 2014, BIOL CELL, V106, P193, DOI 10.1111/boc.201400007; Yeo CX, 2009, BIOL REPROD, V80, P1072, DOI 10.1095/biolreprod.108.073908; Zhang Y, 2014, MOL REPROD DEV, V81, P725, DOI 10.1002/mrd.22341; Zhao M, 2018, NEUROTHERAPEUTICS, V15, P966, DOI 10.1007/s13311-018-00686-0; Zhou W, 2017, MOL HUM REPROD, V23, P657, DOI 10.1093/molehr/gax044	62	3	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5162	5177		10.1096/fj.201902184R	http://dx.doi.org/10.1096/fj.201902184R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32065700	Bronze			2022-12-28	WOS:000530242100024
J	Morhayim, J; Ghebes, CA; Erkeland, SJ; ter Borg, MND; Hoogenboezem, RM; Bindels, EMJ; van Alphen, FPJ; Kassem, M; van Wijnen, AJ; Cornelissen, JJ; van Leeuwen, JP; van der Eerden, BCJ; Voermans, C; van de Peppel, J; Braakman, E				Morhayim, Jess; Ghebes, Corina A.; Erkeland, Stefan J.; ter Borg, Mariette N. D.; Hoogenboezem, Remco M.; Bindels, Eric M. J.; van Alphen, Floris P. J.; Kassem, Moustapha; van Wijnen, Andre J.; Cornelissen, Jan J.; van Leeuwen, Johannes P.; van der Eerden, Bram C. J.; Voermans, Carlijn; van de Peppel, Jeroen; Braakman, Eric			Identification of osteolineage cell-derived extracellular vesicle cargo implicated in hematopoietic support	FASEB JOURNAL			English	Article						bone; hematopoietic expansion; hematopoietic niche; intercellular communication	STEM-CELLS; VIVO EXPANSION; SELF-RENEWAL; ENGRAFTMENT; EXPRESSION; DIFFERENTIATION; TRANSPLANTATION; PROGENITORS; MICRORNAS; PROTEINS	Osteolineage cell-derived extracellular vesicles (EVs) play a regulatory role in hematopoiesis and have been shown to promote the ex vivo expansion of human hematopoietic stem and progenitor cells (HSPCs). Here, we demonstrate that EVs from different human osteolineage sources do not have the same HSPC expansion promoting potential. Comparison of stimulatory and non-stimulatory osteolineage EVs by next-generation sequencing and mass spectrometry analyses revealed distinct microRNA and protein signatures identifying EV-derived candidate regulators of ex vivo HSPC expansion. Accordingly, the treatment of umbilical cord blood-derived CD34(+) HSPCs with stimulatory EVs-altered HSPC transcriptome, including genes with known roles in cell proliferation. An integrative bioinformatics approach, which connects the HSPC gene expression data with the candidate cargo in stimulatory EVs, delineated the potentially targeted biological functions and pathways during hematopoietic cell expansion and development. In conclusion, our study gives novel insights into the complex biological role of EVs in osteolineage cell-HSPC crosstalk and promotes the utility of EVs and their cargo as therapeutic agents in regenerative medicine.	[Morhayim, Jess; ter Borg, Mariette N. D.; Hoogenboezem, Remco M.; Bindels, Eric M. J.; Cornelissen, Jan J.; Braakman, Eric] Erasmus MC, Dept Hematol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Ghebes, Corina A.; van Alphen, Floris P. J.; Voermans, Carlijn] Sanquin Res, Amsterdam, Netherlands; [Erkeland, Stefan J.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Kassem, Moustapha] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [van Wijnen, Andre J.] Mayo Clin, Dept Orthped Surg, Rochester, MN USA; [van Leeuwen, Johannes P.; van der Eerden, Bram C. J.; van de Peppel, Jeroen] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Southern Denmark; Odense University Hospital; Mayo Clinic; Erasmus University Rotterdam; Erasmus MC	Braakman, E (corresponding author), Erasmus MC, Dept Hematol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	e.braakman@erasmusmc.nl	van Wijnen, Andre J./AAG-3578-2019; van de Peppel, Jeroen/K-6683-2019; van der Eerden, Bram CJ/I-7496-2012; Voermans, Carlijn/GPP-3405-2022; van Leeuwen, Johannes/D-5015-2014	van Wijnen, Andre J./0000-0002-4458-0946; van de Peppel, Jeroen/0000-0002-6524-727X; van der Eerden, Bram CJ/0000-0003-4403-6497; Erkeland, Stefan/0000-0002-1019-7957; van Leeuwen, Johannes/0000-0002-2282-4006; Morhayim, Jess/0000-0001-7610-9342	Erasmus MC; Sanquin [PPOC-16-05]; US National Institutes of Health [R01-AR049069, F32-AR066508]	Erasmus MC; Sanquin; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Erasmus MC, Grant/Award Number: Mrace grant 2015; Sanquin, Grant/Award Number: PPOC-16-05; US National Institutes of Health, Grant/Award Number: R01-AR049069 and F32-AR066508	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barker JN, 2010, BLOOD, V115, P1843, DOI 10.1182/blood-2009-07-231068; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; CHIBA H, 1993, CELL STRUCT FUNCT, V18, P419, DOI 10.1247/csf.18.419; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Duinhouwer LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119086; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; Ekstrom K, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18389; Emmrich S, 2014, GENE DEV, V28, P858, DOI 10.1101/gad.233791.113; Fei XM, 2007, CYTOTHERAPY, V9, P338, DOI 10.1080/14653240701291638; Goloviznina NA, 2016, J BIOL CHEM, V291, P24607, DOI 10.1074/jbc.M116.745653; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kerkhoff C, 2002, J BIOL CHEM, V277, P41879, DOI 10.1074/jbc.M207990200; Ko KH, 2011, STEM CELLS, V29, P108, DOI 10.1002/stem.551; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Krater M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02352-5; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lee YT, 2013, BLOOD, V122, P1034, DOI 10.1182/blood-2012-12-472308; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Morhayim J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32034; Morhayim J, 2014, ARCH BIOCHEM BIOPHYS, V561, P38, DOI 10.1016/j.abb.2014.05.011; Nair R, 2014, STEM CELLS DEV, V23, P1625, DOI 10.1089/scd.2013.0633; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pineault N, 2015, EXP HEMATOL, V43, P498, DOI 10.1016/j.exphem.2015.04.011; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Roden C, 2016, CURR STEM CELL REP, V2, P183, DOI 10.1007/s40778-016-0057-1; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Starczynowski DT, 2011, EXP HEMATOL, V39, P167, DOI 10.1016/j.exphem.2010.09.011; Stik G, 2017, J CELL BIOL, V216, P2217, DOI 10.1083/jcb.201601109; Su YH, 2015, HUM CELL, V28, P14, DOI 10.1007/s13577-014-0098-7; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Varnum-Finney B, 2003, BLOOD, V101, P1784, DOI 10.1182/blood-2002-06-1862; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Walenda T, 2011, EXP HEMATOL, V39, P617, DOI 10.1016/j.exphem.2011.02.011; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	56	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5435	5452		10.1096/fj.201902610R	http://dx.doi.org/10.1096/fj.201902610R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086861	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000515259300001
J	Plewes, MR; Hou, XY; Talbott, HA; Zhang, P; Wood, JR; Cupp, AS; Davis, JS				Plewes, Michele R.; Hou, Xiaoying; Talbott, Heather A.; Zhang, Pan; Wood, Jennifer R.; Cupp, Andrea S.; Davis, John S.			Luteinizing hormone regulates the phosphorylation and localization of the mitochondrial effector dynamin-related protein-1 (DRP1) and steroidogenesis in the bovine corpus luteum	FASEB JOURNAL			English	Article						bovine; corpus luteum; dynamin-like protein 1; mitochondria; progesterone; protein kinase A; steroidogenesis	PROGESTERONE PRODUCTION; SPATIAL-DISTRIBUTION; THERAPEUTIC TARGETS; LIPID MICRODOMAINS; FISSION PROTEINS; LATERAL MOBILITY; S-NITROSYLATION; CANCER CELLS; CYCLIC-AMP; FISH-OIL	The corpus luteum is an endocrine gland that synthesizes and secretes progesterone. Luteinizing hormone (LH) activates protein kinase A (PKA) signaling in luteal cells, increasing delivery of substrate to mitochondria for progesterone production. Mitochondria maintain a highly regulated equilibrium between fusion and fission in order to sustain biological function. Dynamin-related protein 1 (DRP1), is a key mediator of mitochondrial fission. The mechanism by which DRP1 is regulated in the ovary is largely unknown. We hypothesize that LH via PKA differentially regulates the phosphorylation of DRP1 on Ser616 and Ser637 in bovine luteal cells. In primary cultures of steroidogenic small luteal cells (SLCs), LH, and forskolin stimulated phosphorylation of DRP1 (Ser 637), and inhibited phosphorylation of DRP1 (Ser 616). Overexpression of a PKA inhibitor blocked the effects of LH and forskolin on DRP1 phosphorylation. In addition, LH decreased the association of DRP1 with the mitochondria. Genetic knockdown of the DRP1 mitochondria receptor, and a small molecule inhibitor of DRP1 increased basal and LH-induced progesterone production. Studies with a general Dynamin inhibitor and siRNA knockdown of DRP1 showed that DRP1 is required for optimal LH-induced progesterone biosynthesis. Taken together, the findings place DRP1 as an important target downstream of PKA in steroidogenic luteal cells.	[Plewes, Michele R.; Hou, Xiaoying; Talbott, Heather A.; Zhang, Pan; Davis, John S.] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, 983255 Nebraska Med Ctr, Omaha, NE 68198 USA; [Plewes, Michele R.; Davis, John S.] Nebraska Western Iowa Vet Hlth Care Syst, Omaha, NE USA; [Wood, Jennifer R.; Cupp, Andrea S.] Univ Nebraska, Dept Anim Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Lincoln	Davis, JS (corresponding author), Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, 983255 Nebraska Med Ctr, Omaha, NE 68198 USA.	jsdavis@unmc.edu	Wood, Jennifer R/S-3213-2019	Wood, Jennifer R/0000-0001-9337-5837; Talbott, Heather/0000-0002-6140-9059; Davis, John/0000-0003-3468-4079	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2018-67012-29531 MRP, 2017-67015-26450 JSD]; NIH [R01 HD087402, R01HD092263]; Department of Veterans Affairs; Olson Center for Women's Health	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Olson Center for Women's Health	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2018-67012-29531 MRP and 2017-67015-26450 JSD from the USDA National Institute of Food and Agriculture; NIH grants R01 HD087402 and R01HD092263, the Department of Veterans Affairs; and The Olson Center for Women's Health.	ALILA HW, 1988, J REPROD FERTIL, V82, P645, DOI 10.1530/jrf.0.0820645; Arikan S, 2010, REPROD DOMEST ANIM, V45, pe434, DOI 10.1111/j.1439-0531.2010.01596.x; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bertoldo MJ, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.04; Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Bowdridge EC, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129411; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang CR, 2007, EMBO REP, V8, P1088, DOI 10.1038/sj.embor.7401118; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen DB, 1998, ENDOCRINOLOGY, V139, P3876, DOI 10.1210/en.139.9.3876; Chen DB, 2001, ENDOCRINOLOGY, V142, P887, DOI 10.1210/en.142.2.887; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; DAVIS JS, 1987, P NATL ACAD SCI USA, V84, P3728, DOI 10.1073/pnas.84.11.3728; DAVIS JS, 1987, J BIOL CHEM, V262, P8515; DONALDSON L, 1965, J DAIRY SCI, V48, P905, DOI 10.3168/jds.S0022-0302(65)88360-6; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Flynn MP, 2016, J CELL SCI, V129, P2983, DOI 10.1242/jcs.190397; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Girard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029042; Hall AR, 2014, BRIT J PHARMACOL, V171, P1890, DOI 10.1111/bph.12516; HANSEL W, 1991, J REPROD FERTIL, P77; HANSEL W, 1987, AUST J BIOL SCI, V40, P331, DOI 10.1071/BI9870331; HARRISON LM, 1987, J REPROD FERTIL, V79, P539, DOI 10.1530/jrf.0.0790539; Hou XY, 2010, ENDOCRINOLOGY, V151, P2846, DOI 10.1210/en.2009-1032; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; JOHNSON KR, 1962, J DAIRY SCI, V45, P633, DOI 10.3168/jds.S0022-0302(62)89463-6; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Law NC, 2016, J BIOL CHEM, V291, P4547, DOI 10.1074/jbc.M115.698761; Lee DG, 2016, TOXICOLOGY, V365, P17, DOI 10.1016/j.tox.2016.07.022; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Li J, 2015, J MOL CELL CARDIOL, V86, P62, DOI 10.1016/j.yjmcc.2015.07.010; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mao DG, 2013, MOL ENDOCRINOL, V27, P2066, DOI 10.1210/me.2013-1274; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; MARSH JM, 1976, BIOL REPROD, V14, P30, DOI 10.1095/biolreprod14.1.30; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Miller WL, 2017, J STEROID BIOCHEM, V165, P18, DOI 10.1016/j.jsbmb.2016.03.009; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; Nakamura T, 2010, MITOCHONDRION, V10, P573, DOI 10.1016/j.mito.2010.04.007; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Ong SB, 2015, EUR J PHARMACOL, V763, P104, DOI 10.1016/j.ejphar.2015.04.056; Otera Hidenori, 2012, Int J Cell Biol, V2012, P821676, DOI 10.1155/2012/821676; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Park JE, 2019, ENDOCRINOLOGY, V160, P729, DOI 10.1210/en.2019-00029; Park J, 2015, TOXICOLOGY, V337, P39, DOI 10.1016/j.tox.2015.08.009; Pennanen C, 2014, J CELL SCI, V127, P2659, DOI 10.1242/jcs.139394; Plewes MR, 2018, DOMEST ANIM ENDOCRIN, V63, P38, DOI 10.1016/j.domaniend.2017.12.001; Plewes MR, 2017, DOMEST ANIM ENDOCRIN, V60, P9, DOI 10.1016/j.domaniend.2017.02.001; Plewes MR, 2017, DOMEST ANIM ENDOCRIN, V58, P39, DOI 10.1016/j.domaniend.2016.08.001; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Ramachandran R, 2018, SEMIN CELL DEV BIOL, V76, P201, DOI 10.1016/j.semcdb.2017.07.039; Roy L, 2009, ENDOCRINOLOGY, V150, P5036, DOI 10.1210/en.2009-0771; Roy M, 2015, CURR OPIN CELL BIOL, V33, P111, DOI 10.1016/j.ceb.2015.02.001; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Takao Y, 1997, MOL HUM REPROD, V3, P569, DOI 10.1093/molehr/3.7.569; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Taurin S, 2008, AM J PHYSIOL-CELL PH, V294, pC1169, DOI 10.1152/ajpcell.00096.2008; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang QL, 2017, AUTOPHAGY, V13, P404, DOI 10.1080/15548627.2016.1263776; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wikstrom JD, 2013, MOL ENDOCRINOL, V27, P1706, DOI 10.1210/me.2013-1109; WILTBANK MC, 1991, J REPROD FERTIL, P65; Wu Q, 2017, HISTOL HISTOPATHOL, V32, P551, DOI 10.14670/HH-11-841; Xiao L, 2015, J BIOL CHEM, V290, P24961, DOI 10.1074/jbc.M115.673343; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zaja I, 2014, BIOCHEM BIOPH RES CO, V453, P710, DOI 10.1016/j.bbrc.2014.09.144; Zhou J, 2015, AUTOPHAGY, V11, P1259, DOI 10.1080/15548627.2015.1056970	80	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5299	5316		10.1096/fj.201902958R	http://dx.doi.org/10.1096/fj.201902958R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32077149	Bronze, Green Accepted			2022-12-28	WOS:000515256400001
J	Miyata, H; Shimada, K; Morohoshi, A; Oura, S; Matsumura, T; Xu, ZL; Oyama, Y; Ikawa, M				Miyata, Haruhiko; Shimada, Keisuke; Morohoshi, Akane; Oura, Seiya; Matsumura, Takafumi; Xu, Zoulan; Oyama, Yuki; Ikawa, Masahito			Testis-enriched kinesin KIF9 is important for progressive motility in mouse spermatozoa	FASEB JOURNAL			English	Article						fertilization; male fertility; sperm motility	CILIARY MOTILITY; PROTEINS; FLAGELLA; DYNEIN; FERTILITY; SHEATH; CELLS; HYDIN	Kinesin is a molecular motor that moves along microtubules. Kinesin family member 9 (KIF9) is evolutionarily conserved and expressed strongly in mouse testis. In the unicellular flagellate Chlamydomonas, KLP1 (ortholog of KIF9) is localized to the central pair microtubules of the axoneme and regulates flagellar motility. In contrast, the function of KIF9 remains unclear in mammals. Here, we mutated KIF9 in mice using the CRISPR/Cas9 system. Kif9 mutated mice exhibit impaired sperm motility and subfertility. Further analysis reveals that the flagella lacking KIF9 showed an asymmetric waveform pattern, which leads to a circular motion of spermatozoa. In spermatozoa that lack the central pair protein HYDIN, KIF9 was not detected by immunofluorescence and immunoblot analysis. These results suggest that KIF9 is associated with the central pair microtubules and regulates flagellar motility in mice.	[Miyata, Haruhiko; Shimada, Keisuke; Morohoshi, Akane; Oura, Seiya; Matsumura, Takafumi; Xu, Zoulan; Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Morohoshi, Akane; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Oura, Seiya; Matsumura, Takafumi; Xu, Zoulan; Ikawa, Masahito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Oyama, Yuki] Doshisha Univ, Grad Sch Life & Med Sci, Kyotanabe, Japan; [Ikawa, Masahito] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Matsumura, Takafumi] Yokohama City Univ, Inst Mol Med & Life Sci, Assoc Med Sci, Yokohama, Kanagawa, Japan	Osaka University; Osaka University; Osaka University; Doshisha University; University of Tokyo; Yokohama City University	Miyata, H; Ikawa, M (corresponding author), Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiya003@biken.osaka-u.ac.jp; ikawa@biken.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Shimada, Keisuke/N-6112-2019; Shimada, Keisuke/E-8958-2019	ikawa, masahito/0000-0001-9859-6217; Shimada, Keisuke/0000-0003-3739-7163; Shimada, Keisuke/0000-0003-3739-7163; OYAMA, Yuki/0000-0003-4579-5487; Miyata, Haruhiko/0000-0003-4758-5803; Oura, Seiya/0000-0002-7606-732X	MEXT | Japan Society for the Promotion of Science (JSPS) [JP17H04987, JP17K17852, JP19J12450, JP19J21619, JP17H01394]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [JP25112007, JP19H05750]; Takeda Science Foundation; Japan Agency for Medical Research and Development (AMED) [JP19gm5010001]; HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [P01HD087157, R01HD088412]; Bill and Melinda Gates Foundation [OPP1160866]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP17H04987, JP17K17852, JP19J12450, JP19J21619 and JP17H01394; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: JP25112007 and JP19H05750; Takeda Science Foundation; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm5010001; HHS vertical bar NIH vertical bar Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: P01HD087157 and R01HD088412; Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation), Grant/Award Number: OPP1160866	Abbasi F, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221648; BABA SA, 1985, CELL MOTIL CYTOSKEL, V5, P475, DOI 10.1002/cm.970050605; BERNSTEIN M, 1994, J CELL BIOL, V125, P1313, DOI 10.1083/jcb.125.6.1313; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Castaneda JM, 2017, P NATL ACAD SCI USA, V114, pE5370, DOI 10.1073/pnas.1621279114; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornfine S, 2011, MOL BIOL CELL, V22, P202, DOI 10.1091/mbc.E10-05-0394; Demonchy R, 2009, J CELL BIOL, V187, P615, DOI 10.1083/jcb.200903139; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Fujihara Y, 2018, EXP ANIM TOKYO, V67, P91, DOI 10.1538/expanim.17-0153; Fujihara Y, 2013, TRANSGENIC RES, V22, P195, DOI 10.1007/s11248-012-9635-x; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Gyobu S, 2016, MOL CELL BIOL, V36, P645, DOI 10.1128/MCB.00919-15; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Hirokawa N, 2015, EXP CELL RES, V334, P16, DOI 10.1016/j.yexcr.2015.02.016; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Ishijima S, 2002, MOL REPROD DEV, V61, P376, DOI 10.1002/mrd.10017; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Konjikusic MJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007817; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lechtreck KF, 2007, J CELL BIOL, V176, P473, DOI 10.1083/jcb.200611115; Lehti MS, 2013, MOL CELL ENDOCRINOL, V377, P44, DOI 10.1016/j.mce.2013.06.030; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; McKenzie CW, 2015, MOL BIOL CELL, V26, P3140, DOI 10.1091/mbc.E15-02-0121; Miller MG, 1999, BIOL REPROD, V60, P1047, DOI 10.1095/biolreprod60.4.1047; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; Morohoshi A, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008585; Muro Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135368; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oji A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31666; Oura S, 2019, EXP ANIM TOKYO, V68, P25, DOI 10.1538/expanim.18-0071; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sasaki K, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0462-y; Schou KB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14177; Shimada K, 2019, J REPROD DEVELOP, V65, P155, DOI 10.1262/jrd.2018-136; Sironen A, 2011, BIOL REPROD, V85, P690, DOI 10.1095/biolreprod.111.091132; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Yokoyama R, 2004, P NATL ACAD SCI USA, V101, P17398, DOI 10.1073/pnas.0406817101; Zeleznik A.J., 2014, PHYSL REPROD, V1, P99	43	14	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5389	5400		10.1096/fj.201902755R	http://dx.doi.org/10.1096/fj.201902755R		FEB 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32072696	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000515254200001
J	Strainic, MG; Pohlmann, E; Valley, CC; Sammeta, A; Hussain, W; Lidke, DS; Medof, ME				Strainic, Michael G.; Pohlmann, Elliot; Valley, Christopher C.; Sammeta, Ajay; Hussain, Wasim; Lidke, Diane S.; Medof, M. Edward			RTK signaling requires C3ar1/C5ar1 and IL-6R joint signaling to repress dominant PTEN, SOCS1/3 and PHLPP restraint	FASEB JOURNAL			English	Article						IL-6 receptor; local complement; VEGFR2 signaling	GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE-CELLS; EGF RECEPTOR; ERK1/2 ACTIVATION; C5A RECEPTOR; BETA; PHOSPHORYLATION; TRANSACTIVATION; SUPPRESSOR; SPHINGOSINE-1-PHOSPHATE	How receptor tyrosine kinase (RTK) growth signaling is controlled physiologically is incompletely understood. We have previously provided evidence that the survival and mitotic activities of vascular endothelial cell growth factor receptor-2 (VEGFR2) signaling are dependent on C3a/C5a receptor (C3ar1/C5ar1) and IL-6 receptor (IL-6R)-gp130 joint signaling in a physically interactive platform. Herein, we document that the platelet derived and epidermal growth factor receptors (PDGFR and EGFR) are regulated by the same interconnection and clarify the mechanism underlying the dependence. We show that the joint signaling is required to overcome dominant restraint on RTK function by the combined repression of tonically activated PHLPP, SOCS1/SOCS3, and CK2/Fyn dependent PTEN. Signaling studies showed that augmented PI-3K gamma activation is the process that overcomes the multilevel growth restraint. Live-cell flow cytometry and single-particle tracking indicated that blockade of C3ar1/C5ar1 or IL-6R signaling suppresses RTK growth factor binding and RTK complex formation. C3ar1/C5ar1 blockade abrogated growth signaling of four additional RTKs. Active relief of dominant growth repression via joint C3ar1/C5ar1 and IL-6R joint signaling thus enables RTK mitotic/survival signaling.	[Strainic, Michael G.; Pohlmann, Elliot; Sammeta, Ajay; Hussain, Wasim; Medof, M. Edward] Case w Reserve Univ, Dept Pathol, Cleveland Hts, OH USA; [Strainic, Michael G.; Pohlmann, Elliot; Sammeta, Ajay; Hussain, Wasim; Medof, M. Edward] Case w Reserve Univ Sch Med, Cleveland Hts, OH USA; [Valley, Christopher C.; Lidke, Diane S.] Univ New Mexico Hlth Sciences Ctr, Comprehens Canc Ctr, Dept Pathol, Albuquerque, NM USA; Inst Pathol Room 301, Edward Medof, 2085 Adelbert Rd, Cleveland Hts, OH 44106 USA		Medof, ME (corresponding author), Case w Reserve Univ, Dept Pathol, Cleveland Hts, OH USA.	mxm16@case.edu		Strainic, Michael/0000-0003-2438-8540; Hussain, Wasim/0000-0001-7659-6654	NCI NIH HHS [P30 CA118100] Funding Source: Medline; NEI NIH HHS [P30 EY011373] Funding Source: Medline; NHLBI NIH HHS [R01 HL109561] Funding Source: Medline; NIAMS NIH HHS [R01 AR067182] Funding Source: Medline; NIGMS NIH HHS [P50 GM085273, R35 GM126934] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; Babon JJ, 2012, GROWTH FACTORS, V30, P207, DOI 10.3109/08977194.2012.687375; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; BUHL AM, 1993, FEBS LETT, V323, P132, DOI 10.1016/0014-5793(93)81464-B; Burg M, 1995, FEBS LETT, V377, P426, DOI 10.1016/0014-5793(95)01379-2; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Durlacher-Betzer K, 2018, KIDNEY INT, V94, P315, DOI 10.1016/j.kint.2018.02.026; El-Shewy HM, 2006, J BIOL CHEM, V281, P31399, DOI 10.1074/jbc.M605339200; Ezure T, 2000, AM J PATHOL, V156, P1627, DOI 10.1016/S0002-9440(10)65034-1; Flaherty P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000185; Fragoso R, 2015, METHODS, V77-78, P75, DOI 10.1016/j.ymeth.2014.10.015; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Gupta MK, 2018, INT REV CEL MOL BIO, V339, P63, DOI 10.1016/bs.ircmb.2018.03.002; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Huang YH, 2014, ANGIOGENESIS, V17, P407, DOI 10.1007/s10456-013-9386-1; Hwang MS, 2019, J CELL SCI, V132, DOI 10.1242/jcs.219352; Ishida A, 2001, J CELL PHYSIOL, V188, P359, DOI 10.1002/jcp.1121; Jiang HP, 1996, J BIOL CHEM, V271, P13430, DOI 10.1074/jbc.271.23.13430; Kato K, 2012, LIFE SCI, V90, P71, DOI 10.1016/j.lfs.2011.10.023; Kuhn KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114195; LEE CH, 1995, MOL PHARMACOL, V47, P218; Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084; Lima-Fernandes E, 2011, EMBO J, V30, P2557, DOI 10.1038/emboj.2011.178; Liu JB, 2008, J IMMUNOL, V180, P5882, DOI 10.4049/jimmunol.180.9.5882; Liu ZJ, 2000, LIVER, V20, P114, DOI 10.1034/j.1600-0676.2000.020002114.x; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mahabeleshwar Ganapati H., 2006, V129, P197; Markiewski MM, 2004, J IMMUNOL, V173, P747, DOI 10.4049/jimmunol.173.2.747; Mehenni H, 2005, HUM MOL GENET, V14, P2209, DOI 10.1093/hmg/ddi225; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Roach TIA, 2008, J BIOL CHEM, V283, P17351, DOI 10.1074/jbc.M800907200; Rodriguez-Berriguete G, 2010, EUR CYTOKINE NETW, V21, P241, DOI 10.1684/ecn.2010.0211; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Schlessinger J, 2014, COLD SPRING HARB PER, V6, P3, DOI DOI 10.1101/CSHPERSPECT.A008912; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; Spets H, 2002, EUR J HAEMATOL, V69, P76, DOI 10.1034/j.1600-0609.2002.01549.x; Steinkamp MP, 2014, MOL CELL BIOL, V34, P965, DOI 10.1128/MCB.01605-13; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wang WJ, 2018, TRENDS PHARMACOL SCI, V39, P367, DOI 10.1016/j.tips.2018.01.001; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Williams JJL, 2014, CELLS-BASEL, V3, P546, DOI 10.3390/cells3020546; Yamada E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089604; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	60	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2105	2125		10.1096/fj.201900677R	http://dx.doi.org/10.1096/fj.201900677R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908021	Green Accepted, Bronze			2022-12-28	WOS:000514663600014
J	Wu, SP; Anderson, ML; Wang, TY; Zhou, LC; Emery, OM; Li, XL; DeMayo, FJ				Wu, San-Pin; Anderson, Matthew L.; Wang, Tianyuan; Zhou, Lecong; Emery, Olivia M.; Li, Xilong; DeMayo, Francesco J.			Dynamic transcriptome, accessible genome, and PGR cistrome profiles in the human myometrium	FASEB JOURNAL			English	Article						genome accessibility; human myometrial tissue; PGR cistrome; transcriptome	FUNCTIONAL PROGESTERONE WITHDRAWAL; SPONTANEOUS HUMAN LABOR; CELL-PROLIFERATION; GENE-EXPRESSION; PRETERM LABOR; RECEPTOR; ACTIVATION; PREGNANCY; TERM; CHROMATIN	The myometrium undergoes structural and functional remodeling during pregnancy. We hypothesize that myometrial genomic elements alter correspondingly in preparation for parturition. Human myometrial tissues from nonpregnant (NP) and term pregnant (TP) human subjects were examined by RNAseq, ATACseq, and PGR ChIPseq assays to profile transcriptome, assessible genome, and PGR occupancy. NP and TP specimens exhibit 2890 differentially expressed genes, reflecting an increase of metabolic, inflammatory, and PDGF signaling, among others, in adaptation to pregnancy. At the epigenome level, patterns of accessible genome change between NP and TP myometrium, leading to the altered enrichment of binding motifs for hormone and muscle regulators such as the progesterone receptor (PGR), Kruppel-like factors, and MEF2A transcription factors. PGR genome occupancy exhibits a significant difference between the two stages of the myometrium, concomitant with distinct transcriptomic profiles including genes such as ENO1, LHDA, and PLCL1 in the glycolytic and calcium signaling pathways. Over-representation of SRF, MYOD, and STAT binding motifs in PGR occupying sites further suggests interactions between PGR and major muscle regulators for myometrial gene expression. In conclusion, changes in accessible genome and PGR occupancy are part of the myometrial remodeling process and may serve as mechanisms to formulate the state-specific transcriptome profiles.	[Wu, San-Pin; Emery, Olivia M.; DeMayo, Francesco J.] NIEHS, Reprod & Dev Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA; [Anderson, Matthew L.] Univ S Florida, Morsani Coll Med, Dept Obstet & Gynecol, Tampa, FL 33620 USA; [Anderson, Matthew L.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Wang, Tianyuan; Zhou, Lecong] NIEHS, Integrat Bioinformat Support Grp, POB 12233, Res Triangle Pk, NC 27709 USA; [Li, Xilong] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Baylor College of Medicine	DeMayo, FJ (corresponding author), NIEHS, Reprod & Dev Biol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	francesco.demayo@nih.gov	, San Pin Wu/AAF-8371-2020	, San Pin Wu/0000-0001-9626-784X	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [Z1AES103311-01] Funding Source: Medline	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)		Ackerman WE, 2018, BIOL REPROD, V98, P834, DOI 10.1093/biolre/ioy040; Akerman AW, 2018, ANN VASC SURG, V46, P193, DOI 10.1016/j.avsg.2017.10.001; Amini P, 2019, MOL CELL ENDOCRINOL, V479, P1, DOI 10.1016/j.mce.2018.08.005; Anamthathmakula P, 2019, EBIOMEDICINE, V39, P520, DOI 10.1016/j.ebiom.2018.11.038; Baek S, 2017, CELL REP, V19, P1710, DOI 10.1016/j.celrep.2017.05.003; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bhurke AS, 2016, AM J REPROD IMMUNOL, V75, P237, DOI 10.1111/aji.12473; Birth P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181219; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chan YW, 2014, EXP PHYSIOL, V99, P510, DOI 10.1113/expphysiol.2013.072868; CHOW L, 1994, AM J OBSTET GYNECOL, V170, P788, DOI 10.1016/S0002-9378(94)70284-5; Ciarmela P, 2009, ENDOCRINOLOGY, V150, P906, DOI 10.1210/en.2008-0880; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Gao Y, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125146; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Grimm SL, 2016, J MOL BIOL, V428, P3831, DOI 10.1016/j.jmb.2016.06.020; Gualdrini F, 2016, MOL CELL, V64, P1048, DOI 10.1016/j.molcel.2016.10.016; Hanley JA, 2015, J PHYSIOL-LONDON, V593, P4603, DOI 10.1113/JP270631; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jaffer S, 2009, ENDOCRINOLOGY, V150, P4672, DOI 10.1210/en.2009-0419; Joshi S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006600; Karwacz K, 2017, NAT IMMUNOL, V18, P412, DOI 10.1038/ni.3683; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952; Kimura T, 1996, ENDOCRINOLOGY, V137, P780, DOI 10.1210/en.137.2.780; Kyathanahalli C, 2013, ENDOCRINOLOGY, V154, P4873, DOI 10.1210/en.2013-1325; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee WS, 1997, NAT MED, V3, P1005, DOI 10.1038/nm0997-1005; Lee Y, 2012, J CELL MOL MED, V16, P2487, DOI 10.1111/j.1582-4934.2012.01567.x; Lei KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050167; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Li QX, 2016, ENDOCRINOLOGY, V157, P1764, DOI 10.1210/en.2015-2031; Li YP, 2007, J CELL BIOCHEM, V100, P129, DOI 10.1002/jcb.21033; LONGENECKER JP, 1984, J CELL BIOL, V98, P534, DOI 10.1083/jcb.98.2.534; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MacIntyre DA, 2014, FASEB J, V28, P2358, DOI 10.1096/fj.13-247783; Madaan A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.072; Mazur EC, 2015, ENDOCRINOLOGY, V156, P2239, DOI 10.1210/en.2014-1566; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Medina-Rivera A, 2018, TRENDS BIOCHEM SCI, V43, P452, DOI 10.1016/j.tibs.2018.03.004; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mittal P, 2010, J PERINAT MED, V38, P617, DOI [10.1515/JPM.2010.097, 10.1515/jpm.2010.097]; Muter J, 2016, ENDOCRINOLOGY, V157, P2883, DOI 10.1210/en.2015-1914; Nadeem L, 2018, J CELL MOL MED, V22, P452, DOI 10.1111/jcmm.13335; Nadeem L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13488-9; Nadeem L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11565; Navathe R, 2016, CURR OPIN OBSTET GYN, V28, P464, DOI 10.1097/GCO.0000000000000327; Noakes, 2019, VET REPROD OBSTET, P148; Oldenhof AD, 2002, AM J PHYSIOL-CELL PH, V283, pC1530, DOI 10.1152/ajpcell.00607.2001; Ono M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.127126; Ono M, 2013, P NATL ACAD SCI USA, V110, P17053, DOI 10.1073/pnas.1313650110; Pabona JMP, 2015, J CLIN ENDOCR METAB, V100, P166, DOI 10.1210/jc.2014-2846; PARRATT J, 1994, LANCET, V344, P717, DOI 10.1016/S0140-6736(94)92209-8; Patel B, 2015, HUM REPROD UPDATE, V21, P155, DOI 10.1093/humupd/dmu056; Payson M, 2009, FERTIL STERIL, V92, P748, DOI 10.1016/j.fertnstert.2008.06.030; Pont JNA, 2012, MOL ENDOCRINOL, V26, P1743, DOI 10.1210/me.2012-1057; Quenby S, 2004, OBSTET GYNECOL, V103, P718, DOI 10.1097/01.AOG.0000118306.82556.43; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Renthal NE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023069; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Shynlova O, 2006, BIOL REPROD, V74, P839, DOI 10.1095/biolreprod.105.048124; Shynlova O, 2010, REPRODUCTION, V139, P247, DOI 10.1530/REP-09-0260; Stanfield Z, 2019, MOL HUM REPROD, V25, P408, DOI 10.1093/molehr/gaz028; Stanfield Z, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00185; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Watt KI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7048; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Welsh T, 2012, J ENDOCRINOL, V212, P227, DOI 10.1530/JOE-11-0358; Whirledge S, 2012, HORM CANCER-US, V3, P79, DOI 10.1007/s12672-012-0103-0; Williams KC, 2012, P NATL ACAD SCI USA, V109, P7529, DOI 10.1073/pnas.1200650109; Wu SP, 2017, CURR TOP DEV BIOL, V125, P171, DOI 10.1016/bs.ctdb.2017.03.001; Zeng ZY, 2008, BIOL REPROD, V78, P1029, DOI 10.1095/biolreprod.107.065821; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao QY, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0635-9	85	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2252	2268		10.1096/fj.201902654R	http://dx.doi.org/10.1096/fj.201902654R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908010	Green Submitted, Bronze			2022-12-28	WOS:000514663600023
J	Xu, YY; Li, FF; Zhao, XJ; Tan, CK; Wang, BY; Chen, YY; Cao, J; Wu, DF; Yu, H				Xu, Yanyong; Li, Feifei; Zhao, Xiaojie; Tan, Chenkun; Wang, Binyi; Chen, Yiyong; Cao, Jia; Wu, Dongfang; Yu, Hong			Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice	FASEB JOURNAL			English	Article						atherosclerosis; high-density lipoprotein; inflammation; methionine sulfoxide reductase A; scavenger receptor class B type I	HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E; SR-BI; REDUCES ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; MITOCHONDRIAL-FUNCTION; METABOLISM; LIVER	High-density lipoprotein (HDL), a well-known atheroprotective factor, can be converted to proatherogenic particles in chronic inflammation. HDL-targeted therapeutic strategy for atherosclerotic cardiovascular disease (CVD) is currently under development. This study aims to assess the role of methionine sulfoxide reductase A (MsrA) in abnormal HDL and its related disorders in scavenger receptor class B type I deficient (SR-BI-/-) mice. First, we demonstrated that MsrA overexpression attenuated ROS level and inflammation in HepG2 cells. For the in vivo study, SR-BI-/- mice were intravenously injected with lentivirus to achieve hepatic MsrA overexpression. High-level hepatic MsrA significantly reduced the plasma free cholesterol contents, improved HDL functional proteins apolipoprotein A-I (apoAI), apoE, paraoxonase1 (PON1), and lecithin:cholesterol acyltransferase (LCAT), while decreased the pro-inflammatory property of dysfunctional HDL, contributing to reduced atherosclerosis and hepatic steatosis in Western diet-fed mice. Furthermore, the study revealed that hepatic MsrA altered the expression of several genes controlling HDL biogenesis, cholesterol esterification, cholesterol uptake mediated by low-density lipoprotein receptor (LDLR) and biliary excretion, as well as suppressed nuclear factor kappa B (NF-kappa B) signaling pathway, which largely relied on liver X receptor alpha (LXR alpha)-upregulation. These results provide original evidence that MsrA may be a promising target for the therapy of dysfunctional HDL-related CVD.	[Xu, Yanyong; Li, Feifei; Zhao, Xiaojie; Tan, Chenkun; Wang, Binyi; Chen, Yiyong; Cao, Jia; Yu, Hong] Wuhan Univ, Dept Biochem & Mol Biol, Hubei Prov Key Lab Dev Originated Dis, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Wu, Dongfang] Wuhan Univ, Dept Pharm, Zhongnan Hosp, Wuhan, Peoples R China	Wuhan University; Wuhan University	Yu, H (corresponding author), Wuhan Univ, Dept Biochem & Mol Biol, Hubei Prov Key Lab Dev Originated Dis, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	yu.hong@whu.edu.cn		xu, yanyong/0000-0002-2811-0725	National Natural Science Foundation of China (NSFC) [81270364]; Medical Science advancement Program of Wuhan University [TFJC2018001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Medical Science advancement Program of Wuhan University	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81670423; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570417; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81270364; Medical Science advancement Program of Wuhan University, Grant/Award Number: TFJC2018001	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Armitage J, 2019, J AM COLL CARDIOL, V73, P477, DOI 10.1016/j.jacc.2018.10.072; Beltowski J, 2008, CARDIOVASC THER, V26, P297, DOI 10.1111/j.1755-5922.2008.00062.x; Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018; Brites F, 2017, BBA CLIN, V8, P66, DOI 10.1016/j.bbacli.2017.07.002; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Cao J, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1502-y; Du F, 2014, ARTERIOSCL THROM VAS, V34, P759, DOI 10.1161/ATVBAHA.113.302701; Fan H, 2015, ANTIOXID REDOX SIGN, V22, P832, DOI 10.1089/ars.2014.6022; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Hafiane A, 2017, ATHEROSCLEROSIS, V257, P90, DOI 10.1016/j.atherosclerosis.2017.01.013; Hafiane A, 2015, ANN CLIN LAB SCI, V45, P659; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Korber M, 2017, BBA-MOL CELL BIOL L, V1862, P1534, DOI 10.1016/j.bbalip.2017.09.002; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Linton MF, 2017, TRENDS ENDOCRIN MET, V28, P461, DOI 10.1016/j.tem.2017.02.001; Ljunggren SA, 2015, BBA-MOL CELL BIOL L, V1851, P1587, DOI 10.1016/j.bbalip.2015.09.006; Ma K, 2005, ARTERIOSCL THROM VAS, V25, P149, DOI 10.1161/01.ATV.0000150414.89591.6a; Malerod L, 2002, BIOCHEM BIOPH RES CO, V299, P916, DOI 10.1016/S0006-291X(02)02760-2; Manichaikul A, 2012, ARTERIOSCL THROM VAS, V32, P1991, DOI 10.1161/ATVBAHA.112.249714; Mardones P, 2001, J LIPID RES, V42, P170; Masson D, 2004, J LIPID RES, V45, P543, DOI 10.1194/jlr.M300432-JLR200; Meilhac O, 2015, HANDB EXP PHARMACOL, V224, P509, DOI 10.1007/978-3-319-09665-0_16; Moskovitz J, 2016, AM J PHYSIOL-ENDOC M, V310, pE388, DOI 10.1152/ajpendo.00453.2015; Musso G, 2013, PROG LIPID RES, V52, P175, DOI 10.1016/j.plipres.2012.11.002; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nan CL, 2010, BIOCHEM BIOPH RES CO, V402, P608, DOI 10.1016/j.bbrc.2010.10.064; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nicholls SJ, 2019, PATHOLOGY, V51, P142, DOI 10.1016/j.pathol.2018.10.017; Nofer JR, 2002, ATHEROSCLEROSIS, V161, P1, DOI 10.1016/S0021-9150(01)00651-7; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; Ouimet M, 2019, CIRC RES, V124, P1505, DOI 10.1161/CIRCRESAHA.119.312617; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Panzenbock U, 2005, BBA-PROTEINS PROTEOM, V1703, P171, DOI 10.1016/j.bbapap.2004.11.003; Qi Y, 2018, J CLIN LIPIDOL, V12, P89, DOI 10.1016/j.jacl.2017.11.003; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Schulman IG, 2017, FEBS LETT, V591, P2978, DOI 10.1002/1873-3468.12702; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Subedi BH, 2014, VASC HEALTH RISK MAN, V10, P205, DOI 10.2147/VHRM.S45648; Van Eck M, 2007, ARTERIOSCL THROM VAS, V27, P2413, DOI 10.1161/ATVBAHA.107.145474; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Witkowski A, 2018, FASEB J, V32, P3149, DOI 10.1096/fj.201701127R; Xu YY, 2015, J LIPID RES, V56, P1891, DOI 10.1194/jlr.M058776; Yu H, 2006, ARTERIOSCL THROM VAS, V26, P150, DOI 10.1161/01.ATV.0000194096.89476.73; Zanoni P, 2016, SCIENCE, V351, P1166, DOI 10.1126/science.aad3517; Zhang C, 2010, J CELL BIOCHEM, V111, P94, DOI 10.1002/jcb.22666; Zhang WW, 2003, CIRCULATION, V108, P2258, DOI 10.1161/01.CIR.0000093189.97429.9D; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhou CY, 2013, DIS MARKERS, V2013, P97, DOI 10.1155/2013/816189	56	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3805	3819		10.1096/fj.201902429R	http://dx.doi.org/10.1096/fj.201902429R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31975555	hybrid			2022-12-28	WOS:000509219700001
J	Xu, R; Gopireddy, RR; Wu, YD; Wu, L; Tao, X; Shao, J; Wang, WX; Li, L; Jovanovic, A; Xu, B; Kenyon, NJ; Lu, Q; Xiang, YK; Fu, Q				Xu, Rui; Gopireddy, Raghavender Reddy; Wu, Yudi; Wu, Lei; Tao, Xiang; Shao, Ji; Wang, Wenxin; Li, Li; Jovanovic, Aleksandra; Xu, Bing; Kenyon, Nicolas J.; Lu, Quan; Xiang, Yang K.; Fu, Qin			Hyperinsulinemia promotes heterologous desensitization of beta(2) adrenergic receptor in airway smooth muscle in obesity	FASEB JOURNAL			English	Article						asthma; obesity; phosphodiesterase 4; beta-adrenergic receptor agonist	PROTEIN-COUPLED RECEPTORS; BRONCHODILATOR SUBSENSITIVITY; PHOSPHODIESTERASE-4 INHIBITOR; INSULIN-RESISTANCE; INCIDENT ASTHMA; ROFLUMILAST; HYPERRESPONSIVENESS; METAANALYSIS; ACTIVATION; RESPONSES	beta-Adrenergic receptor (beta-AR) agonists are the most common clinical bronchodilators for asthma. Obesity influences asthma severity and may impair response to beta-AR agonists. Previous studies show that in obese mice, hyperinsulinemia plays a crucial role in beta-AR desensitization in the heart. We therefore investigated whether insulin promotes beta-AR desensitization in airway smooth muscle (ASM) and compromises airway relaxation responsiveness to beta-AR agonists. We found that human ASM cells and mouse airway tissues exposed to insulin exhibit impaired beta(2)AR-induced cAMP accumulation and airway relaxation. This impaired relaxation is associated with insulin-induced phosphorylation and expression of phosphodiesterase 4D (PDE4D) through transactivation of a G protein-coupled receptor kinase 2 (GRK2)-dependent beta(2)AR-G(i)-ERK1/2 cascade. Both acute and chronic pharmacological inhibition of PDE4 effectively reversed impaired beta(2)AR-mediated ASM relaxation in an obesity mouse model induced by a high fat diet. Collectively, these findings reveal that cross talk between insulin and beta(2)AR signaling promotes ASM beta(2)AR desensitization in obesity through upregulation of PDE4D phosphorylation and expression. Our results identify a novel pathway of asthma pathogenesis in patients with obesity/metabolic syndrome, in which the GRK2-mediated signaling can be a potential therapeutic modality to prevent or treat beta(2)AR desensitization in ASM. Moreover, PDE4 inhibitors may be used as efficacious therapeutic agents for asthma in obese and diabetic subjects.	[Xu, Rui; Wu, Yudi; Wu, Lei; Tao, Xiang; Shao, Ji; Wang, Wenxin; Li, Li; Fu, Qin] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Pharmacol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Xu, Rui; Li, Li; Fu, Qin] Key Lab Drug Target Res & Pharmacodynam Evaluat H, Wuhan, Peoples R China; [Gopireddy, Raghavender Reddy; Jovanovic, Aleksandra; Xu, Bing; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Xu, Bing; Xiang, Yang K.] VA Northern Calif Healthcare Syst, Mather, CA USA; [Kenyon, Nicolas J.] Univ Calif Davis, Dept Med, Davis, CA 95616 USA; [Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Huazhong University of Science & Technology; University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Harvard T.H. Chan School of Public Health	Fu, Q (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Pharmacol, Tongji Med Coll, Wuhan 430030, Peoples R China.; Xiang, YK (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	ykxiang@ucdavis.edu; fuqin@mails.tjmu.edu.cn	Fu, Qin/O-6960-2014	Fu, Qin/0000-0002-7954-7708	NSFC\ Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao [81729004]; National Natural Science Foundation of China (NSFC) [81773730, 81473212]; California Tobacco-Related Disease Research Program [TRDRP587390]	NSFC\ Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); California Tobacco-Related Disease Research Program(University of California System)	NSFC vertical bar Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao, Grant/Award Number: 81729004; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81773730 and 81473212; California Tobacco-Related Disease Research Program, Grant/Award Number: TRDRP587390	Arshi M, 2010, RESPIROLOGY, V15, P779, DOI 10.1111/j.1440-1843.2010.01767.x; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Chuang TT, 1996, TRENDS PHARMACOL SCI, V17, P416, DOI 10.1016/S0165-6147(96)10048-1; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Fu Q, 2015, CELL SIGNAL, V27, P707, DOI 10.1016/j.cellsig.2014.11.018; Fu Q, 2014, DIABETES, V63, P2676, DOI 10.2337/db13-1763; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Giembycz MA, 2006, EUR RESPIR J, V27, P1286, DOI 10.1183/09031936.06.00112605; Gosens R, 2003, EUR J PHARMACOL, V481, P125, DOI 10.1016/j.ejphar.2003.08.081; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Hu AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118712; Kanehiro A, 2001, AM J RESP CRIT CARE, V163, P173, DOI 10.1164/ajrccm.163.1.2001118; Krymskaya VP, 2007, CURR TOP DEV BIOL, V79, P61, DOI 10.1016/S0070-2153(06)79003-2; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Mellbin LG, 2013, EUR HEART J, V34, P3137, DOI 10.1093/eurheartj/eht332; NEWNHAM DM, 1994, AM J MED, V97, P29, DOI 10.1016/0002-9343(94)90045-0; Nie ZY, 2014, AM J RESP CELL MOL, V51, P251, DOI 10.1165/rcmb.2013-0452OC; Park HJ, 2016, AM J RESP CELL MOL, V55, P82, DOI 10.1165/rcmb.2015-0345OC; Pera T, 2015, FASEB J, V29, P4227, DOI 10.1096/fj.15-273094; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Schaafsma D, 2007, BRIT J PHARMACOL, V150, P136, DOI 10.1038/sj.bjp.0706985; SETTE C, 1994, J BIOL CHEM, V269, P9245; Shi Q, 2017, CARDIOVASC RES, V113, P656, DOI 10.1093/cvr/cvx036; Shore SA, 2003, RESP PHYSIOL NEUROBI, V137, P179, DOI 10.1016/S1569-9048(03)00146-0; Sutherland ER, 2009, J ALLERGY CLIN IMMUN, V123, P1328, DOI 10.1016/j.jaci.2009.04.005; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; van Schalkwyk E, 2005, J ALLERGY CLIN IMMUN, V116, P292, DOI 10.1016/j.jaci.2005.04.023; Wang QT, 2017, CIRCULATION, V135, P73, DOI 10.1161/CIRCULATIONAHA.116.022281; Wouters EFM, 2012, J CLIN ENDOCR METAB, V97, pE1720, DOI 10.1210/jc.2011-2886; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102	35	4	5	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3996	4008		10.1096/fj.201800688RR	http://dx.doi.org/10.1096/fj.201800688RR		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960515	Bronze			2022-12-28	WOS:000508662600001
J	Lenzi, RN; Korn, SJ; Wallace, M; Desmond, NL; Labosky, PA				Lenzi, Rebecca N.; Korn, Stephen J.; Wallace, Madeleine; Desmond, Nancy L.; Labosky, Patricia A.			The NIH "BEST" programs: Institutional programs, the program evaluation, and early data	FASEB JOURNAL			English	Article						biomedical research careers; career development; education; graduate students; postdoctoral scientists; professional development; training		Biomedical research training has undergone considerable change over the past several years. At its core, the goal of graduate and postdoctoral training is to provide individuals with the skills and knowledge to become outstanding scientists and expand knowledge through the scientific method. Historically, graduate school training has focused on preparation for academic positions. Increasingly, however, a shift toward preparation for a wider range of career options has emerged. This is largely because most biomedical PhD graduates do not become Principal Investigators in academic laboratories. Here we describe an National Institutes of Health Common Fund program with the major goal of culture change for biomedical research training and training that prepares individuals for a broader expanse of careers in the biomedical research enterprise. These "Broadening Experiences in Scientific Training" (BEST) awards, issued in 2012 and 2013, provided support to institutions to develop innovative approaches to achieving these goals, as a complement to traditional training. Awardees were tasked with catalyzing change at their institutions and sharing best practices across the training community. Awardees were required to participate in a cross-site evaluation that assessed the impact of BEST activities on three main areas: (a) trainee confidence and knowledge to make career decisions, (b) influence of this added activity on time in training, and (c) ability of the institutions to sustain activities deemed to be beneficial. Here we present the fundamental approach to the BEST program and early evaluative data.	[Lenzi, Rebecca N.; Labosky, Patricia A.] NIH, Div Program Coordinat Planning & Strateg Initiati, 6001 Execut Blvd,Suite 8180A, Bethesda, MD 20892 USA; [Korn, Stephen J.] NINDS, Off Training & Workforce Dev, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Wallace, Madeleine] Windrose Vis LLC, Fairfax, VA USA; [Desmond, Nancy L.] NIMH, Div Neurosci & Basic Behav Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Labosky, PA (corresponding author), NIH, Div Program Coordinat Planning & Strateg Initiati, 6001 Execut Blvd,Suite 8180A, Bethesda, MD 20892 USA.	patricia.labosky@nih.gov		Lenzi, Rebecca/0000-0002-7975-9268	NIH Common Fund	NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH Common Fund, Grant/Award Number: NA	[Anonymous], 2017, P BEST PRACT WORKSH; Blank R, 2017, SCIENCE, V358, P1388, DOI 10.1126/science.aar4638; Cyranoski D, 2011, NATURE, V472, P276, DOI 10.1038/472276a; Fuhrmann CN, MYIDP INDIVIDUAL DEV; Fuhrmann CN, 2016, HUM GENE THER, V27, P871, DOI 10.1089/hum.2016.154; Garrison HH, 2003, FASEB J, V17, P2169, DOI 10.1096/fj.03-0836life; Kolata Gina, 2016, NEW YORK TIMES; Mathur A, 2018, J CLIN TRANSL SCI, V2, P63, DOI 10.1017/cts.2018.22; Mathur A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8200; Meyers FJ, 2016, FASEB J, V30, P507, DOI 10.1096/fj.15-276139; National Academies, 1998, TRENDS EARL CAR LIF; National Academies of Sciences E, 2018, NEXT GEN BIOM BEH SC, DOI [10.17226/25008, DOI 10.17226/25008]; National Endowment for the Humanities, 2018, NEH ANN 17000000 NEX; National Institutes of Health, 2012, BIOM RES WORKF WORK; National Institutes of Health, 2013, RFARM12022 NAT I HLT; National Institutes of Health, 2014, RFARM13019 NAT I HLT; National Research Council, 2011, RES TRAIN BIOM BEH C, DOI [10.17226/12983, DOI 10.17226/12983]; National Science Foundation, 2018, DEAR COLL LETT NON R; National Science Foundation, 2019, NAT SCI FDN RES TRAI; National Science Foundation, 2016, DEAR COLL LETT IMPR; NIGMS, 2017, T32 NIGMS NRSA PRED; NIH BEST Consortium, 2018, EM BEST PRACT TRACK; NIH BEST Consortium, 2018, INT EXP LEARN; NIH BEST Consortium, TRACK PART EV OUTC; NIH BEST Consortium, 2017, M CAR OUTC; NIH BEST Consortium Development of Workshops and Courses, 2017, DEV WORKSH COURS; Roach M, 2017, PLOS ONE, V12, P9, DOI DOI 10.1371/J0URNAL.P0NE.0184130; Rockey SJ, 2014, DEFINING DUAL ROLE G; Schaller MD, 2017, ELIFE, V6, DOI 10.7554/eLife.32437; Schnoes AM, 2018, CBE-LIFE SCI EDUC, V17, DOI 10.1187/cbe.17-08-0164; St Clair R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177035; Stayart CA, 2018, APPL INTERRATER REAL, P370783, DOI [10.1101/370783, DOI 10.1101/370783]; Watts SW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210189	33	10	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3570	3582		10.1096/fj.201902064	http://dx.doi.org/10.1096/fj.201902064		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960495				2022-12-28	WOS:000508635600001
J	Dache, ZA; Otandault, A; Tanos, R; Pastor, B; Meddeb, R; Sanchez, C; Arena, G; Lasorsa, L; Bennett, A; Grange, T; El Messaoudi, S; Mazard, T; Prevostel, C; Thierry, AR				Dache, Zahra Al Amir; Otandault, Amaelle; Tanos, Rita; Pastor, Brice; Meddeb, Romain; Sanchez, Cynthia; Arena, Giuseppe; Lasorsa, Laurence; Bennett, Andrew; Grange, Thierry; El Messaoudi, Safia; Mazard, Thibault; Prevostel, Corinne; Thierry, Alain R.			Blood contains circulating cell-free respiratory competent mitochondria	FASEB JOURNAL			English	Article						blood; circulating DNA; mitochondria; mitochondrial genome; respiratory competent	MESENCHYMAL STEM-CELLS; SINGLE-STRAND; DNA; BIOMARKER; DISEASE; SENSORS	Mitochondria are considered as the power-generating units of the cell due to their key role in energy metabolism and cell signaling. However, mitochondrial components could be found in the extracellular space, as fragments or encapsulated in vesicles. In addition, this intact organelle has been recently reported to be released by platelets exclusively in specific conditions. Here, we demonstrate for the first time, that blood preparation with resting platelets, contains whole functional mitochondria in normal physiological state. Likewise, we show, that normal and tumor cultured cells are able to secrete their mitochondria. Using serial centrifugation or filtration followed by polymerase chain reaction-based methods, and Whole Genome Sequencing, we detect extracellular full-length mitochondrial DNA in particles over 0.22 mu m holding specific mitochondrial membrane proteins. We identify these particles as intact cell-free mitochondria using fluorescence-activated cell sorting analysis, fluorescence microscopy, and transmission electron microscopy. Oxygen consumption analysis revealed that these mitochondria are respiratory competent. In view of previously described mitochondrial potential in intercellular transfer, this discovery could greatly widen the scope of cell-cell communication biology. Further steps should be developed to investigate the potential role of mitochondria as a signaling organelle outside the cell and to determine whether these circulating units could be relevant for early detection and prognosis of various diseases.	[Dache, Zahra Al Amir; Otandault, Amaelle; Tanos, Rita; Pastor, Brice; Meddeb, Romain; Sanchez, Cynthia; Lasorsa, Laurence; El Messaoudi, Safia; Mazard, Thibault; Prevostel, Corinne; Thierry, Alain R.] Univ Montpellier, Inst Reg Canc Montpellier, INSERM U1194, IRCM, Montpellier, France; [Arena, Giuseppe] INSERM U1030, Gustave Roussy Canc Campus, F-94805 Villejuif, France; [Bennett, Andrew; Grange, Thierry] Univ Paris Diderot, Inst Jacques Monod, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite	Thierry, AR (corresponding author), INSERM, IRCM, U1194, 208 Rue Apothicaires, F-34298 Montpellier 5, France.	alain.thierry@inserm.fr	MAZARD, Thibault/ABH-6334-2020; Prevostel, Corinne/AAO-1433-2020; Arena, Giuseppe/ABE-8093-2021	MAZARD, Thibault/0000-0002-5644-9603; Arena, Giuseppe/0000-0003-2398-5503; Al Amir Dache, Zahra/0000-0001-7415-4940; PREVOSTEL, Corinne/0000-0002-7553-087X; Grange, Thierry/0000-0001-8700-3092; pastor, brice/0000-0001-9096-3537	SIRIC Montpellier Grant [INCa-DGOS-Inserm 6045]; Institut National de la Sante et de la Recherche Medicale	SIRIC Montpellier Grant; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	SIRIC Montpellier Grant, Grant/Award Number: INCa-DGOS-Inserm 6045; Institut National de la Sante et de la Recherche Medicale	Bennett EA, 2014, BIOTECHNIQUES, V56, P289, DOI 10.2144/000114176; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Dames Shale, 2015, Methods Mol Biol, V1264, P77, DOI 10.1007/978-1-4939-2257-4_8; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gansauge MT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx033; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mahrouf-Yorgov M, 2017, CELL DEATH DIFFER, V24, P1224, DOI 10.1038/cdd.2017.51; Malik AN, 2015, DIABETES RES CLIN PR, V110, P257, DOI 10.1016/j.diabres.2015.10.006; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meddeb R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41593-4; Meddeb R, 2019, CLIN CHEM, V65, P623, DOI 10.1373/clinchem.2018.298323; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104; Newell C, 2018, MOL GENET METAB, V125, P332, DOI 10.1016/j.ymgme.2018.10.002; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Otandault A, 2019, ANN ONCOL, V30, P374, DOI 10.1093/annonc/mdz031; Patel D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13227-0; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601; Rigothier C, 2016, J CELL BIOCHEM, V117, P2737, DOI 10.1002/jcb.25571; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Roberts RG, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002338; Rodriguez AM, 2018, CELL CYCLE, V17, P712, DOI 10.1080/15384101.2018.1445906; Rodriguez-Nuevo A, 2019, CELL STRESS, V3, P195, DOI 10.15698/cst2019.06.190; Sanchez C, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0069-0; Sansone P, 2017, P NATL ACAD SCI USA, V114, pE9066, DOI 10.1073/pnas.1704862114; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Sudakov NP, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1387, DOI 10.1134/S000629791510020X; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Thierry AR, 2016, CANCER METAST REV, V35, P347, DOI 10.1007/s10555-016-9629-x; Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107; Wang JY, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0832-2; Wiemerslage L, 2016, MITOCHONDRION, V30, P138, DOI 10.1016/j.mito.2016.07.004; Yu M, 2012, MITOCHONDR DNA, V23, P329, DOI 10.3109/19401736.2012.696625; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang RY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36097	43	144	145	9	47	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3616	3630		10.1096/fj.201901917RR	http://dx.doi.org/10.1096/fj.201901917RR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957088	Green Submitted, hybrid			2022-12-28	WOS:000508135400001
J	Chambers, ED; White, A; Vang, A; Wang, ZK; Ayala, A; Weng, TT; Blackburn, M; Choudhary, G; Rounds, S; Lu, Q				Chambers, Eboni D.; White, Alexis; Vang, Alexander; Wang, Zhengke; Ayala, Alfred; Weng, Tingting; Blackburn, Michael; Choudhary, Gaurav; Rounds, Sharon; Lu, Qing			Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa-induced acute lung injury and NLRP3 inflammasome activation	FASEB JOURNAL			English	Article						acute lung injury; equilibrative nucleoside transporters; NLRP3 inflammasome; pneumonia; Pseudomonas aeruginosa	ADENOSINE-DEAMINASE DEFICIENCY; RESPIRATORY-DISTRESS-SYNDROME; EXTRACELLULAR ADENOSINE; INTERNATIONAL UNION; BARRIER DYSFUNCTION; PULMONARY; RECEPTORS; PNEUMONIA; CLASSIFICATION; EPIDEMIOLOGY	Pseudomonas aeruginosa infections are increasingly multidrug resistant and cause healthcare-associated pneumonia, a major risk factor for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Adenosine is a signaling nucleoside with potential opposing effects; adenosine can either protect against acute lung injury via adenosine receptors or cause lung injury via adenosine receptors or equilibrative nucleoside transporter (ENT)-dependent intracellular adenosine uptake. We hypothesized that blockade of intracellular adenosine uptake by inhibition of ENT1/2 would increase adenosine receptor signaling and protect against P. aeruginosa-induced acute lung injury. We observed that P. aeruginosa (strain: PA103) infection induced acute lung injury in C57BL/6 mice in a dose- and time-dependent manner. Using ENT1/2 pharmacological inhibitor, nitrobenzylthioinosine (NBTI), and ENT1-null mice, we demonstrated that ENT blockade elevated lung adenosine levels and significantly attenuated P. aeruginosa-induced acute lung injury, as assessed by lung wet-to-dry weight ratio, BAL protein levels, BAL inflammatory cell counts, pro-inflammatory cytokines, and pulmonary function (total lung volume, static lung compliance, tissue damping, and tissue elastance). Using both agonists and antagonists directed against adenosine receptors A(2A)R and A(2B)R, we further demonstrated that ENT1/2 blockade protected against P. aeruginosa -induced acute lung injury via activation of A(2A)R and A(2B)R. Additionally, ENT1/2 chemical inhibition and ENT1 knockout prevented P. aeruginosa-induced lung NLRP3 inflammasome activation. Finally, inhibition of inflammasome prevented P. aeruginosa-induced acute lung injury. Our results suggest that targeting ENT1/2 and NLRP3 inflammasome may be novel strategies for prevention and treatment of P. aeruginosa-induced pneumonia and subsequent ARDS.	[Chambers, Eboni D.; White, Alexis; Vang, Alexander; Wang, Zhengke; Choudhary, Gaurav; Rounds, Sharon; Lu, Qing] Brown Univ, Alpert Med Sch, Providence Vet Affairs Med Ctr, Vasc Res Lab, Providence, RI 02912 USA; [Ayala, Alfred] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Div Surg Res, Providence, RI 02903 USA; [Weng, Tingting; Blackburn, Michael] Univ Texas Houston, Sch Med, Dept Biochem, Houston, TX USA; [Weng, Tingting; Blackburn, Michael] Univ Texas Houston, Sch Med, Dept Mol Biol, Houston, TX USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Lu, Q (corresponding author), Providence VA Med Ctr, Res Serv, 830 Chalkstone Ave, Providence, RI 02908 USA.	Qing_Lu@brown.edu	Rounds, Sharon/AAF-7380-2020; Choudhary, Gaurav/M-1643-2019	Choudhary, Gaurav/0000-0001-9343-5481	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL130230, HL128661]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [P20 GM103652, R35GM118097]; NIH [AR073284]; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [T32 ES007272]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL130230 and HL128661; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20 GM103652 and R35GM118097; NIH, Grant/Award Number: AR073284; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: T32 ES007272	Aggarwal NR, 2013, AM J RESP CELL MOL, V48, P635, DOI 10.1165/rcmb.2012-0351OC; Alfaro TM, 2017, PULM PHARMACOL THER, V45, P90, DOI 10.1016/j.pupt.2017.04.009; Antonioli L, 2014, DRUG DISCOV TODAY, V19, P1051, DOI 10.1016/j.drudis.2014.02.010; Archer RGE, 2004, BRIT J PHARMACOL, V143, P202, DOI 10.1038/sj.bjp.0705921; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Barletta KE, 2012, ARTERIOSCL THROM VAS, V32, P856, DOI 10.1161/ATVBAHA.111.226845; Baron L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.576; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Borgas D, 2016, AM J RESP CELL MOL, V54, P683, DOI 10.1165/rcmb.2015-0149OC; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; de Zoete MR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016287; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Furuta GT, 2014, ANN ALLERG ASTHMA IM, V113, P3, DOI 10.1016/j.anai.2014.04.002; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Ibrahim EH, 2000, CHEST, V117, P1434, DOI 10.1378/chest.117.5.1434; Jin LL, 2017, J IMMUNOL, V198, P1253, DOI 10.4049/jimmunol.1601745; KOLLER DY, 1994, THORAX, V49, P496, DOI 10.1136/thx.49.5.496; Kumar VS, 2014, JOVE-J VIS EXP, DOI 10.3791/52044; Linch SN, 2009, INFECT IMMUN, V77, P4976, DOI 10.1128/IAI.00306-09; Liu H, 2015, INT IMMUNOPHARMACOL, V29, P937, DOI 10.1016/j.intimp.2015.10.010; Longhi MS, 2013, J MOL MED, V91, P165, DOI 10.1007/s00109-012-0991-z; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL591, DOI 10.1152/ajplung.00335.2013; Lu Q, 2013, AM J PHYSIOL-LUNG C, V304, pL361, DOI 10.1152/ajplung.00161.2012; Lu Q, 2012, AM J RESP CELL MOL, V47, P604, DOI 10.1165/rcmb.2012-0012OC; Lu Q, 2011, AM J PHYSIOL-LUNG C, V301, pL847, DOI 10.1152/ajplung.00178.2011; Lu Q, 2010, AM J PHYSIOL-LUNG C, V298, pL755, DOI 10.1152/ajplung.00330.2009; Meduri GU, 1998, AM J RESP CRIT CARE, V158, P870, DOI 10.1164/ajrccm.158.3.9706112; Morote-Garcia JC, 2013, AM J RESP CELL MOL, V49, P296, DOI 10.1165/rcmb.2012-0457OC; Ramirez-Estrada S, 2016, INFECT DRUG RESIST, V9, P7, DOI 10.2147/IDR.S50669; Schultz MJ, 2003, INFECT IMMUN, V71, P1630, DOI 10.1128/IAI.71.4.1630-1634.2003; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; US Department of Health and Human Services Centers for Disease Control and Prevention., 2013, ANT RES THREATS US; Villar J, 2016, CURR OPIN CRIT CARE, V22, P1, DOI 10.1097/MCC.0000000000000266; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Wilson CN, 2002, J ENDOTOXIN RES, V8, P263, DOI 10.1179/096805102125000470; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093	57	16	17	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1516	1531		10.1096/fj.201902286R	http://dx.doi.org/10.1096/fj.201902286R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914698	Green Accepted, Bronze			2022-12-28	WOS:000507308900100
J	Chen, PH; Chen, YT; Chu, TY; Ma, TH; Wu, MH; Lin, HH; Chang, YS; Tan, BCM; Lo, SJ				Chen, Po-Hsiang; Chen, Yi-Tung; Chu, Tai-Ying; Ma, Tian-Hsiang; Wu, Mei-Hsuan; Lin, Hsi-Hsien; Chang, Yu-Sun; Tan, Bertrand Chin-Ming; Lo, Szecheng J.			Nucleolar control by a non-apoptotic p53-caspases-deubiquitinylase axis promotes resistance to bacterial infection	FASEB JOURNAL			English	Article						bacterial resistance; caspases; deubiquitinylase; fibrillarin; nucleolus; p53	PROGRAMMED CELL-DEATH; CAENORHABDITIS-ELEGANS; RIBOSOMAL-RNA; TRANSLATIONAL INHIBITION; C-ELEGANS; P53; ACTIVATION; CANCER; DISRUPTION; CASPASES	The nucleolus is best known for its cellular role in regulating ribosome production and growth. More recently, an unanticipated role for the nucleolus in innate immunity has recently emerged whereby downregulation of fibrillarin and nucleolar contraction confers pathogen resistance across taxa. The mechanism of this downregulation, however, remains obscure. Here we report that rather than fibrillarin itself being the proximal factor in this pathway, the key player is a fibrillarin-stabilizing deubiquitinylase USP-33. This was discovered by a candidate-gene search of Caenorhabditis elegans in which CED-3 caspase was revealed to execute targeted cleavage of USP-33, thus destabilizing fibrillarin. We also showed that cep-1 and ced-3 mutant worms altered nucleolar size and decreased antimicrobial peptide gene, spp-1, expression rendering susceptibility to bacterial infection. These phenotypes were reversed by usp-33 knockdown, thus linking the CEP-1-CED-3-USP-33 pathway with nucleolar control and resistance to bacterial infection in worms. Parallel experiments with the human analogs of caspases and USP36 revealed similar roles in coordinating these two processes. In summary, our work outlined a conserved cascade that connects cell death signaling to nucleolar control and innate immune response.	[Chen, Po-Hsiang; Chen, Yi-Tung; Wu, Mei-Hsuan; Tan, Bertrand Chin-Ming; Lo, Szecheng J.] Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan, Taiwan; [Chen, Po-Hsiang; Lin, Hsi-Hsien; Chang, Yu-Sun; Tan, Bertrand Chin-Ming; Lo, Szecheng J.] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan; [Chu, Tai-Ying; Lin, Hsi-Hsien] Chang Gung Univ, Dept Microbiol & Immunol, Taoyuan, Taiwan; [Ma, Tian-Hsiang; Chang, Yu-Sun; Tan, Bertrand Chin-Ming] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Dept Neurosurg, Lin Kou Med Ctr, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chang, YS; Tan, BCM; Lo, SJ (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan.	ysc@mail.cgu.edu.tw; btan@mail.cgu.edu.tw; losj@mail.cgu.edu.tw	LIN, Hsi-Hsien/N-1488-2015	Chen, Yi-Tung/0000-0001-9715-648X; Chu, Tang-Yuan/0000-0003-2717-2681	Ministry of Science and Technology, Taiwan (MOST) [MOST105-2314-B-182-061-MY4]; Chang Gung Memorial Hospital (CGMH) [BMRP742]; Ministry of Education (MOE) [EMRPD1C0051]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital (CGMH)(Chang Gung Memorial Hospital); Ministry of Education (MOE)(Ministry of Education, Singapore)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST104-2320-B-182-029-MY3; Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST105-2314-B-182-061-MY4; Chang Gung Memorial Hospital (CGMH), Grant/Award Number: CMRPD1F0442; Chang Gung Memorial Hospital (CGMH), Grant/Award Number: CMRPD1H0021; Chang Gung Memorial Hospital (CGMH), Grant/Award Number: BMRP960; Chang Gung Memorial Hospital (CGMH), Grant/Award Number: BMRP742; Ministry of Education (MOE), Grant/Award Number: EMRPD1C0051	Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Bastide A, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0044-8; BRENNER S, 1974, GENETICS, V77, P71; Buchwalter A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00322-z; Chen LD, 2015, ONCOTARGET, V6, P10207, DOI 10.18632/oncotarget.3504; Cmarko D, 2008, HISTOL HISTOPATHOL, V23, P1291, DOI 10.14670/HH-23.1291; Conradt B, 2016, GENETICS, V203, P1533, DOI 10.1534/genetics.115.186247; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Endo A, 2009, J BIOL CHEM, V284, P27918, DOI 10.1074/jbc.M109.037218; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Frank DJ, 1998, J CELL BIOL, V140, P1321, DOI 10.1083/jcb.140.6.1321; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fuhrman LE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000657; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Genuth NR, 2018, MOL CELL, V71, P364, DOI 10.1016/j.molcel.2018.07.018; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hollville E, 2018, SEMIN CELL DEV BIOL, V82, P127, DOI 10.1016/j.semcdb.2017.11.037; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Khajuria RK, 2018, CELL, V173, P90, DOI 10.1016/j.cell.2018.02.036; Kumar S, 2015, LEUKEMIA LYMPHOMA, V56, P1846, DOI 10.3109/10428194.2014.974042; Labed SA, 2018, IMMUNITY, V48, P963, DOI 10.1016/j.immuni.2018.04.017; Lee CC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.114; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Liu XR, 2013, NUCLEIC ACIDS RES, V41, P6034, DOI 10.1093/nar/gkt305; Lo SJ, 2006, CELL RES, V16, P530, DOI 10.1038/sj.cr.7310070; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; McIlwain DR, 2015, CSH PERSPECT BIOL, V7; Mello SS, 2018, CURR OPIN CELL BIOL, V51, P65, DOI 10.1016/j.ceb.2017.11.005; Menon Vijay, 2014, Subcell Biochem, V85, P321, DOI 10.1007/978-94-017-9211-0_17; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nakajima YI, 2017, CELL DEATH DIFFER, V24, P1422, DOI 10.1038/cdd.2017.36; Nicholson SA, 2001, CANCER RES, V61, P5636; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; Park SY, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.52; Parrales A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00288; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; PERRY RP, 1968, J CELL PHYSIOL, V72, P235, DOI 10.1002/jcp.1040720311; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pinan-Lucarre B, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001331; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Shaham S, 1998, J BIOL CHEM, V273, P35109, DOI 10.1074/jbc.273.52.35109; Simsek D, 2017, CELL, V169, P1051, DOI 10.1016/j.cell.2017.05.022; Sun XX, 2015, CELL CYCLE, V14, P3786, DOI 10.1080/15384101.2015.1093713; Sun XX, 2015, P NATL ACAD SCI USA, V112, P3734, DOI 10.1073/pnas.1411713112; Tiku V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06051-1; Tiku V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16083; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tsai RYL, 2014, FASEB J, V28, P3290, DOI 10.1096/fj.14-254680; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; Uppaluri S, 2016, CELL REP, V17, P345, DOI 10.1016/j.celrep.2016.09.007; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Weaver BP, 2014, ELIFE, V3, DOI 10.7554/eLife.04265; Wu YC, 2000, GENE DEV, V14, P536; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Yang K, 2018, CELL STRESS, V2, P125, DOI 10.15698/cst2018.06.139; Yang K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13599; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Yi YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005580; Yu H, 2015, BIOCHEM J, V470, P145, DOI 10.1042/BJ20150563; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	68	1	1	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1107	1121		10.1096/fj.201901959R	http://dx.doi.org/10.1096/fj.201901959R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914708	hybrid			2022-12-28	WOS:000507308900075
J	Franzolin, E; Coletta, S; Ferraro, P; Pontarin, G; D'Aronco, G; Stevanoni, M; Palumbo, E; Cagnin, S; Bertoldi, L; Feltrin, E; Valle, G; Russo, A; Bianchi, V; Rampazzo, C				Franzolin, Elisa; Coletta, Sara; Ferraro, Paola; Pontarin, Giovanna; D'Aronco, Giulia; Stevanoni, Martina; Palumbo, Elisa; Cagnin, Stefano; Bertoldi, Loris; Feltrin, Erika; Valle, Giorgio; Russo, Antonella; Bianchi, Vera; Rampazzo, Chiara			SAMHD1-deficient fibroblasts from Aicardi-Goutieres Syndrome patients can escape senescence and accumulate mutations	FASEB JOURNAL			English	Article						deoxynucleotide catabolism; deoxynucleotide pool imbalance; sterile alpha motif and HD domain containing protein 1 (SAMHD1); UV-induced DNA repair	RESTRICTION FACTOR SAMHD1; DNA-REPLICATION; TRIPHOSPHOHYDROLASE ACTIVITY; READ ALIGNMENT; ORIGIN CHOICE; GENOME-WIDE; DNTP POOLS; S-PHASE; CANCER; GENE	In mammalian cells, the catabolic activity of the dNTP triphosphohydrolase SAMHD1 sets the balance and concentration of the four dNTPs. Deficiency of SAMHD1 leads to unequally increased pools and marked dNTP imbalance. Imbalanced dNTP pools increase mutation frequency in cancer cells, but it is not known if the SAMHD1-induced dNTP imbalance favors accumulation of somatic mutations in non-transformed cells. Here, we have investigated how fibroblasts from Aicardi-Goutieres Syndrome (AGS) patients with mutated SAMHD1 react to the constitutive pool imbalance characterized by a huge dGTP pool. We focused on the effects on dNTP pools, cell cycle progression, dynamics and fidelity of DNA replication, and efficiency of UV-induced DNA repair. AGS fibroblasts entered senescence prematurely or upregulated genes involved in G1/S transition and DNA replication. The normally growing AGS cells exhibited unchanged DNA replication dynamics and, when quiescent, faster rate of excision repair of UV-induced DNA damages. To investigate whether the lack of SAMHD1 affects DNA replication fidelity, we compared de novo mutations in AGS and WT cells by exome next-generation sequencing. Somatic variant analysis indicated a mutator phenotype suggesting that SAMHD1 is a caretaker gene whose deficiency is per se mutagenic, promoting genome instability in non-transformed cells.	[Franzolin, Elisa; Coletta, Sara; Ferraro, Paola; Pontarin, Giovanna; D'Aronco, Giulia; Stevanoni, Martina; Cagnin, Stefano; Bertoldi, Loris; Feltrin, Erika; Valle, Giorgio; Bianchi, Vera; Rampazzo, Chiara] Univ Padua, Dept Biol, Padua, Italy; [Palumbo, Elisa; Russo, Antonella] Univ Padua, Dept Mol Med, Padua, Italy; [Cagnin, Stefano] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Cagnin, Stefano] Univ Padua, CIR Myo Myol Ctr, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Rampazzo, C (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	chiara.rampazzo.1@unipd.it	Russo, Antonella/K-8970-2016; Cagnin, Stefano/B-4800-2014; Palumbo, Elisa/J-9121-2016	Russo, Antonella/0000-0001-6691-257X; Cagnin, Stefano/0000-0001-7271-4625; Palumbo, Elisa/0000-0002-5812-6760; Bertoldi, Loris/0000-0002-8516-7680	Fondazione Telethon [GGP14005]; Associazione Italiana per la ricerca sul cancro (AIRC project) Dipartimento di Biologia-BIRD2018 (Universita di Padova) [IG15818]	Fondazione Telethon(Fondazione TelethonEuropean Commission); Associazione Italiana per la ricerca sul cancro (AIRC project) Dipartimento di Biologia-BIRD2018 (Universita di Padova)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Fondazione Telethon (project GGP14005 to V.B), Associazione Italiana per la ricerca sul cancro (AIRC project IG15818 to VB) Dipartimento di Biologia-BIRD2018 (Universita di Padova) to CR	Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Coquel F, 2018, NATURE, V557, P57, DOI 10.1038/s41586-018-0050-1; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Daddacha W, 2017, CELL REP, V20, P1921, DOI 10.1016/j.celrep.2017.08.008; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Franzolin E, 2015, J BIOL CHEM, V290, P25986, DOI 10.1074/jbc.M115.675082; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; GODAY A, 1984, CLIN EXP IMMUNOL, V56, P39; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Johansson P, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-017-0036-5; Kasher PR, 2015, J IMMUNOL, V194, P2819, DOI 10.4049/jimmunol.1403157; Kolinjivadi AM, 2017, FEBS LETT, V591, P1083, DOI 10.1002/1873-3468.12556; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Lee EJ, 2017, ONCOTARGET, V8, P68517, DOI 10.18632/oncotarget.19704; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; MEUTH M, 1979, P NATL ACAD SCI USA, V76, P6505, DOI 10.1073/pnas.76.12.6505; Miazzi C, 2014, J BIOL CHEM, V289, P18339, DOI 10.1074/jbc.M114.571091; Nguyen LA, 2014, J BIOL CHEM, V289, P2489, DOI 10.1074/jbc.C113.522326; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Palumbo E, 2013, EXP CELL RES, V319, P3081, DOI 10.1016/j.yexcr.2013.10.001; Palumbo E, 2013, GENE CHROMOSOME CANC, V52, P832, DOI 10.1002/gcc.22079; Palumbo E, 2010, CHROMOSOMA, V119, P575, DOI 10.1007/s00412-010-0279-4; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Ramesh V, 2010, DEV MED CHILD NEUROL, V52, P725, DOI 10.1111/j.1469-8749.2010.03727.x; Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schmidt TT, 2019, NUCLEIC ACIDS RES, V47, P237, DOI 10.1093/nar/gky1154; Stevanoni M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006201; Tang CX, 2015, J BIOL CHEM, V290, P26352, DOI 10.1074/jbc.M115.677435; Thyagarajan B, 2007, MUTAGENESIS, V22, P147, DOI 10.1093/mutage/gel071; Tramentozzi E, 2018, CELL CYCLE, V17, P1102, DOI 10.1080/15384101.2018.1480216; Wang JL, 2014, BIOCHEM BIOPH RES CO, V455, P229, DOI 10.1016/j.bbrc.2014.10.153; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Watt DL, 2016, NUCLEIC ACIDS RES, V44, P1669, DOI 10.1093/nar/gkv1298; WEINBERG G, 1981, P NATL ACAD SCI-BIOL, V78, P2447, DOI 10.1073/pnas.78.4.2447; Wittmann S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0229-6	63	9	9	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					631	647		10.1096/fj.201902508R	http://dx.doi.org/10.1096/fj.201902508R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914608	Green Published			2022-12-28	WOS:000507308900044
J	Lee, Y; Park, J; Kim, SM; Nam, K; Lee, W; Cho, H; Han, IO				Lee, Yunkyoung; Park, Jiwon; Kim, Sang-Min; Nam, Kyunghyun; Lee, Woojoo; Cho, Hyeongjin; Han, Inn-Oc			Sleep deprivation impairs learning and memory by decreasing protein O-GlcNAcylation in the brain of adult zebrafish	FASEB JOURNAL			English	Article						Danio rerio; glucosamine; HBP; learning and memory; OGA; sleep deprivation	SYNAPTIC PLASTICITY; HIPPOCAMPUS; GLUCOSE; TAU	Sleep is an evolutionarily conserved physiological process implicated in the consolidation of learning and memory (L/M). Here, we report that sleep deprivation (SD)-induced cognitive deficits in zebrafish are mediated through reduction in O-GlcNAcylation of brain. Microarray-based gene expression profiling of zebrafish brain demonstrated significant changes in genes involved in metabolism by SD or fear conditioning (FC), compared to the control group. In particular, it was observed that a marked decrease in the number of genes involved in carboxylic acid and organic acid metabolic processes in the brains of SD group compared to control group. SD downregulated O-GlcNAc transferase (OGT) and O-GlcNAcylation, while the expression of O-GlcNAcase was upregulated. FC activated protein kinase A (PKA) and phosphorylated cAMP response element binding protein (p-CREB), an effect that was greatly inhibited by SD. Moreover, FC upregulated expressions of OGT and increased O-GlcNAcylation in the brains of normal but not SD zebrafish. Intriguingly, upregulation of O-GlcNAcylation by glucosamine restored defects in L/M functions and PKA/p-CREB activity in SD group. Our findings highlight the O-GlcNAcylation changes in the brain during the L/M process and further provide a foundation for future studies seeking the molecular and biochemical mechanisms by which HBP of glucose metabolism affects cognitive function.	[Lee, Yunkyoung; Park, Jiwon; Kim, Sang-Min; Han, Inn-Oc] Inha Univ, Coll Med, Dept Physiol & Biophys, 100 Inha Ro, Incheon 22212, South Korea; [Nam, Kyunghyun; Lee, Woojoo] Inha Univ, Dept Stat, Incheon, South Korea; [Cho, Hyeongjin] Inha Univ, Dept Chem, Incheon, South Korea	Inha University; Inha University; Inha University	Han, IO (corresponding author), Inha Univ, Coll Med, Dept Physiol & Biophys, 100 Inha Ro, Incheon 22212, South Korea.	iohan@inha.ac.kr			National Research Foundation [NRF-2017R1A2B2007199, NRF-2017R1D1A1B03031431]; Inha University	National Research Foundation; Inha University	National Research Foundation, Grant/Award Number: NRF-2017R1A2B2007199 and NRF-2017R1D1A1B03031431; Inha University	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Barco A, 2003, EXPERT OPIN THER TAR, V7, P101, DOI 10.1517/14728222.7.1.101; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; Gerlai R, 2011, REV NEUROSCIENCE, V22, P3, DOI 10.1515/RNS.2011.002; Havekes R, 2015, CURR TOP BEHAV NEURO, V25, P183, DOI 10.1007/7854_2015_369; Hwang SY, 2013, AM J PHYSIOL-CELL PH, V305, pC601, DOI 10.1152/ajpcell.00042.2013; Jacobsen KT, 2011, BIOCHEM BIOPH RES CO, V404, P882, DOI 10.1016/j.bbrc.2010.12.080; Kalueff AV, 2014, PROG NEURO-PSYCHOPH, V55, P1, DOI 10.1016/j.pnpbp.2014.01.022; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; Lee Y, 2018, MOL NEUROBIOL, V55, P8738, DOI 10.1007/s12035-018-1017-9; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Monti B, 2005, HIPPOCAMPUS, V15, P1041, DOI 10.1002/hipo.20099; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Pinheiro-da-Silva J, 2017, PHARMACOL BIOCHEM BE, V159, P36, DOI 10.1016/j.pbb.2017.06.011; Sigurgeirsson B, 2013, BEHAV BRAIN RES, V256, P377, DOI 10.1016/j.bbr.2013.08.032; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Yang YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep44921; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Yuzwa SA, 2014, CHEM SOC REV, V43, P6839, DOI 10.1039/c4cs00038b	27	3	3	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					853	864		10.1096/fj.201901399RR	http://dx.doi.org/10.1096/fj.201901399RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914627				2022-12-28	WOS:000507308900058
J	Schilperoort, M; Bravenboer, N; Lim, J; Mletzko, K; Busse, B; van Ruijven, L; Kroon, J; Rensen, PCN; Kooijman, S; Winter, EM				Schilperoort, Maaike; Bravenboer, Nathalie; Lim, Joann; Mletzko, Kathrin; Busse, Bjoern; van Ruijven, Leo; Kroon, Jan; Rensen, Patrick C. N.; Kooijman, Sander; Winter, Elizabeth M.			Circadian disruption by shifting the light-dark cycle negatively affects bone health in mice	FASEB JOURNAL			English	Article						bone mineralization; bone structure; bone turnover; circadian rhythm; clock genes	TURNOVER MARKERS; GENE-EXPRESSION; CLOCK; WORK; MINERALIZATION; RESORPTION; RHYTHMS; MOUSE; STRENGTH; SKELETAL	The past decade, it has become evident that circadian rhythms within metabolically active tissues are very important for physical health. However, although shift work has also been associated with an increased risk of fractures, circadian rhythmicity has not yet been extensively studied in bone. Here, we investigated which genes are rhythmically expressed in bone, and whether circadian disruption by shifts in light-dark cycle affects bone turnover and structure in mice. Our results demonstrate diurnal expression patterns of clock genes (Rev-erb alpha, Bmal1, Per1, Per2, Cry1, Clock), as well as genes involved in osteoclastogenesis, osteoclast proliferation and function (Rankl, Opg, Ctsk), and osteocyte function (c-Fos) in bone. Weekly alternating light-dark cycles disrupted rhythmic clock gene expression in bone and caused a reduction in plasma levels of procollagen type 1 amino-terminal propeptide (P1NP) and tartrate-resistant acidic phosphatase (TRAP), suggestive of a reduced bone turnover. These effects coincided with an altered trabecular bone structure and increased cortical mineralization after 15 weeks of light-dark cycles, which may negatively affect bone strength in the long term. Collectively, these results show that a physiological circadian rhythm is important to maintain bone health, which stresses the importance of further investigating the association between shift work and skeletal disorders.	[Schilperoort, Maaike; Bravenboer, Nathalie; Lim, Joann; Kroon, Jan; Rensen, Patrick C. N.; Kooijman, Sander; Winter, Elizabeth M.] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Postal Zone 9600, NL-2300 RC Leiden, Netherlands; [Schilperoort, Maaike; Lim, Joann; Kroon, Jan; Rensen, Patrick C. N.; Kooijman, Sander; Winter, Elizabeth M.] Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Bravenboer, Nathalie; Winter, Elizabeth M.] Leiden Univ, Med Ctr, Ctr Bone Qual, Dept Med, Leiden, Netherlands; [Bravenboer, Nathalie] Vrije Univ Amsterdam, Amsterdam Movement Sci, Dept Clin Chem, Amsterdam, Netherlands; [Mletzko, Kathrin; Busse, Bjoern] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech IOBM, Hamburg, Germany; [van Ruijven, Leo] Acad Ctr Dent Amsterdam ACTA, Dept Funct Anat, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Winter, EM (corresponding author), Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Postal Zone 9600, NL-2300 RC Leiden, Netherlands.; Winter, EM (corresponding author), Leiden Univ, Med Ctr, Ctr Bone Qual, Postal Zone 9600, NL-2300 RC Leiden, Netherlands.	e.m.winter@lumc.nl	Kooijman, Sander/S-3857-2016; Schilperoort, Maaike/AAM-3846-2021; Winter, Elizabeth M./ABI-7501-2020; Rensen, Patrick C.N./D-7176-2018	Kooijman, Sander/0000-0002-0014-5571; Winter, Elizabeth M./0000-0002-0119-1588; Rensen, Patrick C.N./0000-0002-8455-4988; Busse, Bjorn/0000-0002-3099-8073	Leiden University Fund / Elise Mathilde Fund; Board of Directors of Leiden University Medical Center; Dutch Heart Foundation [2017T016]; European Foundation for the Study of Diabetes [RS FS 2016_3]	Leiden University Fund / Elise Mathilde Fund; Board of Directors of Leiden University Medical Center; Dutch Heart Foundation(Netherlands Heart Foundation); European Foundation for the Study of Diabetes	This work was supported by a personal grant of the Leiden University Fund / Elise Mathilde Fund to EMW and by a personal grants from the Board of Directors of Leiden University Medical Center to MS. Additionally, this work was supported by the Dutch Heart Foundation (grant 2017T016 to SK) and the European Foundation for the Study of Diabetes (grant RS FS 2016_3 to SK). We thank Natasha Appelman-Dijkstra (Division of Endocrinology, Department of Medicine, Center for Bone Quality, LUMC, Leiden, the Netherlands) for her valuable support and constructive recommendations. We thank Lianne van der Wee-Pals, Hetty Sips, Trea Streefland, Cheraine Bouten, Isabel Mol and Chris van der Bent (Division of Endocrinology, Department of Medicine, LUMC, Leiden, The Netherlands), and Huib van Essen (Department of Clinical Chemistry, Amsterdam University Medical Center, Amsterdam, The Netherlands) for their excellent technical assistance.	Alswat Khaled A, 2017, J Clin Med Res, V9, P382, DOI 10.14740/jocmr2970w; Alterman T, 2013, AM J IND MED, V56, P647, DOI 10.1002/ajim.22108; Aoyama S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00063; Boyce Brendan F, 2007, Curr Osteoporos Rep, V5, P98; Brennan TA, 2014, DIS MODEL MECH, V7, P583, DOI 10.1242/dmm.014928; Burr DB, 2014, BASIC AND APPLIED BONE BIOLOGY, P3, DOI 10.1016/B978-0-12-416015-6.00001-0; CURREY JD, 1984, PHILOS T ROY SOC B, V304, P509, DOI 10.1098/rstb.1984.0042; Fehrendt H, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/318924; Feskanich D, 2009, OSTEOPOROSIS INT, V20, P537, DOI 10.1007/s00198-008-0729-5; Follet H, 2004, BONE, V34, P783, DOI 10.1016/j.bone.2003.12.012; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Fujihara Y, 2014, BONE, V61, P1, DOI 10.1016/j.bone.2013.12.026; Greenblatt MB, 2017, CLIN CHEM, V63, P464, DOI 10.1373/clinchem.2016.259085; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Harfmann BD, 2015, J BIOL RHYTHM, V30, P84, DOI 10.1177/0748730414561638; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hirai T, 2014, J CELL SCI, V127, P3711, DOI 10.1242/jcs.148148; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V217, P264, DOI 10.1006/bbrc.1995.2773; Johannesdottir F, 2017, BONE, V105, P93, DOI 10.1016/j.bone.2017.07.023; Kiehn JT, 2017, COMPR PHYSIOL, V7, P383, DOI 10.1002/cphy.c160017; Kivell TL, 2016, J ANAT, V228, P569, DOI 10.1111/joa.12446; Knutsson A, 2014, CHRONOBIOL INT, V31, P1146, DOI 10.3109/07420528.2014.957308; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Komoto S, 2012, CHRONOBIOL INT, V29, P66, DOI 10.3109/07420528.2011.636496; Koorneef LL, 2018, ENDOCRINOLOGY, V159, P3925, DOI 10.1210/en.2018-00671; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mohamed AM, 2008, MALAYS J MED SCI, V15, P4; Mukherji A, 2019, J HEPATOL, V71, P200, DOI 10.1016/j.jhep.2019.03.020; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Parent-Thirion A., 2007, 4 EUROPEAN WORKING C; Pouresmaeili F, 2018, THER CLIN RISK MANAG, V14, P2029, DOI 10.2147/TCRM.S138000; Quevedo I, 2010, J CLIN DENSITOM, V13, P467, DOI 10.1016/j.jocd.2010.07.004; Redmond J, 2016, J CLIN ENDOCR METAB, V101, P3222, DOI 10.1210/jc.2016-1183; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Rouhi G, 2004, FORMA, V19, P165, DOI [10.1016/j.ijengsci.2006.02.001, DOI 10.1016/J.IJENGSCI.2006.02.001]; Samsa WE, 2016, BONE, V84, P194, DOI 10.1016/j.bone.2016.01.006; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Schilperoort M, 2020, J PINEAL RES, V68, DOI 10.1111/jpi.12614; Sozen T, 2017, EUR J RHEUMATOL, V4, P46, DOI 10.5152/eurjrheum.2016.048; Sun M, 2018, OBES REV, V19, P28, DOI 10.1111/obr.12621; Swanson CM, 2017, J CLIN ENDOCR METAB, V102, P3722, DOI 10.1210/jc.2017-01147; Takarada T, 2017, J BONE MINER RES, V32, P872, DOI 10.1002/jbmr.3053; Tobias JH, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00020; Torquati L, 2018, SCAND J WORK ENV HEA, V44, P229, DOI 10.5271/sjweh.3700; Tsao YT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010159; van't Hof RJ, 2017, BONE, V99, P69, DOI 10.1016/j.bone.2017.03.051; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; Willinghamm MD, 2010, CALCIFIED TISSUE INT, V86, P470, DOI 10.1007/s00223-010-9359-y; Xu C, 2016, J BONE MINER RES, V31, P1344, DOI 10.1002/jbmr.2803; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yuan GS, 2017, J BONE MINER RES, V32, P861, DOI 10.1002/jbmr.3046; Zimmermann EA, 2019, J BONE MINER RES, V34, P1461, DOI 10.1002/jbmr.3730	55	13	18	5	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1052	1064		10.1096/fj.201901929R	http://dx.doi.org/10.1096/fj.201901929R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914701	hybrid, Green Published			2022-12-28	WOS:000507308900071
J	Kolesnikov, AV; Chrispell, JD; Osawa, S; Kefalov, VJ; Weiss, ER				Kolesnikov, Alexander V.; Chrispell, Jared D.; Osawa, Shoji; Kefalov, Vladimir J.; Weiss, Ellen R.			Phosphorylation at Serine 21 in G protein-coupled receptor kinase 1 (GRK1) is required for normal kinetics of dark adaption in rod but not cone photoreceptors	FASEB JOURNAL			English	Article						cAMP; photoreceptor; phototransduction; protein phosphorylation; vision	VISUAL-PIGMENT REGENERATION; RHODOPSIN KINASE; LIGHT ADAPTATION; DOMINANT RETINAS; CYCLIC-AMP; WILD-TYPE; PHOTOTRANSDUCTION; MICE; EXPRESSION; RECOVERIN	Timely recovery of the light response in photoreceptors requires efficient inactivation of photoactivated rhodopsin. This process is initiated by phosphorylation of its carboxyl terminus by G protein-coupled receptor kinase 1 (GRK1). Previously, we showed that GRK1 is phosphorylated in the dark at Ser21 in a cAMP-dependent manner and dephosphorylated in the light. Results in vitro indicate that dephosphorylation of Ser21 increases GRK1 activity, leading to increased phosphorylation of rhodopsin. This creates the possibility of light-dependent regulation of GRK1 activity and its efficiency in inactivating the visual pigment. To address the functional role of GRK1 phosphorylation in rods and cones in vivo, we generated mutant mice in which Ser21 is substituted with alanine (GRK1-S21A), preventing dark-dependent phosphorylation of GRK1. GRK1-S21A mice had normal retinal morphology, without evidence of degeneration. The function of dark-adapted GRK1-S21A rods and cones was also unaffected, as demonstrated by the normal amplitude and kinetics of their responses obtained by ex vivo and in vivo ERG recordings. In contrast, rod dark adaptation following exposure to bright bleaching light was significantly delayed in GRK1-S21A mice, suggesting that the higher activity of this kinase results in enhanced rhodopsin phosphorylation and therefore delays its regeneration. In contrast, dark adaptation of cones was unaffected by the S21A mutation. Taken together, these data suggest that rhodopsin phosphorylation/dephosphorylation modulates the recovery of rhodopsin to the ground state and rod dark adaptation. They also reveal a novel role for cAMP-dependent phosphorylation of GRK1 in regulating the dark adaptation of rod but not cone photoreceptors.	[Kolesnikov, Alexander V.; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA; [Chrispell, Jared D.; Osawa, Shoji; Weiss, Ellen R.] Univ N Carolina, Dept Cell Biol & Physiol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA	Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill	Kefalov, VJ (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.; Weiss, ER (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, CB 7545,5340B MBRB,111 Mason Farm Rd, Chapel Hill, NC 27599 USA.	kefalov@wustl.edu; erweiss@med.unc.edu	Weiss, Ellen/AAK-9868-2020; Kolesnikov, Alexander V/O-1840-2016		HHS \ NIH \ National Eye Institute (NEI) [EY01224, EY005722, EY026675, EY019312, EY02687]; Research to Prevent Blindness (RPB)	HHS \ NIH \ National Eye Institute (NEI); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY01224, EY005722 (Duke Univ. Core), EY026675, EY019312 and EY02687 (Washington Univ. Core); Research to Prevent Blindness (RPB)	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Berry J, 2016, J NEUROSCI, V36, P6973, DOI 10.1523/JNEUROSCI.3544-15.2016; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen CK, 2015, J GEN PHYSIOL, V145, P213, DOI 10.1085/jgp.201411273; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; COHEN AI, 1990, VISUAL NEUROSCI, V4, P43, DOI 10.1017/S0952523800002753; FARBER DB, 1981, INVEST OPHTH VIS SCI, V20, P24; Frederiksen R, 2016, J GEN PHYSIOL, V148, P1, DOI 10.1085/jgp.201511538; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Hisatomi O, 1998, FEBS LETT, V424, P159, DOI 10.1016/S0014-5793(98)00162-8; Horner TJ, 2005, J BIOL CHEM, V280, P28241, DOI 10.1074/jbc.M505117200; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kolesnikov AV, 2017, P NATL ACAD SCI USA, V114, pE9675, DOI 10.1073/pnas.1712405114; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Latek D, 2012, ACTA BIOCHIM POL, V59, P515; Lee BY, 2004, J BIOL CHEM, V279, P54008, DOI 10.1074/jbc.M405669200; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Orban T, 2012, BIOCHEMISTRY-US, V51, P3404, DOI 10.1021/bi300295y; Osawa S, 2012, ADV EXP MED BIOL, V723, P821, DOI 10.1007/978-1-4614-0631-0_105; Osawa S, 2011, J BIOL CHEM, V286, P20923, DOI 10.1074/jbc.M111.230904; Osawa S, 2008, J NEUROCHEM, V107, P1314, DOI 10.1111/j.1471-4159.2008.05691.x; Sakurai K, 2015, J BIOL CHEM, V290, P9239, DOI 10.1074/jbc.M115.639591; Sakurai K, 2011, INVEST OPHTH VIS SCI, V52, P6793, DOI 10.1167/iovs.11-7158; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schott RK, 2018, MOL BIOL EVOL, V35, P1376, DOI 10.1093/molbev/msy025; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Wada Y, 2006, J NEUROCHEM, V98, P824, DOI 10.1111/j.1471-4159.2006.03920.x; Weiss E R, 1998, Mol Vis, V4, P27; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Woodruff ML, 2004, J PHYSIOL-LONDON, V557, P821, DOI 10.1113/jphysiol.2004.064014; Yamaoka H, 2015, J BIOL CHEM, V290, P24381, DOI 10.1074/jbc.M115.674101; Zhao XY, 1998, J BIOL CHEM, V273, P5124, DOI 10.1074/jbc.273.9.5124	50	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2677	2690		10.1096/fj.201902535R	http://dx.doi.org/10.1096/fj.201902535R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908030	Green Accepted			2022-12-28	WOS:000504872400001
J	da Cruz, DB; Helms, J; Aquino, LR; Stiel, L; Cougourdan, L; Broussard, C; Chafey, P; Ries-Kautt, M; Meziani, F; Toti, F; Gaussem, P; Angles-Cano, E				da Cruz, Dayana Barbosa; Helms, Julie; Aquino, Lluvia Ramirez; Stiel, Laure; Cougourdan, Lucas; Broussard, Cedric; Chafey, Philippe; Ries-Kautt, Madeleine; Meziani, Ferhat; Toti, Florence; Gaussem, Pascale; Angles-Cano, Eduardo			DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma	FASEB JOURNAL			English	Article						neutrophil proteases; elastase inhibitors; multiorgan dysfunction; fibrinolytic failure; disseminated intravascular coagulation	MUCUS PROTEINASE-INHIBITOR; CATHEPSIN-G; MONOCLONAL-ANTIBODIES; MINI-PLASMINOGEN; BINDING-SITES; FRAGMENTS; ACTIVATION; MECHANISM; CLEAVAGE; IMPAIRS	Activation of platelets and neutrophils in septic shock results in the formation of microvascular clots containing an intricate scaffold of fibrin with neutrophil extracellular traps (NETs) DNA. NETs contain multiple components that might impact endogenous fibrinolysis, resulting in failure to lyse clots in the microcirculation and residual systemic microthrombosis. We propose herein that the reservoir of human neutrophil elastase (HNE) on NETs may directly interfere with the fibrinolytic mechanism via a plasminogen proteolytic pathway. To investigate this mechanism, we constructed fibrin-NETs matrices by seeding and activating neutrophils onto a fibrin surface and monitored plasminogen activation or degradation. We demonstrate that the elastase activity of HNE-DNA complexes is protected from inhibition by plasma antiproteases and sustains its ability to degrade plasminogen. Using mass spectrometry proteomic analysis, we identified plasminogen fragments composed of kringle (K) domains (K-1+2,K-3, k(1+2+3+4)) and the serine protease (SP) region (K-5-SP). We further demonstrate that patients with septic shock with disseminated intravascular coagulation have circulating HNE-DNA complexes, HNE-derived plasminogen fragments, a low plasminogen concentration, and a reduced capacity to generate plasmin onto fibrin. In conclusion, we show that NETs bearing active HNE-DNA complexes reduce plasminogen into fragments, thus impairing fibrinolysis by decreasing the local plasminogen concentration, plasminogen binding to fibrin, and localized plasmin formation.	[da Cruz, Dayana Barbosa; Aquino, Lluvia Ramirez; Cougourdan, Lucas; Gaussem, Pascale; Angles-Cano, Eduardo] Univ Paris, INSERM, UMR S 1140, Innovat Therapies Haemostasis, Paris, France; [Broussard, Cedric; Chafey, Philippe; Ries-Kautt, Madeleine] Univ Paris, CNRS, INSERM, Plateforme Prote 3P5, Paris, France; [Broussard, Cedric; Chafey, Philippe; Ries-Kautt, Madeleine] Univ Paris, CNRS, INSERM, Inst Cochin, Paris, France; [Helms, Julie; Stiel, Laure; Meziani, Ferhat] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Med Intens Reanimat, Strasbourg, France; [Helms, Julie] Univ Strasbourg, Fac Med, Federat Med Translat Strasbourg, ImmunoRhumatol Mol,INSERM,UMR S 1109, Strasbourg, France; [Stiel, Laure; Meziani, Ferhat; Toti, Florence] Univ Strasbourg, Regenerat Nanomed, INSERM, UMR S 1260, Strasbourg, France; [Gaussem, Pascale] Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Angles-Cano, E (corresponding author), Fac Pharm Paris, INSERM, UMR S1140, 4 Ave Observ, F-75006 Paris, France.	eduardo.angles-cano@inserm.fr	ANGLES-CANO, Eduardo/ABA-1739-2020; Gaussem, Pascale/AGY-9723-2022; Gaussem, Pascale/ABA-2228-2020; Gaussem, P./ABA-1222-2020	ANGLES-CANO, Eduardo/0000-0001-7891-3975; Gaussem, P./0000-0002-9139-2147; Broussard, Cedric/0000-0001-9508-2341; STIEL, Laure/0000-0003-1080-6924	University of Paris; INSERM; Agence National pour la Recherche Grants [ANR-16-CE29-0009-02, ANR-17-CE17-0024-03]	University of Paris; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National pour la Recherche Grants(French National Research Agency (ANR))	The authors thank Fatiha El Ghazouani (INSERM, U1260, Universite de Strasbourg), Keiththana Kamaleswaran (INSERM, U1140), and Samir Chenaf (Hopital Civil de Strasbourg, Strasbourg, France) for experimental support. Adele Barriere, Sophie Fouyet, and Kevin Ricard (all from INSERM, Unite Mixte de Recherche_S 1140, Universite de Paris) were Master's students who contributed to the work. D.B.D.C. was a recipient of an International Mobility Grant from the University of Paris to the Jequitinhonha and Mucuri Valleys Federal University (Diamantina, Brazil). Elsa Bianchini (INSERM, U1176, Bicetre, France) provided assistance to D.B.D.C. with the isolation of neutrophils from blood. Sonia Poirault-Chassac (INSERM, U1140) provided assistance with fluorescence microscopy. The authors acknowledge the generous provision of methyl(malonyl)hydroxy-prolylarginine-p-nitroanilide, CBS0065 by Genevieve Contant (Stago, Gennevilliers, France). This research was supported by INSERM and the Agence National pour la Recherche Grants ANR-16-CE29-0009-02 and ANR-17-CE17-0024-03. F.M., F.T., P.G., and E.A.-C. are senior authors. The authors declare no conflicts of interest.	Abrams S. T., 2019, AM J RESP CRIT CARE; ANGLESCANO E, 1984, J IMMUNOL METHODS, V69, P115, DOI 10.1016/0022-1759(84)90283-7; Bangert K, 2000, THROMB HAEMOSTASIS, V84, P299, DOI 10.1055/s-0037-1614011; BEATTY K, 1980, J BIOL CHEM, V255, P3931; Belorgey D, 1998, BIOCHEMISTRY-US, V37, P16416, DOI 10.1021/bi981536o; BELORGEY D, 1995, FEBS LETT, V361, P265, DOI 10.1016/0014-5793(95)00173-7; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Campbell EJ, 2007, J BIOL CHEM, V282, P14645, DOI 10.1074/jbc.M608346200; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; de Boer OJ, 2013, THROMB HAEMOSTASIS, V109, P290, DOI 10.1160/TH12-06-0425; Delabranche X, 2017, SHOCK, V47, P313, DOI 10.1097/SHK.0000000000000719; Dominguez M, 2002, BBA-PROTEINS PROTEOM, V1598, P165, DOI 10.1016/S0167-4838(02)00364-3; Duboscq C, 1997, THROMB HAEMOSTASIS, V77, P1090; Duboscq C, 1997, THROMB RES, V86, P505, DOI 10.1016/S0049-3848(97)00099-6; Ducroux C, 2018, STROKE, V49, P754, DOI 10.1161/STROKEAHA.117.019896; Duranton J, 2000, J BIOL CHEM, V275, P3787, DOI 10.1074/jbc.275.6.3787; Duranton J, 2000, FEBS LETT, V473, P154, DOI 10.1016/S0014-5793(00)01512-X; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; FLEURY V, 1993, EUR J BIOCHEM, V216, P549, DOI 10.1111/j.1432-1033.1993.tb18173.x; FLEURY V, 1991, BIOCHEMISTRY-US, V30, P7630, DOI 10.1021/bi00244a035; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gould TJ, 2015, ARTERIOSCL THROM VAS, V35, P2544, DOI 10.1161/ATVBAHA.115.306035; Grassle S, 2014, ARTERIOSCL THROM VAS, V34, P1382, DOI 10.1161/ATVBAHA.113.303016; GRAILHE P, 1994, EUR J BIOCHEM, V219, P961, DOI 10.1111/j.1432-1033.1994.tb18578.x; Grenier A, 1999, BLOOD, V93, P1413, DOI 10.1182/blood.V93.4.1413.404k06_1413_1421; Herren T, 2006, BIOCHEMISTRY-US, V45, P9463, DOI 10.1021/bi060756w; HOLVOET P, 1985, J BIOL CHEM, V260, P2106; Iba T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1468-1; Kenny EF, 2017, ELIFE, V6, DOI [10.7554/eLife.24437, 10.7554/elife.24437]; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kolaczkowska E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7673; KOPPERT PW, 1985, BLOOD, V66, P503; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Kumar S, 2019, CLIN CHIM ACTA, V495, P606, DOI 10.1016/j.cca.2019.06.008; Lamanuzzi LB, 2004, THROMB HAEMOSTASIS, V92, P1066, DOI 10.1160/TH04-04-0241; Laridan E, 2017, ANN NEUROL, V82, P223, DOI 10.1002/ana.24993; Li X, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2246-z; Longstaff C, 2015, J THROMB HAEMOST, V13, pS98, DOI 10.1111/jth.12935; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; MACHOVICH R, 1989, BIOCHEMISTRY-US, V28, P4517, DOI 10.1021/bi00436a059; Maruchi Y, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2109-7; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; McDonald B, 2017, BLOOD, V129, P1357, DOI 10.1182/blood-2016-09-741298; Montes R, 1996, BRIT J HAEMATOL, V92, P979, DOI 10.1046/j.1365-2141.1996.416951.x; MOROZ LA, 1981, BLOOD, V58, P97; Noubouossie DF, 2019, BLOOD, V133, P2186, DOI 10.1182/blood-2018-10-862243; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; PLOW EF, 1975, J CLIN INVEST, V56, P30, DOI 10.1172/JCI108076; POUIT L, 1973, BIOCHIM BIOPHYS ACTA, V317, P99, DOI 10.1016/0005-2795(73)90201-8; Riegger J, 2016, EUR HEART J, V37, P1538, DOI 10.1093/eurheartj/ehv419; ROUY D, 1992, BIOCHEMISTRY-US, V31, P6333, DOI 10.1021/bi00142a024; RYLATT DB, 1983, THROMB RES, V31, P767, DOI 10.1016/0049-3848(83)90108-1; Scapini P, 2002, J IMMUNOL, V168, P5798, DOI 10.4049/jimmunol.168.11.5798; Singer M, 2016, INTENS CARE MED, V42, P2027, DOI 10.1007/s00134-016-4600-4; SUENSON E, 1984, EUR J BIOCHEM, V140, P513, DOI 10.1111/j.1432-1033.1984.tb08132.x; Thomas MP, 2014, J IMMUNOL, V192, P5390, DOI 10.4049/jimmunol.1303296; THORSEN S, 1981, BIOCHIM BIOPHYS ACTA, V668, P377, DOI 10.1016/0005-2795(81)90171-9; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Varju I, 2015, THROMB HAEMOSTASIS, V113, P1289, DOI 10.1160/TH14-08-0669; Warejcka DJ, 2005, BIOCHEM J, V392, P703, DOI 10.1042/BJ20050907; WU K, 1995, BLOOD, V86, P1056, DOI 10.1182/blood.V86.3.1056.bloodjournal8631056; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x	65	15	16	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14270	14280		10.1096/fj.201901363RRR	http://dx.doi.org/10.1096/fj.201901363RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31682515				2022-12-28	WOS:000507466100094
J	Helassa, N; Nugues, C; Rajamanoharan, D; Burgoyne, RD; Haynes, LP				Helassa, Nordine; Nugues, Charlotte; Rajamanoharan, Dayani; Burgoyne, Robert D.; Haynes, Lee P.			A centrosome-localized calcium signal is essential for mammalian cell mitosis	FASEB JOURNAL			English	Article						GCaMP; regulation; cell division	INTRACELLULAR FREE CALCIUM; ENDOPLASMIC-RETICULUM; CYCLE PROGRESSION; ANAPHASE; DIVISION; CA-2+; INHIBITION; CALMODULIN; ONSET; ENTRY	Mitosis defects can lead to premature ageing and cancer. Understanding mitosis regulation therefore has important implications for human disease. Early data suggested that calcium (Ca2+) signals could influence mitosis, but these have hitherto not been observed in mammalian cells. Here, we reveal a prolonged yet spatially restricted Ca2+ signal at the centrosomes of actively dividing cells. Local buffering of the centrosomal Ca2+ signals, by flash photolysis of the caged Ca2+ chelator diazo-2-acetoxymethyl ester, arrests mitosis. We also provide evidence that this Ca2+ signal emanates from the endoplasmic reticulum. In summary, we characterize a unique centrosomal Ca2+ signal as a functionally essential input into mitosis.	[Helassa, Nordine; Nugues, Charlotte; Rajamanoharan, Dayani; Burgoyne, Robert D.; Haynes, Lee P.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Crown St, Liverpool L69 3GE, Merseyside, England	University of Liverpool	Haynes, LP (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Crown St, Liverpool L69 3GE, Merseyside, England.	leeh@liverpool.ac.uk	Helassa, Nordine/AAX-2880-2021	Helassa, Nordine/0000-0003-3743-1886	Leverhulme Trust [RPG-2014-194]; Wellcome Trust [105348/2/14/2, 096565/2/11/2]	Leverhulme Trust(Leverhulme Trust); Wellcome Trust(Wellcome Trust)	The authors thank Alan Morgan and Alexei Tepikin (Department of Cellular and Molecular Physiology, University of Liverpool) for insightful comments on the manuscript. All light and electronmicroscopy was performed at the Biomedical Imaging Facility, Institute of Translational Medicine, University of Liverpool. The authors thank Dr. Alison Beckett (Institute of Translational Medicine, University of Liverpool) for assistance with transmission electron microscopy work at the Electron Microscopy Unit (University of Liverpool). This work was funded by Leverhulme Trust Project Grant RPG-2014-194 (to L.P.H.) and Wellcome Trust Prize Ph.D. Studentships (105348/2/14/2 to C.N. and 096565/2/11/2 to D.R.). The authors declare no conflicts of interest.	ADAMS SR, 1989, J AM CHEM SOC, V111, P7957, DOI 10.1021/ja00202a042; Casimiro Mathew C, 2012, Genes Cancer, V3, P649, DOI 10.1177/1947601913479022; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chun JT, 2009, BIOCHEM BIOPH RES CO, V384, P141, DOI 10.1016/j.bbrc.2009.04.087; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Farina F, 2019, EMBO J, V38, DOI 10.15252/embj.201899843; Farina F, 2016, NAT CELL BIOL, V18, P65, DOI 10.1038/ncb3285; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Groigno L, 1998, CELL, V92, P193, DOI 10.1016/S0092-8674(00)80914-9; Helassa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep38276; HEPLER PK, 1980, J CELL BIOL, V86, P490, DOI 10.1083/jcb.86.2.490; HEPLER PK, 1994, CELL CALCIUM, V16, P322, DOI 10.1016/0143-4160(94)90096-5; HEPLER PK, 1987, J CELL BIOL, V105, P2137, DOI 10.1083/jcb.105.5.2137; Hubert T, 2011, BIOCHEM BIOPH RES CO, V404, P153, DOI 10.1016/j.bbrc.2010.11.084; Itzhak DN, 2016, ELIFE, V5, DOI 10.7554/eLife.16950; KAO JPY, 1990, J CELL BIOL, V111, P183, DOI 10.1083/jcb.111.1.183; KEITH CH, 1985, NATURE, V316, P848, DOI 10.1038/316848a0; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Mccue HV, 2013, BIOCHEM J, V449, P449, DOI 10.1042/BJ20120898; Miller AL, 2011, CURR BIOL, V21, pR976, DOI 10.1016/j.cub.2011.10.044; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; POENIE M, 1986, SCIENCE, V233, P886, DOI 10.1126/science.3755550; POENIE M, 1985, NATURE, V315, P147, DOI 10.1038/315147a0; Potapova T, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010012; RASMUSSEN CD, 1989, EMBO J, V8, P73, DOI 10.1002/j.1460-2075.1989.tb03350.x; RATAN RR, 1986, P NATL ACAD SCI USA, V83, P5136, DOI 10.1073/pnas.83.14.5136; Saleem H, 2014, BRIT J PHARMACOL, V171, P3298, DOI 10.1111/bph.12685; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sawant DB, 2015, MOL BIOL CELL, V26, P3741, DOI 10.1091/mbc.E14-07-1248; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shigetomi E, 2010, NEURON GLIA BIOL, V6, P183, DOI 10.1017/S1740925X10000219; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Smyth JT, 2012, BIOCHEM SOC T, V40, P119, DOI 10.1042/BST20110612; STEINHARDT RA, 1988, NATURE, V332, P364, DOI 10.1038/332364a0; SWANN MM, 1957, CANCER RES, V17, P727; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thillaiappan NB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01644-8; TOMBES RM, 1989, J CELL BIOL, V109, P627, DOI 10.1083/jcb.109.2.627; Torok K, 1998, CURR BIOL, V8, P692, DOI 10.1016/S0960-9822(98)70275-1; TWIGG J, 1988, NATURE, V332, P366, DOI 10.1038/332366a0; Visweshwaran SP, 2018, EMBO J, V37, DOI 10.15252/embj.201797706; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x; Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018; Wilding M, 1996, J CELL BIOL, V135, P191, DOI 10.1083/jcb.135.1.191; Yoshino T, 2007, EUR J PHARMACOL, V560, P225, DOI 10.1016/j.ejphar.2007.01.012	50	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14602	14610		10.1096/fj.201901662R	http://dx.doi.org/10.1096/fj.201901662R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31682764	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000507466100118
J	Levinsky, NC; Mallela, J; Opoka, AM; Harmon, K; Lewis, HV; Zingarelli, B; Wong, HR; Alder, MN				Levinsky, Nick C.; Mallela, Jaya; Opoka, Amy M.; Harmon, Kelli; Lewis, Hannah V.; Zingarelli, Basilia; Wong, Hector R.; Alder, Matthew N.			The olfactomedin-4 positive neutrophil has a role in murine intestinal ischemia/reperfusion injury	FASEB JOURNAL			English	Article						neutrophil subsets; neutrophil heterogeneity; OLFM4; iNos	STAPHYLOCOCCUS-AUREUS; INNATE IMMUNITY; SUBSET; INHIBITION; MICE	Olfactomedin-4 (OLFM4) identifies a subset of neutrophils conserved in both mouse and man, associated with worse outcomes in several inflammatory conditions. We investigated the role of OLFM4-positive neutrophils in murine intestinal ischemia/reperfusion (IR) injury. Wild-type (WT) C57B1/6 and OLFM4 null mice were subjected to intestinal IR injury and then monitored for survival or tissues harvested for further analyses. In vivo intestinal barrier function was determined via functional assay of permeability to FITC-dextran. OLFM4 null mice had a significant 7-d survival benefit and less intestinal barrier dysfunction compared with WT. Early after IR, WT mice had worse mucosal damage on histologic examination. Experiments involving adoptive transfer of bone marrow demonstrated that the mortality phenotype associated with OLFM4-positive neutrophils was transferrable to OLFM4 null mice. After IR injury, WT mice also had increased intestinal tissue activation of NF kappa B and expression of iNOS, 2 signaling pathways previously demonstrated to be involved in intestinal IR injury. In combination, these experiments show that OLFM4-positive neutrophils are centrally involved in the pathologic pathway leading to intestinal damage and mortality after IR injury. This may provide a therapeutic target for mitigation of intestinal IR injury in a variety of common clinical situations.	[Levinsky, Nick C.; Lewis, Hannah V.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Mallela, Jaya; Opoka, Amy M.; Harmon, Kelli; Zingarelli, Basilia; Wong, Hector R.; Alder, Matthew N.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Mallela, Jaya; Opoka, Amy M.; Harmon, Kelli; Zingarelli, Basilia; Wong, Hector R.; Alder, Matthew N.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Alder, MN (corresponding author), Cincinnati Childrens Hosp Med Ctr, Crit Care Med, 3333 Burnet Ave MLC 7006, Cincinnati, OH 45229 USA.	matthew.alder@cchmc.org	, Basilia/AAV-7582-2021; Mallela, Jaya/AAJ-9875-2021		U.S. National Institutes of Health, National Institute of General Medical Sciences [R35 GM126943, K08 GM124298, T32 GM008478-25]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008478, K08GM124298, R35GM126943] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Cincinnati Children's Hospital Medical Center Animal Bone Marrow Transplantation Core and Flow Cytometry Core facilities for assistance with this work. This work was funded by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants R35 GM126943, K08 GM124298, and T32 GM008478-25. The authors declare no conflicts of interest.	Alder MN, 2019, INNATE IMMUN-LONDON, V25, P22, DOI 10.1177/1753425918817611; Alder MN, 2017, CRIT CARE MED, V45, pE426, DOI 10.1097/CCM.0000000000002102; Barocelli E, 2006, NITRIC OXIDE-BIOL CH, V14, P212, DOI 10.1016/j.niox.2005.11.006; Brand HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131927; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Grootjans J, 2016, WORLD J GASTROENTERO, V22, P2760, DOI 10.3748/wjg.v22.i9.2760; Gubernatorova E. O., 2016, JOVE-J VIS EXP, V2016, P111; Guette C, 2015, PROTEOM CLIN APPL, V9, P58, DOI 10.1002/prca.201400083; Kalogeris T, 2017, COMPR PHYSIOL, V7, P113, DOI 10.1002/cphy.c160006; Kangelaris KN, 2015, AM J PHYSIOL-LUNG C, V308, pL1102, DOI 10.1152/ajplung.00380.2014; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Liu W, 2016, ONCOGENE, V35, P5237, DOI 10.1038/onc.2016.58; Liu WL, 2018, AM J PHYSIOL-CELL PH, V315, pC494, DOI 10.1152/ajpcell.00336.2017; Liu WL, 2016, CANCER METAST REV, V35, P201, DOI 10.1007/s10555-016-9624-2; Liu WL, 2013, J CLIN INVEST, V123, P3751, DOI 10.1172/JCI68453; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Ma YG, 2016, CARDIOVASC RES, V110, P51, DOI 10.1093/cvr/cvw024; Ode Y, 2018, J LEUKOCYTE BIOL, V103, P693, DOI 10.1002/JLB.3A0817-327RR; Quaedackers JSLT, 2000, TRANSPLANT P, V32, P1307, DOI 10.1016/S0041-1345(00)01238-0; Rosenbauer F, 2004, BLOOD, V103, P4294, DOI 10.1182/blood-2003-08-2688; SCHOENBERG MH, 1991, GUT, V32, P905, DOI 10.1136/gut.32.8.905; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Souza DG, 2005, BRIT J PHARMACOL, V145, P246, DOI 10.1038/sj.bjp.0706190; Sun ZW, 2002, SHOCK, V18, P99, DOI 10.1097/00024382-200208000-00001; Suzuki T, 2008, J SURG RES, V149, P69, DOI 10.1016/j.jss.2008.01.020; Suzuki Y, 2000, CRIT CARE MED, V28, P3692, DOI 10.1097/00003246-200011000-00026; Tak T, 2017, BLOOD, V129, P3476, DOI 10.1182/blood-2016-07-727669; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Welin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069575; Wu ZP, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006067; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	33	5	5	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13660	13668		10.1096/fj.201901231R	http://dx.doi.org/10.1096/fj.201901231R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31593636	Green Published, Bronze			2022-12-28	WOS:000507466100048
J	Lin, HP; Ho, HM; Chang, CW; Yeh, SD; Su, YW; Tan, TH; Lin, WJ				Lin, Hsiu-Ping; Ho, Hui-Min; Chang, Cheng-Wei; Yeh, Shauh-Der; Su, Yu-Wen; Tan, Tse-Hua; Lin, Wen-Jye			DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis	FASEB JOURNAL			English	Article						dual-specificity phosphatases; MAP kinases; phosphorylation; dephosphorylation	ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; ANDROGEN RECEPTOR; SPLICE VARIANT; PHOSPHATASE 1; EXPRESSION; PROGRESSION; EPCAM; PHOSPHORYLATION; CONTRIBUTES	Dual-specificity phosphatases (DUSPs) regulate the activity of various downstream kinases through serine or threonine or tyrosine dephosphorylation. Loss of function and aberrant expression of DUSPs has been implicated in cancer progression and poor survival, yet the function of DUSP22 in prostate cancer (PCa) cells is not clear. Gene Expression Omnibus and cBioPortal microarray database analyses showed that DUSP22 expression was lower in PCa tissues than normal prostate tissues, and altered DUSP22 expression was associated with shorter progression-free and disease-free survival of patients with PCa. Exogenous DUSP22 expression in LNCaP, PC3, and C4-2B PCa cells inhibited cellular proliferation and colony formation, supporting a growth inhibitory role for DUSP22 in PCa cells. DUSP22 expression significantly attenuated epidermal growth factor (EGF) receptor (EGFR) and its downstream ERK1/2 signaling by dephosphorylation. However, DUSP22 failed to suppress the growth of CWR22Rv1 and DU145 cells with elevated phosphorylated (p-)ERK1/2 levels. A serine-to-alanine mutation at position 58, a potential ERK1/2-targeted phosphorylation site in DUSP22, was sufficient to suppress growth of CWR22Rv1 cells with elevated p-ERK1/2 levels, suggesting a mutually antagonistic relationship between DUSP22 and ERK1/2 dependent on phosphorylation status. We showed that DUSP22 can suppress prostate-specific antigen gene expression through phosphatase-dependent pathways, suggesting that DUSP22 is an important regulator of the androgen receptor (AR) in PCa cells. Mechanistically, DUSP22 can interact with AR as a regulatory partner and interfere with EGF-induced AR phosphorylation at Tyr534, suggesting that DUSP22 serves as a crucial suppressor of both EGFR and AR-dependent signaling in PCa cells via dephosphorylation. Our findings indicate that loss of function of DUSP22 in PCa cells leads to aberrant activation of both EGFR-ERKs and AR signaling and ultimately progression of PCa, supporting the potential for novel therapeutic design of harnessing DUSP22 in the treatment of PCa.	[Lin, Hsiu-Ping; Ho, Hui-Min; Chang, Cheng-Wei; Su, Yu-Wen; Tan, Tse-Hua; Lin, Wen-Jye] Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan; [Yeh, Shauh-Der] Taipei Med Univ, Grad Inst Clin Med, Dept Urol, Taipei, Taiwan	National Health Research Institutes - Taiwan; Taipei Medical University	Lin, WJ (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	020808@nhri.edu.tw	Lin, Wen-Jye/GVW-3018-2022; Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Lin, Wen-Jye/0000-0001-8821-9813	National Health Research Institutes [06A1-IMPP05-015]; Taiwan Ministry of Science and Technology (MOST) [106-2314-B-400-010]; MOST postdoctoral fellowship [105-2811-B-400-014]	National Health Research Institutes(National Health Research Institutes, Japan); Taiwan Ministry of Science and Technology (MOST); MOST postdoctoral fellowship	The authors thank members of T.H.T.'s laboratory and the National RNAi Core Facility (Academia Sinica, Taipei, Taiwan) for technical assistance. The authors thank Dr. Loretta Collins (WriteScience, LLC, Hannewa Falls, NY, USA), for scientific editing. The authors thank Drs. C. P. Chuu [National Health Research Institutes (NHRI)] and Hsing-Jien Kung (University of California-Davis, Davis, CA, USA) for providing reagents and cell lines. This study was supported by funding from the National Health Research Institutes (06A1-IMPP05-015 to W.-J.L.), and a Taiwan Ministry of Science and Technology (MOST) grant (106-2314-B-400-010 to W.-J.L.). C.-W.C. is a recipient of a MOST postdoctoral fellowship (105-2811-B-400-014). The authors declare no conflicts of interest.	Arnoldussen YJ, 2008, CANCER RES, V68, P9255, DOI 10.1158/0008-5472.CAN-08-1224; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Cain E. L., 2013, ONCOGENE CANC; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Castellar ERP, 2014, BLOOD, V124, P1473, DOI 10.1182/blood-2014-04-571091; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Chen HF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112668; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Daniels G, 2013, AM J CLIN EXP UROL, V1, P25; Day KC, 2017, CANCER RES, V77, P74, DOI 10.1158/0008-5472.CAN-16-1656; DeHaan AM, 2009, PROSTATE, V69, P528, DOI 10.1002/pros.20903; Gil-Araujo B, 2014, MOL ONCOL, V8, P27, DOI 10.1016/j.molonc.2013.08.012; Gioeli D, 1999, CANCER RES, V59, P279; Gioeli D, 2011, MOL CANCER THER, V10, P1581, DOI 10.1158/1535-7163.MCT-10-1033; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Igawa T, 2017, INT J UROL, V24, P16, DOI 10.1111/iju.13197; Ilagan R, 2006, CANCER RES, V66, P10778, DOI 10.1158/0008-5472.CAN-05-3577; Isikbay M, 2014, HORM CANCER-US, V5, P72, DOI 10.1007/s12672-014-0173-2; Jamaspishvili T, 2018, NAT REV UROL, V15, P222, DOI 10.1038/nrurol.2018.9; Kharaziha P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.1; Kibel AS, 2004, INT J CANCER, V109, P668, DOI 10.1002/ijc.20060; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Li JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4618; Li JP, 2010, J BIOL CHEM, V285, P5472, DOI 10.1074/jbc.M109.060186; Lin HK, 2004, MOL ENDOCRINOL, V18, P2409, DOI 10.1210/me.2004-0117; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; Liu Y, 2010, ONCOGENE, V29, P3208, DOI 10.1038/onc.2010.103; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; MagiGalluzzi C, 1997, LAB INVEST, V76, P37; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Martowicz A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-501; Massoner P, 2014, BRIT J CANCER, V111, P955, DOI 10.1038/bjc.2014.366; Mukherjee R, 2011, BRIT J CANCER, V104, P1920, DOI 10.1038/bjc.2011.163; Ni J, 2013, INT J BIOCHEM CELL B, V45, P2736, DOI 10.1016/j.biocel.2013.09.008; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pignon JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760; RAVENNA L, 1995, PROSTATE, V26, P290, DOI 10.1002/pros.2990260604; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Sampson N, 2013, ENDOCR-RELAT CANCER, V20, pR49, DOI 10.1530/ERC-12-0401; Segawa N, 2001, CANCER RES, V61, P6060; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Sharp A, 2019, J CLIN INVEST, V129, P192, DOI 10.1172/JCI122819; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; THALMANN GN, 1994, CANCER RES, V54, P2577; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Wen Y, 2000, CANCER RES, V60, P6841; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Yoshida GJ, 2014, BIOCHEM BIOPH RES CO, V443, P239, DOI 10.1016/j.bbrc.2013.11.093	57	8	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14653	14667		10.1096/fj.201802558RR	http://dx.doi.org/10.1096/fj.201802558RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31693867	Bronze			2022-12-28	WOS:000507466100122
J	Dumas, K; Ayachi, C; Gilleron, J; Lacas-Gervais, S; Pastor, F; Favier, FB; Peraldi, P; Vaillant, N; Yvan-Charvet, L; Bonnafous, S; Patouraux, S; Anty, R; Tran, A; Gual, P; Cormont, M; Tanti, JF; Giorgetti-Peraldi, S				Dumas, Karine; Ayachi, Chaima; Gilleron, Jerome; Lacas-Gervais, Sandra; Pastor, Faustine; Favier, Francois B.; Peraldi, Pascal; Vaillant, Nathalie; Yvan-Charvet, Laurent; Bonnafous, Stephanie; Patouraux, Stephanie; Anty, Rodolphe; Tran, Albert; Gual, Philippe; Cormont, Mireille; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie			REDD1 deficiency protects against nonalcoholic hepatic steatosis induced by high-fat diet	FASEB JOURNAL			English	Article						autophagy; hepatic steatosis; obesity; REDD1	DNA-DAMAGE 1; INSULIN-RESISTANCE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; MAMMALIAN TARGET; FEEDBACK-CONTROL; GENE-EXPRESSION; LIVER-DISEASE; OBESITY; MTORC1	Nonalcoholic fatty liver disease is a chronic liver disease which is associated with obesity and insulin resistance. We investigated the implication of REDD1 (Regulated in development and DNA damage response-1), a stress-induced protein in the development of hepatic steatosis. REDD1 expression was increased in the liver of obese mice and morbidly obese patients, and its expression correlated with hepatic steatosis and insulin resistance in obese patients. REDD1 deficiency protected mice from the development of hepatic steatosis induced by high-fat diet (HFD) without affecting body weight gain and glucose intolerance. This protection was associated with a decrease in the expression of lipogenic genes, SREBP1c, FASN, and SCD-1 in liver of HFD-fed REDD1-KO mice. Healthy mitochondria are crucial for the adequate control of lipid metabolism and failure to remove damaged mitochondria is correlated with liver steatosis. Expression of markers of autophagy and mitophagy, Beclin, LC3-II, Parkin, BNIP3L, was enhanced in liver of HFD-fed REDD1-KO mice. The number of mitochondria showing colocalization between LAMP2 and AIF was increased in liver of HFD-fed REDD1-KO mice. Moreover, mitochondria in liver of REDD1-KO mice were smaller than in WT. These results are correlated with an increase in PGC-1 alpha and CPT-1 expression, involved in fatty acid oxidation. In conclusion, loss of REDD1 protects mice from the development of hepatic steatosis.	[Dumas, Karine; Ayachi, Chaima; Gilleron, Jerome; Pastor, Faustine; Cormont, Mireille; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie] Univ Cote dAzur, INSERM, Nice, France; [Lacas-Gervais, Sandra] Univ Cote dAzur, Ctr Commun Microscopie Appliquee, CCMA, Nice, France; [Favier, Francois B.] Univ Montpellier, INRA, DMEM, Montpellier, France; [Peraldi, Pascal] Univ Cote dAzur, CNRS, INSERM, IBV, Nice, France; [Vaillant, Nathalie; Yvan-Charvet, Laurent] Univ Cote dAzur, INSERM, C3M Team Haematometabolism Dis, Nice, France; [Bonnafous, Stephanie; Patouraux, Stephanie; Anty, Rodolphe; Tran, Albert; Gual, Philippe] Univ Cote dAzur, Team Chron Liver Dis Associated Steatosis & Alcoh, INSERM, Nice, France; [Bonnafous, Stephanie; Patouraux, Stephanie; Anty, Rodolphe; Tran, Albert] Univ Cote dAzur, CHU, INSERM, C3M Team, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Giorgetti-Peraldi, S (corresponding author), Univ Cote dAzur, INSERM, Nice, France.	Sophie.GIORGETTI-PERALDI@inserm.fr	Peraldi, Pascal/O-4592-2016; Gual, Philippe/P-9833-2019; Gilleron, Jerome/GRX-8574-2022	Peraldi, Pascal/0000-0003-0205-9252; Gual, Philippe/0000-0001-7393-8356; Gilleron, Jerome/0000-0002-6389-8685; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618; CORMONT, Mireille/0000-0001-6918-2410; Tanti, Jean-Francois/0000-0003-1782-1318; Favier, Francois/0000-0002-9084-4797; Albert, TRAN/0000-0003-0003-5361; patouraux, stephanie/0000-0001-6004-7685; Yvan-Charvet, Laurent/0000-0002-7748-4942; Anty, Rodolphe/0000-0001-8194-9805	INSERM (France); French Government (National Research Agency, ANR) [ANR-15-CE14-0016-01, ANR-18-CE14-0019-02]; "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; UCAJEDI Investments in the Future project [ANR-15-IDEX-01]; Societe Francophone du Diabete SFD/ Abbott; Universite Cote d'Azur; Region Provence-Alpes-Cote-d'Azur; Conseil General des Alpes Maritimes; Region Sud-ProvenceAlpes-Cote-d'Azur; GIS-IBiSA and Canceropole Provence-Alpes-Cote d'Azur	INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Government (National Research Agency, ANR)(French National Research Agency (ANR)); "Investments for the Future" LABEX SIGNALIFE; UCAJEDI Investments in the Future project; Societe Francophone du Diabete SFD/ Abbott; Universite Cote d'Azur; Region Provence-Alpes-Cote-d'Azur(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Region Sud-ProvenceAlpes-Cote-d'Azur(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); GIS-IBiSA and Canceropole Provence-Alpes-Cote d'Azur	This work was supported by grants from INSERM (France), the French Government (National Research Agency, ANR): #ANR-15-CE14-0016-01, #ANR-18-CE14-0019-02 and through the "Investments for the Future" LABEX SIGNALIFE (#ANR-11-LABX-0028-01) and the UCAJEDI Investments in the Future project (#ANR-15-IDEX-01), Societe Francophone du Diabete SFD/ Abbott, Universite Cote d'Azur, Region Provence-Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes and CCMA electron microscopy equipment have been funded by the Region Sud-ProvenceAlpes-Cote-d'Azur, the Conseil General des Alpes Maritimes, the GIS-IBiSA and Canceropole Provence-Alpes-Cote d'Azur	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Alvarez-Garcia O, 2017, ARTHRITIS RHEUMATOL, V69, P1418, DOI 10.1002/art.40104; Anty R, 2006, AM J GASTROENTEROL, V101, P1824, DOI 10.1111/j.1572-0241.2006.00724.x; Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Britto FA, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0525-4; Chattopadhyay M, 2011, DIABETES, V60, P1483, DOI 10.2337/db10-0869; Cho SS, 2018, FREE RADICAL BIO MED, V124, P221, DOI 10.1016/j.freeradbiomed.2018.06.014; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dungan CM, 2014, BIOCHEM BIOPH RES CO, V453, P778, DOI 10.1016/j.bbrc.2014.10.032; Elam MB, 2009, OBESITY, V17, P1563, DOI 10.1038/oby.2009.49; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Gelmetti V, 2017, AUTOPHAGY, V13, P654, DOI 10.1080/15548627.2016.1277309; Gordon BS, 2016, AM J PHYSIOL-ENDOC M, V311, pE157, DOI 10.1152/ajpendo.00059.2016; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Hu MY, 2017, BIOCHIMIE, V143, P37, DOI 10.1016/j.biochi.2017.10.019; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kenerson HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117000; Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075; Kimball SR, 2012, BIOCHEM BIOPH RES CO, V427, P485, DOI 10.1016/j.bbrc.2012.09.074; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Lafarge JC, 2014, DIABETOLOGIA, V57, P1674, DOI 10.1007/s00125-014-3280-2; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Lipina C, 2016, TRENDS ENDOCRIN MET, V27, P868, DOI 10.1016/j.tem.2016.08.005; MCGARRY JD, 1995, BIOCHEM SOC T, V23, P321, DOI 10.1042/bst0230321; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Nassir Fatiha, 2015, Gastroenterol Hepatol (N Y), V11, P167; Nassir F, 2014, INT J MOL SCI, V15, P8713, DOI 10.3390/ijms15058713; Neuman MG, 2014, EXP MOL PATHOL, V97, P492, DOI 10.1016/j.yexmp.2014.09.005; Pastor F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07182-z; Patouraux S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.174; Patouraux S, 2017, J HEPATOL, V67, P328, DOI 10.1016/j.jhep.2017.03.003; Patouraux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035612; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014; Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027; Regazzetti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052154; Regazzetti C, 2010, J BIOL CHEM, V285, P5157, DOI 10.1074/jbc.M109.047688; Rieusset J, 2017, BBA-MOL CELL RES, V1864, P865, DOI 10.1016/j.bbamcr.2017.01.001; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scheen AJ, 2002, BEST PRACT RES CL EN, V16, P703, DOI 10.1053/beem.2002.0225; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schupp M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-758; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Vadysirisack DD, 2011, MOL CELL BIOL, V31, P4356, DOI 10.1128/MCB.05541-11; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Williamson DL, 2015, AM J PHYSIOL-REG I, V309, pR855, DOI 10.1152/ajpregu.00285.2015; Williamson DL, 2014, J APPL PHYSIOL, V117, P246, DOI 10.1152/japplphysiol.01350.2013; Wolff NC, 2011, MOL CELL BIOL, V31, P1870, DOI 10.1128/MCB.01393-10; Xu MC, 2013, MOL MED REP, V8, P147, DOI 10.3892/mmr.2013.1468; Yamada T, 2018, CELL METAB, V28, P588, DOI 10.1016/j.cmet.2018.06.014; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zeng QH, 2018, CLIN CANCER RES, V24, P445, DOI 10.1158/1078-0432.CCR-17-0419	73	11	13	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5046	5060		10.1096/fj.201901799RR	http://dx.doi.org/10.1096/fj.201901799RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32043636	Green Submitted			2022-12-28	WOS:000512671100001
J	Liu, SW; Li, HT; Wu, SW; Li, LX; Ge, RS; Cheng, CY				Liu, Shiwen; Li, Huitao; Wu, Siwen; Li, Linxi; Ge, Renshan; Cheng, C. Yan			NC1-peptide regulates spermatogenesis through changes in cytoskeletal organization mediated by EB1	FASEB JOURNAL			English	Article						+TIP; collagen alpha 3(IV) chain; cytoskeleton; EB1; microtubules; spermatogenesis; testis	BLOOD-TESTIS BARRIER; GERM CELL-INTERACTIONS; ECTOPLASMIC SPECIALIZATION; SEMINIFEROUS EPITHELIUM; PROTEIN TRAFFICKING; ADHERENS JUNCTIONS; PASSIVE TRANSFER; LIFE-HISTORY; COLLAGEN-IV; IN-VITRO	During the epithelial cycle of spermatogenesis, different sets of cellular events take place across the seminiferous epithelium in the testis. For instance, remodeling of the blood-testis barrier (BTB) that facilitates the transport of preleptotene spermatocytes across the immunological barrier and the release of sperms at spermiation take place at the opposite ends of the epithelium simultaneously at stage VIII of the epithelial cycle. These cellular events are tightly coordinated via locally produced regulatory biomolecules. Studies have shown that collagen alpha 3 (IV) chains, a major constituent component of the basement membrane, release the non-collagenous (NC) 1 domain, a 28-kDa peptide, designated NC1-peptide, from the C-terminal region, via the action of MMP-9 (matrix metalloproteinase 9). NC1-peptide was found to be capable of inducing BTB remodeling and spermatid release across the epithelium. As such, the NC1-peptide is an endogenously produced biologically active peptide which coordinates these cellular events across the epithelium in stage VIII tubules. Herein, we used an animal model, wherein NC1-peptide cloned into the pCI-neo mammalian expression vector was overexpressed in the testis, to better understanding the molecular mechanism by which NC1-peptide regulated spermatogenic function. It was shown that NC1-peptide induced considerable downregulation on a number of cell polarity and planar cell polarity (PCP) proteins, and studies have shown these polarity and PCP proteins modulate spermatid polarity and adhesion via their effects on microtubule (MT) and F-actin cytoskeletal organization across the epithelium. More important, NC1-peptide exerted its effects by downregulating the expression of microtubule (MT) plus-end tracking protein (+TIP) called EB1 (end-binding protein 1). We cloned the full-length EB1 cDNA for its overexpression in the testis, which was found to block the NC1-peptide-mediated disruptive effects on cytoskeletal organization in Sertoli cell epithelium and pertinent Sertoli cell functions. These findings thus illustrate that NC1-peptide is working in concert with EB1 to support spermatogenesis.	[Liu, Shiwen; Li, Huitao; Wu, Siwen; Li, Linxi; Ge, Renshan; Cheng, C. Yan] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou, Peoples R China; [Liu, Shiwen; Li, Huitao; Wu, Siwen; Li, Linxi; Ge, Renshan; Cheng, C. Yan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Liu, Shiwen; Li, Huitao; Wu, Siwen; Li, Linxi; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA	Wenzhou Medical University; Wenzhou Medical University; Population Council	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Li, Linxi/AFZ-9275-2022	Cheng, C Yan/0000-0003-3117-3791	National Institutes of Health (NICHD) [R01 HD056034]; National Natural Science Foundation of China (NSFC) [81971367, 81730042]	National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the National Institutes of Health (NICHD, R01 HD056034 to CYC), National Natural Science Foundation of China (NSFC, grants 81971367 to L.L., and 81730042 to R.G.).	Ahmad K, 2021, SEMIN CANCER BIOL, V69, P325, DOI 10.1016/j.semcancer.2019.08.030; Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Assadin S, 2008, EXPERT OPIN BIOL TH, V8, P941, DOI [10.1517/14712590802184482, 10.1517/14712598.8.7.941 ]; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bogdan Sven, 2013, Commun Integr Biol, V6, pe27634, DOI 10.4161/cib.27634; Bonnet ME, 2013, J CONTROL RELEASE, V170, P183, DOI 10.1016/j.jconrel.2013.05.015; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; Brassart-Pasco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029587; Burute M, 2019, ANNU REV CELL DEV BI, V35, P2221; Chen HQ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0339-x; Chen HQ, 2017, FASEB J, V31, P3587, DOI 10.1096/fj.201700052R; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Cho HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01823; CLERMONT Y, 1987, ANN NY ACAD SCI, V513, P1, DOI 10.1111/j.1749-6632.1987.tb24994.x; de Kretser D.M., 1988, P837; DENDUCHIS B, 1985, J REPROD IMMUNOL, V7, P59, DOI 10.1016/0165-0378(85)90021-X; DYM M, 1994, ENDOCR REV, V15, P102, DOI 10.1210/er.15.1.102; Eshun-Wilson L, 2019, P NATL ACAD SCI USA, V116, P10366, DOI 10.1073/pnas.1900441116; Gao Y, 2017, ENDOCRINOLOGY, V158, P963, DOI 10.1210/en.2016-1630; Gao Y, 2017, FASEB J, V31, P584, DOI 10.1096/fj.201600870R; Gao Y, 2016, ONCOTARGET, V7, P64203, DOI 10.18632/oncotarget.11887; Gao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep28589; Garcin C, 2019, ESSAYS BIOCHEM, V63, P509, DOI 10.1042/EBC20190016; Goode BL, 2018, TRENDS CELL BIOL, V28, P749, DOI 10.1016/j.tcb.2018.04.008; Gunda Venugopal, 2013, Invest Ophthalmol Vis Sci, V54, P7828, DOI 10.1167/iovs.12-10870; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P409, DOI 10.1002/jemt.20786; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P364, DOI 10.1002/jemt.20785; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Lanning LL, 2002, TOXICOL PATHOL, V30, P507, DOI 10.1080/01926230290105695; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Lee NPY, 2004, J ANDROL, V25, P200; Li JCH, 2001, J ANDROL, V22, P266; Li LX, 2019, ASIAN J ANDROL, V21, P365, DOI 10.4103/aja.aja_126_18; Li LX, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1394-7; Li Linxi, 2017, F1000Res, V6, P1565, DOI 10.12688/f1000research.11421.1; Lie PPY, 2010, P NATL ACAD SCI USA, V107, P11411, DOI 10.1073/pnas.1001823107; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; Lui WY, 2003, BIOL REPROD, V68, P1597, DOI 10.1095/biolreprod.102.011387; LUSTIG L, 1978, ARCH ANDROLOGY, V1, P333, DOI 10.3109/01485017808988354; Ma Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08894; Mao YH, 2011, TRENDS CELL BIOL, V21, P625, DOI 10.1016/j.tcb.2011.08.005; McDonald JA, 2014, INT REV CEL MOL BIO, V312, P169, DOI 10.1016/B978-0-12-800178-3.00006-3; Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452; Mok KW, 2014, J CELL SCI, V127, P4870, DOI 10.1242/jcs.152231; Monboisse JC, 2014, BBA-GEN SUBJECTS, V1840, P2589, DOI 10.1016/j.bbagen.2013.12.029; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Nissen G, 2018, CLIN EXP ALLERGY, V48, P1483, DOI 10.1111/cea.13236; O'Bryan MK, 2008, ADV EXP MED BIOL, V636, P92, DOI 10.1007/978-0-387-09597-4_6; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Oudart JB, 2016, ONCOTARGET, V7, P1516, DOI 10.18632/oncotarget.6399; Patel DF, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0017-2018; Pelletier RM, 2011, PROG HISTOCHEM CYTO, V46, P49, DOI 10.1016/j.proghi.2011.05.001; Rajshankar D, 2020, J CELL PHYSIOL, V235, P3096, DOI 10.1002/jcp.29215; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Steinbacher T, 2018, HISTOCHEM CELL BIOL, V150, P341, DOI 10.1007/s00418-018-1691-8; Su LL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2171; Su WH, 2013, CRIT REV BIOCHEM MOL, V48, P153, DOI 10.3109/10409238.2012.758084; Su WH, 2012, ENDOCRINOLOGY, V153, P6041, DOI 10.1210/en.2012-1670; Sudhakar A, 2008, PHARM RES-DORD, V25, P2731, DOI 10.1007/s11095-008-9634-z; Sudhakar YA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04136; Sun C, 2019, MOL PHARMACEUT, V16, P867, DOI 10.1021/acs.molpharmaceut.8b01190; Tang EI, 2016, SEMIN CELL DEV BIOL, V59, P35, DOI 10.1016/j.semcdb.2016.01.004; Tang EI, 2015, ENDOCRINOLOGY, V156, P680, DOI 10.1210/en.2014-1720; Tang Elizabeth I, 2012, Spermatogenesis, V2, P117; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Vogl AW, 2013, INT REV CEL MOL BIO, V303, P319, DOI 10.1016/B978-0-12-407697-6.00008-8; Wen Q, 2018, AM J PHYSIOL-ENDOC M, V315, pE924, DOI 10.1152/ajpendo.00114.2018; Wen Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0201-6; Wen Q, 2018, BBA-BIOMEMBRANES, V1860, P141, DOI 10.1016/j.bbamem.2017.04.020; Wong EWP, 2008, P NATL ACAD SCI USA, V105, P9657, DOI 10.1073/pnas.0801527105; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Wong EWP, 2010, P NATL ACAD SCI USA, V107, P11399, DOI 10.1073/pnas.1001077107; Yan HHN, 2008, P NATL ACAD SCI USA, V105, P8950, DOI 10.1073/pnas.0711264105; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Yasuda J, 2019, J PHARMACOL SCI, V139, P193, DOI 10.1016/j.jphs.2019.01.010; Yasuda J, 2017, N-S ARCH PHARMACOL, V390, P1135, DOI 10.1007/s00210-017-1413-0	86	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3105	3128		10.1096/fj.201901968RR	http://dx.doi.org/10.1096/fj.201901968RR		JAN 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909540				2022-12-28	WOS:000505694700001
J	Dey, S; Eisa, A; Kline, D; Wagner, FF; Abeysirigunawardena, S; Vijayaraghavan, S				Dey, Souvik; Eisa, Alaa; Kline, Douglas; Wagner, Florence F.; Abeysirigunawardena, Sanjaya; Vijayaraghavan, Srinivasan			Roles of glycogen synthase kinase 3 alpha and calcineurin in regulating the ability of sperm to fertilize eggs	FASEB JOURNAL			English	Article						calcineurin; fertilization; GSK3 alpha; infertile; male contraceptives	TYROSINE PHOSPHORYLATION; MOTILITY INITIATION; PROTEIN; CALCIUM; EPIDIDYMIS; ELEMENTS; PH	Glycogen synthase kinase 3 (GSK3) was identified as an enzyme regulating sperm protein phosphatase. The GSK3 alpha paralog, but not GSK3 beta, is essential for sperm function. Sperm lacking GSK3 alpha display altered motility and are unable to undergo hyperactivation, which is essential for fertilization. Male mice lacking sperm-specific calcineurin (PP2B), a calcium regulated phosphatase, in testis and sperm, are also infertile. Loss of PP2B results in impaired epididymal sperm maturation and motility. The phenotypes of GSK3 alpha and PP2B knockout mice are similar, prompting us to examine the interrelationship between these two enzymes in sperm. High calcium levels must exist to permit catalytically active calcineurin to function during epididymal sperm maturation. Total and free calcium levels are high in immotile compared to motile epididymal sperm. Inhibition of calcineurin by FK506 results in an increase in the net phosphorylation and a consequent decrease in catalytic activity of sperm GSK3. The inhibitor FK506 and an isoform-selective inhibitor of GSK3 alpha, BRD0705, also inhibited fertilization of eggs in vitro. Interrelated functions of GSK3 alpha and sperm PP2B are essential during epididymal sperm maturation and during fertilization. Our results should enable the development of male contraceptives targeting one or both enzymes.	[Dey, Souvik; Kline, Douglas; Vijayaraghavan, Srinivasan] Kent State Univ, Dept Biol Sci, Cunningham Hall Annex Rm A301,POB 5190, Kent, OH 44242 USA; [Eisa, Alaa] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Wagner, Florence F.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Ctr Dev Therapeut, Cambridge, MA 02142 USA; [Abeysirigunawardena, Sanjaya] Kent State Univ, Dept Chem & Biochem, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Dey, S (corresponding author), Kent State Univ, Dept Biol Sci, Cunningham Hall Annex Rm A301,POB 5190, Kent, OH 44242 USA.	sdey4@kent.edu	Kline, Douglas/AAH-5955-2020; Dey, Souvik/AAB-2252-2021	Kline, Douglas/0000-0003-2555-6729; Dey, Souvik/0000-0003-1799-5270	National Institute of Health [R03HD096176, R21HD086839]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institute of Health (SV): R03HD096176 and R21HD086839	Alon LT, 2011, FEBS LETT, V585, P1158, DOI 10.1016/j.febslet.2011.03.025; Ando S, 2005, MOL CELL ENDOCRINOL, V245, P1, DOI 10.1016/j.mce.2005.09.011; Aquila S, 2005, J CLIN ENDOCR METAB, V90, P4753, DOI 10.1210/jc.2004-2233; Aquila S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-140; Barford D, 2002, ANNU REV BIOPH BIOM, V27, P133; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bhattacharjee R, 2018, BIOL REPROD, V99, P384, DOI 10.1093/biolre/ioy020; Bhattacharjee R, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124495; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; BROKAW CJ, 1987, J CELL BIOCHEM, V35, P175, DOI 10.1002/jcb.240350302; CARR DW, 1989, BIOL REPROD, V41, P907, DOI 10.1095/biolreprod41.5.907; Bennett JC, 2010, J BIOL CHEM, V285, P26269, DOI 10.1074/jbc.M109.095752; Chen C, 2016, ASIAN J ANDROL, V18, P600, DOI 10.4103/1008-682X.157650; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; COMHAIRE FH, 1987, INT J ANDROL, V10, P653, DOI 10.1111/j.1365-2605.1987.tb00366.x; da Rocha AM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.128181; Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420; Desseyn J-L, 2002, P NATL ACAD SCI USA, V97, P6433; Dey S, 2018, J CELL PHYSIOL, V233, P7239, DOI 10.1002/jcp.26557; Dey S, 2015, MOL REPROD DEV, V82, P1001, DOI 10.1002/mrd.22586; Dey S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110669; du Plessis SS, 2015, ASIAN J ANDROL, V17, P230, DOI 10.4103/1008-682X.135123; Ecroyd H, 2004, DEV BIOL, V268, P53, DOI 10.1016/j.ydbio.2003.12.015; Fardilha M, 2011, MOL HUM REPROD, V17, P466, DOI 10.1093/molehr/gar004; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Freitas MJ, 2017, BIOL REPROD, V96, P2, DOI 10.1095/biolreprod.116.144337; Garzon-Nino J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43468; Goodson SG, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102673; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Goswami S, 2019, J CELL PHYSIOL, V234, P3105, DOI 10.1002/jcp.27130; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HINSVARK ON, 1953, ANAL CHEM, V25, P320, DOI 10.1021/ac60074a030; Honda Z, 2009, GENES CELLS, V14, P1383, DOI 10.1111/j.1365-2443.2009.01355.x; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jaiswal BS, 1996, BIOCHEM CELL BIOL, V74, P669, DOI 10.1139/o96-072; JENKINS AD, 1980, BIOL REPROD, V23, P981, DOI 10.1095/biolreprod23.5.981; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kanamaru Yusuke, 2012, J Signal Transduct, V2012, P931215, DOI 10.1155/2012/931215; Kim Y, 2009, J NEUROCHEM, V111, P344, DOI 10.1111/j.1471-4159.2009.06318.x; Koch S, 2015, CELL, V163, P1225, DOI 10.1016/j.cell.2015.10.029; Lybaert P, 2009, HISTOL HISTOPATHOL, V24, P999, DOI 10.14670/HH-24.999; MAJUMDER GC, 1990, ARCH ANDROLOGY, V24, P287, DOI 10.3109/01485019008987585; Mannowetz N, 2012, J CELL PHYSIOL, V227, P2154, DOI 10.1002/jcp.22949; Manojlovic Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065897; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; MORTON BE, 1978, FERTIL STERIL, V29, P695; Muramatsu T, 2006, P NATL ACAD SCI USA, V89, P529; Nagy A, 2003, MANIPULATING MOUSE E, P814; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nishigaki T, 2014, BIOCHEM BIOPH RES CO, V450, P1149, DOI 10.1016/j.bbrc.2014.05.100; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Orta G, 2018, J BIOL CHEM, V293, P16830, DOI 10.1074/jbc.RA117.001566; Molina LCP, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00072; Sinha N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047623; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Somanath PR, 2004, J ANDROL, V25, P605; THOMSON AW, 1995, THER DRUG MONIT, V17, P584, DOI 10.1097/00007691-199512000-00007; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; VIJAYARAGHAVAN S, 1990, MOL REPROD DEV, V25, P186, DOI 10.1002/mrd.1080250212; VIJAYARAGHAVAN S, 1985, BIOL REPROD, V32, P489, DOI 10.1095/biolreprod32.3.489; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Wagner FF, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam8460; Weissgerber P, 2012, J BIOL CHEM, V287, P17930, DOI 10.1074/jbc.M111.328286; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wuttke M S, 2001, JOP, V2, P154; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Yu R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00853-x; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhao J, 2013, CELL MOL LIFE SCI, V70, P951, DOI 10.1007/s00018-012-1066-6	71	6	6	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1247	1269		10.1096/fj.201902163R	http://dx.doi.org/10.1096/fj.201902163R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914663	Green Accepted			2022-12-28	WOS:000507308900084
J	Du, HB; Zou, LZ; Ren, R; Li, NN; Li, J; Wang, YF; Sun, JP; Yang, J; Xiong, W; Xu, ZG				Du, Haibo; Zou, Linzhi; Ren, Rui; Li, Nana; Li, Jie; Wang, Yanfei; Sun, Jinpeng; Yang, Jun; Xiong, Wei; Xu, Zhigang			Lack of PDZD7 long isoform disrupts ankle-link complex and causes hearing loss in mice	FASEB JOURNAL			English	Article						ankle links; hair cells; inner ear; PDZD7 long isoform; stereocilia	USHER-SYNDROME TYPE-2; COCHLEAR HAIR-CELLS; INNER-EAR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; WHIRLIN ISOFORMS; PROTEIN COMPLEX; MYOSIN-XVA; GENE; COMPONENT; LOCALIZATION	Usher syndrome (USH) is the most frequent form of combined hereditary deafness-blindness, characterized by hearing loss and retinitis pigmentosa, with or without vestibular dysfunction. PDZD7 is a PDZ domain-containing scaffold protein that was suggested to be a USH modifier and a contributor to digenic USH. In the inner ear hair cells, PDZD7 localizes at the ankle region of the stereocilia and constitutes the so-called ankle-link complex together with three other USH proteins Usherin, WHRN, and ADGRV1. PDZD7 gene is subjected to alternative splicing, which gives rise to two types of PDZD7 isoforms, namely the long and short isoforms. At present, little is known which specific isoform is involved in ankle-link formation and stereocilia development. In this work, we showed that PDZD7 long isoform, but not short isoforms, localizes at the ankle region of the stereocilia. Moreover, we established Pdzd7 mutant mice by introducing deletions into exon 14 of the Pdzd7 gene, which causes potential premature translational stop in the long isoform but leaves short isoforms unaffected. We found that lack of PDZD7 long isoform affects the localization of other ankle-link complex components in the stereocilia. Consequently, Pdzd7 mutant mice showed stereocilia development deficits and hearing loss as well as reduced mechanotransduction (MET) currents, suggesting that PDZD7 long isoform is indispensable for hair cells. Furthermore, by performing yeast two-hybrid screening, we identified a PDZD7 long isoform-specific binding partner PIP5K1C, which has been shown to play important roles in hearing and might participate in the function and/or transportation of PDZD7.	[Du, Haibo; Ren, Rui; Li, Nana; Wang, Yanfei; Xu, Zhigang] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cell & Dev Biol, Qingdao 266237, Shandong, Peoples R China; [Zou, Linzhi; Li, Jie; Xiong, Wei] Tsinghua Univ, IDG McGovern Inst Brain Res Tsinghua, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Jinpeng] Shandong Univ, Dept Biochem & Mol Biol, Key Lab Expt Teratol, Minist Educ,Sch Med, Jinan, Shandong, Peoples R China; [Yang, Jun] Univ Utah, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT USA; [Xu, Zhigang] Shandong Normal Univ, Shandong Prov Collaborat Innovat Ctr Cell Biol, Jinan, Shandong, Peoples R China	Shandong University; Tsinghua University; Shandong University; Utah System of Higher Education; University of Utah; Shandong Normal University	Xu, ZG (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cell & Dev Biol, Qingdao 266237, Shandong, Peoples R China.; Xiong, W (corresponding author), Tsinghua Univ, IDG McGovern Inst Brain Res Tsinghua, Sch Life Sci, Beijing 100084, Peoples R China.	wei_xiong@tsinghua.edu.cn; xuzg@sdu.edu.cn	sun, Jinpeng/AAR-9196-2020; Xiong, Wei/AAY-5944-2020	Xiong, Wei/0000-0002-2784-7696	National Key Basic Research Program of China [2018YFC1003600, 2013CB967700]; National Natural Science Foundation of China [81771001, 31522025, 31571080, 81873703, 3181101148]; Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology [SPKLACDB-2019000]; Fundamental Research Funds of Shandong University [2018JC025]; National Eye Institute [EY020853, EY014800]; Research to Prevent Blindness	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology; Fundamental Research Funds of Shandong University; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by grants from the National Key Basic Research Program of China (2018YFC1003600, 2013CB967700), the National Natural Science Foundation of China (81771001, 31522025, 31571080, 81873703, and 3181101148), Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology (SPKLACDB-2019000), the Fundamental Research Funds of Shandong University (2018JC025), the National Eye Institute (EY020853 and EY014800), and Research to Prevent Blindness.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Booth KT, 2015, AM J MED GENET A, V167, P2957, DOI 10.1002/ajmg.a.37274; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Chen Q, 2014, J BIOL CHEM, V289, P36070, DOI 10.1074/jbc.M114.610535; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Du HB, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/2062346; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Ebrahim S, 2016, CELL REP, V15, P935, DOI 10.1016/j.celrep.2016.03.081; Effertz T, 2017, J NEUROSCI, V37, P11632, DOI 10.1523/JNEUROSCI.1351-17.2017; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Grati M, 2012, J NEUROSCI, V32, P14288, DOI 10.1523/JNEUROSCI.3071-12.2012; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Keats BJB, 1999, AM J MED GENET, V89, P158, DOI 10.1002/(SICI)1096-8628(19990924)89:3<158::AID-AJMG6>3.3.CO;2-R; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Mathur P, 2015, BBA-MOL BASIS DIS, V1852, P406, DOI 10.1016/j.bbadis.2014.11.020; Mathur PD, 2015, HUM MOL GENET, V24, P7017, DOI 10.1093/hmg/ddv403; Mathur PD, 2015, HUM MOL GENET, V24, P6213, DOI 10.1093/hmg/ddv339; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Morgan CP, 2016, ELIFE, V5, DOI 10.7554/eLife.18312; Rodriguez L, 2012, P NATL ACAD SCI USA, V109, P14013, DOI 10.1073/pnas.1211869109; Schneider E, 2009, HUM MOL GENET, V18, P655, DOI 10.1093/hmg/ddn395; Shen J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav071; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Vona B, 2016, EAR HEARING, V37, pE238, DOI 10.1097/AUD.0000000000000278; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Xiong W, 2014, NAT PROTOC, V9, P2438, DOI 10.1038/nprot.2014.168; Xiong W, 2012, CELL, V151, P1283, DOI 10.1016/j.cell.2012.10.041; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; Zhai XY, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00461; Zhao HY, 2012, J NEUROSCI, V32, P4600, DOI 10.1523/JNEUROSCI.6184-11.2012; Zou JH, 2017, HUM MOL GENET, V26, P624, DOI 10.1093/hmg/ddw421; Zou JH, 2015, HUM MOL GENET, V24, P6944, DOI 10.1093/hmg/ddv398; Zou JH, 2014, HUM MOL GENET, V23, P2374, DOI 10.1093/hmg/ddt629	45	10	10	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1136	1149		10.1096/fj.201901657RR	http://dx.doi.org/10.1096/fj.201901657RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914662	Green Accepted			2022-12-28	WOS:000507308900077
J	Luo, JQ; Wang, X; Jiang, XH; Liu, C; Li, YZ; Han, XW; Zuo, X; Li, YN; Li, N; Xu, YN; Si, SY				Luo, Jinque; Wang, Xiao; Jiang, Xinhai; Liu, Chao; Li, Yongzhen; Han, Xiaowan; Zuo, Xuan; Li, Yining; Li, Ni; Xu, Yanni; Si, Shuyi			Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport	FASEB JOURNAL			English	Article						ABCA1; IL-1 beta; macrophage; MAPK; NF-kappa B	NF-KAPPA-B; INTERLEUKIN-1 RECEPTOR ANTAGONIST; DOWN-REGULATION; APOE(-/-) MICE; ACTIVATION; MECHANISMS; MACROPHAGES; EXPRESSION; CROSSTALK; PATHWAY	Atherosclerosis is a chronic disease characterized by lipid deposition and inflammatory response. NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome-facilitated inflammatory responses are crucial in the pathogenesis of atherosclerosis, and thus new therapeutic approaches are emerging that target NLRP3 and inflammation. Here, we explored the anti-atherosclerotic effect and mechanisms of a new rutaecarpine derivative, 5-deoxy-rutaecarpine (R3) in vitro and in vivo. R3 treatment attenuated atherosclerosis development and increased plaque stability in Apoe(-/-) mice fed a high-fat diet, and decreased levels of inflammatory mediators, such as interleukin-1 beta, in the serum of Apoe(-/-) mice and in oxidized low-density lipoprotein (ox-LDL)-stimulated murine macrophages. R3 treatment inhibited NLRP3 inflammasome activation in the livers of Apoe(-/-) mice and ox-LDL-stimulated murine macrophages by inhibiting NF-kappa B and MAPK pathways. Additionally, R3 significantly decreased total cholesterol in the serum and livers of Apoe(-/-) mice and promoted cholesterol efflux in murine macrophages through upregulating protein expression of ATP-binding cassette subfamily A member 1 and scavenger receptor class B type I/human CD36 and lysosomal integral membrane protein-II analogous-1. Our results demonstrated that R3 prevented atherosclerotic progression via attenuating NLRP3 inflammasome-related inflammation and modulating cholesterol transport.	[Luo, Jinque; Wang, Xiao; Jiang, Xinhai; Liu, Chao; Li, Yongzhen; Han, Xiaowan; Zuo, Xuan; Li, Yining; Li, Ni; Xu, Yanni; Si, Shuyi] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Natl Ctr Screening Novel Microbial Drugs, NHC Key Lab Biotechnol Antibiot, Beijing, Peoples R China; [Li, Ni] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, YN; Si, SY (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Tiantan Xili 1, Beijing 100050, Peoples R China.	xuyanniwendeng@hotmail.com; sisyimb@hotmail.com			National Natural Science Foundation of China (NSFC) [81573482, 81621064, 81973328]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2018ZX09711001003-006, 2018ZX09711001-007-002, 2018ZX09735001-001-002]; CAMS Fundamental Research Funds [2019-RC-HL-009]; CAMS Innovation Fund for Medical Sciences [2016-I2M-1-011]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; CAMS Fundamental Research Funds; CAMS Innovation Fund for Medical Sciences	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81573482, 81621064 and 81973328; National Science and Technology Major Project of the Ministry of Science and Technology of China, Grant/Award Number: 2018ZX09711001003-006, 2018ZX09711001-007-002, 2018ZX09735001-001-002; CAMS Fundamental Research Funds, Grant/Award Number: 2019-RC-HL-009; CAMS Innovation Fund for Medical Sciences, Grant/Award Number: 2016-I2M-1-011	Abderrazak A, 2015, CIRCULATION, V131, P1061, DOI 10.1161/CIRCULATIONAHA.114.013730; Ahmad F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28056; Azzam KM, 2012, TRENDS ENDOCRIN MET, V23, P169, DOI 10.1016/j.tem.2012.02.001; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Chen H, 2017, CELL HOST MICROBE, V21, P47, DOI 10.1016/j.chom.2016.12.004; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1493, DOI 10.1152/ajpcell.00016.2006; de Jager SCA, 2013, CARDIOVASC RES, V100, P4, DOI 10.1093/cvr/cvt199; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elhage R, 1998, CIRCULATION, V97, P242, DOI 10.1161/01.CIR.97.3.242; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gibson MS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00654; Gomez D, 2018, NAT MED, V24, P1418, DOI 10.1038/s41591-018-0124-5; Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guo K, 2018, J MOL CELL CARDIOL, V116, P69, DOI 10.1016/j.yjmcc.2018.01.013; Heo SK, 2009, J CELL BIOCHEM, V107, P123, DOI 10.1002/jcb.22109; Hoseini Z, 2018, J CELL PHYSIOL, V233, P2116, DOI 10.1002/jcp.25930; Jiang H, 2017, J EXP MED, V214, P3219, DOI 10.1084/jem.20171419; Jones JG, 2016, DIABETOLOGIA, V59, P1098, DOI 10.1007/s00125-016-3940-5; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Khovidhunkit W, 2003, J LIPID RES, V44, P1728, DOI 10.1194/jlr.M300100-JLR200; Ko HC, 2007, EUR J PHARMACOL, V555, P211, DOI 10.1016/j.ejphar.2006.10.002; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Ni WH, 2001, CIRCULATION, V103, P2096; Nie XQ, 2016, ACTA PHARMACOL SIN, V37, P483, DOI 10.1038/aps.2015.167; Olofsson PS, 2009, CIRC J, V73, P1531, DOI 10.1253/circj.CJ-08-1150; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Quintans JSS, 2019, FOOD CHEM TOXICOL, V123, P233, DOI 10.1016/j.fct.2018.10.058; Ramji DP, 2015, CYTOKINE GROWTH F R, V26, P673, DOI 10.1016/j.cytogfr.2015.04.003; Reustle A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123761; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen P, 2019, BIOMED PHARMACOTHER, V110, P786, DOI 10.1016/j.biopha.2018.12.033; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Tian KM, 2019, PHARMACOL RES, V141, P541, DOI 10.1016/j.phrs.2018.12.019; Tumurkhuu G, 2018, CELL METAB, V28, P432, DOI 10.1016/j.cmet.2018.05.027; Vallurupalli S, 2016, CARDIOVASC INNOV APP, V1, P443, DOI 10.15212/CVIA.2016.0028; Varghese GP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003031; Wang CH, 2017, MOL MED REP, V16, P922, DOI 10.3892/mmr.2017.6631; Wang XQ, 2002, ARTERIOSCL THROM VAS, V22, pE5, DOI 10.1161/01.ATV.0000018287.03856.DD; Xu YN, 2014, J LIPID RES, V55, P1634, DOI 10.1194/jlr.M044198; Zarzycka B, 2015, EXPERT REV CLIN PHAR, V8, P297, DOI 10.1586/17512433.2015.1025052; Zeller I, 2014, CIRC RES, V115, pE83, DOI 10.1161/CIRCRESAHA.114.305641; Zhao Y, 2015, MOLECULES, V20, P2658, DOI 10.3390/molecules20022658	49	14	15	3	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1398	1411		10.1096/fj.201900903RRR	http://dx.doi.org/10.1096/fj.201900903RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914630				2022-12-28	WOS:000507308900093
J	Matos, CO; Passos, YM; do Amaral, MJ; Macedo, B; Tempone, MH; Bezerra, OCL; Moraes, MO; Almeida, MS; Weber, G; Missailidis, S; Silva, JL; Uversky, VN; Pinheiro, AS; Cordeiro, Y				Matos, Carolina O.; Passos, Yulli M.; do Amaral, Mariana J.; Macedo, Bruno; Tempone, Matheus H.; Bezerra, Ohanna C. L.; Moraes, Milton O.; Almeida, Marcius S.; Weber, Gerald; Missailidis, Sotiris; Silva, Jerson L.; Uversky, Vladimir N.; Pinheiro, Anderson S.; Cordeiro, Yraima			Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer	FASEB JOURNAL			English	Article						neurodegenerative diseases; nucleic acid; phase transitions; prions; SELEX	NUCLEIC-ACID; SECONDARY STRUCTURE; CONFORMATION; TRANSITION; BINDING; PRP; DROPLETS; SEQUENCE; COMPLEXITY; PREDICTION	Structural conversion of cellular prion protein (PrP (c)) into scrapie PrP (PrPSc) and subsequent aggregation are key events associated with the onset of transmissible spongiform encephalopathies (TSEs). Experimental evidence supports the role of nucleic acids (NAs) in assisting this conversion. Here, we asked whether PrP undergoes liquid-liquid phase separation (LLPS) and if this process is modulated by NAs. To this end, two 25-mer DNA aptamers, A1 and A2, were selected against the globular domain of recombinant murine PrP (rPrP(90-231)) using SELEX methodology. Multiparametric structural analysis of these aptamers revealed that A1 adopts a hairpin conformation. Aptamer binding caused partial unfolding of rPrP(90-231) and modulated its ability to undergo LLPS and fibrillate. In fact, although free rPrP(90-231) phase separated into large droplets, aptamer binding increased the number of droplets but noticeably reduced their size. Strikingly, a modified A1 aptamer that does not adopt a hairpin structure induced formation of amyloid fibrils on the surface of the droplets. We show here that PrP undergoes LLPS, and that the PrP interaction with NAs modulates phase separation and promotes PrP fibrillation in a NA structure and concentration-dependent manner. These results shed new light on the roles of NAs in PrP misfolding and TSEs.	[Matos, Carolina O.; Pinheiro, Anderson S.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Rio De Janeiro, Brazil; [Passos, Yulli M.; Macedo, Bruno; Tempone, Matheus H.; Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Pharm, Av Carlos Chagas Filho 373,Bl BSs 17, BR-21941902 Rio De Janeiro, Brazil; [do Amaral, Mariana J.; Almeida, Marcius S.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging CENABIO, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil; [Bezerra, Ohanna C. L.; Moraes, Milton O.] Oswaldo Cruz Fdn FIOCRUZ, Inst Oswaldo Cruz, Leprosy Lab, Rio De Janeiro, Brazil; [Weber, Gerald] Univ Fed Minas Gerais, Dept Phys, Belo Horizonte, MG, Brazil; [Missailidis, Sotiris] Oswaldo Cruz Fdn FIOCRUZ, Inst Technol Immunobiol Biomanguinhos, Rio De Janeiro, Brazil; [Uversky, Vladimir N.] Univ S Florida, USF Hlth Byrd Alzheimers Res Inst, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Lab New Methods Biol, Pushchino, Russia	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; State University System of Florida; University of South Florida; Russian Academy of Sciences	Cordeiro, Y (corresponding author), Univ Fed Rio de Janeiro, Fac Pharm, Av Carlos Chagas Filho 373,Bl BSs 17, BR-21941902 Rio De Janeiro, Brazil.; Pinheiro, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Av Athos da Silveira Ramos 149,Bl A,536-B, BR-21941909 Rio De Janeiro, RJ, Brazil.	pinheiro@iq.ufrj.br; yraima@pharma.ufrj.br	Moraes, Milton Ozório/G-9753-2011; Weber, Gerald/A-8669-2010; Silva, Jerson/J-8984-2014; Uversky, Vladimir N./F-4515-2011; Pinheiro, Anderson S/B-6350-2014; Bezerra, Ohanna Cavalcanti/GXG-0231-2022; Moraes, Milton/AFF-1842-2022; SILVA, JERSON Lima/GRF-1442-2022; Pinheiro, Anderson/AAL-5299-2021; Oliveira Matos, Carolina/GNP-7810-2022	Moraes, Milton Ozório/0000-0003-2653-0037; Weber, Gerald/0000-0002-2935-1571; Silva, Jerson/0000-0001-9523-9441; Uversky, Vladimir N./0000-0002-4037-5857; SILVA, JERSON Lima/0000-0001-9523-9441; Pinheiro, Anderson/0000-0001-5118-6931	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [01]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brown University (Brown), Brazil Initiative Collaboration Grant	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brown University (Brown), Brazil Initiative Collaboration Grant	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant/Award Number: Finance Code 01; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brown University (Brown), Grant/Award Number: Brazil Initiative Collaboration Grant	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Balzani E, 2016, CELL REP, V16, P615, DOI 10.1016/j.celrep.2016.06.017; Banerjee A, 2017, ADV PURE APPL MATH, V8, P1, DOI 10.1515/apam-2016-0032; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Beaudoin S, 2009, BBA-MOL CELL RES, V1793, P335, DOI 10.1016/j.bbamcr.2008.10.009; Biasini E, 2019, NAT BIOMED ENG, V3, P167, DOI 10.1038/s41551-019-0367-6; BRAM S, 1971, J MOL BIOL, V58, P277, DOI 10.1016/0022-2836(71)90246-4; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Cavaliere P, 2013, NUCLEIC ACIDS RES, V41, P1; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Cordeiro Y, 2019, BBA-PROTEINS PROTEOM, V1867, P933, DOI 10.1016/j.bbapap.2019.02.006; Dard R, 2017, EUR J MED GENET, V60, P639, DOI 10.1016/j.ejmg.2017.08.015; Darling AL, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11060990; de Oliveira GAP, 2016, SCI REP-UK, V6, DOI 10.1038/srep37990; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dragich JM, 2016, ELIFE, V5, DOI 10.7554/eLife.14810; Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Fang XJ, 2017, CHINESE MED J-PEKING, V130, P242, DOI 10.4103/0366-6999.198019; Gasset-Rosa F, 2019, NEURON, V102, P339, DOI 10.1016/j.neuron.2019.02.038; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Hamilton MJ, 2018, J MED GENET, V55, P28, DOI 10.1136/jmedgenet-2017-104620; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; Kostylev MA, 2018, MOL CELL, V72, P426, DOI 10.1016/j.molcel.2018.10.009; Kovachev PS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48883-x; Kroschwald S, 2017, CELL, V168, P947, DOI 10.1016/j.cell.2017.02.029; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Langdon EM, 2018, SCIENCE, V7432, P1; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Macedo B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051023; Macedo B, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0361-y; Macedo B, 2012, BIOCHEMISTRY-US, V51, P5402, DOI 10.1021/bi300440e; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; Mange A, 2004, J CELL SCI, V117, P2411, DOI 10.1242/jcs.01094; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Schmidt HB, 2016, CELL REP, V16, P1228, DOI 10.1016/j.celrep.2016.06.088; Sebollela A, 2014, ACS CHEM NEUROSCI, V5, P1238, DOI 10.1021/cn500156r; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2016, J BIOL CHEM, V291, P15482, DOI 10.1074/jbc.R116.733428; Steinberg TH, 1996, ANAL BIOCHEM, V239, P223, DOI 10.1006/abio.1996.0319; Takemura K, 2006, EXP BIOL MED, V231, P204; Tataurov AV, 2008, BIOPHYS CHEM, V133, P66, DOI 10.1016/j.bpc.2007.12.004; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Turoverov KK, 2019, TRENDS BIOCHEM SCI, V44, P716, DOI 10.1016/j.tibs.2019.03.005; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; VOORHEES PW, 1992, ANNU REV MATER SCI, V22, P197, DOI 10.1146/annurev.ms.22.080192.001213; Warwicker J, 2000, BIOCHEM BIOPH RES CO, V278, P646, DOI 10.1006/bbrc.2000.3829; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yin S, 2008, J BIOL CHEM, V283, P25446, DOI 10.1074/jbc.M800814200; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zhang J, 2019, BRIEF BIOINFORM, V20, P1250, DOI 10.1093/bib/bbx168; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	79	24	24	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					365	385		10.1096/fj.201901897R	http://dx.doi.org/10.1096/fj.201901897R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914616				2022-12-28	WOS:000507308900026
J	Nussinov, R; Tsai, CJ; Jang, H				Nussinov, Ruth; Tsai, Chung-Jung; Jang, Hyunbum			Autoinhibition can identify rare driver mutations and advise pharmacology	FASEB JOURNAL			English	Review						allostery; allosteric drugs; autoinhibition; driver mutation; free energy landscape; precision medicine; review	FREE-ENERGY LANDSCAPE; PROTEIN-PROTEIN INTERACTIONS; PLECKSTRIN-HOMOLOGY-DOMAIN; SOMATIC MUTATIONS; KINASE DOMAIN; CONFORMATIONAL LANDSCAPE; FUNCTIONAL CONSEQUENCES; MOLECULAR-MECHANISM; ACTIVATING MUTATION; ALLOSTERIC SITES	Identification of protein mutations that drive cancer is a major challenge. A primary reason is that driver mutations are principally identified by their high frequency even though they can also be rare. Driver mutations can locate at functional (binding or active) sites. We dub these orthosteric drivers. However, often they are allosteric drivers. Identification is particularly formidable for rare allosteric drivers. Autoinhibition, where a segment of the protein covers its functional site, is a common allosteric regulation mechanism. A modest shift in the equilibrium can switch the system from the autoinhibited to the active state. This can suggest why (i) mutations are likely to evolve to target it; (ii) inhibitors can straightforwardly relieve the autoinhibition but not vice versa; and why (iii) mutations that relieve the autoinhibition are likely to be drivers-even if they are rare. We explain in simple terms the linkage between allosteric driver mutations, release of autoinhibition, free energy landscapes, and targeted pharmacology in precision medicine. We review the literature and propose new concepts in identification of rare drivers in this framework.	[Nussinov, Ruth] Frederick Natl Lab Canc Res, Computat Struct Biol Sect, Basic Sci Program, Frederick, MD USA; [Nussinov, Ruth; Tsai, Chung-Jung; Jang, Hyunbum] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Nussinov, R (corresponding author), NCI, Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, 1050 Boyles St, Frederick, MD 21702 USA.	NussinoR@mail.nih.gov		Nussinov, Ruth/0000-0002-8115-6415	HHS \ NIH \ National Cancer Institute (NCI) [HHSN261200800001E]	HHS \ NIH \ National Cancer Institute (NCI)	HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: HHSN261200800001E	Acuner-Ozbabacan ES, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S2; Agache I, 2019, J CLIN INVEST, V129, P1493, DOI 10.1172/JCI124611; Agajanian S, 2018, J CHEM INF MODEL, V58, P2131, DOI 10.1021/acs.jcim.8b00414; Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Alexov E, 2014, ADV BIOL, V2014, P471836; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Arencibia JM, 2017, ACS CHEM BIOL, V12, P564, DOI 10.1021/acschembio.6b00827; Artim SC, 2012, BIOCHEM J, V448, P213, DOI 10.1042/BJ20121365; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bayliss R, 2015, BBA-PROTEINS PROTEOM, V1854, P1586, DOI 10.1016/j.bbapap.2015.04.025; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Buisson R, 2019, SCIENCE, V364, P1251, DOI 10.1126/science.aaw2872; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chavan TS, 2015, BIOPHYS J, V109, P2602, DOI 10.1016/j.bpj.2015.09.034; Chen HB, 2017, ELIFE, V6, DOI 10.7554/eLife.21137; Chen MC, 2018, J PHYS CHEM B, V122, P11414, DOI 10.1021/acs.jpcb.8b07364; Cheng FX, 2019, PHARMACOL REV, V71, P1, DOI 10.1124/pr.118.016253; Chu N, 2018, CELL, V174, P897, DOI 10.1016/j.cell.2018.07.003; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cui DS, 2017, J MOL BIOL, V429, P2360, DOI 10.1016/j.jmb.2017.06.009; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dickson A, 2018, BIOPHYS J, V115, P1707, DOI 10.1016/j.bpj.2018.09.021; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ebner M, 2017, MOL CELL, V65, P416, DOI 10.1016/j.molcel.2016.12.028; Ekimoto Toru, 2018, Biophys Rev, V10, P605, DOI 10.1007/s12551-017-0373-4; Emptage RP, 2017, BIOCHEM J, V474, P385, DOI 10.1042/BCJ20160792; Fan QW, 2017, CANCER CELL, V31, P424, DOI 10.1016/j.ccell.2017.01.014; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Gao JJ, 2017, GENOME MED, V9, DOI 10.1186/s13073-016-0393-x; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Goncearenco A, 2017, NUCLEIC ACIDS RES, V45, pW514, DOI 10.1093/nar/gkx367; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Grasso M, 2016, ACS CHEM BIOL, V11, P2876, DOI 10.1021/acschembio.6b00529; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guo JJ, 2016, CHEM REV, V116, P6503, DOI 10.1021/acs.chemrev.5b00590; Haq T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9771; Hashimoto K, 2012, HUM MUTAT, V33, P1566, DOI 10.1002/humu.22145; Hruska E, 2018, J CHEM PHYS, V149, DOI 10.1063/1.5053582; Huang CH, 2008, CELL CYCLE, V7, P1151, DOI 10.4161/cc.7.9.5817; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Huang WK, 2017, METHODS MOL BIOL, V1529, P439, DOI 10.1007/978-1-4939-6637-0_23; Hubbard SR, 2018, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00361; Hulsen T, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00034; Iida S, 2016, BIOCHEM J, V473, P1651, DOI 10.1042/BCJ20160053; Ip CKM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06949-w; Janes MR, 2018, CELL, V172, P578, DOI 10.1016/j.cell.2018.01.006; Jang H, 2016, FASEB J, V30, P1643, DOI 10.1096/fj.15-279091; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kannan S, 2018, CHEM SCI, V9, P5212, DOI 10.1039/c8sc01262h; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Karchin R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005043; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kondo Y, 2019, SCIENCE, V366, P109, DOI 10.1126/science.aay0543; Kumar RD, 2016, NAT GENET, V48, P1288, DOI 10.1038/ng.3658; Kumar S, 2017, NATURE, V547, P40, DOI 10.1038/nature23085; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Lang JD, 2018, METHODS MOL BIOL, V1706, P367, DOI 10.1007/978-1-4939-7471-9_20; LaRochelle JR, 2016, BIOCHEMISTRY-US, V55, P2269, DOI 10.1021/acs.biochem.5b01287; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lehmann LC, 2017, MOL CELL, V68, P847, DOI 10.1016/j.molcel.2017.10.017; Leontiadou H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27044-6; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li MH, 2017, METHODS MOL BIOL, V1550, P235, DOI 10.1007/978-1-4939-6747-6_17; Li MH, 2016, CANCER RES, V76, P561, DOI 10.1158/0008-5472.CAN-14-3812; Liao TJ, 2017, PHYS CHEM CHEM PHYS, V19, P6470, DOI 10.1039/c6cp08596b; Liao TJ, 2016, CURR OPIN STRUC BIOL, V41, P217, DOI 10.1016/j.sbi.2016.09.001; Lu SY, 2019, ACCOUNTS CHEM RES, V52, P492, DOI 10.1021/acs.accounts.8b00570; Lu SY, 2018, DRUG DISCOV TODAY, V23, P359, DOI 10.1016/j.drudis.2017.10.001; Lu XY, 2018, MED RES REV, V38, P1550, DOI 10.1002/med.21488; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; McNally R, 2019, ACS CHEM BIOL, V14, P587, DOI 10.1021/acschembio.8b00722; Meyer MJ, 2016, HUM MUTAT, V37, P447, DOI 10.1002/humu.22963; Miller MS, 2017, BIOORGAN MED CHEM, V25, P1481, DOI 10.1016/j.bmc.2017.01.012; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Millis SZ, 2016, JAMA ONCOL, V2, P1565, DOI 10.1001/jamaoncol.2016.0891; Nagel D, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5081767; Novelli ET, 2018, BIOCHEMISTRY-US, V57, P6356, DOI 10.1021/acs.biochem.8b00878; Nussinov R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006658; Nussinov Ruth, 2019, Biophys Rev, V11, P5, DOI 10.1007/s12551-018-0496-2; Nussinov Ruth, 2018, Biophys Rev, V10, P1263, DOI 10.1007/s12551-018-0461-0; Nussinov R, 2017, CELL MOL LIFE SCI, V74, P3245, DOI 10.1007/s00018-017-2564-3; Nussinov R, 2015, CURR OPIN STRUC BIOL, V32, P25, DOI 10.1016/j.sbi.2015.01.004; Nussinov R, 2015, ANNU REV PHARMACOL, V55, P249, DOI 10.1146/annurev-pharmtox-010814-124401; Nussinov R, 2014, ONCOTARGET, V5, P7285, DOI 10.18632/oncotarget.2439; Nussinov R, 2014, TRENDS PHARMACOL SCI, V35, P256, DOI 10.1016/j.tips.2014.03.006; Nussinov R, 2014, CHEM BIOL, V21, P311, DOI 10.1016/j.chembiol.2013.12.015; Nussinov R, 2014, PHYS CHEM CHEM PHYS, V16, P6321, DOI 10.1039/c4cp90027h; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Ozturk K, 2019, METHODS MOL BIOL, V1907, P51, DOI 10.1007/978-1-4939-8967-6_4; Padua RAP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06814-w; Parikh C, 2012, P NATL ACAD SCI USA, V109, P19368, DOI 10.1073/pnas.1204384109; Park E, 2019, NATURE, V575, P545, DOI 10.1038/s41586-019-1660-y; Pon JR, 2015, ANNU REV PATHOL-MECH, V10, P25, DOI 10.1146/annurev-pathol-012414-040312; Poulos Rebecca C, 2019, Biophys Rev, V11, P21, DOI 10.1007/s12551-018-0415-6; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Raphael BJ, 2014, GENOME MED, V6, DOI 10.1186/gm524; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW127, DOI 10.1093/nar/gky375; Ryslik GA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-190; Saladino G, 2016, CURR OPIN STRUC BIOL, V37, P108, DOI 10.1016/j.sbi.2016.01.005; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; Scholl C, 2019, CURR OPIN GENET DEV, V54, P1, DOI 10.1016/j.gde.2019.02.004; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; Shendure J, 2019, CELL, V177, P45, DOI 10.1016/j.cell.2019.02.003; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Spellicy CJ, 2019, J HUM GENET, V64, P561, DOI 10.1038/s10038-019-0585-5; Sun L, 2014, BIOPHYS J, V107, P2941, DOI 10.1016/j.bpj.2014.10.021; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Tang SC, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.e23209; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Terrell EM, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a033746; Topacio BR, 2019, MOL CELL, V74, P758, DOI 10.1016/j.molcel.2019.03.020; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Tsai CJ, 2014, PHYS CHEM CHEM PHYS, V16, P6332, DOI 10.1039/c3cp54253j; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Tsang H, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00214; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Vasaikar S, 2019, CELL, V177, P1035, DOI 10.1016/j.cell.2019.03.030; Verkhivker GM, 2019, BBA-GEN SUBJECTS, V1863, P210, DOI 10.1016/j.bbagen.2018.10.009; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wei GH, 2016, CHEM REV, V116, P6516, DOI 10.1021/acs.chemrev.5b00562; Wilson C, 2015, SCIENCE, V347, P882, DOI 10.1126/science.aaa1823; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Xie Q, 2019, CELL CHEM BIOL, V26, P548, DOI 10.1016/j.chembiol.2019.01.006; Yang HJ, 2017, NATURE, V552, P368, DOI 10.1038/nature25023; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Ye JJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-11; Yi KH, 2016, ONCOTARGET, V7, P4241, DOI 10.18632/oncotarget.6648; Zhang B, 2016, J AM CHEM SOC, V138, P8126, DOI 10.1021/jacs.6b02893; Zhang MZ, 2019, PHYS CHEM CHEM PHYS, V21, P12021, DOI 10.1039/c9cp00101h; Zhang MZ, 2019, CHEM SCI, V10, P3671, DOI 10.1039/c8sc04498h; Zhao FY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072113; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	151	17	18	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					16	29		10.1096/fj.201901341R	http://dx.doi.org/10.1096/fj.201901341R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914624	hybrid			2022-12-28	WOS:000507308900003
J	Quercini, L; Brunetti, J; Riolo, G; Bindi, S; Scali, S; Lampronti, I; D'Aversa, E; Wronski, S; Pollini, S; Gentile, M; Lupetti, P; Rossolini, GM; Falciani, C; Bracci, L; Pini, A				Quercini, Leila; Brunetti, Jlenia; Riolo, Giulia; Bindi, Stefano; Scali, Silvia; Lampronti, Ilaria; D'Aversa, Elisabetta; Wronski, Sabine; Pollini, Simona; Gentile, Mariangela; Lupetti, Pietro; Rossolini, Gian Maria; Falciani, Chiara; Bracci, Luisa; Pini, Alessandro			An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue	FASEB JOURNAL			English	Article						antibacterial agents; antibiotic resistance; antimicrobial peptides; drug development	HOST-DEFENSE PEPTIDES; RESISTANCE	The peptide sequence KKIRVRLSA was synthesized in a dimeric structure (SET-M33DIM) and evaluated as a candidate drug for infections due to multidrug-resistant (MDR) Gram-negative pathogens. SET-M33DIM showed significant antibacterial activity against MDR strains of Klebsiella pneumoniae, Acinetobacter baumannii, and Escherichia coli (Minimal Inhibitory Concentration [MICs], 1.5-11 mu M), and less activity against Pseudomonas aeruginosa (MICs, 11-22 mu M). It showed very low toxicity in vitro, ex vivo, and in vivo; in cytotoxicity tests, its EC50 was as much as 22 times better than that of SET-M33, a peptide with the same amino-acid sequence, but synthesized in tetra-branched form (638 vs 28 mu M). In in vivo and ex vivo experiments, SET-M33DIM cleared P. aeruginosa infection, significantly reducing signs of sepsis in animals, and restoring cell viability in lung tissue after bacterial challenge. It also quelled inflammation triggered by LPS and live bacterial cells, inhibiting expression of inflammatory mediators in lung tissue, cultured macrophages, and bronchial cells from a cystic fibrosis patient.	[Quercini, Leila] SetLance Srl, Siena, Italy; [Brunetti, Jlenia; Riolo, Giulia; Bindi, Stefano; Scali, Silvia; Falciani, Chiara; Bracci, Luisa; Pini, Alessandro] Univ Siena, Dept Med Biotechnol, Via A Moro 2, Siena, Italy; [Lampronti, Ilaria; D'Aversa, Elisabetta] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy; [Wronski, Sabine] Fraunhofer Int Consortium AntiInfect Res iCAIR, Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany; [Pollini, Simona; Rossolini, Gian Maria] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Pollini, Simona] Florence Careggi Univ Hosp, Microbiol & Virol Unit, Florence, Italy; [Gentile, Mariangela; Lupetti, Pietro] Univ Siena, Dept Life Sci, Siena, Italy	University of Siena; University of Ferrara; Fraunhofer Gesellschaft; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Siena	Pini, A (corresponding author), Univ Siena, Dept Med Biotechnol, Via A Moro 2, Siena, Italy.	pinia@unisi.it	Riolo, Giulia/AAC-4485-2022; Pini, Alessandro/R-1359-2018; BRACCI, LUISA/V-9913-2018; Falciani, Chiara/R-1330-2018; Brunetti, Jlenia/E-6464-2019	Riolo, Giulia/0000-0003-2888-5755; Pini, Alessandro/0000-0002-3832-8349; BRACCI, LUISA/0000-0002-0738-5746; Falciani, Chiara/0000-0002-1027-8482; Gentile, Mariangela/0000-0002-4928-4652; Brunetti, Jlenia/0000-0001-8144-7186; D'Aversa, Elisabetta/0000-0003-3058-5866	European Union's Seventh Program for Research [604434]; Italian Foundation for Cystic Fibrosis [17/2016]; FAR [60760]	European Union's Seventh Program for Research; Italian Foundation for Cystic Fibrosis(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); FAR	European Union's Seventh Program for Research, Grant/Award Number: 604434 (PNEUMO-NP); Italian Foundation for Cystic Fibrosis, Grant/Award Number: Project FFC#17/2016; FAR 2018, Grant/Award Number: 60760	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Andrei Stefan, 2018, Discoveries (Craiova), V6, pe81, DOI 10.15190/d.2018.1; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Brunetti J, 2018, PEPTIDE SCI, V110, DOI 10.1002/pep2.24089; Brunetti J, 2017, CURR TOP MED CHEM, V17, P613, DOI 10.2174/1568026616666160713143017; Brunetti J, 2016, J BIOL CHEM, V291, P25742, DOI 10.1074/jbc.M116.750257; Brunetti J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26077; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Falciani C, 2014, AMINO ACIDS, V46, P1403, DOI 10.1007/s00726-014-1686-2; Farha MA, 2019, NAT MICROBIOL, V4, P565, DOI 10.1038/s41564-019-0357-1; Garrido-Mesa J, 2018, BRIT J PHARMACOL, V175, P4353, DOI 10.1111/bph.14494; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2016, NAT REV IMMUNOL, V16, P321, DOI 10.1038/nri.2016.29; Haney EF, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00043; Jiang ZQ, 2014, PHARMACEUTICALS, V7, P366, DOI 10.3390/ph7040366; Lampronti I, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/960603; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Neuhaus V, 2018, JOVE-J VIS EXP, V9, P135; Neuhaus V, 2017, J OCCUP MED TOXICOL, V12, DOI 10.1186/s12995-017-0158-5; Niehof Monika, 2017, BMC Res Notes, V10, P121, DOI 10.1186/s13104-017-2447-6; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/ERI.13.12, 10.1586/eri.13.12]; Pini A, 2007, J PEPT SCI, V13, P393, DOI 10.1002/psc.858; Pini A, 2012, AMINO ACIDS, V43, P467, DOI 10.1007/s00726-011-1103-z; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Pollini S, 2017, J PEPT SCI, V23, P329, DOI 10.1002/psc.2978; Roscia G, 2013, CURR PROTEIN PEPT SC, V14, P641, DOI 10.2174/138920371408131227155308; Silva ON, 2018, DRUG DISCOV TODAY, V23, P1666, DOI 10.1016/j.drudis.2018.05.024; Steckbeck JD, 2014, EXPERT OPIN BIOL TH, V14, P11, DOI 10.1517/14712598.2013.844227; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tamanini A, 2011, AM J PHYSIOL-LUNG C, V300, pL380, DOI 10.1152/ajplung.00129.2010; van der Weide H, 2017, BBA-BIOMEMBRANES, V1859, P1796, DOI 10.1016/j.bbamem.2017.06.001; World Health Organization, 2016, ANTIMICROBIAL RESIST	40	5	5	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					192	207		10.1096/fj.201901896RR	http://dx.doi.org/10.1096/fj.201901896RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914681	Green Published			2022-12-28	WOS:000507308900015
J	Silva, MJ; Holguin, N				Silva, Matthew J.; Holguin, Nilsson			Aging aggravates intervertebral disc degeneration by regulating transcription factors toward chondrogenesis	FASEB JOURNAL			English	Article						biomechanics; genetic animal models; osterix; Wnt; beta-catenin; LRPs	BETA-CATENIN; CHONDROCYTE DIFFERENTIATION; NUCLEUS PULPOSUS; CRE RECOMBINASE; CELLS; BONE; LUMBAR; MICE; CALCIFICATION; ACTIVATION	Osterix is a critical transcription factor of mesenchymal stem cell fate, where its loss or loss of Wnt signaling diverts differentiation to a chondrocytic lineage. Intervertebral disc (IVD) degeneration activates the differentiation of prehypertrophic chondrocyte-like cells and inactivates Wnt signaling, but its interactive role with osterix is unclear. First, compared to young-adult (5 mo), mechanical compression of old (18 mo) IVD induced greater IVD degeneration. Aging (5 vs 12 mo) and/or compression reduced the transcription of osterix and notochordal marker T by 40-75%. Compression elevated the transcription of hypertrophic chondrocyte marker MMP13 and pre-osterix transcription factor RUNX2, but less so in 12 mo IVD. Next, using an Ai9/td reporter and immunohistochemical staining, annulus fibrosus and nucleus pulposus cells of young-adult IVD expressed osterix, but aging and compression reduced its expression. Lastly, in vivo LRP5-deficiency in osterix-expressing cells inactivated Wnt signaling in the nucleus pulposus by 95%, degenerated the IVD to levels similar to aging and compression, reduced the biomechanical properties by 45-70%, and reduced the transcription of osterix, notochordal markers and chondrocytic markers by 60-80%. Overall, these data indicate that age-related inactivation of Wnt signaling in osterix-expressing cells may limit regeneration by depleting the progenitors and attenuating the expansion of chondrocyte-like cells.	[Silva, Matthew J.] Washington Univ, Dept Biomed Engn, Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63110 USA; [Holguin, Nilsson] IUPUI, Dept Mech & Energy Engn, Indiana Ctr Musculoskeletal Hlth, 723 W Michigan St,635 Barnhill Dr, Indianapolis, IN 46202 USA; [Holguin, Nilsson] IUPUI, Dept Anat & Cell Biol, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN USA	Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Holguin, N (corresponding author), IUPUI, Dept Mech & Energy Engn, Indiana Ctr Musculoskeletal Hlth, 723 W Michigan St,635 Barnhill Dr, Indianapolis, IN 46202 USA.	nholguin@iupui.edu			NIH [R01 AR047867, F32 AR064667]; Washington University Musculoskeletal Research Center [P30 AR057235, T32 AR060719]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Musculoskeletal Research Center	NIH, Grant/Award Number: R01 AR047867 and F32 AR064667; Washington University Musculoskeletal Research Center, Grant/Award Number: P30 AR057235 and T32 AR060719	Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Alam I, 2016, ENDOCRINOLOGY, V157, P722, DOI 10.1210/en.2015-1281; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Bedore J, 2016, J CELL COMMUN SIGNAL, V10, P137, DOI 10.1007/s12079-016-0329-7; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Boos N, 1997, HISTOCHEM CELL BIOL, V108, P471, DOI 10.1007/s004180050187; Brisby H, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0179; Chen J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004688; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Chen M, 2014, EUR CELLS MATER, V28, P236, DOI 10.22203/eCM.v028a16; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; D'Angelo M, 2000, J CELL BIOCHEM, V77, P678, DOI 10.1002/(SICI)1097-4644(20000615)77:4<678::AID-JCB15>3.3.CO;2-G; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Holguin N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29352-3; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Holguin N, 2014, J APPL PHYSIOL, V116, P1551, DOI 10.1152/japplphysiol.01322.2013; Holguin N, 2013, SPINE J, V13, P428, DOI 10.1016/j.spinee.2013.01.046; Holguin N, 2011, J APPL PHYSIOL, V111, P1846, DOI 10.1152/japplphysiol.00846.2011; Holguin N, 2010, AVIAT SPACE ENVIR MD, V81, P1078, DOI 10.3357/ASEM.2818.2010; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; Imuta Y, 2013, GENESIS, V51, P210, DOI 10.1002/dvg.22376; Iwata M, 2015, J CELL PHYSIOL, V230, P180, DOI 10.1002/jcp.24697; Kondo N, 2011, SPINE, V36, pE513, DOI 10.1097/BRS.0b013e3181f52cb5; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Ma B, 2013, CALCIFIED TISSUE INT, V92, P399, DOI 10.1007/s00223-012-9675-5; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; Merceron C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110768; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Mundy C, 2011, DEV BIOL, V351, P70, DOI 10.1016/j.ydbio.2010.12.022; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nalesso G, 2017, ANN RHEUM DIS, V76, P218, DOI 10.1136/annrheumdis-2015-208577; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Richardson SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01567-w; Rutges JPHJ, 2010, OSTEOARTHR CARTILAGE, V18, P1487, DOI 10.1016/j.joca.2010.08.006; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sato S, 2008, ARTHRITIS RHEUM, V58, P2764, DOI 10.1002/art.23805; Shao J, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1015-x; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Smolders LA, 2012, J ORTHOP RES, V30, P950, DOI 10.1002/jor.22000; Tam V, 2018, J ORTHOP RES, V36, P233, DOI 10.1002/jor.23637; Torre OM, 2018, FASEB J, V32, P4753, DOI 10.1096/fj.201701492R; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Wang MN, 2012, ARTHRITIS RHEUM-US, V64, P2611, DOI 10.1002/art.34469; Winkler T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098444; Wu Q, 2019, JBMR PLUS, V3, P10069; Yurube T, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4460; Zheng YX, 2019, J CELL PHYSIOL, V234, P14422, DOI 10.1002/jcp.28166	54	17	18	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1970	1982		10.1096/fj.201902109R	http://dx.doi.org/10.1096/fj.201902109R		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909538	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000504269400001
J	Chen, HX; Zhang, JJ; Wang, YJ; Cheuk, KY; Hung, ALH; Lam, TP; Qiu, Y; Feng, JQ; Lee, WYW; Cheng, JCY				Chen, Huanxiong; Zhang, Jiajun; Wang, Yujia; Cheuk, Ka-Yee; Hung, Alec L. H.; Lam, Tsz-Ping; Qiu, Yong; Feng, Jian Q.; Lee, Wayne Y. W.; Cheng, Jack C. Y.			Abnormal lacuno-canalicular network and negative correlation between serum osteocalcin and Cobb angle indicate abnormal osteocyte function in adolescent idiopathic scoliosis	FASEB JOURNAL			English	Article						bone biopsy; bone serum markers; scanning electron microscopy; calcium to phosphorous ratio; microindentation	BONE-MINERAL DENSITY; HUMAN TRABECULAR BONE; CURVE PROGRESSION; ASSOCIATION; OSTEOPENIA; GIRLS; MASS; OSTEOPOROSIS; BIOMARKERS; TURNOVER	Adolescent idiopathic scoliosis (AIS) is a prevalent spinal deformity occurring during peripubertal growth period that affects 1-4% of adolescents globally without clear etiopathogenetic mechanism. Low bone mineral density is an independent and significant prognostic factor for curve progression. Currently, the cause underlying low bone mass in AIS remains elusive. Osteocytes play an important role in bone metabolism and mineral homeostasis, but its role in AIS has not been studied. In the present study, iliac bone tissues were harvested from 21 patients with AIS (mean age of 14.3 +/- 2.20 yr old) with a mean Cobb angle of 55.6 +/- 10.61 degrees and 13 non-AIS controls (mean age of 16.5 +/- 4.79 yr old) intraoperatively. Acid-etched scanning electron microscopy (SEM) images of AIS demonstrated abnormal osteocytes that were more rounded and cobblestone-like in shape and were aligned in irregular clusters with shorter and disorganized canaliculi. Further quantitative analysis with FITC-Imaris technique showed a significant reduction in the canalicular number and length as well as an increase in lacunar volume and area in AIS. SEM with energy-dispersive X-ray spectroscopy analysis demonstrated a lower calcium-to-phosphorus ratio at the perilacunar/canalicular region. Moreover, microindentaion results revealed lower values of Vickers hardness and elastic modulus in AIS when compared with controls. In addition, in the parallel study of 99 AIS (27 with severe Cobb angle of 65.8 +/- 14.1 degrees and 72 with mild Cobb angle of 26.6 +/- 9.1 degrees) with different curve severity, the serum osteocalcin level was found to be significantly and negatively associated with the Cobb angle. In summary, the findings in this series of studies demonstrated the potential link of abnormal osteocyte lacuno-canalicular network structure and function to the observed abnormal bone mineralization in AIS, which may shed light on etiopathogenesis of AIS.	[Chen, Huanxiong] Hainan Med Univ, Affiliated Hosp 1, Dept Spine & Osteopath Surg, Haikou, Hainan, Peoples R China; [Chen, Huanxiong; Zhang, Jiajun; Wang, Yujia; Cheuk, Ka-Yee; Hung, Alec L. H.; Lam, Tsz-Ping; Lee, Wayne Y. W.; Cheng, Jack C. Y.] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, SH Ho Scoliosis Res Lab, Hong Kong, Peoples R China; [Chen, Huanxiong; Zhang, Jiajun; Wang, Yujia; Cheuk, Ka-Yee; Hung, Alec L. H.; Lam, Tsz-Ping; Qiu, Yong; Lee, Wayne Y. W.; Cheng, Jack C. Y.] Chinese Univ Hong Kong, Joint Scoliosis Res Ctr Chinese Univ Hong Kong Na, Hong Kong, Peoples R China; [Qiu, Yong] Nanjing Univ, Nanjing Drum Tower Hosp, Spine Surg, Nanjing, Peoples R China; [Feng, Jian Q.] Texas A&M Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA	Hainan Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong; Nanjing University	Feng, JQ (corresponding author), Texas A&M Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA.; Lee, WYW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, New Town, Room 904,9-F,Li Ka Shing Med Sci Bldg, Hong Kong, Peoples R China.	jfeng@tamu.edu; waynelee@cuhk.edu.hk	Lam, Tsz Ping/P-9963-2016; Cheng, Jack/J-3878-2018; Lee, Wayne YW/H-8298-2013	Lam, Tsz Ping/0000-0002-2427-2719; Cheng, Jack/0000-0001-8153-364X; Lee, Wayne YW/0000-0002-0486-360X; Cheuk, Ka Yee/0000-0001-7431-0093	Hainan Provincial Natural Science Foundation of China [819QN365]; Research Grants Council of Hong Kong [14163517, 14135016, 14120818]; Health and Medical Research Fund [04152176]; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) Joint Research Scheme - Research Grants Council of the Hong Kong Special Administrative Region; NSFC [N_CUHK416/16, 8161101087]; U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant [DE025659]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025659] Funding Source: NIH RePORTER	Hainan Provincial Natural Science Foundation of China; Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Health and Medical Research Fund; National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) Joint Research Scheme - Research Grants Council of the Hong Kong Special Administrative Region; NSFC(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Hainan Provincial Natural Science Foundation of China (Project 819QN365 to H.C.), the Research Grants Council of Hong Kong (Projects 14163517 and 14135016 to J.C.Y.C, and 14120818 to W.Y.W.L.), the Health and Medical Research Fund (04152176 to J.C.Y.C.), the National Natural Science Foundation of China/Research Grants Council (NSFC/RGC) Joint Research Scheme sponsored by the Research Grants Council of the Hong Kong Special Administrative Region, the NSFC (Projects N_CUHK416/16 and 8161101087 to J.C.Y.C. and Y.Q.), and U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant DE025659 (to J.Q.F.). The authors declare no conflicts of interest.	AKESSON K, 1994, CALCIFIED TISSUE INT, V55, P236, DOI 10.1007/BF00425881; Bellido T, 2014, CALCIFIED TISSUE INT, V94, P25, DOI 10.1007/s00223-013-9774-y; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1; Carpentier VT, 2012, BONE, V50, P688, DOI 10.1016/j.bone.2011.11.021; Cheng J. C. Y., 2001, Hong Kong Medical Journal, V7, P241; CHENG JC, 2015, NAT REV DIS PRIMERS, V1, DOI DOI 10.1038/NRDP.2015.30; Cheng JCY, 1999, SPINE, V24, P1218, DOI 10.1097/00007632-199906150-00008; Cheuk KY, 2015, CALCIFIED TISSUE INT, V97, P343, DOI 10.1007/s00223-015-0025-2; Cheung CSK, 2006, SPINE, V31, P330, DOI 10.1097/01.brs.0000197410.92525.10; Chiru Mariana, 2011, Maedica (Bucur), V6, P17; Chow DHK, 2014, J ORTHOP RES, V32, P507, DOI 10.1002/jor.22566; Clark EM, 2014, J BONE MINER RES, V29, P1729, DOI 10.1002/jbmr.2207; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; COOK SD, 1987, J PEDIATR ORTHOPED, V7, P168, DOI 10.1097/01241398-198703000-00011; Csakvary V, 2012, HORM RES PAEDIAT, V78, P203, DOI 10.1159/000342335; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Eastell R, 2008, P NUTR SOC, V67, P157, DOI 10.1017/S002966510800699X; Harel Z, 2007, J ADOLESCENT HEALTH, V40, P44, DOI 10.1016/j.jadohealth.2006.08.013; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Hermus JPS, 2007, EUR SPINE J, V16, pS338, DOI 10.1007/s00586-007-0335-9; Hung VWY, 2005, J BONE JOINT SURG AM, V87A, P2709, DOI 10.2106/JBJS.D.02782; Ishida K, 2015, SCOLIOSIS SPINAL DIS, V10, DOI 10.1186/s13013-015-0033-z; Jones SJ, 1999, CALCIFIED TISSUE INT, V64, P8, DOI 10.1007/s002239900571; Kaya S, 2017, J BONE MINER RES, V32, P688, DOI 10.1002/jbmr.3044; Kesling KL, 1997, SPINE, V22, P2009, DOI 10.1097/00007632-199709010-00014; Kourkoumelis N, 2012, J BIOL PHYS, V38, P279, DOI 10.1007/s10867-011-9247-3; Lam TP, 2013, OSTEOPOROSIS INT, V24, P1623, DOI 10.1007/s00198-012-2144-1; Lee WTK, 2005, OSTEOPOROSIS INT, V16, P1924, DOI 10.1007/s00198-005-1964-7; LEGROS R, 1987, CALCIFIED TISSUE INT, V41, P137, DOI 10.1007/BF02563793; McCreadie BR, 2004, J BIOMECH, V37, P563, DOI 10.1016/S0021-9290(03)00287-2; Milovanovic P, 2015, BIOMATERIALS, V45, P46, DOI 10.1016/j.biomaterials.2014.12.024; Milovanovic P, 2013, ACS NANO, V7, P7542, DOI 10.1021/nn401360u; Mullender MG, 2005, CALCIFIED TISSUE INT, V77, P291, DOI 10.1007/s00223-005-0043-6; Okada S, 2002, MICROSC MICROANAL, V8, P104, DOI 10.1017/S1431927601020037; Okata H, 2015, ORAL DIS, V21, P74, DOI 10.1111/odi.12212; Poundarik AA, 2012, P NATL ACAD SCI USA, V109, P19178, DOI 10.1073/pnas.1201513109; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Qiu SJ, 2003, J BONE MINER RES, V18, P1657, DOI 10.1359/jbmr.2003.18.9.1657; Ren Y, 2014, CONNECT TISSUE RES, V55, P129, DOI 10.3109/03008207.2014.923879; Sadat-Ali M, 2008, EUR SPINE J, V17, P944, DOI 10.1007/s00586-008-0671-4; SASAKI T, 1987, J DENT RES, V66, P778, DOI 10.1177/00220345870660031501; Stokes IAF, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-16; Suh KT, 2007, EUR SPINE J, V16, P1563, DOI 10.1007/s00586-007-0390-2; Swaminathan R, 2001, CLIN CHIM ACTA, V313, P95, DOI 10.1016/S0009-8981(01)00656-8; Tam EMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087939; Tanabe H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202165; Tanabe H, 2017, EUR SPINE J, V26, P1600, DOI 10.1007/s00586-017-4974-1; Tate MLK, 2004, INT J BIOCHEM CELL B, V36, P1, DOI 10.1016/S1357-2725(03)00241-3; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; THOMAS KA, 1992, J PEDIATR ORTHOPED, V12, P235, DOI 10.1097/01241398-199203000-00016; Tzaphlidou M, 2005, APPL RADIAT ISOTOPES, V62, P569, DOI 10.1016/j.apradiso.2004.10.003; van Coeverden SCCM, 2002, CLIN ENDOCRINOL, V57, P107, DOI 10.1046/j.1365-2265.2002.01573.x; van Oers RFM, 2015, CURR OSTEOPOROS REP, V13, P61, DOI 10.1007/s11914-015-0256-1; van Rhijn LW, 2001, ACTA ORTHOP SCAND, V72, P621, DOI 10.1080/000164701317269058; Wang ZW, 2017, EUR SPINE J, V26, P1586, DOI 10.1007/s00586-016-4422-7; Wang ZW, 2017, SCI REP-UK, V7, DOI 10.1038/srep40265; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Yip BHK, 2016, SCI REP-UK, V6, DOI 10.1038/srep39220; Yu WS, 2014, BONE, V61, P109, DOI 10.1016/j.bone.2013.12.033; Zhang JJ, 2018, FASEB J, V32, P6537, DOI 10.1096/fj.201800281	61	7	7	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13882	13892		10.1096/fj.201901227R	http://dx.doi.org/10.1096/fj.201901227R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31626573	hybrid, Green Published			2022-12-28	WOS:000507466100064
J	Jouvene, CC; Shay, AE; Soens, MA; Norris, PC; Haeggstrom, JZ; Serhan, CN				Jouvene, Charlotte C.; Shay, Ashley E.; Soens, Mieke A.; Norris, Paul C.; Haeggstrom, Jesper Z.; Serhan, Charles N.			Biosynthetic metabolomes of cysteinyl-containing immunoresolvents	FASEB JOURNAL			English	Article						maresin; protectin; resolvin; resolution; inflammation	PRO-RESOLVING MEDIATORS; TISSUE-REGENERATIVE RESOLVIN; FATTY-ACID SUPPLEMENTATION; GLUTATHIONE-S-TRANSFERASE; LIPID MEDIATORS; DOUBLE-BLIND; RESOLUTION; D1; INFLAMMATION; N-3	Resolution of inflammation is an active process regulated by specialized proresolving mediators where we identified 3 new pathways producing allylic epoxide derived mediators that stimulate regeneration [i.e., peptido-conjugates in tissue regeneration (CTRs)]. Here, using self-limited Escherichia coli peritonitis in mice, we identified endogenous maresin (MaR) CTR (MCTR), protectin (PD) CTR (PCTR), and resolvin CTR in infectious peritoneal exudates and distal spleens, as well as investigated enzymes involved in their biosynthesis. PCTRs were identified to be temporally regulated in peritoneal exudates and spleens. PCTR1 and MCTR1 were each produced by human recombinant leukotriene (LT) C-4 synthase (LTC4S) and glutathione S-transferases (GSTs) [microsomal GST (mGST)2, mGST3, and GST-mu(GSTM)4] from their epoxide precursors [16S,17S-epoxy-PD (ePD) and 13S,14-Sepoxy-MaR (eMaR)1, with preference for GSTM4. Both eMaR and ePD inhibited LTB4 production by LTA(4) hydrolase. LTC4S, mGST2, mGST3, and GSTM4 were each expressed in human M1- and M2-like macrophages where LTC4S inhibition increased CTRs. Finally, PCTR1 showed potent analgesic action. These results demonstrate CTR biosynthesis in mouse peritonitis, human spleens, and human macrophages, as well as identification of key enzymes in these pathways. Moreover, targeting LTC4S increases CTR metabolomes, giving a new strategy to stimulate resolution and tissue regeneration.	[Jouvene, Charlotte C.; Shay, Ashley E.; Soens, Mieke A.; Norris, Paul C.; Serhan, Charles N.] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 60 Fenwood Rd,HBTM 3-016, Boston, MA 02115 USA; [Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Karolinska Institutet	Serhan, CN (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 60 Fenwood Rd,HBTM 3-016, Boston, MA 02115 USA.	cserhan@bwh.harvard.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [P01GM095467, 3T32GM007592-40S1]; Swedish Research Council [10350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Mary Halm Small (Brigham and Women's Hospital) for expert assistance in manuscript preparation. This work was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants P01GM095467 (to C.N.S.) and 3T32GM007592-40S1 (to M.A.S.), and Swedish Research Council Grant 10350 (to J.Z.H.). The authors declare no conflicts of interest.	Ahmad S, 2013, BIOCHEMISTRY-US, V52, P1755, DOI 10.1021/bi3014104; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Bang SS, 2018, J CLIN INVEST, V128, P3568, DOI 10.1172/JCI99888; Barden AE, 2016, PROSTAG LEUKOTR ESS, V107, P24, DOI 10.1016/j.plefa.2016.03.004; Bhatt L, 2017, SEMIN IMMUNOL, V33, P65, DOI 10.1016/j.smim.2017.08.007; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Chang M, 1987, Arch Biochem Biophys, V259, P536, DOI 10.1016/0003-9861(87)90520-0; Chen G, 2018, NEURON, V100, P1292, DOI 10.1016/j.neuron.2018.11.009; Chiang N, 2017, MOL ASPECTS MED, V58, P114, DOI 10.1016/j.mam.2017.03.005; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; COMSTOCK KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P487, DOI 10.1006/abbi.1994.1266; Cox R, 2015, AM J RESP CELL MOL, V53, P422, DOI 10.1165/rcmb.2014-0339OC; Dalli J, 2016, P NATL ACAD SCI USA, V113, P12232, DOI 10.1073/pnas.1607003113; Dalli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149319; Dalli J, 2015, FASEB J, V29, P2120, DOI 10.1096/fj.14-268441; Dalli J, 2014, P NATL ACAD SCI USA, V111, pE4753, DOI 10.1073/pnas.1415006111; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dantes RB, 2018, CLIN INFECT DIS, V67, P1300, DOI 10.1093/cid/ciy342; de la Rosa X, 2018, AM J PATHOL, V188, P950, DOI 10.1016/j.ajpath.2018.01.004; DOHERTY NS, 1987, BRIT J PHARMACOL, V91, P39, DOI 10.1111/j.1476-5381.1987.tb08981.x; Duffney PF, 2018, J CLIN INVEST, V128, P2724, DOI 10.1172/JCI97951; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Gilbert K, 2014, MAR DRUGS, V12, P5396, DOI 10.3390/md12115396; Haeggstrom JZ, 2018, J CLIN INVEST, V128, P2680, DOI 10.1172/JCI97945; Hellmann J, 2018, J INVEST DERMATOL, V138, P2051, DOI 10.1016/j.jid.2018.03.1498; Hong S, 2005, PROSTAG OTH LIPID M, V78, P107, DOI 10.1016/j.prostaglandins.2005.04.004; Hsiao HM, 2014, J IMMUNOL, V193, P4980, DOI 10.4049/jimmunol.1400313; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Keelan JA, 2015, REPRODUCTION, V149, P171, DOI 10.1530/REP-14-0549; Kim N, 2016, EUR J IMMUNOL, V46, P81, DOI 10.1002/eji.201545673; Kleinschmidt TK, 2015, J PHARMACOL EXP THER, V355, P108, DOI 10.1124/jpet.115.227157; Lee CR, 2015, NEW ENGL J MED, V373, P2183, DOI 10.1056/NEJMcibr1511280; Lima-Garcia JF, 2011, BRIT J PHARMACOL, V164, P278, DOI 10.1111/j.1476-5381.2011.01345.x; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Mueller MJ, 1998, J BIOL CHEM, V273, P11570, DOI 10.1074/jbc.273.19.11570; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Niegowski D, 2014, J BIOL CHEM, V289, P5199, DOI 10.1074/jbc.M113.534628; Norris PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36679-4; Ono E, 2014, AM J RESP CRIT CARE, V190, P886, DOI 10.1164/rccm.201403-0544OC; Perretti M, 2015, TRENDS PHARMACOL SCI, V36, P737, DOI 10.1016/j.tips.2015.07.007; Prieto P, 2015, AUTOPHAGY, V11, P1729, DOI 10.1080/15548627.2015.1078958; Raatz SK, 2011, J AGR FOOD CHEM, V59, P11278, DOI 10.1021/jf202576k; Ramon S, 2016, AM J PATHOL, V186, P962, DOI 10.1016/j.ajpath.2015.12.012; Ramsden CE, 2013, PAIN, V154, P2441, DOI 10.1016/j.pain.2013.07.028; Rao NL, 2007, J PHARMACOL EXP THER, V321, P1154, DOI 10.1124/jpet.106.115436; Rathod KS, 2017, J CLIN INVEST, V127, P169, DOI 10.1172/JCI89429; Robinson DT, 2017, PROSTAG LEUKOTR ESS, V121, P1, DOI 10.1016/j.plefa.2017.05.003; Rodriguez AR, 2017, TETRAHEDRON LETT, V58, P1662, DOI 10.1016/j.tetlet.2017.03.041; Rodriguez AR, 2015, TETRAHEDRON LETT, V56, P5811, DOI 10.1016/j.tetlet.2015.09.020; Rossi S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/149381; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sasaki A, 2015, ANAL BIOANAL CHEM, V407, P1625, DOI 10.1007/s00216-014-8412-5; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; See VHL, 2017, PROSTAG LEUKOTR ESS, V126, P126, DOI 10.1016/j.plefa.2017.08.008; See VHL, 2017, BRIT J NUTR, V118, P971, DOI [10.1017/S0007114517002914, 10.1017/s0007114517002914]; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Ward P. A, 2010, FUNDAMENTALS INFLAMM, P1; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Xu ZZ, 2013, ANN NEUROL, V74, P490, DOI 10.1002/ana.23928	67	9	10	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13794	13807		10.1096/fj.201902003R	http://dx.doi.org/10.1096/fj.201902003R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31589826	Green Published, Bronze			2022-12-28	WOS:000507466100058
J	Kovalcikova, J; Vrbacky, M; Pecina, P; Tauchmannova, K; Nuskova, H; Kaplanova, V; Brazdova, A; Alan, L; Elias, J; Cunatova, K; Korinek, V; Sedlacek, R; Mracek, T; Houstek, J				Kovalcikova, Jana; Vrbacky, Marek; Pecina, Petr; Tauchmannova, Katerina; Nuskova, Hana; Kaplanova, Vilma; Brazdova, Andrea; Alan, Lukas; Elias, Jan; Cunatova, Kristyna; Korinek, Vladimir; Sedlacek, Radislav; Mracek, Tomas; Houstek, Josef			TMEM70 facilitates biogenesis of mammalian ATP synthase by promoting subunit c incorporation into the rotor structure of the enzyme	FASEB JOURNAL			English	Article						mouse knockout; mitochondria; ancillary factor; ATP5G assembly	F1FO-ATP SYNTHASE; INNER-MEMBRANE; NUCLEAR GENE; MITOCHONDRIAL; DEFICIENCY; PROTEIN; OXA1; SEQUENCE; MUTATION; OXIDASE	Biogenesis of F1F0 ATP synthase, the key enzyme of mitochondrial energy provision, depends on transmembrane protein 70 (TMEM70), localized in the inner mitochondrial membrane of higher eukaryotes. TMEM70 absence causes severe ATP-synthase deficiency and leads to a neonatal mitochondrial encephalocardiomyopathy in humans. However, the exact biochemical function of TMEM70 remains unknown. Using TMEM70 conditional knockout in mice, we show that absence of TMEM70 impairs the early stage of enzyme biogenesis by preventing incorporation of hydrophobic subunit c into rotor structure of the enzyme. This results in the formation of an incomplete, pathologic enzyme complex consisting of F-1 domain and peripheral stalk but lacking F-o proton channel composed of subunits c and a. We demonstrated direct interaction between TMEM70 and subunit c and showed that overexpression of subunit c in TMEM70(-/-) cells partially rescued TMEM70 defect. Accordingly, TMEM70 knockdown prevented subunit c accumulation otherwise observed in F-1-deficient cells. Altogether, we identified TMEM70 as specific ancillary factor for subunit c. The biologic role of TMEM70 is to increase the low efficacy of spontaneous assembly of subunit c oligomer, the key and rate-limiting step of ATP-synthase biogenesis, and thus to reach an adequately high physiologic level of ATP synthase in mammalian tissues.	[Kovalcikova, Jana; Vrbacky, Marek; Pecina, Petr; Tauchmannova, Katerina; Nuskova, Hana; Kaplanova, Vilma; Brazdova, Andrea; Alan, Lukas; Elias, Jan; Cunatova, Kristyna; Mracek, Tomas; Houstek, Josef] Czech Acad Sci, Inst Physiol, Dept Bioenerget, Videnska 1083, Prague 14220, Czech Republic; [Korinek, Vladimir] Czech Acad Sci, Inst Mol Genet, Lab Cell & Dev Biol, Prague, Czech Republic; [Sedlacek, Radislav] Czech Acad Sci, Inst Mol Genet, Prague, Czech Republic; [Sedlacek, Radislav] Czech Acad Sci, Lab Transgen Models Dis, Prague, Czech Republic; [Sedlacek, Radislav] Czech Acad Sci, Czech Ctr Phenogen, Prague, Czech Republic; [Kovalcikova, Jana; Brazdova, Andrea] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Nuskova, Hana] German Canc Res Ctr, Heidelberg, Germany	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Helmholtz Association; German Cancer Research Center (DKFZ)	Mracek, T; Houstek, J (corresponding author), Czech Acad Sci, Inst Physiol, Dept Bioenerget, Videnska 1083, Prague 14220, Czech Republic.	tomas.mracek@fgu.cas.cz; houstek@biomed.cas.cz	Mikesova, Jana/C-7301-2014; Vrbacky, Marek/A-1044-2010; Cunatova, Kristyna/AAF-8462-2021; Nuskova, Hana/A-4059-2010; Mracek, Tomas/C-5003-2012; Tauchmannova, Katerina/G-1023-2014; Korinek, Vladimir/G-6348-2014; Pecina, Petr/A-9396-2010; Houstek, Josef/C-5019-2012; Alán, Lukáš/H-9063-2013	Vrbacky, Marek/0000-0001-7218-8370; Cunatova, Kristyna/0000-0001-9993-2040; Nuskova, Hana/0000-0002-5562-9207; Mracek, Tomas/0000-0002-9492-0718; Tauchmannova, Katerina/0000-0002-3745-8790; Korinek, Vladimir/0000-0002-9777-4664; Pecina, Petr/0000-0003-0641-2834; Houstek, Josef/0000-0002-8413-4772; Alán, Lukáš/0000-0001-7417-2620; Brazdova, Andrea/0000-0002-2384-6012; Mikesova, Jana/0000-0001-6715-6614	Grant Agency of the Czech Republic [14-36804G]; Grant Agency for Medical Research [16-33018A]; Czech Academy of Sciences [RVO: 67985823]; Ministry of Education, Youth, and Sports [LM2015040, CZ.1.05/2.1.00/19.0395, CZ.1.05/1.1.00/02.0109]; European Regional Development Fund (ERDF) [LM2015040, CZ.1.05/2.1.00/19.0395, CZ.1.05/1.1.00/02.0109]; OP VaVpI [CZ.1.05/1.1.00/02.0109]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency for Medical Research; Czech Academy of Sciences(Czech Academy of Sciences); Ministry of Education, Youth, and Sports(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund (ERDF)(European Commission); OP VaVpI	This work was supported by the Grant Agency of the Czech Republic (14-36804G) and the Grant Agency for Medical Research (16-33018A). Institutional support (Institute of Physiology) was provided by the Czech Academy of Sciences (RVO: 67985823). This project utilized Czech Centre for Phenogenomics infrastructure (supported by the Ministry of Education, Youth, and Sports and European Regional Development Fund (ERDF) Grants LM2015040, OP VaVpI CZ.1.05/2.1.00/19.0395, and CZ.1.05/1.1.00/02.0109) for generation of transmembrane protein 70deficient mice, and the Proteomic Core Facility [Biotechnology and Biomedicine Center of the Czech Academy of Sciences (BIOCEV), Faculty of Science, Charles University in Prague (supported by OP VaVpI CZ.1.05/1.1.00/02.0109)] for the mass spectrometric measurements. The authors declare no conflicts of interest.	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Angerer Heike, 2015, Biology-Basel, V4, P133, DOI 10.3390/biology4010133; Arechaga I, 2002, FEBS LETT, V515, P189, DOI 10.1016/S0014-5793(02)02447-X; BARACCA A, 1989, BIOCHIM BIOPHYS ACTA, V976, P77, DOI 10.1016/S0005-2728(89)80191-4; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cameron JM, 2011, MITOCHONDRION, V11, P191, DOI 10.1016/j.mito.2010.09.008; Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Dubot A, 2004, BIOCHEM BIOPH RES CO, V313, P687, DOI 10.1016/j.bbrc.2003.12.013; DYER MR, 1993, BIOCHEM J, V293, P51, DOI 10.1042/bj2930051; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Hartmannova H, 2016, HUM MOL GENET, V25, P4062, DOI 10.1093/hmg/ddw245; Havlickova V, 2010, BBA-BIOENERGETICS, V1797, P1124, DOI 10.1016/j.bbabio.2009.12.009; He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hejzlarova K, 2015, BIOCHEM J, V466, P601, DOI 10.1042/BJ20141462; Hejzlarova K, 2011, BBA-BIOENERGETICS, V1807, P144, DOI 10.1016/j.bbabio.2010.10.005; Honzik T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096; Houstek J, 1999, HUM MOL GENET, V8, P1967; HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A; Houstek J, 2009, BBA-BIOENERGETICS, V1787, P529, DOI 10.1016/j.bbabio.2008.11.013; Jagr M, 2012, EUR J ORAL SCI, V120, P259, DOI 10.1111/j.1600-0722.2012.00977.x; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Karbanova VH, 2012, BBA-BIOENERGETICS, V1817, P1037, DOI 10.1016/j.bbabio.2012.03.004; Kolli R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020641; Kratochvilova H, 2014, MITOCHONDRION, V15, P1, DOI 10.1016/j.mito.2014.02.010; Li Y, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005653; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; MORADIAMELI M, 1983, P NATL ACAD SCI-BIOL, V80, P6167, DOI 10.1073/pnas.80.20.6167; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; Pecina P, 2012, BBA-BIOENERGETICS, V1817, pS20, DOI 10.1016/j.bbabio.2012.06.065; Pecina P, 2018, BBA-BIOENERGETICS, V1859, P374, DOI 10.1016/j.bbabio.2018.02.007; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; ROJO EE, 1995, EMBO J, V14, P3445, DOI 10.1002/j.1460-2075.1995.tb07350.x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Su CH, 2014, J BIOL CHEM, V289, P31605, DOI 10.1074/jbc.M114.602706; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Thompson K, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809060; Torraco Alessandra, 2012, Neurogenetics, V13, P375, DOI 10.1007/s10048-012-0343-8; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Vrbacky M, 2016, HUM MOL GENET, V25, P4674, DOI 10.1093/hmg/ddw295; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Williams EG, 2018, MOL CELL PROTEOMICS, V17, P1766, DOI 10.1074/mcp.RA118.000554; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021; Wittig I, 2009, PROTEOMICS, V9, P5214, DOI 10.1002/pmic.200900151; Woellhaf MW, 2016, MOL BIOL CELL, V27, P3031, DOI 10.1091/mbc.E16-07-0513; YAN WL, 1994, GENOMICS, V24, P375, DOI 10.1006/geno.1994.1631; Yumen I, 2012, PROTEIN EXPRES PURIF, V82, P396, DOI 10.1016/j.pep.2012.02.005; Zeng XM, 2008, MOL BIOL CELL, V19, P1366, DOI 10.1091/mbc.E07-08-0746	62	12	12	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14103	14117		10.1096/fj.201900685RR	http://dx.doi.org/10.1096/fj.201900685RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31652072				2022-12-28	WOS:000507466100080
J	Poganik, JR; Long, MJC; Disare, MT; Liu, XY; Chang, SH; Hla, T; Aye, Y				Poganik, Jesse R.; Long, Marcus J. C.; Disare, Michael T.; Liu, Xuyu; Chang, Sung-Hee; Hla, Timothy; Aye, Yimon			Post-transcriptional regulation of Nrf2-mRNA by the mRNA-binding proteins HuR and AUF1	FASEB JOURNAL			English	Article						antioxidant response; zebrafish; mRNA-stabilization; mRNA-maturation; mRNA-trafficking	RECOGNITION MOTIFS; NRF2; IDENTIFICATION; EXPRESSION; NUCLEAR; PATHWAY; REDOX; STABILIZATION; MECHANISMS; STRESS	The nuclear factor erythroid 2 related factor 2 (Nrf2) signaling axis is a target of covalent drugs and bioactive native electrophiles. However, much of our understanding of Nrf2 regulation has been focused at the protein level. Here we report a post-transcriptional modality to directly regulate Nrf2-mRNA. Our initial studies focused on the effects of the key mRNA-binding protein (mRBP) HuR on global transcriptomic changes incurred upon oxidant or electrophile stimulation. These RNA-sequencing data and subsequent mechanistic analyses led us to discover a novel role of HuR in regulating Nrf2 activity, and in the process, we further identified the related mRBP AUF1 as an additional novel Nrf2 regulator. Both mRBPs regulate Nrf2 activity by direct interaction with the Nrf2 transcript. Our data showed that HuR enhances Nrf2-mRNA maturation and promotes its nuclear export, whereas AUF1 stabilizes Nrf2-mRNA. Both mRBPs target the 3'-UTR of Nrf2-mRNA. Using a Nrf2 activity-reporter zebrafish strain, we document that this post-transcriptional control of Nrf2 activity is conserved at the whole-vertebrate level.	[Poganik, Jesse R.; Liu, Xuyu; Aye, Yimon] Swiss Fed Inst Technol Lausanne EPFL, Stn 6, CH-1015 Lausanne, Switzerland; [Poganik, Jesse R.; Long, Marcus J. C.; Disare, Michael T.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Chang, Sung-Hee] Weill Cornell Med, Dept Med, New York, NY USA; [Hla, Timothy] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA; [Hla, Timothy] Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Long, Marcus J. C.] Univ Geneva, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; Cornell University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Geneva	Aye, Y (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, Stn 6, CH-1015 Lausanne, Switzerland.	yimon.aye@epfl.ch	Liu, Xuyu/AAV-8725-2021; Poganik, Jesse R./AAP-3784-2021; Hla, Timothy/G-5873-2012	Liu, Xuyu/0000-0003-4096-3090; Long, marcus/0000-0002-0343-9671; Hla, Timothy/0000-0001-8355-4065; Poganik, Jesse/0000-0003-3098-8550	American Heart Association predoctoral fellowship [17PRE33670395]; Swiss National Science Foundation (SNSF); Swiss Federal Institute of Technology Lausanne (EPFL); Novartis Medical-Biological Research Foundation; National Centre of Competence in Research Chemical Biology (NCCR) Chemical Biology; U.S. National Institutes of Health (NIH) [1DP2GM114850]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, T32GM008720] Funding Source: NIH RePORTER	American Heart Association predoctoral fellowship(American Heart Association); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Federal Institute of Technology Lausanne (EPFL); Novartis Medical-Biological Research Foundation; National Centre of Competence in Research Chemical Biology (NCCR) Chemical Biology(Swiss National Science Foundation (SNSF)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Jen Grenier [Cornell RNA Sequencing Core (RSC) Cornell University] for assistance with RNA sequencing. The authors also thank Alexandra Van Hall Beauvais and Gene Hu (Cornell University) for assistance with initial studies of HuR. The following organizations have supported this study: American Heart Association predoctoral fellowship (17PRE33670395 to J.R.P.); Swiss National Science Foundation (SNSF); Swiss Federal Institute of Technology Lausanne (EPFL); Novartis Medical-Biological Research Foundation; National Centre of Competence in Research Chemical Biology (NCCR) Chemical Biology; and U.S. National Institutes of Health (NIH) Director's New Innovator (Office of the Director, 1DP2GM114850 to Y.A.). The authors declare no conflicts of interest.	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Aluise CD, 2013, CHEM RES TOXICOL, V26, P270, DOI 10.1021/tx300449g; Barker A, 2012, J BIOCHEM, V151, P423, DOI 10.1093/jb/mvs010; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chang N, 2010, MOL CELL BIOL, V30, P3875, DOI 10.1128/MCB.00169-10; Chang SH, 2014, P NATL ACAD SCI USA, V111, P18309, DOI 10.1073/pnas.1412172111; Chang SH, 2011, TRENDS MOL MED, V17, P650, DOI 10.1016/j.molmed.2011.06.008; Cheng XH, 2013, FREE RADICAL BIO MED, V64, P4, DOI 10.1016/j.freeradbiomed.2013.07.025; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cok SJ, 2004, J BIOL CHEM, V279, P8196, DOI 10.1074/jbc.M308475200; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Cuadrado A, 2019, NAT REV DRUG DISCOV, V18, P295, DOI 10.1038/s41573-018-0008-x; DeMaria CT, 1997, J BIOL CHEM, V272, P27635, DOI 10.1074/jbc.272.44.27635; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Huang Y, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-40; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Jacobs AT, 2010, ACCOUNTS CHEM RES, V43, P673, DOI 10.1021/ar900286y; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau A, 2013, ANTIOXID REDOX SIGN, V18, P91, DOI 10.1089/ars.2012.4754; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Li X, 2014, BLOOD, V123, P1384, DOI 10.1182/blood-2013-09-526962; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Long MJ, 2017, CELL CHEM BIOL, V24, P944, DOI 10.1016/j.chembiol.2017.06.009; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mehta M, 2016, ONCOTARGET, V7, P64820, DOI 10.18632/oncotarget.11706; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Moore MJ, 2002, CELL, V108, P431, DOI 10.1016/S0092-8674(02)00645-1; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Muralidharan R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07787-4; Nioi P, 2007, BIOCHEM BIOPH RES CO, V362, P816, DOI 10.1016/j.bbrc.2007.08.051; Panda AC, 2014, MOL CELL BIOL, V34, P3106, DOI 10.1128/MCB.00423-14; Parvez S, 2018, CHEM REV, V118, P8798, DOI 10.1021/acs.chemrev.7b00698; Parvez S, 2016, NAT PROTOC, V11, P2328, DOI 10.1038/nprot.2016.114; Parvez S, 2015, J AM CHEM SOC, V137, P10, DOI 10.1021/ja5084249; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Sorrells S, 2013, JOVE-J VIS EXP, DOI 10.3791/51060; Spitzer J, 2014, METHOD ENZYMOL, V539, P113, DOI 10.1016/B978-0-12-420120-0.00008-6; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Strobel EJ, 2016, CURR OPIN BIOTECH, V39, P182, DOI 10.1016/j.copbio.2016.03.019; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tsujita T, 2011, GENES CELLS, V16, P46, DOI 10.1111/j.1365-2443.2010.01466.x; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Wang T, 2015, NUCLEIC ACIDS RES, V43, P5263, DOI 10.1093/nar/gkv439; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; Wang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138780; Wu XQ, 2015, ACS CHEM BIOL, V10, P1476, DOI 10.1021/cb500851u; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Yoon JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6248	71	22	22	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14636	14652		10.1096/fj.201901930R	http://dx.doi.org/10.1096/fj.201901930R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31665914	Green Published, Green Submitted			2022-12-28	WOS:000507466100121
J	Zhang, L; Wang, RY; Bai, T; Xiang, XL; Qian, W; Song, J; Hou, XH				Zhang, Lei; Wang, Ruiyun; Bai, Tao; Xiang, Xuelian; Qian, Wei; Song, Jun; Hou, Xiaohua			EphrinB2/ephB2-mediated myenteric synaptic plasticity: mechanisms underlying the persistent muscle hypercontractility and pain in postinfectious IBS	FASEB JOURNAL			English	Article						enteric nervous system; irritable bowel syndrome; pain processing; smooth muscle	IRRITABLE-BOWEL-SYNDROME; ENTERIC NERVOUS-SYSTEM; COLONIC MOTILITY; VISCERAL HYPERSENSITIVITY; STRUCTURAL PLASTICITY; F-ACTIN; MODULATION; ACTIVATION; KINASES; NEURONS	Patients with irritable bowel syndrome (IBS) show pain hypersensitivity and smooth muscle hypercontractility in response to colorectal distension (CRD). Synaptic plasticity, a key process of memory formation, in the enteric nervous system may be a novel explanation. This study aimed to explore the regulatory role of ephrinB2/ephB2 in enteric synaptic plasticity and colonic hyperreactive motility in IBS. Postinfectious (PI)-IBS was induced by Trichinella spiralis infection in rats. Isometric contractions of colonic circular muscle strips, particularly neural-mediated contractions, were recorded ex vivo. Meanwhile, ephrinB2/ephB2-mediated enteric structural and functional synaptic plasticity were assessed in the colonic muscularis, indicating that ephrinB2 and ephB2 were located on enteric nerves and up-regulated in the colonic muscularis of PI-IBS rats. Colonic hypersensitivity to CRD and neural-mediated colonic hypercontractility were present in PI-IBS rats, which were correlated with increased levels of cellular homologous fos protein (c-fos) and activity-regulated cystoskeleton-associated protein (arc), the synaptic plasticity related immediate early genes, and were ameliorated by ephB2Fc (an ephB2 receptor blocker) or MK801 (an NMDA receptor inhibitor) exposure. EphrinB2/ephB2 facilitated synaptic sprouting and NMDA receptor mediated synaptic potentiation in the colonic muscularis of PI-IBS rats and in the longitudinal muscle-myenteric plexus cultures, involving the Erk-MAPK and PI3K protein kinase B pathways. In conclusion, ephrinB2/ephB2 promoted the synaptic sprouting and potentiation of myenteric nerves involved in persistent muscle hypercontractility and pain in PI-IBS. Hence, ephrinB2/ephB2 may be an emerging target for the treatment of IBS.	[Zhang, Lei; Bai, Tao; Xiang, Xuelian; Qian, Wei; Song, Jun; Hou, Xiaohua] Huazhong Univ Sci & Technol, Div Gastroenterol, Union Hosp, Tongji Med Coll, 1277 Jiefang Rd, Wuhan 430022, Peoples R China; [Wang, Ruiyun] Huazhong Univ Sci & Technol, Dept Gerontol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Song, J; Hou, XH (corresponding author), Huazhong Univ Sci & Technol, Div Gastroenterol, Union Hosp, Tongji Med Coll, 1277 Jiefang Rd, Wuhan 430022, Peoples R China.	song111jun@126.com; houxh@hust.edu.cn	Bai, Tao/ABD-7952-2020		National Natural Science Foundation of China (NSFC) [81570486, 81720108006, 81800463, 81300283]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (NSFC; 81570486, 81720108006, 81800463, and 81300283). L.Z. and R.W. contributed equally to this study. The authors declare no conflicts of interest.	Akiho H, 2005, GASTROENTEROLOGY, V129, P131, DOI 10.1053/j.gastro.2005.03.049; Annahazi A, 2014, WORLD J GASTROENTERO, V20, P6031, DOI 10.3748/wjg.v20.i20.6031; Bustos FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094037; Cao JL, 2008, PAIN, V139, P617, DOI 10.1016/j.pain.2008.06.023; Carmichael RE, 2018, SEMIN CELL DEV BIOL, V77, P3, DOI 10.1016/j.semcdb.2017.09.007; Chen L, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13301; Chey WY, 2001, AM J GASTROENTEROL, V96, P1499; Di Lorenzo F, 2019, BRAIN STIMUL, V12, P148, DOI 10.1016/j.brs.2018.10.009; Di Stefano M, 2006, GUT, V55, P1409, DOI 10.1136/gut.2005.076323; Dothel G, 2015, GASTROENTEROLOGY, V148, P1002, DOI 10.1053/j.gastro.2015.01.042; Elibol-Can B, 2014, INT J DEV NEUROSCI, V33, P106, DOI 10.1016/j.ijdevneu.2013.12.003; Fujikawa Y, 2015, NEUROGASTROENT MOTIL, V27, P1010, DOI 10.1111/nmo.12577; Fukudo S, 2002, J GASTROENTEROL, V37, P145, DOI 10.1007/BF03326434; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Giaroni C, 2003, EUR J PHARMACOL, V476, P63, DOI 10.1016/S0014-2999(03)02147-2; Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039; Haddad JJ, 2005, PROG NEUROBIOL, V77, P252, DOI 10.1016/j.pneurobio.2005.10.008; Juan WS, 2014, J PINEAL RES, V56, P213, DOI 10.1111/jpi.12114; Kanazawa M, 2014, NEUROGASTROENT MOTIL, V26, P696, DOI 10.1111/nmo.12318; Kanazawa M, 2008, AM J GASTROENTEROL, V103, P2550, DOI 10.1111/j.1572-0241.2008.02066.x; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Klein R, 2014, CURR OPIN NEUROBIOL, V27, P16, DOI 10.1016/j.conb.2014.02.006; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Krauter EM, 2007, J PHYSIOL-LONDON, V581, P787, DOI 10.1113/jphysiol.2007.128082; Lai HH, 2011, PAIN, V152, P2117, DOI 10.1016/j.pain.2011.05.017; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Mazet B, 2015, PFLUG ARCH EUR J PHY, V467, P191, DOI 10.1007/s00424-014-1635-7; Miampamba M, 2007, NEUROREPORT, V18, P679, DOI 10.1097/WNR.0b013e3280bef7f8; Newpher TM, 2018, SEMIN CELL DEV BIOL, V77, P25, DOI 10.1016/j.semcdb.2017.09.022; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Planaguma J, 2016, ANN NEUROL, V80, P388, DOI 10.1002/ana.24721; Posserud I, 2007, GASTROENTEROLOGY, V133, P1113, DOI 10.1053/j.gastro.2007.07.024; Quigley EMM, 2016, J CLIN GASTROENTEROL, V50, P704, DOI 10.1097/MCG.0000000000000653; Ruan JP, 2010, ANESTHESIOLOGY, V112, P1234, DOI 10.1097/ALN.0b013e3181d3e0df; Rychter J, 2014, THER ADV GASTROENTER, V7, P156, DOI 10.1177/1756283X14525250; Sheffler-Collins SI, 2012, TRENDS NEUROSCI, V35, P293, DOI 10.1016/j.tins.2012.03.003; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Shin OH, 2014, COMPR PHYSIOL, V4, P149, DOI 10.1002/cphy.c130021; Slack S, 2008, NEUROSCIENCE, V156, P175, DOI 10.1016/j.neuroscience.2008.07.023; Smith TH, 2013, JOVE-J VIS EXP, DOI 10.3791/50688; Song J, 2015, J NEUROGASTROENTEROL, V21, P236, DOI 10.5056/jnm14095; Song XJ, 2008, PAIN, V139, P168, DOI 10.1016/j.pain.2008.03.019; Thomas Hugh, 2016, Nat Rev Gastroenterol Hepatol, V13, P436, DOI 10.1038/nrgastro.2016.103; Tong JF, 2003, J BIOL CHEM, V278, P6111, DOI 10.1074/jbc.M208972200; Tsang SW, 2012, EUR J PAIN, V16, P463, DOI 10.1016/j.ejpain.2011.07.005; Vasileiou I, 2013, EXPERT OPIN THER TAR, V17, P879, DOI 10.1517/14728222.2013.801456; Vork L, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13189; Yang XJ, 2009, DIGEST DIS SCI, V54, P937, DOI 10.1007/s10620-008-0444-2; Yu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040930; Zhang L, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13430; Zhang L, 2016, EUR J PHARMACOL, V780, P180, DOI 10.1016/j.ejphar.2016.03.047; Zhao J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-77; Zhou QQ, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-3; Zhou QQ, 2010, PAIN, V148, P454, DOI 10.1016/j.pain.2009.12.005; Zhou XL, 2015, NEUROSCIENCE, V307, P64, DOI 10.1016/j.neuroscience.2015.08.048	56	11	13	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13644	13659		10.1096/fj.201901192R	http://dx.doi.org/10.1096/fj.201901192R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31601124	Bronze			2022-12-28	WOS:000507466100047
J	Kim, YY; Um, JH; Yoon, JH; Lee, DY; Lee, YJ; Kim, DH; Park, JI; Yun, J				Kim, Young Yeon; Um, Jee-Hyun; Yoon, Jeong-Hyun; Lee, Da-Ye; Lee, Yoon Jung; Kim, Dong Hyun; Park, Joo-In; Yun, Jeanho			p53 regulates mitochondrial dynamics by inhibiting Drp1 translocation into mitochondria during cellular senescence	FASEB JOURNAL			English	Article						cellular senescence; Drp1; mitochondria dynamics; p53; PKA; senescence	WILD-TYPE P53; GIANT MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN; PHOSPHORYLATION; FISSION; BIOLOGY; CELLS; MICE	Cellular senescence acts as an important barrier to tumorigenesis by eliminating precancerous cells. Previous studies have shown an essential role of the tumor suppressor p53 in cellular senescence, but how p53 induces cellular senescence is not fully understood. We found that p53 promoted the formation of highly interconnected and elongated mitochondria prior to the onset of cellular senescence. The inhibition of mitochondrial elongation upon p53 expression suppressed cellular senescence, suggesting that mitochondrial elongation is required for the induction of p53-dependent senescence. p53-induced mitochondrial elongation resulted in mitochondrial dysfunction and subsequent increases in intracellular reactive oxygen species (ROS) levels, an important mediator of cellular senescence. Mechanistically, the inhibitory phosphorylation of Drp1 Ser637 increased upon p53 expression, suppressing the translocation of Drp1 into mitochondria. The transcriptional function of p53 was crucial for controlling the inhibitory phosphorylation of Drp1, whereas p21 was nonessential. Protein kinase A (PKA) activity was responsible for p53-mediated Drp1 Ser637 phosphorylation and mitochondrial dysfunction. Taken together, these results suggest that p53 regulates mitochondrial dynamics through the PKA-Drp1 pathway to induce cellular senescence.	[Kim, Young Yeon; Um, Jee-Hyun; Yoon, Jeong-Hyun; Lee, Da-Ye; Lee, Yoon Jung; Kim, Dong Hyun; Park, Joo-In; Yun, Jeanho] Dong A Univ, Peripheral Neuropathy Res Ctr, Busan, South Korea; [Kim, Young Yeon; Um, Jee-Hyun; Yoon, Jeong-Hyun; Lee, Da-Ye; Lee, Yoon Jung; Park, Joo-In; Yun, Jeanho] Dong A Univ, Dept Biochem, Coll Med, Busan 49201, South Korea; [Kim, Dong Hyun] Dong A Univ, Dept Med Biotechnol, Coll Hlth Sci, Busan, South Korea	Dong A University; Dong A University; Dong A University	Yun, J (corresponding author), Dong A Univ, Dept Biochem, Coll Med, Busan 49201, South Korea.	yunj@dau.ac.kr		Yun, Jeanho/0000-0001-7700-5123				Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Cheng G, 2018, J BIOL CHEM, V293, P10363, DOI 10.1074/jbc.RA118.003044; COLEMAN R, 1987, GERONTOLOGY, V33, P34, DOI 10.1159/000212851; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Jee HJ, 2010, CELL CYCLE, V9, P4703, DOI 10.4161/cc.9.23.14059; Kaiser AM, 2018, CELL DEATH DIFFER, V25, P93, DOI 10.1038/cdd.2017.171; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kim MA, 2007, EXP MOL MED, V39, P205, DOI 10.1038/emm.2007.23; Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Liu J, 2017, J CELL BIOCHEM, V118, P7, DOI 10.1002/jcb.25609; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; MURAKOSHI M, 1985, Tokai Journal of Experimental and Clinical Medicine, V10, P531; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Palacios G, 2008, CELL CYCLE, V7, P2584, DOI 10.4161/cc.7.16.6070; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pavan B, 2009, DRUG DISCOV TODAY, V14, P982, DOI 10.1016/j.drudis.2009.07.007; Qian Yingjuan, 2013, Methods Mol Biol, V965, P37, DOI 10.1007/978-1-62703-239-1_3; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Roelofs BA, 2015, FREE RADICAL BIO MED, V86, P250, DOI 10.1016/j.freeradbiomed.2015.05.032; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; SATO T, 1975, ACTA PATHOL JAPON, V25, P403; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287	55	20	21	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2451	2464		10.1096/fj.201901747RR	http://dx.doi.org/10.1096/fj.201901747RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908078				2022-12-28	WOS:000514663600036
J	Schroder, A; Aitken, KJ; Jiang, JX; Sidler, M; Tolg, C; Siebenaller, A; Jeffrey, N; Kirwan, T; Leslie, B; Wu, CH; Weksberg, R; Delgado-Olguin, P; Bagli, DJ				Schroder, Annette; Aitken, Karen J.; Jiang, Jia-Xin; Sidler, Martin; Tolg, Cornelia; Siebenaller, Aliza; Jeffrey, Nefateri; Kirwan, Tyler; Leslie, Bruno; Wu, Changhao; Weksberg, Rosanna; Delgado-Olguin, Paul; Bagli, Darius J.			Persistent myopathy despite release of partial obstruction: in vivo reversal of dysfunction and transcriptional responses using rapamycin	FASEB JOURNAL			English	Article						bladder obstruction; core clock genes; drug therapy; rapamycin; smooth muscle	BLADDER-OUTLET-OBSTRUCTION; MUSCLE-CELL DIFFERENTIATION; URINARY-TRACT SYMPTOMS; BENIGN PROSTATIC HYPERPLASIA; SMOOTH-MUSCLE; EXTRACELLULAR-MATRIX; DETRUSOR; GROWTH; RELIEF; HYPERTROPHY	Current and potential medical therapy for obstruction-induced myopathic bladder dysfunction (from benign prostatic hyperplasia or posterior urethral valves) focuses on symptoms. The persistent tissue pathology and dysfunction after release of obstruction is often deemed irreversible without any systematic therapeutic approaches. As rapamycin can attenuate bladder smooth muscle hypertrophy and dysfunction during the genesis of partial obstruction in vivo, we tested whether rapamycin could improve persistent function after release of obstruction (de-obstruction or REL). Female Sprague-Dawley rat bladders were partially obstructed (PBO) by suturing around both the urethra and a para-urethral steel rod, then removing the rod. One day prior to release of obstruction (preREL), voiding parameters and residual urine volume of preREL+future rapa, preREL+future veh groups were recorded. Release of obstruction (REL) was performed by suture removal following 6 weeks of PBO. For 4 more weeks after the de-obstruction, REL animals were randomized to rapamycin (REL+rapa) or vehicle (REL+veh). PBO for 6 weeks were used as positive controls. In shams, the urethra was exposed, but no suture tied. Voiding parameters and residual urine volume were measured prior to sacrifice of sham and REL+veh or REL+rapa, and PBO. Rapamycin efficacy was tested by pair-wise comparison of changes in individual voiding data from preREL+future veh or preREL+future rapa versus REL+veh or REL+rapa, respectively, as well as by comparisons of REL+veh to REL+rapa groups. Bladders were weighed and processed for a high-throughput QPCR array, and histopathology. Bladder/body mass ratios with PBO increased significantly and remained higher in the release phase in REL+veh animals. REL+rapa versus REL+veh improved residual volumes and micturition fractions toward sham levels. Three genes encoding extracellular proteins, BMP2, SOD3, and IGFBP7, correlated with functional improvement by Pearson's correlations. The promoters of these genes showed enrichment for several motifs including circadian E-boxes. While obstruction and REL augmented CLOCK and NPAS2 expression above sham levels, rapamycin treatment during release significantly blocked their expression. This experimental design of pharmaco-intervention during the de-obstruction phase revealed a novel pathway dysregulated during the clinically relevant treatment phase of obstructive bladder myopathy.	[Schroder, Annette; Sidler, Martin; Leslie, Bruno; Bagli, Darius J.] Hosp Sick Children, Dept Surg, Urol Div, Toronto, ON, Canada; [Schroder, Annette; Aitken, Karen J.; Jiang, Jia-Xin; Sidler, Martin; Tolg, Cornelia; Siebenaller, Aliza; Jeffrey, Nefateri; Kirwan, Tyler; Leslie, Bruno; Bagli, Darius J.] Hosp Sick Children, Dev & Stem Cell Biol Res Inst, Toronto, ON, Canada; [Jiang, Jia-Xin; Bagli, Darius J.] Univ Toronto, Dept Physiol, Fac Med, Toronto, ON, Canada; [Sidler, Martin; Weksberg, Rosanna; Bagli, Darius J.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Wu, Changhao] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem & Physiol, Guildford, Surrey, England; [Weksberg, Rosanna] Hosp Sick Children, Genet & Genome Biol Res Inst, Toronto, ON, Canada; [Weksberg, Rosanna; Delgado-Olguin, Paul] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Delgado-Olguin, Paul] Hosp Sick Children, Translat Med, Toronto, ON, Canada; [Delgado-Olguin, Paul] Heart & Stroke Richard Lewar Ctr Excellence Card, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Surrey; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bagli, DJ (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Res Inst, 159420TUV PGCRL Bldg,686 Bay St, Toronto, ON M5G 0A4, Canada.	darius.bagli@sickkids.ca	Olguin, Paul Delgado/H-9293-2019	Olguin, Paul Delgado/0000-0002-5355-247X	CIHR; TPRM strategic training program in regenerative medicine; Deutsche Forschungsgemeinschaft; Department of Physiology, University of Toronto; Research Training competition, Sickkids Hospital Research Institute; Biotechnology and Biological Sciences Research Council [BB/P004695/1]; National Institute of Aging [1R01AG049321-01A1]; Heart and Stroke Foundation of Canada [G-17-0018613]; Natural Sciences and Engineering Research Council of Canada [500865]; Canadian Institutes of Health Research (CIHR) [162208, 149046]; Hospital for Sick Children; BBSRC [BB/P004695/1] Funding Source: UKRI	CIHR(Canadian Institutes of Health Research (CIHR)); TPRM strategic training program in regenerative medicine; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Department of Physiology, University of Toronto(University of Toronto); Research Training competition, Sickkids Hospital Research Institute; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CIHR Operating Grant -DJB; TPRM strategic training program in regenerative medicine -KJA; Deutsche Forschungsgemeinschaft -AS; Department of Physiology, University of Toronto JX J; Research Training competition, Sickkids Hospital Research Institute -JXJ; Biotechnology and Biological Sciences Research Council, Grant/Award Number: BB/P004695/1 -CW; National Institute of Aging, Grant/Award Number: 1R01AG049321-01A1 -CW; Heart and Stroke Foundation of Canada, Grant/Award Number: G-17-0018613; Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: 500865; the Canadian Institutes of Health Research (CIHR), Grant/Award Number: 162208 and 149046; Hospital for Sick Children.	Adam RM, 2003, J UROLOGY, V169, P2388, DOI 10.1097/01.ju.0000063980.99368.35; Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969; Aitken KJ, 2010, AM J PATHOL, V176, P304, DOI 10.2353/ajpath.2010.080834; Aitken KJ, 2009, NAT REV UROL, V6, P596, DOI 10.1038/nrurol.2009.201; Anea CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078626; Anumanthan G, 2009, J UROLOGY, V182, P1775, DOI 10.1016/j.juro.2009.05.126; Capolicchio G, 2001, J UROLOGY, V165, P2235, DOI 10.1016/S0022-5347(05)66173-3; Chai TC, 1999, J UROLOGY, V161, P1689, DOI 10.1016/S0022-5347(05)69006-4; Chalmers JA, 2008, AM J PHYSIOL-REG I, V295, pR1529, DOI 10.1152/ajpregu.90572.2008; Chang AY, 2011, AM J PHYSIOL-RENAL, V301, pF813, DOI 10.1152/ajprenal.00586.2010; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; de Jong BWD, 2008, NEUROUROL URODYNAM, V27, P454, DOI 10.1002/nau.20567; Denniff M, 2014, J MOL CELL CARDIOL, V66, P133, DOI 10.1016/j.yjmcc.2013.11.009; Duan LJ, 2015, CELL SIGNAL, V27, P215, DOI 10.1016/j.cellsig.2014.11.001; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Ekman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082308; Elkelini MS, 2009, BJU INT, V103, P537, DOI 10.1111/j.1464-410X.2008.08131.x; Elliott CS, 2014, NEUROUROL URODYNAM, V33, P1178, DOI 10.1002/nau.22480; Fusco F, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0329-4; GABELLA G, 1994, CELL TISSUE RES, V277, P333, DOI 10.1007/BF00327781; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; GUAN ZC, 1995, J UROLOGY, V154, P580, DOI 10.1016/S0022-5347(01)67115-5; Halachmi S, 2006, CELL TISSUE RES, V326, P149, DOI 10.1007/s00441-006-0204-6; Holmdahl G, 2005, J UROLOGY, V174, P1031, DOI 10.1097/01.ju.0000170233.87210.4f; Ihara T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46517-w; Ihare T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168234; Imamura M, 2007, AM J PHYSIOL-RENAL, V293, pF1007, DOI 10.1152/ajprenal.00107.2007; Jin LH, 2011, AM J PHYSIOL-REG I, V301, pR896, DOI 10.1152/ajpregu.00046.2011; Jock M, 2014, BJU INT, V114, P946, DOI 10.1111/bju.12687; Kageyama S, 2000, NEUROUROL URODYNAM, V19, P233, DOI 10.1002/(SICI)1520-6777(2000)19:3<233::AID-NAU4>3.0.CO;2-M; Kanno Y, 2016, NEUROUROL URODYNAM, V35, P377, DOI 10.1002/nau.22721; Kim JC, 2001, UROLOGY, V57, P371, DOI 10.1016/S0090-4295(00)00886-4; Kim JC, 2000, NEUROUROL URODYNAM, V19, P29, DOI 10.1002/(SICI)1520-6777(2000)19:1<29::AID-NAU5>3.3.CO;2-R; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Kiss Z, 2016, ENDOCR-RELAT CANCER, V23, pT123, DOI 10.1530/ERC-16-0366; Kojima M, 1997, J UROLOGY, V158, P89, DOI 10.1097/00005392-199707000-00024; Kudo T, 1999, Nihon Hinyokika Gakkai Zasshi, V90, P651; Kuo HC, 1996, J FORMOS MED ASSOC, V95, P469; Kupelian V, 2006, ARCH INTERN MED, V166, P2381, DOI 10.1001/archinte.166.21.2381; Layne JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC611, DOI 10.1152/ajpcell.00435.2007; LEACH GE, 1987, J UROLOGY, V138, P574, DOI 10.1016/S0022-5347(17)43263-0; Lee KJ, 2009, CIRCULATION, V119, P2078, DOI 10.1161/CIRCULATIONAHA.107.737734; Lee SR, 2010, J UROLOGY, V183, P2440, DOI 10.1016/j.juro.2010.02.003; Lee T, 2007, J UROLOGY, V177, P1562, DOI 10.1016/j.juro.2006.11.070; Leng WW, 2003, J UROLOGY, V169, P563, DOI 10.1016/S0022-5347(05)63953-5; Levin RM, 1997, EUR UROL, V32, P15; Lin WY, 2012, BJU INT, V110, P1208, DOI 10.1111/j.1464-410X.2012.11185.x; Litlekalsoy J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2580-y; Makino J, 2016, J CELL BIOCHEM, V117, P2496, DOI 10.1002/jcb.25542; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Maselli G, 2011, INT J UROL, V18, P515, DOI 10.1111/j.1442-2042.2011.02772.x; Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058; Negoro H, 2013, J UROLOGY, V190, P843, DOI 10.1016/j.juro.2013.02.024; Negoro H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1812; Nishino Y, 2006, BJU INT, V97, P747, DOI 10.1111/j.1464-410X.2006.06030.x; Noh JY, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.153; O'Reilly PH., 2012, OBSTRUCTIVE UROPATHY; Parsons JK, 2008, UROLOGY, V72, P318, DOI 10.1016/j.urology.2008.03.057; Pen A, 2011, CANCER BIOL THER, V12, P634, DOI 10.4161/cbt.12.7.17171; Peters CA, 1997, AM J PHYSIOL-REG I, V272, pR1960, DOI 10.1152/ajpregu.1997.272.6.R1960; Rodrigo GC, 2018, FREE RADICAL BIO MED, V119, P115, DOI 10.1016/j.freeradbiomed.2017.10.381; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Saito Toshiro, 2015, J Smooth Muscle Res, V51, P95, DOI 10.1540/jsmr.51.95; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schroder A, 2013, J UROLOGY, V189, P2377, DOI 10.1016/j.juro.2012.12.110; SEKI N, 1992, J UROLOGY, V148, P1957, DOI 10.1016/S0022-5347(17)37092-1; Shi BK, 2009, UROL INT, V82, P43, DOI 10.1159/000176024; Sidler M, 2018, AM J PATHOL, V188, P2177, DOI 10.1016/j.ajpath.2018.06.024; Sidler M, 2017, UROLOGY, V105, DOI 10.1016/j.urology.2017.03.032; Sigurdardottir LG, 2012, CANCER EPIDEM BIOMAR, V21, P1002, DOI 10.1158/1055-9965.EPI-12-0116; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Song M, 2014, STEM CELLS DEV, V23, P654, DOI 10.1089/scd.2013.0277; Song YS, 2013, INT J UROL, V20, P116, DOI 10.1111/j.1442-2042.2012.03217.x; Streng T, 2012, BJU INT, V110, pE125, DOI 10.1111/j.1464-410X.2011.10838.x; Tolg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059413; Torihashi S, 2009, DIFFERENTIATION, V77, P277, DOI 10.1016/j.diff.2008.10.003; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Wei JT, 2008, J UROLOGY, V179, pS75, DOI 10.1016/j.juro.2008.03.141; White RS, 2015, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00293; Wolffenbuttel KP, 2008, NEUROUROL URODYNAM, V27, P782, DOI 10.1002/nau.20588; Wu C, 2012, J UROL, V187; Wu CH, 2014, FASEB J, V28, P4610, DOI 10.1096/fj.13-243295; Xie Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005482; Zhang EY, 2004, AM J PATHOL, V164, P601, DOI 10.1016/S0002-9440(10)63149-5; Zhu YF, 2008, UROL INT, V81, P222, DOI 10.1159/000144066	85	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3594	3615		10.1096/fj.201900547RR	http://dx.doi.org/10.1096/fj.201900547RR		JAN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31984552	Green Submitted			2022-12-28	WOS:000509779800001
J	Yu, AXD; Xu, ML; Yao, P; Kwan, KKL; Liu, YX; Duan, R; Dong, TTX; Ko, RKM; Tsim, KWK				Yu, Anna Xiao-Dan; Xu, Miranda Li; Yao, Ping; Kwan, Kenneth Kin-Leung; Liu, Yong-Xiang; Duan, Ran; Dong, Tina Ting-Xia; Ko, Robert Kam-Ming; Tsim, Karl Wah-Keung			Corylin, a flavonoid derived from Psoralea Fructus, induces osteoblastic differentiation via estrogen and Wnt/beta-catenin signaling pathways	FASEB JOURNAL			English	Article						bioenergetics; estrogen signaling; micromass; natural product; osteoblast; Wnt; beta-catenin signaling	TRANSCRIPTION FACTOR; MICROMASS CULTURES; ENERGY-METABOLISM; BONE-DEVELOPMENT; CELL-LINE; OSTEOPROTEGERIN; EXPRESSION; WNT; INHIBITION; MECHANISM	Corylin is a naturally occurring flavonoid isolated from the fruit of Psoralea corylifolia L. (Fabaceae), which is a Chinese medicinal herb in treating osteoporosis. Although a variety of pharmacological activities of corylin have been reported, its osteogenic action and the underlying mechanism in bone development remain unclear. In the present study, the involvement of bone-specific genes in corylininduced differentiated osteoblasts was analyzed by RT-PCR, promoter-reporter assay, and Western blotting. In cultured osteoblasts, corylin-induced cell differentiation and mineralization, as well as increased the expressions of vital biological markers for osteogenesis, such as Runx2, Osterix, Col1, and ALP. Corylin was proposed to have dual pathways in triggering the osteoblastic differentiation. First, the osteogenic function of corylin acted through the activation of Wnt/beta-catenin signaling. The nuclear translocation of beta-catenin of cultured osteoblasts, as determined by flow cytometry and confocal microscopy, was triggered by applied corylin, and which was blocked by DKK-1, an inhibitor of Wnt/beta-catenin signaling. Second, the application of corylin-induced estrogenic response in a dose-dependent manner, and which was blocked by ICI 182 780, an antagonist of estrogen receptor. Furthermore, the activation of Runx2 promoter by corylin was abolished by both DKK-1 and ICI 182,780, indicating that the corylin exhibited its osteogenic effect via estrogen and Wnt/beta-catenin signaling pathways. In addition, corylin regulated the metabolic profiles, as well as the membrane potential of mitochondria, in cultured osteoblasts. Corylin also stimulated the osteogenesis in bone micromass derived from mesenchymal progenitor cells. This study demonstrated the osteogenic activities of corylin in osteoblasts and micromass, suggesting that corylin has the potential to be developed as a novel pro-osteogenic agent in targeting for the treatment of osteoblast-mediated osteoporosis.	[Yu, Anna Xiao-Dan; Xu, Miranda Li; Yao, Ping; Kwan, Kenneth Kin-Leung; Duan, Ran; Dong, Tina Ting-Xia; Tsim, Karl Wah-Keung] HKUST Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen, Peoples R China; [Yu, Anna Xiao-Dan; Xu, Miranda Li; Yao, Ping; Kwan, Kenneth Kin-Leung; Liu, Yong-Xiang; Duan, Ran; Dong, Tina Ting-Xia; Ko, Robert Kam-Ming; Tsim, Karl Wah-Keung] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Yu, Anna Xiao-Dan; Xu, Miranda Li; Yao, Ping; Kwan, Kenneth Kin-Leung; Liu, Yong-Xiang; Duan, Ran; Dong, Tina Ting-Xia; Ko, Robert Kam-Ming; Tsim, Karl Wah-Keung] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), HKUST Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen, Peoples R China.	botsim@ust.hk			Shenzhen Science and Technology Innovation Committee [JCYJ20170413173747440, ZDSYS201707281432317, JCYJ20180306174903174]; China Postdoctoral Science Foundation [2019M653087]; Guangzhou Science and Technology Committee Research [GZSTI16SC02, GZSTI17SC02]; Hong Kong RGC Theme-based Research Scheme [T13-607/12R]; Hong Kong Innovation Technology Fund [UIM/340, UIM/385, ITS/500/18FP, TCPD/17-9]; Dr. Lau Wah Sham Foundation [PD18SC01, HMRF18SC06]	Shenzhen Science and Technology Innovation Committee; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangzhou Science and Technology Committee Research; Hong Kong RGC Theme-based Research Scheme; Hong Kong Innovation Technology Fund; Dr. Lau Wah Sham Foundation	Shenzhen Science and Technology Innovation Committee, Grant/Award Number: JCYJ20170413173747440, ZDSYS201707281432317 and JCYJ20180306174903174; China Postdoctoral Science Foundation, Grant/Award Number: 2019M653087; Guangzhou Science and Technology Committee Research, Grant/Award Number: GZSTI16SC02 and GZSTI17SC02; Hong Kong RGC Theme-based Research Scheme, Grant/Award Number: T13-607/12R; Hong Kong Innovation Technology Fund, Grant/Award Number: UIM/340, UIM/385, ITS/500/18FP and TCPD/17-9; Dr. Lau Wah Sham Foundation, Grant/Award Number: PD18SC01 and HMRF18SC06	Almeida M, 2013, J GERONTOL A-BIOL, V68, P1197, DOI 10.1093/gerona/glt079; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bagan J, 2016, ORAL DIS, V22, P324, DOI 10.1111/odi.12447; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Boyce BF, 2005, CELL METAB, V2, P344, DOI 10.1016/j.cmet.2005.11.011; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot065490; Cong Q, 2016, STEM CELL REP, V6, P566, DOI 10.1016/j.stemcr.2016.02.001; Dai J, 2003, J BONE MINER RES, V18, pS312; Daniels K, 1996, METHOD CELL BIOL, V51, P237, DOI 10.1016/S0091-679X(08)60631-7; Drake MT, 2015, CLIN THER, V37, P1837, DOI 10.1016/j.clinthera.2015.06.006; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eggerschwiler B, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1170-8; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; Garnero P, 2014, BONE, V66, P46, DOI 10.1016/j.bone.2014.05.016; Greco KV, 2011, BIOCHEM PHARMACOL, V82, P1919, DOI 10.1016/j.bcp.2011.09.009; Guo JM, 2005, FOOD CHEM, V91, P287, DOI 10.1016/j.foodchem.2004.04.029; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; Hung YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46299; Karner CM, 2017, CELL MOL LIFE SCI, V74, P1649, DOI 10.1007/s00018-016-2425-5; Komarova SV, 2000, AM J PHYSIOL-CELL PH, V279, pC1220, DOI 10.1152/ajpcell.2000.279.4.C1220; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Latha PG, 2000, FITOTERAPIA, V71, P223, DOI 10.1016/S0367-326X(99)00151-3; Lee SW, 2012, PLANTA MED, V78, P903, DOI 10.1055/s-0031-1298482; Li ZQ, 2018, INT J MED SCI, V15, P1415, DOI 10.7150/ijms.26741; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Onal M, 2013, J BIOL CHEM, V288, P17432, DOI 10.1074/jbc.M112.444190; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Papachristou DJ, 2005, HISTOCHEM CELL BIOL, V124, P215, DOI 10.1007/s00418-005-0026-8; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; RAMP WK, 1994, BONE MINER, V24, P59, DOI 10.1016/S0169-6009(08)80131-6; Riddle RC, 2014, J CLIN INVEST, V124, P1465, DOI 10.1172/JCI75554; Seo E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/897296; Seo E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/678028; Shen CY, 2017, BRIT J PHARMACOL, V174, P1395, DOI 10.1111/bph.13631; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Thangaraj G, 2016, CHEM-BIOL INTERACT, V259, P313, DOI 10.1016/j.cbi.2016.03.027; Ucer S, 2017, J BONE MINER RES, V32, P560, DOI 10.1002/jbmr.3014; Wang DW, 2001, PLANTA MED, V67, P748, DOI 10.1055/s-2001-18343; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Xu ML, 2017, J BIOL CHEM, V292, P12667, DOI 10.1074/jbc.M117.777581; Yao QQ, 2017, BONE, V97, P175, DOI 10.1016/j.bone.2017.01.028; Zhang XN, 2016, AM J CHINESE MED, V44, P35, DOI 10.1142/S0192415X16500038; Zou P, 2012, FOOD CHEM TOXICOL, V50, P2831, DOI 10.1016/j.fct.2012.05.009	54	31	31	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4311	4328		10.1096/fj.201902319RRR	http://dx.doi.org/10.1096/fj.201902319RRR		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31965654				2022-12-28	WOS:000508585300001
J	Lopez-Vicchi, F; Ladyman, SR; Ornstein, AM; Gustafson, P; Knowles, P; Luque, GM; Grattan, DR; Becu-Villalobos, D				Lopez-Vicchi, Felicitas; Ladyman, Sharon R.; Ornstein, Ana Maria; Gustafson, Papillon; Knowles, Penelope; Maria Luque, Guillermina; Grattan, David R.; Becu-Villalobos, Damasia			Chronic high prolactin levels impact on gene expression at discrete hypothalamic nuclei involved in food intake	FASEB JOURNAL			English	Article						AGRP; arcuate nucleus; leptin; NPY; STAT	MESSENGER-RIBONUCLEIC-ACID; DOPAMINE D2 RECEPTORS; BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; LEPTIN RESISTANCE; NEUROPEPTIDE-Y; BODY-WEIGHT; ENERGY-BALANCE; DORSOMEDIAL HYPOTHALAMUS; SIGNAL TRANSDUCER	To study the pathological effects of continuous hyperprolactinemia on food intake mechanisms we used female mice that lack dopamine D2 receptors in lactotropes (lacDrd2KO). These mice had lifelong hyperprolactinemia, increased food intake, and gradual development of obesity from 5 to 10 months of age. Ongoing endogenous prolactin signaling in lacDrd2KO mice was evidenced by increased basal phosphorylation of STAT5b in hypothalamic areas related to food intake, such as the arcuate (ARN), dorsomedial (DMN), and ventromedial nuclei. In the ARN of young lacDrd2KO mice there were higher Prlr mRNA levels and in obese 10-month-old lacDrd2KO mice increased expression of the orexigenic genes Neuropeptide Y (Npy) and Agouti-related peptide, compared to controls. Furthermore, Npy expression was increased in the DMN, probably contributing to increased food intake and decreased expression of Uncoupling protein-1 in brown adipose tissue, both events favoring weight gain. Leptin resistance in obese lacD2RKO mice was evidenced by its failure to lower food intake and a dampened response of STAT3 phosphorylation, specifically in the mediobasal hypothalamus. Our results suggest that pathological chronically high prolactin levels, as found in psychiatric treatments or patients with prolactinomas, may impact on specific hypothalamic nuclei altering gene expression, leptin response, and food intake.	[Lopez-Vicchi, Felicitas; Ornstein, Ana Maria; Maria Luque, Guillermina; Becu-Villalobos, Damasia] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina; [Ladyman, Sharon R.; Gustafson, Papillon; Knowles, Penelope; Grattan, David R.] Univ Otago, Ctr Neuroendocrinol, Dept Anat, Sch Biomed Sci, Dunedin, New Zealand; [Ladyman, Sharon R.; Grattan, David R.] Maurice Wilkins Ctr, Auckland, New Zealand	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Otago	Becu-Villalobos, D (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	dbecu@dna.uba.ar	Luque, Guillermina/M-9237-2019	Luque, Guillermina/0000-0002-2745-8236; Grattan, Dave/0000-0001-5606-2559	National Institute of Diabetes and Digestive and Kidney Diseases' National Hormone and Pituitary Program [14, 568]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1343-2015, PICT 526-2016]; Fundacion Rene Baron; Fundacion Williams; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Fundacion Bunge & Born-Oster Fellowship; Health Research Council [14/568]; Maurice Wilkins Centre for Molecular Biodiscovery	National Institute of Diabetes and Digestive and Kidney Diseases' National Hormone and Pituitary Program; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Rene Baron; Fundacion Williams; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Bunge & Born-Oster Fellowship; Health Research Council; Maurice Wilkins Centre for Molecular Biodiscovery	National Institute of Diabetes and Digestive and Kidney Diseases' National Hormone and Pituitary Program, Grant/Award Number: 14 and 568,; Agencia Nacional de Promocion Cientifica y Tecnologica, Grant/Award Number: PICT 1343-2015 and PICT 526-2016; Fundacion Rene Baron; Fundacion Williams; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Fundacion Bunge & Born-Oster Fellowship; Health Research Council, Grant/Award Number: 14/568; Maurice Wilkins Centre for Molecular Biodiscovery	Anderson GM, 2006, ENDOCRINOLOGY, V147, P4996, DOI 10.1210/en.2005-0755; Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Augustine RA, 2008, ENDOCRINOLOGY, V149, P1049, DOI 10.1210/en.2007-1018; Augustine RA, 2008, J PHYSIOL-LONDON, V586, P387, DOI 10.1113/jphysiol.2007.146316; Bellinger LL, 2002, PHYSIOL BEHAV, V76, P431, DOI 10.1016/S0031-9384(02)00756-4; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; Bi S, 2012, NEUROPEPTIDES, V46, P309, DOI 10.1016/j.npep.2012.09.002; Billesa SK, 2012, MOL METAB, V1, P86, DOI 10.1016/j.molmet.2012.07.003; Bridges RS, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12669; Brown RSE, 2011, BIOL REPROD, V84, P826, DOI 10.1095/biolreprod.110.089185; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Buonfiglio DC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22421; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; Chen PL, 1999, ENDOCRINOLOGY, V140, P2645, DOI 10.1210/en.140.6.2645; Chen PL, 2004, ENDOCRINOLOGY, V145, P823, DOI 10.1210/en.2003-1255; Chhabra KH, 2016, MOL METAB, V5, P869, DOI 10.1016/j.molmet.2016.07.012; Cordeira J, 2011, MOL NEUROBIOL, V44, P441, DOI 10.1007/s12035-011-8212-2; Doknic M, 2002, EUR J ENDOCRINOL, V147, P77, DOI 10.1530/eje.0.1470077; Donner N, 2007, EUR J NEUROSCI, V25, P1804, DOI 10.1111/j.1460-9568.2007.05416.x; EGAWA M, 1991, AM J PHYSIOL, V260, pR328, DOI 10.1152/ajpregu.1991.260.2.R328; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Garcia-Tornadu I, 2009, NEUROPEPTIDES, V43, P267, DOI 10.1016/j.npep.2009.06.002; GERARDOGETTENS T, 1989, AM J PHYSIOL, V256, pR701, DOI 10.1152/ajpregu.1989.256.3.R701; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; GUSTAFSON AB, 1980, J CLIN ENDOCR METAB, V51, P242, DOI 10.1210/jcem-51-2-242; Hofker M, 2009, NAT GENET, V41, P139, DOI 10.1038/ng0209-139; Jeon Y, 2016, BIOCHEM BIOPH RES CO, V470, P818, DOI 10.1016/j.bbrc.2016.01.115; Kamiji MM, 2007, ENDOCR REV, V28, P664, DOI 10.1210/er.2007-0003; Kim KW, 2012, J CLIN INVEST, V122, P2578, DOI 10.1172/JCI62848; Kim KS, 2010, J BIOL CHEM, V285, P8905, DOI 10.1074/jbc.M109.079590; Kokay Ilona C, 2018, J Neuroendocrinol, V30, pe12634, DOI 10.1111/jne.12634; Lacruz A, 2000, MOL PSYCHIATR, V5, P70, DOI 10.1038/sj.mp.4000566; Ladyman SR, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12474; Ladyman SR, 2012, REPRODUCTION, V144, P83, DOI 10.1530/REP-12-0112; Ladyman SR, 2010, J NEUROENDOCRINOL, V22, P805, DOI 10.1111/j.1365-2826.2010.02017.x; Ladyman SR, 2005, ENDOCRINOLOGY, V146, P3868, DOI 10.1210/en.2005-0194; Ladyman SR, 2004, ENDOCRINOLOGY, V145, P3704, DOI 10.1210/en.2004-0338; Lau J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00313; Le TN, 2013, GENET TEST MOL BIOMA, V17, P567, DOI 10.1089/gtmb.2013.0009; LeBaron MJ, 2007, ENDOCRINOLOGY, V148, P989, DOI 10.1210/en.2006-1219; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Vicchi FL, 2016, PHARMACOL RES, V109, P74, DOI 10.1016/j.phrs.2015.12.029; Luque GM, 2016, AM J PHYSIOL-ENDOC M, V311, pE974, DOI 10.1152/ajpendo.00200.2016; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Naef L, 2007, ENDOCRINOLOGY, V148, P5977, DOI 10.1210/en.2007-0442; Nagaishi VS, 2014, NEUROSCIENCE, V259, P71, DOI 10.1016/j.neuroscience.2013.11.050; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Nilsson L, 2011, MOL GENET METAB, V102, P78, DOI 10.1016/j.ymgme.2010.08.017; Noain D, 2013, J NEUROSCI, V33, P5834, DOI 10.1523/JNEUROSCI.5673-12.2013; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pala NA, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0094-4; Paxinos G, 2008, MOUSE BRAIN STEROTAX; Millan MIP, 2014, ENDOCRINOLOGY, V155, P829, DOI 10.1210/en.2013-1707; Roh E, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.4; Salais-Lopez H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208960; Sapsford TJ, 2012, J COMP NEUROL, V520, P1062, DOI 10.1002/cne.22775; Sauve D, 2000, BRAIN RES, V868, P306, DOI 10.1016/S0006-8993(00)02344-1; Scarpace PJ, 2000, DIABETES, V49, P431, DOI 10.2337/diabetes.49.3.431; SCHERNTHANER G, 1985, DIABETOLOGIA, V28, P138; Serri O, 2006, CLIN ENDOCRINOL, V64, P366, DOI 10.1111/j.1365-2265.2006.02469.x; Sjoeholm A, 2011, ENDOCRINOLOGY, V152, P1979, DOI 10.1210/en.2010-1220; Tanner JM, 2010, EXP BIOL MED, V235, P1489, DOI 10.1258/ebm.2010.010171; Tuzcu A, 2009, PITUITARY, V12, P330, DOI 10.1007/s11102-009-0183-1; Viengchareun S, 2004, J MOL ENDOCRINOL, V33, P679, DOI 10.1677/jme.1.01563; Viengchareun S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001535; Wu QL, 2014, ENDOCRINOLOGY, V155, P840, DOI 10.1210/en.2013-1831; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yavuz D, 2003, EUR J ENDOCRINOL, V149, P187, DOI 10.1530/eje.0.1490187; Zhang Y, 2011, J NEUROSCI, V31, P1873, DOI 10.1523/JNEUROSCI.3223-10.2011	71	13	13	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3902	3914		10.1096/fj.201902357R	http://dx.doi.org/10.1096/fj.201902357R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944423	Bronze			2022-12-28	WOS:000507595100001
J	Iriyama, T; Wang, W; Parchim, NF; Sayama, S; Kumasawa, K; Nagamatsu, T; Song, AR; Xia, Y; Kellems, RE				Iriyama, Takayuki; Wang, Wei; Parchim, Nicholas F.; Sayama, Seisuke; Kumasawa, Keiichi; Nagamatsu, Takeshi; Song, Anren; Xia, Yang; Kellems, Rodney E.			Reciprocal upregulation of hypoxia-inducible factor-1 alpha and persistently enhanced placental adenosine signaling contribute to the pathogenesis of preeclampsia	FASEB JOURNAL			English	Article						adenosine signaling; angiotensin II type I receptor agonistic autoantibody (AT(1)-AA); hypoxia-inducible factor-1 alpha; preeclampsia; tumor necrosis factor superfamily member 14 (TNFSF14)	AGONISTIC AUTOANTIBODIES; TRANSCRIPTION FACTORS; RECEPTOR; HYPERTENSION; EXPRESSION; HIF-1A; OXYGEN	Recent evidence indicates that elevated placental adenosine signaling contributes to preeclampsia (PE). However, the molecular basis for the chronically enhanced placental adenosine signaling in PE remains unclear. Here, we report that hypoxia-inducible factor-1 alpha (HIF-1 alpha) is crucial for the enhancement of placental adenosine signaling. Utilizing a pharmacologic approach to reduce placental adenosine levels, we found that enhanced adenosine underlies increased placental HIF-1 alpha in an angiotensin receptor type 1 receptor agonistic autoantibody (AT(1)-AA)-induced mouse model of PE. Knockdown of placental HIF-1 alpha in vivo suppressed the accumulation of adenosine and increased ecto-5'-nucleotidase (CD73) and adenosine A(2B) receptor (ADORA2B) in the placentas of PE mouse models induced by AT(1)-AA or LIGHT, a TNF superfamily cytokine (TNFSF14). Human in vitro studies using placental villous explants demonstrated that increased HIF-1 alpha resulting from ADORA2B activation facilitates the induction of CD73, ADORA2B, and FLT-1 expression. Overall, we demonstrated that (a) elevated placental HIF-1 alpha by AT(1)-AA or LIGHT upregulates CD73 and ADORA2B expression and (b) enhanced adenosine signaling through upregulated ADORA2B induces placental HIF-1 alpha expression, which creates a positive feedback loop that promotes FLT-1 expression leading to disease development. Our results suggest that adenosine-based therapy targeting the malicious cycle of placental adenosine signaling may elicit therapeutic effects on PE.	[Iriyama, Takayuki; Sayama, Seisuke; Kumasawa, Keiichi; Nagamatsu, Takeshi] Univ Tokyo, Dept Obstet & Gynecol, Fac Med, Tokyo, Japan; [Iriyama, Takayuki; Wang, Wei; Parchim, Nicholas F.; Sayama, Seisuke; Song, Anren; Xia, Yang; Kellems, Rodney E.] Univ Texas Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX USA; [Wang, Wei; Xia, Yang] Cent South Univ, Dept Nephrol, Xiangya Hosp, Changsha, Peoples R China; [Parchim, Nicholas F.] Univ New Mexico Hosp, Dept Emergency Med, Albuquerque, NM USA; [Xia, Yang; Kellems, Rodney E.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Tokyo; University of Texas System; University of Texas Health Science Center Houston; Central South University; University of New Mexico; University of Texas System; University of Texas Health Science Center Houston	Iriyama, T (corresponding author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	iriyama-tky@umin.ac.jp	Nagamatsu, Takeshi/AAC-5201-2021	Nagamatsu, Takeshi/0000-0003-1480-5785	MEXT \ Japan Society for the Promotion of Science (JSPS) [15H06171, 19K09774]; Foundation for the National Institutes of Health (FNIH) [RC4HD067977]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for the National Institutes of Health (FNIH)	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15H06171 and 19K09774; Foundation for the National Institutes of Health (FNIH), Grant/Award Number: RC4HD067977	Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Espinoza J, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.034; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Huang AJ, 2017, HYPERTENSION, V70, P209, DOI 10.1161/HYPERTENSIONAHA.117.09536; Irani RA, 2009, J EXP MED, V206, P2809, DOI 10.1084/jem.20090872; Iriyama T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46660-4; Iriyama T, 2015, HYPERTENSION, V65, P1307, DOI 10.1161/HYPERTENSIONAHA.115.05314; Iriyama T, 2015, CIRCULATION, V131, P730, DOI 10.1161/CIRCULATIONAHA.114.013740; Januar V, 2015, AM J OBSTET GYNECOL, V213, pS182, DOI 10.1016/j.ajog.2015.07.011; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Liu C, 2014, HYPERTENSION, V63, P353, DOI 10.1161/HYPERTENSIONAHA.113.02361; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; Wang W, 2014, HYPERTENSION, V63, P595, DOI 10.1161/HYPERTENSIONAHA.113.02458; Wilson SL, 2018, HUM MOL GENET, V27, P135, DOI 10.1093/hmg/ddx391; Yoneyama Y, 2002, OBSTET GYNECOL, V100, P1266, DOI 10.1016/S0029-7844(02)02247-0; Zhang WR, 2013, CIRC RES, V112, P1466, DOI 10.1161/CIRCRESAHA.111.300166; Zhang YJ, 2012, MICROBES INFECT, V14, P863, DOI 10.1016/j.micinf.2012.05.005; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	36	15	15	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4041	4054		10.1096/fj.201902583R	http://dx.doi.org/10.1096/fj.201902583R		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930569	Green Accepted, Bronze			2022-12-28	WOS:000507881000001
J	Lu, HT; Chen, W; Liu, WR; Si, YC; Zhao, TT; Lai, XL; Kang, ZM; Sun, XJ; Guo, ZY				Lu, Hongtao; Chen, Wei; Liu, Wenrui; Si, Yachen; Zhao, Tingting; Lai, Xueli; Kang, Zhimin; Sun, Xuejun; Guo, Zhiyong			Molecular hydrogen regulates PTEN-AKT-mTOR signaling via ROS to alleviate peritoneal dialysis-related peritoneal fibrosis	FASEB JOURNAL			English	Article						hydrogen; peritoneal fibrosis; phosphatase and tensin homolog (PTEN); reactive oxygen species (ROS)	MESOTHELIAL CELLS; TENSIN HOMOLOG; MESENCHYMAL TRANSITION; ACTIVATION; HEMODIALYSIS; PHOSPHATASE; MACROPHAGES; MIR-718; MIR-21; WATER	As a convenient, effective and economical kidney replacement therapy for end-stage renal disease (ESRD), peritoneal dialysis is available in approximately 11% of ESRD patients worldwide. However, long-term peritoneal dialysis treatment causes peritoneal fibrosis. In recent years, the application potential of molecular hydrogen in the biomedicine has been well recognized. Molecular hydrogen selectively scavenges cytotoxic reactive oxygen species (ROS) and acts as an antioxidant. In this experiment, a high glucose-induced peritoneal fibrosis mouse model was successfully established by intraperitoneal injection of high glucose peritoneal dialysate, and peritoneal fibrosis mice were treated with hydrogen-rich peritoneal dialysate. In addition, in vitro studies of high glucose-induced peritoneal fibrosis were performed using MeT-5A cells. In vitro and in vivo experiments show that molecular hydrogen could inhibit peritoneal fibrosis progress induced by high glucose effectively. Furthermore, it has been found that molecular hydrogen alleviate fibrosis by eliminating intracellular ROS and inhibiting the activation of the PTEN/AKT/mTOR pathway. The present data proposes that molecular hydrogen exerts the capacity of anti-peritoneal fibrosis through the ROS/PTEN/AKT/mTOR pathway. Therefore, molecule hydrogen is a potential, safe, and effective treatment agent, with peritoneal protective property and great clinical significance.	[Lu, Hongtao; Chen, Wei; Liu, Wenrui; Si, Yachen; Zhao, Tingting; Lai, Xueli; Guo, Zhiyong] Naval Med Univ, Changhai Hosp, Dept Nephrol, Shanghai, Peoples R China; [Lu, Hongtao; Sun, Xuejun] Naval Med Univ, Dept Naval Med, Shanghai, Peoples R China; [Kang, Zhimin] Shanghai Huikang Hydrogen Med Res Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Chen, W; Guo, ZY (corresponding author), Naval Med Univ, Changhai Hosp, Dept Nephrol, Shanghai, Peoples R China.; Sun, XJ (corresponding author), Naval Med Univ, Dept Naval Med, Shanghai, Peoples R China.	wujiang02@163.com; sunxjk@hotmail.com; drguozhiyong@163.com	Sun, Xuejun/GLR-4436-2022; sun, xuejun/A-5561-2010; yachen, Si yachen/G-1567-2019	Sun, Xuejun/0000-0003-2387-5531; sun, xuejun/0000-0003-2387-5531; 	National Natural Science Foundation of China (NSFC) [81770763, 81800678, 81371316]; Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund) [18441905900]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770763, 81800678 and 81371316; Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund), Grant/Award Number: 18441905900	Balzer MS, 2019, NEPHROL DIAL TRANSPL, V34, P947, DOI 10.1093/ndt/gfy282; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; Bhatt K, 2015, J AM SOC NEPHROL, V26, P1588, DOI 10.1681/ASN.2014050463; Busnadiego O, 2015, J AM SOC NEPHROL, V26, P173, DOI 10.1681/ASN.2013070799; Chen J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00499; Gao L, 2019, EXP PHYSIOL, V104, P1942, DOI 10.1113/EP088028; Gupta A, 2017, MOL CELL, V65, P999, DOI 10.1016/j.molcel.2017.02.019; Hung KY, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/642793; Kalantari P, 2017, J BIOL CHEM, V292, P5634, DOI 10.1074/jbc.M116.749325; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Kim JH, 2018, CELL DEATH DIFFER, V25, P1921, DOI 10.1038/s41418-018-0165-9; Koyama Y, 2014, HEPATOL RES, V44, P663, DOI 10.1111/hepr.12165; Krediet RT, 2013, NAT REV NEPHROL, V9, P419, DOI 10.1038/nrneph.2013.99; Lee YC, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-35; Leslie NR, 2016, BIOCHEM SOC T, V44, P273, DOI 10.1042/BST20150224; Liu JY, 2014, BIOL TRACE ELEM RES, V161, P202, DOI 10.1007/s12011-014-0091-8; McClelland AD, 2015, CLIN SCI, V129, P1237, DOI 10.1042/CS20150427; Mehrotra R, 2016, J AM SOC NEPHROL, V27, P3238, DOI 10.1681/ASN.2016010112; Nakayama M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18537-x; Nakayama M, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0741-0; Nakayama M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184535; Nakayama M, 2009, NEPHRON CLIN PRACT, V112, pC9, DOI 10.1159/000210569; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ren JD, 2016, BBA-MOL CELL RES, V1863, P50, DOI 10.1016/j.bbamcr.2015.10.012; Rivera-Barahona A, 2017, J INHERIT METAB DIS, V40, P471, DOI 10.1007/s10545-017-0018-6; Shin HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05836-6; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sun HY, 2011, J HEPATOL, V54, P471, DOI 10.1016/j.jhep.2010.08.011; Takashima M, 2009, J GASTROENTEROL, V44, P847, DOI 10.1007/s00535-009-0073-3; Tao H, 2017, TOXICOLOGY, V386, P11, DOI 10.1016/j.tox.2017.05.007; Terawaki H, 2015, PERITON DIALYSIS INT, V35, DOI 10.3747/pdi.2013.00255; Terawaki H, 2014, HEMODIAL INT, V18, P459, DOI 10.1111/hdi.12112; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Xie KL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807635; Xu L, 2017, NEPHROL DIAL TRANSPL, V32, P1285, DOI 10.1093/ndt/gfv382; Xue M, 2014, NUCLEIC ACIDS RES, V42, P9862, DOI 10.1093/nar/gku583; Yang J, 2017, MOL MED REP, V16, P1771, DOI 10.3892/mmr.2017.6849; Yang JM, 2015, METHODS, V77-78, P119, DOI 10.1016/j.ymeth.2014.10.018; Yang T, 2016, SHOCK, V45, P228, DOI 10.1097/SHK.0000000000000503; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhao PH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06630-2; Zhou Q, 2016, KIDNEY INT, V90, P515, DOI 10.1016/j.kint.2016.03.040	43	14	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4134	4146		10.1096/fj.201901981R	http://dx.doi.org/10.1096/fj.201901981R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930571	Bronze			2022-12-28	WOS:000507880400001
J	Che, P; Wagener, BM; Zhao, XK; Brandon, AP; Evans, CA; Cai, GQ; Zhao, R; Xu, ZX; Han, XS; Pittet, JF; Ding, Q				Che, Pulin; Wagener, Brant M.; Zhao, Xueke; Brandon, Angela P.; Evans, Cilina A.; Cai, Guo-Qiang; Zhao, Rui; Xu, Zhi-Xiang; Han, Xiaosi; Pittet, Jean-Francois; Ding, Qiang			Neuronal Wiskott-Aldrich syndrome protein regulates Pseudomonas aeruginosa-induced lung vascular permeability through the modulation of actin cytoskeletal dynamics	FASEB JOURNAL			English	Article						beta-catenin; alpha v beta 6; acute lung injury; small Rho GTPases; VE-cadherin	N-WASP; ENDOTHELIAL BARRIER; IN-VITRO; INTEGRIN; ACTIVATION; KINASE; INJURY; ADHESION; RHOA; FAK	Pulmonary edema associated with increased vascular permeability is a severe complication of Pseudomonas (P.) aeruginosa-induced acute lung injury. The mechanisms underlying P aeruginosa-induced vascular permeability are not well understood. In the present study, we investigated the role of neuronal Wiskott Aldrich syndrome protein (N-WASP) in modulating P aeruginosa-induced vascular permeability. Using lung microvascular endothelial and alveolar epithelial cells, we demonstrated that N-WASP downregulation attenuated P aeruginosa-induced actin stress fiber formation and prevented paracellular permeability. P aeruginosa-induced dissociation between VE-cadherin and beta-catenin, but increased association between N-WASP and VE-cadherin, suggesting a role for N-WASP in promoting P aeruginosa-induced adherens junction rupture. P aeruginosa increased N-WASP-Y256 phosphorylation, which required the activation of Rho GTPase and focal adhesion kinase. Increased N-WASP-Y256 phosphorylation promotes N-WASP and integrin alpha V beta 6 association as well as TGF-beta-mediated permeability across alveolar epithelial cells. Inhibition of N-WASP-Y256 phosphorylation by N-WASP-Y256F overexpression blocked N-WASP effects in P aeruginosa-induced actin stress fiber formation and increased paracellular permeability. In vivo, N-WASP knockdown attenuated the development of pulmonary edema and improved survival in a mouse model of P aeruginosa pneumonia. Together, our data demonstrate that N-WASP plays an essential role in P aeruginosa-induced vascular permeability and pulmonary edema through the modulation of actin cytoskeleton dynamics.	[Che, Pulin; Wagener, Brant M.; Brandon, Angela P.; Evans, Cilina A.; Cai, Guo-Qiang; Pittet, Jean-Francois; Ding, Qiang] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Che, Pulin; Wagener, Brant M.; Ding, Qiang] Univ Alabama Birmingham, Mol & Translat Biomed, Birmingham, AL USA; [Wagener, Brant M.; Pittet, Jean-Francois] Univ Alabama Birmingham, Div Crit Care, Birmingham, AL USA; [Wagener, Brant M.] Univ Alabama Birmingham, Ctr Free Radical Biol, Birmingham, AL USA; [Zhao, Xueke] Guizhou Med Univ, Affiliated Hosp, Dept Infect Dis, Guiyang, Peoples R China; [Zhao, Rui] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Xu, Zhi-Xiang] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Han, Xiaosi] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Guizhou Medical University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ding, Q (corresponding author), Univ Alabama Birmingham, Div Mol & Translat Biomed, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35294 USA.	qding@uab.edu	Wagener, Brant/AAI-7480-2020		HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [R01HL143017, R01HL127338]; Flight Attendant Medical Research Institute (FAMRI); Foundation for Anesthesia Education and Research (FAER); American Heart Association (AHA)	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); Flight Attendant Medical Research Institute (FAMRI); Foundation for Anesthesia Education and Research (FAER); American Heart Association (AHA)(American Heart Association)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL143017 and R01HL127338; Flight Attendant Medical Research Institute (FAMRI); Foundation for Anesthesia Education and Research (FAER); American Heart Association (AHA)	Balczon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074343; Beaufort N, 2011, CELL MICROBIOL, V13, P1149, DOI 10.1111/j.1462-5822.2011.01606.x; Bechara RI, 2004, AM J RESP CRIT CARE, V170, P188, DOI 10.1164/rccm.200304-478OC; Bir N, 2011, AM J RESP CELL MOL, V45, P632, DOI 10.1165/rcmb.2010-0397OC; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Cai GQ, 2012, AM J PHYSIOL-LUNG C, V303, pL692, DOI 10.1152/ajplung.00390.2011; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Carles M, 2010, ANESTHESIOLOGY, V113, P1134, DOI 10.1097/ALN.0b013e3181f4171b; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Che PL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08453; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Coon TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3881; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Cott C, 2016, BBA-MOL CELL RES, V1863, P1106, DOI 10.1016/j.bbamcr.2016.02.004; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Ding Q, 2002, CANCER RES, V62, P5336; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Duluc L, 2014, CELL TISSUE RES, V355, P675, DOI 10.1007/s00441-014-1805-0; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Ganter MT, 2009, AM J RESP CELL MOL, V40, P108, DOI 10.1165/rcmb.2007-0454OC; Geiser TK, 2001, CELL MICROBIOL, V3, P223, DOI 10.1046/j.1462-5822.2001.00107.x; Golovkine G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003939; Hijazi MH, 2000, SEMIN RESP CRIT CARE, V21, P245, DOI 10.1055/s-2000-9855; Jian MY, 2013, AM J PHYSIOL-LUNG C, V305, pL844, DOI 10.1152/ajplung.00173.2013; Kloth C, 2018, TOXINS, V10, DOI 10.3390/toxins10050185; Leligdowicz A, 2018, AM J PHYSIOL-LUNG C, V315, pL638, DOI 10.1152/ajplung.00286.2018; Liu AR, 2019, AM J RESP CRIT CARE, V200, P1234, DOI 10.1164/rccm.201812-2296OC; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; Lu Q, 2011, AM J PHYSIOL-LUNG C, V301, pL847, DOI 10.1152/ajplung.00178.2011; Mooren OL, 2015, J BIOL CHEM, V290, P18796, DOI 10.1074/jbc.M115.668285; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Pittet JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063907; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Reboud E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006579; Rello J, 1997, CRIT CARE MED, V25, P1862, DOI 10.1097/00003246-199711000-00026; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sawa T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0668-9; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schmidt TT, 2013, AM J PHYSIOL-LUNG C, V305, pL291, DOI 10.1152/ajplung.00094.2013; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Song YL, 2008, INFECT IMMUN, V76, P2325, DOI 10.1128/IAI.01431-07; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Sturge J, 2002, J CELL SCI, V115, P699; Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Wagener BM, 2016, FASEB J, V30, P2557, DOI 10.1096/fj.201600102R; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; WIENERKRONISH JP, 1993, J APPL PHYSIOL, V75, P1661, DOI 10.1152/jappl.1993.75.4.1661	63	7	7	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3305	3317		10.1096/fj.201902915R	http://dx.doi.org/10.1096/fj.201902915R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916311	Green Accepted			2022-12-28	WOS:000506441800001
J	Guo, FY; Xu, DK; Lin, YZ; Wang, GQ; Wang, F; Gao, Q; Wei, QJ; Lei, SX				Guo, Fuyou; Xu, Dingkang; Lin, Yazhou; Wang, Guoqing; Wang, Fang; Gao, Qiang; Wei, Qingjie; Lei, Shixiong			Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage	FASEB JOURNAL			English	Article						acute intracerebral hemorrhage; BBB; CCL2; p38 MAPK; PG	MONOCYTE CHEMOATTRACTANT PROTEIN-1; CEREBRAL VASOSPASM; BRAIN-INJURY; INHIBITION; ACTIVATION; STROKE; KINASE; MCP-1	Intracerebral hemorrhage (ICH) remains a devastating type of stroke that lacks an effective treatment. Recent evidence has demonstrated that CCL2 is involved in the blood-brain barrier (BBB) disruption and propagermanium (PG) as a CCL2 receptor inhibitor is neuroprotective in ischemic stroke. However, whether PG therapy exert effective role in acute ICH still unclear. In this study, our goal was to investigate the potential role of CCL2 and the effects of PG in ICH. Differentially expressed RNAs including CCL2 were detected in human ICH. CCL2 and the activation of p-p38 MAPK and AQP4 expression were analyzed in rats after ICH. Brain water content and BBB integrity as well as neurological function were also examined after PG administration. In addition, the mechanism by which CCL2-mediated BBB injury was further investigated by cell coculture. Our findings showed that PG could effectively reduce brain edema and improve neurobehavioral functions. p-p38 MAPK and AQP4 expression were significantly inhibited by PG in vivo and in vitro. To the best of our knowledge, this is the first demonstration of PG in neuroprotecting the BBB integrity by inhibition of CCL2-CCR2-p38 MAPK pathway following ICH, targeting CCL2 could be developed as a novel treatment for hemorrhagic stroke.	[Guo, Fuyou; Xu, Dingkang; Wang, Guoqing; Wang, Fang; Gao, Qiang; Wei, Qingjie; Lei, Shixiong] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 East Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China; [Lin, Yazhou] Zhengzhou Univ, Sch Basic Med Sci, Dept Human Anat, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Guo, FY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 East Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China.	chyou666@hotmail.com	Xu, Dingkang/AAC-4094-2020; Gao, Qiang/AGN-1675-2022	Xu, Dingkang/0000-0002-9153-773X; Gao, Qiang/0000-0001-7262-3942	National Natural Science Foundation of China (NSFC) [U1204807]; Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department) [192102310113]; Medical science and technique foundation of Henan Province [SB201901007]; Education Department of Henan Province (Henan Provincial Education Department) [19B320017]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department); Medical science and technique foundation of Henan Province; Education Department of Henan Province (Henan Provincial Education Department)	National Natural Science Foundation of China (NSFC), Grant/Award Number: U1204807; Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department), Grant/Award Number: 192102310113; Medical science and technique foundation of Henan Province, Grant/Award Number: SB201901007; Education Department of Henan Province (Henan Provincial Education Department), Grant/Award Number: 19B320017	Chu HL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081249; Fang WR, 2018, THERANOSTICS, V8, P3530, DOI 10.7150/thno.24475; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Galego O, 2018, NEURORADIOL J, V31, P456, DOI 10.1177/1971400918769912; Georgakis MK, 2019, CIRCULATION, V139, P256, DOI 10.1161/CIRCULATIONAHA.118.035905; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Guo FY, 2012, TRANSL STROKE RES, V3, P130, DOI 10.1007/s12975-011-0106-0; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Han YW, 2018, EUR J PHARMACOL, V839, P12, DOI 10.1016/j.ejphar.2018.09.018; He SC, 2019, NEUROCHEM INT, V125, P99, DOI 10.1016/j.neuint.2019.02.010; Hirayama C, 2003, J GASTROENTEROL, V38, P525, DOI 10.1007/s00535-003-1098-7; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kim GH, 2008, J NEUROSURG, V109, P38, DOI 10.3171/JNS/2008/109/7/0038; Landreneau MJ, 2018, ANN CLIN TRANSL NEUR, V5, P962, DOI 10.1002/acn3.595; Li GC, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9149-x; Li ZD, 2012, NEUROSCIENCES, V17, P314; Li ZH, 2017, J MOL NEUROSCI, V61, P279, DOI 10.1007/s12031-017-0883-3; Mao LL, 2017, BRAIN, V140, P1914, DOI 10.1093/brain/awx111; Ni YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170346; Roberts TK, 2012, LAB INVEST, V92, P1213, DOI 10.1038/labinvest.2012.80; Sasaki T, 2004, STROKE, V35, P1466, DOI 10.1161/01.STR.0000127425.47266.20; Savarraj JPJ, 2017, NEUROLOGY, V88, P1535, DOI 10.1212/WNL.0000000000003842; Song YQ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038492; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Strecker JK, 2013, STROKE, V44, P2536, DOI 10.1161/STROKEAHA.111.000528; Wang GQ, 2019, NEUROSCIENCE, V415, P135, DOI 10.1016/j.neuroscience.2019.06.038; Wilkinson DA, 2018, NEUROPHARMACOLOGY, V134, P240, DOI 10.1016/j.neuropharm.2017.09.033; Yang Z, 2016, INT IMMUNOPHARMACOL, V33, P18, DOI 10.1016/j.intimp.2016.01.016; Yao Y, 2014, CELL MOL LIFE SCI, V71, P683, DOI 10.1007/s00018-013-1459-1; Yao Y, 2012, GLIA, V60, P908, DOI 10.1002/glia.22323; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Yumimoto K, 2019, CANCER SCI, V110, P2090, DOI 10.1111/cas.14075; Zhang LJ, 2018, MOL MED REP, V18, P4213, DOI 10.3892/mmr.2018.9468; Zhang X, 2011, ANN CLIN LAB SCI, V41, P244; Zhang Y, 2019, J CELL BIOCHEM, V120, P14372, DOI 10.1002/jcb.28693; Zhou J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00091; Zhu W, 2018, BRAIN BEHAV IMMUN, V69, P568, DOI 10.1016/j.bbi.2018.02.004	38	29	30	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1872	1884		10.1096/fj.201902203RR	http://dx.doi.org/10.1096/fj.201902203RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914700				2022-12-28	WOS:000507308900124
J	Rodriguez, S; Little, HC; Daneshpajouhnejad, P; Shepard, BD; Tan, SY; Wolfe, A; Cheema, MU; Jandu, S; Woodward, OM; Talbot, CC; Berkowitz, DE; Rosenberg, AZ; Pluznick, JL; Wong, GW				Rodriguez, Susana; Little, Hannah C.; Daneshpajouhnejad, Parnaz; Shepard, Blythe D.; Tan, Stefanie Y.; Wolfe, Andrew; Cheema, Muhammad Umar; Jandu, Sandeep; Woodward, Owen M.; Talbot, C. Conover, Jr.; Berkowitz, Dan E.; Rosenberg, Avi Z.; Pluznick, Jennifer L.; Wong, G. William			Late-onset renal hypertrophy and dysfunction in mice lacking CTRP1	FASEB JOURNAL			English	Article						aging-associated renal physiology; C1q; TNF-related protein 1; kidney function	ADIPOSE-TISSUE INFLAMMATION; FACTOR-RELATED PROTEIN-9; IMPROVES INSULIN ACTION; C1Q/TNF-RELATED PROTEIN-1; MOLECULAR-MECHANISMS; CARDIAC-HYPERTROPHY; HEPATIC STEATOSIS; MYOCARDIAL INJURY; FOOD-INTAKE; ADIPOKINE	Local and systemic factors that influence renal structure and function in aging are not well understood. The secretory protein C1q/TNF-related protein 1 (CTRP1) regulates systemic metabolism and cardiovascular function. We provide evidence here that CTRP1 also modulates renal physiology in an age- and sex-dependent manner. In mice lacking CTRP1, we observed significantly increased kidney weight and glomerular hypertrophy in aged male but not female or young mice. Although glomerular filtration rate, plasma renin and aldosterone levels, and renal response to water restriction did not differ between genotypes, CTRP1-deficient male mice had elevated blood pressure. Echocardiogram and pulse wave velocity measurements indicated normal heart function and vascular stiffness in CTRP1-deficient animals, and increased blood pressure was not due to greater salt retention. Paradoxically, CTRP1-deficient mice had elevated urinary sodium and potassium excretion, partially resulting from reduced expression of genes involved in renal sodium and potassium reabsorption. Despite renal hypertrophy, markers of inflammation, fibrosis, and oxidative stress were reduced in CTRP1-deficient mice. RNA sequencing revealed alterations and enrichments of genes in metabolic processes in CTRP1-deficient animals. These results highlight novel contributions of CTRP1 to aging-associated changes in renal physiology.	[Rodriguez, Susana; Little, Hannah C.; Shepard, Blythe D.; Tan, Stefanie Y.; Cheema, Muhammad Umar; Pluznick, Jennifer L.; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Rodriguez, Susana; Little, Hannah C.; Tan, Stefanie Y.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [Daneshpajouhnejad, Parnaz; Rosenberg, Avi Z.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wolfe, Andrew] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Jandu, Sandeep; Berkowitz, Dan E.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Woodward, Owen M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Talbot, C. Conover, Jr.] Johns Hopkins Univ, Sch Med, Inst Basic Biomed Sci, Baltimore, MD USA; [Rosenberg, Avi Z.] NIDDK, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA; [Shepard, Blythe D.] Georgetown Univ, Dept Human Sci, Washington, DC USA; [Tan, Stefanie Y.] Pfizer Inc, Cambridge, MA USA; [Wolfe, Andrew] NIH, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA; [Berkowitz, Dan E.] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Georgetown University; Pfizer; National Institutes of Health (NIH) - USA; University of Alabama System; University of Alabama Birmingham	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.; Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA.	gwwong@jhmi.edu		Daneshpajouhnejad, Parnaz/0000-0002-8845-5813; Jandu, Sandeep/0000-0002-3931-9372; Rosenberg, Avi/0000-0003-2356-950X; Shepard, Blythe/0000-0001-6194-5268; Woodward, Owen M./0000-0001-9514-2180	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK084171, F31DK116537, DK107726]; American Diabetes Association (ADA) [1-18-PMF-022]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL128512]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American Diabetes Association (ADA)(American Diabetes Association); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK084171, F31DK116537 and DK107726; American Diabetes Association (ADA), Grant/Award Number: 1-18-PMF-022; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL128512	Akchurin OM, 2015, BLOOD PURIFICAT, V39, P84, DOI 10.1159/000368940; Appari M, 2017, CIRC RES, V120, P66, DOI 10.1161/CIRCRESAHA.116.309398; Arias T, 2013, J AM SOC ECHOCARDIOG, V26, P910, DOI 10.1016/j.echo.2013.04.016; Bai B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172271; Benavides-Vallve C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041691; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Chatterjee S, 2014, CIRCULATION, V129, P2403, DOI 10.1161/CIRCULATIONAHA.113.007559; CHO KJ, 2013, KOREAN J PHYS ANTHR, V26, P147, DOI DOI 10.11637/KJPA.2013.26.4.147; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Esteva-Font C, 2012, CELL MOL LIFE SCI, V69, P683, DOI 10.1007/s00018-011-0858-4; Han S, 2018, CIRC RES, V123, pE5, DOI 10.1161/CIRCRESAHA.118.312871; Han S, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/5479627; Han S, 2016, J NUTR BIOCHEM, V27, P43, DOI 10.1016/j.jnutbio.2015.08.018; Hoenig MP, 2014, CLIN J AM SOC NEPHRO, V9, P1272, DOI 10.2215/CJN.08860813; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; Kambara T, 2015, MOL CELL BIOL, V35, P2173, DOI 10.1128/MCB.01518-14; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kanemura N, 2017, ATHEROSCLEROSIS, V257, P138, DOI 10.1016/j.atherosclerosis.2017.01.014; Kann M, 2015, J AM SOC NEPHROL, V26, P2097, DOI 10.1681/ASN.2014090940; Knepper MA, 2001, CURR OPIN NEPHROL HY, V10, P655, DOI 10.1097/00041552-200109000-00017; Kurata A, 2006, KIDNEY INT, V70, P1717, DOI 10.1038/sj.ki.5001810; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Lei X, 2017, J BIOL CHEM, V292, P14836, DOI [10.1074/jbc.m116.766808, 10.1074/jbc.M116.766808]; Lei X, 2016, AM J PHYSIOL-ENDOC M, V310, pE1036, DOI 10.1152/ajpendo.00010.2016; Lei X, 2015, AM J PHYSIOL-ENDOC M, V308, pE792, DOI 10.1152/ajpendo.00383.2014; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Little HC, 2018, MOL CELL PROTEOMICS, V17, P1546, DOI 10.1074/mcp.RA118.000794; Liu ZH, 2017, BIOCHEM BIOPH RES CO, V490, P580, DOI 10.1016/j.bbrc.2017.06.081; Lu L, 2016, EUR HEART J, V37, P1762, DOI 10.1093/eurheartj/ehv649; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052587; Murayama MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9483; Murayama MA, 2014, BIOCHEM BIOPH RES CO, V443, P42, DOI 10.1016/j.bbrc.2013.11.040; Olson LE, 2003, CANCER RES, V63, P6602; Pan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094478; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Petersen PS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12735; Petersen PS, 2014, AM J PHYSIOL-REG I, V307, pR1458, DOI 10.1152/ajpregu.00335.2014; Peterson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088535; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Ramkumar N, 2014, AM J PHYSIOL-RENAL, V307, pF931, DOI 10.1152/ajprenal.00367.2014; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Scheler M, 2013, AM J PHYSIOL-CELL PH, V305, pC877, DOI 10.1152/ajpcell.00043.2013; Schmitt R, 2017, KIDNEY INT, V92, P569, DOI 10.1016/j.kint.2017.02.036; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Shabani P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118650; Shen Y, 2014, INT J CARDIOL, V174, P203, DOI 10.1016/j.ijcard.2014.03.205; Sun Y, 2013, CIRCULATION, V128, pS113, DOI 10.1161/CIRCULATIONAHA.112.000010; Svensson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158716; Tan SY, 2016, PHYSIOL GENOMICS, V48, P936, DOI 10.1152/physiolgenomics.00111.2016; Tang J, 2015, IEEE ICC, P1, DOI 10.1109/ICC.2015.7248289; Tighe P, 2013, METHODS, V61, P23, DOI 10.1016/j.ymeth.2013.01.003; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Wang HZ, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0266-7; Wei H, 2012, P NATL ACAD SCI USA, V109, pE841, DOI 10.1073/pnas.1202081109; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Weinstein JR, 2010, ADV CHRONIC KIDNEY D, V17, P302, DOI 10.1053/j.ackd.2010.05.002; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wolf RM, 2016, AM J PHYSIOL-ENDOC M, V310, pE332, DOI 10.1152/ajpendo.00248.2015; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu D, 2015, J MOL MED, V93, P1311, DOI 10.1007/s00109-015-1309-8; Xin YP, 2014, ENDOCR J, V61, P841, DOI 10.1507/endocrj.EJ14-0016; Yan WJ, 2017, CIRCULATION, V136, P2162, DOI 10.1161/CIRCULATIONAHA.117.029557; Yang Y, 2017, CELL PHYSIOL BIOCHEM, V42, P2130, DOI 10.1159/000479915; Yuasa D, 2016, FASEB J, V30, P1065, DOI 10.1096/fj.15-279885; Yuasa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099846; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319	85	3	3	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2657	2676		10.1096/fj.201900558RR	http://dx.doi.org/10.1096/fj.201900558RR		DEC 2019	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908037	Bronze, Green Accepted			2022-12-28	WOS:000504667600001
J	Komarynets, O; Chassot, A; Bernabeu, E; Czogalla, J; Roth, I; Liaudet, N; Prodon, F; Loffing, J; Feraille, E				Komarynets, Olga; Chassot, Alexandra; Bernabeu, Eva; Czogalla, Jan; Roth, Isabelle; Liaudet, Nicolas; Prodon, Francois; Loffing, Johannes; Feraille, Eric			Aldosterone controls primary cilium length and cell size in renal collecting duct principal cells	FASEB JOURNAL			English	Article						aldosterone; cell volume; collecting duct; primary cilium; sodium	EPITHELIAL NA+ CHANNEL; SODIUM-TRANSPORT; KIDNEY; AUTOPHAGY; DISEASE; INJURY; MTOR; FLOW; HOMEOSTASIS; ABSORPTION	Primary cilia are nonmotile sensory organelles found on the surface of almost all kidney tubule epithelial cells. Being exposed to the tubular lumen, primary cilia are thought to be chemo- and mechanosensors of luminal composition and flux, respectively. We hypothesized that, Na+ transport and primary cilia exist in a sensory functional connection in mature renal tubule epithelial cells. Our results demonstrate that primary cilium length is reduced in mineralocorticoid receptor (MR) knockout (KO) mice in a cell autonomous manner along the aldosterone-sensitive distal nephron (ADSN) compared with wild type (as mu m +/- SEM; 3.1 +/- 0.2 vs 4.0 +/- 0.1). In mouse cortical collecting duct (mCCD)(cl1) cells, which are a model of collecting duct (CD) principal cells, changes in Na+ transport intensity were found to mediate primary cilium length in response to aldosterone (as mu m +/- SEM: control: 2.7 +/- 0.9 vs aldosterone treated: 3.8 +/- 0.8). Cilium length was positively correlated with the availability of IFT88, a major intraflagellar anterograde transport complex B component, which is stabilized in response to exposure to aldosterone treatment. This suggests that the abundance of IFT88 is a regulated, rate limiting factor in the elongation of primary cilia. As previously observed in vivo, aldosterone treatment increased cell volume of cultured CD principal cells. Knockdown of IFT88 prevents ciliogenesis and inhibits the adaptive increase in cell size that was observed in response to aldosterone treatment. In conclusion, our results reveal a functional connection between Na+ transport, primary cilia, and cell size, which may play a key role in the morphological and functional adaptation of the CD to sustained changes in active Na+ reabsorption due to variations in aldosterone secretion.	[Komarynets, Olga; Chassot, Alexandra; Bernabeu, Eva; Roth, Isabelle; Feraille, Eric] Univ Geneva, Univ Med Ctr, Fac Med Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Czogalla, Jan; Loffing, Johannes] Univ Zurich, Inst Anat, Zurich, Switzerland; [Liaudet, Nicolas; Prodon, Francois] Univ Geneva, Serv Bioimaging, Geneva, Switzerland	University of Geneva; University of Zurich; University of Geneva	Feraille, E (corresponding author), Univ Med Ctr, Fac Med Geneva, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@unige.ch	Czogalla, Jan/AAI-9223-2020; Loffing, Johannes/ABG-9973-2020	Feraille, Eric/0000-0003-1656-8365; Loffing, Johannes/0000-0002-9415-6588; Liaudet, Nicolas/0000-0002-0749-5857	Swiss National Science Foundation [31003A_156736/1, 31003A_175471/1]; Fondation Ernst et Lucie Schmidheiny; National Center of Competence in Research Kidney Control of Homeostasis	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Ernst et Lucie Schmidheiny; National Center of Competence in Research Kidney Control of Homeostasis	National Center of Competence in Research Kidney Control of Homeostasis and Swiss National Science Foundation, Grant/Award Number: 31003A_156736/1 and 31003A_175471/1; Fondation Ernst et Lucie Schmidheiny	Atkinson KF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00103; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Barker AR, 2014, ORGANOGENESIS, V10, P96, DOI 10.4161/org.27375; Benmerah Alexandre, 2015, Cilia, V4, P5, DOI 10.1186/s13630-015-0014-0; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Boron WF., 2009, MED PHYSL CELLULAR M, V2nd edition; Canonica J, 2016, PFLUG ARCH EUR J PHY, V468, P895, DOI 10.1007/s00424-015-1785-2; Carrisoza-Gaytan R, 2017, AM J PHYSIOL-RENAL, V312, pF143, DOI 10.1152/ajprenal.00256.2016; Chen ZG, 2014, J AM SOC NEPHROL, V25, P534, DOI 10.1681/ASN.2013030225; Czogalla J, 2016, PFLUG ARCH EUR J PHY, V468, P849, DOI 10.1007/s00424-016-1798-5; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Ernandez T, 2018, AM J PHYSIOL-RENAL, V314, pF763, DOI 10.1152/ajprenal.00200.2017; Fantus D, 2016, NAT REV NEPHROL, V12, P587, DOI 10.1038/nrneph.2016.108; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gorelik J, 2005, P NATL ACAD SCI USA, V102, P15000, DOI 10.1073/pnas.0507008102; Han SJ, 2017, BBA-MOL BASIS DIS, V1863, P1817, DOI 10.1016/j.bbadis.2017.05.004; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22281; Ivanova EA, 2016, J INHERIT METAB DIS, V39, P457, DOI 10.1007/s10545-016-9919-z; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kim JI, 2013, AM J PHYSIOL-RENAL, V304, pF1283, DOI 10.1152/ajprenal.00427.2012; Kohli P, 2017, EMBO REP, V18, P1521, DOI 10.15252/embr.201643846; Lang F, 2016, NEPHROL DIAL TRANSPL, V31, P200, DOI 10.1093/ndt/gfv270; Malicki J, 2014, ORGANOGENESIS, V10, P138, DOI 10.4161/org.29055; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mounier R, 2011, CELL CYCLE, V10, P2640, DOI 10.4161/cc.10.16.17102; Nag S, 2017, AM J PHYSIOL-RENAL, V313, pF706, DOI 10.1152/ajprenal.00172.2017; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; O'Connor Amber K, 2013, Cilia, V2, P8, DOI 10.1186/2046-2530-2-8; Olteanu D, 2006, AM J PHYSIOL-CELL PH, V290, pC952, DOI 10.1152/ajpcell.00339.2005; Orhon I, 2015, CELL DEATH DIFFER, V22, P389, DOI 10.1038/cdd.2014.171; Orhon I, 2016, NAT CELL BIOL, V18, P657, DOI 10.1038/ncb3360; Pala R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112272; Park Kwon Moo, 2018, Chonnam Med J, V54, P83, DOI 10.4068/cmj.2018.54.2.83; Pluznick JL, 2015, CLIN J AM SOC NEPHRO, V10, P1626, DOI 10.2215/CJN.00730114; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Praetorius HA, 2013, SEMIN CELL DEV BIOL, V24, P3, DOI 10.1016/j.semcdb.2012.10.003; Rafestin-Oblin ME, 2002, MOL PHARMACOL, V62, P1306, DOI 10.1124/mol.62.6.1306; Raghavan V, 2016, AM J PHYSIOL-RENAL, V310, pF1, DOI 10.1152/ajprenal.00373.2015; Rodat-Despoix L, 2009, PFLUG ARCH EUR J PHY, V458, P179, DOI 10.1007/s00424-008-0632-0; Saigusa T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12405; Sanchez I, 2016, NAT CELL BIOL, V18, P711, DOI 10.1038/ncb3370; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Song JP, 2017, HYPERTENSION, V70, P324, DOI 10.1161/HYPERTENSIONAHA.117.09584; Spasic M, 2017, EUR CELLS MATER, V33, P158, DOI 10.22203/eCM.v033a12; Sullivan LM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004142; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Viau A, 2018, EMBO J, V37, DOI 10.15252/embj.201798615; WADE JB, 1990, AM J PHYSIOL, V259, pF88, DOI 10.1152/ajprenal.1990.259.1.F88; Wall SM, 2013, AM J PHYSIOL-RENAL, V305, pF427, DOI 10.1152/ajprenal.00022.2013; Wang L, 2015, AM J PHYSIOL-REG I, V309, pR757, DOI 10.1152/ajpregu.00173.2015; Wang SX, 2015, AUTOPHAGY, V11, P607, DOI 10.1080/15548627.2015.1023983; Wang SX, 2013, AM J PHYSIOL-RENAL, V305, pF1085, DOI 10.1152/ajprenal.00399.2013; Wang YB, 2014, J AM SOC NEPHROL, V25, P250, DOI 10.1681/ASN.2013040429; Wildman SSP, 2008, J AM SOC NEPHROL, V19, P731, DOI 10.1681/ASN.2007040443	58	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2625	2640		10.1096/fj.201901947R	http://dx.doi.org/10.1096/fj.201901947R		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908048	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000503398300001
J	Chang, XB; Shi, XB; Zhang, XZ; Chen, J; Fan, XM; Yang, YH; Wang, L; Wang, AP; Deng, RG; Zhou, EM; Zhang, GP				Chang, Xiaobo; Shi, Xibao; Zhang, Xiaozhuan; Chen, Jing; Fan, Xiaomin; Yang, Yuanhao; Wang, Li; Wang, Aiping; Deng, Ruiguang; Zhou, Enmin; Zhang, Gaiping			miR-382-5p promotes porcine reproductive and respiratory syndrome virus (PRRSV) replication by negatively regulating the induction of type I interferon	FASEB JOURNAL			English	Article						antiviral protein; HSP60; MAVS	ANTIVIRAL INNATE IMMUNITY; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; MICRORNA; MAVS; PATHOGENESIS; MACROPHAGES; RECOGNITION; SUPPRESSOR; COMPLEX	Previous studies have indicated that inhibition of type I interferon production may be an important reason for porcine reproductive and respiratory syndrome virus (PRRSV) to achieve immune escape, revealing the mechanism of inhibiting the production of type I interferon will help design novel strategies for controlling PRRS. Here, we found that PRRSV infection upregulated the expression of miR-382-5p, which in turn inhibited polyI:C-induced the production of type I interferon by targeting heat shock protein 60 (HSP60), thus facilitating PRRSV replication in MARC-145 cells. Furthermore, we found that HSP60 could interact with mitochondrial antiviral signaling protein (MAVS), an important signal transduction protein for inducing production of type I interferon, and promote polyI:C-mediated the production of type I interferon in a MAVS-dependent manner. Finally, we also found that HSP60 could inhibit PRRSV replication in a MAVS-dependent manner, which indicated that HSP60 was a novel antiviral protein against PRRSV replication. In conclusion, the study demonstrated that miR-382-5p was upregulated during PRRSV infection and may promote PRRSV replication by negatively regulating the production of type I interferon, which also indicated that miR-382-5p and HSP60 might be the potential therapeutic targets for anti-PRRSV.	[Chang, Xiaobo; Shi, Xibao; Wang, Li; Deng, Ruiguang; Zhang, Gaiping] Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, 116 Huayuan Rd, Zhengzhou 450002, Henan, Peoples R China; [Chang, Xiaobo; Zhou, Enmin; Zhang, Gaiping] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Shi, Xibao; Zhang, Xiaozhuan; Fan, Xiaomin; Yang, Yuanhao] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China; [Chen, Jing; Zhang, Gaiping] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Wang, Aiping; Zhang, Gaiping] Zhengzhou Univ, Dept Bioengn, Zhengzhou, Peoples R China	Henan Academy of Agricultural Sciences; Northwest A&F University - China; Henan Normal University; Henan Agricultural University; Zhengzhou University	Zhang, GP (corresponding author), Henan Acad Agr Sci, Henan Prov Key Lab Anim Immunol, 116 Huayuan Rd, Zhengzhou 450002, Henan, Peoples R China.	zhanggaiping2003@163.com			National Natural Science Fund [31490600]; Henan Natural Science Foundation [182300410077]; Henan Normal University Outstanding Youth Science Fund [20170031]; Henan Province Animal Immunology Key Laboratory Open Project [PKLAI20170605]; Key Scientific Research Projects of Henan Provincial Institution of Higher Education [17A180006]; National Foundation of China [31472177]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Henan Natural Science Foundation; Henan Normal University Outstanding Youth Science Fund; Henan Province Animal Immunology Key Laboratory Open Project; Key Scientific Research Projects of Henan Provincial Institution of Higher Education; National Foundation of China	National Natural Science Fund, Grant/Award Number: 31490600; Henan Natural Science Foundation, Grant/Award Number: 182300410077; Henan Normal University Outstanding Youth Science Fund, Grant/Award Number: 20170031; Henan Province Animal Immunology Key Laboratory Open Project, Grant/Award Number: PKLAI20170605; Key Scientific Research Projects of Henan Provincial Institution of Higher Education, Grant/Award Number: 17A180006; National Foundation of China, Grant/Award Number: 31472177	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; [Anonymous], CELL MOL IMMUNOL, DOI DOI 10.1099/vir.0.030213-0; [Anonymous], FRONT VET SCI; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beura LK, 2010, J VIROL, V84, P1574, DOI 10.1128/JVI.01326-09; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Catalfamo M, 2018, CELL MOL IMMUNOL, V15, P402, DOI 10.1038/cmi.2017.80; Chang XB, 2018, VET RES, V49, DOI 10.1186/s13567-018-0571-5; Chen J, 2017, J VIROL, V91, DOI 10.1128/JVI.01311-16; Chen LQ, 2016, J BIOL CHEM, V291, P14706, DOI 10.1074/jbc.M115.700252; Chen NH, 2019, INFECT GENET EVOL, V68, P127, DOI 10.1016/j.meegid.2018.12.011; Chen YN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003248; Chun JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009422; Dey R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28279; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Gammazza AM, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120224; Gomez-Laguna J, 2013, VET J, V195, P148, DOI 10.1016/j.tvjl.2012.11.012; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hanada K, 2005, MOL BIOL EVOL, V22, P1024, DOI 10.1093/molbev/msi089; He X, 2018, EXP CELL RES, V369, P197, DOI 10.1016/j.yexcr.2018.05.019; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jang SI, 2019, EBIOMEDICINE, V48, P526, DOI 10.1016/j.ebiom.2019.09.010; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Leelarasamee N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006947; Li AM, 2013, INT J BIOCHEM CELL B, V45, P858, DOI 10.1016/j.biocel.2013.01.008; Lin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114874; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu BY, 2018, CURR OPIN IMMUNOL, V50, P75, DOI 10.1016/j.coi.2017.12.002; Liu BY, 2017, NAT IMMUNOL, V18, P214, DOI 10.1038/ni.3641; Liuyu TZ, 2019, CELL RES, V29, P67, DOI 10.1038/s41422-018-0107-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunney JK, 2016, ANNU REV ANIM BIOSCI, V4, P129, DOI 10.1146/annurev-animal-022114-111025; Luo R, 2008, MOL IMMUNOL, V45, P2839, DOI 10.1016/j.molimm.2008.01.028; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Milani A, 2019, IMMUNOTHERAPY-UK, V11, P215, DOI 10.2217/imt-2018-0105; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Overend C, 2007, J GEN VIROL, V88, P925, DOI 10.1099/vir.0.82585-0; Padwad YS, 2009, IMMUNOBIOLOGY, V214, P422, DOI 10.1016/j.imbio.2008.11.010; Parissi V, 2001, J VIROL, V75, P11344, DOI 10.1128/JVI.75.23.11344-11353.2001; Park SG, 2001, J VIROL, V75, P6962, DOI 10.1128/JVI.75.15.6962-6968.2001; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saliminejad K, 2019, J CELL PHYSIOL, V234, P5451, DOI 10.1002/jcp.27486; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi X, 2016, ACTA VIROL, V60, P290, DOI 10.4149/av_2016_03_290; Shi XB, 2010, VIRUS RES, V153, P151, DOI 10.1016/j.virusres.2010.07.028; Smith S, 2017, J AUTOIMMUN, V79, P105, DOI 10.1016/j.jaut.2017.03.003; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V318, P461, DOI 10.1016/j.bbrc.2004.04.046; VanReeth K, 1996, VET MICROBIOL, V48, P325, DOI 10.1016/0378-1135(95)00145-X; Vilasi S, 2018, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00099; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wu JM, 2017, TRENDS PHARMACOL SCI, V38, P226, DOI 10.1016/j.tips.2016.11.009; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang F, 2017, J HEALTHC ENG, V2017, DOI 10.1155/2017/4620732; Younis S, 2018, P NATL ACAD SCI USA, V115, pE3808, DOI 10.1073/pnas.1722333115; Zhang FM, 2019, BIOMED PHARMACOTHER, V111, P740, DOI 10.1016/j.biopha.2018.12.103; Zhang SM, 2005, ARCH VIROL, V150, P1579, DOI 10.1007/s00705-005-0521-1; Zheng HQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113381; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19	71	11	11	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4497	4511		10.1096/fj.201902031RRR	http://dx.doi.org/10.1096/fj.201902031RRR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32037657				2022-12-28	WOS:000512569700001
J	Li, TG; Gong, H; Yuan, QC; Du, M; Ren, FZ; Mao, XY				Li, Tiange; Gong, Han; Yuan, Qichen; Du, Min; Ren, Fazheng; Mao, Xueying			Supplementation of polar lipids-enriched milk fat globule membrane in high-fat diet-fed rats during pregnancy and lactation promotes brown/beige adipocyte development and prevents obesity in male offspring	FASEB JOURNAL			English	Article						beige adipogenesis; maternal obesity; polar lipids-enriched milk fat globule membrane; thermogenesis; uncoupling protein 1	BROWN ADIPOSE-TISSUE; UNCOUPLING PROTEIN-1 EXPRESSION; UNTIL 12 MO; MATERNAL OBESITY; BODY-FAT; RESVERATROL SUPPLEMENTATION; ENDOCANNABINOID SYSTEM; ENERGY-EXPENDITURE; GUT MICROBIOTA; CHOLINE INTAKE	Promoting brown adipose tissue (BAT) function or browning of white adipose tissue (WAT) provides a defense against obesity. The aim of the study was to investigate whether maternal polar lipids-enriched milk fat globule membrane (MFGM-PL) supplementation to high-fat diet (HFD) rats during pregnancy and lactation could promote brown/beige adipogenesis and protect against HFD-induced adiposity in offspring. Female SD rats were fed a HFD for 8 weeks to induce obesity and, then, fed a HFD during pregnancy and lactation with or without MFGM-PL. Male offspring were weaned at postnatal Day 21 and then fed a HFD for 9 weeks. MFGM-PL treatment to HFD dams decreased the body weight gain and WAT mass as well as lowered the serum levels of insulin and triglycerides in male offspring at weaning. MFGM-PL+HFD offspring showed promoted thermogenic function in BAT and inguinal WAT through the upregulation of UCP1 and other thermogenic genes. In adulthood, maternal MFGM-PL supplementation reduced adiposity and increased oxygen consumption, respiratory exchange ratio, and heat production in male offspring. The enhancement of energy expenditure was correlated with elevated BAT activity and inguinal WAT thermogenic program. In conclusion, maternal MFGM-PL treatment activated thermogenesis in offspring, which exerted long-term beneficial effects against HFD-induced obesity in later life.	[Li, Tiange; Gong, Han; Yuan, Qichen; Ren, Fazheng; Mao, Xueying] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Key Lab Funct Dairy, Beijing, Peoples R China; [Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	China Agricultural University; Washington State University	Mao, XY (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100083, Peoples R China.	maoxueying@cau.edu.cn	Du, Min/H-4311-2011	Du, Min/0000-0002-7232-072X; Yuan, Qichen/0000-0001-9588-0968; Li, Tiange/0000-0002-5601-9224	NSFC; National Natural Science Foundation of China [31871806]; Beijing Dairy Industry Innovation Team [BAIC06-2020]	NSFC(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Dairy Industry Innovation Team	NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 31871806; Beijing Dairy Industry Innovation Team, Grant/Award Number: BAIC06-2020	Al-Makdissy N, 2003, CELL SIGNAL, V15, P1019, DOI 10.1016/S0898-6568(03)00070-6; Alfaradhi MZ, 2016, ENDOCRINOLOGY, V157, P4246, DOI 10.1210/en.2016-1314; Almeida MM, 2017, BRIT J NUTR, V118, P788, DOI 10.1017/S0007114517002884; Baars A, 2016, BRIT J NUTR, V115, P1930, DOI 10.1017/S0007114516001082; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Beals E, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.11; Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Butruille L, 2019, INT J OBESITY, V43, P2381, DOI 10.1038/s41366-018-0310-z; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Carobbio S, 2019, BBA-MOL CELL BIOL L, V1864, P37, DOI 10.1016/j.bbalip.2018.05.013; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; CHAO CK, 1988, BIOCHEM J, V254, P33, DOI 10.1042/bj2540033; Chondronikola M, 2019, BBA-MOL CELL BIOL L, V1864, P91, DOI 10.1016/j.bbalip.2018.05.014; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; del Bas JM, 2015, INT J OBESITY, V39, P7, DOI 10.1038/ijo.2014.159; Dias-Rocha CP, 2018, J NUTR BIOCHEM, V51, P56, DOI 10.1016/j.jnutbio.2017.09.019; Fischer LM, 2010, AM J CLIN NUTR, V92, P336, DOI 10.3945/ajcn.2010.29459; Franco JG, 2012, J PHYSIOL-LONDON, V590, P5503, DOI 10.1113/jphysiol.2012.240655; Gil-Sanchez A, 2010, AM J CLIN NUTR, V92, P115, DOI 10.3945/ajcn.2010.29589; Haramizu S, 2014, AM J PHYSIOL-REG I, V307, pR1009, DOI 10.1152/ajpregu.00004.2014; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hari S, 2015, BIOSCI BIOTECH BIOCH, V79, P1172, DOI 10.1080/09168451.2015.1012150; He X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36292-5; Hernell O, 2016, J PEDIATR-US, V173, pS60, DOI 10.1016/j.jpeds.2016.02.077; Jeremic N, 2017, J CELL PHYSIOL, V232, P61, DOI 10.1002/jcp.25450; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kruse M, 2013, ENDOCRINOLOGY, V154, P3565, DOI 10.1210/en.2012-1877; Lamothe S, 2008, J DAIRY RES, V75, P439, DOI 10.1017/S002202990800349X; Lecoutre S, 2014, ADIPOCYTE, V3, P256, DOI 10.4161/adip.29806; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Li TE, 2018, J FUNCT FOODS, V47, P56, DOI 10.1016/j.jff.2018.05.038; Li TG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030331; Liang XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34345; Liang XW, 2016, J PHYSIOL-LONDON, V594, P4453, DOI 10.1113/JP272123; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Markworth JF, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0161-y; McNamara JP, 2018, ANNU REV ANIM BIOSCI, V6, P177, DOI 10.1146/annurev-animal-030117-014720; Merkestein M, 2014, MAMM GENOME, V25, P413, DOI 10.1007/s00335-014-9528-9; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Nestel PJ, 2014, AM J CLIN NUTR, V99, P46, DOI 10.3945/ajcn.113.071712; Norris GH, 2017, J NUTR BIOCHEM, V40, P36, DOI 10.1016/j.jnutbio.2016.09.017; Norris GH, 2016, J NUTR BIOCHEM, V30, P93, DOI 10.1016/j.jnutbio.2015.12.003; Ohta T, 2017, ANIM SCI J, V88, P149, DOI 10.1111/asj.12606; Reis MG, 2013, J AGR FOOD CHEM, V61, P2729, DOI 10.1021/jf303795b; Roberts VHJ, 2014, FASEB J, V28, P2466, DOI 10.1096/fj.13-245472; Saito M, 2013, DIABETES METAB J, V37, P22, DOI 10.4093/dmj.2013.37.1.22; Scholler M, 2012, J CLIN ENDOCR METAB, V97, P2466, DOI 10.1210/jc.2011-2969; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Segovia SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07108-9; Sellayah D, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121832; Symonds ME, 2012, DIABETOLOGIA, V55, P1597, DOI 10.1007/s00125-012-2505-5; Symonds ME, 2003, J ENDOCRINOL, V179, P293, DOI 10.1677/joe.0.1790293; Taylor PD, 2014, ACTA PHYSIOL, V210, P508, DOI 10.1111/apha.12223; Timby N, 2014, PEDIATR RES, V76, P394, DOI 10.1038/pr.2014.110; Timby N, 2014, AM J CLIN NUTR, V99, P860, DOI 10.3945/ajcn.113.064295; Uhl O, 2015, DIABETES RES CLIN PR, V109, P364, DOI 10.1016/j.diabres.2015.05.032; Wang B, 2017, EBIOMEDICINE, V18, P288, DOI 10.1016/j.ebiom.2017.03.041; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wankhade UD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175675; Wat E, 2009, ATHEROSCLEROSIS, V205, P144, DOI 10.1016/j.atherosclerosis.2008.12.004; Wiedeman AM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101513; Zhang X, 2016, INT J OBESITY, V40, P1841, DOI 10.1038/ijo.2016.108; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493; Zou TD, 2017, J PHYSIOL-LONDON, V595, P1547, DOI 10.1113/JP273478	68	16	16	5	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4619	4634		10.1096/fj.201901867RRR	http://dx.doi.org/10.1096/fj.201901867RRR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32020679				2022-12-28	WOS:000512309000001
J	Ge, QW; Hu, YY; He, JM; Chen, F; Wu, LP; Tu, XT; Qi, YD; Zhang, ZH; Xue, M; Chen, SJ; Zhong, J; Wang, LJ				Ge, Qiwei; Hu, Yingying; He, Jiamin; Chen, Fei; Wu, Lunpo; Tu, Xintao; Qi, Yadong; Zhang, Zizhen; Xue, Meng; Chen, Shujie; Zhong, Jing; Wang, Liangjing			Zic1 suppresses gastric cancer metastasis by regulating Wnt/beta-catenin signaling and epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						EMT; gastric cancer; metastasis; Wnt; beta-catenin; Zic1	GENE-EXPRESSION; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; BINDING	Gastric cancer (GC) patients with metastasis had limited treatment options and dismal outcome. We have previously reported the aberrant expression of Zic family member 1 (Zic1) in GC. However, the functional roles and underlying mechanism of Zic1 in GC metastasis remain unknown. Here, we demonstrate that lower expression of Zic1 was correlated with more lymph node metastasis and poor outcome of GC patients. Ectopic expression of Zic1 suppressed both lung metastasis and peritoneal tumor dissemination of GC in mice. The metastatic suppressing ability of Zic1 was mediated by regulating the process of cell invasion, adhesion and epithelial-mesenchymal transition (EMT). Mechanistically, Zic1 could downregulate Wnt targets including c-Myc and Cyclin D1 by inhibiting LEF transcriptional activity in GC cells. Notably, Zic1 was inversely related to the expression of Cyclin D1 in GC tissues tested. In addition, Zic1 could physically interact with beta-catenin/transcription factor 4 (TCF4) and disrupt their complex formation, while not affecting beta-catenin nuclear localization. Collectively, our study indicated that Zic1 suppressed GC metastasis through attenuating Wnt/beta-catenin signaling and the EMT process. Our work may provide novel therapeutic strategies for the metastasis of GC.	[Ge, Qiwei; Chen, Fei; Wu, Lunpo; Zhang, Zizhen; Xue, Meng; Zhong, Jing; Wang, Liangjing] Second Affiliated Hosp Zhejiang Univ Sch Med, Dept Gastroenterol, Hangzhou, Peoples R China; [Ge, Qiwei; Hu, Yingying; He, Jiamin; Chen, Fei; Wu, Lunpo; Qi, Yadong; Zhang, Zizhen; Xue, Meng; Chen, Shujie; Zhong, Jing; Wang, Liangjing] Zhejiang Univ, Institut Gastroenterol, Hangzhou, Peoples R China; [Hu, Yingying; He, Jiamin; Qi, Yadong; Chen, Shujie] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou, Peoples R China; [Tu, Xintao] Univ Texas SW Med Ctr, Dept Immunol, Dallas, TX USA; Second Affiliated Hosp Zhejiang Univ Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhong, J; Wang, LJ (corresponding author), Second Affiliated Hosp Zhejiang Univ Sch Med, Dept Gastroenterol, Hangzhou, Peoples R China.	2512022@zju.edu.cn; wangljzju@zju.edu.cn	Qi, Yadong/GVT-3797-2022; Tu, Xintao/AGW-3112-2022; Zhang, Zizhen/AAA-1539-2022; Hu, Ying/GQZ-8100-2022					Ali RG, 2012, INT J BIOCHEM CELL B, V44, P2065, DOI 10.1016/j.biocel.2012.08.012; Aruga J, 1998, J NEUROSCI, V18, P284; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brill E, 2010, CANCER RES, V70, P6891, DOI 10.1158/0008-5472.CAN-10-0745; Chen XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115116; Cheng YY, 2013, J THORAC ONCOL, V8, P1317, DOI 10.1097/JTO.0b013e3182a0840a; Chiacchiera F, 2016, CELL STEM CELL, V18, P91, DOI 10.1016/j.stem.2015.09.019; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Degreef I, 2009, SCAND J PLAST RECONS, V43, P36, DOI 10.1080/02844310802489806; Deng YZ, 2012, GASTROENTEROLOGY, V142, P812, DOI 10.1053/j.gastro.2011.12.046; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujimi TJ, 2012, DEV BIOL, V361, P220, DOI 10.1016/j.ydbio.2011.10.026; Gan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016916; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Han W, 2018, INT J ONCOL, V53, P937, DOI 10.3892/ijo.2018.4450; Howe LR, 2003, CANCER RES, V63, P1906; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Liu LM, 2018, BIOCHEM BIOPH RES CO, V503, P2173, DOI 10.1016/j.bbrc.2018.08.009; Lu Y, 2017, CELL RES, V27, P1422, DOI 10.1038/cr.2017.107; Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm; Milet C, 2013, P NATL ACAD SCI USA, V110, P5528, DOI 10.1073/pnas.1219124110; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Pourebrahim R, 2007, FEBS LETT, V581, P5122, DOI 10.1016/j.febslet.2007.09.061; Pourebrahim R, 2011, J BIOL CHEM, V286, P37732, DOI 10.1074/jbc.M111.242826; Qiang W, 2014, J CLIN ENDOCR METAB, V99, pE1163, DOI 10.1210/jc.2013-3729; Tejpar S, 2005, ACTA GASTRO-ENT BELG, V68, P5; Thrumurthy SG, 2015, NAT REV CLIN ONCOL, V12, P676, DOI 10.1038/nrclinonc.2015.132; Townsley FM, 2004, J BIOL CHEM, V279, P5177, DOI 10.1074/jbc.M309722200; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang LJ, 2009, BIOCHEM BIOPH RES CO, V379, P959, DOI 10.1016/j.bbrc.2008.12.180; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Yang SC, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0700-1; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhao ZB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0698; Zhong J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-290	41	11	14	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2161	2172		10.1096/fj.201901372RR	http://dx.doi.org/10.1096/fj.201901372RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909528				2022-12-28	WOS:000514663600017
J	Izquierdo, AG; Carreira, MC; Amil, M; Mosteiro, CS; Garcia-Caballero, T; Fernandez-Quintela, A; Portillo, MP; Casanueva, FF; Crujeiras, AB				Izquierdo, Andrea G.; Carreira, Marcos C.; Amil, Maria; Mosteiro, Carlos S.; Garcia-Caballero, Tomas; Fernandez-Quintela, Alfredo; Portillo, Maria P.; Casanueva, Felipe F.; Crujeiras, Ana B.			An energy restriction-based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor-promoting genes	FASEB JOURNAL			English	Article						adipose tissue dysfunction; carcinogenesis; inflammation; NAFLD; NASH; oxidative stress	INFLAMMATION-RELATED GENES; OXIDATIVE STRESS; ADIPOSE-TISSUE; MONONUCLEAR-CELLS; SECRETED FACTORS; FATTY LIVER; CANCER; OVERWEIGHT; SURVIVIN; DISEASE	The epidemiological evidence regarding the association of obesity with liver disease and possibly hepatocellular carcinoma highlights the need for investigations of whether obesity itself could induce the differential expression of genes commonly associated with the initial phase of liver tumorigenesis, and whether such phenomenon could be reversed after a weight loss intervention. In this study, obese Zucker rats were found to have dysregulated cell proliferation, antioxidative defenses, and tumor suppressor gene expression in association with liver dysfunction parameters, as well as oxidative stress and inflammation. Importantly, after a 4-week weight loss protocol of energy restriction and/or exercise, this effect on the liver carcinogenesis-related genes was reversed concomitantly with reductions in the fat mass, hepatic lipid content, oxidative stress, and inflammation. The findings indicate that the oxidative stress and inflammation associated with excess adiposity promote dysregulation of the genes involved in liver tumorigenesis. This is clinically relevant because these effects were detectable in the liver without evidence of a tumoral mass and were reversed after weight loss. Consequently, this study reveals the susceptibility of obese individuals to the initiation of a hepatocarcinogenic process, and how this can be prevented by achieving a healthy body weight.	[Izquierdo, Andrea G.; Crujeiras, Ana B.] Complejo Hospitalario Universitario Santiago Comp, Lab Epign Endocrinol, Instituto Investigac Sanitaria Santiago Compostel, IDIS,CHUS,SERGAS,Nutr, Santiago De Compostela, Spain; [Izquierdo, Andrea G.; Carreira, Marcos C.; Amil, Maria; Fernandez-Quintela, Alfredo; Portillo, Maria P.; Casanueva, Felipe F.; Crujeiras, Ana B.] CIBER Fisiopatol Obes Nutr, CIBERobn, Madrid, Spain; [Carreira, Marcos C.; Amil, Maria; Mosteiro, Carlos S.; Casanueva, Felipe F.] Santiago Compostela Univ, Complejo Hospitalario Universitario Santiago Comp, Lab Mol, Instituto Investigac Sanitaria Santiago Compostel, Santiago De Compostela, Spain; [Garcia-Caballero, Tomas] Univ Santiago Compostela, Sch Med, Dept Morphol Sciences, Santiago De Compostela, Spain; [Fernandez-Quintela, Alfredo; Portillo, Maria P.] Univ Basque Country, Lucio Lascaray Res Inst,Hlth Res Inst BIOARABA, Dept Nutr,UPV,EHU,Nutr,Obes Grp,Food Sci, Vitoria, Spain; Epign Unit, E-15706 Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidade de Santiago de Compostela; Bioaraba Health Research Institute; University of Basque Country	Crujeiras, AB (corresponding author), Complejo Hospitalario Universitario Santiago Comp, Lab Epign Endocrinol, Instituto Investigac Sanitaria Santiago Compostel, IDIS,CHUS,SERGAS,Nutr, Santiago De Compostela, Spain.	anabelencrujeiras@hotmail.com	Portillo, Maria Puy/ABH-2374-2020; Crujeiras, Ana/ABA-8866-2021; Izquierdo, Andrea G/ABB-9559-2020	Portillo, Maria Puy/0000-0003-0210-6549; Crujeiras, Ana/0000-0003-4392-0301; Izquierdo, Andrea G/0000-0002-0846-8834; Garcia-Caballero, Tomas/0000-0002-7938-1437; PORTILLO BAQUEDANO, MARIA PUY/0000-0003-2290-592X; Fernandez-Quintela, Alfredo/0000-0003-2709-4118				Abraham PE, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.178, 10.1038/nplants.2016.178]; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Beltran-Ramirez O, 2010, TRANSL ONCOL, V3, P142, DOI 10.1593/tlo.09298; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Boutari C, 2018, METABOLISM, V81, pA3, DOI 10.1016/j.metabol.2017.12.015; Bultman SJ, 2018, TRENDS ENDOCRIN MET, V29, P529, DOI 10.1016/j.tem.2018.05.004; Cabia B, 2016, OBES REV, V17, P361, DOI 10.1111/obr.12377; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Crujeiras AB, 2008, EUR J CLIN INVEST, V38, P672, DOI 10.1111/j.1365-2362.2008.01998.x; Crujeiras AB, 2017, INT J OBESITY, V41, P1570, DOI 10.1038/ijo.2017.138; Crujeiras AB, 2016, INT J OBESITY, V40, P514, DOI 10.1038/ijo.2015.208; Crujeiras AB, 2016, INT J OBESITY, V40, P403, DOI 10.1038/ijo.2015.206; Crujeiras AB, 2009, EUR J NUTR, V48, P341, DOI 10.1007/s00394-009-0019-9; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gan L, 2018, BBA-REV CANCER, V1869, P97, DOI 10.1016/j.bbcan.2017.12.006; Garces-Rimon M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040441; Gomez-Arbelaez D, 2017, J CLIN ENDOCR METAB, V102, P488, DOI 10.1210/jc.2016-2385; Gomez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753; Halliwell B., 2007, FREE RADICALS BIOL M; Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Krstic J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030921; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Li RF, 2018, CELL REP, V22, P624, DOI 10.1016/j.celrep.2017.12.071; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; Mi CJ, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431x20198009, 10.1590/1414-431X20198009]; Morgan MM, 2019, FASEB J, V33, P8623, DOI 10.1096/fj.201802347RRR; O'Sullivan J, 2018, NAT REV GASTRO HEPAT, V15, P699, DOI 10.1038/s41575-018-0069-7; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Said A, 2017, WORLD J CLIN ONCOL, V8, P429, DOI 10.5306/wjco.v8.i6.429; Sanchez-Perez Y, 2005, CANCER LETT, V217, P25, DOI 10.1016/j.canlet.2004.07.019; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Upadhyay J, 2018, MED CLIN N AM, V102, P13, DOI 10.1016/j.mcna.2017.08.004; Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177	48	9	9	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2312	2325		10.1096/fj.201901147RR	http://dx.doi.org/10.1096/fj.201901147RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908001	Bronze			2022-12-28	WOS:000514663600027
J	Jacob, S; Kohler, M; Troster, P; Visa, M; Garcia-Prieto, CF; Alanentalo, T; Moede, T; Leibiger, B; Leibiger, IB; Berggren, PO				Jacob, Stefan; Kohler, Martin; Troster, Philip; Visa, Montse; Garcia-Prieto, Concha F.; Alanentalo, Tomas; Moede, Tilo; Leibiger, Barbara; Leibiger, Ingo B.; Berggren, Per-Olof			In vivo Ca2+ dynamics in single pancreatic beta cells	FASEB JOURNAL			English	Article						calcium dynamics; diabetes mellitus; fluorescence microscopy; in vivo imaging; pancreatic islets	INHIBITS INSULIN-SECRETION; CALCIUM DYNAMICS; ISLETS; GLUCOSE; ISOFLURANE; EXPOSURE; MODEL	The dynamics of cytoplasmic free Ca2+ concentration ([Ca2+](i)) in pancreatic beta cells is central to our understanding of beta-cell physiology and pathology. In this context, there are numerous in vitro studies available but existing in vivo data are scarce. We now critically evaluate the anterior chamber of the eye as an in vivo, non-invasive, imaging site for measuring [Ca2+](i) dynamics longitudinally in three dimensions and at single-cell resolution. By applying a fluorescently labeled glucose analogue 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose in vivo, we followed how glucose almost simultaneously distributes to all cells within the islet volume, resulting in [Ca2+](i) changes. We found that almost all beta cells in healthy mice responded to a glucose challenge, while in hyperinsulinemic, hyperglycemic mice about 80% of the beta cells could not be further stimulated from fasting basal conditions. This finding indicates that our imaging modality can resolve functional heterogeneity within the beta-cell population in terms of glucose responsiveness. Importantly, we demonstrate that glucose homeostasis is markedly affected using isoflurane compared to hypnorm/midazolam anesthetics, which has major implications for [Ca2+](i) measurements. In summary, this setup offers a powerful tool to further investigate in vivo pancreatic beta-cell [Ca2+](i) response patterns at single-cell resolution in health and disease.	[Jacob, Stefan; Kohler, Martin; Troster, Philip; Visa, Montse; Garcia-Prieto, Concha F.; Alanentalo, Tomas; Moede, Tilo; Leibiger, Barbara; Leibiger, Ingo B.; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden	Karolinska Institutet	Troster, P; Berggren, PO (corresponding author), Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, Solna L1 03, SE-17176 Stockholm, Sweden.	philip.troster@ki.se; Per-Olof.Berggren@ki.se	Visa, Montse/AAQ-8529-2021	Berggren, Per-Olof/0000-0001-8991-413X; Jacob, Stefan/0000-0001-8456-3924; Moede, Tilo/0000-0002-2045-9244	Svenska Forskningsradet Formas (Swedish Research Council Formas); Erling-Persson Foundation; Stichting af Jochnick Foundation (Jochnick Foundation); Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research); Swedish Diabetes Association; Scandia Insurance Company Ltd; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; BetaImage ERC-2013-AdG [338936]; Swedish Foundation for Strategic Research; Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); EYELETS ERC-2018-AdG [834860]; BETASCREEN ERC-2017-PoC [727306]; Diabetes Research and Wellness Foundation	Svenska Forskningsradet Formas (Swedish Research Council Formas)(Swedish Research Council Formas); Erling-Persson Foundation; Stichting af Jochnick Foundation (Jochnick Foundation); Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research); Swedish Diabetes Association; Scandia Insurance Company Ltd; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; BetaImage ERC-2013-AdG; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); EYELETS ERC-2018-AdG; BETASCREEN ERC-2017-PoC; Diabetes Research and Wellness Foundation	Svenska Forskningsradet Formas (Swedish Research Council Formas); Erling-Persson Foundation; Stichting af Jochnick Foundation (Jochnick Foundation); Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research); Swedish Diabetes Association; Scandia Insurance Company Ltd; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; BetaImage, Grant/Award Number: ERC-2013-AdG 338936; BETASCREEN, Grant/Award Number: ERC-2017-PoC 727306; Swedish Foundation for Strategic Research; Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); EYELETS, Grant/Award Number: ERC-2018-AdG 834860	Behdad S, 2014, DIABETES METAB J, V38, P311, DOI 10.4093/dmj.2014.38.4.311; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Bertram R, 1998, BIOPHYS J, V74, P1722, DOI 10.1016/S0006-3495(98)77883-X; Chen CG, 2016, DIABETES, V65, P2676, DOI 10.2337/db15-1718; de Monvel JB, 2001, BIOPHYS J, V80, P2455, DOI 10.1016/S0006-3495(01)76214-5; DESBOROUGH JP, 1993, BRIT J ANAESTH, V71, P873, DOI 10.1093/bja/71.6.873; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Ilegems E, 2013, P NATL ACAD SCI USA, V110, P20581, DOI 10.1073/pnas.1313696110; Irles E, 2015, MOL CELL ENDOCRINOL, V404, P46, DOI 10.1016/j.mce.2015.01.033; JOHANSEN O, 1994, LAB ANIM, V28, P244, DOI 10.1258/002367794780681723; Johnston NR, 2016, CELL METAB, V24, P389, DOI 10.1016/j.cmet.2016.06.020; Kauri LM, 2003, BIOCHEM BIOPH RES CO, V304, P371, DOI 10.1016/S0006-291X(03)00595-3; Kroon D.-J., 2011, SEGMENTATION MANDIBU; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Michau A, 2016, DIABETES, V65, P463, DOI 10.2337/db15-1168; Rodriguez-Diaz R, 2012, P NATL ACAD SCI USA, V109, P21456, DOI 10.1073/pnas.1211659110; Roder PV, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.6; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Rutter GA, 2017, DIABETES OBES METAB, V19, P30, DOI 10.1111/dom.12990; Salem V, 2019, NAT METAB, V1, P615, DOI 10.1038/s42255-019-0075-2; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Stoer A, 2013, PLOS COMPUT BIOL, V9, P1; Stoer A, 2013, PLOS ONE, V8; Tanaka K, 2009, ANESTHESIOLOGY, V111, P1044, DOI 10.1097/ALN.0b013e3181bbcb0d; Torturo CL, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0278-18.2018; Turkyilmaz S, 2011, LANGMUIR, V27, P14380, DOI 10.1021/la2035278; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; Westacott MJ, 2017, BIOPHYS J, V113, P1093, DOI 10.1016/j.bpj.2017.07.021; ZAITSEV SV, 1995, P NATL ACAD SCI USA, V92, P9712, DOI 10.1073/pnas.92.21.9712; Zanella R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02523	33	16	16	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					945	959		10.1096/fj.201901302RR	http://dx.doi.org/10.1096/fj.201901302RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914664	hybrid			2022-12-28	WOS:000507308900064
J	Symons, LK; Miller, JE; Tyryshkin, K; Monsanto, SP; Marks, RM; Lingegowda, H; Vanderbeck, K; Childs, T; Young, SL; Lessey, BA; Koti, M; Tayade, C				Symons, Lindsey K.; Miller, Jessica E.; Tyryshkin, Kathrin; Monsanto, Stephany P.; Marks, Ryan M.; Lingegowda, Harshavardhan; Vanderbeck, Kaitlin; Childs, Timothy; Young, Steven L.; Lessey, Bruce A.; Koti, Madhuri; Tayade, Chandrakant			Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model	FASEB JOURNAL			English	Article						angiogenesis; endometrium; immune microenvironment; inflammation; leukocytes	PERITONEAL-FLUID; APOPTOTIC NEUTROPHILS; TNF-ALPHA; T-CELLS; EXPRESSION; WOMEN; CANCER; ANGIOGENESIS; ERADICATION; RESOLUTION	Endometriosis is a chronic inflammatory, gynecological disease characterized by the presence of endometrial-like tissue lesions outside of the uterus. Neutrophils are elevated in the systemic circulation and peritoneal fluid of endometriosis patients; however, whether and how neutrophils contribute to endometriosis pathophysiology remain poorly understood. With emerging roles for neutrophils in chronic and sterile inflammatory conditions, we sought to provide in-depth characterization of neutrophil involvement in endometriosis. We demonstrate that neutrophils reside within patient endometriotic lesions and that patient lesions possess a microenvironment that may influence neutrophil recruitment and function. We also provide the first evidence that systemic circulating neutrophils from endometriosis patients display distinct transcriptomic differences compared neutrophils from healthy control subjects. Time course characterization of our syngeneic, immunocompetent mouse model of endometriosis revealed that neutrophils are rapidly recruited to the peritoneal environment early after endometriotic lesion establishment and remain present in murine lesions long term. In vivo neutrophil depletion altered the systemic and peritoneal immune microenvironment of mice with endometriosis as demonstrated by changes in pro-inflammatory and angiogenic mediators. Taken together, these findings highlight a novel role for neutrophils in early events such as angiogenesis and modulation of the local inflammatory environment associated with endometriosis pathogenesis.	[Symons, Lindsey K.; Miller, Jessica E.; Monsanto, Stephany P.; Marks, Ryan M.; Lingegowda, Harshavardhan; Koti, Madhuri; Tayade, Chandrakant] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Tyryshkin, Kathrin; Vanderbeck, Kaitlin; Childs, Timothy] Kingston Hlth Sci Ctr, Dept Pathol & Mol Med, Kingston, ON, Canada; [Young, Steven L.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Lessey, Bruce A.] Wake Forest Baptist Hlth, Winston Salem, NC USA; [Koti, Madhuri] Kingston Hlth Sci Ctr, Dept Obstet & Gynecol, Kingston, ON, Canada; [Koti, Madhuri] Queens Univ, Div Canc Biol & Genet, Kingston, ON, Canada	Queens University - Canada; McMaster University; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center; Queens University - Canada	Tayade, C (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	tayadec@queensu.ca			Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [394340]	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: 394340	Ahn SH, 2016, FERTIL STERIL, V106, P1420, DOI 10.1016/j.fertnstert.2016.07.005; Ahn SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795976; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armstrong GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17565-x; Bai M, 2017, BLOOD, V130, P2092, DOI 10.1182/blood-2017-03-768507; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Canis M, 1997, FERTIL STERIL, V67, P817; Cheong YC, 2002, HUM REPROD, V17, P69, DOI 10.1093/humrep/17.1.69; Cho S, 2008, FERTIL STERIL, V90, P2073, DOI 10.1016/j.fertnstert.2008.03.061; Christoffersson G, 2012, BLOOD, V120, P4653, DOI 10.1182/blood-2012-04-421040; Chung HH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46485; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Cross A, 2008, BLOOD, V111, P878, DOI 10.1182/blood-2007-05-087833; Deniset JF, 2017, J EXP MED, V214, P1333, DOI 10.1084/jem.20161621; Forster R, 2019, FASEB J, V33, P11210, DOI 10.1096/fj.201900797R; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5; Greenlee-Wacker MC, 2016, IMMUNOL REV, V273, P357, DOI 10.1111/imr.12453; Gupta S, 2018, J IMMUNOL, V200, P869, DOI 10.4049/jimmunol.1700905; HALME J, 1984, OBSTET GYNECOL, V64, P151; Jiang KY, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0128-7; Jones HR, 2016, SEMIN IMMUNOL, V28, P137, DOI 10.1016/j.smim.2016.03.007; Kalu E, 2007, J OBSTET GYNAECOL RE, V33, P490, DOI 10.1111/j.1447-0756.2007.00569.x; Kim HK, 2018, J PSYCHIATR RES, V99, P39, DOI 10.1016/j.jpsychires.2018.01.011; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kumar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089742; Lakschevitz FS, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.37; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Mahnke JL, 2000, FERTIL STERIL, V73, P166, DOI 10.1016/S0015-0282(99)00466-5; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Milewski L, 2011, J REPROD IMMUNOL, V91, P64, DOI 10.1016/j.jri.2011.05.008; Miller JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18224-x; Monsanto SP, 2016, FERTIL STERIL, V105, P968, DOI 10.1016/j.fertnstert.2015.11.047; Moynihan KD, 2016, NAT MED, V22, P1402, DOI 10.1038/nm.4200; Neubert E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00012; Nisolle M, 1997, FERTIL STERIL, V68, P585, DOI 10.1016/S0015-0282(97)00191-X; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Panarelli N, 2019, ENDOCR-RELAT CANCER, V26, P47, DOI 10.1530/ERC-18-0244; Ren RH, 2017, ONCOTARGET, V8, P70982, DOI 10.18632/oncotarget.20237; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Shaul ME, 2019, NAT REV CLIN ONCOL, V16, P601, DOI 10.1038/s41571-019-0222-4; Shaul ME, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232221; Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Suryawanshi S, 2014, CLIN CANCER RES, V20, P6163, DOI 10.1158/1078-0432.CCR-14-1338; Symons LK, 2018, TRENDS MOL MED, V24, P748, DOI 10.1016/j.molmed.2018.07.004; Takamura M, 2016, AM J REPROD IMMUNOL, V76, P193, DOI 10.1111/aji.12540; Tariverdian N, 2009, J REPROD IMMUNOL, V80, P80, DOI 10.1016/j.jri.2008.12.005; Tecchio C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00508; Turashvili G, 2018, FASEB J, V32, P5937, DOI 10.1096/fj.201800120R; Wang J, 2018, CELL TISSUE RES, V371, P531, DOI 10.1007/s00441-017-2785-7; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Wright HL, 2014, NAT REV RHEUMATOL, V10, P593, DOI 10.1038/nrrheum.2014.80; Zhou GX, 2018, CARCINOGENESIS, V39, P272, DOI 10.1093/carcin/bgx142; Zhou GX, 2018, GUT, V67, P1052, DOI 10.1136/gutjnl-2016-313535; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	62	19	20	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1558	1575		10.1096/fj.201902272R	http://dx.doi.org/10.1096/fj.201902272R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914688				2022-12-28	WOS:000507308900103
J	Pan, HC; Xue, WK; Zhao, WJ; Schachner, M				Pan, Hongchao; Xue, Weikang; Zhao, Weijiang; Schachner, Melitta			Expression and function of chondroitin 4-sulfate and chondroitin 6-sulfate in human glioma	FASEB JOURNAL			English	Article						chondroitin 4-sulfate; chondroitin 6-sulfate; glioma; invasion; migration	SULFATE GLYCOSAMINOGLYCAN; MESENCHYMAL TRANSITION; CELL-MIGRATION; PROTEOGLYCANS; MELANOMA; GLIOBLASTOMA; ADHESION; BRAIN; PROLIFERATION; BIOSYNTHESIS	Key molecules promoting migration and invasion exist in the extracellular matrix, and include chondroitin 4-sulfate (C4S) and chondroitin 6-sulfate (C6S), functionally important carbohydrate chains of chondroitin sulfate proteoglycans that participate in regulating cancer development. Here, we show that C4S and C6S expression is upregulated in human glioma tissues, when compared to normal brain tissue, and that the extent of upregulation positively correlated with glioma malignancy. Treatment of cultured glioma cells with C4S and C6S enhanced cell viability, migration, and invasion, increased MMP-2 and MMP-9 levels, enhanced N-cadherin, but reduced E-cadherin expression. Inhibition of expression of the two CS synthetic enzymes chondroitin 4-O-sulfotransferase-1 (C4ST-1/CHST11) and chondroitin 6-O-sulfotransferase-1 (C6ST-1/CHST3) suppressed cell viability, migration and invasion, reduced MMP-2 and MMP-9 expression, and reduced N-cadherin expression, but increased E-cadherin levels. The C4S- and C6S-enhanced epithelial-to-mesenchymal transition and expression of MMP-2 occurred via activation of the PI3K/AKT signaling pathway, known to be involved in promoting cell migration and invasion. In immune-deficient larval zebrafish, C4S and C6S increased the numbers of viable tumor cells, thereby promoting glioma cell proliferation. The present observations point to a novel role of C4S and C6S in human glioma cell functions, thus possibly representing targets in glioma therapy.	[Pan, Hongchao; Xue, Weikang; Zhao, Weijiang; Schachner, Melitta] Shantou Univ Med Coll, Ctr Neurosci, 22 Xin Lin Rd, Shantou 515041, Peoples R China; [Pan, Hongchao] Shantou Univ Med Coll, Guangdong Prov Key Lab Breast Canc Diag & Treatme, Canc Hosp, Shantou, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Zhao, WJ; Schachner, M (corresponding author), Shantou Univ Med Coll, Ctr Neurosci, 22 Xin Lin Rd, Shantou 515041, Peoples R China.	neuromancn@aliyun.com; schachner@stu.edu.cn			Guangdong Provincial Natural Science Foundation [2014A030313469]; National Natural Science Foundation of China [81471279, 81171138, LD030302]	Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Guangdong Provincial Natural Science Foundation, Grant/Award Number: 2014A030313469; National Natural Science Foundation of China, Grant/Award Number: 81471279, 81171138 and LD030302	Alexander BM, 2017, J CLIN ONCOL, V35, P2402, DOI 10.1200/JCO.2017.73.0119; Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; ALINI M, 1991, CANCER RES, V51, P1443; Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853; BERTOLOTTO A, 1986, ACTA NEUROPATHOL, V72, P189, DOI 10.1007/BF00685982; Borsig L, 2007, J BIOL CHEM, V282, P14984, DOI 10.1074/jbc.M610560200; Canas N, 2007, J PHARMACOL EXP THER, V323, P946, DOI 10.1124/jpet.107.123505; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870; Cheng WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034352; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; de Aguiar CBNM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-31; de Aguiar CBNM, 2002, INT J DEV NEUROSCI, V20, P563, DOI 10.1016/S0736-5748(02)00081-3; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Ferrer VP, 2018, GLIA, V66, P1542, DOI 10.1002/glia.23309; Forsyth PA, 1999, BRIT J CANCER, V79, P1828, DOI 10.1038/sj.bjc.6690291; Fthenou E, 2006, INT J BIOCHEM CELL B, V38, P2141, DOI 10.1016/j.biocel.2006.06.006; Fthenou E, 2009, IN VIVO, V23, P69; GOWDA DC, 1986, J BIOL CHEM, V261, P4926; Heredia A, 1996, ARCH BIOCHEM BIOPHYS, V333, P198, DOI 10.1006/abbi.1996.0381; Hoshiba T, 2018, EXP CELL RES, V370, P571, DOI 10.1016/j.yexcr.2018.07.022; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Kim YW, 2013, NEURO-ONCOLOGY, V15, P829, DOI 10.1093/neuonc/not024; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kobayashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054278; Kubelt C, 2015, INT J ONCOL, V46, P2515, DOI 10.3892/ijo.2015.2944; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lara-Velazquez M, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120166; Lin RT, 2018, MOL CELL, V69, P923, DOI 10.1016/j.molcel.2018.02.010; Logun MT, 2016, J MATER CHEM B, V4, P6052, DOI [10.1039/c6tb01083k, 10.1039/C6TB01083K]; Lv HZ, 2007, ONCOLOGY-BASEL, V72, P347, DOI 10.1159/000113145; Mahabir R, 2014, NEURO-ONCOLOGY, V16, P671, DOI 10.1093/neuonc/not239; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Murai T, 2004, IMMUNOL LETT, V93, P163, DOI 10.1016/j.imlet.2004.03.013; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nadanaka S, 2018, J BIOL CHEM, V293, P444, DOI 10.1074/jbc.M117.814509; NIOKA H, 1994, J NEURO-ONCOL, V21, P233, DOI 10.1007/BF01063772; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; Ricciardelli C, 1997, CLIN CANCER RES, V3, P983; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Svensson KJ, 2011, INT J ONCOL, V39, P1421, DOI 10.3892/ijo.2011.1164; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Tysnes BB, 1996, INT J CANCER, V67, P777, DOI 10.1002/(SICI)1097-0215(19960917)67:6<777::AID-IJC5>3.0.CO;2-O; Vallen MJE, 2012, GYNECOL ONCOL, V127, P202, DOI 10.1016/j.ygyno.2012.06.022; Vitucci M, 2013, NEURO-ONCOLOGY, V15, P1317, DOI 10.1093/neuonc/not084; Wilson Taylor A, 2014, Surg Neurol Int, V5, P64, DOI 10.4103/2152-7806.132138	51	14	16	3	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2853	2868		10.1096/fj.201901621RRR	http://dx.doi.org/10.1096/fj.201901621RRR		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908019	Bronze			2022-12-28	WOS:000504271100001
J	Liang, RY; Liu, BH; Huang, CJ; Lin, KT; Ko, CC; Huang, LL; Hsu, B; Wu, CY; Chuang, SM				Liang, Ruei-Yue; Liu, Bang-Hung; Huang, Chih-Jou; Lin, Kuan-Ting; Ko, Chih-Chung; Huang, Lin-Lun; Hsu, Bin; Wu, Chun-Ying; Chuang, Show-Mei			MEK2 is a critical modulating mechanism to down-regulate GCIP stability and function in cancer cells	FASEB JOURNAL			English	Article						GCIP; MEK2; tumor suppressor; ubiquitination	LOOP-HELIX PROTEIN; GROWTH; EXPRESSION; KINASE; BREAST; ACTIVATION; CARCINOMA; GENE; MAP; SURVIVAL	Loss of tumor suppressor activity and upregulation of oncogenic pathways simultaneously contribute to tumorigenesis. Expression of the tumor suppressor, GCIP (Grap2- and cyclin D1-interacting protein), is usually reduced or lost in advanced cancers, as seen in both mouse tumor models and human cancer patients. However, no previous study has examined how cancer cells down-regulate GCIP expression. In this study, we first validate the tumor suppressive function of GCIP using clinical gastric cancer tissues and online database analysis. We then reveal a novel mechanism whereby MEK2 directly interacts with and phosphorylates GCIP at its Ser313 and Ser356 residues to promote the turnover of GCIP by ubiquitin-mediated proteasomal degradation. We also reveal that decreased GCIP stability enhances cell proliferation and promotes cancer cell migration and invasion. Taken together, these findings provide a more comprehensive view of GCIP in tumorigenesis and suggest that the oncogenic MEK/ERK signaling pathway negatively regulates the protein level of GCIP to promote cell proliferation and migration.	[Liang, Ruei-Yue; Liu, Bang-Hung; Huang, Chih-Jou; Lin, Kuan-Ting; Ko, Chih-Chung; Huang, Lin-Lun; Hsu, Bin; Chuang, Show-Mei] Natl Chung Hsing Univ, Inst Biomed Sci, 145 Xingda Rd, Taichung 402, Taiwan; [Wu, Chun-Ying] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan	National Chung Hsing University; Taipei Veterans General Hospital	Chuang, SM (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, 145 Xingda Rd, Taichung 402, Taiwan.	smchuang@dragon.nchu.edu.tw	Wu, Chun-Ying/AAX-5077-2021	Wu, Chun-Ying/0000-0001-5053-1801; Chuang, Show-Mei/0000-0003-2986-0736	Ministry of Science and Technology, Taiwan (MOST) [MOST 107-2635-B-005-002]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 107-2635-B-005-002	Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chang TW, 2008, ONCOGENE, V27, P332, DOI 10.1038/sj.onc.1210651; Chen KY, 2014, ONCOTARGET, V5, P5017, DOI 10.18632/oncotarget.2075; Chen WC, 2008, HISTOPATHOLOGY, V53, P554, DOI 10.1111/j.1365-2559.2008.03154.x; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Chuang SM, 2013, BBA-GEN SUBJECTS, V1830, P4960, DOI 10.1016/j.bbagen.2013.06.025; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ishii R, 2012, EMBO J, V31, P2541, DOI 10.1038/emboj.2012.77; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Ma W, 2006, ONCOGENE, V25, P4207, DOI 10.1038/sj.onc.1209450; Ma WB, 2007, J CELL BIOCHEM, V100, P1376, DOI 10.1002/jcb.21140; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Natrajan R, 2003, CANCER RES, V63, P7657; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; Papatheodorou I, 2018, NUCLEIC ACIDS RES, V46, pD246, DOI 10.1093/nar/gkx1158; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Seto A, 2009, ACTA CRYSTALLOGR F, V65, P21, DOI 10.1107/S1744309108038219; Sonnenberg-Riethmacher E, 2007, HEPATOLOGY, V45, P404, DOI 10.1002/hep.21461; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Su T, 2007, J EXP THER ONCOL, V6, P117; Tang ZJ, 2015, CELL, V160, P729, DOI 10.1016/j.cell.2015.01.028; Terai S, 2000, HEPATOLOGY, V32, P357, DOI 10.1053/jhep.2000.9092; Xia CZ, 2000, J BIOL CHEM, V275, P20942, DOI 10.1074/jbc.M002598200; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Yao Y, 2000, EXP CELL RES, V257, P22, DOI 10.1006/excr.2000.4884; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004	33	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1958	1969		10.1096/fj.201901911R	http://dx.doi.org/10.1096/fj.201901911R		DEC 2019	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907980				2022-12-28	WOS:000503398500001
J	Caceres, FT; Gaspari, TA; Samuel, CS; Pinar, AA				Caceres, Felipe Tapia; Gaspari, Tracey A.; Samuel, Chrishan S.; Pinar, Anita A.			Serelaxin inhibits the profibrotic TGF-beta 1/IL-1 beta axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts	FASEB JOURNAL			English	Article						cardiac fibrosis; IL-1 beta serelaxin; cardiomyopathy; RXFP1; nNOS	AGE-RELATED PROGRESSION; MYOCARDIAL-INFARCTION; EXPERIMENTAL-MODEL; ANGIOTENSIN-II; RECEPTOR 4; RELAXIN; FIBROSIS; FIBROBLASTS; COLLAGEN; MICE	The recombinant form of the peptide hormone relaxin, serelaxin (RLX), mediates its anti-fibrotic actions by impeding the profibrotic activity of cytokines including TGF-beta 1 and IL-beta 3. As IL-1 beta can be produced by the nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domains-containing protein 3 (NLRP3) inflammasome, this study determined whether RLX targeted the inflammasome to inhibit the profibrotic TGF-beta 1/IL-1 beta axis in primary human cardiac myofibroblasts (HCMFs) in vitro and in mice with isoproterenol (ISO)-induced cardiomyopathy in vivo. HCMFs stimulated with TGF-beta 1 (5 ng/ml), LPS (100 ng/ml), and ATP (5 mM) (T+L+A) for 8 h, to induce the NLRP3 inflammasome, demonstrated significantly increased protein expression of markers of NLRP3 priming (NLRP3, apoptosis-associated speck-like protein containing a C-terminal caspase-recruitment domain, procaspase-1) and activity (IL-1 beta, IL-18). After 72 h, there was significantly increased neuronal NOS (nNOS), TLR-4, procaspase-1, myofibroblast differentiation, and collagen-I deposition. These measures, along with interstitial TGF-beta 1 expression and collagen deposition, were also increased in the left ventricle (LV) of ISO-injured mice 14 d postinjury. RLX [16.8 nM (100 ng/ml) in vitro; 0.5 mg/kg per day in vivo] inhibited T+L+A- and ISO-induced TLR-4 expression, NLRP3 priming, IL-1 beta, IL-18, myofibroblast differentiation, and interstitial collagen deposition at the time points studied, via the promotion of nNOS; with the NLRP3- and IL-1 beta-inhibitory effects of RLX in HCMFs being abrogated by pharmacological blockade of nNOS or TLR-4. Comparatively, the small molecule NLRP3 inhibitor, N-{(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl}-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide (1 mu M in vitro, 10 mg/kg/d in vivo), inhibited components of the NLRP3 inflammasome in vitro and in vivo and ISO-induced interstitial LV fibrosis in vivo but did not affect nNOS, TLR-4, myofibroblast differentiation, or myofibroblast-induced collagen deposition. Hence, RLX can inhibit the TGF-beta 1/IL-1 beta axis via a nNOS-TLR-4-NLRP3 inflammasome-dependent mechanism on cardiac myofibroblasts.	[Caceres, Felipe Tapia; Gaspari, Tracey A.; Samuel, Chrishan S.; Pinar, Anita A.] Monash Univ, Monash Biomed Discovery Inst, Cardiovasc Dis Program, Clayton, Vic, Australia; [Caceres, Felipe Tapia; Gaspari, Tracey A.; Samuel, Chrishan S.; Pinar, Anita A.] Monash Univ, Dept Pharmacol, 9 Ancora Imparo Way, Clayton, Vic 3800, Australia; [Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia	Monash University; Monash University; University of Melbourne	Samuel, CS; Pinar, AA (corresponding author), Monash Univ, Dept Pharmacol, 9 Ancora Imparo Way, Clayton, Vic 3800, Australia.; Samuel, CS; Pinar, AA (corresponding author), Monash Univ, Monash Biomed Discovery Inst BDI, 9 Ancora Imparo Way, Clayton, Vic 3800, Australia.	chrishan.samuel@monash.edu; anita.pinar@monash.edu			Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Programa Formacion de Capital Humano Avanzado/Becas Para Estudios de Postgrado en Chile y en el Extranjero (PFCHA/DOCTORADO BECAS CHILE) [2017 -72180028]; National Health and Medical Research Council (NHMRC) of Australia [GNT1041766]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Programa Formacion de Capital Humano Avanzado/Becas Para Estudios de Postgrado en Chile y en el Extranjero (PFCHA/DOCTORADO BECAS CHILE)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the facilities and technical assistance of the Monash Histology Platform, Department of Anatomy and Developmental Biology, Monash University. This work was supported by the Comision Nacional de Investigacion Cient ' ifica y Tecnologica (CONICYT) Programa Formaci ' on de Capital Humano Avanzado/Becas Para Estudios de Postgrado en Chile y en el Extranjero (PFCHA/DOCTORADO BECAS CHILE); 2017 -72180028 to F.T.C.), and a National Health and Medical Research Council (NHMRC) of Australia Senior Research Fellowship (GNT1041766 to C.S.S.). The authors declare no conflicts of interest.	Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Beiert T, 2017, BIOCHEM BIOPH RES CO, V490, P643, DOI 10.1016/j.bbrc.2017.06.091; Bhattacharyya S, 2013, AM J PATHOL, V182, P192, DOI 10.1016/j.ajpath.2012.09.007; Bolli P, 2010, ANN NY ACAD SCI, V1211, P113, DOI 10.1111/j.1749-6632.2010.05814.x; Boza P, 2016, MOL IMMUNOL, V74, P96, DOI 10.1016/j.molimm.2016.05.001; Brecht A, 2011, REGUL PEPTIDES, V166, P76, DOI 10.1016/j.regpep.2010.09.001; Chen L, 2017, ONCOTARGET, V8, P21044, DOI 10.18632/oncotarget.15483; Chow BSM, 2014, KIDNEY INT, V86, P75, DOI 10.1038/ki.2013.518; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Collino M, 2013, J CELL MOL MED, V17, P1494, DOI 10.1111/jcmm.12120; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Fang L, 2008, CLIN SCI, V115, P99, DOI 10.1042/CS20070365; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Frangogiannis NG, 2019, MOL ASPECTS MED, V65, P70, DOI 10.1016/j.mam.2018.07.001; Gan WQ, 2018, BBA-MOL BASIS DIS, V1864, P1, DOI 10.1016/j.bbadis.2017.10.001; Kocan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02916-5; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Krishnan SM, 2016, BRIT J PHARMACOL, V173, P752, DOI 10.1111/bph.13230; Krishnan SM, 2019, CARDIOVASC RES, V115, P776, DOI 10.1093/cvr/cvy252; Li L, 2018, MATRIX BIOL, V68-69, P490, DOI 10.1016/j.matbio.2018.01.013; Li X, 2018, EXP CELL RES, V362, P489, DOI 10.1016/j.yexcr.2017.12.013; Martin B, 2019, MOL CELL ENDOCRINOL, V487, P45, DOI 10.1016/j.mce.2018.12.016; Mookerjee I, 2009, FASEB J, V23, P1219, DOI 10.1096/fj.08-120857; Ng HH, 2019, MOL CELL ENDOCRINOL, V487, P59, DOI 10.1016/j.mce.2019.01.015; Nistri S, 2008, INFLAMM RES, V57, pS7, DOI 10.1007/s00011-007-0602-6; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Raleigh JV, 2017, CARDIOVASC RES, V113, P609, DOI 10.1093/cvr/cvw246; Royce SG, 2013, CLIN SCI, V124, P41, DOI 10.1042/CS20120024; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Samuel CS, 2014, HYPERTENSION, V64, P315, DOI 10.1161/HYPERTENSIONAHA.114.03594; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2005, J INVEST DERMATOL, V125, P692, DOI 10.1111/j.0022-202X.2005.23880.x; Samuel CS, 2004, KIDNEY INT, V65, P2054, DOI 10.1111/j.1523-1755.2004.00628.x; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Sarwar M, 2015, BRIT J PHARMACOL, V172, P1005, DOI 10.1111/bph.12964; Sarwar M, 2017, BRIT J PHARMACOL, V174, P933, DOI 10.1111/bph.13523; Sasser JM, 2011, HYPERTENSION, V58, P197, DOI 10.1161/HYPERTENSIONAHA.110.164392; Sassoli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063896; Saxena A, 2013, J IMMUNOL, V191, P4838, DOI 10.4049/jimmunol.1300725; Schroer AK, 2015, J CELL SCI, V128, P1865, DOI 10.1242/jcs.162891; Sokolova M, 2017, BBA-MOL CELL BIOL L, V1862, P234, DOI 10.1016/j.bbalip.2016.11.003; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Vogel S, 2019, BIOCHEM BIOPH RES CO, V508, P614, DOI 10.1016/j.bbrc.2018.11.125; Wang C, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00091; Wang YL, 2013, CARDIOLOGY, V126, P1, DOI 10.1159/000351179; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Wu XP, 2018, EXP CELL RES, V362, P17, DOI 10.1016/j.yexcr.2017.10.004; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao H, 2018, EUR HEART J, V39, P60, DOI 10.1093/eurheartj/ehx261; Zhou WY, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5702103	55	22	23	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14717	14733		10.1096/fj.201901079RR	http://dx.doi.org/10.1096/fj.201901079RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689135	Bronze			2022-12-28	WOS:000507466100127
J	Hofer, DC; Zirkovits, G; Pelzmann, HJ; Huber, K; Pessentheiner, AR; Xia, WM; Uno, K; Miyazaki, T; Kon, K; Tsuneki, H; Pendl, T; Al Zoughbi, W; Madreiter-Sokolowski, CT; Trausinger, G; Abdellatif, M; Schoiswohl, G; Schreiber, R; Eisenberg, T; Magnes, C; Sedej, S; Eckhardt, M; Sasahara, M; Sasaoka, T; Nitta, A; Hoefler, G; Graier, WF; Kratky, D; Auwerx, J; Bogner-Strauss, JG				Hofer, Dina C.; Zirkovits, Gabriel; Pelzmann, Helmut J.; Huber, Katharina; Pessentheiner, Ariane R.; Xia, Wenmin; Uno, Kyosuke; Miyazaki, Toh; Kon, Kanta; Tsuneki, Hiroshi; Pendl, Tobias; Al Zoughbi, Wael; Madreiter-Sokolowski, Corina T.; Trausinger, Gert; Abdellatif, Mahmoud; Schoiswohl, Gabriele; Schreiber, Renate; Eisenberg, Tobias; Magnes, Christoph; Sedej, Simon; Eckhardt, Matthias; Sasahara, Masakiyo; Sasaoka, Toshiyasu; Nitta, Atsumi; Hoefler, Gerald; Graier, Wolfgang F.; Kratky, Dagmar; Auwerx, Johan; Bogner-Strauss, Juliane G.			N-acetylaspartate availability is essential for juvenile survival on fat-free diet and determines metabolic health	FASEB JOURNAL			English	Article						NAA; acetyl-CoA; energy homeostasis; adipose tissue; insulin secretion	BROWN ADIPOSE-TISSUE; L-ASPARTIC ACID; MAGNETIC-RESONANCE-SPECTROSCOPY; ATGL-MEDIATED LIPOLYSIS; BETA-CELL LINE; TOXICITY ASSESSMENT; FOLLOW-UP; BRAIN; DEFICIENCY; GLUCOSE	N-acetylaspartate (NAA) is synthesized by aspartate N-acetyltransferase (gene: Nat8l) from acetyl-coenzyme A and aspartate. In the brain, NAA is considered an important energy metabolite for lipid synthesis. However, the role of NAA in peripheral tissues remained elusive. Therefore, we characterized the metabolic phenotype of knockout (ko) and adipose tissue-specific (ako) Nat8l-ko mice as well as NAA-supplemented mice on various diets. We identified an important role of NAA availability in the brain during adolescence, as 75% of Nat8l-ko mice died on fat-free diet (FFD) after weaning but could be rescued by NAA supplementation. In adult life, NAA deficiency promotes a beneficial metabolic phenotype, as Nat8l-ko and Nat8l-ako mice showed reduced body weight, increased energy expenditure, and improved glucose tolerance on chow, high-fat, and FFDs. Furthermore, Nat8l-deficient adipocytes exhibited increased mitochondrial respiration, ATP synthesis, and an induction of browning. Conversely, NAA-treated wild-type mice showed reduced adipocyte respiration and lipolysis and increased de novo lipogenesis, culminating in reduced energy expenditure, glucose tolerance, and insulin sensitivity. Mechanistically, our data point to a possible role of NAA as modulator of pancreatic insulin secretion and suggest NAA as a critical energy metabolite for adipocyte and whole-body energy homeostasis.	[Hofer, Dina C.; Zirkovits, Gabriel; Pelzmann, Helmut J.; Huber, Katharina; Pessentheiner, Ariane R.; Xia, Wenmin; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, Humboldtstr 46-3, A-8010 Graz, Austria; [Hofer, Dina C.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Pelzmann, Helmut J.] Fresenius Kabi Austria GmbH, Graz, Austria; [Huber, Katharina] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Pessentheiner, Ariane R.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Uno, Kyosuke; Miyazaki, Toh; Nitta, Atsumi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama, Japan; [Kon, Kanta; Tsuneki, Hiroshi; Sasaoka, Toshiyasu] Univ Toyama, Dept Clin Pharmacol, Toyama, Japan; [Sasahara, Masakiyo] Univ Toyama, Dept Pathol, Toyama, Japan; [Pendl, Tobias; Eisenberg, Tobias] Karl Franzens Univ Graz, NAWI Graz, Inst Mol Biosci, Graz, Austria; [Schoiswohl, Gabriele; Schreiber, Renate] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Al Zoughbi, Wael; Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Madreiter-Sokolowski, Corina T.; Graier, Wolfgang F.; Kratky, Dagmar] Med Univ Graz, Gottfried Schatz Res Ctr, Graz, Austria; [Abdellatif, Mahmoud; Sedej, Simon] Med Univ Graz, Dept Cardiol, Graz, Austria; [Trausinger, Gert; Magnes, Christoph] Joanneum Res, HLTH Inst Biomed & Hlth Sci, Graz, Austria; [Eisenberg, Tobias; Sedej, Simon; Graier, Wolfgang F.; Kratky, Dagmar; Bogner-Strauss, Juliane G.] BioTechMed Graz, Graz, Austria; [Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, Bonn, Germany	Graz University of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of California System; University of California San Diego; University of Toyama; University of Toyama; University of Toyama; University of Graz; University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Bonn	Bogner-Strauss, JG (corresponding author), Graz Univ Technol, Inst Biochem, Humboldtstr 46-3, A-8010 Graz, Austria.	juliane.bogner-strauss@tugraz.at	Eisenberg, Tobias/AAV-7806-2021; Auwerx, Johan/ABE-9307-2021; Madreiter-Sokolowski, Corina/AAK-4722-2020; Kratky, Dagmar/ABF-5699-2021; Abdellatif, Mahmoud/AAD-5810-2019; Sedej, Simon/L-3066-2015; Graier, Wolfgang F./B-7052-2008; Hoefler, Gerald/H-1796-2016	Madreiter-Sokolowski, Corina/0000-0002-8631-9949; Abdellatif, Mahmoud/0000-0002-5042-9054; Sedej, Simon/0000-0002-4419-6821; Graier, Wolfgang F./0000-0003-1871-3298; Magnes, Christoph/0000-0002-5153-7444; Huber, Katharina/0000-0002-4072-4877; Schreiber, Renate/0000-0002-3475-157X; Eisenberg, Tobias/0000-0003-3559-1130; Pessentheiner, Ariane/0000-0002-5010-9528; Schoiswohl, Gabriele/0000-0002-7346-2834; Hoefler, Gerald/0000-0002-9056-3063	Austrian Science Fund (FWF; Grants DKMCD) [W1226, P24143, P27108, P27070]; Joint Teaching, Research and Doctoral Programmes in the Natural Sciences (NAWI) Graz and BioTechMed-Graz	Austrian Science Fund (FWF; Grants DKMCD)(Austrian Science Fund (FWF)); Joint Teaching, Research and Doctoral Programmes in the Natural Sciences (NAWI) Graz and BioTechMed-Graz	The authors thank Thomas Schreiner and Wolfgang Krispel (both from the Institute of Biochemistry, Graz University of Technology) for excellent technical assistance. This work was supported by the Austrian Science Fund (FWF; Grants DKMCD W1226, P24143, P27108, and P27070). The authors gratefully acknowledge support from Joint Teaching, Research and Doctoral Programmes in the Natural Sciences (NAWI) Graz and BioTechMed-Graz. The authors declare no conflicts of interest.	Abdellatif M, 2016, AM J PHYSIOL-HEART C, V310, pH4, DOI 10.1152/ajpheart.00399.2015; ANDREEV SV, 1978, B EXP BIOL MED+, V86, P1003, DOI 10.1007/BF00799573; Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bogner-Strauss JG, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00240; Bogner-Strauss JG, 2010, CELL MOL LIFE SCI, V67, P4049, DOI 10.1007/s00018-010-0424-5; Boltshauser E, 2004, NEUROPEDIATRICS, V35, P255, DOI 10.1055/s-2004-821036; Burlina AP, 2006, ADV EXP MED BIOL, V576, P283; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; DADAMO AF, 1966, J NEUROCHEM, V13, P961, DOI 10.1111/j.1471-4159.1966.tb10292.x; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; FENSTERMACHER MJ, 1990, INVEST RADIOL, V25, P1034, DOI 10.1097/00004424-199009000-00016; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furukawa-Hibi Y, 2012, NEUROSCI LETT, V526, P79, DOI 10.1016/j.neulet.2012.08.028; Gao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11960; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hofer DC, 2017, BBA-MOL CELL BIOL L, V1862, P358, DOI 10.1016/j.bbalip.2016.12.009; Huber K, 2019, BBA-MOL CELL RES, V1866, P337, DOI 10.1016/j.bbamcr.2018.08.017; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Karaman S, 2011, FOOD CHEM TOXICOL, V49, P3192, DOI 10.1016/j.fct.2011.08.025; Karaman S, 2011, FOOD CHEM TOXICOL, V49, P155, DOI 10.1016/j.fct.2010.10.011; KAUL R, 1991, J NEUROCHEM, V56, P129, DOI 10.1111/j.1471-4159.1991.tb02571.x; KLUNK WE, 1992, NEUROLOGY, V42, P1578, DOI 10.1212/WNL.42.8.1578; Knittelfelder OL, 2014, J CHROMATOGR B, V951, P119, DOI 10.1016/j.jchromb.2014.01.011; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; LARSSON HBW, 1991, MAGN RESON MED, V22, P23, DOI 10.1002/mrm.1910220104; Leor-Librach RJ, 2003, IEEE T BIO-MED ENG, V50, P797, DOI 10.1109/TBME.2003.813547; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P609, DOI 10.1139/y86-101; MacPherson REK, 2016, AM J PHYSIOL-CELL PH, V311, pC269, DOI 10.1152/ajpcell.00126.2016; Maier H, 2015, J NEUROSCI, V35, P14501, DOI 10.1523/JNEUROSCI.1056-15.2015; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Moody G. B., IEEE C PUBLICATION; Nakashima K, 2009, ENDOCR J, V56, P45, DOI 10.1507/endocrj.K08E-172; Newsholme Philip, 2012, Clin Biochem Rev, V33, P35; PEELING J, 1993, NEUROLOGY, V43, P589, DOI 10.1212/WNL.43.3_Part_1.589; Pessentheiner AR, 2013, J BIOL CHEM, V288, P36040, DOI 10.1074/jbc.M113.491324; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; PRICHARD BNC, 1991, ACTA CARDIOL, V46, P309; Prokesch A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23723; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; SARKIOJA T, 1984, FORENSIC SCI INT, V24, P247, DOI 10.1016/0379-0738(84)90159-2; Schreiber R, 2017, CELL METAB, V26, P753, DOI 10.1016/j.cmet.2017.09.004; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Toriumi K, 2015, EUR NEUROPSYCHOPHARM, V25, P2108, DOI 10.1016/j.euroneuro.2015.08.003; Vangipurapu J, 2019, DIABETES, V68, P1353, DOI 10.2337/db18-1076; Waterson MJ, 2015, CELL METAB, V22, P962, DOI 10.1016/j.cmet.2015.09.026; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; WINEGRAD AI, 1960, AM J CLIN NUTR, V8, P651, DOI 10.1093/ajcn/8.5.651; Zand B, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv426; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	59	2	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13808	13824		10.1096/fj.201801323R	http://dx.doi.org/10.1096/fj.201801323R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31638418	hybrid, Green Published			2022-12-28	WOS:000507466100059
J	Jaggar, JH; Gomez, MF				Jaggar, Jonathan H.; Gomez, Maria F.			The 2019 FASEB Science Research Conference on Smooth Muscle, July 14-19, 2019, Palm Beach Florida, USA	FASEB JOURNAL			English	Editorial Material									[Jaggar, Jonathan H.] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Physiol, Memphis, TN 38163 USA; [Gomez, Maria F.] Lund Univ, Dept Clin Sci, Ctr Diabet, Diabet Complicat Unit, Malmo, Sweden	University of Tennessee System; University of Tennessee Health Science Center; Lund University	Jaggar, JH (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Physiol, Memphis, TN 38163 USA.	jjaggar@uthsc.eduail	Gomez, Maria F/D-3696-2014	Gomez, Maria F/0000-0001-6210-3142	FASEB; Boehringer Ingelheim International GmbH; Sanofi-Aventis [1R13HL147524-01]; National Heart, Lung, and Blood Institute (NIMBI), U.S. National Institutes of Health (NIH) - NIH/NHLBI [HL133256, HL137745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R13HL147524] Funding Source: NIH RePORTER	FASEB; Boehringer Ingelheim International GmbH(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); National Heart, Lung, and Blood Institute (NIMBI), U.S. National Institutes of Health (NIH) - NIH/NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Special thanks go to FASEB for a tmly supportive and encouraging role throughout the organization of the 2019 conference. This 2019 FASEB meeting was supported by generous contributions from Boehringer Ingelheim International GmbH and Sanofi-Aventis. Funding for this conference was also made possible in part by Grant 1R13HL147524-01 from the National Heart, Lung, and Blood Institute (NIMBI), U.S. National Institutes of Health (NIH). Dr. Jaggar is funded by NIH/NHLBI grants HL133256 and HL137745. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the NIH, nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13068	13070		10.1096/fj.201902633	http://dx.doi.org/10.1096/fj.201902633			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31795032	Bronze, Green Published			2022-12-28	WOS:000507466100003
J	Jung, KM; Kim, YM; Keyte, AL; Biegler, MT; Rengaraj, D; Lee, HJ; Mello, CV; Velho, TAF; Fedrigo, O; Haase, B; Jarvis, ED; Han, JY				Jung, Kyung Min; Kim, Young Min; Keyte, Anna L.; Biegler, Matthew T.; Rengaraj, Deivendran; Lee, Hong Jo; Mello, Claudio V.; Velho, Tarciso A. F.; Fedrigo, Olivier; Haase, Bettina; Jarvis, Erich D.; Han, Jae Yong			Identification and characterization of primordial germ cells in a vocal learning Neoaves species, the zebra finch	FASEB JOURNAL			English	Article						songbird; embryo development; germ cells; DAZL; transgenesis	CHICK; EXPRESSION; MIGRATION; ORIGIN; DAZL; BIRDSONG; CHIMERAS; QUAIL	The zebra finch has been used as a valuable vocal learning animal model for human spoken language. It is representative of vocal learning songbirds specifically, which comprise half of all bird species, and of Neoaves broadly, which comprise 95% of all bird species. Although transgenesis in the zebra finch has been accomplished, it is with a very low efficiency of germ-line transmission and far from the efficiency with a more genetically tractable but vocal nonlearning species, the chicken (a Galloanseriformes). To improve germ-line transmission in the zebra finch, we identified and characterized its primordial germ cells (PGCs) and compared them with chicken. We found striking differences between the 2 species, including that zebra finch PGCs were more numerous, more widely distributed in early embryos before colonization into the gonads, had slower timing of colonization, and had a different developmental gene-expression program. We improved conditions for isolating and culturing zebra finch PGCs in vitro and were able to transfect them with gene-expression vectors and incorporate them into the gonads of host embryos. Our findings demonstrate important differences in the PGCs of the zebra finch and advance the first stage of creating PGC-mediated germ-line transgenics of a vocal learning species.	[Jung, Kyung Min; Kim, Young Min; Rengaraj, Deivendran; Lee, Hong Jo; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Keyte, Anna L.; Biegler, Matthew T.; Jarvis, Erich D.] Rockefeller Univ, Lab Neurogenet Language, 1230 York Ave, New York, NY 10021 USA; [Fedrigo, Olivier; Haase, Bettina] Rockefeller Univ, Lab Vertebrate Genomes, 1230 York Ave, New York, NY 10021 USA; [Biegler, Matthew T.; Jarvis, Erich D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Mello, Claudio V.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Velho, Tarciso A. F.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Velho, Tarciso A. F.] Univ Fed Rio Grande do Norte, Inst Brain, Natal, RN, Brazil; [Jarvis, Erich D.] Howard Hughes Med Inst, Chevy Chase, MD USA	Seoul National University (SNU); Rockefeller University; Rockefeller University; Duke University; Oregon Health & Science University; California Institute of Technology; Universidade Federal do Rio Grande do Norte; Howard Hughes Medical Institute	Jarvis, ED (corresponding author), Rockefeller Univ, New York, NY 10065 USA.; Han, JY (corresponding author), Seoul Natl Univ, Seoul 08826, South Korea.	ejarvis@rockefeller.edu; jaehan@snu.ac.kr	Jarvis, Erich D/A-2319-2008; Biegler, Matthew/AAW-2452-2021; Rengaraj, Deivendran/C-5593-2015	Jarvis, Erich D/0000-0001-8931-5049; Biegler, Matthew/0000-0003-4331-9890; Rengaraj, Deivendran/0000-0001-9274-9921; Jung, Kyung Min/0000-0002-5791-2655	Creative Research Initiatives Program (Center for Avian Germ Cell Modulation and Cloning) from a National Research Foundation of Korea (NRF) - Korean government [Ministry of Science and Information and Communications Technology (MSIP)] [2015R1A3A2033826]; National Science Foundation (NSF) Enabling Discovery through Genomic Tools (EDGE) [1645199]; Howard Hughes Medical Insitute (HHMI)	Creative Research Initiatives Program (Center for Avian Germ Cell Modulation and Cloning) from a National Research Foundation of Korea (NRF) - Korean government [Ministry of Science and Information and Communications Technology (MSIP)](National Research Foundation of Korea); National Science Foundation (NSF) Enabling Discovery through Genomic Tools (EDGE)(National Science Foundation (NSF)); Howard Hughes Medical Insitute (HHMI)	The authors thank the members of the J.Y.H. and E.D.J. laboratories for suggestions and inspirational discussions. The authors also thank Carlos Lois (California Institute of Technology) for useful discussions on the experiments and feedback on the manuscript. This work was supported by the Creative Research Initiatives Program (Center for Avian Germ Cell Modulation and Cloning) from a National Research Foundation of Korea (NRF) grant, funded by the Korean government [Ministry of Science and Information and Communications Technology (MSIP) 2015R1A3A2033826 to J.Y.H.], and the National Science Foundation (NSF) Enabling Discovery through Genomic Tools (EDGE; Award 1645199) and Howard Hughes Medical Insitute (HHMI) funds to E.D.J., Carlos Lois, C.V.M., and T.A.F.V. The authors declare no conflicts of interest.	Bachvarova RF, 2009, EVOL DEV, V11, P525, DOI 10.1111/j.1525-142X.2009.00360.x; Chen YC, 2019, POULTRY SCI, V98, P1820, DOI 10.3382/ps/pey515; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; EYALGILADI H, 1976, DIFFERENTIATION, V6, P13, DOI 10.1111/j.1432-0436.1976.tb01462.x; FUJIMOTO T, 1976, ANAT REC, V185, P139, DOI 10.1002/ar.1091850203; GINSBURG M, 1986, J EMBRYOL EXP MORPH, V95, P53; Guioli S, 2014, SEX DEV, V8, P227, DOI 10.1159/000358406; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Haston KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005654; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jung JS, 2005, STEM CELLS, V23, P689, DOI 10.1634/stemcells.2004-0208; Jung KM, 2017, MOL REPROD DEV, V84, P508, DOI 10.1002/mrd.22802; Kang KS, 2015, REPRODUCTION, V149, P179, DOI 10.1530/REP-14-0433; Kim B, 2012, DEVELOPMENT, V139, P568, DOI 10.1242/dev.075846; Kim JN, 2004, MOL REPROD DEV, V68, P81, DOI 10.1002/mrd.20051; Lee HC, 2016, STEM CELLS DEV, V25, P68, DOI 10.1089/scd.2015.0208; Mak SS, 2015, ELIFE, V4, DOI 10.7554/eLife.07178; Moon CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053900; Mozdziak PE, 2006, POULTRY SCI, V85, P1764, DOI 10.1093/ps/85.10.1764; Mozdziak PE, 2005, POULTRY SCI, V84, P594, DOI 10.1093/ps/84.4.594; Murray JR, 2013, J MORPHOL, V274, P1090, DOI 10.1002/jmor.20165; NAKAMURA M, 1988, ANAT REC, V222, P90, DOI 10.1002/ar.1092220113; Ono T, 1999, COMP BIOCHEM PHYS A, V122, P255, DOI 10.1016/S1095-6433(99)00008-2; Park T. S., 2014, J STEM CELL RES THER, V4; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Rengaraj D, 2008, BIOL REPROD, V79, P413, DOI 10.1095/biolreprod.108.067959; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; Soderstrom K, 2007, J NEUROSCI METH, V164, P116, DOI 10.1016/j.jneumeth.2007.04.007; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Wernery U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015824; YASUDA Y, 1992, J REPROD FERTIL, V96, P521, DOI 10.1530/jrf.0.0960521	37	14	14	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13825	13836		10.1096/fj.201900760RR	http://dx.doi.org/10.1096/fj.201900760RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31604057	Green Published, Bronze			2022-12-28	WOS:000507466100060
J	Lee, HJ; Moon, J; Chung, I; Chung, JH; Park, C; Lee, JO; Han, JA; Kang, MJ; Yoo, EH; Kwak, SY; Jo, G; Park, W; Park, J; Kim, KM; Lim, S; Ngoei, KRW; Ling, NXY; Oakhill, JS; Galic, S; Murray-Segal, L; Kemp, BE; Mantzoros, CS; Krauss, RM; Shin, MJ; Kim, HS				Lee, Hye Jeong; Moon, Jiyoung; Chung, InHyeok; Chung, Ji Hyung; Park, Chan; Lee, Jung Ok; Han, Jeong Ah; Kang, Min Ju; Yoo, Eun Hye; Kwak, So-Young; Jo, Garam; Park, Wonil; Park, Jonghoon; Kim, Kyoung Min; Lim, Soo; Ngoei, Kevin R. W.; Ling, Naomi X. Y.; Oakhill, Jonathan S.; Galic, Sandra; Murray-Segal, Lisa; Kemp, Bruce E.; Mantzoros, Christos S.; Krauss, Ronald M.; Shin, Min-Jeong; Kim, Hyeon Soo			ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways	FASEB JOURNAL			English	Article						diabetes; glucose uptake	ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; IN-VITRO; CONTRACTION; INTERLEUKIN-6; STIMULATION; MECHANISMS; EXPRESSION; RECEPTORS; TRANSPORT	ATPase inhibitory factor 1 (IF1) is an ATP synthase interacting protein that suppresses the hydrolysis activity of ATP synthase. In this study, we observed that the expression of IF1 was up-regulated in response to electrical pulse stimulation of skeletal muscle cells and in exercized mice and healthy men. IF1 stimulates glucose uptake via AMPK in skeletal muscle cells and primary cultured myoblasts. Reactive oxygen species and Rac family small GTPase 1 (Rac1) function in the upstream and downstream of AMPK, respectively, in IF1-mediated glucose uptake. In diabetic animal models, the administration of recombinant IF1 improved glucose tolerance and down-regulated blood glucose level. In addition, IF1 inhibits ATP hydrolysis by beta-F1-ATPase in plasma membrane, thereby increasing extracellular ATP and activating the protein kinase B (Akt) pathway, ultimately leading to glucose uptake. Thus, we suggest that IF1 is a novel myokine and propose a mechanism by which AMPK and Akt contribute independently to IF1-mediated improvement of glucose tolerance impairment. These results demonstrate the importance of IF1 as a potential antidiabetic agent.	[Lee, Hye Jeong; Lee, Jung Ok; Han, Jeong Ah; Kang, Min Ju; Kim, Hyeon Soo] Korea Univ, Dept Anat, Coll Med, Seoul 02841, South Korea; [Moon, Jiyoung; Chung, InHyeok; Yoo, Eun Hye; Kwak, So-Young; Jo, Garam; Shin, Min-Jeong] Korea Univ, Dept Publ Hlth Sci, Seoul, South Korea; [Park, Wonil; Park, Jonghoon] Korea Univ, Dept Phys Educ, Seoul, South Korea; [Moon, Jiyoung] Pennington Biomed Res Ctr, Lab Gene Regulat & Metab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Chung, Ji Hyung; Park, Chan] CHA Univ, Dept Biotechnol, Pochon, South Korea; [Kim, Kyoung Min; Lim, Soo] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea; [Ngoei, Kevin R. W.; Galic, Sandra; Murray-Segal, Lisa; Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Prot Chem & Metab, Fitzroy, Vic, Australia; [Ling, Naomi X. Y.; Oakhill, Jonathan S.] Univ Melbourne, St Vincents Inst Med Res, Metab Signaling Lab, Fitzroy, Vic, Australia; [Oakhill, Jonathan S.; Kemp, Bruce E.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Mantzoros, Christos S.] Harvard Med Sch, Div Endocrinol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Pochon Cha University; Seoul National University (SNU); St. Vincent's Institute of Medical Research; University of Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; Australian Catholic University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Kim, HS (corresponding author), Korea Univ, Dept Anat, Coll Med, Seoul 02841, South Korea.; Shin, MJ (corresponding author), Korea Univ, Grad Sch, BK21PLUS Program Embodiment Hlth Soc Interact, Dept Publ Hlth Sci, Seoul 02841, South Korea.	mjshin@korea.ac.kr; anatomykim@korea.ac.kr	Kemp, Bruce/G-9602-2019; Galic, Sandra/C-6098-2014; Oakhill, Jon/F-5724-2011	Kemp, Bruce/0000-0001-6735-5082; Galic, Sandra/0000-0002-7611-5619; Oakhill, Jon/0000-0002-9475-1440; Ling, Naomi/0000-0001-6240-4092	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1610722]; Korea Research Fellowship (KRF) Grant [2018R1E1A2A02085743]	National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); Korea Research Fellowship (KRF) Grant	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1610722). This work was also supported by Korea Research Fellowship (KRF) Grant 2018R1E1A2A02085743. The authors declare no conflicts of interest.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Almendro V, 2006, BBA-MOL CELL BIOL L, V1761, P37, DOI 10.1016/j.bbalip.2005.12.006; Andrianaivomananjaona T, 2011, BBA-BIOENERGETICS, V1807, P197, DOI 10.1016/j.bbabio.2010.10.002; Arakaki N, 2007, FEBS LETT, V581, P3405, DOI 10.1016/j.febslet.2007.06.041; Bertrand L, 2006, AM J PHYSIOL-HEART C, V291, pH239, DOI 10.1152/ajpheart.01269.2005; Mota MVB, 2019, CELL MOL NEUROBIOL, V39, P149, DOI 10.1007/s10571-018-0641-2; Boniol M, 2017, ACTA DIABETOL, V54, P983, DOI 10.1007/s00592-017-1037-3; Burwick NR, 2005, J BIOL CHEM, V280, P1740, DOI 10.1074/jbc.M405947200; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Carson BP, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00097; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Casas M, 2014, EXERC SPORT SCI REV, V42, P110, DOI 10.1249/JES.0000000000000017; Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x; Esparza-Molto PB, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00053; Gogh IJAEV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10944; Formentini L, 2017, DIABETOLOGIA, V60, P2052, DOI 10.1007/s00125-017-4379-z; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jae SY, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.01.014; Jensen TE, 2009, ACTA PHYSIOL, V196, P155, DOI 10.1111/j.1748-1716.2009.01979.x; Kahancova A, 2018, FEBS LETT, V592, P999, DOI 10.1002/1873-3468.12991; Kim MS, 2002, ARCH BIOCHEM BIOPHYS, V401, P205; Kita T, 2015, BIOMED RES-TOKYO, V36, P115, DOI 10.2220/biomedres.36.115; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Merry TL, 2010, AM J PHYSIOL-ENDOC M, V298, pE577, DOI 10.1152/ajpendo.00239.2009; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Osorio-Fuentealba C, 2013, DIABETES, V62, P1519, DOI 10.2337/db12-1066; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Qiu SH, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0711-2; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; ROUSLIN W, 1993, AM J PHYSIOL, V264, pC209, DOI 10.1152/ajpcell.1993.264.1.C209; Sanchez-Arago M, 2012, CELL CYCLE, V11, P2963, DOI 10.4161/cc.21387; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Sandstrom ME, 2006, J PHYSIOL-LONDON, V575, P251, DOI 10.1113/jphysiol.2006.110601; Santacatterina F, 2016, ONCOTARGET, V7, P490, DOI 10.18632/oncotarget.6357; Shafique E, 2013, AGING-US, V5, P515, DOI 10.18632/aging.100569; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; WARBURG O, 1956, SCIENCE, V124, P269; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wewege MA, 2018, ATHEROSCLEROSIS, V274, P162, DOI 10.1016/j.atherosclerosis.2018.05.002; Willers IM, 2011, BBA-BIOENERGETICS, V1807, P543, DOI 10.1016/j.bbabio.2010.10.016; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Yang K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11251-8; Yano S, 2011, J PHARMACOL SCI, V115, P94, DOI 10.1254/jphs.10185SC; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	55	12	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14825	14840		10.1096/fj.201901440RR	http://dx.doi.org/10.1096/fj.201901440RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31670977				2022-12-28	WOS:000507466100135
J	Yura, Y; Chong, BSH; Johnson, RD; Watanabe, Y; Tsukahara, Y; Ferran, B; Murdoch, CE; Behring, JB; McComb, ME; Costello, CE; Janssen-Heininger, YMW; Cohen, RA; Bachschmid, MM; Matsui, R				Yura, Yoshimitsu; Chong, Brian S. H.; Johnson, Ryan D.; Watanabe, Yosuke; Tsukahara, Yuko; Ferran, Beatriz; Murdoch, Colin E.; Behring, Jessica B.; McComb, Mark E.; Costello, Catherine E.; Janssen-Heininger, Yvonne M. W.; Cohen, Richard A.; Bachschmid, Markus M.; Matsui, Reiko			Endothelial cell-specific redox gene modulation inhibits angiogenesis but promotes B16F0 tumor growth in mice	FASEB JOURNAL			English	Article						S-glutathionylation; glutaredoxin; vasculogenic mimicry; vascular; melanoma	PROTEIN S-GLUTATHIONYLATION; HUMAN-MELANOMA CELLS; CANCER STEM-CELLS; VASCULOGENIC MIMICRY; FUNCTIONAL-SIGNIFICANCE; CHANNEL FORMATION; ENDOGLIN CD105; UP-REGULATION; MOUSE MODEL; VEGF-A	Glutaredoxin-1 (Glrx) is a small cytosolic enzyme that removes S-glutathionylation, glutathione adducts of protein cysteine residues, thus modulating redox signaling and gene transcription. Although Glrx up -regulation prevented endothelial cell (EC) migration and global Glrx transgenic mice had impaired ischemic vascularization, the effects of cell-specific Glrx overexpression remained unknown. Here, we examined the role of EC-specific Glrx up-regulation in distinct models of angiogenesis; namely, hind limb ischemia and tumor angiogenesis. EC-specific Glrx transgenic (EC-Glrx TG) overexpression in mice significantly impaired EC migration in Matrigel implants and hind limb revascularization after femoral artery ligation. Additionally, ECs migrated less into subcutaneously implanted B16F0 melanoma tumors as assessed by decreased staining of EC markers. Despite reduced angiogenesis, EC-Glrx TG mice unexpectedly developed larger tumors compared with control mice. EC-Glrx TG mice showed higher levels of VEGF-A in the tumors, indicating hypoxia, which may stimulate tumor cells to form vascular channels without EC, referred to as vasculogenic mimicry. These data suggest that impaired ischemic vascularization does not necessarily associate with suppression of tumor growth, and that antiangiogenic therapies may be ineffective for melanoma tumors because of their ability to implement vasculogenic mimicry during hypoxia.	[Yura, Yoshimitsu; Chong, Brian S. H.; Johnson, Ryan D.; Watanabe, Yosuke; Tsukahara, Yuko; Ferran, Beatriz; Murdoch, Colin E.; Behring, Jessica B.; Cohen, Richard A.; Bachschmid, Markus M.; Matsui, Reiko] Boston Univ, Sch Med, Dept Med, Vasc Biol Sect,Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [McComb, Mark E.; Costello, Catherine E.] Boston Univ, Sch Med, Cardiovasc Prote Ctr, Boston, MA 02118 USA; [Janssen-Heininger, Yvonne M. W.] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT USA; [Yura, Yoshimitsu] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Watanabe, Yosuke] Univ Yamanashi, Dept Internal Med 2, Yamanashi, Japan; [Murdoch, Colin E.] Univ Dundee, Med Syst, Dundee, Scotland	Boston University; Boston University; University of Vermont; University of Virginia; University of Yamanashi; University of Dundee	Matsui, R (corresponding author), Boston Univ, Sch Med, Vasc Biol Sect, 650 Albany St X-729, Boston, MA 02118 USA.	rmatsui@bu.edu	; Murdoch, Colin/J-9798-2016	/0000-0002-1070-6408; Murdoch, Colin/0000-0002-0274-819X; Bachschmid, Markus Michael/0000-0002-0748-5528	U.S. National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) [R01 HL133013, T32 HL70024, R37 HL104017, HHSN268201000031C]; NIH/National Institute on Aging [R03 AG051857]; NIH/National Center for Advancing Translational Sciences Grant [1UL1 TR001430]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK103750]; American Heart Association [16GRNT27660006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133013, R01HL137268, T32HL007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG051857] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/National Center for Advancing Translational Sciences Grant; NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Nader Rahimi for advice, and Dominique Croteau for editing the manuscript (both from the Boston University School of Medicine). The authors also thank Professor Stephen Chlopicki and his laboratory members (Jagiellonian Centre for Experimental Therapeutics, Krakow, Poland) for helpful advice, and the Analytical Instrumentation Core at Boston University Medical Campus for their service. This research was supported by U.S. National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) Grant R01 HL133013 (to R.M.), postdoctoral training Grant T32 HL70024 (to B.F.), R37 HL104017 (to R.A.C.), and contract HHSN268201000031C (to C.E.C.); NIH/National Institute on Aging Grant R03 AG051857 (to R.M.); NIH/National Center for Advancing Translational Sciences Grant 1UL1 TR001430 (to M.M.B. and R.M.); NIH/National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK103750 (to M.M.B.); and American Heart Association Grant 16GRNT27660006 (to M.M.B.). The authors declare no conflicts of interest.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Anathy V, 2018, NAT MED, V24, P1128, DOI 10.1038/s41591-018-0090-y; Anathy V, 2014, AM J RESP CRIT CARE, V189, P463, DOI 10.1164/rccm.201310-1905OC; Anathy V, 2009, J CELL BIOL, V184, P241, DOI 10.1083/jcb.200807019; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bachschmid MM, 2010, FREE RADICAL BIO MED, V49, P1221, DOI 10.1016/j.freeradbiomed.2010.07.005; Barsnes H, 2018, J PROTEOME RES, V17, P2552, DOI 10.1021/acs.jproteome.8b00175; Behring JB, 2014, FASEB J, V28, P1975, DOI 10.1096/fj.13-233445; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Carvalho PC, 2016, NAT PROTOC, V11, P102, DOI 10.1038/nprot.2015.133; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Daniel AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145684; Delgado-Bellido D, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0631-x; Dunleavey JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6200; Evangelista AM, 2012, ANTIOXID REDOX SIGN, V17, P1099, DOI 10.1089/ars.2011.4022; Fernandez-Barral A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032989; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Han JY, 2016, REDOX BIOL, V9, P306, DOI 10.1016/j.redox.2016.09.003; Hendrix MJC, 2016, PHARMACOL THERAPEUT, V159, P83, DOI 10.1016/j.pharmthera.2016.01.006; Hendrix MJC, 2002, CANCER RES, V62, P665; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Hess AR, 2001, CANCER RES, V61, P3250; Huang TT, 2017, ONCOTARGET, V8, P84546, DOI 10.18632/oncotarget.19165; INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jeon D, 2018, BIOCHEM BIOPH RES CO, V495, P212, DOI 10.1016/j.bbrc.2017.11.018; Jin-Lu M, 2011, BIOCHEM BIOPH RES CO, V408, P686, DOI 10.1016/j.bbrc.2011.04.089; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Matsui R, 2017, REDOX BIOL, V12, P1011, DOI 10.1016/j.redox.2017.04.040; Misra RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050153; Murdoch CE, 2014, J BIOL CHEM, V289, P8633, DOI 10.1074/jbc.M113.517219; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Ramazani Y, 2018, MATRIX BIOL, V68-69, P44, DOI 10.1016/j.matbio.2018.03.007; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schnegg CI, 2015, CANCER RES, V75, P1682, DOI 10.1158/0008-5472.CAN-14-1855; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; Sun BC, 2007, CANCER LETT, V249, P188, DOI 10.1016/j.canlet.2006.08.016; Sun BC, 2017, ONCOTARGET, V8, P30502, DOI 10.18632/oncotarget.8461; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang JY, 2008, CANCER BIOL THER, V7, P758, DOI 10.4161/cbt.7.5.5765; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Watanabe Y, 2016, P NATL ACAD SCI USA, V113, P6011, DOI 10.1073/pnas.1524198113; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233	56	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14147	14158		10.1096/fj.201900786R	http://dx.doi.org/10.1096/fj.201900786R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31647879	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000507466100084
J	Wang, SH; Li, MX; Zhao, XJ; Wang, H; Zhu, J; Wang, C; Zhou, MS; Dong, HF; Zhou, R				Wang, Shuhong; Li, Mingxuan; Zhao, Xuejun; Wang, Huan; Zhu, Jie; Wang, Cheng; Zhou, Mengsi; Dong, Huifen; Zhou, Rui			Upregulation of KSRP by miR-27b attenuates schistosomiasis-induced hepatic fibrosis by targeting TGF-beta 1	FASEB JOURNAL			English	Article						KSRP; liver fibrosis; miR-27b; Schistosoma japonicum; TGF-beta	STELLATE CELLS; KUPFFER CELLS; PATHOGENESIS; ACTIVATION; MECHANISMS	Hepatic stellate cells (HSCs) are the main effectors for various types of hepatic fibrosis, including Schistosome-induced hepatic fibrosis. Multiple inflammatory cytokines/chemokines, such as transforming growth factor-beta 1 (TGF-beta 1), activate HSCs, and contribute to the development of hepatic fibrosis. MicroRNAs regulate gene expression at the posttranscriptional level and are involved in regulation of inflammatory cytokine/chemokine synthesis. In this study, we showed that soluble egg antigen (SEA) stimulation and Schistosoma japonicum infection downregulate miR-27b expression and increase KH-type splicing regulatory protein (KSRP) mRNA and protein levels in vitro and in vivo. miR-27b regulates the stabilization of TGF-beta 1 mRNA through targeting KSRP by interacting with their AU-rich elements in hepatocytes and non-parenchymal cells, which has an effect on the activation of HSCs. Importantly, our results have shown that either knockdown miR-27b or overexpression of KSRP attenuates S. japonicum-induced hepatic fibrosis in vivo. Therefore, our study highlights the crucial role of miR-27b and KSRP in the negative regulation of immune reactions in hepatocyte and non-parenchymal cells in response to SEA stimulation and S. japonicum infection. It reveals that manipulation of miR-27b or KSRP might be a useful strategy not only for treating Schistosome-induced hepatic fibrosis but also for curing hepatic fibrosis in general.	[Wang, Shuhong; Li, Mingxuan; Zhao, Xuejun; Zhu, Jie; Wang, Cheng; Zhou, Mengsi; Dong, Huifen; Zhou, Rui] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Allergy & Immunol, Wuhan, Hubei, Peoples R China; [Wang, Shuhong; Li, Mingxuan; Zhao, Xuejun; Wang, Huan; Zhu, Jie; Wang, Cheng; Zhou, Mengsi; Dong, Huifen; Zhou, Rui] Wuhan Univ, Sch Basic Med Sci, Dept Med Parasitol, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Dong, HF; Zhou, R (corresponding author), Wuhan Univ, Sch Basic Med Sci, 185 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	hfdong@whu.edu.cn; ruizhou@whu.edu.cn						Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; Chen C, 2017, CELL BIOL INT, V41, P871, DOI 10.1002/cbin.10804; Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Duan YN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005268; Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003; Hao CQ, 2014, CLIN EXP MED, V14, P141, DOI 10.1007/s10238-013-0229-6; He X, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006957; He X, 2018, P NATL ACAD SCI USA, V115, P180, DOI 10.1073/pnas.1715965115; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Jin CY, 2016, STEM CELLS, V34, P2707, DOI 10.1002/stem.2439; Khera TK, 2010, FEBS J, V277, P2754, DOI 10.1111/j.1742-4658.2010.07692.x; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Lewis FA, 2014, ADV EXP MED BIOL, V766, P47, DOI 10.1007/978-1-4939-0915-5_3; Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Sugimoto R, 2005, LIVER INT, V25, P420, DOI 10.1111/j.1478-3231.2005.01087.x; Wang JX, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003106; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; World Health Organization, 2019, SCHISTOSOMIASIS; Xia ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17590; Xidakis C, 2005, DIGEST DIS SCI, V50, P935, DOI 10.1007/s10620-005-2668-8; Yu Q, 2017, MOL BIOTECHNOL, V59, P365, DOI 10.1007/s12033-017-0025-8; Zhou R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002702; Zhu DD, 2018, FASEB J, V32, P4798, DOI 10.1096/fj.201700520RR; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044032	35	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4120	4133		10.1096/fj.201902438R	http://dx.doi.org/10.1096/fj.201902438R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31953889				2022-12-28	WOS:000519218400046
J	Zhang, J; Kong, XM; Zhang, YH; Sun, WQ; Xu, EH; Chen, XB				Zhang, Jin; Kong, Xiangmudong; Zhang, Yanhong; Sun, Wenqiang; Xu, Enshun; Chen, Xinbin			Mdm2 is a target and mediator of IRP2 in cell growth control	FASEB JOURNAL			English	Article						Iron homeostasis; Iron-response element (IRE); IRP2; Mdm2; mRNA stability	IRON REGULATORY PROTEIN-1; P53; MICE; DEGRADATION; DEREPRESSION; EXPRESSION; MULTIPLE; PROMOTES; DELETION; ARREST	Iron is an essential element to all living organisms and plays a vital role in many cellular processes, such as DNA synthesis and energy production. The Mdm2 oncogene is an E3 ligase and known to promote tumor growth. However, the role of Mdm2 in iron homeostasis is not certain. Here, we showed that Mdm2 expression was increased by iron depletion but decreased by iron repletion. We also showed that Iron Regulatory Protein 2 (IRP2) mediated iron-regulated Mdm2 expression. Specifically, Mdm2 expression was increased by ectopic IRP2 but decreased by knockdown or knockout of IRP2 in human cancer cells as well as in mouse embryonic fibroblasts. In addition, we showed that IRP2-regulated Mdm2 expression was independent of tumor suppressor p53. Mechanistically, we found that IRP2 stabilized Mdm2 transcript via binding to an iron response element (IRE) in the 3MODIFIER LETTER PRIMEUTR of Mdm2 mRNA. Finally, we showed that Mdm2 is required for IRP2-mediated cell proliferation and Mdm2 expression is highly associated with IRP2 in both the normal and cancerous liver tissues. Together, we uncover a novel regulation of Mdm2 by IRP2 via mRNA stability and that the IRP2-Mdm2 axis may play a critical role in cell growth.	[Zhang, Jin; Kong, Xiangmudong; Zhang, Yanhong; Sun, Wenqiang; Xu, Enshun; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Schools Vet Med, Med, Davis, CA USA; Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Zhang, J; Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Schools Vet Med, Med, Davis, CA USA.	jinzhang@ucdavis.edu; xbchen@ucdavis.edu			NCI NIH HHS [R01 CA081237, R01 CA224433] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Azer SA, 2018, J CLIN MED, V7, DOI 10.3390/jcm7040064; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Deb Swati Palit, 2014, Subcell Biochem, V85, P215, DOI 10.1007/978-94-017-9211-0_12; Deng ZY, 2017, ONCOTARGET, V8, P82231, DOI 10.18632/oncotarget.19288; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dongiovanni P, 2010, AM J PATHOL, V176, P1006, DOI 10.2353/ajpath.2010.090249; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; INOUE S, 1987, CANCER RES, V47, P6522; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jung YS, 2012, DNA REPAIR, V11, P177, DOI 10.1016/j.dnarep.2011.10.017; Khiroya H, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00711-2016; Maffettone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010163; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Muto Y, 2019, J EXP MED, V216, P950, DOI 10.1084/jem.20180900; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Smith SR, 2006, BLOOD CELL MOL DIS, V36, P283, DOI 10.1016/j.bcmd.2005.12.006; Torti SV, 2018, ANNU REV NUTR, V38, P97, DOI 10.1146/annurev-nutr-082117-051732; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2002, MOL CELL BIOL, V22, P4638, DOI 10.1128/MCB.22.13.4638-4651.2002; Wang W, 2014, CANCER RES, V74, P497, DOI 10.1158/0008-5472.CAN-13-1224; Xu E, 2013, ONCOGENE, V32, P2169, DOI 10.1038/onc.2012.238; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; Zhang J, 2018, CANCER RES, V78, P1511, DOI 10.1158/0008-5472.CAN-17-2457; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang YH, 2017, GENE DEV, V31, P1243, DOI 10.1101/gad.299388.117	39	9	9	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2301	2311		10.1096/fj.201902278RR	http://dx.doi.org/10.1096/fj.201902278RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907996	Green Accepted, Bronze			2022-12-28	WOS:000514663600026
J	Li, CY; Zhou, JQ; Liu, ZJ; Zhou, JL; Yao, W; Tao, JL; Shen, M; Liu, HL				Li, Chengyu; Zhou, Jiaqi; Liu, Zhaojun; Zhou, Jilong; Yao, Wang; Tao, Jingli; Shen, Ming; Liu, Honglin			FSH prevents porcine granulosa cells from hypoxia-induced apoptosis via activating mitophagy through the HIF-1 alpha-PINK1-Parkin pathway	FASEB JOURNAL			English	Article						apoptosis; FSH; HIF-1 alpha; hypoxia; mitophagy; Parkin; PINK1; porcine granulosa cells	MOLECULAR-MECHANISMS; FAMILY PROTEASES; HIF-ALPHA; AUTOPHAGY; BCL-2; ANGIOGENESIS; DESTRUCTION; INVOLVEMENT; EXPRESSION; SURVIVAL	In developing follicles, the granulosa cells (GCs) live in a hypoxic environment due to the devoid of blood supply. Upon hypoxic conditions, several types of mammalian cells have been reported to undergo apoptosis. Follicle-stimulating hormone (FSH) is known as the primary survival factor for antral follicles by preventing GCs apoptosis. Mitophagy is a type of organelle-specific autophagy that removes damaged or stressed mitochondria to maintain cellular health. This study provides the first evidence suggesting that FSH-mediated mitophagy protected porcine GCs from hypoxia-induced apoptosis. Our data showed that the GCs apoptosis caused by mitochondrial pathway upon hypoxia stress was markedly attenuated after FSH treatment, which was correlated with enhanced activation of mitophagy. Interestingly, FSH also stimulated mitochondrial biogenesis as suggested by increased expression of mitochondrial transcription factor A and nuclear respiratory factor 1 during hypoxia exposure. Notably, the protein level of hypoxia inducible factor-1 alpha (HIF-1 alpha) was significantly increased in hypoxic GCs following FSH treatment, accompanied by elevated mitophagic activity and dampened apoptotic signaling. Blocking HIF-1 alpha inhibited mitophagy and restored hypoxia-induced apoptosis despite FSH treatment. Importantly, FSH promoted the expression of serine/threonine kinase PTEN induced putative kinase 1 (PINK1) and the E3 ligase Parkin during hypoxia stress through a HIF-1 alpha dependent manner. This induced the mitophagic clearance of damaged mitochondria, hence inhibiting apoptosis by reducing cytochrome c releasing. The inhibition of HIF-1 alpha and/or PINK1 using inhibitor or RNAi further confirmed the role of the FSH-HIF-1 alpha-PINK1-Parkin-mitophagy axis in suppressing GC apoptosis under hypoxic conditions. These findings highlight a novel function of FSH in preserving GCs viability against hypoxic damage by activating HIF-1 alpha-PINK1-Parkin-mediated mitophagy.	[Li, Chengyu; Zhou, Jiaqi; Liu, Zhaojun; Yao, Wang; Tao, Jingli; Shen, Ming; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Weigang 1, Nanjing 210095, Peoples R China; [Zhou, Jilong] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Inst Stem Cell & Regenerat Biol, Wuhan, Peoples R China	Nanjing Agricultural University; Huazhong Agricultural University	Shen, M; Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Weigang 1, Nanjing 210095, Peoples R China.	shenm2015@njau.edu.cn; liuhonglin@njau.edu.cn	liu, zhao/GXV-6141-2022; liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Natural Science Foundation of China (NSFC) [31630072, 31601939, 31972564]; Priority Academic Program Development of Jiangsu Higher Education Institutions [DKQB201903]; fundamental research funds for the central universities [KJQN201705]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: No. 31630072, 31601939 and 31972564; A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, Grant/Award Number: No. DKQB201903; the fundamental research funds for the central universities, Grant/Award Number: No. KJQN201705	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Bianco F, 2005, VET RES COMMUN, V29, P157, DOI 10.1007/s11259-005-0031-3; Chen L, 2009, EXP MOL MED, V41, P849, DOI 10.3858/emm.2009.41.12.103; Cheng Y, 2013, PHARMACOL REV, V65, P1162, DOI 10.1124/pr.112.007120; Chun SY, 1996, ENDOCRINOLOGY, V137, P1447, DOI 10.1210/en.137.4.1447; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dlamini Z, 2004, PHARMACOL THERAPEUT, V101, P1, DOI 10.1016/j.pharmthera.2003.08.005; Dong Z, 2016, CELL DEATH DIFFER, V23, P1602, DOI 10.1038/cdd.2016.47; Fadhillah, 2014, J REPROD DEVELOP, V60, P194, DOI 10.1262/jrd.2014-014; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Greijer AE, 2008, VIRCHOWS ARCH, V452, P535, DOI 10.1007/s00428-008-0578-9; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koh MY, 2008, MOL CANCER THER, V7, P90, DOI 10.1158/1535-7163.MCT-07-0463; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Neeman M, 1997, INT J EXP PATHOL, V78, P57, DOI 10.1046/j.1365-2613.1997.d01-247.x; Nishimura R, 2016, REPROD FERT DEVELOP, V28, P1479, DOI 10.1071/RD15010; PRINTZ RH, 1972, ANAT REC, V173, P157, DOI 10.1002/ar.1091730205; Redding GP, 2007, REPRODUCTION, V133, P1095, DOI 10.1530/REP-06-0171; Redmer D A, 1996, Rev Reprod, V1, P182; Rico C, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115634; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Shen M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.400; Shen M, 2017, AUTOPHAGY, V13, P1364, DOI 10.1080/15548627.2017.1327941; Shen M, 2012, J BIOL CHEM, V287, P25727, DOI 10.1074/jbc.M112.349902; Shimizu S, 1996, AM J PHYSIOL-GASTR L, V271, pG949, DOI 10.1152/ajpgi.1996.271.6.G949; Shimizu S, 1996, CANCER RES, V56, P2161; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Suzuki T, 1998, HUM REPROD, V13, P953, DOI 10.1093/humrep/13.4.953; Temple-Smith P, 2013, HUM REPROD, V28, P35; Wu H, 2015, ANTIOXID REDOX SIGN, V22, P1032, DOI 10.1089/ars.2014.6204; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhou JL, 2018, BIOL REPROD, V99, P308, DOI 10.1093/biolre/ioy061; Zhou JL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.371	42	17	18	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3631	3645		10.1096/fj.201901808RRR	http://dx.doi.org/10.1096/fj.201901808RRR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960530				2022-12-28	WOS:000508661300001
J	Jojima, K; Edagawa, M; Sawai, M; Ohno, Y; Kihara, A				Jojima, Keisuke; Edagawa, Mai; Sawai, Megumi; Ohno, Yusuke; Kihara, Akio			Biosynthesis of the anti-lipid-microdomain sphingoid base 4,14-sphingadiene by the ceramide desaturase FADS3	FASEB JOURNAL			English	Article						4,14-sphingadiene; ceramide; fatty acid desaturase; lipid; sphingolipid	MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; GENE ENCODES; SPHINGOLIPIDS; 1-PHOSPHATE; ACID; IDENTIFICATION; SPHINGOSINE-1-PHOSPHATE; CHROMATOGRAPHY; SYNTHASE	Sphingolipids are multifunctional lipids. Among the sphingolipid-component sphingoid bases, 4,14-sphingadiene (SPD) is unique such that it has a cis double bond with a bent structure. Although SPD was discovered half a century ago, its tissue distribution, biosynthesis, and degradation remain poorly understood. Here, we established a specific and quantitative method for SPD measurement and found that SPD exists in a wide range of mammalian tissues. SPD was especially abundant in kidney, where the amount of SPD was similar to 2/3 of sphingosine, the most abundant sphingoid base in mammals. Although SPD is metabolized to ceramides and SPD 1-phosphate with almost the same efficiency as sphingosine, it is less susceptible to degradation by a cleavage reaction, at least in vitro. We identified the fatty acid desaturase family protein FADS3 as a ceramide desaturase that produces SPD ceramides by desaturating ceramides containing sphingosine. SPD sphingolipids were preferentially localized outside lipid microdomains, suggesting that SPD has different functions compared to other sphingoid bases in the formation of lipid microdomains. In summary, we revealed the biosynthesis and degradation pathways of SPD and its characteristic membrane localization. Our findings contribute to the elucidation of the molecular mechanism underlying the generation of sphingolipid diversity.	[Jojima, Keisuke; Edagawa, Mai; Sawai, Megumi; Ohno, Yusuke; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Sapporo, Hokkaido, Japan	Hokkaido University	Ohno, Y; Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	yusuke-ohno@pharm.hokudai.ac.jp; kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012; Ohno, Yusuke/B-5621-2014	KIHARA, AKIO/0000-0001-5889-0788; Sawai-Ogawa, Megumi/0000-0002-7406-802X; Jojima, Keisuke/0000-0003-0721-790X; Ohno, Yusuke/0000-0003-3702-1043	Japan Agency for Medical Research and Development (AMED) [JP19gm0910002h0005]; MEXT | Japan Society for the Promotion of Science (JSPS) [JP18H03976]; MEXT \ Japan Society for the Promotion of Science (JSPS) [JP18H04664]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm0910002h0005; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18H03976; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18H04664	Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Castro LFC, 2016, PROG LIPID RES, V62, P25, DOI 10.1016/j.plipres.2016.01.001; Colsch B, 2004, J LIPID RES, V45, P281, DOI 10.1194/jlr.M300331-JLR200; Edagawa M, 2018, BBA-MOL CELL BIOL L, V1863, P1441, DOI 10.1016/j.bbalip.2018.09.002; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Ishikawa J, 2009, J DERMATOL SCI, V56, P216, DOI 10.1016/j.jdermsci.2009.09.002; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Jones JW, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3822; Karsai G, 2019, J CLIN INVEST, V129, P1229, DOI 10.1172/JCI124159; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kitamura T, 2017, P NATL ACAD SCI USA, V114, pE2616, DOI 10.1073/pnas.1700138114; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kondo N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6338; Kulkarni AA, 2010, MED RES REV, V30, P327, DOI 10.1002/med.20196; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu X, 2018, CLIN CHEM, V64, P810, DOI 10.1373/clinchem.2017.277905; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Melero R, 2014, STRUCTURE, V22, P1105, DOI 10.1016/j.str.2014.05.015; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Narayanaswamy P, 2014, ANAL CHEM, V86, P3043, DOI 10.1021/ac4039652; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Ohno Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14610; PANGANAMALA RV, 1969, J LIPID RES, V10, P445; Pedrono F, 2010, J LIPID RES, V51, P472, DOI 10.1194/jlr.M000588; POLITO AJ, 1968, BIOCHEMISTRY-US, V7, P2609, DOI 10.1021/bi00847a024; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; RENKONEN O, 1969, J LIPID RES, V10, P687; Rioux V, 2013, J LIPID RES, V54, P3438, DOI 10.1194/jlr.M042572; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Sassa T, 2016, J BIOL CHEM, V291, P7477, DOI 10.1074/jbc.M115.695858; Sawai M, 2017, J BIOL CHEM, V292, P15538, DOI 10.1074/jbc.M117.803171; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sugawara T, 2010, J LIPID RES, V51, P1761, DOI 10.1194/jlr.M002204; t'Kindt R, 2012, ANAL CHEM, V84, P403, DOI 10.1021/ac202646v; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Yatomi Y, 2000, BLOOD, V96, P3431; Zhang JY, 2017, PROSTAG LEUKOTR ESS, V123, P25, DOI 10.1016/j.plefa.2017.07.001; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	51	24	24	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3318	3335		10.1096/fj.201902645R	http://dx.doi.org/10.1096/fj.201902645R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916624	hybrid			2022-12-28	WOS:000506440300001
J	Jiang, C; Wang, YL; Hu, QF; Shou, JX; Zhu, L; Tian, N; Sun, L; Luo, H; Zuo, FF; Li, FF; Wang, YY; Zhang, J; Wang, JR; Wang, J; Zhang, JW				Jiang, Chao; Wang, Yali; Hu, Qiangfu; Shou, Jixin; Zhu, Li; Tian, Ning; Sun, Lu; Luo, Huan; Zuo, Fangfang; Li, Fangfang; Wang, Yingying; Zhang, Jing; Wang, Jiarui; Wang, Jian; Zhang, Jiewen			Immune changes in peripheral blood and hematoma of patients with intracerebral hemorrhage	FASEB JOURNAL			English	Article						hematoma; immune changes; intracerebral hemorrhage; outcome; patients	REGULATORY T-CELLS; MINIMALLY INVASIVE SURGERY; TUFTSIN FRAGMENT 1-3; INFLAMMATORY RESPONSE; MICROGLIA/MACROPHAGE POLARIZATION; CEREBRAL-ISCHEMIA; LYMPHOCYTE RATIO; HUMAN MICROGLIA; M1 PHENOTYPE; BRAIN-INJURY	Immunologic changes in the hematoma of patients with intracerebral hemorrhage (ICH) and the contribution of these changes to prognosis are unknown. We collected the blood samples and hematoma fluid from 35 patients with acute ICH (<30 hours from symptom onset) and 55 age-matched healthy controls. Using flow cytometry and ELISA, we found that the percentages of granulocytes, regulatory T cells, helper T (Th) 17 cells, and dendritic cells were higher in the peripheral blood of patients with ICH than in healthy controls, whereas the percentages of lymphocytes, M1-like macrophages, and M2-like macrophages were lower. Levels of IL-6, IL-17, IL-23, TNF-alpha, IL-4, IL-10, and TGF-beta were higher in the peripheral blood of patients with ICH. The absolute counts of white blood cells, lymphocytes, monocytes, and granulocytes in the hematoma tended to be greater at 12-30 hours than they were within 12 hours after ICH, but the percentage of Th cells decreased in peripheral blood. Increased levels of IL-10 in the serum and hematoma, and a reduction in M1-like macrophages in hematoma were independently associated with favorable outcome on day 90. These results indicate that immunocytes present in the hematoma may participate in the acute-phase inflammatory response after ICH.	[Jiang, Chao; Wang, Yali; Zhu, Li; Tian, Ning; Sun, Lu; Luo, Huan; Zuo, Fangfang; Li, Fangfang; Wang, Yingying; Zhang, Jing] Zhengzhou Univ, Affiliated Hosp 5, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China; [Hu, Qiangfu] Zhengzhou Univ, Affiliated Hosp 5, Dept Anesthesiol, Zhengzhou, Peoples R China; [Shou, Jixin] Zhengzhou Univ, Affiliated Hosp 5, Dept Neurosurg, Zhengzhou, Peoples R China; [Wang, Jiarui] Winston Churchill High Sch, Potomac, MD USA; [Wang, Jian] Zhengzhou Univ, Dept Anat, Coll Basic Med Sci, Zhengzhou, Henan, Peoples R China; [Zhang, Jiewen] Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou 450000, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University	Jiang, C (corresponding author), Zhengzhou Univ, Affiliated Hosp 5, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China.; Zhang, JW (corresponding author), Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou 450000, Peoples R China.	chaojzzu@126.com; zhangjiewen9900@126.com	Wang, Jian/I-4874-2019; Zhang, Jiewen/GSE-5744-2022	Wang, Jian/0000-0003-2291-640X; 	National Natural Science Foundation of China [81301006, 81671165]; Excellent Youth Foundation of Henan Scientific Committee [2018JQ0016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Henan Scientific Committee	National Natural Science Foundation of China, Grant/Award Number: 81301006 and 81671165; Excellent Youth Foundation of Henan Scientific Committee, Grant/Award Number: 2018JQ0016	Adachi T, 2017, CEREBROVASC DIS EXTR, V7, P62, DOI 10.1159/000462985; Adeoye O, 2014, J STROKE CEREBROVASC, V23, pE107, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.006; Allam JP, 2011, J CLIN PERIODONTOL, V38, P879, DOI 10.1111/j.1600-051X.2011.01752.x; An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Askenase MH, 2016, SEMIN NEUROL, V36, P288, DOI 10.1055/s-0036-1582132; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Benarafa C, 2017, BIOCHEM BIOPH RES CO, V482, P473, DOI 10.1016/j.bbrc.2016.11.086; Bramer D, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-9; Cai YY, 2015, EXP NEUROL, V266, P120, DOI 10.1016/j.expneurol.2015.02.013; Chang CF, 2017, NEUROBIOL DIS, V103, P54, DOI 10.1016/j.nbd.2017.03.016; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; De Haas AH, 2008, GLIA, V56, P888, DOI 10.1002/glia.20663; Dieterlen MT, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5946807; Easton AS, 2013, INT IMMUNOPHARMACOL, V17, P1218, DOI 10.1016/j.intimp.2013.06.015; Fam MD, 2017, NEUROLOGY, V89, P1553, DOI 10.1212/WNL.0000000000004493; Feigin VL., 2013, NEUROEPIDEMIOLOGY, V45, P161, DOI DOI 10.1159/000441085; Fiorella D, 2016, STROKE, V47, P1399, DOI 10.1161/STROKEAHA.115.011415; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Gelderblom M, 2012, J CEREBR BLOOD F MET, V32, P835, DOI 10.1038/jcbfm.2011.189; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Giede-Jeppe A, 2017, CEREBROVASC DIS, V44, P26, DOI 10.1159/000468996; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Hammond MD, 2012, TRANSL STROKE RES, V3, pS125, DOI 10.1007/s12975-012-0174-9; Han ZP, 2018, AGING DIS, V9, P235, DOI 10.14336/AD.2017.0328; Hanley DF, 2016, LANCET NEUROL, V15, P1226, DOI 10.1016/S1474-4422(16)30234-4; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hjorth E, 2013, J ALZHEIMERS DIS, V35, P697, DOI 10.3233/JAD-130131; Hu YH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/813045; Illanes S, 2011, NEUROSCI LETT, V490, P170, DOI 10.1016/j.neulet.2010.11.065; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Jiang C, 2017, ONCOTARGET, V8, P3553, DOI 10.18632/oncotarget.12201; Jiang C, 2016, NEUROBIOL AGING, V42, P13, DOI 10.1016/j.neurobiolaging.2016.02.029; Koyasu S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00101; Kramer AH, 2015, J CEREBR BLOOD F MET, V35, P1241, DOI 10.1038/jcbfm.2015.47; Krausgruber T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11627; Lan X, 2019, J CEREBR BLOOD F MET, V39, P184, DOI 10.1177/0271678X18805675; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Lattanzi S, 2017, ONCOTARGET, V8, P57489, DOI 10.18632/oncotarget.15423; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Law JP, 2009, CYTOM PART A, V75A, P1040, DOI 10.1002/cyto.a.20815; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Liang QJ, 2015, IUBMB LIFE, V67, P710, DOI 10.1002/iub.1429; Liotta EM, 2017, NEUROLOGY, V89, P813, DOI [10.1212/WNL.0000000000004249, 10.1212/wnl.0000000000004249]; Liu W, 2016, NEUROSCI LETT, V620, P74, DOI 10.1016/j.neulet.2016.03.047; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Luo Y, 2015, BRAIN RES, V1597, P86, DOI 10.1016/j.brainres.2014.12.005; Lutz MB, 2016, IMMUNE NETW, V16, P13, DOI 10.4110/in.2016.16.1.13; Ma YG, 2016, CARDIOVASC RES, V110, P51, DOI 10.1093/cvr/cvw024; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Mracsko E, 2014, STROKE, V45, P2107, DOI 10.1161/STROKEAHA.114.005801; Na SY, 2015, STROKE, V46, P212, DOI 10.1161/STROKEAHA.114.007756; Ohlsson SM, 2014, CLIN IMMUNOL, V152, P10, DOI 10.1016/j.clim.2014.02.016; Peferoen LAN, 2015, J NEUROPATH EXP NEUR, V74, P48, DOI 10.1097/NEN.0000000000000149; Perez-de Puig I, 2013, J CEREBR BLOOD F MET, V33, P1955, DOI 10.1038/jcbfm.2013.155; Poppensieker K, 2012, P NATL ACAD SCI USA, V109, P3897, DOI 10.1073/pnas.1114153109; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Sembill JA, 2017, NEUROLOGY, V89, P423, DOI 10.1212/WNL.0000000000004174; Subramanian S, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1187-7; Szulzewsky F, 2018, NEURO-ONCOLOGY, V20, P355, DOI 10.1093/neuonc/nox165; Tapia-Perez JH, 2016, CLIN NEUROL NEUROSUR, V150, P72, DOI 10.1016/j.clineuro.2016.07.010; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Truettner JS, 2017, J CEREBR BLOOD F MET, V37, P2952, DOI 10.1177/0271678X16680003; Venema E, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1710; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang J, 2005, STROKE, V36, P613, DOI 10.1161/01.STR.0000155729.12931.8f; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wilson D, 2017, NEUROLOGY, V88, P1693, DOI 10.1212/WNL.0000000000003886; Wilson D, 2016, NEUROLOGY, V86, P360, DOI 10.1212/WNL.0000000000002310; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu H, 2010, BRAIN RES, V1342, P111, DOI 10.1016/j.brainres.2010.04.033; Yang JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00061; Yang Z, 2014, INT IMMUNOPHARMACOL, V22, P522, DOI 10.1016/j.intimp.2014.06.037; Yin YT, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0993-4; Yu S, 2016, J NEUROL SCI, V361, P112, DOI 10.1016/j.jns.2015.12.033; Zernecke A, 2015, ARTERIOSCL THROM VAS, V35, P763, DOI 10.1161/ATVBAHA.114.303566; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097; Zhao XR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00770-7; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015; Zheng Y, 2015, NEUROSCIENCE, V290, P321, DOI 10.1016/j.neuroscience.2015.01.041; Zhou K, 2017, J CEREBR BLOOD F MET, V37, P967, DOI 10.1177/0271678X16648712; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003; Zhu HM, 2019, PROG NEUROBIOL, V178, P6, DOI 10.1016/j.pneurobio.2019.03.003	91	20	21	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2774	2791		10.1096/fj.201902478R	http://dx.doi.org/10.1096/fj.201902478R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31912591				2022-12-28	WOS:000506146800001
J	Wang, JL; Bai, MJ; Elsheikha, HM; Liang, QL; Li, TT; Cao, XZ; Zhu, XQ				Wang, Jin-Lei; Bai, Meng-Jie; Elsheikha, Hany M.; Liang, Qin-Li; Li, Ting-Ting; Cao, Xue-Zhen; Zhu, Xing-Quan			Novel roles of dense granule protein 12 (GRA12) in Toxoplasma gondii infection	FASEB JOURNAL			English	Article						dense granule protein 12; immunity-related GTPases; intravacuolar network; rhoptry protein 18; Toxoplasma gondii; virulence	PARASITOPHOROUS VACUOLE; ACUTE VIRULENCE; INTRAVACUOLAR NETWORK; NANOTUBULAR NETWORK; HOST; KINASES; VESICLES; IMMUNITY; GTPASES; PLAYS	Dense granule protein 12 (GRA12) is implicated in a range of processes related to the establishment of Toxoplasma gondii infection, such as the formation of the intravacuolar network (IVN) within the parasitophorous vacuole (PV). This protein is also thought to be important for T. gondii-host interaction, pathogenesis, and immune evasion, but their exact roles remain unknown. In this study, the contributions of GRA12 to the molecular pathogenesis of T. gondii infection were examined in vitro and in vivo. Deletion of GRA12 in type I RH and type II Pru T. gondii strains did not affect the parasite growth and replication in vitro, however, it caused a significant reduction in the parasite virulence and tissue cyst burden in vivo. T. gondii Delta gra12 mutants were more vulnerable to be eliminated by host immunity, without the accumulation of immunity-related GTPase a6 (Irga6) onto the PV membrane. The ultrastructure of IVN in Delta gra12 mutants appeared normal, suggesting that GRA12 is not required for biogenesis of the IVN. Combined deletion of GRA12 and ROP18 induced more severe attenuation of virulence compared to single Delta gra12 or Delta rop18 mutant strains. These data suggest a functional association between GRA12 and ROP18 that is revealed by the severe attenuation of virulence in a double mutant relative to the single individual mutations. Future studies are needed to define the molecular basis of this putative association. Collectively these findings indicate that although GRA12 is not essential for the parasite growth and replication in vitro, it contributes to the virulence and growth of T. gondii in mice.	[Wang, Jin-Lei; Bai, Meng-Jie; Liang, Qin-Li; Li, Ting-Ting; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China; [Elsheikha, Hany M.] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Cao, Xue-Zhen] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; University of Nottingham; South China Agricultural University	Wang, JL; Zhu, XQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China.	wangjinlei90@126.com; xingquanzhu1@hotmail.com	Elsheikha, Hany/G-7573-2011; ZOU, Fengcai/ABE-4598-2021	ZOU, Fengcai/0000-0002-9613-3734	National Natural Science Foundation of China [31802180]; International Science and Technology Cooperation Project of Gansu Provincial Key Research and Development Program [17JR7WA031]; Agricultural Science and Technology Innovation Program (ASTIP) [CAAS-ASTIP-2016-LVRI-03]; Elite Program of Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2016-LVRI-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Project of Gansu Provincial Key Research and Development Program; Agricultural Science and Technology Innovation Program (ASTIP); Elite Program of Chinese Academy of Agricultural Sciences	This study was supported by the National Natural Science Foundation of China, Grant/Award Number: 31802180; the International Science and Technology Cooperation Project of Gansu Provincial Key Research and Development Program, Grant/Award Number: 17JR7WA031; the Elite Program of Chinese Academy of Agricultural Sciences, and the Agricultural Science and Technology Innovation Program (ASTIP), Grant/Award Number: CAAS-ASTIP-2016-LVRI-03	Adjogble KDZ, 2004, INT J PARASITOL, V34, P1255, DOI 10.1016/j.ijpara.2004.07.011; Alaganan A, 2014, P NATL ACAD SCI USA, V111, P1126, DOI 10.1073/pnas.1313501111; Bai MJ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00300; Behnke MS, 2016, ANNU REV MICROBIOL, V70, P63, DOI 10.1146/annurev-micro-091014-104353; Beraki T, 2019, P NATL ACAD SCI USA, V116, P6361, DOI 10.1073/pnas.1816161116; Blader IJ, 2015, ANNU REV MICROBIOL, V69, P463, DOI 10.1146/annurev-micro-091014-104100; Bohne W, 1997, MOL BIOCHEM PARASIT, V88, P115, DOI 10.1016/S0166-6851(97)00087-X; Boothroyd JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003296; Clough B, 2017, TRENDS PARASITOL, V33, P473, DOI 10.1016/j.pt.2017.02.007; Dou ZC, 2014, MBIO, V5, DOI 10.1128/mBio.01188-14; Dubois DJ, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13018; Etheridge RD, 2014, CELL HOST MICROBE, V15, P537, DOI 10.1016/j.chom.2014.04.002; Fleckenstein MC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001358; Fox BA, 2019, MBIO, V10, DOI 10.1128/mBio.00589-19; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Hakimi MA, 2017, CLIN MICROBIOL REV, V30, P615, DOI 10.1128/CMR.00005-17; Hakimi MA, 2015, CURR OPIN MICROBIOL, V26, P24, DOI 10.1016/j.mib.2015.04.003; Han B, 2019, MBIO, V10, DOI 10.1128/mBio.01944-19; He H, 2018, ELIFE, V7, DOI 10.7554/eLife.39887; Hermanns T, 2016, CELL MICROBIOL, V18, P244, DOI 10.1111/cmi.12499; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Kim SK, 2007, INFECT IMMUN, V75, P1626, DOI 10.1128/IAI.01862-06; Krishnamurthy S, 2016, MBIO, V7, DOI [10.1128/mBio.00754-16, 10.1128/mbio.00754-16]; Labruyere E, 1999, MOL BIOCHEM PARASIT, V102, P311, DOI 10.1016/S0166-6851(99)00092-4; Lei T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099744; Lopez J, 2015, CELL REP, V13, P2273, DOI 10.1016/j.celrep.2015.11.001; Magno RC, 2005, MICROSC RES TECHNIQ, V67, P45, DOI 10.1002/jemt.20182; Mercier C, 1998, INFECT IMMUN, V66, P4176; Mercier C, 2002, MOL BIOL CELL, V13, P2397, DOI 10.1091/mbc.E02-01-0021; Mercier C, 2015, TRENDS PARASITOL, V31, P60, DOI 10.1016/j.pt.2014.12.002; Michelin A, 2009, INT J PARASITOL, V39, P299, DOI 10.1016/j.ijpara.2008.07.011; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nadipuram SM, 2016, MBIO, V7, DOI 10.1128/mBio.00808-16; Pan M, 2019, J PROTEOME RES, V18, P319, DOI 10.1021/acs.jproteome.8b00626; Paredes-Santos T, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00321; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Romano JD, 2013, MOL BIOL CELL, V24, P1974, DOI 10.1091/mbc.E12-11-0827; Rommereim LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159306; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JP, 2017, CURR OPIN MICROBIOL, V40, P72, DOI 10.1016/j.mib.2017.10.021; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; SIBLEY LD, 1995, J CELL SCI, V108, P1669; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Travier L, 2008, INT J PARASITOL, V38, P757, DOI 10.1016/j.ijpara.2007.10.010; Wang JL, 2018, J INFECT DIS, V218, P768, DOI 10.1093/infdis/jiy211; Wang Jin-Lei, 2017, Front Microbiol, V8, P84, DOI 10.3389/fmicb.2017.00084; Wang JL, 2016, PARASITOL RES, V115, P697, DOI 10.1007/s00436-015-4791-6; Xia NB, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12794; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Young J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11855-w	55	17	18	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3165	3178		10.1096/fj.201901416RR	http://dx.doi.org/10.1096/fj.201901416RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908049	Green Submitted, Bronze			2022-12-28	WOS:000505939800001
J	Lee, NG; Jeung, IC; Heo, SC; Song, J; Kim, W; Hwang, B; Kwon, MG; Kim, YG; Lee, J; Park, JG; Shin, MG; Cho, YL; Son, MY; Bae, KH; Lee, SH; Kim, JH; Min, JK				Lee, Na Geum; Jeung, In Cheul; Heo, Soon Chul; Song, Jinhoi; Kim, Wooil; Hwang, Byungtae; Kwon, Min-Gi; Kim, Yeon-Gu; Lee, Jangwook; Park, Jong-Gil; Shin, Min-Gyeong; Cho, Young-Lai; Son, Mi-Young; Bae, Kwang-Hee; Lee, Sang-Hyun; Kim, Jae Ho; Min, Jeong-Ki			Ischemia-induced Netrin-4 promotes neovascularization through endothelial progenitor cell activation via Unc-5 Netrin receptor B	FASEB JOURNAL			English	Article						angiogenesis-dependent diseases; endothelial progenitor cells; EPC-based therapy; neovascularization; Netrin-4	GUIDANCE; ANGIOGENESIS; VASCULARIZATION; TRANSPLANTATION; PROLIFERATION; MOBILIZATION; RECRUITMENT; PATHWAYS; BINDING; STEM	Endothelial progenitor cells (EPCs) promote neovascularization and tissue repair by migrating to vascular injury sites; therefore, factors that enhance EPC homing to damaged tissues are of interest. Here, we provide evidence of the prominent role of the Netrin-4 (NTN4)-Unc-5 Netrin receptor B (UNC5B) axis in EPC-specific promotion of ischemic neovascularization. Our results showed that NTN4 promoted the proliferation, chemotactic migration, and paracrine effects of small EPCs (SEPCs) and significantly increased the incorporation of large EPCs (LEPCs) into tubule networks. Additionally, NTN4 prominently augmented neovascularization in mice with hindlimb ischemia by increasing the homing of exogenously transplanted EPCs to the ischemic limb and incorporating EPCs into vessels. Moreover, silencing of UNC5B, an NTN4 receptor, abrogated the NTN4-induced cellular activities of SEPCs in vitro and blood-flow recovery and neovascularization in vivo in ischemic muscle by reducing EPC homing and incorporation. These findings suggest NTN4 as an EPC-based therapy for treating angiogenesis-dependent diseases.	[Lee, Na Geum; Song, Jinhoi; Kim, Wooil; Hwang, Byungtae; Kwon, Min-Gi; Kim, Yeon-Gu; Lee, Jangwook; Park, Jong-Gil; Shin, Min-Gyeong; Lee, Sang-Hyun; Min, Jeong-Ki] Korea Res Inst Biosci & Biotechnol KRIBB, Biotherapeut Translat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea; [Lee, Na Geum; Kim, Wooil; Kwon, Min-Gi; Min, Jeong-Ki] Korea Univ Sci & Technol, KRIBB Sch Biosci, Dept Biomol Sci, Daejeon, South Korea; [Jeung, In Cheul] Catholic Univ Korea, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Heo, Soon Chul; Kim, Jae Ho] Pusan Natl Univ, Dept Physiol, Yangsan Hosp, Yangsan, South Korea; [Cho, Young-Lai; Bae, Kwang-Hee] Korea Res Inst Biosci & Biotechnol KRIBB, Res Ctr Metab Regulat, Daejeon, South Korea; [Son, Mi-Young] Korea Res Inst Biosci & Biotechnol KRIBB, Stem Cell Res Ctr, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Catholic University of Korea; Pusan National University; Pusan National University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, SH; Min, JK (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Biotherapeut Translat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea.; Kim, JH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 50612, South Korea.	leesh@kribb.re.kr; jhkimst@pusan.ac.kr; jekmin@kribb.re.kr		Min, Jeong-Ki/0000-0003-4924-8739; Kim, Jae Ho/0000-0003-4323-4790; Lee, Sang-Hyun/0000-0002-9682-1473	Korea Research Institute of Bioscience and Biotechnology; National Research Foundation of Korea; Ministry of Science, Information & Communication Technology and Future Planning [NRF-2015M3A9C6030280, NRF-2015M3A9C6030284, NRF-2013M3A9B6046566, NRF2019R1A2C1089258, NRF2018R1A2B2006724]; Research of Korea Centers [2018ER610300]	Korea Research Institute of Bioscience and Biotechnology; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, Information & Communication Technology and Future Planning; Research of Korea Centers	Korea Research Institute of Bioscience and Biotechnology; National Research Foundation of Korea; Ministry of Science, Information & Communication Technology and Future Planning, Grant/Award Number: NRF-2015M3A9C6030280, NRF-2015M3A9C6030284, NRF-2013M3A9B6046566, NRF2019R1A2C1089258 and NRF2018R1A2B2006724; Research of Korea Centers, Grant/Award Number: 2018ER610300	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Alev C, 2011, ANTIOXID REDOX SIGN, V15, P949, DOI 10.1089/ars.2010.3872; Bouvard C, 2010, ARTERIOSCL THROM VAS, V30, P1569, DOI 10.1161/ATVBAHA.110.209163; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Choi HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7943; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Dakouane-Giudicelli M, 2015, PLACENTA, V36, P1260, DOI 10.1016/j.placenta.2015.09.007; de la Puente P, 2013, CLIN CANCER RES, V19, P3360, DOI 10.1158/1078-0432.CCR-13-0462; Di Santo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095731; Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Eveno C, 2011, AM J PATHOL, V178, P1861, DOI 10.1016/j.ajpath.2010.12.019; Feng NP, 2015, J MOL NEUROSCI, V57, P426, DOI 10.1007/s12031-015-0589-3; Freitas C, 2008, ANGIOGENESIS, V11, P23, DOI 10.1007/s10456-008-9096-2; Freixa X, 2011, MICROVASC RES, V82, P177, DOI 10.1016/j.mvr.2011.06.008; Hayano Y, 2014, P NATL ACAD SCI USA, V111, P15226, DOI 10.1073/pnas.1402095111; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Hoang S, 2009, J CEREBR BLOOD F MET, V29, P385, DOI 10.1038/jcbfm.2008.128; Hu YZ, 2012, NEOPLASIA, V14, P219, DOI 10.1593/neo.111396; Janic B, 2010, THESCIENTIFICWORLDJO, V10, P1088, DOI 10.1100/tsw.2010.100; Jung C, 2013, INT J CARDIOL, V168, P1017, DOI 10.1016/j.ijcard.2012.10.032; Kim J, 2015, ARTERIOSCL THROM VAS, V35, P2020, DOI 10.1161/ATVBAHA.115.306142; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Kociok N, 2016, SCI REP-UK, V6, DOI 10.1038/srep18828; Lambert E, 2012, J BIOL CHEM, V287, P3987, DOI 10.1074/jbc.M111.289371; Larrieu-Lahargue F, 2011, CIRC RES, V109, P770, DOI 10.1161/CIRCRESAHA.111.247239; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Larrivee B, 2007, GENE DEV, V21, P2433, DOI 10.1101/gad.437807; Lee DG, 2015, J HEPATOL, V63, P1429, DOI 10.1016/j.jhep.2015.08.007; Lee K, 2019, J NANOBIOTECHNOL, V17, DOI 10.1186/s12951-019-0456-4; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Lejmi E, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-1; Liu NM, 2017, J MOL MED, V95, P335, DOI 10.1007/s00109-016-1490-4; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Nacht M, 2009, EXP CELL RES, V315, P784, DOI 10.1016/j.yexcr.2008.11.018; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rodriguez-Grande B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0227-y; Shen L, 2011, MED HYPOTHESES, V76, P256, DOI 10.1016/j.mehy.2010.10.014; Shi Y, 2014, EUR CELLS MATER, V27, P64, DOI 10.22203/eCM.v027a06; Smadja DM, 2011, ARTERIOSCL THROM VAS, V31, P551, DOI 10.1161/ATVBAHA.110.220624; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Wu LW, 2019, FASEB J, V33, P2388, DOI 10.1096/fj.201800658R; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yang Y, 2007, CANCER BIOL THER, V6, P743, DOI 10.4161/cbt.6.5.3976; Yebra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022750; Youn SW, 2011, BLOOD, V117, P4376, DOI 10.1182/blood-2010-07-295964; Young PP, 2002, P NATL ACAD SCI USA, V99, P11951, DOI 10.1073/pnas.182215799; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044	57	5	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1231	1246		10.1096/fj.201900866RR	http://dx.doi.org/10.1096/fj.201900866RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914695				2022-12-28	WOS:000507308900083
J	Lee, YS; Park, JS; Lee, DH; Han, J; Bae, SH				Lee, Yu Seol; Park, Jeong Su; Lee, Da Hyun; Han, Jisu; Bae, Soo Han			Ezetimibe ameliorates lipid accumulation during adipogenesis by regulating the AMPK-mTORC1 pathway	FASEB JOURNAL			English	Article						adipogenesis; AMPK; ezetimibe; mitotic clonal expansion; obesity	MITOTIC CLONAL EXPANSION; ADIPOCYTE DIFFERENTIATION; HIGH-FAT; INHIBITS ADIPOGENESIS; 3T3-L1 CELLS; IN-VITRO; AMPK; PROTEIN; OBESITY; COMBINATION	Adipogenesis, a critical process that converts adipocyte precursors into adipocytes, is considered a potential therapeutic target for the treatment of obesity. Ezetimibe, a drug approved by the United States Food and Drug Administration, is used for the treatment of hypercholesterolemia. Recently, it was reported to ameliorate high fat diet-induced dyslipidemia in mice and reduce lipid accumulation in hepatocytes through the activation of AMPK. However, the anti-adipogenic effects of ezetimibe and the underlying molecular mechanism have not yet been elucidated. Here, we found that ezetimibe reduced lipid accumulation via activating AMPK during the early phase of adipogenesis. We also observed that ezetimibe inhibited peroxisome proliferator-activated receptor gamma, which is a major transcription factor of adipogenesis. Furthermore, ezetimibe-mediated AMPK activation reduced lipid accumulation by inhibiting mTORC1 signaling, leading to the downregulation of lipogenesis-related genes. Mitotic clonal expansion, required for adipogenesis, accelerates cell cycle progression and cell proliferation. We additionally observed that ezetimibe prevented the progression of mitotic clonal expansion by arresting the cell cycle at the G0/G1 phase, which was followed by the inhibition of cell proliferation. Collectively, ezetimibe-mediated inhibition of adipogenesis is dependent on the AMPK-mTORC1 pathway. Thus, we suggest that ezetimibe might be a promising drug for the treatment of obesity.	[Lee, Yu Seol; Park, Jeong Su; Lee, Da Hyun; Han, Jisu; Bae, Soo Han] Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Severance Biomed Sci Inst, 50 Yonsei Ro, Seoul 03722, South Korea; [Lee, Yu Seol; Lee, Da Hyun] Yonsei Univ, Brain Korea 21 PLUS Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Bae, SH (corresponding author), Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Severance Biomed Sci Inst, 50 Yonsei Ro, Seoul 03722, South Korea.	soohanbae@yuhs.ac		Park, Jeong Su/0000-0003-4551-4294; Lee, Da Hyun/0000-0002-5412-6878; Bae, Soo Han/0000-0002-8007-2906	National Research Foundation of Korea (NRF) [NRF-2017R1A2B4007400, NRF-2017R1D1A1B03032808]; Yonsei University | Yonsei University College of Medicine (YUCM) [6-2019-0068]; Korea Health Industry Development Institute (KHIDI) [HI17C0913, HI16C0257]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Yonsei University | Yonsei University College of Medicine (YUCM); Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI))	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2017R1A2B4007400 and NRF-2017R1D1A1B03032808; Yonsei University | Yonsei University College of Medicine (YUCM), Grant/Award Number: 6-2019-0068; Korea Health Industry Development Institute (KHIDI), Grant/Award Number: HI17C0913 and HI16C0257	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Ballantyne CM, 2005, AM HEART J, V149, P464, DOI 10.1016/j.ahj.2004.11.023; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Cai H, 2016, TRENDS PHARMACOL SCI, V37, P303, DOI 10.1016/j.tips.2015.11.011; Cha JY, 2013, P NATL ACAD SCI USA, V110, P20575, DOI 10.1073/pnas.1320454110; Chang E, 2019, MOLECULES, V24, DOI 10.3390/molecules24061157; Choi HS, 2015, MOL NUTR FOOD RES, V59, P1458, DOI 10.1002/mnfr.201500021; Choi KM, 2012, OBESITY, V20, P1365, DOI 10.1038/oby.2011.388; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Gormand A, 2014, J MOL ENDOCRINOL, V53, P117, DOI 10.1530/JME-13-0296; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Han YH, 2016, J CELL BIOCHEM, V117, P2067, DOI 10.1002/jcb.25509; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heymsfield SB, 2017, NEW ENGL J MED, V376, P1492, DOI 10.1056/NEJMc1701944; Jang YJ, 2015, FOOD FUNCT, V6, P2365, DOI 10.1039/c5fo00397k; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Jung Y, 2018, FASEB J, V32, P3483, DOI 10.1096/fj.201700231RRERR; Kakkar AK, 2015, EUR J INTERN MED, V26, P89, DOI 10.1016/j.ejim.2015.01.005; Kim SH, 2017, AUTOPHAGY, V13, P1767, DOI 10.1080/15548627.2017.1356977; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee DH, 2016, FREE RADICAL BIO MED, V99, P520, DOI 10.1016/j.freeradbiomed.2016.09.009; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee HW, 2018, BIOMED PHARMACOTHER, V102, P670, DOI 10.1016/j.biopha.2018.03.124; Li CC, 2018, TOXICOL APPL PHARM, V359, P82, DOI 10.1016/j.taap.2018.09.028; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Nagasu H, 2019, FASEB J, V33, P12253, DOI 10.1096/fj.201900217R; Novac N, 2013, TRENDS PHARMACOL SCI, V34, P267, DOI 10.1016/j.tips.2013.03.004; Nozaki Y, 2009, J HEPATOL, V51, P548, DOI 10.1016/j.jhep.2009.05.017; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Park H, 2011, J GASTROENTEROL, V46, P101, DOI 10.1007/s00535-010-0291-8; Pilch PF, 2006, MOL PHARMACOL, V70, P779, DOI 10.1124/mol.106.026104; Poudel B, 2014, INT J MOL MED, V34, P1401, DOI 10.3892/ijmm.2014.1921; Qin L, 2014, ACTA PHARMACOL SIN, V35, P1129, DOI 10.1038/aps.2014.10; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sharma AM, 2005, ACTA DIABETOL, V42, pS3, DOI 10.1007/s00592-005-0175-1; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Tan YQ, 2019, FASEB J, V33, P6526, DOI 10.1096/fj.201801518RR; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Ushio M, 2013, AM J PHYSIOL-ENDOC M, V305, pE293, DOI 10.1152/ajpendo.00442.2012; Varshney S, 2014, J LIPID RES, V55, P1019, DOI 10.1194/jlr.M039925; Vingtdeux V, 2011, MOL MED, V17, P1022, DOI 10.2119/molmed.2011.00163; Zheng SQ, 2008, EUR J PHARMACOL, V584, P118, DOI 10.1016/j.ejphar.2008.01.045	51	9	9	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					898	911		10.1096/fj.201901569R	http://dx.doi.org/10.1096/fj.201901569R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914598				2022-12-28	WOS:000507308900061
J	Shishikura, K; Kuroha, S; Matsueda, S; Iseki, H; Matsui, T; Inoue, A; Arita, M				Shishikura, Kyosuke; Kuroha, Sayoko; Matsueda, Shinnosuke; Iseki, Hachiro; Matsui, Takeshi; Inoue, Azusa; Arita, Makoto			Acyl-CoA synthetase 6 regulates long-chain polyunsaturated fatty acid composition of membrane phospholipids in spermatids and supports normal spermatogenic processes in mice	FASEB JOURNAL			English	Article						testis; ACSL6; docosahexaenoic acid; docosapentaenoic acid	DOCOSAHEXAENOIC ACID; CELLS; LIPIDS; EXPRESSION; SPHINGOLIPIDS; METABOLISM; FERTILITY; DISCOVERY; MS	Long-chain polyunsaturated fatty acids (LCPUFAs), such as docosahexaenoic acid (DHA, 22:6) and docosapentaenoic acid (DPA, 22:5), have versatile physiologic functions. Studies have suggested that DHA and DPA are beneficial for maintaining sperm quality. However, their mechanisms of action are still unclear because of the poor understanding of DHA/DPA metabolism in the testis. DHA and DPA are mainly stored as LCPUFA-containing phospholipids and support normal spermatogenesis. Long-chain acyl-conenzyme A (CoA) synthetase (ACSL) 6 is an enzyme that preferentially converts LCPUFA into LCPUFA-CoA. Here, we report that ACSL6 knockout (KO) mice display severe male infertility due to attenuated sperm numbers and function. ACSL6 is highly expressed in differentiating spermatids, and ACSL6 KO mice have reduced LCPUFA-containing phospholipids in their spermatids. Delayed sperm release and apoptosis of differentiated spermatids were observed in these mice. The results of this study indicate that ACSL6 contributes to the local accumulation of DHA- and DPA-containing phospholipids in spermatids to support normal spermatogenesis.	[Shishikura, Kyosuke; Kuroha, Sayoko; Matsueda, Shinnosuke; Arita, Makoto] RIKEN, Ctr Integrat Med Sci, Lab Metabol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Iseki, Hachiro; Matsui, Takeshi] RIKEN, Ctr Integrat Med Sci, Lab Skin Homeostasis, Yokohama, Kanagawa, Japan; [Inoue, Azusa] RIKEN, Ctr Integrat Med Sci, Lab Metab Epigenet, Yokohama, Kanagawa, Japan; [Shishikura, Kyosuke; Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Kuroha, Sayoko; Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Minato Ku, Tokyo, Japan	RIKEN; RIKEN; RIKEN; Yokohama City University; Keio University	Arita, M (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Metabol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	makoto.arita@riken.jp	Matsui, Takeshi/C-4730-2017	Arita, Makoto/0000-0001-9902-0463; Shishikura, Kyosuke/0000-0001-8192-2485	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [JP15H05897, 15H05898, 15H04648]; Riken Junior Research Associate Program	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Riken Junior Research Associate Program	This study was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI; JP15H05897, 15H05898, and 15H04648 to M.A.), and Riken Junior Research Associate Program (to K.S.). The authors thank T. Ogawa (Yokohama City University Association of Medical Science) for constructive comments on the research, and K. Toyooka (Science Technology Platform Division, Center for Sustainable Resource, Riken) for technical support for the FE-SEM analyses, and all the members of the M.A. laboratory and the Laboratory for Developmental Genetics (Riken Center for Integrative Medical Sciences) for technical support for the histological analysis. The authors also thank the staff at BioMed Proofreading, LLC (Cleveland, OH, USA) for help with the English translation of the manuscript. The authors declare no conflicts of interest.	Agnihotri SK, 2016, IN VITRO CELL DEV-AN, V52, P953, DOI 10.1007/s11626-016-0061-x; Aoyagi R, 2017, J LIPID RES, V58, P2229, DOI 10.1194/jlr.D077123; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen YM, 2009, REPRODUCTION, V138, P655, DOI 10.1530/REP-09-0101; Chouinard-Watkins R, 2018, P NATL ACAD SCI USA, V115, P12343, DOI 10.1073/pnas.1817557115; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Esmaeili V, 2015, ANDROLOGY-US, V3, P450, DOI 10.1111/andr.12024; Fuchs B, 2007, ANAL BIOANAL CHEM, V389, P827, DOI 10.1007/s00216-007-1488-4; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Hishikawa D, 2017, FEBS LETT, V591, P2730, DOI 10.1002/1873-3468.12825; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Iijima H, 1996, EUR J BIOCHEM, V242, P186, DOI 10.1111/j.1432-1033.1996.0186r.x; Iizuka-Hishikawa Y, 2017, J BIOL CHEM, V292, P12065, DOI [10.1074/jbc.M117.791277, 10.1074/jbc.m117.791277]; Ikeda K., 2015, BIOACTIVE LIPID MEDI, P349, DOI DOI 10.1007/978-4-431-55669-5_25; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Killion EA, 2018, MOL METAB, V9, P43, DOI 10.1016/j.molmet.2018.01.012; Kumar Naina, 2015, J Hum Reprod Sci, V8, P191, DOI 10.4103/0974-1208.170370; Lands B, 2017, PROSTAG OTH LIPID M, V133, P4, DOI 10.1016/j.prostaglandins.2017.05.002; Lee EJ, 2005, BIOCHEM BIOPH RES CO, V327, P84, DOI 10.1016/j.bbrc.2004.11.141; Lenzi A, 1996, HUM REPROD UPDATE, V2, P246, DOI 10.1093/humupd/2.3.246; Li LO, 2015, DIABETES, V64, P23, DOI 10.2337/db13-1070; Li QL, 2014, J LIPID RES, V55, P592, DOI 10.1194/jlr.D045112; LIN DS, 1993, J LIPID RES, V34, P491; Marszalek JR, 2005, J BIOL CHEM, V280, P10817, DOI 10.1074/jbc.M411750200; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; MAYSHOOPES LL, 1995, BIOL REPROD, V53, P1003, DOI 10.1095/biolreprod53.5.1003; Meller N, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-88; Narita T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25469; Oikawa E, 1998, J BIOCHEM, V124, P679, DOI 10.1093/oxfordjournals.jbchem.a022165; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Roqueta-Rivera M, 2011, BIOL REPROD, V85, P721, DOI 10.1095/biolreprod.110.089524; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Russell LD, 1993, INT J ANDROL, V1, P83, DOI DOI 10.1111/J.1365-2605.1993.TB01156.X; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soupene E, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-18; Spector AA, 2015, J LIPID RES, V56, P11, DOI 10.1194/jlr.R055095; Suh M, 2011, BRIT J NUTR, V106, P1005, DOI 10.1017/S0007114511001292; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346; Zanetti SR, 2007, CANCER RES, V67, P6973, DOI 10.1158/0008-5472.CAN-07-0376	46	8	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14194	14203		10.1096/fj.201901074R	http://dx.doi.org/10.1096/fj.201901074R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31648559	Green Published, hybrid			2022-12-28	WOS:000507466100088
J	Zhang, AQ; Wang, HD; Wang, B; Yuan, YG; Klein, JD; Wang, XNH				Zhang, Aiqing; Wang, Haidong; Wang, Bin; Yuan, Yanggang; Klein, Janet D.; Wang, Xiaonan H.			Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease	FASEB JOURNAL			English	Article						exosome; UUO; muscle atrophy; CTGF; TGF-beta 1	EXOSOMES; MICRORNA-26A; ATROPHY; CTGF; METABOLISM; MECHANISMS; INHIBITION; MYOGENESIS; MEDIATOR; MODEL	Kidney fibrosis occurs in almost every type of chronic kidney disease. We found that microRNA (miR)-26a was decreased in the kidney, muscle, and exosomes of unilateral ureteral obstruction (UUO) mice. We hypothesized that exogenous miR-26 could suppresses renal fibrosis and muscle wasting in obstructive kidney disease. For this purpose, we generated exosomes that encapsulated miR-26, then injected these into skeletal muscle of UUO mice. The expression of miR-26a was elevated in serum exosomes from UUO mice following exosome-miR-26a injection. In these mice, muscle wasting has been ameliorated as evidenced by increased muscle weights. In addition, a muscle atrophy marker, myostatin, is increased in UUO muscle; provision of miR-26a abolished this increase. We detected a remote effect of exosomes containing miR-26a in UUO-induced renal fibrosis. The intervention of miR-26a attenuated UUO-induced renal fibrosis as determined by immunohistological assessment of alpha-smooth muscle actin and Masson's trichrome staining. Furthermore, exogenous miR-26a decreased the protein levels of 2 profibrosis proteins, connective tissue growth factor (CTGF) and TGF-beta 1, in UUO kidney. Our data showed that exosomes containing miR-26a prevented muscle atrophy by inhibiting the transcription factor forkhead box O1. Likewise, the exosome-carried miR-26a limited renal fibrosis by directly suppressing CTGF. Our findings provide an experimental basis for exosome-mediated therapy of muscle atrophy and renal fibrosis.	[Zhang, Aiqing] Nanjing Med Univ, Affiliated Hosp 2, Dept Pediat Nephrol, Nanjing, Peoples R China; [Zhang, Aiqing; Wang, Haidong; Wang, Bin; Klein, Janet D.; Wang, Xiaonan H.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Wang, Haidong] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Jinzhong, Shanxi, Peoples R China; [Wang, Bin] Southeast Univ, Zhong Da Hosp, Inst Nephrol, Nanjing, Peoples R China; [Yuan, Yanggang] Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Nephrol, Nanjing, Peoples R China	Nanjing Medical University; Emory University; Shanxi Agricultural University; Southeast University - China; Nanjing Medical University	Wang, XNH (corresponding author), Emory Univ, Sch Med, Dept Med, Div Renal, WMB Room 338C,M-S 1930-001-1AG,1639 Pierce, Atlanta, GA 30322 USA.	xwang03@emory.edu			U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR060268]; American Heart Association by the Bayer Group [17IBDG33780000]; National Natural Science Foundation of China [81670628]; Jangsu Province Science Foundation of China [BK20161071]; Nanjing Medical Science and Technique Foundation [YKK17213]; Genomics Core of Yerkes National Primate Research Center [NIH Office of Research Infrastructure Programs/Office of the Director (ORIP/OD)] [P51OD011132]; Emory Integrated Genomics Core (EIGC) [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060268] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association by the Bayer Group; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jangsu Province Science Foundation of China; Nanjing Medical Science and Technique Foundation; Genomics Core of Yerkes National Primate Research Center [NIH Office of Research Infrastructure Programs/Office of the Director (ORIP/OD)]; Emory Integrated Genomics Core (EIGC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Matthew Wood and Dr. Yiqi Seow (University of Oxford, Oxford, United Kingdom) for providing the pLamp2b-Flag vector. This research was supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant R01 AR060268), American Heart Association Discover and Innovation grants supported by the Bayer Group (17IBDG33780000 to X.W.), the National Natural Science Foundation of China (81670628 to Y.Y.), and the Jangsu Province Science Foundation of China (BK20161071) and Nanjing Medical Science and Technique Foundation (YKK17213 to A.Z.). This research was also supported, in part (microRNA deep sequencing), by the Genomics Core of Yerkes National Primate Research Center [NIH Office of Research Infrastructure Programs/Office of the Director (ORIP/OD) P51OD011132] and, in part (luciferase constructs), by the Emory Integrated Genomics Core (EIGC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities (UL1TR000454). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the NIH or the U.S. Government. The authors declare no conflicts of interest.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Bivol LM, 2016, J PHYSIOL-LONDON, V594, P1709, DOI 10.1113/JP271578; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chen X, 2017, CELL DEATH DIFFER, V24, P1990, DOI 10.1038/cdd.2017.147; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fu XH, 2015, J CLIN INVEST, V125, P2497, DOI 10.1172/JCI75438; Ha D, 2016, ACTA PHARM SIN B, V6, P287, DOI 10.1016/j.apsb.2016.02.001; Hanatani S, 2014, J AM SOC NEPHROL, V25, P2800, DOI 10.1681/ASN.2013091025; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hu L, 2015, J AM SOC NEPHROL, V26, P626, DOI 10.1681/ASN.2014020144; Hu ZY, 2014, AGING-US, V6, P160, DOI 10.18632/aging.100643; Koga K, 2015, DIABETOLOGIA, V58, P2169, DOI 10.1007/s00125-015-3642-4; Lawson C, 2016, J ENDOCRINOL, V228, pR57, DOI 10.1530/JOE-15-0201; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Liang HH, 2014, MOL THER, V22, P1122, DOI 10.1038/mt.2014.42; LIN J, 2015, SCI WORLD J, V15, DOI DOI 10.1155/2015/657086; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Parada C, 2013, MOL CELL BIOL, V33, P3482, DOI 10.1128/MCB.00615-13; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Qu L, 2016, CANCER CELL, V29, P653, DOI 10.1016/j.ccell.2016.03.004; Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Su Z, 2017, AM J PHYSIOL-RENAL, V312, pF1128, DOI 10.1152/ajprenal.00600.2016; Su Z, 2016, J APPL PHYSIOL, V120, P426, DOI 10.1152/japplphysiol.00175.2015; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; Vinas JL, 2016, KIDNEY INT, V90, P1238, DOI 10.1016/j.kint.2016.07.015; Wang B, 2019, THERANOSTICS, V9, P1864, DOI 10.7150/thno.29579; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; Wang B, 2016, MOL THER, V24, P1290, DOI 10.1038/mt.2016.90; Wang HD, 2019, MOL THER, V27, P571, DOI 10.1016/j.ymthe.2019.01.008; WANG QM, 1994, J BIOL CHEM, V269, P14566; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wang XNH, 2013, INT J BIOCHEM CELL B, V45, P2230, DOI 10.1016/j.biocel.2013.06.027; Wang XNH, 2013, CURR OPIN CLIN NUTR, V16, P258, DOI 10.1097/MCO.0b013e32835f81b9; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Wang XNH, 2010, J BIOL CHEM, V285, P21249, DOI 10.1074/jbc.M109.041707; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; Wu YL, 2017, KIDNEY INT, V91, P830, DOI 10.1016/j.kint.2016.09.039; Xu J, 2012, KIDNEY INT, V82, P401, DOI 10.1038/ki.2012.84; Zhang AQ, 2018, J CACHEXIA SARCOPENI, V9, P755, DOI 10.1002/jcsm.12296; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zheng ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37492	47	23	23	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13590	13601		10.1096/fj.201900884R	http://dx.doi.org/10.1096/fj.201900884R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31593640	Bronze, Green Published			2022-12-28	WOS:000507466100043
J	Zhou, JW; Fang, LR; Yang, ZX; Xu, SG; Lv, MT; Sun, Z; Chen, JY; Wang, D; Gao, J; Xiao, SB				Zhou, Junwei; Fang, Liurong; Yang, Zhixiang; Xu, Shangen; Lv, Mengting; Sun, Zheng; Chen, Jiyao; Wang, Dang; Gao, Jun; Xiao, Shaobo			Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach	FASEB JOURNAL			English	Article						biosensor; catalytic residue; molecular dynamics; molecular mechanism	PORCINE EPIDEMIC DIARRHEA; RESPIRATORY SYNDROME CORONAVIRUS; PARTICLE MESH EWALD; SUBSTRATE RECOGNITION; MOLECULAR-DYNAMICS; DRUG-RESISTANCE; MAIN PROTEINASE; POTENT INHIBITORS; NS3/4A INHIBITORS; A VIRUS	Coronaviruses (CoVs) infect humans and multiple other animal species, causing highly prevalent and severe diseases. 3C-like proteases (3CL(pro)s) from CoVs (also called main proteases) are essential for viral replication and are also involved in polyprotein cleavage and immune regulation, making them attractive and effective targets for the development of antiviral drugs. Herein, the 3CL(pro) from the porcine epidemic diarrhea virus, an enteropathogenic CoV, was used as a model to identify novel crucial residues for enzyme activity. First, we established a rapid, sensitive, and efficient luciferase-based biosensor to monitor the activity of PDEV 3CL(pro) in vivo. Using this luciferase biosensor, along with confirming the well-known catalytic residues (His41 and Cys144), we identified 4 novel proteolytically inactivated mutants of PDEV 3CL(pro), which was also confirmed in mammalian cells by biochemical experiments. Our molecular dynamics (MD) simulations showed that the hydrogen bonding interactions occurring within and outside of the protease's active site and the dynamic fluctuations of the substrate, especially the van der Waals contacts, were drastically altered, a situation related to the loss of 3CL(pro) activity. These data suggest that changing the intermolecular dynamics in protein-substrate complexes eliminates the mechanism underlying the protease activity. The discovery of novel crucial residues for enzyme activity in the binding pocket could potentially provide more druggable sites for the design of protease inhibitors. In addition, our in-depth study of the dynamic substrate's envelope model using MD simulations is an approach that could augment the discovery of new inhibitors against 3CL(pro) in CoVs and other viral 3C proteases.	[Zhou, Junwei; Fang, Liurong; Yang, Zhixiang; Xu, Shangen; Lv, Mengting; Sun, Zheng; Chen, Jiyao; Wang, Dang; Xiao, Shaobo] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Gao, Jun] Huazhong Agr Univ, Coll Informat, Agr Bioinformat Key Lab Hubei Prov, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China; [Zhou, Junwei; Fang, Liurong; Yang, Zhixiang; Xu, Shangen; Lv, Mengting; Sun, Zheng; Chen, Jiyao; Wang, Dang; Xiao, Shaobo] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Gao, J (corresponding author), Huazhong Agr Univ, Coll Informat, Agr Bioinformat Key Lab Hubei Prov, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.; Xiao, SB (corresponding author), Huazhong Agr Univ, Coll Vet Med, Lab Anim Virol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.	gaojun@mail.hzau.edu.cn; vet@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188	National Key Research and Development Program of China [2016YFD0500103, 2017YFB0203405]; National Natural Science Foundation of China [21873034, 31672569, 31672566]; Natural Science Foundation of Hubei Province [2017CFA059]; Special Project for Technology Innovation of Hubei Province [2017ABA138]; Fundamental Research Funds for the Central Universities [2662016PY070, 2662018JC027, 2015RC008]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Special Project for Technology Innovation of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Research and Development Program of China (2016YFD0500103 and 2017YFB0203405), the National Natural Science Foundation of China (21873034, 31672569, and 31672566), the Natural Science Foundation of Hubei Province (2017CFA059), the Special Project for Technology Innovation of Hubei Province (2017ABA138), and the Fundamental Research Funds for the Central Universities (2662016PY070, 2662018JC027, and 2015RC008). The authors declare no conflicts of interest.	Ali A, 2013, ACS CHEM BIOL, V8, P1469, DOI 10.1021/cb400100g; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327; Anand K, 2005, BIRK ADV INFECT DIS, P173; Bacha U, 2004, BIOCHEMISTRY-US, V43, P4906, DOI 10.1021/bi0361766; Blanchard JE, 2004, CHEM BIOL, V11, P1445, DOI 10.1016/j.chembiol.2004.08.011; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Case D., 2015, AMBER, V14; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; Colell EA, 2018, NUCLEIC ACIDS RES, V46, pW323, DOI 10.1093/nar/gky419; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Deeks SG, 1997, JAMA-J AM MED ASSOC, V277, P145, DOI 10.1001/jama.277.2.145; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Galban S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066248; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Holmes KV, 1996, FIELDS VIROLOGY, P1075; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jain RP, 2004, J MED CHEM, V47, P6113, DOI 10.1021/jm0494873; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kao RY, 2004, CHEM BIOL, V11, P1293, DOI 10.1016/j.chembiol.2004.07.013; Kilianski A, 2013, J VIROL, V87, P11955, DOI 10.1128/JVI.02105-13; Kim Y, 2012, J VIROL, V86, P11754, DOI 10.1128/JVI.01348-12; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Kweon CH, 1999, VACCINE, V17, P2546, DOI 10.1016/S0264-410X(99)00059-6; Lai M.M.C., 2001, FIELDS VIROLOGY, P1163; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15; Matthew AN, 2018, STRUCTURE, V26, P1360, DOI 10.1016/j.str.2018.07.004; Matthew AN, 2017, J MED CHEM, V60, P5699, DOI 10.1021/acs.jmedchem.7b00426; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Ozen A, 2013, J CHEM THEORY COMPUT, V9, P5693, DOI 10.1021/ct400603p; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Pereira H., 1989, CORONAVIRIDAE ANDREW, P42; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ragland DA, 2014, J AM CHEM SOC, V136, P11956, DOI 10.1021/ja504096m; Romano KP, 2011, J VIROL, V85, P6106, DOI 10.1128/JVI.00377-11; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Soumana DI, 2016, J AM CHEM SOC, V138, P11850, DOI 10.1021/jacs.6b06454; Soumana DI, 2016, ACS CHEM BIOL, V11, P900, DOI 10.1021/acschembio.5b00647; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Tanner JA, 2005, CHEM BIOL, V12, P303, DOI 10.1016/j.chembiol.2005.01.006; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Wang D, 2016, J VIROL, V90, P2090, DOI 10.1128/JVI.02514-15; Wigdal Susan S, 2008, Curr Chem Genomics, V2, P16, DOI 10.2174/1875397300802010016; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101; Yang HT, 2005, PLOS BIOL, V3, P1742, DOI 10.1371/journal.pbio.0030324; Ye G, 2016, VIROLOGY, V494, P225, DOI 10.1016/j.virol.2016.04.018; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zhou JW, 2017, BIOCHEM BIOPH RES CO, V488, P621, DOI 10.1016/j.bbrc.2017.05.063; Zhu XY, 2017, J VIROL, V91, DOI [10.1128/JVI.00003-17, 10.1128/jvi.00003-17]	61	29	31	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14575	14587		10.1096/fj.201901624RR	http://dx.doi.org/10.1096/fj.201901624RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690127				2022-12-28	WOS:000507466100116
J	Shumakovich, MA; Mencio, CP; Siglin, JS; Moriarty, RA; Geller, HM; Stroka, KM				Shumakovich, Marina A.; Mencio, Caitlin P.; Siglin, Jonathan S.; Moriarty, Rebecca A.; Geller, Herbert M.; Stroka, Kimberly M.			Astrocytes from the brain microenvironment alter migration and morphology of metastatic breast cancer cells	FASEB JOURNAL			English	Article						extracellular matrix; tumor; actin cytoskeleton; blood-brain barrier; matrix metalloproteinases	MATRIX METALLOPROTEINASES; GROWTH-FACTOR; ENDOTHELIAL INTERACTIONS; TARGETED INHIBITION; AMYLOID-BETA; TGF-BETA; PROMOTE; ADHESION; INVASION; DISEASE	Tumor cell metastasis to the brain involves cell migration through biochemically and physically complex microenvironments at the blood-brain barrier (BBB). The current understanding of tumor cell migration across the BBB is limited. We hypothesize that an interplay between biochemical cues and physical cues at the BBB affects the mechanisms of brain metastasis. We found that astrocyte conditioned medium(ACM) applied directly to tumor cells increased tumor cell velocity, induced elongation, and promoted actin stress fiber organization. Notably, treatment of the extracellular matrix with ACMled to even more significant increases in tumor cell velocity in comparison with ACM treatment of cells directly. Furthermore, inhibiting matrix metalloproteinases in ACM reversed ACM's effect on tumor cells. The effects of ACM on tumor cell morphology and migration also depended on astrocytes' activation state. Finally, using a microfluidic device, we found that the effects of ACM were abrogated in confinement. Overall, our work demonstrates that astrocyte-secreted factors alter migration and morphology of metastatic breast tumor cells, and this effect depends on the cells' mechanical microenvironment.-Shumakovich, M. A., Mencio, C. P., Siglin, J. S., Moriarty, R. A., Geller, H. M., Stroka, K. M. Astrocytes from the brain microenvironment alter migration and morphology of metastatic breast cancer cells.	[Shumakovich, Marina A.; Siglin, Jonathan S.; Moriarty, Rebecca A.; Stroka, Kimberly M.] Univ Maryland, Fischell Dept Bioengn, 1140 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA; [Mencio, Caitlin P.; Geller, Herbert M.] NHLBI, Dev Neurobiol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Stroka, Kimberly M.] Univ Maryland, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Stroka, Kimberly M.] Univ Maryland, Marlene & Stewart Greenbaum Comprehens Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Stroka, KM (corresponding author), Univ Maryland, Fischell Dept Bioengn, 1140 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.	kstroka@umd.edu		Mencio, Caitlin/0000-0001-5045-3583	Burroughs Wellcome Career Award at the Scientific Interface; Fischell Department of Bioengineering (University of Maryland); U.S. National Institutes of Health, National Heart Lung and Blood Institute (NHLBI) Intramural Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006021] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); Fischell Department of Bioengineering (University of Maryland); U.S. National Institutes of Health, National Heart Lung and Blood Institute (NHLBI) Intramural Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank The University of Maryland Core Imaging Facility for providing resources for confocal imaging; the University of Maryland Micro and Nano Fabrication Laboratory (FabLab) for providing photolithography resources; Mary Doolin for help with editing custom MatLab code; and Gregory Dawson for help with data analysis. This study was supported by a Burroughs Wellcome Career Award at the Scientific Interface (to K.M.S.), the Fischell Department of Bioengineering (University of Maryland), and the U.S. National Institutes of Health, National Heart Lung and Blood Institute (NHLBI) Intramural Research Program (to C.P.M. and H.M.G.). The authors declare no conflicts of interest.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Dowell JA, 2009, J PROTEOME RES, V8, P4135, DOI 10.1021/pr900248y; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Fokas E, 2007, CANCER METAST REV, V26, P705, DOI 10.1007/s10555-007-9088-5; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Hohensee I, 2017, ONCOTARGET, V8, P6155, DOI 10.18632/oncotarget.14047; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Isaksen B, 2001, J CLIN PATHOL-MOL PA, V54, P289, DOI 10.1136/mp.54.5.289; Kapoor A, 2012, INT J CELL BIOL, V2012; Kim JA, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4917508; Kuzet SE, 2016, CELL TISSUE RES, V365, P607, DOI 10.1007/s00441-016-2467-x; Liang YY, 2006, ENDOCR-RELAT CANCER, V13, P905, DOI 10.1677/erc.1.01221; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Lyons SM, 2016, BIOL OPEN, V5, P289, DOI 10.1242/bio.013409; McAndrews KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16941; Miller MA, 2013, P NATL ACAD SCI USA, V110, pE2074, DOI 10.1073/pnas.1222387110; Nosoudi N, 2015, CIRC RES, V117, pE80, DOI 10.1161/CIRCRESAHA.115.307207; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Preston SD, 2003, NEUROPATH APPL NEURO, V29, P106, DOI 10.1046/j.1365-2990.2003.00424.x; Proia P, 2008, INT J MOL MED, V21, P63; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Seike T, 2011, CLIN EXP METASTAS, V28, P13, DOI 10.1007/s10585-010-9354-8; Skau CT, 2016, CELL, V167, P1571, DOI 10.1016/j.cell.2016.10.023; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Smith LA, 2007, BIOPHYS J, V92, P632, DOI 10.1529/biophysj.105.079418; Sochocka M., 2016, MOL NEUROBIOL, DOI [10.1007/212035-016-0297-1, DOI 10.1007/212035-016-0297-1]; Stroka KM, 2017, ONCOTARGET, V8, P54004, DOI 10.18632/oncotarget.10997; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Taylor AR, 2007, NAT PROTOC, V2, P1499, DOI 10.1038/nprot.2007.208; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080933; Witzel I, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0665-1; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Xing F, 2013, EMBO MOL MED, V5, P384, DOI 10.1002/emmm.201201623; Xu XP, 2005, CANCER RES, V65, P130; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Yu ZH, 2014, J NEUROCHEM, V130, P41, DOI 10.1111/jnc.12710	49	27	28	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5049	5067		10.1096/fj.201700254R	http://dx.doi.org/10.1096/fj.201700254R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	32083386	Green Published			2022-12-28	WOS:000413398500033
J	Kalev-Altman, R; Hanael, E; Zelinger, E; Blum, M; Monsonego-Ornan, E; Sela-Donenfeld, D				Kalev-Altman, Rotem; Hanael, Erez; Zelinger, Einat; Blum, Martin; Monsonego-Ornan, Efrat; Sela-Donenfeld, Dalit			Conserved role of matrix metalloproteases 2 and 9 in promoting the migration of neural crest cells in avian and mammalian embryos	FASEB JOURNAL			English	Article						cell migration; chick embryo; EMT; gelatinases; MMP2; MMP9; mouse embryo	B-LIKE ENZYME; IV COLLAGENASE; CRANIOFACIAL DEVELOPMENT; MOLECULAR-CLONING; PROGENITOR CELLS; SKELETAL-MUSCLE; GROWTH-FACTOR; MOUSE EMBRYO; GELATINASE-B; EXPRESSION	Neural crest cells (NCCs) are a unique embryonic cell population that initially reside at the dorsal neural tube but later migrate in the embryo and differentiate into multiple types of derivatives. To acquire motility, NCCs undergo epithelial-to-mesenchymal transition and invade the surrounding extracellular matrix (ECM). Matrix metalloproteases (MMPs) are a large family of proteases which regulate migration of various embryonic and adult cells via ECM remodeling. The gelatinase's subgroup of MMPs is the most studied one due to its key role in metastasis. As it is composed of only two proteases, MMP2 and MMP9, it is important to understand whether each is indispensable or redundant in its biological function. Here we explored the role of the gelatinases in executing NCC migration, by determining whether MMP2 and/or MMP9 regulate migration across species in singular, combined, or redundant manners. Chick and mouse embryos were utilized to compare expression and activity of both MMPs using genetic and pharmacological approaches in multiple in vivo and ex vivo assays. Both MMPs were found to be expressed and active in mouse and chick NCCs. Inhibition of each MMP was sufficient to prevent NCC migration in both species. Yet, NCC migration was maintained in MMP2(-/-) or MMP9(-/-) mouse mutants due to compensation between the gelatinases, but reciprocal pharmacological inhibition in each mutant prevented NCC migration. This study reveals for the first time that both gelatinases are expressed in avian and mammalian NCCs, and demonstrates their fundamental and conserved role in promoting embryonic cell migration.	[Kalev-Altman, Rotem; Hanael, Erez; Sela-Donenfeld, Dalit] Hebrew Univ Jerusalem, Fac Agr Food & Environm Sci, Koret Sch Vet Med, Rehovot, Israel; [Kalev-Altman, Rotem; Monsonego-Ornan, Efrat] Hebrew Univ Jerusalem, Fac Agr Food & Environm Sci, Inst Biochem & Nutr, Rehovot, Israel; [Zelinger, Einat] Hebrew Univ Jerusalem, Fac Agr Food & Environm Sci, Core Facil Unit, Rehovot, Israel; [Blum, Martin] Univ Hohenheim, Inst Zool, Stuttgart, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University Hohenheim	Monsonego-Ornan, E (corresponding author), Hebrew Univ Jerusalem, Inst Biochem & Nutr, POB 12, IL-76100 Rehovot, Israel.; Sela-Donenfeld, D (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, POB 12, IL-76100 Rehovot, Israel.	Efrat.mo@mail.huji.ac.il; dalit.seladon@mail.huji.ac.il		Sela-Donenfeld, Dalit/0000-0001-7498-061X	Ministry of Health, Chief Scientist Fund [3-0000-33793]; Israel Science Foundation [1252/19]; Einstein Kaye Foundation; University of Hohenheim; Hebrew University	Ministry of Health, Chief Scientist Fund; Israel Science Foundation(Israel Science Foundation); Einstein Kaye Foundation; University of Hohenheim; Hebrew University	Ministry of Health, Chief Scientist Fund, Grant/Award Number: 3-0000-33793; University of Hohenheim; Hebrew University; Israel Science Foundation, Grant/Award Number: 1252/19; Einstein Kaye Foundation	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Alexander SM, 1997, DEV DYNAM, V209, P261, DOI 10.1002/(SICI)1097-0177(199707)209:3<261::AID-AJA2>3.0.CO;2-G; Alfandari D, 2018, GENESIS, V56, DOI 10.1002/dvg.23095; Andrieu C, 2018, BASOLATERAL LOCALIZA; Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Bar A., 2014, ROLE PROTEASES CELLU, P103, DOI [10.1007/978-1-4614-9099-9, DOI 10.1007/978-1-4614-9099-9]; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Biga PR, 2013, J NUTR BIOCHEM, V24, P1462, DOI 10.1016/j.jnutbio.2012.12.005; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Burstyn-Cohen T, 2004, DEVELOPMENT, V131, P5327, DOI 10.1242/dev.01424; Burstyn-Cohen T, 2002, DEV CELL, V3, P383, DOI 10.1016/S1534-5807(02)00221-6; Cai DH, 2000, ANAT RECORD, V259, P168, DOI 10.1002/(SICI)1097-0185(20000601)259:2<168::AID-AR7>3.0.CO;2-U; Chen JW, 2017, ARCH ORAL BIOL, V76, P30, DOI 10.1016/j.archoralbio.2017.01.002; Chin JR, 1997, DEVELOPMENT, V124, P1519; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Crawford BD, 2005, DEV BIOL, V286, P405, DOI 10.1016/j.ydbio.2005.06.035; Dan H, 2009, J ANIM SCI, V87, P3544, DOI 10.2527/jas.2009-2068; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Garmon T, 2018, DEV DYNAM, V247, P1083, DOI 10.1002/dvdy.24661; Gross JB, 2008, DEV BIOL, V317, P389, DOI 10.1016/j.ydbio.2008.02.046; Hahn-Dantona EA, 2000, J BIOL CHEM, V275, P40827, DOI 10.1074/jbc.M006234200; Hanael E, 2019, EPILEPSIA, V60, P1005, DOI 10.1111/epi.14739; Hotta R, 2016, NEUROGASTROENT MOTIL, V28, P498, DOI 10.1111/nmo.12744; Hutchins EJ, 2018, J CELL BIOL, V217, P3683, DOI 10.1083/jcb.201709149; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kalcheim C, 2019, METHODS MOL BIOL, V1976, P1, DOI 10.1007/978-1-4939-9412-0_1; Kalev-Altman R, 2017, PROTEASES PHYSL PATH, P27; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Keow JY, 2011, MATRIX BIOL, V30, P169, DOI 10.1016/j.matbio.2011.01.003; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Le Douarin NM, 1999, NEURAL CREST, V2; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Levin JI, 2001, BIOORG MED CHEM LETT, V11, P235, DOI 10.1016/S0960-894X(00)00642-9; Maeda Y, 2017, EUR J HISTOCHEM, V61, P20, DOI 10.4081/ejh.2017.2750; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Mannello F, 2012, PROG HISTOCHEM CYTO, V47, P27, DOI 10.1016/j.proghi.2011.12.002; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; McKeown SJ, 2013, DEV BIOL, V373, P244, DOI 10.1016/j.ydbio.2012.10.028; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Monsonego-Ornan E, 2012, DEV BIOL, V364, P162, DOI 10.1016/j.ydbio.2012.01.028; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Mosig RA, 2013, DIS MODEL MECH, V6, P397, DOI 10.1242/dmm.007914; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; NICHOLS DH, 1981, J EMBRYOL EXP MORPH, V64, P105; Orgaz JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5255; Pirici D, 2012, NEUROPATHOLOGY, V32, P492, DOI 10.1111/j.1440-1789.2011.01279.x; Randall LE, 2002, CONNECT TISSUE RES, V43, P205, DOI 10.1080/03008200290000538; Reich A, 2010, J APPL PHYSIOL, V108, P172, DOI 10.1152/japplphysiol.00821.2009; REPONEN P, 1992, J BIOL CHEM, V267, P7856; REPONEN P, 1995, DEV DYNAM, V202, P388, DOI 10.1002/aja.1002020408; Robbins JR, 1999, DEV BIOL, V212, P255, DOI 10.1006/dbio.1999.9373; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Roth L, 2017, INT J DEV BIOL, V61, P245, DOI 10.1387/ijdb.160286ds; Rubino MT, 2011, CHEMMEDCHEM, V6, P1258, DOI 10.1002/cmdc.201000540; Schiffmacher AT, 2018, DEV BIOL, V444, pS237, DOI 10.1016/j.ydbio.2018.06.018; Schwarz Q, 2009, P NATL ACAD SCI USA, V106, P6164, DOI 10.1073/pnas.0811521106; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Shibata S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-31; Shimo T, 2004, DEV DYNAM, V231, P136, DOI 10.1002/dvdy.20109; Simsa S, 2007, AM J PHYSIOL-REG I, V292, pR2216, DOI 10.1152/ajpregu.00864.2006; Sternlicht M, 2009, ANN REV CELL BIOL, V17, P463; Tamura Y, 1998, J MED CHEM, V41, P640, DOI 10.1021/jm9707582; Taneyhill LA, 2008, CELL ADHES MIGR, V2, P223, DOI 10.4161/cam.2.4.6835; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomlinson ML, 2009, CHEM BIOL, V16, P93, DOI 10.1016/j.chembiol.2008.12.005; Tong A, 2003, J BONE MINER RES, V18, P1443, DOI 10.1359/jbmr.2003.18.8.1443; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Werb Z, 1998, ANN NY ACAD SCI, V857, P110, DOI 10.1111/j.1749-6632.1998.tb10111.x; Yeghiazaryan M, 2012, HISTOCHEM CELL BIOL, V138, P75, DOI 10.1007/s00418-012-0940-5; Zimowska M, 2013, BIOL CELL, V105, P334, DOI 10.1111/boc.201300020	87	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5240	5261		10.1096/fj.201901217RR	http://dx.doi.org/10.1096/fj.201901217RR		FEB 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067275				2022-12-28	WOS:000515248200001
J	Shi, XL; Zhu, KY; Ye, ZD; Yue, JB				Shi, Xianli; Zhu, Kaiyuan; Ye, Zuodong; Yue, Jianbo			VCP/p97 targets the nuclear export and degradation of p27(Kip1) during G1 to S phase transition	FASEB JOURNAL			English	Article						cell cycle; p21(Cip1); p27(Kip1); UFD1; VCP/p97	VALOSIN-CONTAINING PROTEIN; CELL-CYCLE; EXPRESSION LEVEL; AAA-ATPASE; ELEVATED EXPRESSION; POOR-PROGNOSIS; P97; PHOSPHORYLATION; INHIBITORS; BINDING	One of the critical regulatory mechanisms for cell cycle progression is the timely degradation of CDK inhibitors, including p21(Cip1) and p27(Kip1). VCP/p97, an AAA-ATPase, is reported to be overexpressed in many types of cancers. Here, we found that treatment of MCF-7 human breast cancer cells with DBeQ, a VCP inhibitor, or VCP knockdown in MCF-7 cells arrested cells at G1 phase, accompanied with the blockage of both p21 and p27 degradation. Whereas, double knockdown of p21 and p27 in MCF-7 cells rendered cells refractory to DBeQ-induced G1 arrest. Moreover, inhibition or knockdown of VCP or UFD1, one of VCP's co-factors, in MCF-7, NIH3T3, or HEK293T cells blocked the nuclear export of p27 during earlier G1 phase after mitogen stimulation. We also identified the nuclear localization sequence (NLS) of VCP, and found that adding back wild-type VCP, not the NLS-deleted VCP mutant, restored the nuclear export and degradation of p27 in VCP knockout MCF-7 cells. Importantly, we found that VCP inhibition sensitized breast cancer cells to the treatment of several anticancer therapeutics both in vitro and in vivo. Taken together, our study not only uncovers the mechanisms underlying VCP-mediated cell proliferation control but also provides potential therapeutic option for cancer treatment.	[Shi, Xianli; Zhu, Kaiyuan; Ye, Zuodong; Yue, Jianbo] City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Shi, Xianli; Zhu, Kaiyuan; Ye, Zuodong; Yue, Jianbo] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong	Yue, JB (corresponding author), City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	yue.jianbo@cityu.edu.hk	; Yue, Jianbo/K-8002-2015	ZHU, Kaiyuan/0000-0003-4579-0790; Yue, Jianbo/0000-0001-6384-5447	Hong Kong Research Grant Council (RGC) [11101717]; CAS-Croucher Funding Scheme for Joint Laboratories (CAS-Croucher Joint Lab Scheme) [2016A050503010]; Guangdong-Hong Kong joint innovation Research Scheme [2016A050503010]; Shenzhen government research grant [JCYJ20160229165235739, JCYJ20170413141331470]; NSFC \ International Cooperation and Exchange Programme [21778045]; Sichuan Science & Technology Research [2019YJ0633]	Hong Kong Research Grant Council (RGC)(Hong Kong Research Grants Council); CAS-Croucher Funding Scheme for Joint Laboratories (CAS-Croucher Joint Lab Scheme); Guangdong-Hong Kong joint innovation Research Scheme; Shenzhen government research grant; NSFC \ International Cooperation and Exchange Programme(National Natural Science Foundation of China (NSFC)); Sichuan Science & Technology Research	Hong Kong Research Grant Council (RGC), Grant/Award Number: 11101717; CAS-Croucher Funding Scheme for Joint Laboratories (CAS-Croucher Joint Lab Scheme), Grant/Award Number: 2016A050503010; Guangdong-Hong Kong joint innovation Research Scheme, Grant/Award Number: 2016A050503010; Shenzhen government research grant, Grant/Award Number: JCYJ20160229165235739 and JCYJ20170413141331470; NSFC | International Cooperation and Exchange Programme, Grant/Award Number: 21778045; Sichuan Science & Technology Research, Grant/Award Number: 2019YJ0633	Abbastabar M, 2018, DNA REPAIR, V69, P63, DOI 10.1016/j.dnarep.2018.07.008; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Bachs Oriol, 2018, Oncotarget, V9, P26259, DOI 10.18632/oncotarget.25447; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Buchberger A, 2015, FEBS LETT, V589, P2578, DOI 10.1016/j.febslet.2015.08.028; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Cayli S, 2009, J BIOL CHEM, V284, P34944, DOI 10.1074/jbc.M109.037952; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Cui Y, 2015, TUMOR BIOL, V36, P9919, DOI 10.1007/s13277-015-3748-9; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; HAYASHI M, 1992, BIOCHEM BIOPH RES CO, V182, P939, DOI 10.1016/0006-291X(92)91822-8; Heubes S, 2007, J CELL SCI, V120, P1325, DOI 10.1242/jcs.006924; Hnit SST, 2015, INT J BIOCHEM CELL B, V68, P9, DOI 10.1016/j.biocel.2015.08.005; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Jang BC, 2003, J BIOL CHEM, V278, P2773, DOI 10.1074/jbc.C200620200; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; Mayr PSM, 1999, EUR J CELL BIOL, V78, P224, DOI 10.1016/S0171-9335(99)80055-7; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D; Nowis D, 2006, EXP CELL RES, V312, P2921, DOI 10.1016/j.yexcr.2006.05.013; Parisi E, 2018, EMBO J, V37, DOI 10.15252/embj.201798724; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Sa G, 2005, CELL CYCLE, V4, P618; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016; Stach L, 2017, BIOCHEM J, V474, P2953, DOI 10.1042/BCJ20160783; Tang DM, 2008, J BIOL CHEM, V283, P6085, DOI 10.1074/jbc.M707715200; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Totsukawa G, 2011, EMBO J, V30, P3581, DOI 10.1038/emboj.2011.260; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; van den Boom J, 2018, MOL CELL, V69, P182, DOI 10.1016/j.molcel.2017.10.028; van den Boom J, 2016, MOL CELL, V64, P189, DOI 10.1016/j.molcel.2016.08.037; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Vekaria PH, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00181; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Yamamoto S, 2005, ANN SURG ONCOL, V12, P925, DOI 10.1245/ASO.2005.07.002; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Yamamoto S, 2003, J CLIN ONCOL, V21, P2537, DOI 10.1200/JCO.2003.12.102; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zhu WW, 2013, ASIAN PAC J CANCER P, V14, P6439, DOI 10.7314/APJCP.2013.14.11.6439	60	4	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5193	5207		10.1096/fj.201901506R	http://dx.doi.org/10.1096/fj.201901506R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067276				2022-12-28	WOS:000515246400001
J	He, LQ; Long, J; Zhou, XH; Liu, YH; Li, TJ; Wu, X				He, Liuqin; Long, Jing; Zhou, Xihong; Liu, Yonghui; Li, Tiejun; Wu, Xin			Serine is required for the maintenance of redox balance and proliferation in the intestine under oxidative stress	FASEB JOURNAL			English	Article						apoptosis; cell growth; glutathione; reactive oxygen species	GLUTATHIONE SYNTHESIS; METABOLISM; AMPK; PATHOGENESIS; PROTEIN; CYCLE; MTOR; ACID	Serine has critical roles in maintaining cell growth and redox balance in cancer cells. However, the role of exogenous serine played in oxidative response and proliferation in normal mammalian intestine need to be further elucidated. We used a mouse model and intestinal porcine epithelial cells (IPEC-J2) to reveal that exogenous serine deficiency did not lead to redox imbalance and inhibition of proliferation in the intestine. However, serine deficiency exacerbated oxidative stress, mitochondrial dysfunction, apoptosis, and inhibition of proliferation in IPEC-J2 cells challenged by hydrogen peroxide, while serine supplementation rescued redox imbalance and those proliferation defects. Importantly, serine supplementation restored the glutathione content and decreased the accumulation of reactive oxygen species, while no such effects were observed when glutathione synthesis was inhibited. Additionally, serine supplementation increased nuclear nrf2 expression in IPEC-J2 cells. These results suggested that serine alleviates oxidative stress through supporting glutathione synthesis and activating nrf2 signaling. We further found that serine supplementation activated the mTOR pathway, while inhibition of mTOR diminished the effects of serine on promoting proliferation, suggesting critical roles of the mTOR pathway in this context. Taken together, our study underlines the importance of serine in the maintenance of redox status and proliferation in the intestine and reveals a novel potential mechanism that mediates these effects.	[He, Liuqin; Long, Jing; Zhou, Xihong; Liu, Yonghui; Li, Tiejun; Wu, Xin] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, 644,Yuanda 2nd Rd, Changsha 410125, Hunan, Peoples R China; [He, Liuqin; Long, Jing; Liu, Yonghui] Hunan Normal Univ, Coll Life Sci, Hunan Int Joint Lab Anim Intestinal Ecol & Hlth, Lab Anim Nutr & Human Hlth, Changsha, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Hunan Normal University	Zhou, XH (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, 644,Yuanda 2nd Rd, Changsha 410125, Hunan, Peoples R China.	xhzhou@isa.ac.cn	Liu, Yong/GWQ-6163-2022		National Natural Science Foundation of China (NSFC) [31702125]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31702125	AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; Bauchart-Thevret C, 2010, AM J PHYSIOL-ENDOC M, V299, pE899, DOI 10.1152/ajpendo.00068.2010; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; FELL DA, 1988, BIOCHEM J, V256, P97, DOI 10.1042/bj2560097; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; He LQ, 2018, J AGR FOOD CHEM, V66, P11273, DOI 10.1021/acs.jafc.8b04470; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim M, 2015, INT J MOL MED, V35, P755, DOI 10.3892/ijmm.2014.2046; Lucas S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800036; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Minton DR, 2018, MOL CELL, V69, P610, DOI 10.1016/j.molcel.2018.01.024; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Park SY, 2002, NUTR RES, V22, P283, DOI 10.1016/S0271-5317(01)00398-0; Parker SJ, 2016, MOL CELL, V61, P185, DOI 10.1016/j.molcel.2016.01.006; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wu HM, 2009, ECOTOX ENVIRON SAFE, V72, P572, DOI 10.1016/j.ecoenv.2008.03.001; Wyant GA, 2017, CELL, V171, P642, DOI 10.1016/j.cell.2017.09.046; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yin J, 2017, ONCOTARGET, V8, P3124, DOI 10.18632/oncotarget.13844; Zhang HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03062; Zhang T, 2018, MOL NEUROBIOL, V55, P7025, DOI 10.1007/s12035-017-0840-8; Zhou XH, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700262; Zhou XH, 2018, BBA-MOL BASIS DIS, V1864, P488, DOI 10.1016/j.bbadis.2017.11.009; Zhou XH, 2017, J FUNCT FOODS, V39, P225, DOI 10.1016/j.jff.2017.10.026; Zhou XH, 2014, J PHYSIOL BIOCHEM, V70, P547, DOI 10.1007/s13105-014-0334-3	36	20	22	16	43	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4702	4717		10.1096/fj.201902690R	http://dx.doi.org/10.1096/fj.201902690R		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030825	Bronze			2022-12-28	WOS:000512333800001
J	Loehfelm, A; Elder, MK; Boucsein, A; Jones, PP; Williams, JM; Tups, A				Loehfelm, Aline; Elder, Megan K.; Boucsein, Alisa; Jones, Peter P.; Williams, Joanna M.; Tups, Alexander			Docosahexaenoic acid prevents palmitate-induced insulin-dependent impairments of neuronal health	FASEB JOURNAL			English	Article						cortex; cytoskeleton; fatty acids; high-fat diet; hippocampus; synaptic innervation	HIGH-FAT DIET; BETA/NF-KAPPA-B; HYPOTHALAMIC NEURONS; RESISTANCE; BRAIN; STRESS; ACTIVATION; INHIBITION; APOPTOSIS; LOCALIZATION	The importance of fatty acids (FAs) for healthy brain development and function has become more evident in the past decades. However, most studies focus on the hypothalamus as an important FA-sensing brain region involved in energy homeostasis. Less work has been done to evaluate the effects of FAs on brain regions such as the hippocampus or cortex, two important centres of learning, memory formation, and cognition. Furthermore, the mechanisms of how FAs modulate the neuronal development and function are incompletely understood. Therefore, this study examined the effects of the saturated FA palmitic acid (PA) and the polyunsaturated FA docosahexaenoic acid (DHA) on primary hippocampal and cortical cultures isolated from P0/P1 Sprague Dawley rat pups. Exposure to PA, but not DHA, resulted in severe morphological changes in primary neurons such as cell body swelling, axonal and dendritic blebbing, and a reduction in synaptic innervation, compromising healthy cell function and excitability. Pharmacological assessment revealed that the PA-mediated alterations were caused by overactivation of neuronal insulin signaling, demonstrated by insulin stimulation and phosphoinositide 3-kinase inhibition. Remarkably, co-exposure to DHA prevented all PA-induced morphological changes. This work provides new insights into how FAs can affect the cytoskeletal rearrangements and neuronal function via modulation of insulin signaling.	[Loehfelm, Aline; Boucsein, Alisa; Tups, Alexander] Univ Otago, Ctr Neuroendocrinol, Sch Med Sci, Dept Physiol, Dunedin, New Zealand; [Loehfelm, Aline; Boucsein, Alisa; Tups, Alexander] Univ Otago, Brain Hlth Res Ctr, POB 56, Dunedin 9054, New Zealand; [Elder, Megan K.; Williams, Joanna M.] Univ Otago, Brain Hlth Res Ctr, Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Jones, Peter P.] Univ Otago, Sch Med Sci, Dept Physiol & HeartOtago, Dunedin, New Zealand; [Elder, Megan K.] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Otago; University of Otago; University of Otago; University of Otago; New York University	Tups, A (corresponding author), Univ Otago, Brain Hlth Res Ctr, POB 56, Dunedin 9054, New Zealand.; Tups, A (corresponding author), Univ Otago, Dept Physiol, Ctr Neuroendocrinol, POB 56, Dunedin 9054, New Zealand.	alexander.tups@otago.ac.nz		Elder, Megan/0000-0002-9111-3152; Jones, Pete/0000-0001-7977-1737; Boucsein, Alisa/0000-0002-6266-8802	Royal Society of New Zealand \ Marsden Fund (Royal Society of New Zealand Marsden Fund); University of Otago (Te Whare Wananga o Otago)	Royal Society of New Zealand \ Marsden Fund (Royal Society of New Zealand Marsden Fund); University of Otago (Te Whare Wananga o Otago)	Royal Society of New Zealand vertical bar Marsden Fund (Royal Society of New Zealand Marsden Fund); University of Otago (Te Whare Wananga o Otago)	Antollini SS, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00573; Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Benzler J, 2015, DIABETES, V64, P2015, DOI 10.2337/db14-0093; Benzler M, 2019, J COMP PHYSIOL B, V189, P413, DOI 10.1007/s00360-019-01220-0; Caires R, 2017, CELL REP, V21, P246, DOI 10.1016/j.celrep.2017.09.029; Calvo-Ochoa E, 2014, J CEREBR BLOOD F MET, V34, P1001, DOI 10.1038/jcbfm.2014.48; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Cordner ZA, 2015, PHYSIOL BEHAV, V152, P363, DOI 10.1016/j.physbeh.2015.06.008; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; da Silva-Santi LG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091277; Dalvi PS, 2017, INT J OBESITY, V41, P149, DOI 10.1038/ijo.2016.183; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Dieck ST, 2015, NAT METHODS, V12, P411, DOI [10.1038/nmeth.3319, 10.1038/NMETH.3319]; Dubey J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00343; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; Fogarty MJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00153; Fonteh AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100519; Guest J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-79; Guixa-Gonzalez R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19839; Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hall E, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-103; Honen BN, 2003, J MEMBRANE BIOL, V196, P95, DOI 10.1007/s00232-003-0628-9; Hou QM, 2008, MOL CELL NEUROSCI, V38, P213, DOI 10.1016/j.mcn.2008.02.010; Hsiao YH, 2014, INT J MOL SCI, V15, P20876, DOI 10.3390/ijms151120876; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jembrek MJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/346783; Jia D, 2014, NEUROSCIENCE, V258, P228, DOI 10.1016/j.neuroscience.2013.11.016; Karmi A, 2010, DIABETES, V59, P2171, DOI 10.2337/db09-0138; Khazen T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48800-2; Kim J, 2011, BRAIN RES, V1418, P42, DOI 10.1016/j.brainres.2011.08.059; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; Kuda O, 2017, BIOCHIMIE, V136, P12, DOI 10.1016/j.biochi.2017.01.002; Kwon B, 2014, BBA-MOL CELL RES, V1843, P1402, DOI 10.1016/j.bbamcr.2014.04.004; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Larrieu T, 2012, J PHYSIOL BIOCHEM, V68, P671, DOI 10.1007/s13105-012-0179-6; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; Laws SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09577-4; Martinez-Garcia C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142291; Maulik M, 2019, J FUNCT FOODS, V53, P306, DOI 10.1016/j.jff.2018.12.028; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McLean FH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30265-4; Morselli E, 2014, CELL REP, V9, P633, DOI 10.1016/j.celrep.2014.09.025; Nasaruddin ML, 2016, AM J TRANSL RES, V8, P154; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; OISHI K, 1990, J BIOL CHEM, V265, P70; Orr SK, 2013, J NEUROCHEM, V127, P378, DOI 10.1111/jnc.12392; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Piro S, 2010, ENDOCRINOLOGY, V151, P4197, DOI 10.1210/en.2009-1472; Rapoport SI, 2001, J LIPID RES, V42, P678; Rodriguez-Navas C, 2016, MOL METAB, V5, P680, DOI 10.1016/j.molmet.2016.06.014; Sargsyan E, 2016, BBA-MOL CELL BIOL L, V1861, P1151, DOI 10.1016/j.bbalip.2016.06.012; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Stillwell W., 2006, Scandinavian Journal of Food & Nutrition, V50, P107, DOI 10.1080/17482970601066165; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Tewari KP, 2000, AM J PHYSIOL-CELL PH, V279, pC40, DOI 10.1152/ajpcell.2000.279.1.C40; Tups A, 2010, J NEUROENDOCRINOL, V22, P534, DOI 10.1111/j.1365-2826.2010.01975.x; Vreugdenhil M, 1996, P NATL ACAD SCI USA, V93, P12559, DOI 10.1073/pnas.93.22.12559; Watkins PA, 2001, J MOL NEUROSCI, V16, P87, DOI 10.1385/JMN:16:2-3:87; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236; World Health Organization, 2018, OB OV FACT SHEET 311; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	73	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4635	4652		10.1096/fj.201902517R	http://dx.doi.org/10.1096/fj.201902517R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030816	Bronze			2022-12-28	WOS:000512332900001
J	Lane, SL; Doyle, AS; Bales, ES; Houck, JA; Lorca, RA; Moore, LG; Julian, CG				Lane, Sydney L.; Doyle, Alexandrea S.; Bales, Elise S.; Houck, Julie A.; Lorca, Ramon A.; Moore, Lorna G.; Julian, Colleen G.			Peroxisome proliferator-activated receptor gamma blunts endothelin-1-mediated contraction of the uterine artery in a murine model of high-altitude pregnancy	FASEB JOURNAL			English	Article						hypoxia; intrauterine growth restriction; thiazolidinedione; vascular function	INTRAUTERINE GROWTH RESTRICTION; PLASMA ENDOTHELIN LEVELS; PPAR-GAMMA; BLOOD-FLOW; BIRTH-WEIGHT; VASODILATOR RESPONSE; INSULIN-RESISTANCE; CHRONIC HYPOXIA; PROTEIN-KINASE; FETAL-GROWTH	The environmental hypoxia of high altitude (HA) increases the incidence of intrauterine growth restriction (IUGR) approximately threefold. The peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated nuclear receptor that promotes vasorelaxation by increasing nitric oxide and downregulating endothelin-1 (ET-1) production, has been implicated in IUGR. Based on our prior work indicating that pharmacologic activation of the PPAR gamma pathway protects against hypoxia-associated IUGR, we used an experimental murine model to determine whether such effects may be attributed to vasodilatory effects in the uteroplacental circulation. Using wire myography, ex vivo vasoreactivity studies were conducted in uterine arteries (UtA) isolated from pregnant mice exposed to hypoxia or normoxia from gestational day 14.5 to 18.5. Exposure to troglitazone, a high-affinity PPAR gamma agonist-induced vasorelaxation in UtA preconstricted with phenylephrine, with HA-UtA showing increased sensitivity. Troglitazone blunted ET-1-induced contraction of UtA in hypoxic and normoxic dams equivalently. Immunohistological analysis revealed enhanced staining for ET-1 receptors in the placental labyrinthine zone in hypoxic compared to normoxic dams. Our results suggest that pharmacologic PPAR-gamma activation, via its vasoactive properties, may protect the fetal growth under hypoxic conditions by improving uteroplacental perfusion and thereby justify further investigation into PPAR gamma as a therapeutic target for IUGR in pregnancies complicated by hypoxia.	[Lane, Sydney L.] Univ Colorado, Grad Sch, Integrated Physiol Program, Aurora, CO USA; [Lane, Sydney L.; Bales, Elise S.; Lorca, Ramon A.; Moore, Lorna G.] Univ Colorado, Dept Obstet & Gynecol, Sch Med, Aurora, CO USA; [Doyle, Alexandrea S.; Houck, Julie A.] Colorado Mesa Univ, Dept Biochem, Grand Junction, CO USA; [Julian, Colleen G.] Univ Colorado, Dept Med, Sch Med, 12700 E 19th Ave,Mailstop 8611,3rd Floor, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Julian, CG (corresponding author), Univ Colorado, Dept Med, Sch Med, 12700 E 19th Ave,Mailstop 8611,3rd Floor, Aurora, CO 80045 USA.	colleen.julian@cuanschutz.edu		Lane, Sydney/0000-0003-0345-2849	American Heart Association [7PRE33410652]; NIH [R01 HL138181, R01 HD088590]	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the American Heart Association Pre-Doctoral Award 7PRE33410652 (SLL), NIH R01 HL138181 (CGJ), and NIH R01 HD088590 (LGM, CGJ)	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aljunaidy MM, 2016, AM J PHYSIOL-REG I, V311, pR1068, DOI 10.1152/ajpregu.00119.2016; Barak Y, 2008, PPAR RES, V2008, DOI 10.1155/2008/142082; Barrett-O'Keefe Z, 2013, AM J PHYSIOL-HEART C, V304, pH162, DOI 10.1152/ajpheart.00603.2012; Bashir SO, 2015, ACTA PHYSIOL HUNG, V102, P391, DOI 10.1556/036.102.2015.4.6; Bjarnegard N, 2013, ULTRASOUND OBST GYN, V41, P177, DOI 10.1002/uog.12314; Browne VA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0068; Browne VA, 2011, AM J PHYSIOL-REG I, V300, pR1221, DOI 10.1152/ajpregu.91046.2008; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Chen ZG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12650; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Derosa G, 2005, HYPERTENS RES, V28, P917, DOI 10.1291/hypres.28.917; Diaz M, 2012, J CLIN ENDOCR METAB, V97, pE1468, DOI 10.1210/jc.2012-1064; Erdem A, 2003, J PERINAT MED, V31, P52, DOI 10.1515/JPM.2003.008; Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009; Froment P, 2006, PPAR RES, V2006, DOI 10.1155/PPAR/2006/73986; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; FURUHASHI N, 1995, GYNECOL OBSTET INVES, V39, P88, DOI 10.1159/000292386; Geach Tim, 2015, Nat Rev Endocrinol, V11, P446, DOI 10.1038/nrendo.2015.101; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Gilbert WM, 2003, AM J OBSTET GYNECOL, V188, P1596, DOI 10.1067/mob.2003.384; Gokina NI, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00184; Gong KZ, 2011, AM J PHYSIOL-LUNG C, V301, pL899, DOI 10.1152/ajplung.00062.2011; Holobotovskyy V, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5038; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Julian CG, 2014, FASEB J, V28, P1268, DOI 10.1096/fj.13-239749; Julian CG, 2008, AM J PHYSIOL-REG I, V295, pR906, DOI 10.1152/ajpregu.00164.2008; Julian CG, 2007, ARCH DIS CHILD-FETAL, V92, P372, DOI 10.1136/adc.2006.109579; Kang BY, 2016, AM J RESP CELL MOL, V54, P136, DOI 10.1165/rcmb.2014-0337OC; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Ketsawatsomkron P, 2015, CURR OPIN NEPHROL HY, V24, P123, DOI 10.1097/MNH.0000000000000103; Ketsawatsomkron P, 2010, J BIOL CHEM, V285, P9311, DOI 10.1074/jbc.R109.025031; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Konje JC, 2003, BJOG-INT J OBSTET GY, V110, P301, DOI 10.1016/S1470-0328(02)02963-4; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kung J, 2012, EXPERT OPIN DRUG SAF, V11, P565, DOI 10.1517/14740338.2012.691963; Lane SL, 2019, FASEB J, V33, P8999, DOI 10.1096/fj.201900214R; LE SQ, 1993, AM J OBSTET GYNECOL, V169, P919, DOI 10.1016/0002-9378(93)90027-G; LICHTY JA, 1957, AMA J DIS CHILD, V93, P666, DOI 10.1001/archpedi.1957.02060040668009; Lorca RA, 2019, HYPERTENSION, V73, P1319, DOI 10.1161/HYPERTENSIONAHA.119.12641; Martin-Nizard F, 2002, J CARDIOVASC PHARM, V40, P822, DOI 10.1097/00005344-200212000-00003; Mateev S, 2003, AM J PHYSIOL-HEART C, V284, pH820, DOI 10.1152/ajpheart.00701.2002; McCarthy FP, 2011, HYPERTENSION, V58, P882, DOI 10.1161/HYPERTENSIONAHA.111.179440; National Research Council, 2011, GUIDE CARE USE LAB A; NELSON DM, 1989, J CLIN ENDOCR METAB, V68, P676, DOI 10.1210/jcem-68-3-676; Nielsen AH, 2000, PLACENTA, V21, P468, DOI 10.1053/plac.2000.0535; Osol G, 2014, MICROCIRCULATION, V21, P38, DOI 10.1111/micc.12080; Parast MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008055; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schaiff WT, 2000, J CLIN ENDOCR METAB, V85, P3874, DOI 10.1210/jc.85.10.3874; Tache V, 2013, STEM CELLS DEV, V22, P2815, DOI 10.1089/scd.2012.0596; Thaete LG, 2004, J SOC GYNECOL INVEST, V11, P16, DOI 10.1016/j.jsgi.2003.07.001; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; UNGER C, 1988, JAMA-J AM MED ASSOC, V259, P3427, DOI 10.1001/jama.259.23.3427; Usha K, 2011, J OBSTET GYN INDIA, V61, P505, DOI 10.1007/s13224-011-0092-x; Waite LL, 2000, J CLIN ENDOCR METAB, V85, P3808, DOI 10.1210/jc.85.10.3808; Waite LL, 2005, J CLIN ENDOCR METAB, V90, P620, DOI 10.1210/jc.2004-0849; WALSH SW, 1995, J CLIN ENDOCR METAB, V80, P1888, DOI 10.1210/jc.80.6.1888; WALSH SW, 1985, AM J OBSTET GYNECOL, V152, P335, DOI 10.1016/S0002-9378(85)80223-4; Wang YF, 2015, J MOL MED, V93, P327, DOI 10.1007/s00109-014-1216-4; White MM, 2000, AM J PHYSIOL-HEART C, V278, pH2069, DOI 10.1152/ajpheart.2000.278.6.H2069; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; ZAMUDIO S, 1995, J APPL PHYSIOL, V79, P7, DOI 10.1152/jappl.1995.79.1.7; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou JJ, 2013, HYPERTENSION, V62, P599, DOI 10.1161/HYPERTENSIONAHA.113.01449	68	1	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4283	4292		10.1096/fj.201902264RR	http://dx.doi.org/10.1096/fj.201902264RR		JAN 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31970838	Bronze, Green Accepted			2022-12-28	WOS:000508878800001
J	Hudson, L; Rashdan, E; Bonn, CA; Chavan, B; Rawlings, D; Birch-Machin, MA				Hudson, Laura; Rashdan, Eyman; Bonn, Catherine A.; Chavan, Bhaven; Rawlings, David; Birch-Machin, Mark A.			Individual and combined effects of the infrared, visible, and ultraviolet light components of solar radiation on damage biomarkers in human skin cells	FASEB JOURNAL			English	Article						oxidative stress; photoaging; photodamage; photoprotection; sunlight	MITOCHONDRIAL-DNA DAMAGE; OXIDATIVE STRESS; UVA; KERATINOCYTES; FIBROBLASTS; APOPTOSIS; EXPOSURE; ERYTHEMA; IMPACT; HEAT	The ability of solar ultraviolet (UV) to induce skin cancer and photoaging is well recognized. The effect of the infrared (IR) and visible light (Vis) components of solar radiation on skin and their interaction with UV is less well known. This study compared the effects of physiologically relevant doses of complete (UV + Vis + IR) solar-simulated light and its individual components on matched primary dermal fibroblasts and epidermal keratinocytes from human donors on three biomarkers of cellular damage (reactive oxygen species (ROS) generation, mitochondrial DNA (mtDNA), and nuclear DNA (nDNA) damage). There was a greater induction of ROS, mtDNA, and nDNA damage with the inclusion of the visible and IR components of solar-simulated light in primary fibroblast cells compared to primary keratinocytes (P < .001). Experiments using exposure to specific components of solar light alone or in combination showed that the UV, Vis, and IR components of solar light synergistically increased ROS generation in primary fibroblasts but not primary keratinocytes (P < .001). Skin cell lines were used to confirm these findings. These observations have important implications for different skin cell type responses to the individual and interacting components of solar light and therefore photodamage mechanisms and photoprotection interventions.	[Hudson, Laura; Rashdan, Eyman; Bonn, Catherine A.; Birch-Machin, Mark A.] Newcastle Univ, Sch Med, Translat & Clin Res Inst, Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Chavan, Bhaven] Croda Europe Ltd, Snaith, England; [Rawlings, David] Freeman Rd Hosp, Northern Med Phys & Clin Engn, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK	Birch-Machin, MA (corresponding author), Newcastle Univ, Sch Med, Translat & Clin Res Inst, Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	mark.birch-machin@ncl.ac.uk			Innovate UK [BH142095]; DH | National Institute for Health Research (NIHR) [RES0247/7538/122]; UKRI | Biotechnology and Biological Sciences Research Council (BBSRC) [BH172520]; BBSRC [1959726] Funding Source: UKRI	Innovate UK(UK Research & Innovation (UKRI)Innovate UK); DH | National Institute for Health Research (NIHR); UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Innovate UK, Grant/Award Number: BH142095; DH | National Institute for Health Research (NIHR), Grant/Award Number: RES0247/7538/122; UKRI | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BH172520	Akhalaya MY, 2014, AGEING RES REV, V16, P1, DOI 10.1016/j.arr.2014.03.006; APPLEGATE LA, 1995, PHOTOCHEM PHOTOBIOL, V61, P285, DOI 10.1111/j.1751-1097.1995.tb03973.x; Avola R, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110197; Barolet D, 2016, J PHOTOCH PHOTOBIO B, V155, P78, DOI 10.1016/j.jphotobiol.2015.12.014; Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x; Bernerd F, 1998, CELL DEATH DIFFER, V5, P792, DOI 10.1038/sj.cdd.4400413; Birch-Machin MA, 2013, BRIT J DERMATOL, V169, P9, DOI 10.1111/bjd.12207; Birch-Machin MA, 2008, PRINCIPLES PRACTICE, P51; Bonn CA, 2018, HPC TODAY, V13, P10; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boulton SJ, 2015, EXP DERMATOL, V24, P12, DOI 10.1111/exd.12597; Bowman Amy, 2015, Methods Mol Biol, V1265, P379, DOI 10.1007/978-1-4939-2288-8_27; Cho S, 2008, J DERMATOL SCI, V50, P123, DOI 10.1016/j.jdermsci.2007.11.009; Cho S, 2009, J INVEST DERM SYMP P, V14, P15, DOI 10.1038/jidsymp.2009.7; D'Errico M, 2007, MUTAT RES-FUND MOL M, V614, P37, DOI 10.1016/j.mrfmmm.2006.06.009; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; Diffey BL, 1997, PHOTODERMATOL PHOTO, V13, P64, DOI 10.1111/j.1600-0781.1997.tb00110.x; Diffey B, 2016, PHOTOCH PHOTOBIO SCI, V15, P361, DOI 10.1039/c5pp00451a; Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Hanna R, 2019, MITOCHONDRION, V46, P172, DOI 10.1016/j.mito.2018.04.009; Hornig-Do HT, 2007, J INVEST DERMATOL, V127, P1084, DOI 10.1038/sj.jid.5700666; Hudson L, 2016, MATURITAS, V93, P34, DOI 10.1016/j.maturitas.2016.04.021; Jantschitsch C, 2009, J INVEST DERMATOL, V129, P1271, DOI 10.1038/jid.2008.362; Kandola K, 2015, INT J COSMETIC SCI, V37, P1, DOI 10.1111/ics.12287; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Koohgoli R, 2017, EXP DERMATOL, V26, P384, DOI 10.1111/exd.13257; Latimer JA, 2015, J INVEST DERMATOL, V135, P2512, DOI 10.1038/jid.2015.194; Liebel F, 2012, J INVEST DERMATOL, V132, P1901, DOI 10.1038/jid.2011.476; Mahmoud BH, 2010, J INVEST DERMATOL, V130, P2092, DOI 10.1038/jid.2010.95; McDaniel D, 2018, J COSMET DERMATOL-US, V17, P124, DOI 10.1111/jocd.12518; Naidoo K, 2017, COSMETICS-BASEL, V4, DOI [10.3390/cosmetics4010004, DOI 10.3390/COSMETICS4010004]; Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404; Oyewole AO, 2014, FASEB J, V28, P485, DOI 10.1096/fj.13-237008; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Randhawa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130949; Schieke SM, 2003, PHOTODERMATOL PHOTO, V19, P228, DOI 10.1034/j.1600-0781.2003.00054.x; Schroeder P, 2007, FREE RADICAL BIO MED, V43, P128, DOI 10.1016/j.freeradbiomed.2007.04.002; Sklar LR, 2013, PHOTOCH PHOTOBIO SCI, V12, P54, DOI 10.1039/c2pp25152c; Stout R, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020029; Tulah AS, 2013, MITOCHONDRION, V13, P444, DOI 10.1016/j.mito.2012.11.007; Zakaria NNA, 2018, PHYTOTHER RES, V32, P1064, DOI 10.1002/ptr.6045	43	22	23	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3874	3883		10.1096/fj.201902351RR	http://dx.doi.org/10.1096/fj.201902351RR		JAN 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944399	Green Published, hybrid			2022-12-28	WOS:000507596300001
J	Cordes, M; Bucichowski, P; Alfaar, AS; Tsang, SH; Almedawar, S; Reichhart, N; Strauss, O				Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Tsang, Stephen H.; Almedawar, Seba; Reichhart, Nadine; Strauss, Olaf			Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells	FASEB JOURNAL			English	Article						bestrophin-1; Ca(V)1; 3; retinal degeneration; RPE; surface expression	RETINAL-PIGMENT EPITHELIUM; BEST-DISEASE; MISSENSE MUTATIONS; ION CHANNELS; LIGHT PEAK; CL-CHANNEL; GENE; PHAGOCYTOSIS; MEMBRANE; PROTEIN	The BEST1 gene product bestrophin-1, a Ca2+-dependent anion channel, interacts with Ca(V)1.3 Ca2+ channels in the retinal pigment epithelium (RPE). BEST1 mutations lead to Best vitelliform macular dystrophy. A common functional defect of these mutations is reduced trafficking of bestrophin-1 into the plasma membrane. We hypothesized that this defect affects the interaction partner Ca(V)1.3 channel affecting Ca2+ signaling and altered RPE function. Thus, we investigated the protein interaction between Ca(V)1.3 channels and bestrophin-1 by immunoprecipitation, Ca(V)1.3 activity in the presence of mutant bestrophin-1 and intracellular trafficking of the interaction partners in confluent RPE monolayers. We selected four BEST1 mutations, each representing one mutational hotspot of the disease: T6P, F80L, R218C, and F305S. Heterologously expressed L-type channels and mutant bestrophin-1 showed reduced interaction, reduced Ca(V)1.3 channel activity, and changes in surface expression. Transfection of polarized RPE (porcine primary cells, iPSC-RPE) that endogenously express Ca(V)1.3 and wild-type bestrophin-1, with mutant bestrophin-1 confirmed reduction of Ca(V)1.3 surface expression. For the four selected BEST1 mutations, presence of mutant bestrophin-1 led to reduced Ca(V)1.3 activity by modulating pore-function or decreasing surface expression. Reduced Ca(V)1.3 activity might open new ways to understand symptoms of Best vitelliform macular dystrophy such as reduced electro-oculogram, lipofuscin accumulation, and vision impairment.	[Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Reichhart, Nadine; Strauss, Olaf] Charite Univ Med Berlin, Dept Ophthalmol, Expt Ophthalmol, Berlin, Germany; [Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Reichhart, Nadine; Strauss, Olaf] Freie Univ, Berlin, Germany; [Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Reichhart, Nadine; Strauss, Olaf] Humboldt Univ, Berlin, Germany; [Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Reichhart, Nadine; Strauss, Olaf] Berlin Inst Hlth, Berlin, Germany; [Almedawar, Seba] Tech Univ Dresden, CRTD, CMCB, Dresden, Germany; [Tsang, Stephen H.] Columbia Univ, Coll Phys & Surg, Jonas Childrens Vis Care, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, Coll Phys & Surg,Dept Ophthalmol Pathol, Inst Human Nutr,Dept Ophthalmol,Columbia Stem Cel, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, Coll Phys & Surg,Dept Cell Biol, Inst Human Nutr,Dept Ophthalmol,Columbia Stem Cel, New York, NY USA; [Tsang, Stephen H.] New York Presbyterian Hosp, Edward S Harkness Eye Inst, New York, NY USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Technische Universitat Dresden; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital	Reichhart, N; Strauss, O (corresponding author), Charite, Dept Ophthalmol, Expt Ophthalmol, Campus Virchow Clin, Augustenburger Pl 1, D-13353 Berlin, Germany.	Nadine.seichhart@charite.de; olaf.strauss@charite.de	Alfaar, Ahmad/C-8483-2011	Alfaar, Ahmad/0000-0002-0930-4583; Strauss, Olaf/0000-0002-6272-8596	DFG [480/12-1]; German Research Foundation (DFG); Charite-Universitatsmedizin Berlin	DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Charite-Universitatsmedizin Berlin	Funding was provided by a DFG grant to Prof. Dr O.Strauss (480/12-1). We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fonds of the Charite-Universitatsmedizin Berlin	Arden GB, 2006, PROG RETIN EYE RES, V25, P207, DOI 10.1016/j.preteyeres.2005.11.001; Bakall B, 2007, EXP EYE RES, V85, P34, DOI 10.1016/j.exer.2007.02.018; Barro-Soria R, 2010, PFLUG ARCH EUR J PHY, V459, P485, DOI 10.1007/s00424-009-0745-0; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Constable PA, 2011, GRAEF ARCH CLIN EXP, V249, P677, DOI 10.1007/s00417-010-1604-6; Gomez NM, 2013, PFLUG ARCH EUR J PHY, V465, P481, DOI 10.1007/s00424-012-1181-0; Guziewicz KE, 2018, ADV EXP MED BIOL, V1074, P309, DOI [10.1007/978-3-319-75402-4_38, 10.1007/978-3-319-75402-4_39]; Guziewicz KE, 2018, P NATL ACAD SCI USA, V115, pE2839, DOI 10.1073/pnas.1720662115; Guziewicz KE, 2017, PROG RETIN EYE RES, V58, P70, DOI 10.1016/j.preteyeres.2017.01.005; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Johnson AA, 2017, PROG RETIN EYE RES, V58, P45, DOI 10.1016/j.preteyeres.2017.01.006; Johnson AA, 2013, HUM MOL GENET, V22, P4688, DOI 10.1093/hmg/ddt316; Karl MO, 2008, CELL SIGNAL, V20, P1159, DOI 10.1016/j.cellsig.2008.02.005; Keckeis S, 2017, EXP EYE RES, V154, P139, DOI 10.1016/j.exer.2016.12.003; Korkka I, 2019, STEM CELL TRANSL MED, V8, P179, DOI 10.1002/sctm.18-0026; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21651-z; Marmorstein AD, 2015, MOL VIS, V21, P347; Marmorstein LY, 2002, J BIOL CHEM, V277, P30591, DOI 10.1074/jbc.M204269200; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Milenkovic A, 2019, BIOL OPEN, V8, DOI 10.1242/bio.041335; Milenkovic A, 2018, HUM MOL GENET, V27, P1630, DOI 10.1093/hmg/ddy070; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; Milenkovic VM, 2011, J CELL SCI, V124, P2988, DOI 10.1242/jcs.085878; Milenkovic VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019364; MILLER SS, 1990, J PHYSIOL-LONDON, V424, P283, DOI 10.1113/jphysiol.1990.sp018067; Muller C, 2014, CELL SIGNAL, V26, P968, DOI 10.1016/j.cellsig.2013.12.021; Mullins RF, 2005, ARCH OPHTHALMOL-CHIC, V123, P1588, DOI 10.1001/archopht.123.11.1588; Neussert R, 2010, PFLUG ARCH EUR J PHY, V460, P163, DOI 10.1007/s00424-010-0840-2; Park M, 2019, BIOCHEM BIOPH RES CO, V514, P344, DOI 10.1016/j.bbrc.2019.04.078; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Reichhart N, 2010, EXP EYE RES, V91, P630, DOI 10.1016/j.exer.2010.08.001; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Rosenthal R, 2001, FASEB J, V15, P970, DOI 10.1096/fj.00-0188com; Singh R, 2015, MOL THER, V23, P1700, DOI 10.1038/mt.2015.141; Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strauss O, 2016, ADV EXP MED BIOL, V854, P739, DOI 10.1007/978-3-319-17121-0_98; Strauss O, 2014, ADV EXP MED BIOL, V801, P113, DOI 10.1007/978-1-4614-3209-8_15; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Wu JA, 2007, J NEUROPHYSIOL, V97, P3731, DOI 10.1152/jn.00146.2007; Yang TT, 2014, SCIENCE, V346, P355, DOI 10.1126/science.1259723; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Zhang YW, 2010, HUM MOL GENET, V19, P1108, DOI 10.1093/hmg/ddp583; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054552	48	4	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4055	4071		10.1096/fj.201901202RR	http://dx.doi.org/10.1096/fj.201901202RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930599	hybrid, Green Published			2022-12-28	WOS:000507260600001
J	Duan, CW; Fukuda, T; Isaji, T; Qi, F; Yang, J; Wang, YQ; Takahashi, S; Gu, JG				Duan, Chengwei; Fukuda, Tomohiko; Isaji, Tomoya; Qi, Feng; Yang, Jie; Wang, Yuqin; Takahashi, Shinichiro; Gu, Jianguo			Deficiency of core fucosylation activates cellular signaling dependent on FLT3 expression in a Ba/F3 cell system	FASEB JOURNAL			English	Article						acute myeloid leukemia; cellular signaling; core fucosylation; FLT3; Fut8	INTERNAL TANDEM DUPLICATION; GROWTH-FACTOR RECEPTOR; ACUTE MYELOID-LEUKEMIA; CONSTITUTIVE ACTIVATION; N-ACETYLGLUCOSAMINE; ARSENIC TRIOXIDE; KINASE; INHIBITION; MUTATIONS; FUCOSE	Fms-like tyrosine kinase 3 (FLT3) is a glycoprotein, that is a member of the class III receptor tyrosine kinase family. Approximately one-third of acute myeloid leukemia (AML) patients have mutations of this gene, and activation of the FLT3 downstream pathway plays an important role in both normal and malignant hematopoiesis. However, the role of N-glycosylation for FLT3 activation remains unclear. In this study, we showed that the N-glycan structures on wild type (WT), internal tandem duplication (ITD), and tyrosine kinase domain (TKD) mutants of FLT3 were different. Interestingly, expression of either WT or mutant FLT3 in Ba/F3 cells, an interleukin-3 (IL-3)-dependent hematopoietic progenitor cell, greatly induced core fucosylation. To elucidate the function of core fucosylation in FLT3-mediated signaling, we used a CRISPR/Cas9 system to establish alpha 1,6-fucosyltransferase (Fut8) knockout (KO) cells. Surprisingly, the Fut8KO resulted in cell proliferation in an IL-3-independent manner in FLT3-WT cells, which was not observed in the parental cells, and suggested that this proliferation is dependent on FLT3 expression. Fut8KO greatly increased cellular tyrosine phosphorylation levels, together with an activation of STAT5, AKT, and ERK signaling, which could be completely neutralized by restoration with Fut8 in the KO cells. Consistently, a tyrosine kinase inhibitor efficiently inhibited cell proliferation induced by Fut8KO or specific fucosylation inhibitor. Additionally, immunostaining with FLT3 showed that the proteins were mainly expressed on the cell surface in the KO cells, which is similar to FLT3-WT cells, but different from the ITD mutant. Finally, we found that Fut8KO could induce dimer-formation in FLT3 without ligand-stimulation. Taken together, the present study clearly defines the regulatory function of core fucosylation in FLT3, which could provide a valuable direction for development of drugs could be effective in the treatment of AML.	[Duan, Chengwei; Fukuda, Tomohiko; Isaji, Tomoya; Qi, Feng; Yang, Jie; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan; [Wang, Yuqin] Nantong Univ, Dept Pharmacol, Coll Pharm, Nantong, Peoples R China; [Takahashi, Shinichiro] Tohoku Med & Pharmaceut Univ, Div Lab Med, Fac Med, Sendai, Miyagi, Japan	Tohoku Medical & Pharmaceutical University; Nantong University; Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.; Takahashi, S (corresponding author), Tohoku Med & Pharmaceut Univ, Fac Med, Div Lab Med, Miyagino Ku, 1-15-1 Fukumuro, Sendai, Miyagi 9838536, Japan.	shintakahashi@tohoku-mpu.ac.jp; jgu@tohoku-mpu.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021; Takahashi, Shinichiro/AAX-7125-2020	Takahashi, Shinichiro/0000-0003-0011-6065	Japan Society for the Promotion of Science [19H03184, 17K09019, 17K08284]; National Natural Science Foundation of China [31670807]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [18H04868]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Japan Society for the Promotion of Science, Grant/Award Number: 19H03184, 17K09019 and 17K08284; National Natural Science Foundation of China, Grant/Award Number: 31670807; Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant/Award Number: 18H04868	Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bacher U, 2008, BLOOD, V111, P2527, DOI 10.1182/blood-2007-05-091215; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Callus BA, 1998, BLOOD, V91, P3182, DOI 10.1182/blood.V91.9.3182.3182_3182_3192; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Daver N, 2019, LEUKEMIA, V33, P299, DOI 10.1038/s41375-018-0357-9; Fujii H, 2016, GASTROENTEROLOGY, V150, P1620, DOI 10.1053/j.gastro.2016.03.002; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grafone T, 2012, ONCOL REV, V6, P64, DOI 10.4081/oncol.2012.e8; Gu W, 2015, J BIOL CHEM, V290, P17566, DOI 10.1074/jbc.M114.579938; Gu W, 2013, FASEB J, V27, P3947, DOI 10.1096/fj.12-225805; Hang QL, 2015, J BIOL CHEM, V290, P29345, DOI 10.1074/jbc.M115.682229; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kazi JU, 2019, PHYSIOL REV, V99, P1433, DOI 10.1152/physrev.00029.2018; KEENAN RW, 1981, BIOCHEMISTRY-US, V20, P2968, DOI 10.1021/bi00513a039; Kiyoi H, 2002, ONCOGENE, V21, P2555, DOI 10.1038/sj.onc.1205332; Kizuka Y, 2017, CELL CHEM BIOL, V24, P1467, DOI 10.1016/j.chembiol.2017.08.023; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Koch S, 2008, CELLS TISSUES ORGANS, V188, P225, DOI 10.1159/000118788; Larrue C, 2015, MOL CANCER THER, V14, P2364, DOI 10.1158/1535-7163.MCT-15-0163; Leischner H, 2012, BLOOD, V119, P4026, DOI 10.1182/blood-2011-07-365726; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li WZ, 2015, J IMMUNOL, V194, P2596, DOI 10.4049/jimmunol.1402678; Liang W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00078; Liu J, 2013, EUR J MED CHEM, V65, P83, DOI 10.1016/j.ejmech.2013.03.035; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lu X, 2019, BBA-GEN SUBJECTS, V1863, P598, DOI 10.1016/j.bbagen.2018.12.008; Masson K, 2009, BRIT J HAEMATOL, V146, P193, DOI 10.1111/j.1365-2141.2009.07725.x; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nagai Kozo, 2018, Oncotarget, V9, P32885, DOI 10.18632/oncotarget.25972; Nakao M, 1996, LEUKEMIA, V10, P1911; Ng BG, 2018, AM J HUM GENET, V102, P188, DOI 10.1016/j.ajhg.2017.12.009; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okada M, 2017, CELL REP, V20, P1017, DOI 10.1016/j.celrep.2017.07.027; Okeley NM, 2013, P NATL ACAD SCI USA, V110, P5404, DOI 10.1073/pnas.1222263110; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Razumovskaya E, 2009, EXP HEMATOL, V37, P979, DOI 10.1016/j.exphem.2009.05.008; Reiter K, 2018, LEUKEMIA, V32, P313, DOI 10.1038/leu.2017.257; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Steffen B, 2005, CRIT REV ONCOL HEMAT, V56, P195, DOI 10.1016/j.critrevonc.2004.10.012; Takahashi S, 2005, LEUKEMIA RES, V29, P893, DOI 10.1016/j.leukres.2005.01.008; Takahashi S, 2004, BLOOD, V103, P4650, DOI 10.1182/blood-2003-08-2759; Takahashi S, 2006, INT J HEMATOL, V84, P256, DOI 10.1532/IJH97.06076; Takahashi S, 2016, BIOMED REP, V4, P83, DOI 10.3892/br.2015.541; Takahashi S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-13; Takahashi S, 2010, ANTI-CANCER AGENT ME, V10, P504, DOI 10.2174/1871520611009060504; Tse KF, 2000, LEUKEMIA, V14, P1766, DOI 10.1038/sj.leu.2401905; Tsitsipatis D, 2017, ONCOTARGET, V8, P26613, DOI 10.18632/oncotarget.15772; Vempati S, 2008, CLIN CANCER RES, V14, P4437, DOI 10.1158/1078-0432.CCR-07-1873; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang YQ, 2015, FASEB J, V29, P3217, DOI 10.1096/fj.15-270710; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Williams AB, 2012, BLOOD, V120, P3069, DOI 10.1182/blood-2012-01-403493; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Wu M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0675-4; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Xu ZW, 2019, J BIOL CHEM, V294, P3117, DOI 10.1074/jbc.RA118.005923; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhou Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11911-9	79	3	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3239	3252		10.1096/fj.201902313RR	http://dx.doi.org/10.1096/fj.201902313RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908039	Bronze			2022-12-28	WOS:000505692700001
J	Hamraz, M; Abolhassani, R; Andriamihaja, M; Ransy, C; Lenoir, V; Schwartz, L; Bouillaud, F				Hamraz, Minoo; Abolhassani, Raymond; Andriamihaja, Mireille; Ransy, Celine; Lenoir, Veronique; Schwartz, Laurent; Bouillaud, Frederic			Hypertonic external medium represses cellular respiration and promotes Warburg/Crabtree effect	FASEB JOURNAL			English	Article						bioenergetics; cancer; Crabtree effect; inflammation; Krebs cycle; Warburg effect	CANCER; METABOLISM; MECHANISMS; ORIGIN; ANOXIA; TUMORS; CELLS	Hyperosmotic conditions are associated to several pathological states. In this article, we evaluate the consequence of hyperosmotic medium on cellular energy metabolism. We demonstrate that exposure of cells to hyperosmotic conditions immediately reduces the mitochondrial oxidative phosphorylation rate. This causes an increase in glycolysis, which represses further respiration. This is known as the Warburg or Crabtree effect. In addition to aerobic glycolysis, we observed two other cellular responses that would help to preserve cellular ATP level and viability: A reduction in the cellular ATP turnover rate and a partial mitochondrial uncoupling which is expected to enhance ATP production by Krebs cycle. The latter is likely to constitute another metabolic adaptation to compensate for deficient oxidative phosphorylation that, importantly, is not dependent on glucose.	[Hamraz, Minoo; Ransy, Celine; Lenoir, Veronique; Bouillaud, Frederic] Univ Paris, Inst Cochin, CNRS, INSERM, F-75014 Paris, France; [Abolhassani, Raymond] SAS Vaccinopole, Paris, France; [Andriamihaja, Mireille] AgroParisTech, INRA, UMR Physiol Nutr & Comportement Alimentaire 914, Paris, France; [Schwartz, Laurent] AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP)	Bouillaud, F (corresponding author), Univ Paris, Inst Cochin, CNRS, INSERM, F-75014 Paris, France.	frederic.bouillaud@inserm.fr		Bouillaud, Frederic/0000-0002-7518-9237	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite Paris Descartes (Paris Descartes University)	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes (Paris Descartes University)	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite Paris Descartes (Paris Descartes University)	[Anonymous], SEAH XF REAL TIM ATP; Asgari Y, 2015, GENOMICS, V105, P275, DOI 10.1016/j.ygeno.2015.03.001; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brocker Chad, 2012, Biomol Concepts, V3, P345; Buck LT, 2006, RESP PHYSIOL NEUROBI, V154, P226, DOI 10.1016/j.resp.2006.03.004; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Di Paolo Antonello, 2007, Curr Oncol Rep, V9, P109; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; El Kasmi KC, 2015, SEMIN IMMUNOL, V27, P267, DOI 10.1016/j.smim.2015.09.001; Gaude E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13041; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; JAIN RK, 1991, INT J RADIAT BIOL, V60, P85, DOI 10.1080/09553009114551621; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lemus MR, 2018, J BIOL CHEM, V293, P12843, DOI 10.1074/jbc.RA118.003672; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Moreira JD, 2016, METABOLITES, V6, DOI 10.3390/metabo6040033; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; SCHILLI R, 1982, GUT, V23, P326, DOI 10.1136/gut.23.4.326; Schwartz L, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-21; Stohrer M, 2000, CANCER RES, V60, P4251; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; Wojtczak L, 1999, EUR J BIOCHEM, V263, P495, DOI 10.1046/j.1432-1327.1999.00522.x; ZWEIBAUM A, 1985, J CELL PHYSIOL, V122, P21, DOI 10.1002/jcp.1041220105	33	2	2	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					222	236		10.1096/fj.201900706RR	http://dx.doi.org/10.1096/fj.201900706RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914644				2022-12-28	WOS:000507308900017
J	Liu, P; Zhu, CC; Luo, JJ; Lan, S; Su, DS; Wang, QJ; Wei, Z; Cui, W; Xu, C; Yang, XJ				Liu, Pei; Zhu, Chenchen; Luo, Juanjuan; Lan, Sheng; Su, Dongsheng; Wang, Qiongjin; Wei, Zhe; Cui, Wei; Xu, Chuan; Yang, Xiaojun			Par6 regulates cell cycle progression through enhancement of Akt/PI3K/GSK-3 beta signaling pathway activation in glioma	FASEB JOURNAL			English	Article						cell proliferation; cyclin D1; glioma; Par6	POLARITY PROTEIN PAR6; MALIGNANT GLIOMA; CANCER; PROLIFERATION; GROWTH; GSK-3-BETA; APOPTOSIS; MIGRATION; INVASION; COMPLEX	As the key factor of the polarity protein complex, Par6 not only regulates polarization processes, but also plays important roles in tumor metastasis and progression in many epithelium malignancy tumors. Here, we showed that Par6 is an essential component in glioma tumorigenesis. Our results indicated the aberrant expression of Par6 in malignant glioma tissues and cell lines. We found that the regulation of Par6 expression induces cell proliferation and tumor growth in vivo and in vitro. Additionally, RNA-seq revealed the effects of Par6 were associated with cyclin D1-regulated cell cycle progression in glioma cells. Moreover, our results demonstrated that the regulation of Par6 can enhance the activation of Akt/PI3K signaling pathway, and subsequently upregulate the expression level of GSK-3 beta protein, which then regulate cyclin D1-mediated cell cycle regulation. Furthermore, we found that TGF-beta-induced the upregulation of Par6 expression may be involved in this process. The pathological analysis confirmed the correlation between Par6 expression and the prognosis in human glioma tissues, suggesting the regulation of Par6 expression regulates glioma tumorigenesis and progression. Thus, our findings showed that Par6 might be a potential biomarker for the diagnosis and providing a therapeutic strategy for the treatment of malignant glioma.	[Liu, Pei; Zhu, Chenchen; Luo, Juanjuan; Lan, Sheng; Su, Dongsheng; Wang, Qiongjin; Yang, Xiaojun] Shantou Univ, Coll Med, Neurosci Ctr, 22 Xinling Rd, Shantou 515041, Peoples R China; [Wei, Zhe] Lishui Univ, Fac Med & Hlth, Lishui, Peoples R China; [Cui, Wei] Shenyang Pharmaceut Univ, Dept Pharmacol, Coll Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Xu, Chuan] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, 55 Renmin South Rd, Chengdu 610047, Peoples R China	Shantou University; Lishui University; Shenyang Pharmaceutical University; University of Electronic Science & Technology of China	Yang, XJ (corresponding author), Shantou Univ, Coll Med, Neurosci Ctr, 22 Xinling Rd, Shantou 515041, Peoples R China.; Xu, C (corresponding author), Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, 55 Renmin South Rd, Chengdu 610047, Peoples R China.	xuchuan100@163.com; yangx@stu.edu.cn		XU, CHUAN/0000-0002-5320-2277	National Natural Science Foundation of China [81572494, 81872070, 81673652]; Li Ka Shing Foundation Grant for Joint Research Program; Shantou University; TechnionIsrael Institute of Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Foundation Grant for Joint Research Program; Shantou University; TechnionIsrael Institute of Technology	National Natural Science Foundation of China, Grant/Award Number: 81572494, 81872070 and 81673652; Li Ka Shing Foundation Grant for Joint Research Program; Shantou University; TechnionIsrael Institute of Technology	Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Avery-Cooper G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-19; Bose R, 2006, CURR OPIN CELL BIOL, V18, P206, DOI 10.1016/j.ceb.2006.02.005; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chen XH, 2015, EUR REV MED PHARMACO, V19, P3412; Cline EG, 2007, MOL CELL BIOL, V27, P4431, DOI 10.1128/MCB.02235-06; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Gunaratne A, 2013, MOL CELL BIOL, V33, P874, DOI 10.1128/MCB.00837-12; Guo ZF, 2017, BIOMED PHARMACOTHER, V94, P774, DOI 10.1016/j.biopha.2017.07.081; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2017, BIOCHEM BIOPH RES CO, V494, P542, DOI 10.1016/j.bbrc.2017.10.116; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Kim M, 2007, J CELL SCI, V120, P2309, DOI 10.1242/jcs.007443; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kolsi LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34131-1; Kwiatkowska A, 2013, ADV EXP MED BIOL, V986, P121, DOI 10.1007/978-94-007-4719-7_7; Li Y, 2017, BIOMED PHARMACOTHER, V93, P435, DOI 10.1016/j.biopha.2017.06.058; Lin JT, 2015, CELL CYCLE, V14, P408, DOI 10.4161/15384101.2014.977103; Liu HJ, 2015, INT J CLIN EXP PATHO, V8, P9140; Liubich L. D., 2017, Experimental Oncology, V39, P258; Marques Elsa, 2015, Oncoscience, V2, P894; Mu Y, 2015, BRIT J CANCER, V112, P1223, DOI 10.1038/bjc.2015.71; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Ong CS, 2010, CANCER LETT, V298, P167, DOI 10.1016/j.canlet.2010.07.001; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Preusser M, 2006, WIEN MED WOCHENSCHR, V156, P332, DOI 10.1007/s10354-006-0304-7; Ramljak D, 2000, CARCINOGENESIS, V21, P1537, DOI 10.1093/carcin/21.8.1537; Renschler FA, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam9899; Ruan LL, 2017, CLIN EXP PHARMACOL P, V44, P909, DOI 10.1111/1440-1681.12794; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watts JL, 1996, DEVELOPMENT, V122, P3133; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Zhang K, 2016, ONCOGENE, V35, P1271, DOI 10.1038/onc.2015.184; Zhu YC, 2017, INT J MOL MED, V40, P1165, DOI 10.3892/ijmm.2017.3100	43	7	7	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1481	1496		10.1096/fj.201901629RR	http://dx.doi.org/10.1096/fj.201901629RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914615	Bronze			2022-12-28	WOS:000507308900098
J	Sorkin, BC; Kuszak, AJ; Bloss, G; Fukagawa, NK; Hoffman, FA; Jafari, M; Barrett, B; Brown, PN; Bushman, FD; Casper, SJ; Chilton, FH; Coffey, CS; Ferruzzi, MG; Hopp, DC; Kiely, M; Lakens, D; MacMillan, JB; Meltzer, DO; Pahor, M; Paul, J; Pritchett-Corning, K; Quinney, SK; Rehermann, B; Setchell, KDR; Sipes, NS; Stephens, JM; Taylor, DL; Tiriac, H; Walters, MA; Xi, D; Zappala, G; Pauli, GF				Sorkin, Barbara C.; Kuszak, Adam J.; Bloss, Gregory; Fukagawa, Naomi K.; Hoffman, Freddie Ann; Jafari, Mahtab; Barrett, Bruce; Brown, Paula N.; Bushman, Frederic D.; Casper, Steven J.; Chilton, Floyd H.; Coffey, Christopher S.; Ferruzzi, Mario G.; Hopp, D. Craig; Kiely, Mairead; Lakens, Daniel; MacMillan, John B.; Meltzer, David O.; Pahor, Marco; Paul, Jeffrey; Pritchett-Corning, Kathleen; Quinney, Sara K.; Rehermann, Barbara; Setchell, Kenneth D. R.; Sipes, Nisha S.; Stephens, Jacqueline M.; Taylor, D. Lansing; Tiriac, Herve; Walters, Michael A.; Xi, Dan; Zappala, Giovanna; Pauli, Guido F.			Improving natural product research translation: From source to clinical trial	FASEB JOURNAL			English	Article						clinical predictive validity; dietary supplements; model systems; rigor and replicability; value of information	HUMAN HEALTH-RISK; IN-VITRO; DROSOPHILA-MELANOGASTER; DRUG DISCOVERY; ANIMAL-MODELS; HUMAN-DISEASE; HYDRASTIS-CANADENSIS; METABOLITE EQUOL; PUBLICATION BIAS; IMMUNE-RESPONSE	While great interest in health effects of natural product (NP) including dietary supplements and foods persists, promising preclinical NP research is not consistently translating into actionable clinical trial (CT) outcomes. Generally considered the gold standard for assessing safety and efficacy, CTs, especially phase III CTs, are costly and require rigorous planning to optimize the value of the information obtained. More effective bridging from NP research to CT was the goal of a . Participants emphasized that replicability and likelihood of successful translation depend on rigor in experimental design, interpretation, and reporting across the continuum of NP research. Discussions spanned good practices for NP characterization and quality control; use and interpretation of models (computational through in vivo) with strong clinical predictive validity; controls for experimental artefacts, especially for in vitro interrogation of bioactivity and mechanisms of action; rigorous assessment and interpretation of prior research; transparency in all reporting; and prioritization of research questions. Natural product clinical trials prioritized based on rigorous, convergent supporting data and current public health needs are most likely to be informative and ultimately affect public health. Thoughtful, coordinated implementation of these practices should enhance the knowledge gained from future NP research.	[Sorkin, Barbara C.; Kuszak, Adam J.] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA; [Bloss, Gregory] NIAAA, NIH, Bethesda, MD USA; [Fukagawa, Naomi K.] ARS, USDA, Beltsville, MD USA; [Hoffman, Freddie Ann] HeteroGeneity LLC, Washington, DC USA; [Jafari, Mahtab] Univ Calif Irvine, Irvine, CA USA; [Barrett, Bruce] Univ Wisconsin, Madison, WI USA; [Brown, Paula N.] British Columbia Inst Technol, Burnaby, BC, Canada; [Bushman, Frederic D.] Univ Penn, Philadelphia, PA 19104 USA; [Casper, Steven J.] US FDA, Off Dietary Supplement Programs, Ctr Food Safety & Appl Nutr, Hyattsville, MD USA; [Chilton, Floyd H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ USA; [Chilton, Floyd H.] Univ Arizona, BIO5 Inst, Tucson, AZ USA; [Coffey, Christopher S.] Univ Iowa, Iowa City, IA USA; [Ferruzzi, Mario G.] North Carolina State Univ, Plants Human Hlth Inst, Kannapolis, NC USA; [Hopp, D. Craig] NIH, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA; [Kiely, Mairead] Univ Coll Cork, Sch Food & Nutr Sci, Cork Ctr Vitamin D & Nutr Res, Cork, Ireland; [Lakens, Daniel] Eindhoven Univ Technol, Eindhoven, Netherlands; [MacMillan, John B.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Meltzer, David O.] Univ Chicago Med, Chicago, IL USA; [Pahor, Marco] Univ Florida, Gainesville, FL USA; [Paul, Jeffrey] Coll Med, Drexel Grad Coll Biomed Sci, Evanston, IL USA; [Pritchett-Corning, Kathleen] Harvard Univ, Cambridge, MA 02138 USA; [Quinney, Sara K.] Indiana Univ, Indianapolis, IN 46204 USA; [Rehermann, Barbara] NIDDK, NIH, Bethesda, MD 20892 USA; [Setchell, Kenneth D. R.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Sipes, Nisha S.] NIEHS, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Stephens, Jacqueline M.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Taylor, D. Lansing] Univ Pittsburgh, Pittsburgh, PA USA; [Tiriac, Herve] Univ Calif San Diego, La Jolla, CA 92093 USA; [Walters, Michael A.] Univ Minnesota, Inst Therapeut Discovery & Dev, Minneapolis, MN USA; [Xi, Dan] NCI, Off Canc Complementary & Alternat Med, NIH, Shady Grove, MD USA; [Zappala, Giovanna] NIA, NIH, Bethesda, MD 20892 USA; [Pauli, Guido F.] Univ Illinois, Coll Pharm, CENAPT, Chicago, IL USA; [Pauli, Guido F.] Univ Illinois, Coll Pharm, PCRPS, Chicago, IL USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Agriculture (USDA); University of California System; University of California Irvine; University of Wisconsin System; University of Wisconsin Madison; British Columbia Institute of Technology; University of Pennsylvania; US Food & Drug Administration (FDA); University of Arizona; University of Arizona; University of Iowa; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; University College Cork; Eindhoven University of Technology; University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; Harvard University; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Louisiana State University System; Louisiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sorkin, BC (corresponding author), NIH, Off Dietary Supplements, 6100 Execut Blvd,Ste 3B01,MSC 7517, North Bethesda, MD 20892 USA.	barbara.sorkin@nih.gov	Stephens, Jacqueline M/R-5217-2018; Pauli, Guido F/C-1159-2009; Quinney, Sara K/J-5130-2014; Sorkin, Barbara/I-6897-2019; Kiely, Mairead E/ABA-3235-2020; Lakens, Daniel/K-3831-2015	Quinney, Sara K/0000-0002-6554-0695; Sorkin, Barbara/0000-0001-8198-6921; Tiriac, Herve/0000-0001-5039-6750; Lakens, Daniel/0000-0002-0247-239X; Rehermann, Barbara/0000-0001-6832-9951; Chilton, Floyd/0000-0002-3686-0198; Kuszak, Adam/0000-0001-8719-145X	HHS \ National Institutes of Health (NIH)	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: NA	Aberle MR, 2018, BRIT J SURG, V105, pE48, DOI 10.1002/bjs.10726; Albers C, 2018, J EXP SOC PSYCHOL, V74, P187, DOI 10.1016/j.jesp.2017.09.004; Applequist WL, 2013, ANAL BIOANAL CHEM, V405, P4419, DOI 10.1007/s00216-012-6595-1; Baden MY, 2019, CIRCULATION, V140, P979, DOI 10.1161/CIRCULATIONAHA.119.041014; Baell JB, 2016, J NAT PROD, V79, P616, DOI 10.1021/acs.jnatprod.5b00947; Baker LA, 2016, TRENDS CANCER, V2, P176, DOI 10.1016/j.trecan.2016.03.004; Barrett B, 2013, MED DECIS MAKING, V33, P869, DOI 10.1177/0272989X13476764; Barrett B, 2011, ANN FAM MED, V9, P312, DOI 10.1370/afm.1250; Barrington WT, 2018, GENETICS, V208, P399, DOI 10.1534/genetics.117.300536; Battiste M., 2018, PALGRAVE HDB ED LAW, P567, DOI DOI 10.1007/978-3-319-77751-1; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Becker KJ, 2016, TRANSL STROKE RES, V7, P303, DOI 10.1007/s12975-016-0455-9; Bell SM, 2018, TOXICOL IN VITRO, V47, P213, DOI 10.1016/j.tiv.2017.11.016; Belzung C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-9; Berman J, 2011, FITOTERAPIA, V82, P80, DOI 10.1016/j.fitote.2010.07.014; Boudreau A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00018; Box G.E., 1987, EMPIRICAL MODEL BUIL; Bozin B, 2013, MOLECULES, V18, P11733, DOI 10.3390/molecules181011733; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Brenna JT, 2018, AM J CLIN NUTR, V108, P211, DOI 10.1093/ajcn/nqy089; Britton ER, 2018, J NAT PROD, V81, P484, DOI 10.1021/acs.jnatprod.7b00654; Brown LaVerne L, 2018, BMC Proc, V12, P6, DOI 10.1186/s12919-018-0102-4; Brown NM, 2010, FOOD CHEM TOXICOL, V48, P3042, DOI 10.1016/j.fct.2010.07.042; Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641; Button Katherine S, 2013, Nat Rev Neurosci, V14, P877, DOI 10.1038/nrn3475-c6; Caesar LK, 2019, NAT PROD REP, V36, P869, DOI 10.1039/c9np00011a; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/nmeth.4397, 10.1038/NMETH.4397]; Catlin NR, 2018, FOOD CHEM TOXICOL, V118, P328, DOI 10.1016/j.fct.2018.05.013; Cech NB, 2012, PLANTA MED, V78, P1556, DOI 10.1055/s-0032-1315042; Center for Drug Evaluation and Research, 2016, BOT DRUG DEV GUID IN; Center for Drug Evaluation and Research, 2018, EXP COH US 1 IN HUM; Chen SN, 2009, PLANTA MED, V75, P757, DOI 10.1055/s-0028-1112209; Chen SH, 2016, SCIENCE, V351, P1204, DOI 10.1126/science.aac5610; Chen TY, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700111; Cheng CW, 2017, ANN INTERN MED, V167, P112, DOI [10.7326/M16-2977, 10.7326/IsTranslatedFrom_M17-2977_2, 10.7326/IsTranslatedFrom_M17-2977_1]; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Clark M, 2018, REGUL TOXICOL PHARM, V96, P94, DOI 10.1016/j.yrtph.2018.04.018; Clerici C, 2007, J NUTR, V137, P2270, DOI 10.1093/jn/137.10.2270; Contijoch EJ, 2019, ELIFE, V8, DOI 10.7554/eLife.40553; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; Cui Yuanyuan, 2014, BMC Syst Biol, V8, P6, DOI 10.1186/s12918-014-0140-0; Dahlin J. L., 2015, ASSAY GUIDANCE MANUA; Dahlin JL, 2014, FUTURE MED CHEM, V6, P1265, DOI [10.4155/FMC.14.60, 10.4155/fmc.14.60]; Das B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22090-6; Davis DJ, 2017, BRAIN BEHAV IMMUN, V59, P38, DOI 10.1016/j.bbi.2016.09.003; Deaton A, 2018, SOC SCI MED, V210, P2, DOI 10.1016/j.socscimed.2017.12.005; Di L, 2013, DRUG METAB DISPOS, V41, P1975, DOI 10.1124/dmd.113.054031; Dotson CD, 2012, CURR NUTR REP, V1, P175, DOI DOI 10.1007/S13668-012-0021-3; Duan D, 2015, ACS CHEM BIOL, V10, P978, DOI 10.1021/cb5009487; Duric K, 2019, J NAT PROD, V82, P2400, DOI 10.1021/acs.jnatprod.8b00962; Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007; Eisenman S.W., 2012, JAMP, V1, P30, DOI DOI 10.7275/R50K26HC; Elfawal MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052746; Eruslanov EB, 2017, TRENDS CANCER, V3, P149, DOI 10.1016/j.trecan.2016.12.006; Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539; Ewart L, 2017, EXP BIOL MED, V242, P1579, DOI 10.1177/1535370217715441; Fenclova M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47250-0; Ferreira ML, 2013, J CLIN EPIDEMIOL, V66, P1397, DOI 10.1016/j.jclinepi.2013.02.018; Fischbach MA, 2018, CELL, V174, P785, DOI 10.1016/j.cell.2018.07.038; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Freedman Leonard P, 2017, F1000Res, V6, P604, DOI 10.12688/f1000research.11334.1; Freedman LP, 2015, BIOTECHNIQUES, V59, P189, DOI 10.2144/000114344; Friesen JB, 2019, J NAT PROD, V82, P621, DOI 10.1021/acs.jnatprod.9b00020; Frolinger T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39994-6; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Gagnier JJ, 2006, J CLIN EPIDEMIOL, V59, P1134, DOI 10.1016/j.jclinepi.2005.12.020; Gagnier JJ, 2011, J CLIN EPIDEMIOL, V64, P760, DOI 10.1016/j.jclinepi.2010.10.005; Gallin J.I., 2017, PRINCIPLES PRACTICE, V4th ed.; Gallo P, 2006, J BIOPHARM STAT, V16, P275, DOI 10.1080/10543400600614742; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gurley BJ, 2018, CLIN PHARMACOL THER, V104, P470, DOI 10.1002/cpt.1131; Gusev PA, CURR DEV NUTR BOST M; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hajirahimkhan A, 2018, J NAT PROD, V81, P966, DOI 10.1021/acs.jnatprod.7b01070; Hansen J, 2013, CLIN PHARMACOL THER, V93, P117, DOI 10.1038/clpt.2012.199; Harrington D, 2019, NEW ENGL J MED, V381, P285, DOI 10.1056/NEJMe1906559; Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a; Herati RS, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a031583; Hildreth J, 2007, ANAL BIOANAL CHEM, V389, P13, DOI 10.1007/s00216-007-1405-x; Hintze KJ, 2014, GUT MICROBES, V5, P183, DOI 10.4161/gmic.28403; Ho L, 2019, J NUTR BIOCHEM, V64, P170, DOI 10.1016/j.jnutbio.2018.10.019; Hoomans T, 2012, VALUE HEALTH, V15, pA2, DOI 10.1016/j.jval.2012.03.014; Hopp C, 2015, HERBALGRAM, V107, P44; Hubbard Troy D, 2019, Appl In Vitro Toxicol, V5, P10, DOI 10.1089/aivt.2018.0020; Ingolfsson HI, 2014, ACS CHEM BIOL, V9, P1788, DOI 10.1021/cb500086e; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Jafari M, 2015, REJUV RES, V18, P573, DOI 10.1089/rej.2015.1774; Jafari M, 2010, FLY, V4, P253, DOI 10.4161/fly.4.3.11997; Jayasekera J, 2018, JNCI-J NATL CANCER I, V110, P1360, DOI 10.1093/jnci/djy059; Jia M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00906; Jones HM, 2015, CLIN PHARMACOL THER, V97, P247, DOI 10.1002/cpt.37; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Justice MJ, 2016, DIS MODEL MECH, V9, P101, DOI 10.1242/dmm.024547; Kaelin WG, 2017, NAT REV CANCER, V17, P441, DOI 10.1038/nrc.2017.32; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Karran E, 2014, ANN NEUROL, V76, P185, DOI 10.1002/ana.24188; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kavlock RJ, 2009, RISK ANAL, V29, P485, DOI 10.1111/j.1539-6924.2008.01168.x; Kellogg JJ, 2019, NAT PROD REP, V36, P1196, DOI 10.1039/c8np00065d; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0267-5; Kleerebezem M, 2018, NAT MICROBIOL, V3, P650, DOI 10.1038/s41564-018-0172-0; Klein MA, 1192, J NUTR, V140, p1192S; Klurfeld DM, 2018, AM J PHYSIOL-ENDOC M, V315, pE1087, DOI 10.1152/ajpendo.00058.2018; KNOPF K, 1978, J NUTR, V108, P773, DOI 10.1093/jn/108.5.773; Korach-Rechtman H, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00826-19; Kroeger CM, 2018, AM J CLIN NUTR, V107, P484, DOI 10.1093/ajcn/nqx067; Labachyan KE, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0239-8; Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8; Li WW, 2018, J AGR FOOD CHEM, V66, P11468, DOI 10.1021/acs.jafc.8b04770; Li X, 2018, LAB CHIP, V18, P2614, DOI 10.1039/c8lc00418h; Liang X, 2015, P NATL ACAD SCI USA, V112, P10479, DOI 10.1073/pnas.1501305112; Lithgow GJ, 2017, NATURE, V548, P387, DOI 10.1038/548387a; Litichevskiy L, 2018, CELL SYST, V6, P424, DOI 10.1016/j.cels.2018.03.012; Lopez T, 2014, J MED FOOD, V17, P1314, DOI 10.1089/jmf.2013.0190; Low LA, 2017, LAB CHIP, V17, P3026, DOI 10.1039/c7lc00462a; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Masopust D, 2017, J IMMUNOL, V199, P383, DOI 10.4049/jimmunol.1700453; McBurney MI, 2019, J NUTR, V149, P1880, DOI 10.1093/jn/nxz154; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; McManis C. R, 1998, WASH U LQ, V76, P255; Mebane CA, 2019, INTEGR ENVIRON ASSES, V15, P320, DOI 10.1002/ieam.4119; Meltzer DO, 2011, MED DECIS MAKING, V31, pE1, DOI 10.1177/0272989X11412975; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Milanowski DJ, 2002, J NAT PROD, V65, P814, DOI 10.1021/np000270v; Miller J, 2011, PSYCHOL METHODS, V16, P337, DOI 10.1037/a0023347; Minekus M, 1995, ALTERN ANIM; Mirza RD, 2018, JAMA INTERN MED, V178, P1378, DOI 10.1001/jamainternmed.2018.3979; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; Morgan SJ, 2013, TOXICOL PATHOL, V41, P508, DOI 10.1177/0192623312457273; Munafo MR, 2018, NATURE, V553, P399, DOI 10.1038/d41586-018-01023-3; Munyangi J, 2019, PHYTOMEDICINE, V57, P49, DOI 10.1016/j.phymed.2018.12.002; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Narayanapillai SC, 2014, CHEM RES TOXICOL, V27, P1871, DOI 10.1021/tx5003194; National Academies of Sciences Engineering and Medicine (NASEM)., 2019, REPRODUCIBILITY REPL, DOI [10.17226/25303, DOI 10.17226/25303]; National Center for Complementary and Integrative Health, NCCIH POL NAT PROD I; National Center for Complementary and Integrative Health, 2012, DAT SAF MON NCCIH FU; National Institutes of Health, ENH REPR RIG TRANSP; Neal JT, 2018, CELL, V175, P1972, DOI 10.1016/j.cell.2018.11.021; Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407; Neilson AP, 2011, ANNU REV FOOD SCI T, V2, P125, DOI 10.1146/annurev-food-022510-133725; Nelson KM, 2017, J MED CHEM, V60, P1620, DOI 10.1021/acs.jmedchem.6b00975; Novotny JA, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700043; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Ochoa JL, 2015, J NAT PROD, V78, P2242, DOI 10.1021/acs.jnatprod.5b00455; Ortiz D, 2016, J AGR FOOD CHEM, V64, P2727, DOI 10.1021/acs.jafc.5b05698; Peng YS, 2015, J ASIAN NAT PROD RES, V17, P89, DOI 10.1080/10286020.2014.960856; Perry NB, 1999, J AGR FOOD CHEM, V47, P2048, DOI 10.1021/jf981170m; Piper MDW, 2017, CELL METAB, V25, P1206, DOI 10.1016/j.cmet.2017.04.020; Plesser HE, 2018, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00076; Potts MB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004657; Preston RA, 2000, ARCH INTERN MED, V160, P1449, DOI 10.1001/archinte.160.10.1449; Ramaiahgari SC, 2019, TOXICOL SCI, V169, P553, DOI 10.1093/toxsci/kfz065; Ramaiahgari SC, 2017, TOXICOL SCI, V160, P189, DOI 10.1093/toxsci/kfx194; Redan BW, 2016, ADV NUTR, V7, P1090, DOI 10.3945/an.116.013029; Rider CV, 2018, CLIN PHARMACOL THER, V104, P429, DOI 10.1002/cpt.1088; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Ruben MD, 2019, SCIENCE, V365, P547, DOI 10.1126/science.aax7621; Salinero AE, 2018, INT J OBESITY, V42, P1088, DOI 10.1038/s41366-018-0023-3; Scargle J. D., 2000, J SCI EXPLORATION, V14, P91; Schinkovitz A, 2008, J NAT PROD, V71, P1604, DOI 10.1021/np800137n; Schmidt CW, 2015, ENVIRON HEALTH PERSP, V123, pA64, DOI 10.1289/ehp.123-A64; Schneider C, 2015, J AGR FOOD CHEM, V63, P7606, DOI 10.1021/acs.jafc.5b00244; Schriner SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063886; Schriner SE, 2009, FREE RADICAL RES, V43, P836, DOI 10.1080/10715760903089724; Selvaraj V, 2004, BIOL REPROD, V71, P966, DOI 10.1095/biolreprod.104.029512; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sertkaya A, 2016, CLIN TRIALS, V13, P117, DOI 10.1177/1740774515625964; Setchell KDR, 2005, AM J CLIN NUTR, V81, P1072; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Shen L, 2011, HEPATOLOGY, V53, P2139, DOI 10.1002/hep.24296; Sheng BB, 2019, ORG LETT, V21, P6295, DOI 10.1021/acs.orglett.9b02172; Shulman LP, 2011, FITOTERAPIA, V82, P88, DOI 10.1016/j.fitote.2010.10.013; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Simmler C, 2018, FITOTERAPIA, V129, P401, DOI 10.1016/j.fitote.2017.11.017; Simmler C, 2014, PHYTOCHEM ANALYSIS, V25, P378, DOI 10.1002/pca.2472; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988; Sipes NS, 2017, ENVIRON SCI TECHNOL, V51, P10786, DOI 10.1021/acs.est.7b00650; Sittampalam G.S., 2004, ASSAY GUIDANCE MANUA; Skardal A, 2016, DRUG DISCOV TODAY, V21, P1399, DOI 10.1016/j.drudis.2016.07.003; Smith AJ, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k760; Sorger P. K., 2011, QUANTITATIVE SYSTEMS; Sorkin BC, 2016, ADV NUTR, V7, P383, DOI 10.3945/an.115.010595; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stanley TD, 2014, RES SYNTH METHODS, V5, P60, DOI 10.1002/jrsm.1095; Stern AM, 2016, J BIOMOL SCREEN, V21, P521, DOI 10.1177/1087057116635818; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; TALAN M, 1984, EXP GERONTOL, V19, P25, DOI 10.1016/0531-5565(84)90028-7; Thomas RS, 2019, TOXICOL SCI, V169, P317, DOI 10.1093/toxsci/kfz058; Thomas RS, 2018, ALTEX-ALTERN ANIM EX, V35, P163, DOI 10.14573/altex.1803011; Tu HB, 2017, EBIOMEDICINE, V23, P125, DOI 10.1016/j.ebiom.2017.08.017; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Tuttle AH, 2018, NAT METHODS, V15, P994, DOI 10.1038/s41592-018-0224-7; Tuveson D, 2019, SCIENCE, V364, P952, DOI 10.1126/science.aaw6985; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; US Food and Drug Administration, 2017, CONS DEM INT REF PRO; Vaden RM, 2017, MAR DRUGS, V15, DOI 10.3390/md15030075; Velazquez EM, 2019, NAT MICROBIOL, V4, P1057, DOI 10.1038/s41564-019-0407-8; Vernetti L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42296; Vernetti LA, 2017, CLIN LIVER DIS, V21, P197, DOI 10.1016/j.cld.2016.08.013; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Waidyanatha S, 2018, FOOD CHEM TOXICOL, V121, P194, DOI 10.1016/j.fct.2018.08.062; Wambaugh JF, 2018, TOXICOL SCI, V163, P152, DOI 10.1093/toxsci/kfy020; Wang J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02794-5; Wang ZC, 2018, BIOINFORMATICS, V34, P2150, DOI 10.1093/bioinformatics/bty060; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Williams S., 2019, SCI MAGAZINE    0715; WIRED Staff, 2009, PLAC AR GETT MOR EFF; Wood AC, 2019, JAMA PEDIATR, V173, P311, DOI 10.1001/jamapediatrics.2019.0015; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062; Yoshihara M, 2018, J NEUROGENET, V32, P53, DOI 10.1080/01677063.2018.1468443; Zarin DA, 2019, JAMA-J AM MED ASSOC, V322, P813, DOI 10.1001/jama.2019.9892; Zeisel SH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00200; Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3; Zschaler J, 2014, CRIT REV IMMUNOL, V34, P433	233	26	26	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					41	65		10.1096/fj.201902143R	http://dx.doi.org/10.1096/fj.201902143R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914647	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000507308900005
J	Titone, R; Robertson, DM				Titone, Rossella; Robertson, Danielle M.			Insulin receptor preserves mitochondrial function by binding VDAC1 in insulin insensitive mucosal epithelial cells	FASEB JOURNAL			English	Article						bronchial epithelial cells; corneal epithelial cells; insulin; mitochondria; receptor tyrosine kinases; VDAC1	LOCALIZED EGFR; CYTOCHROME-C; GSK-3-BETA; MITOPHAGY; KINASE; GROWTH; ROLES; HEXOKINASE; RESISTANCE; REDUCTION	Unlike many epithelial tissues, the corneal epithelium is insulin insensitive, meaning it does not require insulin for glucose uptake. In this study, we show that insulin differentially regulates mitochondrial respiration in two human mucosal epithelial cell types: insulin-insensitive corneal epithelial cells and insulin-sensitive bronchial epithelial cells. In both cell types, insulin blocks glycogen synthase kinase beta (GSK3 beta) activity. In the corneal epithelium however, insulin selectively regulates PTEN-induced kinase 1 (PINK-1)-mediated mitophagy and mitochondrial accumulation of insulin receptor (INSR). While insulin blocked basal levels of PINK-1-mediated mitophagy in bronchial epithelial cells, mitochondrial trafficking of INSR was not detectable. We further show that in corneal epithelia, INSR interacts with the voltage-dependent anion channel-1 (VDAC1) in mitochondria and that INSR knockdown triggers robust mitochondrial fragmentation, alterations in mitochondrial polarization, and blocks the induction of PINK-1-mediated mitophagy. Collectively, these data demonstrate that INSR interacts with VDAC1 to mediate mitochondrial stability. We also demonstrate unique interactions between VDAC1 and other receptor tyrosine kinases, indicating a novel role for this family of receptors in mitochondria.	[Titone, Rossella; Robertson, Danielle M.] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Robertson, DM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Danielle.Robertson@UTSouthwestern.edu		Titone, Rossella/0000-0002-1528-331X	HHS | NIH | National Eye Institute (NEI) [EY024546, EY029258, EY030413]; Research to Prevent Blindness (RPB); Fight for Sight (FFS)	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Fight for Sight (FFS)	Funding information HHS | NIH | National Eye Institute (NEI), Grant/Award Number: EY024546, EY029258 and EY030413; Research to Prevent Blindness (RPB), Grant/Award Number: unrestricted grant; Fight for Sight (FFS)	Beutner G, 1998, BBA-BIOMEMBRANES, V1368, P7, DOI 10.1016/S0005-2736(97)00175-2; Che TF, 2015, ONCOTARGET, V6, P37349, DOI 10.18632/oncotarget.5736; Cunha DA, 2005, AM J PHYSIOL-ENDOC M, V289, pE768, DOI 10.1152/ajpendo.00469.2004; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Elrod JW, 2018, CURR OPIN PHYSIOL, V3, pIV, DOI 10.1016/j.cophys.2018.05.001; FRIEND J, 1980, INVEST OPHTH VIS SCI, V19, P913; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; Henriksen EJ, 2010, CURR DIABETES REV, V6, P285, DOI 10.2174/157339910793360888; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Kim I, 2011, AM J PHYSIOL-CELL PH, V300, pC308, DOI 10.1152/ajpcell.00056.2010; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Li HS, 2017, CELL SIGNAL, V35, P223, DOI 10.1016/j.cellsig.2017.04.012; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Lyons A, 2017, J BIOL CHEM, V292, P16983, DOI 10.1074/jbc.M117.792838; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Molina SA, 2017, AM J PHYSIOL-LUNG C, V312, P1688, DOI 10.1152/ajplung.00364.2016; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rocha EM, 2002, INVEST OPHTH VIS SCI, V43, P963; Rocha EM, 2000, CURR EYE RES, V21, P833, DOI 10.1076/ceyr.21.5.833.5535; Shanley LJ, 2004, INVEST OPHTH VIS SCI, V45, P1088, DOI 10.1167/iovs.03-1064; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Takenaka T, 2017, ANTICANCER RES, V37, P4779, DOI 10.21873/anticanres.11884; Titone R, 2019, J CELL PHYSIOL, V234, P1426, DOI 10.1002/jcp.26948; Titone R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21031-7; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Vyssokikh M, 2004, BBA-MOL CELL RES, V1644, P27, DOI 10.1016/j.bbamcr.2003.10.007; Wang TH, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.62; Wu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042483; Yang K, 2017, CELL PHYSIOL BIOCHEM, V44, P1445, DOI 10.1159/000485580; Yao YA, 2010, ACTA BIOCH BIOPH SIN, V42, P763, DOI 10.1093/abbs/gmq090; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8402, DOI 10.1002/jcp.27754; Yue XJ, 2008, AUTOPHAGY, V4, P641, DOI 10.4161/auto.5971; Zagon IS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1082, DOI 10.1001/archopht.125.8.1082; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang Y, 2018, BEHAV BRAIN RES, V339, P57, DOI 10.1016/j.bbr.2017.11.015	41	8	8	2	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					754	775		10.1096/fj.201901316RR	http://dx.doi.org/10.1096/fj.201901316RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914671	Green Accepted			2022-12-28	WOS:000507308900052
J	Yan, SX; Wang, YL; Zhang, YJ; Wang, L; Zhao, XF; Du, CL; Gao, P; Yan, F; Liu, FW; Gong, XL; Guan, Y; Cui, XY; Wang, XM; Zhang, CX				Yan, Shuxin; Wang, Yalong; Zhang, Yujia; Wang, Le; Zhao, Xiaofang; Du, Cuilian; Gao, Pei; Yan, Feng; Liu, Fengwei; Gong, Xiaoli; Guan, Yuan; Cui, Xiuyu; Wang, Xiaomin; Zhang, Claire Xi			Synaptotagmin-11 regulates the functions of caveolae and responds to mechanical stimuli in astrocytes	FASEB JOURNAL			English	Article						astrocyte swelling; endocytosis; hypoosmotic stress; mechanoprotection	PLASMA-MEMBRANE; CAVIN FAMILY; PARKINSONS-DISEASE; CYTOKINE SECRETION; EXPRESSION; GENE; PROTEIN; XI; ENDOCYTOSIS; CELLS	Caveolae play crucial roles in intracellular membrane trafficking and mechanosensation. In this study, we report that synaptotagmin-11 (Syt11), a synaptotagmin isoform associated with Parkinson's disease and schizophrenia, regulates both caveolae-mediated endocytosis and the caveolar response to mechanical stimuli in astrocytes. Syt11-knockout (KO) accelerated caveolae-mediated endocytosis. Interestingly, the caveolar structures on the cell surface were markedly fewer in the absence of Syt11. Caveolar disassembly in response to hypoosmotic stimuli and astrocyte swelling were both impaired in Syt11-KO astrocytes. Live imaging revealed that Syt11 left caveolar structures before cavin1 during hypoosmotic stress and returned earlier than cavin1 after isoosmotic recovery. Chronic hypoosmotic stress led to proteasome-mediated Syt11 degradation. In addition, Syt11-KO increased the turnover of cavin1 and EH domain-containing protein 2 (EHD2), accompanied by compromised membrane integrity, suggesting a mechanoprotective role of Syt11. Direct interactions between Syt11 and cavin1 and EHD2, but not caveolin-1, are found. Altogether, we propose that Syt11 stabilizes caveolar structures on the cell surface of astrocytes and regulates caveolar functions under physiological and pathological conditions through cavin1 and EHD2.	[Yan, Shuxin; Wang, Yalong; Zhang, Yujia; Zhao, Xiaofang; Du, Cuilian; Gao, Pei; Yan, Feng; Liu, Fengwei; Guan, Yuan; Cui, Xiuyu; Wang, Xiaomin; Zhang, Claire Xi] Capital Med Univ, Collaborat Innovat Ctr Brain Disorders, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China; [Wang, Le; Wang, Xiaomin] Capital Med Univ, Beijing Ctr Neural Regenerat & Repair, Beijing Key Lab Parkinson Dis, Dept Neurobiol,Key Lab Neurodegenerat Dis,Minist, Beijing, Peoples R China; [Du, Cuilian] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Clin Neuroimmunol, Munich, Germany; [Du, Cuilian] Ludwig Maximilians Univ Munchen, Biomed Ctr, Munich, Germany; [Gong, Xiaoli; Wang, Xiaomin] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Guan, Yuan] Tsinghua Univ, Hosp 1, Dept Anesthesiol, Huaxin Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University; University of Munich; University of Munich; Capital Medical University; Tsinghua University	Wang, XM; Zhang, CX (corresponding author), Capital Med Univ, Collaborat Innovat Ctr Brain Disorders, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.	xmwang@ccmu.edu.cn; clairexizhang@ccmu.edu.cn		yan, feng/0000-0001-8663-6859	National Natural Science Foundation of China (NSFC) [31471085]; Beijing Natural Science Foundation Program; Scientific Research Key Program of Beijing Municipal Commision of Education [KM201610025014]; Scientific Research Common Program of Beijing Municipal Commission of Education [KM201610025014]; Chaoyang District Science and Technology Plan Project [CYSF-1933]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Program(Beijing Natural Science Foundation); Scientific Research Key Program of Beijing Municipal Commision of Education; Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Chaoyang District Science and Technology Plan Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31471085; Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commision of Education, Grant/Award Number: KZ201510025023; Scientific Research Common Program of Beijing Municipal Commission of Education, Grant/Award Number: KM201610025014; Chaoyang District Science and Technology Plan Project, Grant/Award Number: CYSF-1933	Albinsson S, 2008, AM J PHYSIOL-CELL PH, V294, pC271, DOI 10.1152/ajpcell.00297.2007; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bento CF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11803; Cameron PL, 1997, J NEUROSCI, V17, P9520; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Du CL, 2017, GLIA, V65, P1656, DOI 10.1002/glia.23186; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Duque GA, 2014, J IMMUNOL, V193, P2363, DOI 10.4049/jimmunol.1303043; Duque GA, 2013, J IMMUNOL, V190, P1737, DOI 10.4049/jimmunol.1202500; Galbiati F, 1998, P NATL ACAD SCI USA, V95, P10257, DOI 10.1073/pnas.95.17.10257; Gorg B, 2010, GLIA, V58, P691, DOI 10.1002/glia.20955; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hoernke M, 2017, P NATL ACAD SCI USA, V114, pE4360, DOI 10.1073/pnas.1614066114; Hsiao IL, 2017, ENVIRON TOXICOL, V32, P1742, DOI 10.1002/tox.22397; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Inoue S, 2007, AM J MED GENET B, V144B, P332, DOI 10.1002/ajmg.b.30465; Kim KS, 2013, HUM MOL GENET, V22, P4805, DOI 10.1093/hmg/ddt332; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lafrenaye AD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020330; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lamaze C, 2017, CURR OPIN CELL BIOL, V47, P117, DOI 10.1016/j.ceb.2017.02.014; Lisjak M, 2017, J NEUROSCI, V37, P10748, DOI 10.1523/JNEUROSCI.0776-17.2017; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Marks DL, 2005, METHODS, V36, P186, DOI 10.1016/j.ymeth.2004.12.001; MASSA PT, 1982, AM J ANAT, V165, P69, DOI 10.1002/aja.1001650107; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Minetti C, 2002, AM J PATHOL, V160, P265, DOI 10.1016/S0002-9440(10)64370-2; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Mittelsteadt T, 2009, J COMP NEUROL, V512, P514, DOI 10.1002/cne.21908; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nassar ZD, 2015, INT REV CEL MOL BIO, V320, P235, DOI 10.1016/bs.ircmb.2015.07.009; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Niesman IR, 2013, MOL CELL NEUROSCI, V56, P283, DOI 10.1016/j.mcn.2013.07.002; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Pangrsic T, 2006, J NEUROCHEM, V99, P514, DOI 10.1111/j.1471-4159.2006.04042.x; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Parton RG, 2018, ANNU REV CELL DEV BI, V34, P111, DOI 10.1146/annurev-cellbio-100617-062737; Parton RG, 2018, CURR BIOL, V28, pR402, DOI 10.1016/j.cub.2017.11.075; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pihlstrom L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.019; Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Rewatkar PV, 2015, ADV DRUG DELIVER REV, V91, P92, DOI 10.1016/j.addr.2015.01.003; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Sesar A, 2016, J NEUROL SCI, V362, P321, DOI 10.1016/j.jns.2016.02.014; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Shimojo M, 2019, GENE DEV, V33, P365, DOI 10.1101/gad.320077.118; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sreetama SC, 2016, CELL DEATH DIFFER, V23, P596, DOI 10.1038/cdd.2015.124; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Torrino S, 2018, J CELL BIOL, V217, P4092, DOI 10.1083/jcb.201801122; Volynski KE, 2018, CURR OPIN NEUROBIOL, V51, P154, DOI 10.1016/j.conb.2018.05.006; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Wang CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02593-y; Wang CH, 2016, EMBO REP, V17, P47, DOI 10.15252/embr.201540689; Yeow I, 2017, CURR BIOL, V27, P2951, DOI 10.1016/j.cub.2017.07.047; Yokota H, 2003, DNA RES, V10, P287, DOI 10.1093/dnares/10.6.287; Zschocke J, 2002, J BIOL CHEM, V277, P38772, DOI 10.1074/jbc.M205664200	69	6	7	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2609	2624		10.1096/fj.201901715R	http://dx.doi.org/10.1096/fj.201901715R		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908017				2022-12-28	WOS:000503756600001
J	Conaway, HH; Henning, P; Lie, A; Tuckermann, J; Lerner, UH				Conaway, H. Herschel; Henning, Petra; Lie, Antia; Tuckermann, Jan; Lerner, Ulf H.			Glucocorticoids employ the monomeric glucocorticoid receptor to potentiate vitamin D-3 and parathyroid hormone-induced osteoclastogenesis	FASEB JOURNAL			English	Article						osteoporosis; bone resorption; calcium-regulating hormones; osteoclasts	INDUCED BONE LOSS; NF-KAPPA-B; INDUCED OSTEOPOROSIS; OSTEOPROTEGERIN LIGAND; VERTEBRAL FRACTURE; RANKL; DIFFERENTIATION; RESORPTION; INHIBITION; APOPTOSIS	Glucocorticoid (GC) therapy decreases bone mass and increases the risk of fractures. We investigated interactions between the GC dexamethasone (DEX) and the bone resorptive agents 1,25(OH)(2)-vitamin D-3 (D3) and parathyroid hormone (PTH) on osteodastogenesis. We observed a synergistic potentiation of osteoclast progenitor cell differentiation and formation of osteoclasts when DEX was added to either D3- or PTH-treated mouse bone marrow cell (BMC) cultures. Cotreatment of DEX with D3 or PTH increased gene encoding calcitonin receptor (Calcr), acid phosphatase 5, tartrate resistant (Acp5), cathepsin K (Ctsk), and TNF superfamily member 11 (Tnfsf11) mRNA, receptor activator of NF-kappa B ligand protein (RANKL), numbers of osteoclasts on plastic, and pit formation and release of C-terminal fragment of type I collagen from cells cultured on bone slices. Enhanced RANKL protein expression caused by D3 and DEX was absent in BMC from mice in which the GC receptor (GR) was deleted in stromal cells/osteoblasts. Synergistic interactions between DEX and D3 on RANKL and osteodast formation were present in BMC from mice with attenuated GR dimerization. These data demonstrate that the GR cooperates with D3 and PTH signaling, causing massive osteoclastogenesis, which may explain the rapid bone loss observed with high dosages of GC treatment.	[Conaway, H. Herschel] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Henning, Petra; Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Vita Straket 11, S-41345 Gothenburg, Sweden; [Lie, Antia] Umea Univ, Dept Mol Periodontol, Umea, Sweden; [Tuckermann, Jan] Univ Ulm, Inst Comparat Mol Endocrinol, Ulm, Germany	University of Arkansas System; University of Arkansas Medical Sciences; University of Gothenburg; Umea University; Ulm University	Lerner, UH (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Vita Straket 11, S-41345 Gothenburg, Sweden.	ulf.lerner@gu.se		Henning, Petra/0000-0002-9330-6265; Lerner, Ulf/0000-0002-3579-1960	Swedish Research Council; Swedish government; Medical Training and Research Agreement (ALF) [237551]; Lundberg Foundation; Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V; County Council of Vasterbotten; Funds of the German Research Council (DFG) [CRC 1149]; Swedish county councils	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish government; Medical Training and Research Agreement (ALF); Lundberg Foundation(European Commission); Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V; County Council of Vasterbotten; Funds of the German Research Council (DFG)(German Research Foundation (DFG)); Swedish county councils	The authors are grateful for the skillful technical assistance by Dr. Christina Drevinge (Sahlgrenska Academy, University of Gothenburg), Inger Lundgren (Umea University), and Anna Westerlund (Sahlgrenska Academy, University of Gothenburg). This study was supported by the Swedish Research Council, the Swedish state under the agreement between the Swedish government and the county councils, the Medical Training and Research Agreement (ALF; 237551), the Lundberg Foundation, the Swedish Rheumatism Association, the Royal 80 Year Fund of King Gustav V, and the County Council of Vasterbotten. Funds of the German Research Council (DFG) were awarded to J.T. in the frame of the CRC 1149. The authors declare no conflicts of interest.	Angeli A, 2006, BONE, V39, P253, DOI 10.1016/j.bone.2006.02.005; Brandstrom H, 2001, BIOCHEM BIOPH RES CO, V280, P831, DOI 10.1006/bbrc.2000.4223; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; Carbonare LD, 2001, J BONE MINER RES, V16, P97, DOI 10.1359/jbmr.2001.16.1.97; Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K; Conaway HH, 2016, BONE, V93, P43, DOI 10.1016/j.bone.2016.08.024; Conaway HH, 2011, J BIOL CHEM, V286, P31425, DOI 10.1074/jbc.M111.247734; Conaway HH, 1997, J ENDOCRINOL, V155, P513, DOI 10.1677/joe.0.1550513; Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137; Frenkel B, 2015, ADV EXP MED BIOL, V872, P179, DOI 10.1007/978-1-4939-2895-8_8; Frijters R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-359; Geusens PP, 2006, ARTHRITIS RHEUM-US, V54, P1772, DOI 10.1002/art.21896; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382; Hofbauer LC, 2009, ARTHRITIS RHEUM, V60, P1427, DOI 10.1002/art.24445; Humphrey EL, 2006, BONE, V38, P652, DOI 10.1016/j.bone.2005.10.004; Jensen PR, 2015, BONE, V73, P16, DOI 10.1016/j.bone.2014.12.004; Jia D, 2006, ENDOCRINOLOGY, V147, P5592, DOI 10.1210/en.2006-0459; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kitazawa R, 1999, BBA-GENE STRUCT EXPR, V1445, P134, DOI 10.1016/S0167-4781(99)00032-9; Kitazawa R, 2002, BIOCHEM BIOPH RES CO, V290, P650, DOI 10.1006/bbrc.2001.6251; LAAN RFJM, 1993, CALCIFIED TISSUE INT, V52, P5, DOI 10.1007/BF00675619; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Maresova KB, 2013, CALCIFIED TISSUE INT, V92, P354, DOI 10.1007/s00223-012-9684-4; Mazziotti G, 2006, TRENDS ENDOCRIN MET, V17, P144, DOI 10.1016/j.tem.2006.03.009; Moutsatsou P, 2012, TRENDS MOL MED, V18, P348, DOI 10.1016/j.molmed.2012.04.005; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Nevius E, 2015, J EXP MED, V212, P1931, DOI 10.1084/jem.20150088; Nile CJ, 2013, J CLIN PERIODONTOL, V40, P875, DOI 10.1111/jcpe.12134; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Okamoto K, 2017, PHYSIOL REV, V97, P1295, DOI 10.1152/physrev.00036.2016; Palmqvist P, 2006, J BIOL CHEM, V281, P2414, DOI 10.1074/jbc.M510160200; PHILIBERT D, 1991, FRONT HORM RES, V19, P1; Plotkin LI, 2011, BONE, V49, P122, DOI 10.1016/j.bone.2010.08.011; Pluijm SMF, 2009, J BONE MINER RES, V24, P768, DOI [10.1359/JBMR.081244, 10.1359/jbmr.081244]; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Sato AY, 2018, CLIN REV BONE MINER, V16, P33, DOI 10.1007/s12018-018-9242-3; Sivagurunathan S, 2005, J BONE MINER RES, V20, P390, DOI 10.1359/JBMR.041233; Soe K, 2010, J BONE MINER RES, V25, P2184, DOI 10.1002/jbmr.113; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Swanson C, 2006, ENDOCRINOLOGY, V147, P3613, DOI 10.1210/en.2005-0717; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Van Staa TP, 2003, ARTHRITIS RHEUM, V48, P3224, DOI 10.1002/art.11283; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; Vidal NOA, 1998, J ENDOCRINOL, V159, P191, DOI 10.1677/joe.0.1590191; Wallach S, 2000, CALCIFIED TISSUE INT, V67, P277, DOI 10.1007/s002230001146; Weinstein RS, 2002, J CLIN INVEST, V109, P1041, DOI 10.1172/JCI200214538; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Xiong JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05244-y; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	55	5	5	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14394	14409		10.1096/fj.201802729RRR	http://dx.doi.org/10.1096/fj.201802729RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31675485	Green Published, hybrid			2022-12-28	WOS:000507466100103
J	Veech, RL; King, MT; Pawlosky, R; Bradshaw, PC; Curtis, W				Veech, Richard L.; King, M. Todd; Pawlosky, Robert; Bradshaw, Patrick C.; Curtis, William			Relationship between inorganic ion distribution, resting membrane potential, and the Delta G ' of ATP hydrolysis: a new paradigm	FASEB JOURNAL			English	Review						Gibbs-Donnan equilibrium; sodium-potassium ATPase; free energy; thermodynamics of ion transport; intravenous fluid therapies	NERVE; CELLS; LIVER	Cell membrane potential and inorganic ion distributions are currently viewed from a kinetic electric paradigm, which ignores thermodynamics. The resting membrane potential is viewed as a diffusion potential. The 9 major inorganic ions found in blood plasma (Ca2+, Na+, Mg2+, H+, Cl-, HCO3-, H2PO4-, and HPO42-) are distributed unequally across the plasma membrane. This unequal distribution requires the energy of ATP hydrolysis through the action of the Na+-K+ ATPase. The cell resting membrane potential in each of 3 different tissues with widely different resting membrane potentials has been shown to be equal to the Nernst equilibrium potential of the most permeant inorganic ion. The energy of the measured distribution of the 9 major inorganic ions between extra- and intracellular phases was essentially equal to the independently measured energy of ATP hydrolysis, showing that the distribution of these 9 major ions was in near-equilibrium with the Delta G ' of ATP. Therefore, thermodynamics does appear to play an essential role in the determination of the cell resting membrane potential and the inorganic ion distribution across the plasma membrane.	[Veech, Richard L.; King, M. Todd; Pawlosky, Robert] NIAAA, Lab Metab Control, NIH, 5625 Fishers Ln,Bldg 5625FL Room 2S-28, Rockville, MD 20852 USA; [Bradshaw, Patrick C.; Curtis, William] East Tennessee State Univ, Coll Med, Dept Biomed Sci, Johnson City, TN USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); East Tennessee State University	Veech, RL (corresponding author), NIAAA, Lab Metab Control, NIH, 5625 Fishers Ln,Bldg 5625FL Room 2S-28, Rockville, MD 20852 USA.	rveech@mail.nih.gov	Bradshaw, Patrick C./AAR-9189-2020	Bradshaw, Patrick C./0000-0002-4591-6798; Curtis, William/0000-0002-9434-2794				Alvarez O, 2017, J GEN PHYSIOL, V149, P911, DOI 10.1085/jgp.201711839; Donnan FG, 1924, CHEM REV, V1, P73, DOI 10.1021/cr60001a003; Gibbs J. W., 1876, T CONNECTICUT ACADEM, V3, P108, DOI DOI 10.2475/AJS.S3-16.96.441; HODGKIN AL, 1951, BIOL REV, V26, P339, DOI 10.1111/j.1469-185X.1951.tb01204.x; Hodgkin AL, 1939, NATURE, V144, P710, DOI 10.1038/144710a0; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; KLEBER AG, 1983, CIRC RES, V52, P442, DOI 10.1161/01.RES.52.4.442; Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33; MASUDA T, 1990, J BIOL CHEM, V265, P20321; MURPHY WP, 1952, J LAB CLIN MED, V40, P436; Nernst W., 1888, Z F PHYS CHEM, V2U, P613, DOI 10.1515/zpch- 1888-0274.; SKOU JC, 1965, PHYSIOL REV, V45, P596, DOI 10.1152/physrev.1965.45.3.596; Veech RL, 2019, IUBMB LIFE, V71, P565, DOI 10.1002/iub.1997; VEECH RL, 1986, AM J CLIN NUTR, V44, P519, DOI 10.1093/ajcn/44.4.519; Veech RL, 1995, INTEGR PHYS BEH SCI, V30, P283, DOI 10.1007/BF02691602; Veech RL, 2002, IUBMB LIFE, V54, P241, DOI 10.1080/15216540215678; VEECH RL, 1994, ALCOHOL CLIN EXP RES, V18, P1040, DOI 10.1111/j.1530-0277.1994.tb00081.x; VEECH RL, 1979, J BIOL CHEM, V254, P6538; WONDERGEM R, 1980, J CELL PHYSIOL, V102, P193, DOI 10.1002/jcp.1041020210	19	5	5	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13126	13130		10.1096/fj.201901942R	http://dx.doi.org/10.1096/fj.201901942R			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690124	Bronze, Green Published			2022-12-28	WOS:000507466100008
J	Wang, YJ; Wei, SM; Song, HH; Zhang, XJ; Wang, WJ; Du, N; Song, TC; Liang, H; Chen, XJ; Wang, YJ				Wang, Yingjie; Wei, Sumei; Song, Honghua; Zhang, Xuejie; Wang, Wenjuan; Du, Nan; Song, Tiancheng; Liang, Hao; Chen, Xiaojun; Wang, Yongjun			Macrophage migration inhibitory factor derived from spinal cord is involved in activation of macrophages following gecko tail amputation	FASEB JOURNAL			English	Article						MIF; nerve; regeneration; immune cells; reptile	FACTOR MIF; CELL-MIGRATION; REGENERATION; EXPRESSION; CYTOKINE; PATHWAY; PROTEIN; REPAIR; VITRO; CD44	Macrophages and their initiation of acute inflammation have been defined to be functionally important in tissue repair and regeneration. In injury-induced production of macrophage migration inhibitory factor (MIF), which has been described as a pleiotropic protein that participates in multiple cellular and biologic processes, it is unknown whether it is involved in the regulation of macrophage events during the epimorphic regeneration. In the model of gecko tail amputation, the protein levels of gecko MIF (gMIF) have been determined to be significantly increased in the nerve cells of the spinal cord in association with the recruitment of macrophages to the lesion site. gMIF has been shown to interact with the CD74 receptor to promote the migration of macrophages through activation of Ras homolog gene family member A and to trigger inflammatory responses through MAPK signaling pathways. The determination of microsphere phagocytosis also indicated that gMIF could enhance macrophage phagocytosis. gMIF-mediated recruitment and activation of macrophages have been found to be necessary for gecko tail regeneration, as evidenced by the depletion of macrophages using clodronate liposomes. The results present a novel function of MIF during the epimorphic regeneration, which is beneficial for insights into its pleiotropic property.	[Wang, Yingjie; Wei, Sumei; Song, Honghua; Zhang, Xuejie; Wang, Wenjuan; Du, Nan; Song, Tiancheng; Liang, Hao; Chen, Xiaojun; Wang, Yongjun] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu & Minist Educ, 19 Qixiu Rd, Nantong 226001, Peoples R China	Nantong University	Wang, YJ (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu & Minist Educ, 19 Qixiu Rd, Nantong 226001, Peoples R China.	wyjbs@ntu.edu.cn		Wang, Yongjun/0000-0001-5040-8926	National Natural Science Foundation of China [31471011, 31871211, 31640042, 31702022]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the National Natural Science Foundation of China (31471011, 31871211, 31640042, and 31702022) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors declare no conflicts of interest.	Alibardi L, 2014, PROG HISTOCHEM CYTO, V48, P143, DOI 10.1016/j.proghi.2013.12.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Burland T G, 2000, Methods Mol Biol, V132, P71; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chalimoniuk M, 2006, NEUROSCIENCE, V139, P1117, DOI 10.1016/j.neuroscience.2005.12.056; Chazaud B, 2014, IMMUNOBIOLOGY, V219, P172, DOI 10.1016/j.imbio.2013.09.001; Crichlow GV, 2009, BIOCHEMISTRY-US, V48, P132, DOI 10.1021/bi8014423; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Dong YY, 2013, J BIOL CHEM, V288, P18204, DOI 10.1074/jbc.M113.463810; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470; Harrison RA, 2009, BIOCHEM BIOPH RES CO, V390, P171, DOI 10.1016/j.bbrc.2009.09.112; Heit Bryan, 2003, Sci STKE, V2003, pPL5, DOI 10.1126/stke.2003.170.pl5; Koda M, 2004, ACTA NEUROPATHOL, V108, P31, DOI 10.1007/s00401-004-0853-z; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Leyton-Jaimes MF, 2018, EXP NEUROL, V301, P83, DOI 10.1016/j.expneurol.2017.06.021; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10033; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Lue HQ, 2011, CELL SIGNAL, V23, P135, DOI 10.1016/j.cellsig.2010.08.013; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Nguyen-Chi M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0751-2; Nguyen-Chi M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.374; Nishio Y, 2009, ACTA NEUROPATHOL, V117, P321, DOI 10.1007/s00401-008-0476-x; Ogata A, 1998, NEUROSCI LETT, V246, P173, DOI 10.1016/S0304-3940(98)00203-1; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Schrans-Stassen BHGJ, 2005, ANTIOXID REDOX SIGN, V7, P1211, DOI 10.1089/ars.2005.7.1211; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Simkin J, 2017, DEVELOPMENT, V144, P3907, DOI 10.1242/dev.150086; Simkin J, 2017, ELIFE, V6, DOI 10.7554/eLife.24623; Slack JMW, 2017, EMBO REP, V18, P1497, DOI 10.15252/embr.201643795; Su HT, 2017, INFLAMM RES, V66, P209, DOI 10.1007/s00011-016-0995-1; Wang YJ, 2012, INT J BIOCHEM CELL B, V44, P2288, DOI 10.1016/j.biocel.2012.09.011; Yoo SA, 2016, P NATL ACAD SCI USA, V113, pE7917, DOI 10.1073/pnas.1612717113; Yun MH, 2015, ELIFE, V4, DOI 10.7554/eLife.05505; Zhang S, 2014, FASEB J, V28, P4394, DOI 10.1096/fj.14-253625	47	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14798	14810		10.1096/fj.201801966RRR	http://dx.doi.org/10.1096/fj.201801966RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689136	Bronze			2022-12-28	WOS:000507466100133
J	Han, SJ; Lovaszi, M; Kim, M; D'Agati, V; Hasko, G; Lee, HT				Han, Sang Jun; Lovaszi, Marianna; Kim, Mihwa; D'Agati, Vivette; Hasko, Gyorgy; Lee, H. Thomas			P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling	FASEB JOURNAL			English	Article						apoptosis; inflammasome; inflammation; ischemia and reperfusion injury; necrosis; neutrophil	ACUTE KIDNEY INJURY; A2B ADENOSINE RECEPTOR; REPERFUSION INJURY; SPHINGOSINE KINASE; HEPATIC-INJURY; KNOCKOUT MICE; PROTECTS; HYPOXIA; ACTIVATION; METABOLISM	We tested the hypothesis that the P2X4 purinergic receptor (P2X4) exacerbates ischemic acute kidney injury (AKI) by promoting renal tubular inflammation after ischemia and reperfusion (IR). Supporting this, P2X4-deficient (KO) mice were protected against ischemic AKI with significantly attenuated renal tubular necrosis, inflammation, and apoptosis when compared to P2X4 wild-type (WT) mice subjected to renal IR. Furthermore, WT mice treated with P2X4 allosteric agonist ivermectin had exacerbated renal IR injury whereas P2X4 WT mice treated with a selective P2X4 antagonist (5-BDBD) were protected against ischemic AKI. Mechanistically, induction of kidney NLRP3 inflammasome signaling after renal IR was significantly attenuated in P2X4 KO mice. A P2 agonist ATP gamma S increased NLRP3 inflammasome signaling (NLRP3 and caspase 1 induction and IL-1 beta processing) in isolated renal proximal tubule cells from WT mice whereas these increases were absent in renal proximal tubules isolated from P2X4 KO mice. Moreover, 5-BDBD attenuated ATP gamma S induced NLRP3 inflammasome induction in renal proximal tubules from WT mice. Finally, P2X4 agonist ivermectin induced NLRP3 inflammasome and pro-inflammatory cytokines in cultured human proximal tubule cells. Taken together, our studies suggest that renal proximal tubular P2X4 activation exacerbates ischemic AKI and promotes NLRP3 inflammasome signaling.	[Han, Sang Jun; Lovaszi, Marianna; Kim, Mihwa; Hasko, Gyorgy; Lee, H. Thomas] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY USA; [D'Agati, Vivette] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA	Columbia University; Columbia University	Lee, HT (corresponding author), Columbia Univ, Dept Anesthesiol, Anesthesiol Res Labs, P&S Box 46,PH-5,630 West 168th St, New York, NY 10032 USA.	tl128@columbia.edu			HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK-109544, DK-115694, DK-113790]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [GM-066189]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK-109544, DK-115694 and DK-113790; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM-066189	Antonioli L, 2019, CURR OPIN PHARMACOL, V47, P65, DOI 10.1016/j.coph.2019.02.011; Bakker PJ, 2014, AM J PATHOL, V184, P2013, DOI 10.1016/j.ajpath.2014.04.005; Bauerle JD, 2011, J AM SOC NEPHROL, V22, P14, DOI 10.1681/ASN.2009121217; Burnstock G, 2016, PURINERG SIGNAL, V12, P59, DOI 10.1007/s11302-015-9493-0; Chan AH, 2019, J EXP MED; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; Colgan SP, 2012, ANNU REV PHYSIOL, V74, P153, DOI 10.1146/annurev-physiol-020911-153230; Csoka B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99431; Daemen MARC, 2002, TRANSPLANTATION, V73, P1693; de Caestecker M, 2015, J AM SOC NEPHROL, V26, P2905, DOI 10.1681/ASN.2015070832; Dunton CL, 2018, INT UROL NEPHROL, V50, P1607, DOI 10.1007/s11255-018-1948-0; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Elapavaluru S, 2007, ACTA CLIN BELG, V62, P326, DOI 10.1179/acb.2007.074; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, METH MOL B, V341, P73; Eltzschig HK, 2013, TRENDS MOL MED, V19, P345, DOI 10.1016/j.molmed.2013.02.005; Frangogiannis NG, 2007, THROMB HAEMOSTASIS, V97, P738, DOI 10.1160/TH07-01-0022; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gallos G, 2005, AM J PHYSIOL-RENAL, V289, pF369, DOI 10.1152/ajprenal.00470.2004; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Han SJ, 2019, KIDNEY RES CLIN PRAC, V38, P427, DOI 10.23876/j.krcp.19.062; Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Hung SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070210; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Jacobson KA, 2016, NEUROPHARMACOLOGY, V104, P31, DOI 10.1016/j.neuropharm.2015.12.001; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Joo JD, 2007, AM J PHYSIOL-RENAL, V293, pF1847, DOI 10.1152/ajprenal.00336.2007; Joo JD, 2006, J AM SOC NEPHROL, V17, P3115, DOI 10.1681/ASN.2006050424; Ju C, 2016, J MOL MED, V94, P613, DOI 10.1007/s00109-016-1408-1; Kim HJ, 2013, J PHARMACOL EXP THER, V346, P465, DOI 10.1124/jpet.113.205732; Kim M, 2010, AM J NEPHROL, V31, P353, DOI 10.1159/000298339; Kim MJ, 2014, NEPHROL DIAL TRANSPL, V29, P1350, DOI 10.1093/ndt/gfu019; Kim M, 2010, AM J PHYSIOL-RENAL, V299, pF347, DOI 10.1152/ajprenal.00194.2010; Koeppen M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03105-2; Koeppen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006784; Lee HT, 2006, AM J PHYSIOL-REG I, V291, pR959, DOI 10.1152/ajpregu.00034.2006; Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943; Lee HT, 2012, AM J PHYSIOL-RENAL, V303, pF1216, DOI 10.1152/ajprenal.00220.2012; Lee HT, 2004, J AM SOC NEPHROL, V15, P102, DOI 10.1097/01.ASN.0000102474.68613.AE; Lee JW, 2019, ANESTHESIOLOGY; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Menzies RI, 2017, KIDNEY INT, V91, P315, DOI 10.1016/j.kint.2016.08.029; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Molitoris BA, 2014, J CLIN INVEST, V124, P2355, DOI 10.1172/JCI72269; Nazir S, 2017, BLOOD, V130, P2664, DOI 10.1182/blood-2017-05-782102; Okusa MD, 2000, AM J PHYSIOL-RENAL, V279, pF809, DOI 10.1152/ajprenal.2000.279.5.F809; Ozaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25893; Park SW, 2012, AM J PHYSIOL-RENAL, V303, pF721, DOI 10.1152/ajprenal.00157.2012; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Park SW, 2011, KIDNEY INT, V80, P1315, DOI 10.1038/ki.2011.281; Park SW, 2009, AM J PHYSIOL-RENAL, V297, pF885, DOI 10.1152/ajprenal.00317.2009; Pefanis A, 2019, KIDNEY INT, V96, P291, DOI 10.1016/j.kint.2019.02.009; Rabadi M, 2018, AM J PHYSIOL-RENAL, V314, pF293, DOI 10.1152/ajprenal.00364.2017; Ronco C, 2019, LANCET, V394, P1949, DOI 10.1016/S0140-6736(19)32563-2; Roy JP, 2020, INDIAN J PEDIATR, V87, P600, DOI 10.1007/s12098-019-03096-y; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Sim JA, 2006, J NEUROSCI, V26, P9006, DOI 10.1523/JNEUROSCI.2370-06.2006; Solini A, 2015, J AM SOC NEPHROL, V26, P1007, DOI 10.1681/ASN.2014070721; Song JH, 2010, AM J PHYSIOL-RENAL, V298, pF1041, DOI 10.1152/ajprenal.00115.2009; Spinello A, 2019, J CHEM INF MODEL, V59, P351, DOI 10.1021/acs.jcim.8b00565; Tang TT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0378-3; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Verma R, 2017, BRAIN BEHAV IMMUN, V66, P302, DOI 10.1016/j.bbi.2017.07.155; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Xu J, 2016, J NEUROSCI, V36, P8902, DOI 10.1523/JNEUROSCI.1496-16.2016; Yan YL, 2015, AM J PHYSIOL-CELL PH, V308, pC463, DOI 10.1152/ajpcell.00245.2014; Yang RH, 2015, COMPUT STRUCT BIOTEC, V13, P1, DOI 10.1016/j.csbj.2014.11.002; Yang TH, 2014, CIRC-HEART FAIL, V7, P510, DOI 10.1161/CIRCHEARTFAILURE.113.001023; Yap SC, 2012, CURR OPIN NEPHROL HY, V21, P24, DOI 10.1097/MNH.0b013e32834d2ec9; Yuan XY, 2018, ANESTH ANALG, V126, P308, DOI 10.1213/ANE.0000000000002288	76	22	27	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5465	5482		10.1096/fj.201903287R	http://dx.doi.org/10.1096/fj.201903287R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086866	Green Accepted, Bronze			2022-12-28	WOS:000515260000001
J	Hsu, WC; Li, WM; Lee, YC; Huang, AM; Chang, LL; Lin, HH; Wu, WJ; Li, CC; Liang, PI; Ke, HL				Hsu, Wei-Chi; Li, Wei-Ming; Lee, Yi-Chen; Huang, A-Mei; Chang, Lin-Li; Lin, Hui-Hui; Wu, Wen-Jeng; Li, Ching-Chia; Liang, Peir-In; Ke, Hung-Lung			MicroRNA-145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6	FASEB JOURNAL			English	Article						ARF6; cell invasion; miR-145-5p; MMP7; upper tract urothelial carcinoma	POOR-PROGNOSIS; RADICAL NEPHROURETERECTOMY; PROSTATE-CANCER; METALLOPROTEINASE-7 MATRILYSIN; MATRIX METALLOPROTEINASE-7; MIR-145 EXPRESSION; TUMOR-SUPPRESSOR; OVER-EXPRESSION; DOWN-REGULATION; METASTASIS	ADP-ribosylation factor 6 (ARF6) is a well-studied protein that is involved in multiple biological functions including cell migration and invasion. The mechanism by which ARF6 regulates the migration and invasion of upper tract urothelial carcinoma (UTUC) is still unknown. MiR-145-5p is a tumor suppressor microRNA, which is downregulated in several cancer types. We aimed to elucidate the molecular mechanism underlying the regulation of ARF6 by miR-145-5p in UTUC. ARF6 expression was observed to be higher in UTUC tissues than paired adjacent normal tissues. A reverse correlation between ARF6 and miR-145-5p was found in UTUC tissues. MiR-145-5p inhibited ARF6 expression by directly targeting its 3 '-UTR. The functional studies indicated that ARF6 expression reversed the miR-145-5p-reduced tumor cell migration and invasion. Notably, miR-145-5p reduced MMP2, N-cadherin, FAK and MMP7, and elevated E-cadherin protein levels in vitro; however, the above effects were reversed by ARF6. Further, the expression of epithelial-to-mesenchymal transition (EMT) markers and cell invasion was suppressed by knocking down MMP7 in UTUC cells. These findings suggest that miR-145-5p may suppress UTUC cell motility and invasion by targeting ARF6/MMP7 through EMT.	[Hsu, Wei-Chi; Huang, A-Mei; Chang, Lin-Li; Lin, Hui-Hui; Wu, Wen-Jeng; Ke, Hung-Lung] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Li, Wei-Ming; Lin, Hui-Hui; Wu, Wen-Jeng; Li, Ching-Chia; Ke, Hung-Lung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Li, Wei-Ming; Wu, Wen-Jeng; Li, Ching-Chia; Ke, Hung-Lung] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Urol, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan; [Li, Wei-Ming] Minist Hlth & Welf Pingtung Hosp, Dept Urol, Pingtung, Taiwan; [Lee, Yi-Chen] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Anat, Kaohsiung, Taiwan; [Huang, A-Mei] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Huang, A-Mei] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Biochem, Kaohsiung, Taiwan; [Huang, A-Mei] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chang, Lin-Li] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Microbiol, Kaohsiung, Taiwan; [Liang, Peir-In] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Ke, HL (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Urol, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.	hunglungke@gmail.com	Ke, Hung-Lung/HCH-9079-2022	Lin, Hui-Hui/0000-0002-3514-0391; Ke, Hung-Lung/0000-0002-4208-3858; Hsu, Wei-Chi/0000-0001-8184-6945	Ministry of Science and Technology [MOST107-2314-B-037-011]; Kaohsiung Medical University Hospital [KMUH-104-4R43, KMUH-105-5R70, KMUH106-6R59]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Medical University Hospital	Ministry of Science and Technology, Grant/Award Number: MOST107-2314-B-037-011; Kaohsiung Medical University Hospital, Grant/Award Number: KMUH-104-4R43, KMUH-105-5R70 and KMUH106-6R59	Avgeris M, 2013, BRIT J CANCER, V108, P2573, DOI 10.1038/bjc.2013.250; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Barille S, 1999, J IMMUNOL, V163, P5723; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bolenz C, 2018, BLADDER CANCER, V4, P67, DOI 10.3233/BLC-170124; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chang L, 2017, AM J CANCER RES, V7, P2305; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Cui SY, 2014, J CELL MOL MED, V18, P1913, DOI 10.1111/jcmm.12358; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Duan XC, 2014, GENE, V541, P67, DOI 10.1016/j.gene.2014.03.018; Eades G, 2015, MOL CANCER RES, V13, P330, DOI 10.1158/1541-7786.MCR-14-0251; Favaretto RL, 2018, INT BRAZ J UROL, V44, P22, DOI [10.1590/s1677-5538.ibju.2017.0204, 10.1590/S1677-5538.IBJU.2017.0204]; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fernandez MI, 2009, UROLOGY, V73, P142, DOI 10.1016/j.urology.2008.07.042; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Grada A, 2017, J INVEST DERMATOL, V137, pE11, DOI 10.1016/j.jid.2016.11.020; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Grindel BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25435-3; Grollman AP, 2013, ENVIRON MOL MUTAGEN, V54, P1, DOI 10.1002/em.21756; Grossmann Allie H, 2019, Small GTPases, V10, P1, DOI 10.1080/21541248.2016.1259710; Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Hashimoto A, 2016, J CELL BIOL, V213, P81, DOI 10.1083/jcb.201510002; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hashimoto S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10656; Health Promotion Administration Ministry of Health and Welfare T, 2018, CANC REG ANN REP TAI, V2016, P88; Hu ZZ, 2013, EXP CELL RES, V319, P1932, DOI 10.1016/j.yexcr.2013.05.028; Ii M, 2006, EXP BIOL MED, V231, P20; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Lee YC, 2017, CLIN GENITOURIN CANC, V15, pE653, DOI 10.1016/j.clgc.2017.01.002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CC, 2008, EUR UROL, V54, P1127, DOI 10.1016/j.eururo.2008.01.054; Li R, 2017, LIFE SCI, V182, P80, DOI 10.1016/j.lfs.2017.06.008; Li WM, 2017, INT J MED SCI, V14, P1360, DOI 10.7150/ijms.17367; Liang C, 2017, CANCER LETT, V388, P303, DOI 10.1016/j.canlet.2016.12.014; Liu Q, 2019, J CELL BIOCHEM, V120, P8409, DOI 10.1002/jcb.28126; Marchesin V, 2015, J CELL BIOL, V211, P339, DOI 10.1083/jcb.201506002; Margulis V, 2009, CANCER-AM CANCER SOC, V115, P1224, DOI 10.1002/cncr.24135; Munoz JJ, 2000, J UROLOGY, V164, P1523, DOI 10.1016/S0022-5347(05)67019-X; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Noe V, 2001, J CELL SCI, V114, P111; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Shen H, 2015, BIOMED PHARMACOTHER, V69, P301, DOI 10.1016/j.biopha.2014.12.019; Shen SN, 2019, MOL ONCOL, V13, P2554, DOI 10.1002/1878-0261.12555; Shi L, 2019, J CELL BIOCHEM, V120, P8016, DOI 10.1002/jcb.28079; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soria F, 2017, WORLD J UROL, V35, P379, DOI 10.1007/s00345-016-1928-x; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Szarvas T, 2011, PATHOL ONCOL RES, V17, P325, DOI 10.1007/s12253-010-9320-4; Szarvas T, 2010, CANCER SCI, V101, P1300, DOI 10.1111/j.1349-7006.2010.01506.x; Tokar T, 2018, NUCLEIC ACIDS RES, V46, pD360, DOI 10.1093/nar/gkx1144; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; Tzeng CC, 1996, ANTICANCER RES, V16, P1797; Wang FQ, 2006, CANCER LETT, V236, P292, DOI 10.1016/j.canlet.2005.05.042; Wang FQ, 2005, INT J CANCER, V114, P19, DOI 10.1002/ijc.20697; Wang M, 2016, INT J ONCOL, V48, P595, DOI 10.3892/ijo.2015.3270; Wang QY, 2015, TUMOR BIOL, V36, P3703, DOI 10.1007/s13277-014-3009-3; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yamauchi Yohei, 2017, Advances in Biological Regulation, V63, P115, DOI 10.1016/j.jbior.2016.10.004; Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015; Zeinali T, 2019, BIOMED PHARMACOTHER, V109, P195, DOI 10.1016/j.biopha.2018.10.037; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104; Zhang X, 2015, PROSTATE INT, V3, P71, DOI 10.1016/j.prnil.2014.09.001; Zhang Y, 2016, EUR REV MED PHARMACO, V20, P3026	68	20	21	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5975	5992		10.1096/fj.201902555R	http://dx.doi.org/10.1096/fj.201902555R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32077148	Bronze			2022-12-28	WOS:000515256100001
J	Chen, LS; Yao, XW; Yao, HB; Ji, Q; Ding, G; Liu, XF				Chen, Lisha; Yao, Xingwang; Yao, Hongbing; Ji, Qin; Ding, Guo; Liu, Xiangfeng			Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells	FASEB JOURNAL			English	Article						exosome; hepatic fibrosis; hepatic stellate cell; macrophage; miRNA	GENE-EXPRESSION; LIVER FIBROSIS; INFLAMMATION; BIOGENESIS; MICRORNAS; MECHANISM; GAMMA	Hepatic fibrosis occurs during chronic hepatic injury and is involved in hepatic stellate cells (HSCs) activated by several types of immune cells. Among the immune cells, hepatic macrophages and their crosstalk with HSCs play a vital role in all stages of hepatic fibrosis. Exosomes, which are 30-150 nm lipid bilayer vehicles, can transfer specific lipid, nucleic acids, proteins, and other bioactive molecules. Exosomes can act as good communication between macrophages and HSCs. Herein, we investigated the role of exosomes between THP-1 macrophage and HSCs in the progression of liver fibrosis. Exosomes originating from lipopolysaccharide (LPS)-treated THP-1 macrophages promoted HSCs proliferation and induced the increased expression of fibrotic genes. LPS could alter the miRNA profile in exosomes secreted from THP-1 macrophages. The changed miR-103-3p in exosomes could promote HSCs proliferation and activation by targeting Kruppel-like factor 4 (KLF4) and it plays important roles in the crosstalk between THP-1 macrophages and HSCs during the progression of liver fibrosis. Moreover, miR-103-3p in serum exosomes from liver fibrosis patients could be a biomarker for liver fibrosis. Therefore, exosomes may have important roles in the crosstalk between macrophage and HSCs in the progression of chronic liver diseases.	[Chen, Lisha] Cent South Univ, Xiangya Hosp 2, Dept Neurosurg, Cent Lab, Changsha, Peoples R China; [Yao, Xingwang; Ji, Qin; Ding, Guo; Liu, Xiangfeng] Cent South Univ, Xiangya Hosp 2, Dept Hepatobiliary & Pancreat Surg, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China; [Yao, Hongbing] Guilin Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Guilin, Peoples R China	Central South University; Central South University; Guilin Medical University	Liu, XF (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Hepatobiliary & Pancreat Surg, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China.	Thomasxy93@csu.edu.cn	Chen, Lisha/HGC-6247-2022		Scientific Research Project of the Hunan Finance Department of China [2050205]	Scientific Research Project of the Hunan Finance Department of China	Scientific Research Project of the Hunan Finance Department of China, Grant/Award Number: 2050205	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chen L, 2019, HEPATOL COMMUN, V3, P180, DOI 10.1002/hep4.1290; Chen L, 2017, METHODS MOL BIOL, V1489, P465, DOI 10.1007/978-1-4939-6430-7_38; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Devhare PB, 2017, J VIROL, V91, DOI 10.1128/JVI.02225-16; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Ge SF, 2016, ANN HEPATOL, V15, P918, DOI 10.5604/16652681.1222111; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lee YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03389-2; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Liu Y, 2003, J BIOL CHEM, V278, P48004, DOI 10.1074/jbc.M301902200; Men RT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40468; Niu ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00523-6; Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170; Ramachandran P, 2012, J HEPATOL, V56, P1417, DOI 10.1016/j.jhep.2011.10.026; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Seo W, 2016, HEPATOLOGY, V64, P616, DOI 10.1002/hep.28644; Shen JL, 2017, J CELL MOL MED, V21, P986, DOI 10.1111/jcmm.12950; Sun X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196541; Sun ZQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0897-7; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tao L, 2018, ARCH TOXICOL, V92, P2935, DOI 10.1007/s00204-018-2278-9; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Xiao XC, 2015, INT J MOL MED, V35, P1596, DOI 10.3892/ijmm.2015.2189; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yu FJ, 2016, CELL PHYSIOL BIOCHEM, V40, P183, DOI 10.1159/000452536; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001	35	47	50	8	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5178	5192		10.1096/fj.201902307RRR	http://dx.doi.org/10.1096/fj.201902307RRR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32061112	hybrid			2022-12-28	WOS:000517898100001
J	Li, XQ; Zhang, YY; Pei, WY; Zhang, MY; Yang, H; Zhong, M; Kong, X; Xu, Y; Zhu, XL; Chen, TB; Ye, JJ; Lv, K				Li, Xueqin; Zhang, Yingying; Pei, Weiya; Zhang, Mengying; Yang, Hui; Zhong, Min; Kong, Xiang; Xu, Yang; Zhu, Xiaolong; Chen, Tianbing; Ye, Jingjing; Lv, Kun			LncRNA Dnmt3aos regulates Dnmt3a expression leading to aberrant DNA methylation in macrophage polarization	FASEB JOURNAL			English	Article						DNA methylation; Dnmt3a; LncRNA; macrophage polarization	LONG NONCODING RNA; GENE-EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; MICROARRAY; INFLAMMATION; ACTIVATION; INTERACTS; PROFILES; PATTERNS	Long non-coding RNAs (lncRNAs) play key roles in various biological processes. However, the roles of lncRNAs in macrophage polarization remain largely unexplored. In this study, thousands of lncRNAs were identified that are differentially expressed in distinct polarized bone marrow-derived macrophages. Among them, Dnmt3aos (DNA methyltransferase 3A, opposite strand), as a known lncRNA, locates on the antisense strand of Dnmt3a. Functional experiments further confirmed that Dnmt3aos were highly expressed in M(IL-4) macrophages and participated in the regulation of Dnmt3a expression, and played a key role in macrophage polarization. The DNA methylation profiles between the Dnmt3aos knockdown group and the control group in M(IL-4) macrophages were determined by MeDIP-seq technique for the first time, and the Dnmt3aos-Dnmt3a axis-mediated DNA methylation modification-regulated macrophage polarization- related gene IFN-gamma was identified. Our study will help to enrich our knowledge of the mechanism of macrophage polarization.	[Li, Xueqin; Zhang, Yingying; Pei, Weiya; Zhang, Mengying; Yang, Hui; Zhong, Min; Kong, Xiang; Xu, Yang; Zhu, Xiaolong; Chen, Tianbing; Ye, Jingjing; Lv, Kun] Wannan Med Coll, Key Lab Noncoding RNA Transformat Res, Anhui Higher Educ Inst, Wuhu, Peoples R China; [Li, Xueqin; Pei, Weiya; Zhang, Mengying; Yang, Hui; Zhong, Min; Kong, Xiang; Xu, Yang; Zhu, Xiaolong; Chen, Tianbing; Ye, Jingjing; Lv, Kun] Wannan Med Coll, Cent Lab, Yijishan Hosp, 2 Western Zheshan Rd, Wuhu 241001, Peoples R China; [Zhang, Yingying] Wannan Med Coll, Yijishan Hosp, Lab Med, Wuhu, Peoples R China	Wannan Medical College; Wannan Medical College; Wannan Medical College	Lv, K (corresponding author), Wannan Med Coll, Cent Lab, Yijishan Hosp, 2 Western Zheshan Rd, Wuhu 241001, Peoples R China.	lvkun315@126.com	Yang, Xu/AGR-8189-2022	Yang, Xu/0000-0001-8778-3885; Chen, Tianbing/0000-0002-3487-6487; Yang, Hui/0000-0002-3938-9530	National Natural Science Foundation of China (NSFC) [81772180, 81701557, 81802503, 81870017, 81970699]; Key Projects of Natural Science Research of Universities in Anhui Province [KJ2019A0413, KJ2018A0265]; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College [GF2019T01, GF2019G09]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Projects of Natural Science Research of Universities in Anhui Province; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772180, 81701557, 81802503, 81870017 and 81970699; Key Projects of Natural Science Research of Universities in Anhui Province, Grant/Award Number: KJ2019A0413 and KJ2018A0265; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College, Grant/Award Number: GF2019T01 and GF2019G09	Alderborn A, 2000, GENOME RES, V10, P1249, DOI 10.1101/gr.10.8.1249; Backdahl L, 2009, INT J BIOCHEM CELL B, V41, P176, DOI 10.1016/j.biocel.2008.08.023; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Buscher K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16041; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Chan J, 2015, J IMMUNOL, V195, P1359, DOI 10.4049/jimmunol.1500264; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Chen MT, 2015, MOL CELL BIOL, V35, P3212, DOI 10.1128/MCB.00429-15; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gong CG, 2015, DEV CELL, V34, P181, DOI 10.1016/j.devcel.2015.05.009; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haney SL, 2016, CELL REP, V15, P1190, DOI 10.1016/j.celrep.2016.04.004; Huang ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19705; Jiang L, 2017, MOL MED REP, V16, P7382, DOI 10.3892/mmr.2017.7511; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Mao AP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1270-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051; Qin WS, 2016, NUCLEIC ACIDS RES, V44, P6423, DOI 10.1093/nar/gkw341; Reddy MA, 2014, DIABETES, V63, P4249, DOI 10.2337/db14-0298; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shikauchi Y, 2009, MOL CELL BIOL, V29, P1944, DOI 10.1128/MCB.00840-08; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Tang RZ, 2019, J MOL CELL CARDIOL, V128, P11, DOI 10.1016/j.yjmcc.2019.01.009; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wang LH, 2016, ELIFE, V5, DOI 10.7554/eLife.14620; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wang XF, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87748; Xu J, 2014, P NATL ACAD SCI USA, V111, P2620, DOI 10.1073/pnas.1400150111; Yang XS, 2014, MOL ENDOCRINOL, V28, P565, DOI 10.1210/me.2013-1293; Yu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30053; Zhang GQ, 2015, NUCLEIC ACIDS RES, V43, P6112, DOI 10.1093/nar/gkv518; Zhang YY, 2017, INT J MOL MED, V39, P373, DOI 10.3892/ijmm.2017.2852; Zhang YY, 2013, INT J MOL MED, V31, P797, DOI 10.3892/ijmm.2013.1260; Zhang YT, 2016, P CHIN MARK INT CONF, P6; Zhao JL, 2016, CANCER RES, V76, P1403, DOI 10.1158/0008-5472.CAN-15-2019; Zhou YX, 2018, INT J BIOCHEM CELL B, V104, P25, DOI 10.1016/j.biocel.2018.08.017	54	16	18	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5077	5091		10.1096/fj.201902379R	http://dx.doi.org/10.1096/fj.201902379R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052888	Green Submitted, hybrid			2022-12-28	WOS:000513849600001
J	McCullagh, EA; Rotschafer, SE; Auerbach, BD; Klug, A; Kaczmarek, LK; Cramer, KS; Kulesza, RJ; Razak, KA; Lovelace, JW; Lu, Y; Koch, U; Wang, Y				McCullagh, Elizabeth A.; Rotschafer, Sarah E.; Auerbach, Benjamin D.; Klug, Achim; Kaczmarek, Leonard K.; Cramer, Karina S.; Kulesza, Randy J., Jr.; Razak, Khaleel A.; Lovelace, Jonathan W.; Lu, Yong; Koch, Ursula; Wang, Yuan			Mechanisms underlying auditory processing deficits in Fragile X syndrome	FASEB JOURNAL			English	Article						auditory system; autism spectrum disorders; circuit development; Fragile X syndrome; hyperacusis; synaptic transmission	MENTAL-RETARDATION PROTEIN; FMR1 KNOCKOUT MICE; SENSORIMOTOR GATING ABNORMALITIES; ACOUSTIC STARTLE RESPONSE; BRAIN-STEM RESPONSES; MOUSE MODEL; POTASSIUM CHANNEL; MEDIAL NUCLEUS; GLYCINERGIC TRANSMISSION; SYNAPTIC-TRANSMISSION	Autism spectrum disorders (ASD) are strongly associated with auditory hypersensitivity or hyperacusis (difficulty tolerating sounds). Fragile X syndrome (FXS), the most common monogenetic cause of ASD, has emerged as a powerful gateway for exploring underlying mechanisms of hyperacusis and auditory dysfunction in ASD. This review discusses examples of disruption of the auditory pathways in FXS at molecular, synaptic, and circuit levels in animal models as well as in FXS individuals. These examples highlight the involvement of multiple mechanisms, from aberrant synaptic development and ion channel deregulation of auditory brainstem circuits, to impaired neuronal plasticity and network hyperexcitability in the auditory cortex. Though a relatively new area of research, recent discoveries have increased interest in auditory dysfunction and mechanisms underlying hyperacusis in this disorder. This rapidly growing body of data has yielded novel research directions addressing critical questions regarding the timing and possible outcomes of human therapies for auditory dysfunction in ASD.	[McCullagh, Elizabeth A.; Klug, Achim] Univ Colorado Anschutz, Dept Physiol & Biophys, Aurora, CO USA; [McCullagh, Elizabeth A.] Oklahoma State Univ, Dept Integrat Biol, 501 Life Sci West, Stillwater, OK 74078 USA; [Rotschafer, Sarah E.; Cramer, Karina S.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Rotschafer, Sarah E.] Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA USA; [Auerbach, Benjamin D.] SUNY Buffalo, Dept Commun Disorders & Sci, Ctr Hearing & Deafness, Buffalo, NY USA; [Kaczmarek, Leonard K.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Kaczmarek, Leonard K.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA; [Kulesza, Randy J., Jr.] Lake Erie Coll Osteopath Med, Dept Anat, Erie, PA USA; [Razak, Khaleel A.; Lovelace, Jonathan W.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Lu, Yong] Northeast Ohio Med Univ, Coll Med, Dept Anat & Neurobiol, Rootstown, OH USA; [Koch, Ursula] Free Univ Berlin, Inst Biol, Neurophysiol, Berlin, Germany; [Wang, Yuan] Florida State Univ, Program Neurosci, Dept Biomed Sci, Tallahassee, FL 32306 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Oklahoma State University System; Oklahoma State University - Stillwater; University of California System; University of California Irvine; Mercer University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University; Yale University; University of California System; University of California Riverside; Northeast Ohio Medical University (NEOMED); Free University of Berlin; State University System of Florida; Florida State University	McCullagh, EA (corresponding author), Oklahoma State Univ, Dept Integrat Biol, 501 Life Sci West, Stillwater, OK 74078 USA.; Wang, Y (corresponding author), Florida State Univ, Coll Med, 1115 West Call St, Tallahassee, FL 32306 USA.	elizabeth.mccullagh@okstate.edu; yuan.wang@med.fsu.edu	, WaNgtJ/AAR-7045-2020; Klug, Achim/N-6956-2014	Klug, Achim/0000-0002-3383-850X; Kulesza, Randy/0000-0001-8589-1532; Cramer, Karina/0000-0003-3793-4862; Wang, Yuan/0000-0003-4347-7063	HHS \ NIH \ National Institute on Deafness and Other Communication Disorders (NIDCD) [3T32DC012280-05S1, R01DC01919, NS102239, R01DC010796, R01DC017924, R01DC016054, R01DC13074, R21DC17267, F32DC015160-01A1]; FRAXA Research Foundation (FRAXA); Deutsche Forschungsgemeinschaft (DFG) [SFB665]; HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [U54 HD082008]; DOD \ United States Army \ MEDCOM \ Congressionally Directed Medical Research Programs (CDMRP) [PR140683]; United States-Israel Binational Science Foundation; SFARI	HHS \ NIH \ National Institute on Deafness and Other Communication Disorders (NIDCD); FRAXA Research Foundation (FRAXA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); DOD \ United States Army \ MEDCOM \ Congressionally Directed Medical Research Programs (CDMRP); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); SFARI	HHS vertical bar NIH vertical bar National Institute on Deafness and Other Communication Disorders (NIDCD), Grant/Award Number: 3T32DC012280-05S1, R01DC01919, NS102239, R01DC010796, R01DC017924, R01DC016054, R01DC13074, R21DC17267 and F32DC015160-01A1; FRAXA Research Foundation (FRAXA); Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB665; HHS vertical bar NIH vertical bar Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: U54 HD082008; DOD vertical bar United States Army vertical bar MEDCOM vertical bar Congressionally Directed Medical Research Programs (CDMRP), Grant/Award Number: PR140683; United States-Israel Binational Science Foundation; SFARI	Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Albrecht O, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00083; [Anonymous], 2018, MOL PSYCHIAT; Antoine MW, 2019, NEURON, V101, P648, DOI 10.1016/j.neuron.2018.12.026; ARINAMI T, 1989, AM J HUM GENET, V45, P978; ARINAMI T, 1988, AM J HUM GENET, V43, P46; Arnett MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109116; Arsenault J, 2016, HUM GENE THER, V27, P982, DOI 10.1089/hum.2016.090; Auerbach BD, 2019, NEUROSCIENCE, V407, P93, DOI 10.1016/j.neuroscience.2018.09.036; Awatramani GB, 2005, J NEUROPHYSIOL, V93, P819, DOI 10.1152/jn.00798.2004; Badran HS, 2013, CLIN MED INSIGHTS EA, V6, pCMENTS11157; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Baker KB, 2010, GENES BRAIN BEHAV, V9, P562, DOI 10.1111/j.1601-183X.2010.00585.x; BAKKER CE, 1994, CELL, V78, P23; Balmer TS, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0112-16.2016; Banerjee A, 2018, BRAIN RES, V1693, P24, DOI 10.1016/j.brainres.2018.04.008; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beebe K, 2014, NEUROSCIENCE, V273, P79, DOI 10.1016/j.neuroscience.2014.05.006; Berry-Kravis E, 2010, AJIDD-AM J INTELLECT, V115, P461, DOI 10.1352/1944-7558-115.6.461; Biacabe B, 2001, AURIS NASUS LARYNX, V28, P85, DOI 10.1016/S0385-8146(00)00080-8; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Brew HM, 2003, J PHYSIOL-LONDON, V548, P1, DOI 10.1113/jphysiol.2002.035568; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Bullock AE, 1997, BEHAV NEUROSCI, V111, P1353, DOI 10.1037/0735-7044.111.6.1353; Castren M, 2003, BRAIN TOPOGR, V15, P165, DOI 10.1023/A:1022606200636; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; Curry RJ, 2018, J NEUROSCI, V38, P8187, DOI 10.1523/JNEUROSCI.0603-18.2018; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Darwin CJ, 2008, PHILOS T R SOC B, V363, P1011, DOI 10.1098/rstb.2007.2156; Davis JK, 2017, TRENDS GENET, V33, P703, DOI 10.1016/j.tig.2017.07.008; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Deng PY, 2019, J NEUROSCI, V39, P28, DOI 10.1523/JNEUROSCI.1593-18.2018; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Ding Q, 2014, BEHAV BRAIN RES, V271, P72, DOI 10.1016/j.bbr.2014.05.046; Dodson PD, 2002, J NEUROSCI, V22, P6953; Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dondzillo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160241; El-Hassar L, 2019, J NEUROSCI, V39, P4797, DOI 10.1523/JNEUROSCI.0839-18.2019; Errijgers V, 2008, GENET RES, V90, P341, DOI 10.1017/S0016672308009415; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Ethridge LE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.48; Ethridge LE, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0140-1; FERRI R, 1989, AM J HUM GENET, V45, P977; Ferri R, 1987, EVOKED POTENTIAL, P167; Ferri R., 1986, MATURATION CNS EVOKE, P369; Ferron L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4628; Flores EN, 2015, CURR BIOL, V25, P606, DOI 10.1016/j.cub.2015.01.009; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Frick A, 2017, FRAGILE X SYNDROME: FROM GENETICS TO TARGETED TREATMENT, P323, DOI 10.1016/B978-0-12-804461-2.00016-0; Galvez R, 2005, DEV BRAIN RES, V157, P214, DOI 10.1016/j.devbrainres.2005.03.010; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Galvez R, 2003, BRAIN RES, V971, P83, DOI 10.1016/S0006-8993(03)02363-1; Gantois I, 2017, NAT MED, V23, P674, DOI 10.1038/nm.4335; Garcia-Pino E, 2017, J NEUROSCI, V37, P7403, DOI 10.1523/JNEUROSCI.2310-16.2017; Gholizadeh S, 2014, NEUROPSYCHOPHARMACOL, V39, P3100, DOI 10.1038/npp.2014.167; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; GILLBERG C, 1986, J MENT DEFIC RES, V30, P27; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Gkogkas CG, 2014, CELL REP, V9, P1742, DOI 10.1016/j.celrep.2014.10.064; Goel A, 2018, NAT NEUROSCI, V21, P1404, DOI 10.1038/s41593-018-0231-0; Gonzalez D, 2019, J NEUROSCI, V39, P9852, DOI 10.1523/JNEUROSCI.0886-19.2019; Gothelf D, 2008, ANN NEUROL, V63, P40, DOI 10.1002/ana.21243; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Grande G, 2011, J NEUROSCI, V31, P13386, DOI 10.1523/JNEUROSCI.0400-11.2011; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; HAGERMAN RJ, 1987, AM J DIS CHILD, V141, P184, DOI 10.1001/archpedi.1987.04460020074031; Hall SS, 2009, J NEURODEV DISORD, V1, P91, DOI 10.1007/s11689-009-9007-x; Hardman RM, 2009, J PHYSIOL-LONDON, V587, P2487, DOI 10.1113/jphysiol.2009.170548; Hartig W, 2001, BRAIN RES, V899, P123, DOI 10.1016/S0006-8993(01)02211-9; He CX, 2017, J NEUROSCI, V37, P6475, DOI 10.1523/JNEUROSCI.0651-17.2017; Hessl D, 2009, AM J MED GENET B, V150B, P545, DOI 10.1002/ajmg.b.30858; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; JEWETT DL, 1970, SCIENCE, V167, P1517, DOI 10.1126/science.167.3924.1517; Kim H, 2013, J NEUROSCI, V33, P15686, DOI 10.1523/JNEUROSCI.3246-12.2013; Knudson IM, 2016, JARO-J ASSOC RES OTO, V17, P223, DOI 10.1007/s10162-016-0555-y; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Kokash J, 2019, BRAIN RES, V1719, P24, DOI 10.1016/j.brainres.2019.05.029; Kopp-Scheinpflug C, 2003, J NEUROSCI, V23, P9199, DOI 10.1523/jneurosci.23-27-09199.2003; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kulesza RJ, 2008, BRAIN RES, V1200, P132, DOI 10.1016/j.brainres.2008.01.009; Kwon H, 2001, AM J PSYCHIAT, V158, P1040, DOI 10.1176/appi.ajp.158.7.1040; Lauer AM, 2017, NEUROSCI BIOBEHAV R, V77, P194, DOI 10.1016/j.neubiorev.2017.03.009; Lauer Amanda M., 2007, Seminars in Hearing, V28, P319, DOI 10.1055/s-2007-990718; Leao RM, 2005, J NEUROSCI, V25, P3724, DOI 10.1523/JNEUROSCI.3983-04.2005; Lensjo KK, 2017, J NEUROSCI, V37, P1269, DOI 10.1523/JNEUROSCI.2504-16.2016; Li W, 2001, J COMP NEUROL, V437, P196, DOI 10.1002/cne.1279; Loesch DZ, 2007, NEUROSCI BIOBEHAV R, V31, P315, DOI 10.1016/j.neubiorev.2006.09.007; Loesch DZ, 2004, MENT RETARD DEV D R, V10, P31, DOI 10.1002/mrdd.20006; Lovelace JW, 2018, NEUROBIOL DIS, V115, P39, DOI 10.1016/j.nbd.2018.03.012; Lovelace JW, 2016, NEUROBIOL DIS, V89, P126, DOI 10.1016/j.nbd.2016.02.002; Lovelace JW, CEREBRAL CORTEX, P141; Lu Y, 2019, BRAIN RES, V1717, P95, DOI 10.1016/j.brainres.2019.04.006; Macica CM, 2003, J NEUROSCI, V23, P1133, DOI 10.1523/JNEUROSCI.23-04-01133.2003; Manohar S, 2017, HEARING RES, V353, P197, DOI 10.1016/j.heares.2017.07.001; Martin BS, 2014, J NEUROPHYSIOL, V112, P890, DOI 10.1152/jn.00597.2013; Mayer F, 2014, J NEUROPHYSIOL, V112, P2901, DOI 10.1152/jn.00864.2013; McCullagh EA, 2017, J COMP NEUROL, V262, P375; McCullagh EA, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0300-19.2019; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Miezejeski CM, 1997, AM J MED GENET, V74, P167, DOI 10.1002/(SICI)1096-8628(19970418)74:2<167::AID-AJMG10>3.0.CO;2-G; Moller AR, 1999, EEG CL N SU, P27; Muscas M, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0097-19.2019; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Myrick LK, 2015, P NATL ACAD SCI USA, V112, P949, DOI 10.1073/pnas.1423094112; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Neuwirth LS, 2015, ADV EXP MED BIOL, V803, P425, DOI 10.1007/978-3-319-15126-7_33; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; Niu MM, 2017, J CHILD NEUROL, V32, P903, DOI 10.1177/0883073817712875; Okray Z, 2015, EMBO MOL MED, V7, P423, DOI 10.15252/emmm.201404576; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Pacey LKK, 2009, MOL PHARMACOL, V76, P18, DOI 10.1124/mol.109.056127; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Paylor R, 2008, BEHAV NEUROSCI, V122, P1371, DOI 10.1037/a0013047; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Qin M, 2005, NEUROSCIENCE, V135, P999, DOI 10.1016/j.neuroscience.2005.06.081; Rais M, 2018, ASN NEURO, V10, DOI 10.1177/1759091418801092; Rajaratnam Akash, 2017, F1000Res, V6, P2112, DOI 10.12688/f1000research.11885.1; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Roberts J, 2005, J SPEECH LANG HEAR R, V48, P494, DOI 10.1044/1092-4388(2005/034); Rojas DC, 2001, NEUROREPORT, V12, P2573, DOI 10.1097/00001756-200108080-00056; Rotschafer S, 2013, BRAIN RES, V1506, P12, DOI 10.1016/j.brainres.2013.02.038; Rotschafer SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117266; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Ruby K, 2015, NEUROSCIENCE, V303, P285, DOI 10.1016/j.neuroscience.2015.06.061; Sakano H, 2017, J COMP NEUROL, V525, P3341, DOI 10.1002/cne.24281; SANES DH, 1989, J COMP NEUROL, V279, P436, DOI 10.1002/cne.902790308; SANES DH, 1988, J NEUROSCI, V8, P682; Santos AR, 2014, LEARN MEMORY, V21, P543, DOI 10.1101/lm.035956.114; Sawicka K, 2016, P NATL ACAD SCI USA, V113, pE6290, DOI 10.1073/pnas.1610812113; Schneider A, 2013, J PSYCHOPHARMACOL, V27, P956, DOI 10.1177/0269881113494105; Sidhu H, 2014, J NEUROSCI, V34, P9867, DOI 10.1523/JNEUROSCI.1162-14.2014; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; Strumbos JG, 2010, NEUROSCIENCE, V167, P567, DOI 10.1016/j.neuroscience.2010.02.046; Strumbos JG, 2010, J NEUROSCI, V30, P10263, DOI 10.1523/JNEUROSCI.1125-10.2010; Tang B, 2015, P NATL ACAD SCI USA, V112, pE4697, DOI 10.1073/pnas.1502258112; Teder-Salejarvi WA, 2005, COGNITIVE BRAIN RES, V23, P221, DOI 10.1016/j.cogbrainres.2004.10.021; Thomas AM, 2012, PSYCHOPHARMACOLOGY, V219, P47, DOI 10.1007/s00213-011-2375-4; Thomas CC, 2008, INT J DEV NEUROSCI, V26, P805, DOI 10.1016/j.ijdevneu.2008.06.003; Tozer AJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032256; Van der Molen MJW, 2012, CLIN NEUROPHYSIOL, V123, P1309, DOI 10.1016/j.clinph.2011.11.039; Veeraragavan S, 2012, BEHAV BRAIN RES, V228, P1, DOI 10.1016/j.bbr.2011.11.018; Visser E, 2013, J PSYCHIATR NEUROSCI, V38, P398, DOI 10.1503/jpn.120177; von Hehn CAA, 2004, J NEUROSCI, V24, P1936, DOI 10.1523/JNEUROSCI.4554-03.2004; Wang J, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9191-z; Wang TT, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00234; Wang XY, 2018, J NEUROSCI, V38, P6445, DOI 10.1523/JNEUROSCI.0665-18.2018; Wang Y, 2014, J COMP NEUROL, V522, P2107, DOI 10.1002/cne.23520; Wang Y, 2012, J NEUROSCI, V32, P11495, DOI 10.1523/JNEUROSCI.1737-12.2012; Wen TH, 2019, NEUROSCIENCE, V398, P126, DOI 10.1016/j.neuroscience.2018.11.047; Wen TH, 2018, CEREB CORTEX, V28, P3951, DOI 10.1093/cercor/bhx258; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; WISNIEWSKI KE, 1985, ANN NEUROL, V18, P665, DOI 10.1002/ana.410180607; Xu BH, 2018, NEUROSCIENCE, V371, P469, DOI 10.1016/j.neuroscience.2017.12.023; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yun SW, 2006, BRAIN RES, V1110, P159, DOI 10.1016/j.brainres.2006.06.086; Zangenehpour S, 2009, BRAIN RES, V1264, P76, DOI 10.1016/j.brainres.2009.01.059; Zhang C, 2014, BEHAV BRAIN RES, V271, P16, DOI 10.1016/j.bbr.2014.05.045; Zhang Y, 2016, CELL, V165, P434, DOI 10.1016/j.cell.2016.02.009; Zhang YL, 2012, J NEUROSCI, V32, P15318, DOI 10.1523/JNEUROSCI.2162-12.2012; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005; Zorio DAR, 2017, J COMP NEUROL, V525, P818, DOI 10.1002/cne.24100	171	28	28	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3501	3518		10.1096/fj.201902435R	http://dx.doi.org/10.1096/fj.201902435R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32039504	Green Accepted, Bronze			2022-12-28	WOS:000512567600001
J	Wang, J; Li, YY; Wang, SY; Liu, F				Wang, Jian; Li, Yangyang; Wang, Shouyu; Liu, Fei			Dynamics of transmissible gastroenteritis virus internalization unraveled by single-virus tracking in live cells	FASEB JOURNAL			English	Article						actin; caveolae; clathrin; dynamin 2; TGEV	GROWTH-FACTOR RECEPTOR; MEDIATED ENDOCYTOSIS; DEPENDENT FUSION; CLATHRIN; ENTRY; CHOLESTEROL; INFECTION; CAVEOLAE	Transmissible gastroenteritis virus (TGEV) is a swine enteropathogenic coronavirus that causes significant economic losses in swine industry. Current studies on TGEV internalization mainly focus on viral receptors, but the internalization mechanism is still unclear. In this study, we used single-virus tracking to obtain the detailed insights into the dynamic events of the TGEV internalization and depict the whole sequential process. We observed that TGEVs could be internalized through clathrin- and caveolae-mediated endocytosis, and the internalization of TGEVs was almost completed within similar to 2 minutes after TGEVs attached to the cell membrane. Furthermore, the interactions of TGEVs with actin and dynamin 2 in real time during the TGEV internalization were visualized. To our knowledge, this is the first report that single-virus tracking technique is used to visualize the entire dynamic process of the TGEV internalization: before the TGEV internalization, with the assistance of actin, clathrin, and caveolin 1 would gather around the virus to form the vesicle containing the TGEV, and after similar to 60 seconds, dynamin 2 would be recruited to promote membrane fission. These results demonstrate that TGEVs enter ST cells via clathrin- and caveolae-mediated endocytic, actin-dependent, and dynamin 2-dependent pathways.	[Wang, Jian; Li, Yangyang; Wang, Shouyu; Liu, Fei] Nanjing Agr Univ, Joint Int Res Lab Anim Hlth & Food Safety, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Jian; Li, Yangyang; Wang, Shouyu; Liu, Fei] Nanjing Agr Univ, Single Mol Nanometry Lab Sinmolab, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Shouyu] Jiangnan Univ, Computat Opt Lab, Sch Sci, Wuxi, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Jiangnan University	Liu, F (corresponding author), Nanjing Agr Univ, Joint Int Res Lab Anim Hlth & Food Safety, Nanjing 210095, Jiangsu, Peoples R China.; Liu, F (corresponding author), Nanjing Agr Univ, Single Mol Nanometry Lab Sinmolab, Nanjing 210095, Jiangsu, Peoples R China.	feiliu24@njau.edu.cn			National Key Research and Development Program [2018YFD0500100]; National Natural Science Foundation of China (NSFC) [31870154, 31522056, 61705092]; Natural Science Foundation of Jiangsu Province of China [BK20170194]; Jiangsu Key Research and Development Program [BE2018709]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Key Research and Development Program; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Key Research and Development Program; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Key Research and Development Program, Grant/Award Number: 2018YFD0500100; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31870154, 31522056 and 61705092; Natural Science Foundation of Jiangsu Province of China, Grant/Award Number: BK20170194; Jiangsu Key Research and Development Program, Grant/Award Number: BE2018709; Priority Academic Program Development of Jiangsu Higher Education Institutions	Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Hansen GH, 1998, J VIROL, V72, P527, DOI 10.1128/JVI.72.1.527-534.1998; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Holla P, 2015, TRAFFIC, V16, P398, DOI 10.1111/tra.12260; Hoornweg TE, 2016, J VIROL, V90, P4745, DOI 10.1128/JVI.03184-15; Hu WW, 2018, VIROLOGY, V521, P33, DOI 10.1016/j.virol.2018.05.009; Hu WW, 2016, ONCOTARGET, V7, P12206, DOI 10.18632/oncotarget.7723; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; LAUDE H, 1990, VET MICROBIOL, V23, P147, DOI 10.1016/0378-1135(90)90144-K; Li Q, 2017, ACS NANO, V11, P3890, DOI 10.1021/acsnano.7b00275; Li Z, 2017, J VIROL, V91, DOI [10.1128/jvi.01083-17, 10.1128/JVI.01083-17]; Liu HB, 2011, J VIROL, V85, P6252, DOI 10.1128/JVI.00109-11; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Ren XF, 2008, VIRUS RES, V137, P220, DOI 10.1016/j.virusres.2008.07.023; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; RUST MJ, 2011, COLD SPRING HARB PRO, V2011, P1042, DOI DOI 10.1101/PDB.T0P065623; Salanueva IJ, 1999, J VIROL, V73, P7952, DOI 10.1128/JVI.73.10.7952-7964.1999; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schwegmann-Wessels C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-435; Sun E, 2013, CURR OPIN VIROL, V3, P34, DOI 10.1016/j.coviro.2013.01.005; Sun EZ, 2017, ACS NANO, V11, P4395, DOI 10.1021/acsnano.6b07853; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zhang FX, 2018, VIROLOGY, V513, P195, DOI 10.1016/j.virol.2017.09.019; Zhang S, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0283-5; Zhao TT, 2019, VIROLOGY, V529, P160, DOI 10.1016/j.virol.2019.01.009	43	12	12	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4653	4669		10.1096/fj.201902455R	http://dx.doi.org/10.1096/fj.201902455R		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32017270	Green Published, Bronze			2022-12-28	WOS:000511115000001
J	Lyons, CE; Razzoli, M; Larson, E; Svedberg, D; Frontini, A; Cinti, S; Vulchanova, L; Sanders, M; Thomas, M; Bartolomucci, A				Lyons, Carey E.; Razzoli, Maria; Larson, Erin; Svedberg, Daniel; Frontini, Andrea; Cinti, Saverio; Vulchanova, Lucy; Sanders, Mark; Thomas, Mark; Bartolomucci, Alessandro			Optogenetic-induced sympathetic neuromodulation of brown adipose tissue thermogenesis	FASEB JOURNAL			English	Article						AAV6; CLARITY; opsin; peripheral nervous system; UCP1	MICE; ACTIVATION; PEPTIDE; STRESS; VECTOR; NERVES; WHITE	The brown adipose tissue (BAT) is a thermogenic organ that plays a major role in energy balance, obesity, and diabetes due to the potent glucose and lipid clearance that fuels its thermogenesis, which is largely mediated via sympathetic nervous system activation. However, thus far there has been little experimental validation of the hypothesis that selective neuromodulation of the sympathetic nerves innervating the BAT is sufficient to elicit thermogenesis in mice. We generated mice expressing blue light-activated channelrhodopsin-2 (ChR2) in the sympathetic nerves innervating the BAT using two different strategies: injecting the BAT of C57Bl/6J mice with AAV6-hSyn-ChR2 (H134R)-EYFP; crossbreeding tyrosine hydroxylase-Cre mice with floxed-stop ChR2-EYFP mice. The nerves in the BAT expressing ChR2 were selectively stimulated with a blue LED light positioned underneath the fat pad of anesthetized mice, while the BAT and core temperatures were simultaneously recorded. Using immunohistochemistry we confirmed the selective expression of EYFP in TH positive nerves fibers. In addition, local optogenetic stimulation of the sympathetic nerves induced significant increase in the BAT temperature followed by an increase in core temperature in mice expressing ChR2, but not in the respective controls. The BAT activation was also paralleled by increased levels of pre-UCP1 transcript. Our results demonstrate that local optogenetic stimulation of the sympathetic nerves is sufficient to elicit BAT and core thermogenesis, thus suggesting that peripheral neuromodulation has the potential to be exploited as an alternative to pharmacotherapies to elicit organ activation and thus ameliorate type 2 diabetes and/or obesity.	[Lyons, Carey E.; Razzoli, Maria; Svedberg, Daniel; Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol, Physiology, Minneapolis, MN USA; [Lyons, Carey E.] Univ Minnesota, Grad Program Neuroscience, Minneapolis, MN USA; [Larson, Erin; Vulchanova, Lucy; Thomas, Mark] Univ Minnesota, Dept Neuroscience, Minneapolis, MN USA; [Frontini, Andrea] Univ Pavia, Dept Publ Hlth, Expt, Forens Med, Pavia, Italy; [Cinti, Saverio] Univ Politecn Marche, Dept Expt, Clin Med, Ancona, Italy; [Sanders, Mark] Univ Minnesota, Univ Imaging Ctr, Minneapolis, MN USA; Univ Minnesota, Dept Integrat Biol, Alessandro Bartolomucci, Physiology, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Pavia; Marche Polytechnic University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bartolomucci, A (corresponding author), Univ Minnesota, Dept Integrat Biol, Physiology, Minneapolis, MN USA.	abartolo@umn.edu	Thomas, Mark John/HHC-7509-2022	Thomas, Mark John/0000-0001-5721-5350; CINTI, Saverio/0000-0003-0362-5017; Lyons, Carey/0000-0002-9858-5021; Lind, Erin/0000-0003-2198-9922; Svedberg, Daniel/0000-0002-4605-9572	NIA NIH HHS [T32 AG029796] Funding Source: Medline; NIDDK NIH HHS [R01 DK117504, R01 DK102496, R56 DK118150] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bell BB, 2018, MOL METAB, V8, P1, DOI 10.1016/j.molmet.2017.12.006; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chappuis S, 2013, MOL METAB, V2, P184, DOI 10.1016/j.molmet.2013.05.002; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dunbar CE, 2018, SCIENCE, V359, P175, DOI 10.1126/science.aan4672; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Giordano Antonio, 2008, V456, P83, DOI 10.1007/978-1-59745-245-8_6; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Jeong JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25265-3; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kataoka N, 2014, CELL METAB, V20, P346, DOI 10.1016/j.cmet.2014.05.018; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Leitner BP, 2017, P NATL ACAD SCI USA, V114, P8649, DOI 10.1073/pnas.1705287114; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Montgomery KL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7577; Morrison SF, 2018, HAND CLINIC, V156, P281, DOI 10.1016/B978-0-444-63912-7.00017-5; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Peirce V, 2013, LANCET DIABETES ENDO, V1, P353, DOI 10.1016/S2213-8587(13)70055-X; Razzoli M, 2018, FASEB J, V32, P5640, DOI 10.1096/fj.201800452R; Razzoli M, 2016, TRENDS ENDOCRIN MET, V27, P504, DOI 10.1016/j.tem.2016.04.007; Razzoli M, 2016, MOL METAB, V5, P19, DOI 10.1016/j.molmet.2015.10.005; Rondini EA, 2017, J PHARMACOL EXP THER, V363, P367, DOI 10.1124/jpet.117.243253; Rooks CR, 2005, AM J PHYSIOL-REG I, V289, pR92, DOI 10.1152/ajpregu.00858.2004; Sack BK, 2009, CURR OPIN MOL THER, V11, P493; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; San Sebastian W, 2013, GENE THER, V20, P1178, DOI 10.1038/gt.2013.48; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Swindle MM, 2002, LAB ANIMAL MED, P955, DOI DOI 10.1016/B978-012263951-7/50025-9; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Uhrig-Schmidt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116288; Xiao CY, 2015, OBESITY, V23, P1450, DOI 10.1002/oby.21124; Xue RD, 2015, NAT MED, V21, P760, DOI 10.1038/nm.3881; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055	43	8	9	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2765	2773		10.1096/fj.201901361RR	http://dx.doi.org/10.1096/fj.201901361RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908033	Green Accepted			2022-12-28	WOS:000514663600057
J	Taghian, T; Metelev, VG; Zhang, SR; Bogdanov, AA				Taghian, Toloo; Metelev, Valeriy G.; Zhang, Surong; Bogdanov, Alexei A., Jr.			Imaging NF-kappa B activity in a murine model of early stage diabetes	FASEB JOURNAL			English	Article						beta cells; imaging probes; NF-kappa B; oligodeoxyribonucleotide duplex; type 1 diabetes	BETA-CELL DEATH; CRYSTAL-STRUCTURE; HUMAN ISLETS; TYPE-1; FLUORESCENCE; RECEPTOR; MICE; INFLAMMATION; INHIBITION; ACTIVATION	Early pro-inflammatory signaling in the endocrine pancreas involves activation of NF-kappa B, which is believed to be important for determining the ultimate fate of beta-cells and hence progression of type 1 diabetes (T1D). Thus, early non-invasive detection of NF-kappa B in pancreatic islets may serve as a potential strategy for monitoring early changes in pancreatic endocrine cells eventually leading to T1D. We investigated the feasibility of optical imaging of NF-kappa B transcription factor activation induced by low-dose streptozocin (LD-STZ) treatment in the immunocompetent SKH1 mouse model of early stage diabetes. In this model, we showed that the levels of NF-kappa B may be visualized and measured by fluorescence intensity of specific near-infrared (NIR) fluorophore-labeled oligodeoxyribonucleotide duplex (ODND) probes. In addition, NF-kappa B activation following LD-STZ treatment was validated using immunofluorescence and transgenic animals expressing NF-kappa B inducible imaging reporter. We showed that LD-STZ-treated SKH1 mice had significantly higher (2-3 times, P < .01) specific NIR FI in the nuclei and cytoplasm of islets cells than in non-treated control mice and this finding was corroborated by immunoblotting and electrophoretic mobility shift assays. Finally, using semi-quantitative confocal analysis of non-fixed pancreatic islet microscopy we demonstrated that ODND probes may be used to distinguish between the islets with high levels of NF-kappa B transcription factor and control islet cells.	[Taghian, Toloo; Metelev, Valeriy G.; Zhang, Surong; Bogdanov, Alexei A., Jr.] Univ Massachusetts, Sch Med, Dept Radiol, 55 Lake Ave North, Worcester, MA 01655 USA; [Metelev, Valeriy G.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia	University of Massachusetts System; University of Massachusetts Worcester; Lomonosov Moscow State University	Bogdanov, AA (corresponding author), Univ Massachusetts, Sch Med, Dept Radiol, 55 Lake Ave North, Worcester, MA 01655 USA.	alexei.bogdanov@umassmed.edu	Bogdanov, Alexei A/K-4946-2017	Bogdanov, Alexei A/0000-0003-4806-5869	NIH [1R01DK095728, 2R01EB000858]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: 1R01DK095728 and 2R01EB000858	Adenis A, 2005, B CANCER, V92, pS21; Bogdanov AA, 2012, MOL BIOSYST, V8, P2166, DOI 10.1039/c2mb25057h; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chang I, 2003, DIABETES, V52, P1169, DOI 10.2337/diabetes.52.5.1169; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.0404307101; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; Gaglia JL, 2015, P NATL ACAD SCI USA, V112, P2139, DOI 10.1073/pnas.1424993112; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Imagawa A, 2001, DIABETES, V50, P1269, DOI 10.2337/diabetes.50.6.1269; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; KOLB H, 1990, Journal of Autoimmunity, V3, P117; Laurent D, 2016, DIABETES OBES METAB, V18, P6, DOI 10.1111/dom.12544; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Liuwantara D, 2006, DIABETES, V55, P2491, DOI 10.2337/db06-0142; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Medarova Z, 2011, DIABETES-METAB RES, V27, P767, DOI 10.1002/dmrr.1249; Metelev V, 2013, MOL BIOSYST, V9, P2447, DOI 10.1039/c3mb70108e; Metelev V, 2011, BIOCONJUGATE CHEM, V22, P759, DOI 10.1021/bc100553e; Naamane N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-55; Ntziachristos V, 2002, NAT MED, V8, P757, DOI 10.1038/nm729; PAPACCIO G, 1993, HISTOL HISTOPATHOL, V8, P751; Pirot P, 2008, ARQ BRAS ENDOCRINOL, V52, P156, DOI 10.1590/S0004-27302008000200003; Reiner T, 2011, P NATL ACAD SCI USA, V108, P12815, DOI 10.1073/pnas.1109859108; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Schott-Ohly P, 2004, EXP BIOL MED, V229, P1177, DOI 10.1177/153537020422901113; Sevick-Muraca EM, 2002, CURR OPIN CHEM BIOL, V6, P642, DOI 10.1016/S1367-5931(02)00356-3; Shehata AM, 2011, PHYTOMEDICINE, V18, P1037, DOI 10.1016/j.phymed.2011.06.035; Signore A, 1996, CLIN EXP RHEUMATOL, V14, pS41; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Tabatadze D, 2008, NUCLEOS NUCLEOT NUCL, V27, P157, DOI 10.1080/15257770701795938; Wang P, 2014, DIABETES, V63, P1465, DOI 10.2337/db13-1543; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63; Zhang S, 2008, OLIGONUCLEOTIDES, V18, P235, DOI 10.1089/oli.2008.0135; Zhang S, 2008, P NATL ACAD SCI USA, V105, P4156, DOI 10.1073/pnas.0800162105	43	1	1	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1198	1210		10.1096/fj.201801147R	http://dx.doi.org/10.1096/fj.201801147R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914655	Green Accepted			2022-12-28	WOS:000507308900081
J	Teng, YS; Zhao, YL; Li, MS; Liu, YG; Cheng, P; Lv, YP; Mao, FY; Chen, W; Yang, SM; Hao, CJ; Peng, LS; Zhang, JY; Zhang, WJ; Zou, QM; Zhuang, Y				Teng, Yong-Sheng; Zhao, Yong-Liang; Li, Mao-Shi; Liu, Yu-Gang; Cheng, Ping; Lv, Yi-Pin; Mao, Fang-Yuan; Chen, Weisan; Yang, Shi-Ming; Hao, Chuan-Jie; Peng, Liu-Sheng; Zhang, Jin-Yu; Zhang, Wei-Jun; Zou, Quan-Ming; Zhuang, Yuan			Upexpression of BHLHE40 in gastric epithelial cells increases CXCL12 production through interaction with p-STAT3 in Helicobacter pylori-associated gastritis	FASEB JOURNAL			English	Article						BHLHE40; cagA; CXCL12; Helicobacter pylori; p-STAT3	TRANSCRIPTION FACTOR DEC1; TH17 RESPONSES; H. PYLORI; EXPRESSION; REGULATOR; CHEMOKINE; HYPOXIA; MUCOSA; STRA13; STAT3	BHLHE40, a member of the basic helix-loop-helix transcription factor family, has been reported to play an important role in inflammatory diseases. However, the regulation and function of BHLHE40 in Helicobacter pylori (H pylori)-associated gastritis is unknown. We observed that gastric BHLHE40 was significantly elevated in patients and mice with H pylori infection. Then, we demonstrate that H pylori-infected GECs express BHLHE40 via cagA-ERK pathway. BHLHE40 translocates to cell nucleus, and then binds to cagA protein-activated p-STAT3 (Tyr705). The complex increases chemotactic factor CXCL12 expression (production). Release of CXCL12 from GECs fosters CD4(+) T cell infiltration in the gastric mucosa. Our results identify the cagA-BHLHE40-CXCL12 axis that contributes to inflammatory response in gastric mucosa during H pylori infection.	[Teng, Yong-Sheng; Liu, Yu-Gang; Cheng, Ping; Lv, Yi-Pin; Mao, Fang-Yuan; Hao, Chuan-Jie; Peng, Liu-Sheng; Zhang, Jin-Yu; Zhang, Wei-Jun; Zou, Quan-Ming; Zhuang, Yuan] Third Mil Med Univ, Dept Microbiol & Biochem Pharm, Coll Pharm & Lab Med, Natl Engn Res Ctr Immunol Prod, 30 Gaotanyan St, Chongqing 400038, Peoples R China; [Zhao, Yong-Liang] Third Mil Med Univ, Dept Gen Surg, Chongqing, Peoples R China; [Zhao, Yong-Liang] Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, Chongqing, Peoples R China; [Li, Mao-Shi] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Chen, Weisan] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Yang, Shi-Ming] Third Mil Med Univ, XinQiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; La Trobe University; Army Medical University	Zou, QM; Zhuang, Y (corresponding author), Third Mil Med Univ, Dept Microbiol & Biochem Pharm, Coll Pharm & Lab Med, Natl Engn Res Ctr Immunol Prod, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	qmzou@tmmu.edu.cn; yuanzhuang1983@yahoo.com	Mao, Fangyuan/CAF-1614-2022; Teng, Yong-sheng/CAG-8033-2022; lv, yipin/CAI-9979-2022	/0000-0003-4634-1460	National Key Research and Development Program of China [2016YFC1302200]; National Natural Science Foundation of China (NSFC) [81870394, 81372560]	National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Key Research and Development Program of China, Grant/Award Number: 2016YFC1302200; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870394 and 81372560	Amieva M, 2016, GASTROENTEROLOGY, V150, P64, DOI 10.1053/j.gastro.2015.09.004; Bagheri V, 2016, CYTOKINE, V85, P1, DOI 10.1016/j.cyto.2016.05.025; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Bodger K, 1998, BRIT MED BULL, V54, P139; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dotan I, 2010, INFLAMM BOWEL DIS, V16, P583, DOI 10.1002/ibd.21106; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Fakhari Shohreh, 2014, Adv Biomed Res, V3, P19, DOI 10.4103/2277-9175.124650; Fallone CA, 2019, GASTROENTEROLOGY, V157, P44, DOI 10.1053/j.gastro.2019.04.011; Garhart CA, 2002, INFECT IMMUN, V70, P3529, DOI 10.1128/IAI.70.7.3529-3538.2002; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Jia YF, 2018, GASTRIC CANCER, V21, P632, DOI 10.1007/s10120-017-0780-z; Kanda M, 2016, P NATL ACAD SCI USA, V113, pE3394, DOI 10.1073/pnas.1604178113; Kandulski A, 2010, ANTICANCER RES, V30, P1093; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Legler DF, 2016, CHIMIA, V70, P856, DOI 10.2533/chimia.2016.856; Lin CC, 2016, J EXP MED, V213, P251, DOI 10.1084/jem.20150568; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lina TT, 2013, J IMMUNOL, V191, P3838, DOI 10.4049/jimmunol.1300524; Liu H, 2018, EXP NEUROL, V306, P55, DOI 10.1016/j.expneurol.2018.04.013; Martinez-Llordella M, 2013, J EXP MED, V210, P1603, DOI 10.1084/jem.20122387; Mejias-Luque R, 2017, GUT, V66, P1369, DOI 10.1136/gutjnl-2015-310783; Menheniott TR, 2015, CELL MICROBIOL, V17, P1570, DOI 10.1111/cmi.12518; Miyazaki K, 2010, J IMMUNOL, V185, P7330, DOI 10.4049/jimmunol.1001381; Roussel Y, 2005, J MICROBIOL METH, V62, P71, DOI 10.1016/j.mimet.2005.01.011; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Seimiya M, 2004, EUR J IMMUNOL, V34, P1322, DOI 10.1002/eji.200324700; Seimiya M, 2002, BIOCHEM BIOPH RES CO, V292, P121, DOI 10.1006/bbrc.2002.6605; Shi Y, 2010, J IMMUNOL, V184, P5121, DOI 10.4049/jimmunol.0901115; Shibata W, 2013, GUT, V62, P192, DOI 10.1136/gutjnl-2011-301824; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Zhang W, 2015, GUT, V64, P1715, DOI 10.1136/gutjnl-2015-309900; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014; Zhuang Y, 2015, GUT, V64, P1368, DOI 10.1136/gutjnl-2014-307020	37	9	9	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1169	1181		10.1096/fj.201900464RR	http://dx.doi.org/10.1096/fj.201900464RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914631				2022-12-28	WOS:000507308900079
J	Tolson, KP; Marooki, N; De Bond, JAP; Walenta, E; Stephens, SBZ; Liaw, RB; Savur, R; Wolfe, A; Oh, DY; Smith, JT; Kauffman, AS				Tolson, Kristen P.; Marooki, Nuha; De Bond, Julie-Ann P.; Walenta, Evelyn; Stephens, Shannon B. Z.; Liaw, Reanna B.; Savur, Rishi; Wolfe, Andrew; Oh, Da Young; Smith, Jeremy T.; Kauffman, Alexander S.			Conditional knockout of kisspeptin signaling in brown adipose tissue increases metabolic rate and body temperature and lowers body weight	FASEB JOURNAL			English	Article						adipose; BAT; fat; GPR54; Kiss1; Kiss1r; kisspeptin; metabolism; obesity; temperature	PROTEIN-COUPLED RECEPTOR; TRANSCRIPTIONAL CONTROL; EXPRESSION; CORTEX; FAT	The peptide kisspeptin and its receptor, Kiss1r, act centrally to stimulate reproduction. Evidence indicates that kisspeptin signaling is also important for body weight (BW) and metabolism. We recently reported that Kiss1r KO mice develop obesity, along with reduced metabolism and energy expenditure, independent of estradiol levels. Outside the brain, Kiss1r is expressed in several metabolic tissues, including brown adipose tissue (BAT), but it is unknown which specific tissue is responsible for the metabolic phenotype in Kiss1r KOs. We first determined that global Kiss1r KO mice have significant alterations in body temperature and BAT thermogenic gene expression, perhaps contributing to their obesity. Next, to test whether kisspeptin signaling specifically in BAT influences BW, metabolism, or body temperature, we used Cre/lox technology to generate conditional Kiss1r knockout exclusively in BAT (BAT-Kiss1r KO). Unlike global Kiss1r KOs, BAT-Kiss1r KOs (lacking Kiss1r in just BAT) were not hypogonadal, as expected. Surprisingly, however, BAT-Kiss1r KOs of both sexes displayed significantly lower BW and adiposity than controls. This novel BAT-Kiss1r KO phenotype was of greater magnitude in females and was associated with improved glucose tolerance, increased metabolism, energy expenditure, and locomotor activity, along with increased body temperature and BAT gene expression, specifically Cox8b. Our findings suggest that the previously observed obesity and decreased metabolism in global Kiss1r KOs reflect impaired kisspeptin signaling in non-BAT tissues. However, the novel finding of increased metabolism and body temperature and lower BW in BAT-Kiss1r KOs reveal a previously unidentified role for endogenous kisspeptin signaling in BAT in modulating metabolic and thermogenic physiology.	[Tolson, Kristen P.; Marooki, Nuha; Stephens, Shannon B. Z.; Liaw, Reanna B.; Savur, Rishi; Kauffman, Alexander S.] Univ Calif San Diego, Dept OBGYN & Reprod Sci, 9500 Gilman Dr,0674, La Jolla, CA 92093 USA; [De Bond, Julie-Ann P.; Smith, Jeremy T.] Univ Western Australia, Sch Human Sci, Perth, WA, Australia; [Walenta, Evelyn; Oh, Da Young] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wolfe, Andrew] Johns Hopkins Univ, Dept Pediat & Physiol, Baltimore, MD USA; [Wolfe, Andrew] NIH, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA	University of California System; University of California San Diego; University of Western Australia; University of California System; University of California San Diego; Johns Hopkins University; National Institutes of Health (NIH) - USA	Kauffman, AS (corresponding author), Univ Calif San Diego, Dept OBGYN & Reprod Sci, 9500 Gilman Dr,0674, La Jolla, CA 92093 USA.	akauffman@ucsd.edu		Stephens, Shannon/0000-0002-4645-4214	NIH [R01 HD082567, R01 HD090161, R01 HD068777, R01 DK108773, P30 DK063491, U01 HD066432, K99 HD092894, P50 HD012303, F32 HD076606, T32 HD007203]; American Heart Association [14SDG19880020]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	NIH, Grant/Award Number: R01 HD082567, R01 HD090161, R01 HD068777, R01 DK108773, P30 DK063491, U01 HD066432, K99 HD092894, P50 HD012303, F32 HD076606 and T32 HD007203; American Heart Association, Grant/Award Number: 14SDG19880020	Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001; Colledge WH, 2009, PEPTIDES, V30, P34, DOI 10.1016/j.peptides.2008.05.006; De Bond JAP, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12430; Dror T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108555; Dudek M, 2016, NEUROPEPTIDES, V56, P41, DOI 10.1016/j.npep.2016.01.005; Herbison AE, 2018, ENDOCRINOLOGY, V159, P3723, DOI 10.1210/en.2018-00653; Herbison AE, 2016, NAT REV ENDOCRINOL, V12, P452, DOI 10.1038/nrendo.2016.70; Herbison AE, 2010, ENDOCRINOLOGY, V151, P312, DOI 10.1210/en.2009-0552; Kauffman AS, 2010, MOL CELL ENDOCRINOL, V324, P51, DOI 10.1016/j.mce.2010.01.017; Koemeter-Cox AI, 2014, P NATL ACAD SCI USA, V111, P10335, DOI 10.1073/pnas.1403286111; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Laursen WJ, 2015, P NATL ACAD SCI USA, V112, P1607, DOI 10.1073/pnas.1421419112; Lengacher S, 2004, J CEREBR BLOOD F MET, V24, P780, DOI 10.1097/01.WCB.0000122743.72175.52; Mehler-Wex C, 2006, J NEURAL TRANSM, V113, P1383, DOI 10.1007/s00702-005-0425-y; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Novaira HJ, 2014, MOL ENDOCRINOL, V28, P225, DOI 10.1210/me.2013-1319; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pruszynska-Oszmaek E, 2017, ENDOCRINE, V56, P54, DOI 10.1007/s12020-017-1248-y; Seale P, 2010, INT J OBESITY, V34, pS17, DOI 10.1038/ijo.2010.178; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Silva JE, 1997, EUR J ENDOCRINOL, V136, P251, DOI 10.1530/eje.0.1360251; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Tolson KP, 2019, MOL CELL ENDOCRINOL, V498, DOI 10.1016/j.mce.2019.110559; Tolson KP, 2016, ENDOCRINOLOGY, V157, P4192, DOI 10.1210/en.2016-1501; Tolson KP, 2014, J CLIN INVEST, V124, P3075, DOI 10.1172/JCI71075	27	21	21	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					107	121		10.1096/fj.201901600R	http://dx.doi.org/10.1096/fj.201901600R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914628	Green Published, Green Accepted			2022-12-28	WOS:000507308900009
J	Xue, MT; Shi, Y; Pang, AM; Men, L; Hu, YH; Zhou, PF; Long, GF; Tian, X; Wang, R; Zhao, YH; Liao, XD; Shen, YN; Cui, YJ				Xue, Meiting; Shi, Yue; Pang, Aiming; Men, Li; Hu, Yahui; Zhou, Pengfei; Long, Guangfeng; Tian, Xin; Wang, Rong; Zhao, Yonghua; Liao, Xudong; Shen, Yanna; Cui, Yujie			Corin plays a protective role via upregulating MAPK and downregulating eNOS in diabetic nephropathy endothelial dysfunction	FASEB JOURNAL			English	Article						Corin; diabetic nephropathy; endothelial dysfunction; eNOS; MAPK	ATRIAL-NATRIURETIC-PEPTIDE; SERINE-PROTEASE; PROGRESSION	Diabetic nephropathy (DN) is one of the leading causes of mortality in diabetic patients, but its pathogenesis is unclear. We aimed to study the role of the pro-ANP convertase Corin in the pathogenesis of DN. Corin and ANP expression in DN rat kidneys and high-glucose-treated HK-2 cells was analyzed by real-time PCR, western blotting, and immunohistochemical staining. The effect of Corin-siRNA or ANP-siRNA HK-2 cells on EA.hy926 cell migration was determined by scratch-wound healing assay. The expression of mitogen-activated protein kinase (MAPK) and endothelial NO synthase (eNOS) in EA.hy926 cells treated with conditioned medium from Corin-siRNA- or ANP-siRNA-transfected HK-2 cells was determined by western blotting. We found a significant reduction in Corin and ANP expression in DN rat kidneys. These results were recapitulated in HK-2 cells treated with high glucose. EA.hy926 cells treated with conditioned medium from Corin-deficient HK-2 cells had inhibited migration, increased MAPK activity, and decreased eNOS activity. Similar effects were observed with ANP-siRNA transfection. Finally, adding ANP to the Corin-deficient HK-2 conditioned medium rescued the above defects, indicating that Corin mediates its effects through ANP. In conclusion, Corin plays a renoprotective role through pro-ANP processing, and defects in Corin cause endothelial dysfunction through MAPK and eNOS signaling in DN.	[Xue, Meiting; Shi, Yue; Men, Li; Hu, Yahui; Zhou, Pengfei; Long, Guangfeng; Tian, Xin; Wang, Rong; Shen, Yanna; Cui, Yujie] Tianjin Med Univ, Sch Med Lab, 1 Guangdong Rd, Tianjin 300203, Peoples R China; [Xue, Meiting] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Xue, Meiting] Tianjins Clin Res Ctr Canc, Key Lab Canc Immunol & Biotherapy, Tianjin, Peoples R China; [Pang, Aiming] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Hematopoiet Stem Cell Transplantat Ctr, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Zhao, Yonghua] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau, Peoples R China; [Liao, Xudong] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Univ Hosp Cleveland Med Ctr, Cleveland, OH USA	Tianjin Medical University; Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; University of Macau; Case Western Reserve University; University Hospitals of Cleveland	Shen, YN; Cui, YJ (corresponding author), Tianjin Med Univ, Sch Med Lab, 1 Guangdong Rd, Tianjin 300203, Peoples R China.	shenyanna@sina.com; yujiecui1@126.com	Zhao, Yonghua/AAC-4728-2019	Zhao, Yonghua/0000-0001-8714-0476	National Natural Science Foundation of China [81200116, 81772252, 81601836]; Yeehong Business School of Shenyang Pharmaceutical University (Sansheng TCP Young Research Funding) [57]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yeehong Business School of Shenyang Pharmaceutical University (Sansheng TCP Young Research Funding)	This work was supported by the National Natural Science Foundation of China (81200116, 81772252, and 81601836) and Thrombocytopenia Funding from Yeehong Business School of Shenyang Pharmaceutical University (Sansheng TCP Young Research Funding, No. 57)	Breton-Romero R, 2016, ARTERIOSCL THROM VAS, V36, P561, DOI 10.1161/ATVBAHA.115.306578; Chandra S, 2019, EUR J PHARMACOL, V844, P26, DOI 10.1016/j.ejphar.2018.11.027; Charan K, 2016, J SURG RES, V201, P272, DOI 10.1016/j.jss.2015.10.045; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Everett TR, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0717-2; Fang CD, 2013, CLIN SCI, V124, P709, DOI 10.1042/CS20120517; Fathy SA, 2015, BIOMARKERS, V20, P460, DOI 10.3109/1354750X.2015.1093032; Hou BY, 2017, CELL PHYSIOL BIOCHEM, V44, P2378, DOI 10.1159/000486154; Hovind P, 2001, KIDNEY INT, V59, P702, DOI 10.1046/j.1523-1755.2001.059002702.x; Kaur R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0763-3; Kerkela R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002423; King GL, 2016, DIABETES, V65, P1462, DOI 10.2337/db16-0152; Klein JD, 2010, KIDNEY INT, V78, P635, DOI 10.1038/ki.2010.223; Lin XP, 2018, J VASC RES, V55, P169, DOI 10.1159/000489958; Nagasu H, 2012, AM J PHYSIOL-RENAL, V302, pF1402, DOI 10.1152/ajprenal.00459.2011; Nicholls SJ, 2008, J AM COLL CARDIOL, V52, P255, DOI 10.1016/j.jacc.2008.03.051; Pang AM, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0298-9; Pernow J, 2015, BRIT J PHARMACOL, V172, P4684, DOI 10.1111/bph.13242; Polzin D, 2010, KIDNEY INT, V78, P650, DOI 10.1038/ki.2010.197; Qi HY, 2017, DIABETES, V66, P763, DOI 10.2337/db16-0695; Ricciardi CA, 2016, CLIN EXP MED, V16, P443, DOI 10.1007/s10238-015-0374-1; Roussel R, 2004, DIABETES, V53, P1394, DOI 10.2337/diabetes.53.5.1394; Sharma A, 2015, DIABETES, V64, P3937, DOI 10.2337/db15-0472; Shi Y, 2017, J DIABETES, V9, P434, DOI 10.1111/1753-0407.12521; Singh Lakhwinder, 2018, Journal of Basic and Clinical Physiology and Pharmacology, V29, P499, DOI 10.1515/jbcpp-2017-0146; Stark RJ, 2018, FASEB J, V32, P945, DOI 10.1096/fj.201700410R; Tulafu M, 2014, J SURG RES, V186, P217, DOI 10.1016/j.jss.2013.07.033; Vicen M, 2019, FASEB J, V33, P6099, DOI 10.1096/fj.201802245R; Wang J, 2017, J CELL BIOCHEM, V118, P2325, DOI 10.1002/jcb.25889; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woodman OL, 2008, LIFE SCI, V82, P847, DOI 10.1016/j.lfs.2008.01.016; Xu XD, 2019, ECOTOX ENVIRON SAFE, V170, P188, DOI 10.1016/j.ecoenv.2018.11.124; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097; Zhou HB, 2018, J TISSUE ENG REGEN M, V12, P973, DOI 10.1002/term.2514	35	8	9	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					95	106		10.1096/fj.201900531RR	http://dx.doi.org/10.1096/fj.201900531RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914697				2022-12-28	WOS:000507308900008
J	Yu, HT; Wang, YM; Zeng, XF; Cai, S; Wang, G; Liu, L; Huang, S; Li, N; Liu, HB; Ding, XL; Song, QL; Qiao, SY				Yu, Haitao; Wang, Yuming; Zeng, Xiangfang; Cai, Shuang; Wang, Gang; Liu, Lu; Huang, Shuo; Li, Ning; Liu, Hongbin; Ding, Xiuliang; Song, Qinglong; Qiao, Shiyan			Therapeutic administration of the recombinant antimicrobial peptide microcin J25 effectively enhances host defenses against gut inflammation and epithelial barrier injury induced by enterotoxigenic Escherichia coli infection	FASEB JOURNAL			English	Article						gut microbiota; inflamed gut; inflammation diseases; intestinal barrier injury; mice; pathogens infection	ENCODED ANTIBACTERIAL PEPTIDES; TIGHT JUNCTION PERMEABILITY; CHAIN FATTY-ACIDS; GROWTH-PERFORMANCE; CATHELICIDIN-WA; MICROBIOTA; EXPRESSION; IMPROVES; BACTERIA; DIARRHEA	Recombinant antimicrobial peptide microcin J25 (MccJ25) causes potent antimicrobial activity against enterotoxigenic Escherichia coli (ETEC) in vitro; however, independently of this activity, its role in suppressing intestinal inflammation and epithelial barrier injury in vivo remains unclear. We investigated the therapeutic effects of MccJ25 on intestinal inflammation and epithelial barrier dysfunction and the underlying mechanism, using gentamicin for comparison. In a mouse model of intestinal inflammation, therapeutic administration of either MccJ25 or gentamicin after ETEC K88 infection attenuated clinical symptoms, reduced intestinal pathogen colonization, improved intestinal morphology, and decreased inflammatory pathologies and intestinal permeability, ultimately improving the hosts' health. MccJ25 also attenuated ETEC-induced mouse intestinal barrier dysfunction by enhancing tight junction proteins (TJPs). Using the human epithelial cell line Caco-2, we verified the epithelial barrier-strengthening and mucosal injury-alleviating effects of MccJ25 on ETEC infection: increased expression of TJPs by activating the p38/MAPK pathway, balancing the microbiota, and improving short-chain fatty acid concentrations in the cecum of ETEC-infected mice. Although gentamicin and MccJ25 had similar effects in the inflamed gut, MccJ25 was superior to gentamicin with regard to defending the host from ETEC infection. Overall, MccJ25 may be a promising therapeutic drug for treating enteric pathogen-induced intestinal inflammation diseases.	[Yu, Haitao; Wang, Yuming; Zeng, Xiangfang; Cai, Shuang; Wang, Gang; Liu, Lu; Huang, Shuo; Li, Ning; Liu, Hongbin; Ding, Xiuliang; Song, Qinglong; Qiao, Shiyan] China Agr Univ, Feed Ind Ctr, Minist Agr & Rural Affairs, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China; [Yu, Haitao; Wang, Yuming; Zeng, Xiangfang; Cai, Shuang; Wang, Gang; Liu, Lu; Huang, Shuo; Li, Ning; Liu, Hongbin; Ding, Xiuliang; Song, Qinglong; Qiao, Shiyan] Beijing Key Lab Biofeed Addit, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Qiao, SY (corresponding author), China Agr Univ, Feed Ind Ctr, Minist Agr & Rural Affairs, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	qiaoshiyan@cau.edu.cn	Wang, Yu/GZL-9655-2022; hongbin, Liu/GPC-5156-2022	hongbin, Liu/0000-0002-5840-2374	National Key Research and Development Program of China [2016YFD0501308]; Special Fund for Agro-scientific Research in the Public Interest (Agro-Scientific Research in the Public Interest of China) [201403047]; Beijing Swine Innovation Team of Modern Agriculture Industry Technological System	National Key Research and Development Program of China; Special Fund for Agro-scientific Research in the Public Interest (Agro-Scientific Research in the Public Interest of China); Beijing Swine Innovation Team of Modern Agriculture Industry Technological System	National Key Research and Development Program of China, Grant/Award Number: 2016YFD0501308; Special Fund for Agro-scientific Research in the Public Interest (Agro-Scientific Research in the Public Interest of China), Grant/Award Number: 201403047; the Beijing Swine Innovation Team of Modern Agriculture Industry Technological System	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Agus A, 2015, GASTROENTEROLOGY, V148, pS706; Ahmed I., 2016, MICROBIOME METABOLOM, V4, P20, DOI [10.3390/microorganisms402002027681914, DOI 10.3390/MICROORGANISMS402002027681914]; Akiyama T, 2014, J INNATE IMMUN, V6, P739, DOI 10.1159/000362789; Al-Sadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085345; BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; BLACK RE, 1990, REV INFECT DIS, V12, pS73; Blond A, 1999, EUR J BIOCHEM, V259, P747, DOI 10.1046/j.1432-1327.1999.00085.x; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Cao JC, 2018, ACS SYNTH BIOL, V7, P896, DOI 10.1021/acssynbio.7b00396; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; de la Fuente-Nunez C, 2017, CURR OPIN MICROBIOL, V37, P95, DOI 10.1016/j.mib.2017.05.014; Duquesne S, 2007, J MOL MICROB BIOTECH, V13, P200, DOI 10.1159/000104748; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Falagas ME, 2012, ANTIMICROB AGENTS CH, V56, P4214, DOI 10.1128/AAC.00663-12; Faure M, 2003, DIGEST DIS SCI, V48, P1366, DOI 10.1023/A:1024175629909; Feng T, 2011, MUCOSAL IMMUNOL, V4, P15, DOI 10.1038/mi.2010.60; Forkus B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40695; Frick JS, 2013, CURR TOP MICROBIOL, V358, P273, DOI 10.1007/82_2012_217; Furter M, 2019, CELL REP, V27, P2665, DOI 10.1016/j.celrep.2019.04.106; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Han FF, 2015, J IMMUNOL, V194, P1882, DOI 10.4049/jimmunol.1402300; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jiang Q, 2016, INT IMMUNOPHARMACOL, V39, P181, DOI 10.1016/j.intimp.2016.07.029; Johnson AM, 2010, VET MICROBIOL, V141, P115, DOI 10.1016/j.vetmic.2009.08.020; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kiatsurayanon C, 2014, J INVEST DERMATOL, V134, P2163, DOI 10.1038/jid.2014.143; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Langerholc T, 2011, TRENDS FOOD SCI TECH, V22, pS11, DOI 10.1016/j.tifs.2011.03.010; Ling KH, 2016, CHEM RES TOXICOL, V29, P823, DOI 10.1021/acs.chemrestox.6b00001; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Lopez FE, 2007, J ANTIMICROB CHEMOTH, V59, P676, DOI 10.1093/jac/dkm009; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Ma X, 2012, J ANIM SCI, V90, P266, DOI 10.2527/jas.50965; Ma X, 2015, J CELL PHYSIOL, V230, P752, DOI 10.1002/jcp.24838; Ma ZX, 2018, J HAZARD MATER, V341, P248, DOI 10.1016/j.jhazmat.2017.07.071; Markey L, 2018, GUT MICROBES, V9, P497, DOI 10.1080/19490976.2018.1465158; Mondal D, 2009, AM J TROP MED HYG, V80, P824, DOI 10.4269/ajtmh.2009.80.824; Myerscough N, 1995, BIOCHEM SOC T, V23, pS536, DOI 10.1042/bst023536s; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Pizarro-Guajardo M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00365; Rabanal F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10558; Rebuffat S, 2004, CURR PROTEIN PEPT SC, V5, P383, DOI 10.2174/1389203043379611; Ren WK, 2014, MICROBES INFECT, V16, P954, DOI 10.1016/j.micinf.2014.09.005; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; SALOMON RA, 1992, J BACTERIOL, V174, P7428, DOI 10.1128/jb.174.22.7428-7435.1992; Sam QH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020330; Sassone-Corsi M, 2016, NATURE, V540, P280, DOI 10.1038/nature20557; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Song DG, 2017, ACS APPL MATER INTER, V9, P14724, DOI 10.1021/acsami.7b03377; Song JC, 2001, AM J PHYSIOL-CELL PH, V281, pC649, DOI 10.1152/ajpcell.2001.281.2.C649; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang Q, 2008, SHOCK, V29, P531, DOI 10.1097/SHK.0b013e318150737f; Wang S, 2015, J ANIM SCI, V93, P4750, DOI 10.2527/jas.2015-9284; Wang S, 2017, J AGR FOOD CHEM, V65, P8595, DOI 10.1021/acs.jafc.7b02592; Wang YZ, 2007, ANIM FEED SCI TECH, V135, P263, DOI 10.1016/j.anifeedsci.2006.07.013; Wilson JC, 2016, J CROHNS COLITIS, V10, P186, DOI 10.1093/ecco-jcc/jjv193; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Wlodarska M, 2010, MUCOSAL IMMUNOL, V3, P100, DOI 10.1038/mi.2009.135; Wu SD, 2012, PEPTIDES, V35, P225, DOI 10.1016/j.peptides.2012.03.030; Wu YP, 2016, VET IMMUNOL IMMUNOP, V172, P55, DOI 10.1016/j.vetimm.2016.03.005; Xia X, 2015, MICROBIOL RES, V171, P45, DOI 10.1016/j.micres.2014.12.009; Xiao L, 2016, MOL BIOL CELL, V27, P617, DOI 10.1091/mbc.E15-10-0703; Yi HB, 2017, J IMMUNOL, V198, P1696, DOI 10.4049/jimmunol.1601221; Yi HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep25679; Yu HT, 2017, J ANIM SCI, V95, P5064, DOI 10.2527/jas2017.1494; Yu HT, 2018, J AGR FOOD CHEM, V66, P11301, DOI 10.1021/acs.jafc.8b03405; Yu HT, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00242; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752; Zhu HL, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700814; Zong X, 2016, BIOCHEM PHARMACOL, V104, P74, DOI 10.1016/j.bcp.2016.01.009	85	27	29	3	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1018	1037		10.1096/fj.201901717R	http://dx.doi.org/10.1096/fj.201901717R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914603				2022-12-28	WOS:000507308900069
J	Cai, J; Shao, X; Yan, ZD; Liu, XY; Yang, YQ; Luo, EP; Jing, D				Cai, Jing; Shao, Xi; Yan, Zedong; Liu, Xiyu; Yang, Yongqing; Luo, Erping; Jing, Da			Differential skeletal response in adult and aged rats to independent and combinatorial stimulation with pulsed electromagnetic fields and mechanical vibration	FASEB JOURNAL			English	Article						age-related osteopenia; osteoporosis; bone anabolism; bone quality; canonical Wnt signaling; pulsed electromagnetic fields; whole-body vibration	WHOLE-BODY VIBRATION; PROMOTING BONE-FORMATION; LOW-MAGNITUDE; THERAPY; OSTEOPOROSIS; FRACTURE; STRENGTH; WOMEN; ACTIVATION; PREVENTION	Pulsed electromagnetic fields (PEMFs) and whole-body vibration (WBV) are proved to partially preserve bone mass/strength in hindlimb-unloaded and ovariectomized animals. However, the potential age-dependent skeletal response to either PEMF or WBV has not been fully investigated. Moreover, whether the coupled "mechano-electro-magnetic" signals can induce greater osteogenic potential than single stimulation remains unknown. Herein, 5-month-old or 20-month-old rats were assigned to the Control, PEMF, WBV, and PEMF + WBV groups. After 8-week treatment, single PEMF/WBV enhanced bone mass, strength, and anabolism in 5-month-old rats, but not in 20-month-old rats. PEMF + WBV induced greater increase of bone quantity, quality, and anabolism than single PEMF/WBV in young adult rats. PEMF + WBV also inhibited bone loss in elderly rats by primarily improving osteoblast and osteocyte activity, but had no effects on bone resorption. PEMF + WBV upregulated the expression of various canonical Wnt ligands and downstream molecules (p-GSK-3 beta and beta-catenin), but had no impacts on noncanonical Wnt5a expression in aged skeleton, revealing the potential involvement of canonical Wnt signaling in bone anabolism of PEMF + WBV. This study not only reveals much weaker responsiveness of aged skeleton to single PEMF/WBV relative to young adult skeleton, but also presents a novel noninvasive approach based on combinatorial treatment with PEMF + WBV for improving bone health and preserving bone quantity/quality (especially for age-related osteoporosis) with stronger anabolic effects.	[Cai, Jing] Shaanxi Univ Chinese Med, Coll Basic Med, Xianyang, Peoples R China; [Cai, Jing; Shao, Xi; Yan, Zedong; Liu, Xiyu; Yang, Yongqing; Luo, Erping; Jing, Da] Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China	Shaanxi University of Chinese Medicine; Air Force Military Medical University	Jing, D (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.	jingdaasq@126.com			National Natural Science Foundation of China [31500760, 51777211, 11972366, 51907111]; Young Talent Supporting Project in Military Technology of China [17-JCJQ-QT-038]; Shaanxi Provincial Natural Science Foundation of China [2018JQ8056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talent Supporting Project in Military Technology of China; Shaanxi Provincial Natural Science Foundation of China	National Natural Science Foundation of China, Grant/Award Number: 31500760, 51777211, 11972366 and 51907111; Young Talent Supporting Project in Military Technology of China, Grant/Award Number: 17-JCJQ-QT-038; Shaanxi Provincial Natural Science Foundation of China, Grant/Award Number: 2018JQ8056	ANDERSON JC, 1970, NATURE, V227, P491, DOI 10.1038/227491a0; Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24; Bala Y, 2012, J BONE MINER RES, V27, P825, DOI 10.1002/jbmr.1501; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; BASSETT CAL, 1974, SCIENCE, V184, P575; Benhaj K, 2006, ONCOL REP, V15, P701; Blume SW, 2011, OSTEOPOROSIS INT, V22, P1835, DOI 10.1007/s00198-010-1419-7; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cai J, 2018, OSTEOPOROSIS INT, V29, P1177, DOI 10.1007/s00198-018-4392-1; Catalano A, 2018, BONE, V116, P42, DOI 10.1016/j.bone.2018.07.010; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Chan ME, 2013, CURR OSTEOPOROS REP, V11, P36, DOI 10.1007/s11914-012-0132-1; Chan ME, 2012, FASEB J, V26, P4855, DOI 10.1096/fj.12-209841; Clarke BL, 1996, J CLIN ENDOCR METAB, V81, P2264, DOI 10.1210/jc.81.6.2264; De Laet CEDH, 2000, BEST PRACT RES CL EN, V14, P171, DOI 10.1053/beem.2000.0067; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Gabel L, 2017, J BONE MINER RES, V32, P1525, DOI 10.1002/jbmr.3115; Ganesan K, 2009, INDIAN J EXP BIOL, V47, P939; Gao JZ, 2016, ANN BIOMED ENG, V44, P2489, DOI 10.1007/s10439-015-1532-z; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Grace KLR, 1998, ORTHOPEDICS, V21, P297; Gruntmanis U, 2007, AM J MED SCI, V333, P85, DOI 10.1097/00000441-200702000-00004; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Jing D, 2011, OSTEOPOROSIS INT, V22, P1885, DOI 10.1007/s00198-010-1447-3; Jing D, 2018, BONE, V106, P11, DOI 10.1016/j.bone.2017.10.001; Jing D, 2016, J BONE MINER RES, V31, P1713, DOI 10.1002/jbmr.2837; Jing D, 2014, J BONE MINER RES, V29, P2250, DOI 10.1002/jbmr.2260; Jing D, 2014, FASEB J, V28, P1582, DOI 10.1096/fj.13-237578; Jing D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079377; Jing D, 2010, BONE, V46, P487, DOI 10.1016/j.bone.2009.09.021; Khosla S, 2008, ENDOCR REV, V29, P441, DOI 10.1210/er.2008-0002; Kiel DP, 2015, J BONE MINER RES, V30, P1319, DOI 10.1002/jbmr.2448; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lambert Jessica K, 2011, Curr Osteoporos Rep, V9, P229, DOI 10.1007/s11914-011-0066-z; Li XD, 2010, J BONE MINER RES, V25, P2371, DOI 10.1002/jbmr.182; Lynch MA, 2010, J ORTHOP RES, V28, P241, DOI 10.1002/jor.20965; Mahavni V, 2001, CURR OPIN ONCOL, V13, P384, DOI 10.1097/00001622-200109000-00012; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Musette P, 2010, OSTEOPOROSIS INT, V21, P723, DOI 10.1007/s00198-009-1097-5; Olivares-Navarrete R, 2011, ACTA BIOMATER, V7, P2740, DOI 10.1016/j.actbio.2011.02.030; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Razi H, 2015, J BONE MINER RES, V30, P1864, DOI 10.1002/jbmr.2528; Rizzoli R, 2011, CALCIFIED TISSUE INT, V89, P91, DOI 10.1007/s00223-011-9499-8; Rubin C, 2001, FASEB J, V15, P2225, DOI 10.1096/fj.01-0166com; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Sanudo B, 2017, MENOPAUSE, V24, P1208, DOI 10.1097/GME.0000000000000872; Sehmisch S, 2009, OSTEOPOROSIS INT, V20, P1999, DOI 10.1007/s00198-009-0892-3; Shen WW, 2010, BIOELECTROMAGNETICS, V31, P113, DOI 10.1002/bem.20535; Sherk VD, 2013, J CLIN DENSITOM, V16, P104, DOI 10.1016/j.jocd.2012.07.009; Sinder BP, 2013, J BONE MINER RES, V28, P73, DOI 10.1002/jbmr.1717; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Vanleene M, 2013, BONE, V53, P507, DOI 10.1016/j.bone.2013.01.023; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Wang P, 2019, J CELL PHYSIOL, V234, P10588, DOI 10.1002/jcp.27734; Wang T, 2019, OSTEOPOROSIS INT, V30, P267, DOI 10.1007/s00198-018-04822-6; Zhai MM, 2016, BIOELECTROMAGNETICS, V37, P152, DOI 10.1002/bem.21961; Zhu SY, 2017, BIOELECTROMAGNETICS, V38, P406, DOI 10.1002/bem.22065	61	8	8	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3037	3050		10.1096/fj.201902779R	http://dx.doi.org/10.1096/fj.201902779R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908035	Bronze			2022-12-28	WOS:000504854800001
J	Chen, JR; Zhao, HJ; Lazarenko, OP; Blackburn, ML; Shankar, K				Chen, Jin-Ran; Zhao, Haijun; Lazarenko, Oxana P.; Blackburn, Michael L.; Shankar, Kartik			Maternal regulation of SATB2 in osteo-progeniters impairs skeletal development in offspring	FASEB JOURNAL			English	Article						bone; epigenetic; high fat diet; osteoblast	TRANSCRIPTION FACTOR OSTERIX; ADIPOGENIC DIFFERENTIATION; BONE-FORMATION; OBESITY; EZH2; METHYLATION; INHIBITION; ORIGINS; OSTEOPOROSIS; EPIGENETICS	Nutritional status during intrauterine and/or early postnatal life has substantial influence on adult offspring health. Along these lines, there is a growing body of evidence illustrating that high fat diet (HFD)-induced maternal obesity can regulate fetal bone development. Thus, we investigated the effects of maternal obesity on both fetal skeletal development and mechanisms linking maternal obesity to osteoblast differentiation in offspring. Embryonic osteogenic calvarial cells (EOCCs) were isolated from fetuses at gestational day 18.5 (E18.5) of HFD-induced obese rat dams. We observed impaired differentiation of EOCCs to mature osteoblasts from HFD obese dams. ChIP-seq-based genome-wide localization of the repressive histone mark H3K27me3 (mediated via the polycomb histone methyltransferase, enhancer of zeste homologue 2 [Ezh2]) showed that this phenotype was associated with increased enrichment of H3K27me3 on the gene of SATB2, a critical transcription factor required for osteoblast differentiation. Knockdown of Ezh2 in EOCCs and ST2 cells increased SATB2 expression; while Ezh2 overexpression in EOCCs and ST2 cells decreased SATB2 expression. These data were consistent with experimental results showing strong association between H3K27me3, Ezh2, and SATB2 in cells from rats and humans. We have further presented that SATB2 mRNA and protein expression were increased in bones, and increased trabecular bone mass from pre-osteoblast specific Ezh2 deletion (Ezh2(flox/flox) Osx-Cre(+) cko) mice compared with those from control Cre(+) mice. These findings indicate that maternal HFD-induced obesity may be associated with decreasing fetal pre-osteoblastic cell differentiation, under epigenetic control of SATB2 expression via Ezh2-dependent mechanisms.	[Chen, Jin-Ran; Zhao, Haijun; Lazarenko, Oxana P.; Blackburn, Michael L.; Shankar, Kartik] Arkansas Childrens Nutr Ctr, 15 Childrens Way,Slot 512-20B, Little Rock, AR 72202 USA; [Chen, Jin-Ran; Zhao, Haijun; Lazarenko, Oxana P.; Blackburn, Michael L.; Shankar, Kartik] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, 15 Childrens Way,Slot 512-20B, Little Rock, AR 72202 USA.	chenjinran@uams.edu			United States Department of Agriculture [6026-51000-010-05S]; Agricultural Research Service	United States Department of Agriculture(United States Department of Agriculture (USDA)); Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	United States Department of Agriculture, Grant/Award Number: 6026-51000-010-05S; Agricultural Research Service	Adamik J, 2017, MOL CANCER RES, V15, P405, DOI 10.1158/1541-7786.MCR-16-0242-T; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bengani H, 2017, GENET MED, V19, P900, DOI 10.1038/gim.2016.211; Bishop KS, 2015, NUTRIENTS, V7, P922, DOI 10.3390/nu7020922; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen JR, 2018, J ENDOCRINOL, V239, P33, DOI 10.1530/JOE-18-0244; Chen JR, 2016, ENDOCRINOLOGY, V157, P4172, DOI 10.1210/en.2016-1408; Chen JR, 2015, ENDOCRINOLOGY, V156, P475, DOI 10.1210/en.2014-1427; Chen JR, 2013, FASEB J, V27, P3514, DOI 10.1096/fj.12-226464; Chen JR, 2012, FASEB J, V26, P1131, DOI 10.1096/fj.11-197822; Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704; Cooper C, 2009, ADV EXP MED BIOL, V646, P31, DOI 10.1007/978-1-4020-9173-5_3; Dennison EM, 2013, CLIN OBSTET GYNECOL, V56, P549, DOI 10.1097/GRF.0b013e31829cb9b0; Dudakovic A, 2018, J BIOL CHEM, V293, P12894, DOI 10.1074/jbc.RA118.002983; Dudakovic A, 2016, J BIOL CHEM, V291, P24594, DOI 10.1074/jbc.M116.740571; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Kawai M, 2012, ENDOCRIN METAB CLIN, V41, P323, DOI 10.1016/j.ecl.2012.04.013; Kereliuk SM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071451; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Liang C, 2009, BIRTH DEFECTS RES B, V86, P362, DOI 10.1002/bdrb.20204; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Moritz LE, 2018, J BIOL CHEM, V293, P13805, DOI 10.1074/jbc.R117.800367; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Petersen SB, 2015, NUTRIENTS, V7, P2382, DOI 10.3390/nu7042382; Saben J, 2014, EXP BIOL MED, V239, P1340, DOI 10.1177/1535370214539225; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shankar K, 2015, PLACENTA, V36, P1342, DOI 10.1016/j.placenta.2015.10.010; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; Thornburg KL, 2010, ADV GENET, V71, P57, DOI [10.1016/B978-0-12-380864-6.00003-1, 10.1016/S0065-2660(10)71003-8]; Tosh DN, 2010, AM J PHYSIOL-GASTR L, V299, pG1023, DOI 10.1152/ajpgi.00052.2010; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yang QY, 2013, DIABETES, V62, P3727, DOI 10.2337/db13-0433; Yu Fangtang, 2017, Bone Rep, V6, P109, DOI 10.1016/j.bonr.2017.04.001; Zhang YF, 2015, GENOM DATA, V6, P12, DOI 10.1016/j.gdata.2015.07.024; Zhu DH, 2009, AGING-US, V1, P740, DOI 10.18632/aging.100078	43	6	6	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2511	2523		10.1096/fj.201901901R	http://dx.doi.org/10.1096/fj.201901901R		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908011	hybrid			2022-12-28	WOS:000504225100001
J	Park, S; Kim, YH; Jeong, PS; Park, C; Lee, JW; Kim, JS; Wee, G; Song, BS; Park, BJ; Kim, SH; Sim, BW; Kim, SU; Triggs-Raine, B; Baba, T; Lee, SR; Kim, E				Park, Soojin; Kim, Young-Hyun; Jeong, Pil-Soo; Park, Chaeri; Lee, Jeong-Woong; Kim, Ju-Sung; Wee, Gabin; Song, Bong-Seok; Park, Boon-Joo; Kim, Sang-Hyun; Sim, Bo-Woong; Kim, Sun-Uk; Triggs-Raine, Barbara; Baba, Tadashi; Lee, Sang-Rae; Kim, Ekyune			SPAM1/HYAL5 double deficiency in male mice leads to severe male subfertility caused by a cumulus-oocyte complex penetration defect	FASEB JOURNAL			English	Article						sperm hyaluronidase; dispersal of COC; fertilization; subfertility	CHONDROITIN SULFATE HYDROLASE; MOUSE SPERM; HYALURONIDASE ACTIVITY; MEMBRANE-PROTEIN; PLASMA-MEMBRANE; SPAM1 PH-20; IDENTIFICATION; EXPRESSION; GENES; LAYER	The glycosylphosphatidylinositol-anchored sperm hyaluronidases (Hyals), sperm adhesion molecule 1 (SPAM1) and HYAL5, have long been believed to assist in sperm penetration through the cumulus-oocyte complex (COC), but their role in mammalian fertilization remains unclear. Previously, we have shown that mouse sperm devoid of either Spam1 or Hyal5 are still capable of penetrating the COC and that the loss of either Spam1 or Hyal5 alone does not cause male infertility in mice. In the present study, we found that Spam1/Hyal5 double knockout (dKO) mice produced significantly fewer offspring compared with wild-type (WT) mice, and this was due to defective COC dispersal. A comparative analysis between WT and Spam1/Hyal5 dKO epididymal sperm revealed that the absence of these 2 sperm Hyals resulted in a marked accumulation of sperm on the outside of the COC. This impaired sperm activity is likely due to the deficiency in the sperm Hyals, even though other somatic Hyals are expressed normally in the dKO mice. The fertilization ability of the Spam1/Hyal5 dKO sperm was restored by adding purified human sperm Hyal to the in vitro fertilization medium. Our results suggest that Hyal deficiency in sperm may be a significant risk factor for male sterility.	[Park, Soojin; Park, Chaeri; Park, Boon-Joo; Kim, Ekyune] Catholic Univ Daegu, Coll Pharm, Gyongsan, South Korea; [Kim, Young-Hyun; Sim, Bo-Woong; Kim, Sun-Uk; Lee, Sang-Rae] Korea Res Inst Biosci & Biotechnol, NPRC, Cheongju, Chungcheongbuk, South Korea; [Jeong, Pil-Soo; Song, Bong-Seok; Kim, Sun-Uk] Korea Res Inst Biosci & Biotechnol, Futurist Anim Resource & Res Ctr, Cheongju, Chungcheongbuk, South Korea; [Lee, Jeong-Woong] KRIBB, Biotherapeut Translat Res Ctr, Deajeon, South Korea; [Kim, Ju-Sung] Jeju Natl Univ, Res Inst Subtrop Agr & Biotechnol, Coll Appl Life Sci, Jeju, South Korea; [Wee, Gabin] Daegu Gyeongbuk Med Innovat Fdn, Lab Anim Ctr, Daegu, South Korea; [Kim, Sang-Hyun] Gyeongsang Natl Univ, Inst Anim Med, Coll Vet Med, Jinju, South Korea; [Triggs-Raine, Barbara] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Baba, Tadashi] Univ Tsukuba, TARA, Life Sci Ctr Survival Dynam, Fac Life & Environm Sci, Ibaraki, Japan; [Park, Soojin] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Catholic University of Daegu; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Jeju National University; Gyeongsang National University; University of Manitoba; University of Tsukuba; Osaka University	Lee, SR (corresponding author), Korea Res Inst Biosci & Biotechnol, NPRC, Cheongju, Chungcheongbuk, South Korea.; Kim, E (corresponding author), Daegu Catholic Univ, Coll Pharm, Gyeong Buk 38430, South Korea.	srlee@kribb.re.kr; ekyune@cu.ac.kr	Triggs-Raine, Barbara/AAF-6209-2021	Triggs-Raine, Barbara/0000-0003-4719-6779; Jeong, Pil-Soo/0000-0002-8477-4358; Park, Soojin/0000-0002-9901-719X; SIM, BO-WOONG/0000-0002-4492-1085	Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program [KGM5281921, KGM4251913]; National Research Foundation of Korea - Korean Government [NRF-2017R1D1A1B03031420]	Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program; National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	The authors thank Jinyoung Kim (Korea University, Seoul, South Korea) for figure assistance. This research was partly supported by Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program (KGM5281921 and KGM4251913) and a National Research Foundation of Korea Grant funded by the Korean Government (NRF-2017R1D1A1B03031420). The authors declare no conflicts of interest.	ABDULAZIZ M, 1995, FERTIL STERIL, V64, P1147, DOI 10.1016/S0015-0282(16)57976-X; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Baba D, 2002, J BIOL CHEM, V277, P30310, DOI 10.1074/jbc.M204596200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; DANDEKAR P, 1992, HUM REPROD, V7, P391, DOI 10.1093/oxfordjournals.humrep.a137656; Frost GL, 1996, TRENDS GLYCOSCI GLYC, V8, P419, DOI 10.4052/tigg.8.419; GMACHL M, 1993, P NATL ACAD SCI USA, V90, P3569, DOI 10.1073/pnas.90.8.3569; Hunnicutt GR, 1996, BIOL REPROD, V54, P1343, DOI 10.1095/biolreprod54.6.1343; Imundo L, 2011, J INHERIT METAB DIS, V34, P1013, DOI 10.1007/s10545-011-9343-3; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; Kaneiwa T, 2012, J BIOL CHEM, V287, P42119, DOI 10.1074/jbc.M112.360693; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kim E, 2006, J BIOL CHEM, V281, P5634, DOI 10.1074/jbc.M510558200; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Kim E, 2008, INT J DEV BIOL, V52, P677, DOI 10.1387/ijdb.072528ek; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kimura M, 2009, BIOL REPROD, V81, P939, DOI 10.1095/biolreprod.109.078816; KREIL G, 1995, PROTEIN SCI, V4, P1666, DOI 10.1002/pro.5560040902; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LIN Y, 1993, P NATL ACAD SCI USA, V90, P10071, DOI 10.1073/pnas.90.21.10071; LIN Y, 1994, J CELL BIOL, V125, P1157, DOI 10.1083/jcb.125.5.1157; Meyer K., 1971, ENZYMES, V5, P307; Modelski MJ, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115857; OVERSTREET JW, 1995, BIOL REPROD, V52, P105, DOI 10.1095/biolreprod52.1.105; PHELPS BM, 1988, SCIENCE, V240, P1780, DOI 10.1126/science.3381102; Reese KL, 2010, MOL REPROD DEV, V77, P759, DOI 10.1002/mrd.21217; Yanagimachi R., 1994, P189; Zhang H, 2004, BIOL REPROD, V71, P1101, DOI 10.1095/biolreprod.104.030403; Zhang H, 2003, BIOL REPROD, V69, P446, DOI 10.1095/biolreprod.102.013854	31	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14440	14449		10.1096/fj.201900889RRR	http://dx.doi.org/10.1096/fj.201900889RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31670981	Bronze			2022-12-28	WOS:000507466100106
J	Rosario, R; Crichton, JH; Stewart, HL; Childs, AJ; Adams, IR; Anderson, RA				Rosario, Roseanne; Crichton, James H.; Stewart, Hazel L.; Childs, Andrew J.; Adams, Ian R.; Anderson, Richard A.			Dazl determines primordial follicle formation through the translational regulation of Tex14	FASEB JOURNAL			English	Article						germ cell maturation; intercellular bridge; siRNA knockdown; fetal ovary culture	AZOOSPERMIA-LIKE DAZL; GERM-CELL DEVELOPMENT; GENE-EXPRESSION; INTERCELLULAR BRIDGES; IN-VIVO; CYSTS; DIFFERENTIATION; OOGENESIS; BREAKDOWN; HOMOLOG	Deleted in azoospermia-like (DAZL) is a germ cell RNA-binding protein that is essential for entry and progression through meiosis. The phenotype of the Dazl knockout mouse has extensive germ cell loss because of incomplete meiosis. We have created a Dazl hypomorph model using short interfering RNA knockdown in mouse fetal ovary cultures, allowing investigation of Dazl function in germ cell maturation. Dazl hypomorph ovaries had a phenotype of impaired germ cell nest breakdown with a 66% reduction in total follicle number and an increase in the proportion of primordial follicles (PMFs), with smaller oocytes within these follicles. There was no significant early germ cell loss or meiotic delay. Immunostaining of intercellular bridge component testis-expressed protein (Tex)14 showed similar to 59 % reduction in foci number and size, without any change in Tex14 mRNA levels. TEX14 expression was also confirmed in the human fetal ovary across gestation. Using 3'UTR-luciferase reporter assays, translational regulation of TEX14 was demonstrated to be DAZL-dependant. Dazl is therefore essential for normal intercellular bridges within germ cell nests and their timely breakdown, with a major impact on subsequent assembly of PMFs.	[Rosario, Roseanne; Stewart, Hazel L.; Anderson, Richard A.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Crichton, James H.; Adams, Ian R.] Western Gen Hosp, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Childs, Andrew J.] Imperial Coll London, Fac Med, Inst Reprod & Dev Biol, Dept Surg & Canc, London, England	University of Edinburgh; University of Edinburgh; Imperial College London	Rosario, R (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	roseanne.rosario@ed.ac.uk	Adams, Ian R/AAU-1231-2021	Adams, Ian R/0000-0001-8838-1271	Medical Research Council (MRC) [G1100357, MR/N022556/1]; Biotechnology and Biological Sciences Research Council [BB/R015635/1]; BBSRC [BB/R015635/1] Funding Source: UKRI; MRC [G1100357, MC_UU_00007/6, MR/N022556/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Anne Saunderson and the staff of the Bruntsfield Suite, Royal Infirmary of Edinburgh, for recruitment, and to members of the Shared University Research Facilities (SuRF) at the University of Edinburgh (https://surf.ed.ac.uk), especially Mike Millar, for assistance. The authors' work in this field was support by grants from the Medical Research Council (MRC; G1100357 to R.A.A., MR/N022556/1 to the MRC Centre for Reproductive Health, and an intramural programme grant to I.R.A.) and the Biotechnology and Biological Sciences Research Council (BB/R015635/1 to R.A.A., R.R., and I.R.A.). The authors declare no conflicts of interest.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Adams IR, 2002, DEVELOPMENT, V129, P1155; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Bartoloni L, 2004, MOL HUM REPROD, V10, P613, DOI 10.1093/molehr/gah073; Chen HH, 2014, STEM CELL REP, V3, P892, DOI 10.1016/j.stemcr.2014.09.003; Chen J, 2011, GENE DEV, V25, P755, DOI 10.1101/gad.2028911; Childs AJ, 2012, METHODS MOL BIOL, V825, P199, DOI 10.1007/978-1-61779-436-0_15; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; Dokshin GA, 2013, NAT GENET, V45, P877, DOI 10.1038/ng.2672; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Feng CW, 2014, MOL CELL ENDOCRINOL, V382, P488, DOI 10.1016/j.mce.2013.09.026; Fukuda K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007436; GINSBURG M, 1990, DEVELOPMENT, V110, P521; GONDOS B, 1971, AM J OBSTET GYNECOL, V110, P644, DOI 10.1016/0002-9378(71)90245-6; Greenbaum MP, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005850; Greenbaum MP, 2009, BIOL REPROD, V80, P449, DOI 10.1095/biolreprod.108.070649; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Haston KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005654; He J., 2013, PLOS ONE, V10; He J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073996; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Karashima T, 2000, DEVELOPMENT, V127, P1069; Lei L, 2016, SCIENCE, V352, P95, DOI 10.1126/science.aad2156; Lei L, 2013, DEVELOPMENT, V140, P2075, DOI 10.1242/dev.093864; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McNeilly JR, 2011, BIOL REPROD, V85, P584, DOI 10.1095/biolreprod.110.086264; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; Rosario R, 2017, MOL HUM REPROD, V23, P177, DOI 10.1093/molehr/gax004; Rosario R, 2016, MOL HUM REPROD, V22, P377, DOI 10.1093/molehr/gaw024; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Stefansdottir A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2505-9; Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073; Tsui SL, 2000, BIOL REPROD, V62, P1655, DOI 10.1095/biolreprod62.6.1655; Tung JY, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-40; Tung JY, 2006, HUM GENET, V118, P730, DOI 10.1007/s00439-005-0098-5; van den Bergen JA, 2009, BIOL REPROD, V81, P362, DOI 10.1095/biolreprod.109.076224; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venables JP, 2001, NUCLEIC ACIDS RES, V29, P2479, DOI 10.1093/nar/29.12.2479; Welling M, 2015, EMBO REP, V16, P791, DOI 10.15252/embr.201540538; Witschi Emil, 1948, CONTRIBUTIONS TO EMBRYOLOGY [CARNEGIE INST OF WASHINGTON PUBL], V32, P67; Zerbetto I, 2008, FERTIL STERIL, V90, P2264, DOI 10.1016/j.fertnstert.2007.10.036	53	5	5	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14221	14233		10.1096/fj.201901247R	http://dx.doi.org/10.1096/fj.201901247R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31659914	Green Published			2022-12-28	WOS:000507466100090
J	Choy, MHV; Wong, RMY; Li, MC; Wang, BY; Liu, XD; Lee, W; Cheng, JCY; Chow, SKH; Cheung, WH				Choy, Man-Huen Victoria; Wong, Ronald Man-Yeung; Li, Meng-Chen; Wang, Bai Yan; Liu, Xiao Dong; Lee, Wayne; Cheng, Jack Chun-Yiu; Chow, Simon Kwoon-Ho; Cheung, Wing-Hoi			Can we enhance osteoporotic metaphyseal fracture healing through enhancing ultrastructural and functional changes of osteocytes in cortical bone with low-magnitude high-frequency vibration?	FASEB JOURNAL			English	Article						lacuna-canalicular network (LCN); mechanical loading; osteocytes; osteoporotic fracture healing; vibration	ESTROGEN-RECEPTOR-ALPHA; DENTIN MATRIX PROTEIN-1; IN-VIVO; MECHANICAL STIMULATION; CALLUS FORMATION; RAT MODEL; ER-ALPHA; EXPRESSION; MINERALIZATION; DENSITY	Fragility fractures are related to the loss of bone integrity and deteriorated morphology of osteocytes. Our previous studies have reported that low-magnitude high-frequency vibration (LMHFV) promoted osteoporotic fracture healing. As osteocytes are known for mechanosensing and initiating bone repair, we hypothesized that LMHFV could enhance osteoporotic fracture healing through enhancing morphological changes in the osteocyte lacuna-canalicular network (LCN) and mineralization. A metaphyseal fracture model was established in female Sprague-Dawley rats to investigate changes in osteocytes and healing outcomes from early to late phase post-fracture. Our results showed that the LCN exhibited an exuberant outgrowth of canaliculi in the osteoporotic fractured bone at day 14 after LMHFV. LMHFV upregulated the E11, dentin matrix protein 1 (DMP1), and fibroblast growth factor 23 (FGF23), but downregulated sclerostin (Sost) in osteocytes. Moreover, LMHFV promoted mineralization with significant enhancements of Ca/P ratio, mineral apposition rate (MAR), mineralizing surface (MS/BS), and bone mineral density (BMD) in the osteoporotic group. Consistently, better healing was confirmed by microarchitecture and mechanical properties, whereas the enhancement in osteoporotic group was comparable or even greater than the normal group. This is the first report to reveal the enhancement effect of LMHFV on the osteocytes' morphology and functions in osteoporotic fracture healing.	[Choy, Man-Huen Victoria; Wong, Ronald Man-Yeung; Li, Meng-Chen; Lee, Wayne; Cheng, Jack Chun-Yiu; Chow, Simon Kwoon-Ho; Cheung, Wing-Hoi] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China; [Wang, Bai Yan] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Liu, Xiao Dong] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anaesthesia & Intens Care, Hong Kong, Peoples R China; [Cheng, Jack Chun-Yiu; Chow, Simon Kwoon-Ho; Cheung, Wing-Hoi] Chinese Univ Hong Kong, Res Inst, CUHK ACC Space Med Ctr Hlth Maintenance Musculosk, Shenzhen, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong, Shenzhen	Cheung, WH (corresponding author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Shatin, 5-F Clin Sci Bldg, Hong Kong, Peoples R China.	louis@ort.cuhk.edu.hk	Cheung, Wing-Hoi/J-2150-2018; Chow, Simon Kwoon-ho/J-1554-2018; Cheng, Jack/J-3878-2018; Wong, Ronald Man Yeung/GYU-4740-2022; Lee, Wayne YW/H-8298-2013	Cheung, Wing-Hoi/0000-0003-3247-8255; Chow, Simon Kwoon-ho/0000-0003-1742-980X; Cheng, Jack/0000-0001-8153-364X; Lee, Wayne YW/0000-0002-0486-360X; Wong, Ronald Man Yeung/0000-0001-5615-6627; Li, Meng Chen Michelle/0000-0001-8720-2008	Research Grants Council, University Grants Committee (RGC, UGC) [14113018]; General Research Fund [14113018]; CUHK [2017.045]; university research grant of CUHK [2017.045]	Research Grants Council, University Grants Committee (RGC, UGC); General Research Fund; CUHK(Chinese University of Hong Kong); university research grant of CUHK	Research Grants Council, University Grants Committee (RGC, UGC), Grant/Award Number: Ref: 14113018; direct grant, university research grant of CUHK, Grant/Award Number: Ref: 2017.045; General Research Fund, Grant/Award Number: 14113018; CUHK, Grant/Award Number: 2017.045	Adachi T, 2009, J BIOMECH, V42, P1989, DOI 10.1016/j.jbiomech.2009.04.034; Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002; Batra GS, 2003, J PATHOL, V200, P65, DOI 10.1002/path.1332; Boivin G, 2008, BONE, V43, P532, DOI 10.1016/j.bone.2008.05.024; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Cadena E, 2016, PEERJ, V4, DOI 10.7717/peerj.1618; Carpentier VT, 2012, BONE, V50, P688, DOI 10.1016/j.bone.2011.11.021; Chappard D, 2011, OSTEOPOROSIS INT, V22, P2225, DOI 10.1007/s00198-011-1573-6; Chen WT, 2015, ACTA ORTHOP, V86, P238, DOI 10.3109/17453674.2014.1003127; Cheung WH, 2012, ULTRASOUND MED BIOL, V38, P2120, DOI 10.1016/j.ultrasmedbio.2012.07.025; Chow DHK, 2011, J ORTHOP RES, V29, P746, DOI 10.1002/jor.21303; Chow SKH, 2016, OSTEOPOROSIS INT, V27, P2989, DOI 10.1007/s00198-016-3619-2; Chow SK, 2014, ARCH ORTHOP TRAUM SU, V134, P1405, DOI 10.1007/s00402-014-2070-0; Claes L, 2011, J ORTHOP RES, V29, P425, DOI 10.1002/jor.21227; Compton JT, 2014, J BONE JOINT SURG AM, V96A, P1659, DOI 10.2106/JBJS.M.01096; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Ehrlich PJ, 2002, J BONE MINER RES, V17, P1646, DOI 10.1359/jbmr.2002.17.9.1646; Fan W, 2008, BONE, V42, P81, DOI 10.1016/j.bone.2007.08.048; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Goebel S, 2009, J ORTHOP RES, V27, P1141, DOI 10.1002/jor.20857; Hadjiargyrou M, 2001, BONE, V29, P149, DOI 10.1016/S8756-3282(01)00489-6; Haffner-Luntzer M, 2018, BONE, V110, P11, DOI 10.1016/j.bone.2018.01.017; Hazenberg JG, 2006, J BIOMECH, V39, P2096, DOI 10.1016/j.jbiomech.2005.06.006; Hernandez CJ, 2004, BONE, V35, P1095, DOI 10.1016/j.bone.2004.07.002; Himeno-Ando A, 2012, BIOCHEM BIOPH RES CO, V417, P765, DOI 10.1016/j.bbrc.2011.12.031; Inagaki Y, 2015, VIRCHOWS ARCH, V466, P445, DOI 10.1007/s00428-014-1706-3; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kruck B, 2018, J BONE MINER RES, V33, P1686, DOI 10.1002/jbmr.3454; Leung KS, 2009, J ORTHOP RES, V27, P458, DOI 10.1002/jor.20753; Li CY, 2011, BONE, V49, P1178, DOI 10.1016/j.bone.2011.08.012; Li YF, 2016, INT J CLIN EXP MED, V9, P13329; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Maginot M, 2015, BONE, V81, P602, DOI 10.1016/j.bone.2015.08.018; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Miller LM, 2007, J BONE MINER RES, V22, P1037, DOI 10.1359/JBMR.070402; Moverare S, 2003, P NATL ACAD SCI USA, V100, P13573, DOI 10.1073/pnas.2233084100; Mullender MG, 1996, BONE, V18, P109, DOI 10.1016/8756-3282(95)00444-0; Neagu TP, 2016, ROM J MORPHOL EMBRYO, V57, P1051; Okata H, 2015, ORAL DIS, V21, P74, DOI 10.1111/odi.12212; Power J, 2002, BONE, V30, P859, DOI 10.1016/S8756-3282(02)00731-7; Ren Y, 2014, CONNECT TISSUE RES, V55, P129, DOI 10.3109/03008207.2014.923879; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; ROSCHGER P, 1995, SCANNING MICROSCOPY, V9, P75; Sapir-Koren R, 2014, OSTEOPOROSIS INT, V25, P2685, DOI 10.1007/s00198-014-2808-0; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Shah FA, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5779-1; Shi HF, 2010, BONE, V46, P1299, DOI 10.1016/j.bone.2009.11.028; Skedros JG, 2005, CELLS TISSUES ORGANS, V180, P215, DOI 10.1159/000088938; Stuermer EK, 2010, LANGENBECK ARCH SURG, V395, P163, DOI 10.1007/s00423-008-0436-x; Sturmer EK, 2006, J BONE MINER RES, V21, P89, DOI 10.1359/JBMR.050913; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Swift SN, 2014, J APPL PHYSIOL, V117, P1349, DOI 10.1152/japplphysiol.00588.2013; Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118; Temiyasathit S, 2010, ANN NY ACAD SCI, V1192, P422, DOI 10.1111/j.1749-6632.2009.05243.x; Thompson WR, 2011, J BONE MINER RES, V26, P618, DOI 10.1002/jbmr.236; Toyosawa S, 2004, BONE, V35, P553, DOI 10.1016/j.bone.2004.03.030; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Wong RMY, 2019, EUR CELLS MATER, V37, P420, DOI 10.22203/eCM.v037a25; Wong RMY, 2018, BONE JOINT RES, V7, P6, DOI 10.1302/2046-3758.71.BJR-2016-0334.R2; Yang DQ, 2013, BIOCHEM BIOPH RES CO, V440, P62, DOI 10.1016/j.bbrc.2013.09.030; Yeni YN, 1998, BONE, V22, P79, DOI 10.1016/S8756-3282(97)00227-5; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhou XZ, 2009, BONE, V45, P704, DOI 10.1016/j.bone.2009.06.026	73	10	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4234	4252		10.1096/fj.201901595R	http://dx.doi.org/10.1096/fj.201901595R		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31961009				2022-12-28	WOS:000508663200001
J	Parente, A; Boukredine, A; Baraige, F; Duprat, N; Gondran-Tellier, V; Magnol, L; Blanquet, V				Parente, Alexis; Boukredine, Axel; Baraige, Fabienne; Duprat, Nathalie; Gondran-Tellier, Victor; Magnol, Laetitia; Blanquet, Veronique			GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics	FASEB JOURNAL			English	Article						muscle; myostatin; GASP-1; GASP-2; hypertrophy; hyperplasia	SKELETAL-MUSCLE; STRIATED-MUSCLE; MYOSTATIN; GROWTH; WFIKKN2; CELLS	Muscle atrophy is associated with many diseases including genetic disorders, sarcopenia, or cachexia syndromes. Myostatin (Mstn), a transforming growth factor-beta (TGF-beta) member, plays a key role in skeletal muscle homeostasis as a powerful negative regulator. Over the last decade, about 15 clinical trials aimed at inhibiting the Mstn pathway, failed to produce conclusive results. In this context, we investigated whether growth and differentiation factor-associated serum protein-1 (GASP-1) or GASP-2, two natural inhibitors of Mstn, might represent a potential therapeutic. As we previously reported, mice overexpressing Gasp-1 (Tg(Gasp-1)) present an increase of muscle mass but develop metabolic disorders with aging. Here, we showed that overexpression of Gasp-2 increases the muscular mass without metabolic defects. We also found that Tg(Gasp-2) mice displayed, like Mstn(-/-) mice, a switch from slow- to fast-twitch myofibers whereas Tg(Gasp-1) mice exhibit a reverse switch. Our studies supported the fact that GASP-2 has less affinity than GASP-1 for Mstn, leading to a constitutive Mstn upregulation only in Tg(Gasp-1) mice, responsible for the observed phenotypic differences. Altogether, our findings highlighted a gene expression regulatory network of TGF-beta members and their inhibitors in muscle.	[Parente, Alexis; Boukredine, Axel; Baraige, Fabienne; Duprat, Nathalie; Gondran-Tellier, Victor; Magnol, Laetitia; Blanquet, Veronique] Univ Limoges, INRA, GAMAA, PEIRENE EA7500,USC1061, 123 Av A Thomas, F-87060 Limoges, France	INRAE; Universite de Limoges	Blanquet, V (corresponding author), Univ Limoges, INRA, GAMAA, PEIRENE EA7500,USC1061, 123 Av A Thomas, F-87060 Limoges, France.	veronique.blanquet@unilim.fr		Parente, Alexis/0000-0002-6746-2520	European Union; Limousin Regional Council; French National Institute for Agricultural Research	European Union(European Commission); Limousin Regional Council; French National Institute for Agricultural Research	European Union; Limousin Regional Council; French National Institute for Agricultural Research	Al-Zaidy Samiah A, 2015, J Neuromuscul Dis, V2, P185; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Brun C, 2014, CELL PHYSIOL BIOCHEM, V34, P1241, DOI 10.1159/000366335; Brun C, 2012, CELL PHYSIOL BIOCHEM, V30, P791, DOI 10.1159/000341458; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231; Hoogaars WMH, 2018, ADV EXP MED BIOL, V1088, P153, DOI 10.1007/978-981-13-1435-3_8; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Lee Se-Jin, 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P183; Lee YS, 2013, P NATL ACAD SCI USA, V110, pE3713, DOI 10.1073/pnas.1309907110; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mendell JR, 2017, MOL THER, V25, P870, DOI 10.1016/j.ymthe.2017.02.015; Meunier B, 2010, HISTOCHEM CELL BIOL, V134, P307, DOI 10.1007/s00418-010-0733-7; Monestier O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-541; OLIVER MH, 1989, J CELL SCI, V92, P513; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; Parente A, 2019, METHODS MOL BIOL, V1889, P229, DOI 10.1007/978-1-4939-8897-6_13; Perie L, 2017, CELL PHYSIOL BIOCHEM, V44, P1896, DOI 10.1159/000485878; Perie Luce, 2016, Biochem Biophys Rep, V6, P39, DOI 10.1016/j.bbrep.2016.03.001; Pirruccello-Straub M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20524-9; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Walker RG, 2015, J BIOL CHEM, V290, P7506, DOI 10.1074/jbc.M114.624130; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Zhang YH, 2017, ONCOTARGET, V8, P81604, DOI 10.18632/oncotarget.20258	31	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4026	4040		10.1096/fj.201901220R	http://dx.doi.org/10.1096/fj.201901220R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960486	hybrid, Green Published			2022-12-28	WOS:000508839900001
J	Wang, FF; Wu, HS; Fan, MJ; Yu, RK; Zhang, Y; Liu, JX; Zhou, XJ; Cai, YS; Huang, SH; Hu, ZH; Jin, XD				Wang, Feifan; Wu, Hongshen; Fan, Mengjing; Yu, Rikao; Zhang, Yan; Liu, Jiaxin; Zhou, Xuejian; Cai, Yueshu; Huang, Shihan; Hu, Zhenghui; Jin, Xiaodong			Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human bladder cancer cells	FASEB JOURNAL			English	Article						apoptosis; autophagy; bladder cancer; migration; miR-139-5p; Bmi-1 axis; reactive oxygen species (ROS); sodium butyrate	OXYGEN SPECIES ROS; IN-VITRO; MITOCHONDRIAL; PREVENTION; TARGET	Bladder cancer is one of the most frequently occurring malignant tumors in the urinary system. Sodium butyrate (NaB) is a histone deacetylase inhibitor and exerts remarkable antitumor effects in various cancer cells. MicroRNAs (miRNAs) and autophagy play crucial roles in cancer occurrence and development. In the present study, we evaluated the anticancer effects, including cell migration inhibition and the apoptotic effects of NaB in human bladder cancer cells. Furthermore, we found that NaB inhibited migration and induced AMPK/mTOR pathway-activated autophagy and reactive oxygen species (ROS) overproduction via the miR-139-5p/Bmi-1 axis. In addition, we found that ROS overproduction contributed to NaB-induced caspase-dependent apoptosis and autophagy. The interplay between autophagy and apoptosis in NaB treatment was clarified. Our findings provide a further understanding of EMT reversion, apoptosis and autophagy induced by antitumor drugs and a novel perspective and alternative strategy for bladder cancer chemotherapy.	[Wang, Feifan; Wu, Hongshen; Yu, Rikao; Zhang, Yan; Liu, Jiaxin; Zhou, Xuejian; Cai, Yueshu; Huang, Shihan; Hu, Zhenghui; Jin, Xiaodong] Zhejiang Univ, Affiliated Hosp 1, Dept Urol, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Fan, Mengjing] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Cent Lab,Biomed Res Ctr, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Jin, XD (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Urol, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	xiaodong-jin@zju.edu.cn		Jin, Xiao-Dong/0000-0003-2734-3882	Natural Science Foundation of Zhejiang Province [LGF18H050001, LY17H050004, LY16H050002]; National Natural Science Foundation of China [81370799]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Natural Science Foundation of Zhejiang Province, Grant/Award Number: LGF18H050001, Xiaodong Jin; LY17H050004, Zhenghui Hu and LY16H050002, Geming Chen. National Natural Science Foundation of China, Grant/Award Number: 81370799, Xiaodong Jin	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bharathy N, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aau7632; Burge F, 2016, UROL INT, V97, P373, DOI 10.1159/000449256; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Cheng P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.17; Deng S, 2019, CANCER-AM CANCER SOC, V125, P1228, DOI 10.1002/cncr.31978; Dey A, 2016, AUTOPHAGY, V12, P659, DOI 10.1080/15548627.2016.1147670; Dobruch J, 2016, EUR UROL, V69, P300, DOI 10.1016/j.eururo.2015.08.037; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Fransolet M, 2019, J ASSIST REPROD GEN, V36, P349, DOI 10.1007/s10815-018-1353-8; Grimmel M, 2015, CELLS-BASEL, V4, P202, DOI 10.3390/cells4020202; Hsieh TH, 2015, MOL THER, V23, P656, DOI 10.1038/mt.2014.247; Huang KM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0166-5; Huang LL, 2017, ONCOL LETT, V14, P1215, DOI 10.3892/ol.2017.6351; Jiang F, 2018, INT J MOL MED, V42, P1295, DOI 10.3892/ijmm.2018.3712; Kamat AM, 2016, LANCET, V388, P2796, DOI 10.1016/S0140-6736(16)30512-8; Kamat AM, 2014, J UROLOGY, V192, P305, DOI 10.1016/j.juro.2014.02.2573; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kubisch J, 2013, SEMIN CANCER BIOL, V23, P252, DOI 10.1016/j.semcancer.2013.06.009; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Lai TH, 2016, CLIN CANCER RES, V22, P3537, DOI 10.1158/1078-0432.CCR-15-1063; Lang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129196; Lemasters JJ, 1998, GASTROENTEROLOGY, V115, P783, DOI 10.1016/S0016-5085(98)70160-X; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu YQ, 2014, J BIOL CHEM, V289, P4116, DOI 10.1074/jbc.M113.533505; Lu SJ, 2015, EUR J PHARM SCI, V72, P57, DOI 10.1016/j.ejps.2015.03.006; Luo HB, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317718414; Maruyama T, 2012, J INFECT CHEMOTHER, V18, P288, DOI 10.1007/s10156-011-0322-2; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patel N, 2016, LIFE SCI, V164, P60, DOI 10.1016/j.lfs.2016.08.028; Pero ME, 2018, THERIOGENOLOGY, V108, P127, DOI 10.1016/j.theriogenology.2017.11.031; Salimi V, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0593-4; Sanli O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.22; Santamaria PG, 2017, MOL ONCOL, V11, P718, DOI 10.1002/1878-0261.12091; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Su LY, 2017, AUTOPHAGY, V13, P1496, DOI 10.1080/15548627.2017.1332549; Sylvester RJ, 2016, EUR UROL, V69, P231, DOI 10.1016/j.eururo.2015.05.050; Tailor D, 2014, MITOCHONDRION, V16, P55, DOI 10.1016/j.mito.2013.10.004; Thorstenson A, 2016, SCAND J UROL, V50, P292, DOI 10.3109/21681805.2016.1158207; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Valcifahmetoglu-Norberg H, 2015, J CLIN INVEST, V125, P5, DOI 10.1172/JCI73937; Xu ZY, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700844; Yonemori M, 2016, CANCER SCI, V107, P1233, DOI 10.1111/cas.13002; Yue ZY, 2008, AUTOPHAGY, V4, P94, DOI 10.4161/auto.5202; Zhang HD, 2015, TUMOR BIOL, V36, P1355, DOI 10.1007/s13277-015-3199-3; Zhang T, 2012, AUTOPHAGY, V8, P559, DOI 10.4161/auto.18867	58	40	43	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4266	4282		10.1096/fj.201902626R	http://dx.doi.org/10.1096/fj.201902626R		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957111				2022-12-28	WOS:000508135800001
J	Park, JS; Yoo, SH; Lim, MA; Ryu, JG; Oh, HJ; Hwang, SH; Yang, S; Jung, KA; Yoon, S; Park, BC; Park, SH; Kim, HY; Cho, ML; Park, YW				Park, Jin-Sil; Yoo, Seok-Ho; Lim, Mi-Ae; Ryu, Jun-Geol; Oh, Hye-Joa; Hwang, Sun-Hee; Yang, SeungCheon; Jung, Kyung-Ah; Yoon, Sunha; Park, Bum-Chan; Park, Sung-Hwan; Kim, Ho-Youn; Cho, Mi-La; Park, Young-woo			A bispecific soluble receptor fusion protein that targets TNF-alpha and IL-21 for synergistic therapy in inflammatory arthritis	FASEB JOURNAL			English	Article						bispecific fusion protein; cytokine; IL-17-producing T cells; rheumatoid arthritis; osteoclastogenesis	TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; PROMOTES OSTEOCLASTOGENESIS; AUTOIMMUNE ARTHRITIS; INCREASED RISK; ANIMAL-MODELS; TH17 CELLS; B-CELLS; INTERLEUKIN-21; GENERATION	This study was aimed at investigating the therapeutic effects of BITRAP, a bispecific fusion protein targeting TNF-alpha and IL-21, on the development of autoimmune arthritis in humans and mice. To verify the effects of BITRAP in human, peripheral blood mononuclear cells were cultured with BITRAP under IL-17-producing T (Th17) cell-polarizing conditions or osteoclast differentiation conditions. BITRAP treatment inhibited the production of IL-17 and vascular endothelial growth factor but increased the production of IL-10 in CD4(+) T cells, as well as directly suppressed osteoclastogenesis. Collagen-induced arthritis (CIA) and IL-1R antagonist (IL-1Ra) knockout mice were treated with BITRAP. Following injection in CIA mice, BITRAP rapidly migrated into the inflamed joints and remained there for 72 hours. Application of BITRAP attenuated the severity of autoimmune arthritis in CIA and IL-1Ra knockout mice by reducing the numbers of inflammatory cytokine-expressing cells and Th17 cells and antibody secretion. Finally, BITRAP suppressed STAT3 phosphorylation, as well as production of IL-17 and TNF-alpha, in murine splenic CD4(+) T cells. These findings suggest that BITRAP, a bispecific fusion protein targeting TNF-alpha and IL-21, may be an effective treatment to overcome the limitations of anti-TNF therapy for patients with rheumatoid arthritis.	[Park, Jin-Sil; Lim, Mi-Ae; Ryu, Jun-Geol; Oh, Hye-Joa; Hwang, Sun-Hee; Yang, SeungCheon; Jung, Kyung-Ah; Park, Sung-Hwan; Kim, Ho-Youn; Cho, Mi-La] Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Yoo, Seok-Ho; Yoon, Sunha; Park, Bum-Chan; Park, Young-woo] Y Biol, Daejeon, South Korea; [Park, Sung-Hwan] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Dept Med Lifesci, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea	Cho, ML (corresponding author), Catholic Univ Korea, Catholic Inst Med Sci, Rheumatism Res Ctr, 222 Banpo Daero, Seoul 06591, South Korea.	iammila@catholic.ac.kr			National Research Foundation of Korea (NRF) [20100029601]; Ministry for health and welfare, Republic of Korea [HI14C3417]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry for health and welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 20100029601; Ministry for health and welfare, Republic of Korea, Grant/Award Number: HI14C3417	Ali T, 2013, DRUG HEALTHC PATIENT, V5, P79, DOI 10.2147/DHPS.S28801; Alzabin S, 2012, ANN RHEUM DIS, V71, P1741, DOI 10.1136/annrheumdis-2011-201024; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Buch MH, 2007, RHEUMATOLOGY, V46, P1153, DOI 10.1093/rheumatology/kem075; Burmester GR, 2014, NAT REV RHEUMATOL, V10, P77, DOI 10.1038/nrrheum.2013.168; Cho ML, 2002, ARTHRITIS RHEUM-US, V46, P42, DOI 10.1002/1529-0131(200201)46:1<42::AID-ART10026>3.0.CO;2-A; FAVA RA, 1994, J EXP MED, V180, P341, DOI 10.1084/jem.180.1.341; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Genovese MC, 2018, ARTHRITIS RHEUMATOL, V70, P1710, DOI 10.1002/art.40580; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Hu YP, 2013, CLIN RHEUMATOL, V32, P161, DOI 10.1007/s10067-012-2041-1; Jablonska-Trypuc A, 2016, J ENZYM INHIB MED CH, V31, P177, DOI 10.3109/14756366.2016.1161620; Jungel A, 2004, ARTHRITIS RHEUM, V50, P1468, DOI 10.1002/art.20218; Kalden JR, 2017, NAT REV RHEUMATOL, V13, P707, DOI 10.1038/nrrheum.2017.187; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kim Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20150; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwok SK, 2012, ARTHRITIS RHEUM-US, V64, P740, DOI 10.1002/art.33390; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu ZH, 2018, INT J PHARMACEUT, V547, P72, DOI 10.1016/j.ijpharm.2018.05.058; Lloyd S, 2010, RHEUMATOLOGY, V49, P2313, DOI 10.1093/rheumatology/keq169; Long D, 2019, J AUTOIMMUN, V99, P1, DOI 10.1016/j.jaut.2019.01.013; Mease PJ, 2018, ARTHRITIS RHEUMATOL, V70, P1778, DOI 10.1002/art.40579; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2000, P NATL ACAD SCI USA, V97, P11439, DOI 10.1073/pnas.200360997; Park JS, 2017, AM J PATHOL, V187, P2034, DOI 10.1016/j.ajpath.2017.05.008; Park JS, 2013, AM J PATHOL, V183, P857, DOI 10.1016/j.ajpath.2013.05.027; Park JS, 2013, ARTHRITIS RHEUM-US, V65, P949, DOI 10.1002/art.37841; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Rosloniec EF, 2001, CURR PROTOC IMMUNOL; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188; Spolski R, 2008, CURR OPIN IMMUNOL, V20, P295, DOI 10.1016/j.coi.2008.02.004; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121; Xing R, 2016, SCAND J IMMUNOL, V83, P64, DOI 10.1111/sji.12396; Zwerina J, 2004, ARTHRITIS RHEUM, V50, P277, DOI 10.1002/art.11487	49	3	3	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					248	262		10.1096/fj.201900816RR	http://dx.doi.org/10.1096/fj.201900816RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914604				2022-12-28	WOS:000507308900019
J	Tao, Y; Yue, MF; Lv, CJ; Yun, XM; Qiao, SM; Fang, YL; Wei, ZF; Xia, YF; Dai, Y				Tao, Yu; Yue, Mengfan; Lv, Changjun; Yun, Xinming; Qiao, Simiao; Fang, Yulai; Wei, Zhifeng; Xia, Yufeng; Dai, Yue			Pharmacological activation of ER beta by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases	FASEB JOURNAL			English	Article						arctigenin; ER beta; inflammatory bowel diseases; MLCK; tight junction	LIGHT-CHAIN KINASE; TIGHT JUNCTION; TNF-ALPHA; PATHOGENESIS; EXPRESSION; PERMEABILITY; DYSFUNCTION; PROTEINS; STRESS	Intestinal epithelial barrier dysfunction is deeply involved in the pathogenesis of inflammatory bowel diseases (IBD). Arctigenin, the main active constituent in Fructus Arctii (a traditional Chinese medicine), has previously been found to attenuate colitis induced by dextran sulfate sodium (DSS) in mice. The present study investigated whether and how arctigenin protects against the disruption of the intestinal epithelial barrier in IBD. Arctigenin maintained the intestinal epithelial barrier function of mice with DSS- and TNBS-induced colitis. In Caco-2 and HT-29 cells, arctigenin lowered the monolayer permeability, increased TEER, reversed the abnormal expression of tight junction proteins, and restored the altered localization of F-actin induced by TNF-alpha and IL-1 beta. The specific antagonist PHTPP or shRNA of ER beta largely weakened the protective effect of arctigenin on the epithelial barrier function of Caco-2 and HT-29 cells. Molecular docking demonstrated that arctigenin had high affinity for ER beta mainly through hydrogen bonds as well as hydrophobic effects, and the protective effect of arctigenin on the intestinal barrier function was largely diminished in ER beta-mutated (ARG346 and/or GLU305) Caco-2 cells. Moreover, arctigenin-blocked TNF-alpha induced increase of the monolayer permeability in Caco-2 and HT-29 cells and the activation of myosin light chain kinase (MLCK)/myosin light chain (MLC) pathway in an ER beta-dependent manner. ER beta deletion in colons of mice with DSS-induced colitis resulted in a significant attenuation of the protective effect of arctigenin on the barrier integrity and colon inflammation. Arctigenin maintained the integrity of the intestinal epithelial barrier under IBD by upregulating the expression of tight junction proteins through the ER beta-MLCK/MLC pathway.	[Tao, Yu; Yue, Mengfan; Lv, Changjun; Yun, Xinming; Qiao, Simiao; Fang, Yulai; Wei, Zhifeng; Xia, Yufeng; Dai, Yue] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Sch Tradit Chinese Pharm, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Xia, YF; Dai, Y (corresponding author), China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Sch Tradit Chinese Pharm, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China.	yfxiacpu@126.com; yuedaicpu@hotmail.com			China National Natural Science Foundation [81673666, CPU2018GY10]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	China National Natural Science Foundation, Grant/Award Number: 81673666 and CPU2018GY10	Akiyama T, 2014, J INNATE IMMUN, V6, P739, DOI 10.1159/000362789; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Baumert TF, 2018, GUT; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Belibasakis GN, 2015, VIRULENCE, V6, P704, DOI 10.1080/21505594.2015.1081731; Bohringer M, 2016, CELL MICROBIOL, V18, P889, DOI 10.1111/cmi.12566; Bowie RV, 2012, AM J PHYSIOL-GASTR L, V302, pG781, DOI 10.1152/ajpgi.00002.2011; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Chen SW, 2019, J CROHNS COLITIS, V13, P1067, DOI 10.1093/ecco-jcc/jjz027; Du J, 2015, INFLAMM BOWEL DIS, V21, P2495, DOI 10.1097/MIB.0000000000000526; Fischer A, 2013, AM J PHYSIOL-GASTR L, V304, pG970, DOI 10.1152/ajpgi.00183.2012; Genser L, 2018, J PATHOL, V246, P217, DOI 10.1002/path.5134; Gentile C, 2015, EUR J NUTR, V54, P811, DOI 10.1007/s00394-014-0760-6; Gilbert S, 2012, EMBO MOL MED, V4, P109, DOI 10.1002/emmm.201100192; Goggins BJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00272; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Gu Y, 2012, ACTA PHARMACOL SIN, V33, P941, DOI 10.1038/aps.2012.60; Hisamatsu T, 2013, PHARMACOL THERAPEUT, V137, P283, DOI 10.1016/j.pharmthera.2012.10.008; Jacenik D, 2018, MOL CELL ENDOCRINOL, V471, P89, DOI 10.1016/j.mce.2017.07.036; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Keszthelyi D, 2014, ALIMENT PHARM THER, V40, P392, DOI 10.1111/apt.12842; Konstantinopoulos PA, 2003, EUR J CANCER, V39, P1251, DOI 10.1016/S0959-8049(03)00239-9; Krug SM, 2014, SEMIN CELL DEV BIOL, V36, P166, DOI 10.1016/j.semcdb.2014.09.002; Laukoetter MG, 2006, CURR OPIN GASTROEN, V22, P85, DOI 10.1097/01.mog.0000203864.48255.4f; Li X, 2006, ENDOCRINOLOGY, V147, P5236, DOI 10.1210/en.2006-0779; Looijer-van Langen M, 2011, AM J PHYSIOL-GASTR L, V300, pG621, DOI 10.1152/ajpgi.00274.2010; Lopez-Posadas R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01240; Luettig J, 2016, MOL NUTR FOOD RES, V60, P2576, DOI 10.1002/mnfr.201600274; Manthari RK, 2018, ARCH TOXICOL, V92, P3255, DOI 10.1007/s00204-018-2304-y; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mok KW, 2012, ENDOCRINOLOGY, V153, P5036, DOI 10.1210/en.2012-1665; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Park CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043282; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rodgers LS, 2011, CYTOSKELETON, V68, P653, DOI 10.1002/cm.20547; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Scaldaferri F, 2012, J CLIN GASTROENTEROL, V46, pS12, DOI 10.1097/MCG.0b013e31826ae849; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Shouval DS, 2017, JAMA PEDIATR, V171, P999, DOI 10.1001/jamapediatrics.2017.2571; Sun Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00268; Tao Y, 2017, CELL PHYSIOL BIOCHEM, V44, P1106, DOI 10.1159/000485416; Thatcher SE, 2011, J PHARMACOL SCI, V116, P116, DOI 10.1254/jphs.10296FP; Triplett KD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37951-3; Turner JR, 2014, SEMIN CELL DEV BIOL, V36, P204, DOI 10.1016/j.semcdb.2014.09.022; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2017, MOL BIOL CELL, V28, P524, DOI 10.1091/mbc.E16-10-0698; Wang K, 2018, BIOCHEM PHARMACOL, V155, P494, DOI 10.1016/j.bcp.2018.07.039; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Wu X, 2016, ONCOTARGET, V7, P83893, DOI 10.18632/oncotarget.13338; Wu X, 2014, INT IMMUNOPHARMACOL, V23, P505, DOI 10.1016/j.intimp.2014.09.026; Yano T, 2017, ANN NY ACAD SCI, V1405, P32, DOI 10.1111/nyas.13432; Zhang N, 2013, INT J MOL SCI, V14, P18657, DOI 10.3390/ijms140918657	53	16	16	3	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3069	3090		10.1096/fj.201901638RR	http://dx.doi.org/10.1096/fj.201901638RR		DEC 2019	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908053				2022-12-28	WOS:000505009000001
J	Xia, B; Yu, J; He, T; Liu, X; Su, JH; Wang, MJ; Wang, JF; Zhu, YH				Xia, Bing; Yu, Jiao; He, Ting; Liu, Xiao; Su, Jinhui; Wang, Meijun; Wang, Jiufeng; Zhu, Yaohong			Lactobacillus johnsonii L531 ameliorates enteritis via elimination of damaged mitochondria and suppression of SQSTM1-dependent mitophagy in a Salmonella infantis model of piglet diarrhea	FASEB JOURNAL			English	Article						autophagy; inflammasome; IPEC-J2; pig; probiotic	INDUCED AUTOPHAGY; SECRETORY IGA; RHAMNOSUS GG; INFLAMMASOME; NLRP3; PIGS; ACTIVATION; EXPRESSION; PROBIOTICS; MICROBIOTA	Newly weaned piglets challenged with Salmonella infantis were particularly susceptible, whereas oral preadministration of Lactobacillus johnsonii L531 alleviated enteritis and promoted intestinal secretory IgA production. Salmonella infantis-induced activation of NLRC4 and NLRP3 inflammasomes and (nuclear factor kappa B) NF-kappa B signaling in the small intestine was also inhibited by L. johnsonii L531 pretreatment, thus limiting inflammation. An IPEC-J2 cell model of S. infantis infection yielded similar results. Salmonella infantis infection also resulted in mitochondrial damage and impaired mitophagy in the ileum and IPEC-J2 cells, as demonstrated by immunofluorescence colocalization of mitochondria with microtubule-binding protein light chain 3 (LC3) and high expression of autophagy-related proteins PTEN-induced putative kinase 1 (PINK1), sequestosome 1 (SQSTM1/p62), optineurin (OPTN), and LC3 by Western blotting analysis. However, L. johnsonii L531 pretreatment reduced both the extent of mitochondrial damage and autophagy-related protein expression. Our findings suggest that the amelioration of S. infantis-associated enteritis by L. johnsonii L531 is associated with regulation of NLRC4 and NLRP3 inflammasomes and NF-kappa B signaling pathway activation and suppression of mitochondrial damage. Amelioration of impaired mitophagy by L. johnsonii L531 could involve eliminating damaged mitochondria and regulating S. infantis-induced activation of the NF-kappa B-SQSTM1mitophagy signaling pathway in host cells to prevent the further mitochondrial damage and S. infantis dissemination.	[Xia, Bing; Yu, Jiao; He, Ting; Liu, Xiao; Su, Jinhui; Wang, Meijun; Wang, Jiufeng; Zhu, Yaohong] China Agr Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	China Agricultural University	Zhu, YH (corresponding author), China Agr Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	zhu_yaohong@hotmail.com			National Key R&D Program of China [2017YFD0502200]; National Natural Science Foundation of China (NSFC) [31672613]; National Natural Science Foundation of China [31672613, 31873034]	National Key R&D Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Key R&D Program of China, Grant/Award Number: 2017YFD0502200; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31873034; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31672613; National Natural Science Foundation of China, Grant/Award Number: 31873034 and 31672613	Bereswill S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02436-2; Brodsky IE, 2009, SEMIN IMMUNOL, V21, P199, DOI 10.1016/j.smim.2009.05.007; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Corthesy B, 2013, AUTOIMMUN REV, V12, P661, DOI 10.1016/j.autrev.2012.10.012; Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992; Dore K, 2004, EPIDEMIOL INFECT, V132, P485, DOI 10.1017/S0950268803001924; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Gresse R, 2017, TRENDS MICROBIOL, V25, P851, DOI 10.1016/j.tim.2017.05.004; Han CQ, 2016, CELL PHYSIOL BIOCHEM, V38, P2464, DOI 10.1159/000445597; He T, 2019, VET MICROBIOL, V230, P187, DOI 10.1016/j.vetmic.2019.02.003; Jabir MS, 2015, AUTOPHAGY, V11, P166, DOI 10.4161/15548627.2014.981915; Jabir MS, 2014, CELL HOST MICROBE, V15, P214, DOI 10.1016/j.chom.2014.01.010; Kanayama M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6779; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; Lazarou M, 2015, IMMUNOL CELL BIOL, V93, P3, DOI 10.1038/icb.2014.75; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040666; Lievin-Le Moal V, 2014, CLIN MICROBIOL REV, V27, P167, DOI 10.1128/CMR.00080-13; Lopez-Perez O, 2019, VET MICROBIOL, V233, P78, DOI 10.1016/j.vetmic.2019.04.026; Masud S, 2019, AUTOPHAGY, V15, P796, DOI 10.1080/15548627.2019.1569297; Mathias A, 2014, GUT MICROBES, V5, P688, DOI 10.4161/19490976.2014.983763; McCracken BA, 1999, J NUTR, V129, P613, DOI 10.1093/jn/129.3.613; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Petibone DM, 2017, J APPL TOXICOL, V37, P23, DOI 10.1002/jat.3393; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Qian X, 2017, MOL CELL, V65, P917, DOI 10.1016/j.molcel.2017.01.027; Ramakrishnan SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08581-8; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Su JH, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040117; Sun YX, 2018, CIRCULATION, V138, P2247, DOI 10.1161/CIRCULATIONAHA.117.032821; Tohno M, 2011, VET IMMUNOL IMMUNOP, V144, P410, DOI 10.1016/j.vetimm.2011.09.010; van Wijk SJL, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.66; Verlhac P, 2015, CELL HOST MICROBE, V17, P515, DOI 10.1016/j.chom.2015.02.008; Walczak M, 2013, AUTOPHAGY, V9, P424, DOI 10.4161/auto.22931; Wang YP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02987; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wu SP, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-22; Yang GY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00323; Yu J, 2017, VET MICROBIOL, V210, P91, DOI 10.1016/j.vetmic.2017.08.008; Zaki MH, 2014, P NATL ACAD SCI USA, V111, P385, DOI 10.1073/pnas.1317643111; Zhang Wei, 2017, Front Microbiol, V8, P2705, DOI 10.3389/fmicb.2017.02705; Zheng W, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0353-3; Zhong Z, 2016, CLIN EXP RHEUMATOL, V34, pS12; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhu YH, 2014, APPL ENVIRON MICROB, V80, P1787, DOI 10.1128/AEM.03668-13	50	20	22	2	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2821	2839		10.1096/fj.201901445RRR	http://dx.doi.org/10.1096/fj.201901445RRR		DEC 2019	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908018				2022-12-28	WOS:000504667300001
J	Menarim, BC; Gillis, KH; Oliver, A; Mason, C; Ngo, Y; Werre, SR; Barrett, SH; Luo, X; Byron, CR; Dahlgren, LA				Menarim, Bruno C.; Gillis, Kiersten H.; Oliver, Andrea; Mason, Caitlin; Ngo, Ying; Werre, Stephen R.; Barrett, Sarah H.; Luo, Xin; Byron, Christopher R.; Dahlgren, Linda A.			Autologous bone marrow mononuclear cells modulate joint homeostasis in an equine in vivo model of synovitis	FASEB JOURNAL			English	Article						osteoarthritis; macrophage; inflammation resolution; treatment; inflammatory joint disease	MESENCHYMAL STEM-CELLS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; EXPERIMENTALLY-INDUCED ARTHRITIS; PRORESOLVING LIPID MEDIATORS; EXPERIMENTAL OSTEOARTHRITIS; MONOCLONAL-ANTIBODIES; ARTICULAR-CARTILAGE; RHEUMATOID-ARTHRITIS; DIMETHYL-SULFOXIDE; CONDITIONED SERUM	Osteoarthritis (OA) is characterized by macrophage-driven synovitis. Macrophages promote synovial health but become inflammatory when their regulatory functions are overwhelmed. Bone marrow mononuclear cells (BMNCs) are a rich source of macrophage progenitors used for treating chronic inflammation and produce essential molecules for cartilage metabolism. This study investigated the response to autologous BMNC injection in normal and inflamed joints. Synovitis was induced in both radiocarpal joints of 6 horses. After 8 h, 1 inflamed radiocarpal and 1 normal tarsocrural joint received BMNC injection. Contralateral joints were injected with saline. Synovial fluid was collected at 24,96, and 144 h for cytology, cytokine quantification, and flow cytometry. At 144 h, horses were euthanatized, joints were evaluated, and synovium was harvested for histology and immunohistochemistry. Four days after BMNC treatment, inflamed joints had 24% higher macrophage counts with 10% more IL-10(+) cells than saline-treated controls. BMNC-treated joints showed gross and analytical improvements in synovial fluid and synovial membrane, with increasing regulatory macrophages and synovial fluid IL-10 concentrations compared with saline-treated controls. BMNC-treated joints were comparable to healthy joints histologically, which remained abnormal in saline-treated controls. Autologous BMNCs are readily available, regulate synovitis through macrophage-associated effects, and can benefit thousands of patients with OA.	[Menarim, Bruno C.; Gillis, Kiersten H.; Oliver, Andrea; Mason, Caitlin; Ngo, Ying; Byron, Christopher R.; Dahlgren, Linda A.] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Large Anim Clin Sci, Blacksburg, VA 24061 USA; [Werre, Stephen R.] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Lab Study Design & Stat Anal, Blacksburg, VA 24061 USA; [Barrett, Sarah H.; Luo, Xin] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Dahlgren, LA (corresponding author), Virginia Tech, Virginia Maryland Coll Vet Med, Dept Large Anim Clin Sci, 205 Duck Pond Dr, Blacksburg, VA 24061 USA.	lad11@vt.edu	Luo, Xin M/J-6544-2016	Luo, Xin M/0000-0002-2809-5836; Menarim, Bruno/0000-0003-1829-4978	Grayson-Jockey Club Research Foundation; Interdisciplinary Graduate Education Program at Virginia Tech; Virginia-Maryland College of Veterinary Medicine	Grayson-Jockey Club Research Foundation; Interdisciplinary Graduate Education Program at Virginia Tech; Virginia-Maryland College of Veterinary Medicine	This study was supported by the Grayson-Jockey Club Research Foundation. B.C.M. received graduate assistantship support from the Interdisciplinary Graduate Education Program at Virginia Tech and the Virginia-Maryland College of Veterinary Medicine. The authors declare no conflicts of interest.	ADAIR HS, 1991, AM J VET RES, V52, P333; Agadi S, 2015, STEM CELLS, V33, P2093, DOI 10.1002/stem.2029; Ahrens N, 2004, TRANSPLANTATION, V78, P925, DOI 10.1097/01.tp.0000133305.81823.2a; Amin AR, 2014, DNA CELL BIOL, V33, P550, DOI 10.1089/dna.2013.2198; [Anonymous], THESIS; [Anonymous], JOINT DIS HORSE; [Anonymous], 2014, THESIS U AUSTRAL CHI; [Anonymous], 2016, BRAZ ARCH BIOL TECHN; [Anonymous], 2018, ATLAS OSTEOARTHRITIS; Barrera P, 2000, ARTHRITIS RHEUM-US, V43, P1951, DOI 10.1002/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K; Barussi FCM, 2016, RESP PHYSIOL NEUROBI, V232, P35, DOI 10.1016/j.resp.2016.07.002; Behrendt P, 2018, OSTEOARTHR CARTILAGE, V26, P264, DOI 10.1016/j.joca.2017.11.007; Behrendt P, 2016, OSTEOARTHR CARTILAGE, V24, P1981, DOI 10.1016/j.joca.2016.06.016; Bekkers JEJ, 2013, OSTEOARTHR CARTILAGE, V21, P950, DOI 10.1016/j.joca.2013.03.015; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Bertone AL, 2001, VET SURG, V30, P528, DOI 10.1053/jvet.2001.28430; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Caron JP, 2019, PROSTAG OTH LIPID M, V142, P1, DOI 10.1016/j.prostaglandins.2019.02.007; Caron JP, 1996, ARTHRITIS RHEUM, V39, P1535, DOI 10.1002/art.1780390914; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Cruz FF, 2016, STEM CELL TRANSL MED, V5, P488, DOI 10.5966/sctm.2015-0141; Cuende N, 2012, STEM CELL TRANSL MED, V1, P403, DOI 10.5966/sctm.2011-0064; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; de Grauw JC, 2016, EQUINE VET J, V48, P152, DOI 10.1111/evj.12383; de Grauw JC, 2009, EQUINE VET J, V41, P693, DOI 10.2746/042516409X436286; de Grauw JC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2640; Dingenouts CKE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00114; Dymock DC, 2014, AM J VET RES, V75, P722, DOI 10.2460/ajvr.75.8.722; Fahy N, 2014, OSTEOARTHR CARTILAGE, V22, P1167, DOI 10.1016/j.joca.2014.05.021; Fendl B, 2019, BIOCHEM BIOPH RES CO, V517, P709, DOI 10.1016/j.bbrc.2019.07.120; Fichadiya A, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0120-9; Filardo G, 2015, KNEE SURG SPORT TR A, V23, P2459, DOI 10.1007/s00167-013-2743-1; Finnegan A, 2012, AUTOIMMUNITY, V45, P353, DOI 10.3109/08916934.2012.665526; FIRTH EC, 1987, CORNELL VET, V77, P107; Flaminio MJBF, 2007, VET IMMUNOL IMMUNOP, V119, P92, DOI 10.1016/j.vetimm.2007.06.035; Francoz D, 2007, CAN J VET RES, V71, P129; Frisbie DD, 2008, OSTEOARTHR CARTILAGE, V16, P1196, DOI 10.1016/j.joca.2008.03.008; Frisbie DD, 2007, AM J VET RES, V68, P290, DOI 10.2460/ajvr.68.3.290; Giraldi-Guimaraes A, 2012, BRAIN RES, V1452, P173, DOI 10.1016/j.brainres.2012.03.002; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; GOLDRING MB, 1990, ANN NY ACAD SCI, V580, P536, DOI 10.1111/j.1749-6632.1990.tb17983.x; Goncars V, 2019, CARTILAGE, V10, P26, DOI 10.1177/1947603517746721; Iannone F, 2001, CLIN EXP RHEUMATOL, V19, P139; Ibrahim S, 2007, VET IMMUNOL IMMUNOP, V119, P63, DOI 10.1016/j.vetimm.2007.06.034; Ibrahim S, 2012, VET IMMUNOL IMMUNOP, V145, P7, DOI 10.1016/j.vetimm.2011.07.021; Iijima H, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0041-8; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jain S, 2015, BIOMATERIALS, V61, P162, DOI 10.1016/j.biomaterials.2015.05.028; Jayadev C, 2012, J IMMUNOL METHODS, V386, P22, DOI 10.1016/j.jim.2012.08.012; Kabithe E, 2010, VET IMMUNOL IMMUNOP, V138, P149, DOI 10.1016/j.vetimm.2010.07.003; Kamm JL, 2010, EQUINE VET J, V42, P693, DOI 10.1111/j.2042-3306.2010.00140.x; Karagianni AE, 2017, EQUINE VET J, V49, P375, DOI 10.1111/evj.12584; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Kay AT, 2008, AM J VET RES, V69, P1646, DOI 10.2460/ajvr.69.12.1646; Kennedy A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00052; King A, 2014, ADV WOUND CARE, V3, P315, DOI 10.1089/wound.2013.0461; Kraus VB, 2016, OSTEOARTHR CARTILAGE, V24, P1613, DOI 10.1016/j.joca.2016.04.010; Lasarzik J, 2018, J EQUINE VET SCI, V60, P35, DOI 10.1016/j.jevs.2016.09.014; Laudy ABM, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094036; Lettesjo H, 1998, SCAND J IMMUNOL, V48, P286; Leveque M, 2017, FASEB J, V31, P1891, DOI 10.1096/fj.201600772R; Li J, 2015, INT J CLIN EXP PATHO, V8, P11386; Lopes EBP, 2017, CURR OSTEOPOROS REP, V15, P593, DOI 10.1007/s11914-017-0411-y; Ludwig EK, 2016, VET SURG, V45, P859, DOI 10.1111/vsu.12531; Manferdini C, 2017, OSTEOARTHR CARTILAGE, V25, P1161, DOI 10.1016/j.joca.2017.01.011; Manferdini C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0983-4; Manferdini C, 2013, ARTHRITIS RHEUM-US, V65, P1271, DOI 10.1002/art.37908; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mathiessen A, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1229-9; McIlwraith CW, 2012, BONE JOINT RES, V1, P297, DOI 10.1302/2046-3758.111.2000132; McIlwraith CW, 2010, OSTEOARTHR CARTILAGE, V18, pS93, DOI 10.1016/j.joca.2010.05.031; McIlwraith CW, 2011, ARTHROSCOPY, V27, P1552, DOI 10.1016/j.arthro.2011.06.002; MCILWRAITH CW, 1979, AM J VET RES, V40, P11; MCILWRAITH CW, 1981, AM J VET RES, V42, P209; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; MORRIS EA, 1994, AM J VET RES, V55, P138; Morton AJ, 2005, RES VET SCI, V78, P189, DOI 10.1016/j.rvsc.2004.07.006; Murphy LB, 2018, ARTHRIT CARE RES, V70, P869, DOI 10.1002/acr.23425; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nawaz A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00231-1; Liem NT, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0992-x; Odobasic D, 2008, IMMUNOLOGY, V124, P503, DOI 10.1111/j.1365-2567.2007.02802.x; Oh BJ, 2015, AM J TRANSPLANT, V15, P1543, DOI 10.1111/ajt.13157; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; PALMER JL, 1994, EQUINE VET J, V26, P492, DOI 10.1111/j.2042-3306.1994.tb04056.x; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Peffers MJ, 2015, OSTEOARTHR CARTILAGE, V23, P1204, DOI 10.1016/j.joca.2015.03.019; Pelletier JP, 1997, ARTHRITIS RHEUM-US, V40, P1012, DOI 10.1002/art.1780400604; Pessler F, 2008, CLIN RHEUMATOL, V27, P1127, DOI 10.1007/s10067-008-0878-0; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poulsen RC, 2008, AM J HEMATOL, V83, P437, DOI 10.1002/ajh.21170; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Riyazi N, 2005, ARTHRITIS RHEUM-US, V52, P1443, DOI 10.1002/art.21014; Rose BJ, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/4895050; Ross TN, 2012, OSTEOARTHR CARTILAGE, V20, P1583, DOI 10.1016/j.joca.2012.08.008; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Ryncarz RE, 1998, BLOOD, V91, P3892, DOI 10.1182/blood.V91.10.3892.3892_3892_3900; Safi W, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.11; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Saw KY, 2009, ARTHROSCOPY, V25, P1391, DOI 10.1016/j.arthro.2009.07.011; Scanzello CR, 2017, J ORTHOP RES, V35, P735, DOI 10.1002/jor.23471; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sergijenko A, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1060-8; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Shizhu J, 2012, TURK J GASTROENTEROL, V23, P344, DOI 10.4318/tjg.2012.0344; Smith G, 1998, AM J VET RES, V59, P1149; Smith Malcolm D, 2011, Open Rheumatol J, V5, P100, DOI 10.2174/1874312901105010100; St Clair EW, 1999, ANN RHEUM DIS, V58, P99; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Suzuki Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31565-5; Todhunter PG, 1996, AM J VET RES, V57, P1080; Trombetta AC, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0891-z; Tsubosaka Y, 2019, FASEB J, V33, P6829, DOI 10.1096/fj.201802153R; van de Water E, 2017, EQUINE VET J, V49, P532, DOI 10.1111/evj.12629; van Lent PLEM, 2004, ARTHRITIS RHEUM, V50, P103, DOI 10.1002/art.11422; van Loon JPAM, 2013, VET J, V196, P40, DOI 10.1016/j.tvjl.2012.07.030; van Loon JPAM, 2010, EQUINE VET J, V42, P412, DOI 10.1111/j.2042-3306.2010.00077.x; Verde CK, 2001, J VET PHARMACOL THER, V24, P179, DOI 10.1046/j.1365-2885.2001.00336.x; Wagner B, 2008, VET IMMUNOL IMMUNOP, V122, P57, DOI 10.1016/j.vetimm.2007.10.012; Wang CQ, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-6; Williams LB, 2016, EQUINE VET J, V48, P619, DOI 10.1111/evj.12477; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Xu Q, 2012, J INVEST MED, V60, P898, DOI 10.2310/JIM.0b013e31825f9f69; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; YARON I, 1989, ARTHRITIS RHEUM, V32, P173, DOI 10.1002/anr.1780320210; Zamani F, 2013, ADV PHARM BULL, V3, P329, DOI 10.5681/apb.2013.053; ZHANG DE, 1994, J IMMUNOL, V153, P3276; Zhou YD, 2017, MOL MED REP, V15, P3949, DOI 10.3892/mmr.2017.6491	137	8	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14337	14353		10.1096/fj.201901684RR	http://dx.doi.org/10.1096/fj.201901684RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31665925	Bronze			2022-12-28	WOS:000507466100099
J	Nagai, A; Mizushige, T; Matsumura, S; Inoue, K; Ohinata, K				Nagai, Akitoshi; Mizushige, Takafumi; Matsumura, Shigenobu; Inoue, Kazuo; Ohinata, Kousaku			Orally administered milk-derived tripeptide improved cognitive decline in mice fed a high-fat diet	FASEB JOURNAL			English	Article						milk protein; bioactive peptide; neurogenesis; neurotrophic factor	ANXIOLYTIC-LIKE ACTIVITY; NEUROTROPHIC FACTOR; HIPPOCAMPAL NEUROGENESIS; INSULIN-RESISTANCE; DOPAMINE; DEMENTIA; RISK	The functions of the brain, which is thought of as an organ highly independent from the periphery, are often affected by the peripheral environment. Indeed, epidemiologic studies demonstrated that diabetes was a risk factor for dementia. It was also reported that the intake of dairy products, such as milk, reduces the risk of developing dementia. We found that mice on a short-term high-fat diet (HFD) for 1 wk had reduced cognitive function. Thus, using this acute model, we investigated the effects of milk-derived peptide on cognitive decline induced by HFD. Tyr-Leu-Gly (YLG), a tripeptide derived from alpha(S1)-casein, a major bovine milk protein, is released by gastrointestinal proteases. We found that orally administered YLG improved cognitive decline induced by 1-wk HFD intake in the object recognition test. YLG also improved cognitive decline in the object location test. Thus, we found that YLG improved cognitive decline induced by HFD. Next, we examined the effects of YLG on the hippocampus, a brain area essential for cognitive function. HFD intake decreased the number of 5-bromo-2'-deoxyuridine (BrdU)-positive cells, and this decrease was improved by YLG administration. HFD intake decreased nerve growth factor (NGF) and glial cell line derived neurotrophic factor, whereas YLG increased NGF and ciliary neurotrophic factor, suggesting that these neurotropic factors play a role in hippocampal neurogenesis after YLG administration. In conclusion, we demonstrated that 1-wk HFD reduced cognitive function. Furthermore, we found that YLG, a milk-derived tripeptide, improved cognitive decline in mice on HFD. The HFD reduced neural stem cell proliferation, and YLG improved this reduction. YLG is the first reported milk peptide to improve cognitive decline induced by HFD intake.	[Nagai, Akitoshi; Matsumura, Shigenobu; Inoue, Kazuo; Ohinata, Kousaku] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6110011, Japan; [Mizushige, Takafumi] Utsunomiya Univ, Fac Agr, Dept Appl Biol Chem, Utsunomiya, Tochigi, Japan	Kyoto University; Utsunomiya University	Ohinata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6110011, Japan.	ohinata@kais.kyoto-u.ac.jp			Food Science Institute Foundation (Ryoushoku Kenkyukai)	Food Science Institute Foundation (Ryoushoku Kenkyukai)	This study was supported, in part, by a Grant-in-Aid for challenging Exploratory Research and the Food Science Institute Foundation (Ryoushoku Kenkyukai). The authors declare no conflicts of interest.	Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Castanon N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00229; Diehl T, 2017, TRANSL RES, V183, P26, DOI 10.1016/j.trsl.2016.12.005; Heydemann A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2902351; Hirose M, 2016, PAIN PRACT, V16, P175, DOI 10.1111/papr.12342; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kanegawa N, 2010, FEBS LETT, V584, P599, DOI 10.1016/j.febslet.2009.12.008; Kimura S, 2018, BIOCHEM BIOPH RES CO, V505, P1050, DOI 10.1016/j.bbrc.2018.09.195; Kita Y, 2013, PSYCHOPHARMACOLOGY, V225, P543, DOI 10.1007/s00213-012-2841-7; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f; Mizushige T, 2013, FASEB J, V27, P2911, DOI 10.1096/fj.12-225474; Mizushige T, 2013, NEUROSCI LETT, V543, P126, DOI 10.1016/j.neulet.2013.03.043; Mori Y, 2018, FASEB J, V32, P568, DOI 10.1096/fj.201700333RR; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Ogiwara M, 2018, FOOD FUNCT, V9, P4635, DOI [10.1039/c8fo00919h, 10.1039/C8FO00919H]; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Oliveira SLB, 2013, CYTOM PART A, V83A, P76, DOI 10.1002/cyto.a.22161; Ozawa M, 2014, J AM GERIATR SOC, V62, P1224, DOI 10.1111/jgs.12887; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Pasquin S, 2015, CYTOKINE GROWTH F R, V26, P507, DOI 10.1016/j.cytogfr.2015.07.007; Patrone C, 2014, LANCET DIABETES ENDO, V2, P256, DOI 10.1016/S2213-8587(13)70125-6; Pepeu G, 2017, BRAIN RES, V1670, P173, DOI 10.1016/j.brainres.2017.06.023; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Yamamoto Y, 2015, NEUROPEPTIDES, V51, P25, DOI 10.1016/j.npep.2015.04.002; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008	31	7	7	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14095	14102		10.1096/fj.201900621R	http://dx.doi.org/10.1096/fj.201900621R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31652095				2022-12-28	WOS:000507466100079
J	Pang, ZD; Wang, Y; Wang, XJ; She, G; Ma, XZ; Song, Z; Zhao, LM; Wang, HF; Lai, BC; Gou, W; Du, XJ; Deng, XL				Pang, Zheng-Da; Wang, Yan; Wang, Xiao-Jing; She, Gang; Ma, Xiao-Zhen; Song, Zheng; Zhao, Li-Mei; Wang, Hui-Fang; Lai, Bao-Chang; Gou, Wei; Du, Xiao-Jun; Deng, Xiu-Ling			K(Ca)3.1 channel mediates inflammatory signaling of pancreatic beta cells and progression of type 2 diabetes mellitus	FASEB JOURNAL			English	Article						pancreatic islet beta cells; inflammation; nuclear factor-kappa B	ACTIVATED POTASSIUM CHANNEL; K+ CHANNEL; KAPPA-B; GLUCOSE; INHIBITOR; CHEMOKINE; BLOCKADE; PROTEIN; KCA3.1; RISK	Chronic islet inflammation is associated with development of type 2 diabetes mellitus (T2DM). Intermediate-conductance calcium-activated K+ (K(Ca)3.1) channel plays an important role in inflammatory diseases. However, the role and regulation of K(Ca)3.1 in pancreatic beta cells in progression of T2DM remain unclarified. In the present study, we evaluated the effect of the specific K(Ca)3.1 channel blocker 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34) on diabetic phenotype in the db/db model. In diabetic mice, blockade of K(Ca)3.1 significantly improved glucose tolerance, enhanced secretion of postprandial insulin level, and reduced loss of beta-cell mass through attenuating the expression and secretion of inflammatory mediators. Furthermore, in cultured pancreatic 13 cells, exposure to high levels of glucose or palmitic acid significantly increased expression and current density of the K(Ca)3.1 channel as well as secretion of proinflammatory chemokines, and the effects were similarly reversed by preincubation with TRAM-34 or a NF-kappa B inhibitor pyrrolidinedithiocarbamate. Additionally, expression of K(Ca)3.1 in pancreas islet cells was up-regulated by activation of NF-kappa B with IL-1 beta stimulation. In summary, up-regulated K(Ca)3.1 due to activation of NF-kappa B pathway leads to pancreatic inflammation via expression and secretion of chemokines and cytokines by pancreatic beta cells, thereby facilitating progression of T2DM.	[Pang, Zheng-Da; Wang, Yan; Wang, Xiao-Jing; She, Gang; Ma, Xiao-Zhen; Song, Zheng; Zhao, Li-Mei; Du, Xiao-Jun; Deng, Xiu-Ling] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Hlth Sci Ctr, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Lai, Bao-Chang; Deng, Xiu-Ling] Xi An Jiao Tong Univ, Sch Basic Med Sci, Cardiovasc Res Ctr, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Gou, Wei] Xi An Jiao Tong Univ, Sch Basic Med Sci, Basic Expt Teaching Ctr, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Wang, Hui-Fang] Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian Guangren Hosp, Dept Pathol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Deng, XL (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Hlth Sci Ctr, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	dengxl@mail.xjtu.edu.cn			National Natural Science Foundation of China [81600656, 81570214, 81370191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 81600656, 81570214, and 81370191). The authors declare no conflicts of interest.	Basu S, 2019, LANCET DIABETES ENDO, V7, P25, DOI 10.1016/S2213-8587(18)30303-6; Burke SJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE715, DOI 10.1152/ajpendo.00153.2015; Burke SJ, 2015, BIOMOLECULES, V5, P1020, DOI 10.3390/biom5021020; Di L, 2010, J BIOL CHEM, V285, P38765, DOI 10.1074/jbc.M110.168070; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Drews G, 2009, ISLETS, V1, P148, DOI 10.4161/isl.1.2.9056; Dufer M, 2009, DIABETES, V58, P1835, DOI 10.2337/db08-1324; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Ma XZ, 2018, EXP CELL RES, V369, P208, DOI 10.1016/j.yexcr.2018.05.020; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Maedler K, 2017, J CLIN INVEST, V127, P1589, DOI 10.1172/JCI92172; Marchetti P, 2016, DIABETOLOGIA, V59, P668, DOI 10.1007/s00125-016-3875-x; Ortis F, 2012, FEBS LETT, V586, P984, DOI 10.1016/j.febslet.2012.02.021; Pang ZD, 2014, P NATL ACAD SCI USA, V111, pE1256, DOI 10.1073/pnas.1322009111; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Ripsin CM, 2009, AM FAM PHYSICIAN, V79, P29; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Schumann DM, 2007, P NATL ACAD SCI USA, V104, P2861, DOI 10.1073/pnas.0611487104; She G, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010418; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Tamarina NA, 2003, DIABETES, V52, P2000, DOI 10.2337/diabetes.52.8.2000; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Westwell-Roper CY, 2015, DIABETOLOGIA, V58, P575, DOI 10.1007/s00125-014-3447-x; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Zhao LM, 2015, PFLUG ARCH EUR J PHY, V467, P2275, DOI 10.1007/s00424-015-1694-4	37	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14760	14771		10.1096/fj.201901329RR	http://dx.doi.org/10.1096/fj.201901329RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690106	Bronze			2022-12-28	WOS:000507466100130
J	Javed, E; Thangavel, C; Frara, N; Singh, J; Mohanty, I; Hypolite, J; Birbe, R; Braverman, AS; Den, RB; Rattan, S; Zderic, SA; Deshpande, DA; Penn, RB; Ruggieri, MR; Chacko, S; Boopathi, E				Javed, Elham; Thangavel, Chellappagounder; Frara, Nagat; Singh, Jagmohan; Mohanty, Ipsita; Hypolite, Joseph; Birbe, Ruth; Braverman, Alan S.; Den, Robert B.; Rattan, Satish; Zderic, Stephen A.; Deshpande, Deepak A.; Penn, Raymond B.; Ruggieri, Michael R., Sr.; Chacko, Samuel; Boopathi, Ettickan			Increased expression of desmin and vimentin reduces bladder smooth muscle contractility via JNK2	FASEB JOURNAL			English	Article						bladder; carbachol; cholinergic agonist; intermediate filaments; KCl	INTERMEDIATE-FILAMENTS; SIGNAL-TRANSDUCTION; MECHANICAL STRETCH; OUTLET OBSTRUCTION; MAP KINASE; G-PROTEINS; CELL; ACTIN; CYTOSKELETAL; GENE	Bladder dysfunction is associated with the overexpression of the intermediate filament (IF) proteins desmin and vimentin in obstructed bladder smooth muscle (BSM). However, the mechanisms by which these proteins contribute to BSM dysfunction are not known. Previous studies have shown that desmin and vimentin directly participate in signal transduction. In this study, we hypothesized that BSM dysfunction associated with overexpression of desmin or vimentin is mediated via c-Jun N-terminal kinase (JNK). We employed a model of murine BSM tissue in which increased expression of desmin or vimentin was induced by adenoviral transduction to examine the sufficiency of increased IF protein expression to reduce BSM contraction. Murine BSM strips overexpressing desmin or vimentin generated less force in response to KCl and carbachol relative to the levels in control murine BSM strips, an effect associated with increased JNK2 phosphorylation and reduced myosin light chain (MLC20) phosphorylation. Furthermore, desmin and vimentin overexpressions did not alter BSM contractility and MLC20 phosphorylation in strips isolated from JNK2 knockout mice. Pharmacological JNK2 inhibition produced results qualitatively similar to those caused by JNK2 knockout. These findings suggest that inhibition of JNK2 may improve diminished BSM contractility associated with obstructive bladder disease.	[Javed, Elham; Hypolite, Joseph; Deshpande, Deepak A.; Penn, Raymond B.; Boopathi, Ettickan] Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Philadelphia, PA USA; [Thangavel, Chellappagounder; Den, Robert B.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA USA; [Frara, Nagat; Braverman, Alan S.; Ruggieri, Michael R., Sr.] Temple Univ, Lewis Katz Sch Med, Dept Anat & Cell Biol, Philadelphia, PA USA; [Singh, Jagmohan; Mohanty, Ipsita; Rattan, Satish] Thomas Jefferson Univ, Dept Med, Div Gastroenterol & Hepatol, Philadelphia, PA USA; [Birbe, Ruth] Cooper Univ Hlth Care, Dept Pathol & Lab Med, Camden, NJ USA; [Zderic, Stephen A.] Childrens Hosp Philadelphia, Dept Urol, Philadelphia, PA USA; [Chacko, Samuel; Boopathi, Ettickan] Univ Penn, Div Urol, Philadelphia, PA USA; [Chacko, Samuel] Univ Penn, Dept Pathobiol, Philadelphia, PA USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Boopathi, E (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Philadelphia, PA USA.	boopathi.ettickan@jefferson.edu	MOHANTY, IPSITA/AAB-3667-2020	MOHANTY, IPSITA/0000-0003-0894-4770; Javed, Elham/0000-0002-8867-0724	NIDDK NIH HHS [R01 DK035385, R01 DK100483] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam RM, 2004, PHYSIOL GENOMICS, V20, P36, DOI 10.1152/physiolgenomics.00181.2004; ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amini N, 2014, ATHEROSCLEROSIS, V235, P613, DOI 10.1016/j.atherosclerosis.2014.05.950; ANDERSON DJ, 1983, METHOD ENZYMOL, V96, P111; Angell RM, 2007, BIOORG MED CHEM LETT, V17, P1296, DOI 10.1016/j.bmcl.2006.12.003; Arner A, 1999, Rev Physiol Biochem Pharmacol, V134, P63; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; DARBY I, 1990, LAB INVEST, V63, P21; Despa S, 2012, CIRC RES, V110, P598, DOI [10.1161/CIRCRESAHA.111.258285, 10.1161/circresaha.111.258285]; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; DRAEGER A, 1990, J CELL BIOL, V111, P2463, DOI 10.1083/jcb.111.6.2463; Drake MJ, 2014, NAT REV UROL, V11, P454, DOI 10.1038/nrurol.2014.156; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GABBIANI G, 1981, P NATL ACAD SCI-BIOL, V78, P298, DOI 10.1073/pnas.78.1.298; Gianni D, 2010, CIRCULATION, V121, P1216, DOI 10.1161/CIRCULATIONAHA.109.879510; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Hypolite JA, 2001, AM J PHYSIOL-CELL PH, V280, pC254, DOI 10.1152/ajpcell.2001.280.2.C254; Janosch P, 2000, FASEB J, V14, P2008, DOI 10.1096/fj.99-0883com; Jiu Y, 2017, J CELL SCI, V130, P892, DOI 10.1242/jcs.196881; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kim HD, 1996, ANAT RECORD, V246, P271, DOI 10.1002/(SICI)1097-0185(199610)246:2<271::AID-AR13>3.0.CO;2-L; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Kushida N, 2001, AM J PHYSIOL-CELL PH, V281, pC1165, DOI 10.1152/ajpcell.2001.281.4.C1165; Lamarre NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109314; Laukeviciene A, 2006, EUR J PHARM SCI, V29, P335, DOI 10.1016/j.ejps.2006.06.012; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359; MALMQVIST U, 1991, SCAND J UROL NEPHROL, V25, P261, DOI 10.3109/00365599109024556; NAGAI R, 1989, J BIOL CHEM, V264, P9734; Nguyen HT, 2000, AM J PHYSIOL-CELL PH, V279, pC1155, DOI 10.1152/ajpcell.2000.279.4.C1155; OSBORN M, 1981, DIFFERENTIATION, V20, P196, DOI 10.1111/j.1432-0436.1981.tb01176.x; Osman NI, 2018, EUR UROL FOCUS, V4, P6, DOI 10.1016/j.euf.2018.03.012; Osto E, 2008, CIRCULATION, V118, P2073, DOI 10.1161/CIRCULATIONAHA.108.765032; OWENS GK, 1995, PHYSIOL REV, V75, P487; Palmisano MG, 2015, J CELL SCI, V128, P219, DOI 10.1242/jcs.142463; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Polyak E, 2009, J UROLOGY, V182, P2497, DOI 10.1016/j.juro.2009.07.011; QUINLAN RA, 1982, P NATL ACAD SCI-BIOL, V79, P3452, DOI 10.1073/pnas.79.11.3452; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Ridge KM, 2016, METHOD ENZYMOL, V568, P389, DOI 10.1016/bs.mie.2015.09.036; SCHMID E, 1982, EXP CELL RES, V137, P329, DOI 10.1016/0014-4827(82)90034-9; Scott RS, 2008, AM J PHYSIOL-CELL PH, V295, pC324, DOI 10.1152/ajpcell.90622.2007; Sjuve R, 1998, J MUSCLE RES CELL M, V19, P415, DOI 10.1023/A:1005353805699; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; van der Velden JLJ, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0117-2; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang TC, 2012, AM J PHYSIOL-RENAL, V303, pF1382, DOI 10.1152/ajprenal.00261.2011; WOODCOCKMITCHELL J, 1988, DIFFERENTIATION, V39, P161, DOI 10.1111/j.1432-0436.1988.tb00091.x; Zhang EY, 2004, AM J PATHOL, V164, P601, DOI 10.1016/S0002-9440(10)63149-5; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	67	2	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2126	2146		10.1096/fj.201901301R	http://dx.doi.org/10.1096/fj.201901301R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909533	Green Accepted			2022-12-28	WOS:000514663600015
J	Ren, SQ; Pan, XY; Gao, F; Sangild, PT; Nguyen, DN				Ren, Shuqiang; Pan, Xiaoyu; Gao, Fei; Sangild, Per T.; Nguyen, Duc Ninh			Prenatal inflammation suppresses blood Th1 polarization and gene clusters related to cellular energy metabolism in preterm newborns	FASEB JOURNAL			English	Article						chorioamnionitis; immune development; lipopolysaccharide; neonatal sepsis; preterm infants	INNATE IMMUNE-RESPONSES; MITOCHONDRIAL DYSFUNCTION; CHORIOAMNIONITIS; MODEL; ASSOCIATION; SEPSIS; GROWTH; CELLS; BIRTH; RISK	Chorioamnionitis (CA, fetal membrane inflammation) predisposes to preterm birth and is associated with increased neonatal infection risk, but the separate effects of prematurity, CA, and postnatal adaptations on this risk are unclear. Using pigs as models for infants, we examined the systemic immune-metabolic status in cesarean-delivered preterm pigs, with and without CA induced by intra-amniotic (IA) LPS exposure. At birth, cord blood of preterm pigs showed neutropenia and low expressions of innate and adaptive immune genes, relative to term pigs. IA LPS induced CA and fetal systemic innate immune activation via complement and neutrophil-related pathways. These were mainly modulated via cellular regulations rather than granulopoiesis, as validated by the in vitro LPS stimulation of cord blood. After birth, IA LPS-exposed preterm pigs did not follow normal immune-metabolic ontogenies found in fetuses or newborns without prenatal insults, but showed consistently high levels of Treg, impaired Th1 polarization, and reduced expressions of multiple genes related to cellular oxidative phosphorylation and ribosomal activities. In conclusion, our results provide cellular and molecular evidence for CA-induced distinct neonatal immune-metabolic status with increased disease tolerance strategy, suggesting mechanisms for the clinical observation of elevated sepsis risks in immune-compromised preterm infants born with CA.	[Ren, Shuqiang; Pan, Xiaoyu; Gao, Fei; Sangild, Per T.; Nguyen, Duc Ninh] Univ Copenhagen, Sect Comparat Pediat & Nutr, Dept Vet & Anim Sci, Dyrlaegevej 68, DK-1870 Frederiksberg C, Denmark; [Gao, Fei] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Guangdong, Peoples R China; [Sangild, Per T.] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark; [Sangild, Per T.] Univ Southern Denmark, Odense, Denmark	University of Copenhagen; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Nguyen, DN (corresponding author), Univ Copenhagen, Sect Comparat Pediat & Nutr, Dept Vet & Anim Sci, Dyrlaegevej 68, DK-1870 Frederiksberg C, Denmark.	dnn@sund.ku.dk	Pan, Xiaoyu/AAT-9002-2021; Nguyen, Duc Ninh/AAX-1131-2020	Pan, Xiaoyu/0000-0002-0282-6047; Nguyen, Duc Ninh/0000-0002-4997-555X				Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersen AD, 2016, AM J PHYSIOL-REG I, V310, pR481, DOI 10.1152/ajpregu.00349.2015; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brunse A, 2019, SHOCK, V51, P337, DOI 10.1097/SHK.0000000000001131; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; de Jong E, 2018, IMMUNOL CELL BIOL, V96, P792, DOI 10.1111/imcb.12037; Nguyen DN, 2018, AM J PATHOL, V188, P2629, DOI 10.1016/j.ajpath.2018.07.020; Nguyen DN, 2016, SCI REP-UK, V6, DOI 10.1038/srep36816; Nguyen DN, 2016, INNATE IMMUN-LONDON, V22, P51, DOI 10.1177/1753425915615195; Duvigneau JC, 2008, LAB INVEST, V88, P70, DOI 10.1038/labinvest.3700691; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Harbeson D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01918; Harbeson D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01077; Hibbert JE, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00357; Kallapur SG, 2005, AM J RESP CRIT CARE, V172, P1315, DOI 10.1164/rccm.200506-1007OC; Kallapur SG, 2014, SEMIN REPROD MED, V32, P56, DOI 10.1055/s-0033-1361823; Kallapur SG, 2013, J IMMUNOL, V191, P1102, DOI 10.4049/jimmunol.1300270; Kallapur SG, 2011, J IMMUNOL, V187, P2688, DOI 10.4049/jimmunol.1100779; Kan B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07215-9; Kramer BW, 2011, NEONATOLOGY, V99, P320, DOI 10.1159/000326620; Kuypers E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081644; Lee AH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08794-x; Lee I, 2014, BBA-MOL BASIS DIS, V1842, P1579, DOI 10.1016/j.bbadis.2014.05.031; Lindqvist LM, 2018, CURR OPIN GENET DEV, V48, P104, DOI 10.1016/j.gde.2017.11.003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luciano AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095867; Madsen-Bouterse SA, 2010, AM J REPROD IMMUNOL, V63, P73, DOI 10.1111/j.1600-0897.2009.00791.x; Maerkedahl RB, 2015, CLIN CHEM LAB MED, V53, P1181, DOI 10.1515/cclm-2014-1054; Matsuoka T, 2001, PEDIATR INT, V43, P453, DOI 10.1046/j.1442-200X.2001.01445.x; Miller JE, 2016, LANCET INFECT DIS, V16, P952, DOI 10.1016/S1473-3099(16)00150-X; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Pagel J, 2016, CLIN EXP IMMUNOL, V185, P219, DOI 10.1111/cei.12810; Piriou-Guzylack L, 2008, VET RES, V39, DOI 10.1051/vetres:2008030; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Sadeghi K, 2007, J INFECT DIS, V195, P296, DOI 10.1086/509892; Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359; Shen RL, 2015, AM J PHYSIOL-GASTR L, V309, pG310, DOI 10.1152/ajpgi.00163.2015; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Snyder CC, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.018; Soler-Rodriguez AM, 2000, J IMMUNOL, V164, P2674, DOI 10.4049/jimmunol.164.5.2674; Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Weitkamp JH, 2016, EARLY HUM DEV, V98, P1, DOI 10.1016/j.earlhumdev.2016.06.001; Wolfs TGAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018355	48	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2896	2911		10.1096/fj.201902629R	http://dx.doi.org/10.1096/fj.201902629R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908027	Bronze			2022-12-28	WOS:000514663600066
J	Shinohara, M; Tashiro, Y; Shinohara, M; Hirokawa, J; Suzuki, K; Onishi-Takeya, M; Mukouzono, M; Takeda, S; Saito, T; Fukumori, A; Saido, TC; Morishita, R; Sato, N				Shinohara, Mitsuru; Tashiro, Yoshitaka; Shinohara, Motoko; Hirokawa, Junko; Suzuki, Kaoru; Onishi-Takeya, Miyuki; Mukouzono, Masahiro; Takeda, Shuko; Saito, Takashi; Fukumori, Akio; Saido, Takaomi C.; Morishita, Ryuichi; Sato, Naoyuki			Increased levels of A beta 42 decrease the lifespan of ob/ob mice with dysregulation of microglia and astrocytes	FASEB JOURNAL			English	Article						Alzheimer's disease; astrocytes; diabetes; lifespan; microglia; obesity	ALZHEIMERS-DISEASE PATIENTS; INSULIN-RESISTANCE; A-BETA; MOUSE MODEL; EXPECTANCY; PATHOLOGY; OBESITY; ACCUMULATION; DEMENTIA; MEMORY	Clinical studies have indicated that obesity and diabetes are associated with Alzheimer's disease (AD) and neurodegeneration. Although the mechanisms underlying these associations remain elusive, the bidirectional interactions between obesity/diabetes and Alzheimer's disease (AD) may be involved in them. Both obesity/diabetes and AD significantly reduce life expectancy. We generated App(NL-F/wt) knock-in; ob/ob mice by crossing App(NL-F/wt) knock-in mice and ob/ob mice to investigate whether amyloid-beta (A beta) affects the lifespan of ob/ob mice. App(NL-F/wt) knock-in; ob/ob mice displayed the shortest lifespan compared to wild-type mice, App(NL-F/wt) knock-in mice, and ob/ob mice. Notably, the A beta 42 levels were increased at minimum levels before deposition in App(NL-F/wt) knock-in mice and App(NL-F/wt) knock-in; ob/ob mice at 18 months of age. No differences in the levels of several neuronal markers were observed between mice at this age. However, we observed increased levels of glial fibrillary acidic protein (GFAP), an astrocyte marker, in App(NL-F/wt) knock-in; ob/ob mice, while the levels of several microglial markers, including CD11b, TREM2, and DAP12, were decreased in both ob/ob mice and App(NL-F/wt) knock-in; ob/ob mice. The increase in GFAP levels was not observed in young App(NL-F/wt) knock-in; ob/ob mice. Thus, the increased A beta 42 levels may decrease the lifespan of ob/ob mice, which is associated with the dysregulation of microglia and astrocytes in an age-dependent manner. Based on these findings, the imbalance in these neuroinflammatory cells may provide a clue to the mechanisms by which the interaction between obesity/diabetes and early AD reduces life expectancy.	[Shinohara, Mitsuru; Tashiro, Yoshitaka; Shinohara, Motoko; Hirokawa, Junko; Suzuki, Kaoru; Fukumori, Akio; Sato, Naoyuki] Natl Ctr Geriatr, Ctr Dev Adv Med Dementia, Dept Aging Neurobiol, Gerontology, Morioka, Japan; [Shinohara, Mitsuru; Fukumori, Akio; Sato, Naoyuki] Osaka Univ, Grad Sch Med, Dept Aging Neurobiol, Suita, Japan; [Onishi-Takeya, Miyuki] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Japan; [Mukouzono, Masahiro; Takeda, Shuko; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Japan; [Saito, Takashi; Saido, Takaomi C.] RIKEN Ctr Brain Sci, Lab Proteolyt Neuroscience, Wako, Japan; [Saito, Takashi] Nagoya City Univ Grad Sch Med Sci, Dept Neurocognit Sci, Nagoya, Japan; Ctr Dev Adv Med Dementia, Morioka, Japan	Osaka University; Osaka University; Osaka University; RIKEN; Nagoya City University	Sato, N (corresponding author), Natl Ctr Geriatr, Ctr Dev Adv Med Dementia, Dept Aging Neurobiol, Gerontology, Morioka, Japan.	nsato@ncgg.go.jp	Suzuki, Kaoru/AHC-0437-2022; Saito, Takashi/G-2563-2015	Saito, Takashi/0000-0002-9659-9251; Suzuki, Kaoru/0000-0002-5168-9018				Adebakin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045179; Akintola AA, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00013; Arvanitakis Z, 2006, NEUROLOGY, V67, P1960, DOI 10.1212/01.wnl.0000247053.45483.4e; AUSTIN BP, 1984, EXP GERONTOL, V19, P121, DOI 10.1016/0531-5565(84)90015-9; Buckley RF, 2019, NEUROBIOL AGING, V78, P178, DOI 10.1016/j.neurobiolaging.2019.02.019; Carmona S, 2018, LANCET NEUROL, V17, P721, DOI 10.1016/S1474-4422(18)30232-1; Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637; Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hiller AJ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00471; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kalaria RN, 2009, NAT REV NEUROL, V5, P305, DOI 10.1038/nrneurol.2009.72; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Kojima G, 2017, CURR ALZHEIMER RES, V14, P1256, DOI 10.2174/1567205014666170417104236; Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425; MENAHAN LA, 1983, METABOLISM, V32, P172, DOI 10.1016/0026-0495(83)90225-1; Oveisgharan S, 2018, ACTA NEUROPATHOL, V136, P887, DOI 10.1007/s00401-018-1920-1; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Perez-Nievas BG, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00114; Pierpont Yvonne N, 2014, ISRN Obes, V2014, P638936, DOI 10.1155/2014/638936; Ratter JM, 2018, TRENDS ENDOCRIN MET, V29, P468, DOI 10.1016/j.tem.2018.04.008; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Roberts RO, 2014, J NUCL MED, V55, P759, DOI 10.2967/jnumed.113.132647; Sato N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00143; Sato N, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00064; Sato N, 2013, DIABETES, V62, P1005, DOI 10.2337/db12-1549; Shinohara M, 2017, NEUROCHEM INT, V108, P296, DOI 10.1016/j.neuint.2017.04.020; Shinohara M, 2014, BRAIN, V137, P1533, DOI 10.1093/brain/awu046; Shinohara M, 2010, J BIOL CHEM, V285, P22091, DOI 10.1074/jbc.M110.102277; SHULTZ LD, 1995, J IMMUNOL, V154, P180; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Starks EJ, 2015, J ALZHEIMERS DIS, V46, P525, DOI 10.3233/JAD-150072; Sutherland GT, 2017, J ALZHEIMERS DIS, V59, P393, DOI 10.3233/JAD-161194; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Takeda S, 2012, DEMENT GERIATR COGN, V34, P25, DOI 10.1159/000338704; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Dinh T, 2012, DIABETES, V61, P2937, DOI 10.2337/db12-0227; Tomita N, 2013, GERIATR GERONTOL INT, V13, P215, DOI 10.1111/j.1447-0594.2012.00880.x; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Vemuri P, 2017, JAMA NEUROL, V74, P718, DOI 10.1001/jamaneurol.2017.0244; Vloeberghs E, 2008, BEHAV NEUROSCI, V122, P491, DOI 10.1037/0735-7044.122.3.491; Wallace LMK, 2019, LANCET NEUROL, V18, P177, DOI 10.1016/S1474-4422(18)30371-5; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Wright AK, 2017, DIABETES CARE, V40, P338, DOI 10.2337/dc16-1616; Zhang Y, 2012, DIABETES, V61, P1434, DOI 10.2337/db11-0499	51	9	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2425	2435		10.1096/fj.201901028RR	http://dx.doi.org/10.1096/fj.201901028RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907998	hybrid			2022-12-28	WOS:000514663600034
J	Song, B; Lee, JM; Park, YJ; Kim, IK; Kim, BS; Shin, KS; Jeon, I; Koh, CH; Bae, EA; Seo, H; Byun, Y; Kang, CY				Song, Boyeong; Lee, Jeong-Mi; Park, Young-Jun; Kim, Il-Kyu; Kim, Byung-Seok; Shin, Kwang-Soo; Jeon, Insu; Koh, Choong-Hyun; Bae, Eun-Ah; Seo, Hyungseok; Byun, Youngro; Kang, Chang-Yuil			Differentiation of c-Kit(+)CD24(+) natural killer cells into myeloid cells in a GATA-2-dependent manner	FASEB JOURNAL			English	Article						CD24; c-Kit; GATA-2; myeloid cell development; natural killer cell	PRECURSOR ACUTE-LEUKEMIA; NK-CELLS; T-CELLS; UP-REGULATION; STEM-CELLS; B-CELLS; LINEAGE; PROGENITOR; CONVERSION; IDENTIFICATION	Myeloid progenitor cells have generally been considered the predominant source of myeloid cells under steady-state conditions. Here we show that NK cells contributed to a myeloid cell lineage pool in naive and tumor-bearing mice. Using fate tracing of NKp46(+) cells, we found that myeloid cells could be derived from NK cells. Notably, among mature CD11b(+)CD27(+) NK cells, c-Kit(+)CD24(+) NK cells were capable of differentiating into a range of myeloid lineages in vitro and produced neutrophils and monocytes in vivo. The differentiation was completely inhibited by NK-stimulating cytokines. In addition to the potential for differentiation into myeloid cells, c-Kit(+)CD24(+) NK cells retained NK cell phenotypes and effector functions. Mechanistically, GATA-2 was necessary for the differentiation of c-Kit(+)CD24(+) NK cells. Therefore, we discovered that GATA-2-dependent differentiation of c-Kit(+)CD24(+) NK cells contributes to myeloid cell development and identified a novel pathway for myeloid lineage commitment under physiological conditions.	[Song, Boyeong; Jeon, Insu; Bae, Eun-Ah; Seo, Hyungseok; Kang, Chang-Yuil] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Lab Immunol, Seoul, South Korea; [Lee, Jeong-Mi; Shin, Kwang-Soo; Koh, Choong-Hyun; Kang, Chang-Yuil] Seoul Natl Univ, Coll Pharm, Lab Immunol, Seoul, South Korea; [Park, Young-Jun; Kim, Byung-Seok] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Lab Immune Regulat, Seoul, South Korea; [Kim, Il-Kyu; Seo, Hyungseok] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Lab Immunol, Seoul, South Korea; [Byun, Youngro] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, CY (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Lab Immunol, Seoul, South Korea.	cykang@snu.ac.kr	Park, Youngjun/AAK-2026-2020	Seo, hyungseok/0000-0002-6632-1208; Bae, Eunah/0000-0003-2670-4578	National Research Foundation of Korea (NRF) [NRF-2018R1A2A1A05077627, NRF-2016M3A9B5941426]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A2A1A05077627 and NRF-2016M3A9B5941426	Abel AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01869; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Ayre DC, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00146; Batta K, 2014, CELL REP, V9, P1871, DOI 10.1016/j.celrep.2014.11.002; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Benson DM, 2009, BLOOD, V113, P2706, DOI 10.1182/blood-2008-05-159285; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; CARSON WE, 1994, P NATL ACAD SCI USA, V91, P7553, DOI 10.1073/pnas.91.16.7553; Chen BB, 2009, INT J HEMATOL, V89, P365, DOI 10.1007/s12185-009-0282-9; Chen QF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15118; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cichocki F, 2014, SEMIN IMMUNOL, V26, P114, DOI 10.1016/j.smim.2014.02.003; Cieslar-Pobuda A, 2017, BBA-MOL CELL RES, V1864, P1359, DOI 10.1016/j.bbamcr.2017.04.017; Cirovic B, 2017, STEM CELL REP, V8, P346, DOI 10.1016/j.stemcr.2016.12.015; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Collier AJ, 2017, CELL STEM CELL, V20, P874, DOI 10.1016/j.stem.2017.02.014; Colucci F, 2000, BLOOD, V95, P984, DOI 10.1182/blood.V95.3.984.003k40_984_991; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Ehlers M, 2012, ENDOCRINOLOGY, V153, P4367, DOI 10.1210/en.2012-1247; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Filipovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06918-3; Gao X, 2013, J EXP MED, V210, P2833, DOI 10.1084/jem.20130733; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Goode DK, 2016, DEV CELL, V36, P572, DOI 10.1016/j.devcel.2016.01.024; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Grzywacz B, 2011, BLOOD, V117, P3548, DOI 10.1182/blood-2010-04-281394; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hu TY, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00268; Kang H, 2018, STEM CELL REP, V11, P197, DOI 10.1016/j.stemcr.2018.05.002; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Loyon R, 2016, J IMMUNOL, V197, P85, DOI 10.4049/jimmunol.1501147; Lui JB, 2015, CELL REP, V10, P574, DOI 10.1016/j.celrep.2014.12.053; Marquez C, 1998, BLOOD, V91, P2760, DOI 10.1182/blood.V91.8.2760.2760_2760_2771; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Nakayama M, 2011, P NATL ACAD SCI USA, V108, P18360, DOI 10.1073/pnas.1110584108; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Omi A, 2014, EUR J IMMUNOL, V44, P2638, DOI 10.1002/eji.201444570; Park E, 2019, ELIFE, V8, DOI 10.7554/eLife.47605; Park YJ, 2013, CANCER RES, V73, P5669, DOI 10.1158/0008-5472.CAN-13-0545; Peng H, 2017, SEMIN IMMUNOL, V31, P3, DOI 10.1016/j.smim.2017.07.006; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Pradier A, 2014, EUR J IMMUNOL, V44, P511, DOI 10.1002/eji.201343868; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Pulecio J, 2016, CELL REP, V17, P671, DOI 10.1016/j.celrep.2016.09.036; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/nmeth.2510, 10.1038/NMETH.2510]; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Shakiba N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8329; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Suzuki R, 1999, LEUKEMIA RES, V23, P615, DOI 10.1016/S0145-2126(98)00194-5; Suzuki R, 1997, BLOOD, V90, P2417; Terme M, 2012, CANCER RES, V72, P2757, DOI 10.1158/0008-5472.CAN-11-3379; Theurich S, 2017, CELL METAB, V26, P171, DOI 10.1016/j.cmet.2017.05.018; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; [于丽娜 Yu Lina], 2017, [现代化工, Modern Chemical Industry], V37, P1	72	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4462	4481		10.1096/fj.201902662R	http://dx.doi.org/10.1096/fj.201902662R		JAN 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31989715				2022-12-28	WOS:000509780000001
J	Mohammed, S; Vineetha, NS; James, S; Aparna, JS; Lankadasari, MB; Maeda, T; Ghosh, A; Saha, S; Li, QZ; Spiegel, S; Harikumar, KB				Mohammed, Sabira; Vineetha, Nalanda S.; James, Shirley; Aparna, Jayasekharan S.; Lankadasari, Manendra Babu; Maeda, Takahiro; Ghosh, Abhirupa; Saha, Sudipto; Li, Quan-Zhen; Spiegel, Sarah; Harikumar, Kuzhuvelil B.			Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity	FASEB JOURNAL			English	Article						auto-immunity; interferon; plasmacytoid dendritic cells; sphingosine 1-Phosphate; sphingosine kinase; systemic lupus erythematosus	PLASMACYTOID DENDRITIC CELLS; IFN-ALPHA PRODUCTION; INDUCED LUPUS; SPHINGOSINE; SPHINGOSINE-1-PHOSPHATE; MICE; FTY720; MODULATION; EXPRESSION; INHIBITOR	Plasmacytoid dendritic cells (pDCs) express Toll like receptors (TLRs) that modulate the immune response by production of type I interferons. Here, we report that sphingosine kinase 1 (SphK1) which produces the bioactive sphingolipid metabolite, sphingosine 1-phosphate (S1P), plays a critical role in the pDC functions and interferon production. Although dispensable for the pDC development, SphK1 is essential for the pDC activation and production of type I IFN and pro-inflammatory cytokines stimulated by TLR7/9 ligands. SphK1 interacts with TLRs and specific inhibition or deletion of SphK1 in pDCs mitigates uptake of CpG oligonucleotide ligands by TLR9 ligand. In the pristane-induced murine lupus model, pharmacological inhibition of SphK1 or its genetic deletion markedly decreased the IFN signature, pDC activation, and glomerulonephritis. Moreover, increases in the SphK1 expression and S1P levels were observed in human lupus patients. Taken together, our results indicate a pivotal regulatory role for the SphK1/S1P axis in maintaining the balance between immunosurveillance and immunopathology and suggest that specific SphK1 inhibitors might be a new therapeutic avenue for the treatment of type I IFN-linked autoimmune disorders.	[Mohammed, Sabira; James, Shirley; Aparna, Jayasekharan S.; Lankadasari, Manendra Babu; Harikumar, Kuzhuvelil B.] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Mohammed, Sabira; Lankadasari, Manendra Babu] MAHE, Manipal, India; [Vineetha, Nalanda S.] Govt Med Coll, Dept Nephrol, Thiruvananthapuram, Kerala, India; [Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Isl Med Res Inst, Dept Isl & Community Med, Nagasaki, Japan; [Ghosh, Abhirupa; Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, India; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX 75390 USA; [Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Nagasaki University; Department of Science & Technology (India); Bose Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Virginia Commonwealth University	Harikumar, KB (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India.	harikumar@rgcb.res.in	Ghosh, Abhirupa/GWC-7986-2022; Harikumar, Kuzhuvelil/AAC-2407-2020; Lankadasari, Manendra/AAI-9639-2021	Ghosh, Abhirupa/0000-0002-3980-4749; Harikumar, Kuzhuvelil/0000-0002-1763-4179; Saha, Sudipto/0000-0001-9433-8894; Jazir, Sabira Mohammed/0000-0002-0332-3660	Deaprtment of Science and Technology [SR/FT/LS-159/2012]; Department of Biotechnology, Ministry of Science and Technology (DBT) [BT/RLF/Reentry/38/2011]; Council of Scientific and Industrial Research (CSIR) [37 (1720)/18/EMR-II]; National Institute of Health, USA [R01GM043880]	Deaprtment of Science and Technology; Department of Biotechnology, Ministry of Science and Technology (DBT); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Deaprtment of Science and Technology, Grant/Award Number: SR/FT/LS-159/2012; Department of Biotechnology, Ministry of Science and Technology (DBT), Grant/Award Number: BT/RLF/Reentry/38/2011; Council of Scientific and Industrial Research (CSIR), Grant/Award Number: No.37 (1720)/18/EMR-II; National Institute of Health, USA, Grant/Award Number: R01GM043880	Alculumbre S, 2019, SEMIN CELL DEV BIOL, V86, P24, DOI 10.1016/j.semcdb.2018.02.014; Aloia AL, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.32; Ando S, 2010, BIOCHEM BIOPH RES CO, V394, P804, DOI 10.1016/j.bbrc.2010.03.078; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Dillmann C, 2016, J IMMUNOL, V196, P1579, DOI 10.4049/jimmunol.1403168; Freitas E, 2017, CLIN RHEUMATOL, V36, P2403, DOI 10.1007/s10067-017-3811-6; Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962; Guerrier T, 2014, J AUTOIMMUN, V51, P23, DOI 10.1016/j.jaut.2014.02.005; Hayashi S, 2002, J BIOL CHEM, V277, P33319, DOI 10.1074/jbc.M201442200; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Janovec V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00364; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Khan N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002676; Kienhofer D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92920; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Lankadasari MB, 2018, THERANOSTICS, V8, P3824, DOI 10.7150/thno.25308; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Liao XF, 2015, J IMMUNOL, V195, P4578, DOI 10.4049/jimmunol.1501157; Lima S, 2018, AUTOPHAGY, V14, P942, DOI 10.1080/15548627.2018.1429875; Lima S, 2017, J BIOL CHEM, V292, P3074, DOI 10.1074/jbc.M116.762377; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Meyer-Schwesinger C, 2011, J IMMUNOL, V187, P3218, DOI 10.4049/jimmunol.1003451; Mohammed S, 2019, FASEB J, V33, P7061, DOI 10.1096/fj.201802535R; Newton J, 2017, FASEB J, V31, P1719, DOI 10.1096/fj.201601041R; Okazaki H, 2002, J RHEUMATOL, V29, P707; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Sasawatari S, 2011, GASTROENTEROLOGY, V140, P1513, DOI 10.1053/j.gastro.2011.01.041; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Scott JL, 2017, CLIN IMMUNOL, V175, P109, DOI 10.1016/j.clim.2016.12.009; Seo YJ, 2010, J VIROL, V84, P8124, DOI 10.1128/JVI.00510-10; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Steinhagen F, 2016, EUR J IMMUNOL, V46, P647, DOI 10.1002/eji.201545911; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sui MS, 2012, MOL BIOL REP, V39, P389, DOI 10.1007/s11033-011-0750-1; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Teijaro JR, 2016, P NATL ACAD SCI USA, V113, P1351, DOI 10.1073/pnas.1525356113; Theofilopoulos AN, 2012, J CLIN INVEST, V122, P3464, DOI 10.1172/JCI63835; Vijayan M, 2014, VIROLOGY, V450, P55, DOI 10.1016/j.virol.2013.11.039; Watson L, 2012, J CLIN IMMUNOL, V32, P1019, DOI 10.1007/s10875-012-9710-3; Xu Y, 2015, ARTHRITIS RHEUMATOL, V67, P225, DOI 10.1002/art.38882; Young MM, 2016, CELL REP, V17, P1532, DOI 10.1016/j.celrep.2016.10.019; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587; Zhou ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20373; Zhuang HY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00291	65	10	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4329	4347		10.1096/fj.201902847R	http://dx.doi.org/10.1096/fj.201902847R		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31971297	Green Accepted			2022-12-28	WOS:000508880400001
J	Liu, BD; Pan, XH; Liu, ZH; Han, ML; Xu, GH; Dai, XS; Wang, W; Zhang, HB; Xie, LW				Liu, Bingdong; Pan, Xiaohan; Liu, Zhihong; Han, Mulan; Xu, Guohuan; Dai, Xiaoshuang; Wang, Wei; Zhang, Huabing; Xie, Liwei			Fecal microbiota as a noninvasive biomarker to predict the tissue iron accumulation in intestine epithelial cells and liver	FASEB JOURNAL			English	Article						ferritin assay; iron; LASSO; ramdom forest; RDA; microbiota	NEONATAL GUT FLORA; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; FORTIFICATION; FAMILY; GROWTH	Iron is an essential trace mineral required for growth, metabolism, and immune response. Dysregulation of iron homeostasis is linked with the development and progression of various diseases. Iron accumulation is associated with inflammatory diseases and cancer, while iron deficiency leads to the growth retardation. Several studies have suggested that iron imbalance results in alteration of gut microbiota, leading to the disruption of microbial diversity, the increase of pathogen abundance, and the induction of intestinal inflammation. However, in screening studies done in the past decades, the association between the iron availability and gut microbiota has not been systemically explored. Furthermore, a noninvasive and convenient approach to determine the iron levels in tissues is lacking. In the present study, a murine model for iron dysregulation was established. 16S rRNA amplicon sequencing and bioinformatic algorithms were used to identify the key taxa. Using the key taxa identified and machine learning models, we established an easily accessible prediction model, which could accurately distinguish between iron-deprived or iron-fortified condition. This prediction model could precisely predict the iron level of the intestinal epithelial cells and the liver and could be used for early diagnosis of iron dysbiosis-related diseases, in a noninvasive manner, in the future.	[Liu, Bingdong; Pan, Xiaohan; Liu, Zhihong; Han, Mulan; Xu, Guohuan; Xie, Liwei] Guangdong Acad Sci, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol,Guangdong Inst, Guangzhou 510070, Guangdong, Peoples R China; [Liu, Bingdong] Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Dai, Xiaoshuang] BGI Shenzhen, BGI Inst Appl Agr, Shenzhen, Guangdong, Peoples R China; [Wang, Wei] Jilin Univ, Coll Vet Med, Changchun 130062, Jilin, Peoples R China; [Zhang, Huabing] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China; [Xie, Liwei] Southern Med Univ, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Wei] Zhongkai Univ Agr & Engn, Coll Anim Sci & Technol, Key Lab Waterfowl Hlth Breeding Guangdong Prov, Innovat Inst Anim Hlth Breeding, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Jinan University; Beijing Genomics Institute (BGI); Jilin University; Anhui Medical University; Southern Medical University - China; Zhongkai University of Agriculture & Engineering	Xie, LW (corresponding author), Guangdong Acad Sci, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol,Guangdong Inst, Guangzhou 510070, Guangdong, Peoples R China.; Wang, W (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130062, Jilin, Peoples R China.; Zhang, HB (corresponding author), Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China.	wang_wei99@jlu.edu.cn; slzhang1977@163.com; xielw@gdim.cn	Dai, Xiaoshuang/AAP-2367-2021	Dai, Xiaoshuang/0000-0001-6563-7756; zhang, huabing/0000-0001-8402-7830; Liu, Zhihong/0000-0001-8370-2419	"GDAS" Project of Science and Technology Development [2018GDASCX-0806]; National Natural Science Foundation of China [81900797]	"GDAS" Project of Science and Technology Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by "GDAS" Project of Science and Technology Development (Grant No. 2018GDASCX-0806) to Liwei Xie and by National Natural Science Foundation of China (Grant No. 81900797) to Liwei Xie	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P1415, DOI 10.1080/15287390802328630; Alexander H, 1999, J AM COLL NUTR, V18, P127, DOI 10.1080/07315724.1999.10718840; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ARTEMENKO VD, 1984, ZH MIKROB EPID IMMUN, P20; Atarashi M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020175; Bian XM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00487; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bordenstein SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13155; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Doherty MK, 2018, MBIO, V9, DOI [10.1128/mBio.02120-17, 10.1128/mbio.02120-17]; Dostal A, 2012, J NUTR, V142, P271, DOI 10.3945/jn.111.148643; Elli M, 2000, J APPL MICROBIOL, V88, P695, DOI 10.1046/j.1365-2672.2000.01013.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501; Garcia-Mantrana I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00890; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Goyette P, 2007, ANN MED, V39, P177, DOI 10.1080/07853890701197615; Hansen LBS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07019-x; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Krebs NF, 2013, J PEDIATR-US, V163, P416, DOI 10.1016/j.jpeds.2013.01.024; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liang DC, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0230-4; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076; Lozano R, 2017, ACONTEC MUND, P117; MELBY CL, 1993, J AM COLL NUTR, V12, P262; MELBY CL, 1994, AM J CLIN NUTR, V59, P103, DOI 10.1093/ajcn/59.1.103; MEVISSENVERHAGE EAE, 1985, EUR J CLIN MICROBIOL, V4, P14, DOI 10.1007/BF02148653; MEVISSENVERHAGE EAE, 1985, EUR J CLIN MICROBIOL, V4, P273, DOI 10.1007/BF02013651; Parmanand BA, 2019, J NUTR BIOCHEM, V67, P20, DOI 10.1016/j.jnutbio.2019.01.010; Pfeiffer CM, 2017, AM J CLIN NUTR, V106, p1606S, DOI 10.3945/ajcn.117.155887; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ren ZG, 2019, GUT, V68, P1014, DOI 10.1136/gutjnl-2017-315084; Rocha ER, 2013, BIOMETALS, V26, P577, DOI 10.1007/s10534-013-9650-2; Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4; Sjodin KS, 2019, GUT, V68, DOI 10.1136/gutjnl-2018-316988; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049; Tompkins GR, 2001, CURR MICROBIOL, V43, P38, DOI 10.1007/s002840010257; Toohey ML, 1998, J AM COLL NUTR, V17, P425, DOI 10.1080/07315724.1998.10718789; Triner D, 2019, GASTROENTEROLOGY, V156, P1467, DOI 10.1053/j.gastro.2018.12.003; Ward T, 2017, BUGBASE PREDICTS ORG; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Wood JC, 2015, BRIT J HAEMATOL, V170, P15, DOI 10.1111/bjh.13374; Yao XP, 2019, BIOCHEM BIOPH RES CO, V509, P125, DOI 10.1016/j.bbrc.2018.12.082; Zhu J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0515-3; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	57	8	8	12	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3006	3020		10.1096/fj.201901635RR	http://dx.doi.org/10.1096/fj.201901635RR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31912587	Green Submitted			2022-12-28	WOS:000506146700001
J	Howard, MC; Nauser, CL; Farrar, CA; Wallis, R; Sacks, SH				Howard, Mark C.; Nauser, Christopher L.; Farrar, Conrad A.; Wallis, Russell; Sacks, Steven H.			l-Fucose prevention of renal ischaemia/reperfusion injury in Mice	FASEB JOURNAL			English	Article						collectin-11; complement; ischemia; reperfusion; l-fucose; lectin pathway; transplantation	ISCHEMIA-REPERFUSION INJURY; DELAYED GRAFT FUNCTION; COLLECTIN 11 CL-11; LECTIN PATHWAY; COMPLEMENT; COMPLEXES; CL-K1; MASPS; CL-L1	In a recent study, we identified a fucosylated damage-associated ligand exposed by ischemia on renal tubule epithelial cells, which after recognition by collectin-11 (CL-11 or collectin kidney 1 (CL-K1)), initiates complement activation and acute kidney injury. We exploited the ability to increase the local tissue concentration of free l-fucose following systemic administration, in order to block ligand binding by local CL-11 and prevent complement activation. We achieved a thirty-five-fold increase in the intrarenal concentration of l-fucose following an IP bolus given before the ischemia induction procedure - a concentration found to significantly block in vitro binding of CL-11 on hypoxia-stressed renal tubule cells. At this l-fucose dose, complement activation and acute post-ischemic kidney injury are prevented, with additional protection achieved by a second bolus after the induction procedure. CL-11(-/-) mice gained no additional protection from l-fucose administration, indicating that the mechanism of l-fucose therapy was largely CL-11-dependent. The hypothesis is that a high dose of l-fucose delivered to the kidney obstructs the carbohydrate recognition site on CL-11 thereby reducing complement-mediated damage following ischemic insult. Further work will examine the utility in preventing post-ischemic injury during renal transplantation, where acute kidney injury is known to correlate with poor graft survival.	[Howard, Mark C.; Nauser, Christopher L.; Farrar, Conrad A.; Sacks, Steven H.] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, MRC Ctr Transplantat, London, England; [Wallis, Russell] Univ Leicester, Dept Resp Sci & Infect, London, England	University of London; King's College London; University of Leicester	Howard, MC (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, MRC,Ctr Transplantat,Guys Hosp, 5th Floor Tower Wing, London SE1 9RT, England.	mark.howard@kcl.ac.uk		Howard, Mark/0000-0001-9779-5302	RCUK | MRC | Medical Research Foundation [MR/M012263/1]; MRC [MR/M012263/1] Funding Source: UKRI	RCUK | MRC | Medical Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RCUK | MRC | Medical Research Foundation, Grant/Award Number: MR/M012263/1	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Asgari E, 2014, FASEB J, V28, P3996, DOI 10.1096/fj.13-246306; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Damman J, 2008, TRANSPLANTATION, V85, P923, DOI 10.1097/TP.0b013e3181683cf5; Dobo J, 2016, IMMUNOL REV, V274, P98, DOI 10.1111/imr.12460; Fanelli G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15212-z; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; Farrar CA, 2016, J CLIN INVEST, V126, P1911, DOI 10.1172/JCI83000; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Girija UV, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0136-2; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Hansen SWK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01757; Henriksen ML, 2013, J IMMUNOL, V191, P6117, DOI 10.4049/jimmunol.1302121; Howard M, 2018, SEMIN IMMUNOPATHOL, V40, P75, DOI 10.1007/s00281-017-0642-0; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Killick J, 2018, SEMIN IMMUNOPATHOL, V40, P37, DOI 10.1007/s00281-017-0644-y; Kjaer TR, 2015, STRUCTURE, V23, P342, DOI 10.1016/j.str.2014.10.024; Li K, 2004, J AM SOC NEPHROL, V15, P2414, DOI 10.1097/01.ASN.0000135974.06478.7B; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Munye MM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006679; Nauser CL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02023; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pfaff WW, 1998, TRANSPLANTATION, V65, P219; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; Pirsch JD, 1996, TRANSPLANTATION, V61, P1581, DOI 10.1097/00007890-199606150-00006; Ponticelli C, 2014, NEPHROL DIAL TRANSPL, V29, P1134, DOI 10.1093/ndt/gft488; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Schnaar RL, 2015, J ALLERGY CLIN IMMUN, V135, P609, DOI 10.1016/j.jaci.2014.10.057; Selman L, 2012, IMMUNOBIOLOGY, V217, P851, DOI 10.1016/j.imbio.2011.12.008; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tomsik P, 2011, CENT EUR J BIOL, V6, P1, DOI 10.2478/s11535-010-0087-0; Wild MK, 2002, CELLS TISSUES ORGANS, V172, P161, DOI 10.1159/000066968; Yaseen S, 2017, FASEB J, V31, P2210, DOI 10.1096/fj.201601306R; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	39	10	10	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					822	834		10.1096/fj.201901582R	http://dx.doi.org/10.1096/fj.201901582R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914693	Green Published, hybrid			2022-12-28	WOS:000507308900056
J	Kasahara, T; Kubota-Sakashita, M; Nagatsuka, Y; Hirabayashi, Y; Hanasaka, T; Tohyama, K; Kato, T				Kasahara, Takaoki; Kubota-Sakashita, Mie; Nagatsuka, Yasuko; Hirabayashi, Yoshio; Hanasaka, Tomohito; Tohyama, Koujiro; Kato, Tadafumi			Cardiolipin is essential for early embryonic viability and mitochondrial integrity of neurons in mammals	FASEB JOURNAL			English	Article						Crls1; mitochondrial cristae; calcium retention capacity; peri-implantation lethality; Camk2 alpha-Cre mice	GENOME-WIDE ASSOCIATION; SYNTHASE; GENE; PERMEABILITY; DISCOVERY; MEMBRANE; ROLES; CELLS; LOCI	Cardiolipin (CL) is a hallmark phospholipid of mitochondria and plays a significant role in maintaining the mitochondrial structure and functions. Despite the physiological importance of CL, mutant organisms, yeast, Arabidopsis, C elegans, and Drosophila, which lack CL synthase (Crls1) gene and consequently are deprived of CL, are viable. Here we report conditional Crls1-deficient mice using targeted insertion of loxP sequences flanking the functional domain of CRLS1 enzyme. Homozygous null mutant mice exhibited early embryonic lethality at the peri-implantation stage. We generated neuron-specific Crls1 knockout (cKO) mice by crossing with Camk2 alpha-Cre mice. Neuronal loss and gliosis were gradually manifested in the forebrains, where CL levels were significantly decreased. In the surviving neurons, malformed mitochondria with bubble-like or onion-like inner membrane structures were observed. We showed decreased supercomplex assembly and reduced enzymatic activities of electron transport chain complexes in the forebrain of cKO mice, resulting in affected mitochondrial calcium dynamics, a slower rate of Ca2+ uptake and a smaller calcium retention capacity. These observations clearly demonstrate indispensable roles of CL as well as of Crls1 gene in mammals.	[Kasahara, Takaoki; Kubota-Sakashita, Mie; Kato, Tadafumi] RIKEN, Ctr Brain Sci, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan; [Nagatsuka, Yasuko] Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol,Itabashi Ku, Tokyo, Japan; [Hirabayashi, Yoshio] RIKEN, Cellular Informat Lab, Cluster Pioneering Res, Wako, Saitama, Japan; [Hirabayashi, Yoshio] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Japan; [Hanasaka, Tomohito; Tohyama, Koujiro] Iwate Med Univ, Ctr Electron Microscopy & Bioimaging Res, Sch Dent, Dept Physiol, Yahaba, Iwate, Japan	RIKEN; Nihon University; RIKEN; Juntendo University; Iwate Medical University	Kasahara, T; Kato, T (corresponding author), RIKEN, Ctr Brain Sci, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan.	takaoki.kasahara@riken.jp; tadafumi.kato@riken.jp	Kato, Tadafumi/J-3583-2014; Kasahara, Takaoki/AAJ-5367-2020; Kubota-Sakashita, Mie/AAM-4064-2021	Kato, Tadafumi/0000-0001-7856-3952; Kasahara, Takaoki/0000-0002-0953-5146; Hirabayashi, Yoshio/0000-0002-5774-7354	RIKEN; MEXT	RIKEN; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	RIKEN; MEXT	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; ANDERSON RL, 1982, CLIN CHIM ACTA, V121, P111, DOI 10.1016/0009-8981(82)90216-9; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Choi CI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.14; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DEBOLAND AR, 1975, J BIOL CHEM, V250, P7501; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V693, P1, DOI 10.1016/0005-2736(82)90464-3; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090; Fajardo VA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02089-1; Govindarajan S, 2012, FEMS MICROBIOL REV, V36, P1005, DOI 10.1111/j.1574-6976.2012.00348.x; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Ikeda M, 2018, MOL PSYCHIATR, V23, P639, DOI 10.1038/mp.2016.259; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156; Katayama K, 2004, FEBS LETT, V577, P193, DOI 10.1016/j.febslet.2004.10.009; Kato T, 2017, SCHIZOPHR RES, V187, P62, DOI 10.1016/j.schres.2016.10.037; Kato TM, 2018, MOL PSYCHIATR, V23, P2039, DOI 10.1038/s41380-018-0074-9; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006; Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001; Lu B, 2006, J LIPID RES, V47, P1140, DOI 10.1194/jlr.C600004-JLR200; Luevano-Martinez LA, 2015, BBA-BIOENERGETICS, V1847, P599, DOI 10.1016/j.bbabio.2015.03.005; Lynch M, 2017, ELIFE, V6, DOI 10.7554/eLife.20437; Maguire JJ, 2017, BBA-MOL CELL BIOL L, V1862, P8, DOI 10.1016/j.bbalip.2016.08.001; Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Miettinen TP, 2016, DEV CELL, V39, P370, DOI 10.1016/j.devcel.2016.09.004; Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055; Munoz-Gomez SA, 2017, MOL BIOL EVOL, V34, P943, DOI 10.1093/molbev/msw298; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Phoon CKL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000455; Pineau B, 2013, PLANT CELL, V25, P4195, DOI 10.1105/tpc.113.118018; Sakamoto T, 2012, J BIOL CHEM, V287, P4590, DOI 10.1074/jbc.M111.314823; Saric A, 2016, FRONT GENET, V6, DOI 10.3389/fgene.2015.00359; Saunders CJ, 2015, HUM MUTAT, V36, P301, DOI 10.1002/humu.22743; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6; Sigitova E, 2017, PSYCHIAT CLIN NEUROS, V71, P77, DOI 10.1111/pcn.12476; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Soustek MS, 2011, HUM GENE THER, V22, P865, DOI 10.1089/hum.2010.199; Stahl EA, 2019, NAT GENET, V51, P793, DOI 10.1038/s41588-019-0397-8; Sustarsic EG, 2018, CELL METAB, V28, P159, DOI 10.1016/j.cmet.2018.05.003; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Ye CQ, 2016, J BIOENERG BIOMEMBR, V48, P113, DOI 10.1007/s10863-014-9591-7; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	59	10	10	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1465	1480		10.1096/fj.201901598R	http://dx.doi.org/10.1096/fj.201901598R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914590	Bronze			2022-12-28	WOS:000507308900097
J	Xiong, W; Huang, J; Li, XY; Zhang, Z; Jin, ML; Wang, J; Xu, YW; Wang, ZL				Xiong, Wen; Huang, Jing; Li, Xueying; Zhang, Zhu; Jin, Meilan; Wang, Jian; Xu, Yuwei; Wang, Zili			Icariin and its phosphorylated derivatives alleviate intestinal epithelial barrier disruption caused by enterotoxigenic Escherichia coli through modulate p38 MAPK in vivo and in vitro	FASEB JOURNAL			English	Article						enterotoxigenic Escherichia coli K88; icariin; intestinal barrier function; p38 MAPK; phosphorylated icariin	TIGHT JUNCTION DISRUPTION; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; WEANED PIGS; ZINC-OXIDE; PROTECTION; CELLS; PIGLETS; K88; SUPPLEMENTATION	The natural product icariin (ICA) and its phosphorylated derivatives (pICA) have been shown to have outstanding anti-inflammatory and antioxidant properties. This study was to explore the protective effects of ICA and pICA on the intestinal epithelium of enterotoxigenic Escherichia coli (ETEC)-induced piglet diarrhea and its underlying mechanisms in vivo and in vitro. ETEC K88 increased pro-inflammatory cytokine expression, activated oxidative stress and inhibited antioxidant enzyme activity, induced phosphorylated p38 MAPK gene and protein expression, disrupted intestinal barrier function, and led to diarrhea in piglets. Pretreatment with ICA and pICA effectively alleviated ETEC-induced intestinal barrier dysfunction in vivo and in vitro. Pretreatment with p38 MAPK inhibitor (SB203580) significantly rescued the IPEC-J2 cells barrier function damaged by ETEC challenge. However, pretreatment with p38 MAPK activator (anisomycin) did not alleviated the IPEC-J2 cells barrier function damaged by ETEC challenge. Our data demonstrated that ICA and pICA regulate the inflammatory response and oxidative stress of intestinal epithelial cells by inhibiting the expression of p38 MAPK, thereby alleviating ETEC K88-induced disruption of intestinal barrier function and intestinal permeability. These findings provide new insights into the prevention and treatment of intestinal barrier dysfunction induced by ETEC K88.	[Xiong, Wen; Huang, Jing; Li, Xueying; Zhang, Zhu; Jin, Meilan; Wang, Jian; Xu, Yuwei; Wang, Zili] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China	Southwest University - China	Wang, ZL (corresponding author), Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.	wzl9698@126.com	xiong, wen/Q-4069-2017	xiong, wen/0000-0003-0217-2992	National Nature Science Foundation of China [31902313]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Nature Science Foundation of China, Grant/Award Number: 31902313	Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Bailey M, 2009, DEV COMP IMMUNOL, V33, P375, DOI 10.1016/j.dci.2008.07.003; Che LQ, 2017, BRIT J NUTR, V118, P949, DOI [10.1017/s0007114517003051, 10.1017/S0007114517003051]; Chen TT, 2017, FOOD FUNCT, V8, P1166, DOI [10.1039/c6fo01532h, 10.1039/C6FO01532H]; Deng YL, 2017, CURR TOP MED CHEM, V17, P2977, DOI 10.2174/1568026617666170821130315; de Barboza GD, 2017, WORLD J GASTROENTERO, V23, P2841, DOI 10.3748/wjg.v23.i16.2841; Dors A, 2016, VET REC, V179, P598, DOI 10.1136/vr.103811; Enaud R, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050645; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Gangwar R, 2017, BIOCHEM J, V474, P731, DOI 10.1042/BCJ20160679; Guan GP, 2019, SCI CHINA LIFE SCI, V62, P1019, DOI 10.1007/s11427-018-9494-6; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hua WB, 2017, CURR PHARM DESIGN, V23, P6071, DOI 10.2174/1381612823666170615112158; Ji JJ, 2018, INT J MOL MED, V41, P137, DOI 10.3892/ijmm.2017.3229; Johnson AM, 2010, VET MICROBIOL, V141, P115, DOI 10.1016/j.vetmic.2009.08.020; Kim KY, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5718396; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Lee CY, 2017, J ANIM PHYSIOL AN N, V101, P88, DOI 10.1111/jpn.12513; Li HF, 2012, FITOTERAPIA, V83, P44, DOI 10.1016/j.fitote.2011.09.010; Lin J, 2013, VET MICROBIOL, V162, P731, DOI 10.1016/j.vetmic.2012.09.025; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Minamiyama Y, 2010, FREE RADICAL RES, V44, P1398, DOI 10.3109/10715762.2010.510523; Owusu-Asiedu A, 2003, J ANIM SCI, V81, P1790; Palatinus JA, 2011, AM J PHYSIOL-HEART C, V300, pH583, DOI 10.1152/ajpheart.00999.2010; Roselli M, 2003, J NUTR, V133, P4077, DOI 10.1093/jn/133.12.4077; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Sargeant HR, 2011, MOL IMMUNOL, V48, P2113, DOI 10.1016/j.molimm.2011.07.002; Saxena A, 2018, INFLAMM RES, V67, P829, DOI 10.1007/s00011-018-1172-5; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Song DG, 2017, ACS APPL MATER INTER, V9, P14724, DOI 10.1021/acsami.7b03377; Song YH, 2016, BIOMED PHARMACOTHER, V83, P1089, DOI 10.1016/j.biopha.2016.08.016; Tao SY, 2019, J CELL PHYSIOL, V234, P3621, DOI 10.1002/jcp.27132; Tao SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28778; Tao SY, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0235-2; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Uwada J, 2017, CELL SIGNAL, V35, P188, DOI 10.1016/j.cellsig.2017.04.007; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wang SD, 2017, J CELL MOL MED, V21, P1182, DOI 10.1111/jcmm.13050; Wu YP, 2016, VET IMMUNOL IMMUNOP, V172, P55, DOI 10.1016/j.vetimm.2016.03.005; Xiao DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104192; Xiong W, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01850; Xiong W, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0226-3; Xu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104183; Yu HT, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00242; Yu L, 2017, RENAL FAILURE, V39, P440, DOI 10.1080/0886022X.2017.1305968; Zeng Q, 2019, TOXICOLOGY, V411, P122, DOI 10.1016/j.tox.2018.09.010; Zhu H, 2017, EUR REV MED PHARMACO, V21, P5239, DOI 10.26355/eurrev_201711_13847	49	23	25	6	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1783	1801		10.1096/fj.201902265R	http://dx.doi.org/10.1096/fj.201902265R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914584	hybrid			2022-12-28	WOS:000507308900118
J	Zhang, P; Ha, M; Li, LB; Huang, X; Liu, CJ				Zhang, Pei; Ha, Mei; Li, Lianbing; Huang, Xu; Liu, Changjiang			MicroRNA-3064-5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1/CD24/Src pathway	FASEB JOURNAL			English	Article						ceRNA; FOXA1; CD24; Src pathway; HCC angiogenesis; lncRNA MALAT1; miR-3064-5p	LONG NONCODING RNA; PROMOTES TUMOR ANGIOGENESIS; FOXA1; EXPRESSION; PROLIFERATION; PROGRESSION; CD24; SRC	Angiogenesis is critical for the development, progression, and metastasis of hepatocellular carcinoma (HCC), but the roles of miR-3064-5p in HCC angiogenesis are still unknown. In this study, the roles of miR-3064-5p in HCC angiogenesis were studied in 192 HCC patients, xenograft mouse models, and HCC cell lines. The results showed that miR-3064-5p expression was significantly decreased in HCC tissues and cells, and downregulated miR-3064-5p was associated with upregulated angiogenic potential of HCC. MiR-3064-5p inhibited proangiogenic VEGFA and angiogenin expressions but induced antiangiogenic endostatin and MMP12 expressions, finally leading to suppression of HCC angiogenesis, as shown by the decline in intratumoral microvessel density (MVD). Moreover, miR-3064-5p was inversely correlated with lncRNA MALAT1 and FOXA1. FOXA1 bound to and interacted with CD24 and then regulated Src phosphorylation. MiR-3064-5p played an antiangiogenic role by inhibiting the FOXA1/CD24/Src pathway, whereas oncogenic MALAT1 functioned as a competing endogenous RNA (ceRNA) by sponging miR-3064-5p to alleviate the suppressive effect on the FOXA1 pathway. HCC patients with high miR-3064-5p, low MALAT1, or low FOXA1 expression had a better prognosis with longer overall survival and recurrence-free survival. In univariate and multivariate analyses, miR-3064-5p was identified as the independent prognostic predicator for HCC progression and patient survival. Taken together, miR-3064-5p exerts an antiangiogenic role by targeting the FOXA1/CD24/Src pathway but oncogenic lncRNA MALAT1 acts as a ceRNA to sponge miR-3064-5p. MiR-3064-5p is of great clinical significance and is a novel prognostic indicator and an attractive therapeutic target for HCC.	[Zhang, Pei] Huazhong Univ Sci & Technol, Union Hosp, Dept Gastrointestinal Surg, Tongji Med Coll, Wuhan, Peoples R China; [Ha, Mei] Chongqing Med & Pharmaceut Coll, Sch Nursing, Chongqing, Peoples R China; [Li, Lianbing; Huang, Xu; Liu, Changjiang] Chongqing Populat & Family Planning Sci & Technol, NHC Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China	Huazhong University of Science & Technology	Liu, CJ (corresponding author), Chongqing Populat & Family Planning Sci & Technol, 18 Honghuang Rd, Chongqing 400020, Peoples R China.	cj_514@163.com			Chongqing Science and Technology Bureau [cstc2018jcyjAX0380]	Chongqing Science and Technology Bureau	Chongqing Science and Technology Bureau, Grant/Award Number: cstc2018jcyjAX0380	Amata I, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00181; Baumann P, 2012, CELL MOL LIFE SCI, V69, P435, DOI 10.1007/s00018-011-0756-9; Bretz N, 2012, CLIN EXP METASTAS, V29, P27, DOI 10.1007/s10585-011-9426-4; Bretz NP, 2012, CELL MOL LIFE SCI, V69, P3863, DOI 10.1007/s00018-012-1055-9; Cao C, 2017, ONCOGENE, V36, P1112, DOI 10.1038/onc.2016.278; Chang RM, 2017, CLIN CANCER RES, V23, P2593, DOI 10.1158/1078-0432.CCR-16-0851; Cheng SU, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35786-6; Dou CW, 2015, ONCOTARGET, V6, P13216, DOI 10.18632/oncotarget.3916; Du CL, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0182-1; Guo PY, 2018, ONCOGENE, V37, P1220, DOI 10.1038/s41388-017-0017-y; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Hisai H, 2003, CLIN CANCER RES, V9, P4852; Hu YC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0978-y; Li W, 2019, EUR J PHARMACOL, V849, P106, DOI 10.1016/j.ejphar.2019.01.049; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Lin L, 2002, CANCER RES, V62, P5273; Malakar P, 2017, CANCER RES, V77, P1155, DOI 10.1158/0008-5472.CAN-16-1508; Moon WS, 2003, MODERN PATHOL, V16, P552, DOI 10.1097/01.MP.0000071841.17900.69; Musso O, 2001, CANCER RES, V61, P45; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Nucera C, 2009, CLIN CANCER RES, V15, P3680, DOI 10.1158/1078-0432.CCR-08-3155; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Takayama T, 2011, JPN J CLIN ONCOL, V41, P447, DOI 10.1093/jjco/hyr016; Wang LM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20859-3; Yang C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.356; Yang X, 2014, HEPATOLOGY, V59, P1874, DOI 10.1002/hep.26941; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Yu WW, 2019, ONCOGENE, V38, P1225, DOI 10.1038/s41388-018-0463-1; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882; Zhuang M, 2019, EBIOMEDICINE, V41, P286, DOI 10.1016/j.ebiom.2018.12.049	30	33	34	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					66	81		10.1096/fj.201901834R	http://dx.doi.org/10.1096/fj.201901834R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914639				2022-12-28	WOS:000507308900006
J	Huang, YF; Gu, CJ; Wang, Q; Xu, L; Chen, J; Zhou, W; Zhou, Z; Zhao, SJ; Li, LW; Kong, FQ; Qian, DF; Zhao, X; Fan, J; Li, QQ; Yin, GY				Huang, Yi-Fan; Gu, Chang-Jiang; Wang, Qian; Xu, Lin; Chen, Jian; Zhou, Wei; Zhou, Zheng; Zhao, Shu-Jie; Li, Lin-Wei; Kong, Fan-Qi; Qian, Ding-Fei; Zhao, Xuan; Fan, Jin; Li, Qing-Qing; Yin, Guo-Yong			The protective effort of GPCR kinase 2-interacting protein-1 in neurons via promoting Beclin1-Parkin induced mitophagy at the early stage of spinal cord ischemia-reperfusion injury	FASEB JOURNAL			English	Article						GIT1; mitophagy; neuron; spinal cord injury	IN-VITRO; APOPTOSIS; MITOCHONDRIA; UBIQUITIN; PARKIN; PINK1; INHIBITION; AUTOPHAGY; DEGRADATION; BECN1	In spinal cord ischemia-reperfusion (I/R) injury, large amounts of reactive oxygen species can cause mitochondrial damage. Therefore, mitophagy acts as the main mechanism for removing damaged mitochondria and protects nerve cells. This study aimed to illustrate the important role of GPCR kinase 2-interacting protein-1 (GIT1) in mitophagy in vivo and in vitro. The level of mitophagy in the neurons of Git1 knockout mice was significantly reduced after ischemia-reperfusion. However, the overexpression of adeno-associated virus with Git1 promoted mitophagy and inhibited the apoptosis of neurons. GIT1 regulated the phosphorylation of Beclin-1 in Thr119, which could promote the translocation of Parkin to the mitochondrial outer membrane. This process was independent of PTEN-induced kinase 1 (PINK1), but it could not rescue the role in the absence of PINK1. Overall, GIT1 enhanced mitophagy and protected neurons against ischemia-reperfusion injury and, hence, might serve as a new research site for the protection of ischemia-reperfusion injury.	[Huang, Yi-Fan; Gu, Chang-Jiang; Wang, Qian; Xu, Lin; Chen, Jian; Zhou, Wei; Zhou, Zheng; Zhao, Shu-Jie; Li, Lin-Wei; Kong, Fan-Qi; Qian, Ding-Fei; Zhao, Xuan; Fan, Jin; Li, Qing-Qing; Yin, Guo-Yong] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Xu, Lin] Wuxi Xishan Peoples Hosp, Dept Orthoped, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University	Fan, J; Li, QQ; Yin, GY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	fanjin@njmu.edu.cn; liqingqing_1999@163.com; guoyong_yin@sina.com			National Natural Science Foundation of China (NSFC) [81772351, 81520108018, 81472080, 81772352, 81902211, 81401800]; Jiangsu Committee of Science and Technology-Social Development Plan [BE2017755]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX19_1161]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Committee of Science and Technology-Social Development Plan; Postgraduate Research & Practice Innovation Program of Jiangsu Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772351, 81520108018, 81520108018, 81472080, 81772352, 81902211 and 81401800; Jiangsu Committee of Science and Technology-Social Development Plan, Grant/Award Number: BE2017755; Postgraduate Research & Practice Innovation Program of Jiangsu Province, Grant/Award Number: KYCX19_1161	Aguirre JD, 2017, P NATL ACAD SCI USA, V114, P298, DOI 10.1073/pnas.1613040114; Ando M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0174-z; Balsam LB, 2017, J THORAC CARDIOV SUR, V154, P1509, DOI 10.1016/j.jtcvs.2017.06.010; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Chen J, 2018, FASEB J, V32, P6833, DOI 10.1096/fj.201800548; Choubey V, 2014, AUTOPHAGY, V10, P1105, DOI 10.4161/auto.28615; Feng JH, 2018, MOL NEUROBIOL, V55, P6369, DOI 10.1007/s12035-017-0859-x; Gelmetti V, 2017, AUTOPHAGY, V13, P654, DOI 10.1080/15548627.2016.1277309; Gladkova C, 2018, NATURE, V559, P411, DOI 10.1038/s41586-018-0224-x; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Honda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5004; Jeyaraju DV, 2006, P NATL ACAD SCI USA, V103, P18562, DOI 10.1073/pnas.0604983103; Jiang X, 2006, ANN SURG, V244, P148, DOI 10.1097/01.sla.0000217608.08582.35; Jin SH, 2016, EMBO J, V35, P866, DOI 10.15252/embj.201593596; Karadimas SK, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6524; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Kong H, 2019, J MOL CELL BIOL, V11, P1056, DOI 10.1093/jmcb/mjz002; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kumar A, 2018, SCI REP, V8, P1; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Li Q, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00865; Liu K, 2017, J THORAC CARDIOV SUR, V154, P1498, DOI 10.1016/j.jtcvs.2017.05.046; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lonskaya I, 2013, EMBO MOL MED, V5, P1247, DOI 10.1002/emmm.201302771; Matsuda N, 2016, J BIOCHEM, V159, P379, DOI 10.1093/jb/mvv125; McIlwain DL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-19; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Pang JJ, 2011, J MOL CELL CARDIOL, V51, P769, DOI 10.1016/j.yjmcc.2011.06.020; Pao KC, 2016, NAT CHEM BIOL, V12, P324, DOI [10.1038/nchembio.2045, 10.1038/NCHEMBIO.2045]; Perelman A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.171; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Sun N, 2017, NAT PROTOC, V12, P1576, DOI 10.1038/nprot.2017.060; Tang CY, 2018, AUTOPHAGY, V14, P880, DOI 10.1080/15548627.2017.1405880; Tenorio ER, 2019, J CARDIOVASC SURG, V60, P54, DOI 10.23736/S0021-9509.18.10739-7; Wang LP, 2009, J NEUROTRAUM, V26, P55, DOI 10.1089/neu.2008.0538; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Yin GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089127; Yoshii SR, 2015, BBA-MOL CELL RES, V1853, P2797, DOI 10.1016/j.bbamcr.2015.01.013; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu DT, 2013, NEUROTOX RES, V24, P512, DOI 10.1007/s12640-013-9397-0; Zhang Y, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12542; Zhang ZR, 2019, J NEURORESTORATOLOGY, V7, P55, DOI 10.26599/JNR.2019.9040011; Zhao S., 2018, FRONT MICROBIAL, V9, P1; Zhou H, 2017, REDOX BIOL, V13, P498, DOI 10.1016/j.redox.2017.07.007; Zhou W, 2016, J CELL SCI, V129, P1963, DOI 10.1242/jcs.179465; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	54	12	13	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2055	2074		10.1096/fj.201902047R	http://dx.doi.org/10.1096/fj.201902047R		DEC 2019	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908016	hybrid			2022-12-28	WOS:000504677200001
J	Imbriglio, T; Verhaeghe, R; Martinello, K; Pascarelli, MT; Chece, G; Bucci, D; Notartomaso, S; Quattromani, M; Mascio, G; Scalabri, F; Simeone, A; Maccari, S; Del Percio, C; Wieloch, T; Fucile, S; Babiloni, C; Battaglia, G; Limatola, C; Nicoletti, F; Cannella, M				Imbriglio, Tiziana; Verhaeghe, Remy; Martinello, Katiuscia; Pascarelli, Maria Teresa; Chece, Giuseppina; Bucci, Domenico; Notartomaso, Serena; Quattromani, Miriana; Mascio, Giada; Scalabri, Francesco; Simeone, Antonio; Maccari, Stefania; Del Percio, Claudio; Wieloch, Tadeusz; Fucile, Sergio; Babiloni, Claudio; Battaglia, Giuseppe; Limatola, Cristina; Nicoletti, Ferdinando; Cannella, Milena			Developmental abnormalities in cortical GABAergic system in mice lacking mGlu3 metabotropic glutamate receptors	FASEB JOURNAL			English	Article						mGlu3 receptors; cortical interneurons; development; oscillations; perineuronal nets	DORSOLATERAL PREFRONTAL CORTEX; WILD-TYPE MICE; PERINEURONAL NETS; PARVALBUMIN NEURONS; WORKING-MEMORY; COGNITIVE CONTROL; GENE-EXPRESSION; GABA; INTERNEURONS; CELL	Polymorphic variants of the gene encoding for metabotropic glutamate receptor 3 (mGlu3) are linked to schizophrenia. Because abnormalities of cortical GABAergic interneurons lie at the core of the pathophysiology of schizophrenia, we examined whether mGlu3 receptors influence the developmental trajectory of cortical GABAergic transmission in the postnatal life. mGlu3(-/-) mice showed robust changes in the expression of interneuron-related genes in the prefrontal cortex (PFC), including large reductions in the expression of parvalbumin (PV) and the G1uN1 subunit of NMDA receptors. The number of cortical cells enwrapped by perineuronal nets was increased in mGlu3(-/-) mice, suggesting that mGlu3 receptors shape the temporal window of plasticity of PV+ interneurons. Electrophysiological measurements of GABA(A) receptor-mediated responses revealed a more depolarized reversal potential of GABA currents in the somata of PFC pyramidal neurons in mGlu3(-/-) mice at postnatal d 9 associated with a reduced expression of the K+/Cl- symporter. Finally, adult mGlu3(-/-) mice showed lower power in electroencephalographic rhythms at 1-45 Hz in quiet wakefulness as compared with their wild-type counterparts. These findings suggest that mGlu3 receptors have a strong impact on the development of cortical GABAergic transmission and cortical neural synchronization mechanisms corroborating the concept that genetic variants of mGlu3 receptors may predispose to psychiatric disorders.	[Imbriglio, Tiziana; Verhaeghe, Remy; Pascarelli, Maria Teresa; Chece, Giuseppina; Del Percio, Claudio; Fucile, Sergio; Babiloni, Claudio; Battaglia, Giuseppe; Limatola, Cristina; Nicoletti, Ferdinando] Univ Sapienza Rome, Dept Physiol & Pharmacol V Erspamer, Rome, Italy; [Maccari, Stefania] Univ Sapienza Rome, Dept Sci & Med Surg Biotechnol, Rome, Italy; [Martinello, Katiuscia; Bucci, Domenico; Notartomaso, Serena; Mascio, Giada; Fucile, Sergio; Battaglia, Giuseppe; Limatola, Cristina; Nicoletti, Ferdinando; Cannella, Milena] IRCCS Neuromed, Pozzilli, IS, Italy; [Pascarelli, Maria Teresa] IRCCS, Oasi Res Inst, Troina, Italy; [Quattromani, Miriana; Wieloch, Tadeusz] Lund Univ, Dept Clin Sci, Expt Brain Res Lab, Lund, Sweden; [Scalabri, Francesco] IRBM Sci Pk SpA, Rome, Italy; [Simeone, Antonio] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy; [Maccari, Stefania] Univ Lille, CNRS, UMR 8576, UGSF, Lille, France; [Babiloni, Claudio] Hosp San Raffaele Cassino, Cassino, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Neuromed; Lund University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Nicoletti, F (corresponding author), IRCCS Neuromed, Pozzilli, IS, Italy.	ferdinandonicoletti@hotmail.com	Verhaeghe, Remy/AAA-4265-2021; Simeone, Antonio/ABG-5269-2020; Pascarelli, Maria Teresa/AAF-5963-2019; Imbriglio, Tiziana/AAA-2919-2021; Martinello, Katiuscia/K-5899-2016; Nicoletti, Ferdinando/A-2446-2010; Battaglia, Giuseppe/A-7709-2010	Simeone, Antonio/0000-0003-2693-9836; Pascarelli, Maria Teresa/0000-0002-7082-975X; Martinello, Katiuscia/0000-0002-0423-5689; Nicoletti, Ferdinando/0000-0003-0917-443X; SCALABRI', Francesco/0000-0001-7713-235X; limatola, cristina/0000-0001-7504-8197; Battaglia, Giuseppe/0000-0001-7571-3417	Italian Ministry of Health (Ricerca Corrente); Alborada Trust; Swedish Research Council	Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Alborada Trust; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors thank Eli Lilly and Co. (Indianapolis, IN, USA) for kindly providing wild-type, mGlu2<SUP>-/-</SUP> and mGlu3<SUP>-/-</SUP> mice. This study was supported by funds from the Italian Ministry of Health (Ricerca Corrente 2019), the Alborada Trust (to T.W.), and Swedish Research Council (to T.W.). F.N. and M.C. are colast authors. S.M. and F.N. are coheads of the Associated International Laboratory (LIA): Perinatal Stress and Neurodegenerative Diseases, University of Lille, Centre National de la Recherche Scientifique (CNRS), Unite Mixte de Recherche (UMR) 8576, and Sapienza University of Rome/Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, France/Italy. The authors declare no conflicts of interest.	Amin H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15793-9; Arnsten AFT, 2014, PROG MOL BIOL TRANSL, V122, P211, DOI 10.1016/B978-0-12-420170-5.00008-8; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Barnes SA, 2015, MOL PSYCHIATR, V20, P1161, DOI 10.1038/mp.2015.113; Battaglia G, 2015, NEUROBIOL DIS, V74, P126, DOI 10.1016/j.nbd.2014.11.012; Battaglia G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006591; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Bernard C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006035; Bernard C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7931693; Berretta S, 2015, SCHIZOPHR RES, V167, P18, DOI 10.1016/j.schres.2014.12.040; Berretta S, 2012, NEUROPHARMACOLOGY, V62, P1584, DOI 10.1016/j.neuropharm.2011.08.010; Bozzelli PL, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5735789; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Bruno V, 2017, NEUROPHARMACOLOGY, V115, P180, DOI 10.1016/j.neuropharm.2016.04.044; Bucci D, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00098; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Canty AJ, 2009, J NEUROSCI, V29, P10695, DOI 10.1523/JNEUROSCI.2658-09.2009; CATANIA MV, 1994, NEUROSCIENCE, V61, P481, DOI 10.1016/0306-4522(94)90428-6; Cau E, 1997, DEVELOPMENT, V124, P1611; Chaki S, 2018, CURR OPIN PHARMACOL, V38, P24, DOI 10.1016/j.coph.2018.02.001; Chaki S, 2017, TRENDS PHARMACOL SCI, V38, P569, DOI 10.1016/j.tips.2017.03.008; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Corti C, 2007, BIOL PSYCHIAT, V62, P747, DOI 10.1016/j.biopsych.2006.12.005; Crunelli V, 2015, CURR OPIN NEUROBIOL, V31, P72, DOI 10.1016/j.conb.2014.09.001; Curley AA, 2012, J PHYSIOL-LONDON, V590, P715, DOI 10.1113/jphysiol.2011.224659; Del Percio C, 2018, CURR ALZHEIMER RES, V15, P259, DOI 10.2174/1567205014666170704113405; Del Percio C, 2017, NEUROBIOL AGING, V49, P20, DOI 10.1016/j.neurobiolaging.2016.09.004; del Pino I, 2017, NAT NEUROSCI, V20, P784, DOI 10.1038/nn.4544; Di Menna L, 2018, NEUROPHARMACOLOGY, V128, P301, DOI 10.1016/j.neuropharm.2017.10.026; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Duman RS, 2019, NEURON, V102, P75, DOI 10.1016/j.neuron.2019.03.013; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Enwright JF, 2016, NEUROPSYCHOPHARMACOL, V41, P2206, DOI 10.1038/npp.2016.24; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Fogaca MV, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00087; Foster DJ, 2017, NEURON, V94, P431, DOI 10.1016/j.neuron.2017.03.016; Fujioka R, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-31; Glausier JR, 2014, MOL PSYCHIATR, V19, P30, DOI 10.1038/mp.2013.152; Golding B, 2014, NEURON, V81, P1057, DOI 10.1016/j.neuron.2014.01.032; Gonzalez-Burgos G, 2015, BIOL PSYCHIAT, V77, P1031, DOI 10.1016/j.biopsych.2015.03.010; Gopal PP, 2008, CEREB CORTEX, V18, P752, DOI 10.1093/cercor/bhm114; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; Haji-Ghassemi O, 2016, J BIOL CHEM, V291, P24085, DOI 10.1074/jbc.M116.750463; Happel M. F., 2016, COMPOSITION FUNCTION, P143, DOI DOI 10.5772/62452; Harrison PJ, 2008, J PSYCHOPHARMACOL, V22, P308, DOI 10.1177/0269881108089818; HARTIG W, 1992, NEUROREPORT, V3, P869; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hilbig H, 2001, ANAT EMBRYOL, V203, P45, DOI 10.1007/s004290000135; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Ishii K, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00229; Jiang ZH, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00116; Jin LE, 2017, MOL PSYCHIATR, V22, P1615, DOI 10.1038/mp.2016.129; Kandel A, 1997, J NEUROSCI, V17, P6783; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kinon BJ, 2015, BIOL PSYCHIAT, V78, P754, DOI 10.1016/j.biopsych.2015.03.016; Kon E, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00163; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Lainiola M, 2014, BEHAV BRAIN RES, V266, P94, DOI 10.1016/j.bbr.2014.03.008; Lewis DA, 2008, NEUROTOX RES, V14, P237, DOI 10.1007/BF03033813; Linden AM, 2005, PSYCHOPHARMACOLOGY, V179, P284, DOI 10.1007/s00213-004-2098-x; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Maj C, 2016, CURR NEUROPHARMACOL, V14, P540, DOI 10.2174/1570159X13666150514232745; Maksymetz J, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0293-z; Marsh ED, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0265-8; Matthews RT, 2002, J NEUROSCI, V22, P7536; Mauney SA, 2013, BIOL PSYCHIAT, V74, P427, DOI 10.1016/j.biopsych.2013.05.007; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Merner ND, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00386; Minzenberg MJ, 2010, NEUROPSYCHOPHARMACOL, V35, P2590, DOI 10.1038/npp.2010.150; Miyamae T, 2017, J NEUROSCI, V37, P4883, DOI 10.1523/JNEUROSCI.3325-16.2017; Miyata S, 2018, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00003; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Nikiforuk A, 2010, J PHARMACOL EXP THER, V335, P665, DOI 10.1124/jpet.110.170506; NUECHTERLEIN KH, 1984, SCHIZOPHRENIA BULL, V10, P300, DOI 10.1093/schbul/10.2.300; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Paxinos G, 2007, RAT BRAIN STEREOTAXI, V6; Paylor JW, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0253-18.2018; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Perez-Santiago J, 2012, J PSYCHIATR RES, V46, P1464, DOI 10.1016/j.jpsychires.2012.08.005; Perrinjaquet M, 2011, J CELL SCI, V124, P2797, DOI 10.1242/jcs.083717; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pritchett D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125523; Quattromani MJ, 2018, MOL NEUROBIOL, V55, P2196, DOI 10.1007/s12035-017-0461-2; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Saini SM, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.172; Sakai A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00307; Schmiedt C, 2005, COGNITIVE BRAIN RES, V25, P936, DOI 10.1016/j.cogbrainres.2005.09.015; Slaker M, 2015, J NEUROSCI, V35, P4190, DOI 10.1523/JNEUROSCI.3592-14.2015; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Sullivan CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123158; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; TANABE Y, 1993, J NEUROSCI, V13, P1372; Ueno H, 2017, NEUROSCIENCE, V343, P115, DOI 10.1016/j.neuroscience.2016.11.035; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Uvarov P, 2005, J NEUROCHEM, V95, P1144, DOI 10.1111/j.1471-4159.2005.03434.x; Volk DW, 2016, SCHIZOPHR RES, V177, P3, DOI 10.1016/j.schres.2016.03.001; Walker AG, 2015, CURR OPIN PHARMACOL, V20, P40, DOI 10.1016/j.coph.2014.11.003; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Wong FK, 2018, NATURE, V557, P668, DOI 10.1038/s41586-018-0139-6; Woo TU, 1997, AM J PSYCHIAT, V154, P1013; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yabuno K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144560; Yamada J, 2017, J COMP NEUROL, V525, P2035, DOI 10.1002/cne.24198	118	3	3	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14204	14220		10.1096/fj.201901093RRR	http://dx.doi.org/10.1096/fj.201901093RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31665922	Bronze			2022-12-28	WOS:000507466100089
J	Liu, T; Woo, JAA; Yan, Y; LePochat, P; Bukhari, MZ; Kang, DE				Liu, Tian; Woo, Jung-A. A.; Yan, Yan; LePochat, Patrick; Bukhari, Mohammed Zaheen; Kang, David E.			Dual role of cofilin in APP trafficking and amyloid-beta clearance	FASEB JOURNAL			English	Article						amyloid precursor protein; endocytosis; A beta microglia; actin dynamics	PRECURSOR PROTEIN TRAFFICKING; ADF/COFILIN-ACTIN RODS; DYNAMICS; RECEPTOR; ENDOCYTOSIS; FAMILY; PHOSPHORYLATION; CYTOSKELETON; MECHANISM; CLEAVAGE	The accumulation of amyloid-beta (A beta) plays a pivotal early event in the pathogenesis of Alzheimer's disease (AD). In the brain, neurons produce A beta by the proteolytic processing of amyloid precursor protein (APP) through the endocytic pathway, whereas microglia mediate A beta clearance also via endocytic mechanisms. Previous studies have shown the critical importance of cofilin, a filamentous actin-severing protein, in actin dynamics and pathogen-triggered endocytic processes. Moreover, the binding of A beta 42 oligomers to beta 1-integrin triggers the cofilin activation, and in turn, cofilin promotes the internalization of surface beta 1-integrin. However, a role for cofilin in APP processing and A beta metabolism has not been investigated. In this study, we found that knockdown of cofilin in Chinese hamster ovary 7WD10 cells and primary neurons significantly reduces A beta production by increasing surface APP (sAPP) levels. Expression of active (S3A) but not inactive (S3E) cofilin reduces sAPP levels by enhancing APP endocytosis. Accordingly, A beta deposition in APP and presenilin 1 (PS1) transgenic mice is significantly reduced by genetic reduction of cofilin (APP/PS1;cofilin(+/-)). However, the reduction of A beta load in APP/PS1;cofilin(+/-) mice is paradoxically associated with significantly increased ionized calcium-binding adaptor molecule 1-positive microglial activation surrounding A beta deposits. Primary microglia isolated from cofilin(+/-) mice demonstrate significantly enhanced state of activation and greater ability to uptake and clear A beta 42, which is reversed with the active (S3A) but not inactive (S3E) form of cofilin. These results taken together indicate a significant role for cofilin in Ap accumulation via dual and opposing endocytic mechanisms of promoting Ap production in neurons and inhibiting Ap clearance in microglia.	[Liu, Tian; Woo, Jung-A. A.; Yan, Yan; LePochat, Patrick; Bukhari, Mohammed Zaheen; Kang, David E.] USF Hlth, Morsani Coll Med, Byrd Alzheimers Inst, 4001 E Fletcher Ave, Tampa, FL 33613 USA; [Liu, Tian; Yan, Yan; LePochat, Patrick; Bukhari, Mohammed Zaheen; Kang, David E.] USF Hlth, Morsani Coll Med, Dept Mol Med, Tampa, FL USA; [Woo, Jung-A. A.] USF Hlth, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Kang, David E.] James A Haley Vet Adm Hosp, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Liu, T; Kang, DE (corresponding author), USF Hlth, Morsani Coll Med, Byrd Alzheimers Inst, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	tianliu@health.usf.edu; dkang@health.usf.edu		Liu, Tian/0000-0002-6437-8892; Kang, David E./0000-0002-7132-821X; Woo, Jung A/0000-0002-9194-1361	U.S. Veterans Administration [1 I01 BX002478-01A1]; U.S. National Institutes of Health, National Institute on Aging [R01 AG053060-01A1]; Florida Department of Health [8AZ29]; NATIONAL INSTITUTE ON AGING [RF1AG053060] Funding Source: NIH RePORTER	U.S. Veterans Administration(US Department of Veterans Affairs); U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Florida Department of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. James Bamburg (Colorado State University, Fort Collins, CO, USA) for providing adenovirus and constructs for cofilin-mRFP variants. This work was supported, in part, by grants from the U.S. Veterans Administration (1 I01 BX002478-01A1, to D.E. K.), U.S. National Institutes of Health, National Institute on Aging (R01 AG053060-01A1, to D.E. K.), and the Florida Department of Health (8AZ29, to D. E.K.). The authors declare no conflicts of interest.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Bamburg JR, 2016, CYTOSKELETON, V73, P477, DOI 10.1002/cm.21282; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Carlsson AE, 2018, CURR OPIN CELL BIOL, V50, P1, DOI 10.1016/j.ceb.2017.11.007; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; Frotscher M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00148; Grassart A, 2014, J CELL BIOL, V205, P721, DOI 10.1083/jcb.201403041; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lee SJ, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0173-3; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu T, 2017, CRISPR/CAS SYSTEM: EMERGING TECHNOLOGY AND APPLICATION, P1, DOI 10.21775/9781910190630.01; Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Okreglak V, 2007, J CELL BIOL, V178, P1251, DOI 10.1083/jcb.200703092; Rahman T, 2014, J ALZHEIMERS DIS, V42, P1443, DOI 10.3233/JAD-140393; Ries M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00160; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Senju Y, 2019, CURR OPIN CELL BIOL, V56, P7, DOI 10.1016/j.ceb.2018.08.003; Serezani CH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002448; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Storck SE, 2016, J CLIN INVEST, V126, P123, DOI 10.1172/JCI81108; Svitkina Tatyana, 2018, Cold Spring Harb Perspect Biol, V10, DOI 10.1101/cshperspect.a018267; Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Van Gool B, 2019, MOL NEUROBIOL, V56, P7234, DOI 10.1007/s12035-019-1594-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vitriol EA, 2013, MOL BIOL CELL, V24, P2238, DOI 10.1091/mbc.E13-03-0156; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Woo JA, 2015, CELL DEATH DIFFER, V22, P1069, DOI 10.1038/cdd.2015.41; Woo JA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.37; Woo JA, 2012, FASEB J, V26, P1672, DOI 10.1096/fj.11-194423; Woo JAA, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0359-9; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; Zhang XJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt211; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zheng K, 2016, CRIT REV MICROBIOL, V42, P677, DOI 10.3109/1040841X.2015.1010139	56	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14234	14247		10.1096/fj.201901268R	http://dx.doi.org/10.1096/fj.201901268R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31646885	Green Published, Bronze			2022-12-28	WOS:000507466100091
J	Vyas, V; Guerra, DD; Bok, R; Powell, T; Jansson, T; Hurt, KJ				Vyas, Vibhuti; Guerra, Damian D.; Bok, Rachael; Powell, Theresa; Jansson, Thomas; Hurt, K. Joseph			Adiponectin links maternal metabolism to uterine contractility	FASEB JOURNAL			English	Article						adipoQ; myometrium; obstetric; oxytocin; parturition	ACTIVATED PROTEIN-KINASE; FULL-LENGTH ADIPONECTIN; FATTY-ACID OXIDATION; SERUM ADIPONECTIN; MUSCLE-CELLS; IN-VITRO; AMP; EXPRESSION; PREGNANCY; LEPTIN	Adiponectin is secreted by adipose tissue and promotes insulin sensitivity. Low circulating adiponectin is associated with increased risk for preterm labor, but the influence of adiponectin on uterine myometrial physiology is unknown. We hypothesized that adiponectin receptors (AdipoRs) decrease myometrial contractility via AMPK to promote uterine quiescence in pregnancy. Using quantitative RT-PCR, we found that nonpregnant or pregnant human and mouse myometrium express AdipoRl and AdipoR2 mRNAs. We confirmed AdipoR2 protein expression in human and mouse myometrium, with increased abundance in late mouse pregnancy. Both recombinant adiponectin and a pharmacologic AdipoR agonist, AdipoRon, potently inhibited uterine myometrial strip contractions in physiologic organ bath. The relaxation was independent of contractile stimulus (oxytocin, KCl, U46619). AdipoR agonists increased AMPK phosphorylation in pregnant mouse myometrium, and the direct AMPK activator A769662 also relaxed myometrial strips. However, the AMPK inhibitor dorsomorphin (compound C) blocked AMPK phosphorylation but did not abolish relaxation with either AdipoRon or A769662. In summary, adiponectin inhibits myometrial contractility consistent with the possibility that it is a previously unrecognized link between maternal metabolism and pregnancy maintenance. We also identify a separate role for AMPK regulating myometrial contractions that may influence labor onset.	[Vyas, Vibhuti; Guerra, Damian D.; Bok, Rachael; Powell, Theresa; Jansson, Thomas; Hurt, K. Joseph] Univ Colorado Anschutz Med Campus, Dept Obstet & Gynecol, Div Reprod Sci, Aurora, CO USA; [Powell, Theresa] Univ Colorado Anschutz Med Campus, Dept Pediat, Div Neonatol, Aurora, CO USA; [Hurt, K. Joseph] Univ Colorado Anschutz Med Campus, Dept Obstet & Gynecol, Div Maternal Fetal Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Hurt, KJ (corresponding author), Univ Colorado Anschutz Med Campus, Room P15-3003,Mail Stop 8613,12700 East 19th Ave, Aurora, CO 80045 USA.	k.joseph.hurt@cuanschutz.edu	Hurt, K. Joseph/J-8266-2019; Powell, Theresa/AAE-4249-2020	Hurt, K. Joseph/0000-0001-6906-350X; 	U.S. National Institutes of Health (NIH)/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD065007]; NIH/NICHD T32 Training Grant [HD007186-37]; Society for Maternal-Fetal Medicine/American Association of Obstetricians and Gynecologists (SMFM/AAOGF) Scholar Award; Ferring Innovation Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007186, R01HD065007] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH/NICHD T32 Training Grant; Society for Maternal-Fetal Medicine/American Association of Obstetricians and Gynecologists (SMFM/AAOGF) Scholar Award; Ferring Innovation Grant(Ferring Pharmaceuticals); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge graphic design support from KimenDesign4Research (https://www.kimendesign4research.com/). This work was supported by U.S. National Institutes of Health (NIH)/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Grant HD065007 (to T. J. and T.P.), an NIH/NICHD T32 Training Grant HD007186-37 (to D. D.G.), a Society for Maternal-Fetal Medicine/American Association of Obstetricians and Gynecologists (SMFM/AAOGF) Scholar Award (to K.J.H.), and a Ferring Innovation Grant (to K.J.H.). The authors declare no conflicts of interest.	Alotaibi M, 2015, P NATL ACAD SCI USA, V112, P9763, DOI 10.1073/pnas.1503497112; Arrowsmith S, 2011, BJOG-INT J OBSTET GY, V118, P578, DOI 10.1111/j.1471-0528.2010.02889.x; Aye ILMH, 2015, P NATL ACAD SCI USA, V112, P12858, DOI 10.1073/pnas.1515484112; Aye ILMH, 2014, MOL ENDOCRINOL, V28, P512, DOI 10.1210/me.2013-1401; Barker G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042943; Buxton ILO, 2010, J PHARMACOL EXP THER, V335, P256, DOI 10.1124/jpet.110.171934; Carlhall S, 2018, ACTA OBSTET GYN SCAN, V97, P1248, DOI 10.1111/aogs.13380; Carlson NS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0129-6; Chen XH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010008; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Crankshaw DJ, 2017, J PERINATOL, V37, P492, DOI 10.1038/jp.2016.271; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; Curry AE, 2007, ACTA OBSTET GYN SCAN, V86, P1103, DOI 10.1080/00016340701515423; Dasgupta B, 2018, METHODS MOL BIOL, V1732, P195, DOI 10.1007/978-1-4939-7598-3_12; Dos Santos E, 2012, FERTIL STERIL, V97, P771, DOI 10.1016/j.fertnstert.2011.12.042; Ehrenberg HM, 2009, OBSTET GYNECOL, V113, P48, DOI 10.1097/AOG.0b013e318191c818; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Fakor F, 2016, J TURK-GER GYNECOL A, V17, P182, DOI 10.5152/jtgga.2016.16121; Fang X, 2009, DIABETOLOGIA, V52, P2190, DOI 10.1007/s00125-009-1462-0; Fesus G, 2007, CARDIOVASC RES, V75, P719, DOI 10.1016/j.cardiores.2007.05.025; Frey HA, 2016, SEMIN FETAL NEONAT M, V21, P68, DOI 10.1016/j.siny.2015.12.011; Fuglsang J, 2005, CLIN ENDOCRINOL, V62, P554, DOI 10.1111/j.1365-2265.2005.02257.x; Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Haghiac M, 2014, J CLIN ENDOCR METAB, V99, P3427, DOI 10.1210/jc.2013-4074; Hehir MP, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.032; Hehir MP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.040; Hong K, 2016, MICROCIRCULATION, V23, P207, DOI 10.1111/micc.12266; Horman S, 2008, J BIOL CHEM, V283, P18505, DOI 10.1074/jbc.M802053200; Ito R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205645; Jones HN, 2010, DIABETES, V59, P1161, DOI 10.2337/db09-0824; Khatibi A, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.002; Kim SS, 2017, BJOG-INT J OBSTET GY, V124, P1708, DOI 10.1111/1471-0528.14613; Kim ST, 2011, HUM REPROD, V26, P82, DOI 10.1093/humrep/deq292; Kossowska-Tomaszczuk K, 2009, STEM CELLS, V27, P210, DOI 10.1634/stemcells.2008-0233; Kourtis A, 2011, CLIN ENDOCRINOL, V75, P367, DOI 10.1111/j.1365-2265.2011.04061.x; Lekva T, 2017, J CLIN ENDOCR METAB, V102, P2552, DOI 10.1210/jc.2017-00289; Longo M, 2003, AM J OBSTET GYNECOL, V188, P1468, DOI 10.1067/mob.2003.454; Martinez J, 2020, Border Hispanisms, P1, DOI 10.7560/321713; Masuyama H, 2007, J CLIN ENDOCR METAB, V92, P2672, DOI 10.1210/jc.2006-2349; Mazaki-Tovi S, 2007, J PERINATOL, V27, P77, DOI 10.1038/sj.jp.7211639; Mazaki-Tovi S, 2009, J MATERN-FETAL NEO M, V22, P887, DOI 10.1080/14767050902994655; Mazaki-Tovi S, 2009, J MATERN-FETAL NEO M, V22, P693, DOI 10.1080/14767050902994788; Mazaki-Tovi S, 2009, J PERINAT MED, V37, P349, DOI 10.1515/JPM.2009.085; Mazaki-Tovi S, 2009, J PERINAT MED, V37, P206, DOI 10.1515/JPM.2009.054; Morgan SA, 2008, PEPTIDES, V29, P1382, DOI 10.1016/j.peptides.2008.04.010; Mostafa Abeer F., 2013, Journal of Basic and Clinical Physiology and Pharmacology, V24, P137, DOI 10.1515/jbcpp-2012-0063; Moynihan AT, 2006, AM J OBSTET GYNECOL, V195, P504, DOI 10.1016/j.ajog.2006.01.106; Mumtaz S, 2015, LIFE SCI, V125, P57, DOI 10.1016/j.lfs.2015.01.020; Nien JK, 2007, J PERINAT MED, V35, P522, DOI 10.1515/JPM.2007.123; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Retnakaran R, 2012, CAN MED ASSOC J, V184, P1353, DOI 10.1503/cmaj.111154; Robertson SA, 2010, ENDOCRINOLOGY, V151, P3996, DOI 10.1210/en.2010-0063; Rosario FJ, 2012, J PHYSIOL-LONDON, V590, P1495, DOI 10.1113/jphysiol.2011.226399; Ruan H, 2016, J MOL CELL BIOL, V8, P101, DOI 10.1093/jmcb/mjw014; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schneider H, 2015, HYPERTENSION, V66, P108, DOI 10.1161/HYPERTENSIONAHA.115.05514; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Suto M, 2019, GYNECOL ENDOCRINOL, V35, P242, DOI 10.1080/09513590.2018.1512572; Takemura Y, 2006, ENDOCRINOLOGY, V147, P3203, DOI 10.1210/en.2005-1510; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Wang YJ, 2017, AUTOPHAGY, V13, P1855, DOI 10.1080/15548627.2017.1358848; Williams MA, 2004, J CLIN ENDOCR METAB, V89, P2306, DOI 10.1210/jc.2003-031201; Williams TC, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0121; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang Ming-Jie, 2005, J Chin Med Assoc, V68, P452, DOI 10.1016/S1726-4901(09)70073-5; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Yoshida H, 2012, J MOL CELL CARDIOL, V52, P410, DOI 10.1016/j.yjmcc.2011.08.013; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	76	6	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14588	14601		10.1096/fj.201901646R	http://dx.doi.org/10.1096/fj.201901646R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31665924	Green Published			2022-12-28	WOS:000507466100117
J	Wei, YK; Chen, SS; Sun, DM; Li, X; Wei, RH; Li, XR; Nian, H				Wei, Yankai; Chen, Sisi; Sun, Deming; Li, Xue; Wei, Ruihua; Li, Xiaorong; Nian, Hong			miR-223-3p promotes autoreactive T(h)17 cell responses in experimental autoimmune uveitis (EAU) by inhibiting transcription factor FOXO3 expression	FASEB JOURNAL			English	Article						IL-23; pathogenic Th17 cells; IL-23R; GM-CSF; IL-22	REGULATORY T-CELLS; TGF-BETA; DENDRITIC CELLS; TH17 RESPONSES; DIFFERENTIATION; EFFECTOR; MICRORNAS; ACTIVATION; INDUCTION; RECEPTOR	Pathogenic T helper (T-h)17 cells are key mediators of autoimmune diseases such as uveitis and its animal model, experimental autoimmune uveitis (EAU). However, the contribution of microRNAs (miRs) to the intrinsic control of pathogenic T(h)17 cells in EAU remains largely unknown. Here, we have reported that miR-223-3p was significantly up-regulated in interphotoreceptor retinoid-binding protein specific Th17 cells, and its expression was enhanced by IL-23 signal transducer and activator of transcription 3 signaling. Knockdown of miR-223-3p decreased the pathogenicity of T(h)17 cells in a T-cell transfer model of EAU. Mechanistic studies showed that miR-2233-p directly repressed the expression of forkhead box 03 (FOXO3), and FOXO3 negatively regulated pathogenic Th17 cell responses partially via suppression of IL-23 receptor expression. Thus, our results reveal an important role for miR-223-3p in autoreactive T(h)17 cell responses and suggest a potential therapeutic avenue for uveitis.	[Wei, Yankai; Chen, Sisi; Li, Xue; Wei, Ruihua; Li, Xiaorong; Nian, Hong] Tianjin Med Univ, Hosp Eye, Inst Eye, Tianjin Key Lab Retinal Funct & Dis, 251 Fukang Rd, Tianjin 300384, Peoples R China; [Wei, Yankai; Chen, Sisi; Li, Xue; Wei, Ruihua; Li, Xiaorong; Nian, Hong] Tianjin Med Univ, Hosp Eye, Sch Optometry, 251 Fukang Rd, Tianjin 300384, Peoples R China; [Sun, Deming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Sun, Deming] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA	Tianjin Medical University; Tianjin Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Doheny Eye Institute	Li, XR; Nian, H (corresponding author), Tianjin Med Univ, Hosp Eye, Inst Eye, Tianjin Key Lab Retinal Funct & Dis, 251 Fukang Rd, Tianjin 300384, Peoples R China.; Li, XR; Nian, H (corresponding author), Tianjin Med Univ, Hosp Eye, Sch Optometry, 251 Fukang Rd, Tianjin 300384, Peoples R China.	xiaorli@163.com; nianhong@126.com			National Natural Science Foundation of China [81570834, 81770901, 81870675]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry [48]; Tianjin Clinical Key Discipline Project [TJLCZDXKT003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; Tianjin Clinical Key Discipline Project	This work was supported by the National Natural Science Foundation of China (81570834, 81770901, and 81870675), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the State Education Ministry (No. 48), and the Tianjin Clinical Key Discipline Project (TJLCZDXKT003). The authors declare no conflicts of interest.	Agalioti T, 2018, J AUTOIMMUN, V87, P50, DOI 10.1016/j.jaut.2017.12.003; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chang R, 2018, BRIT J OPHTHALMOL, V102, P282, DOI 10.1136/bjophthalmol-2017-311079; Chavali S, 2013, RNA, V19, P1552, DOI 10.1261/rna.038414.113; Chen JQ, 2016, AUTOIMMUN REV, V15, P1171, DOI 10.1016/j.autrev.2016.09.003; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; DARFLER FJ, 1980, P NATL ACAD SCI-BIOL, V77, P5993, DOI 10.1073/pnas.77.10.5993; Deknuydt F, 2009, CLIN IMMUNOL, V131, P298, DOI 10.1016/j.clim.2008.12.008; Ding QP, 2018, PATHOL RES PRACT, V214, P1330, DOI 10.1016/j.prp.2018.05.012; Du Xingrong, 2014, J Immunol, V192, P1525, DOI 10.4049/jimmunol.1301060; Dunaeva M, 2018, CLIN EXP IMMUNOL, V193, P376, DOI 10.1111/cei.13156; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Erre GL, 2015, CLIN EXP RHEUMATOL, V33, pS72; Feng Q, 2018, GENE, V658, P152, DOI 10.1016/j.gene.2018.03.013; Fulci V, 2010, HUM IMMUNOL, V71, P206, DOI 10.1016/j.humimm.2009.11.008; Ghorbani S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00758; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Herberth G, 2014, J ALLERGY CLIN IMMUN, V133, P543, DOI 10.1016/j.jaci.2013.06.036; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Hosseini A, 2016, CELL J, V18, P371; Ichiyama K, 2016, IMMUNITY, V44, P1284, DOI 10.1016/j.immuni.2016.05.015; Ifergan I, 2016, J IMMUNOL, V196, P1455, DOI 10.4049/jimmunol.1501965; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee PW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91663; Li B, 2017, J CLIN INVEST, V127, P3702, DOI 10.1172/JCI94012; Liu AJ, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12550; Lu MC, 2014, CLIN EXP IMMUNOL, V177, P641, DOI 10.1111/cei.12374; Luger D, 2008, SEMIN IMMUNOPATHOL, V30, P135, DOI 10.1007/s00281-008-0108-5; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Luo P, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1079-1; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mufazalov IA, 2017, EMBO J, V36, P102, DOI 10.15252/embj.201694615; Murugaiyan G, 2015, J CLIN INVEST, V125, P1069, DOI 10.1172/JCI74347; Na SY, 2016, CLIN EXP RHEUMATOL, V34, pS56; Okuzaki D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19456; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Park Y, 2013, J CLIN INVEST, V123, P5165, DOI 10.1172/JCI69751; Puccetti A, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2405150; Qin DZ, 2016, J BIOL CHEM, V291, P20247, DOI 10.1074/jbc.M116.732735; Satoorian T, 2016, IMMUNOLOGY, V148, P326, DOI 10.1111/imm.12611; Stienne C, 2016, IMMUNITY, V45, P774, DOI 10.1016/j.immuni.2016.09.010; Tang Q, 2018, EUR J PHARMACOL, V841, P67, DOI 10.1016/j.ejphar.2018.10.014; Thurau SR, 1997, CLIN EXP IMMUNOL, V109, P370, DOI 10.1046/j.1365-2249.1997.4571356.x; Tulunay A, 2015, GENES IMMUN, V16, P170, DOI 10.1038/gene.2014.64; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verhagen FH, 2018, INVEST OPHTH VIS SCI, V59, P878, DOI 10.1167/iovs.17-23643; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Watanabe T, 2016, BRIT J OPHTHALMOL, V100, P425, DOI 10.1136/bjophthalmol-2015-306924; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu YX, 2018, BLOOD, V131, P1974, DOI 10.1182/blood-2017-06-789321; Xavier JM, 2013, J MOL MED, V91, P1013, DOI 10.1007/s00109-013-1022-4; Xiao Q, 2016, J IMMUNOL, V197, P3820, DOI 10.4049/jimmunol.1600333; Xiao W, 2019, AGING-US, V11, P615, DOI 10.18632/aging.101763; Zhang LJ, 2018, J AUTOIMMUN, V90, P84, DOI 10.1016/j.jaut.2018.02.004; Zhang ZM, 2018, BRAIN BEHAV IMMUN, V70, P305, DOI 10.1016/j.bbi.2018.03.011; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; zu Horste GM, 2016, CELL REP, V16, P392, DOI 10.1016/j.celrep.2016.05.088	69	15	20	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13951	13965		10.1096/fj.201901446R	http://dx.doi.org/10.1096/fj.201901446R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31645142	Bronze, Green Submitted			2022-12-28	WOS:000507466100069
J	Xiao, MC; Liu, Y; Wang, LY; Liang, J; Wang, TJ; Zhai, YQ; Wang, YF; Liu, S; Liu, WJ; Luo, XT; Wang, FH; Sun, XD				Xiao, Meichun; Liu, Yang; Wang, Lingyu; Liang, Jian; Wang, Tianjun; Zhai, Yuanqi; Wang, Yafang; Liu, Shu; Liu, Wenjia; Luo, Xueting; Wang, Fenghua; Sun, Xiaodong			Intraocular VEGF deprivation induces degeneration and fibrogenic response in retina	FASEB JOURNAL			English	Article						sFLT-1; retinal degeneration; fibrosis; RNA-Seq; AMD	ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; GENE-THERAPY; INTRAVITREAL INJECTION; CHOROIDAL NEOVASCULARIZATION; SURVIVAL FACTOR; SOLUBLE VEGF; FOLLOW-UP; BEVACIZUMAB; SAFETY	VEGF is a critical driver of ocular neovascularization under disease conditions. Current therapeutic strategies rely on intraocular delivery of VEGF-antagonizing reagents, which results in sustained suppression of pathogenic vascularization. Although significant advancement has been achieved in VEGF antagonism, substantial adverse effects have been reported in retrospective clinical studies. To study mechanisms for VEGF antagonism associated adverse effects in visual system, we intravitreally delivered recombinant adeno-associated virus mediated expression of soluble Fms-related tyrosine kinase-1 (rAAV.sFLT-1), the extracellular domain of VEGF receptor, and analyzed the morphology and functions of retinal tissue. Here, we confirmed that intraocular VEGF antagonism induced retinal degeneration and gliosis. The functional deficit in retinal response to visual stimulation was also demonstrated in rAAV.sFLT-1 treated eyes by electroretinogram. Moreover, high-throughput RNA sequencing analysis suggests that VEGF antagonism activates retinal degeneration, inflammation, and other adverse effects. Taken together, our findings have shed light on pathogenic mechanisms for VEGF antagonism-associated adverse effects and potential therapeutic targets.	[Xiao, Meichun; Liu, Yang; Liang, Jian; Zhai, Yuanqi; Wang, Yafang; Liu, Shu; Liu, Wenjia; Luo, Xueting; Wang, Fenghua; Sun, Xiaodong] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Ophthalmol, Sch Med, Shanghai, Peoples R China; [Wang, Lingyu] GloriousMed Technol Co Ltd, Shanghai, Peoples R China; [Liang, Jian; Luo, Xueting] Shanghai Key Lab Ocular Fundus Dis, Shanghai, Peoples R China; [Wang, Tianjun] Univ Liverpool, Sch Life Sci, Liverpool, Merseyside, England; [Zhai, Yuanqi; Wang, Fenghua; Sun, Xiaodong] Shanghai Engn Ctr Visual Sci & Photomed, Shanghai, Peoples R China	Shanghai Jiao Tong University; University of Liverpool	Luo, XT (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Shanghai Gen Hosp, Dept Ophthalmol,Sch Med,Shanghai Key Lab Fundus D, 100 Haining Rd, Shanghai 200080, Peoples R China.; Wang, FH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Shanghai Gen Hosp, Dept Ophthalmol,Sch Med,Shanghai Engn Ctr Visual, 100 Haining Rd, Shanghai 200080, Peoples R China.	xtluo@sjtu.edu.cn; shretina@sjtu.edu.cn	Wang, Lingyu/AAT-3381-2021	Wang, Lingyu/0000-0002-2736-7588	National Natural Science Foundation of China [817008280, 81470640]; National Key Research and Development Program of China [2017YFA0105300]; Program for Eastern Young Scholar at Shanghai Institutions of Higher Learning [QD2016003]; Shanghai Rising-Star Program [17QA1402800]; Science and Technology Commission of Shanghai Municipality [16411952900, 16dz2251500, 17140902800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Program for Eastern Young Scholar at Shanghai Institutions of Higher Learning; Shanghai Rising-Star Program; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by the National Natural Science Foundation of China (817008280 and 81470640), the National Key Research and Development Program of China (2017YFA0105300), the Program for Eastern Young Scholar at Shanghai Institutions of Higher Learning (QD2016003), the Shanghai Rising-Star Program (17QA1402800), and the Science and Technology Commission of Shanghai Municipality (16411952900, 16dz2251500, and 17140902800). The funding institutions played no role in the study design, data collection, data analysis, or preparation of this manuscript. The authors declare no conflicts of interest.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Ambade A, 2019, HEPATOLOGY, V69, P1105, DOI 10.1002/hep.30249; Ambati BK, 2007, BRIT J OPHTHALMOL, V91, P505, DOI 10.1136/bjo.2006.107417; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Andrews S., 2010, FASTQC QUALITY CONTR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahcecioglu IH, 2008, INFLAMMATION, V31, P215, DOI 10.1007/s10753-008-9067-1; Barikian A, 2015, AM J OPHTHALMOL, V159, P131, DOI 10.1016/j.ajo.2014.10.005; Branchini L, 2013, JAMA OPHTHALMOL, V131, P693, DOI 10.1001/jamaophthalmol.2013.692; Brar VS, 2010, MOL VIS, V16, P1848; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chakraborty D, 2016, INVEST OPHTH VIS SCI, V57, P787, DOI 10.1167/iovs.15-18516; Chakravarthy U, 2013, OPHTHALMOLOGY, V120, P1719; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Chen M, 2015, J LEUKOCYTE BIOL, V98, P713, DOI 10.1189/jlb.3RI0615-239R; Constable IJ, 2017, AM J OPHTHALMOL, V177, P150, DOI 10.1016/j.ajo.2017.02.018; Constable IJ, 2016, EBIOMEDICINE, V14, P168, DOI 10.1016/j.ebiom.2016.11.016; Daniel E, 2014, OPHTHALMOLOGY, V121, P656, DOI 10.1016/j.ophtha.2013.10.019; Datta P, 2015, P NATL ACAD SCI USA, V112, pE4400, DOI 10.1073/pnas.1510111112; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Feiner L, 2006, RETINA-J RET VIT DIS, V26, P882, DOI 10.1097/01.iae.0000230717.85319.f5; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Foxton R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.110; Foxton RH, 2013, AM J PATHOL, V182, P1379, DOI 10.1016/j.ajpath.2012.12.032; Fu YL, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.605774; Gan L, 2018, MOL CELL BIOCHEM, V441, P191, DOI 10.1007/s11010-017-3185-8; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Gomes E, 2007, MOL CELL BIOCHEM, V305, P179, DOI 10.1007/s11010-007-9542-2; Grunwald JE, 2017, OPHTHALMOLOGY, V124, P97, DOI 10.1016/j.ophtha.2016.09.012; GUERRIN M, 1995, J CELL PHYSIOL, V164, P385, DOI 10.1002/jcp.1041640219; Januschowski K, 2014, ACTA OPHTHALMOL, V92, pe305, DOI 10.1111/aos.12300; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Joachim SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182407; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kohen MC, 2018, MOL VIS, V24, P239; Kothary PC, 2010, ADV EXP MED BIOL, V664, P419, DOI 10.1007/978-1-4419-1399-9_48; Kuiper EJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1457, DOI 10.1001/archopht.124.10.1457; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Lai CM, 2012, GENE THER, V19, P999, DOI 10.1038/gt.2011.169; Lai CM, 2009, INVEST OPHTH VIS SCI, V50, P4279, DOI 10.1167/iovs.08-3253; Lai CM, 2005, MOL THER, V12, P659, DOI 10.1016/j.ymthe.2005.04.022; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li XX, 2014, OPHTHALMOLOGY, V121, P1740, DOI 10.1016/j.ophtha.2014.03.026; Liu ZC, 2018, EXP THER MED, V16, P3903, DOI 10.3892/etm.2018.6715; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Luo L, 2013, ELIFE, V2, DOI 10.7554/eLife.00324; Luo XT, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.032060; Manzano RPA, 2006, RETINA-J RET VIT DIS, V26, P257, DOI 10.1097/00006982-200603000-00001; Murakami Y, 2010, HUM GENE THER, V21, P199, DOI 10.1089/hum.2009.102; Myers AC, 2012, CURR EYE RES, V37, P399, DOI 10.3109/02713683.2011.611609; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Onishi A, 2010, P NATL ACAD SCI USA, V107, P11579, DOI 10.1073/pnas.1000102107; Palmhof M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061636; Rakoczy EP, 2015, LANCET, V386, P2395, DOI 10.1016/S0140-6736(15)00345-1; Renninger SL, 2011, EUR J NEUROSCI, V33, P658, DOI 10.1111/j.1460-9568.2010.07574.x; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Romano MR, 2012, BRAIN RES, V1478, P55, DOI 10.1016/j.brainres.2012.08.014; Rosenfeld PJ, 2011, OPHTHALMOLOGY, V118, P523, DOI 10.1016/j.ophtha.2010.07.011; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Shahar J, 2006, RETINA-J RET VIT DIS, V26, P262, DOI 10.1097/00006982-200603000-00002; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Takehana Y, 1999, INVEST OPHTH VIS SCI, V40, P459; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thulliez M, 2018, JAMA OPHTHALMOL, V136, P557, DOI 10.1001/jamaophthalmol.2018.0002; Tolosa L, 2008, J NEUROCHEM, V105, P1080, DOI 10.1111/j.1471-4159.2007.05206.x; Wei QL, 2017, INVEST OPHTH VIS SCI, V58, P5775, DOI 10.1167/iovs.17-22345; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yodoi Y, 2009, AM J OPHTHALMOL, V147, P816, DOI 10.1016/j.ajo.2008.11.020; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuzawa M, 2015, OPHTHALMOLOGY, V122, P571, DOI 10.1016/j.ophtha.2014.09.024; Zhang Q, 2016, BRIT J OPHTHALMOL, V100, P1443, DOI 10.1136/bjophthalmol-2015-308199	83	4	4	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13920	13934		10.1096/fj.201901283RR	http://dx.doi.org/10.1096/fj.201901283RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31648566	Bronze			2022-12-28	WOS:000507466100067
J	Wang, BB; Li, Y; Sui, M; Qi, QQ; Wang, T; Liu, D; Zhou, ML; Zheng, YJ; Zhu, LQ; Zhang, B				Wang, Beibei; Li, Yang; Sui, Ming; Qi, Qinqin; Wang, Ting; Liu, Dan; Zhou, Meiling; Zheng, Yunjie; Zhu, Ling-Qiang; Zhang, Bin			Identification of the downstream molecules of agrin/Dok-7 signaling in muscle	FASEB JOURNAL			English	Article						Anxa3; CRISPR; Cas9; neuromuscular junction; phosphoproteomics	NEUROMUSCULAR-JUNCTION FORMATION; ACETYLCHOLINE-RECEPTOR; BETA-SUBUNIT; SYNAPSE FORMATION; GENE-EXPRESSION; NITRIC-OXIDE; ANNEXIN A3; AGRIN; PROTEIN; TARGET	The development of the neuromuscular junction depends on signaling processes that involve protein phosphorylation. Motor neuron releases agrin to activate muscle protein Dok-7, a key tyrosine kinase essential for the formation of a mature and functional neuromuscular junction. However, the signaling cascade downstream of Dok-7 remains poorly understood. In this study, we combined the clustered regularly interspaced short palindromic repeats/Cas9 technique and quantitative phosphoproteomics analysis to study the tyrosine phosphorylation events triggered by agrin/Dok-7. We found tyrosine phosphorylation level of 36 proteins increased specifically by agrin stimulation. In Dok-7 mutant myotubes, however, 13 of the 36 proteins failed to be enhanced by agrin stimulation, suggesting that these 13 proteins are Dok-7-dependent tyrosine-phosphorylated proteins, could work as downstream molecules of agrin/Dok-7 signaling. We validated one of the proteins, Anxa3, by in vitro and in vivo assays. Knocking down of Anxa3 in the cultured myotubes inhibited agrin-induced AChR clustering, whereas reduction of Anxa3 in mouse muscles induced abnormal postsynaptic development. Collectively, our phosphoproteomics analysis provides novel insights into the complicated signaling network downstream of agrin/Dok-7.	[Wang, Beibei; Li, Yang; Sui, Ming; Qi, Qinqin; Wang, Ting; Liu, Dan; Zhou, Meiling; Zheng, Yunjie; Zhang, Bin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Physiol, Sch Basic Med, Wuhan 430030, Peoples R China; [Wang, Beibei; Li, Yang; Sui, Ming; Qi, Qinqin; Wang, Ting; Liu, Dan; Zhou, Meiling; Zhu, Ling-Qiang; Zhang, Bin] Huazhong Univ Sci & Technol, Collaborat Innovat Ctr Brain Sci, Inst Brain Res, Wuhan, Peoples R China; [Zhu, Ling-Qiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Sch Basic Med, Wuhan, Peoples R China; [Zhang, Bin] Huazhong Univ Sci & Technol, Hubei Key Lab Drug Target Res & Pharmacodynam Ev, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Physiol, Sch Basic Med, Wuhan 430030, Peoples R China.	binzhang@hust.edu.cn	Zhang, Bin/ABD-9523-2020	Zhang, Bin/0000-0003-1323-8678; Wang, Beibei/0000-0001-5887-4286	National Natural Science Foundation of China (NSFC) [81471283]; Fundamental Research Funds for the Central Universities [HUST: 2015QT007]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81471283; Fundamental Research Funds for the Central Universities, Grant/Award Number: HUST: 2015QT007	Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Bauche S, 2016, AM J HUM GENET, V99, P753, DOI 10.1016/j.ajhg.2016.06.033; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; BLOCH RJ, 1989, EXP CELL RES, V182, P583, DOI 10.1016/0014-4827(89)90261-9; Bloch RJ, 1997, SOC GEN PHY, V52, P177; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Cartaud A, 2011, BIOL CELL, V103, P287, DOI 10.1042/BC20110018; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Darabid H, 2014, NAT REV NEUROSCI, V15, P703, DOI 10.1038/nrn3821; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Defour A, 2017, HUM MOL GENET, V26, P1979, DOI 10.1093/hmg/ddx065; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dobbins GC, 2006, J MOL NEUROSCI, V30, P115, DOI 10.1385/JMN:30:1:115; Du RK, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0143-z; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Godfrey EW, 2007, DEV BIOL, V307, P195, DOI 10.1016/j.ydbio.2007.04.021; Godfrey EW, 2010, EXP CELL RES, V316, P1935, DOI 10.1016/j.yexcr.2010.03.016; Grewal T, 2016, BIOL CHEM, V397, P1031, DOI 10.1515/hsz-2016-0168; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jones MA, 2004, MOL CELL NEUROSCI, V25, P195, DOI 10.1016/j.mcn.2003.10.013; Jones MA, 2000, MOL CELL NEUROSCI, V16, P649, DOI 10.1006/mcne.2000.0901; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kollerrmann J, 2008, EUR UROL, V54, P1314, DOI 10.1016/j.eururo.2008.01.001; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Li L, 2018, ANNU REV PHYSIOL, V80, P159, DOI 10.1146/annurev-physiol-022516-034255; Lin H, 2008, J AM SOC NEPHROL, V19, P339, DOI 10.1681/ASN.2007050550; Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Luo SW, 2008, NEURON, V60, P97, DOI 10.1016/j.neuron.2008.08.013; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RODERICK TH, 1974, GENETICS, V76, P109; Rudell JB, 2013, DEV NEUROBIOL, V73, P399, DOI 10.1002/dneu.22070; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Schmidt N, 2012, J CELL BIOL, V198, P421, DOI 10.1083/jcb.201111130; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sun CJ, 2013, PROTEOMICS, V13, P3523, DOI 10.1002/pmic.201300286; Swaggart KA, 2014, P NATL ACAD SCI USA, V111, P6004, DOI 10.1073/pnas.1324242111; Tong M, 2015, STEM CELL REP, V5, P45, DOI 10.1016/j.stemcr.2015.05.013; van der Mijn JC, 2015, J PROTEOMICS, V127, P259, DOI 10.1016/j.jprot.2015.04.006; Vidaki M, 2017, NEURON, V95, P608, DOI 10.1016/j.neuron.2017.06.048; WALKER JH, 1984, EMBO J, V3, P2287, DOI 10.1002/j.1460-2075.1984.tb02127.x; Wang Q, 2006, J MOL NEUROSCI, V30, P223, DOI 10.1385/JMN:30:1:223; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Wu N, 2013, CLIN TRANSL ONCOL, V15, P106, DOI 10.1007/s12094-012-0928-6; Xing GL, 2019, ELIFE, V8, DOI 10.7554/eLife.49180; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zhu D, 2008, J NEUROSCI, V28, P1688, DOI 10.1523/JNEUROSCI.4130-07.2008; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	75	1	1	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5144	5161		10.1096/fj.201901693RR	http://dx.doi.org/10.1096/fj.201901693RR		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32043676				2022-12-28	WOS:000512670500001
J	Sun, Y; Geng, MY; Yuan, YM; Guo, PL; Chen, YC; Yang, D; Petersen, RB; Huang, K; Zheng, L				Sun, Yu; Geng, Mengyuan; Yuan, Yangmian; Guo, Peilian; Chen, Yuchen; Yang, Dong; Petersen, Robert B.; Huang, Kun; Zheng, Ling			Lmo4-resistin signaling contributes to adipose tissue-liver crosstalk upon weight cycling	FASEB JOURNAL			English	Article						adipose tissue-liver crosstalk; diet-induced weight cycling; hepatic inflammation; Lmo4; resistin	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INSULIN-RESISTANCE; GENE-EXPRESSION; LIM DOMAIN; RISK; GLUCOSE; PATHWAY; INFLAMMATION; HOMEOSTASIS; METABOLISM	Repeated cycles of weight loss and regain, known as weight cycling, is often seen when people try to lose weight. The exact pathophysiological effects and the underlying mechanisms of weight cycling remain largely unclear. Here, we report that weight cycling induced by alternating feeding mice with a low-fat diet or a high-fat diet in a 1-week switch protocol caused further increased epididymal white adipose tissue (eWAT) weight, preadipocyte proliferation, hepatic inflammation, fasting blood glucose level, and glucose intolerance, compared with the continuously HF-fed mice. Combining the secretory protein database with RNA-sequencing and quantitative PCR (qPCR) results in eWAT, the mRNA levels of several adipokines, including Retn (encoding resistin), were found altered by weight cycling. A transcriptional co-factor Lmo4 was found regulated by weight cycling; Lmo4 enhanced preadipocyte proliferation, in vitro adipogenesis, transcription of Retn, and resistin secretion in 3T3-L1 cells. Primary mouse hepatocytes administrated with recombinant mouse resistin (rm-resistin), or exposed to media from Lmo4-overexpressed 3T3-L1 cells, showed increased inflammatory responses and gluconeogenesis. Furthermore, rm-resistin-injected normal chow-fed mice showed upregulated blood glucose level by increasing gluconeogenesis, and upregulated the hepatic inflammatory responses. Together, our results suggest a regulatory role of Lmo4-resistin signaling in weight cycling, indicating a crosstalk between the adipose tissue and liver.	[Sun, Yu; Geng, Mengyuan; Yuan, Yangmian; Guo, Peilian; Zheng, Ling] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China; [Chen, Yuchen; Yang, Dong; Huang, Kun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Sch Pharm, Wuhan 430030, Peoples R China; [Petersen, Robert B.] Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA; [Zheng, Ling] Wuhan Univ, Frontier Sci Ctr Immunol & Metab, Wuhan, Peoples R China	Wuhan University; Huazhong University of Science & Technology; Central Michigan University; Wuhan University	Zheng, L (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China.; Huang, K (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Sch Pharm, Wuhan 430030, Peoples R China.	kunhuang@hust.edu.cn; lzheng@whu.edu.cn		Zheng, Ling/0000-0002-6545-4180	National Natural Science Foundation of China (NSFC) [91957114, 31871381, 31971066]; National Key Research and Development Program of China [2018YFA0800700, 2019YFA0802701]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 91957114, 31871381 & 31971066; National Key Research and Development Program of China, Grant/Award Number: 2018YFA0800700 & 2019YFA0802701	Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; BLACKBURN GL, 1989, AM J CLIN NUTR, V49, P1105, DOI 10.1093/ajcn/49.5.1105; Cai RQ, 2015, FASEB J, V29, P2749, DOI 10.1096/fj.14-265801; Chen H, 2017, J AM SOC NEPHROL, V28, P2695, DOI 10.1681/ASN.2016111210; Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040; Chikamoto K, 2016, BIOCHEM BIOPH RES CO, V478, P1310, DOI 10.1016/j.bbrc.2016.08.117; Cho Youngjin, 2011, J Am Coll Cardiol, V57, P99, DOI 10.1016/j.jacc.2010.07.035; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Dankel SN, 2014, AM J PHYSIOL-ENDOC M, V306, pE210, DOI 10.1152/ajpendo.00188.2013; Delahanty LM, 2014, DIABETES CARE, V37, P2738, DOI 10.2337/dc14-0018; Ding Y, 2014, INT J OBESITY, V38, P198, DOI 10.1038/ijo.2013.98; Feve B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62; Haczeyni F, 2018, OBES REV, V19, P406, DOI 10.1111/obr.12646; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Jiao XM, 2014, EUR REV MED PHARMACO, V18, P2025; Kim KH, 2017, CELL RES, V27, P1309, DOI 10.1038/cr.2017.126; Koch CE, 2014, J NEUROENDOCRINOL, V26, P58, DOI 10.1111/jne.12131; Li GL, 2017, CELL METAB, V26, P672, DOI 10.1016/j.cmet.2017.08.019; Li J, 2012, J HEPATOL, V56, P900, DOI 10.1016/j.jhep.2011.10.018; Linden MA, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12071; Liu CY, 2020, DIABETES, V69, P35, DOI 10.2337/db19-0502; Liu SS, 2017, HEPATOLOGY, V66, P631, DOI 10.1002/hep.29202; Liu XR, 2014, CANCER RES, V74, P6623, DOI 10.1158/0008-5472.CAN-14-1279; Maher JJ, 2001, SEMIN LIVER DIS, V21, P417, DOI 10.1055/s-2001-17555; Maiorana Arianna, 2007, Rev Diabet Stud, V4, P134, DOI 10.1900/RDS.2007.4.134; Menegaut L, 2017, CURR OPIN LIPIDOL, V28, P19, DOI 10.1097/MOL.0000000000000370; Menon SS, 2019, CLIN CHIM ACTA, V491, P39, DOI 10.1016/j.cca.2019.01.011; Montani JP, 2015, OBES REV, V16, P7, DOI 10.1111/obr.12251; Mousses S, 2002, CANCER RES, V62, P1256; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Muse ED, 2007, J CLIN INVEST, V117, P1670, DOI 10.1172/JCI30440; Peppler WT, 2019, AM J PHYSIOL-GASTR L, V316, pG166, DOI 10.1152/ajpgi.00097.2018; Rabbitts TH, 1999, CANCER RES, V59, p1798S; Reilly SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7047; Rhee EJ, 2018, DIABETES RES CLIN PR, V139, P230, DOI 10.1016/j.diabres.2018.03.018; Rodriguez-Pacheco F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/479739; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Schofield S, 2017, INT J OBESITY, V41, P402, DOI 10.1038/ijo.2016.193; Schroeder M, 2018, MOL METAB, V9, P176, DOI 10.1016/j.molmet.2018.01.015; Serbulea V, 2018, P NATL ACAD SCI USA, V115, pE6254, DOI 10.1073/pnas.1800544115; Simonds SE, 2018, PHYSIOL BEHAV, V194, P184, DOI 10.1016/j.physbeh.2018.05.026; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Syngal S, 1999, ANN INTERN MED, V130, P471, DOI 10.7326/0003-4819-130-6-199903160-00003; Taniwaki M, 2006, INT J ONCOL, V29, P567; Tsai CJ, 2006, ARCH INTERN MED, V166, P2369, DOI 10.1001/archinte.166.21.2369; Vergnaud AC, 2008, INT J OBESITY, V32, P315, DOI 10.1038/sj.ijo.0803739; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wan DY, 2017, J MOL CELL BIOL, V9, P325, DOI 10.1093/jmcb/mjx027; Wang WJ, 2017, AUTOPHAGY, V13, P941, DOI 10.1080/15548627.2017.1293768; Xu Y, 2017, ONCOTARGET, V8; Yang JL, 2011, CANCER-AM CANCER SOC, V117, P4925, DOI 10.1002/cncr.26116; Yang Y, 2009, BIOMED PHARMACOTHER, V63, P366, DOI 10.1016/j.biopha.2008.06.033; Ying CJ, 2016, ENDOCRINE, V53, P81, DOI 10.1007/s12020-016-0867-z; Yu J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-93; Zhang Y, 2020, CELL DEATH DIFFER, V27, P1243, DOI 10.1038/s41418-019-0412-8; Zhang Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02355-w; Zhao SG, 2019, CELL METAB, V30, P706, DOI 10.1016/j.cmet.2019.08.005	60	11	12	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4732	4748		10.1096/fj.201902708R	http://dx.doi.org/10.1096/fj.201902708R		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030835	Bronze			2022-12-28	WOS:000512334000001
J	Yin, JL; Tu, G; Peng, MX; Zeng, H; Wan, XY; Qiao, YN; Qin, YL; Liu, MR; Luo, HJ				Yin, Jiali; Tu, Gang; Peng, Meixi; Zeng, Huan; Wan, Xueying; Qiao, Yina; Qin, Yilu; Liu, Manran; Luo, Haojun			GPER-regulated lncRNA-Glu promotes glutamate secretion to enhance cellular invasion and metastasis in triple-negative breast cancer	FASEB JOURNAL			English	Article						G protein-coupled estrogen receptor; glutamate N-methyl-D-aspartate receptor; glutamate signaling; triple-negative breast cancer	LONG NONCODING RNAS; TUMOR-GROWTH; ESTROGEN; RECEPTOR; CELLS; TUMORIGENESIS; TRANSLOCATION; INVASIVENESS; ACTIVATION; EXPRESSION	Triple-negative breast cancer (TNBC) is a group of breast cancer with heterogeneity and poor prognosis and effective therapeutic targets are not available currently. TNBC has been recognized as estrogen-independent breast cancer, while the novel estrogen receptor, namely G protein-coupled estrogen receptor (GPER), was claimed to mediate estrogenic actions in TNBC tissues and cell lines. Through mRNA microarrays, lncRNA microarrays, and bioinformatics analysis, we found that GPER is activated by 17 beta-estradiol (E2) and GPER-specific agonist G1, which downregulates a novel lncRNA (termed as lncRNA-Glu). LncRNA-Glu can inhibit glutamate transport activity and transcriptional activity of its target gene VGLUT2 via specific binding. GPER-mediated reduction of lncRNA-Glu promotes glutamate transport activity and transcriptional activity of VGLUT2. Furthermore, GPER-mediated activation of cAMP-PKA signaling contributes to glutamate secretion. LncRNA-Glu-VGLUT2 signaling synergizes with cAMP-PKA signaling to increase autologous glutamate secretion in TNBC cells, which activates glutamate N-methyl-D-aspartate receptor (NMDAR) and its downstream CaMK and MEK-MAPK pathways, thus enhancing cellular invasion and metastasis in vitro and in vivo. Our data provide new insights into GPER-mediated glutamate secretion and its downstream signaling NMDAR-CaMK/MEK-MAPK during TNBC invasion. The mechanisms we discovered may provide new targets for clinical therapy of TNBC.	[Yin, Jiali; Peng, Meixi; Zeng, Huan; Wan, Xueying; Qiao, Yina; Qin, Yilu; Liu, Manran] Chongqing Med Univ, Key Lab Lab Med Diagnost, Chinese Minist Educ, 1 Yi Xue Yuan Rd, Chongqing 400016, Peoples R China; [Tu, Gang] Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing, Peoples R China; [Luo, Haojun] Chongqing Med Univ, Dept Thyroid & Breast Surg, Affiliated Hosp 2, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Liu, MR (corresponding author), Chongqing Med Univ, Key Lab Lab Med Diagnost, Chinese Minist Educ, 1 Yi Xue Yuan Rd, Chongqing 400016, Peoples R China.; Luo, HJ (corresponding author), Chongqing Med Univ, Dept Thyroid & Breast Surg, Affiliated Hosp 2, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China.	manranliu@cqmu.edu.cn; luohaojun@hospital.cqmu.edu.cn			National Natural Science Foundation of China (NSFC) [NSFC 81402184, NSFC 81874199, NSFC 31671481]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: NSFC 81402184, NSFC 81874199 and NSFC 31671481	Blesson CS, 2012, MOL CELL ENDOCRINOL, V361, P179, DOI 10.1016/j.mce.2012.04.006; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Cao Y, 2017, THERANOSTICS, V7, P3021, DOI 10.7150/thno.18992; Chen ZJ, 2016, MOL ONCOL, V10, P775, DOI 10.1016/j.molonc.2016.01.002; Denkert C, 2017, LANCET, V389, P2430, DOI 10.1016/S0140-6736(16)32454-0; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; Dornier E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02101-2; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Han BC, 2018, ONCOGENE, V37, P1399, DOI 10.1038/s41388-017-0021-2; Herrero I, 1996, J BIOL CHEM, V271, P30554, DOI 10.1074/jbc.271.48.30554; Iriondo O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04460-w; Jiang YZ, 2019, CANCER CELL, V35, P428, DOI 10.1016/j.ccell.2019.02.001; Jonsson P, 2015, MOL ENDOCRINOL, V29, P1634, DOI 10.1210/me.2015-1153; Jorgensen EM, 2016, FASEB J, V30, P3194, DOI 10.1096/fj.201500089R; KUMAR MS, 1979, CANCER RES, V39, P3515; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; Lappano R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00066; Li L, 2018, CANCER CELL, V33, P736, DOI 10.1016/j.ccell.2018.02.011; Li L, 2013, CELL, V153, P86, DOI 10.1016/j.cell.2013.02.051; Luo HJ, 2011, J BREAST CANCER, V14, P185, DOI 10.4048/jbc.2011.14.3.185; Marjon NA, 2014, MOL CANCER RES, V12, P1644, DOI 10.1158/1541-7786.MCR-14-0128-T; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P113, DOI 10.1038/nrclinonc.2017.1; Otters S, 2016, TRENDS ENDOCRIN MET, V27, P177, DOI 10.1016/j.tem.2015.12.004; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Prossnitz ER, 2009, PROSTAG OTH LIPID M, V89, P89, DOI 10.1016/j.prostaglandins.2009.05.001; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P1, DOI 10.1016/j.mce.2009.04.005; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rigiracciolo D, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1056-8; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; TANAKA S, 1989, CELL, V57, P675, DOI 10.1016/0092-8674(89)90136-0; Vivacqua A, 2012, BREAST CANCER RES TR, V133, P1025, DOI 10.1007/s10549-011-1901-8; Wu LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31716; Xiao B, 2019, MOL CARCINOGEN, V58, P1314, DOI 10.1002/mc.23014; Xu FY, 2017, ENVIRON POLLUT, V231, P1609, DOI 10.1016/j.envpol.2017.09.069; Yam C, 2017, ONCOLOGIST, V22, P1086, DOI 10.1634/theoncologist.2017-0095; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yu LMJ, 2017, NEUROPHARMACOLOGY, V115, P193, DOI 10.1016/j.neuropharm.2016.02.011; Yu T, 2017, ONCOGENE, V36, P2131, DOI 10.1038/onc.2016.370; Yu TH, 2014, J STEROID BIOCHEM, V143, P392, DOI 10.1016/j.jsbmb.2014.05.003; Zeng QQ, 2019, NATURE, V573, P526, DOI 10.1038/s41586-019-1576-6; Zhang JW, 2018, HEPATOLOGY, V67, P171, DOI 10.1002/hep.29405; Zhou R, 2018, CANCER RES, V78, P5521, DOI 10.1158/0008-5472.CAN-17-3988	45	8	8	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4557	4572		10.1096/fj.201901384RR	http://dx.doi.org/10.1096/fj.201901384RR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030797	Bronze			2022-12-28	WOS:000512332500001
J	Dakup, PP; Porter, KI; Gajula, RP; Goel, PN; Cheng, ZK; Gaddameedhi, S				Dakup, Panshak P.; Porter, Kenneth I.; Gajula, Rajendra P.; Goel, Peeyush N.; Cheng, Zhaokang; Gaddameedhi, Shobhan			The circadian clock protects against ionizing radiation-induced cardiotoxicity	FASEB JOURNAL			English	Article						Bmal1; circadian clock; heart; radiation; toxicity	DNA-DAMAGE RESPONSE; CARDIOVASCULAR-DISEASE RISK; CONTRACTILE FUNCTION; GENE-EXPRESSION; HEART-DISEASE; CANCER-CELLS; METABOLISM; SENSITIVITY; REPAIR; CRYPTOCHROME	Radiation therapy (RT) is commonly used to treat solid tumors of the breast, lung, and esophagus; however, the heart is an unintentional target of ionizing radiation (IR). IR exposure to the heart results in chronic toxicities including heart failure. We hypothesize that the circadian system plays regulatory roles in minimizing the IR-induced cardiotoxicity. We treated mice in control (Day Shift), environmentally disrupted (Rotating Shift), and genetically disrupted (Per 1/2 mutant) circadian conditions with 18 Gy of IR to the heart. Compared to control mice, circadian clock disruption significantly exacerbated post-IR systolic dysfunction (by ultrasound echocardiography) and increased fibrosis in mice. At the cellular level, Bmal1 protein bound to Atm, Brca1, and Brca2 promoter regions and its expression level was inversely correlated with the DNA damage levels based on the state of the clock. Further studies with circadian synchronized cardiomyocytes revealed that Bmal1 depletion increased the IR-induced DNA damage and apoptosis. Collectively, these findings suggest that the circadian clock protects from IR-induced toxicity and potentially impacts RT treatment outcome in cancer patients through IR-induced DNA damage responses.	[Dakup, Panshak P.; Porter, Kenneth I.; Gajula, Rajendra P.; Goel, Peeyush N.; Cheng, Zhaokang; Gaddameedhi, Shobhan] Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Spokane, WA USA; [Gaddameedhi, Shobhan] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA; [Goel, Peeyush N.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Washington State University; Washington State University; University of Pennsylvania; Pennsylvania Medicine	Gaddameedhi, S (corresponding author), Washington State Univ, POB 1495, Spokane, WA 99210 USA.	shobhan.gaddameedhi@wsu.edu	Goel, Peeyush/AAA-6017-2019; Dakup, Panshak/AAR-6158-2020; GADDAMEEDHI, SHOBHAN/GZM-8298-2022; Porter, Kenneth/AAQ-5751-2020; Dakup, Panshak/AAQ-2090-2020	GADDAMEEDHI, SHOBHAN/0000-0002-4978-6951; Porter, Kenneth/0000-0003-3644-1011; Dakup, Panshak/0000-0003-3534-7744; Cheng, Zhaokang/0000-0002-9646-4824	HHS | NIH | National Cancer Institute (NCI) [CA227381]; American Heart Association (AHA) [19PRE34450077]	HHS | NIH | National Cancer Institute (NCI); American Heart Association (AHA)(American Heart Association)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: CA227381; American Heart Association (AHA), Grant/Award Number: 19PRE34450077	Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; Abbott DW, 1998, J NATL CANCER I, V90, P978, DOI 10.1093/jnci/90.13.978; Azimi R, 2012, MED PHYS, V39, P3766, DOI 10.1118/1.4735339; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Boekel NB, 2016, INT J RADIAT ONCOL, V94, P1061, DOI 10.1016/j.ijrobp.2015.11.040; Bray FN, 2016, DERMATOLOGY THER, V6, P185, DOI 10.1007/s13555-016-0120-y; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Chan S, 2017, ANN PALLIAT MED, V6, P14, DOI 10.21037/apm.2016.09.07; Cheng Z, 2014, J MOL CELL CARDIOL, V67, P1, DOI 10.1016/j.yjmcc.2013.12.002; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Dakup P, 2017, PHOTOCHEM PHOTOBIOL, V93, P296, DOI 10.1111/php.12662; Dakup Panshak P, 2018, Oncotarget, V9, P14524, DOI 10.18632/oncotarget.24539; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Gotoh T, 2015, MOL BIOL CELL, V26, P359, DOI 10.1091/mbc.E14-05-0994; Gu Q, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-253; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; IJIRI K, 1990, INT J RADIAT BIOL, V58, P165, DOI 10.1080/09553009014551521; Janko M, 2012, RADIAT RES, V178, P166, DOI 10.1667/RR3097.1; Ka NL, 2017, CANCER RES, V77, P2453, DOI 10.1158/0008-5472.CAN-16-2099; Kiessling S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0349-7; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Kohsaka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112811; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kumar V, 2017, NUCLEIC ACIDS RES, V45, P10595, DOI 10.1093/nar/gkx705; Kuznetsov AV, 2015, BBA-MOL CELL RES, V1853, P276, DOI 10.1016/j.bbamcr.2014.11.015; LAPPENBUSCH WL, 1972, RADIAT RES, V50, P600, DOI 10.2307/3573557; Latimer JJ, 2015, PHOTOCHEM PHOTOBIOL, V91, P493, DOI 10.1111/php.12387; Lee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002918; Martino TA, 2015, J BIOL RHYTHM, V30, P183, DOI 10.1177/0748730415575246; McMenamin TM, 2007, MON LABOR REV, P1; Mezzaroma E, 2012, INT J CARDIOL, V156, P231, DOI 10.1016/j.ijcard.2012.01.038; Montaigne D, 2018, LANCET, V391, P59, DOI 10.1016/S0140-6736(17)32132-3; Morris CJ, 2016, P NATL ACAD SCI USA, V113, pE1402, DOI 10.1073/pnas.1516953113; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Papp SJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04883; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Plikus MV, 2013, P NATL ACAD SCI USA, V110, pE2106, DOI 10.1073/pnas.1215935110; Puukila S, 2017, RADIAT RES, V188, P539, DOI 10.1667/RR14864.1; Ruben MD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat8806; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 2015, BIOCHEMISTRY-US, V54, P110, DOI 10.1021/bi5007354; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sulli G, 2018, NATURE, V553, P351, DOI 10.1038/nature25170; Tripathi K, 2015, ONCOTARGET, V6, P5237, DOI 10.18632/oncotarget.3026; Trump RP, 2013, J MED CHEM, V56, P4729, DOI 10.1021/jm400458q; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; Van Dycke KCG, 2015, CURR BIOL, V25, P1932, DOI 10.1016/j.cub.2015.06.012; Vetter C, 2016, JAMA-J AM MED ASSOC, V315, P1726, DOI 10.1001/jama.2016.4454; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Welch RD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17496-7; Xu HY, 2015, NAT STRUCT MOL BIOL, V22, P476, DOI 10.1038/nsmb.3018; Ye R, 2014, GENE DEV, V28, P1989, DOI 10.1101/gad.249417.114; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young ME, 2014, J BIOL RHYTHM, V29, P257, DOI 10.1177/0748730414543141; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	64	13	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3347	3358		10.1096/fj.201901850RR	http://dx.doi.org/10.1096/fj.201901850RR		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31919902	Green Accepted			2022-12-28	WOS:000506612100001
J	Jacobs, DT; Allard, BA; Pottorf, TS; Silva, LM; Wang, W; Al-Naamani, A; Agborbesong, E; Wang, T; Carr, DA; Tran, PV				Jacobs, Damon T.; Allard, Bailey A.; Pottorf, Tana S.; Silva, Luciane M.; Wang, Wei; Al-Naamani, Aisha; Agborbesong, Ewud; Wang, Tao; Carr, Dajanae A.; Tran, Pamela V.			Intraflagellar-transport A dysfunction causes hyperphagia-induced systemic insulin resistance in a pre-obese state	FASEB JOURNAL			English	Article						adipogenesis; liver; metabolism; mouse model; primary cilia	BIEDL SYNDROME PROTEINS; IFT-A COMPLEX; PRIMARY-CILIUM; OBESITY; DIFFERENTIATION; ADIPOGENESIS; BBSOME; TRAFFICKING; MUTATION; DISEASE	Deletion of murine Thm1, an intraflagellar transport A (IFT-A) component that mediates ciliary protein trafficking, causes hyperphagia, obesity, and metabolic syndrome. The role of Thm1 or IFT-A in adipogenesis and insulin sensitivity is unknown. Here, we report that Thm1 knockdown in 3T3-L1 pre-adipocytes promotes adipogenesis and enhances insulin sensitivity in vitro. Yet, pre-obese Thm1 conditional knockout mice show systemic insulin resistance. While insulin-induced AKT activation in Thm1 mutant adipose depots and skeletal muscle are similar to those of control littermates, an attenuated insulin response arises in the mutant liver. Insulin treatment of control and Thm1 mutant primary hepatocytes results in similar AKT activation. Moreover, pair-feeding Thm1 conditional knockout mice produces a normal insulin response, both in the liver and systemically. Thus, hyperphagia caused by a cilia defect, induces hepatic insulin resistance via a non-cell autonomous mechanism. In turn, hepatic insulin resistance drives systemic insulin resistance prior to an obese phenotype. These data demonstrate that insulin signaling across cell types is regulated differentially, and that the liver is particularly susceptible to hyperphagia-induced insulin resistance and a critical determinant of systemic insulin resistance.	[Jacobs, Damon T.; Allard, Bailey A.; Pottorf, Tana S.; Silva, Luciane M.; Wang, Wei; Al-Naamani, Aisha; Agborbesong, Ewud; Wang, Tao; Carr, Dajanae A.; Tran, Pamela V.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Jared Grantham Kidney Inst, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Tran, PV (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, 3901 Rainbow Blvd,MS 3038, Kansas City, KS 66160 USA.; Tran, PV (corresponding author), Univ Kansas, Med Ctr, Jared Grantham Kidney Inst, 3901 Rainbow Blvd,MS 3038, Kansas City, KS 66160 USA.	ptran@kumc.edu	Pottorf, Tana/AAP-2801-2021	Pottorf, Tana/0000-0001-9410-6110; Wang, Tao/0000-0003-4832-1148	Department of Education, GEAR-UP Washington Cluster [DED0068469]; HHS | National Institutes of Health (NIH) [P20GM103418, P30DK106912, R01DK103033, P30GM118247]	Department of Education, GEAR-UP Washington Cluster; HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Department of Education, GEAR-UP Washington Cluster, Grant/Award Number: DED0068469; HHS | National Institutes of Health (NIH), Grant/Award Number: P20GM103418, P30DK106912, R01DK103033 and P30GM118247	Benzinou M, 2006, DIABETES, V55, P2876, DOI 10.2337/db06-0337; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Dalbay MT, 2015, STEM CELLS, V33, P1952, DOI 10.1002/stem.1975; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Forcioli-Conti N, 2015, BIOCHEM BIOPH RES CO, V458, P117, DOI 10.1016/j.bbrc.2015.01.078; Fu WX, 2016, CELL REP, V17, P1505, DOI 10.1016/j.celrep.2016.10.018; Gerdes JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6308; Girard D, 2011, NAT REV ENDOCRINOL, V7, P77, DOI 10.1038/nrendo.2010.210; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guo DF, 2011, TRENDS ENDOCRIN MET, V22, P286, DOI 10.1016/j.tem.2011.02.009; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huang-Doran I, 2010, INT J OBESITY, V34, P1554, DOI 10.1038/ijo.2010.92; Jacobs DT, 2016, DIS MODEL MECH, V9, P789, DOI 10.1242/dmm.025791; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim SP, 2003, DIABETES, V52, P2453, DOI 10.2337/diabetes.52.10.2453; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Machado MV, 2018, J HEPATOL, V68, P550, DOI 10.1016/j.jhep.2017.10.017; Marion V, 2012, CELL METAB, V16, P363, DOI 10.1016/j.cmet.2012.08.005; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Melvin A, 2018, CURR OPIN GENET DEV, V50, P60, DOI 10.1016/j.gde.2018.02.002; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Ni HM, 2016, J HEPATOL, V65, P354, DOI 10.1016/j.jhep.2016.04.025; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qiu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015240; Ritter A, 2018, STEM CELL REP, V10, P583, DOI 10.1016/j.stemcr.2017.12.022; Scheidecker S, 2014, J MED GENET, V51, P132, DOI 10.1136/jmedgenet-2013-101785; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Starks RD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005311; Stephens JM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001436; Su XF, 2014, HUM MOL GENET, V23, P5441, DOI 10.1093/hmg/ddu267; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Xu QW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11855; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	41	1	1	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					148	160		10.1096/fj.201900751R	http://dx.doi.org/10.1096/fj.201900751R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914634	Green Accepted			2022-12-28	WOS:000507308900012
J	Jang, HJ; Lim, S; Kim, JM; Yoon, S; Lee, CY; Hwang, HJ; Shin, JW; Shin, KJ; Kim, HY; Park, KI; Nam, D; Lee, JY; Yea, K; Hirabayashi, Y; Lee, YJ; Chae, YC; Suh, PG; Choi, JH				Jang, Hyun-Jun; Lim, Seyoung; Kim, Jung-Min; Yoon, Sora; Lee, Chae Young; Hwang, Hyeon-Jeong; Shin, Jeong Woo; Shin, Kyeong Jin; Kim, Hye Yun; Park, Kwang Il; Nam, Dougu; Lee, Ja Yil; Yea, Kyungmoo; Hirabayashi, Yoshio; Lee, Yu Jin; Chae, Young Chan; Suh, Pann-Ghill; Choi, Jang Hyun			Glucosylceramide synthase regulates adipo-osteogenic differentiation through synergistic activation of PPAR gamma with GlcCer	FASEB JOURNAL			English	Article						adipogenesis; glucosylceramide; glucosylceramide synthase; mesenchymal stem cells; osteogenesis; PDMP; peroxisome proliferator-activated receptor gamma	GAUCHER-DISEASE; FATE DECISION; CELLS; INHIBITION; METABOLISM; OSTEOBLAST; CERAMIDE; MARKERS; MOUSE	Dysregulation of the adipo-osteogenic differentiation balance of mesenchymal stem cells (MSCs), which are common progenitor cells of adipocytes and osteoblasts, has been associated with many pathophysiologic diseases, such as obesity, osteopenia, and osteoporosis. Growing evidence suggests that lipid metabolism is crucial for maintaining stem cell homeostasis and cell differentiation; however, the detailed underlying mechanisms are largely unknown. Here, we demonstrate that glucosylceramide (GlcCer) and its synthase, glucosylceramide synthase (GCS), are key determinants of MSC differentiation into adipocytes or osteoblasts. GCS expression was increased during adipogenesis and decreased during osteogenesis. Targeting GCS using RNA interference or a chemical inhibitor enhanced osteogenesis and inhibited adipogenesis by controlling the transcriptional activity of peroxisome proliferator-activated receptor gamma (PPAR gamma). Treatment with GlcCer sufficiently rescued adipogenesis and inhibited osteogenesis in GCS knockdown MSCs. Mechanistically, GlcCer interacted directly with PPAR gamma through A/B domain and synergistically enhanced rosiglitazone-induced PPAR gamma activation without changing PPAR gamma expression, thereby treatment with exogenous GlcCer increased adipogenesis and inhibited osteogenesis. Animal studies demonstrated that inhibiting GCS reduced adipocyte formation in white adipose tissues under normal chow diet and high-fat diet feeding and accelerated bone repair in a calvarial defect model. Taken together, our findings identify a novel lipid metabolic regulator for the control of MSC differentiation and may have important therapeutic implications.	[Jang, Hyun-Jun; Lim, Seyoung; Kim, Jung-Min; Yoon, Sora; Lee, Chae Young; Hwang, Hyeon-Jeong; Shin, Jeong Woo; Shin, Kyeong Jin; Kim, Hye Yun; Nam, Dougu; Lee, Ja Yil; Lee, Yu Jin; Chae, Young Chan; Suh, Pann-Ghill; Choi, Jang Hyun] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [Park, Kwang Il] Korea Inst Oriental Med, Korean Med KM Applicat Ctr, Daegu, South Korea; [Yea, Kyungmoo] DGIST, Dept New Biol, Daegu, South Korea; [Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Hirabayashi Res Unit, Wako, Saitama, Japan	Ulsan National Institute of Science & Technology (UNIST); Korea Institute of Oriental Medicine (KIOM); Daegu Gyeongbuk Institute of Science & Technology (DGIST); RIKEN	Suh, PG; Choi, JH (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea.	pgsuh@unist.ac.kr; janghchoi@unist.ac.kr	Kim, Jung Min/AAL-8604-2021; Nam, Dougu/AAC-7173-2019; Nam, Dougu/F-5057-2010	Kim, Jung Min/0000-0002-9072-4293; Nam, Dougu/0000-0003-0239-2899; Yoon, Sora/0000-0002-0107-0057; Hirabayashi, Yoshio/0000-0002-5774-7354	Korea Mouse Phenotyping Project [2016M3A9D5A01952411]; Ministry of Science and ICT through the National Research Foundation (NRF); Bio AMP; Medical Technology Development Program of the NRF [2014M3A9D8034459, 2017R1A2B2007378]	Korea Mouse Phenotyping Project; Ministry of Science and ICT through the National Research Foundation (NRF); Bio AMP; Medical Technology Development Program of the NRF	This work was supported by Korea Mouse Phenotyping Project (NO. 2016M3A9D5A01952411) of the Ministry of Science and ICT through the National Research Foundation (NRF) and Bio & Medical Technology Development Program of the NRF (NO. 2014M3A9D8034459, 2017R1A2B2007378).	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Bergante S, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/4706943; Bergante S, 2014, J LIPID RES, V55, P549, DOI 10.1194/jlr.M046672; Bondar C, 2017, BONE, V103, P262, DOI 10.1016/j.bone.2017.07.020; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Choi JS, 2015, CELL SIGNAL, V27, P614, DOI 10.1016/j.cellsig.2014.11.035; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Deegan PB, 2011, MEDICINE, V90, P52, DOI 10.1097/MD.0b013e3182057be4; Elstein D, 2004, J INHERIT METAB DIS, V27, P757, DOI 10.1023/B:BOLI.0000045756.54006.17; Ersek A, 2015, J CLIN INVEST, V125, P2279, DOI 10.1172/JCI59987; Ficicioglu Can, 2008, Ther Clin Risk Manag, V4, P425; Futerman AH, 2017, MOL GENET METAB, V120, P22, DOI 10.1016/j.ymgme.2016.11.390; Ge CX, 2016, J CELL PHYSIOL, V231, P587, DOI 10.1002/jcp.25102; Goker-Alpan O, 2011, MOL GENET METAB, V104, P438, DOI 10.1016/j.ymgme.2011.08.004; Hagberg CE, 2018, CELL REP, V24, P2746, DOI 10.1016/j.celrep.2018.08.006; Hu LF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020360; Kim JM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2313; Kohyama-Koganeya A, 2011, J LIPID RES, V52, P1392, DOI 10.1194/jlr.M014266; Lacava G, 2019, J CELL PHYSIOL, V234, P16338, DOI 10.1002/jcp.28299; Lee SY, 2017, DIABETES, V66, P2596, DOI 10.2337/db16-1232; Levental KR, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1193; Li CJ, 2015, J CLIN INVEST, V125, P1509, DOI 10.1172/JCI77716; Lim S, 2012, J CELL BIOCHEM, V113, P3436, DOI 10.1002/jcb.24220; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1124/jpet.106.104950; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; Marycz K, 2015, CELL MOL BIOL LETT, V20, P510, DOI 10.1515/cmble-2015-0029; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mikosch P, 2011, BEST PRACT RES CL RH, V25, P665, DOI 10.1016/j.berh.2011.10.015; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Norris-Cervetto E, 2004, J BIOL CHEM, V279, P40412, DOI 10.1074/jbc.M404466200; Nuttall ME, 2014, CALCIFIED TISSUE INT, V94, P78, DOI 10.1007/s00223-013-9807-6; Ogretmen B, 2001, J BIOL CHEM, V276, P24901, DOI 10.1074/jbc.M100314200; Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325; Picke AK, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6806; Rocca-Serra P, 2003, CR BIOL, V326, P1075, DOI 10.1016/j.crvi.2003.09.026; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; STOWENS DW, 1985, MEDICINE, V64, P310, DOI 10.1097/00005792-198509000-00003; van Dussen L, 2011, J CLIN ENDOCR METAB, V96, P2194, DOI 10.1210/jc.2011-0162; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; van Zoelen EJ, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0375-3; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328; Zhu HH, 2015, GENE DEV, V29, P1218, DOI 10.1101/gad.263483.115	45	6	6	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1270	1287		10.1096/fj.201901437R	http://dx.doi.org/10.1096/fj.201901437R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914593				2022-12-28	WOS:000507308900085
J	Kl'uckova, K; Thakker, A; Vettore, L; Escribano-Gonzalez, C; Hindshaw, RL; Tearle, JLE; Goncalves, J; Kaul, B; Lavery, GG; Favier, J; Tennant, DA				Kl'uckova, Katarina; Thakker, Alpesh; Vettore, Lisa; Escribano-Gonzalez, Cristina; Hindshaw, Rebecca L.; Tearle, Jacqueline L. E.; Goncalves, Judith; Kaul, Baksho; Lavery, Gareth G.; Favier, Judith; Tennant, Daniel A.			Succinate dehydrogenase deficiency in a chromaffin cell model retains metabolic fitness through the maintenance of mitochondrial NADH oxidoreductase function	FASEB JOURNAL			English	Article						electron transport chain; metabolism; mitochondria; pheochromocytoma; succinate dehydrogenase	RESPIRATORY-CHAIN; SDH MUTATIONS; COMPLEX-II; GENE; PHEOCHROMOCYTOMA; PHENOTYPE; MUSCLE	Mutations in succinate dehydrogenase (SDH) lead to the development of tumors in a restricted subset of cell types, including chromaffin cells and paraganglia. The molecular basis for this specificity is currently unknown. We show that loss of SDH activity in a chromaffin cell model does not perturb complex I function, retaining the ability to oxidize NADH within the electron transport chain. This activity supports continued oxidation of substrates within the tricarboxylic acid (TCA) cycle. However, due to the block in the TCA cycle at SDH, the high glutamine oxidation activity is only maintained through an efflux of succinate. We also show that although the mitochondria of SDH-deficient cells are less active per se, their higher mass per cell results in an overall respiratory rate that is comparable with wild-type cells. Finally, we observed that when their mitochondria are uncoupled, SDH-deficient cells are unable to preserve their viability, suggesting that the mitochondrial metabolic network is unable to compensate when exposed to additional stress. We therefore show that in contrast to models of SDH deficiency based on epithelial cells, a chromaffin cell model retains aspects of metabolic "health," which could form the basis of cell specificity of this rare tumor type.	[Kl'uckova, Katarina; Thakker, Alpesh; Vettore, Lisa; Escribano-Gonzalez, Cristina; Hindshaw, Rebecca L.; Tearle, Jacqueline L. E.; Kaul, Baksho; Lavery, Gareth G.; Tennant, Daniel A.] Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England; [Goncalves, Judith; Favier, Judith] Univ Paris, PARCC, INSERM, Equipe Labellisee Ligue Canc, Paris, France; [Kl'uckova, Katarina] Queen Mary Univ London, Barts Canc Inst, London, England; [Tearle, Jacqueline L. E.] UNSW, Lowy Canc Res Ctr, Sch Med Sci, EMBL Australia Single Mol Sci, Sydney, NSW, Australia	University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; Queen Mary University London; University of New South Wales Sydney	Tennant, DA (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England.; Favier, J (corresponding author), Hop Europeen Georges Pompidou, PARCC, 56 Rue Leblanc, F-75015 Paris, France.	judith.favier@inserm.fr; d.tennant@bham.ac.uk	Kluckova, Katarina/ABF-2155-2020; Tennant, Daniel/ABE-8145-2021; Thakker, Alpesh/K-8529-2017; Favier, Judith/M-7601-2017	Tennant, Daniel/0000-0003-0499-2732; Thakker, Alpesh/0000-0003-3901-0479; Favier, Judith/0000-0001-8190-5853; Escribano-Gonzalez, Cristina/0000-0001-8696-6049; Tearle, Jacqueline/0000-0001-7464-6187; Vettore, Lisa A./0000-0001-8396-5358; Lavery, Gareth/0000-0001-5794-748X	Paradifference Foundation; Cancer Research UK [C42109/A26982, C42109/A24891]; Wellcome Trust [104612/Z/14/Z]	Paradifference Foundation; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank Professor Mark Viant and Dr Stefan Schade for the use and assistance with the CASY cell counter. We thank Professors Ed Rainger and David Hodson and Mr Nick Fine for kindly providing reagents. KK, AT, and JG are supported by the Paradifference Foundation, LV, CEG, and BK are supported by Cancer Research UK (C42109/A26982 and C42109/A24891) and GGL holds a Wellcome Trust Senior Fellowship (104612/Z/14/Z).	Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Ben Aim L, 2019, J MED GENET, V56, P513, DOI 10.1136/jmedgenet-2018-105714; Bezawork-Geleta A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04603-z; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Burnichon N, 2011, HUM MOL GENET, V20, P3974, DOI 10.1093/hmg/ddr324; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Christen S, 2016, CELL REP, V17, P837, DOI 10.1016/j.celrep.2016.09.042; D'Antongiovanni V, 2017, ENDOCR-RELAT CANCER, V24, P555, DOI 10.1530/ERC-17-0212; Dekker PBD, 2003, J PATHOL, V201, P480, DOI 10.1002/path.1461; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; GARLICK PB, 1979, BIOCHEM J, V184, P547, DOI 10.1042/bj1840547; Housley SL, 2010, HISTOPATHOLOGY, V56, P405, DOI 10.1111/j.1365-2559.2010.03482.x; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Laurenti G, 2016, BIOCHEM SOC T, V44, P1111, DOI 10.1042/BST20160099; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Lorendeau D, 2017, METAB ENG, V43, P187, DOI 10.1016/j.ymben.2016.11.005; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Nonnenmacher Y, 2017, METAB ENG, V43, P147, DOI 10.1016/j.ymben.2016.12.005; Pang Y, 2018, CLIN CANCER RES, V24, P3423, DOI 10.1158/1078-0432.CCR-17-3406; ROUSLIN W, 1983, J BIOL CHEM, V258, P9657; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Szarek E, 2015, ENDOCR-RELAT CANCER, V22, P345, DOI 10.1530/ERC-15-0069	27	13	13	6	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					303	315		10.1096/fj.201901456R	http://dx.doi.org/10.1096/fj.201901456R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914648	Green Published, hybrid			2022-12-28	WOS:000507308900022
J	Li, X; Peng, ZM; Long, LL; Tuo, Y; Wang, LQ; Zhao, XY; Le, W; Wan, Y				Li, Xiang; Peng, Zhiming; Long, Lingli; Tuo, Ying; Wang, Liqin; Zhao, Xiaoyang; Le, Wang; Wan, Yong			Wnt4-modified NSC transplantation promotes functional recovery after spinal cord injury	FASEB JOURNAL			English	Article						neural stem cell transplantation; neuronal differentiation; Notch; Wnt	NEURAL STEM-CELLS; OLFACTORY ENSHEATHING CELLS; CATENIN SIGNALING PATHWAY; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; NOTCH; ACTIVATION; NEUROGENESIS; MAINTENANCE; THERAPY	Spinal cord injury (SCI) can lead to severe motor and sensory dysfunction, yet there are no effective therapies currently due to the failure of reconstructing the interruption of the neuroanatomical circuit. While neural stem cell (NSC) transplantation has been considered a potential strategy to repair the neural circuit after SCI, the efficacy of this strategy remains unproven. The main reason is that most of the transplanted NSC differentiates into astrocyte rather than neuron in the microenvironment of SCI. Our results demonstrated that Wnt4 significantly promotes the differentiation of NSC into neuron by activating both beta-catenin and MAPK/JNK pathways and suppressing the activation of Notch signaling, which is acknowledged as prevention of NSC differentiation into neuron, through downregulating NICD expression, translocating and preventing the combination of NICD and RbpJ in nucleus. In addition, Wnt4 rescues the negative effect of Jagged, the ligand of Notch signaling, to promote neuronal differentiation. Moreover, in vivo study, transplantation of Wnt4-modified NSC efficaciously repairs the injured spinal cord and recovers the motor function of hind limbs after SCI. This study sheds new light into mechanisms that Wnt4-modified NSC transplantation is sufficient to repair the injured spinal cord and recover the motor dysfunction after SCI.	[Li, Xiang; Peng, Zhiming; Zhao, Xiaoyang; Le, Wang; Wan, Yong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spine Surg, Guangzhou, Peoples R China; [Long, Lingli] Sun Yat Sen Univ, Affiliated Hosp 1, Res Ctr Translat Med, Guangzhou, Peoples R China; [Tuo, Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China; [Wang, Liqin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou, Peoples R China; [Le, Wang; Wan, Yong] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Orthopaed & Traumatol, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wan, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Orthopaed, 58 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China.	wanyong65@outlook.com			National Natural Science Foundation of China [81472069, 81971151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81472069 and 81971151	Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Basak O, 2012, J NEUROSCI, V32, P5654, DOI 10.1523/JNEUROSCI.0455-12.2012; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Blakely BD, 2013, STEM CELLS DEV, V22, P2132, DOI 10.1089/scd.2013.0066; Chen NN, 2016, CRIT CARE MED, V44, pE146, DOI 10.1097/CCM.0000000000001351; Ding Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-35; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Elizalde C, 2011, STEM CELLS, V29, P141, DOI 10.1002/stem.562; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; Gao YH, 2016, J PINEAL RES, V60, P303, DOI 10.1111/jpi.12311; Gomes ED, 2019, NEURAL REGEN RES, V14, P69, DOI 10.4103/1673-374.243705; Hirabayashi Y, 2004, CELL STRUCT FUNCT, V29, P83; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Inoue S, 2013, J THORAC CARDIOV SUR, V146, P696, DOI 10.1016/j.jtcvs.2012.11.040; Ishizaki Y, 2008, FEBS J, V275, P90; Jang S, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/178618; Jin MC, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2018.12.FOCUS18602; Klein S, 2005, NAT NEUROSCI, V8, P259, DOI 10.1038/nn0305-259; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Li G, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00241; Mackay-Sim A, 2011, EXP NEUROL, V229, P174, DOI 10.1016/j.expneurol.2010.08.025; Ohta K, 1999, SPINAL CORD, V37, P580, DOI 10.1038/sj.sc.3100881; Park SY, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0383-6; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Saberi H, 2011, J NEUROSURG-SPINE, V15, P515, DOI 10.3171/2011.6.SPINE10917; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Simard JM, 2013, SPINAL CORD, V51, P823, DOI 10.1038/sc.2013.99; Song Y, 2012, J BIOL CHEM, V287, P17716, DOI 10.1074/jbc.M112.360719; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; Yang L, 2018, INT J CLIN EXP MED, V11, P10487; Zhang J, 2008, NEUROSCIENCE, V153, P406, DOI 10.1016/j.neuroscience.2008.02.067; Zhang RR, 2018, CELL TISSUE RES, V371, P73, DOI 10.1007/s00441-017-2641-9; Zhao XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23751-2; Zhu YC, 2018, DEV DYNAM, V247, P75, DOI 10.1002/dvdy.24558	38	23	24	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					82	94		10.1096/fj.201901478RR	http://dx.doi.org/10.1096/fj.201901478RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914702				2022-12-28	WOS:000507308900007
J	Watanabe, H; Higashimoto, K; Miyake, N; Morita, S; Horii, T; Kimura, M; Suzuki, T; Maeda, T; Hidaka, H; Aoki, S; Yatsuki, H; Okamoto, N; Uemura, T; Hatada, I; Matsumoto, N; Soejima, H				Watanabe, Hidetaka; Higashimoto, Ken; Miyake, Noriko; Morita, Sumiyo; Horii, Takuro; Kimura, Mika; Suzuki, Takayuki; Maeda, Toshiyuki; Hidaka, Hidenori; Aoki, Saori; Yatsuki, Hitomi; Okamoto, Nobuhiko; Uemura, Tetsuji; Hatada, Izuho; Matsumoto, Naomichi; Soejima, Hidenobu			DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer	FASEB JOURNAL			English	Article						Beckwith-Wiedemann syndrome; epigenome editing; genomic imprinting; histone modifications; NSD1	BECKWITH-WIEDEMANN-SYNDROME; TEMPLE SYNDROME; OVERGROWTH SYNDROME; NSD1 MUTATIONS; HISTONE 3; METHYLTRANSFERASE; DNMT3A; GROWTH; MOUSE; IDENTIFICATION	Haploinsufficiency of NSD1, which dimethylates histone H3 lysine 36 (H3K36), causes Sotos syndrome (SoS), an overgrowth syndrome. DNMT3A and DNMT3B recognizes H3K36 trimethylation (H3K36me3) through PWWP domain to exert de novo DNA methyltransferase activity and establish imprinted differentially methylated regions (DMRs). Since decrease of H3K36me3 and genome-wide DNA hypomethylation in SoS were observed, hypomethylation of imprinted DMRs in SoS was suggested. We explored DNA methylation status of 28 imprinted DMRs in 31 SoS patients with NSD1 defect and found that hypomethylation of IGF2-DMR0 and IG-DMR in a substantial proportion of SoS patients. Luciferase assay revealed that IGF2-DMR0 enhanced transcription from the IGF2 P0 promoter but not the P3 and P4 promoters. Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) revealed active enhancer histone modifications at IGF2-DMR0, with high enrichment of H3K4me1 and H3 lysine 27 acetylation (H3K27ac). CRISPR-Cas9 epigenome editing revealed that specifically induced hypomethylation at IGF2-DMR0 increased transcription from the P0 promoter but not the P3 and P4 promoters. NSD1 knockdown suggested that NSD1 targeted IGF2-DMR0; however, IGF2-DMR0 DNA methylation and IGF2 expression were unaltered. This study could elucidate the function of IGF2-DMR0 as a DNA methylation dependent, P0 promoter-specific enhancer. NSD1 may play a role in the establishment or maintenance of IGF2-DMR0 methylation during the postimplantation period.	[Watanabe, Hidetaka; Higashimoto, Ken; Aoki, Saori; Yatsuki, Hitomi; Soejima, Hidenobu] Saga Univ, Div Mol Genet & Epigenet, Dept Biomol Sci, Fac Med, Saga 8498501, Japan; [Watanabe, Hidetaka; Uemura, Tetsuji] Saga Univ Hosp, Dept Plast & Reconstruct Surg, Saga, Japan; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa, Japan; [Morita, Sumiyo; Horii, Takuro; Kimura, Mika; Hatada, Izuho] Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, Maebashi, Gunma, Japan; [Suzuki, Takayuki] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi, Japan; [Maeda, Toshiyuki] Saga Univ, Dept Pediat, Fac Med, Saga, Japan; [Hidaka, Hidenori] Saga Univ, Dept Internal Med & Gastrointestinal Endoscopy, Fac Med, Saga, Japan; [Okamoto, Nobuhiko] Osaka Womens & Childrens Hosp, Dept Med Genet, Izumi, Japan	Saga University; Saga University; Yokohama City University; Gunma University; Nagoya University; Saga University; Saga University	Higashimoto, K; Soejima, H (corresponding author), Saga Univ, Div Mol Genet & Epigenet, Dept Biomol Sci, Fac Med, Saga 8498501, Japan.	higashim@cc.saga-u.ac.jp; soejimah@cc.saga-u.ac.jp			MEXT \ Japan Society for the Promotion of Science (JSPS) [16K09970, 17K08687, 19H03621, 17H01539]; Japan Agency for Medical Research and Development (AMED) [17ek0109280h0001, 17ek0109234h0001, 17ek0109205h0001, JP19ek0109280, JP19dm0107090, JP19ek0109301]; Ministry of Health, Labour and Welfare (MHLW) [H29-nanchitou(nan)-ippan-025]; National Center for Child Health and Development (NCCHD) [26-13]; Gunma University [16029]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); National Center for Child Health and Development (NCCHD); Gunma University	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16K09970, 17K08687, 19H03621 and 17H01539; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: 17ek0109280h0001, 17ek0109234h0001, 17ek0109205h0001, JP19ek0109280, JP19dm0107090 and JP19ek0109301; Ministry of Health, Labour and Welfare (MHLW), Grant/Award Number: H29-nanchitou(nan)-ippan-025; National Center for Child Health and Development (NCCHD), Grant/Award Number: 26-13; Gunma University, Grant/Award Number: 16029	Aref-Eshghi E, 2018, AM J HUM GENET, V102, P156, DOI 10.1016/j.ajhg.2017.12.008; Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Ayesh B, 2003, MOL THER, V7, P535, DOI 10.1016/S1525-0016(03)00056-X; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Baujat G, 2004, AM J HUM GENET, V74, P715, DOI 10.1086/383093; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Brioude F, 2018, NAT REV ENDOCRINOL, V14, P229, DOI 10.1038/nrendo.2017.166; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; COLE TRP, 1994, J MED GENET, V31, P20, DOI 10.1136/jmg.31.1.20; COLE TRP, 1990, J MED GENET, V27, P571, DOI 10.1136/jmg.27.9.571; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cui HM, 2002, CANCER RES, V62, P6442; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; EKSTROM TJ, 1995, DEVELOPMENT, V121, P309; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hidaka H, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0578-9; Ioannides Y, 2014, J MED GENET, V51, P495, DOI 10.1136/jmedgenet-2014-102396; Kagami M, 2017, GENET MED, V19, P1356, DOI 10.1038/gim.2017.53; Kagami M, 2017, GENET MED, V19, P476, DOI 10.1038/gim.2016.123; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kamimura J, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.11.e126; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kurotaki N, 2003, HUM MUTAT, V22, P378, DOI 10.1002/humu.10270; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lee SC, 2016, ONCOGENE, V35, P5515, DOI 10.1038/onc.2016.92; Lee TY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S3; Lewis MP, 1996, PLACENTA, V17, P137, DOI 10.1016/S0143-4004(96)80006-3; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Maeda T, 2014, GENET MED, V16, P903, DOI 10.1038/gim.2014.46; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore GE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0074; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Morselli M, 2015, ELIFE, V4, DOI 10.7554/eLife.06205; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Soejima H, 2013, J HUM GENET, V58, P402, DOI 10.1038/jhg.2013.51; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; SOTOS JF, 1964, NEW ENGL J MED, V271, P109, DOI 10.1056/NEJM196407162710301; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Sun FF, 2019, J HUM GENET, V64, P937, DOI 10.1038/s10038-019-0634-0; Tatton-Brown K, 2007, EUR J HUM GENET, V15, P264, DOI 10.1038/sj.ejhg.5201686; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Tlemsani C, 2016, J MED GENET, V53, P743, DOI 10.1136/jmedgenet-2015-103638; Weinberg DN, 2019, NATURE, V573, P281, DOI 10.1038/s41586-019-1534-3; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106	54	5	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					960	973		10.1096/fj.201901757R	http://dx.doi.org/10.1096/fj.201901757R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914674	Green Published, hybrid			2022-12-28	WOS:000507308900065
J	Angelini, A; Gorey, MA; Dumont, F; Mougenot, N; Chatzifrangkeskou, M; Muchir, A; Li, ZL; Mericskay, M; Decaux, JF				Angelini, Aude; Gorey, Mark-Alexander; Dumont, Florent; Mougenot, Nathalie; Chatzifrangkeskou, Maria; Muchir, Antoine; Li, Zhenlin; Mericskay, Mathias; Decaux, Jean-Francois			Cardioprotective effects of alpha-cardiac actin on oxidative stress in a dilated cardiomyopathy mouse model	FASEB JOURNAL			English	Article						cardiac remodeling; dilated cardiomyopathy; oxidative stress; alpha-cardiac actin	SERUM RESPONSE FACTOR; NADPH OXIDASES; SKELETAL-MUSCLE; GENE-EXPRESSION; NUCLEAR ACTIN; HUMAN HEART; NOX FAMILY; MUTATIONS; RNA; SUPEROXIDE	The expression of alpha-cardiac actin, a major constituent of the cytoskeleton of cardiomyocytes, is dramatically decreased in a mouse model of dilated cardiomyopathy triggered by inducible cardiac-specific serum response factor (Srf) gene disruption that could mimic some forms of human dilated cardiomyopathy. To investigate the consequences of the maintenance of alpha-cardiac actin expression in this model, we developed a new transgenic mouse based on Cre/LoxP strategy, allowing together the induction of SRF loss and a compensatory expression of alpha-cardiac actin. Here, we report that maintenance of alpha-cardiac actin within cardiomyocytes temporally preserved cytoarchitecture from adverse cardiac remodeling through a positive impact on both structural and transcriptional levels. These protective effects were accompanied in vivo by the decrease of ROS generation and protein carbonylation and the downregulation of NADPH oxidases NOX2 and NOX4. We also show that ectopic expression of alpha-cardiac actin protects HEK293 cells against oxidative stress induced by H2O2. Oxidative stress plays an important role in the development of cardiac remodeling and contributes also to the pathogenesis of heart failure. Taken together, these findings indicate that alpha-cardiac actin could be involved in the regulation of oxidative stress that is a leading cause of adverse remodeling during dilated cardiomyopathy development.	[Angelini, Aude; Gorey, Mark-Alexander; Li, Zhenlin; Decaux, Jean-Francois] Sorbonne Univ, Inst Biol Paris Seine IBPS, Biol Adaptat & Ageing, CNRS UMR 8256,INSERM ERL U1164, Paris, France; [Dumont, Florent; Mericskay, Mathias] Univ Paris Saclay, Signalling & Cardiovasc Pathophysiol, INSERM UMR S 1180, Chatenay Malabry, France; [Mougenot, Nathalie] Sorbonne Univ, Fac Med Pierre & Marie Curie, INSERM UMS 28 Phenotypage Petit Anim, Paris, France; [Chatzifrangkeskou, Maria; Muchir, Antoine] Sorbonne Univ, Inst Myol, Ctr Res Myol, INSERM UMRS 974, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Li, ZL (corresponding author), Sorbonne Univ, Inst Biol Paris Seine IBPS, Biol Adaptat & Ageing, CNRS UMR 8256,INSERM ERL U1164, Paris, France.	zhenlin.li@sorbonne-universite.fr	MERICSKAY, Mathias/M-3477-2018	MERICSKAY, Mathias/0000-0002-6779-092X; Angelini, Aude/0000-0001-5339-5315; LI, Zhenlin/0000-0002-3706-4505; DECAUX, Jean-Francois/0000-0003-0014-4197	l'Association Francaise contre les Myopathies (AFM) [19814]; PhD fellowship of Universite Paris 05; Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); Societe Francaise de Cardiologie (SFC); Fondation de la Recherche Medicale (FRM)	l'Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); PhD fellowship of Universite Paris 05; Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); Societe Francaise de Cardiologie (SFC); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by l'Association Francaise contre les Myopathies (AFM#19814). AA was supported by a PhD fellowship of Universite Paris 05, a fellowship of Fondation de la Recherche Medicale (FRM), and a fellowship of Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC) and Societe Francaise de Cardiologie (SFC).	Agbulut O, 1996, BIOL CELL, V88, P131, DOI 10.1016/S0248-4900(97)83528-9; Agbulut O, 2001, CELL MOTIL CYTOSKEL, V49, P51, DOI 10.1002/cm.1020; Angelini A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139858; Asakura M, 2009, CIRC J, V73, P1568, DOI 10.1253/circj.CJ-09-0465; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cave A, 2005, PHILOS T R SOC B, V360, P2327, DOI 10.1098/rstb.2005.1772; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Daehmlow S, 2002, BIOCHEM BIOPH RES CO, V298, P116, DOI 10.1016/S0006-291X(02)02374-4; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; de Tombe PP, 2003, J BIOMECH, V36, P721, DOI 10.1016/S0021-9290(02)00450-5; Debold EP, 2010, J MOL CELL CARDIOL, V48, P286, DOI 10.1016/j.yjmcc.2009.09.014; Dieterich S, 2000, CIRCULATION, V101, P33, DOI 10.1161/01.CIR.101.1.33; Diguet N, 2018, CIRCULATION, V137, P2256, DOI 10.1161/CIRCULATIONAHA.116.026099; Diguet N, 2011, J BIOL CHEM, V286, P35007, DOI 10.1074/jbc.M111.252395; Farah ME, 2007, MOL BIOL CELL, V18, P1359, DOI 10.1091/mbc.E06-08-0718; Farah ME, 2011, CYTOSKELETON, V68, P340, DOI 10.1002/cm.20516; GARNER I, 1986, EMBO J, V5, P2559, DOI 10.1002/j.1460-2075.1986.tb04535.x; Gary-Bobo G, 2008, EUR J HEART FAIL, V10, P635, DOI 10.1016/j.ejheart.2008.04.014; Gourlay CW, 2005, J CELL SCI, V118, P2119, DOI 10.1242/jcs.02337; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; HALLIWELL B, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3432205; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; HEWETT TE, 1994, CIRC RES, V74, P740, DOI 10.1161/01.RES.74.4.740; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; Ichihara S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08546-1; Ide T, 2000, CIRC RES, V86, P152, DOI 10.1161/01.RES.86.2.152; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Lamon S, 2014, PFLUG ARCH EUR J PHY, V466, P1659, DOI 10.1007/s00424-014-1475-5; Lynch TL, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/424751; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; Muller M, 2012, CELL MOL LIFE SCI, V69, P3457, DOI 10.1007/s00018-012-1030-5; Mundia MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036821; Nabeebaccus A, 2011, HEART FAIL REV, V16, P5, DOI 10.1007/s10741-010-9186-2; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Paclet MH, 2007, FASEB J, V21, P1244, DOI 10.1096/fj.06-6852com; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Percipalle P, 2002, NUCLEIC ACIDS RES, V30, P1725, DOI 10.1093/nar/30.8.1725; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44; SASSOON DA, 1988, DEVELOPMENT, V104, P155; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Shao D, 2012, J MOL CELL CARDIOL, V52, P550, DOI 10.1016/j.yjmcc.2011.09.009; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sjolinder M, 2005, GENE DEV, V19, P1871, DOI 10.1101/gad.339405; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Suzuki M, 2005, BIOPHYS J, V89, P321, DOI 10.1529/biophysj.104.054957; Touvron M, 2012, DIS MODEL MECH, V5, P481, DOI 10.1242/dmm.009456; Tritsch E, 2013, CARDIOVASC RES, V98, P372, DOI 10.1093/cvr/cvt042; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; VANDEKERCKHOVE J, 1986, J BIOL CHEM, V261, P1838; Victorino VJ, 2015, LIFE SCI, V129, P42, DOI 10.1016/j.lfs.2014.11.008; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Weintraub RG, 2017, LANCET, V390, P400, DOI 10.1016/S0140-6736(16)31713-5; Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	72	3	3	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2987	3005		10.1096/fj.201902389R	http://dx.doi.org/10.1096/fj.201902389R		DEC 2019	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908029	Green Submitted			2022-12-28	WOS:000504854600001
J	Liverani, E; Tursi, SA; Cornwell, WD; Mondrinos, MJ; Sun, S; Buttaro, BA; Wolfson, MR; Rogers, TJ; Tukel, C; Kilpatrick, LE				Liverani, Elisabetta; Tursi, Sarah A.; Cornwell, William D.; Mondrinos, Mark J.; Sun, Shuang; Buttaro, Bettina A.; Wolfson, Marla R.; Rogers, Thomas J.; Tuekel, Cagla; Kilpatrick, Laurie E.			Protein kinase C-delta inhibition is organ-protective, enhances pathogen clearance, and improves survival in sepsis	FASEB JOURNAL			English	Article						cecal ligation and puncture; inflammation; macrophages; organ injury; phagocytosis	SEPTIC SHOCK; LUNG INJURY; PKC-DELTA; NEUTROPHILS; BIODISTRIBUTION; INFLAMMATION; PI-3-KINASE; EXPRESSION; MORTALITY; DELIVERY	Sepsis is a leading cause of morbidity and mortality in intensive care units. Previously, we identified Protein Kinase C-delta (PKC delta) as an important regulator of the inflammatory response in sepsis. An important issue in development of anti-inflammatory therapeutics is the risk of immunosuppression and inability to effectively clear pathogens. In this study, we investigated whether PKC delta inhibition prevented organ dysfunction and improved survival without compromising pathogen clearance. Sprague Dawley rats underwent sham surgery or cecal ligation and puncture (CLP) to induce sepsis. Post-surgery, PBS or a PKC delta inhibitor (200 mu g/kg) was administered intra-tracheally (IT). At 24 hours post-CLP, there was evidence of lung and kidney dysfunction. PKC delta inhibition decreased leukocyte influx in these organs, decreased endothelial permeability, improved gas exchange, and reduced blood urea nitrogen/creatinine ratios indicating organ protection. PKC delta inhibition significantly decreased bacterial levels in the peritoneal cavity, spleen and blood but did not exhibit direct bactericidal properties. Peritoneal chemokine levels, neutrophil numbers, or macrophage phenotypes were not altered by PKC delta inhibition. Peritoneal macrophages isolated from PKC delta inhibitor-treated septic rats demonstrated increased bacterial phagocytosis. Importantly, PKC delta inhibition increased survival. Thus, PKC delta inhibition improved survival and improved survival was associated with increased phagocytic activity, enhanced pathogen clearance, and decreased organ injury.	[Liverani, Elisabetta; Cornwell, William D.; Mondrinos, Mark J.; Sun, Shuang; Wolfson, Marla R.; Rogers, Thomas J.; Kilpatrick, Laurie E.] Temple Univ, Ctr Inflammat Clin & Translat Lung Res, Dept Thorac Med & Surg, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Liverani, Elisabetta; Mondrinos, Mark J.; Kilpatrick, Laurie E.] Temple Univ, Thrombosis Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Tursi, Sarah A.; Buttaro, Bettina A.; Tuekel, Cagla] Temple Univ, Dept Microbiol & Immunol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Wolfson, Marla R.; Kilpatrick, Laurie E.] Temple Univ, Dept Physiol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kilpatrick, LE (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res, 3500 North Broad St,Rm 1153 MERB, Philadelphia, PA 19140 USA.	laurie.kilpatrick@temple.edu	Liverani, Elisabetta/AAR-4132-2021	Liverani, Elisabetta/0000-0001-5540-0456	National Institute of General Medical Sciences of the National Institutes of Health (NIH) [HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996, AI125429]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996, AI125429]; National Institute on Drug Abuse of the National Institutes of Health (NIH) [HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996, AI125429]; National Heart, Lung; Blood Institute of the National Institutes of Health (NIH) [HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996, AI125429]	National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse of the National Institutes of Health (NIH); National Heart, Lung; Blood Institute of the National Institutes of Health (NIH)	National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute on Drug Abuse, and National Heart, Lung; Blood Institute of the National Institutes of Health (NIH), Grant/Award Number: HL111552, GM114359, GM134701, DA040619, P30DA13429, AI132996 and AI125429	Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Bhargava R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079037; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Castoldi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037584; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chichger H, 2012, AM J PHYSIOL-LUNG C, V303, pL880, DOI 10.1152/ajplung.00169.2012; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Craciun FL, 2014, SHOCK, V41, P97, DOI 10.1097/SHK.0000000000000073; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Figueiredo N, 2013, IMMUNITY, V39, P874, DOI 10.1016/j.immuni.2013.08.039; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hazeki K, 2009, J BIOCHEM, V145, P87, DOI 10.1093/jb/mvn142; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kilpatrick LE, 2004, AM J PHYSIOL-CELL PH, V287, pC633, DOI 10.1152/ajpcell.00486.2003; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; Kubo-Murai M, 2007, MOL IMMUNOL, V44, P2257, DOI 10.1016/j.molimm.2006.11.005; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Liverani E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195379; Medzhitov R, 2013, IMMUNITY, V39, P799, DOI 10.1016/j.immuni.2013.10.012; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Mestry N, 2009, THORAX, V64, P532, DOI 10.1136/thx.2008.099143; Mondrinos MJ, 2015, J PHARMACOL EXP THER, V355, P86, DOI 10.1124/jpet.115.224832; Mondrinos MJ, 2014, AM J PATHOL, V184, P200, DOI 10.1016/j.ajpath.2013.09.010; Mondrinos MJ, 2013, SHOCK, V39, P467, DOI 10.1097/SHK.0b013e318294f85a; Neumann B, 1999, INT IMMUNOL, V11, P217, DOI 10.1093/intimm/11.2.217; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Perl M, 2010, CRIT CARE MED, V38, P1179, DOI 10.1097/CCM.0b013e3181d4563f; Poston JT, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4891; Ramnath R, 2010, J MOL MED BERL, V88, P1; Shukla A, 2007, AM J PATHOL, V170, P140, DOI 10.2353/ajpath.2007.060381; Castanheira FVES, 2018, SHOCK, V49, P682, DOI 10.1097/SHK.0000000000000969; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Slutsky AS, 2002, J CLIN INVEST, V110, P737, DOI 10.1172/JCI200216551; Soroush F, 2019, SHOCK, V51, P538, DOI 10.1097/SHK.0000000000001247; Soroush F, 2016, J LEUKOCYTE BIOL, V100, P1027, DOI 10.1189/jlb.3MA0216-087R; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Sudan R, 2012, J IMMUNOL, V188, P2328, DOI 10.4049/jimmunol.1101678; Tang Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1342-y; Tao XT, 2017, J INFECT DIS, V215, P321, DOI 10.1093/infdis/jiw535; Toledo-Rodriguez M, 2012, TOXICOL LETT, V213, P228, DOI 10.1016/j.toxlet.2012.06.009; Vancurova I, 2001, J BIOL CHEM, V276, P19746, DOI 10.1074/jbc.M100234200; Villa P, 2002, J INFECT DIS, V185, P1115, DOI 10.1086/340042; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Weiss YG, 2002, J CLIN INVEST, V110, P801, DOI 10.1172/JCI200215888; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013	56	6	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2497	2510		10.1096/fj.201900897R	http://dx.doi.org/10.1096/fj.201900897R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908004	Green Accepted, Bronze			2022-12-28	WOS:000504090700001
J	Jiang, AW; Dong, C; Li, BJ; Zhang, ZK; Chen, YJ; Ning, CB; Wu, WJ; Liu, HL				Jiang, Aiwen; Dong, Chao; Li, Bojiang; Zhang, Zengkai; Chen, Yujun; Ning, Caibo; Wu, Wangjun; Liu, Honglin			MicroRNA-206 regulates cell proliferation by targeting G6PD in skeletal muscle	FASEB JOURNAL			English	Article						miR-206; cell cycle; myogenesis; skeletal muscle fiber; muscle diseases	MIR-206; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; DIFFERENTIATION; CANCER; FIBER	Skeletal muscle is a major component of body mass and plays a central role in the control of whole-body metabolism in humans and animals. Therefore, elucidation of the underlying mechanisms of skeletal growth and development are expected to lead to the discovery of novel genes and pathways related to muscle disease. miR-206, a skeletal muscle-specific microRNA, plays a crucial role in myogenesis; however, miR-206 is known to function in myogenic differentiation, whether or not it affects muscle cells' proliferation, and the underlying mechanisms are unknown. In this study, we investigated the effect of miR-206 on muscle cell proliferation and differentiation, as well as its effect on myofiber type conversion using mouse C2C12 myoblasts. The results showed that over-expression of miR-206 inhibited cell proliferation and promoted muscle cell differentiation, but it did not affect myofiber type conversion. Intriguingly, we found that overexpression of miR-206 suppressed muscle cell proliferation and induced cell cycle arrest in G(0)/G(1) phase by inhibiting the glucose-6-phosphate dehydrogenase (G6PD) gene. Taken together, we demonstrated that the miR-206-G6PD pathway suppresses muscle cell proliferation, and these findings may facilitate the treatment of muscle diseases.	[Jiang, Aiwen; Dong, Chao; Li, Bojiang; Zhang, Zengkai; Chen, Yujun; Ning, Caibo; Wu, Wangjun; Liu, Honglin] Nanjing Agr Univ, Dept Anim Genet Breeding & Reprod, Coll Anim Sci & Technol, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China; [Li, Bojiang] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang, Peoples R China	Nanjing Agricultural University; Shenyang Agricultural University	Wu, WJ; Liu, HL (corresponding author), Nanjing Agr Univ, Dept Anim Genet Breeding & Reprod, Coll Anim Sci & Technol, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China.	wuwangjun2012@njau.edu.cn; wangjunwu4062@163.com	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Key Research and Development Program of China [2017YFD0502002]; National Natural Science Foundation of China [31501920]; Natural Science Foundation of Jiangsu Province [BK20130693]; National Major Project for Breeding of Transgenic Pigs [2016ZX08006001-003]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Major Project for Breeding of Transgenic Pigs	The authors are grateful to Irene Bozzoni (Sapienza University of Rome, Rome, Italy) for providing the miR-206 overexpression vector. This work was supported by the National Key Research and Development Program of China (2017YFD0502002), the National Natural Science Foundation of China (31501920), the Natural Science Foundation of Jiangsu Province (BK20130693), and the National Major Project for Breeding of Transgenic Pigs (2016ZX08006001-003). The authors declare no conflicts of interest.	Alteri A, 2013, CELL CYCLE, V12, P3781, DOI 10.4161/cc.26674; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Bonnet M, 2007, J ANIM SCI, V85, P2882, DOI 10.2527/jas.2007-0062; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Cai TC, 2015, AM J CANCER RES, V5, P1610; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Georgantas RW, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12200; Gondret F, 2000, J NUTR, V130, P228, DOI 10.1093/jn/130.2.228; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Han H, 2016, ONCOTARGET, V7, P16409, DOI 10.18632/oncotarget.7653; Huang QK, 2016, MED SCI MONITOR, V22, P1161, DOI 10.12659/MSM.897909; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Lawler JM, 2001, MECH AGEING DEV, V122, P291, DOI 10.1016/S0047-6374(00)00235-9; Lee JS, 2013, ANIM GENET, V44, P101, DOI 10.1111/j.1365-2052.2012.02362.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee-Young RS, 2016, MOL METAB, V5, P1083, DOI 10.1016/j.molmet.2016.09.002; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mador MJ, 2001, RESP RES, V2, P216; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Miller CJ, 2012, BBA-MOL BASIS DIS, V1822, P1038, DOI 10.1016/j.bbadis.2012.02.007; Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Ren XL, 2016, J CANCER RES CLIN, V142, P581, DOI 10.1007/s00432-015-2053-8; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Stouth DW, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00870; Wang R, 2012, CELL PHYSIOL BIOCHEM, V29, P381, DOI 10.1159/000338493; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Xu SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26619; Zammit PS, 2017, SEMIN CELL DEV BIOL, V72, P19, DOI 10.1016/j.semcdb.2017.11.011; Zhang D, 2014, J CELL BIOL, V207, P753, DOI 10.1083/jcb.201406068; Zhang YJ, 2015, INT J CLIN EXP MED, V8, P9107; Zhou J, 2013, BIOCHEM BIOPH RES CO, V433, P207, DOI 10.1016/j.bbrc.2013.02.084	40	12	14	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14083	14094		10.1096/fj.201900502RRRR	http://dx.doi.org/10.1096/fj.201900502RRRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31675481	Bronze			2022-12-28	WOS:000507466100078
J	Liu, W; Zhou, Y; Liang, R; Zhang, Y				Liu, Wei; Zhou, Yi; Liang, Rui; Zhang, Yue			Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits	FASEB JOURNAL			English	Article						diabetes mellitus; hippocampus; apoptosis	NEURONAL APOPTOSIS; CDK5; P38; DEMENTIA; NEUROTOXICITY; MECHANISMS; RELEVANCE; ACTIVATOR; DECLINE; PATHWAY	Cognitive deficit is a prevalent and underestimated complication of diabetes, and the underlying cellular and molecular mechanisms are not well understood. Aberrant activity of cyclin-dependent kinase (Cdk)5 is implicated in a number of neurodegenerative diseases. The present study examined the role of Cdk5 in the progression of diabetes-related cognitive deficits. We showed that the Cdk5 protein expression and kinase activity were significantly increased in diabetic mice at 16 wk. In primary cultured hippocampal neurons exposed to 30 mM glucose, Cdk5 protein and kinase activity were also elevated in a time-dependent manner. Moreover, the high glucose exposure led to an aberrant Cdk5 activation due to its activator p25 that was cleaved from p35 by calpain. Both in diabetic mice and in cultured hippocampal neurons exposed to high glucose, inhibition of Cdk5 activity with roscovitine (Ros) or short hairpin RNA (shRNA) decreased the protein levels of cleaved caspase-3 and the ratio of Bax and Bcl-2. The apoptotic rate detected by TUNEL in vivo or Annexin V and propidium iodide staining for flow cytometry in vitro also had obvious reduction. In addition, high glucose exposure resulted in the increase of phosphorylated (phospho)-MAPK kinase (MKK)6, phospho-p38, and c-Jun, which were rescued by Ros or Cdk5 shRNA. It is more important that the cognitive deficits of diabetic mice were also effectively alleviated by Ros. These results indicate that aberrant Cdk5 activity triggered hippocampal neuron apoptosis by activating MKK6/p38 MAPK cascade in hyperglycemia. Inhibition of Cdk5 overactivation attenuates neuronal apoptosis and cognitive deficits and contributes to the relief of diabetic neurotoxicity in the brain.	[Liu, Wei; Liang, Rui] Hebei Med Univ, Hosp 2, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Zhou, Yi] Hebei Med Univ, Hosp 2, Dept Clin Diagnost, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yue] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Zhang, Y (corresponding author), Hebei Med Univ, Dept Clin Diagnost, 361 Zhongshan East Rd, Shijiazhuang, Hebei, Peoples R China.	zhyue515@126.com			National Natural Science Foundation of China [81770720]; China Postdoctoral Science Foundation Project [2016M591403]; Natural Science Fundation of Hebei Province [H2019206549, H2019206550]; Key Project of Scientific and Technological Research of Hebei Province [ZD2018003]; People's Livelihood Science and Technology Project of Hebei Province [19277784D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Project(China Postdoctoral Science Foundation); Natural Science Fundation of Hebei Province; Key Project of Scientific and Technological Research of Hebei Province; People's Livelihood Science and Technology Project of Hebei Province	This work was supported by the National Natural Science Foundation of China (81770720), the China Postdoctoral Science Foundation Project (2016M591403), the Natural Science Fundation of Hebei Province (H2019206549 and H2019206550), the Key Project of Scientific and Technological Research of Hebei Province (ZD2018003), and the People's Livelihood Science and Technology Project of Hebei Province (19277784D). The authors declare no conflicts of interest.	Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Bahar-Fuchs A, 2020, J GERONTOL A-BIOL, V75, P747, DOI 10.1093/gerona/glz073; BEER K, 2017, COCHRANE DB SYST REV, V7, DOI DOI 10.1038/S41598-017-15014-3; Biessels GJ, 2018, NAT REV ENDOCRINOL, V14, P591, DOI 10.1038/s41574-018-0048-7; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Chang KH, 2010, J NEUROCHEM, V113, P1221, DOI 10.1111/j.1471-4159.2010.06687.x; Corre I, 2017, ONCOTARGET, V8, P55684, DOI 10.18632/oncotarget.18264; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cukierman-Yaffe T, 2014, DIABETES-METAB RES, V30, P341, DOI 10.1002/dmrr.2507; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Eriksson JG, 2019, J ENDOCRINOL, V242, pT95, DOI 10.1530/JOE-18-0680; Hamdane Malika, 2007, Biotechnology Journal, V2, P967, DOI 10.1002/biot.200700059; Hardigan T, 2016, CLIN SCI, V130, P1807, DOI 10.1042/CS20160397; Harding JL, 2019, DIABETOLOGIA, V62, P3, DOI 10.1007/s00125-018-4711-2; Hasegawa Y, 2018, J ALZHEIMERS DIS, V61, P259, DOI 10.3233/JAD-170645; Jia WP, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3158; Kawauchi T, 2014, DEV GROWTH DIFFER, V56, P335, DOI 10.1111/dgd.12138; Kesavapany Sashi, 2007, Biotechnology Journal, V2, P978, DOI 10.1002/biot.200700057; Kheiri G, 2019, REV NEUROSCIENCE, V30, P9, DOI 10.1515/revneuro-2018-0008; Kong FJ, 2018, CLIN SCI, V132, P111, DOI 10.1042/CS20171432; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Lee JK, 2017, MOLECULES, V22, DOI 10.3390/molecules22081287; Li W, 2017, J ALZHEIMERS DIS, V57, P29, DOI 10.3233/JAD-161250; Liu SL, 2016, MOL NEUROBIOL, V53, P4328, DOI 10.1007/s12035-015-9369-x; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Martins RN, 2017, J ALZHEIMERS DIS, V59, P389, DOI 10.3233/JAD-170309; Matioli Maria Niures Pimentel dos Santos, 2017, Dement. neuropsychol., V11, P406, DOI 10.1590/1980-57642016dn11-040010; Moran C, 2017, J ALZHEIMERS DIS, V59, P405, DOI 10.3233/JAD-161166; Mushtaq G, 2016, CURR PHARM DESIGN, V22, P527, DOI 10.2174/1381612822666151124235028; Ojo O, 2015, INT J ENV RES PUB HE, V12, P8281, DOI 10.3390/ijerph120708281; Reno CM, 2013, AM J PHYSIOL-ENDOC M, V304, pE1331, DOI 10.1152/ajpendo.00084.2013; Shah K, 2017, MOL NEUROBIOL, V54, P2255, DOI 10.1007/s12035-016-9792-7; Simo R, 2017, ACTA DIABETOL, V54, P417, DOI 10.1007/s00592-017-0970-5; Wang NN, 2018, LIFE SCI, V212, P194, DOI 10.1016/j.lfs.2018.09.035; Wang WY, 2014, NEUROPHARMACOLOGY, V77, P90, DOI 10.1016/j.neuropharm.2013.09.006; Wilkaniec A, 2016, J NEUROCHEM, V136, P222, DOI 10.1111/jnc.13365; Xourgia E, 2019, WORLD J DIABETES, V10, P169, DOI 10.4239/wjd.v10.i3.169; Young PR, 2013, J BIOMOL SCREEN, V18, P1156, DOI 10.1177/1087057113497401; Yu JL, 2019, J CELL PHYSIOL, V234, P10655, DOI 10.1002/jcp.27746; Zhang HM, 2017, TOXICOL LETT, V277, P41, DOI 10.1016/j.toxlet.2017.05.027; Zhang J, 2008, CELL CYCLE, V7, P3487, DOI 10.4161/cc.7.22.7045; Zhu XW, 2001, J NEUROCHEM, V79, P311, DOI 10.1046/j.1471-4159.2001.00597.x	43	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14506	14515		10.1096/fj.201901292R	http://dx.doi.org/10.1096/fj.201901292R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689375	Bronze			2022-12-28	WOS:000507466100111
J	Yang, JE; Zhang, F; Shi, HR; Gao, Y; Dong, Z; Ma, LL; Sun, XL; Li, X; Chang, SC; Wang, Z; Qu, YN; Li, H; Hu, K; Sun, AJ; Ge, JB				Yang, Ji'e; Zhang, Feng; Shi, Huairui; Gao, Yang; Dong, Zhen; Ma, Leilei; Sun, Xiaolei; Li, Xiao; Chang, Suchi; Wang, Zeng; Qu, Yanan; Li, Hua; Hu, Kai; Sun, Aijun; Ge, Junbo			Neutrophil-derived advanced glycation end products-N epsilon-(carboxymethyl) lysine promotes RIP3-mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia/reperfusion injury	FASEB JOURNAL			English	Article						glyoxalase-1; myocardial infarction; cell death	ISCHEMIA-REPERFUSION INJURY; PRODUCTS; MECHANISM; RECEPTOR; HEART; GLYCOSYLATION; MACROPHAGES; NECROSIS; RIP3; CARDIOMYOCYTE	NE-(carboxymethyl) lysine (CML), the major member of advanced glycation end products, was widely studied in diabetic complications and aging-associated diseases. However, the impact of CML on myocardial ischemia/ reperfusion injury (MI/RI) was rarely reported. In the present study, CML was increased in both patients with acute myocardial infarction (53.4 +/- 7.8 vs. 28.1 +/- 4.4 ng; P = 0.017), and mice underwent MI/RI (16.4 +/- 1.4 vs. 10.8 +/- 0.9 ng; P = 0.006). Depletion of neutrophils reduced CML (17.8 +/- 1.0 vs. 9.9 +/- 0.3 ng; P < 0.001), indicating neutrophils were the major cells contributing to CML formation during MI/RI. CML treatment exacerbated MI/RI by elevating myocardial injury marker (274.3 +/- 18.0 vs. 477.2 +/- 34.3 pg; P < 0.001), enlarging myocardial infarct size (32.9 +/- 3.6 vs. 45.2 +/- 3.8%; P = 0.03), increasing myocardial fibrosis (17.5 +/- 1.6 vs. 29.7 +/- 2.2%; P < 0.001) and impairing cardiac function (59.4 +/- 2.4% vs. 46.0 +/- 1.3%; P = 0.001). Further study revealed that CML increased the phosphorylation of receptor interacting protein (RIP) 3, an important initiator of necroptosis, and its downstream proteins. Receptor for advanced glycation end product (RAGE) deficiency effectively blocked RIP3 phosphorylation induced by CML and rescued CML-mediated MI/RI, indicating CML promoted RIP3-mediated necroptosis through RAGE. In addition, glyoxalase-1 overexpression could effectively attenuate MI/RI by reducing CML formation, providing a potential therapeutic target for MI/RI.	[Yang, Ji'e; Zhang, Feng; Shi, Huairui; Gao, Yang; Dong, Zhen; Ma, Leilei; Chang, Suchi; Qu, Yanan; Hu, Kai; Sun, Aijun; Ge, Junbo] Fudan Univ, Inst Cardiovasc Dis, Zhongshan Hosp, Dept Cardiol, Shanghai, Peoples R China; [Sun, Xiaolei; Li, Xiao; Wang, Zeng; Li, Hua; Sun, Aijun; Ge, Junbo] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China	Fudan University; Fudan University	Sun, AJ; Ge, JB (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Zhongshan Hosp,Inst Biomed Sci, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	sun.aijun@zs-hospital.sh.cn; jbge@zs-hospital.sh.cn		Qu, Yi/0000-0002-9993-8810	National Natural Science Foundation [81521001, 81570224, 81725002, 81870268, 91639104]; National Key Research and Development Program [2016YFC1301204]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	The authors acknowledge Prof. Ruiyan Zhang and Prof. Lin Lu (Ruijin Hospital, Medical College of Shanghai Jiao Tong University, Shanghai, China) for kindly providing homozygous RAGE knockout mice. The authors express gratitude to Prof. Shuhui Sun (Laboratory of Medical Molecular Virology, Fudan University), for excellent technical assistance in flow cytometry analysis. The authors are also grateful to the coronary interventional team from Cardiological Intervention Center, Zhongshan Hospital, for collecting blood samples of patients with AMI. The authors acknowledge Beiqi Chen, Rifeng Gao, and Heng Yang (Shanghai Jiao Tong University) for help with this study. This work was supported by the National Natural Science Foundation (Grants 81521001, 81570224, 81725002, 81870268, and 91639104), and the National Key Research and Development Program (Grant 2016YFC1301204). The authors declare no conflicts of interest.	Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Binder A, 2015, EXPERT REV CARDIOVAS, V13, P1045, DOI 10.1586/14779072.2015.1070669; Blackburn NJR, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0646-x; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Byun K, 2017, PHARMACOL THERAPEUT, V177, P44, DOI 10.1016/j.pharmthera.2017.02.030; Cheng AS, 2012, J AGR FOOD CHEM, V60, P9180, DOI 10.1021/jf302831d; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Fernandez-Jimenez R, 2015, J AM COLL CARDIOL, V66, P816, DOI 10.1016/j.jacc.2015.06.023; Gaens KHJ, 2015, ARTERIOSCL THROM VAS, V35, P2707, DOI 10.1161/ATVBAHA.115.306106; Gaens KHJ, 2012, J HEPATOL, V56, P647, DOI 10.1016/j.jhep.2011.07.028; Garay-Sevilla ME, 2005, J ENDOCRINOL INVEST, V28, P223, DOI 10.1007/BF03345377; Ge JB, 2005, ARTERIOSCL THROM VAS, V25, P2157, DOI 10.1161/01.ATV.0000181744.58265.63; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Guo XY, 2017, CIRCULATION, V136, P729, DOI 10.1161/CIRCULATIONAHA.116.026240; Hausenloy DJ, 2017, EUR HEART J, V38, P935, DOI 10.1093/eurheartj/ehw145; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Heusch G, 2017, EUR HEART J, V38, P774, DOI 10.1093/eurheartj/ehw224; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Kapur NK, 2015, JACC-HEART FAIL, V3, P873, DOI 10.1016/j.jchf.2015.06.010; Kralev S, 2009, CLIN CHEM LAB MED, V47, P446, DOI 10.1515/CCLM.2009.100; Lippi G, 2013, SEMIN THROMB HEMOST, V39, P202, DOI 10.1055/s-0032-1333543; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Machahua C, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0460-2; Maessen DEM, 2015, CLIN SCI, V128, P839, DOI 10.1042/CS20140683; Maher P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021226; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Miller AG, 2010, DIABETES, V59, P3208, DOI 10.2337/db10-0552; Morgenstern J, 2017, J BIOL CHEM, V292, P3224, DOI 10.1074/jbc.M116.760132; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shang LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010092; Sreejit P, 2008, IN VITRO CELL DEV-AN, V44, P45, DOI 10.1007/s11626-007-9079-4; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tian YK, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0583-0; Trellu S, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-018-1801-y; Wolk MJ, 2014, J AM COLL CARDIOL, V63, P380, DOI 10.1016/j.jacc.2013.11.009; Wozniak KL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-65; Xie L, 2015, J MOL CELL CARDIOL, V80, P156, DOI 10.1016/j.yjmcc.2015.01.007; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Zhang T, 2016, NAT MED, V22, P175, DOI 10.1038/nm.4017	45	12	12	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14410	14422		10.1096/fj.201900115RR	http://dx.doi.org/10.1096/fj.201900115RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31665609	Bronze			2022-12-28	WOS:000507466100104
J	Zub, E; Canet, G; Garbelli, R; Blaquiere, M; Rossini, L; Pastori, C; Sheikh, M; Reutelingsperger, C; Klement, W; de Bock, F; Audinat, E; Givalois, L; Solito, E; Marchi, N				Zub, Emma; Canet, Geoffrey; Garbelli, Rita; Blaquiere, Marine; Rossini, Laura; Pastori, Chiara; Sheikh, Madeeha; Reutelingsperger, Chris; Klement, Wendy; de Bock, Frederic; Audinat, Etienne; Givalois, Laurent; Solito, Egle; Marchi, Nicola			The GR-ANXA1 pathway is a pathological player and a candidate target in epilepsy	FASEB JOURNAL			English	Article						annexin A1; glucocorticoid receptor; brain/peripheral inflammation; endogenous antiinflammatory signals; epilepsy	ANNEXIN A1; INFLAMMATION; RESOLUTION; IL-6	Immune changes occur in experimental and clinical epilepsy. Here, we tested the hypothesis that during epileptogenesis and spontaneous recurrent seizures (SRS) an impairment of the endogenous anti-inflammatory pathway glucocorticoid receptor (GR)-annexin A1 (ANXA1) occurs. By administrating exogenous ANXA1, we studied whether pharmacological potentiation of the anti-inflammatory response modifies seizure activity and pathophysiology. We used an in vivo model of temporal lobe epilepsy based on intrahippocampal kainic acid (KA) injection. Video-electroencephalography, molecular biology analyses on brain and peripheral blood samples, and pharmacological investigations were performed in this model. Human epileptic cortices presenting type II focal cortical dysplasia (IIa and b), hippocampi with or without hippocampal sclerosis (HS), and available controls were used to study ANXA1 expression. A decrease of phosphorylated (phospho-) GR and phospho-GR/tot-GR protein expression occurred in the hippocampus during epileptogenesis. Downstream to GR, the anti-inflammatory protein ANXA1 remained at baseline levels while inflammation installed and endured. In peripheral blood, ANXA1 and corticosterone levels showed no significant modifications during disease progression except for an early and transient increase poststatus epilepticus. These results indicate inadequate ANXA1 engagement over time and in these experimental conditions. By analyzing human brain specimens, we found that where significant inflammation exists, the pattern of ANXA1 immunoreactivity was abnormal because the typical perivascular ANXA1 immunoreactivity was reduced. We next asked whether potentiation of the endogenous anti-inflammatory mechanism by ANXA1 administration modifies the disease pathophysiology. Although with varying efficacy, administration of exogenous ANXA1 somewhat reduced the time spent in seizure activity as compared to saline. These results indicate that the anti-inflammatory GR-ANXA1 pathway is defective during experimental seizure progression. The prospect of pharmacologically restoring or potentiating this endogenous anti-inflammatory mechanism as an add-on therapeutic strategy for specific forms of epilepsy is proposed.	[Zub, Emma; Blaquiere, Marine; Klement, Wendy; de Bock, Frederic; Audinat, Etienne; Marchi, Nicola] Univ Montpellier, Lab Cerebrovasc & Glia Res, Inst Funct Genom,Dept Neurosci, INSERM,Unite Mixtes Rech UMR 5203,CNRS,U1191, Montpellier, France; [Canet, Geoffrey; Givalois, Laurent] Univ Montpellier, INSERM, Mol Mech Neurodegenerat Dis, U1198, Montpellier, France; [Garbelli, Rita; Rossini, Laura; Pastori, Chiara] Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Ist Neurol Carlo Besta, Epilepsy Unit, Milan, Italy; [Sheikh, Madeeha; Solito, Egle] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Reutelingsperger, Chris] Maastricht Univ, Cardiovasc Res Inst, Dept Biochem, Maastricht, Netherlands; [Solito, Egle] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; IRCCS Istituto Neurologico Besta; University of London; Queen Mary University London; Maastricht University; University of Naples Federico II	Solito, E (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England.; Marchi, N (corresponding author), INSERM, Inst Funct Genom, Cerebrovasc & Glia Res, CNRS,UMR5203,U1191, 141 Rue Cardonille, F-34094 Montpellier 5, France.; Marchi, N (corresponding author), Univ Montpellier, 141 Rue Cardonille, F-34094 Montpellier 5, France.	e.solito@qmul.ac.uk; nicola.marchi@igf.cnrs.fr	Pastori, Chiara/J-8826-2016; Rossini, Laura/AAN-2654-2021; Audinat, Etienne/F-4789-2019; Garbelli, Rita/J-8327-2016; Marchi, Nicola/J-8607-2016	Pastori, Chiara/0000-0002-9121-5087; Rossini, Laura/0000-0003-3571-8779; Audinat, Etienne/0000-0002-6389-422X; Garbelli, Rita/0000-0002-6475-4974; Marchi, Nicola/0000-0001-9124-0226; Sheikh, Madeeha/0000-0001-7029-2457; Solito, Egle/0000-0001-5279-0049; CANET, Geoffrey/0000-0001-7291-4512; Givalois, Laurent/0000-0002-6698-5346	Agence Nationale de la Recherche (ANR)-Epicyte; Federation Recherche sur le Cerveau (FRC); Citizens United for Research in Epilepsy (CURE) Innovator Award; Italian Ministry of Health [RF-2016-02362195]; Fondazione Italiana Sclerosi Multipla (FISM) [2014/R/21]; British Heart Foundation (BHF); University of Montpellier	Agence Nationale de la Recherche (ANR)-Epicyte(French National Research Agency (ANR)); Federation Recherche sur le Cerveau (FRC); Citizens United for Research in Epilepsy (CURE) Innovator Award; Italian Ministry of Health(Ministry of Health, Italy); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); British Heart Foundation (BHF)(British Heart Foundation); University of Montpellier	This work was supported by the Agence Nationale de la Recherche (ANR)-Epicyte, Federation Recherche sur le Cerveau (FRC), and Citizens United for Research in Epilepsy (CURE) Innovator Award (to N.M.), and by Italian Ministry of Health Grant RF-2016-02362195 (to R.G.). The authors thank Dr. A. Maiorana (Istituto Neurologico Carlo Besta Institute) for providing autoptic tissues. The E.S. Laboratory was supported by Fondazione Italiana Sclerosi Multipla (FISM; 2014/R/21) and the British Heart Foundation (BHF). G.C. was supported by the University of Montpellier [Sciences Chimiques et Biologiques pour la Sante (CBS2) Ph.D. Program]. The authors declare no conflicts of interest.	Bakker DP, 2015, EUR J PAEDIATR NEURO, V19, P553, DOI 10.1016/j.ejpn.2015.04.006; Bar-Klein G, 2014, ANN NEUROL, V75, P864, DOI 10.1002/ana.24147; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Clarkson BDS, 2019, ANN NEUROL, V85, P526, DOI 10.1002/ana.25439; Cristante E, 2013, P NATL ACAD SCI USA, V110, P832, DOI 10.1073/pnas.1209362110; DeSena AD, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1063-2; Frigerio F, 2018, BRAIN, V141, P3130, DOI 10.1093/brain/awy247; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Garbelli R, 1999, BRAIN PATHOL, V9, P445, DOI 10.1111/j.1750-3639.1999.tb00534.x; Gimenes AD, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1414-7; Gussenhoven R, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020137; Klement W, 2019, EPILEPSIA, V60, P1399, DOI 10.1111/epi.16019; Klement W, 2018, NEUROBIOL DIS, V113, P70, DOI 10.1016/j.nbd.2018.02.002; Kusters DHM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130484; Marchi N, 2014, TRENDS NEUROSCI, V37, P55, DOI 10.1016/j.tins.2013.11.002; Marchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018200; Perretti M, 2015, TRENDS PHARMACOL SCI, V36, P737, DOI 10.1016/j.tips.2015.07.007; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Peshavariya HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060790; Pineau F, 2016, NEUROBIOL AGING, V45, P109, DOI 10.1016/j.neurobiolaging.2016.05.018; Purvis GSD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00938; Purvis GSD, 2018, DIABETOLOGIA, V61, P482, DOI 10.1007/s00125-017-4469-y; Ramos AB, 2019, J INVEST MED HIGH IM, V7, DOI 10.1177/2324709619848816; Roviezzo F, 2002, J PHYSIOL PHARMACOL, V53, P541; Runtz L, 2018, EPILEPSIA, V59, P123, DOI 10.1111/epi.13942; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258; Trentin PG, 2015, BRIT J PHARMACOL, V172, P3058, DOI 10.1111/bph.13109; van Vliet EA, 2012, EPILEPSIA, V53, P1254, DOI 10.1111/j.1528-1167.2012.03513.x; Varvel NH, 2016, P NATL ACAD SCI USA, V113, pE5665, DOI 10.1073/pnas.1604263113; Verhelst H, 2005, SEIZURE-EUR J EPILEP, V14, P412, DOI 10.1016/j.seizure.2005.07.002; Vezzani A, 2019, NAT REV NEUROL, V15, P459, DOI 10.1038/s41582-019-0217-x; Vezzani Annamaria, 2012, Handb Clin Neurol, V107, P163, DOI 10.1016/B978-0-444-52898-8.00010-0; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wang Z, 2017, J CEREBR BLOOD F MET, V37, P2509, DOI 10.1177/0271678X16669513; Xu D, 2018, J EXP MED, V215, P1169, DOI 10.1084/jem.20171285; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yang YH, 2006, J IMMUNOL, V177, P8148, DOI 10.4049/jimmunol.177.11.8148; Yang YH, 2013, NAT REV RHEUMATOL, V9, P595, DOI 10.1038/nrrheum.2013.126; Yang YH, 2009, J IMMUNOL, V183, P1435, DOI 10.4049/jimmunol.0804000; Yao BZ, 2015, MED SCI MONIT BASIC, V21, P241, DOI 10.12659/MSMBR.895487	41	12	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13998	14009		10.1096/fj.201901596R	http://dx.doi.org/10.1096/fj.201901596R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31618599	Green Submitted			2022-12-28	WOS:000507466100072
J	Li, ZL; Zhang, ZL; Ke, LR; Sun, YS; Li, WX; Feng, X; Zhu, W; Chen, SF				Li, Zilun; Zhang, Zili; Ke, Liangru; Sun, Yanshuang; Li, Wenxue; Feng, Xiang; Zhu, Wei; Chen, Sifan			Resveratrol promotes white adipocytes browning and improves metabolic disorders in Sirt1-dependent manner in mice	FASEB JOURNAL			English	Article						adipose tissues; browning; metabolites; obesity; resveratrol; silent information regulator 1	ADIPOSE-TISSUE THERMOGENESIS; INSULIN-RESISTANCE; FAT; OBESITY; SIRT1; SULFOTRANSFERASES; SUPPLEMENTATION; BIOAVAILABILITY; ABSORPTION; ACTIVATION	Obesity has become an epidemic concern in modern society. The chronic obesity is associated with metabolic disorders, such as hyperglycemia, hyperlipidemia, fatty liver, and cadiovascular disease, which cause high risk for mortality. The novel potential strategy to overcome obesity is to "burn out" the extra fat via "browning" of the white adipose tissues. The phytochemical resveratrol (Res) has attracted substantial attention due to its powerful amelioratory effects in metabolic diseases. However, how Res regulates the browning of adipose tissues remains largely elusive. Our data show that the NAD(+)-dependent deacetylase silent information regulator 1 (Sirt1) mediates Res-induced browning and fat reduction of adipocytes, as well as other Res-improved metabolic phenotypes including hyperglycemina and hyperlipidemia in mice. Interestingly, we found that the major metabolites of Res in vivo (Res-3-O-glucuronide, Res-4 '-O-glucuronide, and Res-3-O-sulfate) were much less potent in promoting browning gene expressions and reducing fat content in comparison to Res itself in mouse and human adipocytes in vitro, suggesting the importance and necessarity to enhance the bioavailability of Res in vivo in consideration of therapeutic application. Taken together, our findings clarify the beneficial effects of Res on excess fat utilization via promotion of browning in a Sirt1-dependent manner, suggesting the potential therapeutic application of Res in the treatment of obesity and related metabolic disorders.	[Li, Zilun] Sun Yat Sen Univ, Affiliated Hosp 1, Div Vasc Surg, Guangzhou, Peoples R China; [Zhang, Zili] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Peoples R China; [Ke, Liangru] Sun Yat Sen Univ, Dept Radiol, Canc Ctr, Guangzhou, Peoples R China; [Sun, Yanshuang; Feng, Xiang] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Peoples R China; [Li, Wenxue; Zhu, Wei] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Peoples R China; [Chen, Sifan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, SF (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China.	chensf26@mail.sysu.edu.cn						Alberdi G, 2013, FOOD CHEM, V141, P1530, DOI 10.1016/j.foodchem.2013.03.085; Andreadi C, 2014, AUTOPHAGY, V10, P524, DOI 10.4161/auto.27593; Arias N, 2017, OBESITY, V25, P111, DOI 10.1002/oby.21706; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Blanchard OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090131; Bohmdorfer M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121347; Borrell LN, 2014, AM J PUBLIC HEALTH, V104, P512, DOI 10.2105/AJPH.2013.301597; Calleri E, 2014, CHEMBIOCHEM, V15, P1154, DOI 10.1002/cbic.201300754; Cercato C, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0468-0; Chen SF, 2018, J NUTR BIOCHEM, V55, P209, DOI 10.1016/j.jnutbio.2018.02.007; Chen SF, 2012, J NUTR BIOCHEM, V23, P1100, DOI 10.1016/j.jnutbio.2011.06.003; Chen SF, 2012, CAN J PHYSIOL PHARM, V90, P237, DOI [10.1139/Y11-123, 10.1139/y11-123]; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Colom H, 2011, PHARM RES-DORDR, V28, P1606, DOI 10.1007/s11095-011-0395-8; Das S, 2008, PHARM RES-DORDR, V25, P2593, DOI 10.1007/s11095-008-9677-1; Chu DT, 2017, BIOCHIMIE, V138, P102, DOI 10.1016/j.biochi.2017.04.017; Dong SZ, 2011, MOL CELL BIOCHEM, V358, P281, DOI 10.1007/s11010-011-0978-z; Eseberri I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063918; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; Johnson JJ, 2011, MOL NUTR FOOD RES, V55, P1169, DOI 10.1002/mnfr.201100117; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lam YY, 2013, EXP GERONTOL, V48, P1018, DOI 10.1016/j.exger.2013.04.005; Liang L, 2013, PHYTOMEDICINE, V20, P558, DOI 10.1016/j.phymed.2012.12.012; Meldrum DR, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.02.104; Mena P, 2018, J AGR FOOD CHEM, V66, P8221, DOI 10.1021/acs.jafc.8b03249; Miksits M, 2005, XENOBIOTICA, V35, P1101, DOI 10.1080/00498250500354253; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Okla M, 2017, ADV NUTR, V8, P473, DOI 10.3945/an.116.014332; Andrade JMO, 2014, EUR J NUTR, V53, P1503, DOI 10.1007/s00394-014-0655-6; Pan Y, 2013, MOL CELL ENDOCRINOL, V367, P116, DOI 10.1016/j.mce.2012.12.027; Park SY, 2016, ONCOL REP, V35, P3248, DOI 10.3892/or.2016.4716; Patel KR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005870; Piche ME, 2018, PROG CARDIOVASC DIS, V61, P103, DOI 10.1016/j.pcad.2018.06.004; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Silvester AJ, 2019, J NUTR BIOCHEM, V64, P1, DOI 10.1016/j.jnutbio.2018.09.028; Soleas GJ, 2001, METHOD ENZYMOL, V335, P145; Springer M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010143; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Timmers S, 2016, DIABETES CARE, V39, P2211, DOI 10.2337/dc16-0499; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Voloshyna I, 2016, EXP BIOL MED, V241, P1611, DOI 10.1177/1535370216647181; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; Zou TD, 2017, J PHYSIOL-LONDON, V595, P1547, DOI 10.1113/JP273478	50	16	18	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4527	4539		10.1096/fj.201902222R	http://dx.doi.org/10.1096/fj.201902222R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32003501				2022-12-28	WOS:000519218400072
J	Anderson-Baron, M; Kunze, M; Mulet-Sierra, A; Adesida, AB				Anderson-Baron, Matthew; Kunze, Melanie; Mulet-Sierra, Aillette; Adesida, Adetola B.			Effect of cell seeding density on matrix-forming capacity of meniscus fibrochondrocytes and nasal chondrocytes in meniscus tissue engineering	FASEB JOURNAL			English	Article						meniscus; nasal cartilage; pellet model; tissue engineering	MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; SAFRANIN-O; KNEE; OSTEOARTHRITIS; PHENOTYPE; COLLAGEN; TIME; DIFFERENTIATION; REGENERATION	The presence of intact menisci is imperative for the proper function of the knee joint. Meniscus injuries are often treated by the surgical removal of the damaged tissue, which increases the likelihood of post-traumatic osteoarthritis. Tissue engineering holds great promise in producing viable engineered meniscal tissue for implantation using the patient's own cells; however, the cell source for producing the engineered tissue is unclear. Nasal chondrocytes (NC) possess many attractive features for engineering meniscus. However, in order to validate the use of NC for engineering meniscus fibrocartilage, a thorough comparison of NC and meniscus fibrochondrocytes (MFC) must be considered. Our study presents an analysis of the relative features of NC and MFC and their respective chondrogenic potential in a pellet culture model. We showed considerable differences in the cartilage tissue formed by the two different cell types. Our data showed that NC were more proliferative in culture, deposited more extracellular matrix, and showed higher expression of chondrogenic genes than MFC. Overall, our data suggest that NC produce superior cartilage tissue to MFC in a pellet culture model. In addition, NCs produce higher quality cartilage tissue at higher cell seeding densities during cell expansion.	[Anderson-Baron, Matthew; Kunze, Melanie; Mulet-Sierra, Aillette; Adesida, Adetola B.] Univ Alberta, Fac Med & Dent, Dept Surg, Div Orthopaed Surg, Edmonton, AB T6G 2E1, Canada; [Anderson-Baron, Matthew; Kunze, Melanie; Mulet-Sierra, Aillette; Adesida, Adetola B.] Univ Alberta, Fac Med & Dent, Dept Surg, Div Surg Res, Edmonton, AB T6G 2E1, Canada; [Anderson-Baron, Matthew; Kunze, Melanie; Mulet-Sierra, Aillette; Adesida, Adetola B.] 3 021 Li Ka Shing Ctr Hlth Res Innovat, Lab Stem Cell Biol & Orthopaed Tissue Engn, Edmonton, AB, Canada	University of Alberta; University of Alberta	Adesida, AB (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, Div Orthopaed Surg, Edmonton, AB T6G 2E1, Canada.; Adesida, AB (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, Div Surg Res, Edmonton, AB T6G 2E1, Canada.	adesida@ualberta.ca	Adesida, Adetola B/H-3549-2011	Adesida, Adetola B/0000-0003-1798-6251	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [CIHR MOP 125921, CIHR PS 159661]; Alberta Cancer Foundation [ACFMIBRP 27128]; Canadian Foundation for Innovation [CFI 33786]; University Hospital Foundation [RES0028185]	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); University Hospital Foundation	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: CIHR MOP 125921 and CIHR PS 159661; Alberta Cancer Foundation, Grant/Award Number: ACFMIBRP 27128; Canadian Foundation for Innovation, Grant/Award Number: CFI 33786; University Hospital Foundation, Grant/Award Number: RES0028185	Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Andrews SHJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06666-2; Andrews SHJ, 2017, CONNECT TISSUE RES, V58, P271, DOI 10.1080/03008207.2017.1303489; Baker BM, 2009, OSTEOARTHR CARTILAGE, V17, P336, DOI 10.1016/j.joca.2008.08.001; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; Bornes TD, 2016, TISSUE ENG PART C-ME, V22, P208, DOI [10.1089/ten.tec.2015.0365, 10.1089/ten.TEC.2015.0365]; Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X; CAMPLEJOHN KL, 1988, HISTOCHEMISTRY, V89, P185, DOI 10.1007/BF00489922; Candrian C, 2008, ARTHRITIS RHEUM-US, V58, P197, DOI 10.1002/art.23155; Chen S, 2017, CELL TISSUE RES, V370, P53, DOI 10.1007/s00441-017-2613-0; Cigan AD, 2016, J BIOMECH, V49, P1909, DOI 10.1016/j.jbiomech.2016.04.039; EVANS CH, 1983, MECH AGEING DEV, V22, P179, DOI 10.1016/0047-6374(83)90111-2; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664, DOI 10.1302/0301-620X.30B4.664; Frohlich M, 2007, CELL BIOL INT, V31, P620, DOI 10.1016/j.cellbi.2006.12.003; Fulco I, 2014, LANCET, V384, P337, DOI 10.1016/S0140-6736(14)60544-4; Gunja NJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2293; Hatsushika D, 2014, OSTEOARTHR CARTILAGE, V22, P941, DOI 10.1016/j.joca.2014.04.028; Hatsushika D, 2013, J ORTHOP RES, V31, P1354, DOI 10.1002/jor.22370; HEINEGARD D, 1989, FASEB J, V3, P2042, DOI 10.1096/fasebj.3.9.2663581; HERWIG J, 1984, ANN RHEUM DIS, V43, P635, DOI 10.1136/ard.43.4.635; Karia M, 2019, EUR J ORTHOP SURG TR, V29, P509, DOI 10.1007/s00590-018-2317-5; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kobayashi S, 2008, J ORTHOP RES, V26, P493, DOI 10.1002/jor.20507; Kon E, 2012, TISSUE ENG PT A, V18, P1573, DOI [10.1089/ten.TEA.2011.0572, 10.1089/ten.tea.2011.0572]; Liang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12096-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Marsano A, 2007, OSTEOARTHR CARTILAGE, V15, P48, DOI 10.1016/j.joca.2006.06.009; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8; Mine T, 2013, J ORTHOP SURG-HONG K, V21, P216, DOI 10.1177/230949901302100221; Mounts T, 2012, CARTILAGE, V3, P181, DOI 10.1177/1947603511420999; Mumme M, 2016, LANCET, V388, P1985, DOI 10.1016/S0140-6736(16)31658-0; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nakata K, 2001, CLIN ORTHOP RELAT R, pS208; Papalia R, 2011, BRIT MED BULL, V99, P89, DOI 10.1093/bmb/ldq043; Pelttari K, 2017, CURR OPIN BIOTECH, V47, P1, DOI 10.1016/j.copbio.2017.05.007; Pelttari K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009688; RANGGER C, 1995, AM J SPORT MED, V23, P240, DOI 10.1177/036354659502300219; Roos H, 1995, OSTEOARTHR CARTILAGE, V3, P261, DOI 10.1016/S1063-4584(05)80017-2; ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scotti C, 2012, TISSUE ENG PT A, V18, P362, DOI [10.1089/ten.tea.2011.0234, 10.1089/ten.TEA.2011.0234]; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; STOKER MGP, 1967, NATURE, V215, P171, DOI 10.1038/215171a0; Tan GK, 2011, CELL ADHES MIGR, V5, P220, DOI 10.4161/cam.5.3.14463; Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572; Verdonk PCM, 2005, OSTEOARTHR CARTILAGE, V13, P548, DOI 10.1016/j.joca.2005.01.010; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wilson CG, 2009, TISSUE ENG PT A, V15, P1513, DOI 10.1089/ten.tea.2008.0106; Yang BW, 2019, CURR REV MUSCULOSKE, V12, P233, DOI 10.1007/s12178-019-09554-6; Yu HN, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0077-2	54	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5538	5551		10.1096/fj.201902559R	http://dx.doi.org/10.1096/fj.201902559R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32090374	Bronze			2022-12-28	WOS:000515261300001
J	Bhandarkar, NS; Mouatt, P; Goncalves, P; Thomas, T; Brown, L; Panchal, SK				Bhandarkar, Nikhil S.; Mouatt, Peter; Goncalves, Priscila; Thomas, Torsten; Brown, Lindsay; Panchal, Sunil K.			Modulation of gut microbiota by spent coffee grounds attenuates diet-induced metabolic syndrome in rats	FASEB JOURNAL			English	Article						gut microbiota; metabolic syndrome; obesity; rats; spent coffee grounds	CHAIN FATTY-ACIDS; HIGH-CARBOHYDRATE; LIPID PROFILE; GREEN COFFEE; OBESITY; WASTE; HEALTH; INDUSTRY; CANCER; OLIGOSACCHARIDES	Coffee brewing produces spent coffee grounds as waste; few studies have investigated the health benefits of these grounds. This study investigated responses to spent coffee grounds in a diet-induced rat model of metabolic syndrome. Male Wistar rats aged 8-9 weeks were fed either corn starch-rich diet or high-carbohydrate, high-fat diet for 16 weeks, which were supplemented with 5% spent coffee grounds during the last 8 weeks. Rats fed non-supplemented diets were used as controls. High-carbohydrate, high-fat diet-fed rats developed metabolic syndrome including abdominal obesity, impaired glucose tolerance, dyslipidemia, and cardiovascular and liver damage. Body weight, abdominal fat, total body fat mass, systolic blood pressure, and concentrations of plasma triglycerides and non-esterified fatty acids were reduced by spent coffee grounds along with improved glucose tolerance and structure and function of heart and liver. Spent coffee grounds increased the diversity of the gut microbiota and decreased the ratio of Firmicutes to Bacteroidetes. Changes in gut microbiota correlated with the reduction in obesity and improvement in glucose tolerance and systolic blood pressure. These findings indicate that intervention with spent coffee grounds may be useful for managing obesity and metabolic syndrome by altering the gut microbiota, thus increasing the value of this food waste.	[Bhandarkar, Nikhil S.; Brown, Lindsay; Panchal, Sunil K.] Univ Southern Queensland, Funct Foods Res Grp, Toowoomba, Qld, Australia; [Bhandarkar, Nikhil S.; Brown, Lindsay] Univ Southern Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld, Australia; [Mouatt, Peter] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia; [Goncalves, Priscila; Thomas, Torsten] Univ New South Wales, Ctr Marine Sci & Innovat, Sydney, NSW, Australia; [Goncalves, Priscila; Thomas, Torsten] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Panchal, Sunil K.] Western Sydney Univ, Sch Sci, Richmond, NSW 2753, Australia; [Bhandarkar, Nikhil S.] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel	University of Southern Queensland; University of Southern Queensland; Southern Cross University; University of New South Wales Sydney; University of New South Wales Sydney; Western Sydney University; Ben Gurion University	Panchal, SK (corresponding author), Western Sydney Univ, Sch Sci, Richmond, NSW 2753, Australia.	S.Panchal@westernsydney.edu.au	Bhandarkar, Nikhil Suresh/AAV-4263-2020	Bhandarkar, Nikhil Suresh/0000-0001-8790-8940	University of Southern Queensland (USQ) [SRF-09]	University of Southern Queensland (USQ)	University of Southern Queensland (USQ), Grant/Award Number: SRF-09	Bekedam EK, 2008, J AGR FOOD CHEM, V56, P7138, DOI 10.1021/jf800999a; Bhandarkar NS, 2019, J FUNCT FOODS, V57, P141, DOI 10.1016/j.jff.2019.04.003; Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002; Bravo J, 2013, FOOD CHEM TOXICOL, V60, P397, DOI 10.1016/j.fct.2013.08.002; Byrne CS, 2015, INT J OBESITY, V39, P1331, DOI 10.1038/ijo.2015.84; Caligiuri SPB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-232; CAMERON A, 2016, COFFEE GROUND RECOVE; Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012; Candela M, 2014, WORLD J GASTROENTERO, V20, P908, DOI 10.3748/wjg.v20.i4.908; Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723; Cervera-Mata A, 2019, FOOD CHEM, V282, P1, DOI 10.1016/j.foodchem.2018.12.101; Choi B, 2017, FOOD SCI BIOTECHNOL, V26, P921, DOI 10.1007/s10068-017-0144-9; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Coppo E, 2014, CURR PHARM BIOTECHNO, V15, P380, DOI 10.2174/138920101504140825121142; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eteberria U, 2015, J NUTR BIOCHEM, V26, P651, DOI 10.1016/j.jnutbio.2015.01.002; Fan L, 2000, ACTA BIOTECHNOL, V20, P41, DOI 10.1002/abio.370200108; Fernandes AS, 2017, ECOTOX ENVIRON SAFE, V141, P30, DOI 10.1016/j.ecoenv.2017.03.011; Filosa S, 2018, NEURAL REGEN RES, V13, P2055, DOI 10.4103/1673-5374.241429; Fisgativa H, 2017, J ENVIRON MANAGE, V188, P95, DOI 10.1016/j.jenvman.2016.11.058; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Fu XY, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-3; Garcia-Garcia G, 2019, J CLEAN PROD, V211, P1339, DOI 10.1016/j.jclepro.2018.11.269; Guo Z, 2012, CLIN LIPIDOL, V7, P215, DOI 10.2217/CLP.12.8; Harakeh SM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00095; Rodiguez MH, 2018, J ENVIRON CHEM ENG, V6, P1161, DOI 10.1016/j.jece.2017.12.045; *INT COFF ORG, TOT PROD ALL EXP COU; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Karmee SK, 2018, WASTE MANAGE, V72, P240, DOI 10.1016/j.wasman.2017.10.042; Kim J, 2017, BIORESOURCE TECHNOL, V241, P1182, DOI 10.1016/j.biortech.2017.06.012; Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1; Kourmentza C, 2018, J CLEAN PROD, V172, P980, DOI 10.1016/j.jclepro.2017.10.088; Kwon EE, 2013, BIORESOURCE TECHNOL, V136, P475, DOI 10.1016/j.biortech.2013.03.052; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahboobi S, 2018, ADV PHARM BULL, V8, P565, DOI 10.15171/apb.2018.065; Hernandez-Arriaga AM, 2017, FOOD RES INT, V97, P191, DOI 10.1016/j.foodres.2017.04.004; Lopez-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175; Martinez I, 2013, APPL ENVIRON MICROB, V79, P516, DOI 10.1128/AEM.03046-12; Martinez-Saez N, 2017, FOOD CHEM, V216, P114, DOI 10.1016/j.foodchem.2016.07.173; MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Mesias M, 2017, CURR OPIN FOOD SCI, V14, P37, DOI 10.1016/j.cofs.2017.01.007; Mohsin GF, 2018, FOOD CHEM, V245, P761, DOI 10.1016/j.foodchem.2017.11.115; Morales FJ, 2012, AMINO ACIDS, V42, P1097, DOI 10.1007/s00726-010-0774-1; Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f; Murugesan S, 2015, EUR J CLIN MICROBIOL, V34, P1337, DOI 10.1007/s10096-015-2355-4; O'Connor S, 2017, MATURITAS, V104, P11, DOI 10.1016/j.maturitas.2017.07.005; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Ooi LG, 2010, INT J MOL SCI, V11, P2499, DOI 10.3390/ijms11062499; Oseguera-Castro KY, 2019, FOOD FUNCT, V10, P4546, DOI [10.1039/C9FO01021A, 10.1039/c9fo01021a]; Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013; Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Passos CP, 2019, CARBOHYD POLYM, V214, P53, DOI 10.1016/j.carbpol.2019.02.094; Paun A, 2016, PEDIATR DIABETES, V17, P469, DOI 10.1111/pedi.12424; Perez-Burillo S, 2019, J AGR FOOD CHEM, V67, P2500, DOI 10.1021/acs.jafc.8b06604; Petrik S, 2014, BIOCHEM ENG J, V90, P307, DOI 10.1016/j.bej.2014.06.025; Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024; Rahim MBHA, 2019, ACTA DIABETOL, V56, P493, DOI 10.1007/s00592-019-01312-x; Ramalakshmi K, 2009, FOOD CHEM, V115, P79, DOI 10.1016/j.foodchem.2008.11.063; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ribeiro H, 2013, EUR J LIPID SCI TECH, V115, P330, DOI 10.1002/ejlt.201200239; Ribeiro JP, 2017, ENVIRON SCI POLLUT R, V24, P15270, DOI 10.1007/s11356-017-9134-y; Sales AL, 2020, FOOD FUNCT, V11, P1410, DOI [10.1039/C9FO02589H, 10.1039/c9fo02589h]; Santos C, 2017, WASTE MANAGE, V59, P37, DOI 10.1016/j.wasman.2016.10.020; Schoeler M, 2019, REV ENDOCR METAB DIS, V20, P461, DOI 10.1007/s11154-019-09512-0; Sekar S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46457; Stylianou M, 2018, ENVIRON SCI POLLUT R, V25, P35776, DOI 10.1007/s11356-018-2359-6; Tagliazucchi D, 2015, AMINO ACIDS, V47, P1077, DOI 10.1007/s00726-015-1951-z; Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715; Tian T, 2017, J AGR FOOD CHEM, V65, P2784, DOI 10.1021/acs.jafc.6b04716; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Vazquez-Sanchez K, 2018, FOOD CHEM, V261, P253, DOI 10.1016/j.foodchem.2018.04.064; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wang LL, 2017, FOOD FUNCT, V8, P1966, DOI [10.1039/C7FO00031F, 10.1039/c7fo00031f]; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Wanyonyi S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111261; Wu LF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15904; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	85	14	14	5	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4783	4797		10.1096/fj.201902416RR	http://dx.doi.org/10.1096/fj.201902416RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32039529				2022-12-28	WOS:000512571500001
J	Namuduri, AV; Heras, G; Lauschke, VM; Vitadello, M; Traini, L; Cacciani, N; Gorza, L; Gastaldello, S				Namuduri, Arvind Venkat; Heras, Gabriel; Lauschke, Volker M.; Vitadello, Maurizio; Traini, Leonardo; Cacciani, Nicola; Gorza, Luisa; Gastaldello, Stefano			Expression of SUMO enzymes is fiber type dependent in skeletal muscles and is dysregulated in muscle disuse	FASEB JOURNAL			English	Article						atrophy; muscle inactivity; PAX6; skeletal muscles; SUMO cycle; UBC9	SIGNALING PATHWAYS; SUMOYLATION; CONJUGATION; DIAPHRAGM; ATROPHY	SUMOylation is a dynamic, reversible, enzymatic drug-targetable post-translational modification (PTM) reaction where the Small Ubiquitin-like Modifier (SUMO) moieties are attached to proteins. This reaction regulates various biological functions like cell growth, differentiation, and it is crucial for maintaining organ homeostasis. However, the actions of SUMO in skeletal muscle pathophysiology are still not investigated. In this study, we quantified the abundance of the SUMO enzymes and determined the distribution of SUMOylated proteins along the fibers of nine different muscles. We find that skeletal muscles contain a distinctive group of SUMO enzymes and SUMOylated proteins in relation to their different metabolism, functions, and fiber type composition. In addition, before the activation of protein degradation pathways, this unique set is quickly altered in response to muscle sedentariness. Finally, we demonstrated that PAX6 acts as an upstream regulator of the SUMO conjugation reaction, which can become a potential therapeutic marker to prevent muscle diseases generated by inactivity.	[Namuduri, Arvind Venkat; Heras, Gabriel; Lauschke, Volker M.; Cacciani, Nicola; Gastaldello, Stefano] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Vitadello, Maurizio; Gorza, Luisa] Univ Padua, Dept Biomed Sci, Padua, Italy; [Traini, Leonardo] German Canc Res Ctr, Helmholtz Univ Grp Cell Plast & Epigenet Remodeli, Heidelberg, Germany; [Traini, Leonardo] Univ Hosp, Inst Pathol, Heidelberg, Germany; [Cacciani, Nicola] Karolinska Inst, Dept Clin Neurosci, Clin Neurophysiol, Stockholm, Sweden; [Gastaldello, Stefano] Binzhou Med Univ, Precis Med Res Ctr, Yantai, Peoples R China	Karolinska Institutet; University of Padua; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Karolinska Institutet; Binzhou Medical University	Gastaldello, S (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Solnavagen 9, S-17165 Solna, Sweden.	stefano.gastaldello@ki.se	Gastaldello, Stefano/AAM-6768-2020; Lauschke, Volker/O-3014-2017	Gastaldello, Stefano/0000-0001-7369-8452; Lauschke, Volker/0000-0002-1140-6204				Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Brocca L, 2012, J PHYSIOL-LONDON, V590, P5211, DOI 10.1113/jphysiol.2012.240267; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chopard A, 2009, J CELL MOL MED, V13, P3032, DOI 10.1111/j.1582-4934.2009.00864.x; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Da Silva-Ferrada E, 2016, INT J BIOCHEM CELL B, V79, P443, DOI 10.1016/j.biocel.2016.09.015; Dalla Libera L, 2009, J APPL PHYSIOL, V107, P549, DOI 10.1152/japplphysiol.00280.2009; de Albuquerque CP, 2016, J BIOL CHEM, V291, P8825, DOI 10.1074/jbc.M116.716399; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Grichko VP, 2000, J APPL PHYSIOL, V88, P473, DOI 10.1152/jappl.2000.88.2.473; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Henley JM, 2014, PHYSIOL REV, V94, P1249, DOI 10.1152/physrev.00008.2014; Heras G, 2019, J MOL CELL BIOL, V11, P356, DOI 10.1093/jmcb/mjy036; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Hirasawa T, 2013, J ANAT, V222, P504, DOI 10.1111/joa.12037; Hu YH, 2014, J BIOL CHEM, V289, P21289, DOI 10.1074/jbc.C114.582122; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Terradas ALI, 2018, J PATHOL, V246, P433, DOI 10.1002/path.5149; Liang YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26509; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mendler L, 2016, CIRC RES, V118, P132, DOI 10.1161/CIRCRESAHA.115.307730; Merrell AJ, 2013, FEBS J, V280, P4026, DOI 10.1111/febs.12274; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Namuduri AV, 2017, MOL CELL PROTEOMICS, V16, P1081, DOI 10.1074/mcp.M116.066159; Nikolic M, 2001, COLLEGIUM ANTROPOL, V25, P545; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salah H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7099; Santos AL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5716409; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Sinha N, 2016, MOL BIOL REP, V43, P345, DOI 10.1007/s11033-016-3979-x; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Suetta C, 2009, J APPL PHYSIOL, V107, P1172, DOI 10.1152/japplphysiol.00290.2009; Taherbhoy AM, 2012, ESSAYS BIOCHEM, V52, P51, DOI [10.1042/BSE0520051, 10.1042/bse0520051]; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wang J, 2010, CIRC RES, V107, P19, DOI 10.1161/CIRCRESAHA.110.220491; Wang J, 2009, FRONT BIOSCI-LANDMRK, V14, P1219, DOI 10.2741/3304; Wei LM, 2018, MOL CELL PROTEOMICS, V17, P148, DOI 10.1074/mcp.RA117.000124; Widmer CG, 2010, PROG BRAIN RES, V187, P63, DOI [10.1016/S0079-6123(10)87005-0, 10.1016/B978-0-444-53613-6.00005-8]; Xiong DZ, 2017, P NATL ACAD SCI USA, V114, pE6686, DOI 10.1073/pnas.1706267114; Yan Q, 2010, P NATL ACAD SCI USA, V107, P21034, DOI 10.1073/pnas.1007866107; Yang W, 2016, STROKE VASC NEUROL, V1, P101, DOI 10.1136/svn-2016-000031	46	2	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2269	2286		10.1096/fj.201901913R	http://dx.doi.org/10.1096/fj.201901913R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908008	Bronze			2022-12-28	WOS:000514663600024
J	Skarratt, KK; Gu, B; Lovelace, MD; Milligan, CJ; Stokes, L; Glover, R; Petrou, S; Wiley, JS; Fuller, SJ				Skarratt, Kristen K.; Gu, Ben J.; Lovelace, Michael D.; Milligan, Carol J.; Stokes, Leanne; Glover, Rachel; Petrou, Steven; Wiley, James S.; Fuller, Stephen J.			A P2RX7 single nucleotide polymorphism haplotype promotes exon 7 and 8 skipping and disrupts receptor function	FASEB JOURNAL			English	Article						alternative splicing; heteromer; single nucleotide polymorphism	P2X(7) RECEPTOR; P2X7 RECEPTOR; QUANTITATIVE METHOD; PORE FORMATION; CANCER-CELLS; ATP-BINDING; ION-CHANNEL; C-TERMINUS; ACTIVATION; ALLELE	P2X7 is an ATP-gated membrane ion channel that is expressed by multiple cell types. Brief exposure to ATP induces the opening of a nonselective cation channel; while repeated or prolonged exposure induces formation of a transmembrane pore. This process may be partially regulated by alternative splicing of full-length P2RX7A pre-mRNA, producing isoforms that delete or retain functional domains. Here, we report cloning and expression of a novel P2RX7 splice variant, P2RX7L, that is, characterized by skipping of exons 7 and 8. In HEK 293 cells, expression of P2RX7L produces a protein isoform, P2X7L, that forms a heteromer with P2X7A. A haplotype defined by six single nucleotide polymorphisms (SNPs) (rs208307, rs208306, rs36144485, rs208308, rs208309, and rs373655596) promotes allele-specific alternative splicing, increasing mRNA levels of P2RX7L and another isoform, P2RX7E, which in addition has a truncated C-terminus. Skipping of exons 7 and 8 is predicted to delete critical amino acids in the ATP-binding site. P2X7L-transfected HEK 293 cells have phagocytic but not channel, pore, or membrane-blebbing function, and double-transfected P2X7L and P2X7A cells have reduced pore function. Heteromeric receptor complexes of P2X7A and P2X7L are predicted to have reduced numbers of ATP-binding sites, which potentially alters receptor function compared to homomeric P2X7A complexes.	[Skarratt, Kristen K.; Lovelace, Michael D.; Stokes, Leanne; Glover, Rachel; Fuller, Stephen J.] Univ Sydney, Fac Med & Hlth, Sydney Med Sch Nepean, Dept Med, Kingswood, NSW, Australia; [Gu, Ben J.; Milligan, Carol J.; Petrou, Steven; Wiley, James S.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Stokes, Leanne] Univ East Anglia, Sch Pharm, Norwich Res Pk, Norwich, Norfolk, England	University of Sydney; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of East Anglia	Fuller, SJ (corresponding author), Univ Sydney, Nepean Clin Sch, 62 Derby St, Kingswood, NSW 2747, Australia.	stephen.fuller@sydney.edu.au	Skarratt, Kristy/AAN-1479-2020; Lovelace, Michael D./AAB-5258-2019; Fuller, Stephen/W-6646-2019	Lovelace, Michael D./0000-0003-2066-3031; Fuller, Stephen/0000-0003-4637-7391; Skarratt, Kristy/0000-0003-4971-2773; Wiley, James/0000-0001-9421-4154; Gu, Ben/0000-0001-5500-4453	Sydney Medical School Foundation; Nepean Medical Research Fund	Sydney Medical School Foundation; Nepean Medical Research Fund	Sydney Medical School Foundation, Nepean Medical Research Fund, Grant/Award Number: 2011	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chessell IP, 1998, FEBS LETT, V439, P26, DOI 10.1016/S0014-5793(98)01332-5; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Denlinger LC, 2006, CLIN CHEM, V52, P995, DOI 10.1373/clinchem.2005.065425; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; Feng YH, 2006, NUCLEOS NUCLEOT NUCL, V25, P1271, DOI 10.1080/15257770600890921; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Gu BJ, 2014, CYTOM PART A, V85, P313, DOI 10.1002/cyto.a.22400; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Gu BJ, 2009, AM J PHYSIOL-CELL PH, V297, pC430, DOI 10.1152/ajpcell.00079.2009; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2012, FLOW CYTOMETRY RECEN, P185; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Jursik C, 2007, J IMMUNOL METHODS, V325, P67, DOI 10.1016/j.jim.2007.06.002; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khadra A, 2013, BIOPHYS J, V104, P2612, DOI 10.1016/j.bpj.2013.05.006; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Leeson HC, 2019, JOVE-J VIS EXP, DOI 10.3791/59313; Mankus C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028541; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Masin M, 2012, BRIT J PHARMACOL, V165, P978, DOI 10.1111/j.1476-5381.2011.01624.x; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sadovnick AD, 2017, HUM MUTAT, V38, P736, DOI 10.1002/humu.23218; Skarratt KK, 2005, FEBS LETT, V579, P2675, DOI 10.1016/j.febslet.2005.03.091; Skarratt KK, 2014, J MICROBIOL METH, V96, P99, DOI 10.1016/j.mimet.2013.11.011; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Sun CQ, 2010, PURINERG SIGNAL, V6, P31, DOI 10.1007/s11302-009-9168-9; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Trabanelli S, 2012, J IMMUNOL, V189, P1303, DOI 10.4049/jimmunol.1103800; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Wilkinson SM, 2017, ACS CHEM NEUROSCI, V8, P2374, DOI 10.1021/acschemneuro.7b00272; Worthington RA, 2002, FEBS LETT, V512, P43, DOI 10.1016/S0014-5793(01)03311-7	48	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3884	3901		10.1096/fj.201901198RR	http://dx.doi.org/10.1096/fj.201901198RR		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32003498	Green Accepted			2022-12-28	WOS:000510460800001
J	Vutukuri, R; Koch, A; Trautmann, S; Schreiber, Y; Thomas, D; Mayser, F; zu Heringdorf, DM; Pfeilschifter, J; Pfeilschifter, W; Brunkhorst, R				Vutukuri, Rajkumar; Koch, Alexander; Trautmann, Sandra; Schreiber, Yannick; Thomas, Dominique; Mayser, Franziska; zu Heringdorf, Dagmar Meyer; Pfeilschifter, Josef; Pfeilschifter, Waltraud; Brunkhorst, Robert			S1P d20:1, an endogenous modulator of S1P d18:1/S1P(2)-dependent signaling	FASEB JOURNAL			English	Article						brain; cyclooxygenase 2; glioblastoma cells; S1P receptors; sphingosine 1-phosphate	MAMMALIAN SERINE PALMITOYLTRANSFERASE; LONG-CHAIN BASES; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE RECEPTOR-2; COX-2 EXPRESSION; CANCER; RISK; CYCLOOXYGENASE-2; PERMEABILITY; INTEGRITY	Sphingosine 1-phosphate (S1P) signaling influences numerous cell biological mechanisms such as differentiation, proliferation, survival, migration, and angiogenesis. Intriguingly, our current knowledge is based solely on the role of S1P with an 18-carbon long-chain base length, S1P d18:1. Depending on the composition of the first and rate-limiting enzyme of the sphingolipid de novo metabolism, the serine palmitoyltransferase, other chain lengths have been described in vivo. While cells are also able to produce S1P d20:1, its abundance and function remains elusive so far. Our experiments are highlighting the role of S1P d20:1 in the mouse central nervous system (CNS) and human glioblastoma. We show here that S1P d20:1 and its precursors are detectable in both healthy mouse CNS-tissue and human glioblastoma. On the functional level, we focused our work on one particular, well-characterized pathway, the induction of cyclooxygenase (COX)-2 expression via the S1P receptor 2 (S1P(2)). Intriguingly, S1P d20:1 only fairly induces COX-2 expression and can block the S1P d18:1-induced COX-2 expression mediated via S1P(2) activation in the human glioblastoma cell line LN229. This data indicates that S1P d20:1 might act as an endogenous modulator of S1P signaling via a partial agonism at the S1P(2) receptor. While our findings might stimulate further research on the relevance of long-chain base lengths in sphingolipid signaling, the metabolism of S1P d20:1 has to be considered as an integral part of S1P signaling pathways in vivo.	[Vutukuri, Rajkumar; Koch, Alexander; zu Heringdorf, Dagmar Meyer; Pfeilschifter, Josef] Goethe Univ Frankfurt, Univ Hosp, Inst Gen Pharmacol & Toxicol, Frankfurt, Germany; [Trautmann, Sandra; Thomas, Dominique] Goethe Univ Frankfurt, Univ Hosp, Inst Clin Pharmacol, Frankfurt, Germany; [Schreiber, Yannick] Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol IME TMP, Frankfurt, Germany; [Mayser, Franziska; Pfeilschifter, Waltraud; Brunkhorst, Robert] Goethe Univ Frankfurt, Univ Hosp, Dept Neurol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Fraunhofer Gesellschaft; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Brunkhorst, R (corresponding author), Goethe Univ Hosp, Dept Neurol, Frankfurt, Germany.	robert.brunkhorst@kgu.de	Heringdorf, Dagmar Meyer zu/A-7705-2018	Heringdorf, Dagmar Meyer zu/0000-0003-1246-9677	Deutsche Forschungsgemeinschaft (DFG) [SFB1039]; Fondation Leducq	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fondation Leducq(Leducq Foundation)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB1039; Fondation Leducq	Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Blankenbach KV, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00167; Brunkhorst R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051390; Chajes V, 1999, INT J CANCER, V83, P585, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;585::AID-IJC2&gt;3.0.CO;2-Z; CHIGORNO V, 1994, EUR J BIOCHEM, V221, P1095, DOI 10.1111/j.1432-1033.1994.tb18829.x; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Cross AJ, 2014, CANCER-AM CANCER SOC, V120, P3049, DOI 10.1002/cncr.28799; Cruz-Orengo L, 2014, J CLIN INVEST, V124, P2571, DOI 10.1172/JCI73408; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harris GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035129; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hsu CK, 2015, J CELL PHYSIOL, V230, P702, DOI 10.1002/jcp.24795; Imeri F, 2014, NEUROPHARMACOLOGY, V85, P314, DOI 10.1016/j.neuropharm.2014.05.012; Kelly FD, 2001, EUR J CLIN NUTR, V55, P88, DOI 10.1038/sj.ejcn.1601122; Kim GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8893; Kim JI, 2003, J BIOL CHEM, V278, P31731, DOI 10.1074/jbc.M300625200; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kuhn T, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0552-3; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; Mahajan-Thakur S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112448; Mondul AM, 2015, INT J CANCER, V137, P2124, DOI 10.1002/ijc.29576; O'Sullivan C, 2013, TRENDS PHARMACOL SCI, V34, P401, DOI 10.1016/j.tips.2013.05.002; Othman A, 2015, ATHEROSCLEROSIS, V240, P216, DOI 10.1016/j.atherosclerosis.2015.03.011; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Qiu JG, 2017, DRUG DISCOV TODAY, V22, P148, DOI 10.1016/j.drudis.2016.09.017; SAMBASIVARAO K, 1964, J LIPID RES, V5, P103; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; SCHWARZ HP, 1967, J NEUROCHEM, V14, P91, DOI 10.1111/j.1471-4159.1967.tb09497.x; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8; Sung H. K., 2007, J BIOL CHEM, V282, P1938; Suriyanarayanan S, 2019, NEUROMOL MED, V21, P182, DOI 10.1007/s12017-019-08534-w; Troupiotis-Tsailaki A., 2017, SCI REP-UK, V7, P1; Volzke A, 2014, BBA-MOL CELL BIOL L, V1841, P11, DOI 10.1016/j.bbalip.2013.09.009; Zhao LH, 2015, P NATL ACAD SCI USA, V112, P12962, DOI 10.1073/pnas.1516733112	39	6	6	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3932	3942		10.1096/fj.201902391R	http://dx.doi.org/10.1096/fj.201902391R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944406	hybrid, Green Published			2022-12-28	WOS:000507594100001
J	Draper, ACE; Wilson, Z; Maile, C; Faccenda, D; Campanella, M; Piercy, RJ				Draper, Alexandra C. E.; Wilson, Zoe; Maile, Charlotte; Faccenda, Danilo; Campanella, Michelangelo; Piercy, Richard J.			Species-specific consequences of an E40K missense mutation in superoxide dismutase 1 (SOD1)	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis; degenerative myelopathy; dog; horse; superoxide dismutase 1	CANINE DEGENERATIVE MYELOPATHY; COMPLEX-I; SELECTIVE VULNERABILITY; MOTOR-NEURONS; WILD-TYPE; ALS; PROTEIN; AGGREGATION; DISEASE; RNA	A glutamic acid to lysine (E40K) residue substitution in superoxide dismutase 1 (SOD1) is associated with canine degenerative myelopathy: the only naturally occurring large animal model of amyotrophic lateral sclerosis (ALS). The E40 residue is highly conserved across mammals, except the horse, which naturally carries the (dog mutant) K40 residue. Here we hypothesized that in vitro expression of mutant dog SOD1 would recapitulate features of human ALS (ie, SOD1 protein aggregation, reduced cell viability, perturbations in mitochondrial morphology and membrane potential, reduced ATP production, and increased superoxide ion levels); further, we hypothesized that an equivalent equine SOD1 variant would share similar perturbations in vitro, thereby explain horses' susceptibility to certain neurodegenerative diseases. As in human ALS, expression of mutant dog SOD1 was associated with statistically significant increased aggregate formation, raised superoxide levels (ROS), and altered mitochondrial morphology (increased branching (form factor)), when compared to wild-type dog SOD1-expressing cells. Similar deficits were not detected in cells expressing the equivalent horse SOD1 variant. Our data helps explain the ALS-associated cellular phenotype of dogs expressing the mutant SOD1 protein and reveals that species-specific sequence conservation does not necessarily predict pathogenicity. The work improves understanding of the etiopathogenesis of canine degenerative myelopathy.	[Draper, Alexandra C. E.; Wilson, Zoe; Maile, Charlotte; Piercy, Richard J.] Univ London, Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England; [Faccenda, Danilo; Campanella, Michelangelo] Univ London, Royal Vet Coll, Dept Comparat Biomed Sci, Mitochondrial Cell Biol & Pharmaceut Res Unit, London, England; [Campanella, Michelangelo] Univ London, Univ Coll London, Univ Coll London Consortium Mitochondrial Res, London, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University College London	Piercy, RJ (corresponding author), Royal Vet Coll, Comparat Neuromuscular Dis Lab, 4 Royal Coll St, London NW1 0TU, England.	rpiercy@rvc.ac.uk	Campanella, Michelangelo/K-8172-2016	Campanella, Michelangelo/0000-0002-6948-4184	Horserace Betting Levy Board [RS251]; BBSRC [BB/I013695/1, BB/N007042/1] Funding Source: UKRI	Horserace Betting Levy Board; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Alex Draper's PhD was kindly funded by the Horserace Betting Levy Board (RS251).	Abdolvahabi A, 2015, BIOPHYS J, V108, P1199, DOI 10.1016/j.bpj.2015.01.014; Abu-Hamad S, 2017, ACS CHEM NEUROSCI, V8, P2225, DOI 10.1021/acschemneuro.7b00140; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Berglund AC, 2018, RBPDB DATABASE RNA B; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chung CY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06543-0; Coates JR, 2010, VET CLIN N AM-SMALL, V40, P929, DOI 10.1016/j.cvsm.2010.05.001; Coussee E, 2011, CELL CALCIUM, V49, P217, DOI 10.1016/j.ceca.2011.02.004; Crisp MJ, 2013, EXP NEUROL, V248, P1, DOI 10.1016/j.expneurol.2013.05.009; Crown AM, 2019, G3-GENES GENOM GENET, V9, P719, DOI 10.1534/g3.118.200787; Deheshi S, 2015, J NEUROCHEM, V133, P684, DOI 10.1111/jnc.13090; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; Draper ACE, 2018, J VET INTERN MED, V32, P1397, DOI 10.1111/jvim.15142; Finno CJ, 2012, J VET INTERN MED, V26, P1251, DOI 10.1111/j.1939-1676.2012.00994.x; Ge WW, 2006, NEUROBIOL DIS, V23, P342, DOI 10.1016/j.nbd.2006.03.007; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; Goodwin M, 2015, CELL REP, V12, P1159, DOI 10.1016/j.celrep.2015.07.029; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Green SL, 2002, J HERED, V93, P119, DOI 10.1093/jhered/93.2.119; Hayyan M, 2016, CHEM REV, V116, P3029, DOI 10.1021/acs.chemrev.5b00407; Henriques SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191274; Hildyard John C W, 2018, J Neuromuscul Dis, V5, P177, DOI 10.3233/JND-170267; Hildyard John C W, 2014, PLoS Curr, V6, DOI 10.1371/currents.md.faafdde4bea8df4aa7d06cd5553119a6; Hoerndli FJ, 2004, ANAL BIOCHEM, V335, P30, DOI 10.1016/j.ab.2004.08.028; Innovagen, 2015, INN PROT CALC; Ivansson EL, 2016, P NATL ACAD SCI USA, V113, pE3091, DOI 10.1073/pnas.1600084113; Katz ML, 2017, J NEUROL SCI, V378, P193, DOI 10.1016/j.jns.2017.05.009; Kaufmann W, 2012, TOXICOL PATHOL, V40, P87, DOI 10.1177/0192623312439125; Keskin I, 2017, AMYOTROPH LAT SCL FR, V18, P457, DOI 10.1080/21678421.2017.1301481; Keskin I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150133; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kobatake Y, 2017, J NEUROL SCI, V372, P369, DOI 10.1016/j.jns.2016.10.034; Kobuke K, 2008, HUM MOL GENET, V17, P1201, DOI 10.1093/hmg/ddn009; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Lee DY, 2015, EXP NEUROBIOL, V24, P226, DOI 10.5607/en.2015.24.3.226; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Li QA, 2010, P NATL ACAD SCI USA, V107, P21146, DOI 10.1073/pnas.1014862107; Librado P, 2017, SCIENCE, V356, P442, DOI 10.1126/science.aam5298; Maile CA, 2017, BBA-GEN SUBJECTS, V1861, P3388, DOI 10.1016/j.bbagen.2016.08.021; Mccue ME, 2008, GENOMICS, V91, P458, DOI 10.1016/j.ygeno.2008.01.011; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Milani P, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/458427; Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112; MOHAMMED HO, 1994, VET RES, V25, P275; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Nakamae S, 2015, NEUROSCIENCE, V303, P229, DOI 10.1016/j.neuroscience.2015.06.066; Naylor RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042317; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Raimondi A, 2006, EUR J NEUROSCI, V24, P387, DOI 10.1111/j.1460-9568.2006.04922.x; Richardson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068256; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shi Y, 2014, PROTEIN SCI, V23, P1417, DOI 10.1002/pro.2526; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Votion DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034890; Wang H, 2018, BONE, V106, P126, DOI 10.1016/j.bone.2017.10.010; Windley Z, 2012, COMP BIOMEDICAL SCI, P94; Zimmennan MC, 2007, J NEUROCHEM, V102, P609, DOI 10.1111/j.1471-4159.2007.04502.x	70	1	1	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					458	473		10.1096/fj.201901455R	http://dx.doi.org/10.1096/fj.201901455R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914665	Green Accepted			2022-12-28	WOS:000507308900032
J	Liu, H; Chen, ZY; Weng, XD; Chen, H; Du, Y; Diao, CH; Liu, XH; Wang, L				Liu, Hao; Chen, Zhiyuan; Weng, Xiaodong; Chen, Hui; Du, Yang; Diao, Changhui; Liu, Xiuheng; Wang, Lei			Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model	FASEB JOURNAL			English	Article						enhancer of zeste homolog 2; ischemia-reperfusion injury; oxidative stress; pyroptosis; Nox4; reactive oxygen species	RENAL ISCHEMIA; NADPH OXIDASES; MECHANISM; METHYLTRANSFERASE; EPIGENETICS; INHIBITION; APOPTOSIS; FIBROSIS	Enhancer of zeste homolog 2 (EZH2), a well-known methyltransferase, mediates histone H3 lysine 27 trimethylation (H3K27me3) and plays a crucial role in several kidney disease models. However, its role in renal ischemia/reperfusion (I/R) injury still remains unclear. In this study, we found that EZH2 was positively related to renal I/R injury and inhibition of EZH2 with DZNeP alleviated I/R injury and blocked the activation of oxidative stress and pyroptosis in vivo. Similarly, inhibition of EZH2 with either DZNeP or si-RNA also exerted an inhibitory effect on hypoxia/reoxygenation (H/R)-induced oxidative stress and pyroptosis in vitro. Moreover, further study revealed that ablation of reactive oxygen species (ROS) with N-acetyl-cysteine (NAC) suppressed pyroptosis in human renal proximal tubular epithelial cell line cells exposed to H/R stimulation. Furthermore, Nox4, which was positively related to the generation of ROS, was upregulated during H/R process, while it could be reversed by EZH2 inhibition. Consistently, Nox4-mediated ROS generation was attenuated upon inhibition of EZH2 with DZNeP or si-RNA. Additionally, the transcriptional activity of Nox4 was enhanced by the activation of ALK5/Smad2/3 signaling pathway, which was abolished by ALK5 knockdown in vitro. Finally, EZH2 inhibition blocked H/R and I/R-activated ALK5/Smad2/3 pathway and also resulted in an obvious decrease in the transcriptional activity and protein expression levels of Nox4. In conclusion, our results proved that EZH2 inhibition alleviated renal pyroptosis by blocking Nox4-dependent ROS generation through ALK5/Smad2/3 signaling pathway, indicating that EZH2 could be a potential therapeutic target for renal I/R injury.	[Liu, Hao; Chen, Zhiyuan; Weng, Xiaodong; Chen, Hui; Du, Yang; Diao, Changhui; Liu, Xiuheng; Wang, Lei] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan 430060, Hubei, Peoples R China	Wuhan University	Wang, L (corresponding author), Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan 430060, Hubei, Peoples R China.	drwanglei@whu.edu.cn			Application and Basic Reseaach Project of Wuhan City [2018060401011321]; Wuhan Morning Light Plan of Youth Science and Technology [2017050304010281]; Research Project of Wuhan University [2042017kf0097]; Innovation Project of Medical School of Wuhan University [TFZZ2018017]; Natural Science Foundation of Hubei Province [2016CFB114, 2017CFB181]	Application and Basic Reseaach Project of Wuhan City; Wuhan Morning Light Plan of Youth Science and Technology; Research Project of Wuhan University; Innovation Project of Medical School of Wuhan University; Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The Application and Basic Reseaach Project of Wuhan City, Grant/Award Number: 2018060401011321; Wuhan Morning Light Plan of Youth Science and Technology, Grant/Award Number: 2017050304010281; Research Project of Wuhan University, Grant/Award Number: 2042017kf0097; Innovation Project of Medical School of Wuhan University, Grant/Award Number: TFZZ2018017; Natural Science Foundation of Hubei Province, Grant/Award Number: 2016CFB114 and 2017CFB181	Amani H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42633-9; Arai S, 2016, NAT MED, V22, P183, DOI 10.1038/nm.4012; Bamidele AO, 2019, CELL MOL GASTROENTER, V7, P55, DOI 10.1016/j.jcmgh.2018.08.009; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Ben Mkaddem S, 2010, CELL DEATH DIFFER, V17, P1474, DOI 10.1038/cdd.2010.26; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Cui J, 2019, MOL CANC RES; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Italiano A, 2016, PHARMACOL THERAPEUT, V165, P26, DOI 10.1016/j.pharmthera.2016.05.003; Kim SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02563; Li ZY, 2019, AGING-US, V11, P1226, DOI 10.18632/aging.101831; Liang H, 2019, INFLAMM RES, V68, P325, DOI 10.1007/s00011-019-01221-3; Liu H, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101195; Liu ZH, 2019, MOL IMMUNOL, V106, P153, DOI 10.1016/j.molimm.2018.12.028; Lou Z, 2018, EXP THER MED, V16, P1671, DOI 10.3892/etm.2018.6377; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mitic T, 2015, MOL THER, V23, P32, DOI 10.1038/mt.2014.163; Qin J, 2015, KIDNEY BLOOD PRESS R, V40, P89, DOI 10.1159/000368485; Qiu Z, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9743280; Rabadi M, 2016, AM J PHYSIOL-RENAL, V311, pF437, DOI 10.1152/ajprenal.00254.2016; Raup-Konsavage WM, 2018, KIDNEY INT, V93, P365, DOI 10.1016/j.kint.2017.08.014; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shi YF, 2019, AM J PHYSIOL-RENAL, V316, pF488, DOI 10.1152/ajprenal.00234.2018; Tajima T, 2019, KIDNEY INT, V95, P1120, DOI 10.1016/j.kint.2018.11.034; Tang JH, 2015, CURR OPIN NEPHROL HY, V24, P351, DOI 10.1097/MNH.0000000000000140; Walker LM, 2001, TOXICOL SCI, V63, P143, DOI 10.1093/toxsci/63.1.143; Wang WG, 2014, BIRTH DEFECTS RES C, V102, P37, DOI 10.1002/bdrc.21058; Wang Y, 2018, ONCOL LETT, V16, P1231, DOI 10.3892/ol.2018.8779; Wang YF, 2019, J MOL CELL BIOL, V11, P1069, DOI 10.1093/jmcb/mjz020; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; Wu HY, 2016, CELL PHYSIOL BIOCHEM, V40, P1692, DOI 10.1159/000453218; Xiao X, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12915; Yang JR, 2014, AM J PHYSIOL-RENAL, V306, pF75, DOI 10.1152/ajprenal.00117.2013; Yang Y, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0039-0; Yoo KH, 2012, INT J BIOL SCI, V8, P59, DOI 10.7150/ijbs.8.59; Zhang KM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1596-z; Zhou X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1012-0; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457; Zhu K, 2015, FREE RADICAL BIO MED, V83, P21, DOI 10.1016/j.freeradbiomed.2015.02.009	41	27	29	3	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					835	852		10.1096/fj.201901816R	http://dx.doi.org/10.1096/fj.201901816R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914694	hybrid			2022-12-28	WOS:000507308900057
J	Maller, SM; Cagnoni, AJ; Bannoud, N; Sigaut, L; Saez, JMP; Pietrasanta, LI; Yang, RY; Liu, FT; Croci, DO; Di Lella, S; Sundblad, V; Rabinovich, GA; Marino, KV				Maller, Sebastian M.; Cagnoni, Alejandro J.; Bannoud, Nadia; Sigaut, Lorena; Perez Saez, Juan M.; Pietrasanta, Lia I.; Yang, Ri-Yao; Liu, Fu-Tong; Croci, Diego O.; Di Lella, Santiago; Sundblad, Victoria; Rabinovich, Gabriel A.; Marino, Karina V.			An adipose tissue galectin controls endothelial cell function via preferential recognition of 3-fucosylated glycans	FASEB JOURNAL			English	Article						adipose tissue; angiogenesis; galectins; glycosylation	HYPOXIA-DRIVEN ANGIOGENESIS; INSULIN SENSITIVITY; MOLECULAR-DYNAMICS; OBESITY; PROTEIN; INFLAMMATION; SPECIFICITY; MODULATION; MECHANISMS; EXPRESSION	Upon overnutrition, adipocytes activate a homeostatic program to adjust anabolic pressure. An inflammatory response enables adipose tissue (AT) expansion with concomitant enlargement of its capillary network, and reduces energy storage by increasing insulin resistance. Galectin-12 (Gal-12), an endogenous lectin preferentially expressed in AT, plays a key role in adipocyte differentiation, lipolysis, and glucose homeostasis. Here, we reveal biochemical and biophysical determinants of Gal-12 structure, including its preferential recognition of 3-fucosylated structures, a unique feature among members of the galectin family. Furthermore, we identify a previously unanticipated role for this lectin in the regulation of angiogenesis within AT. Gal-12 showed preferential localization within the inner side of lipid droplets, and its expression was upregulated under hypoxic conditions. Through glycosylation-dependent binding to endothelial cells, Gal-12 promoted in vitro angiogenesis. Moreover, analysis of in vivo AT vasculature showed reduced vascular networks in Gal-12-deficient (Lgals12(-/-)) compared to wild-type mice, supporting a role for this lectin in AT angiogenesis. In conclusion, this study unveils biochemical, topological, and functional features of a hypoxia-regulated galectin in AT, which modulates endothelial cell function through recognition of 3-fucosylated glycans. Thus, glycosylation-dependent programs may control AT homeostasis by modulating endothelial cell biology with critical implications in metabolic disorders and inflammation.	[Maller, Sebastian M.; Cagnoni, Alejandro J.; Marino, Karina V.] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Glicom Func & Mol, C1428ADN, Buenos Aires, DF, Argentina; [Maller, Sebastian M.; Perez Saez, Juan M.; Sundblad, Victoria; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Inmunopatol, C1428ADN, Buenos Aires, DF, Argentina; [Bannoud, Nadia; Croci, Diego O.] Univ Nacl Cuyo, CONICET, Fac Ciencias Med, Lab Inmunopatol,IHEM, Mendoza, Argentina; [Sigaut, Lorena; Pietrasanta, Lia I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Buenos Aires, DF, Argentina; [Sigaut, Lorena; Pietrasanta, Lia I.] Consejo Nacl Invest Cient & Tecn, Inst Fis Buenos Aires IFIBA, Buenos Aires, DF, Argentina; [Pietrasanta, Lia I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CMA, Buenos Aires, DF, Argentina; [Yang, Ri-Yao] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Croci, Diego O.] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, Mendoza, Argentina; [Di Lella, Santiago] Consejo Nacl Invest Cient & Tecn, Inst Quim Biol Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [Di Lella, Santiago; Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan; University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Marino, KV (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Lab Glicom Func & Mol, C1428ADN, Buenos Aires, DF, Argentina.; Rabinovich, GA (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Lab Inmunopatol, C1428ADN, Buenos Aires, DF, Argentina.	gabriel.r@ibyme.conicet.gov.ar; kmarino@ibyme.conicet.gov.ar	Liu, FU-TONG/A-5749-2019; Croci, Diego/AAJ-5709-2021; Yang, Riyao/R-7593-2019	Liu, FU-TONG/0000-0002-3354-1001; Croci, Diego/0000-0002-8623-0645; Yang, Riyao/0000-0002-0278-4385; Sigaut, Lorena/0000-0001-9417-9600; Marino, Karina Valeria/0000-0002-0581-8640; PIETRASANTA, LIA/0000-0002-2714-3162; Maller, Sebastian M./0000-0001-5536-7596	CONICET; Sales Foundation; Bunge & Born Foundation; Rene Baron Foundation; Richard Lounsbery Foundation (USA); Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2015-0564, PICT V 2014-3687, PICT 2016-0205]; University of Buenos Aires [20020120100276]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sales Foundation; Bunge & Born Foundation; Rene Baron Foundation; Richard Lounsbery Foundation (USA); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires)	CONICET; Sales Foundation; Bunge & Born Foundation; Rene Baron Foundation; The Richard Lounsbery Foundation (USA); Agencia Nacional de Promocion Cientifica y Tecnologica, Grant/Award Number: PICT 2015-0564, PICT V 2014-3687 and PICT 2016-0205; The University of Buenos Aires, Grant/Award Number: 20020120100276; 2013-2015	Aanhane E, 2018, ANGIOGENESIS, V21, P545, DOI 10.1007/s10456-018-9607-8; Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bianchet MA, 2002, NAT STRUCT BIOL, V9, P628, DOI 10.1038/nsb817; Bum-Erdene K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20289; Cagnoni AJ, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00109; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Delgado VMC, 2011, FASEB J, V25, P242, DOI 10.1096/fj.09-144907; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Case D.A., 2014, AMBER, V14, P29; Cerliani JP, 2017, TRENDS BIOCHEM SCI, V42, P255, DOI 10.1016/j.tibs.2016.11.003; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Corvera S, 2014, BBA-MOL BASIS DIS, V1842, P463, DOI 10.1016/j.bbadis.2013.06.003; Croci DO, 2014, GLYCOBIOLOGY, V24, P1283, DOI 10.1093/glycob/cwu083; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Croci DO, 2012, J EXP MED, V209, P1985, DOI 10.1084/jem.20111665; Dam TK, 2010, GLYCOBIOLOGY, V20, P1061, DOI 10.1093/glycob/cwq084; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Fasshauer M, 2002, EUR J ENDOCRINOL, V147, P553, DOI 10.1530/eje.0.1470553; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Garcia-Vallejo JJ, 2015, IMMUNITY, V42, P983, DOI 10.1016/j.immuni.2015.05.021; Grant Ryan, 2013, Methods Mol Biol, V1040, P195, DOI 10.1007/978-1-62703-523-1_15; Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003; Guardia CMA, 2011, J CHEM INF MODEL, V51, P1918, DOI 10.1021/ci200180h; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hefti MH, 2001, ANAL BIOCHEM, V295, P180, DOI 10.1006/abio.2001.5214; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; Hotta K, 2001, J BIOL CHEM, V276, P34089, DOI 10.1074/jbc.M105097200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Ilarregui JM, 2005, ANN RHEUM DIS, V64, P96, DOI 10.1136/ard.2005.044347; Katiyar A., 2009, Genomics Proteomics & Bioinformatics, V7, P185, DOI 10.1016/S1672-0229(08)60048-0; Kumar J, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00437-18; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Lijnen HR, 2006, DIABETES, V55, P2698, DOI 10.2337/db06-0526; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meynier C, 2009, J BIOMOL STRUCT DYN, V27, P49, DOI 10.1080/07391102.2009.10507295; Nio-Kobayashi J, 2017, ANAT SCI INT, V92, P25, DOI 10.1007/s12565-016-0366-6; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; Nugroho DB, 2018, BIOCHEM BIOPH RES CO, V503, P378, DOI 10.1016/j.bbrc.2018.06.043; Rabinovich G, 1996, J LEUKOCYTE BIOL, V59, P363, DOI 10.1002/jlb.59.3.363; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rapoport EM, 2010, BIOCHEMISTRY-MOSCOW+, V75, P310, DOI 10.1134/S0006297910030077; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Rodrigues T, 2014, ARCH PHYSIOL BIOCHEM, V120, P1, DOI 10.3109/13813455.2013.838971; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Rubio Ivonne, 2005, Biomed., V25, P34; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sundblad V, 2017, J IMMUNOL, V199, P3721, DOI 10.4049/jimmunol.1701172; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Wan L, 2016, GLYCOBIOLOGY, V26, P732, DOI 10.1093/glycob/cww013; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yang RY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153534; Yang RY, 2011, P NATL ACAD SCI USA, V108, P18696, DOI 10.1073/pnas.1109065108; Yang RY, 2004, J BIOL CHEM, V279, P29761, DOI 10.1074/jbc.M401303200; Yang RY, 2001, J BIOL CHEM, V276, P20252, DOI 10.1074/jbc.M010914200	75	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					735	753		10.1096/fj.201901817R	http://dx.doi.org/10.1096/fj.201901817R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914594				2022-12-28	WOS:000507308900051
J	Qi, F; Isaji, T; Duan, CW; Yang, J; Wang, YQ; Fukuda, T; Gu, JG				Qi, Feng; Isaji, Tomoya; Duan, Chengwei; Yang, Jie; Wang, Yuqin; Fukuda, Tomohiko; Gu, Jianguo			ST3GAL3, ST3GAL4, and ST3GAL6 differ in their regulation of biological functions via the specificities for the alpha 2,3-sialylation of target proteins	FASEB JOURNAL			English	Article						EGFR; glycoproteins; N-glycan; integrin beta 1; alpha 2; 3-sialyltransferase	GROWTH-FACTOR RECEPTOR; BETA-PROPELLER DOMAIN; SIALYL-LEWIS-X; N-GLYCOSYLATION; EXPRESSION PROFILES; CELL-PROLIFERATION; MOLECULAR-CLONING; ACID; CARCINOMA; SIALYLTRANSFERASES	The alpha 2,3-sialylation of N-glycans is considered important but complicated because the functions of the three beta-galactoside alpha 2,3-sialyltransferases, ST3GAL3, ST3GAL4, and ST3GAL6, could be compensating for one another. To distinguish their specific functions, we established each individual knockout (KO) cell line. Loss of either the ST3GAL3 or ST3GAL6 genes decreased cell proliferation and colony formation, as opposed to the effect in the ST3GAL4 KO cells. The phosphorylation levels of ERK and AKT were significantly suppressed in the ST3GAL6 KO and ST3GAL3 KO cells, respectively. The cell aggregations were clearly observed in the KO cells, particularly the ST3GAL3 KO and ST3GAL6 KO cells, and the expression levels of E-cadherin and claudin-1 were enhanced in both those cell lines, but were suppressed in the ST3GAL4 KO cells. Those alterations were reversed with an overexpression of each corresponding gene in rescued cells. Of particular interest, the alpha 2,3-sialylation levels of beta 1 integrin were clearly suppressed in the ST3GAL4 KO cells, but these were increased in the ST3GAL3 KO and ST3GAL6 KO cells, whereas the alpha 2,3-sialylation levels of EGFR were significantly decreased in the ST3GAL6 KO cells. The decrease in alpha 2,3-sialylation increased the alpha 2,6-sialylation on beta 1, but not EGFR. Furthermore, a cross-restoration of each of the three genes in ST3GAL6 KO cells showed that overexpression of ST3GAL6 sufficiently rescued the total alpha 2,3-sialylation levels, cell morphology, and alpha 2,3-sialylation of EGFR, whereas the alpha 2,3-sialylation levels of beta 1 were greatly enhanced by an overexpression of ST3GAL4. These results clearly demonstrate that the three alpha 2,3-sialyltransferases modify characteristic target proteins and regulate cell biological functions in different ways.	[Qi, Feng; Isaji, Tomoya; Duan, Chengwei; Yang, Jie; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan; [Qi, Feng] Nantong Univ, Affiliated Hosp 4, Dept Pharm, Yancheng, Peoples R China; [Wang, Yuqin] Nantong Univ, Coll Pharm, Dept Pharmacol, Nantong, Peoples R China	Tohoku Medical & Pharmaceutical University; Nantong University; Nantong University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp	Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020		MEXT | Japan Society for the Promotion of Science (JSPS) [15H04354, 19H03184, 19K07049]; National Natural Science Foundation of China (NSFC) [31670807]; Science and Technology Project from Jiangsu Traditional Chinese Medicine Bureau [YB2017072]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18H04868]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Project from Jiangsu Traditional Chinese Medicine Bureau; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15H04354, 19H03184 and 19K07049; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31670807; Science and Technology Project from Jiangsu Traditional Chinese Medicine Bureau, Grant/Award Number: YB2017072; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 18H04868	Aco-Tlachi M, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0197-2; Arike L, 2017, GLYCOBIOLOGY, V27, P318, DOI 10.1093/glycob/cww134; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Carvalho AS, 2010, INT J BIOCHEM CELL B, V42, P80, DOI 10.1016/j.biocel.2009.09.010; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Cazet A, 2010, CARBOHYD RES, V345, P1377, DOI 10.1016/j.carres.2010.01.024; Chachadi VB, 2015, GLYCOBIOLOGY, V25, P963, DOI 10.1093/glycob/cwv030; Chung CY, 2015, BIOCHEM BIOPH RES CO, V463, P211, DOI 10.1016/j.bbrc.2015.05.023; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; Dall'Olio F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050998; Dewald JH, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5040043; El-Battari A, 2003, GLYCOBIOLOGY, V13, P941, DOI 10.1093/glycob/cwg117; Engelstaedter V, 2012, HISTOL HISTOPATHOL, V27, P507, DOI 10.14670/HH-27.507; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Glavey SV, 2014, BLOOD, V124, P1765, DOI 10.1182/blood-2014-03-560862; Gretschel S, 2003, ONCOLOGY-BASEL, V65, P139, DOI 10.1159/000072339; Hang QL, 2015, J BIOL CHEM, V290, P29345, DOI 10.1074/jbc.M115.682229; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Hatcher BL, 2016, INFECT IMMUN, V84, P2607, DOI 10.1128/IAI.01514-15; Hou S, 2016, FASEB J, V30, P4120, DOI 10.1096/fj.201600665R; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inokuchi J, 2018, PROG MOL BIOL TRANSL, V156, P151, DOI 10.1016/bs.pmbts.2017.10.004; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Jahangiri A, 2014, CANCER RES, V74, P3, DOI 10.1158/0008-5472.CAN-13-1742; Jia N, 2014, J BIOL CHEM, V289, P28489, DOI 10.1074/jbc.M114.588541; Jin Xiao-Ling, 2004, Hepatobiliary Pancreat Dis Int, V3, P292; Jin Y, 2016, CLIN CHEM LAB MED, V54, P1811, DOI 10.1515/cclm-2015-1014; Kawamura YI, 2014, CANCER GENE THER, V21, P427, DOI 10.1038/cgt.2014.46; Kim HS, 2017, J BIOL CHEM, V292, P10664, DOI 10.1074/jbc.M117.782425; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kolasinska E, 2016, ACTA BIOCHIM POL, V63, P533, DOI 10.18388/abp.2015_1221; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Kudo T, 1998, LAB INVEST, V78, P797; Kurokawa K, 2019, J CELL BIOL, V218, P1602, DOI 10.1083/jcb.201807194; Li J, 2012, MED ONCOL, V29, P84, DOI 10.1007/s12032-010-9771-1; Li YH, 2012, APPL MICROBIOL BIOT, V94, P887, DOI 10.1007/s00253-012-4040-1; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lopez-Morales D, 2009, INVEST CLIN, V50, P45; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Ma HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085113; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Perez-Garay M, 2013, INT J BIOCHEM CELL B, V45, P1748, DOI 10.1016/j.biocel.2013.05.015; Perez-Garay M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012524; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Recchi MA, 1998, CANCER RES, V58, P4066; SASAKI K, 1993, J BIOL CHEM, V268, P22782; Sasaki K, 2019, CELL STRUCT FUNCT, V44, P85, DOI 10.1247/csf.19010; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Shah MH, 2008, GLYCOCONJUGATE J, V25, P279, DOI 10.1007/s10719-007-9086-4; Shimizu S, 2019, J BIOCHEM, V165, P101, DOI 10.1093/jb/mvy068; Sun MM, 2017, CANCER SCI, V108, P267, DOI 10.1111/cas.13128; Suzuki O, 2015, INT J ONCOL, V46, P973, DOI 10.3892/ijo.2015.2818; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; Takahashi T, 2008, PROTEOM CLIN APPL, V2, P1246, DOI 10.1002/prca.200700119; Teppa RE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081286; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; Van Slambrouck S, 2014, BIOSCIENCE REP, V34, P546, DOI 10.1042/BSR20140096; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; Velazquez-Marquez N, 2012, J BIOSCIENCES, V37, P999, DOI 10.1007/s12038-012-9261-z; Wang PH, 2005, GYNECOL ONCOL, V99, P631, DOI 10.1016/j.ygyno.2005.07.016; Wang PH, 2002, GYNECOL ONCOL, V86, P45, DOI 10.1006/gyno.2002.6714; Xu ZW, 2019, J BIOL CHEM, V294, P3117, DOI 10.1074/jbc.RA118.005923; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102; Yuan Y, 2016, LIFE SCI, V149, P138, DOI 10.1016/j.lfs.2016.02.071; Zhang GW, 2019, FASEB J, V33, P2823, DOI 10.1096/fj.201801478R; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhou XX, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122475	82	25	25	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					881	897		10.1096/fj.201901793R	http://dx.doi.org/10.1096/fj.201901793R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914669	Bronze			2022-12-28	WOS:000507308900060
J	Shao, F; Zheng, PL; Yu, D; Zhou, ZG; Jia, LJ				Shao, Feng; Zheng, Peilin; Yu, Di; Zhou, Zhiguang; Jia, Lijing			Follicular helper T cells in type 1 diabetes	FASEB JOURNAL			English	Review						autoimmunity; follicular helper T cells; pathogenesis; type 1 diabetes	CXC CHEMOKINE RECEPTOR-5; LOW-DOSE INTERLEUKIN-2; GERMINAL CENTER; B-CELLS; FREQUENCY; SUBSET; AUTOANTIBODIES; EXPRESSION; RESPONSES; PROMOTE	Type 1 diabetes (T1D) is an autoimmune disease caused by the dysfunction of immune system and consequently the destruction of insulin-producing beta cells. In past decades, numerous studies have uncovered that CD4(+) T cell subsets are critical in the pathogenesis of T1D, manifesting that type 1 T helper (Th1) and Th17 cells are pathogenic, while regulatory T (Treg) cells and Th2 cells are protective. More recently, the pathogenic role of another subset, follicular helper T (Tfh) cells that essentially regulate germinal center (GC) formation and humoral responses, has also been demonstrated in T1D and many other autoimmune diseases. In this review, we summarize the evidence for the aberrant differentiation and function of Tfh cells in T1D, and also discuss the underlying mechanisms. A better understanding on the pathogenic role of Tfh cells in T1D will inspire the design of potential therapeutic strategies to target this subset in the future.	[Shao, Feng; Zhou, Zhiguang] Cent S Univ, Dept Metab & Endocrinol, Xiangya Hosp 2, Changsha, Peoples R China; [Shao, Feng; Zhou, Zhiguang] Cent S Univ, Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol, Minist Educ, Changsha, Peoples R China; [Zheng, Peilin; Jia, Lijing] Southern Univ Sci & Technol, Dept Endocrinol, Shenzhen Peoples Hosp, Jinan Univ,Clin Med Coll 2,Affiliated Hosp 1, Shenzhen, Peoples R China; [Yu, Di] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Yu, Di] Shandong Acad Sci, Shandong Anal & Test Ctr, Jinan, Peoples R China; [Yu, Di] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Shanghai, Peoples R China	Central South University; Central South University; Jinan University; Southern University of Science & Technology; University of Queensland; Qilu University of Technology; Shanghai Jiao Tong University	Zhou, ZG (corresponding author), Cent S Univ, Dept Metab & Endocrinol, Xiangya Hosp 2, Changsha, Peoples R China.; Yu, D (corresponding author), Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia.; Jia, LJ (corresponding author), Shenzhen Peoples Hosp, Dept Endocrinol, Shenzhen, Guangdong, Peoples R China.	di.yu@uq.edu.au; zhouzhiguang@csu.edu.cn; jialijing2012@126.com	Yu, Di/C-2163-2009	Yu, Di/0000-0003-1721-8922	National Natural Science Foundation of China [81670716, 81500600]; Hunan Natural Science Foundation [2019JJ30036]; Central South University [2018zzts921]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province); Central South University	National Natural Science Foundation of China, Grant/Award Number: 81670716 and 81500600; Hunan Natural Science Foundation, Grant/Award Number: 2019JJ30036; Central South University, Grant/Award Number: 2018zzts921	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Byun M, 2013, J EXP MED, V210, P1743, DOI 10.1084/jem.20130592; Caballero-Franco C, 2016, GENES IMMUN, V17, P228, DOI 10.1038/gene.2016.16; Christensen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057820; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cunill V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01097; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Ferreira RC, 2015, DIABETOLOGIA, V58, P781, DOI 10.1007/s00125-015-3509-8; FORSTER R, 1994, BLOOD, V84, P830; Gerold KD, 2011, DIABETES, V60, P1955, DOI 10.2337/db11-0130; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Gomez-Tourino I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01925-2; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Harbers SO, 2007, J CLIN INVEST, V117, P1361, DOI 10.1172/JCI29470; Hartemann A, 2013, LANCET DIABETES ENDO, V1, P295, DOI 10.1016/S2213-8587(13)70113-X; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2016, NAT MED, V22, P991, DOI 10.1038/nm.4148; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Inoue Y, 2007, J IMMUNOL, V179, P764, DOI 10.4049/jimmunol.179.2.764; Jacquemin C, 2015, IMMUNITY, V42, P1159, DOI 10.1016/j.immuni.2015.05.012; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Katsarou Anastasia, 2017, Nat Rev Dis Primers, V3, P17016, DOI 10.1038/nrdp.2017.16; Keck S, 2014, P NATL ACAD SCI USA, V111, P14852, DOI 10.1073/pnas.1403271111; Kendall PL, 2007, J IMMUNOL, V178, P5643, DOI 10.4049/jimmunol.178.9.5643; Kenefeck R, 2015, J CLIN INVEST, V125, P292, DOI 10.1172/JCI76238; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krause S, 2014, DIABETES CARE, V37, P1675, DOI 10.2337/dc13-1719; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Leete P, 2016, DIABETES, V65, P1362, DOI 10.2337/db15-1615; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Li YQ, 2005, J IMMUNOL, V175, P2261, DOI 10.4049/jimmunol.175.4.2261; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Lin J, 2019, RHEUMATOLOGY, V58, P2188, DOI 10.1093/rheumatology/kez228; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Long SA, 2011, GENES IMMUN, V12, P116, DOI 10.1038/gene.2010.54; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Luo CM, 2013, J NEUROIMMUNOL, V256, P55, DOI 10.1016/j.jneuroim.2012.12.001; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Mackay CR, 2000, J EXP MED, V192, pF31, DOI 10.1084/jem.192.11.F31; Maine CJ, 2014, J IMMUNOL, V192, P1415, DOI 10.4049/jimmunol.1302418; McGuire HM, 2011, IMMUNITY, V34, P602, DOI 10.1016/j.immuni.2011.01.021; Miao DM, 2013, DIABETES, V62, P4174, DOI 10.2337/db13-0534; Mingueneau M, 2014, P NATL ACAD SCI USA, V111, P16466, DOI 10.1073/pnas.1419337111; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Reijonen H, 2004, DIABETES, V53, P1987, DOI 10.2337/diabetes.53.8.1987; de Guinoa JS, 2011, BLOOD, V118, P1560, DOI 10.1182/blood-2011-01-332106; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Serr I, 2016, P NATL ACAD SCI USA, V113, pE6659, DOI 10.1073/pnas.1606646113; Seth A, 2019, CURR OPIN IMMUNOL, V61, P1, DOI 10.1016/j.coi.2019.06.005; Shi XJ, 2019, DIABETOLOGIA, V62, P399, DOI 10.1007/s00125-018-4799-4; Silva DG, 2011, DIABETES, V60, P2102, DOI 10.2337/db10-1344; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; Tahiliani V, 2017, J IMMUNOL, V198, P218, DOI 10.4049/jimmunol.1601356; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Vella LA, 2019, J CLIN INVEST, V129, P3185, DOI 10.1172/JCI125628; Viisanen T, 2017, DIABETES, V66, P437, DOI 10.2337/db16-0714; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Webb LMC, 2017, IMMUNOLOGY, V152, P185, DOI 10.1111/imm.12778; Wiede F, 2017, J AUTOIMMUN, V76, P85, DOI 10.1016/j.jaut.2016.09.004; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Xu XY, 2019, J CLIN ENDOCR METAB, V104, P4199, DOI 10.1210/jc.2019-00093; Xu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079858; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu LP, 2012, DIABETES, V61, P179, DOI 10.2337/db11-0670; Zheng PL, 2013, DIABETES, V62, P896, DOI 10.2337/db12-0929	110	14	17	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					30	40		10.1096/fj.201901637R	http://dx.doi.org/10.1096/fj.201901637R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914661				2022-12-28	WOS:000507308900004
J	Zhang, CJ; Wang, Y; Peng, YN; Xu, HJ; Zhou, XL				Zhang, Chenjing; Wang, Yin; Peng, Yunan; Xu, Hongjiao; Zhou, Xuelong			METTL3 regulates inflammatory pain by modulating m(6)A-dependent pri-miR-365-3p processing	FASEB JOURNAL			English	Article						central sensitization; inflammatory pain; METTL3; N-6-methyladenosine; spinal cord	RNA MODIFICATIONS; N-6-METHYLADENOSINE; M(6)A; GENE; HYPERSENSITIVITY; MECHANISMS; LANDSCAPE; MICRORNA; RAT; FTO	N-6-methyladenosine (m(6)A) modification in RNA has been implicated in diverse biological processes. However, very little is currently known about its role in nociceptive modulation. Here, we found that the level of spinal m(6)A modification was significantly increased in a mouse model of Complete Freund's Adjuvant (CFA)-induced chronic inflammatory pain, which was accompanied with the augmentation of methyltransferase-like 3 (METTL3) expression in the spinal cord. Knockdown of spinal METTL3 prevented and reversed CFA-induced pain behaviors and spinal neuronal sensitization. In contrast, overexpression of spinal METTL3 produced pain behaviors and neuronal sensitization in naive mice. Moreover, we found that METTL3 positively modulated the pri-miR-65-3p processing in a microprocessor protein DiGeorge critical region 8-dependent manner. Collectively, our findings reveal an important role of METTL3-mediated m(6)A modification in nociceptive sensitization and provide a novel perspective on m(6)A modification in the development of pathological pain.	[Zhang, Chenjing] Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Peoples R China; [Wang, Yin] Taizhou Peoples Hosp, Dept Anesthesiol, Taizhou, Peoples R China; [Peng, Yunan] Nanjing Univ, Dept Anesthesiol, Affiliated Drum Tower Hosp, Sch Med, Nanjing, Peoples R China; [Xu, Hongjiao] Shanghai Transportat Univ, Peoples Hosp 1, Dept Anesthesiol, Shanghai, Peoples R China; [Zhou, Xuelong] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing 210029, Jiangsu, Peoples R China	Zhejiang Provincial People's Hospital; Nanjing University; Shanghai Jiao Tong University; Nanjing Medical University	Zhou, XL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing 210029, Jiangsu, Peoples R China.	zhouxuelong0258@126.com			 [81701101]		Xuelong Zhou, Grant/Award Number: 81701101	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Descalzi G, 2015, TRENDS NEUROSCI, V38, P237, DOI 10.1016/j.tins.2015.02.001; Engel M, 2018, NEURON, V99, P389, DOI 10.1016/j.neuron.2018.07.009; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fry Nate J, 2018, Oncotarget, V9, P31231, DOI 10.18632/oncotarget.25782; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Koranda JL, 2018, NEURON, V99, P283, DOI 10.1016/j.neuron.2018.06.007; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Gonzalez MJ, 2017, PHARMACOL THERAPEUT, V180, P1, DOI 10.1016/j.pharmthera.2017.06.001; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Pan ZQ, 2016, J NEUROSCI, V36, P2769, DOI 10.1523/JNEUROSCI.3474-15.2016; Rowles J, 2012, EPIGENETICS-US, V7, P1094, DOI 10.4161/epi.21977; Satterlee JS, 2014, J NEUROSCI, V34, P15170, DOI 10.1523/JNEUROSCI.3236-14.2014; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Sun WJ, 2016, NUCLEIC ACIDS RES, V44, pD259, DOI 10.1093/nar/gkv1036; Wang SY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0847-4; Wang Y, 2018, NAT NEUROSCI, V21, P195, DOI 10.1038/s41593-017-0057-1; Zhang JL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09712-x; Zhang ZY, 2018, CELL RES, V28, P1050, DOI 10.1038/s41422-018-0092-9; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou XL, 2017, ANESTHESIOLOGY, V126, P967, DOI 10.1097/ALN.0000000000001588	33	21	21	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					122	132		10.1096/fj.201901555R	http://dx.doi.org/10.1096/fj.201901555R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914601				2022-12-28	WOS:000507308900010
J	Zheng, C; Lin, XS; Liu, H; Lu, WG; Xu, XL; Wang, D; Gao, B; Wang, C; Zhou, JR; Fan, J; Hu, YQ; Jie, Q; Chen, D; Yang, L; Luo, ZJ				Zheng, Chao; Lin, Xisheng; Liu, He; Lu, Weiguang; Xu, Xiaolong; Wang, Di; Gao, Bo; Wang, Cheng; Zhou, Jinru; Fan, Jing; Hu, Yaqian; Jie, Qiang; Chen, Di; Yang, Liu; Luo, Zhuojing			Phenotypic characterization of Slc26a2 mutant mice reveals a multifactorial etiology of spondylolysis	FASEB JOURNAL			English	Article						bone loss; isthmic defect; spondylolysis; vertebral development	FINITE-ELEMENT-ANALYSIS; PEDIATRIC LUMBAR SPINE; NATURAL-HISTORY; RADIOGRAPHIC ASSESSMENT; CHONDROCYTE DEVELOPMENT; FOLLOW-UP; SPONDYLOLISTHESIS; GROWTH; SULFATION; PATHOMECHANISM	Confusion persists over pathogenesis of spondylolysis. To confirm pathogenicity of the previously identified causative mutation of spondylolysis and investigate the genetic etiology, we generate a new mouse line harboring D673V mutation in the Slc26a2 gene. D673V mutation induces delayed endochondral ossification characterized by transiently reduced chondrocyte proliferation in mice at the early postnatal stage. Adult D673V homozygotes exhibit dysplastic isthmus and reduced bone volume of the dorsal vertebra resembling the detached vertebral bony structure when spondylolysis occurs, including the postzygopophysis, vertebral arch, and spinous process, which causes biomechanical alterations around the isthmic region of L4-5 vertebrae indicated by finite element analysis. Consistently, partial ablation of Slc26a2 in vertebral skeletal cells using Col1a1-Cre; Slc26a2 (fl/fl) mouse line recapitulates a similar but worsened vertebral phenotype featured by lamellar isthmus. In addition, when reaching late adulthood, D673V homozygotes develop an evident bone-loss phenotype and show impaired osteogenesis. These findings support a multifactorial etiology, involving congenitally predisposed isthmic conditions, altered biomechanics, and age-dependent bone loss, which leads to SLC26A2-related spondylolysis.	[Zheng, Chao; Lin, Xisheng; Liu, He; Lu, Weiguang; Xu, Xiaolong; Wang, Di; Gao, Bo; Zhou, Jinru; Fan, Jing; Hu, Yaqian; Yang, Liu; Luo, Zhuojing] Fourth Mil Med Univ, Inst Orthoped Surg, Xijing Hosp, Xian, Peoples R China; [Wang, Cheng] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Jie, Qiang] Xi An Jiao Tong Univ, Hong Hui Hosp, Dept Orthoped Surg, Coll Med, Xian, Peoples R China; [Chen, Di] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Yang, Liu; Luo, Zhuojing] Northwestern Polytech Univ, Med Res Inst, Xian, Peoples R China	Air Force Military Medical University; University of Hong Kong; Xi'an Jiaotong University; Rush University; Northwestern Polytechnical University	Yang, L; Luo, ZJ (corresponding author), Fourth Mil Med Univ, Inst Orthoped Surg, Xijing Hosp, Xian, Peoples R China.	yangliu@fmmu.edu.cn; zjluo@fmmu.edu.cn		Yang, Liu/0000-0002-6498-4702; Zheng, Chao/0000-0001-8530-0923	National Natural Science Foundation of China [81972032, 81730065, 81871743]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81972032, 81730065 and 81871743	ALBANESE M, 1982, J PEDIATR ORTHOPED, V2, P496, DOI 10.1097/01241398-198212000-00006; Bajwa NS, 2012, CLIN ORTHOP RELAT R, V470, P3202, DOI 10.1007/s11999-012-2439-8; Belfi LM, 2006, SPINE, V31, pE907, DOI 10.1097/01.brs.0000245947.31473.0a; Beutler WJ, 2003, SPINE, V28, P1027, DOI 10.1097/00007632-200305150-00014; Cai T, 2015, P NATL ACAD SCI USA, V112, P8064, DOI 10.1073/pnas.1502454112; Cavalier R, 2006, J AM ACAD ORTHOP SUR, V14, P417, DOI 10.5435/00124635-200607000-00004; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; da Costa DS, 2017, ANNU REV BIOMED ENG, V19, P1, DOI [10.1146/annurev-bioeng-071516044610, 10.1146/annurev-bioeng-071516-044610]; Dwyer E, 2010, AM J MED GENET A, V152A, P3043, DOI 10.1002/ajmg.a.33736; Elliott DM, 2004, SPINE, V29, P713, DOI 10.1097/01.BRS.0000116982.19331.EA; Fagan MJ, 2002, P I MECH ENG H, V216, P281, DOI 10.1243/09544110260216568; Foreman P, 2013, CHILD NERV SYST, V29, P209, DOI 10.1007/s00381-012-1942-2; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; FREDRICKSON BE, 1984, J BONE JOINT SURG AM, V66A, P699, DOI 10.2106/00004623-198466050-00008; Gao B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099137; Gao B, 2009, NATURE, V458, P1196, DOI 10.1038/nature07862; GOLDSTEIN JD, 1991, AM J SPORT MED, V19, P463, DOI 10.1177/036354659101900507; Gualeni B, 2013, BONE, V54, P83, DOI 10.1016/j.bone.2013.01.036; Gualeni B, 2010, MATRIX BIOL, V29, P453, DOI 10.1016/j.matbio.2010.05.001; Hajjioui A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P53, DOI 10.1016/j.rehab.2010.12.001; Hammerberg KW, 2005, SPINE, V30, pS4, DOI 10.1097/01.brs.0000155576.62159.1c; He LC, 2014, EUR RADIOL, V24, P441, DOI 10.1007/s00330-013-3041-5; Ivo R, 2007, EUR SPINE J, V16, P1636, DOI 10.1007/s00586-006-0293-7; Kang HJ, 2014, J ORTHOP SCI, V19, P682, DOI 10.1007/s00776-012-0324-7; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; Kumar N, 2000, ANAT RECORD, V260, P189, DOI 10.1002/1097-0185(20001001)260:2<189::AID-AR80>3.0.CO;2-N; Lawrence KJ, 2016, PHYS THER SPORT, V20, P56, DOI 10.1016/j.ptsp.2016.04.003; Leone A, 2011, SKELETAL RADIOL, V40, P683, DOI 10.1007/s00256-010-0942-0; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Mertz EL, 2012, J BIOL CHEM, V287, P22030, DOI 10.1074/jbc.M110.116467; OGILVIE JW, 1987, SPINE, V12, P251, DOI 10.1097/00007632-198704000-00010; Remes VM, 2002, EUR SPINE J, V11, P327, DOI 10.1007/s00586-002-0413-y; Rossi A, 1996, J BIOL CHEM, V271, P18456, DOI 10.1074/jbc.271.31.18456; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; ROSSI F, 1978, J SPORT MED PHYS FIT, V18, P317; ROWE GG, 1953, J BONE JOINT SURG AM, V35-A, P102, DOI 10.2106/00004623-195335010-00010; Sairyo K, 2006, EUR SPINE J, V15, P930, DOI 10.1007/s00586-005-1033-0; Sairyo K, 2006, EUR SPINE J, V15, P923, DOI 10.1007/s00586-005-1026-z; Sairyo K, 2015, J MED INVESTIG, V62, P11, DOI 10.2152/jmi.62.11; Sakai T, 2010, J ORTHOP SCI, V15, P281, DOI 10.1007/s00776-010-1454-4; SARASTE H, 1987, J PEDIATR ORTHOPED, V7, P631; SIMPER LB, 1986, ACTA ORTHOP SCAND, V57, P78, DOI 10.3109/17453678608993222; Tabrizi P, 2001, SPINE, V26, P1482, DOI 10.1097/00007632-200107010-00020; TURNER RH, 1971, J BONE JOINT SURG AM, VA 53, P1298, DOI 10.2106/00004623-197153070-00005; Vogt MT, 1999, SPINE, V24, P2536, DOI 10.1097/00007632-199912010-00016; Walter JD, 2019, ELIFE, P8; Wang C, 2018, ELIFE, V7, DOI 10.7554/eLife.37673; Ward CV, 2007, SPINE, V32, pE85, DOI 10.1097/01.brs.0000252200.66545.43; Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009; WYNNEDAVIES R, 1979, J BONE JOINT SURG BR, V61, P301, DOI 10.1302/0301-620X.61B3.383720; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yue R, 2016, ELIFE, V5, DOI 10.7554/eLife.18782; Zehnder SW, 2009, SPINE, V34, P285, DOI 10.1097/BRS.0b013e3181956053; Zhang ST, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0723-3; Zheng C, 2019, EBIOMEDICINE, V40, P695, DOI 10.1016/j.ebiom.2019.01.010; Zhou BO, 2017, NAT CELL BIOL, V19, P891, DOI 10.1038/ncb3570	57	3	3	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					720	734		10.1096/fj.201901040RR	http://dx.doi.org/10.1096/fj.201901040RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914611				2022-12-28	WOS:000507308900050
J	Hector, A; McAnulty, C; Piche-Lemieux, ME; Alves-Pires, C; Buee-Scherrer, V; Buee, L; Brouillette, J				Hector, Audrey; McAnulty, Christina; Piche-Lemieux, Maude-Eloise; Alves-Pires, Claire; Buee-Scherrer, Valerie; Buee, Luc; Brouillette, Jonathan			Tau hyperphosphorylation induced by the anesthetic agent ketamine/xylazine involved the calmodulin-dependent protein kinase II	FASEB JOURNAL			English	Article						anesthesia; CaMKII; ketamine; tau; xylazine	KETAMINE; PHOSPHORYLATION; INHIBITION; RECEPTOR; HIPPOCAMPUS; PROPOFOL; XYLAZINE; CHANNELS; NEURONS; MODELS	Tau hyperphosphorylation is a major neuropathological hallmark of many neurodegenerative disorders such as Alzheimer's disease. Several anesthetics have been shown previously to induced marked tau hyperphosphorylation. Although the ketamine/xylazine mixture is one of the most commonly used anesthetic agents in animal research and veterinary practice, the effect of this anesthetic agent on tau phosphorylation still remains to be determined. Here, we found that ketamine-/xylazine-induced a rapid and robust hyperphosphorylation of tau in a dose-dependent manner under normothermic and hypothermic conditions in mice. When used together, ketamine and xylazine exerted a synergistic action on tau phosphorylation most strongly not only on epitopes S396 and S262, but also on other residues (T181, and S202/T205). We observed that activation of the calmodulin-dependent protein kinase II (CaMKII) is the major upstream molecular event leading to tau hyperphosphorylation following ketamine/xylazine anesthesia in mice. Moreover, we observed that intracerebroventricular injection of the selective CaMKII inhibitor KN93 attenuated tau hyperphosphorylation. Since ketamine/xylazine also had a marked impact on other key molecular signaling pathways involving the MAP/microtubule affinity-regulating kinase (MARK), extracellular signal-regulated kinase (ERK), and glycogen synthase kinase-3 (GSK3), our study calls for high caution and careful monitoring when using this anesthetic agent in laboratory animal settings across all fields of biological sciences in order to avoid artifactual results.	[Hector, Audrey; McAnulty, Christina; Piche-Lemieux, Maude-Eloise; Brouillette, Jonathan] Univ Montreal, Hop Sacre Coeur, Montreal Res Ctr, Dept Pharmacol & Physiol,CIUSSS NIM, Montreal, PQ, Canada; [Alves-Pires, Claire; Buee-Scherrer, Valerie; Buee, Luc] Univ Lille, INSERM, CHU Lille, Alzheimer & Tauopathies, F-59000 Lille, France	Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Brouillette, J (corresponding author), Univ Montreal, Hop Sacre Coeur, Montreal Res Ctr, Dept Pharmacol & Physiol,CIUSSS NIM, Montreal, PQ, Canada.; Buee, L (corresponding author), Univ Lille, INSERM, CHU Lille, Alzheimer & Tauopathies, F-59000 Lille, France.	luc.buee@inserm.fr; jonathan.brouillette@umontreal.ca	BUEE, Luc/B-3126-2010; Brouillette, Jonathan/AAF-6735-2020	BUEE, Luc/0000-0002-6261-4230; Brouillette, Jonathan/0000-0003-1058-1892; McAnulty, Christina/0000-0003-2787-2792	Fonds de Recherche du Quebec -Sante (FRQS); Hopital du Sacre-Coeur de Montreal; LabEx DISTALZ; European consortium MEMOSAD; French National Research Agency	Fonds de Recherche du Quebec -Sante (FRQS); Hopital du Sacre-Coeur de Montreal; LabEx DISTALZ; European consortium MEMOSAD; French National Research Agency(French National Research Agency (ANR))	Fonds de Recherche du Quebec -Sante (FRQS); Hopital du Sacre-Coeur de Montreal; LabEx DISTALZ; European consortium MEMOSAD; French National Research Agency	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Ando K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005917; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BAUDIER J, 1987, J BIOL CHEM, V262, P17577; Berger T, 2003, J NEUROPHYSIOL, V90, P2428, DOI 10.1152/jn.00377.2003; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Cui X, 2009, J NEUROSURG ANESTH, V21, P145, DOI 10.1097/ANA.0b013e31819ac2c0; Dujardin S, 2015, NEUROPATH APPL NEURO, V41, P59, DOI 10.1111/nan.12200; Friederich P, 2001, EUR J ANAESTH, V18, P177, DOI 10.1046/j.0265-0215.2000.00807.x; GAGE PW, 1985, BRIT J PHARMACOL, V85, P675, DOI 10.1111/j.1476-5381.1985.tb10563.x; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Hatakeyama N, 2001, J Anesth, V15, P149, DOI 10.1007/s005400170017; Hirota K, 1996, BRIT J ANAESTH, V77, P441, DOI 10.1093/bja/77.4.441; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Irifune M, 2000, ANESTH ANALG, V91, P230, DOI 10.1097/00000539-200007000-00043; Jin HY, 2013, NEURAL REGEN RES, V8, P1590, DOI 10.3969/j.issn.1673-5374.2013.17.007; Kitayama M, 2002, N-S ARCH PHARMACOL, V366, P246, DOI 10.1007/s00210-002-0590-6; Le Freche H, 2012, ANESTHESIOLOGY, V116, P779, DOI 10.1097/ALN.0b013e31824be8c7; Lebouvier T, 2017, CURR OPIN NEUROL, V30, P589, DOI 10.1097/WCO.0000000000000502; Lenhardt Rainer, 2010, Front Biosci (Schol Ed), V2, P1145; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Orser BA, 1997, ANESTHESIOLOGY, V86, P903, DOI 10.1097/00000542-199704000-00021; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Potez S, 2008, J NEUROPHYSIOL, V99, P1394, DOI 10.1152/jn.01126.2007; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Schnoebel R, 2005, BRIT J PHARMACOL, V146, P826, DOI 10.1038/sj.bjp.0706385; SCHOLFIELD CN, 1980, PFLUG ARCH EUR J PHY, V383, P249, DOI 10.1007/BF00587527; Schwartz DD, 1998, J VET PHARMACOL THER, V21, P107, DOI 10.1046/j.1365-2885.1998.00113.x; Tan WF, 2010, EUR J ANAESTH, V27, P835, DOI 10.1097/EJA.0b013e32833a6561; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wen GH, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00287; Whittington RA, 2013, PROG NEURO-PSYCHOPH, V47, P147, DOI 10.1016/j.pnpbp.2013.03.004; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; Yamakura T, 2000, ANESTHESIOLOGY, V92, P1144, DOI 10.1097/00000542-200004000-00033; Yeung LY, 2010, TOXICOL LETT, V193, P189, DOI 10.1016/j.toxlet.2010.01.008	40	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2968	2977		10.1096/fj.201902135R	http://dx.doi.org/10.1096/fj.201902135R		DEC 2019	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908108				2022-12-28	WOS:000504668000001
J	Park, D; Yoon, HJ; Lee, KY; Park, SJ; Cheon, SH; Lee, HH; Lee, SJ; Lee, BJ				Park, DongWon; Yoon, Hye-Jin; Lee, Ki-Young; Park, Sung-Jean; Cheon, Seung-Ho; Lee, Hyung Ho; Lee, Sang Jae; Lee, Bong-Jin			Crystal structure of proteolyzed VapBC and DNA-bound VapBC from Salmonella enterica Typhimurium LT2 and VapC as a putative Ca2+-dependent ribonuclease	FASEB JOURNAL			English	Article						DNA-free and -bound VapBC complex; toxin-antitoxin; VapC	TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; PIN-DOMAIN; TUBERCULOSIS REVEALS; INHIBITS TRANSLATION; STATISTICAL-ANALYSIS; STRESS-RESPONSE; MESSENGER-RNA; BINDING; COMPLEX	Bacterial toxin-antitoxin (TA) system has gained attention for its essential roles in cellular maintenance and survival under harsh environmental conditions such as nutrient deficiency and antibiotic treatment. There are at least 14 TA systems in Salmonella enterica serovar Typhimurium LT2, a pathogenic bacterium, and none of the structures of these TA systems have been determined. We determined the crystal structure of the VapBC TA complex from S. Typhimurium LT2 in proteolyzed and DNA-bound forms at 2.0 angstrom and 2.8 angstrom resolution, respectively. The VapC toxin possesses a pilT N-terminal domain (PIN-domain) that shows ribonuclease activity, and the VapB antitoxin has an AbrB-type DNA binding domain. In addition, the structure revealed details of interaction mode between VapBC and the cognate promoter DNA, including the inhibition of VapC by VapB and linear conformation of bound DNA in the VapBC complex. The complexation of VapBC with the linear DNA is not consistent with known structures of VapBC homologs in complex with bent DNA. We also identified VapC from S. Typhimurium LT2 as a putative Ca2+-dependent ribonuclease, which differs from previous data showing that VapC homologs have Mg2+ or Mn2+-dependent ribonuclease activities. The present studies could provide structural understanding of the physiology of VapBC systems and foundation for the development of new antibiotic drugs against Salmonella infection.	[Park, DongWon; Cheon, Seung-Ho; Lee, Bong-Jin] Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 08826, South Korea; [Yoon, Hye-Jin; Lee, Hyung Ho] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea; [Lee, Ki-Young] Univ Toronto, Dept Med Biophys, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Park, Sung-Jean] Gachon Univ, Coll Pharm, Incheon, South Korea; [Lee, Sang Jae] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Gachon University; Pohang University of Science & Technology (POSTECH)	Lee, BJ (corresponding author), Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 08826, South Korea.	lbj@nmr.snu.ac.kr	Lee, Sang Jae/AAX-7611-2021; Lee, Bong-Jin/AAQ-1609-2020	Lee, Sang Jae/0000-0002-5366-2900; Lee, Bong-Jin/0000-0001-7896-2961	National Research Foundation of Korea (NRF) [2018R1A2A1A19018526, 2018R1A5A2024425]; 2018 BK21 Plus Project for Medicine, Dentistry and Pharmacy	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); 2018 BK21 Plus Project for Medicine, Dentistry and Pharmacy	National Research Foundation of Korea (NRF), Grant/Award Number: 2018R1A2A1A19018526 and 2018R1A5A2024425; 2018 BK21 Plus Project for Medicine, Dentistry and Pharmacy	Aakre CD, 2013, MOL CELL, V52, P617, DOI 10.1016/j.molcel.2013.10.014; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bendtsen KL, 2017, NUCLEIC ACIDS RES, V45, P2875, DOI 10.1093/nar/gkw1266; Brielle R, 2016, CURR OPIN MICROBIOL, V30, P114, DOI 10.1016/j.mib.2016.01.009; Cates MS, 2002, BIOPHYS J, V82, P1133, DOI 10.1016/S0006-3495(02)75472-6; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Cooper CR, 2009, BIOCHEM SOC T, V37, P123, DOI 10.1042/BST0370123; Corona RI, 2016, PROTEINS, V84, P1147, DOI 10.1002/prot.25061; Coussens NP, 2016, EXP BIOL MED, V241, P1332, DOI 10.1177/1535370216651938; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Das U, 2014, J STRUCT BIOL, V188, P249, DOI 10.1016/j.jsb.2014.10.002; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Dienemann C, 2011, J MOL BIOL, V414, P713, DOI 10.1016/j.jmb.2011.10.024; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Guo YX, 2014, NUCLEIC ACIDS RES, V42, P6448, DOI 10.1093/nar/gku279; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kang SM, 2017, NUCLEIC ACIDS RES, V45, P8564, DOI 10.1093/nar/gkx489; Kirberger M, 2008, J BIOL INORG CHEM, V13, P1169, DOI 10.1007/s00775-008-0402-7; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee IG, 2015, NUCLEIC ACIDS RES, V43, P7624, DOI 10.1093/nar/gkv689; Lee KY, 2016, TOXINS, V8, DOI 10.3390/toxins8100305; MAKAROVA KS, 2009, BIOL DIRECT, V4; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Mate MJ, 2012, NUCLEIC ACIDS RES, V40, P3245, DOI 10.1093/nar/gkr1167; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Min AB, 2012, PROTEIN SCI, V21, P1754, DOI 10.1002/pro.2161; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1155, DOI 10.1016/j.bbapap.2013.02.027; Perticaroli S, 2014, BIOPHYS J, V106, P2667, DOI 10.1016/j.bpj.2014.05.009; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Winther KS, 2009, MOL MICROBIOL, V72, P918, DOI 10.1111/j.1365-2958.2009.06694.x; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061	63	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3051	3068		10.1096/fj.201901989R	http://dx.doi.org/10.1096/fj.201901989R		DEC 2019	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908032				2022-12-28	WOS:000504067300001
J	Turcotte, C; Archambault, AS; Dumais, E; Martin, C; Blanchet, MR; Bissonnette, E; Ohashi, N; Yamamoto, K; Itoh, T; Laviolette, M; Veilleux, A; Boulet, LP; Di Marzo, V; Flamand, N				Turcotte, Caroline; Archambault, Anne-Sophie; Dumais, Elizabeth; Martin, Cyril; Blanchet, Marie-Renee; Bissonnette, Elyse; Ohashi, Nami; Yamamoto, Keiko; Itoh, Toshimasa; Laviolette, Michel; Veilleux, Alain; Boulet, Louis-Philippe; Di Marzo, Vincenzo; Flamand, Nicolas			Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human myeloid leukocytes	FASEB JOURNAL			English	Article						CB2 receptor; Inflammation; JZL184; MAFP; resolution	COLONY-STIMULATING FACTOR; HUMAN-NEUTROPHILS; LEUKOTRIENE BIOSYNTHESIS; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC-ACID; PHOSPHOLIPASE-D; CB2 RECEPTOR; TRIACSIN-C; 2-ARACHIDONOYLGLYCEROL; INVOLVEMENT	The endocannabinoid (eCB) 2-arachidonoyl-gycerol (2-AG) modulates immune responses by activating cannabinoid receptors or through its multiple metabolites, notably eicosanoids. Thus, 2-AG hydrolysis inhibition might represent an interesting anti-inflammatory strategy that would simultaneously increase the levels of 2-AG and decrease those of eicosanoids. Accordingly, 2-AG hydrolysis inhibition increased 2-AG half-life in neutrophils. Under such setting, neutrophils, eosinophils, and monocytes synthesized large amounts of 2-AG and other monoacylglycerols (MAGs) in response to arachidonic acid (AA) and other unsaturated fatty acids (UFAs). Arachidonic acid and UFAs were ~1000-fold more potent than G protein-coupled receptor (GPCR) agonists. Triascin C and thimerosal, which, respectively, inhibit fatty acyl-CoA synthases and acyl-CoA transferases, prevented the UFA-induced MAG biosynthesis, implying glycerolipid remodeling. 2-AG and other MAG biosynthesis was preceded by that of the corresponding lysophosphatidic acid (LPA). However, we could not directly implicate LPA dephosphorylation in MAG biosynthesis. While GPCR agonists poorly induced 2-AG biosynthesis, they inhibited that induced by AA by 25%-50%, suggesting that 2-AG biosynthesis is decreased when leukocytes are surrounded by a pro-inflammatory entourage. Our data strongly indicate that human leukocytes use AA and UFAs to biosynthesize biologically significant concentrations of 2-AG and other MAGs and that hijacking the immune system with 2-AG hydrolysis inhibitors might diminish inflammation in humans.	[Turcotte, Caroline; Archambault, Anne-Sophie; Dumais, Elizabeth; Martin, Cyril; Blanchet, Marie-Renee; Bissonnette, Elyse; Laviolette, Michel; Boulet, Louis-Philippe; Di Marzo, Vincenzo; Flamand, Nicolas] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Fac Med, Dept Med,Ctr Rech, 2725 Chemin St Foy,Room A2142, Quebec City, PQ G1V 4G5, Canada; [Ohashi, Nami; Yamamoto, Keiko; Itoh, Toshimasa] Showa Pharmaceut Univ, Lab Drug Design & Med Chem, Machida, Tokyo, Japan; [Veilleux, Alain; Di Marzo, Vincenzo] Univ Laval, Fac Sci Agr & Alimentat, Ecole Nutr, Quebec City, PQ, Canada; [Di Marzo, Vincenzo] CNR, Joint Int Unit Natl Res Council CNR Italy & Univ, Pozzuoli, Italy	Laval University; Showa Pharmaceutical University; Laval University; Consiglio Nazionale delle Ricerche (CNR)	Flamand, N (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Fac Med, Dept Med,Ctr Rech, 2725 Chemin St Foy,Room A2142, Quebec City, PQ G1V 4G5, Canada.	Nicolas.Flamand@criucpq.ulaval.ca	Ohashi, Nami/ABH-2782-2020; Veilleux, Alain/I-5028-2019; Flamand, Nicolas/H-5823-2019; Di Marzo, Vincenzo/AAD-7742-2019	Veilleux, Alain/0000-0003-4078-1908; Flamand, Nicolas/0000-0001-5944-7200; Di Marzo, Vincenzo/0000-0002-1490-3070; Itoh, Toshimasa/0000-0003-3446-4447; Archambault, Anne-Sophie/0000-0001-7243-7445; Yamamoto, Keiko/0000-0001-6642-7961				Aaltonen Niina, 2012, BMC Pharmacology, V12, P7, DOI 10.1186/1471-2210-12-7; Archambault AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202424; Berdyshev EV, 2001, FASEB J, V15, P2171, DOI 10.1096/fj.01-0181com; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; Bisogno T, 1999, J NEUROCHEM, V72, P2113, DOI 10.1046/j.1471-4159.1999.0722113.x; BOURGOIN S, 1990, J EXP MED, V172, P767, DOI 10.1084/jem.172.3.767; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Chouinard F, 2013, J LEUKOCYTE BIOL, V93, P267, DOI 10.1189/jlb.0412200; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; DePetrocellis L, 1997, BIOCHEM BIOPH RES CO, V231, P82, DOI 10.1006/bbrc.1997.6000; Deutsch DG, 1997, BIOCHEM PHARMACOL, V53, P255, DOI 10.1016/S0006-2952(96)00830-1; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Everard A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08051-7; Fanelli F, 2012, J LIPID RES, V53, P481, DOI 10.1194/jlr.M021378; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Flamand N, 2004, BRIT J PHARMACOL, V141, P552, DOI 10.1038/sj.bjp.0705654; Flamand N, 2000, AM J RESP CRIT CARE, V161, pS88, DOI 10.1164/ajrccm.161.supplement_1.ltta-18; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; HARTMAN EJ, 1989, PROSTAGLANDINS, V37, P655, DOI 10.1016/0090-6980(89)90103-2; Hillard CJ, 2012, NEUROSCIENCE, V204, P207, DOI 10.1016/j.neuroscience.2011.11.020; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; KORCHAK HM, 1994, J BIOL CHEM, V269, P30281; Lankinen M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111785; Larose MC, 2014, J ALLERGY CLIN IMMUN, V133, P1480, DOI 10.1016/j.jaci.2013.12.1081; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Nakane S, 2002, ARCH BIOCHEM BIOPHYS, V402, P51, DOI 10.1016/S0003-9861(02)00038-3; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; PRESCOTT SM, 1983, J BIOL CHEM, V258, P764; Ramsden CE, 2015, J PAIN, V16, P707, DOI 10.1016/j.jpain.2015.04.007; Simon MF, 2002, J BIOL CHEM, V277, P23131, DOI 10.1074/jbc.M201530200; Smith FL, 1998, PHARMACOL BIOCHEM BE, V60, P183, DOI 10.1016/S0091-3057(97)00583-2; Smyth SS, 2003, J BIOL CHEM, V278, P43214, DOI 10.1074/jbc.M306709200; Staiano RI, 2016, J LEUKOCYTE BIOL, V99, P531, DOI 10.1189/jlb.3HI1214-584R; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Turcotte C, 2019, J LEUKOCYTE BIOL, V106, P1337, DOI 10.1002/JLB.3A0919-049RRR; Turcotte C, 2017, J IMMUNOL, V198, P3255, DOI 10.4049/jimmunol.1601767; Turcotte C, 2016, CELL MOL LIFE SCI, V73, P4449, DOI 10.1007/s00018-016-2300-4; Turcotte C, 2015, J LEUKOCYTE BIOL, V97, P1049, DOI 10.1189/jlb.3RU0115-021R; Wood JT, 2010, J LIPID RES, V51, P1416, DOI 10.1194/jlr.M002436; Yamamoto Y, 2017, ORG BIOMOL CHEM, V15, P8186, DOI 10.1039/c7ob01771e; Zarini S, 2006, J BIOL CHEM, V281, P10134, DOI 10.1074/jbc.M510783200	47	20	20	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4253	4265		10.1096/fj.201902916R	http://dx.doi.org/10.1096/fj.201902916R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32012340	hybrid			2022-12-28	WOS:000519218400055
J	Ji, XL; Liu, TJ; Zhao, SY; Li, JJ; Li, LY; Wang, EB				Ji, Xianglu; Liu, Tianjing; Zhao, Shuyi; Li, Jianjun; Li, Lianyong; Wang, Enbo			WISP-2, an upregulated gene in hip cartilage from the DDH model rats, induces chondrocyte apoptosis through PPAR gamma in vitro	FASEB JOURNAL			English	Article						acetabular cartilage complex; chondrocyte apoptosis; developmental dysplasia of the hip; hip development; microarray analysis; pathological mechanism	INFLUENCE DEVELOPMENTAL DYSPLASIA; GROWTH-FACTOR; EXPRESSION; COLLAGEN; OSTEOARTHRITIS; ACTIVATION; CELLS; TISSUE	Chondrocyte apoptosis plays an important role in the developmental dysplasia of the hip (DDH) development. It has been found that WNT1 inducible signaling pathway protein 2 (WISP-2) and peroxisome proliferator-activated receptor gamma (PPAR gamma) are involved in cell apoptosis. In this study, we performed the straight-leg swaddling DDH rat model and we found that cartilage degradation and chondrocyte apoptosis were remarkably increased in DDH rats in vivo. Moreover, we found that WISP-2 was upregulated in hip acetabular cartilage of DDH rats compared to control rats. Next, the effects of WISP-2 on chondrocyte apoptosis and its possible underlying mechanism were examined in vitro. The lentivirus-mediated gain- and loss-of-function experiments of WISP-2 and peroxisome proliferator-activated receptor gamma (PPAR gamma) for cell viability and apoptosis were performed in primary rat chondrocytes. The results showed that the overexpression of WISP-2 induced chondrocyte apoptosis, and knockdown of WISP-2 could suppress the chondrocyte apoptosis induced by advanced glycation end products (AGE). Additionally, WISP-2 could negatively regulate the expression of PPAR gamma in chondrocytes. Moreover, the knockdown of PPAR gamma promoted chondrocyte apoptosis and overexpression of PPAR gamma abated the increased apoptosis and decreased cell viability of chondrocytes induced by WISP-2. This study demonstrated that WISP-2 might contribute to chondrocyte apoptosis of hip acetabular cartilage through regulating PPAR gamma expression and activation, which may play an important role in the development of DDH.	[Ji, Xianglu] China Med Univ, Shengjing Hosp, Dept Hand & Foot Surg, Shenyang, Peoples R China; [Liu, Tianjing; Zhao, Shuyi; Li, Lianyong; Wang, Enbo] China Med Univ, Shengjing Hosp, Dept Pediat Orthoped, 36 Sanhao St, Shenyang 110004, Peoples R China; [Li, Jianjun] China Med Univ, Shengjing Hosp, Dept Traumat Orthped, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, EB (corresponding author), China Med Univ, Shengjing Hosp, Dept Pediat Orthoped, 36 Sanhao St, Shenyang 110004, Peoples R China.	wangenbodor@126.com	Wang, Enbo/AAQ-6993-2020		National Natural Science Foundation of China [30700877, 81171675]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 30700877 and 81171675).	Ashraf A, 2014, CLIN ORTHOP RELAT R, V472, P2237, DOI 10.1007/s11999-014-3587-9; Bo N, 2012, CONNECT TISSUE RES, V53, P513, DOI 10.3109/03008207.2012.700346; Chen LQ, 2017, J CELL MOL MED, V21, P3347, DOI 10.1111/jcmm.13237; Chen XY, 2012, RHEUMATOL INT, V32, P3359, DOI 10.1007/s00296-011-2178-2; Chen YJ, 2015, J ORTHOP RES, V33, P373, DOI 10.1002/jor.22770; Chen YF, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/7691531; Chowdhury S, 2014, ENDOCRINOLOGY, V155, P1629, DOI 10.1210/en.2013-1735; Das A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00916-z; Grunberg JR, 2014, J BIOL CHEM, V289, P6899, DOI 10.1074/jbc.M113.511964; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Hwang HS, 2015, INT J MOL SCI, V16, P26035, DOI 10.3390/ijms161125943; Jansen IDC, 2010, J MOL HISTOL, V41, P9, DOI 10.1007/s10735-010-9257-7; Ji JF, 2014, ONCOL REP, V31, P533, DOI 10.3892/or.2013.2909; Ker DFE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139054; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; Ko J, 2016, TOXICOL LETT, V260, P8, DOI 10.1016/j.toxlet.2016.08.016; Kocabayoglu P, 2017, ANN TRANSPL, V22, P446, DOI 10.12659/AOT.903497; Komatsu M, 2015, J ORTHOP SCI, V20, P708, DOI 10.1007/s00776-015-0727-3; KUTLU A, 1992, J PEDIATR ORTHOPED, V12, P598; Lee MC, 2006, ORTHOP CLIN N AM, V37, P119, DOI 10.1016/j.ocl.2005.12.001; Li CW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.534; Li H, 2011, OSTEOARTHR CARTILAGE, V19, P1246, DOI 10.1016/j.joca.2011.07.011; Li LY, 2013, INT J CLIN EXP PATHO, V6, P212; Li P, 2015, J TOXICOL SCI, V40, P615, DOI 10.2131/jts.40.615; Liu XY, 2014, CELL SIGNAL, V26, P2276, DOI 10.1016/j.cellsig.2014.05.018; Mahan ST, 2008, PEDIATRICS, V121, P177, DOI 10.1542/peds.2007-1618; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Nie HB, 2015, CELL PHYSIOL BIOCHEM, V35, P1201, DOI 10.1159/000373944; Oseni AO, 2013, J SURG RES, V181, P41, DOI 10.1016/j.jss.2012.05.087; Roposch A, 2013, CLIN ORTHOP RELAT R, V471, P2318, DOI 10.1007/s11999-013-2804-2; Russo JW, 2010, J CELL COMMUN SIGNAL, V4, P119, DOI 10.1007/s12079-010-0098-7; Sauer S, 2015, TRENDS PHARMACOL SCI, V36, P688, DOI 10.1016/j.tips.2015.06.010; Schwend RM, 2014, PEDIATR CLIN N AM, V61, P1095, DOI 10.1016/j.pcl.2014.08.008; van Sleuwen BE, 2007, PEDIATRICS, V120, pe1097, DOI 10.1542/peds.2006-2083; Vasheghani F, 2013, AM J PATHOL, V182, P1099, DOI 10.1016/j.ajpath.2012.12.012; Wang EB, 2012, J BONE JOINT SURG AM, V94A, P1071, DOI 10.2106/JBJS.K.00720; Wei YS, 2016, BALK MED J, V33, P639, DOI 10.5152/balkanmedj.2016.150557; Yamabe S, 2013, FEBS J, V280, P1617, DOI 10.1111/febs.12170; Zhang HB, 2016, APOPTOSIS, V21, P1082, DOI 10.1007/s10495-016-1280-z	41	4	4	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4904	4917		10.1096/fj.201901915R	http://dx.doi.org/10.1096/fj.201901915R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32058630	Bronze			2022-12-28	WOS:000515245300001
J	Sekulovski, N; Whorton, AE; Shi, MX; Hayashi, K; MacLean, JA				Sekulovski, Nikola; Whorton, Allison E.; Shi, Mingxin; Hayashi, Kanako; MacLean, James A., II			Periovulatory insulin signaling is essential for ovulation, granulosa cell differentiation, and female fertility	FASEB JOURNAL			English	Article						female reproduction; insulin signaling; knockout mouse; ovary	GROWTH-FACTOR RECEPTOR; OVARIAN GRANULOSA; TARGETED DISRUPTION; MICE; GENES; EXPRESSION; PROGESTERONE; ACTIVATION; FOLLICLE; E2A	Recent studies have demonstrated an essential role for insulin signaling in folliculogenesis as conditional ablation of Igf1r in primary follicles elicits defective follicle-stimulating hormone responsiveness blocking development at the preantral stage. Thus the potential role of insulin action in the periovulatory window and in the corpus luteum is unknown. To examine this, we generated conditional Insr,Igf1r, and double receptor knockout mice driven by Pgr-Cre. These models escape the preantral follicle block and in response to superovulatory gonadotropins exhibit normal distribution of ovarian follicles and corpora lutea. However, single ablation of Igf1r leads to subfertility and mice lacking both receptors are infertile. Double knockout mice have impaired oocyte development and ovulation. While some oocytes are released and fertilized, subsequent embryo development is retarded, and the embryos potentially fail to thrive due to lack of luteal support. In support of this, we found reduced expression of key enzymes in the steroid synthesis pathway and reduced serum progesterone. In addition to metabolic and steroidogenic pathways, RNA-sequencing analysis revealed transcription factor-3 as an important transcription factor downstream of insulin signaling. Collectively, these results highlight the importance of growth factors of the insulin family during two distinct windows of follicular development, ovulation, and luteinization.	[Sekulovski, Nikola; Whorton, Allison E.; Shi, Mingxin; Hayashi, Kanako; MacLean, James A., II] Southern Illinois Univ, Sch Med, Dept Physiol, Life Sci 3, Carbondale, IL USA	Southern Illinois University System; Southern Illinois University	MacLean, JA (corresponding author), Southern Illinois Univ, Dept Physiol, Life Sci 3,Room 2071,1135 Lincoln Dr, Carbondale, IL 62901 USA.	jmaclean@siumed.edu		Whorton, Allison/0000-0003-2983-401X; Hayashi, Kanako/0000-0002-5028-799X				Abazari-Kia AH, 2014, J ASSIST REPROD GEN, V31, P313, DOI 10.1007/s10815-013-0159-y; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; ADASHI EY, 1985, ENDOCR REV, V6, P400, DOI 10.1210/edrv-6-3-400; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bassuk AG, 1998, MOL MED, V4, P392, DOI 10.1007/BF03401746; Baumgarten SC, 2017, ENDOCRINOLOGY, V158, P2309, DOI 10.1210/en.2017-00146; Baumgarten SC, 2014, J CLIN ENDOCR METAB, V99, P2995, DOI 10.1210/jc.2014-1139; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Bhalla S, 2008, J IMMUNOL, V180, P1694, DOI 10.4049/jimmunol.180.3.1694; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; Brown RM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103267; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buensuceso AV, 2016, ENDOCRINOLOGY, V157, P942, DOI 10.1210/en.2015-1216; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; Choi Y, 2018, J CLIN ENDOCR METAB, V103, P4241, DOI 10.1210/jc.2017-02532; Choi Y, 2017, J CLIN ENDOCR METAB, V102, P1971, DOI 10.1210/jc.2016-3153; Davis BJ, 1999, ENDOCRINOLOGY, V140, P2685, DOI 10.1210/en.140.6.2685; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Dunning KR, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127274; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Dupont J, 2016, BIOCHEM J, V473, P1483, DOI 10.1042/BCJ20160124; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Hannon PR, 2018, ENDOCRINOLOGY, V159, P2447, DOI 10.1210/en.2018-00020; Hannon PR, 2016, TOXICOL SCI, V150, P97, DOI 10.1093/toxsci/kfv317; Haywood NJ, 2019, MOL METAB, V19, P86, DOI 10.1016/j.molmet.2018.10.008; Hoang YD, 2009, BIOL REPROD, V81, P636, DOI 10.1095/biolreprod.109.078378; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; John GB, 2007, REPRODUCTION, V133, P855, DOI 10.1530/REP-06-0051; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Kim J, 2009, MOL HUM REPROD, V15, P821, DOI 10.1093/molehr/gap082; King AM, 2009, MECH AGEING DEV, V130, P384, DOI 10.1016/j.mad.2009.03.002; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kong C, 1998, J NEUROIMMUNOL, V88, P91, DOI 10.1016/S0165-5728(98)00094-0; KRASNOW JS, 1990, MOL ENDOCRINOL, V4, P13, DOI 10.1210/mend-4-1-13; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lei ZM, 2001, MOL ENDOCRINOL, V15, P184, DOI 10.1210/me.15.1.184; Li RT, 2016, BIOCHEM CELL BIOL, V94, P247, DOI 10.1139/bcb-2015-0162; Lim J, 2015, ENDOCRINOLOGY, V156, P3329, DOI 10.1210/en.2015-1206; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lisle RS, 2013, REPRODUCTION, V145, P381, DOI 10.1530/REP-12-0338; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Liu QW, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9846274; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Luo C, 2011, J AM ASSOC LAB ANIM, V50, P471; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Mani AM, 2010, REPRODUCTION, V139, P139, DOI 10.1530/REP-09-0050; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Munir I, 2004, ENDOCRINOLOGY, V145, P175, DOI 10.1210/en.2003-0329; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Nandi A, 2010, ENDOCRINOLOGY, V151, P1863, DOI 10.1210/en.2009-0788; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; Pan YY, 2020, J CELL BIOCHEM, V121, P1087, DOI 10.1002/jcb.29345; Peng J, 2015, P NATL ACAD SCI USA, V112, pE5098, DOI 10.1073/pnas.1514498112; Pitetti JL, 2009, SEX DEV, V3, P264, DOI 10.1159/000252813; Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160; Prather GR, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140236; Richards JS, 2018, TRENDS ENDOCRIN MET, V29, P313, DOI 10.1016/j.tem.2018.02.012; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Segales J, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0074-x; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Stodden GR, 2015, ONCOGENE, V34, P2471, DOI 10.1038/onc.2014.193; Stouffer RL, 2007, FRONT BIOSCI, V12, P297, DOI 10.2741/2065; Titone R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21031-7; Walusimbi SS, 2013, J ANIM SCI, V91, P1650, DOI 10.2527/jas.2012-6179; Wayne CM, 2007, MOL ENDOCRINOL, V21, P1940, DOI 10.1210/me.2007-0020; Welborn JP, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.124834; Zhang GQ, 2000, ENDOCRINOLOGY, V141, P2735, DOI 10.1210/en.141.8.2735; Zhang H, 2007, CANCER RES, V67, P391, DOI 10.1158/0008-5472.CAN-06-1712; Zhou J, 1997, MOL ENDOCRINOL, V11, P1924, DOI 10.1210/me.11.13.1924; Zhou P, 2013, MOL ENDOCRINOL, V27, P511, DOI 10.1210/me.2012-1307	79	15	17	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2376	2391		10.1096/fj.201901791R	http://dx.doi.org/10.1096/fj.201901791R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908002	Bronze, Green Accepted			2022-12-28	WOS:000514663600031
J	Skedsmo, FS; Malachin, G; Vage, DI; Hammervold, MM; Salvesen, O; Ersdal, C; Ranheim, B; Stafsnes, MH; Bartosova, Z; Bruheim, P; Jaderlund, KH; Matiasek, K; Espenes, A; Tranulis, MA				Skedsmo, Fredrik S.; Malachin, Giulia; Vage, Dag Inge; Hammervold, Mie Marie; Salvesen, Oyvind; Ersdal, Cecilie; Ranheim, Birgit; Stafsnes, Marit H.; Bartosova, Zdenka; Bruheim, Per; Jaderlund, Karin H.; Matiasek, Kaspar; Espenes, Arild; Tranulis, Michael A.			Demyelinating polyneuropathy in goats lacking prion protein	FASEB JOURNAL			English	Article						lipidomic; myelin; neuropathy; PRNP haplotype	PERIPHERAL-NERVE; MICE; PRP; INJURY; ONSET; GENE	Studies in mice with ablation of Prnp, the gene that encodes the cellular prion protein (PrP (c)), have led to the hypothesis that PrP (c) is important for peripheral nerve myelin maintenance. Here, we have used a nontransgenic animal model to put this idea to the test; namely, goats that, due to a naturally occurring nonsense mutation, lack PrP (c). Teased nerve fiber preparation revealed a demyelinating pathology in goats without PrP (c). Affected nerves were invaded by macrophages and T cells and displayed vacuolated fibers, shrunken axons, and onion bulbs. Peripheral nerve lipid composition was similar in young goats with or without PrP (c), but markedly different between corresponding groups of adult goats, reflecting the progressive nature of the neuropathy. This is the first report of a subclinical demyelinating polyneuropathy caused by loss of Pr (c) function in a nontransgenic mammal.	[Skedsmo, Fredrik S.; Jaderlund, Karin H.] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci, Fac Vet Med, Oslo, Norway; [Malachin, Giulia; Espenes, Arild; Tranulis, Michael A.] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med, Ullevalsveien 72, N-0454 Oslo, Norway; [Vage, Dag Inge; Hammervold, Mie Marie] Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway; [Salvesen, Oyvind; Ersdal, Cecilie; Ranheim, Birgit] Norwegian Univ Life Sci, Dept Prod Anim Clin Sci, Fac Vet Med, Oslo, Norway; [Stafsnes, Marit H.; Bartosova, Zdenka; Bruheim, Per] Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Fac Nat Sci, Trondheim, Norway; [Matiasek, Kaspar] Ludwig Maximilians Univ Munchen, Sect Clin & Comparat Neuropathol, Ctr Clin Vet Med, Munich, Germany	Norwegian University of Life Sciences; Norwegian University of Life Sciences; Norwegian University of Life Sciences; Norwegian University of Life Sciences; Norwegian University of Science & Technology (NTNU); University of Munich	Tranulis, MA (corresponding author), Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med, Ullevalsveien 72, N-0454 Oslo, Norway.	Michael.Tranulis@nmbu.no	Jäderlund, Karin Hultin/AAL-8211-2020; Våge, Dag Inge/AAD-5178-2020; Ranheim, Birgit/AAB-8345-2021	Våge, Dag Inge/0000-0003-2568-1554; Bartosova, Zdenka/0000-0001-5644-1903; Malachin, Giulia/0000-0003-1888-6850; Bruheim, Per/0000-0002-7851-8083	The Research Council of Norway [227386/E40] Funding Source: Medline	The Research Council of Norway(Research Council of Norway)		BRECHENMACHER C, 1987, CLIN NEUROPATHOL, V6, P19; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Dyck PJ, 1984, PERIPHERAL NEUROPATH, V1, P790; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Holcapek M, 2015, J CHROMATOGR A, V1377, P85, DOI 10.1016/j.chroma.2014.12.023; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kouadri A, 2019, ANTIOXID REDOX SIGN, V31, P59, DOI 10.1089/ars.2018.7500; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Lisa M, 2015, ANAL CHEM, V87, P7187, DOI 10.1021/acs.analchem.5b01054; Malachin G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179881; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mizisin AP, 1998, ACTA NEUROPATHOL, V95, P171, DOI 10.1007/s004010050783; Mogha A, 2016, J NEUROSCI, V36, P12351, DOI 10.1523/JNEUROSCI.3854-15.2016; MOORE RC, 1995, BIO-TECHNOL, V13, P999, DOI 10.1038/nbt0995-999; Nishida N, 1999, LAB INVEST, V79, P689; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; Petit CSV, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24377; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodionova NN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185170; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Salvesen O, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0879-5; Salvesen O, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01722; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Weller RO, 1977, PATHOLOGY PERIPHERAL, P61; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008	36	21	21	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2359	2375		10.1096/fj.201902588R	http://dx.doi.org/10.1096/fj.201902588R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907995	Green Published, hybrid			2022-12-28	WOS:000514663600030
J	Dekker, LJM; Wu, SY; Jurriens, C; Mustafa, DAN; Grevers, F; Burgers, PC; Smitt, PAES; Kros, JM; Luider, TM				Dekker, Lennard J. M.; Wu, Suying; Jurriens, Cherise; Mustafa, Dana A. N.; Grevers, Frederieke; Burgers, Peter C.; Smitt, Peter A. E. Sillevis; Kros, Johan M.; Luider, Theo M.			Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level	FASEB JOURNAL			English	Article						glioma; glutaminolysis; IDH1 mutation; metabolism; proteomics; TCA cycle	BRAIN ENERGY; GLUTAMATE; LACTATE; HEALTH	The discovery of the IDH1 R132H (IDH1 mut) mutation in low-grade glioma and the associated change in function of the IDH1 enzyme has increased the interest in glioma metabolism. In an earlier study, we found that changes in expression of genes involved in the aerobic glycolysis and the TCA cycle are associated with IDH1 mut. Here, we apply proteomics to FFPE samples of diffuse gliomas with or without IDH1 mutations, to map changes in protein levels associated with this mutation. We observed significant changes in the enzyme abundance associated with aerobic glycolysis, glutamate metabolism, and the TCA cycle in IDH1 mut gliomas. Specifically, the enzymes involved in the metabolism of glutamate, lactate, and enzymes involved in the conversion of alpha-ketoglutarate were increased in IDH1 mut gliomas. In addition, the bicarbonate transporter (SLC4A4) was increased in IDH1 mut gliomas, supporting the idea that a mechanism preventing intracellular acidification is active. We also found that enzymes that convert proline, valine, leucine, and isoleucine into glutamate were increased in IDH1 mut glioma. We conclude that in IDH1 mut glioma metabolism is rewired (increased input of lactate and glutamate) to preserve TCA-cycle activity in IDH1 mut gliomas.	[Dekker, Lennard J. M.; Wu, Suying; Jurriens, Cherise; Burgers, Peter C.; Smitt, Peter A. E. Sillevis; Luider, Theo M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Mustafa, Dana A. N.; Grevers, Frederieke; Kros, Johan M.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Luider, TM (corresponding author), Erasmus MC, Dept Neurol, Labs Neurooncol Clin & Canc Prote, POB 2040, NL-3000 CA Rotterdam, Netherlands.	t.luider@erasmusmc.nl	Mustafa, Dana/AAQ-6530-2021	Mustafa, Dana/0000-0003-0644-078X	Netherlands Organisation for Scientific Research (NWO) [1631]; Eurostars-2 joint program; European Union Horizon 2020 research and innovation program (Eurostars project) [10688]; British Brain Tumour Charity [GN-000540]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Eurostars-2 joint program; European Union Horizon 2020 research and innovation program (Eurostars project); British Brain Tumour Charity	The mass spectrometry equipment used for this publication is (partly) financed by the Netherlands Organisation for Scientific Research (NWO) infrastructure grant number 1631. This work has received funding from the Eurostars-2 joint program with co-funding from the European Union Horizon 2020 research and innovation program (Eurostars project 10688 (GlioPhos)) and by the British Brain Tumour Charity (GN-000540)	Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Bogdanovic E, 2015, BBA-GEN SUBJECTS, V1850, P1781, DOI 10.1016/j.bbagen.2015.04.014; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Cohen AL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0345-4; Dekker LJM, 2018, J PROTEOME RES, V17, P1654, DOI 10.1021/acs.jproteome.7b00911; Fack F, 2017, EMBO MOL MED, V9, P1681, DOI 10.15252/emmm.201707729; Fuss Taylor L, 2016, Top Magn Reson Imaging, V25, P223; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Gautier EF, 2016, CELL REP, V16, P1470, DOI 10.1016/j.celrep.2016.06.085; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Izquierdo-Garcia JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118781; Khurshed M, 2017, ONCOTARGET, V8, P49165, DOI 10.18632/oncotarget.17106; Kopinja J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14065-w; Lenting K, 2019, FASEB J, V33, P557, DOI 10.1096/fj.201800907RR; Lenting K, 2017, ACTA NEUROPATHOL, V133, P263, DOI 10.1007/s00401-017-1671-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Marcadier JL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-98; Mondesir J, 2016, J BLOOD MED, V7, P171, DOI 10.2147/JBM.S70716; Mustafa DAN, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-6; Oppermann H, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0131-9; Parker SJ, 2015, PHARMACOL THERAPEUT, V152, P54, DOI 10.1016/j.pharmthera.2015.05.003; Riske L, 2017, THER ADV PSYCHOPHARM, V7, P85, DOI 10.1177/2045125316675579; Soleimani M, 2000, KIDNEY INT, V57, P371, DOI 10.1046/j.1523-1755.2000.00857.x; Suijker J, 2015, ONCOTARGET, V6, P12505, DOI 10.18632/oncotarget.3723; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van Lith SAM, 2014, BBA-REV CANCER, V1846, P66, DOI 10.1016/j.bbcan.2014.04.004; Vartanian A, 2016, ONCOTARGET, V7, P69518, DOI 10.18632/oncotarget.11680; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang LF, 2017, ANNU REV BIOMED ENG, V19, P163, DOI 10.1146/annurev-bioeng-071516-044546; Yao JW, 2019, NEURO-ONCOLOGY, V21, P1184, DOI 10.1093/neuonc/noz078; Ye ZX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183800; Zhao H, 2016, ONCOTARGET, V7, P20486, DOI 10.18632/oncotarget.7974; Zhou LN, 2019, J PROTEOME RES, V18, P960, DOI 10.1021/acs.jproteome.8b00663; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8	35	13	13	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3646	3657		10.1096/fj.201902352R	http://dx.doi.org/10.1096/fj.201902352R		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960518	hybrid, Green Published			2022-12-28	WOS:000508840000001
J	Zhu, LP; Wang, WJ; Xie, TH; Zou, J; Nie, XW; Wang, XL; Zhang, MY; Wang, ZY; Gu, S; Zhuang, M; Tan, JX; Shen, CY; Dai, YA; Yang, XS; Yao, Y; Wei, TT				Zhu, Lingpeng; Wang, Wenjuan; Xie, Tian-Hua; Zou, Jian; Nie, Xiaowei; Wang, Xiaolu; Zhang, Meng-Yuan; Wang, Zhong-Yuan; Gu, Shun; Zhuang, Miao; Tan, Jianxin; Shen, Chenyou; Dai, Youai; Yang, Xusheng; Yao, Yong; Wei, Ting-Ting			TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling	FASEB JOURNAL			English	Article						bile acid; diabetic retinopathy; RhoA; ROCK; TGR5; vascular leakage	BILE-ACIDS; PROTEIN; RATS; DYSFUNCTION; EXPRESSION; FASUDIL; CELLS; STAR; RHO	Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus. Abnormal energy metabolism in microvascular endothelium is involved in the progression of diabetic retinopathy. Bile Acid G-Protein-Coupled Membrane Receptor (TGR5) has emerged as a novel regulator of metabolic disorders. However, the role of TGR5 in diabetes mellitus-induced microvascular dysfunction in retinas is largely unknown. Herein, enzyme-linked immunosorbent assay was used for analyzing bile acid (BA) profiles in diabetic rat retinas and retinal microvascular endothelial cells (RMECs) cultured in high glucose medium. The effects of TGR5 agonist on streptozotocin (STZ)-induced diabetic retinopathy were evaluated by HE staining, TUNEL staining, retinal trypsin digestion, and vascular permeability assay. A pharmacological inhibitor of RhoA was used to study the role of TGR5 on the regulation of Rho/Rho-associated coiled-coil containing protein kinase (ROCK) and western blot, immunofluorescence and siRNA silencing were performed to study the related signaling pathways. Here we show that bile acids were downregulated during DR progression in the diabetic rat retinas and RMECs cultured in high glucose medium. The TGR5 agonist obviously ameliorated diabetes-induced retinal microvascular dysfunction in vivo, and inhibited the effect of TNF-alpha on endothelial cell proliferation, migration, and permeability in vitro. In contrast, knockdown of TGR5 by siRNA aggravated TNF-alpha-induced actin polymerization and endothelial permeability. Mechanistically, the effects of TGR5 on the improvement of endothelial function was due to its regulatory role on the ROCK signaling pathway. An inhibitor of RhoA significantly reversed the loss of tight junction protein under TNF-alpha stimulation. Taken together, our findings suggest that insufficient BA signaling plays an important pathogenic role in the development of DR. Upregulation or activation of TGR5 may inhibit RhoA/ROCK-dependent actin remodeling and represent an important therapeutic intervention for DR.	[Zhu, Lingpeng; Wang, Wenjuan; Xie, Tian-Hua; Wang, Xiaolu; Zhang, Meng-Yuan; Wang, Zhong-Yuan; Gu, Shun; Zhuang, Miao; Yao, Yong; Wei, Ting-Ting] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Ophthalmol, 299 Qingyang Rd, Wuxi, Jiangsu, Peoples R China; [Zhu, Lingpeng; Wang, Wenjuan; Zou, Jian; Nie, Xiaowei; Wang, Xiaolu; Tan, Jianxin; Shen, Chenyou; Dai, Youai; Yang, Xusheng; Wei, Ting-Ting] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Ctr Clin Res, Wuxi, Jiangsu, Peoples R China; [Zhu, Lingpeng; Wang, Wenjuan; Zou, Jian; Nie, Xiaowei; Wang, Xiaolu; Tan, Jianxin; Shen, Chenyou; Dai, Youai; Yang, Xusheng; Wei, Ting-Ting] Wuxi Inst Translat Med, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yao, Y; Wei, TT (corresponding author), Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Ophthalmol, 299 Qingyang Rd, Wuxi, Jiangsu, Peoples R China.	yongyao@njmu.edu.cn; sunnytingtingwei@126.com		Nie, Xiaowei/0000-0003-2443-0569	National Natural Science Foundation of China (NSFC) [81770941, 81800845]; Nanjing Medical University (NMU) [NMUB2018363]; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation) [BK20190149, BK20180170]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Nanjing Medical University (NMU); Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)(Natural Science Foundation of Jiangsu Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770941 and 81800845; Nanjing Medical University (NMU), Grant/Award Number: NMUB2018363; Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation), Grant/Award Number: BK20190149 and BK20180170	Abdouh M, 2008, BRIT J PHARMACOL, V154, P136, DOI 10.1038/bjp.2008.48; Ahmadieh H, 2013, JAMA OPHTHALMOL, V131, P923, DOI 10.1001/jamaophthalmol.2013.143; Baptissart M, 2014, HEPATOLOGY, V60, P1054, DOI 10.1002/hep.27204; Battson ML, 2017, J VASC RES, V54, P280, DOI 10.1159/000479967; Beli E, 2018, DIABETES, V67, P1867, DOI 10.2337/db18-0158; Cat AND, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21087-5; Chen J, 2017, ATHEROSCLEROSIS, V257, P152, DOI 10.1016/j.atherosclerosis.2016.12.007; Chou JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50489; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Garcia C, 2008, J CLIN INVEST, V118, P2291, DOI [10.1172/JC134508, 10.1172/JCI34508]; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Han YW, 2018, EUR J PHARMACOL, V839, P12, DOI 10.1016/j.ejphar.2018.09.018; Iban-Arias R, 2018, DIABETES, V67, P321, DOI 10.2337/db17-0391; IBRAHIM E, 2018, SCI REP UK, V8; Jena PK, 2018, FASEB J, V32, P2866, DOI 10.1096/fj.201700984RR; Kundu S, 2017, MEDCHEMCOMM, V8, P2248, DOI 10.1039/c7md00475c; Lai DW, 2017, J MOL MED, V95, P155, DOI 10.1007/s00109-016-1469-1; Lee DH, 2018, MOL CELLS, V41, P771, DOI 10.14348/molcells.2018.0207; Li CY, 2015, J AM SOC HYPERTENS, V9, P507, DOI 10.1016/j.jash.2015.04.006; Li SC, 2018, J AM SOC NEPHROL, V29, P2658, DOI 10.1681/ASN.2018030271; Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156; Lieu T, 2014, BRIT J PHARMACOL, V171, P1156, DOI 10.1111/bph.12426; Lyu D, 2019, INT IMMUNOPHARMACOL, V71, P93, DOI 10.1016/j.intimp.2019.02.044; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Merlen G, 2020, GUT, V69, P146, DOI 10.1136/gutjnl-2018-316975; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Ouyang H, 2018, EUR J PHARMACOL, V840, P20, DOI 10.1016/j.ejphar.2018.09.027; Pan YY, 2018, BIOMED PHARMACOTHER, V97, P1694, DOI 10.1016/j.biopha.2017.11.151; Provost AC, 2003, CR BIOL, V326, P841, DOI 10.1016/j.crvi.2003.09.001; Ren SL, 2004, J LIPID RES, V45, P2123, DOI 10.1194/jlr.M400233-JLR200; Ruta LM, 2013, DIABETIC MED, V30, P387, DOI 10.1111/dme.12119; Sheikh AQ, 2014, AM J PHYSIOL-CELL PH, V306, pC768, DOI 10.1152/ajpcell.00201.2013; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vasam G, 2017, DIABETES, V66, P505, DOI 10.2337/db16-1039; Wang M, 2019, DIABETOLOGIA, V62, P335, DOI 10.1007/s00125-018-4755-3; Wang XXX, 2018, J AM SOC NEPHROL, V29, P118, DOI 10.1681/ASN.2017020222; WONG TY, 2016, NAT REV DIS PRIMERS, V2; Woo SJ, 2010, J OCUL PHARMACOL TH, V26, P223, DOI 10.1089/jop.2010.0012	41	20	20	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4189	4203		10.1096/fj.201902496RR	http://dx.doi.org/10.1096/fj.201902496RR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957105				2022-12-28	WOS:000508135900001
J	Yang, B; Li, SF; Chen, Z; Feng, F; He, L; Liu, B; He, TW; Wang, X; Chen, RQ; Chen, ZH; Xie, PG; Rong, LM				Yang, Bu; Li, Shangfu; Chen, Zheng; Feng, Feng; He, Lei; Liu, Bin; He, Tianwei; Wang, Xuan; Chen, Ruiqiang; Chen, Zihao; Xie, Peigen; Rong, Limin			Amyloid beta peptide promotes bone formation by regulating Wnt/beta-catenin signaling and the OPG/RANKL/RANK system	FASEB JOURNAL			English	Article						Amyloid beta; bone formation; mesenchymal stem cell; osteoblast differentiation; osteoclasts; Wnt; beta-catenin	NF-KAPPA-B; ALZHEIMERS-DISEASE; MEMORY IMPAIRMENT; BRAIN; ACTIVATION; PRECURSOR; TISSUES	Background Amyloid beta peptide (A beta) is involved in osteoporosis, but the effects of A beta on osteoblast and bone formation remain unclear. In this study, we investigated the effect of A beta on bone formation. Methods An animal model of osteoporosis was established by ovariectomy in C57BL/6 mice. The mice received intraperitoneal injection of A beta. The effect of A beta on the osteogenic differentiation of human bone marrow stromal stem cells (hBMSCs) and differentiation of both pre-osteoblasts and pre-osteoclasts in a co-culture system were investigated. Results In the animal study, intraperitoneal injection of A beta for 8 weeks promoted early and late osteogenic differentiation of hBMSCs. A beta treatment significantly elevated osterix(+) (osteoblastic) cells but decreased TRAP(+) cells (osteoclasts) in the distal femur bone. In vitro study showed that A beta treatment significantly enhanced matrix mineralization and osteogenic markers (Runx2 and osteocalcin). A beta treatment activated Wnt/beta-catenin signaling in hBMSCs. The effect of A beta was blocked by DKK1 (a Wnt/beta-catenin inhibitor) treatment. In the co-culture system, A beta treatment significantly increased the ALP activities of MC3T3-E1 cells (pre-osteoblasts) but reduced the TRAP(+) RAW264.7 cells (pre-osteoclasts). A beta treatment upregulated TCF1 and OPG proteins in MC3T3-E1 cells. A beta treatment upregulated I kappa B-alpha but downregulated NFATc1protein in RAW264.7 cells. These effects were blocked by XAV-939 (a Wnt signaling antagonist), and then rescued by additional Wnt3a (a Wnt agonist). Conclusion A beta treatment simultaneously promoted osteogenic differentiation via Wnt/beta-catenin signaling, and inhibited osteoclasts differentiation via the OPG/RANKL/RANK system, suggesting A beta is a positive regulator of osteoblast differentiation and bone formation.	[Yang, Bu; Li, Shangfu; Feng, Feng; He, Lei; Liu, Bin; He, Tianwei; Wang, Xuan; Chen, Ruiqiang; Chen, Zihao; Xie, Peigen; Rong, Limin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, 600 Tianhe Rd, Guangzhou 510630, Peoples R China; [Chen, Zheng] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Stomatol, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xie, PG; Rong, LM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, 600 Tianhe Rd, Guangzhou 510630, Peoples R China.	xiepeigen120@163.com; ronglimin@21cn.com	Chen, zihao/HGE-3792-2022	Rong, Limin/0000-0003-0373-7393	Guangzhou Science and Technology Projects [1563000225]; National Natural Science Foundation of China [81472122, 81772398]	Guangzhou Science and Technology Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Guangzhou Science and Technology Projects, Grant/Award Number: 1563000225; National Natural Science Foundation of China, Grant/Award Number: 81472122 and 81772398	Arias CF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204171; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Cui S, 2011, J BONE MINER RES, V26, P1084, DOI 10.1002/jbmr.299; Ding M, 2006, CALCIFIED TISSUE INT, V78, P113, DOI 10.1007/s00223-005-0028-5; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; Hwang CJ, 2016, BRAIN BEHAV IMMUN, V53, P113, DOI 10.1016/j.bbi.2015.11.013; Hwang CJ, 2015, MOL NEUROBIOL, V52, P176, DOI 10.1007/s12035-014-8853-z; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Kenkre JS, 2018, ANN CLIN BIOCHEM, V55, P308, DOI 10.1177/0004563218759371; Levin-Allerhand J, 2001, J NEUROCHEM, V79, P796, DOI 10.1046/j.1471-4159.2001.00627.x; Li SF, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101683; Li SF, 2014, BONE, V61, P164, DOI 10.1016/j.bone.2014.01.010; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Matsuoka K, 2014, J BONE MINER RES, V29, P1522, DOI 10.1002/jbmr.2187; McGee-Lawrence ME, 2014, BONE, V66, P277, DOI 10.1016/j.bone.2014.06.022; McLeod J, 2009, FASEB J, V23, P2942, DOI 10.1096/fj.08-121657; Moorer MC, 2018, ENDOCRINOL METAB, V33, P318, DOI 10.3803/EnM.2018.33.3.318; Nunan J, 2002, ESSAYS BIOCHEM, V38, P37, DOI 10.1042/bse0380037; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Sajjad R, 2018, INDIAN J PHARM SCI, V80, P581; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Silva I, 2011, ACTA REUMATOL PORT, V36, P209; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005; Zhong ZD, 2014, WIRES DEV BIOL, V3, P489, DOI 10.1002/wdev.159; Zhou R, 2011, J ALZHEIMERS DIS, V24, P101, DOI 10.3233/JAD-2010-101467; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947	29	20	25	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3583	3593		10.1096/fj.201901550R	http://dx.doi.org/10.1096/fj.201901550R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944393	hybrid			2022-12-28	WOS:000507595700001
J	Yu, HF; Duan, CC; Yang, ZQ; Wang, YS; Yue, ZP; Guo, B				Yu, Hai-Fan; Duan, Cui-Cui; Yang, Zhan-Qing; Wang, Yu-Si; Yue, Zhan-Peng; Guo, Bin			Malic enzyme 1 is important for uterine decidualization in response to progesterone/cAMP/PKA/HB-EGF pathway	FASEB JOURNAL			English	Article						decidualization; Me1; mitochondrial function; HB-EGF; progesterone-cAMP-PKA pathway; uterus	EPIDERMAL-GROWTH-FACTOR; MITOCHONDRIAL DYSFUNCTION; NADPH HOMEOSTASIS; STROMAL CELLS; HB-EGF; EXPRESSION; MOUSE; DIFFERENTIATION; METABOLISM; REGULATOR	Malic enzyme 1 (Me1), a member of the malic enzymes involving in glycolytic pathway and citric acid cycle, is essential for the energy metabolism and maintenance of intracellular redox balance state, but its physiological role and regulatory mechanism in the uterine decidualization are still unknown. Current study showed that Me1 was strongly expressed in decidual cells, and could promote the proliferation and differentiation of stromal cells followed by an accelerated cell cycle transition, indicating an importance of Me1 in the uterine decidualization. Silencing of Me1 attenuated NADPH generation and reduced GR activity, while addition of NADPH improved the defect of GR activity elicited by Me1 depletion. Further analysis found that Me1 modulated intracellular GSH content via GR. Meanwhile, Me1 played a role in maintaining mitochondrial function as indicated by these observations that blockadge of Me1 led to the accumulation of mitochondrial O2- level and decreased ATP production and mtDNA copy numbers accompanied with defective mitochondrial membrane potential. In uterine stromal cells, progesterone induced Me1 expression through PR-cAMP-PKA pathway. Knockdown of HB-EGF might impede the regulation of progesterone and cAMP on Me1. Collectively, Me1 is essential for uterine decidualization in response to progesterone/cAMP/PKA/HB-EGF pathway and plays an important role in preventing mitochondrial dysfunction.	[Yu, Hai-Fan; Yang, Zhan-Qing; Wang, Yu-Si; Yue, Zhan-Peng; Guo, Bin] Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China; [Duan, Cui-Cui] Jilin Acad Agr Sci, Inst Agrofood Technol, Changchun, Peoples R China	Jilin University; Jilin Academy of Agricultural Sciences	Yue, ZP; Guo, B (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China.	yuezp@jlu.edu.cn; guobin79@jlu.edu.cn		Guo, Bin/0000-0001-5950-8974; Yu, Hai-Fan/0000-0002-0418-8800; Yue, Zhan-Peng/0000-0001-6776-9015; Yang, Zhan-Qing/0000-0003-1416-7242	National Natural Science Foundation of China [31672503, 31873003, 31472158]; National Key Research and Development Program of China, Stem Cell and Translational Research [2017YFA0105101]; Graduate Innovation Fund of Jilin University [101832018C096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China, Stem Cell and Translational Research; Graduate Innovation Fund of Jilin University(Jilin University)	National Natural Science Foundation of China, Grant/Award Number: 31672503, 31873003 and 31472158; National Key Research and Development Program of China, Stem Cell and Translational Research, Grant/Award Number: 2017YFA0105101; Graduate Innovation Fund of Jilin University, Grant/Award Number: 101832018C096	Agarwal A, 2008, ANTIOXID REDOX SIGN, V10, P1375, DOI 10.1089/ars.2007.1964; Al-Dwairi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113058; Allmann S, 2013, J BIOL CHEM, V288, P18494, DOI 10.1074/jbc.M113.462978; Benkhalifa M, 2014, INT J BIOCHEM CELL B, V55, P60, DOI 10.1016/j.biocel.2014.08.011; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Chobotova K, 2005, J CLIN ENDOCR METAB, V90, P913, DOI 10.1210/jc.2004-0476; Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gu F, 2015, CURR OPIN CLIN NUTR, V18, P89, DOI 10.1097/MCO.0000000000000134; Harvey AJ, 2019, REPRODUCTION, V157, pR159, DOI 10.1530/REP-18-0431; Hu M, 2019, AM J PHYSIOL-ENDOC M, V316, pE794, DOI 10.1152/ajpendo.00359.2018; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Lahey R, 2018, CIRC RES, V122, P836, DOI 10.1161/CIRCRESAHA.118.312660; Li DD, 2014, J ENDOCRINOL, V220, P73, DOI 10.1530/JOE-13-0429; Liang XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22744; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Liu J, 2017, J ENDOCRINOL, V234, P247, DOI 10.1530/JOE-16-0636; Liu MN, 2018, INT J ONCOL, V52, P1923, DOI 10.3892/ijo.2018.4342; Lu YX, 2018, CANCER RES, V78, P1972, DOI 10.1158/0008-5472.CAN-17-3155; Ma XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026774; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Murai S, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.34; Ou XH, 2012, HUM REPROD, V27, P2130, DOI 10.1093/humrep/des137; Qi QR, 2015, CELL CYCLE, V14, P1842, DOI 10.1080/15384101.2015.1033593; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Ratledge C, 2014, BIOTECHNOL LETT, V36, P1557, DOI 10.1007/s10529-014-1532-3; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Stelmanska E, 2013, J STEROID BIOCHEM, V134, P37, DOI 10.1016/j.jsbmb.2012.10.006; Wakefield SL, 2011, BIOL REPROD, V84, P572, DOI 10.1095/biolreprod.110.087262; Wang W, 2010, ENDOCRINOLOGY, V151, P3929, DOI 10.1210/en.2009-1437; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Xin QL, 2017, THERIOGENOLOGY, V104, P55, DOI 10.1016/j.theriogenology.2017.08.005; Yu HF, 2018, J CELL PHYSIOL, V233, P1612, DOI 10.1002/jcp.26067; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhang Y, 2018, FASEB J, V32, P1891, DOI 10.1096/fj.201700626RR; ZHANG ZM, 1994, ENDOCRINOLOGY, V134, P1089, DOI 10.1210/en.134.3.1089; Zhou JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27096; Zhu W, 2018, HYPERTENSION, V71, P752, DOI 10.1161/HYPERTENSIONAHA.117.10213	41	6	6	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3820	3837		10.1096/fj.201902289R	http://dx.doi.org/10.1096/fj.201902289R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944402	Bronze			2022-12-28	WOS:000507591800001
J	Britto, FA; Gnimassou, O; De Groote, E; Balan, E; Warnier, G; Everard, A; Cani, PD; Deldicque, L				Britto, Florian A.; Gnimassou, Olouyoumi; De Groote, Estelle; Balan, Estelle; Warnier, Geoffrey; Everard, Amandine; Cani, Patrice D.; Deldicque, Louise			Acute environmental hypoxia potentiates satellite cell-dependent myogenesis in response to resistance exercise through the inflammation pathway in human	FASEB JOURNAL			English	Article						exercise; hypoxia; inflammation; muscle; myogenesis	MUSCLE HYPERTROPHY; UP-REGULATION; DIFFERENTIATION; INTERLEUKIN-6; PROLIFERATION; TRANSCRIPTION; ACTIVATION; EXPRESSION; AUTOCRINE; REGULATOR	Acute environmental hypoxia may potentiate muscle hypertrophy in response to resistance training but the mechanisms are still unknown. To this end, twenty subjects performed a 1-leg knee extension session (8 sets of 8 repetitions at 80% 1 repetition maximum, 2-min rest between sets) in normoxic or normobaric hypoxic conditions (FiO2 14%). Muscle biopsies were taken 15 min and 4 hours after exercise in the vastus lateralis of the exercised and the non-exercised legs. Blood samples were taken immediately, 2h and 4h after exercise. In vivo, hypoxic exercise fostered acute inflammation mediated by the TNF alpha/NF-kappa B/IL-6/STAT3 (+333%, +194%, + 163% and +50% respectively) pathway, which has been shown to contribute to satellite cells myogenesis. Inflammation activation was followed by skeletal muscle invasion by CD68 (+63%) and CD197 (+152%) positive immune cells, both known to regulate muscle regeneration. The role of hypoxia-induced activation of inflammation in myogenesis was confirmed in vitro. Acute hypoxia promoted myogenesis through increased Myf5 (+300%), MyoD (+88%), myogenin (+1816%) and MRF4 (+489%) mRNA levels in primary myotubes and this response was blunted by siRNA targeting STAT3. In conclusion, our results suggest that hypoxia could improve muscle hypertrophic response following resistance exercise through IL-6/STAT3-dependent myogenesis and immune cells-dependent muscle regeneration.	[Britto, Florian A.; Gnimassou, Olouyoumi; De Groote, Estelle; Balan, Estelle; Warnier, Geoffrey; Deldicque, Louise] Catholic Univ Louvain, UCLouvain, Inst Neurosci, Louvain La Neuve, Belgium; [Everard, Amandine; Cani, Patrice D.] Catholic Univ Louvain, WELBIO Walloon Excellence Life Sci & Biotechnol, UCLouvain, LDRI,Metab & Nutr Res Grp, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Deldicque, L (corresponding author), Catholic Univ Louvain, Inst Neurosci, Pl Pierre de Coubertin 1,Box L08-10-01, B-1348 Louvain La Neuve, Belgium.	louise.deldicque@uclouvain.be	D., Cani Patrice/M-8055-2016; Warnier, Geoffrey/AEK-2389-2022; Britto, Florian/ABE-1255-2021	D., Cani Patrice/0000-0003-2040-2448; Britto, Florian Alexis/0000-0002-7223-6341; Deldicque, Louise/0000-0003-3393-5278; Warnier, Geoffrey/0000-0002-2438-0875; Everard, Amandine/0000-0001-8925-8144	Fonds De La Recherche Scientifique FNRS (FNRS) [J.0050.16, F.4504.17]; Federation Wallonie-Bruxelles (French Community of Belgium); Universite catholique de Louvain	Fonds De La Recherche Scientifique FNRS (FNRS)(Fonds de la Recherche Scientifique - FNRS); Federation Wallonie-Bruxelles (French Community of Belgium); Universite catholique de Louvain	Fonds De La Recherche Scientifique FNRS (FNRS), Grant/Award Number: J.0050.16 and F.4504.17; Federation Wallonie-Bruxelles (French Community of Belgium); Universite catholique de Louvain	Adi S, 2002, ENDOCRINOLOGY, V143, P511, DOI 10.1210/en.143.2.511; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Bazgir B, 2017, CELL J, V18, P473; Begue G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057141; BIGARD AX, 1991, J APPL PHYSIOL, V71, P2114, DOI 10.1152/jappl.1991.71.6.2114; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Chycki J, 2016, J HUM KINET, V53, P91, DOI 10.1515/hukin-2016-0013; D'Hulst G, 2013, ACTA PHYSIOL, V208, P251, DOI 10.1111/apha.12086; Filopoulos D, 2017, EUR J SPORT SCI, V17, P821, DOI 10.1080/17461391.2017.1317834; Fischer M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00041; Francaux M, 2018, PFLUGERS ARCH, V471, P397; Friedmann B, 2003, PFLUG ARCH EUR J PHY, V446, P742, DOI 10.1007/s00424-003-1133-9; Gnimassou O, 2018, FASEB J, V32, P5272, DOI 10.1096/fj.201800049RR; Gnimassou O, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00190; Goldberg A.L., 1972, Muscle Biol, V1, P89; Goldspink G, 1999, J ANAT, V194, P323, DOI 10.1046/j.1469-7580.1999.19430323.x; Hayot M, 2011, MOL CELL ENDOCRINOL, V332, P38, DOI 10.1016/j.mce.2010.09.008; Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012; Inness MWH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00502; Ito T, 2010, NEUROSCI LETT, V472, P104, DOI 10.1016/j.neulet.2010.01.061; JAHN L, 1994, EXP CELL RES, V212, P297, DOI 10.1006/excr.1994.1147; Kon M, 2012, J STRENGTH COND RES, V26, P611, DOI 10.1519/JSC.0b013e3182281c69; Kook SH, 2008, CELL BIOL INT, V32, P871, DOI 10.1016/j.cellbi.2008.03.017; Launay T, 2010, CELL PROLIFERAT, V43, P1, DOI 10.1111/j.1365-2184.2009.00648.x; Liu J, 2018, ACTA BIOCH BIOPH SIN, V50, P1200, DOI 10.1093/abbs/gmy131; Manimmanakorn A, 2013, J SCI MED SPORT, V16, P337, DOI 10.1016/j.jsams.2012.08.009; Nagahisa H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207040; Nishimura A, 2010, INT J SPORT PHYSIOL, V5, P497, DOI 10.1123/ijspp.5.4.497; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pallafacchina G, 2013, NUTR METAB CARDIOVAS, V23, pS12, DOI 10.1016/j.numecd.2012.02.002; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Rossi FE, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01376; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; Sun CS, 2017, STEM CELLS, V35, P1958, DOI 10.1002/stem.2652; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; von Horn H, 2002, J ENDOCRINOL, V172, P457, DOI 10.1677/joe.0.1720457; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; Wei HL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691684; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Yan B, 2016, J STRENGTH COND RES, V30, P184, DOI 10.1519/JSC.0000000000001056; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang J, 2014, ANIMAL, V8, P800, DOI 10.1017/S1751731114000469	46	14	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1885	1900		10.1096/fj.201902244R	http://dx.doi.org/10.1096/fj.201902244R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914659				2022-12-28	WOS:000507308900125
J	Byskov, K; Le Gall, SM; Thiede, B; Camerer, E; Kanse, SM				Byskov, Kristina; Le Gall, Sylvain M.; Thiede, Bernd; Camerer, Eric; Kanse, Sandip M.			Protease activated receptors (PAR)-1 and-2 mediate cellular effects of factor VII activating protease (FSAP)	FASEB JOURNAL			English	Article						apoptosis; FSAP; HABP2; mutations; PARs; vascular	VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; PROTEOLYSIS; DEFICIENCY; APOPTOSIS; PROMOTES; STROKE; MICE	Factor VII activating protease (FSAP) is a circulating serine protease implicated in thrombosis, atherosclerosis, stroke, and cancer. Using an overexpression strategy, we have systematically investigated the role of protease activated receptors (PAR)-1, -2, -3, and -4 on FSAP-mediated signaling in HEK293T and A549 cells. Cleavage of PAR-reporter constructs and MAPK phosphorylation was used to monitor receptor activation. FSAP cleaved PAR-2 and to a lesser degree PAR-1, but not PAR-3 or PAR-4 in both cell types. Robust MAPK activation in response to FSAP was observed after PAR-2, but not PAR-1 overexpression in HEK293T. Recombinant serine protease domain of wild type FSAP, but not the Marburg I isoform of FSAP, could reproduce the effects of plasma purified FSAP. Canonical cleavage of both PARs was suggested by mass spectrometric analysis of synthetic peptide substrates from the N-terminus of PARs and site directed mutagenesis studies. Surprisingly, knockdown of endogenous PAR-1, but not PAR-2, prevented the apoptosis-inhibitory effect of FSAP, suggesting that PAR1 is nevertheless a direct or indirect target in some cell types. This molecular characterization of PAR-1 and -2 as cellular receptors of FSAP will help to define the actions of FSAP in the context of cancer and vascular biology.	[Byskov, Kristina; Kanse, Sandip M.] Univ Oslo, Inst Basic Med Sci, N-0317 Oslo, Norway; [Le Gall, Sylvain M.; Camerer, Eric] Univ Paris, Paris Cardiovasc Res Ctr, INSERM, U970, Paris, France; [Thiede, Bernd] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Oslo, Norway; [Kanse, Sandip M.] Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway	University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oslo; University of Oslo	Kanse, SM (corresponding author), Univ Oslo, Inst Basic Med Sci, N-0317 Oslo, Norway.	sandip.kanse@medisin.uio.no	Camerer, Eric/K-4161-2017	Kanse, Sandip/0000-0003-0782-9957; Camerer, Eric/0000-0002-6271-7125	Research Council of Norway; Helse Sor-Ost	Research Council of Norway(Research Council of Norway); Helse Sor-Ost	This work was supported by grants from Research Council of Norway as well as Helse Sor-Ost to SMK.	Bae JS, 2009, J CELL PHYSIOL, V219, P744, DOI 10.1002/jcp.21718; Borkham-Kamphorst E, 2013, J HEPATOL, V58, P104, DOI 10.1016/j.jhep.2012.09.007; Bulani Y, 2015, CURR PHARM DESIGN, V21, P4392, DOI 10.2174/138161282130151007144725; Byskov K, 2017, ATHEROSCLEROSIS, V265, P133, DOI 10.1016/j.atherosclerosis.2017.08.029; Daniel JM, 2016, J THROMB HAEMOST, V14, P2058, DOI 10.1111/jth.13417; Flaumenhaft R, 2017, TRENDS PHARMACOL SCI, V38, P701, DOI 10.1016/j.tips.2017.05.001; Gara SK, 2015, NEW ENGL J MED, V373, P448, DOI 10.1056/NEJMoa1502449; Griffin JH, 2016, ARTERIOSCL THROM VAS, V36, P2143, DOI 10.1161/ATVBAHA.116.308038; Hamilton JR, 2017, ANNU REV PHARMACOL, V57, P349, DOI 10.1146/annurev-pharmtox-011613-140016; Herold J, 2017, AM J TRANSL RES, V9, P3084; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Huang SH, 2013, CANCER INVEST, V31, P578, DOI 10.3109/07357907.2013.845674; Iablokov V, 2014, J BIOL CHEM, V289, P34366, DOI 10.1074/jbc.M114.610485; Joshi AU, 2015, EUR J NEUROSCI, V41, P963, DOI 10.1111/ejn.12830; Kannemeier C, 2004, FASEB J, V18, P728, DOI 10.1096/fj.03-0898fje; Kanse SM, 2012, J IMMUNOL, V188, P2858, DOI 10.4049/jimmunol.1103029; Kanse SM, 2012, ARTERIOSCL THROM VAS, V32, P427, DOI 10.1161/ATVBAHA.111.238394; Kara E, 2017, THROMB HAEMOSTASIS, V117, P1750, DOI 10.1160/TH17-02-0081; Kress JA, 2006, BIOL CHEM, V387, P1275, DOI 10.1515/BC.2006.158; Le Gall SM, 2016, BLOOD, V127, P3260, DOI 10.1182/blood-2015-11-683110; Ludeman MJ, 2004, J BIOL CHEM, V279, P18592, DOI 10.1074/jbc.M310836200; Mambetsariev N, 2010, ARTERIOSCL THROM VAS, V30, P483, DOI 10.1161/ATVBAHA.109.200451; Mirzapoiazova T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00164; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Nieman MT, 2016, BLOOD, V128, P169, DOI 10.1182/blood-2015-11-636472; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Sedding D, 2006, J EXP MED, V203, P2801, DOI 10.1084/jem.20052546; Subramaniam S, 2015, THROMB HAEMOSTASIS, V113, P870, DOI 10.1160/TH14-06-0519; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Yau MK, 2016, EXPERT OPIN THER PAT, V26, P471, DOI 10.1517/13543776.2016.1154540	30	8	9	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1079	1090		10.1096/fj.201801986RR	http://dx.doi.org/10.1096/fj.201801986RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914657	hybrid, Green Published			2022-12-28	WOS:000507308900073
J	Mahizir, D; Briffa, JF; Wood, JL; Anevska, K; Hill-Yardin, EL; Jefferies, AJ; Gravina, S; Mazzarino, G; Franks, AE; Moritz, KM; Wadley, GD; Wlodek, ME				Mahizir, Dayana; Briffa, Jessica F.; Wood, Jennifer L.; Anevska, Kristina; Hill-Yardin, Elisa L.; Jefferies, Andrew J.; Gravina, Sogand; Mazzarino, Gisella; Franks, Ashley E.; Moritz, Karen M.; Wadley, Glenn D.; Wlodek, Mary E.			Exercise improves metabolic function and alters the microbiome in rats with gestational diabetes	FASEB JOURNAL			English	Article						exercise training; fetal programming; gestational diabetes; microbiome; obesity; pregnancy adaptations	BETA-CELL FUNCTION; BODY-COMPOSITION; PHYSICAL-ACTIVITY; BORN SMALL; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; MATERNAL OBESITY; REGULAR EXERCISE; PREGNANCY; MELLITUS	Gestational diabetes mellitus (GDM) is a common pregnancy complication, particularly prevalent in obese women. Importantly, exercise has beneficial impacts on maternal glucose control and may prevent GDM in "at-risk" women. We aimed to determine whether a high-fat diet (HFD) exacerbates metabolic dysfunction and alters gut microbiome in GDM and whether endurance exercise prevents these changes. Uteroplacental insufficiency was induced by bilateral uterine vessel ligation (Restricted) or sham (Control) surgery on E18 in Wistar-Kyoto rats. Female offspring were fed a Chow or HFD (23% fat) from weaning (5 weeks) and at 16 weeks randomly allocated to remain Sedentary or to an exercise protocol of either Exercise prior to and during pregnancy (Exercise); or Exercise during pregnancy only (PregEx). Females were mated (20 weeks) and underwent indirect calorimetry (embryonic day 16; E16), glucose tolerance testing (E18), followed by 24-hr feces collection at E19 (n = 8-10/group). HFD consumption in female rats with GDM exacerbated the adverse metabolic adaptations to pregnancy and altered gut microbial populations. Specifically, the Firmicutes-to-Bacteroidetes ratio was increased, due to an underlying change in abundance of the orders Clostridiales and Bacteroidales. Maternal Exercise, but not PregEx, prevented the development of metabolic dysfunction, increased pancreatic beta-cell mass, and prevented the alteration of the gut microbiome in GDM females. Our findings suggest that maternal exercise and diet influence metabolic and microbiome dysfunction in females with GDM, which may impact long-term maternal and offspring health.	[Mahizir, Dayana; Briffa, Jessica F.; Hill-Yardin, Elisa L.; Jefferies, Andrew J.; Gravina, Sogand; Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia; [Wood, Jennifer L.; Anevska, Kristina; Franks, Ashley E.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Wood, Jennifer L.; Franks, Ashley E.] La Trobe Univ, Ctr Future Landscapes, Bundoora, Vic, Australia; [Hill-Yardin, Elisa L.] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [Mazzarino, Gisella; Wadley, Glenn D.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Moritz, Karen M.] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia	University of Melbourne; La Trobe University; La Trobe University; Royal Melbourne Institute of Technology (RMIT); University of Queensland; Deakin University	Wlodek, ME (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia.	m.wlodek@unimelb.edu.au	Wood, Jen/AAA-7907-2020; Mahizir, Dayana/AAK-8025-2020; Briffa, Jessica F/H-9059-2019; Wlodek, Mary/A-8939-2019; Moritz, Karen/G-2508-2015	Wood, Jen/0000-0002-7313-5681; Briffa, Jessica F/0000-0001-5173-4790; Mahizir, Nurul Dayana/0000-0003-3617-1496; Wadley, Glenn/0000-0002-6617-4359; Franks, Ashley/0000-0003-1664-6060; Hill-Yardin, Elisa/0000-0002-4146-7198; Wlodek, Mary/0000-0002-8490-9099; Moritz, Karen/0000-0002-8085-0034	Medical Research Council [APP1025426, APP1045602]; Diabetes Australia Research Trust [FT160100126, APP1078164]; University of Melbourne; La Trobe University	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes Australia Research Trust; University of Melbourne(University of Melbourne); La Trobe University	Medical Research Council, Grant/Award Number: APP1025426 and APP1045602; Diabetes Australia Research Trust, Grant/Award Number: FT160100126 and APP1078164; University of Melbourne; La Trobe University	Agha-Jaffar R, 2016, NAT REV ENDOCRINOL, V12, P533, DOI 10.1038/nrendo.2016.88; Artal R, 2003, BRIT J SPORT MED, V37, P6, DOI 10.1136/bjsm.37.1.6; Asif Y, 2018, J PHYSIOL-LONDON, V596, P163, DOI 10.1113/JP275339; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01408; Choi SB, 2006, J ENDOCRINOL, V190, P471, DOI 10.1677/joe.1.06400; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Chu DM, 2016, GUT MICROBES, V7, P459, DOI 10.1080/19490976.2016.1241357; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Damm P, 2016, DIABETOLOGIA, V59, P1396, DOI 10.1007/s00125-016-3985-5; Dempsey JC, 2004, AM J EPIDEMIOL, V159, P663, DOI 10.1093/aje/kwh091; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ferrocino I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30735-9; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Gallo LA, 2012, J PHYSIOL-LONDON, V590, P617, DOI 10.1113/jphysiol.2011.219147; Gohir W, 2015, GUT MICROBES, V6, P310, DOI 10.1080/19490976.2015.1086056; Karstoft K, 2013, DIABETES CARE, V36, P228, DOI 10.2337/dc12-0658; Kim SY, 2013, OBESITY, V21, pE33, DOI 10.1002/oby.20025; Laker RC, 2012, AM J PHYSIOL-ENDOC M, V302, pE1221, DOI 10.1152/ajpendo.00583.2011; Laker RC, 2011, AM J PHYSIOL-ENDOC M, V301, pE931, DOI 10.1152/ajpendo.00114.2011; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mahizir D, 2016, MOL NUTR FOOD RES, V60, P8, DOI 10.1002/mnfr.201500289; Mangwiro YTM, 2018, J PHYSIOL-LONDON, V596, P5947, DOI 10.1113/JP275758; Martin A, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12297; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mendelson M, 2015, PEDIATR OBES, V10, P311, DOI 10.1111/ijpo.255; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; Narendran P, 2015, DIABETOLOGIA, V58, P10, DOI 10.1007/s00125-014-3412-8; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Nobles C, 2015, OBSTET GYNECOL, V125, P1195, DOI 10.1097/AOG.0000000000000738; Oksanen J, 2013, COMMUNITY ECOL PACKA, V2, P7; Park SM, 2007, J APPL PHYSIOL, V103, P1764, DOI 10.1152/japplphysiol.00434.2007; Patton GC, 2018, NATURE, V554, P458, DOI 10.1038/nature25759; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Ronsen O, 2002, J APPL PHYSIOL, V92, P2547, DOI 10.1152/japplphysiol.01263.2001; Russo LM, 2015, OBSTET GYNECOL, V125, P576, DOI 10.1097/AOG.0000000000000691; Singh S, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0836-9; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Speakman JR, 2010, AM J CLIN NUTR, V92, P826, DOI 10.3945/ajcn.2009.28540; Stafne SN, 2012, OBSTET GYNECOL, V119, P29, DOI 10.1097/AOG.0b013e3182393f86; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van den Hoek AM, 2008, J NEUROENDOCRINOL, V20, P120, DOI 10.1111/j.1365-2826.2007.01626.x; Wadley GD, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12720; Wang C, 2017, AM J OBSTET GYNECOL, V216, P340, DOI 10.1016/j.ajog.2017.01.037; Weyer C, 1999, INT J OBESITY, V23, P715, DOI 10.1038/sj.ijo.0800910; Zhang CL, 2006, ARCH INTERN MED, V166, P543, DOI 10.1001/archinte.166.5.543; Zhang H, 2010, J ENDOCRINOL INVEST, V33, P707, DOI [10.1007/BF03346674, 10.3275/6886]; Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x	49	14	14	4	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1728	1744		10.1096/fj.201901424R	http://dx.doi.org/10.1096/fj.201901424R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914625	Green Published, Bronze			2022-12-28	WOS:000507308900114
J	Nath, AK; Ma, JY; Chen, ZZ; Li, ZY; Vitery, MD; Kelley, ML; Peterson, RT; Gerszten, RE; Yeh, JRJ				Nath, Anjali K.; Ma, Junyan; Chen, Zsu-Zsu; Li, Zhuyun; Vitery, Maria del Carmen; Kelley, Michelle L.; Peterson, Randall T.; Gerszten, Robert E.; Yeh, Jing-Ruey J.			Genetic deletion of gpr27 alters acylcarnitine metabolism, insulin sensitivity, and glucose homeostasis in zebrafish	FASEB JOURNAL			English	Article						carnitine palmitoyltransferase I; G protein-coupled receptors; insulin resistance; lipid metabolism; metabolomic profiling	PROTEIN-COUPLED RECEPTORS; THERAPEUTIC TARGETS; DIABETES-MELLITUS; DRUG DISCOVERY; BETA-OXIDATION; RESISTANCE; DISEASE; IDENTIFICATION; PROFILES; INSIGHTS	G protein-coupled receptors (GPCRs) comprise the largest group of membrane receptors in eukaryotic genomes and collectively they regulate nearly all cellular processes. Despite the widely recognized importance of this class of proteins, many GPCRs remain understudied. G protein-coupled receptor 27 (Gpr27) is an orphan GPCR that displays high conservation during vertebrate evolution. Although, GPR27 is known to be expressed in tissues that regulate metabolism including the pancreas, skeletal muscle, and adipose tissue, its functions are poorly characterized. Therefore, to investigate the potential roles of Gpr27 in energy metabolism, we generated a whole body gpr27 knockout zebrafish line. Loss of gpr27 potentiated the elevation in glucose levels induced by pharmacological or nutritional perturbations. We next leveraged a mass spectrometry metabolite profiling platform to identify other potential metabolic functions of Gpr27. Notably, genetic deletion of gpr27 elevated medium-chain acylcarnitines, in particular C6-hexanoylcarnitine, C8-octanoylcarnitine, C9-nonanoylcarnitine, and C10-decanoylcarnitine, lipid species known to be associated with insulin resistance in humans. Concordantly, gpr27 deletion in zebrafish abrogated insulin-dependent Akt phosphorylation and glucose utilization. Finally, loss of gpr27 increased the expression of key enzymes in carnitine shuttle complex, in particular the homolog to the brain-specific isoform of CPT1C which functions as a hypothalamic energy senor. In summary, our findings shed light on the biochemical functions of Gpr27 by illuminating its role in lipid metabolism, insulin signaling, and glucose homeostasis.	[Nath, Anjali K.; Chen, Zsu-Zsu; Gerszten, Robert E.] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, 3 Blackfan Circle,CLS 917, Boston, MA 02215 USA; [Nath, Anjali K.; Gerszten, Robert E.] Broad Inst, Cambridge, MA USA; [Ma, Junyan; Li, Zhuyun; Vitery, Maria del Carmen; Kelley, Michelle L.; Yeh, Jing-Ruey J.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA; [Ma, Junyan; Yeh, Jing-Ruey J.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Peterson, Randall T.] Univ Utah, Coll Pharm, Salt Lake City, UT 84112 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah	Nath, AK (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, 3 Blackfan Circle,CLS 917, Boston, MA 02215 USA.; Yeh, JRJ (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA.	anath1@bidmc.harvard.edu; jyeh1@mgh.harvard.edu		Yeh, Jing-Ruey Joanna/0000-0002-7768-4901; Peterson, Randall/0000-0003-0727-3469	NIH [U01 MH105027, R21 HG010392, R01 HL132320-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: U01 MH105027, NIH R21 HG010392 and NIH R01 HL132320-01	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; Avgerinos KI, 2019, METABOLISM, V92, P121, DOI 10.1016/j.metabol.2018.11.001; Batchuluun B, 2018, DIABETES, V67, P885, DOI 10.2337/db17-1150; Chow L, 2010, METABOLISM, V59, P70, DOI 10.1016/j.metabol.2009.07.009; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; den Broeder MJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040894; Dupuis N, 2017, MOL PHARMACOL, V91, P595, DOI 10.1124/mol.116.107714; Foster Simon R, 2015, Biophys Rev, V7, P77, DOI 10.1007/s12551-014-0154-2; Friesen M, 2019, TRENDS ENDOCRIN MET, V30, P396, DOI 10.1016/j.tem.2019.03.002; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Gut P, 2017, PHYSIOL REV, V97, P889, DOI 10.1152/physrev.00038.2016; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang W, 2014, DEV BIOL, V394, P83, DOI 10.1016/j.ydbio.2014.07.021; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Ku GM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002449; Laakso M, 2014, NAT REV ENDOCRINOL, V10, P293, DOI 10.1038/nrendo.2014.29; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; LECOCO FR, 1964, J CLIN INVEST, V43, P237, DOI 10.1172/JCI104908; Liu LY, 2013, DIS MODEL MECH, V6, P1271, DOI 10.1242/dmm.011726; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maddison LA, 2015, AM J PHYSIOL-ENDOC M, V308, pE662, DOI 10.1152/ajpendo.00441.2014; Mai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082459; Marin-Juez R, 2014, J ENDOCRINOL, V222, P229, DOI 10.1530/JOE-14-0178; Martin AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138463; Matsumoto M, 2000, BIOCHEM BIOPH RES CO, V272, P576, DOI 10.1006/bbrc.2000.2829; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Nath AK, 2015, CELL REP, V10, P694, DOI 10.1016/j.celrep.2015.01.010; Nevis K, 2013, DEV DYNAM, V242, P550, DOI 10.1002/dvdy.23928; Nowak C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26701-0; Oprea TI, 2018, NAT REV DRUG DISCOV, V17, P317, DOI [10.1038/nrd.2018.14, 10.1038/nrd.2018.52]; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Prince VE, 2017, CURR TOP DEV BIOL, V124, P235, DOI 10.1016/bs.ctdb.2016.10.005; Quinlivan VH, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00319; Reimann F, 2016, DIABETOLOGIA, V59, P229, DOI 10.1007/s00125-015-3825-z; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Schlegel A, 2015, CELL MOL LIFE SCI, V72, P2249, DOI 10.1007/s00018-014-1816-8; SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; Shim H, 2016, NUCLEIC ACIDS RES, V44, P9611, DOI 10.1093/nar/gkw897; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Wagner BK, 2011, ACS CHEM BIOL, V6, P900, DOI 10.1021/cb200206w; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wolf M, 2013, J CLIN ENDOCR METAB, V98, pE1137, DOI 10.1210/jc.2012-3976; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Yanai T, 2016, GENES CELLS, V21, P717, DOI 10.1111/gtc.12378; Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8; Zang LQ, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00091	54	7	7	4	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1546	1557		10.1096/fj.201901466R	http://dx.doi.org/10.1096/fj.201901466R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914600	Green Accepted, hybrid			2022-12-28	WOS:000507308900102
J	Wang, HA; Wang, LF; Wang, ZZC; Dang, YN; Shi, Y; Zhao, PP; Zhang, K				Wang, Huanan; Wang, Lefeng; Wang, Zizengchen; Dang, Yanna; Shi, Yan; Zhao, Panpan; Zhang, Kun			The nucleolar protein NOP2 is required for nucleolar maturation and ribosome biogenesis during preimplantation development in mammals	FASEB JOURNAL			English	Article						cattle; embryo; NOP2; nucleolus; preimplantation; ribosome	MATERNAL NUCLEOLUS; RNA; PROVIDES; OOCYTE	The maternal nucleolus plays an indispensable role in zygotic genome activation (ZGA) and early embryonic development in mice. During oocyte-to-embryo transition, the nucleolus is subject to substantial transformation. Despite the primary role of the nucleolus is ribosome biogenesis, accumulating evidence has uncovered its functions in various other cell processes. However, the regulation of nucleolar maturation and ribosome biogenesis and the molecules involved remain unclear during early embryonic development. In this study, we observed that nucleolar protein 2 (NOP2) is restrictedly localized within the nucleolus, first detected in the late two-cell embryos, and increases to a peak level at the eight-cell stage in mice. RNAi-mediated NOP2 depletion leads to a developmental arrest during the morula-to-blastocyst transition. RNA-seq analyses reveal that 208 genes are differentially expressed, including multiple lineage-specific genes and several genes encoding ribosome proteins. Indeed, we observe a failure of the first lineage specification with reduced TEA domain transcription factor 4(TEAD4) (trophectoderm-specific), tir na nog (NANOG), and kruppel-like factor 4 (KLF4) (inner cell mass-specific). Importantly, by Transmission Electron Microscopy (TEM), we noted a decrease in the ratio of the nucleolus size and an increase in the ratio of the size of the nucleolus precursor body, suggesting the nucleolar maturation is disrupted. Moreover, both qPCR and Fluorescence In Situ Hybridization (FISH) data showcase a significant decrease in the abundance of ribosome RNAs. Similarly, NOP2 depletion causes reduced developmental potential and decreased rRNA level in bovine early embryos, suggesting a functional conservation of NOP2 in mammals. Taken together, these results suggest that NOP2 is required for mammalian preimplantation development, presumably by regulating nucleolar maturation and ribosome biogenesis.	[Wang, Huanan; Wang, Lefeng; Wang, Zizengchen; Dang, Yanna; Shi, Yan; Zhao, Panpan; Zhang, Kun] Zhejiang Univ, Assisted Reprod Unit, Lab Mammalian Mol Embryol,Coll Anim Sci, Dept Obstet & Gynecol,Sir Run Run Shaw Hosp,Sch M, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhang, K (corresponding author), Zhejiang Univ, Assisted Reprod Unit, Lab Mammalian Mol Embryol,Coll Anim Sci, Dept Obstet & Gynecol,Sir Run Run Shaw Hosp,Sch M, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	kzhang@zju.edu.cn		Zhang, Kun/0000-0002-2324-9381	National Natural Science Foundation of China (NSFC) [31872348]; Zhejiang Provincial Natural Science Foundation of China [LY19C180002]; Foundation of Key Laboratory of Veterinary Biotechnology [klab201708]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation of Key Laboratory of Veterinary Biotechnology	National Natural Science Foundation of China (NSFC), Grant/Award Number: No. 31672416; National Natural Science Foundation of China (NSFC), Grant/Award Number: No. 31872348; Zhejiang Provincial Natural Science Foundation of China, Grant/Award Number: LY19C180002; the Foundation of Key Laboratory of Veterinary Biotechnology, Grant/Award Number: No. klab201708	Adachi K, 2007, MOL CELL BIOL, V27, P2202, DOI 10.1128/MCB.01908-06; Bohnsack KE, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020102; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Bourgeois G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133321; Chen H, 2008, BIOCHEM BIOPH RES CO, V365, P636, DOI 10.1016/j.bbrc.2007.11.019; Cui W, 2016, MOL REPROD DEV, V83, P124, DOI 10.1002/mrd.22600; Forloni Matteo, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot097758; Fulka H, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136093; Fulka H, 2014, DEVELOPMENT, V141, P1694, DOI 10.1242/dev.105940; Hamdane N, 2019, TRENDS GENET, V35, P868; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hong B, 1997, MOL CELL BIOL, V17, P378, DOI 10.1128/MCB.17.1.378; Kone MC, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136366; Kresoja-Rakic J, 2019, TRENDS GENET, V35, P868, DOI 10.1016/j.tig.2019.06.005; Kressler D, 2017, TRENDS BIOCHEM SCI, V42, P640, DOI 10.1016/j.tibs.2017.05.005; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Lee KB, 2009, ENDOCRINOLOGY, V150, P2463, DOI 10.1210/en.2008-1574; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Natchiar SK, 2017, NATURE, V551, P472, DOI 10.1038/nature24482; Nelson MD, 2011, METHODS MOL BIOL, V772, P459, DOI 10.1007/978-1-61779-228-1_27; Nerurkar P, 2015, INT REV CEL MOL BIO, V319, P107, DOI 10.1016/bs.ircmb.2015.07.002; OCHS RL, 1988, CANCER RES, V48, P6523; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Ogushi S, 2010, J REPROD DEVELOP, V56, P495, DOI 10.1262/jrd.09-184H; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pena C, 2017, NAT STRUCT MOL BIOL, V24, P689, DOI 10.1038/nsmb.3454; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Romanova LG, 2006, BIOL REPROD, V75, P690, DOI 10.1095/biolreprod.106.054072; Rossant J, 2018, ANNU REV GENET, V52, P185, DOI 10.1146/annurev-genet-120116-024544; Sahraeian SME, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00050-4; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Tiku V, 2018, TRENDS CELL BIOL, V28, P662, DOI 10.1016/j.tcb.2018.03.007; Trere D, 2000, J PATHOL, V192, P216, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH695>3.0.CO;2-L; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Zhang K, 2013, DEV BIOL, V383, P15, DOI 10.1016/j.ydbio.2013.09.005; Zhang K, 2013, DEV BIOL, V373, P359, DOI 10.1016/j.ydbio.2012.10.026; Zhao PP, 2019, FASEB J, V33, P12541, DOI 10.1096/fj.201901213R	40	13	13	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2715	2729		10.1096/fj.201902623R	http://dx.doi.org/10.1096/fj.201902623R		DEC 2019	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908012				2022-12-28	WOS:000504269800001
J	Rodriguez, S; Stewart, AN; Lei, X; Cao, X; Little, HC; Fong, V; Sarver, DC; Wong, GW				Rodriguez, Susana; Stewart, Ashley N.; Lei, Xia; Cao, Xi; Little, Hannah C.; Fong, Vincent; Sarver, Dylan C.; Wong, G. William			PRADC1: a novel metabolic-responsive secretory protein that modulates physical activity and adiposity	FASEB JOURNAL			English	Article						lipid metabolism; obesity; diabetes; insulin resistance	TISSUE INFLAMMATION; WEIGHT-LOSS; OBESITY; FAT; GLUCOSE	Interorgan communication mediated by secreted proteins plays a pivotal role in metabolic homeostasis, yet the function of many circulating secretory proteins remains unknown. Here, we describe the function of protease -associated domain-containing 1 (PRADC1), an enigmatic secretory protein widely expressed in humans and mice. In metabolically active tissues (liver, muscle, fat, heart, and kidney), we showed that Pradc1 expression is significantly suppressed by refeeding and reduced in kidney and brown fat in the context of obesity. PRADC1 is dispensable for whole-body metabolism when mice are fed a low-fat diet. However, in obesity induced by high-fat feeding, PRADC1-deficient female mice have reduced weight gain and adiposity despite similar caloric intake. Decreased fat mass is attributed, in part, to increased metabolic rate, physical activity, and energy expenditure in these animals. Reduced adiposity in PRADC1-deficient mice, however, does not improve systemic glucose and lipid metabolism, insulin sensitivity, liver steatosis, or adipose inflammation. Thus, in PRADC1-deficient animals, decreased fat mass and enhanced physical activity are insufficient to confer a healthy metabolic phenotype in the context of an obesogenic diet. Our results shed light on the physiologic function of PRADC1 and the complex regulation of metabolic health.	[Rodriguez, Susana; Stewart, Ashley N.; Lei, Xia; Cao, Xi; Little, Hannah C.; Sarver, Dylan C.; Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA; [Rodriguez, Susana; Stewart, Ashley N.; Lei, Xia; Cao, Xi; Little, Hannah C.; Sarver, Dylan C.; Wong, G. William] Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA; [Fong, Vincent] Johns Hopkins Univ, Dept Med, Div Endocrinol, Baltimore, MD 21205 USA; [Cao, Xi] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Capital Medical University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.; Wong, GW (corresponding author), Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu			U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK084171]; American Diabetes Association [1-18-PMF-022]; Ford Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); Ford Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Susan Aja (Department of Neuroscience and Center for Metabolism and Obesity Research, Johns Hopkins University) for help with indirect calorimetry and Andrew Wolfe for help with multiplex quantification of thyroid hormones. This work was supported by a grant from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (DK084171 to G.W.W.). S.R. was supported by a postdoctoral fellowship from the American Diabetes Association (1-18-PMF-022). A.N.S. was sup-ported by a predoctoral fellowship from the Ford Foundation. The authors declare no conflicts of interest.	Bradley David, 2012, Gastroenterology, V143, P897, DOI 10.1053/j.gastro.2012.07.114; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Lei X, 2017, J BIOL CHEM, V292, P14836, DOI [10.1074/jbc.m116.766808, 10.1074/jbc.M116.766808]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Pandey A, 2015, DIABETES CARE, V38, P1494, DOI 10.2337/dc14-2378; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Varlamov Oleg, 2014, Front Endocrinol (Lausanne), V5, P241, DOI 10.3389/fendo.2014.00241; Vitola BE, 2009, OBESITY, V17, P1744, DOI 10.1038/oby.2009.171; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhou B, 2004, FEBS LETT, V576, P401, DOI 10.1016/j.febslet.2004.09.039	23	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14748	14759		10.1096/fj.201901279R	http://dx.doi.org/10.1096/fj.201901279R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689374	Bronze, Green Published			2022-12-28	WOS:000507466100129
J	Kudo, S; Shiino, H; Furuta, S; Tamura, Y				Kudo, Shinnosuke; Shiino, Hiroya; Furuta, Shiina; Tamura, Yasushi			Yeast transformation stress, together with loss of Pah1, phosphatidic acid phosphatase, leads to Ty1 retrotransposon insertion into the INO4 gene	FASEB JOURNAL			English	Article						Pah1; Phospholipid; Retrotransposon; Yeast	PHOSPHOLIPID BIOSYNTHETIC GENES; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; EXPRESSION; INOSITOL; METABOLISM; CHOLINE; PHOSPHATIDYLETHANOLAMINE; CARDIOLIPIN; TRANSPORT	Most phospholipids are synthesized via modification reactions of a simple phospholipid phosphatidic acid (PA). PA and its modified phospholipids travel between organelle membranes, for example, the endoplasmic reticulum (ER) and mitochondrial inner membrane, to be converted to the other phospholipids. To gain insight into mechanisms of the phospholipid biosynthetic pathways, we searched for factors whose loss affects the phospholipid synthesis using an in vitro phospholipid transport assay. Among the various factors that were tested, we noticed that a lack of Pah1, which is a phosphatidic acid phosphatase, led to severe defects in phospholipid synthesis, which was not rescued by re-expression of wild-type Pah1. These results indicated other mutations in addition to the deletion of Pah1. Interestingly, we found that stress conditions associated with the yeast transformation process triggered a disruption of the INO4 gene by insertion of the Ty1 retrotransposon in pah1 increment strains. Additionally, we noticed that loss of the diacylglycerol kinase Dgk1, which has an opposing function to Pah1, suppressed the insertional mutation of INO4. These findings suggest that normal Pah1 function is critical for the suppression of insertional mutations by retrotransposon elements.	[Kudo, Shinnosuke; Shiino, Hiroya; Furuta, Shiina; Tamura, Yasushi] Yamagata Univ, Fac Sci, 1-4-12 Kojirakawa Machi, Yamagata, Yamagata 9908560, Japan	Yamagata University	Tamura, Y (corresponding author), Yamagata Univ, Fac Sci, 1-4-12 Kojirakawa Machi, Yamagata, Yamagata 9908560, Japan.	tamura@sci.kj.yamagata-u.ac.jp	Tamura, Yasushi/H-8270-2017	Tamura, Yasushi/0000-0002-8462-0607	Japan Agency for Medical Research and Development (AMED) [JP19gm5910026]; JSPS KAKENHI [15H05595, 17H06414, 19H03174]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm5910026; JSPS KAKENHI, Grant/Award Number: 15H05595, 17H06414 and 19H03174	Bachman N, 2004, GENOME RES, V14, P1232, DOI 10.1101/gr.2052904; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Dietz M, 2003, MOL MICROBIOL, V48, P1119, DOI 10.1046/j.1365-2958.2003.03501.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Kitamura H, 2002, J BIOL CHEM, V277, P33720, DOI 10.1074/jbc.M205672200; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; Kojima R, 2019, CELL REP, V26, P518, DOI 10.1016/j.celrep.2018.12.070; Kojima R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30777; Kwiatek JM, 2019, BIOCH BIOPHYS ACTA M, V1865, P1; LAMPING E, 1994, GENETICS, V137, P55; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Morillon A, 2002, MOL CELL BIOL, V22, P2078, DOI 10.1128/MCB.22.7.2078-2088.2002; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Rahman MA, 2018, FEBS J, V285, P1840, DOI 10.1111/febs.14448; Sakaue H, 2019, MOL CELL, V73, P1044, DOI 10.1016/j.molcel.2019.01.003; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Servant G, 2012, NUCLEIC ACIDS RES, V40, P5271, DOI 10.1093/nar/gks166; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Tamura Y, 2019, METHODS MOL BIOL, V1949, P57, DOI 10.1007/978-1-4939-9136-5_6; Tamura Y, 2019, J BIOCHEM, V165, P115, DOI 10.1093/jb/mvy088; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Watanabe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8922	40	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4749	4763		10.1096/fj.201901811RR	http://dx.doi.org/10.1096/fj.201901811RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32037626	hybrid			2022-12-28	WOS:000512570900001
J	Huang, MW; Wang, Q; Long, F; Di, Y; Wang, JH; Zhu, YZ; Liu, XH				Huang, Mengwei; Wang, Qing; Long, Fen; Di, Yang; Wang, Jinghuan; Zhu, Yi Zhun; Liu, Xinhua			Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice	FASEB JOURNAL			English	Article						bone marrow-derived macrophages; inflammatory bowel disease; Jmjd3; NLRP3	SULFATE SODIUM DSS; PATTERN-RECOGNITION; NLRP3; NRF2; EXPRESSION; MECHANISM; RECEPTORS; DISEASE; GENES	The intracellular NOD-like receptor nucleotide-binding domain-like receptors Family Pyrin Domain Containing 3 (NLRP3) is a pivotal regulator of intestinal homeostasis through regulating a variety of inflammatory and autoimmune diseases. The Jumonji domain-containing 3 (Jmjd3) plays important role in inflammatory responses and thus has been proposed as a novel attractive epigenetic target for the treatment of inflammatory diseases. We here investigated whether targeting Jmjd3 regulates NLRP3 inflammasome during experimental colitis. Jmjd3 specific inhibitor GSK J4 or knocking down Jmjd3 significantly inhibited NLRP3 inflammasome activation in lipopolysaccharide (LPS) and nigericin-stimulated bone marrow-derived macrophages. Chromatin immunoprecipitation-PCR analysis validated that GSK J4 rescued the decreased repressive H3K27me3 recruitment level on the promotors of nuclear factor-erythroid 2-related factor 2 (Nrf2) in LPS plus nigericin-induced macrophages. Nrf2 knockdown abolished NLRP3 inflammasome activation. Notably, oral administration of GSK J4 attenuated the disease progression in dextran sodium sulfate-induced colitis mouse model, including reduced disease activity index, improved body weight, rescued bowel shortening and NLRP3 inflammasome activation. Overall, our study reveals that Jmjd3 is a potential epigenetic regulator for the treatment of inflammatory bowel disease (IBD), suggesting that Nrf2 is a potential target gene of Jmjd3 by mediating methylation status of trimethylated H3 lysine 27 (H3K27me3) in the promotor and is required for NLRP3 inflammasome activation, thereby providing the platform for potential future therapeutic interventions in IBD.	[Huang, Mengwei; Wang, Qing; Long, Fen; Di, Yang; Wang, Jinghuan; Zhu, Yi Zhun; Liu, Xinhua] Fudan Univ, Sch Pharm, Dept Pharmacol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China; [Zhu, Yi Zhun] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Zhu, Yi Zhun] Macau Univ Sci & Technol, Sch Pharm, Macau, Peoples R China	Fudan University; Macau University of Science & Technology; Macau University of Science & Technology	Liu, XH (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.	liuxinhua@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	National Natural Science Foundation of China (NSFC) [81673428, 81872861]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81673428 and 81872861	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Alter G, 2007, J IMMUNOL, V178, P7658, DOI 10.4049/jimmunol.178.12.7658; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Das ND, 2012, CELL BIOCHEM FUNCT, V30, P224, DOI 10.1002/cbf.1839; Davis BK, 2014, INFLAMM BOWEL DIS, V20, P2412, DOI 10.1097/MIB.0000000000000151; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Donas C, 2016, J AUTOIMMUN, V75, P105, DOI 10.1016/j.jaut.2016.07.011; Dumont NA, 2013, AM J PATHOL, V182, P505, DOI 10.1016/j.ajpath.2012.10.010; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim Y, 2018, FOOD RES INT, V106, P335, DOI 10.1016/j.foodres.2017.12.058; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu XT, 2017, ANTIOXID REDOX SIGN, V26, P28, DOI 10.1089/ars.2015.6615; Liu XT, 2016, BIOCHEM PHARMACOL, V112, P37, DOI 10.1016/j.bcp.2016.05.002; Loher F, 2004, J PHARMACOL EXP THER, V308, P583, DOI 10.1124/jpet.103.057059; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Luo XL, 2018, CARDIOVASC RES, V114, P1894, DOI 10.1093/cvr/cvy176; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yu SQ, 2017, BIOCHEM BIOPH RES CO, V485, P62, DOI 10.1016/j.bbrc.2017.02.020; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	38	20	20	3	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4107	4119		10.1096/fj.201902200RR	http://dx.doi.org/10.1096/fj.201902200RR		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31971317	Bronze			2022-12-28	WOS:000508880900001
J	Liu, L; Zhou, M; Zhu, RF; Zhou, J; Ni, L; Wang, ZD; Liu, NC; Zhu, F; Shi, TG; Deng, ZT; Wang, Y; Tian, YX; Li, RQ; Yang, HL; Wang, ZH; Jiang, JN; Xu, YZ				Liu, Lei; Zhou, Ming; Zhu, Ruofu; Zhou, Jun; Ni, Li; Wang, Zhidong; Liu, Naicheng; Zhu, Feng; Shi, Tongguo; Deng, Zhantao; Wang, Yong; Tian, Yixing; Li, Rongqun; Yang, Huilin; Wang, Zhenheng; Jiang, Jiannong; Xu, Yaozeng			Hydrogen sulfide protects against particle-induced inflammatory response and osteolysis via SIRT1 pathway in prosthesis loosening	FASEB JOURNAL			English	Article						GYY4137; hydrogen sulfide; inflammation; SIRT1; wear particles	OSTEOCLAST FORMATION; PERIPROSTHETIC OSTEOLYSIS; MOUSE MODEL; BONE LOSS; IN-VITRO; H2S; INTERLEUKIN-6; PATHOGENESIS; MACROPHAGES; ACTIVATION	Wear debris-induced osteolysis and ensuing aseptic loosening is the main cause of implant failure and revision surgery. Wear debris-induced inflammatory response plays key roles in peri-implant osteolysis. Recently, substantial of evidence suggests that hydrogen sulfide (H2S), the third gasotransmitter, is a critical player regulating inflammation. However, the role and therapeutic potential of H2S in wear debris-induced inflammation and osteolysis remains to be defined. In the present study, we investigated the effect of H2S on wear debris-induced pro-inflammatory cytokines expression and osteolysis in vitro and in vivo. With a slow-releasing H2S donor GYY4137, our study demonstrated that H2S attenuated wear debris-induced osteolysis and osteoclastogenesis in murine calvaria resorption models. The expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6) that stimulated by wear particles were significantly reduced by GYY4137. Further, the level of sirtuin 1 (SIRT1), which possesses anti-inflammation property, was examined in vivo and in macrophages. And we found that wear debris decreased the expression of SIRT1. Cotreated macrophages with GYY4137 in part reversed the decline of SIRT1. More importantly, with the SIRT1 recombinant lentivirus and small interfering RNAs (siRNA) against SIRT1, our data indicated that SIRT1 mediated the inhibitory effects of GYY4137 on wear debris-induced inflammation. Collectively, these results suggested that exogenous H2S production (via H2S donors) may represent a potential approach for the treatment of wear particle-induced osteolysis.	[Liu, Lei; Zhou, Ming; Zhu, Ruofu; Zhou, Jun; Ni, Li; Wang, Zhidong; Liu, Naicheng; Zhu, Feng; Tian, Yixing; Li, Rongqun; Yang, Huilin; Wang, Zhenheng; Xu, Yaozeng] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, 899 Pinghai Rd, Suzhou 215000, Peoples R China; [Liu, Lei; Zhou, Ming; Wang, Yong; Jiang, Jiannong] Jiangsu Univ, Affiliated Yixing Hosp, Dept Orthoped, Yixing, Peoples R China; [Liu, Lei; Jiang, Jiannong] Yangzhou Univ, Sch Med, Affiliated Yixing Clin Sch, Yixing, Peoples R China; [Shi, Tongguo] First Affiliated Hosp Soochow, Jiangsu Inst Clin Immunol, Suzhou, Peoples R China; [Deng, Zhantao] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Surg, Div Orthoped Surg, Guangzhou, Peoples R China	Soochow University - China; Jiangsu University; Yangzhou University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Wang, ZH; Xu, YZ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped, 899 Pinghai Rd, Suzhou 215000, Peoples R China.	wangzhenheng1987@163.com; staff1225@yxph.com; xuyaozeng@163.com	Shi, Tongguo/AAS-3460-2021	Shi, Tongguo/0000-0002-5382-2775	National Natural Science Foundation of China (NSFC) [81802223, 81702214, 81802843, 81802222, 81572111, 81772318]; Clinical Medicine and Technological Development Foundation of Jiangsu University [JLY20180071, JLY20180006]; health planning committee younth project of wuxi [Q201710]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Clinical Medicine and Technological Development Foundation of Jiangsu University; health planning committee younth project of wuxi	National Natural Science Foundation of China (NSFC), Grant/Award Number: 8 1802223,81702214,81802843,81802222, 81572111,81772318; Grants from health planning committee younth project of wuxi, Grant/Award Number: Q201710; Clinical Medicine and Technological Development Foundation of Jiangsu University, Grant/Award Number: JLY20180071,JLY20180006	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alves CH, 2016, CLIN REV ALLERG IMMU, V51, P27, DOI 10.1007/s12016-015-8522-7; Amarasekara DS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e8; Axmann R, 2009, ARTHRITIS RHEUM-US, V60, P2747, DOI 10.1002/art.24781; Beneke Sascha, 2012, Frontiers in Genetics, V3, P169, DOI 10.3389/fgene.2012.00169; Bhatia M, 2015, HANDB EXP PHARMACOL, V230, P165, DOI 10.1007/978-3-319-18144-8_8; Burguera EF, 2017, CURR DRUG TARGETS, V18, P1641, DOI 10.2174/1389450117666160829112824; Castelblanco M, 2018, J BIOL CHEM, V293, P2546, DOI 10.1074/jbc.M117.806869; Deng ZT, 2017, ACTA BIOMATER, V49, P541, DOI 10.1016/j.actbio.2016.11.051; Du CK, 2019, ANTIOXID REDOX SIGN, V30, P184, DOI 10.1089/ars.2017.7195; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Flannigan KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071962; Gallo J, 2013, INNATE IMMUN-LONDON, V19, P213, DOI 10.1177/1753425912451779; Goodman SB, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0962; Ha CZ, 2015, INT J MOL MED, V35, P1657, DOI 10.3892/ijmm.2015.2183; Huang CWH, 2016, PHARMACOL RES, V113, P533, DOI 10.1016/j.phrs.2016.09.032; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Ito H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3238; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1; Karrholm J, 2018, SWEDISH HIP ARTHROPL; Kauther MD, 2013, BIOMATERIALS, V34, P2911, DOI 10.1016/j.biomaterials.2013.01.034; Kim HN, 2015, MOL ENDOCRINOL, V29, P1498, DOI 10.1210/me.2015-1133; Kitaura H, 2004, J IMMUNOL, V173, P4838, DOI 10.4049/jimmunol.173.8.4838; Kloesch B, 2010, CELL BIOL INT, V34, P477, DOI 10.1042/CBI20090436; Kudo O, 2003, BONE, V32, P1, DOI 10.1016/S8756-3282(02)00915-8; Langlois J, 2011, INT ORTHOP, V35, P245, DOI 10.1007/s00264-010-1143-0; Lehil MS, 2014, J ARTHROPLASTY, V29, P1915, DOI 10.1016/j.arth.2014.05.017; Li JJ, 2015, INT J MOL SCI, V16, P12560, DOI 10.3390/ijms160612560; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034; Lin Z, 2018, BBA-MOL BASIS DIS, V1864, P2890, DOI 10.1016/j.bbadis.2018.05.023; LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009; Mbalaviele G, 2017, J CLIN INVEST, V127, P2030, DOI 10.1172/JCI93356; Mendes KL, 2017, CYTOKINE GROWTH F R, V38, P98, DOI 10.1016/j.cytogfr.2017.11.001; Morigi M, 2018, J AM SOC NEPHROL, V29, P1799, DOI 10.1681/ASN.2017111218; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nakamura I, 2006, VITAM HORM, V74, P357, DOI 10.1016/S0083-6729(06)74015-8; National Joint Registry for England Wales Northern Ireland and the Isle of Man, 2017, 14 ANN REP 2017; Nevius E, 2016, CLIN REV ALLERG IMMU, V51, P59, DOI 10.1007/s12016-015-8520-9; Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599; Ong ALC, 2018, AGEING RES REV, V43, P64, DOI 10.1016/j.arr.2018.02.004; Pivec R, 2012, LANCET, V380, P1768, DOI 10.1016/S0140-6736(12)60607-2; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; Rao AJ, 2013, J BIOMED MATER RES A, V101, P1925, DOI 10.1002/jbm.a.34486; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Ruscitti P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/782382; Stuhlmeier KM, 2009, EXP BIOL MED, V234, P1327, DOI 10.3181/0904-RM-137; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2013, BIOMATERIALS, V34, P2611, DOI 10.1016/j.biomaterials.2013.01.025; Wang ZH, 2017, INT J NANOMED, V12, DOI 10.2147/IJN.S130485; Wang ZH, 2017, ACTA BIOMATER, V48, P489, DOI 10.1016/j.actbio.2016.11.020; Wang ZH, 2015, AUTOPHAGY, V11, P2358, DOI 10.1080/15548627.2015.1106779; Wedemeyer C, 2007, CALCIFIED TISSUE INT, V81, P394, DOI 10.1007/s00223-007-9077-2; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005	59	14	14	3	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3743	3754		10.1096/fj.201900393RR	http://dx.doi.org/10.1096/fj.201900393RR		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31943384	Bronze			2022-12-28	WOS:000507480500001
J	Troullinaki, M; Chen, LS; Witt, A; Pyrina, I; Phieler, J; Kourtzelis, I; Chmelar, J; Sprott, D; Gercken, B; Koutsilieris, M; Chavakis, T; Chatzigeorgiou, A				Troullinaki, Maria; Chen, Lan-Sun; Witt, Anke; Pyrina, Iryna; Phieler, Julia; Kourtzelis, Ioannis; Chmelar, Jindrich; Sprott, David; Gercken, Bettina; Koutsilieris, Michael; Chavakis, Triantafyllos; Chatzigeorgiou, Antonios			Robo4-mediated pancreatic endothelial integrity decreases inflammation and islet destruction in autoimmune diabetes	FASEB JOURNAL			English	Article						endothelium; insulitis; leukocyte infiltration; pancreatic islets; Type 1 Diabetes Mellitus (T1DM)	BETA-CELL DEATH; GENE-EXPRESSION; ADHESION MOLECULES; ADIPOSE-TISSUE; REAL-TIME; ROBO4; ANGIOGENESIS; RECEPTOR; GROWTH; DISRUPTION	In Type 1 Diabetes Mellitus (T1DM), leukocyte infiltration of the pancreatic islets and the resulting immune-mediated destruction of beta cells precede hyperglycemia and clinical disease symptoms. In this context, the role of the pancreatic endothelium as a barrier for autoimmunity- and inflammation-related destruction of the islets is not well studied. Here, we identified Robo4, expressed on endothelial cells, as a regulator of pancreatic vascular endothelial permeability during autoimmune diabetes. Circulating levels of Robo4 were upregulated in mice subjected to the Multiple Low-Dose Streptozotocin (MLDS) model of diabetes. Upon MLDS induction, Robo4-deficiency resulted in increased pancreatic vascular permeability, leukocyte infiltration to the islets and islet apoptosis, associated with reduced insulin levels and faster diabetes development. On the contrary, in vivo administration of Slit2 in mice modestly delayed the emergence of hyperglycaemia and ameliorated islet inflammation in MLDS-induced diabetes. Thus, Robo4-mediated endothelial barrier integrity reduces insulitis and islet destruction in autoimmune diabetes. Our findings highlight the importance of the endothelium as gatekeeper of pancreatic inflammation during T1DM development and may pave the way for novel Robo4-related therapeutic approaches for autoimmune diabetes.	[Troullinaki, Maria; Chen, Lan-Sun; Witt, Anke; Pyrina, Iryna; Phieler, Julia; Kourtzelis, Ioannis; Sprott, David; Gercken, Bettina; Chavakis, Triantafyllos; Chatzigeorgiou, Antonios] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Inst Clin Chem & Lab Med, Dresden, Germany; [Chmelar, Jindrich] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Koutsilieris, Michael; Chatzigeorgiou, Antonios] Natl & Kapodistrian Univ Athens, Med Sch, Dept Physiol, Athens, Greece; [Chavakis, Triantafyllos] Tech Univ Dresden, Univ Hosp, Helmholtz Ctr Munich, Paul Langerhans Inst Dresden, Dresden, Germany; [Chavakis, Triantafyllos] Tech Univ Dresden, Fac Med, Dresden, Germany; [Chavakis, Triantafyllos] German Ctr Diabet Res DZD, Neuherberg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of South Bohemia Ceske Budejovice; National & Kapodistrian University of Athens; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Chatzigeorgiou, A (corresponding author), Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med, Fetscherstr 74, D-01307 Dresden, Germany.	Antonios.Chatzigeorgiou@uniklinikum-dresden.de	Chmelař, Jindřich/U-1750-2017; Chavakis, Triantafyllos/ABE-8845-2020	Chmelař, Jindřich/0000-0002-7089-6143; Chatzigeorgiou, Antonios/0000-0002-7039-4223; Pyrina, Iryna/0000-0002-9849-6408; Chen, Lan-Sun/0000-0002-5917-3083; Kourtzelis, Ioannis/0000-0003-3006-8885	Deutsche Forschungsgemeinschaft (DFG) [IRTG 2251]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: CH 1862/2-1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: CH 1862/3-1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB-TR 127; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: IRTG 2251	Al-awar A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9051426; Blockus H, 2016, DEVELOPMENT, V143, P3037, DOI 10.1242/dev.132829; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Burke-Gaffney A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111459; Chia JSJ, 2013, DIABETES, V62, P2026, DOI 10.2337/db12-0625; Choi EY, 2015, MOL PSYCHIATR, V20, P880, DOI 10.1038/mp.2014.146; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Coleman HA, 2010, DEVELOPMENT, V137, P2417, DOI 10.1242/dev.047993; Eberhard D, 2010, TRENDS ENDOCRIN MET, V21, P457, DOI 10.1016/j.tem.2010.03.003; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Garcia-Martin R, 2016, MOL CELL BIOL, V36, P376, DOI 10.1128/MCB.00430-15; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; Gohrig A, 2014, CANCER RES, V74, P1529, DOI 10.1158/0008-5472.CAN-13-1012; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; In't Veld P, 2015, DIABETOLOGIA, V58, P4, DOI 10.1007/s00125-014-3418-2; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kaliberov SA, 2013, VIROLOGY, V447, P312, DOI 10.1016/j.virol.2013.09.020; Kaur S, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-61; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kourtzelis I, 2016, THROMB HAEMOSTASIS, V115, P781, DOI 10.1160/TH15-05-0429; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Masjkur J, 2014, J BIOL CHEM, V289, P35503, DOI 10.1074/jbc.M114.590687; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Nirantharakumar K, 2018, DIABETOLOGIA, V61, P1064, DOI 10.1007/s00125-018-4574-6; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Orlova V, 2007, THROMB HAEMOSTASIS, V98, P327, DOI 10.1160/Th07-03-0206; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Paviovic S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02646; Pejnovic NN, 2013, DIABETES, V62, P1932, DOI 10.2337/db12-0222; Pfeil U, 2009, AM J PHYSIOL-LUNG C, V297, pL837, DOI 10.1152/ajplung.90608.2008; Pi LY, 2012, FASEB J, V26, P3365, DOI 10.1096/fj.11-200154; Pugliese A, 2016, PEDIATR DIABETES, V17, P31, DOI 10.1111/pedi.12388; Quan W, 2013, DIABETES OBES METAB, V15, P141, DOI 10.1111/dom.12153; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Sherchan P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00827-z; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Tanno T, 2007, FEBS LETT, V581, P1022, DOI 10.1016/j.febslet.2007.02.001; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Xie JN, 2017, GENE, V616, P31, DOI 10.1016/j.gene.2017.03.027; Yang YHC, 2013, P NATL ACAD SCI USA, V110, P16480, DOI 10.1073/pnas.1214312110; Zanone MM, 2008, CURR DIABETES REV, V4, P1, DOI 10.2174/157339908783502415; Zhao HL, 2014, J IMMUNOL, V192, P385, DOI 10.4049/jimmunol.1302021	50	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3336	3346		10.1096/fj.201900125RR	http://dx.doi.org/10.1096/fj.201900125RR		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916652				2022-12-28	WOS:000506442300001
J	Holter, MM; Garibay, D; Lee, SA; Saikia, M; McGavigan, AK; Ngyuen, L; Moore, ES; Daugherity, E; Cohen, P; Kelly, K; Weiss, RS; Cummings, BP				Holter, Marlena M.; Garibay, Darline; Lee, Seon A.; Saikia, Mridusmita; McGavigan, Anne K.; Ngyuen, Lily; Moore, Elizabeth S.; Daugherity, Erin; Cohen, Paul; Kelly, Kathleen; Weiss, Robert S.; Cummings, Bethany P.			Hepatocyte p53 ablation induces metabolic dysregulation that is corrected by food restriction and vertical sleeve gastrectomy in mice	FASEB JOURNAL			English	Article						bariatric surgery; body weight; energy expenditure; p53	Y GASTRIC BYPASS; ENERGY-EXPENDITURE; MITOCHONDRIAL RESPIRATION; FATTY LIVER; EXPRESSION; SURGERY; GLUCOSE; IDENTIFICATION; INACTIVATION; DYSFUNCTION	P53 has been implicated in the pathogenesis of obesity and diabetes; however, the mechanisms and tissue sites of action are incompletely defined. Therefore, we investigated the role of hepatocyte p53 in metabolic homeostasis using a hepatocyte-specific p53 knockout mouse model. To gain further mechanistic insight, we studied mice under two complementary conditions of restricted weight gain: vertical sleeve gastrectomy (VSG) or food restriction. VSG or sham surgery was performed in high-fat diet-fed male hepatocyte-specific p53 wild-type and knockout littermates. Sham-operated mice were fed ad libitum or food restricted to match their body weight to VSG-operated mice. Hepatocyte-specific p53 ablation in sham-operated ad libitum-fed mice impaired glucose homeostasis, increased body weight, and decreased energy expenditure without changing food intake. The metabolic deficits induced by hepatocyte-specific p53 ablation were corrected, in part by food restriction, and completely by VSG. Unlike food restriction, VSG corrected the effect of hepatocyte p53 ablation to lower energy expenditure, resulting in a greater improvement in glucose homeostasis compared with food restricted mice. These data reveal an important new role for hepatocyte p53 in the regulation of energy expenditure and body weight and suggest that VSG can improve alterations in energetics associated with p53 dysregulation.	[Holter, Marlena M.; Garibay, Darline; Lee, Seon A.; Saikia, Mridusmita; McGavigan, Anne K.; Moore, Elizabeth S.; Daugherity, Erin; Kelly, Kathleen; Weiss, Robert S.; Cummings, Bethany P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Ngyuen, Lily; Cohen, Paul] Rockefeller Univ, Lab Mol Metab, 1230 York Ave, New York, NY 10021 USA	Cornell University; Rockefeller University	Cummings, BP (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	bpc68@cornell.edu		Lee, Seona/0000-0002-0124-6964; Nguyen, Lily/0000-0003-4425-2536	NIH [R21CA195002]; Cornell Comparative Cancer Biology Training Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Comparative Cancer Biology Training Program	NIH, Grant/Award Number: R21CA195002; Cornell Comparative Cancer Biology Training Program, Grant/Award Number: NA	Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Cariello NF, 2005, TOXICOL SCI, V88, P250, DOI 10.1093/toxsci/kfi273; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Coen PM, 2015, DIABETES, V64, P3737, DOI 10.2337/db15-0809; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cummings BP, 2012, ENDOCRINOLOGY, V153, P3620, DOI 10.1210/en.2012-1131; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Elbendary AA, 1996, CLIN CANCER RES, V2, P1571; Faria SL, 2012, SURG OBES RELAT DIS, V8, P797, DOI 10.1016/j.soard.2012.06.008; Garibay D, 2016, ENDOCRINOLOGY, V157, P3405, DOI 10.1210/en.2016-1302; Hallenborg P, 2016, AM J PHYSIOL-ENDOC M, V310, pE116, DOI 10.1152/ajpendo.00119.2015; Hao Z, 2016, OBES SURG, V26, P2173, DOI 10.1007/s11695-016-2062-y; Homayounfar R, 2015, GEN COMP ENDOCR, V214, P134, DOI 10.1016/j.ygcen.2014.06.029; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li J, 2007, OBES SURG, V17, P800, DOI 10.1007/s11695-007-9146-7; Lidell ME, 2010, NAT REV ENDOCRINOL, V6, P319, DOI 10.1038/nrendo.2010.64; Marino S, 2000, GENE DEV, V14, P994; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McGavigan AK, 2017, GUT, V66, P226, DOI 10.1136/gutjnl-2015-309871; Molchadsky A, 2013, CELL DEATH DIFFER, V20, P774, DOI 10.1038/cdd.2013.9; Moulder DE, 2018, CANCERS, V10, DOI 10.3390/cancers10060189; Nestoridi E, 2012, ENDOCRINOLOGY, V153, P2234, DOI 10.1210/en.2011-2041; Nijhawan S, 2013, SURG ENDOSC, V27, P4569, DOI 10.1007/s00464-013-3125-y; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Porteiro B, 2018, MOL METAB, V8, P132, DOI 10.1016/j.molmet.2017.12.005; Prokesch A, 2017, FASEB J, V31, P732, DOI 10.1096/fj.201600845R; Quinones M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05711-6; Rubino F, 2010, NAT REV ENDOCRINOL, V6, P102, DOI 10.1038/nrendo.2009.268; Shin AC, 2013, OBES SURG, V23, P531, DOI 10.1007/s11695-012-0846-2; Vijgen GHEJ, 2013, SURG OBES RELAT DIS, V9, P936, DOI 10.1016/j.soard.2013.03.009; Wang XW, 2013, J MOL CELL BIOL, V5, P147, DOI 10.1093/jmcb/mjs064; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Werling M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060280; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Yahagi N, 2004, J BIOL CHEM, V279, P20571, DOI 10.1074/jbc.M400884200; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang XM, 2016, PANCREAS, V45, P1010, DOI 10.1097/MPA.0000000000000637	46	4	4	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1846	1858		10.1096/fj.201902214R	http://dx.doi.org/10.1096/fj.201902214R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914635	Green Accepted			2022-12-28	WOS:000507308900122
J	Redick, SD; Leehy, L; Rittenhouse, AR; Blodgett, DM; Derr, AG; Kucukural, A; Garber, MG; Shultz, LD; Greiner, DL; Wang, JP; Harlan, DM; Bortell, R; Jurczyk, A				Redick, Sambra D.; Leehy, Linda; Rittenhouse, Ann R.; Blodgett, David M.; Derr, Alan G.; Kucukural, Alper; Garber, Manuel G.; Shultz, Leonard D.; Greiner, Dale L.; Wang, Jennifer P.; Harlan, David M.; Bortell, Rita; Jurczyk, Agata			Recovery of viable endocrine-specific cells and transcriptomes from human pancreatic islet-engrafted mice	FASEB JOURNAL			English	Article						graft recovery; insulin; L-type voltage-gated calcium channel; RNA-Seq; beta cell	GLUCAGON-LIKE PEPTIDE-1; BETA-CELLS; INSULIN-RELEASE; PROLIFERATION; GLUCOSE; ADULT; GENERATION; CHANNELS; MODEL	Human pancreatic islets engrafted into immunodeficient mice serve as an important model for in vivo human diabetes studies. Following engraftment, islet function can be monitored in vivo by measuring circulating glucose and human insulin; however, it will be important to recover viable cells for more complex graft analyses. Moreover, RNA analyses of dissected grafts have not distinguished which hormone-specific cell types contribute to gene expression. We developed a method for recovering live cells suitable for fluorescence-activated cell sorting from human islets engrafted in mice. Although yields of recovered islet cells were relatively low, the ratios of bulk-sorted beta, alpha, and delta cells and their respective hormone-specific RNA-Seq transcriptomes are comparable pretransplant and posttransplant, suggesting that the cellular characteristics of islet grafts posttransplant closely mirror the original donor islets. Single-cell RNA-Seq transcriptome analysis confirms the presence of appropriate beta, alpha, and delta cell subsets. In addition, ex vivo perifusion of recovered human islet grafts demonstrated glucose-stimulated insulin secretion. Viable cells suitable for patch-clamp analysis were recovered from transplanted human embryonic stem cell-derived beta cells. Together, our functional and hormone-specific transcriptome analyses document the broad applicability of this system for longitudinal examination of human islet cells undergoing developmental/metabolic/pharmacogenetic manipulation in vivo and may facilitate the discovery of treatments for diabetes.	[Redick, Sambra D.; Leehy, Linda; Derr, Alan G.; Greiner, Dale L.; Bortell, Rita; Jurczyk, Agata] Univ Massachusetts, Sch Med, Program Mol Med, Diabet Ctr Excellence, 368 Plantat St,AS7-2008, Worcester, MA 01605 USA; [Rittenhouse, Ann R.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Blodgett, David M.; Wang, Jennifer P.; Harlan, David M.] Univ Massachusetts, Sch Med, Dept Med, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Blodgett, David M.] Babson Coll, Div Math & Sci, Wellesley, MA USA; [Derr, Alan G.; Kucukural, Alper; Garber, Manuel G.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Babson College; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory	Jurczyk, A (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Diabet Ctr Excellence, 368 Plantat St,AS7-2008, Worcester, MA 01605 USA.	agata.jurczyk@umassmed.edu	Kucukural, Alper/T-3563-2018	Kucukural, Alper/0000-0001-9983-394X	HHS \ National Institutes of Health (NIH) [NIH R01 AI11692001A1]; HHS \ NIH \ Office of Extramural Research, National Institutes of Health (OER) [NIH R01 AI139095, UC4 DK104218]; NIDDK \ Integrated Islet Distribution Program (IIDP) [NIH 2UC4DK098085]; JDRF \ IIDP Islet Award Initiative	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS \ NIH \ Office of Extramural Research, National Institutes of Health (OER)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK \ Integrated Islet Distribution Program (IIDP); JDRF \ IIDP Islet Award Initiative	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: NIH R01 AI11692001A1; HHS vertical bar NIH vertical bar Office of Extramural Research, National Institutes of Health (OER), Grant/Award Number: NIH R01 AI139095 and UC4 DK104218; NIDDK vertical bar Integrated Islet Distribution Program (IIDP), Grant/Award Number: NIH 2UC4DK098085; JDRF vertical bar IIDP Islet Award Initiative	Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Brehm MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007757; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Carrano AC, 2017, MOL METAB, V6, P991, DOI 10.1016/j.molmet.2017.04.012; Dai CH, 2017, J CLIN INVEST, V127, P3835, DOI 10.1172/JCI91761; Davalli AM, 1996, J ENDOCRINOL, V150, P195, DOI 10.1677/joe.0.1500195; Derr A, 2016, GENOME RES, V26, P1397, DOI 10.1101/gr.207902.116; diIorio P, 2011, PANCREAS, V40, P1147, DOI 10.1097/MPA.0b013e31821ffabe; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Dorrell C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11756; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Gallagher GR, 2015, DIABETES, V64, P1358, DOI 10.2337/db14-1020; Greiner DL, 2011, ANN NY ACAD SCI, V1245, P55, DOI 10.1111/j.1749-6632.2011.06318.x; Jurczyk A, 2016, FASEB J, V30, P983, DOI 10.1096/fj.15-279810; Jurczyk A, 2013, DIABETES METAB SYNDR, V6, P493, DOI 10.2147/DMSO.S53154; Liu LW, 2003, NEUROPHARMACOLOGY, V45, P281, DOI 10.1016/S0028-3908(03)00153-9; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pearson T, 2008, DIABETOLOGIA, V51, P1449, DOI 10.1007/s00125-008-1057-1; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Reinbothe TM, 2013, DIABETOLOGIA, V56, P340, DOI 10.1007/s00125-012-2758-z; Russell MA, 2019, DIABETES, V68, P988, DOI 10.2337/db18-0686; Sasson A, 2016, DIABETES, V65, P3008, DOI 10.2337/db16-0365; Soumillon M., 2014, BIORXIV, DOI [10.1101/003236, DOI 10.1101/003236]; Veres A, 2019, NATURE, V569, P368, DOI 10.1038/s41586-019-1168-5; Yang CX, 2015, DIABET METAB SYND OB, V8, P387, DOI 10.2147/DMSO.S87253; Ziegenhain C, 2017, MOL CELL, V65, P631, DOI 10.1016/j.molcel.2017.01.023	34	2	2	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1901	1911		10.1096/fj.201901022RR	http://dx.doi.org/10.1096/fj.201901022RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914605	Green Published, hybrid			2022-12-28	WOS:000507308900126
J	Shao, LY; Liu, Y; Wang, WB; Li, AX; Wan, P; Liu, WY; Shereen, MA; Liu, F; Zhang, W; Tan, QP; Wu, KL; Liu, YL; Wu, JG				Shao, Luyao; Liu, Yan; Wang, Wenbiao; Li, Aixin; Wan, Pin; Liu, Weiyong; Shereen, Muhammad Adnan; Liu, Fang; Zhang, Wen; Tan, Quiping; Wu, Kailang; Liu, Yingle; Wu, Jianguo			SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation	FASEB JOURNAL			English	Article						inflammasome; innate immune response; interleukin-1 beta; posttranslational modification; SUMO1-catalyzed SUMOylation	NALP3 INFLAMMASOME; CONJUGATION; RECEPTORS; CRYSTALS; PATHWAY; FAMILY; P53; ASC	The NLRP3 inflammasome regulates innate immune and inflammatory responses by promoting caspase1-dependent induction of pro-inflammatory cytokines. However, aberrant inflammasome activation causes diverse diseases, and thus inflammasome activity must be tightly controlled. Here, we reveal a molecular mechanism underlying the regulation of NLRP3 inflammasome. NLRP3 interacts with SUMO-conjugating enzyme (UBC9), which subsequently promotes small ubiquitin-like modifier 1 (SUMO1) to catalyze NLRP3 SUMOylation at residue Lys(204). SUMO1-catalyzed SUMOylation of NLRP3 facilitates ASC oligomerization, inflammasome activation, and interleukin-1 beta secretion. Moreover, this study also reveals that SUMO-specific protease 3 (SENP3) is required for the deSUMOylation of NLRP3. Interestingly, SENP3 deSUMOylates NLRP3 to attenuate ASC recruitment and speck formation, the NLRP3 inflammasome activation, as well as IL-1 beta cleavage and secretion. In conclusion, we reveal that SUMO1-catalyzed SUMOylation and SENP3-mediated deSUMOylation of NLRP3 orchestrate the inflammasome activation.	[Shao, Luyao; Liu, Yan; Wang, Wenbiao; Li, Aixin; Wan, Pin; Liu, Weiyong; Shereen, Muhammad Adnan; Liu, Fang; Wu, Kailang; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Yingle; Wu, Jianguo] Jinan Univ, Inst Med Microbiol, Guangzhou, Peoples R China; [Zhang, Wen; Tan, Quiping] Guangdong LongFan Biol Sci & Technol Co, Foshan, Peoples R China	Wuhan University; Jinan University	Wu, KL; Liu, YL; Wu, JG (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	wukailang@whu.edu.cn; mvlwu@whu.edu.cn; jwu@whu.edu.cn	Liu, Fang/HCH-6710-2022; Li, Aixin/AAO-7926-2020; Wu, Jian/AAU-5221-2020; wang, wenbiao/AAQ-9104-2021; Wu, Jian/AAU-5221-2020	Liu, Fang/0000-0003-0972-9968; Li, Aixin/0000-0002-3158-0170; Wu, Jian/0000-0001-9933-7364; Shereen, Dr. Muhammad Adnan/0000-0002-0914-0697; Shao, Luyao/0000-0001-8272-4325; Wu, Jian/0000-0002-3394-1507	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [81730061]; National Health and Family Planning Commission of the People's Republic of China (Ministry of Health of China) [2017ZX10103005]; Guangdong Province Introduction of Innovative R&D Team (Guangdong Innovative Research Team Program) [2017ZT07Y580]	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); National Health and Family Planning Commission of the People's Republic of China (Ministry of Health of China); Guangdong Province Introduction of Innovative R&D Team (Guangdong Innovative Research Team Program)	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 81730061; National Health and Family Planning Commission of the People's Republic of China (Ministry of Health of China), Grant/Award Number: 2017ZX10103005; Guangdong Province Introduction of Innovative R&D Team (Guangdong Innovative Research Team Program), Grant/Award Number: 2017ZT07Y580	Aillet F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051672; Barry R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05321-2; Bartok E, 2013, NAT METHODS, V10, P147, DOI [10.1038/NMETH.2327, 10.1038/nmeth.2327]; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Enserink JM, 2017, ADV EXP MED BIOL, V963, P89, DOI 10.1007/978-3-319-50044-7_5; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang CJ, 2015, DNA CELL BIOL, V34, P652, DOI 10.1089/dna.2015.2933; Humphries F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03669-z; Iniguez-Lluhi JA, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P13, DOI 10.1007/978-90-481-2649-1_2; Ivanschitz L, 2015, P NATL ACAD SCI USA, V112, P14278, DOI 10.1073/pnas.1507540112; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee MH, 2006, NAT CELL BIOL, V8, P1424, DOI 10.1038/ncb1512; Liu Q, 2009, J BIOL CHEM, V284, P13686, DOI 10.1074/jbc.M809275200; Liu YF, 2018, CURR MOL MED, V18, P523, DOI 10.2174/1566524019666190112142025; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Park S, 2017, P NATL ACAD SCI USA, V114, pE5335, DOI 10.1073/pnas.1703105114; Pichler Andrea, 2017, BioMolecular Concepts, V8, P13, DOI 10.1515/bmc-2016-0030; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; Song N, 2017, MOL CELL, V68, P185, DOI 10.1016/j.molcel.2017.08.017; Stindt MH, 2011, CELL CYCLE, V10; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang M, 2016, PROTEIN CELL, V7, P63, DOI 10.1007/s13238-015-0216-7; Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185	56	21	23	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1497	1515		10.1096/fj.201901653R	http://dx.doi.org/10.1096/fj.201901653R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914638				2022-12-28	WOS:000507308900099
J	Yu, L; Li, GX; Deng, J; Jiang, X; Xue, J; Zhu, YB; Huang, W; Tang, BS; Duan, RH				Yu, Li; Li, Guangxu; Deng, Jing; Jiang, Xuan; Xue, Jin; Zhu, Yingbao; Huang, Wen; Tang, Beisha; Duan, Ranhui			The UFM1 cascade times mitosis entry associated with microcephaly	FASEB JOURNAL			English	Article						cell cycle; Drosophila; microcephaly; ufmylation	UBIQUITIN-LIKE MODIFICATIONS; RETICULUM STRESS-RESPONSE; BIALLELIC VARIANTS; PROTEIN; MECHANISMS; UFMYLATION; PATHWAY; CONJUGATION; ACTIVATION; REGULATOR	Posttranslational modifications enhance the functional diversity of the proteome by modifying the substrates. The UFM1 cascade is a novel ubiquitin-like modification system. The mutations in UFM1, its E1 (UBA5) and E2 (UFC1), have been identified in patients with microcephaly. However, its pathological mechanisms remain unclear. Herein, we observed the disruption of the UFM1 cascade in Drosophila neuroblasts (NBs) decreased the number of NBs, leading to a smaller brain size. The lack of ufmylation in NBs resulted in an increased mitotic index and an extended G2/M phase, indicating a defect in mitotic progression. In addition, live imaging of the embryos revealed an impaired E3 ligase (Ufl1) function resulted in premature entry into mitosis and failed cellularization. Even worse, the embryonic lethality occurred as early as within the first few mitotic cycles following the depletion of Ufm1. Knockdown of ufmylation in the fixed embryos exhibited severe phenotypes, including detached centrosomes, defective microtubules, and DNA bridge. Furthermore, we observed that the UFM1 cascade could alter the level of phosphorylation on tyrosine-15 of CDK1 (pY15-CDK1), which is a negative regulator of the G2 to M transition. These findings yield unambiguous evidence suggesting that the UFM1 cascade is a microcephaly-causing factor that regulates the progression of the cell cycle at mitosis phase entry.	[Yu, Li; Li, Guangxu; Deng, Jing; Jiang, Xuan; Xue, Jin; Zhu, Yingbao; Huang, Wen; Tang, Beisha; Duan, Ranhui] Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha 410008, Hunan, Peoples R China; [Yu, Li; Li, Guangxu; Deng, Jing; Jiang, Xuan; Xue, Jin; Zhu, Yingbao; Huang, Wen; Duan, Ranhui] Cent South Univ, Hunan Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Tang, Beisha] Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Duan, Ranhui] Cent South Univ, Hunan Key Lab Anim Models Human Dis, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Duan, RH (corresponding author), Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha 410008, Hunan, Peoples R China.	duanranhui@sklmg.edu.cn			National Natural Science Foundation of China [81771385]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China, Grant/Award Number: 81571253; The National Natural Science Foundation of China, Grant/Award Number: 81771385	Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Cai YF, 2016, EXP HEMATOL, V44, P442, DOI 10.1016/j.exphem.2016.03.007; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; Colin E, 2016, AM J HUM GENET, V99, P695, DOI 10.1016/j.ajhg.2016.06.030; DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]; Devoy A, 2005, ESSAYS BIOCHEM, V41, P187, DOI 10.1042/EB0410187; Duan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149039; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Eifler K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03486-4; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fang Z, 2019, DNA CELL BIOL, V38, P1030, DOI 10.1089/dna.2019.4861; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; FOE VE, 1983, J CELL SCI, V61, P31; Gannavaram S, 2012, MOL MICROBIOL, V86, P187, DOI 10.1111/j.1365-2958.2012.08183.x; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Hamilton EMC, 2017, NEUROLOGY, V89, P1821, DOI 10.1212/WNL.0000000000004578; Hanzlik E, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060047; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Homrich M, 2014, EXP CELL RES, V324, P192, DOI 10.1016/j.yexcr.2014.04.003; Hu XL, 2014, INT J MOL MED, V33, P1539, DOI 10.3892/ijmm.2014.1728; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lee MT, 2009, DNA REPAIR, V8, P557, DOI 10.1016/j.dnarep.2009.01.004; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Lim NR, 2017, STEM CELL REP, V9, P32, DOI 10.1016/j.stemcr.2017.05.015; Liu H, 2014, EXP MOL PATHOL, V97, P81, DOI 10.1016/j.yexmp.2014.05.010; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Miller C, 2017, AM J PHYSIOL-GASTR L, V312, pG314, DOI 10.1152/ajpgi.00176.2016; Morgan DO, 2007, NEW SCI, P88; Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015; Mukhopadhyay D, 2017, ADV EXP MED BIOL, V963, P171, DOI 10.1007/978-3-319-50044-7_10; Muona M, 2016, AM J HUM GENET, V99, P683, DOI 10.1016/j.ajhg.2016.06.020; Nahorski MS, 2018, BRAIN, V141, P1934, DOI 10.1093/brain/awy135; Nair AR, 2016, CELL REP, V14, P1100, DOI 10.1016/j.celrep.2015.12.097; Pirone L, 2017, SCI REP-UK, V7, DOI 10.1038/srep40756; Pushpavalli SNCVL, 2014, FASEB J, V28, P655, DOI 10.1096/fj.13-231167; Qin B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09175-0; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Riparbelli MG, 2002, J CELL SCI, V115, P913; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rujano MA, 2013, NAT CELL BIOL, V15, P1294, DOI 10.1038/ncb2858; Rump P, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0167-8; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Staller MV, 2013, GENETICS, V193, P51, DOI 10.1534/genetics.112.144915; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Stumpff J, 2004, CURR BIOL, V14, P2143, DOI 10.1016/j.cub.2004.11.050; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425; Wang ZF, 2017, MUTAT RES-FUND MOL M, V803, P56, DOI 10.1016/j.mrfmmm.2017.07.001; Wei Y, 2016, GENOM PROTEOM BIOINF, V14, P140, DOI 10.1016/j.gpb.2016.04.001; Wen DH, 2017, CELL REP, V21, P2147, DOI 10.1016/j.celrep.2017.10.085; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yoo HM, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00036; Yoo HM, 2014, MOL CELL, V56, P261, DOI 10.1016/j.molcel.2014.08.007; Zhang M, 2015, CELL DEATH DIFFER, V22, P1922, DOI 10.1038/cdd.2015.51; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038603; Zielke N, 2014, CELL REP, V7, P588, DOI 10.1016/j.celrep.2014.03.020	70	4	4	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1319	1330		10.1096/fj.201901751R	http://dx.doi.org/10.1096/fj.201901751R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914610				2022-12-28	WOS:000507308900088
J	Zhang, MJ; Zhao, QC; Xia, MX; Chen, J; Chen, YT; Cao, X; Liu, Y; Yuan, ZQ; Wang, XY; Xu, Y				Zhang, Mei-Juan; Zhao, Qiu-Chen; Xia, Ming-Xu; Chen, Jian; Chen, Yan-Ting; Cao, Xiang; Liu, Yi; Yuan, Zeng-Qiang; Wang, Xiao-Ying; Xu, Yun			The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome	FASEB JOURNAL			English	Article						AIM2 inflammasome; HDAC3; microglia; STAT1; stroke	GENE-EXPRESSION PROGRAM; EXPERIMENTAL STROKE; NEGATIVE REGULATOR; CELL-DEATH; MEMORY; ACTIVATION; NLRP3; NRF2; PHOSPHORYLATION; ACETYLATION	Histone deacetylases 3 (HDAC3) modulates the acetylation state of histone and non-histone proteins and could be a powerful regulator of the inflammatory process in stroke. Inflammasome activation is a ubiquitous but poorly understood consequence of acute ischemic stroke. Here, we investigated the potential contributions of HDAC3 to inflammasome activation in primary cultured microglia and experimental stroke models. In this study, we documented that HDAC3 expression was increased in microglia of mouse experimental stroke model. Intraperitoneal injection of RGFP966 (a selective inhibitor of HDAC3) decreased infarct size and alleviated neurological deficits after the onset of middle cerebral artery occlusion (MCAO). In vitro data indicated that LPS stimulation evoked a time-dependent increase of HDAC3 and absent in melanoma 2 (AIM2) inflammasome in primary cultured microglia. Interestingly, AIM2 was subjected to spatiotemporal regulation by RGFP966. The ability of RGFP966 to inhibit the AIM2 inflammasome was confirmed in an experimental mouse model of stroke. As expected, AIM2 knockout mice also demonstrated significant resistance to ischemia injury compared with their wild-type littermates. RGFP966 failed to exhibit extra protective effects in AIM2-/- stroke mice. Furthermore, we found that RGFP966 enhanced STAT1 acetylation and subsequently attenuated STAT1 phosphorylation, which may at least partially contributed to the negative regulation of AIM2 by RGFP966. Together, we initially found that RGFP966 alleviated the inflammatory response and protected against ischemic stroke by regulating the AIM2 inflammasome.	[Zhang, Mei-Juan; Zhao, Qiu-Chen; Xia, Ming-Xu; Chen, Jian; Chen, Yan-Ting; Cao, Xiang; Liu, Yi; Xu, Yun] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurol, Nanjing, Peoples R China; [Zhang, Mei-Juan; Zhao, Qiu-Chen; Xia, Ming-Xu; Chen, Jian; Chen, Yan-Ting; Cao, Xiang; Liu, Yi; Xu, Yun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China; [Zhao, Qiu-Chen; Wang, Xiao-Ying] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Yuan, Zeng-Qiang] Acad Mil Med Sci, Inst Basic Med Sci, Beijing, Peoples R China; [Xu, Yun] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing, Peoples R China; [Xu, Yun] Jiangsu Prov Stroke Ctr Diag & Therapy, Nanjing, Peoples R China	Nanjing University; Nanjing University; Harvard University; Massachusetts General Hospital; Academy of Military Medical Sciences - China; Nanjing University	Xu, Y (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com			 [81571135];  [JQX15003];  [ZDXKA2016020];  [BE2016610];  [2016YFC1300504];  [JQX16024];  [81630028];  [81971112]	; ; ; ; ; ; ; 	Meijuan Zhang, Grant/Award Number: 81571135; Meijuan Zhang, Grant/Award Number: JQX15003; Yun Xu, Grant/Award Number: ZDXKA2016020; Yun Xu, Grant/Award Number: BE2016610; Yun Xu, Grant/Award Number: 2016YFC1300504; Yanting Chen, Grant/Award Number: JQX16024; Yun Xu, Grant/Award Number: 81630028; Meijuan Zhang, Grant/Award Number: 81971112	Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Angiolilli C, 2017, ANN RHEUM DIS, V76, P277, DOI 10.1136/annrheumdis-2015-209064; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Chen YT, 2012, CLIN EXP PHARMACOL P, V39, P751, DOI 10.1111/j.1440-1681.2012.05729.x; Choi HK, 2015, HUM MOL GENET, V24, P1127, DOI 10.1093/hmg/ddu526; Cox DJ, 2015, GLIA, V63, P812, DOI 10.1002/glia.22786; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ganai SA, 2016, CURR NEUROPHARMACOL, V14, P55, DOI 10.2174/1570159X13666151021111609; Hanamsagar R, 2014, J NEUROCHEM, V129, P704, DOI 10.1111/jnc.12669; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hennig P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020562; Hoeksema MA, 2014, EMBO MOL MED, V6, P1124, DOI 10.15252/emmm.201404170; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu SQ, 2015, CELL REP, V13, P1922, DOI 10.1016/j.celrep.2015.10.040; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Komaroff AL, 2018, JAMA-J AM MED ASSOC, V319, P2381, DOI 10.1001/jama.2018.5240; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Leus NGJ, 2016, BIOCHEM PHARMACOL, V108, P58, DOI 10.1016/j.bcp.2016.03.010; Li DJ, 2016, FASEB J, V30, P3388, DOI 10.1096/fj.201600495R; Liu T, 2016, CELL REP, V16, P1988, DOI 10.1016/j.celrep.2016.07.019; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Martin BN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5977; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Pan J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0270-3; Rogge GA, 2013, J NEUROSCI, V33, P6623, DOI 10.1523/JNEUROSCI.4472-12.2013; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vecera J, 2018, J CELL PHYSIOL, V233, P530, DOI 10.1002/jcp.25914; Wang ZF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19626; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wu PJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32405; Xia MX, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/6237351; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yang J, 2017, CELL MOL IMMUNOL, V14, P65, DOI 10.1038/cmi.2016.29; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XY, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00131; Zeng J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0895-5; Zhang J, 2018, AM J PHYSIOL-ENDOC M, V315, pE150, DOI 10.1152/ajpendo.00465.2017; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Zhao QC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1495-3; Zhao QC, 2019, J NEUROCHEM, V149, P298, DOI 10.1111/jnc.14619; Zhu XL, 2017, AGING CELL, V16, P1073, DOI 10.1111/acel.12642; Zhuang SG, 2013, CELL SIGNAL, V25, P1924, DOI 10.1016/j.cellsig.2013.05.007	49	33	35	4	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					648	662		10.1096/fj.201900394RRR	http://dx.doi.org/10.1096/fj.201900394RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914678	hybrid			2022-12-28	WOS:000507308900045
J	Zhang, T; Sui, DX; Zhang, C; Cole, L; Hu, J				Zhang, Tuo; Sui, Dexin; Zhang, Chi; Cole, Logan; Hu, Jian			Asymmetric functions of a binuclear metal center within the transport pathway of a human zinc transporter ZIP4	FASEB JOURNAL			English	Article						crystallography; crystal soaking; metal cluster; transport kinetics	BINDING; FAMILY; SELECTIVITY; AFFINITY; PROTEIN; ATPASE; SITES	Metal clusters are exploited by numerous metalloenzymes for catalysis, but it is not common to utilize a metal cluster for substrate transport across membrane. The recent crystal structure of a prototypic Zrt-/Irt-like protein (ZIP) metal transporter from Bordetella bronchiseptica (BbZIP) revealed an unprecedented binuclear metal center (BMC) within the transport pathway. Here, through a combination of bioinformatics, biochemical and structural approaches, we concluded that the two physically associated metal-binding sites in the BMC of human ZIP4 (hZIP4) zinc transporter exert different functions: one conserved transition metal-binding site acts as the transport site essential for activity, whereas the variable metal-binding site is required for hZIP4's optimal activity presumably by serving as a secondary transport site and modulating the properties of the primary transport site. Sequential soaking experiments on BbZIP crystals clarified the process of metal release from the BMC to the bulky solvent. This work provides important insights into the transport mechanism of the ZIPs broadly involved in transition metal homeostasis and signaling, and also a paradigm on a novel function of metal cluster in metalloproteins.	[Zhang, Tuo; Sui, Dexin; Zhang, Chi; Cole, Logan; Hu, Jian] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Zhang, Tuo] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China	Michigan State University; Michigan State University; China Agricultural University	Hu, J (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	hujian1@msu.edu	, jonah/AAH-2478-2020		NIH [GM115373, GM129004]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: GM115373 and GM129004	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antala S, 2015, J BIOL CHEM, V290, P17796, DOI 10.1074/jbc.M114.617613; Antala S, 2012, BIOCHEMISTRY-US, V51, P963, DOI 10.1021/bi201553p; Anzilotti C, 2019, NAT IMMUNOL, V20, P350, DOI 10.1038/s41590-018-0295-8; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dutta SJ, 2007, BIOCHEMISTRY-US, V46, P3692, DOI 10.1021/bi0616394; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Faxen K, 2011, J BIOL CHEM, V286, P1609, DOI 10.1074/jbc.M110.176784; Gyimesi G, 2019, J BIOL CHEM, V294, P8046, DOI 10.1074/jbc.RA118.006113; INESI G, 1980, J BIOL CHEM, V255, P3025; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; KABACK HR, 1966, P NATL ACAD SCI USA, V55, P920, DOI 10.1073/pnas.55.4.920; Kato T, 2019, NAT PLANTS, V5, P308, DOI 10.1038/s41477-019-0367-2; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Mattle D, 2015, EMBO REP, V16, P728, DOI 10.15252/embr.201439927; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Takagishi T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122708; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2000, IUBMB LIFE, V49, P249, DOI 10.1080/15216540050033087; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wang KT, 2014, NATURE, V514, P518, DOI 10.1038/nature13618; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang TY, 2008, J AM CHEM SOC, V130, P3844, DOI 10.1021/ja076277h; Zhang T, 2019, BIOCHEM J, V476, P1791, DOI 10.1042/BCJ20190108; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344; Zielazinski EL, 2012, BIOCHEMISTRY-US, V51, P7891, DOI 10.1021/bi3006708	32	17	17	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					237	247		10.1096/fj.201902043R	http://dx.doi.org/10.1096/fj.201902043R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914589	Green Accepted			2022-12-28	WOS:000507308900018
J	Piers, TM; Cosker, K; Mallach, A; Johnson, GT; Guerreiro, R; Hardy, J; Pocock, JM				Piers, Thomas M.; Cosker, Katharina; Mallach, Anna; Johnson, Gabriel Thomas; Guerreiro, Rita; Hardy, John; Pocock, Jennifer M.			A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia	FASEB JOURNAL			English	Article						Alzheimer's disease; glycolysis; metabolism; microglia	PROLIFERATOR-ACTIVATED RECEPTOR; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; PPAR-GAMMA; CELLS; EXPRESSION; PFKFB3; GLYCOLYSIS; METABOLISM; PROMOTES	Loss-of-function genetic variants of triggering receptor expressed on myeloid cells 2 (TREM2) are linked with an enhanced risk of developing dementias. Microglia, the resident immune cell of the brain, express TREM2, and microglial responses are implicated in dementia pathways. In a normal surveillance state, microglia use oxidative phosphorylation for their energy supply, but rely on the ability to undergo a metabolic switch to glycolysis to allow them to perform rapid plastic responses. We investigated the role of TREM2 on the microglial metabolic function in human patient iPSC-derived microglia expressing loss of function variants in TREM2. We show that these TREM2 variant iPSC-microglia, including the Alzheimer's disease R47H risk variant, exhibit significant metabolic deficits including a reduced mitochondrial respiratory capacity and an inability to perform a glycolytic immunometabolic switch. We determined that dysregulated PPAR gamma/p38MAPK signaling underlies the observed phenotypic deficits in TREM2 variants and that activation of these pathways can ameliorate the metabolic deficit in these cells and consequently rescue critical microglial cellular function such as beta-Amyloid phagocytosis. These findings have ramifications for microglial focussed-treatments in AD.	[Piers, Thomas M.; Cosker, Katharina; Mallach, Anna; Johnson, Gabriel Thomas; Pocock, Jennifer M.] UCL, Dept Neuroinflammat, Inst Neurol, Queen Sq,1 Wakefield St, London WC1N 1PJ, England; [Guerreiro, Rita] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI USA; [Hardy, John] UCL, Dept Neurodegenerat Dis, Inst Neurol, Queen Sq, London, England	University of London; University College London; Van Andel Institute; University of London; University College London	Pocock, JM (corresponding author), UCL, Dept Neuroinflammat, Inst Neurol, Queen Sq,1 Wakefield St, London WC1N 1PJ, England.	j.pocock@ucl.ac.uk	Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Mallach, Anna/0000-0001-7181-3429; Guerreiro, Rita/0000-0001-5879-3486	Innovative Medicines Initiative (IMI) [115976]; Eisai; RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M009513/1]; MRC [MR/N026004/1, G0901254, UKDRI-1009, MR/M02492X/1, G0701075] Funding Source: UKRI	Innovative Medicines Initiative (IMI); Eisai(Eisai Co Ltd); RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Innovative Medicines Initiative (IMI), Grant/Award Number: 115976; Eisai; RCUK vertical bar Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/M009513/1	Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Bal-Price A, 2002, J NEUROCHEM, V80, P73, DOI 10.1046/j.0022-3042.2001.00675.x; Bolanos Juan P, 2013, Biochem J, V452, pe7, DOI 10.1042/BJ20130560; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Carpentier G., 2010, P IMAGEJ US DEV C, P238; Cheng J., 2016, D3HEATMAP INTERACTIV; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Corona JC, 2016, FREE RADICAL BIO MED, V100, P153, DOI 10.1016/j.freeradbiomed.2016.06.023; Culmsee C, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00739; Finucane OM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40619-1; Machado MMF, 2019, PHARMACOL REP, V71, P556, DOI 10.1016/j.pharep.2018.11.005; Garcia-Reitboeck P, 2018, CELL REP, V24, P2300, DOI 10.1016/j.celrep.2018.07.094; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gu RN, 2017, BRAIN BEHAV IMMUN, V60, P206, DOI 10.1016/j.bbi.2016.10.018; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Haenseler W, 2017, STEM CELL REP, V8, P1727, DOI 10.1016/j.stemcr.2017.05.017; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Ji HY, 2010, INFLAMM RES, V59, P921, DOI 10.1007/s00011-010-0203-7; Ji JD, 2001, J AUTOIMMUN, V17, P215, DOI 10.1006/jaut.2001.0542; Jiang H, 2016, J IMMUNOL, V197, P2880, DOI 10.4049/jimmunol.1600474; Jiang YD, 2014, J BIOL CHEM, V289, P26395, DOI 10.1074/jbc.M114.583880; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khan MA, 2019, CURR NEUROPHARMACOL, V17, P232, DOI 10.2174/1570159X16666180828100002; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Li L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07127-8; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Nair S, 2019, GLIA, V67, P1047, DOI 10.1002/glia.23587; Novellasdemunt L, 2013, BIOCHEM J, V452, P531, DOI 10.1042/BJ20121886; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Park JS, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0829-3; Rodriguez-Garcia A, 2017, FEBS J, V284, P3437, DOI 10.1111/febs.14201; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Sharma PK, 2010, CANCER LETT, V295, P154, DOI 10.1016/j.canlet.2010.02.021; Shen YG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00707-0; Shutt DC, 2010, CANCER BIOL THER, V9, P853, DOI 10.4161/cbt.9.11.11632; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Xiang XY, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0280-6; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015	55	45	45	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2436	2450		10.1096/fj.201902447R	http://dx.doi.org/10.1096/fj.201902447R		DEC 2019	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907987	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000504095300001
J	Bao, H; Zhang, QY; Liu, XY; Song, YX; Li, XH; Wang, Z; Li, CB; Peng, A; Gong, RJ				Bao, Hui; Zhang, Qianyun; Liu, Xinying; Song, Yaxiang; Li, Xinhua; Wang, Zhen; Li, Changbin; Peng, Ai; Gong, Rujun			Lithium targeting of AMPK protects against cisplatin-induced acute kidney injury by enhancing autophagy in renal proximal tubular epithelial cells	FASEB JOURNAL			English	Article						AMP-activated protein kinases; apoptosis; acute tubular necrosis; autophagosome	INDUCED APOPTOSIS; NEPHROTOXICITY; MECHANISM; CHEMOTHERAPY; ACTIVATION; PATHWAYS; SURVIVAL; GROWTH; P53	Autophagy has been demonstrated to be vital for kidney homeostasis and is centrally implicated in the pathogenesis of cisplatin-induced acute kidney injury (AKI). Lithium is a potent autophagy inducer in a number of cell types. However, it remains uncertain whether its autophagic activity is associated with a beneficial effect on renal tubular cells in AKI. This study aimed to examine the effect of lithium on renal autophagy in cisplatin-induced AKI. Mice or renal proximal tubular epithelial cells in culture were exposed to cisplatin-induced acute injury in the presence or absence of lithium treatment. AKI or tubular cell injury was evaluated, and cell signaling associated with autophagy was examined. Lithium pretreatment prominently ameliorated acute renal tubular damage in mice exposed to cisplatin insult, associated with enhanced autophagy in renal tubules, as assessed by measuring microtubule-associated protein 1A/1B-light chain 3 (LC3)BII/I expression and autophagosome formation. Consistently, in cisplatin-injured renal tubular cells in vitro, lithium enhanced autophagic activities, improved cell viability, and attenuated cell death. Mechanistically, lithium triggered AMPK-alpha phosphorylation and activation, which in turn positively correlated with the induced expression of autophagy-related molecules, like mammalian target of rapamycin and LC3BII/I. AMPK-alpha activation is likely required for lithium-induced tubular cell autophagy and protection in cisplatin-induced AKI because blockade of AMPK-alpha phosphorylation by compound C markedly abrogated lithium-induced autophagosome formation and mitigated the protective effect of lithium on AKI. Our findings suggest that lithium represents a promising therapeutic strategy for protecting renal tubular cells against cisplatin-induced AKI by enhancing autophagy via AMPK-alpha activation.	[Bao, Hui; Zhang, Qianyun; Liu, Xinying; Song, Yaxiang; Li, Xinhua; Wang, Zhen; Li, Changbin; Peng, Ai] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nephrol, Shanghai, Peoples R China; [Bao, Hui; Zhang, Qianyun; Liu, Xinying; Song, Yaxiang; Li, Xinhua; Wang, Zhen; Li, Changbin; Peng, Ai] Tongji Univ, Sch Med, Ctr Nephrol & Clin Metabol, Shanghai, Peoples R China; [Bao, Hui; Wang, Zhen; Li, Changbin; Gong, Rujun] Brown Univ, Rhode Isl Hosp, Sch Med, Div Kidney Dis & Hypertens,Dept Med, Providence, RI 02903 USA; [Gong, Rujun] Univ Toledo, Coll Med, Dept Med, Div Nephrol, 3000 Arlington Ave, Toledo, OH 43614 USA	Tongji University; Tongji University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University System of Ohio; University of Toledo	Gong, RJ (corresponding author), Univ Toledo, Coll Med, Dept Med, Div Nephrol, 3000 Arlington Ave, Toledo, OH 43614 USA.	runjun.gong@utoledo.edu	Bao, Hui/AAI-9019-2021	Bao, Hui/0000-0002-1271-6992	Shanghai International Cooperation Program [16410724200]; Fundamental Research Funds for the Central Universities [22120180390]; Natural Science Foundation of China [81500508, 81672938, 81770732]; Foundation for Health; International Society of Nephrology Global Outreach Program	Shanghai International Cooperation Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Health; International Society of Nephrology Global Outreach Program	H.B. was supported, in part, by the Shanghai International Cooperation Program (16410724200), Fundamental Research Funds for the Central Universities (22120180390), and the Natural Science Foundation of China (Grants 81500508, 81672938, and 81770732). R.G. was supported, in part, by the Foundation for Health and the International Society of Nephrology Global Outreach Program. The authors declare no conflicts of interest.	Aiff H, 2015, J PSYCHOPHARMACOL, V29, P608, DOI 10.1177/0269881115573808; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Baldessarini RJ, 2019, MOL PSYCHIATR, V24, P198, DOI 10.1038/s41380-018-0044-2; Bao H, 2014, J AM SOC NEPHROL, V25, P488, DOI 10.1681/ASN.2013040350; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Chiu Chi-Tso, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P461, DOI 10.3969/j.issn.1672-7347.2011.06.001; Cho KH, 2014, ONCOL REP, V31, P248, DOI 10.3892/or.2013.2809; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Del Bello B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057236; Dong BT, 2015, INT J CLIN EXP PATHO, V8, P2473; GOLDSTEIN RS, 1983, LIFE SCI, V32, P685, DOI 10.1016/0024-3205(83)90299-0; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Gong RJ, 2016, AM J PHYSIOL-RENAL, V311, pF1168, DOI 10.1152/ajprenal.00145.2016; Arbelaez LFG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/317456; Grahammer F, 2014, P NATL ACAD SCI USA, V111, pE2817, DOI 10.1073/pnas.1402352111; Hsiao HW, 2012, SHOCK, V37, P289, DOI 10.1097/SHK.0b013e318240b52a; Hu YB, 2018, CANCER LETT, V431, P85, DOI 10.1016/j.canlet.2018.05.035; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jiang M, 2004, AM J PHYSIOL-RENAL, V287, pF1140, DOI 10.1152/ajprenal.00262.2004; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Karasawa T, 2015, TOXICOL LETT, V237, P219, DOI 10.1016/j.toxlet.2015.06.012; Kaushal GP, 2001, KIDNEY INT, V60, P1726, DOI 10.1046/j.1523-1755.2001.00026.x; Kaushal GP, 2016, KIDNEY INT, V89, P779, DOI 10.1016/j.kint.2015.11.021; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Lan Y, 2013, BIOMETALS, V26, P241, DOI 10.1007/s10534-012-9607-x; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li B, 2018, NEUROCHEM RES, V43, P848, DOI 10.1007/s11064-018-2488-9; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; Lieberthal W, 2011, AM J PHYSIOL-RENAL, V301, pF1177, DOI 10.1152/ajprenal.00034.2011; Liu AD, 2013, LIVER TRANSPLANT, V19, P762, DOI 10.1002/lt.23666; Lu ML, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101275; Lyoo IK, 2010, NEUROPSYCHOPHARMACOL, V35, P1743, DOI 10.1038/npp.2010.41; MADIAS NE, 1978, AM J MED, V65, P307, DOI 10.1016/0002-9343(78)90825-2; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Min WW, 2009, NEUROPHARMACOLOGY, V56, P463, DOI 10.1016/j.neuropharm.2008.09.017; Moors TE, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0154-3; Nie DY, 2018, EXP EYE RES, V173, P44, DOI 10.1016/j.exer.2018.04.008; Oosterman JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146969; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Rao EY, 2016, ONCOTARGET, V7, P33783, DOI 10.18632/oncotarget.9277; Rej S, 2014, AGING MENT HEALTH, V18, P847, DOI 10.1080/13607863.2014.888536; Rej S, 2013, INT J GERIATR PSYCH, V28, P450, DOI 10.1002/gps.3841; RIES F, 1986, AM J KIDNEY DIS, V8, P368, DOI 10.1016/S0272-6386(86)80112-3; Rovetta F, 2012, EXP CELL RES, V318, P238, DOI 10.1016/j.yexcr.2011.11.008; Santana-Davila R, 2014, J THORAC ONCOL, V9, P702, DOI 10.1097/JTO.0000000000000146; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Severus E, 2018, PHARMACOPSYCHIATRY, V51, P173, DOI 10.1055/a-0627-7489; Shen CZ, 2016, EXP THER MED, V12, P2803, DOI 10.3892/etm.2016.3736; Si J, 2013, KIDNEY INT, V83, P635, DOI 10.1038/ki.2012.447; Taguchi T, 2005, CONTRIB NEPHROL, V148, P107, DOI 10.1159/000086055; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Wang N, 2018, J CELL PHYSIOL, V233, P2434, DOI 10.1002/jcp.26118; Weijl NI, 2004, EUR J CANCER, V40, P1713, DOI 10.1016/j.ejca.2004.02.029; Wood NI, 2003, BRAIN RES BULL, V61, P375, DOI 10.1016/S0361-9230(03)00141-2; Yano T, 2007, APOPTOSIS, V12, P1901, DOI 10.1007/s10495-007-0110-8; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang D, 2018, PEDIATR PULM, V53, P1053, DOI 10.1002/ppul.24047; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	59	16	16	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14370	14381		10.1096/fj.201901712R	http://dx.doi.org/10.1096/fj.201901712R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31661633	Bronze			2022-12-28	WOS:000507466100101
J	Jiang, Y; Jiang, YF; Zhang, HH; Mei, MR; Song, HL; Ma, XH; Jiang, L; Yu, ZQ; Zhang, Q; Ding, XD				Jiang, Yao; Jiang, Yifan; Zhang, Haihan; Mei, Mengran; Song, Hailiang; Ma, Xianghui; Jiang, Li; Yu, Zhenquan; Zhang, Qin; Ding, Xiangdong			A mutation in MAP2 is associated with prenatal hair follicle density	FASEB JOURNAL			English	Article						pig; hairless; morphogenesis; embryonic period	ECTODERMAL DYSPLASIA; BETA-CATENIN; MODEL; MORPHOGENESIS; GENE; MICE; PIG; DIFFERENTIATION; IDENTIFICATION; POPULATION	Hairlessness is usually a rare trait in pigs; however, in this study, we found hairless (HR) pigs at a relatively high frequency in 1 pig herd. We observed that, the lower hair shaft density of HR pigs could be mainly attributed to the lower hair follicle density, and during the embryonic period, d 39-45 were a critical stage for the formation of the hair follicle. In this regard, d 41 during gestation was a particularly important point. Hair follicle morphogenesis occurring at an early stage of embryo development is similar to humans and mice. Further analyses of association studies based on single-nucleotide polymorphism chip as well as sequence data, mRNA sequencing, immunohistochemistry, and comparative genomics demonstrated that microtubule-associated protein 2 (MAP2) is a key gene responsible for hair follicle density and 1 missense mutation of A-to-G at rs328005415 in MAP2, causing a valine-to-methionine substitution leads to the HR phenotype. Considering the high homology between pigs and humans, our research has some significance for the study of the mechanisms of skin development, hair morphogenesis, and hair loss in humans by showing that the pig may be a more appropriate model in which to study these processes.	[Jiang, Yao; Jiang, Yifan; Zhang, Haihan; Mei, Mengran; Song, Hailiang; Jiang, Li; Zhang, Qin; Ding, Xiangdong] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Lab Anim Genet Breeding & Reprod,Minist Agr, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China; [Ma, Xianghui; Yu, Zhenquan] China Agr Univ, Coll Biol Sci, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, State Key Lab Agrobiotechnol, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Ding, XD (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Lab Anim Genet Breeding & Reprod,Minist Agr, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	xding@cau.edu.cn	jiang, yifan/GQH-5044-2022	Jiang, Li/0000-0002-0648-2173	National Natural Science Foundation of China [31671327]; earmarked fund for China Agriculture Research System [CARS-35]; Changjiang Scholars Program and Innovative Research Team in University [IRT_15R621]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for China Agriculture Research System; Changjiang Scholars Program and Innovative Research Team in University	This study was supported by grants from the National Natural Science Foundation of China (31671327), the earmarked fund for China Agriculture Research System (CARS-35), the Changjiang Scholars Program and Innovative Research Team in University (IRT_15R621). The authors declare no conflicts of interest.	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Bastakoty D, 2015, FASEB J, V29, P4881, DOI 10.1096/fj.15-275941; Bianco E, 2015, MOL ECOL, V24, P2364, DOI 10.1111/mec.13182; Bourneuf E, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00146; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Calvo-Sanchez MI, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39992-8; Calvo-Sanchez MI, 2019, J MOL CELL BIOL, V11, P39, DOI 10.1093/jmcb/mjy051; Choi BY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092703; Collins KJ, 2014, STRUCTURE, V22, P70, DOI 10.1016/j.str.2013.10.010; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Duverger O, 2014, SEMIN CELL DEV BIOL, V25, P22, DOI 10.1016/j.semcdb.2013.12.006; Duverger O, 2009, BIRTH DEFECTS RES C, V87, P263, DOI 10.1002/bdrc.20158; Esteve-Codina A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-148; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Fu J, 2013, J INVEST DERMATOL, V133, P890, DOI 10.1038/jid.2012.407; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Fuchs E, 2016, CURR TOP DEV BIOL, V116, P357, DOI 10.1016/bs.ctdb.2015.11.033; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Gao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151118; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Griaud F, 2017, MABS-AUSTIN, V9, P1337, DOI 10.1080/19420862.2017.1366395; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gutleb DR, 2018, GENES BRAIN BEHAV, V17, DOI 10.1111/gbb.12443; Han K, 2017, HUM MOL GENET, V26, P184, DOI 10.1093/hmg/ddw378; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kobayashi T, 2017, NATURE, V546, P416, DOI 10.1038/nature22812; Ladrech S, 2002, J COMP NEUROL, V451, P70, DOI 10.1002/cne.10334; Lichtenberger BM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10537; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Malhotra H, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00245; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Nguyen MB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04399-y; Mokabber H, 2019, J CELL PHYSIOL, V234, P8941, DOI 10.1002/jcp.27563; Motlik J, 2007, THERIOGENOLOGY, V67, P105, DOI 10.1016/j.theriogenology.2006.09.018; Mundlapati VR, 2015, J PHYS CHEM LETT, V6, P1385, DOI 10.1021/acs.jpclett.5b00491; Neumann C, 2014, BIOMETRICAL J, V56, P1076, DOI 10.1002/bimj.201300148; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Patel S, 2018, J BIOL CHEM, V293, P12149, DOI 10.1074/jbc.RA118.002918; Perez-Enciso M, 2017, HEREDITY, V118, P160, DOI 10.1038/hdy.2016.78; Pissarenko A, 2019, ACTA BIOMATER, V86, P77, DOI 10.1016/j.actbio.2019.01.023; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Plikus MV, 2009, INT J DEV BIOL, V53, P857, DOI 10.1387/ijdb.072564mp; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sahoo S, 2017, J SURG RES, V210, P115, DOI 10.1016/j.jss.2016.10.026; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sardella C, 2018, J INVEST DERMATOL, V138, P500, DOI 10.1016/j.jid.2017.09.024; Schlechter N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01624; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sprecher E, 1999, J INVEST DERMATOL, V113, P687, DOI 10.1046/j.1523-1747.1999.00723.x; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Susin C, 2017, J CLIN PERIODONTOL, V44, P1059, DOI 10.1111/jcpe.12766; Takeo M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023267; Tomann P, 2016, DEVELOPMENT, V143, P1512, DOI 10.1242/dev.130898; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112	67	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14479	14490		10.1096/fj.201901187R	http://dx.doi.org/10.1096/fj.201901187R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31751154	Bronze			2022-12-28	WOS:000507466100109
J	Sanaki, T; Wakabayashi, M; Yoshioka, T; Yoshida, R; Shishido, T; Hall, WW; Sawa, H; Sato, A				Sanaki, Takao; Wakabayashi, Masato; Yoshioka, Takeshi; Yoshida, Ryu; Shishido, Takao; Hall, William W.; Sawa, Hirofumi; Sato, Akihiko			Inhibition of dengue virus infection by 1-stearoyl-2-arachidonoyl-phosphatidylinositol in vitro	FASEB JOURNAL			English	Article						lipid screening; inflammatory responses; Toll-like receptor 4	FATTY-ACID SYNTHASE; VIRAL REPLICATION; INFLAMMATORY RESPONSES; ARACHIDONIC-ACID; LIVER-DISEASE; PHOSPHATIDYLSERINE; PHOSPHOLIPIDS; ACTIVATION; LIPIDS; PHOSPHATIDYLINOSITOL	Dengue fever is an acute febrile infectious disease caused by dengue virus (DENV). Despite the significant public health concerns posed by DENV, there are currently no effective anti-DENV therapeutic agents. To develop such drugs, a better understanding of the detailed mechanisms of DENV infection is needed. Both lipid metabolism and lipid synthesis are activated in DENV-infected cells, so we used lipid screening to identify potential antiviral lipid molecules. We identified 1-stearoyl-2-arachidonoyl-phosphatidylinositol (SAPI), which is the most abundant endogenous phosphatidylinositol (PI) molecular species, as an anti-DENV lipid molecule. SAPI suppressed the cytopathic effects induced by DENV2 infection as well as the replication of all DENV serotypes without inhibiting the entry of DENV2 into host cells. However, no other PI molecular species or PI metabolites, including lysophosphatidylinositols and phosphoinositides, displayed anti-DENV2 activity. Furthermore, SAPI suppressed the production of DENV2 infection induced cytokines and chemokines, including C-C motif chemokine ligand (CCL)5, CCL20, C-X-C chemokine ligand 8, IL-6, and IFN-beta. SAPI also suppressed the TNF-alpha production induced by LPS stimulation in macrophage cells differentiated from THP-1 cells. Our results demonstrated that SAPI is an endogenous inhibitor of DENV and modulated inflammatory responses in DENV2-infected cells, at least in part via TLR 4.	[Sanaki, Takao; Yoshida, Ryu; Shishido, Takao; Sato, Akihiko] Shionogi & Co Ltd, Drug Discovery & Dis Res Lab, Osaka, Japan; [Wakabayashi, Masato; Yoshioka, Takeshi] Shionogi & Co Ltd, Biomarker Res & Dev Dept, Osaka, Japan; [Sanaki, Takao; Sato, Akihiko] Hokkaido Univ, Div Antivirus Drug Res, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Hall, William W.; Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ Gi CoRE, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Sawa, Hirofumi] Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Hall, William W.; Sawa, Hirofumi] Global Virus Network, Baltimore, MD USA; [Hall, William W.] Univ Coll Dublin, Ctr Res Infect Dis, Dublin, Ireland	Shionogi & Company Limited; Shionogi & Company Limited; Hokkaido University; Hokkaido University; Hokkaido University; University College Dublin	Sato, A (corresponding author), Shionogi & Co Ltd, Kita Ku, N21,W11, Sapporo, Hokkaido 0010021, Japan.	akihiko.sato@shionogi.co.jp	Sawa, Hirofumi/F-6954-2012; Sawa, Hirofumi/AAW-8816-2021	Sawa, Hirofumi/0000-0003-2569-2755; sanaki, takao/0000-0001-8847-0071; Yoshioka, Takeshi/0000-0002-8658-8081	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) Kakenhi [JP16H06431, JP16H06429, JP16K21723]; Japan Initiative for Global Research Network of Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED) [JP19fm0108008]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) Kakenhi; Japan Initiative for Global Research Network of Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED)	The authors thank Dr. T. Takasaki (Kanagawa Prefectural Institute of Public Health, Chigasaki, Japan) for providing the dengue virus and Dr. K. Matsuno (Hokkaido University) for providing the THP-1 cells. The authors thank Janine Miller, Ph.D. and Katie Oakley, Ph.D. (Edanz Group, Fukuoka, Japan; www.edanzediting.com/ac) for editing a draft of this manuscript. This work was supported by grants for Scientific Research on Innovative Areas and International Group from Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) Kakenhi (JP16H06431, JP16H06429, and JP16K21723), and the Japan Initiative for Global Research Network of Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED) (JP19fm0108008). The authors declare no conflicts of interests.	Abate W, 2010, J LIPID RES, V51, P334, DOI 10.1194/jlr.M000513; Alayli F, 2016, VIROLOGY, V496, P227, DOI 10.1016/j.virol.2016.06.008; Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787; Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15; Castaneda-Sanchez JI, 2016, INTERVIROLOGY, V59, P8, DOI 10.1159/000446282; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004; Cui L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006217; Cui L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004607; Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673; Hackett BA, 2018, P NATL ACAD SCI USA, V115, P4246, DOI 10.1073/pnas.1720032115; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hinata M, 2018, PAIN, V159, P939, DOI 10.1097/j.pain.0000000000001169; Jeewandara C, 2017, IMMUN INFLAMM DIS, V5, P7, DOI 10.1002/iid3.135; Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003459; KARARA A, 1991, J BIOL CHEM, V266, P7561; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Lee HC, 2012, MOL BIOL CELL, V23, P4689, DOI 10.1091/mbc.E12-09-0673; Liebscher S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007029; Luukkonen PK, 2016, J HEPATOL, V65, P1263, DOI 10.1016/j.jhep.2016.07.045; Mancina RM, 2016, GASTROENTEROLOGY, V150, P1219, DOI 10.1053/j.gastro.2016.01.032; Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005; Martin-Acebes MA, 2016, J LIPID RES, V57, P422, DOI 10.1194/jlr.M064212; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Mueller M, 2005, J IMMUNOL, V174, P1091, DOI 10.4049/jimmunol.174.2.1091; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Nobori H, 2018, ANTIVIR RES, V155, P60, DOI 10.1016/j.antiviral.2018.05.003; Numata M, 2015, J LIPID RES, V56, P578, DOI 10.1194/jlr.M055723; Numata M, 2013, J LIPID RES, V54, P2133, DOI 10.1194/jlr.M037077; Numata M, 2012, AM J RESP CELL MOL, V46, P479, DOI 10.1165/rcmb.2011-0194OC; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Pan American Health Organization, 2017, TOOL DIAGN CAR PAT S; Parker LC, 2008, J IMMUNOL, V181, P5606, DOI 10.4049/jimmunol.181.8.5606; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Pogany J, 2015, J VIROL, V89, P5714, DOI 10.1128/JVI.03711-14; Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Reichel M, 2015, BBA-MOL CELL BIOL L, V1851, P1501, DOI 10.1016/j.bbalip.2015.08.005; Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Sakamoto H, 2017, BIOCHEM BIOPH RES CO, V482, P202, DOI 10.1016/j.bbrc.2016.11.041; Saksono B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123981; Sanaki T., 2015, MOD CHEM APPL, V3; Sanaki T, 2017, J OLEO SCI, V66, P591, DOI 10.5650/jos.ess16227; Sanaki T, 2016, RAPID COMMUN MASS SP, V30, P751, DOI 10.1002/rcm.7504; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10; Stokes CA, 2016, MUCOSAL IMMUNOL, V9, P1303, DOI 10.1038/mi.2015.137; Suwarto S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205965; Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14; Thorley AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021827; Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013; Voge NV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004449; Wang KZ, 2016, INT J BIOL SCI, V12, P872, DOI 10.7150/ijbs.15641; Wang PY, 1998, J BIOL CHEM, V273, P24309, DOI 10.1074/jbc.273.38.24309; WHO, 2009, WHO TECH REP SER, V958, P1; World Health Organization, 2016, DENGUE GUIDELINES PA; Zhang JT, 2016, P NATL ACAD SCI USA, V113, pE1064, DOI 10.1073/pnas.1519730113; Zhang R, 2018, NATURE, V557, P570, DOI 10.1038/s41586-018-0121-3	70	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13866	13881		10.1096/fj.201901095RR	http://dx.doi.org/10.1096/fj.201901095RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31638831	Bronze			2022-12-28	WOS:000507466100063
J	Tu, LF; Cao, LF; Zhang, YH; Guo, YL; Zhou, YF; Lu, WQ; Zhang, TZ; Zhang, T; Zhang, GX; Kurihara, H; Li, YF; He, RR				Tu, Long-Fang; Cao, Ling-Fang; Zhang, Yue-Hong; Guo, Yu-Lin; Zhou, Yang-Fan; Lu, Wei-Qi; Zhang, Tian-Ze; Zhang, Tao; Zhang, Gao-Xiao; Kurihara, Hiroshi; Li, Yi-Fang; He, Rong-Rong			Sirt3-dependent deacetylation of COX-1 counteracts oxidative stress-induced cell apoptosis	FASEB JOURNAL			English	Article						cytochrome c oxidase; ROS; mitochondria	CYTOCHROME-C-OXIDASE; MITOCHONDRIAL DEACETYLASE; SUBUNIT-I; SIRT3; ISCHEMIA/REPERFUSION; PHOSPHORYLATION; METABOLISM; STABILITY; DISEASES; NEURONS	The mitochondrial complexes are prone to sirtuin (Sirt)3-mediated deacetylation modification, which may determine cellular response to stimuli, such as oxidative stress. In this study, we show that the cytochrome c oxidase (COX)-1, a core catalytic subunit of mitochondrial complex IV, was acetylated and deactivated both in 2,2'-azobis(2-amidinopropane) dihydrochloride-treated NIH/3T3 cells and hydrogen peroxide-treated primary neuronal cells, correlating with apoptotic cell death induction by oxidative stress. Inhibition of Sirt3 by small interfering RNA or the inhibitor nicotinamide induced accumulation of acetylation of COX-1, reduced mitochondrial membrane potential, and increased cell apoptosis. In contrast, overexpression of Sirt3 enhanced deacetylation of COX-1 and inhibited oxidative stress-induced apoptotic cell death. Significantly, rats treated with ischemia/reperfusion injury, a typical oxidative stress-related disease, presented an inhibition of Sirt3-induced hyperacetylation of COX-1 in the brain tissues. Furthermore, K13, K264, K319, and K481 were identified as the acetylation sits of COX-1 in response to oxidative stress. In conclusion, COX-1 was discovered as a new deacetylation target of Sirt3, indicating that the Sirt3/COX-1 axis is a promising therapy target of stress-related diseases.	[Tu, Long-Fang; Cao, Ling-Fang; Zhang, Yue-Hong; Guo, Yu-Lin; Zhou, Yang-Fan; Lu, Wei-Qi; Zhang, Tian-Ze; Kurihara, Hiroshi; Li, Yi-Fang; He, Rong-Rong] Jinan Univ, Coll Pharm, Guangdong Engn Res Ctr Chinese Med & Dis Suscepti, 601 Huangpu Ave West, Guangzhou 510632, Peoples R China; [Tu, Long-Fang; Cao, Ling-Fang; Zhang, Yue-Hong; Guo, Yu-Lin; Zhou, Yang-Fan; Lu, Wei-Qi; Zhang, Tian-Ze; Kurihara, Hiroshi; Li, Yi-Fang; He, Rong-Rong] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Peoples R China; [Tu, Long-Fang; Cao, Ling-Fang; Zhang, Yue-Hong; Guo, Yu-Lin; Zhou, Yang-Fan; Lu, Wei-Qi; Zhang, Tian-Ze; Kurihara, Hiroshi; Li, Yi-Fang; He, Rong-Rong] Jinan Univ, Coll Pharm, Int Cooperat Lab Tradit Chinese Med Modernizat &, Chinese Minist Educ MOE, Guangzhou, Peoples R China; [Zhang, Tao; Zhang, Gao-Xiao] Jinan Univ, Coll Pharm, Inst New Drug Res, Guangzhou, Peoples R China; [Zhang, Tao; Zhang, Gao-Xiao] Jinan Univ, Coll Pharm, Guangzhou Key Lab Innovat Chem Drug Res Cardiocer, Guangzhou, Peoples R China; [Li, Yi-Fang] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China	Jinan University; Jinan University; Jinan University; Jinan University; Jinan University; University of Hong Kong	Li, YF; He, RR (corresponding author), Jinan Univ, Coll Pharm, Guangdong Engn Res Ctr Chinese Med & Dis Suscepti, 601 Huangpu Ave West, Guangzhou 510632, Peoples R China.	liyifang706@jnu.edu.cn; rongronghe66@163.com	ZHANG, Tianze/GXN-4011-2022		National Key Research and Development Program of China [2017YFC1700404]; Natural Science Foundation of China [81622050, 81573675, U1801284, 81673709, 81873209]; Guangdong Science and Technology Foundation for Distinguished Young Scholars [2017A030306004]; Youth Top-Notch Talent Support Program of Guangdong Province [2016TQ03R586]; Hong Kong Scholars Program [XJ2016017]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01Y036]; GDUPS; Science and Technology Program of Guangzhou [201903010062]; College Students' Innovation and Entrepreneurship Competition of China [201710559030]	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Foundation for Distinguished Young Scholars; Youth Top-Notch Talent Support Program of Guangdong Province; Hong Kong Scholars Program; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program; GDUPS; Science and Technology Program of Guangzhou; College Students' Innovation and Entrepreneurship Competition of China	The authors thank Dr. Yan Cheng (Pennsylvania State University College of Medicine, Hershey, PA, USA) for providing the Flag-Sirt3 plasmid, and Dr. You-Wei Zhang (Case Western Reserve University, Cleveland, OH, USA) for data discussions and revision of the manuscript. This work was partially supported by the National Key Research and Development Program of China (Grant 2017YFC1700404), the Natural Science Foundation of China (Grants 81622050, 81573675, U1801284, 81673709, and 81873209), the Guangdong Science and Technology Foundation for Distinguished Young Scholars (2017A030306004), the Youth Top-Notch Talent Support Program of Guangdong Province (2016TQ03R586), the Hong Kong Scholars Program (XJ2016017), the Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (Grant 2017BT01Y036) and GDUPS (2019), the Science and Technology Program of Guangzhou (Grant 201903010062), and the College Students' Innovation and Entrepreneurship Competition of China (201710559030). The authors declare no conflicts of interest.	Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ansari A, 2017, AGING CELL, V16, P4, DOI 10.1111/acel.12538; Bansal S, 2012, J BIOL CHEM, V287, P15284, DOI 10.1074/jbc.M111.314062; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Chen YW, 2013, ECON POLIT STUD-EPS, V1, P3, DOI 10.1080/20954816.2013.11673857; Cheng AW, 2016, CELL METAB, V23, P128, DOI 10.1016/j.cmet.2015.10.013; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Duan WJ, 2016, FREE RADICAL BIO MED, V95, P230, DOI 10.1016/j.freeradbiomed.2016.03.022; Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Guan YJ, 2012, STROKE, V43, P888, DOI 10.1161/STROKEAHA.111.636456; He RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057732; Helling S, 2012, PROTEOMICS, V12, P950, DOI 10.1002/pmic.201100618; Hersey P, 2001, NAT REV CANCER, V1, P142, DOI 10.1038/35101078; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Jiang YQ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8519169; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Li L, 2016, LIFE SCI, V157, P97, DOI 10.1016/j.lfs.2016.05.032; Lu Y, 2016, INT J CARDIOL, V220, P700, DOI 10.1016/j.ijcard.2016.06.236; McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001; Okonko DO, 2015, NAT REV CARDIOL, V12, P6, DOI 10.1038/nrcardio.2014.189; Perrelli MG, 2011, WORLD J CARDIOL, V3, P186, DOI 10.4330/wjc.v3.i6.186; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Salvatori I, 2017, NEUROCHEM INT, V109, P184, DOI 10.1016/j.neuint.2017.04.012; Schull S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.62; Sun YW, 2012, J NEUROSCI RES, V90, P1662, DOI 10.1002/jnr.23034; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Wu CG, 2009, AM J PHYSIOL-CELL PH, V297, pC928, DOI 10.1152/ajpcell.00045.2009; Yang X, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00943; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	39	9	9	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14118	14128		10.1096/fj.201900708R	http://dx.doi.org/10.1096/fj.201900708R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31647884	Bronze			2022-12-28	WOS:000507466100081
J	Chen, ZH; Yang, LK; Chen, L; Li, J; Zhang, FT; Xing, YF; Zhao, J				Chen, Zhaohui; Yang, Likun; Chen, Liang; Li, Jin; Zhang, Futian; Xing, Yifei; Zhao, Jun			miR-190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma	FASEB JOURNAL			English	Article						bladder cancer; micro-RNA; NLRC3 expression; Wnt; beta-catenin and mTOR signaling	MTOR; FAMILY	Bladder cancer is one of the most common urogenital malignancies. However, its pathogenesis, especially molecular mechanisms remain elusive. Thus, understanding the molecular mechanisms underlying bladder cancer is important for the discovery of novel therapeutic paradigms for these diseases. In current study, we found that micro-RNA (miR)-190b is highly expressed in bladder cancer tissues and cells. Overexpression of miR-190b enhanced the proliferation, growth, migration and invasion capabilities, and angiogenesis of bladder cancer cells, whereas downregulation of miR-190b reversed these effects. Target prediction and dual luciferase reporter assays identified NLR family CARD domain containing 3 (NLRC3) as a potential target of miR-190b. Pathway analysis indicated that miR-190b promotes bladder cancer progression via the Wnt/beta-catenin and mTOR signaling pathways. Taken together, our findings imply that miR-190b acts as a critical regulator for bladder cancer development by repressing NLRC3 and partly through the Wnt/beta-catenin and mTOR pathways. Our study suggests that miR-190b may be served as a potential therapeutic target for bladder cancer treatment.	[Chen, Zhaohui; Yang, Likun; Chen, Liang; Zhang, Futian; Xing, Yifei; Zhao, Jun] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Li, Jin] Nanchang Univ, Affiliated Hosp 2, Dept Urol, Nanchang, Jiangxi, Peoples R China	Huazhong University of Science & Technology; Nanchang University	Xing, YF; Zhao, J (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	yifei_xing@163.com; zhaojun19621231@126.com						Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Guo LT, 2017, INT J MOL MED, V40, P898, DOI 10.3892/ijmm.2017.3077; Hu B, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0573-9; Hu SF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007266; Karki R, 2017, CELL CYCLE, V16, P1243, DOI 10.1080/15384101.2017.1317414; Karki R, 2016, NATURE, V540, P583, DOI 10.1038/nature20597; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leavy O, 2017, NAT REV IMMUNOL, V17, P79, DOI 10.1038/nri.2016.152; Liu JY, 2018, ONCOGENE, V37, P3937, DOI 10.1038/s41388-018-0223-2; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tartey S, 2019, IMMUNOLOGY, V156, P329, DOI 10.1111/imm.13046; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Wang Q, 2019, CANCER LETT, V444, P9, DOI 10.1016/j.canlet.2018.11.024; Woolbright BL, 2018, UROL ONCOL-SEMIN ORI, V36, P327, DOI 10.1016/j.urolonc.2018.04.010; Zha LH, 2019, J CELL PHYSIOL, V234, P15963, DOI 10.1002/jcp.28255	18	8	9	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4072	4084		10.1096/fj.201901764R	http://dx.doi.org/10.1096/fj.201901764R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31953872	Bronze			2022-12-28	WOS:000519218400043
J	Zheng, WW; Ding, BB; Li, XL; Liu, DQ; Yokota, H; Zhang, P				Zheng, Weiwei; Ding, Beibei; Li, Xinle; Liu, Daquan; Yokota, Hiroki; Zhang, Ping			Knee loading repairs osteoporotic osteoarthritis by relieving abnormal remodeling of subchondral bone via Wnt/beta-catenin signaling	FASEB JOURNAL			English	Article						knee loading; osteoblast; osteoclast; osteoporotic osteoarthritis; Wnt signaling	FEMORAL-HEAD; CARTILAGE; HISTOPATHOLOGY; PATHOGENESIS; EXPRESSION; MODEL	Osteoporotic osteoarthritis (OPOA) is a common bone disease mostly in the elderly, but the relationship between Osteoporotic (OP) and osteoarthritis (OA) is complex. It has been shown that knee loading can mitigate OA symptoms. However, its effects on OPOA remain unclear. In this study, we characterized pathological linkage of OP to OA, and evaluated the effect of knee loading on OPOA. We employed two mouse models (OA and OPOA), and conducted histology, cytology, and molecular analyses. In the OA and OPOA groups, articular cartilage was degenerated and Osteoarthritis Research Society International score was increased. Subchondral bone underwent abnormal remodeling, the differentiation of bone marrow mesenchymal stem cells (BMSCs) to osteoblasts and chondrocytes was reduced, and migration and adhesion of pre-osteoclasts were enhanced. Compared to the OA group, the pathological changes of OA in the OPOA group were considerably aggravated. After knee loading, however, cartilage degradation was effectively prevented, and the abnormal remodeling of subchondral bone was significantly inhibited. The differentiation of BMSCs was also improved, and the expression of Wnt/beta-catenin was elevated. Collectively, this study demonstrates that osteoporosis aggravates OA symptoms. Knee loading restores OPOA by regulating subchondral bone remodeling, and may provide an effective method for repairing OPOA.	[Zheng, Weiwei; Ding, Beibei; Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Key Lab Hormones & Dev, Tianjin Key Lab Metab Dis, Minist Hlth, Tianjin, Peoples R China; [Yokota, Hiroki; Zhang, Ping] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Spine & Spinal Cord, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Indiana University System; Indiana University-Purdue University Indianapolis; Tianjin Medical University	Zhang, P (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	pizhang@tmu.edu.cn			NIAMS NIH HHS [R01 AR052144] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Bultink IEM, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0328-0; Castaneda S, 2006, SKELETAL RADIOL, V35, P34, DOI 10.1007/s00256-005-0022-z; Compston JE, 2019, LANCET, V393, P364, DOI 10.1016/S0140-6736(18)32112-3; Dequeker J, 2003, AGING CLIN EXP RES, V15, P426, DOI 10.1007/BF03327364; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Hamamura K, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-312; Herrero-Beaumont G, 2013, NAT REV RHEUMATOL, V9, P448, DOI 10.1038/nrrheum.2013.113; Holopainen JT, 2008, BONE, V43, P1108, DOI 10.1016/j.bone.2008.07.254; Iijima H, 2016, OSTEOARTHR CARTILAGE, V24, P354, DOI 10.1016/j.joca.2015.09.001; Im GI, 2014, J BONE MINER METAB, V32, P101, DOI 10.1007/s00774-013-0531-0; Javaheri B, 2014, J BONE MINER RES, V29, P705, DOI 10.1002/jbmr.2064; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kodric K, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0294-3; Lara-Castillo N, 2015, BONE, V76, P58, DOI 10.1016/j.bone.2015.03.019; Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368; Li CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18541-1; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Li XH, 2013, INT J MOL MED, V31, P1349, DOI 10.3892/ijmm.2013.1341; Li XL, 2019, FASEB J, V33, P8913, DOI 10.1096/fj.201802711R; Li XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24668; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Loeser RF, 2016, NAT REV RHEUMATOL, V12, P412, DOI 10.1038/nrrheum.2016.65; Lotinun S, 2019, J CLIN INVEST, V129, P3058, DOI 10.1172/JCI122936; Lv HC, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0530-5; Moskowitz RW, 2006, OSTEOARTHR CARTILAGE, V14, P1, DOI 10.1016/j.joca.2005.08.015; Mussazhanova Z, 2016, ENDOCR J, V63, P457, DOI 10.1507/endocrj.EJ15-0629; Neogi T, 2010, ANN RHEUM DIS, V69, P841, DOI 10.1136/ard.2009.110114; Park OJ, 2019, J BONE MINER RES, V34, P975, DOI 10.1002/jbmr.3706; Roman-Blas JA, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0494-0; Sharma R, 2013, HUM MOL GENET, V22, P4818, DOI 10.1093/hmg/ddt333; Shuai B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132104; Tan N, 2018, HEPATOL RES, V48, P839, DOI 10.1111/hepr.13076; Wang CJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4601; Wang HL, 2014, SHOCK, V41, P324, DOI 10.1097/SHK.0000000000000122; Wu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024917; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249; Yang S, 2019, FASEB J, V33, P10742, DOI 10.1096/fj.201900306RR; Yokota H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-197; Zhang P, 2007, BONE, V40, P538, DOI 10.1016/j.bone.2006.09.018; Zhang P, 2012, J BONE MINER METAB, V30, P31, DOI 10.1007/s00774-011-0292-6; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020; Zhang P, 2009, BONE, V44, P989, DOI 10.1016/j.bone.2009.01.367; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zheng WW, 2019, FASEB J, V33, P4077, DOI 10.1096/fj.201801851R; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109	49	13	16	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3399	3412		10.1096/fj.201902117R	http://dx.doi.org/10.1096/fj.201902117R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31925860	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000514663600099
J	Vilades, D; Martinez-Camblor, P; Ferrero-Gregori, A; Bar, C; Lu, DC; Xiao, K; Vea, A; Nasarre, L; Vega, JS; Leta, R; Carreras, F; Thum, T; Llorente-Cortes, V; de Gonzalo-Calvo, D				Vilades, David; Martinez-Camblor, Pablo; Ferrero-Gregori, Andreu; Baer, Christian; Lu, Dongchao; Xiao, Ke; Vea, Angela; Nasarre, Laura; Sanchez Vega, Jesus; Leta, Ruben; Carreras, Francesc; Thum, Thomas; Llorente-Cortes, Vicenta; de Gonzalo-Calvo, David		EU CardioRNA COST Action	Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker	FASEB JOURNAL			English	Article						atherosclerosis; biomarker; chronic coronary syndrome; circular RNA; circSMARCA5; coronary artery disease; coronary heart disease; hsa_circ_0001445; ischemic heart disease; SMARCA5; stability	MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; CT ANGIOGRAPHY; MICRORNA; PREDICTION; ATHEROSCLEROSIS; EXPRESSION; ABUNDANT	The role of circular RNAs (circRNAs) as biomarkers remains poorly characterized. Here, we investigated the performance of the circRNA hsa_circ_0001445 as a biomarker of coronary artery disease (CAD) in a real-world clinical practice setting. Plasma hsa_circ_0001445 was measured in a study population of 200 consecutive patients with suspected stable CAD who had undergone coronary computed tomographic angiography (CTA). Multivariable logistic models were constructed combining conventional risk factors with established biomarkers and hsa_circ_0001445. Model robustness was internally validated by the bootstrap technique. Biomarker accuracy was evaluated using the C-index. The integrated discrimination improvement (IDI) and net reclassification improvement (NRI) were also calculated. Risk groups were developed via classification tree models. The stability of plasma hsa_circ_0001445 was evaluated under different clinical conditions. hsa_circ_0001445 levels were associated with higher coronary atherosclerosis extent and severity with a 2-fold increase across tertiles (28.4%-50.0%). Levels of hsa_circ_0001445 were proportional to coronary atherosclerotic burden, even after comprehensive adjustment for cardiovascular risk factors, medications, and established biomarkers (fully adjusted OR = 0.432 for hsa_circ_0001445 as a continuous variable and fully adjusted OR = 0.277 for hsa_circ_0001445 as a binary variable). The classification of patients was improved with the incorporation of hsa_circ_0001445 into a base clinical model (CM) composed of conventional cardiovascular risk factors, showing an IDI of 0.047 and NRI of 0.482 for hsa_circ_0001445 as a continuous variable and an IDI of 0.056 and NRI of 0.373 for hsa_circ_0001445 as a binary variable. A trend toward higher discrimination capacity was also observed (C-index(CM) = 0.833, C-index(CM+continuous hsa_circ_0001445) = 0.856 and C-index(CM+binary hsa_circ_0001445) = 0.855). Detailed analysis of stability showed that hsa_circ_0001445 was present in plasma in a remarkably stable form. In vitro, hsa_circ_0001445 was downregulated in extracellular vesicles secreted by human coronary smooth muscle cells upon exposure to atherogenic conditions. In patients with suspected stable CAD referred for coronary CTA, plasma hsa_circ_0001445 improves the identification of coronary artery atherosclerosis.	[Vilades, David; Sanchez Vega, Jesus; Leta, Ruben; Carreras, Francesc] UAB, Hosp Santa Creu & St Pau, Cardiol Serv, Cardiac Imaging Unit, Barcelona, Spain; [Martinez-Camblor, Pablo] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Ferrero-Gregori, Andreu] UAB, Hosp Santa Creu & St Pau, Cardiol Serv, Barcelona, Spain; [Ferrero-Gregori, Andreu; Carreras, Francesc; Llorente-Cortes, Vicenta; de Gonzalo-Calvo, David] Inst Hlth Carlos III, CIBER Cardiovasc CIBERCV, Madrid, Spain; [Baer, Christian; Lu, Dongchao; Xiao, Ke; Thum, Thomas; de Gonzalo-Calvo, David] Hannover Med Sch, IMTTS, Hannover, Germany; [Baer, Christian; Thum, Thomas] Hannover Med Sch, REBIRTH Ctr Translat Regenerat Med, Hannover, Germany; [Vea, Angela; Nasarre, Laura; Carreras, Francesc; Llorente-Cortes, Vicenta; de Gonzalo-Calvo, David] Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain; [Llorente-Cortes, Vicenta; de Gonzalo-Calvo, David] CSIC, Spanish Natl Res Council, Inst Biomed Res Barcelona IIBB, Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Dartmouth College; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hannover Medical School; Hannover Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB)	Llorente-Cortes, V; de Gonzalo-Calvo, D (corresponding author), Hosp Santa Creu & Sant Pau, CSIC, Spanish Natl Res Council, Inst Biomed Res Barcelona IIBB, C St Antoni Maria Claret 167, Barcelona 08025, Spain.	cllorente@santpau.cat; david.degonzalo@gmail.com	Bär, Christian/AAC-5914-2019; LU, Dongchao/AAN-6150-2020; de Gonzalo-Calvo, David/F-6108-2018	de Gonzalo-Calvo, David/0000-0003-2240-3532; LU, Dongchao/0000-0002-8578-3790; Vea Badenes, Angela/0000-0001-7856-6635; Bar, Christian/0000-0001-9276-9383; Carreras, Francesc/0000-0002-1944-0562	Ministry of Science Innovation and Universities [IJCI-2016-29393]; Carlos III Health Institute [CB16/11/00403, CB16/11/00276, FIS PI18/01584]; European Fund for Regional Development (EFRD); Deutsche Forschungsgemeinschaft [SFB/Transregio TRR267]; European Research Commission Consolidator Grant LONGHEART	Ministry of Science Innovation and Universities; Carlos III Health Institute(Instituto de Salud Carlos III); European Fund for Regional Development (EFRD)(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Commission Consolidator Grant LONGHEART	DdG-C was a recipient of a Juan de la Cierva-Incorporacion grant from the Ministry of Science Innovation and Universities (IJCI-2016-29393). CIBER Cardiovascular (CB16/11/00403 to VLl-C and DdG-C and CB16/11/00276 to AFG) are projects from Carlos III Health Institute. This work was supported by FIS PI18/01584 (to VLl-C) grant from Carlos III Health Institute, cofinanced by the European Fund for Regional Development (EFRD). This work was supported by Deutsche Forschungsgemeinschaft (SFB/Transregio TRR267, to CB and TT) and European Research Commission Consolidator Grant LONGHEART to TT.	Adamson PD, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.004227; Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; Ayoub C, 2017, J CARDIOVASC COMPUT, V11, P258, DOI 10.1016/j.jcct.2017.05.001; Cury RC, 2014, J CARDIOVASC COMPUT, V8, P480, DOI 10.1016/j.jcct.2014.10.002; de Gonzalo-Calvo D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060780; de Gonzalo-Calvo D, 2019, J INTERN MED, V286, P341, DOI 10.1111/joim.12921; de Gonzalo-Calvo D, 2019, EUR HEART J, V40, P1643, DOI 10.1093/eurheartj/ehy234; de Gonzalo-Calvo D, 2017, J MOL CELL CARDIOL, V106, P55, DOI 10.1016/j.yjmcc.2017.03.005; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devaux Y, 2017, EUR J HEART FAIL, V19, P701, DOI 10.1002/ejhf.801; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Egeland GM, 2019, J INTERN MED, V286, P562, DOI 10.1111/joim.12948; Enuka Y, 2016, NUCLEIC ACIDS RES, V44, P1370, DOI 10.1093/nar/gkv1367; Gnanenthiran SR, 2019, EUR HEART J-CARD IMG, V20, P1279, DOI 10.1093/ehjci/jez067; Gupta SK, 2018, CIRC RES, V122, P246, DOI 10.1161/CIRCRESAHA.117.311335; Hagstrom E, 2018, J INTERN MED, V283, P83, DOI 10.1111/joim.12692; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Holdt LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12429; Inouye M, 2018, J AM COLL CARDIOL, V72, P1883, DOI 10.1016/j.jacc.2018.07.079; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kass GV, 1980, J R STAT SOC C-APPL, P119; Khan MAF, 2016, CIRC RES, V119, P996, DOI 10.1161/CIRCRESAHA.116.309568; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liu MJ, 2019, ARTERIOSCL THROM VAS, V39, P1715, DOI 10.1161/ATVBAHA.119.312131; Maass PG, 2017, J MOL MED, V95, P1179, DOI 10.1007/s00109-017-1582-9; McCarthy CP, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007975; McCarthy CP, 2018, AM HEART J, V196, P82, DOI 10.1016/j.ahj.2017.10.016; Memczak S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141214; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Park KC, 2017, CARDIOVASC RES, V113, P1708, DOI 10.1093/cvr/cvx183; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Santer L, 2019, MOL THER, V27, P1350, DOI 10.1016/j.ymthe.2019.07.001; Schulte C, 2019, CIRC RES, V125, P328, DOI 10.1161/CIRCRESAHA.119.314937; Stocker TJ, 2018, EUR HEART J, V39, P3715, DOI 10.1093/eurheartj/ehy546; Tan WLW, 2017, CARDIOVASC RES, V113, P298, DOI 10.1093/cvr/cvw250; Tesche C, 2016, J CARDIOVASC COMPUT, V10, P458, DOI 10.1016/j.jcct.2016.08.003; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Umekage S., 2012, INNOVATIONS BIOTECHN, P75; Vausort M, 2016, J AM COLL CARDIOL, V68, P1247, DOI 10.1016/j.jacc.2016.06.040; Vea A, 2018, NONCODING RNA INVEST, V2, P1; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang LY, 2019, ATHEROSCLEROSIS, V286, P88, DOI 10.1016/j.atherosclerosis.2019.05.006; Warburton DER, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020274; Werfel S, 2016, J MOL CELL CARDIOL, V98, P103, DOI 10.1016/j.yjmcc.2016.07.007; Wong LL, 2019, J AM COLL CARDIOL, V73, P1300, DOI 10.1016/j.jacc.2018.11.060; Zhao ZZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39918	51	60	61	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4403	4414		10.1096/fj.201902507R	http://dx.doi.org/10.1096/fj.201902507R		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31999007	Green Submitted			2022-12-28	WOS:000510165300001
J	Liu, YY; Lei, P; Row, S; Andreadis, ST				Liu, Yayu; Lei, Pedro; Row, Sindhu; Andreadis, Stelios T.			Cadherin-11 binds to PDGFR beta and enhances cell proliferation and tissue regeneration via the PDGFR-AKT signaling axis	FASEB JOURNAL			English	Article						AKT signaling; Cadherin-11; knockout mice; PDGF receptor; proliferation; wound healing	SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; RECEPTOR; EXPRESSION; ADHESION; IDENTIFICATION; ACTIVATION; MIGRATION; SURVIVAL; CANCER	Intercellular adhesion through homotypic interaction between cadherins regulates multiple cellular processes including cytoskeletal organization, proliferation, and survival. In this paper, we provide evidence that cadherin-11 (CDH11) binds to and promotes cell proliferation both in vitro and in vivo in synergy with the platelet-derived growth factor receptor beta (PDGFR beta). Engagement of CDH11 increased the sensitivity of cells to PDGF-BB by 10- to 100-fold, resulting in rapid and sustained phosphorylation of AKT, ultimately promoting and cell proliferation and tissue regeneration. Indeed, wound healing experiments showed that healing was severely compromised in Cdh11(-/-) mice, as evidenced by significantly decreased proliferation, AKT phosphorylation, and extracellular matrix (ECM) synthesis of dermal cells. Our results shed light into understanding how intercellular adhesion can promote cell proliferation and may have implications for tissue regeneration and cancer progression.	[Liu, Yayu; Andreadis, Stelios T.] Univ Buffalo State Univ New York, Dept Biomed Engn, Amherst, NY 14260 USA; [Lei, Pedro; Row, Sindhu; Andreadis, Stelios T.] Univ Buffalo State Univ New York, Dept Chem & Biol Engn, Amherst, NY 14260 USA; [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY USA		Andreadis, ST (corresponding author), Univ Buffalo State Univ New York, Bioengn Lab, Dept Chem & Biol Engn, 908 Furnas Hall, Amherst, NY 14260 USA.	sandread@buffalo.edu	liu, yayu/AAX-3849-2021		National Science Foundation (NSF) [CBET1403086]	National Science Foundation (NSF)(National Science Foundation (NSF))	National Science Foundation (NSF), Grant/Award Number: CBET1403086	Alimperti S, 2014, J CELL SCI, V127, P2627, DOI 10.1242/jcs.134833; Assefnia S, 2014, ONCOTARGET, V5, P1458, DOI 10.18632/oncotarget.1538; Blaue C, 2018, SEMIN CELL DEV BIOL, V73, P95, DOI 10.1016/j.semcdb.2017.08.058; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Cheung LWT, 2011, ONCOGENE, V30, P2964, DOI 10.1038/onc.2011.7; Coon BG, 2015, J CELL BIOL, V208, P975, DOI 10.1083/jcb.201408103; ERIKSSON A, 1991, J BIOL CHEM, V266, P21138; Fedor-Chaiken M, 2003, CELL COMMUN ADHES, V10, P105, DOI 10.1080/714040416; Feltes CM, 2002, CANCER RES, V62, P6688; Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HOFFMANN I, 1995, DEV BIOL, V169, P337, DOI 10.1006/dbio.1995.1148; Kaur H, 2012, MOL CANCER RES, V10, P293, DOI 10.1158/1541-7786.MCR-11-0457; KIMURA Y, 1995, DEV BIOL, V169, P347, DOI 10.1006/dbio.1995.1149; Langhe RP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10909; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee J, 2002, IN VITRO MUTAGENESIS, V182; Li L, 2012, ONCOGENE, V31, P3901, DOI 10.1038/onc.2011.541; Mathavan K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188963; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; Nakajima Go, 2008, Cancer Genomics & Proteomics, V5, P37; Pedroza M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187109; Pohlodek K, 2016, ONCOL LETT, V12, P4393, DOI 10.3892/ol.2016.5236; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Row S, 2016, J CELL SCI, V129, P2950, DOI 10.1242/jcs.183772; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Takeichi M, 1994, Prog Clin Biol Res, V390, P145; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wu MH, 2014, ARTHRITIS RHEUMATOL, V66, P1010, DOI 10.1002/art.38275; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	34	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3792	3804		10.1096/fj.201902613R	http://dx.doi.org/10.1096/fj.201902613R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930567	Bronze			2022-12-28	WOS:000508012100001
J	Vorstandlechner, V; Laggner, M; Kalinina, P; Haslik, W; Radtke, C; Shaw, L; Lichtenberger, BM; Tschachler, E; Ankersmit, HJ; Mildner, M				Vorstandlechner, Vera; Laggner, Maria; Kalinina, Polina; Haslik, Werner; Radtke, Christine; Shaw, Lisa; Lichtenberger, Beate Maria; Tschachler, Erwin; Ankersmit, Hendrik Jan; Mildner, Michael			Deciphering the functional heterogeneity of skin fibroblasts using single-cell RNA sequencing	FASEB JOURNAL			English	Article						CD26; DPP4; extracellular matrix; fibrosis; transcriptome	DIPEPTIDYL-PEPTIDASE-IV; RETICULAR FIBROBLASTS; GENE-EXPRESSION; 4 INHIBITOR; PAPILLARY; FIBROSIS; DISTINCT; MARKERS; LEPTIN; DIFFERENTIATION	Though skin fibroblasts (FB) are the main cell population within the dermis, the different skin FB subsets are not well characterized and the traditional classification into reticular and papillary FBs has little functional relevance. To fill the gap of knowledge on FB diversity in human skin, we performed single-cell RNA sequencing. Investigation of marker genes for the different skin cell subtypes revealed a heterogeneous picture of FBs. When mapping reticular and papillary FB markers, we could not detect cluster specificity, suggesting that these two populations show a higher transcriptional heterogeneity than expected. This finding was further confirmed by in situ hybridization, showing that DPP4 was expressed in both dermal layers. Our analysis identified six FB clusters with distinct transcriptional signatures. Importantly, we could demonstrate that in human skin DPP4(+) FBs are the main producers of factors involved in extracellular matrix (ECM) assembly. In conclusion, we provide evidence that hitherto considered FB markers are not ideal to characterize skin FB subpopulations in single-cell sequencing analyses. The identification of DPP4(+) FBs as the main ECM-producing cells in human skin will foster the development of anti-fibrotic treatments for the skin and other organs.	[Vorstandlechner, Vera; Laggner, Maria; Ankersmit, Hendrik Jan] Med Univ Vienna, Div Thorac Surg, Vienna, Austria; [Kalinina, Polina; Tschachler, Erwin; Mildner, Michael] Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Lazarettgasse 14, A-1090 Vienna, Austria; [Haslik, Werner; Radtke, Christine] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Vienna, Austria; [Shaw, Lisa] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Lichtenberger, Beate Maria] Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Mildner, M (corresponding author), Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Lazarettgasse 14, A-1090 Vienna, Austria.	michael.mildner@mixluniwien.ac.at	Lichtenberger, Beate M./AAD-1717-2019; Radtke, Christine/B-8491-2018	Lichtenberger, Beate M./0000-0001-6882-0257; Radtke, Christine/0000-0001-6877-5038; Mildner, Michael/0000-0002-6892-925X; Shaw, Lisa/0000-0003-2273-7655; Haslik, Werner/0000-0002-2731-2720; Vorstandlechner, Vera/0000-0002-5938-1552	Osterreichische Forschungsforderungsgesellschaft (FFG) [852748/862068]; Wirtschaftsagentur Wien [2343727]; OAD Sparcling Science [SPA06/055]	Osterreichische Forschungsforderungsgesellschaft (FFG); Wirtschaftsagentur Wien; OAD Sparcling Science	Osterreichische Forschungsforderungsgesellschaft (FFG), Grant/Award Number: 852748/862068; Wirtschaftsagentur Wien, Grant/Award Number: 2343727; OAD Sparcling Science, Grant/Award Number: SPA06/055	Aroor AR, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0544-4; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; CASTOR CW, 1962, LAB INVEST, V11, P703; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; D'souza AM, 2017, MOL METAB, V6, P1052, DOI 10.1016/j.molmet.2017.04.011; Driskell RR, 2015, TRENDS CELL BIOL, V25, P92, DOI 10.1016/j.tcb.2014.10.001; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Freytag Saskia, 2018, F1000Res, V7, P1297, DOI 10.12688/f1000research.15809.2; Gerhard GS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219764; Gschwandtner M, 2017, ALLERGY, V72, P85, DOI 10.1111/all.12919; Gschwandtner M, 2013, ALLERGY, V68, P37, DOI 10.1111/all.12051; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Haydont V, 2019, MECH AGEING DEV, V179, P60, DOI 10.1016/j.mad.2019.01.003; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Heinosalo T, 2018, HUM REPROD, V33, P817, DOI 10.1093/humrep/dey026; Hiraoka C, 2016, J DERMATOL SCI, V82, P84, DOI 10.1016/j.jdermsci.2016.01.009; Hong SK, 2017, METABOLISM, V76, P42, DOI 10.1016/j.metabol.2017.07.007; Hu MS, 2016, PLAST RECONSTR SURG, V138, P1026, DOI 10.1097/PRS.0000000000002634; Janson D, 2013, EXP DERMATOL, V22, P48, DOI 10.1111/exd.12069; Janson DG, 2012, J INVEST DERMATOL, V132, P2565, DOI 10.1038/jid.2012.192; Kaji K, 2014, J GASTROENTEROL, V49, P481, DOI 10.1007/s00535-013-0783-4; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Klemann C, 2016, CLIN EXP IMMUNOL, V185, P1, DOI 10.1111/cei.12781; Klinkhammer BM, 2018, MOL ASPECTS MED, V62, P44, DOI 10.1016/j.mam.2017.11.008; Korosec A, 2019, J INVEST DERMATOL, V139, P342, DOI 10.1016/j.jid.2018.07.033; Li J, 2019, EBIOMEDICINE, V40, P43, DOI 10.1016/j.ebiom.2019.01.009; Lotia S, 2013, BIOINFORMATICS, V29, P1350, DOI 10.1093/bioinformatics/btt138; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maier AB, 2009, AGEING RES REV, V8, P237, DOI 10.1016/j.arr.2009.01.004; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; Nauroy P, 2017, J INVEST DERMATOL, V137, P1787, DOI 10.1016/j.jid.2017.03.028; Novelli M, 1996, BRIT J DERMATOL, V134, P1052, DOI 10.1046/j.1365-2133.1996.d01-900.x; Ong CT, 2010, BRIT J DERMATOL, V162, P1302, DOI 10.1111/j.1365-2133.2010.09660.x; Pageon H, 2012, EUR J DERMATOL, V22, P324, DOI 10.1684/ejd.2012.1693; Pantano S, 2013, J MOL HISTOL, V44, P733, DOI 10.1007/s10735-013-9524-5; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Philippeos C, 2018, J INVEST DERMATOL, V138, P811, DOI 10.1016/j.jid.2018.01.016; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Ring BD, 2000, ENDOCRINOLOGY, V141, P446, DOI 10.1210/en.141.1.446; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Rosenbloom J, 2017, METHODS MOL BIOL, V1627, P1, DOI 10.1007/978-1-4939-7113-8_1; SCHAFER IA, 1985, MECH AGEING DEV, V31, P275, DOI 10.1016/0047-6374(85)90095-8; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Sriram G, 2015, EUR J CELL BIOL, V94, P483, DOI 10.1016/j.ejcb.2015.08.001; STUART T, 2018, COMPREHENSIVE INTEGR; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; Suzuki T, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0660-4; Tabib T, 2018, J INVEST DERMATOL, V138, P802, DOI 10.1016/j.jid.2017.09.045; Thielitz A, 2008, FRONT BIOSCI-LANDMRK, V13, P2864, DOI 10.2741/2850; Thielitz A, 2008, J INVEST DERMATOL, V128, P855, DOI 10.1038/sj.jid.5701104; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Uchida T, 2017, RENAL FAILURE, V39, P340, DOI 10.1080/0886022X.2017.1279553; Van den Oord JJ, 1998, BRIT J DERMATOL, V138, P615; van Lingen RG, 2008, BRIT J DERMATOL, V158, P1264, DOI 10.1111/j.1365-2133.2008.08515.x; Wada N, 2014, J CHEM NEUROANAT, V61-62, P191, DOI 10.1016/j.jchemneu.2014.09.002; Walmsley GG, 2015, TISSUE ENG PART C-ME, V21, P314, DOI [10.1089/ten.tec.2014.0118, 10.1089/ten.TEC.2014.0118]; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wu J, 2004, J TRAUMA, V57, P1276, DOI 10.1097/01.TA.0000108997.49513.DC; Xiao L, 2015, JOVE-J VIS EXP, DOI 10.3791/53072	65	61	62	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3677	3692		10.1096/fj.201902001RR	http://dx.doi.org/10.1096/fj.201902001RR		JAN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930613	hybrid			2022-12-28	WOS:000507261000001
J	Endo, M; Tanaka, Y; Otsuka, M; Minami, Y				Endo, Mitsuharu; Tanaka, Yuki; Otsuka, Mako; Minami, Yasuhiro			E2F1-Ror2 signaling mediates coordinated transcriptional regulation to promote G1/S phase transition in bFGF-stimulated NIH/3T3 fibroblasts	FASEB JOURNAL			English	Article						basic fibroblast growth factor (bFGF); cell cycle; cell signaling; Forkhead box O (FoxO); gene transcription	RECEPTOR TYROSINE KINASE; PLANAR CELL POLARITY; RETINOBLASTOMA PROTEIN; OSTEOSARCOMA CELLS; ROR2; EXPRESSION; MIGRATION; PROLIFERATION; PATHWAY; TARGET	Ror2 signaling has been shown to regulate the cell cycle progression in normal and cancer cells. However, the molecular mechanism of the cell cycle progression upon activation of Ror2 signaling still remains unknown. Here, we found that the expression levels of Ror2 in G1-arrested NIH/3T3 fibroblasts are low and are rapidly increased following the cell cycle progression induced by basic fibroblast growth factor (bFGF) stimulation. By expressing wild-type or a dominant negative mutant of E2F1, we show that E2F1 mediates bFGF-induced expression of Ror2, and that E2F1 binds to the promoter of the Ror2 gene to activate its expression. We also found that G1/S phase transition of bFGF-stimulated NIH/3T3 cells is delayed by the suppressed expression of Ror2. RNA-seq analysis revealed that the suppressed expression of Ror2 results in the decreased expression of various E2F target genes concomitantly with increased expression of Forkhead box O (FoxO) target genes, including p21(Cip1), and p27(Kip1). Moreover, the inhibitory effect of Ror2 knockdown on the cell cycle progression can be restored by suppressed expression of p21(Cip1), p27(Kip1),or FoxO3a. Collectively, these findings indicate that E2F1-Ror2 signaling mediates the transcriptional activation and inhibition of E2F1-driven and FoxO3a-driven cell cycle-regulated genes, respectively, thereby promoting G1/S phase transition of bFGF-stimulated NIH/3T3 cells.	[Endo, Mitsuharu; Tanaka, Yuki; Otsuka, Mako; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Div Cell Physiol, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan	Kobe University	Endo, M; Minami, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Cell Physiol, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan.	mendo@med.kobe-u.ac.jp; minami@kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [18K06486, 16H05152]; Japan Agency for Medical Research and Development (AMED) [JP19gm5010001, JP19gm1210005]; Hyogo Science and Technology association	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Hyogo Science and Technology association	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18K06486 and 16H05152; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm5010001 and JP19gm1210005; Hyogo Science and Technology association	Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Fernandez NB, 2016, MOL CARCINOGEN, V55, P1772, DOI 10.1002/mc.22426; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carrero I, 2019, ONCOGENE, V38, P3551, DOI 10.1038/s41388-018-0659-4; Chavali M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02440-0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Dai B, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0482-y; Endo M, 2017, GLIA, V65, P182, DOI 10.1002/glia.23086; Endo M, 2015, INT REV CEL MOL BIO, V314, P117, DOI 10.1016/bs.ircmb.2014.10.003; Endo M, 2012, J CELL SCI, V125, P2017, DOI 10.1242/jcs.097782; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Frenquelli M, 2020, LEUKEMIA, V34, P257, DOI 10.1038/s41375-019-0486-9; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Huang JJ, 2015, ONCOL LETT, V10, P3705, DOI 10.3892/ol.2015.3797; Ishizuya-Oka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107611; Kamizaki K, 2017, J BIOL CHEM, V292, P15939, DOI 10.1074/jbc.M117.785709; KATO J, 1993, GENE DEV, V7, P331; Laine A, 2014, CLIN CANCER RES, V20, P3644, DOI 10.1158/1078-0432.CCR-13-1942; Laird DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002428; Liu YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127092; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nishita M, 2014, MOL CELL BIOL, V34, P3096, DOI 10.1128/MCB.00491-14; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Siu WY, 1999, FEBS LETT, V461, P299, DOI 10.1016/S0014-5793(99)01481-7; Taguchi A, 2014, PROTEOMICS, V14, P2750, DOI 10.1002/pmic.201400378; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Xu Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317701627; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Zhang HS, 2019, ELIFE, V8, DOI 10.7554/eLife.45303; Zhang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046853	49	12	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3413	3428		10.1096/fj.201902849R	http://dx.doi.org/10.1096/fj.201902849R		JAN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31922321	Bronze			2022-12-28	WOS:000506611700001
J	Haldar, B; Hamilton, CL; Solodushko, V; Abney, KA; Alexeyev, M; Honkanen, RE; Scammell, JG; Cioffi, DL				Haldar, Barnita; Hamilton, Caleb L.; Solodushko, Viktoriya; Abney, Kevin A.; Alexeyev, Mikhail; Honkanen, Richard E.; Scammell, Jonathan G.; Cioffi, Donna L.			S100A6 is a positive regulator of PPP5C-FKBP51-dependent regulation of endothelial calcium signaling	FASEB JOURNAL			English	Article						calcium entry; endothelial I-SOC; endothelial barrier	CELL-CYCLE PROGRESSION; PROTEIN PHOSPHATASE 5; I-SOC; FUNCTIONAL EXPRESSION; TAU; MEMBRANE; CHANNEL; ENTRY; ACTIVATION; BINDING	I-SOC is a cation current permeating the ISOC channel. In pulmonary endothelial cells, I-SOC activation leads to formation of inter-endothelial cell gaps and barrier disruption. The immunophilin FK506-binding protein 51 (FKBP51), in conjunction with the serine/threonine protein phosphatase 5C (PPP5C), inhibits I-SOC. Free PPP5C assumes an autoinhibitory state, which has low "basal" catalytic activity. Several S100 protein family members bind PPP5C increasing PPP5C catalytic activity in vitro. One of these family members, S100A6, exhibits a calcium-dependent translocation to the plasma membrane. The goal of this study was to determine whether S100A6 activates PPP5C in pulmonary endothelial cells and contributes to I-SOC inhibition by the PPP5C-FKBP51 axis. We observed that S100A6 activates PPP5C to dephosphorylate tau T231. Following I-SOC activation, cytosolic S100A6 translocates to the plasma membrane and interacts with the TRPC4 subunit of the ISOC channel. Global calcium entry and I-SOC are decreased by S100A6 in a PPP5C-dependent manner and by FKBP51 in a S100A6-dependent manner. Further, calcium entry-induced endothelial barrier disruption is decreased by S100A6 dependent upon PPP5C, and by FKBP51 dependent upon S100A6. Overall, these data reveal that S100A6 plays a key role in the PPP5C-FKBP51 axis to inhibit I-SOC and protect the endothelial barrier against calcium entry-induced disruption.	[Haldar, Barnita; Solodushko, Viktoriya; Abney, Kevin A.; Honkanen, Richard E.; Cioffi, Donna L.] Univ S Alabama, Dept Biochem & Mol Biol, 5851 USA Dr N,MSB 2316, Mobile, AL 36688 USA; [Haldar, Barnita; Alexeyev, Mikhail; Cioffi, Donna L.] Univ S Alabama, Ctr Lung Biol, 5851 USA Dr N,MSB 2316, Mobile, AL 36688 USA; [Hamilton, Caleb L.] Alabama Coll Osteopath Med, Dept Anat & Mol Med, Dothan, AL USA; [Alexeyev, Mikhail] Univ S Alabama, Physiol & Cell Biol, Mobile, AL 36688 USA; [Scammell, Jonathan G.] Univ S Alabama, Comparat Med, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Cioffi, DL (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, 5851 USA Dr N,MSB 2316, Mobile, AL 36688 USA.; Cioffi, DL (corresponding author), Univ S Alabama, Ctr Lung Biol, 5851 USA Dr N,MSB 2316, Mobile, AL 36688 USA.	dlcioffi@southalabama.edu			National Institutes of Health [R01HL107778, R56HL107778]; University of South Alabama, College of Medicine Intramural Grant Programs [000927, 000540]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Alabama, College of Medicine Intramural Grant Programs	This work was supported by the National Institutes of Health (R01HL107778 to DLC; R56HL107778 to DLC) and the University of South Alabama, College of Medicine Intramural Grant Programs (000927 to DLC; 000540 to BH)	Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Bao LY, 2012, FEBS J, V279, P4576, DOI 10.1111/febs.12044; Bischoff I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23671; Brough GH, 2001, FASEB J, V15, P1727, DOI 10.1096/fj.01-0108com; Chatterjee A, 2010, J BIOL CHEM, V285, P3872, DOI 10.1074/jbc.M109.088427; Chazotte B, 2011, COLD SPRING HARB PRO, V2011; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Cioffi DL, 2012, CIRC RES, V110, P1435, DOI 10.1161/CIRCRESAHA.112.269506; Cioffi DL, 2012, AM J PHYSIOL-LUNG C, V302, pL1067, DOI 10.1152/ajplung.00190.2011; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cortajarena AL, 2006, PROTEIN SCI, V15, P1193, DOI 10.1110/ps.062092506; Courtois-Coutry N, 2002, J BIOL CHEM, V277, P25728, DOI 10.1074/jbc.M112435200; Creighton JR, 2003, AM J PHYSIOL-LUNG C, V284, pL100, DOI 10.1152/ajplung.00083.2002; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Gong CX, 2004, J NEUROCHEM, V88, P298, DOI 10.1046/j.1471-4159.2003.02147.x; Hamilton CL, 2018, PULM CIRC, V8, DOI 10.1177/2045893217753156; Hamilton CL, 2018, PULM CIRC, V8, DOI 10.1177/2045893217749987; Hermann A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00067; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Kadeba PI, 2013, CELL CALCIUM, V53, P275, DOI 10.1016/j.ceca.2012.12.008; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Lerchenmuller C, 2016, ARTERIOSCL THROM VAS, V36, P1854, DOI 10.1161/ATVBAHA.115.306415; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Mandinova A, 1998, J CELL SCI, V111, P2043; Moore TM, 2000, AM J PHYSIOL-LUNG C, V279, pL691, DOI 10.1152/ajplung.2000.279.4.L691; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL574, DOI 10.1152/ajplung.1998.275.3.L574; Morrow KA, 2016, AM J PHYSIOL-LUNG C, V310, P1337, DOI 10.1152/ajplung.00103.2015; Mueller A, 1999, HISTOCHEM CELL BIOL, V111, P453, DOI 10.1007/s004180050381; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; Shimamoto S, 2008, J BIOL CHEM, V283, P28246, DOI 10.1074/jbc.M801473200; Shimamoto S, 2010, FEBS LETT, V584, P1119, DOI 10.1016/j.febslet.2010.02.055; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Sinclair C, 1999, J BIOL CHEM, V274, P23666, DOI 10.1074/jbc.274.33.23666; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Stradal TB, 1999, J BIOL CHEM, V274, P31593, DOI 10.1074/jbc.274.44.31593; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; Wu SW, 2007, J BIOL CHEM, V282, P34801, DOI 10.1074/jbc.M704522200; Wu SW, 2005, CIRC RES, V96, P856, DOI 10.1161/01.RES.0000163632.67282.1f; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; Xia C, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01908; Yamaguchi F, 2012, J BIOL CHEM, V287, P13787, DOI 10.1074/jbc.M111.329771; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	54	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3179	3196		10.1096/fj.201901777R	http://dx.doi.org/10.1096/fj.201901777R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916625	Green Accepted			2022-12-28	WOS:000506443400001
J	Bhedi, CD; Nasirova, S; Toksoz, D; Warburton, RR; Morine, KJ; Kapur, NK; Galper, JB; Preston, IR; Hill, NS; Fanburg, BL; Penumatsa, KC				Bhedi, Chinmayee D.; Nasirova, Sabina; Toksoz, Deniz; Warburton, Rod R.; Morine, Kevin J.; Kapur, Navin K.; Galper, Jonas B.; Preston, Ioana R.; Hill, Nicholas S.; Fanburg, Barry L.; Penumatsa, Krishna C.			Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling	FASEB JOURNAL			English	Article						glycolysis; hyperglycemia; PKM2; TG2; tissue fibrosis	PYRUVATE-KINASE M2; TISSUE TRANSGLUTAMINASE; HEART-FAILURE; PULMONARY-HYPERTENSION; FIBROBLAST ACTIVATION; GLUCOSE-METABOLISM; INHIBITION; CELLS; DYSFUNCTION; MECHANISMS	The pathophysiology of pulmonary hypertension (PH) and heart failure (HF) includes fibrogenic remodeling associated with the loss of pulmonary arterial (PA) and cardiac compliance. We and others have previously identified transglutaminase 2 (TG2) as a participant in adverse fibrogenic remodeling. However, little is known about the biologic mechanisms that regulate TG2 function. We examined physiological mouse models of experimental PH, HF, and type 1 diabetes that are associated with altered glucose metabolism/glycolysis and report here that TG2 expression and activity are elevated in pulmonary and cardiac tissues under all these conditions. We additionally used PA adventitial fibroblasts to test the hypothesis that TG2 is an intermediary between enhanced tissue glycolysis and fibrogenesis. Our in vitro results show that glycolytic enzymes and TG2 are upregulated in fibroblasts exposed to high glucose, which stimulates cellular glycolysis as measured by Seahorse analysis. We examined the relationship of TG2 to a terminal glycolytic enzyme, pyruvate kinase M2 (PKM2), and found that PKM2 regulates glucose-induced TG2 expression and activity as well as fibrogenesis. Our studies further show that TG2 inhibition blocks glucose-induced fibrogenesis and cell proliferation. Our findings support a novel role for glycolysis-mediated TG2 induction and tissue fibrosis associated with experimental PH, HF, and hyperglycemia.	[Bhedi, Chinmayee D.; Nasirova, Sabina; Toksoz, Deniz; Warburton, Rod R.; Preston, Ioana R.; Hill, Nicholas S.; Fanburg, Barry L.; Penumatsa, Krishna C.] Tufts Med Ctr, Dept Med, Div Pulm, Boston, MA 02111 USA; [Morine, Kevin J.; Kapur, Navin K.; Galper, Jonas B.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA	Tufts Medical Center; Tufts Medical Center	Penumatsa, KC (corresponding author), Tufts Med Ctr, Dept Med, Pulm Crit Care & Sleep Div, 800 Washington St,Box 257, Boston, MA 02111 USA.	kpenumatsa@tuftsmedicalcenter.org			Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension; American Heart Association [18CDA34140005]; National Institutes of Health [HL107713, HL074876]	Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by research funding from Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension (KCP), an American Heart Association Career Development Award 18CDA34140005 (KCP) and the National Institutes of Health HL107713 (BLF) and HL074876 (JBG)	Al-Naamani N, 2015, JACC-HEART FAIL, V3, P467, DOI 10.1016/j.jchf.2015.01.013; Altuntas S, 2015, ONCOTARGET, V6, P44941, DOI 10.18632/oncotarget.6759; Archer SL, 2013, PULM CIRC, V3, P144, DOI 10.4103/2045-8932.109960; Baandrup JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015859; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Boroughs LK, 2014, J BIOL CHEM, V289, P10115, DOI 10.1074/jbc.M113.464693; Chen YJ, 2012, HYPERTENSION, V59, P1170, DOI 10.1161/HYPERTENSIONAHA.111.186072; Cho SJ, 2017, AM J RESP CELL MOL, V56, P521, DOI 10.1165/rcmb.2016-0225OC; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; Ding H, 2017, AM J PHYSIOL-RENAL, V313, pF561, DOI 10.1152/ajprenal.00036.2017; DiRaimondo TR, 2014, ACS CHEM BIOL, V9, P266, DOI 10.1021/cb4006408; Dong GC, 2016, ONCOL LETT, V11, P1980, DOI 10.3892/ol.2016.4168; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Isoe T, 2010, KIDNEY INT, V78, P48, DOI 10.1038/ki.2010.99; Jeon HY, 2019, LIFE SCI, V233, DOI 10.1016/j.lfs.2019.116711; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Kapur N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070434; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Kumar S, 2014, INT J CANCER, V134, P2798, DOI 10.1002/ijc.28623; Lai YC, 2019, J PHYSIOL-LONDON, V597, P1143, DOI 10.1113/JP275858; Lee J, 2015, CLIN CANCER RES, V21, P4482, DOI 10.1158/1078-0432.CCR-15-0226; LEE SL, 1987, CIRC RES, V60, P653, DOI 10.1161/01.RES.60.5.653; Lee ZW, 2003, BIOCHEM BIOPH RES CO, V305, P633, DOI 10.1016/S0006-291X(03)00835-0; Liu CY, 2017, CANCER RES, V77, P4734, DOI 10.1158/0008-5472.CAN-16-3535; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; Nave AH, 2014, ARTERIOSCL THROM VAS, V34, P1446, DOI 10.1161/ATVBAHA.114.303534; Oh YJ, 2017, AMINO ACIDS, V49, P695, DOI 10.1007/s00726-016-2295-z; Oh Young S, 2018, Clin Hypertens, V24, P17, DOI 10.1186/s40885-018-0102-8; Paulin R, 2014, CIRC RES, V115, P148, DOI 10.1161/CIRCRESAHA.115.301130; Penumatsa KC, 2014, AM J PHYSIOL-LUNG C, V306, pL309, DOI 10.1152/ajplung.00321.2013; Penumatsa KC, 2017, AM J PHYSIOL-LUNG C, V313, pL752, DOI 10.1152/ajplung.00170.2017; Penumatsa KC, 2014, AM J PHYSIOL-LUNG C, V307, pL576, DOI 10.1152/ajplung.00162.2014; Rain S, 2013, CIRCULATION, V128, P2016, DOI 10.1161/CIRCULATIONAHA.113.001873; Rossin F, 2015, CELL DEATH DIFFER, V22, P408, DOI 10.1038/cdd.2014.106; Sankaralingam S, 2015, PULM CIRC, V5, P15, DOI 10.1086/679608; Schafer M, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-015-0609-2; Shimoda L. A., 1985, J APPL PHYSIOL, V116, P867, DOI DOI 10.1152/JAPPLPHYSIOL.00643.2013.; Shinde AV, 2018, J MOL CELL CARDIOL, V117, P36, DOI 10.1016/j.yjmcc.2018.02.016; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Stenmark KR, 2015, J APPL PHYSIOL, V119, P1164, DOI 10.1152/japplphysiol.00283.2015; Steppan J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000599; SUTO N, 1993, J BIOL CHEM, V268, P7469; Thenappan T, 2018, AM J PHYSIOL-HEART C, V315, pH1322, DOI 10.1152/ajpheart.00136.2018; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Wang ZJ, 2017, J APPL PHYSIOL, V122, P253, DOI 10.1152/japplphysiol.00325.2016; Wang Z, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0573-2; Wei L, 2012, AM J PHYSIOL-LUNG C, V302, pL1273, DOI 10.1152/ajplung.00082.2012; Wei QQ, 2019, AM J PHYSIOL-RENAL, V316, pF1162, DOI 10.1152/ajprenal.00422.2018; Weisbrod RM, 2013, HYPERTENSION, V62, P1105, DOI 10.1161/HYPERTENSIONAHA.113.01744; Xie N, 2015, AM J RESP CRIT CARE; Xiong PY, 2019, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00195; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Zhang H, 2017, CIRCULATION, V136, P2468, DOI 10.1161/CIRCULATIONAHA.117.028069; Zhang YL, 2014, DIABETES, V63, P2097, DOI 10.2337/db12-1459	62	12	12	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					930	944		10.1096/fj.201902155R	http://dx.doi.org/10.1096/fj.201902155R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914588	Green Accepted			2022-12-28	WOS:000507308900063
J	Canet, G; Pineau, F; Zussy, C; Hernandez, C; Hunt, H; Chevallier, N; Perrier, V; Torrent, J; Belanoff, JK; Meijer, OC; Desrumaux, C; Givalois, L				Canet, Geoffrey; Pineau, Fanny; Zussy, Charleine; Hernandez, Celia; Hunt, Hazel; Chevallier, Nathalie; Perrier, Veronique; Torrent, Joan; Belanoff, Joseph K.; Meijer, Onno C.; Desrumaux, Catherine; Givalois, Laurent			Glucocorticoid receptors signaling impairment potentiates amyloid-beta oligomers-induced pathology in an acute model of Alzheimer's disease	FASEB JOURNAL			English	Article						Cdk5; GSK-3 beta; PDK1; ROCK; selective GR modulator	TAU PHOSPHORYLATION; RHO-KINASE; IN-VIVO; HIPPOCAMPAL-NEURONS; PREFRONTAL CORTEX; MOUSE MODEL; PROTEIN; INHIBITION; STRESS; ACTIVATION	Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis occurs early in Alzheimer's disease (AD), associated with elevated circulating glucocorticoids (GC) and glucocorticoid receptors (GR) signaling impairment. However, the precise role of GR in the pathophysiology of AD remains unclear. Using an acute model of AD induced by the intracerebroventricular injection of amyloid-beta oligomers (oA beta), we analyzed cellular and behavioral hallmarks of AD, GR signaling pathways, processing of amyloid precursor protein, and enzymes involved in Tau phosphorylation. We focused on the prefrontal cortex (PFC), particularly rich in GR, early altered in AD and involved in HPA axis control and cognitive functions. We found that oA beta impaired cognitive and emotional behaviors, increased plasma GC levels, synaptic deficits, apoptosis and neuroinflammatory processes. Moreover, oA beta potentiated the amyloidogenic pathway and enzymes involved both in Tau hyperphosphorylation and GR activation. Treatment with a selective GR modulator (sGRm) normalized plasma GC levels and all behavioral and biochemical parameters analyzed. GR seems to occupy a central position in the pathophysiology of AD. Deregulation of the HPA axis and a feed-forward effect on PFC GR sensitivity could participate in the etiology of AD, in perturbing A beta and Tau homeostasis. These results also reinforce the therapeutic potential of sGRm in AD.	[Canet, Geoffrey; Pineau, Fanny; Zussy, Charleine; Hernandez, Celia; Chevallier, Nathalie; Perrier, Veronique; Torrent, Joan; Desrumaux, Catherine; Givalois, Laurent] INSERM, U1198, Mol Mech Neurodegenerat Dementia MMDN Lab, Team Environm Impact Alzheimers Dis & Related Dis, Pl E Bataillon, F-34095 Montpellier, France; [Canet, Geoffrey; Pineau, Fanny; Zussy, Charleine; Hernandez, Celia; Chevallier, Nathalie; Perrier, Veronique; Torrent, Joan; Desrumaux, Catherine; Givalois, Laurent] Univ Montpellier, Montpellier, France; [Canet, Geoffrey; Pineau, Fanny; Zussy, Charleine; Hernandez, Celia; Chevallier, Nathalie; Perrier, Veronique; Torrent, Joan; Desrumaux, Catherine; Givalois, Laurent] EPHE, Paris, France; [Hunt, Hazel; Belanoff, Joseph K.] Corcept Therapeut, Menlo Pk, CA USA; [Meijer, Onno C.] Leiden Univ, Div Endocrinol, Dept Med, Einthoven Lab,Med Ctr, Leiden, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Givalois, L (corresponding author), INSERM, U1198, Mol Mech Neurodegenerat Dementia MMDN Lab, Team Environm Impact Alzheimers Dis & Related Dis, Pl E Bataillon, F-34095 Montpellier, France.	laurent.givalois@umontpellier.fr	Perrier, Veronique/AAK-3594-2020; Desrumaux, Catherine/O-1925-2018	Givalois, Laurent/0000-0002-6698-5346; CANET, Geoffrey/0000-0001-7291-4512	Association France Alzheimer (French Alzheimer's Association) [1512]; Agence Nationale de la Recherche (ANR) [ANR-11-LABEX-0021-LipSTIC]; Corcept Therapeutics (Menlo Park, CA, USA); University of Montpellier, France; University of Montpellier, France, CBS2 PhD program	Association France Alzheimer (French Alzheimer's Association); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Corcept Therapeutics (Menlo Park, CA, USA); University of Montpellier, France; University of Montpellier, France, CBS2 PhD program	Association France Alzheimer (French Alzheimer's Association), Grant/Award Number: SM2016#1512 -LG; Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-11-LABEX-0021-LipSTIC - CD; Corcept Therapeutics (Menlo Park, CA, USA), Grant/Award Number: Exceptional subvention - LG; University of Montpellier, France, Grant/Award Number: CBS2 PhD program - GC; University of Montpellier, France, Grant/Award Number: CBS2 PhD program - CH	Alleaume-Butaux A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005073; Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779; Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Baglietto-Vargas D, 2013, BIOL PSYCHIAT, V74, P357, DOI 10.1016/j.biopsych.2012.12.003; Beaudry JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091248; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Brureau A, 2013, NEUROBIOL AGING, V34, P1426, DOI 10.1016/j.neurobiolaging.2012.11.015; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Chen YM, 2014, J NEUROSCI, V34, P2464, DOI 10.1523/JNEUROSCI.0151-13.2014; Choi GE, 2017, J NEUROSCI, V37, P8459, DOI 10.1523/JNEUROSCI.0074-17.2017; Clark RD, 2008, BIOORG MED CHEM LETT, V18, P1312, DOI 10.1016/j.bmcl.2008.01.027; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Deng J, 2015, J NEUROCHEM, V135, P630, DOI 10.1111/jnc.13351; Dey A, 2017, NEUROBIOL AGING, V57, P75, DOI 10.1016/j.neurobiolaging.2017.05.010; DIORIO D, 1993, J NEUROSCI, V13, P3839; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Castro-Alvarez JF, 2011, BEHAV NEUROSCI, V125, P465, DOI 10.1037/a0023167; Fung J, 2004, J NEUROCHEM, V91, P1398, DOI 10.1111/j.1471-4159.2004.02828.x; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Garcia-Rojo G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00483; Gentry EG, 2016, J NEUROSCI, V36, P1316, DOI 10.1523/JNEUROSCI.2336-15.2016; Gray JD, 2017, NAT REV ENDOCRINOL, V13, P661, DOI 10.1038/nrendo.2017.97; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Groeneweg FL, 2012, MOL CELL ENDOCRINOL, V350, P299, DOI 10.1016/j.mce.2011.06.020; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Hamano T, 2012, NEUROBIOL AGING, V33, P2306, DOI 10.1016/j.neurobiolaging.2011.10.020; Hartmann A, 1997, NEUROBIOL AGING, V18, P285, DOI 10.1016/S0197-4580(97)80309-0; Henderson BW, 2016, J NEUROCHEM, V138, P525, DOI 10.1111/jnc.13688; Herskowitz JH, 2013, J NEUROSCI, V33, P19086, DOI 10.1523/JNEUROSCI.2508-13.2013; Ho GJ, 2005, NEUROBIOL AGING, V26, P625, DOI 10.1016/j.neurobiolaging.2004.06.016; Hoogendijk WJG, 2006, NEUROBIOL AGING, V27, DOI 10.1016/j.neurobiolaging.2005.07.017; Hu YB, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00253; Huang GX, 2017, CANCER LETT, V410, P1, DOI 10.1016/j.canlet.2017.09.005; Hunt HJ, 2015, BIOORG MED CHEM LETT, V25, P5720, DOI 10.1016/j.bmcl.2015.10.097; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Jin NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep08187; Jozic I, 2017, J INVEST DERMATOL, V137, P1144, DOI 10.1016/j.jid.2016.11.036; Kaneko I, 2001, NEUROSCIENCE, V104, P1003, DOI 10.1016/S0306-4522(01)00155-5; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kubo T, 2002, J NEUROSCI RES, V70, P474, DOI 10.1002/jnr.10391; Kurbatskaya K, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0299-2; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Lahiri DK, 2004, ANN NY ACAD SCI, V1030, P282, DOI 10.1196/annals.1329.035; Lai AY, 2018, J NEUROCHEM, V144, P659, DOI 10.1111/jnc.14130; Lante F, 2015, NEUROPSYCHOPHARMACOL, V40, P1772, DOI 10.1038/npp.2015.25; LAPING NJ, 1994, ENDOCRINOLOGY, V135, P1928, DOI 10.1210/en.135.5.1928; Le Menuet D, 2014, STEROIDS, V91, P11, DOI 10.1016/j.steroids.2014.05.018; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Lesuis SL, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0101-2; Li XH, 2007, CHIN MED J, V120, P66974; Lin DW, 2012, BEHAV BRAIN RES, V228, P319, DOI 10.1016/j.bbr.2011.12.010; Liu DZ, 2014, J NEUROTRAUM, V31, P1268, DOI 10.1089/neu.2013.3250; Liu D, 2014, CELL PHYSIOL BIOCHEM, V33, P1654, DOI 10.1159/000362948; Loirand G, 2015, PHARMACOL REV, V67, P1074, DOI 10.1124/pr.115.010595; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; LV Z, 2016, J DIABETES RES, V2016; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Meijer OC, 2018, ANN ENDOCRINOL-PARIS, V79, P107, DOI 10.1016/j.ando.2018.03.004; Meunier J, 2013, EUR J PHARMACOL, V698, P193, DOI 10.1016/j.ejphar.2012.10.033; Meyer M, 2018, NEUROSCIENCE, V384, P384, DOI 10.1016/j.neuroscience.2018.05.042; Naert G, 2015, EUR NEUROPSYCHOPHARM, V25, P2170, DOI 10.1016/j.euroneuro.2015.03.018; Notarianni E, 2013, CURR ALZHEIMER RES, V10, P714, DOI 10.2174/15672050113109990137; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pietri M, 2013, NAT MED, V19, P1124, DOI 10.1038/nm.3302; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pineau F, 2016, NEUROBIOL AGING, V45, P109, DOI 10.1016/j.neurobiolaging.2016.05.018; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Rothman SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.005; Rubenstein NM, 2007, BIOCHEM BIOPH RES CO, V354, P603, DOI 10.1016/j.bbrc.2007.01.024; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Scales TME, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-12; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Solomon MB, 2014, HORM BEHAV, V65, P363, DOI 10.1016/j.yhbeh.2014.02.002; Sullivan RM, 2002, PSYCHONEUROENDOCRINO, V27, P99, DOI 10.1016/S0306-4530(01)00038-5; Sun LH, 2015, J NEUROCHEM, V134, P1139, DOI 10.1111/jnc.13212; Swanger S.A., 2015, CELLULAR LOGISTICS, V5, DOI 10.1080/21592799.2015.1133266; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Yamada K, 2000, PHARMACOL THERAPEUT, V88, P93, DOI 10.1016/S0163-7258(00)00081-4; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zalachoras I, 2013, P NATL ACAD SCI USA, V110, P7910, DOI 10.1073/pnas.1219411110; Zussy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053117; Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021	95	11	12	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1150	1168		10.1096/fj.201900723RRR	http://dx.doi.org/10.1096/fj.201900723RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914623	Green Submitted			2022-12-28	WOS:000507308900078
J	Dickman, CTD; Russo, V; Thain, K; Pan, S; Beyer, ST; Walus, K; Getsios, S; Mohamed, T; Wadsworth, SJ				Dickman, Christopher T. D.; Russo, Valerio; Thain, Katherine; Pan, Sheng; Beyer, Simon T.; Walus, Konrad; Getsios, Spiro; Mohamed, Tamer; Wadsworth, Sam J.			Functional characterization of 3D contractile smooth muscle tissues generated using a unique microfluidic 3D bioprinting technology	FASEB JOURNAL			English	Article						3D bioprinting; airway; decellularized extracellular matrix; intestine; microfluidic; smooth muscle; tissue engineering; tissue remodeling	CUT LUNG SLICES; EXTRACELLULAR-MATRIX; AIRWAY-OBSTRUCTION; CELLS; BETA; HYPERRESPONSIVENESS; SALBUTAMOL; CONSTRUCTS; HISTAMINE; MICE	Conditions such as asthma and inflammatory bowel disease are characterized by aberrant smooth muscle contraction. It has proven difficult to develop human cell-based models that mimic acute muscle contraction in 2D in vitro cultures due to the nonphysiological chemical and mechanical properties of lab plastics that do not allow for muscle cell contraction. To enhance the relevance of in vitro models for human disease, we describe how functional 3D smooth muscle tissue that exhibits physiological and pharmacologically relevant acute contraction and relaxation responses can be reproducibly fabricated using a unique microfluidic 3D bioprinting technology. Primary human airway and intestinal smooth muscle cells were printed into rings of muscle tissue at high density and viability. Printed tissues contracted to physiological concentrations of histamine (0.01-100 mu M) and relaxed to salbutamol, a pharmacological compound used to relieve asthmatic exacerbations. The addition of TGF beta to airway muscle rings induced an increase in unstimulated muscle shortening and a decreased response to salbutamol, a phenomenon which also occurs in chronic lung diseases. Results indicate that the 3D bioprinted smooth muscle is a physiologically relevant in vitro model that can be utilized to study disease pathways and the effects of novel therapeutics on acute contraction and chronic tissue stenosis.	[Dickman, Christopher T. D.; Russo, Valerio; Thain, Katherine; Pan, Sheng; Beyer, Simon T.; Walus, Konrad; Getsios, Spiro; Mohamed, Tamer; Wadsworth, Sam J.] Aspect Biosyst Ltd, 1781 West 75th Ave, Vancouver, BC V6P 6P2, Canada; [Walus, Konrad] Univ British Columbia, Dept Elect & Comp Engn, Fac Engn, Vancouver, BC, Canada	University of British Columbia	Wadsworth, SJ (corresponding author), Aspect Biosyst Ltd, 1781 West 75th Ave, Vancouver, BC V6P 6P2, Canada.	info@aspectbiosystems.com			Industrial Research Assistance Program of the National Research Council Canada [891779]	Industrial Research Assistance Program of the National Research Council Canada	This work was supported by the Industrial Research Assistance Program of the National Research Council Canada (Grant #891779)	An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Backman KS, 1997, CHEST, V112, P1234, DOI 10.1378/chest.112.5.1234; Biopta, 2018, ASS BRONCH TERT LOW; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BROWN RH, 1994, AM J RESP CRIT CARE, V150, P233, DOI 10.1164/ajrccm.150.1.8025755; Choi YJ, 2016, ADV HEALTHC MATER, V5, P2636, DOI 10.1002/adhm.201600483; Costantini M, 2017, BIOMATERIALS, V131, P98, DOI 10.1016/j.biomaterials.2017.03.026; Coutts A, 2001, AM J PHYSIOL-LUNG C, V280, pL999, DOI 10.1152/ajplung.2001.280.5.L999; Doeing DC, 2013, J APPL PHYSIOL, V114, P834, DOI 10.1152/japplphysiol.00950.2012; Fey SJ, 2012, TOXICOL SCI, V127, P403, DOI 10.1093/toxsci/kfs122; Finkbeiner SR, 2015, BIOL OPEN, V4, P1462, DOI 10.1242/bio.013235; Goldsmith AM, 2006, AM J RESP CELL MOL, V34, P247, DOI 10.1165/rcmb.2005-0166OC; Henjakovic M, 2008, TOXICOL SCI, V106, P444, DOI 10.1093/toxsci/kfn178; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ihida-Stansbury K, 2015, PULM CIRC, V5, P382, DOI 10.1086/681272; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Kim JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29968-5; Kitamura N, 2008, INT ARCH ALLERGY IMM, V146, P36, DOI 10.1159/000126059; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; LEMOINE H, 1992, LUNG, V170, P163; Lin CC, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-187; LIPWORTH BJ, 1989, EUR J CLIN PHARMACOL, V37, P567; Maiullari F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31848-x; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; Messner S, 2013, ARCH TOXICOL, V87, P209, DOI 10.1007/s00204-012-0968-2; Mitzner W, 2004, AM J RESP CRIT CARE, V169, P787, DOI 10.1164/rccm.200312-1636PP; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; Nassimi Matthias, 2009, Inhal Toxicol, V21 Suppl 1, P104, DOI 10.1080/08958370903005769; Neuhaus V, 2017, J OCCUP MED TOXICOL, V12, DOI 10.1186/s12995-017-0158-5; Palmans E, 2000, AM J RESP CRIT CARE, V161, P627, DOI 10.1164/ajrccm.161.2.9902094; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Rego SL, 2016, METHODS, V99, P128, DOI 10.1016/j.ymeth.2015.08.014; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; Sakota Y, 2014, BIOL PHARM BULL, V37, P1014, DOI 10.1248/bpb.b13-00996; Schittny JC, 2000, AM J RESP CELL MOL, V23, P11, DOI 10.1165/ajrcmb.23.1.3926; Severi C, 2014, EUR J HISTOCHEM, V58, P307, DOI 10.4081/ejh.2014.2457; Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069; Stock K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28951; SUTERA SP, 1993, ANNU REV FLUID MECH, V25, P1, DOI 10.1146/annurev.fl.25.010193.000245; VERMILLION DL, 1993, GASTROENTEROLOGY, V104, P1692, DOI 10.1016/0016-5085(93)90647-U; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; WIDDOP S, 1993, AM J RESP CELL MOL, V9, P541, DOI 10.1165/ajrcmb/9.5.541; Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051; WOOLCOCK AJ, 1984, AM REV RESPIR DIS, V130, P71; Wright DB, 2013, PULM PHARMACOL THER, V26, P42, DOI 10.1016/j.pupt.2012.08.005; YAN K, 1985, AM REV RESPIR DIS, V132, P25; Yipeng Jin, 2017, Front Physiol, V8, P534, DOI 10.3389/fphys.2017.00534; Young BM, 2017, ACS BIOMATER SCI ENG, V3, P3480, DOI 10.1021/acsbiomaterials.7b00384	52	15	18	14	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1652	1664		10.1096/fj.201901063RR	http://dx.doi.org/10.1096/fj.201901063RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914670				2022-12-28	WOS:000507308900109
J	Xiao, K; Liu, CC; Qin, Q; Zhang, Y; Wang, XY; Zhang, J; Odle, J; Lin, X; Hu, CAA; Liu, YL				Xiao, Kan; Liu, Congcong; Qin, Qin; Zhang, Yang; Wang, Xiuying; Zhang, Jing; Odle, Jack; Lin, Xi; Hu, Chien-An Andy; Liu, Yulan			EPA and DHA attenuate deoxynivalenol-induced intestinal porcine epithelial cell injury and protect barrier function integrity by inhibiting necroptosis signaling pathway	FASEB JOURNAL			English	Article						barrier function; cell injury; deoxynivalenol; necroptosis signaling pathway; n-3 PUFA	POLYUNSATURATED FATTY-ACIDS; WEANED PIGS; HEALTH; DEATH; PHOSPHORYLATION; LOCALIZATION; DISRUPTION; MYCOTOXIN; NECROSIS; DISEASE	Deoxynivalenol (DON) is one of the most common mycotoxins that contaminates food or feed and cause intestinal damage. Long-chain n-3 polyunsaturated fatty acids (PUFA) such as EPA and DHA exert beneficial effects on intestinal integrity in animal models and clinical trials. Necroptosis signaling pathway plays a critical role in intestinal cell injury. This study tested the hypothesis that EPA and DHA could alleviate DON-induced injury to intestinal porcine epithelial cells through modulation of the necroptosis signaling pathway. Intestinal porcine epithelial cell 1 (IPEC-1) cells were cultured with or without EPA or DHA (6.25-25 mu g/mL) in the presence or absence of 0.5 mu g/mL DON for indicated time points. Cell viability, cell number, lactate dehydrogenase (LDH) activity, cell necrosis, transepithelial electrical resistance (TEER), fluorescein isothiocyanate-labeled dextran 4kDa (FD4) flux, tight junction protein distribution, and protein abundance of necroptosis related signals were determined. EPA and DHA promoted cell growth indicated by higher cell viability and cell number, and inhibited cell injury indicated by lower LDH activity in the media. EPA and DHA also improved intestinal barrier function, indicated by higher TEER and lower permeability of FD4 flux as well as increased proportions of tight junction proteins located in the plasma membrane. Moreover, EPA and DHA decreased cell necrosis demonstrated by live cell imaging and transmission electron microscopy. Finally, EPA and DHA downregulated protein expressions of necroptosis related signals including tumor necrosis factor receptor (TNFR1), receptor interacting protein kinase 1 (RIP1), RIP3, phosphorylated mixed lineage kinase-like protein (MLKL), phosphoglycerate mutase family 5 (PGAM5), dynamin-related protein 1 (Drp1), and high mobility group box-1 protein (HMGB1). EPA and DHA also inhibited protein expression of caspase-3 and caspase-8. These results suggest that EPA and DHA prevent DON-induced intestinal cell injury and enhance barrier function, which is associated with inhibition of the necroptosis signaling pathway.	[Xiao, Kan; Liu, Congcong; Qin, Qin; Zhang, Yang; Wang, Xiuying; Zhang, Jing; Hu, Chien-An Andy; Liu, Yulan] Wuhan Polytech Univ, Hubei Key Lab Anim Nutr & Feed Sci, Hubei Collaborat Innovat Ctr Anim Nutr & Feed Saf, Xuefunan Rd, Wuhan 430023, Hubei, Peoples R China; [Odle, Jack; Lin, Xi] North Carolina State Univ, Lab Dev Nutr, Dept Anim Sci, Raleigh, NC USA; [Hu, Chien-An Andy] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA	Wuhan Polytechnic University; University of North Carolina; North Carolina State University; University of New Mexico	Liu, YL (corresponding author), Wuhan Polytech Univ, Hubei Key Lab Anim Nutr & Feed Sci, Hubei Collaborat Innovat Ctr Anim Nutr & Feed Saf, Xuefunan Rd, Wuhan 430023, Hubei, Peoples R China.	yulanflower@126.com	lin, xi/GZL-4959-2022; Odle, Jack/K-9660-2017	Odle, Jack/0000-0003-4965-2096; Xi, Lin/0000-0003-3911-9677; Wang, Xiuying/0000-0001-6693-3813	National Natural Science Foundation of China (NSFC) [31772615]; Wuhan Science and Technology Burea [2018020401011304]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology Burea	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31772615; the projects of Wuhan Science and Technology Burea, Grant/Award Number: 2018020401011304	Adameova A, 2016, HEART FAIL REV, V21, P213, DOI 10.1007/s10741-016-9537-8; Ajami M, 2013, FUND CLIN PHARMACOL, V27, P593, DOI 10.1111/j.1472-8206.2012.01066.x; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bodea GOD, 2009, ROM BIOTECH LETT, V14, P4349; Brahmbhatt V, 2013, J NUTR BIOCHEM, V24, P104, DOI 10.1016/j.jnutbio.2012.02.014; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Camilleri M, 2019, GUT, V68, P1516, DOI 10.1136/gutjnl-2019-318427; Costantini L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122645; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; Flock MR, 2013, NUTR REV, V71, P692, DOI 10.1111/nure.12071; Ghareeb K, 2015, J APPL TOXICOL, V35, P327, DOI 10.1002/jat.3083; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jacobi SK, 2012, ADV NUTR, V3, P687, DOI 10.3945/an.112.002683; Kearney CJ, 2017, MOL CELL, V65, P965, DOI 10.1016/j.molcel.2017.02.024; Kishida E, 2006, BBA-MOL CELL BIOL L, V1761, P454, DOI 10.1016/j.bbalip.2006.03.023; Kolf-Clauw M, 2009, TOXICOL IN VITRO, V23, P1580, DOI 10.1016/j.tiv.2009.07.015; Li QR, 2008, MOL IMMUNOL, V45, P1356, DOI 10.1016/j.molimm.2007.09.003; Li QR, 2008, FEBS J, V275, P411, DOI 10.1111/j.1742-4658.2007.06210.x; Li XL, 2012, BBA-MOL BASIS DIS, V1822, P196, DOI 10.1016/j.bbadis.2011.09.019; Liu YL, 2012, J NUTR, V142, P2017, DOI 10.3945/jn.112.164947; Magee P, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-24; Mayer E, 2017, MYCOTOXIN RES, V33, P297, DOI 10.1007/s12550-017-0289-7; Nossol C, 2018, TOXINS, V9, P10; Nunes T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/218493; Pacheco FJ, 2014, INFLAMM RES, V63, P859, DOI 10.1007/s00011-014-0760-2; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Pierron A, 2016, ANIM NUTR, V2, P63, DOI 10.1016/j.aninu.2016.03.001; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Ren Z, 2019, INT J MOL SCI, V20, P11; Shahidi F, 2018, ANNU REV FOOD SCI T, V9, P345, DOI 10.1146/annurev-food-111317-095850; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7, DOI 10.1152/ajpgi.2001.280.1.G7; Su XF, 2015, NEUROCHEM RES, V40, P643, DOI 10.1007/s11064-014-1510-0; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Whiting CV, 2005, INFLAMM BOWEL DIS, V11, P340, DOI 10.1097/01.MIB.0000164016.98913.7c; Willemsen LEM, 2008, EUR J NUTR, V47, P183, DOI 10.1007/s00394-008-0712-0; Xiao GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073571; Zhu HL, 2016, BRIT J NUTR, V115, P1947, DOI 10.1017/S0007114516001100	46	24	27	6	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2483	2496		10.1096/fj.201902298R	http://dx.doi.org/10.1096/fj.201902298R		DEC 2019	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909535				2022-12-28	WOS:000503397900001
J	Dang, C; Han, B; Li, Q; Han, RR; Hao, JW				Dang, Chun; Han, Bin; Li, Qian; Han, Ranran; Hao, Junwei			Up-regulation of PGC-1 alpha in neurons protects against experimental autoimmune encephalomyelitis	FASEB JOURNAL			English	Article						neuronal apoptosis; EAE; ROS	MITOCHONDRIAL BIOGENESIS; NLRP3 INFLAMMASOME; TRANSCRIPTIONAL CONTROL; UNCOUPLING PROTEINS; DYSFUNCTION; ACTIVATION; EXPRESSION; NEURODEGENERATION; SUPPRESSION; RESPIRATION	Reactive oxygen species (ROS) generation and mitochondrial dysfunction are related to neuron loss in multiple sclerosis (MS). Although peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha) appears to play a key role in modulating levels of mitochondrial ROS, antioxidants, and uncoupling proteins (UCPs), and PGC-1 alpha expression is reduced in the neocortex of patients with MS, it is unclear what its role is in neurons and in the manifestation of clinical symptoms of MS. Here, we show in wild-type (WT) experimental autoimmune encephalomyelitis (EAE) mice that PGC-1 alpha is decreased 13 d after EAE induction followed by a steady decline up to 20 d. These changes were accompanied by parallel alterations in levels of superoxide dismutase 2, peroxiredoxin 3, thioredoxin 2, UCP4, and UCP5. In transgenic (TG) mice with neuron-specific overexpression of PGC-1 alpha (PGC-1 alpha(f/f)Eno2-Cre), clinical symptoms after EAE induction were delayed and less severe than in WT mice. The degrees of apoptotic neuron loss and demyelination were also less severe in PGC-1 alpha-TG mice. Overexpression of PGC-1 alpha in neuronal neuroblastoma spinal cord 34 cells subjected to EAE inflammatory conditions showed similar results to those obtained in vivo. RNA sequencing analysis showed that apoptotic processes were significantly enriched in the top 10 significant gene ontology (GO) terms of differentially expressed genes, and the apoptotic pathway was significantly enriched in Kyoto Encyclopedia of Genes and Genomes pathway analysis. Our findings indicate that up-regulation of neuronal PGC-1 alpha protected neurons from apoptosis in EAE. Manipulating PGC-1 alpha levels in MS may help stave off this devastating disease.	[Dang, Chun; Han, Ranran; Hao, Junwei] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurol, Gen Hosp, Tianjin 300052, Peoples R China; [Han, Bin] Qingdao Univ, Dept Neurol, Affiliated Hosp, Qingdao, Peoples R China; [Li, Qian] Harbin Med Univ, Dept Neurol, Affiliated Hosp 2, Harbin, Peoples R China	Tianjin Medical University; Qingdao University; Harbin Medical University	Hao, JW (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurol, Gen Hosp, Tianjin 300052, Peoples R China.	hjw@tmu.edu.cn	Dang, Chun/AAK-5524-2021	Dang, Chun/0000-0001-5023-6095	National Natural Science Foundation of China [81571600, 81322018, 81273287, 81100887, 81825008, 81870954]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81571600, 81322018,81273287, 81100887, 81825008, and 81870954). The authors declare no conflicts of interest.	Ahmed Z, 2002, AM J PATHOL, V161, P1577, DOI 10.1016/S0002-9440(10)64436-7; Akhtar RS, 2004, BBA-MOL CELL RES, V1644, P189, DOI 10.1016/j.bbamcr.2003.10.013; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Aviello G, 2017, BRIT J PHARMACOL, V174, P1704, DOI 10.1111/bph.13428; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; BENNUN A, 1982, J IMMUNOL, V128, P1450; Bittner S, 2014, JOVE-J VIS EXP, DOI 10.3791/51275; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Chernousova S, 2017, GENE THER, V24, P282, DOI 10.1038/gt.2017.13; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Council N. R, 2011, GUIDE CARE USE LAB A; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Diao L, 2014, SHOCK, V41, P138, DOI 10.1097/SHK.0000000000000075; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; Fonseca-Kelly Zoe, 2012, Front Neurol, V3, P84, DOI 10.3389/fneur.2012.00084; Giatti S, 2012, J NEUROENDOCRINOL, V24, P851, DOI 10.1111/j.1365-2826.2012.02284.x; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hwang IK, 2010, FREE RADICAL BIO MED, V48, P1242, DOI 10.1016/j.freeradbiomed.2010.02.007; Jiang W, 2017, P NATL ACAD SCI USA, V114, pE6202, DOI 10.1073/pnas.1705491114; Kang YH, 2018, CELL REP, V22, P3493, DOI 10.1016/j.celrep.2018.02.071; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kupershmidt L, 2009, FASEB J, V23, P3766, DOI 10.1096/fj.09-130047; Li DJ, 2018, CELL REP, V22, P3574, DOI 10.1016/j.celrep.2018.03.011; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Loh KP, 2010, STROKE, V41, P2661, DOI 10.1161/STROKEAHA.110.589895; Mao GX, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/750963; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Marchev AS, 2017, ANN NY ACAD SCI, V1401, P114, DOI 10.1111/nyas.13407; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Nakase T, 2007, NEUROPATHOLOGY, V27, P442, DOI 10.1111/j.1440-1789.2007.00815.x; Nijland PG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0170-2; Nimmagadda VK, 2013, J IMMUNOL, V190, P4595, DOI 10.4049/jimmunol.1202584; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Pandit A, 2009, J NEUROL SCI, V279, P14, DOI 10.1016/j.jns.2009.01.009; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Remels AHV, 2010, FASEB J, V24, P5052, DOI 10.1096/fj.09-150714; Rupprecht A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041406; Sattler MB, 2010, EXP NEUROL, V225, P40, DOI 10.1016/j.expneurol.2009.08.016; Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Sweeney G, 2016, ANAT CELL BIOL, V49, P1, DOI 10.5115/acb.2016.49.1.1; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Vera-Ramirez L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04070-6; Vince JE, 2016, CELL MOL LIFE SCI, V73, P2349, DOI 10.1007/s00018-016-2205-2; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Witte ME, 2013, ACTA NEUROPATHOL, V125, P231, DOI 10.1007/s00401-012-1052-y; Witte ME, 2009, J PATHOL, V219, P193, DOI 10.1002/path.2582; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Ye XC, 2017, EXP NEUROL, V292, P46, DOI 10.1016/j.expneurol.2017.03.002	65	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14811	14824		10.1096/fj.201901149RR	http://dx.doi.org/10.1096/fj.201901149RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31718280				2022-12-28	WOS:000507466100134
J	Landstrom, M; Liu, J				Landstrom, Marene; Liu, Jun			The 2019 FASEB Science Research Conference on the TGF-beta Superfamily: Signaling in Development and Disease, July 28 to August 2, 2019, West Palm Beach, Florida, USA	FASEB JOURNAL			English	Editorial Material									[Landstrom, Marene] Umea Univ, Dept Med Biosci, Pathol Sect, Bldg 6M,2nd Floor, SE-90185 Umea, Sweden; [Liu, Jun] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Umea University; Cornell University	Landstrom, M (corresponding author), Umea Univ, Dept Med Biosci, Pathol Sect, Bldg 6M,2nd Floor, SE-90185 Umea, Sweden.; Liu, J (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	marene.landstrom@umu.se; kelly.jun.liu@cornell.edu			U.S. National Institutes of Health (NIH) [R35 GM130351]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM130351] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the meeting organizers Mary Mullins (University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA) and Gareth Inman (University of Glasgow, Glasgow, United Kingdom). Mary Mullins gave critical comments on the manuscript. J.L. is supported by grants from the U.S. National Institutes of Health (NIH) Grant R35 GM130351. The authors declare no conflicts of interest.		0	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13064	13067		10.1096/fj.201902632	http://dx.doi.org/10.1096/fj.201902632			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31795031	hybrid, Green Published			2022-12-28	WOS:000507466100002
J	Loonat, AA; Martin, ED; Sarafraz-Shekary, N; Tilgner, K; Hertz, NT; Levin, R; Shokat, KM; Burlingame, AL; Arabacilar, P; Uddin, S; Thomas, M; Marber, MS; Clark, JE				Loonat, Aminah A.; Martin, E. Denise; Sarafraz-Shekary, Negin; Tilgner, Katharina; Hertz, Nicholas T.; Levin, Rebecca; Shokat, Kevan M.; Burlingame, Alma L.; Arabacilar, Pelin; Uddin, Shahzan; Thomas, Max; Marber, Michael S.; Clark, James E.			p38 gamma MAPK contributes to left ventricular remodeling after pathologic stress and disinhibits calpain through phosphorylation of calpastatin	FASEB JOURNAL			English	Article						heart; hypertrophy; failure; protection; kinase	ACTIVATED PROTEIN-KINASE; DILATED CARDIOMYOPATHY; MECHANISM; LOCALIZATION; HYPERTROPHY; INHIBITION; EXPRESSION; CYTOSKELETON; CYPHER/ZASP; CALCINEURIN	Despite the high and preferential expression of p38 gamma MAPK in the myocardium, little is known about its function in the heart. The aim of the current study was to elucidate the physiologic and biochemical roles of p38 gamma in the heart. Expression and subcellular localization of p38 isoforms was determined in mouse hearts. Comparisons of the cardiac function and structure of wild-type and p38 gamma knockout (KO) mice at baseline and after abdominal aortic banding demonstrated that KO mice developed less ventricular hypertrophy and that contractile function is better preserved. To identify potential substrates of p38 gamma, we generated an analog-sensitive mutant to affinity tag endogenous myocardial proteins. Among other proteins, this technique identified calpastatin as a direct p38 gamma substrate. Moreover, phosphorylation of calpastatin by p38 gamma impaired its ability to inhibit the protease, calpain. We have identified p38 gamma as an important determinant of the progression of pathologic cardiac hypertrophy after aortic banding in mice. In addition, we have identified calpastatin, among other substrates, as a novel direct target of p38 gamma that may contribute to the protection observed in p38 gamma KO mice.	[Loonat, Aminah A.; Martin, E. Denise; Sarafraz-Shekary, Negin; Tilgner, Katharina; Arabacilar, Pelin; Uddin, Shahzan; Thomas, Max; Marber, Michael S.; Clark, James E.] Kings Coll London, British Heart Fdn BHF Ctr, Sch Cardiovasc Med & Sci, London, England; [Hertz, Nicholas T.; Levin, Rebecca; Shokat, Kevan M.; Burlingame, Alma L.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of London; King's College London; University of California System; University of California San Francisco	Clark, JE (corresponding author), Kings Coll London, St Thomas Hosp, Sch Cardiovasc Med & Sci, BHF Ctr,Rayne Inst, 4th Floor Lambeth Wing,Lambeth Palace Rd, London SE1 7EH, England.	james.2.clark@kcl.ac.uk	marber, michael/AAW-7916-2021	Clark, James/0000-0001-7574-2162; Marber, Michael/0000-0002-3463-7128; Tilgner, Katharina/0000-0002-6523-0574	Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre and Clinical Research Facilities awards; St. Thomas National Health Service (NHS) Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust - King's College London Graduate School; British Heart Foundation - British Heart Foundation [SP/14/2/30922]; Medical Research Council [MR/J007501/1]; Biotechnology and Biological Sciences Research Council; GlaxoSmithKline [STU100019047]; British Heart Foundation [SP/14/2/30922]; Graduate School of King's College London; Biomedical Technology Research Centers Program of the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); Thermo Fisher Scientific Linear Trap Quadrupole Orbitrap Velos; NIH NIGMS [8P41-GM103481]; Howard Hughes Medical Institute; MRC [MR/J007501/1] Funding Source: UKRI	Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre and Clinical Research Facilities awards; St. Thomas National Health Service (NHS) Foundation Trust; King's College London(General Electric); King's College Hospital NHS Foundation Trust - King's College London Graduate School; British Heart Foundation - British Heart Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); British Heart Foundation(British Heart Foundation); Graduate School of King's College London; Biomedical Technology Research Centers Program of the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); Thermo Fisher Scientific Linear Trap Quadrupole Orbitrap Velos; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre and Clinical Research Facilities awards to Guy and St. Thomas National Health Service (NHS) Foundation Trust, in partnership with King's College London and King's College Hospital NHS Foundation Trust. A.A.L. was funded by King's College London Graduate School. N.S.-S. was funded by the British Heart Foundation. E.D.M. was funded by British Heart Foundation (SP/14/2/30922) and Medical Research Council (MR/J007501/1). P.A. was funded by Biotechnology and Biological Sciences Research Council CASE Ph.D. studentship award with GlaxoSmithKline (STU100019047). This research was supported by the British Heart Foundation (SP/14/2/30922), Medical Research Council (MR/J007501/1), and Graduate School of King's College London. Mass spectrometry data was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at University of California-San Francisco (to A.L.B.), supported by the Biomedical Technology Research Centers Program of the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); and the Thermo Fisher Scientific Linear Trap Quadrupole Orbitrap Velos, supported by NIH NIGMS Grant 8P41-GM103481 and Howard Hughes Medical Institute. The authors declare no conflicts of interest.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Averna M, 1999, FEBS LETT, V450, P13, DOI 10.1016/S0014-5793(99)00461-5; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Boguslavskyi A, 2014, CARDIOVASC RES, V104, P72, DOI 10.1093/cvr/cvu182; Burkard N, 2005, CIRCULATION, V111, P1045, DOI 10.1161/01.CIR.0000156458.80515.F7; Clark JE, 2013, EXP PHYSIOL, V98, P614, DOI 10.1113/expphysiol.2012.064733; Court NW, 2002, J MOL CELL CARDIOL, V34, P413, DOI 10.1006/jmcc.2001.1523; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Dingar D, 2010, CELL SIGNAL, V22, P1634, DOI 10.1016/j.cellsig.2010.06.002; Foster WH, 2012, MUSCLE NERVE, V45, P266, DOI 10.1002/mus.22289; Gillespie MA, 2009, J CELL BIOL, V187, P991, DOI 10.1083/jcb.200907037; Gonzalez-Teran B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10477; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hasegawa M, 1999, J BIOL CHEM, V274, P12626, DOI 10.1074/jbc.274.18.12626; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Hertz Nicholas T, 2010, Curr Protoc Chem Biol, V2, P15, DOI 10.1002/9780470559277.ch090201; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Lopez-Ayala JM, 2015, CLIN GENET, V88, P172, DOI 10.1111/cge.12458; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Sabio G, 2004, BIOCHEM J, V380, P19, DOI 10.1042/BJ20031628; Salamino F, 1997, FEBS LETT, V412, P433, DOI 10.1016/S0014-5793(97)00819-3; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Yang DC, 2010, INT J MOL MED, V26, P159, DOI 10.3892/ijmm_00000448; Ye TQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120178; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400	33	5	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13131	13144		10.1096/fj.201701545R	http://dx.doi.org/10.1096/fj.201701545R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31638431	Green Published, hybrid			2022-12-28	WOS:000507466100009
J	Ruijter, JM; Ruiz-Villalba, A; van den Hoff, AJJ; Gunst, QD; Wittwer, CT; van den Hoff, MJB				Ruijter, Jan M.; Ruiz-Villalba, Adrian; van den Hoff, Axel J. J.; Gunst, Quinn D.; Wittwer, Carl T.; van den Hoff, Maurice J. B.			Removal of artifact bias from qPCR results using DNA melting curve analysis	FASEB JOURNAL			English	Article						RT-qPCR; artifact amplification; qPCR data analysis; amplification curve analysis; PCR efficiency	PCR	Quantitative PCR (qPCR) allows the precise measurement of DNA concentrations and is generally considered to be straightforward and trouble free. However, analyses using validated Sybr Green I-based assays regularly amplify both the correct product and an artifact. Amplification of more than 1 product can be recognized when melting curve analysis is performed after the qPCR. Currently, such reactions need to be excluded from further analysis because the quantification result is considered meaningless. However, when the fraction of the fluorescence associated with the correct product can be determined, the quantitative result of the qPCR analysis can be corrected. The main assumptions of this correction model are: 1) the melting peak of the correct product can be identified, 2) the PCR efficiencies of all amplified products are similar, 3) the relative size of the melting peaks reflects the relative concentrations of the products, and 4) the relative concentrations do not change as the reaction reaches plateau. These assumptions were validated in a series of model experiments. The results show that the quantitative results can be corrected. Implementation of a correction for the presence of artifact amplification in the analysis of qPCR data leads to more reliable quantitative results in qPCR experiments.	[Ruijter, Jan M.; Ruiz-Villalba, Adrian; van den Hoff, Axel J. J.; Gunst, Quinn D.; van den Hoff, Maurice J. B.] Amsterdam Univ Med Ctr, AMC, Dept Med Biol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands; [Ruiz-Villalba, Adrian] Univ Navarra, Ctr Appl Med Res CIMA, Pamplona, Spain; [Wittwer, Carl T.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Navarra; Utah System of Higher Education; University of Utah	van den Hoff, MJB (corresponding author), Amsterdam Univ Med Ctr, AMC, Dept Med Biol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	m.j.vandenhoff@amsterdamumc.nl	Ruiz-Villalba, Adrián/AAP-6130-2020	van den Hoff, Maurice/0000-0002-3837-8055	Fondo Social Europeo (FSE)/Ministerio de Economia, Industria y Competitividad-Agencia Estatal de Investigacion [IJCI-2016-30254]; CadioNeT; European Union FP7-Marie Curie-Innovative Training Networks (ITN) actions [ITN-GA-2011-289600]; BioFire Diagnostics	Fondo Social Europeo (FSE)/Ministerio de Economia, Industria y Competitividad-Agencia Estatal de Investigacion; CadioNeT; European Union FP7-Marie Curie-Innovative Training Networks (ITN) actions; BioFire Diagnostics	The authors thank Valin Reja (Bio Molecular Systems, Upper Coomera, QLD, Australia) for valuable suggestions and discussions. Tommy Riviere and Marina Dor (Polytech Grenoble, SaintMartin-d'H`eres, France) contributed to the initial version of the Melting Curve Analysis Program. A.R.-V. was supported by Fondo Social Europeo (FSE)/Ministerio de Economia, Industria y Competitividad-Agencia Estatal de Investigacion IJCI-2016-30254 grant. J.M.R., A.R.-V., A.J.J.V.D.H., Q.D.G., and M.J.B.V.D.H. were supported by CadioNeT, the European Union FP7-Marie Curie-Innovative Training Networks (ITN) actions ITN-GA-2011-289600 grant. C.T.W. was supported by a grant from BioFire Diagnostics. C.T.W. received royalties through the University of Utah from BioFire Diagnostics for aspects of melting analysis, including the use of dyes in real-time PCR.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Dufresne SD, 2006, ARCH PATHOL LAB MED, V130, P185; Dujols J. S., 2007, REAL TIME PCR, P157; Dwight ZL, 2012, IEEE ACM T COMPUT BI, V9, P1805, DOI 10.1109/TCBB.2012.112; Farrar JS, 2017, MOL DIAGNOSTICS, p79?102, DOI DOI 10.1016/B978-0-12-802971-8.00006-7; Friedman J. H., 1984, TECH REP LCS, V5, P1; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Li M, 2017, ANAL BIOCHEM, V539, P90, DOI 10.1016/j.ab.2017.10.015; Li M, 2014, CLIN CHEM, V60, P864, DOI 10.1373/clinchem.2013.220160; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Palais R, 2009, METHOD ENZYMOL, V454, P323, DOI [10.1016/S0076-6879(08)03813-5, 10.1016/S0076-6879(08)03913-5]; Pornprasert S, 2008, EUR J HAEMATOL, V80, P510, DOI 10.1111/j.1600-0609.2008.01055.x; Pryor RJ, 2017, CLIN CHEM, V63, P1624, DOI 10.1373/clinchem.2017.276147; Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-107; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2003, DENTOMAXILLOFAC RAD, V32, P379, DOI 10.1259/dmfr/23241049; Ruiz-Villalba Adrian, 2017, Biomol Detect Quantif, V14, P7, DOI 10.1016/j.bdq.2017.10.001; Sanford LN, 2013, ANAL CHEM, V85, P9907, DOI 10.1021/ac4024928; Spiess AN, 2015, CLIN CHEM, V61, P379, DOI 10.1373/clinchem.2014.230656; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Zhou LM, 2015, CLIN CHEM, V61, P724, DOI 10.1373/clinchem.2014.236208	25	4	4	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14542	14555		10.1096/fj.201901604R	http://dx.doi.org/10.1096/fj.201901604R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31682470	Bronze			2022-12-28	WOS:000507466100114
J	Sakimoto, Y; Kida, H; Mitsushima, D				Sakimoto, Yuya; Kida, Hiroyuki; Mitsushima, Dai			Temporal dynamics of learning-promoted synaptic diversity in CA1 pyramidal neurons	FASEB JOURNAL			English	Article						AMPA receptor; glutamate; GABA(A) receptor; GABA; contextual learning	GABA(A) RECEPTOR PHOSPHORYLATION; GAMMA-AMINOBUTYRIC-ACID; LONG-TERM POTENTIATION; PROTEIN-KINASE; HOMEOSTATIC PLASTICITY; FUNCTIONAL MODULATION; ALZHEIMERS-DISEASE; SILENT SYNAPSES; AMPA RECEPTORS; DIRECT BINDING	Although contextual learning requires plasticity at both excitatory and inhibitory (E/I) synapses in cornu ammonis 1 (CA1) neurons, the temporal dynamics across the neuronal population are poorly understood. Using an inhibitory avoidance task, we analyzed the dynamic changes in learning-induced E/I synaptic plasticity. The training strengthened GABA(A) receptor mediated synapses within 1 min, peaked at 10 min, and lasted for over 60 min. The intracellular loop (Ser(408-409)) of GABAA receptor beta(3) subunit was also phosphorylated within 1 min of training. As the results of strengthening of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor- mediated synapses, CA1 pyramidal neurons exhibited broad diversity of E/I synaptic currents within 5 min. Moreover, presynaptic glutamate release probability at basal dendrites also increased within 5 min. To further quantify the diversified E/I synaptic currents, we calculated self-entropy (bit) for individual neurons. The neurons showed individual levels of the parameter, which rapidly increased within 1 min of training and maintained for over 60 min. These results suggest that learning-induced synaptic plasticity is critical immediately following encoding rather than during the retrieval phase of the learning. Understanding the temporal dynamics along with the quantification of synaptic diversity would be necessary to identify a failure point for learning-promoted plasticity in cognitive disorders.	[Sakimoto, Yuya; Kida, Hiroyuki; Mitsushima, Dai] Yamaguchi Univ, Grad Sch Med, Dept Physiol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan; [Mitsushima, Dai] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University	Mitsushima, D (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Physiol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	mitsu@yamaguchi-u.ac.jp	Skimoto, Yuya/GLU-9872-2022		Ministry of Education, Culture, Sports, Science, and Technology of Japan [16H05129, 19H03402, 25460314, 26115518]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank H. Tsurutani for technical support of Western blot, and R. Fujimoto for helpful comments (both from Yamaguchi University). This project was supported by Grants-in-Aid for Scientific Research B (Grants 16H05129 and 19H03402 to D. M.), Scientific Research C (Grant 25460314 to Y.S. and D.M.), and Scientific Research in Innovative Areas (Grant 26115518 to D.M.) from the the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare no conflicts of interest.	[Anonymous], 2017, J PHYSIOL SCI; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bonini JS, 2003, BEHAV PHARMACOL, V14, P161, DOI 10.1097/00008877-200303000-00008; Brandon NJ, 2002, J NEUROSCI, V22, P6353; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Bromer C, 2018, P NATL ACAD SCI USA, V115, pE2410, DOI 10.1073/pnas.1716189115; CASTELLANO C, 1990, BEHAV NEURAL BIOL, V54, P156, DOI 10.1016/0163-1047(90)91352-C; Choi JH, 2018, SCIENCE, V360, P430, DOI 10.1126/science.aas9204; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; de Luca E, 2017, NEURON, V95, P63, DOI 10.1016/j.neuron.2017.06.022; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hori T, 2012, NEURON, V76, P511, DOI 10.1016/j.neuron.2012.08.013; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Jaafari N, 2012, J NEUROSCI, V32, P11618, DOI 10.1523/JNEUROSCI.5068-11.2012; JERUSALINSKY D, 1992, BEHAV NEURAL BIOL, V58, P76, DOI 10.1016/0163-1047(92)90982-A; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kida H, 2017, JOVE-J VIS EXP, DOI 10.3791/55876; Kida H, 2016, CEREB CORTEX, V26, P3494, DOI 10.1093/cercor/bhw134; Kim DH, 2012, NEUROPSYCHOPHARMACOL, V37, P422, DOI 10.1038/npp.2011.189; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kowalczyk S, 2013, EUR J NEUROSCI, V37, P544, DOI 10.1111/ejn.12078; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Lu H, 2010, NEURON, V67, P821, DOI 10.1016/j.neuron.2010.08.012; Luft T, 2004, NEUROBIOL LEARN MEM, V82, P52, DOI 10.1016/j.nlm.2004.03.002; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Martinez-Bellver S, 2017, J PHYSIOL-LONDON, V595, P1775, DOI 10.1113/JP272841; MCDONALD BJ, 1994, J BIOL CHEM, V269, P18111; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mele M, 2016, J NEUROCHEM, V139, P997, DOI 10.1111/jnc.13742; Mendez P, 2018, CELL REP, V22, P1451, DOI 10.1016/j.celrep.2018.01.025; MITSUSHIMA D, 1994, P NATL ACAD SCI USA, V91, P395, DOI 10.1073/pnas.91.1.395; Mitsushima D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3760; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Mitsushima D, 2009, J NEUROSCI, V29, P3808, DOI 10.1523/JNEUROSCI.5301-08.2009; Morris R, 2006, HIPPOCAMPUS BOOK, P581, DOI DOI 10.1093/ACPROF:OSO/9780195100273.003.0013; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petrini EM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00300; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Prange O, 1999, J NEUROSCI, V19, P6427; Pugh JR, 2005, BIOPHYS J, V88, P1740, DOI 10.1529/biophysj.104.055814; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ren SQ, 2013, EMBO J, V32, P1365, DOI 10.1038/emboj.2013.60; Renner MC, 2017, ELIFE, V6, DOI 10.7554/eLife.25462; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sakimoto Y, 2019, CEREB CORTEX, V29, P2183, DOI 10.1093/cercor/bhz022; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sheather SJ, 2004, STAT SCI, V19, P588, DOI 10.1214/088342304000000297; Silverman BW., 1986, DENSITY ESTIMATION S, V26, DOI 10.1201/9781315140919; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Takemoto K, 2017, NAT BIOTECHNOL, V35, P38, DOI 10.1038/nbt.3710; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Townsend M, 2016, J NEUROPHYSIOL, V116, P2663, DOI 10.1152/jn.00243.2016; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tretter V, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00023; Ulrich D, 2015, J NEUROSCI, V35, P9205, DOI 10.1523/JNEUROSCI.0950-15.2015; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	83	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14382	14393		10.1096/fj.201801893RRR	http://dx.doi.org/10.1096/fj.201801893RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689120	Green Published, hybrid			2022-12-28	WOS:000507466100102
J	Chen, YX; Yu, HP; Zhu, DY; Liu, P; Yin, JH; Liu, DL; Zheng, MH; Gao, JJ; Zhang, CQ; Gao, YS				Chen, Yixuan; Yu, Hongping; Zhu, Daoyu; Liu, Pei; Yin, Junhui; Liu, Delin; Zheng, Minghao; Gao, Junjie; Zhang, Changqing; Gao, Youshui			miR-136-3p targets PTEN to regulate vascularization and bone formation and ameliorates alcohol-induced osteopenia	FASEB JOURNAL			English	Article						microRNA-136-3p; phosphatase and tensin homolog deleted on chromosome ten; type-H vessel	MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; VESSEL FORMATION; CORTICAL BONE; ETHANOL; REGENERATION; ANGIOGENESIS; OSTEOGENESIS; ASSOCIATION; CONSUMPTION	Alcohol consumption is regarded as one of the leading risk factors for secondary osteopenia. Coupled angiogenesis and osteogenesis via distinct type-H vessels orchestrates subtle biological processes of bone homeostasis. The dysfunction of angiogenesis and osteogenesis contributes to decreased bone mass during the development of osteopenia. Herein, we identified microRNA-136-3p was remarkedly downregulated in the mouse model of alcohol-induced osteopenia. Following the alcohol administration, downregulated microRNA-136-3p significantly suppressed vascularization and osteogenic differentiation in human umbilical vein endothelial cells (HUVECs) and bone mesenchymal stem cells (BMSCs), respectively. Furthermore, microRNA-136-3p could target phosphatase and tensin homolog deleted on chromosome ten (PTEN) in both HUVECs and BMSCs, thus substantially modulating the capacity of vessel formation and osteogenic differentiation. In the mouse model, microRNA-136-3p Agomir ameliorated alcohol-induced osteopenia, with the concomitant restoration of bone mass and type-H vessel formation. For the first time, this study demonstrated the pivotal role of microRNA-136-3p/PTEN axis in regulations of vascularization and bone formation, which might become the potential therapeutic target of alcohol-induced bone loss.	[Chen, Yixuan; Yu, Hongping; Zhu, Daoyu; Liu, Pei; Yin, Junhui; Gao, Junjie; Zhang, Changqing; Gao, Youshui] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Orthoped Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Yin, Junhui; Zhang, Changqing] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Inst Microsurg Extrem, Shanghai, Peoples R China; [Liu, Delin; Zheng, Minghao; Gao, Junjie; Gao, Youshui] Univ Western Australia, Ctr Orthopaed Translat Res, Med Sch, Nedlands, WA, Australia; [Zheng, Minghao; Gao, Junjie; Gao, Youshui] Perron Inst Neurol & Translat Sci, Nedlands, WA, Australia	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Western Australia	Gao, JJ; Zhang, CQ; Gao, YS (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Orthoped Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China.	colingjj@163.com; zhangcq@sjtu.edu.cn; gaoyoushui@sjtu.edu.cn	GAO, YOUSHUI/U-8349-2019	zhang, changqing/0000-0002-7408-4126; Zheng, Minghao/0000-0003-1185-4768	National Natural Science Foundation of China [81672143, 81702137, 81802247, 81902237]; Shanghai Jiao Tong University, School of Medicine [DLY201616]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University, School of Medicine	National Natural Science Foundation of China, Grant/Award Number: 81672143, 81702137, 81802247 and 81902237; Shanghai Jiao Tong University, School of Medicine, Grant/Award Number: DLY201616	Bae WJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061742; Balansky R, 2016, TOXICOLOGY, V373, P54, DOI 10.1016/j.tox.2016.11.008; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Bratton A, 2018, J ORTHOP TRAUMA, V32, P288, DOI 10.1097/BOT.0000000000001160; Cancedda Ranieri, 2003, Novartis Found Symp, V249, P133; Capulli M, 2018, J BONE MINER RES, V33, P1141, DOI 10.1002/jbmr.3406; Chakkalakal DA, 2005, ALCOHOL CLIN EXP RES, V29, P2077, DOI 10.1097/01.alc.0000192039.21305.55; Chamorro-Jorganes A, 2016, CIRC RES, V118, P38, DOI 10.1161/CIRCRESAHA.115.307408; Chen JR, 2006, J PHARMACOL EXP THER, V319, P1182, DOI 10.1124/jpet.106.109454; Chen PJ, 2018, ONCOL LETT, V15, P5995, DOI 10.3892/ol.2018.8081; Chen YX, 2019, FEBS J, V286, P1101, DOI 10.1111/febs.14754; Chen YX, 2017, NANOSCALE, V9, P6765, DOI 10.1039/c7nr00601b; Chen YX, 2017, ONCOTARGET, V8, P31065, DOI 10.18632/oncotarget.16075; Chen YX, 2018, CHEM ENG J, V341, P112, DOI 10.1016/j.cej.2018.02.010; Choi JY, 2018, J BONE MINER RES, V33, P2059, DOI 10.1002/jbmr.3549; Cui Z, 2016, ANN RHEUM DIS, V75, P1714, DOI 10.1136/annrheumdis-2015-207923; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Di Rocco G, 2019, CELL MOL LIFE SCI, V76, P231, DOI 10.1007/s00018-018-2931-8; Elmadhun NY, 2015, J SURG RES, V193, P536, DOI 10.1016/j.jss.2014.05.048; Gaddini GW, 2016, ALCOHOL CLIN EXP RES, V40, P657, DOI 10.1111/acer.13000; Girault V, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.29; Greenhill Claire, 2014, Nat Rev Endocrinol, V10, P250, DOI 10.1038/nrendo.2014.28; Grol MW, 2018, CURR OPIN PHARMACOL, V40, P59, DOI 10.1016/j.coph.2018.03.005; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Hopkins BD, 2014, TRENDS BIOCHEM SCI, V39, P183, DOI 10.1016/j.tibs.2014.02.006; Huang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13885; Huang J, 2018, THERANOSTICS, V8, P2435, DOI 10.7150/thno.22144; Jiang Z, 2014, J CELL PHYSIOL, V229, P384, DOI 10.1002/jcp.24460; Johnson TL, 2014, ALCOHOL CLIN EXP RES, V38, P1365, DOI 10.1111/acer.12366; Kahler-Quesada AM, 2019, ALCOHOL CLIN EXP RES, V43, P2494, DOI 10.1111/acer.14202; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Langen UH, 2017, NAT CELL BIOL, V19, P189, DOI 10.1038/ncb3476; le Noble F, 2014, NATURE, V507, P313, DOI 10.1038/nature13210; Li CJ, 2015, J CLIN INVEST, V125, P1509, DOI 10.1172/JCI77716; Li Y, 2015, MOL THER, V23, P1349, DOI 10.1038/mt.2015.101; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liao L, 2016, STEM CELLS, V34, P1054, DOI 10.1002/stem.2274; Liu Y, 2016, STEM CELLS, V34, P2157, DOI 10.1002/stem.2392; Maeda Y, 2017, J BONE MINER RES, V32, P461, DOI 10.1002/jbmr.3005; Maurel DB, 2012, JOINT BONE SPINE, V79, P492, DOI 10.1016/j.jbspin.2011.10.004; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mikosch P, 2014, WIEN MED WOCHENSCHR, V164, P15, DOI 10.1007/s10354-013-0258-5; Nucera S, 2016, CANCER CELL, V29, P905, DOI 10.1016/j.ccell.2016.05.007; Qiu N, 2012, J CELL SCI, V125, P1945, DOI 10.1242/jcs.095893; Radek KA, 2008, AM J PHYSIOL-HEART C, V295, pH174, DOI 10.1152/ajpheart.00699.2007; Ramasamy SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13601; Ramasamy SK, 2016, ANNU REV CELL DEV BI, V32, P649, DOI 10.1146/annurev-cellbio-111315-124936; Santori C, 2008, J ENDOCRINOL INVEST, V31, P321, DOI 10.1007/BF03346365; Serra H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8935; Shimizu Y, 2011, BONE, V48, P1075, DOI 10.1016/j.bone.2011.01.008; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stegen S, 2018, BONE, V115, P50, DOI 10.1016/j.bone.2017.08.022; Sun L, 2016, P NATL ACAD SCI USA, V113, P164, DOI 10.1073/pnas.1523762113; Wahl E. C., 2012, British Journal of Medicine and Medical Research, V2, P510; Wan L, 2018, EXP THER MED, V16, P3419, DOI 10.3892/etm.2018.6625; Wang G, 2018, J AGR FOOD CHEM, V66, P9522, DOI [10.1021/acs.jafc.8b02949, 10.1021/acs.jafc.8b05116]; Wang G, 2016, J APPL TOXICOL, V36, P692, DOI 10.1002/jat.3201; Wang L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.36; Yang M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16003; Yu KK, 2014, ALCOHOL CLIN EXP RES, V38, P2597, DOI 10.1111/acer.12512; Zhang L, 2017, J BONE MINER RES, V32, P2466, DOI 10.1002/jbmr.3230; Zhang XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10376; Zhang YY, 2016, ALCOHOL, V54, P27, DOI 10.1016/j.alcohol.2016.05.003	69	16	18	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5348	5362		10.1096/fj.201902463RR	http://dx.doi.org/10.1096/fj.201902463RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32072664				2022-12-28	WOS:000515254800001
J	Han, JJ; Wang, XF; Tang, SS; Lu, CY; Wan, HT; Zhou, J; Li, Y; Ming, TH; Wang, ZJ; Su, XR				Han, Jiaojiao; Wang, Xiaofeng; Tang, Shasha; Lu, Chenyang; Wan, Haitao; Zhou, Jun; Li, Ye; Ming, Tinghong; Wang, Zaijie Jim; Su, Xiurong			Protective effects of tuna meat oligopeptides (TMOP) supplementation on hyperuricemia and associated renal inflammation mediated by gut microbiota	FASEB JOURNAL			English	Article						fecal microbiota transplantation; gut microbiota; hyperuricemia; renal inflammation; signaling pathways; Tuna meat oligopeptides	CHAIN FATTY-ACIDS; IDENTIFICATION; ALLOPURINOL; MODULATION; EXPRESSION; GOUT	Recently, interest in using whole food-derived mixtures to alleviate chronic metabolic syndrome through potential synergistic interactions among different components is increasing. In this study, the effects and mechanisms of tuna meat oligopeptides (TMOP) on hyperuricemia and associated renal inflammation were investigated in mice. Dietary administration of TMOP alleviated hyperuricemia and renal inflammation phenotypes, reprogramed uric acid metabolism pathways, inhibited the activation of NLRP3 inflammasome and TLR4/MyD88/NF-kappa B signaling pathways, and suppressed the phosphorylation of p65-NF-kappa B. In addition, TMOP treatments repaired the intestinal epithelial barrier, reversed the gut microbiota dysbiosis and increased the production of short-chain fatty acids. Moreover, the antihyperuricemia effects of TMOP were transmissible by transplanting the fecal microbiota from TMOP-treated mice, indicating that the protective effects were at least partially mediated by the gut microbiota. Thus, for the first time, we clarify the potential effects of TMOP as a whole food derived ingredient on alleviating hyperuricemia and renal inflammation in mice, and additional efforts are needed to confirm the beneficial effects of TMOP on humans.	[Han, Jiaojiao; Wang, Xiaofeng; Tang, Shasha; Lu, Chenyang; Wan, Haitao; Zhou, Jun; Li, Ye; Ming, Tinghong; Su, Xiurong] Ningbo Univ, State Key Lab Managing Biot & Chem Threats Qual, 169 Qixing South Rd, Ningbo, Peoples R China; [Han, Jiaojiao; Wang, Xiaofeng; Tang, Shasha; Lu, Chenyang; Wan, Haitao; Zhou, Jun; Li, Ye; Ming, Tinghong; Su, Xiurong] Ningbo Univ, Sch Marine Sci, Ningbo, Peoples R China; [Wang, Zaijie Jim] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL USA	Ningbo University; Ningbo University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Su, XR (corresponding author), Ningbo Univ, State Key Lab Managing Biot & Chem Threats Qual, 169 Qixing South Rd, Ningbo, Peoples R China.	suxiurong_public@163.com			Natural Science Foundation of Zhejiang Province [LY19C010003, LY18C010001]; National Key R&D Program of China [2018YFD0901102]; Open Fund of State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products; Public Welfare Project of Ningbo city [2019C10064]; Ningbo University	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Key R&D Program of China; Open Fund of State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products; Public Welfare Project of Ningbo city; Ningbo University	Natural Science Foundation of Zhejiang Province, Grant/Award Number: LY19C010003 and LY18C010001; National Key R&D Program of China, Grant/Award Number: 2018YFD0901102; Open Fund of State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products; Public Welfare Project of Ningbo city, Grant/Award Number: 2019C10064; Ningbo University	Ansari-Ramandi MM, 2017, J CARDIOVASC THORAC, V9, P102, DOI 10.15171/jcvtr.2017.17; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen LY, 2013, FOOD CHEM TOXICOL, V52, P28, DOI 10.1016/j.fct.2012.10.037; Dong LS, 2018, J AGR FOOD CHEM, V66, P154, DOI 10.1021/acs.jafc.7b04743; Duan YH, 2019, FASEB J, V33, P10019, DOI 10.1096/fj.201900665RR; Dubchak N, 2010, INT J NEPHROL RENOV, V3, P145, DOI 10.2147/IJNRD.S6048; Guo Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep20602; Han JJ, 2018, RSC ADV, V8, P14109, DOI 10.1039/c8ra00889b; Han X, 2018, J CHROMATOGR B, V1099, P73, DOI 10.1016/j.jchromb.2018.09.013; He WW, 2019, FOOD CHEM, V272, P453, DOI 10.1016/j.foodchem.2018.08.057; Hou CL, 2019, FREE RADICAL BIO MED, V136, P135, DOI 10.1016/j.freeradbiomed.2019.04.007; Hu QH, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801265; Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x; Jhang JJ, 2018, J AGR FOOD CHEM, V66, P765, DOI 10.1021/acs.jafc.7b05113; Ji JJ, 2019, FASEB J, V33, P9308, DOI 10.1096/fj.201802659RR; Kim SC, 2018, J AM COLL CARDIOL, V71, P994, DOI 10.1016/j.jacc.2017.12.052; Koguchi T, 2019, INT J VITAM NUTR RES, V89, P89, DOI 10.1024/0300-9831/a000548; Li LZ, 2017, DRUG DES DEV THER, V11, P3531, DOI 10.2147/DDDT.S150825; Li QY, 2018, FOOD FUNCT, V9, P107, DOI 10.1039/c7fo01174a; Li YJ, 2018, PEPTIDES, V107, P45, DOI 10.1016/j.peptides.2018.08.001; Liu N, 2018, J AGR FOOD CHEM, V67, P220; Liu Y, 2019, INT J FOOD SCI TECH, V54, P263, DOI 10.1111/ijfs.13970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00905; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Murota I, 2014, J AGR FOOD CHEM, V62, P2392, DOI 10.1021/jf405504u; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Nieuwdorp M, 2014, GASTROENTEROLOGY, V146, P1525, DOI 10.1053/j.gastro.2014.02.008; Peng YJ, 2019, FREE RADICAL BIO MED, V136, P96, DOI 10.1016/j.freeradbiomed.2019.04.005; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Shao TJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00268; Song PG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22570-9; Su GW, 2018, FOOD RES INT, V105, P556, DOI 10.1016/j.foodres.2017.11.037; Tan JY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801402; Vieira AT, 2015, ARTHRITIS RHEUMATOL, V67, P1646, DOI 10.1002/art.39107; Wang HN, 2019, NUTRITION, V62, P63, DOI 10.1016/j.nut.2018.11.018; Wang MX, 2015, EUR J PHARMACOL, V747, P59, DOI 10.1016/j.ejphar.2014.11.035; Xu J, 2015, ISME J, V9, P552, DOI 10.1038/ismej.2014.177; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Yu YR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02233; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774	41	29	31	17	88	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5061	5076		10.1096/fj.201902597RR	http://dx.doi.org/10.1096/fj.201902597RR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32043638				2022-12-28	WOS:000512670000001
J	D'Andrea, G; Ceccarelli, M; Bernini, R; Clemente, M; Santi, L; Caruso, C; Micheli, L; Tirone, F				D'Andrea, Giorgio; Ceccarelli, Manuela; Bernini, Roberta; Clemente, Mariangela; Santi, Luca; Caruso, Carla; Micheli, Laura; Tirone, Felice			Hydroxytyrosol stimulates neurogenesis in aged dentate gyrus by enhancing stem and progenitor cell proliferation and neuron survival	FASEB JOURNAL			English	Article						aging; diet; hippocampus; neural stem cells; neurogenic stimuli	ADULT HIPPOCAMPAL NEUROGENESIS; IN-VITRO; DIFFERENTIATION; FLUOXETINE; EXPRESSION; EXERCISE; MEMORY; SUBPOPULATIONS; ACTIVATION; INDUCTION	The dentate gyrus of the hippocampus is one of two brain areas generating throughout life new neurons, which contribute to the formation of episodic/associative memories. During aging, the production of new neurons decreases and a cognitive decline occurs. Dietary factors influence neuronal function and synaptic plasticity; among them the phenolic compound hydroxytyrosol (HTyr), present in olive oil, displays neuroprotective effects. As age impacts primarily on the hippocampus-dependent cognitive processes, we wondered whether HTyr could stimulate hippocampal neurogenesis in vivo in adult and aged wild-type mice as well as in the B-cell translocation 1 gene (Btg1) knockout mouse model of accelerated neural aging. We found that treatment with HTyr activates neurogenesis in the dentate gyrus of adult, aged, and Btg1-null mice, by increasing survival of new neurons and decreasing apoptosis. Notably, however, in the aged and Btg1-null dentate gyrus, HTyr treatment also stimulates the proliferation of stem and progenitor cells, whereas in the adult dentate gyrus HTyr lacks any proliferative effect. Moreover, the new neurons generated in aged mice after HTyr treatment are recruited to existing circuits, as shown by the increase of BrdU(+)/c-fos(+) neurons. Finally, HTyr treatment also reduces the markers of aging lipofuscin and Iba1. Overall, our findings indicate that HTyr treatment counteracts neurogenesis decline during aging.	[D'Andrea, Giorgio; Ceccarelli, Manuela; Micheli, Laura; Tirone, Felice] CNR, IBBC, Via Ercole Ramarini 32, I-00015 Rome, Italy; [D'Andrea, Giorgio; Caruso, Carla] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy; [Bernini, Roberta; Clemente, Mariangela; Santi, Luca] Univ Tuscia, Dept Agr & Forest Sci DAFNE, Viterbo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica e Biologia Cellulare (IBBC-CNR); Tuscia University; Tuscia University	Micheli, L; Tirone, F (corresponding author), CNR, IBBC, Via Ercole Ramarini 32, I-00015 Rome, Italy.	laura.micheli@cnr.it; felice.tirone@cnr.it	Micheli, Laura/AAY-1641-2020; Ceccarelli, Manuela/AAW-2934-2021; Tirone, Felice/P-6745-2014	SANTI, Luca/0000-0003-4638-5084; MICHELI, LAURA/0000-0001-8647-7261; Ceccarelli, Manuela/0000-0001-8741-1600	Regione Lazio (Lazio Region) [85-2017-14785]; Consiglio Nazionale delle Ricerche (CNR) [DSB.AD004.093]; Fondazione Cariplo (Cariplo Foundation) [AGER2-Rif.2016-0169]; University of Viterbo; Fondazione Giovanni Celeghin	Regione Lazio (Lazio Region); Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Fondazione Cariplo (Cariplo Foundation)(Fondazione Cariplo); University of Viterbo; Fondazione Giovanni Celeghin	Regione Lazio (Lazio Region), Grant/Award Number: 85-2017-14785; Consiglio Nazionale delle Ricerche (CNR), Grant/Award Number: DSB.AD004.093; Fondazione Cariplo (Cariplo Foundation), Grant/Award Number: AGER2-Rif.2016-0169; University of Viterbo, Grant/Award Number: PhD fellowship; Fondazione Giovanni Celeghin, Grant/Award Number: Fellowship	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Arunsundar M, 2015, NEUROTOX RES, V27, P143, DOI 10.1007/s12640-014-9492-x; Aunon-Calles D, 2013, FOOD CHEM TOXICOL, V55, P498, DOI 10.1016/j.fct.2013.01.030; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bernini R, 2013, CURR MED CHEM, V20, P655, DOI 10.2174/092986713804999367; Bernini R, 2008, J AGR FOOD CHEM, V56, P8897, DOI 10.1021/jf801558z; Bernini R, 2017, J AGR FOOD CHEM, V65, P6506, DOI 10.1021/acs.jafc.6b05457; Bizon JL, 2003, EUR J NEUROSCI, V18, P215, DOI 10.1046/j.1460-9568.2003.02733.x; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Brandt MD, 2010, EUR J NEUROSCI, V32, P1256, DOI 10.1111/j.1460-9568.2010.07410.x; Calahorra J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102430; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cetrullo S, 2016, BBA-GEN SUBJECTS, V1860, P1181, DOI 10.1016/j.bbagen.2016.03.002; Chen MJ, 2009, HIPPOCAMPUS, V19, P962, DOI 10.1002/hipo.20579; Cheng Y, 2017, MOL MED REP, V16, P8826, DOI 10.3892/mmr.2017.7701; Clark PJ, 2010, BEHAV BRAIN RES, V213, P246, DOI 10.1016/j.bbr.2010.05.007; Cornejo F, 2016, ADV EXP MED BIOL, V949, P205, DOI 10.1007/978-3-319-40764-7_10; Couillard-Despres S, 2009, MOL PSYCHIATR, V14, P856, DOI 10.1038/mp.2008.147; D'Angelo S, 2001, DRUG METAB DISPOS, V29, P1492; Dias GP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/541971; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Farioli-Vecchioli S, 2014, STEM CELLS, V32, P1968, DOI 10.1002/stem.1679; Farioli-Vecchioli S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00124; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; FLOOD JF, 1995, PHYSIOL BEHAV, V58, P819, DOI 10.1016/0031-9384(95)00125-3; Fu P, 2016, EXP THER MED, V11, P1999, DOI 10.3892/etm.2016.3101; Fukuda S, 2003, J NEUROSCI, V23, P9357; Funakohi-Tago M, 2018, EUR J PHARMACOL, V834, P246, DOI 10.1016/j.ejphar.2018.07.043; Garcia-Martinez O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150045; GEBARA E, 2013, FRONT NEUROSCI SWITZ, V7; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hornedo-Ortega R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00373; Imran M, 2018, J FOOD SCI, V83, P1781, DOI 10.1111/1750-3841.14198; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lamy S, 2016, J NUTR BIOCHEM, V27, P136, DOI 10.1016/j.jnutbio.2015.08.026; Li Y, 2015, PHARMACOL BIOCHEM BE, V135, P70, DOI 10.1016/j.pbb.2015.05.013; Hazas MCLD, 2018, J FUNCT FOODS, V46, P110, DOI 10.1016/j.jff.2018.04.028; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Martinez Lorena, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010013; Martinez-Lapiscina EH, 2013, J NUTR HEALTH AGING, V17, P544, DOI 10.1007/s12603-013-0027-6; McAvoy K, 2015, HIPPOCAMPUS, V25, P1429, DOI 10.1002/hipo.22464; Micheli L, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00010; Micheli L, 2018, NEUROPHARMACOLOGY, V141, P316, DOI 10.1016/j.neuropharm.2018.08.023; Micheli L, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00186; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nardiello P, 2018, J ALZHEIMERS DIS, V63, P1161, DOI 10.3233/JAD-171124; NEWTON I, 1994, PESTIC SCI, V41, P187, DOI 10.1002/ps.2780410304; Omar SH, 2018, FITOTERAPIA, V128, P118, DOI 10.1016/j.fitote.2018.05.011; De la Cruz JP, 2015, J AGR FOOD CHEM, V63, P5957, DOI 10.1021/acs.jafc.5b00627; Peng SJ, 2015, FOOD FUNCT, V6, P2091, DOI [10.1039/C5FO00097A, 10.1039/c5fo00097a]; Reus GZ, 2012, J PSYCHIATR RES, V46, P1029, DOI 10.1016/j.jpsychires.2012.04.016; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Romani A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081776; Romani A, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8101002; Sarubbo F, 2018, NEUROSCI BIOBEHAV R, V90, P456, DOI 10.1016/j.neubiorev.2018.05.011; Schaffer S, 2007, J AGR FOOD CHEM, V55, P5043, DOI 10.1021/jf0703710; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Siette J, 2013, BIOL PSYCHIAT, V73, P435, DOI 10.1016/j.biopsych.2012.05.034; Stangl D, 2009, GENES NUTR, V4, P271, DOI 10.1007/s12263-009-0134-5; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Tirone F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00059; Vivar C, 2015, CURR TOP MED CHEM, V15, P2175, DOI 10.2174/1568026615666150610141524; Yamaguchi Y, 2015, CURR TOP DEV BIOL, V114, P159, DOI 10.1016/bs.ctdb.2015.07.016; Zhang ZX, 2019, J INTEGR NEUROSCI, V18, P65, DOI 10.31083/j.jin.2019.01.118; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng A, 2015, J NUTR BIOCHEM, V26, P190, DOI 10.1016/j.jnutbio.2014.10.006	83	12	12	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4512	4526		10.1096/fj.201902643R	http://dx.doi.org/10.1096/fj.201902643R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32027412				2022-12-28	WOS:000512077100001
J	Ehrlicher, SE; Stierwalt, HD; Miller, BF; Newsom, SA; Robinson, MM				Ehrlicher, Sarah E.; Stierwalt, Harrison D.; Miller, Benjamin F.; Newsom, Sean A.; Robinson, Matthew M.			Mitochondrial adaptations to exercise do not require Bcl2-mediated autophagy but occur with BNIP3/Parkin activation	FASEB JOURNAL			English	Article						mitochondrial respiration; protein turnover; skeletal muscle	FATTY-ACID OXIDATION; SKELETAL-MUSCLE; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; RATES; DIET; BIOGENESIS; MITOPHAGY; TURNOVER; OBESITY	Understanding the mechanisms regulating mitochondrial respiratory function and adaptations to metabolic challenges, such as exercise and high dietary fat, is necessary to promote skeletal muscle health and attenuate metabolic disease. Autophagy is a constitutively active degradation pathway that promotes mitochondrial turnover and transiently increases postexercise. Recent evidence indicates Bcl2 mediates exercise-induced autophagy and skeletal muscle adaptions to training during high-fat diet. We determined if improvements in mitochondrial respiration due to exercise training required Bcl2-mediated autophagy using a transgenic mouse model of impaired inducible autophagy (Bcl2(AAA)). Mitochondrial adaptations to a treadmill exercise training protocol, in either low-fat or high-fat diet fed mice, did not require Bcl2-mediated autophagy activation. Instead, training increased protein synthesis rates and basal autophagy in the Bcl2(AAA) mice, while acute exercise activated BNIP3 and Parkin autophagy. High-fat diet stimulated lipid-specific mitochondrial adaptations. These data demonstrate increases in basal mitochondrial turnover, not transient activation with exercise, mediate adaptations to exercise and high-fat diet.	[Ehrlicher, Sarah E.; Stierwalt, Harrison D.; Newsom, Sean A.; Robinson, Matthew M.] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, 118F Milam Hall, Corvallis, OR 97331 USA; [Miller, Benjamin F.] Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA	Oregon State University; Oklahoma Medical Research Foundation	Ehrlicher, SE (corresponding author), Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, 118F Milam Hall, Corvallis, OR 97331 USA.	matthew.robinson@oregonstate.edu	Stierwalt, Harrison/ABC-4410-2020	Newsom, Sean/0000-0003-0585-3830	National Institutes of Health (NIH) [K01DK103829, KL2TR002370]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: K01DK103829 and KL2TR002370	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Boudina S, 2012, ENDOCRINOLOGY, V153, P2677, DOI 10.1210/en.2011-2147; Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Cardinale DA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01133; Chen CCW, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0157-y; Dasari S, 2018, AM J PHYSIOL-ENDOC M, V315, pE425, DOI 10.1152/ajpendo.00051.2018; DAVIES KJA, 1981, ARCH BIOCHEM BIOPHYS, V209, P539, DOI 10.1016/0003-9861(81)90312-X; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Ehrlicher SE, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13810; Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004; Fritzen AM, 2016, CELL SIGNAL, V28, P663, DOI 10.1016/j.cellsig.2016.03.005; Fu TT, 2018, CELL REP, V23, P1357, DOI 10.1016/j.celrep.2018.03.127; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070; Hamilton KL, 2017, J PHYSIOL-LONDON, V595, P6401, DOI 10.1113/JP274335; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Jaleel A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1255, DOI 10.1152/ajpendo.90586.2008; Ju JS, 2016, J PHYSIOL SCI, V66, P417, DOI 10.1007/s12576-016-0440-9; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Lai N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183978; Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lark DS, 2018, DIABETES, V67, P831, DOI 10.2337/db17-1293; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Lo Verso F, 2014, AUTOPHAGY, V10, P1883, DOI 10.4161/auto.32154; Lundsgaard AM, 2019, CELL METAB, V29, P50, DOI 10.1016/j.cmet.2018.08.022; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Miller BF, 2015, J APPL PHYSIOL, V118, P655, DOI 10.1152/japplphysiol.00987.2014; Miller BF, 2012, AGING CELL, V11, P150, DOI 10.1111/j.1474-9726.2011.00769.x; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moller AB, 2017, SCI REP-UK, V7, DOI 10.1038/srep43775; Nabben M, 2011, FEBS LETT, V585, P4010, DOI 10.1016/j.febslet.2011.11.012; Newsom SA, 2017, AM J PHYSIOL-ENDOC M, V313, pE552, DOI 10.1152/ajpendo.00144.2017; Nilsson MI, 2013, FASEB J, V27, P3905, DOI 10.1096/fj.12-224006; Nilsson MI, 2010, AM J PHYSIOL-ENDOC M, V299, pE466, DOI 10.1152/ajpendo.00118.2010; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Pinti MV, 2019, AM J PHYSIOL-ENDOC M, V316, pE268, DOI 10.1152/ajpendo.00314.2018; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Rosa-Caldwell ME, 2017, EXP PHYSIOL, V102, P1194, DOI 10.1113/EP086406; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Shimazu T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19615-4; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vainshtein A, 2016, J APPL PHYSIOL, V120, P664, DOI 10.1152/japplphysiol.00550.2015; Vainshtein A, 2015, AM J PHYSIOL-CELL PH, V308, pC710, DOI 10.1152/ajpcell.00380.2014; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Yan Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08480-2	61	6	6	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4602	4618		10.1096/fj.201902594RR	http://dx.doi.org/10.1096/fj.201902594RR		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030805	Bronze, Green Accepted			2022-12-28	WOS:000512333600001
J	Zhang, L; Zhao, SQ; Zhu, YF				Zhang, Lei; Zhao, Shiqi; Zhu, Yunfeng			Long noncoding RNA growth arrest-specific transcript 5 alleviates renal fibrosis in diabetic nephropathy by downregulating matrix metalloproteinase 9 through recruitment of enhancer of zeste homolog 2	FASEB JOURNAL			English	Article						diabetic nephropathy; enhancer of zeste homolog 2; histone H3 methylated Lys27; long noncoding RNA growth arrest-specific transcript 5; matrix metalloproteinase 9; renal fibrosis	LNCRNA GAS5; TUMOR-GROWTH; EXPRESSION; PATHOGENESIS; CELLS; MMP9	Diabetic nephropathy (DN) is a frequently occurred microvascular complication associated with type I and type II diabetes mellitus. The participation of long noncoding RNAs (lncRNAs) in diabetes-related microvascular complications has been reported extensively. We attempted to unveil the possible regulatory mechanism of lncRNA growth arrest-specific transcript 5 (GAS5) and matrix metalloproteinase 9 (MMP9), an important inflammatory protein, in the progression of DN. A rat DN model was induced by streptozocin (STZ). The low expression of GAS5 and high expression of MMP9 in DN rats with DN was then determined by RT-qPCR and western blot analysis, and lentivirus-mediated GAS5 overexpression was shown to ameliorate STZ-induced renal interstitial fibrosis (RIF) and inflammatory reaction in the kidney of DN rats. Moreover, MMP9 was found to be upregulated in STZ-induced DN, while MMP9 silencing induced by lentivirus expressing shRNA against MMP9 reduced RIF and suppressed inflammation in the kidney of DN rats. RIP, RNA pull-down, and ChIP assays demonstrated that GAS5 downregulated MMP9 via recruiting enhancer of zeste homolog 2 (EZH2) in the promoter region of MMP9. Overall, our study reveals that GAS5 downregulates MMP9 expression through recruiting EZH2 to MMP9 promoter region and alleviates the progression of renal fibrosis in DN rats, which sheds new light on the therapeutic potential of GAS5-targeted therapies in combating that disease.	[Zhang, Lei] Linyi Peoples Hosp, Dept Kidney Med, Linyi, Shandong, Peoples R China; [Zhao, Shiqi; Zhu, Yunfeng] Linyi Peoples Hosp, Dept Emergency Med, 27 Jiefang Rd, Linyi 276000, Shandong, Peoples R China		Zhu, YF (corresponding author), Linyi Peoples Hosp, Dept Emergency Med, 27 Jiefang Rd, Linyi 276000, Shandong, Peoples R China.	ever919@163.com						Biranvand AS, 2018, INT ANGIOL, V37, P451, DOI 10.23736/S0392-9590.18.04022-1; Cakirca G, 2018, IRAN J KIDNEY DIS, V12, P299; Carter G, 2015, BBA CLIN, V4, P102, DOI 10.1016/j.bbacli.2015.09.001; Chen L, 2016, ONCOTARGETS THER, V9, P4075, DOI 10.2147/OTT.S98203; Chen S, 2017, J DIABETES COMPLICAT, V31, P569, DOI 10.1016/j.jdiacomp.2016.11.017; Fernandez-Fernandez B, 2014, NAT REV NEPHROL, V10, P325, DOI 10.1038/nrneph.2014.74; Fineberg D, 2013, NAT REV ENDOCRINOL, V9, P713, DOI 10.1038/nrendo.2013.184; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gao JJ, 2018, BIOMED PHARMACOTHER, V106, P543, DOI 10.1016/j.biopha.2018.06.104; Geng XM, 2019, NEPHROLOGY, V24, P405, DOI 10.1111/nep.13476; Gnudi L, 2016, TRENDS ENDOCRIN MET, V27, P820, DOI 10.1016/j.tem.2016.07.002; Goustin AS, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5030046; Hu MS, 2017, J CELL MOL MED, V21, P2732, DOI 10.1111/jcmm.13189; Inada A, 2008, J CELL PHYSIOL, V215, P383, DOI 10.1002/jcp.21316; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Leti F, 2017, PERS MED, V14, P271, DOI 10.2217/pme-2016-0107; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Lin CY, 2018, J FORMOS MED ASSOC, V117, P727, DOI 10.1016/j.jfma.2017.09.012; Liu HL, 2019, EUR REV MED PHARMACO, V23, P4414, DOI 10.26355/eurrev_201905_17949; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Lotfy M, 2017, CURR DIABETES REV, V13, P3, DOI 10.2174/1573399812666151016101622; Nagib AM, 2019, EXP CLIN TRANSPLANT, V17, P138, DOI 10.6002/ect.2018.0157; Qi M, 2017, CELL PHYSIOL BIOCHEM, V41, P466, DOI 10.1159/000456599; Rao P, 2019, LAB INVEST, V99, P1689, DOI 10.1038/s41374-019-0276-z; Shi Y, 2019, CELL CHEM BIOL, V26, P319, DOI 10.1016/j.chembiol.2018.11.012; Sun DY, 2017, EMBO REP, V18, P1801, DOI 10.15252/embr.201643668; Tan RJ, 2012, AM J PHYSIOL-RENAL, V302, pF1351, DOI 10.1152/ajprenal.00037.2012; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tandon A, 2011, BIOINFORMATION, V5, P310, DOI 10.6026/97320630005310; Umanath K, 2018, AM J KIDNEY DIS, V71, P884, DOI 10.1053/j.ajkd.2017.10.026; van der Zijl NJ, 2010, CLIN BIOCHEM, V43, P635, DOI 10.1016/j.clinbiochem.2010.02.006; Wang HY, 2011, INDIAN J BIOCHEM BIO, V48, P308; Wang MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0013-8; Wang Y, 2018, CURR GENE THER, V18, P275, DOI 10.2174/1566523218666181008125010; Yang XH, 2018, ENDOKRYNOL POL, V69, P269, DOI 10.5603/EP.a2018.0029; Ye JM, 2018, EXP CELL RES, V369, P348, DOI 10.1016/j.yexcr.2018.05.039; Yuan J, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0708-1; Zanchi C, 2017, DIABETOLOGIA, V60, P1114, DOI 10.1007/s00125-017-4248-9; Zhang Q, 2015, ONCOTARGET, V6, P37335, DOI 10.18632/oncotarget.6135; Zheng L, 2017, MOL MED REP, V15, P1702, DOI 10.3892/mmr.2017.6208; Zhong YQW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098850; Zhou X, 2014, J BIOL CHEM, V289, P28827, DOI 10.1074/jbc.M114.596593; Zhou Z, 2017, DIABETES THER, V8, P555, DOI 10.1007/s13300-017-0256-5	43	32	35	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2703	2714		10.1096/fj.201901380RR	http://dx.doi.org/10.1096/fj.201901380RR		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916627				2022-12-28	WOS:000506442700001
J	Kim, JH; Ahn, JB; Kim, DH; Kim, S; Ma, HW; Che, X; Seo, DH; Kim, TI; Kim, WH; Cheon, JH; Kim, SW				Kim, J. H.; Ahn, J. B.; Kim, D. H.; Kim, S.; Ma, H. W.; Che, X.; Seo, D. H.; Kim, T. I.; Kim, W. H.; Cheon, J. H.; Kim, S. W.			Glutathione S-transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Kim, J. H.; Kim, D. H.; Ma, H. W.; Che, X.; Seo, D. H.; Kim, T. I.; Cheon, J. H.; Kim, S. W.] Yonsei Univ, Brain Korea 21 PLUS Project Med Sci, Coll Med, Seoul, South Korea; [Ahn, J. B.] Yonsei Univ, Dept Med, Coll Med, Seoul, South Korea; [Kim, S.; Kim, W. H.] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, S.; Kim, W. H.] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System			Cheon, Jae Hee/B-4523-2015	Cheon, Jae Hee/0000-0002-2282-8904; Kim, Seung Won/0000-0002-1692-1192; Kim, Soochan/0000-0002-2577-2969; Kim, Won Ho/0000-0002-5682-9972; Kim, Tae Il/0000-0003-4807-890X; KIM, JAEHYEON/0000-0003-0064-6656					0	9	9	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	JAN	2020	14			1		P105	S188	S188						1	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	KT1WK	31916636				2022-12-28	WOS:000518803401004
J	Locatelli, L; Cazzaniga, A; De Palma, C; Castiglioni, S; Maier, JAM				Locatelli, Laura; Cazzaniga, Alessandra; De Palma, Clara; Castiglioni, Sara; Maier, Jeanette A. M.			Mitophagy contributes to endothelial adaptation to simulated microgravity	FASEB JOURNAL			English	Article						cytoskeleton; HUVEC; mitochondria; RWV	CELL METABOLISM; AUTOPHAGY; STRESS; MITOCHONDRIA; CYTOSKELETON; PHOSPHORYLATION; GRAVITY; GROWTH	Exposure to real or simulated microgravity is sensed as a stress by mammalian cells, which activate a complex adaptive response. In human primary endothelial cells, we have recently shown the sequential intervention of various stress proteins which are crucial to prevent apoptosis and maintain cell function. We here demonstrate that mitophagy contributes to endothelial adaptation to gravitational unloading. After 4 and 10 d of exposure to simulated microgravity in the rotating wall vessel, the amount of BCL2 interacting protein 3, a marker of mitophagy, is increased and, in parallel, mitochondrial content, oxygen consumption, and maximal respiratory capacity are reduced, suggesting the acquisition of a thrifty phenotype to meet the novel metabolic challenges generated by gravitational unloading. Moreover, we suggest that microgravity induced-disorganization of the actin cytoskeleton triggers mitophagy, thus creating a connection between cytoskeletal dynamics and mitochondrial content upon gravitational unloading.	[Locatelli, Laura; Cazzaniga, Alessandra; Castiglioni, Sara; Maier, Jeanette A. M.] Univ Milan, Dept Biomed & Clin Sci L Sacco, Via GB Grassi 74, I-20157 Milan, Italy; [De Palma, Clara] ASST Fatebenefratelli Sacco, Luigi Sacco Univ Hosp, Unit Clin Pharmacol, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital	Maier, JAM (corresponding author), Univ Milan, Dept Biomed & Clin Sci L Sacco, Via GB Grassi 74, I-20157 Milan, Italy.	jeanette.maier@unimi.it	LOCATELLI, LAURA/AAP-4110-2021; De Palma, Clara/M-9842-2019; castiglioni, sara/H-9289-2012	LOCATELLI, LAURA/0000-0002-4568-7825; De Palma, Clara/0000-0003-0365-7414; Cazzaniga, Alessandra/0000-0001-7153-2256; castiglioni, sara/0000-0002-8785-9891	Agenzia Spaziale Italiana (ASI)	Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI))	Agenzia Spaziale Italiana (ASI), Grant/Award Number: ENDOSTEO Project	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Caja S, 2017, REDOX BIOL, V12, P821, DOI 10.1016/j.redox.2017.04.021; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Castiglioni S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16538; Cazzaniga A, 2019, FASEB J, V33, P5957, DOI 10.1096/fj.201801586RR; Cotrupi S, 2005, BBA-MOL CELL RES, V1746, P163, DOI 10.1016/j.bbamcr.2005.10.002; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Espinosa-Jeffrey A, 2016, J NEUROSCI RES, V94, P1434, DOI 10.1002/jnr.23958; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Feger BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34091; Garcia-Cardena G, 2006, Handb Exp Pharmacol, P79; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/NCHEMBIO.2287, 10.1038/nchembio.2287]; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Griffoni C, 2011, J CELL BIOCHEM, V112, P265, DOI 10.1002/jcb.22921; Grimm D, 2014, TISSUE ENG PART B-RE, V20, P555, DOI [10.1089/ten.teb.2013.0704, 10.1089/ten.TEB.2013.0704]; Helmlinger G, 2000, NATURE, V405, P139, DOI 10.1038/35012132; Indo HP, 2016, SCI REP-UK, V6, DOI 10.1038/srep39015; Janmaleki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32418; Jeong AJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32965-3; Kapitonova M Y, 2012, Malays J Pathol, V34, P103; Kapitonova MY, 2013, B EXP BIOL MED+, V154, P796, DOI 10.1007/s10517-013-2059-7; Kast DJ, 2017, CURR BIOL, V27, pR318, DOI 10.1016/j.cub.2017.02.061; King JS, 2012, TRENDS MOL MED, V18, P583, DOI 10.1016/j.molmed.2012.08.002; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kunz WS, 2003, EXP PHYSIOL, V88, P149, DOI 10.1113/eph8802512; Li CF, 2019, APOPTOSIS, V24, P812, DOI 10.1007/s10495-019-01560-w; Li CF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0185-2; Maier JAM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/434803; Mariotti M, 2008, J CELL BIOCHEM, V104, P129, DOI 10.1002/jcb.21605; Martinez EM, 2015, AM J PHYSIOL-REG I, V308, pR480, DOI 10.1152/ajpregu.00449.2014; Michaletti A., 2017, SCI REP, V7, P1; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Moore AS, 2018, CURR OPIN PHYSIOL, V3, P94, DOI 10.1016/j.cophys.2018.03.003; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Rohlenova K, 2018, TRENDS CELL BIOL, V28, P224, DOI 10.1016/j.tcb.2017.10.010; Strzyz P, 2018, NAT REV MOL CELL BIO, V19, P212, DOI 10.1038/nrm.2018.16; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Wang YC, 2013, BIOCHEM CELL BIOL, V91, P309, DOI 10.1139/bcb-2013-0029; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243	48	21	21	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1833	1845		10.1096/fj.201901785RRR	http://dx.doi.org/10.1096/fj.201901785RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914607	Green Published			2022-12-28	WOS:000507308900121
J	Delitsikou, V; Jarad, G; Rajaram, RD; Ino, F; Rutkowski, JM; Chen, CD; Santos, CXC; Scherer, PE; Abraham, CR; Shah, AM; Feraille, E; Miner, JH; de Seigneux, S				Delitsikou, Vasiliki; Jarad, George; Rajaram, Renuga Devi; Ino, Frederique; Rutkowski, Joseph M.; Chen, Ci-Di; Santos, Celio X. C.; Scherer, Philipp E.; Abraham, Carmela R.; Shah, Ajay M.; Feraille, Eric; Miner, Jeffrey H.; de Seigneux, Sophie			Klotho regulation by albuminuria is dependent on ATF3 and endoplasmic reticulum stress	FASEB JOURNAL			English	Article						albuminuria; ATF3; CKD; ER stress; Klotho	CHRONIC KIDNEY-DISEASE; TRANSCRIPTS ENCODING MEMBRANE; GLOMERULAR-FILTRATION-RATE; ALPHA-KLOTHO; SECRETED KLOTHO; RENAL FIBROSIS; PROTEIN; GENE; PROGRESSION; PHOSPHATE	Proteinuria is associated with renal function decline and cardiovascular mortality. This association may be attributed in part to alterations of Klotho expression induced by albuminuria, yet the underlying mechanisms are unclear. The presence of albumin decreased Klotho expression in the POD-ATTAC mouse model of proteinuric kidney disease as well as in kidney epithelial cell lines. This downregulation was related to both decreased Klotho transcription and diminished protein half-life, whereas cleavage by ADAM proteases was not modified. The regulation was albumin specific since it was neither observed in the analbuminemic Col4 alpha 3(-/-) Alport mice nor induced by exposure of kidney epithelial cells to purified immunoglobulins. Albumin induced features of ER stress in renal tubular cells with ATF3/ATF4 activation. ATF3 and ATF4 induction downregulated Klotho through altered transcription mediated by their binding on the Klotho promoter. Inhibiting ER stress with 4-PBA decreased the effect of albumin on Klotho protein levels without altering mRNA levels, thus mainly abrogating the increased protein degradation. Taken together, albuminuria decreases Klotho expression through increased protein degradation and decreased transcription mediated by ER stress induction. This implies that modulating ER stress may improve proteinuria-induced alterations of Klotho expression, and hence renal and extrarenal complications associated with Klotho loss.	[Delitsikou, Vasiliki; Rajaram, Renuga Devi; Ino, Frederique; Feraille, Eric; de Seigneux, Sophie] Univ Geneva, Dept Cell Physiol & Metab, Fac Med, CMU, Geneva, Switzerland; [Delitsikou, Vasiliki; Rajaram, Renuga Devi; Ino, Frederique; de Seigneux, Sophie] HUG, Dept Internal Med Specialties, Lab Nephrol, Rue Michel Servet 1, CH-1205 Geneva, Switzerland; [Jarad, George; Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Med, Div Nephrol, St Louis, MO 63110 USA; [Rutkowski, Joseph M.; Scherer, Philipp E.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX USA; [Rutkowski, Joseph M.] Texas A&M Coll Med, Dept Med Physiol, College Stn, TX USA; [Chen, Ci-Di; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Santos, Celio X. C.; Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr Excellence, Sch Cardiovasc Med & Sci, London, England	University of Geneva; University of Geneva; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Boston University; University of London; King's College London	de Seigneux, S (corresponding author), HUG, Dept Internal Med Specialties, Lab Nephrol, Rue Michel Servet 1, CH-1205 Geneva, Switzerland.	Sophie.deSeigneux@hcuge.ch		Feraille, Eric/0000-0003-1656-8365; Shah, Ajay/0000-0002-6547-0631	Swiss National Science Foundation [PP00P3_157454]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Grant/Award Number: PP00P3_157454	Banerjee S, 2013, CELL PHYSIOL BIOCHEM, V31, P659, DOI 10.1159/000350085; Barker SL, 2015, NEPHROL DIAL TRANSPL, V30, P223, DOI 10.1093/ndt/gfu291; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen CD, 2014, BIOCHEMISTRY-US, V53, P5579, DOI 10.1021/bi500409n; Cheng YC, 2015, J BIOCHEM, V158, P101, DOI 10.1093/jb/mvv020; Choi YM, 2014, BIOCHEM BIOPH RES CO, V448, P182, DOI 10.1016/j.bbrc.2014.04.083; Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129; de Seigneux S, 2019, NEPHROL DIAL TRANSPL, pgfz083; de Seigneux S, 2015, J AM SOC NEPHROL, V26, P1608, DOI 10.1681/ASN.2014010104; Dizin E, 2013, AM J PHYSIOL-RENAL, V305, pF1053, DOI 10.1152/ajprenal.00006.2013; El Karoui K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10330; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072344; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fernandez-Fernandez B, 2018, NEPHROL DIAL TRANSPL, V33, P1712, DOI 10.1093/ndt/gfx376; GALASKE RG, 1979, KIDNEY INT, V16, P394, DOI 10.1038/ki.1979.142; Goncalves GL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36933-9; Gonin S, 2001, MOL BIOL CELL, V12, P255, DOI 10.1091/mbc.12.2.255; Hage V, 2014, J RENAL NUTR, V24, P390, DOI 10.1053/j.jrn.2014.06.009; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; He FF, 2011, GENE, V484, P18, DOI 10.1016/j.gene.2011.05.025; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hsu SC, 2014, INT J BIOCHEM CELL B, V53, P361, DOI 10.1016/j.biocel.2014.06.002; Hu MC, 2017, KIDNEY INT, V91, P1104, DOI 10.1016/j.kint.2016.10.034; Hu MC, 2016, J AM SOC NEPHROL, V27, P79, DOI 10.1681/ASN.2014101030; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Hu Y, 2016, MOL MED REP, V14, P3229, DOI 10.3892/mmr.2016.5601; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Jarad G, 2016, AM J PHYSIOL-RENAL, V311, pF120, DOI 10.1152/ajprenal.00456.2015; Karalliedde J, 2010, J AM SOC NEPHROL, V21, P2020, DOI 10.1681/ASN.2010030250; Kim H, 2019, NEPHROL DIAL TRANSPL, pgfy403; King GD, 2012, BIOCHEM J, V441, P453, DOI 10.1042/BJ20101909; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lee EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102984; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li HF, 2010, J AM SOC NEPHROL, V21, P1003, DOI 10.1681/ASN.2009070690; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu QF, 2015, IRAN J KIDNEY DIS, V9, P291; Liu SH, 2016, ONCOTARGET, V7, P22116, DOI 10.18632/oncotarget.7904; Maltese G, 2017, DIABETOLOGIA, V60, P911, DOI 10.1007/s00125-017-4219-1; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mencke R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94375; Nie F, 2017, J DIABETES COMPLICAT, V31, P594, DOI 10.1016/j.jdiacomp.2016.11.008; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Qi W, 2011, METABOLISM, V60, P594, DOI 10.1016/j.metabol.2010.07.021; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ravikumar P, 2014, AM J PHYSIOL-LUNG C, V307, pL566, DOI 10.1152/ajplung.00306.2013; Remuzzi G, 2004, KIDNEY INT, V66, pS90, DOI 10.1111/j.1523-1755.2004.09221.x; Rutkowski JM, 2017, KIDNEY INT, V91, P324, DOI 10.1016/j.kint.2016.09.016; Rutkowski JM, 2013, J AM SOC NEPHROL, V24, P268, DOI 10.1681/ASN.2012040414; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Saito K, 2003, FEBS LETT, V551, P58, DOI 10.1016/S0014-5793(03)00894-9; Santos CXC, 2016, EMBO J, V35, P319, DOI 10.15252/embj.201592394; Schuh CD, 2018, J AM SOC NEPHROL, V29, P2696, DOI 10.1681/ASN.2018050522; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; TOJO A, 1992, AM J PHYSIOL, V263, pF601, DOI 10.1152/ajprenal.1992.263.4.F601; Tonelli M, 2011, ANN INTERN MED, V154, P12, DOI 10.7326/0003-4819-154-1-201101040-00003; Williams MJ, 2018, KIDNEY INT, V93, P147, DOI 10.1016/j.kint.2017.06.016; Wu XW, 2010, OMICS, V14, P61, DOI 10.1089/omi.2009.0073; Yoshida T, 2008, J AM SOC NEPHROL, V19, P217, DOI 10.1681/ASN.2005111155; Yum V, 2017, AM J PHYSIOL-RENAL, V312, pF230, DOI 10.1152/ajprenal.00119.2016; Zhang H, 2018, J MOL MED, V96, P53, DOI 10.1007/s00109-017-1601-x; Zhang SQ, 2013, KIDNEY INT, V84, P713, DOI 10.1038/ki.2013.194; Zhou TBT, 2013, J BIOL CHEM, V288, P36302, DOI 10.1074/jbc.M113.490052	72	12	14	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2087	2104		10.1096/fj.201900893R	http://dx.doi.org/10.1096/fj.201900893R		DEC 2019	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907991	Green Published, Bronze			2022-12-28	WOS:000504094300001
J	Chen, YQ; Park, HJ; Park, J; Song, HC; Ryter, SW; Surh, YJ; Kim, UH; Joe, Y; Chung, HT				Chen, Yingqing; Park, Hyeok-Jun; Park, Jeongmin; Song, Hyun-Chul; Ryter, Stefan W.; Surh, Young-Joon; Kim, Uh-Hyun; Joe, Yeonsoo; Chung, Hun Taeg			Carbon monoxide ameliorates acetaminophen-induced liver injury by increasing hepatic HO-1 and Parkin expression	FASEB JOURNAL			English	Article						hepatotoxicity; heme oxygenase-1; reactive oxygen species; PERK; CHOP	INDUCED HEPATOTOXICITY; INDUCED APOPTOSIS; PROTECTS; STRESS; KINASE; MICE; MITOCHONDRIA; DYSFUNCTION; ACTIVATION; AUTOPHAGY	Acetaminophen (APAP) is widely used as an antifebrile and analgesic drug at recommended doses, whereas an overdose of APAP can cause severe liver damage. The molecular mechanisms underlying APAP-induced liver damage remain incompletely understood. Carbon monoxide (CO), an end-product of heme oxygenase (HO)-1 activity, can confer anti-inflammatory and antiapoptotic properties in cellular models of toxicity via regulation of mitochondrial function. The objective of this study was to evaluate the effects of CO on APAP-induced hepatotoxicity and CO's relationship to regulation of endoplasmic reticulum (ER) stress and mitochondrial signaling using CO-releasing molecules or low concentrations of CO applied as pretreatment or post-treatment. Using genetic deletion or knockdown approaches in alpha mouse liver cells or primary hepatocytes, respectively, we investigated the role of HO-1 and the mitophagy regulator protein Parkin on APAP-induced expression of the ER stress associated apoptosis regulator cytosine-cytosine-adenosine-adenosine-thymidine (CCAAT)/enhancer-binding protein homologous protein (CHOP). We found that CO induced Parkin expression in hepatocytes via the protein kinase RNA-like ER kinase/eukaryotic translation initiation factor 2-alpha/activating transcription factor-4 signaling pathway. Additionally, CO gas inhalation significantly alleviated APAP-induced liver damage in vivo and correspondingly reduced serum alanine aminotransferase and aspartate aminotransferase levels as well as proinflammatory cytokines and reduced the expression of CHOP in liver tissues while dramatically increasing hepatic HO-1 and Parkin expression. We found that the protective effects of CO on APAP-induced liver damage were mediated by down-regulation of CHOP at a transcriptional and post-translational level via induction of HO-1 and Parkin, respectively, and associated with decreases in reactive oxygen species production and JNK phosphorylation. We conclude that CO may represent a promising therapeutic agent for APAP-induced liver injury.	[Chen, Yingqing; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju, South Korea; [Chen, Yingqing] Dalian Univ, Coll Med, Dept Pharmacol, Dalian, Peoples R China; [Park, Hyeok-Jun; Park, Jeongmin; Song, Hyun-Chul; Joe, Yeonsoo; Chung, Hun Taeg] Univ Ulsan, Dept Biol Sci, Ulsan 44610, South Korea; [Ryter, Stefan W.] Weill Cornell Med Ctr, Joan & Sanford I Weill Dept Med, Div Pulm & Crit Care Med, New York, NY USA; [Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea	Jeonbuk National University; Dalian University; University of Ulsan; Cornell University; Seoul National University (SNU); Seoul National University (SNU)	Joe, Y (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 44610, South Korea.; Chung, HT (corresponding author), Univ Ulsan, Meta Inflammat Res Inst Basic Res, Dept Biol Sci, Bldg 35,Room 807, Ulsan 44610, South Korea.	jcantibody@ulsan.ac.kr; chung@ulsan.ac.kr	Chen, Yingqing/AAH-1367-2020	Chen, Yingqing/0000-0003-2326-7587	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A6A1030318, NRF-2012R1A3A2026453, NRF-2017R1A6A3A11031089]	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A6A1030318 to H. T.C., NRF-2012R1A3A2026453 to U.-H.K., and NRF-2017R1A6A3A11031089 to Y.J.). Y. C. and H.-J.P. contributed equally to this work as cofirst authors. The authors declare no conflicts of interest.	Blough ER, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00072; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Ding WX, 2011, AUTOPHAGY, V7, P248, DOI 10.4161/auto.7.2.14347; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Du K, 2015, EXPERT OPIN DRUG MET, V11, P1769, DOI 10.1517/17425255.2015.1071353; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Han K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02339-2; Hill S, 2014, REDOX BIOL, V2, P936, DOI 10.1016/j.redox.2014.07.005; Hishiki T, 2012, J MOL MED, V90, P245, DOI 10.1007/s00109-012-0875-2; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; Joe Y, 2018, FASEB J, V32, P2630, DOI 10.1096/fj.201700709RR; Katada K, 2010, INFLAMMATION, V33, P92, DOI 10.1007/s10753-009-9162-y; Kim HJ, 2017, FREE RADICAL BIO MED, V110, P81, DOI 10.1016/j.freeradbiomed.2017.05.026; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Kyokane T, 2001, GASTROENTEROLOGY, V120, P1227, DOI 10.1053/gast.2001.23249; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lawendy AR, 2014, J ORTHOP TRAUMA, V28, pE263, DOI 10.1097/BOT.0000000000000097; Lee YI, 2016, NEUROBIOL AGING, V41, P1, DOI 10.1016/j.neurobiolaging.2015.11.008; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; Matsumaru K, 2003, HEPATOLOGY, V37, P1425, DOI 10.1053/jhep.2003.50230; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Moles A, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00453; Motterlini R, 2004, FASEB J, V18, P284, DOI 10.1096/fj.04-2169fje; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Ndisang JF, 2004, J HYPERTENS, V22, P1057, DOI 10.1097/00004872-200406000-00002; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Obara Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05456-0; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Qin SY, 2015, INFLAMM RES, V64, P537, DOI 10.1007/s00011-015-0834-9; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Serizawa F, 2015, MICROCIRCULATION, V22, P28, DOI 10.1111/micc.12161; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Song RP, 2003, AM J PATHOL, V163, P231, DOI 10.1016/S0002-9440(10)63646-2; Takagi T, 2011, DIGEST DIS SCI, V56, P1663, DOI 10.1007/s10620-010-1484-y; Upadhyay KK, 2018, TOXICOL APPL PHARM, V360, P99, DOI 10.1016/j.taap.2018.09.034; Uzi D, 2013, J HEPATOL, V59, P495, DOI 10.1016/j.jhep.2013.04.024; Wang X, 2018, PHYTOMEDICINE, V38, P90, DOI 10.1016/j.phymed.2017.11.007; Wei YW, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-42; Williams JA, 2015, J BIOL CHEM, V290, P10934, DOI 10.1074/jbc.M114.602284; Winklhofer KF, 2014, TRENDS CELL BIOL, V24, P332, DOI 10.1016/j.tcb.2014.01.001; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yan HM, 2010, TOXICOL SCI, V117, P515, DOI 10.1093/toxsci/kfq208; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003	46	11	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13905	13919		10.1096/fj.201901258RR	http://dx.doi.org/10.1096/fj.201901258RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31645120	Bronze			2022-12-28	WOS:000507466100066
J	Guellec, J; Elbahnsi, A; Le Tertre, M; Uguen, K; Gourlaouen, I; Ferec, C; Ka, C; Callebaut, I; Le Gac, G				Guellec, Julie; Elbahnsi, Ahmad; Le Tertre, Marlene; Uguen, Kevin; Gourlaouen, Isabelle; Ferec, Claude; Ka, Chandran; Callebaut, Isabelle; Le Gac, Gerald			Molecular model of the ferroportin intracellular gate and implications for the human iron transport cycle and hemochromatosis type 4A	FASEB JOURNAL			English	Article						MFS transporters; gating residues; alternating access mechanism; molecular dynamics simulations; iron metabolism	SLC40A1 GENE; MUTATIONS; DISEASE; FAMILY; HYPERFERRITINEMIA; HEPCIDIN; CONSEQUENCES; MECHANISM; DIAGNOSIS; DYNAMICS	Ferroportin 1 (FPN1) is a major facilitator superfamily transporter that is essential for proper maintenance of human iron homeostasis at the systemic and cellular level. FPN1 dysfunction leads to the progressive accumulation of iron in reticuloendothelial cells, causing hemochromatosis type 4A (or ferroportin disease), an autosomal dominant disorder that displays large phenotypic heterogeneity. Although crystal structures have unveiled the outward- and inward-facing conformations of the bacterial homolog Bdellovibrio bacteriovorus Fpn (or Bd2019) and calcium has recently been identified as an essential cofactor, our molecular understanding of the iron transport mechanism remains incomplete. Here, we used a combination of molecular modeling, molecular dynamics simulations, and Ala site-directed mutagenesis, followed by complementary in vitro functional analyses, to explore the structural architecture of the human FPN1 intracellular gate. We reveal an interdomain network that involves 5 key amino acids and is likely very important for stability of the iron exporter facing the extracellular milieu. We also identify inter- and intradomain interactions that rely on the 2 Asp84 and Asn174 critical residues and do not exist in the bacterial homolog. These interactions are thought to play an important role in the modulation of conformational changes during the transport cycle. We interpret these results in the context of hemochromatosis type 4A, reinforcing the idea that different categories of loss-of-function mutations exist. Our findings provide an unprecedented view of the human FPN1 outward-facing structure and the particular function of the so-called "gating residues" in the mechanism of iron export.	[Guellec, Julie; Le Tertre, Marlene; Uguen, Kevin; Gourlaouen, Isabelle; Ferec, Claude; Ka, Chandran; Le Gac, Gerald] Univ Brest, Univ Bretagne Loire, Etab Francais Sang Bretagne, INSERM,UMR 1078,Inst Brestois Sante Agromatiere, Brest, France; [Guellec, Julie; Ferec, Claude] Assoc Gaetan Saleun, Brest, France; [Elbahnsi, Ahmad; Callebaut, Isabelle] Sorbonne Univ, Museum Natl Hist Nat, Inst Mineral Phys Mat & Cosmochim, UMR CNRS 7590,IMPMC, Paris, France; [Le Tertre, Marlene; Uguen, Kevin; Ferec, Claude; Ka, Chandran; Le Gac, Gerald] CHRU Brest, Hop Morvan, Serv Genet Med, Brest, France; [Ka, Chandran; Le Gac, Gerald] Lab Excellence Lab Excellence GR Ex, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); CHU Brest; Universite de Bretagne Occidentale	Le Gac, G (corresponding author), Ctr Hosp Reg Univ Brest, Hop Morvan, Lab Gent Mol & Histocompatibil, Bat 5Bis,2 Ave Foch, F-29200 Brest, France.	gerald.legac@univ-brest.fr	Le Gac, Gérald/AFQ-1679-2022; Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710; Elbahnsi, Ahmad/0000-0002-5356-2440	French Association "Vaincre La Mucoviscidose"; Grand Equipement National de Calcul Intensif (GENCI)/Centre Informatique National de l'Enseignement Superieur (CINES) [2017-A0020707206, 2018-A0040707206, 2019-A0060707206]; French Hospital Clinical Research Program (Progamme Hospitalier de Recherche Clinique 2009; Brest University Hospital) [UF0857]; Gaetan Saleun Association, and the Laboratory of Excellence (GR-Ex) [ANR-11-LABX0051]; Investissement D'avenir d'Excellence (IdEx) program "Investissements d'avenir" of the French National Research Agency [ANR-18-IDEX-0001]	French Association "Vaincre La Mucoviscidose"; Grand Equipement National de Calcul Intensif (GENCI)/Centre Informatique National de l'Enseignement Superieur (CINES); French Hospital Clinical Research Program (Progamme Hospitalier de Recherche Clinique 2009; Brest University Hospital); Gaetan Saleun Association, and the Laboratory of Excellence (GR-Ex); Investissement D'avenir d'Excellence (IdEx) program "Investissements d'avenir" of the French National Research Agency(French National Research Agency (ANR))	The authors thank George Gao and Alain R.M. Townsend (Weatherall Institute, Oxford University, Oxford, United Kingdom) for the generous gift of the CD8 expression vector. The protocol used for molecular dynamics simulation was developed during the research work on the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, which was supported by the French Association "Vaincre La Mucoviscidose," and performed using High-Performance Computing (HPC) resources from Grand Equipement National de Calcul Intensif (GENCI)/Centre Informatique National de l'Enseignement Superieur (CINES) (Grants 2017-A0020707206, 2018-A0040707206, and 2019-A0060707206). This work was also supported by grants from the French Hospital Clinical Research Program (Progamme Hospitalier de Recherche Clinique 2009; Brest University Hospital; UF0857), the Gaetan Saleun Association, and the Laboratory of Excellence (GR-Ex) (ANR-11-LABX0051). The labex GR-Ex is funded by the Investissement D'avenir d'Excellence (IdEx) program "Investissements d'avenir" of the French National Research Agency (ANR-18-IDEX-0001). The authors declare no conflicts of interest.	Bach V, 2006, BLOOD CELL MOL DIS, V36, P41, DOI 10.1016/j.bcmd.2005.09.001; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Callebaut I, 2014, HUM MOL GENET, V23, P4479, DOI 10.1093/hmg/ddu160; Corradi V, 2019, CHEM REV, V119, P5775, DOI 10.1021/acs.chemrev.8b00451; Corradini E, 2005, BLOOD CELL MOL DIS, V35, P315, DOI 10.1016/j.bcmd.2005.07.010; Cunat S, 2007, CLIN CHEM, V53, P2060, DOI 10.1373/clinchem.2007.090605; De Domenico I, 2006, HAEMATOLOGICA, V91, P1092; Deshpande CN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05446-4; di Patti MCB, 2014, FEBS J, V281, P2851, DOI 10.1111/febs.12825; di Patti MCB, 2015, FEBS LETT, V589, P3829, DOI 10.1016/j.febslet.2015.11.025; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Fowler PW, 2015, STRUCTURE, V23, P290, DOI 10.1016/j.str.2014.12.012; Frazer DM, 2017, AM J CLIN NUTR, V105, P1255, DOI 10.3945/ajcn.117.158188; Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112; Griffiths WJH, 2010, HEPATOLOGY, V51, P788, DOI 10.1002/hep.23377; Hart K, 2012, J CHEM THEORY COMPUT, V8, P348, DOI 10.1021/ct200723y; Hattori A, 2012, PATHOL INT, V62, P612, DOI 10.1111/j.1440-1827.2012.02848.x; Heinz LP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25061-z; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hetet G, 2003, BLOOD, V102, P1904, DOI 10.1182/blood-2003-02-0439; Hoffmann B, 2018, CELL MOL LIFE SCI, V75, P3829, DOI 10.1007/s00018-018-2835-7; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jo S, 2017, J COMPUT CHEM, V38, P1114, DOI 10.1002/jcc.24660; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jouanolle AM, 2003, J HEPATOL, V39, P286, DOI 10.1016/S0168-8278(03)00148-X; Ka C, 2005, HUM GENET, V117, P467, DOI 10.1007/s00439-005-1307-y; Ka C, 2018, HAEMATOLOGICA, V103, P1796, DOI 10.3324/haematol.2018.189845; Kaneko Y, 2010, J GASTROENTEROL, V45, P1163, DOI 10.1007/s00535-010-0259-8; Koyama C, 2005, INTERNAL MED, V44, P990, DOI 10.2169/internalmedicine.44.990; Lamoureux G, 2006, J PHYS CHEM B, V110, P3308, DOI 10.1021/jp056043p; Latorraca NR, 2017, CELL, V169, P96, DOI 10.1016/j.cell.2017.03.010; Le Gac G, 2013, HUM MUTAT, V34, P1371, DOI 10.1002/humu.22369; Majore S, 2018, BBA-MOL BASIS DIS, V1864, P464, DOI 10.1016/j.bbadis.2017.11.006; Martens C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06704-1; Muehlenberg K, 2014, Z GASTROENTEROL, V52, P1075, DOI 10.1055/s-0034-1366809; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pelucchi S, 2008, CLIN GENET, V73, P171, DOI 10.1111/j.1399-0004.2007.00950.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pietrangelo A, 2017, HAEMATOLOGICA, V102, P1972, DOI 10.3324/haematol.2017.170720; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Saja K, 2010, BRIT J HAEMATOL, V149, P914, DOI 10.1111/j.1365-2141.2010.08137.x; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Speletas M, 2008, BLOOD CELL MOL DIS, V40, P353, DOI 10.1016/j.bcmd.2007.09.011; Stelzl LS, 2014, J MOL BIOL, V426, P735, DOI 10.1016/j.jmb.2013.10.024; Taniguchi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9545; Vlasveld LT, 2018, HAEMATOLOGICA, V103, P1753, DOI 10.3324/haematol.2018.203315; Wallace DF, 2017, AM J HEMATOL, V92, P1052, DOI 10.1002/ajh.24844; Wallace DF, 2010, AM J PHYSIOL-CELL PH, V298, pC75, DOI 10.1152/ajpcell.00621.2008; Wang YW, 2017, INT J HEMATOL, V105, P521, DOI 10.1007/s12185-016-2150-8; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Yamashita T, 2014, CLIN J GASTROENTEROL, V7, P260, DOI 10.1007/s12328-014-0487-1	54	6	6	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14625	14635		10.1096/fj.201901857R	http://dx.doi.org/10.1096/fj.201901857R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690120	Green Submitted, Bronze			2022-12-28	WOS:000507466100120
J	Zhao, DN; Zhang, SX; Wang, XQ; Gao, D; Liu, J; Cao, K; Chen, L; Liu, R; Liu, JK; Long, JG				Zhao, Daina; Zhang, Shuangxi; Wang, Xueqiang; Gao, Dan; Liu, Jing; Cao, Ke; Chen, Lei; Liu, Run; Liu, Jiankang; Long, Jiangang			ATG7 regulates hepatic Akt phosphorylation through the c-JUN/PTEN pathway in high fat diet-induced metabolic disorder	FASEB JOURNAL			English	Article						autophagy-related protein; transcriptional regulation; insulin signaling	INSULIN-RESISTANCE; MITOCHONDRIAL CLEARANCE; CELL-DEATH; ER STRESS; AUTOPHAGY; TRANSCRIPTION; PTEN; DELETION; CONTRIBUTES; DYSFUNCTION	Growing evidence has suggested that autophagy-related protein 7 (ATG7) plays an important role in insulin signaling, but the mechanism of ATG7 in hepatic insulin sensitivity is not fully understood. The purpose of the present study is to clarify the underlying molecular mechanisms of ATG7 in obesity development. Serum and liver samples from mice fed a high fat diet (HFD) were evaluated for metabolic profile data and ATG expressions during obesity development. We found that compared with other ATGs, ATG7 expression increased earlier with lower hepatic insulin sensitivity in the 4-wk HFD-fed mice. For in vitro analyses, silencing ATG7 significantly up-regulated insulin-stimulated phosphorylation of protein kinase B (Akt) and down-regulated phosphatase and tension homolog deleted on chromosome ten (PTEN) in HepG2 cells. Replenishing PTEN to ATG7-silenced hepatocytes restored the phosphorylated Akt level. Furthermore, ATG7 silencing led to higher c-JUN expression, which transcriptionally reduced PTEN expression. These results reveal a novel mechanism by which ATG7 regulates Akt phosphorylation via the c-JUN/PTEN pathway at the early stage of HFD-induced metabolic disorder.	[Zhao, Daina; Zhang, Shuangxi; Wang, Xueqiang; Liu, Jing; Cao, Ke; Chen, Lei; Liu, Run; Liu, Jiankang; Long, Jiangang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn,Minist Educ, 28 West Xianning Rd, Xian 710049, Shannxi, Peoples R China; [Zhao, Daina; Zhang, Shuangxi; Wang, Xueqiang; Liu, Jing; Cao, Ke; Chen, Lei; Liu, Run; Liu, Jiankang; Long, Jiangang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, 28 West Xianning Rd, Xian 710049, Shannxi, Peoples R China; [Gao, Dan] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Anat Histol & Embryol, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Long, JG (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn,Minist Educ, 28 West Xianning Rd, Xian 710049, Shannxi, Peoples R China.; Long, JG (corresponding author), Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, 28 West Xianning Rd, Xian 710049, Shannxi, Peoples R China.	jglong@mail.xjtu.edu.cn	LIU, JING/ABA-6639-2021	LIU, JING/0000-0002-3113-4015; Chen, Lei/0000-0001-5596-127X; Jiangang, Long/0000-0001-8074-957X	Major State Basic Research Development Program [2015CB856302, 2015CB553602]; National Natural Science Foundation of China [31870848, 81741110]; Natural Science Foundation of Shaanxi [2018JZ3005]	Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi(Natural Science Foundation of Shaanxi Province)	This study was supported by the Major State Basic Research Development Program (2015CB856302 and 2015CB553602), the National Natural Science Foundation of China (31870848 and 81741110), and the Natural Science Foundation of Shaanxi (2018JZ3005). The authors declare no conflicts of interest.	Dunn C, 2002, CELL SIGNAL, V14, P585, DOI 10.1016/S0898-6568(01)00275-3; Eslam M, 2011, GUT, V60, P1139, DOI 10.1136/gut.2010.228262; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Guan ZF, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0070-4; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kang YH, 2016, ONCOTARGET, V7, P35577, DOI 10.18632/oncotarget.9590; Kessel DH, 2012, AUTOPHAGY, V8, P1333, DOI 10.4161/auto.20792; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kitade H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040387; Li AQ, 2017, CURR PHARM DESIGN, V23, P3667, DOI 10.2174/1381612823666170704124611; Li HX, 2014, CELL CYCLE, V13, P565, DOI 10.4161/cc.27406; Li JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141168; Li SL, 2013, J BIOL CHEM, V288, P30094, DOI 10.1074/jbc.M113.494286; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Meijer AJ, 2008, CELL METAB, V8, P275, DOI 10.1016/j.cmet.2008.09.001; Mortensen M, 2010, AUTOPHAGY, V6, P423, DOI 10.4161/auto.6.3.11528; Naderali E, 2018, MOL BIOL REP, V45, P2869, DOI 10.1007/s11033-018-4321-6; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Saha S, 2018, BIOMED PHARMACOTHER, V104, P485, DOI 10.1016/j.biopha.2018.05.007; Shams F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42602-2; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wang HN, 2014, CELL RES, V24, P852, DOI 10.1038/cr.2014.70; Wang L, 2015, CELL PHYSIOL BIOCHEM, V36, P2357, DOI 10.1159/000430198; Wei W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18427-2; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Xiao F, 2019, MOL METAB, V20, P138, DOI 10.1016/j.molmet.2018.12.003; Xie CC, 2016, AUTOPHAGY, V12, P410, DOI 10.1080/15548627.2015.1132134; Yan J, 2012, J NUTR BIOCHEM, V23, P716, DOI 10.1016/j.jnutbio.2011.03.014; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/145641; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8152, DOI 10.1002/jcp.27603; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhou XD, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.313	43	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14296	14306		10.1096/fj.201901414RR	http://dx.doi.org/10.1096/fj.201901414RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31645130	Bronze			2022-12-28	WOS:000507466100096
J	Chen, YC; Su, YC; Shieh, GS; Su, BH; Su, WC; Huang, PH; Jiang, ST; Shiau, AL; Wu, CL				Chen, Yi-Cheng; Su, Yu-Chu; Shieh, Gia-Shing; Su, Bing-Hua; Su, Wen-Cheng; Huang, Pei-Hsin; Jiang, Si-Tse; Shiau, Ai-Li; Wu, Chao-Liang			Prothymosin alpha promotes STAT3 acetylation to induce cystogenesis in Pkd1-deficient mice	FASEB JOURNAL			English	Article						polycystic kidney disease; HDAC3; tubulogenesis	POLYCYSTIC KIDNEY-DISEASE; CYSTIC KIDNEY; PRIMARY CILIA; OVEREXPRESSION; ACTIVATION; PHOSPHORYLATION; TRANSCRIPTION; MODULATION; EXPRESSION; PROTEIN	Polycystic kidney disease (PKD) is characterized by the expansion of fluid-filled cysts in the kidney, which impair the function of kidney and eventually leads to end-stage renal failure. It has been previously demonstrated that transgenic overexpression of prothymosin alpha (ProT) induces the development of PKD; however, the underlying mechanisms remain unclear. In this study, we used a mouse PKD model that sustains kidney-specific low-expression of Pkd1 to illustrate that aberrant up-regulation of ProT occurs in cyst-lining epithelial cells, and we further developed an in vitro cystogenesis model to demonstrate that the suppression of ProT is sufficient to reduce cyst formation. Next, we found that the expression of ProT was accompanied with prominent augmentation of protein acetylation in PKD, which results in the activation of downstream signal transducer and activator of transcription (STAT) 3. The pathologic role of STAT3 in PKD has been previously reported. We determined that this molecular mechanism of protein acetylation is involved with the interaction between ProT and STAT3; consequently, it causes the deprivation of histone deacetylase 3 from the indicated protein. Conclusively, these results elucidate the significant role of ProT, including protein acetylation and STAT3 activation in PKD, which represent potential for ameliorating the disease progression of PKD.	[Chen, Yi-Cheng; Su, Yu-Chu; Su, Bing-Hua; Su, Wen-Cheng; Wu, Chao-Liang] Natl Cheng Kung Univ Hosp, Dept Biochem & Mol Biol, Tainan, Taiwan; [Su, Yu-Chu] Natl Cheng Kung Univ Hosp, Dept Otolaryngol, Tainan, Taiwan; [Shiau, Ai-Li] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, 1 Univ Rd, Tainan 70101, Taiwan; [Shieh, Gia-Shing] Minist Hlth & Welf Execut Yuan, Tainan Hosp, Dept Urol, Tainan, Taiwan; [Huang, Pei-Hsin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Jiang, Si-Tse] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital; National Applied Research Laboratories - Taiwan	Shiau, AL (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, 1 Univ Rd, Tainan 70101, Taiwan.; Wu, CL (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, 1 Univ Rd, Tainan 70101, Taiwan.	alshiau@mail.ncku.edu.tw; wumolbio@mail.ncku.edu.tw		Chen, Yi-Cheng/0000-0002-7255-2176	Ministry of Science and Technology (MOST) [103-2320-B-006-047-MY3, 105-2320-B-006-038-MY3]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	The authors are grateful to Dr. A. B. Vartapetian (Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia) for generously providing the anti-ProT mAb (clone 2F11). The RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center (Academia Sinica, Taipei, Taiwan). This work was supported by grants from the Ministry of Science and Technology (MOST) (103-2320-B-006-047-MY3 and 105-2320-B-006-038-MY3). The authors declare no conflicts of interest.	Avasthi P, 2017, RESULTS PROBL CELL D, V60, P281, DOI 10.1007/978-3-319-51436-9_11; Battini L, 2006, J AM SOC NEPHROL, V17, P3049, DOI 10.1681/ASN.2006030234; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Cotter MA, 2000, MOL CELL BIOL, V20, P5722, DOI 10.1128/MCB.20.15.5722-5735.2000; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Ghataand J, 2017, COMPR PHYSIOL, V7, P945, DOI 10.1002/cphy.c160018; Gomez-Marquez J, 2007, ANN NY ACAD SCI, V1112, P201, DOI 10.1196/annals.1415.020; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Jou YC, 2013, UROL ONCOL-SEMIN ORI, V31, P1806, DOI 10.1016/j.urolonc.2012.03.011; Karetsou Z, 2002, EMBO REP, V3, P361, DOI 10.1093/embo-reports/kvf071; Ko JY, 2016, ADV EXP MED BIOL, V933, P45, DOI 10.1007/978-981-10-2041-4_5; Kobayashi T, 2006, CANCER RES, V66, P3137, DOI 10.1158/0008-5472.CAN-05-2112; Kwon SH, 2011, CURR BIOL, V21, P161, DOI 10.1016/j.cub.2010.12.037; Leonhard WN, 2011, AM J PHYSIOL-RENAL, V300, pF1193, DOI 10.1152/ajprenal.00419.2010; Letsas KP, 2006, NEOPLASMA, V53, P92; Li JS, 2017, HUM MOL GENET, V26, P2949, DOI 10.1093/hmg/ddx183; Li KJ, 2005, KIDNEY INT, V67, P1710, DOI 10.1111/j.1523-1755.2005.00268.x; Liu B, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-109; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049418; Ma M, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028209; Merrick D, 2012, DEV CELL, V22, P197, DOI 10.1016/j.devcel.2011.10.028; Moreira D, 2013, BIOCHEM CELL BIOL, V91, P265, DOI 10.1139/bcb-2012-0090; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nigro EA, 2015, CELLS-BASEL, V4, P687, DOI 10.3390/cells4040687; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qin S, 2012, J AM SOC NEPHROL, V23, P1309, DOI 10.1681/ASN.2011030277; SANTOS OFP, 1993, DEV BIOL, V159, P535, DOI 10.1006/dbio.1993.1262; Su BH, 2016, J PATHOL, V238, P412, DOI 10.1002/path.4664; Su BH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2906; Subramanian C, 2002, J VIROL, V76, P4699, DOI 10.1128/JVI.76.10.4699-4708.2002; Sukhacheva EA, 2002, J IMMUNOL METHODS, V266, P185, DOI 10.1016/S0022-1759(02)00098-4; Takakura A, 2011, HUM MOL GENET, V20, P4143, DOI 10.1093/hmg/ddr338; Talbot JJ, 2011, P NATL ACAD SCI USA, V108, P7985, DOI 10.1073/pnas.1103816108; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; TRUDEL M, 1991, KIDNEY INT, V39, P665, DOI 10.1038/ki.1991.80; Ueda H, 2010, ANN NY ACAD SCI, V1194, P20, DOI 10.1111/j.1749-6632.2010.05466.x; Ueda H, 2009, PHARMACOL THERAPEUT, V123, P323, DOI 10.1016/j.pharmthera.2009.05.007; Van Bodegom D, 2006, J BIOL CHEM, V281, P31234, DOI 10.1074/jbc.M606510200; Yang CH, 2004, EXP CELL RES, V298, P197, DOI 10.1016/j.yexcr.2004.04.008; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhou X, 2013, J CLIN INVEST, V123, P3084, DOI 10.1172/JCI64401	44	4	4	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					13051	13061		10.1096/fj.201900504R	http://dx.doi.org/10.1096/fj.201900504R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31589480	Bronze, Green Published			2022-12-28	WOS:000507461600111
J	Zhou, JM; Sun, XW; Yang, L; Wang, LQ; Ran, G; Wang, JH; Cao, Q; Wu, LZ; Bryant, A; Ling, C; Pi, LY				Zhou, Junmei; Sun, Xiaowei; Yang, Lu; Wang, Liqun; Ran, Gai; Wang, Jinhui; Cao, Qi; Wu, Lizi; Bryant, Andrew; Ling, Chen; Pi, Liya			Hepatocyte nuclear factor 4 alpha negatively regulates connective tissue growth factor during liver regeneration	FASEB JOURNAL			English	Article						connective tissue growth factor (Ctgf); hepatocyte nuclear factor 4 alpha (Hnf4 alpha); liver injury; liver regeneration	GENE-EXPRESSION; FACTOR CTGF; FIBROSIS; IDENTIFICATION; TRANSCRIPTION; DOMAIN; PHASE; CCN2; FATE; RATS	Liver regeneration after injury requires fine-tune regulation of connective tissue growth factor (Ctgf). It also involves dynamic expression of hepatocyte nuclear factor (Hnf)4 alpha, Yes-associated protein (Yap), and transforming growth factor (Tgf)-beta. The upstream inducers of Ctgf, such as Yap, etc, are well-known. However, the negative regulator of Ctgf remains unclear. Here, we investigated the Hnf4 alpha regulation of Ctgf post-various types of liver injury. Both wild-type animals and animals contained siRNA-mediated Hnf4 alpha knockdown and Cre-mediated Ctgf conditional deletion were used. We observed that Ctgf induction was associated with Hnf4 alpha decline, nuclear Yap accumulation, and Tgf-beta upregulation during early stage of liver regeneration. The Ctgf promoter contained an Hnf4 alpha binding sequence that overlapped with the cis-regulatory element for Yap and Tgf-beta. Ctgf loss attenuated inflammation, hepatocyte proliferation, and collagen synthesis, whereas Hnf4 alpha knockdown enhanced Ctgf induction and liver fibrogenesis. These findings provided a new mechanism about fine-tuned regulation of Ctgf through Hnf4 alpha antagonism of Yap and Tgf-beta activities to balance regenerative and fibrotic signals.	[Zhou, Junmei; Sun, Xiaowei; Ran, Gai; Ling, Chen; Pi, Liya] Univ Florida, Dept Pediat, Gainesville, FL USA; [Zhou, Junmei] Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang, Peoples R China; [Sun, Xiaowei] Lanzhou Univ, Inst Pathol, Sch Basic Med Sci, Lanzhou, Peoples R China; [Yang, Lu; Wang, Jinhui] City Hope Natl Med Ctr, Integrat Genom Core, Beckman Res Inst, Duarte, CA USA; [Wang, Liqun; Bryant, Andrew] Univ Florida, Dept Med, Gainesville, FL USA; [Ran, Gai; Ling, Chen] Fudan Univ, Zhongshan Hosp, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Cao, Qi] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD USA; [Wu, Lizi] Univ Florida, Coll Med, Dept Microbiol & Mol Genet, Gainesville, FL USA	State University System of Florida; University of Florida; University of South China; Lanzhou University; City of Hope; Beckman Research Institute of City of Hope; State University System of Florida; University of Florida; Fudan University; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida	Ling, C (corresponding author), Fudan Univ, Zhongshan Hosp, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.; Pi, LY (corresponding author), Univ Florida, Coll Med, Dept Pediat, 1200 S Newell Dr, Gainesville, FL 32610 USA.	lingchenchina@fudan.edu.cn; lingchenchina@fudan.edu.cn	Wang, Jin/GYA-2019-2022		HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA) [KO1AA024174, R01AA028035]; Children Miracle Network Foundation; National Key Research and Development Program of China [2018YFA0109400]; Shanghai Sailing Program [17YF1401300]; Shanghai Eastern Scholarship [TP2016004]	HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA); Children Miracle Network Foundation; National Key Research and Development Program of China; Shanghai Sailing Program; Shanghai Eastern Scholarship	HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: KO1AA024174 and R01AA028035; Children Miracle Network Foundation; National Key Research and Development Program of China, Grant/Award Number: 2018YFA0109400; Shanghai Sailing Program, Grant/Award Number: 17YF1401300; Shanghai Eastern Scholarship, Grant/Award Number: TP2016004	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Cai WY, 2017, HEPATOLOGY, V65, P1206, DOI 10.1002/hep.28911; Deshpande KT, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Geier A, 2008, AM J PHYSIOL-GASTR L, V295, pG226, DOI 10.1152/ajpgi.00012.2008; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huck I, 2019, HEPATOLOGY, V70, P666, DOI 10.1002/hep.30405; Jiao H, 2015, CELL PHYSIOL BIOCHEM, V36, P2317, DOI 10.1159/000430195; Klaas M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27398; Kuttippurathu L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2492-x; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Lin SB, 2018, MOL CELL, V71, P244, DOI 10.1016/j.molcel.2018.06.001; Ling CQ, 2018, J INTEGR MED-JIM, V16, P236, DOI 10.1016/j.joim.2018.05.002; Liu LP, 2012, HEPATOLOGY, V55, P1529, DOI 10.1002/hep.24815; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Lu H, 2010, TOXICOL SCI, V118, P380, DOI 10.1093/toxsci/kfq280; Mitra RN, 2018, BIOMATERIALS, V157, P26, DOI 10.1016/j.biomaterials.2017.12.004; Nishiyama K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136774; Nwidu LL, 2019, J INTEGR MED-JIM, V17, P46, DOI 10.1016/j.joim.2018.11.008; Nwidu LL, 2018, J INTEGR MED-JIM, V16, P263, DOI 10.1016/j.joim.2018.05.001; Oh SH, 2018, J HEPATOL, V69, P359, DOI 10.1016/j.jhep.2018.05.008; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Pi LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00138; Pi LY, 2015, HEPATOLOGY, V61, P678, DOI 10.1002/hep.27425; Pi LY, 2012, FASEB J, V26, P3365, DOI 10.1096/fj.11-200154; Pi LY, 2005, GASTROENTEROLOGY, V128, P2077, DOI 10.1053/j.gastro.2005.03.081; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roychowdhury S, 2012, ALCOHOL CLIN EXP RES, V36, P1139, DOI 10.1111/j.1530-0277.2011.01720.x; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Stroup D, 2000, J LIPID RES, V41, P1; Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zheng M, 2016, FASEB J, V30, P1076, DOI 10.1096/fj.15-280511	45	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4970	4983		10.1096/fj.201902382R	http://dx.doi.org/10.1096/fj.201902382R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32057145	Green Published, hybrid			2022-12-28	WOS:000515244600001
J	Dufresne, S; Gueritat, J; Chiavassa, S; Noblet, C; Assi, M; Rioux-Leclercq, N; Rannou-Bekono, F; Lefeuvre-Orfila, L; Paris, F; Rebillard, A				Dufresne, Suzanne; Gueritat, Jordan; Chiavassa, Sophie; Noblet, Caroline; Assi, Mohamad; Rioux-Leclercq, Nathalie; Rannou-Bekono, Francoise; Lefeuvre-Orfila, Luz; Paris, Francois; Rebillard, Amelie			Exercise training improves radiotherapy efficiency in a murine model of prostate cancer	FASEB JOURNAL			English	Article						oncology; physical activity; radiation therapy; treatment	RUNNING WHEEL EXERCISE; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; AEROBIC EXERCISE; MAMMARY CARCINOGENESIS; CONTROLLED-TRIAL; NK CELLS; PROGRESSION; TUMORS; MECHANISMS	Engaging in exercise while undergoing radiotherapy (RT) has been reported to be safe and achievable. The impact of exercise training (ET) on RT efficiency is however largely unknown. Our study aims to investigate the interactions between ET and RT on prostate cancer growth. Athymic mice received a subcutaneous injection of PPC-1 cells and were randomly assigned to either cancer control, cancer ET, cancer RT, or cancer RT combined with ET (CaRT-ET). Mice were sacrificed 24 days post-injection. All three intervention groups had reduced tumor size, the most important decrease being observed in CaRT-ET mice. Apoptotic marker cleaved caspase-3 was not modified by ET, but enhanced with RT. Importantly, this increase was the highest when the two strategies were combined. Furthermore, NK1.1 staining and gene expression of natural killer (NK) cell receptors Klrk1 and Il2r beta were not affected by ET alone but were increased with RT, this effect being potentiated when combined with ET. Overall, our study shows that (a) ET enhances RT efficiency by potentiating NK cell infiltration, and (b) while ET alone and ET combined with RT both reduce tumor growth, the mechanisms mediating these effects are different.	[Dufresne, Suzanne; Gueritat, Jordan; Assi, Mohamad; Rannou-Bekono, Francoise; Lefeuvre-Orfila, Luz; Rebillard, Amelie] Univ Rennes 2, ENS Rennes, EA 1274, Movement Sport & Hlth Sci Lab, Bruz, France; [Chiavassa, Sophie; Noblet, Caroline; Paris, Francois] Univ Nantes, Univ Angers, INSERM, CRCINA, Nantes, France; [Chiavassa, Sophie; Noblet, Caroline; Paris, Francois] Ouest Ctr Rene Gauducheau, Inst Cancerol, St Herblain, France; [Rioux-Leclercq, Nathalie] Univ Rennes 1, Dept Pathol Anat & Cytol, Rennes, France	Ecole Normale Superieure de Rennes (ENS Rennes); Universite Rennes 2; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Universite de Rennes	Dufresne, S; Rebillard, A (corresponding author), Sport & Hlth Sci Lab, EA 1274, Campus Ker Lann,Ave Robert Schuman, F-35170 Bruz, France.	suzanne.dufresne@ens-rennes.fr; amelie.rebillard@univ-rennes2.fr	Paris, francois E/L-4915-2015	Paris, francois E/0000-0002-0176-7348	Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MENESR)	Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MENESR)	Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MENESR)	Acosta AM, 2018, HUM PATHOL, V75, P1, DOI 10.1016/j.humpath.2017.11.015; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aoi W, 2013, GUT, V62, P882, DOI 10.1136/gutjnl-2011-300776; Ashcraft KA, 2019, SEMIN RADIAT ONCOL, V29, P16, DOI 10.1016/j.semradonc.2018.10.001; Ashcraft KA, 2016, CANCER RES, V76, P4032, DOI 10.1158/0008-5472.CAN-16-0887; Baumfalk DR, 2019, J APPL PHYSIOL, V126, P668, DOI 10.1152/japplphysiol.00829.2018; Betof AS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv040; Bonn SE, 2015, CANCER EPIDEM BIOMAR, V24, P57, DOI 10.1158/1055-9965.EPI-14-0707; Bray F, 2018, CA CANC J CLIN; Cantoni C, 2016, J IMMUNOL RES, V2016, P1; Chamie K, 2015, JAMA ONCOL, V1, P60, DOI 10.1001/jamaoncol.2014.192; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Dayanc BE, 2008, INT J HYPERTHER, V24, P41, DOI 10.1080/02656730701858297; Domanska-Senderowska D, 2019, INT J SPORTS MED, V40, P227, DOI 10.1055/a-0824-4813; Dufresne S, 2018, CANCER EPIDEM BIOMAR, V27, P11, DOI 10.1158/1055-9965.EPI-16-0969; Eisemann N, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0025-6; Esser KA, 2009, PROSTATE, V69, P1372, DOI 10.1002/pros.20987; Feng X, 2015, ONCOTARGET, V6, P32353, DOI 10.18632/oncotarget.5898; Finne E, 2018, CANCER MANAG RES, V10, P5125, DOI 10.2147/CMAR.S170064; Meneses-Echavez JF, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2733-z; Galvao DA, 2018, MED SCI SPORT EXER, V50, P393, DOI 10.1249/MSS.0000000000001454; Gannon NP, 2015, INT J CANCER, V136, pE197, DOI 10.1002/ijc.29142; Garcia E, 2016, J APPL PHYSIOL, V121, P15, DOI 10.1152/japplphysiol.00266.2016; Gueritat J, 2014, FREE RADICAL BIO MED, V77, P95, DOI 10.1016/j.freeradbiomed.2014.09.009; Guo NN, 2018, ONCOL LETT, V16, P6045, DOI 10.3892/ol.2018.9399; Heywood R, 2017, SUPPORT CARE CANCER, V25, P3031, DOI 10.1007/s00520-017-3827-0; Hojman P, 2011, AM J PHYSIOL-ENDOC M, V301, pE504, DOI 10.1152/ajpendo.00520.2010; Idorn M, 2016, TRENDS MOL MED, V22, P565, DOI 10.1016/j.molmed.2016.05.007; IJsbrandy C, 2018, CRIT REV ONCOL HEMAT, V122, P157, DOI 10.1016/j.critrevonc.2017.09.005; Isanejad A, 2016, LIFE SCI, V151, P30, DOI 10.1016/j.lfs.2016.02.090; Jones LW, 2012, J APPL PHYSIOL, V113, P263, DOI 10.1152/japplphysiol.01575.2011; Jones LW, 2005, CLIN CANCER RES, V11, P6695, DOI 10.1158/1078-0432.CCR-05-0844; Karamanolis G, 2013, Mediators Inflamm, V2013, P515048, DOI 10.1155/2013/515048; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kaur P, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00191; Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226; Knols R, 2005, J CLIN ONCOL, V23, P3830, DOI 10.1200/JCO.2005.02.148; Koukourakis MI, 2001, ANTICANCER RES, V21, P4285; Larsen Stine K., 2014, Critical Reviews in Oncogenesis, V19, P91; Lin SC, 2012, J CLIN ENDOCR METAB, V97, pE1515, DOI 10.1210/jc.2012-1450; Liu FF, 2018, ACTA PHARM SIN B, V8, P552, DOI 10.1016/j.apsb.2018.01.008; Mah AY, 2016, CRIT REV IMMUNOL, V36, P131, DOI 10.1615/CritRevImmunol.2016017387; McCullough DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju036; McCullough DJ, 2013, J APPL PHYSIOL, V115, P1846, DOI 10.1152/japplphysiol.00949.2013; Mina DS, 2013, CUAJ-CAN UROL ASSOC, V7, pE692, DOI 10.5489/cuaj.235; Monga U, 2007, ARCH PHYS MED REHAB, V88, P1416, DOI 10.1016/j.apmr.2007.08.110; Park B, 2014, INT J MOL SCI, V15, P927, DOI 10.3390/ijms15010927; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Pedersen L, 2015, CANCER J, V21, P111, DOI 10.1097/PPO.0000000000000096; Peeken JC, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00132; Phillips SM, 2015, J CANCER SURVIV, V9, P500, DOI 10.1007/s11764-015-0426-2; Quarmby S, 1999, ARTERIOSCL THROM VAS, V19, P588, DOI 10.1161/01.ATV.19.3.588; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Richman EL, 2011, CANCER RES, V71, P3889, DOI 10.1158/0008-5472.CAN-10-3932; Roth AJ, 2008, FUTURE ONCOL, V4, P561, DOI 10.2217/14796694.4.4.561; Sak K, 2018, ANTICANCER RES, V38, P6209, DOI 10.21873/anticanres.12975; Schadler KL, 2016, ONCOTARGET, V7, P65429, DOI 10.18632/oncotarget.11748; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Segal RJ, 2009, J CLIN ONCOL, V27, P344, DOI 10.1200/JCO.2007.15.4963; SHEPHARD RJ, 1994, BRIT J SPORT MED, V28, P247, DOI 10.1136/bjsm.28.4.247; Shephard RJ, 2010, EXERC IMMUNOL REV, V16, P194; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Sturgeon K, 2014, AM J PHYSIOL-REG I, V307, pR685, DOI 10.1152/ajpregu.00082.2014; Truong PT, 2011, AM J CLIN ONCOL-CANC, V34, P350, DOI 10.1097/COC.0b013e3181e841ec; UHLENBRUCK G, 1991, INT J SPORTS MED, V12, pS63, DOI 10.1055/s-2007-1024753; Urgard E, 2017, NUCLEIC ACID THER, V27, P295, DOI 10.1089/nat.2017.0670; Vandersluis AD, 2013, PROSTATE, V73, P1223, DOI 10.1002/pros.22673; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Windsor PM, 2004, CANCER, V101, P550, DOI 10.1002/cncr.20378; Zhang Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0131-3; Zheng X, 2008, ONCOL REP, V19, P1583; Zheng X, 2012, NUTR CANCER, V64, P1029, DOI 10.1080/01635581.2012.716899; Zheng X, 2011, EXP THER MED, V2, P221, DOI 10.3892/etm.2011.203; Zhu ZJ, 2008, CANCER EPIDEM BIOMAR, V17, P1920, DOI 10.1158/1055-9965.EPI-08-0175; Zhu ZJ, 2012, CANCER PREV RES, V5, P414, DOI 10.1158/1940-6207.CAPR-11-0454	77	11	11	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4984	4996		10.1096/fj.201901728R	http://dx.doi.org/10.1096/fj.201901728R		FEB 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32043634				2022-12-28	WOS:000512671900001
J	Wu, WC; Wang, SS; Liu, Q; Shan, TZ; Wang, XX; Feng, J; Wang, YZ				Wu, Weiche; Wang, Sisi; Liu, Qing; Shan, Tizhong; Wang, Xinxia; Feng, Jie; Wang, Yizhen			AMPK facilitates intestinal long-chain fatty acid uptake by manipulating CD36 expression and translocation	FASEB JOURNAL			English	Article						AMPK; CD36; fatty acid uptake; intestinal epithelial cell; m(6)A	LIPID-ACCUMULATION; PROTEIN; RNA; INSULIN; METABOLISM; M(6)A; N6-METHYLADENOSINE; TRANSLATION; ACTIVATION; INSIGHTS	Cellular long-chain fatty acids' (LCFAs) uptake is a crucial physiological process that regulates cellular energy homeostasis. AMPK has been shown to modulate LCFAs uptake in several kinds of cells, but whether it exerts an impact on intestinal LCFAs uptake is not quite clear. In the current study, we found that AMPK reinforced LCFAs uptake in intestinal epithelial cells (IECs). Moreover, intestinal epithelium-specific AMPK deletion impaired intestinal LCFAs absorption and protected mice from high-fat diet-induced obesity. Mechanistically, we discovered that AMPK deletion reduced the CD36 protein level by upregulating Parkin-mediated polyubiquitination of CD36 in IECs. Furthermore, our results revealed that AMPK affected PARK2 (gene name of Parkin) mRNA stability in a YTHDF2-dependent manner through FTO-dependent demethylation of N-6-methyladenosine (m(6)A). Besides, AMPK promoted the translocation of CD36 to the plasma membrane in IECs, but the inhibition of AKT signaling suppressed this effect, which also halted the accelerated fatty acid uptake induced by AMPK. These results suggest that AMPK facilitates the intestinal LCFAs uptake by upregulating CD36 protein abundance and promoting its membrane translocation simultaneously. Such findings shed light on the role of AMPK in the regulation of intestinal LCFAs uptake.	[Wu, Weiche; Wang, Sisi; Liu, Qing; Shan, Tizhong; Wang, Xinxia; Feng, Jie; Wang, Yizhen] Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Wu, Weiche; Wang, Sisi; Liu, Qing; Shan, Tizhong; Wang, Xinxia; Feng, Jie; Wang, Yizhen] Zhejiang Univ, Key Lab Anim Nutr & Feed Sci, Minist Agr, Hangzhou, Peoples R China; [Wu, Weiche; Wang, Sisi; Liu, Qing; Shan, Tizhong; Wang, Xinxia; Feng, Jie; Wang, Yizhen] Zhejiang Univ, Zhejiang Prov Lab Feed & Anim Nutr, Hangzhou, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University	Feng, J; Wang, YZ (corresponding author), Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	fengj@zju.edu.cn; yzwang321@zju.edu.cn		wang, yizhen/0000-0002-3908-7102	National Natural Science Foundation of China (NSFC) [3163000269]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 3163000269	Abumrad NA, 2011, J CLIN INVEST, V121, P3389, DOI 10.1172/JCI59219; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016; Calder PC, 2012, P NUTR SOC, V71, P284, DOI 10.1017/S0029665112000067; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Choi YJ, 2017, TOXICOL APPL PHARM, V316, P74, DOI 10.1016/j.taap.2016.12.019; D'Aquila T, 2016, BBA-MOL CELL BIOL L, V1861, P730, DOI 10.1016/j.bbalip.2016.04.012; Fentz J, 2015, FASEB J, V29, P1725, DOI 10.1096/fj.14-266650; Galli C, 1997, NUTRITION, V13, P978, DOI 10.1016/S0899-9007(97)00341-9; Gao ZJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01919-0; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Habets DDJ, 2007, BIOCHEM BIOPH RES CO, V355, P204, DOI 10.1016/j.bbrc.2007.01.141; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hsieh FL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12837; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Jeppesen J, 2011, J LIPID RES, V52, P699, DOI 10.1194/jlr.M007138; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Khalifeh-Soltani A, 2014, NAT MED, V20, P175, DOI 10.1038/nm.3450; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Li D, 2010, J BIOL CHEM, V285, P33499, DOI 10.1074/jbc.M110.159772; Li MM, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1436-y; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; Luiken JJFP, 2016, BBA-MOL BASIS DIS, V1862, P2253, DOI 10.1016/j.bbadis.2016.09.004; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Ruxton CHS, 2005, NUTR RES REV, V18, P113, DOI 10.1079/NRR200497; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031; Sun XF, 2017, CELL DEATH DIFFER, V24, P819, DOI 10.1038/cdd.2017.14; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Toedebusch RG, 2016, PHYSIOL GENOMICS, V48, P101, DOI 10.1152/physiolgenomics.00078.2015; Wang B, 2016, CELL METAB, V23, P492, DOI 10.1016/j.cmet.2016.01.001; Wang TY, 2013, EUR J CLIN INVEST, V43, P1203, DOI 10.1111/eci.12161; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wu WC, 2018, MOL PHARMACEUT, V15, P3272, DOI 10.1021/acs.molpharmaceut.8b00332; Wu WC, 2018, J PHYSIOL BIOCHEM, V74, P195, DOI 10.1007/s13105-017-0604-y; Wu WT, 2017, PROC INT CONF DATA, P7, DOI 10.1109/ICDE.2017.10; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yang XC, 2017, NAT REV NEPHROL, V13, P769, DOI 10.1038/nrneph.2017.126; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhou XH, 2015, J NUTR BIOCHEM, V26, P1678, DOI 10.1016/j.jnutbio.2015.08.014	54	14	15	10	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4852	4869		10.1096/fj.201901994R	http://dx.doi.org/10.1096/fj.201901994R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32048347				2022-12-28	WOS:000512896000001
J	Govindappa, PK; Patil, M; Garikipati, VNS; Verma, SK; Saheera, S; Narasimhan, G; Zhu, WQ; Kishore, R; Zhang, JY; Krishnamurthy, P				Govindappa, Prem Kumar; Patil, Mallikarjun; Garikipati, Venkata Naga Srikanth; Verma, Suresh K.; Saheera, Sherin; Narasimhan, Gayathri; Zhu, Wuqiang; Kishore, Raj; Zhang, Jianyi; Krishnamurthy, Prasanna			Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart	FASEB JOURNAL			English	Article						cardiac fibrosis; cardiac inflammation; diabetes; exosome; HuR; intercellular signaling	BINDING PROTEIN HUR; MESSENGER-RNA; MACROPHAGES; CARDIOMYOCYTES; DYSFUNCTION; ACTIVATION; APOPTOSIS; MEDIATE; RATS	RNA-binding proteins like human antigen R (HuR) are key regulators in post-transcriptional control of gene expression in several pathophysiological conditions. Diabetes adversely affects monocyte/macrophage biology and function. It is not known whether diabetic milieu affects cellular/exosome-HuR and its implications on cardiac inflammation and fibrosis. Here, we evaluate in vitro and in vivo effects of diabetic milieu on macrophage cellular/exosome-HuR, alterations in intercellular cross talk with fibroblasts, and its impact on cardiac remodeling. Human failing hearts show higher HuR levels. Diabetic milieu activates HuR expression in cardiac- and cultured bone marrow-derived macrophages (BMMo) and stimulates HuR nuclear-to-cytoplasmic translocation and exosome transfer. Exosomes from macrophages exposed to diabetic milieu (high glucose or db/db mice) significantly increase inflammatory and profibrogenic responses in fibroblast (in vitro) and cardiac fibrosis in mice. Intriguingly, Exo-HuR deficiency (HuR knockdown in macrophage) abrogates the above effects. In diabetic mice, macrophage depletion followed by reconstitution with BMMo-derived HuR-deficient exosomes inhibits angiotensin II-induced cardiac fibrosis response and preserves left ventricle function as compared to control-exosome administration. To the best of our knowledge, this is the first study to demonstrate that diabetes activates BMMo HuR expression and its transfer into exosome. The data suggest that HuR might be targeted to alleviate macrophage dysfunction and pathological fibrosis in diabetes.	[Govindappa, Prem Kumar; Patil, Mallikarjun; Saheera, Sherin; Narasimhan, Gayathri; Zhu, Wuqiang; Zhang, Jianyi; Krishnamurthy, Prasanna] Univ Alabama Birmingham, Sch Med, Dept Biomed Engn, Birmingham, AL USA; [Govindappa, Prem Kumar; Patil, Mallikarjun; Saheera, Sherin; Narasimhan, Gayathri; Zhu, Wuqiang; Zhang, Jianyi; Krishnamurthy, Prasanna] Univ Alabama Birmingham, Sch Engn, Dept Biomed Engn, Birmingham, AL USA; [Garikipati, Venkata Naga Srikanth; Kishore, Raj] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA USA; [Verma, Suresh K.] Univ Alabama Birmingham, Sch Med, Div Cardiovasc Dis, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham	Krishnamurthy, P (corresponding author), Univ Alabama Birmingham, Sch Med & Engn, Dept Biomed Engn, 1675 Univ Blvd,Volker Hall G094, Birmingham, AL 35294 USA.	prasanak@uab.edu	GOVINDAPPA, PREM KUMAR/AAY-2926-2021; Saheera, Sherin/AAL-4028-2020; Verma, Suresh/AAU-9979-2020	GOVINDAPPA, PREM KUMAR/0000-0001-8069-234X; Saheera, Sherin/0000-0002-1336-5872; Narasimhan, Gayathri/0000-0003-0495-5210; Verma, Suresh Kumar/0000-0002-0739-1302; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364	American Heart Association-American Stroke Association [0930219N] Funding Source: Medline; HHS | National Institutes of Health (NIH) [HL138023, HL126186, HL116729, HL134608] Funding Source: Medline; NHLBI NIH HHS [R01 HL142627, R56 HL142627, R01 HL116729, R01 HL138023, R01 HL126186, P01 HL134608] Funding Source: Medline; NIDDK NIH HHS [P30 DK079626] Funding Source: Medline	American Heart Association-American Stroke Association(American Heart Association); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babu SS, 2015, TRENDS CARDIOVAS MED, V25, P676, DOI 10.1016/j.tcm.2015.02.006; Chen B, 2016, CIRC RES, V119, P776, DOI 10.1161/CIRCRESAHA.116.309624; Chen JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42001; Diaz-Munoz MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01094; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2010, MOL CELL BIOL, V30, P1397, DOI 10.1128/MCB.01373-09; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Garcia-Martinez J, 2016, NUCLEIC ACIDS RES, V44, P3643, DOI 10.1093/nar/gkv1512; Hesketh M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071545; Honold L, 2018, CIRC RES, V122, P113, DOI 10.1161/CIRCRESAHA.117.311071; Hulsmans M, 2018, J EXP MED, V215, P423, DOI 10.1084/jem.20171274; Janakiraman H, 2017, ONCOGENE, V36, P3137, DOI 10.1038/onc.2016.451; Jeyabal P, 2016, BIOCHEM BIOPH RES CO, V471, P423, DOI 10.1016/j.bbrc.2016.02.065; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kotta-Loizou I, 2016, NEOPLASIA, V18, P674, DOI 10.1016/j.neo.2016.09.002; Krishnamurthy P, 2010, FASEB J, V24, P2484, DOI 10.1096/fj.09-149815; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; Mathiyalagan P, 2019, CIRCULATION, V139, P518, DOI 10.1161/CIRCULATIONAHA.118.033794; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Oh JG, 2018, CIRC RES, V123, P673, DOI 10.1161/CIRCRESAHA.118.312751; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Patel B, 2016, ONCOGENE, V35, P3027, DOI 10.1038/onc.2015.358; Roper NA, 2002, DIABETES CARE, V25, P43, DOI 10.2337/diacare.25.1.43; Russo I, 2016, J MOL CELL CARDIOL, V90, P84, DOI 10.1016/j.yjmcc.2015.12.011; Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Slone S, 2016, CELL SIGNAL, V28, P1735, DOI 10.1016/j.cellsig.2016.08.005; Szuszkiewicz-Garcia MM, 2014, ENDOCRIN METAB CLIN, V43, P25, DOI 10.1016/j.ecl.2013.09.001; Thomas MP, 2015, CELL REP, V11, P1079, DOI 10.1016/j.celrep.2015.04.026; Wang XH, 2014, J MOL CELL CARDIOL, V74, P139, DOI 10.1016/j.yjmcc.2014.05.001; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wigington CP, 2015, J BIOL CHEM, V290, P3468, DOI 10.1074/jbc.M114.631937	33	21	23	3	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2238	2251		10.1096/fj.201901995R	http://dx.doi.org/10.1096/fj.201901995R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907992	Green Accepted			2022-12-28	WOS:000514663600022
J	Tian, DY; Hong, HL; Shang, WB; Ho, CC; Dong, JH; Tian, XY				Tian, Danyang; Hong, Huiling; Shang, Wenbin; Ho, Chin Chung; Dong, Jinghui; Tian, Xiao Yu			Deletion of Ppard in CD11c(+) cells attenuates atherosclerosis in ApoE knockout mice	FASEB JOURNAL			English	Article						atherosclerosis; dendritic cells; inflammation; PPARdelta	DENDRITIC CELLS; AGGRAVATES ATHEROSCLEROSIS; REDUCES ATHEROSCLEROSIS; DELTA; ACTIVATION; HOMEOSTASIS; EXPRESSION	Ppard delta, one of the lipid-activated nuclear receptor expressed in many cell types to activate gene transcription, also regulates cellular functions other than lipid metabolism. The mechanism regulating the function of antigen-presenting cells during the development of atherosclerosis is not fully understood. Here we aimed to study the involvement of PPAR delta in CD11c(+) cells in atherosclerosis. We used the Cre-loxP approach to make conditional deletion of Ppard in CD11c(+) cells in mice on Apoe(-/-) background, which were fed with high cholesterol diet to develop atherosclerosis. Ppard deficiency in CD11c(+) cells attenuated atherosclerotic plaque formation and infiltration of myeloid-derived dendritic cells (DCs) and T lymphocytes. Reduced lesion was accompanied by reduced activation of dendritic cells, and also a reduction of activation and differentiation of T cells to Th1 cells. In addition, DC migration to lymph node was also attenuated with Ppard deletion. In bone marrow-derived DCs, Ppard deficiency reduced palmitic acid-induced upregulation of co-stimulatory molecules and pro-inflammatory cytokine IL12 and TNF alpha. Our results indicated PPAR delta activation by fatty acid resulted in the activation of myeloid DCs and subsequent polarization of T lymphocytes, which contributed to atherosclerosis in Apoe(-/-) mice. These findings also reveal the potential regulatory role of PPAR delta in antigen presentation to orchestrate the immune responses during atherosclerosis.	[Tian, Danyang; Hong, Huiling; Shang, Wenbin; Ho, Chin Chung; Tian, Xiao Yu] Chinese Univ Hong Kong, Inst Vasc Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Tian, Danyang; Dong, Jinghui] Hebei Med Univ, Dept Physiol, Shijiazhuang, Hebei, Peoples R China	Chinese University of Hong Kong; Hebei Medical University	Tian, XY (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, LIBSB, Shatin, Room 208A, Hong Kong, Peoples R China.	xytian@cuhk.edu.hk	Tian, Xiao Yu/P-1092-2016; HONG, HUILING/AAT-9954-2020	Tian, Xiao Yu/0000-0003-3472-9898; 	NSFC [91739103]; Hong Kong Research Grant Council [24122318, CUHK4014-16W]; CUHK start-up; Hong Kong Food and Health Bureau Health and Medical Research Fund [05162906]; Department of Education Hebei Province China [CXZZBS2018064]	NSFC(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grant Council(Hong Kong Research Grants Council); CUHK start-up; Hong Kong Food and Health Bureau Health and Medical Research Fund; Department of Education Hebei Province China	This study was supported by NSFC Major Research Programme 91739103, Hong Kong Research Grant Council Early Career Scheme 24122318, Collaborative Research Fund CUHK4014-16W; CUHK start-up; Hong Kong Food and Health Bureau Health and Medical Research Fund 05162906, to X.Y.T; and Postgraduate Innovational Funding Project CXZZBS2018064 from the Department of Education Hebei Province China to D.T.	Adhikary T, 2015, NUCLEIC ACIDS RES, V43, P5033, DOI 10.1093/nar/gkv331; Alberts-Grill N, 2016, J IMMUNOL, V197, P4651, DOI 10.4049/jimmunol.1600206; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Beceiro S, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00534-17; Butcher MJ, 2016, ARTERIOSCL THROM VAS, V36, P1496, DOI 10.1161/ATVBAHA.116.307892; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chaudhari SM, 2015, ARTERIOSCL THROM VAS, V35, P2316, DOI 10.1161/ATVBAHA.115.306171; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Clement M, 2018, CIRC RES, V122, P813, DOI 10.1161/CIRCRESAHA.118.312713; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Gautier EL, 2009, CIRCULATION, V119, P2367, DOI 10.1161/CIRCULATIONAHA.108.807537; Gil-Pulido J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181947; Graham TL, 2005, ATHEROSCLEROSIS, V181, P29, DOI 10.1016/j.atherosclerosis.2004.12.028; Haddad Y, 2017, CIRC RES, V121, P234, DOI 10.1161/CIRCRESAHA.117.310960; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kusters P, 2017, AM J PATHOL, V187, P2912, DOI 10.1016/j.ajpath.2017.08.016; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Li G, 2016, GENE THER, V23, P78, DOI 10.1038/gt.2015.78; Li YL, 2017, EBIOMEDICINE, V18, P188, DOI 10.1016/j.ebiom.2017.04.008; Lieber S, 2015, MOL PHARMACOL, V87, P162, DOI 10.1124/mol.114.094672; Luchtefeld M, 2010, CIRCULATION, V122, P1621, DOI 10.1161/CIRCULATIONAHA.110.956730; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; Marvin J, 2019, ATHEROSCLEROSIS, V285, P108, DOI 10.1016/j.atherosclerosis.2019.04.221; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Sage AP, 2014, CIRCULATION, V130, P1363, DOI 10.1161/CIRCULATIONAHA.114.011090; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Sun L, 2018, LEUKEMIA, V32, P184, DOI 10.1038/leu.2017.162; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Zhao FL, 2018, J IMMUNOL, V201, P2664, DOI 10.4049/jimmunol.1800374; Zuo XS, 2019, GASTROENTEROLOGY, V157, P163, DOI 10.1053/j.gastro.2019.03.018	36	4	4	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3367	3378		10.1096/fj.201902069R	http://dx.doi.org/10.1096/fj.201902069R		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31919912	Bronze			2022-12-28	WOS:000506587300001
J	Nozato, Y; Takami, Y; Yamamoto, K; Nagasawa, M; Nozato, S; Imaizumi, Y; Takeshita, H; Wang, C; Ito, Y; Takeda, S; Takeya, Y; Sugimoto, K; Nakagami, H; Hanayama, R; Rakugi, H				Nozato, Yoichi; Takami, Yoichi; Yamamoto, Koichi; Nagasawa, Motonori; Nozato, Satoko; Imaizumi, Yuki; Takeshita, Hikari; Wang, Cheng; Ito, Yuki; Takeda, Shuko; Takeya, Yasushi; Sugimoto, Ken; Nakagami, Hironori; Hanayama, Rikinari; Rakugi, Hiromi			Novel properties of myoferlin in glucose metabolism via pathways involving modulation of adipose functions	FASEB JOURNAL			English	Article						adipocyte differentiation; insulin resistance; myoferlin; obesity	MUSCLE FIBER-TYPE; INSULIN SENSITIVITY; MYOBLAST FUSION; SKELETAL; OBESITY; DEFICIENCY; PROTEINS; IMPACT; INJURY; NFAT	While adipose tissue is required to maintain glucose metabolism, excessive calorie intake induces obesity via mechanisms including accelerated proliferation and differentiation of preadipocytes, leading to insulin resistance. Here, we investigated the role of myoferlin (MYOF), a ferlin family protein, in regulating glucose metabolism by mainly focusing on its unknown role in adipose tissue. Whereas young MYOF knockout (KO) mice on a normal diet showed aggravated glucose tolerance and insulin sensitivity, those on a high-fat diet (HFD) showed preserved glucose tolerance with an attenuated gain of body weight, reduced visceral fat deposits, and less severe fatty liver. The Adipose MYOF expression was reduced by aging but was restored by an HFD along with the retained expression of NFAT transcription factors. Loss-of-function of MYOF in preadipocytes suppressed proliferation and differentiation into mature adipocytes along with the decreased expression of genes involved in adipogenesis. The MYOF expression in preadipocytes was reduced with differentiation. Attenuated obesity in MYOF KO mice on an HFD was also accompanied with increased oxygen consumption by an unidentified mechanism and with reduced adipose inflammation due to less inflammatory macrophages. These insights suggest that the multifunctional roles of MYOF involve the regulation of preadipocyte function and affect glucose metabolism bidirectionally depending on consumed calories.	[Nozato, Yoichi; Takami, Yoichi; Yamamoto, Koichi; Nagasawa, Motonori; Nozato, Satoko; Imaizumi, Yuki; Takeshita, Hikari; Wang, Cheng; Takeya, Yasushi; Sugimoto, Ken; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, B6,2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Ito, Yuki; Takeda, Shuko] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Nakagami, Hironori] Osaka Univ, Grad Sch Med, Dept Hlth Dev & Med, Suita, Osaka, Japan; [Hanayama, Rikinari] Kanazawa Univ, Grad Sch Med, Dept Immunol, Kanazawa, Ishikawa, Japan; [Hanayama, Rikinari] Kanazawa Univ, WPI Nano Life Sci Inst NanoLSI, Kanazawa, Ishikawa, Japan	Osaka University; Osaka University; Osaka University; Kanazawa University; Kanazawa University	Takami, Y; Yamamoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, B6,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takami@geriat.med.osaka-u.ac.jp; kyamamoto@geriat.med.osaka-u.ac.jp	Nakagami, Hironori/GLU-0570-2022; Hanayama, Rikinari/AAO-4959-2021; Takeshita, Hikari/L-9812-2014	Nakagami, Hironori/0000-0003-4494-3601; Hanayama, Rikinari/0000-0003-2102-3386; Takami, Yoichi/0000-0001-9018-6707; Yamamoto, Koichi/0000-0003-0107-9315	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18K08476]; Osaka Medical Research Foundation for Intractable Diseases	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka Medical Research Foundation for Intractable Diseases	The Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant/Award Number: 18K08476; The Osaka Medical Research Foundation for Intractable Diseases	Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Broekema MF, 2019, BBA-MOL CELL BIOL L, V1864, P715, DOI 10.1016/j.bbalip.2019.02.002; Corvera S, 2014, BBA-MOL BASIS DIS, V1842, P463, DOI 10.1016/j.bbadis.2013.06.003; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Del Corno M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00265; Demonbreun AR, 2010, J CELL SCI, V123, P2413, DOI 10.1242/jcs.065375; Demonbreun AR, 2010, FASEB J, V24, P1284, DOI 10.1096/fj.09-136309; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Fisher G, 2017, EUR J APPL PHYSIOL, V117, P1413, DOI 10.1007/s00421-017-3634-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Haka AS, 2016, J LIPID RES, V57, P980, DOI 10.1194/jlr.M064089; Hausman Dorothy B., 2008, V456, P201, DOI 10.1007/978-1-59745-245-8_15; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hu L, 2018, J MOL ENDOCRINOL, V61, P79, DOI 10.1530/JME-18-0070; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; Kraus NA, 2016, ADIPOCYTE, V5, P351, DOI 10.1080/21623945.2016.1240137; Mikami Y, 2002, J NEUROSURG, V97, P142, DOI 10.3171/spi.2002.97.1.0142; Miyatake Y, 2018, J IMMUNOL, V201, P3051, DOI 10.4049/jimmunol.1800268; PLOUG T, 1987, AM J PHYSIOL, V253, pE12, DOI 10.1152/ajpendo.1987.253.1.E12; Posey AD, 2011, CURR TOP DEV BIOL, V96, P203, DOI 10.1016/B978-0-12-385940-2.00008-5; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Takeshita H, 2017, SCI REP-UK, V7, DOI 10.1038/srep42323; Turtoi A, 2013, CANCER RES, V73, P5438, DOI 10.1158/0008-5472.CAN-13-1142; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang YC, 2016, MOL CELL BIOCHEM, V412, P27, DOI 10.1007/s11010-015-2605-x; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	32	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2792	2811		10.1096/fj.201901539RR	http://dx.doi.org/10.1096/fj.201901539RR		JAN 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31912559				2022-12-28	WOS:000506146900001
J	Ali, SR; Malone, TJ; Zhang, YL; Prechova, M; Kaczmarek, LK				Ali, Syed Rydwan; Malone, Taylor Joseph; Zhang, Yalan; Prechova, Magdalena; Kaczmarek, Leonard Konrad			Phactr1 regulates Slack (KCNT1) channels via protein phosphatase 1 (PP1)	FASEB JOURNAL			English	Article						dephosphorylation; epilepsy; intellectual disability; KCNT1; Phactr1; Slack channels	MENTAL-RETARDATION PROTEIN; MIGRATING PARTIAL SEIZURES; K+ CHANNELS; MUTATIONS; EPILEPSY; LEUKOENCEPHALOPATHY; MEMBRANE; CURRENTS; NEURONS; FAMILY	The Slack (KCNT1) gene encodes sodium-activated potassium channels that are abundantly expressed in the central nervous system. Human mutations alter the function of Slack channels, resulting in epilepsy and intellectual disability. Most of the disease-causing mutations are located in the extended cytoplasmic C-terminus of Slack channels and result in increased Slack current. Previous experiments have shown that the C-terminus of Slack channels binds a number of cytoplasmic signaling proteins. One of these is Phactr1, an actin-binding protein that recruits protein phosphatase 1 (PP1) to certain phosphoprotein substrates. Using co-immunoprecipitation, we found that Phactr1 is required to link the channels to actin. Using patch clamp recordings, we found that co-expression of Phactr1 with wild-type Slack channels reduces the current amplitude but has no effect on Slack channels in which a conserved PKC phosphorylation site (S407) that regulates the current amplitude has been mutated. Furthermore, a Phactr1 mutant that disrupts the binding of PP1 but not that of actin fails to alter Slack currents. Our data suggest that Phactr1 regulates the Slack by linking PP1 to the channel. Targeting Slack-Phactr1 interactions may therefore be helpful in developing the novel therapies for brain disorders associated with the malfunction of Slack channels.	[Ali, Syed Rydwan; Malone, Taylor Joseph; Zhang, Yalan; Kaczmarek, Leonard Konrad] Yale Sch Med, Dept Pharmacol, Sterling Hall Med,333 Cedar St, New Haven, CT 06520 USA; [Prechova, Magdalena] Francis Crick Inst, Signalling & Transcript Grp, London, England; [Prechova, Magdalena] Czech Acad Sci, Lab Integrat Biol, Inst Mol Genet, Prague, Czech Republic; [Kaczmarek, Leonard Konrad] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA	Yale University; Francis Crick Institute; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Yale University	Kaczmarek, LK (corresponding author), Yale Sch Med, Dept Pharmacol, Sterling Hall Med,333 Cedar St, New Haven, CT 06520 USA.	leonard.kaczmarek@yale.edu	, WaNgtJ/AAR-7045-2020; Přechová, Magdalena/AAO-3848-2020	Přechová, Magdalena/0000-0002-4591-854X	NIH [R01DC001919, 1R01NS102239, GM007324]; FRAXA; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health Fellowship [F32HD093292]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health Fellowship	This work is supported by NIH R01DC001919 (LKK), NIH 1R01NS102239, FRAXA (LKK), Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health Fellowship under Award Number F32HD093292 (SRA) and NIH Grant GM007324 (TJM)	Abekhoukh S, 2017, DIS MODEL MECH; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Arai-Ichinoi N, 2016, HUM GENET, V135, P89, DOI 10.1007/s00439-015-1617-7; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Bausch AE, 2015, LEARN MEMORY, V22, P323, DOI 10.1101/lm.037820.114; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Evely KM, 2017, NEUROSCIENCE, V351, P65, DOI 10.1016/j.neuroscience.2017.03.035; Fleming MR, 2016, CELL REP, V16, P2281, DOI 10.1016/j.celrep.2016.07.024; FOEHRING RC, 1989, J NEUROPHYSIOL, V61, P245, DOI 10.1152/jn.1989.61.2.245; Freilinger T, 2012, NAT GENET, V44, P777, DOI 10.1038/ng.2307; Hamada N, 2018, BRAIN, V141, P3098, DOI 10.1093/brain/awy246; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Huang Y, 2015, J INVERTEBR PATHOL, V127, P1, DOI 10.1016/j.jip.2015.01.007; Ishii A, 2013, GENE, V531, P467, DOI 10.1016/j.gene.2013.08.096; Ito H, 2018, NEUROSCI RES, V128, P50, DOI 10.1016/j.neures.2017.08.002; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Juang JMJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06733; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kaczmarek Leonard K, 2013, ISRN Neurosci, V2013; Kaczmarek LK, 2014, NEUROSCI ABSTR, V126.08, P153; Kang S, 2014, J BIOL CHEM, V289, P11536, DOI 10.1074/jbc.M113.528497; Kelloniemi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130502; Kim GE, 2014, CELL REP, V9, P1661, DOI 10.1016/j.celrep.2014.11.015; Kim GE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00209; Kim JY, 2012, NEUROSCIENCE, V221, P37, DOI 10.1016/j.neuroscience.2012.06.059; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Lim CX, 2016, J MED GENET, V53, P217, DOI 10.1136/jmedgenet-2015-103508; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Milligan CJ, 2014, ANN NEUROL, V75, P581, DOI 10.1002/ana.24128; Ohba C, 2015, EPILEPSIA, V56, pE121, DOI 10.1111/epi.13072; Park HA, 2017, CELL DEATH DIFFER, V24, P1963, DOI 10.1038/cdd.2017.123; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Prechova M, 2018, SIGNALLING TRANSCRIP; Quraishi IH, 2019, J NEUROSCI, V39, P7438, DOI 10.1523/JNEUROSCI.1628-18.2019; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Tang QY, 2016, CELL REP, V14, P129, DOI 10.1016/j.celrep.2015.12.019; Vanderver A, 2014, PEDIATR NEUROL, V50, P112, DOI 10.1016/j.pediatrneurol.2013.06.024; Wiezlak M, 2012, J CELL SCI, V125, P5860, DOI 10.1242/jcs.112078; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Zhang Y, 2017, J NEUROSCI, V37, P2258, DOI 10.1523/JNEUROSCI.3102-16.2017; Zhang YL, 2012, J NEUROSCI, V32, P15318, DOI 10.1523/JNEUROSCI.2162-12.2012; Zhang Y, 2012, GENE DEV, V26, P69, DOI 10.1101/gad.179283.111	48	8	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1591	1601		10.1096/fj.201902366R	http://dx.doi.org/10.1096/fj.201902366R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914597	Bronze, Green Accepted			2022-12-28	WOS:000507308900105
J	Li, C; Hu, ZX				Li, Cheng; Hu, Zhenxia			Is liver glycogen fragility a possible drug target for diabetes?	FASEB JOURNAL			English	Review						chain-length distribution; glycogen biosynthesis; glycogen degradation; particle size distribution	MOLECULAR-STRUCTURE; PHOSPHORYLASE-ACTIVITY; DEBRANCHING ENZYME; DIURNAL-VARIATION; SKELETAL-MUSCLE; LAFORA-DISEASE; PROTEIN-KINASE; METABOLISM; GLUCOSE; SYNTHASE	Liver glycogen alpha particles are molecularly fragile in diabetic mice, and readily form smaller beta particles, which degrade more rapidly to glucose. This effect is well associated with the loss of blood-glucose homeostasis in diabetes. The biological mechanism of such fragility is still unknown; therefore, there are perceived opportunities that could eventually lead to new means to manage type 2 diabetes. The hierarchical structures of glycogen particles are controlled by the underlying biosynthesis/degradation process that involves various enzymes, including, for example, glycogen synthase (GS) and glycogen-branching enzyme (GBE). Recent studies have shown that fragile glycogen alpha particles in diabetic mice have longer chains and a higher molecular density compared to wild-type mice, indicating an enhanced enzymatic activity ratio of GS to GBE in diabetes. Furthermore, it has been shown that with an improved blood glucose homeostasis, the glycogen fragility in diabetic mice can be restored by treatment with active ingredients from traditional Chinese medicine, yet the underlying mechanism is unknown. In this review, we summarize recent advances in understandings glycogen fragility from the perspectives of glycogen biosynthesis/degradation, glycogen hierarchical structures, and its relation to diabetes. Importantly, we for the first time set GS/GBE activity ratio as the therapeutic target for diabetes.	[Li, Cheng; Hu, Zhenxia] Wuhan Univ, Dept Pharm, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Peoples R China; [Li, Cheng] Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai, Peoples R China; [Li, Cheng] Yangzhou Univ, Joint Int Res Lab Agr & Agri Prod Safety, Minist Educ China, Yangzhou, Jiangsu, Peoples R China	Wuhan University; University of Shanghai for Science & Technology; Ministry of Education, China; Yangzhou University	Hu, ZX (corresponding author), Wuhan Univ, Dept Pharm, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Peoples R China.	zhenxiahu@whu.edu.cn		Hu, Zhenxia/0000-0003-3056-9356	National Science Foundation of China [81803230]; Fundamental Research Funds for the Central Universities [2042018kf0143]; Renmin Hospital of Wuhan University Guiding Fund [RMYD2018M57]; Yangzhou Lvyangjinfeng Talent Program; Jiangsu Yangzhou Key Research and Development Program [ssf2018000008]; Yangzhou University Young Scientist Innovation Fund; Youth Fund of Jiangsu Natural Science Foundation [BK20190906]; Jiangsu Entrepreneurship and Innovation Phd Program; Yangzhou University Open Research Fund; Yangzhou University Talent Acquisition Startup FundP	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Renmin Hospital of Wuhan University Guiding Fund; Yangzhou Lvyangjinfeng Talent Program; Jiangsu Yangzhou Key Research and Development Program; Yangzhou University Young Scientist Innovation Fund; Youth Fund of Jiangsu Natural Science Foundation; Jiangsu Entrepreneurship and Innovation Phd Program; Yangzhou University Open Research Fund; Yangzhou University Talent Acquisition Startup FundP	National Science Foundation of China, Grant/Award Number: 81803230; Fundamental Research Funds for the Central Universities, Grant/Award Number: 2042018kf0143; Renmin Hospital of Wuhan University Guiding Fund, Grant/Award Number: RMYD2018M57; Yangzhou Lvyangjinfeng Talent Program; Jiangsu Yangzhou Key Research and Development Program, Grant/Award Number: ssf2018000008; Yangzhou University Young Scientist Innovation Fund; Youth Fund of Jiangsu Natural Science Foundation, Grant/Award Number: BK20190906; Jiangsu Entrepreneurship and Innovation Phd Program; Yangzhou University Open Research Fund; Yangzhou University Talent Acquisition Startup FundP	Adeva-Andany MM, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160385; Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; American Diabetes Association, 2019, Diabetes Care, V42, pS13, DOI 10.2337/dc19-S002; Besford QA, 2012, INT J BIOL MACROMOL, V51, P887, DOI 10.1016/j.ijbiomac.2012.06.037; Broberg S, 2000, CARBOHYD POLYM, V43, P285, DOI 10.1016/S0144-8617(00)00152-1; Broz Jan, 2019, Vnitr Lek, V65, P289; CHAN TM, 1975, AM J PHYSIOL, V229, P1702, DOI 10.1152/ajplegacy.1975.229.6.1702; CHEE NP, 1977, FEBS LETT, V73, P164, DOI 10.1016/0014-5793(77)80972-1; CHEN YT, 1987, AM J HUM GENET, V41, P1002; COHN C, 1971, P SOC EXP BIOL MED, V137, P1303, DOI 10.3181/00379727-137-35777; DEAPODACA MAO, 1992, J INHERIT METAB DIS, V15, P213, DOI 10.1007/BF01799633; Deng B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150540; Deng B, 2015, GLYCOCONJUGATE J, V32, P113, DOI 10.1007/s10719-015-9578-6; DePaoli-Roach AA, 2015, J BIOL CHEM, V290, P841, DOI 10.1074/jbc.M114.607796; DEVOS P, 1983, BIOCHEM J, V209, P159, DOI 10.1042/bj2090159; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; FULLER RW, 1970, METABOLIS, V19, P226, DOI 10.1016/0026-0495(70)90056-9; GEDDES R, 1977, CARBOHYD RES, V57, P291, DOI 10.1016/S0008-6215(00)81938-2; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-138; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gilbert RG, 2014, AUST J CHEM, V67, P538, DOI 10.1071/CH13573; Gilbert RG, 2013, ANAL BIOANAL CHEM, V405, P8969, DOI 10.1007/s00216-013-7129-1; Gilbert RG, 2011, ANAL BIOANAL CHEM, V399, P1425, DOI 10.1007/s00216-010-4435-8; Grubisic Z, 1996, J POLYM SCI POL PHYS, V34, P1707, DOI 10.1002/polb.1996.922; Hu ZX, 2019, INT J BIOL MACROMOL, V128, P665, DOI 10.1016/j.ijbiomac.2019.01.186; Hu ZX, 2018, CARBOHYD POLYM, V185, P145, DOI 10.1016/j.carbpol.2018.01.003; Jiang XY, 2016, EUR POLYM J, V82, P175, DOI 10.1016/j.eurpolymj.2016.07.017; Jones RG, 2009, M LOC COMM MACR NOM, DOI [10.1039/9781847559425-FP016, DOI 10.1039/9781847559425-FP016]; Kanungo S, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.59; Kasapkara CS, 2017, J PEDIATR ENDOCR MET, V30, P459, DOI 10.1515/jpem-2016-0317; KEPPENS S, 1993, HEPATOLOGY, V17, P610, DOI 10.1002/hep.1840170414; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Lenzen S, 2014, J BIOL CHEM, V289, P12189, DOI 10.1074/jbc.R114.557314; Li C, 2019, EUR POLYM J, V112, P67, DOI 10.1016/j.eurpolymj.2018.12.039; Li C, 2015, PLANT SCI, V239, P147, DOI 10.1016/j.plantsci.2015.07.026; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; LOMAKO J, 1993, FASEB J, V7, P1386, DOI 10.1096/fasebj.7.14.8224611; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Magliano DJ, 2008, DIABETOLOGIA, V51, P2179, DOI 10.1007/s00125-008-1150-5; MANNERS DJ, 1991, CARBOHYD POLYM, V16, P37, DOI 10.1016/0144-8617(91)90071-J; Martinez-Garcia M, 2016, INT J BIOL MACROMOL, V89, P12, DOI 10.1016/j.ijbiomac.2016.04.051; MEYER F, 1970, J BIOL CHEM, V245, P6642; Nicolescu RC, 2019, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00424; Nielsen JN, 2003, ACTA PHYSIOL SCAND, V178, P309, DOI 10.1046/j.1365-201X.2003.01165.x; Nielsen JN, 2002, J PHYSIOL-LONDON, V541, P979, DOI 10.1113/jphysiol.2002.018044; Nitschke F, 2017, EMBO MOL MED, V9, P906, DOI 10.15252/emmm.201707608; O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4; ORRELL SA, 1964, J BIOL CHEM, V239, P4021; Parker GJ, 2007, BIOCHEM BIOPH RES CO, V362, P811, DOI 10.1016/j.bbrc.2007.08.080; PENG HL, 1993, FEBS LETT, V329, P153, DOI 10.1016/0014-5793(93)80213-E; Powell PO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121337; Raimondo A, 2015, CURR OPIN LIPIDOL, V26, P88, DOI 10.1097/MOL.0000000000000155; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; ROESLER WJ, 1985, HORM METAB RES, V17, P572, DOI 10.1055/s-2007-1013609; ROESLER WJ, 1990, MOL CELL BIOCHEM, V92, P99; ROESLER WJ, 1985, INT J BIOCHEM, V17, P81, DOI 10.1016/0020-711X(85)90089-8; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; Ryu JH, 2009, INT J BIOL MACROMOL, V45, P478, DOI 10.1016/j.ijbiomac.2009.08.006; Sankhala RS, 2015, J BIOL CHEM, V290, P4552, DOI 10.1074/jbc.M114.627406; Sargsyan A, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1195-5; Somogyi M, 1934, J BIOL CHEM, V104, P245; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; STEARNS SB, 1977, LAB INVEST, V37, P180; STETTEN MR, 1956, J BIOL CHEM, V222, P587; Sullivan MA, 2015, CURR DRUG TARGETS, V16, P1088, DOI 10.2174/1389450116666150727123115; Sullivan MA, 2015, CARBOHYD POLYM, V118, P9, DOI 10.1016/j.carbpol.2014.11.005; Sullivan MA, 2014, J CHROMATOGR A, V1332, P21, DOI 10.1016/j.chroma.2014.01.053; Sullivan MA, 2012, BIOMACROMOLECULES, V13, P3805, DOI 10.1021/bm3012727; Sullivan MA, 2011, BIOMACROMOLECULES, V12, P1983, DOI 10.1021/bm2006054; Sullivan MA, 2010, BIOMACROMOLECULES, V11, P1094, DOI 10.1021/bm100074p; Syahariza ZA, 2010, CARBOHYD POLYM, V82, P14, DOI 10.1016/j.carbpol.2010.04.014; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; TAKEUCHI T, 1978, J ELECTRON MICROSC, V27, P31; Tan XL, 2018, ACS OMEGA, V3, P3640, DOI 10.1021/acsomega.8b00119; TAYLOR C, 1975, EUR J BIOCHEM, V51, P105, DOI 10.1111/j.1432-1033.1975.tb03911.x; Testoni G, 2017, CELL METAB, V26, P256, DOI 10.1016/j.cmet.2017.06.008; Verhalen B, 2018, NEUROPEDIATRICS, V49, P357, DOI 10.1055/s-0038-1675238; Vilaplana F, 2010, J SEP SCI, V33, P3537, DOI 10.1002/jssc.201000525; WIDEMAN CH, 1975, LIFE SCI, V17, P1607, DOI 10.1016/0024-3205(75)90183-6; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yu Q, 2012, BIOCHEM J, V442, P283, DOI 10.1042/BJ20111598	84	10	12	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					3	15		10.1096/fj.201901463RR	http://dx.doi.org/10.1096/fj.201901463RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914592	Bronze			2022-12-28	WOS:000507308900002
J	Liu, YY; Wang, CR; Li, JS; Li, TT; Zhang, Y; Liang, YX; Mei, YX				Liu, Yangyang; Wang, Chaorui; Li, Jinshan; Li, Tiantian; Zhang, Yong; Liang, Yunxiang; Mei, Yuxia			Phellinus linteus polysaccharide extract improves insulin resistance by regulating gut microbiota composition	FASEB JOURNAL			English	Article						gut microbiota; insulin signaling; inflammation; Phellinus linteus polysaccharide; short-chain fatty acids	CHAIN FATTY-ACIDS; DIETARY FIBER; AGARICUS-BISPORUS; OBESITY; STREPTOZOTOCIN; METABOLISM; FERMENTATION; DYSFUNCTION; INDIVIDUALS; METAGENOME	The hypoglycemic effect of Phellinus linteus polysaccharide extract (PLPE) has been documented in several previous studies, but the functional interactions among PLPE, gut microbiota, and the hypoglycemic effect remain unclear. We examined the regulatory effect of PLPE on gut microbiota, and the molecular mechanism underlying improvement of insulin resistance, using a type 2 diabetic rat model. Here, 24 male Sprague-Dawley rats were randomly divided into four groups that were subjected to intervention of saline (normal and model control group), metformin (120 mg/kg.bw), and PLPE (600 mg/kg.bw) by oral administration. After 8 weeks of treatment, PLPE increased levels of short-chain fatty acids (SCFAs) by enhancing abundance of SCFA-producing bacteria. SCFAs maintained intestinal barrier function and reduced lipopolysaccharides content in blood, thereby helping to reduce systemic inflammation and reverse insulin resistance. Our findings suggest that PLPE (in which polysaccharides are the major component) has potential application as a prebiotic for regulating gut microbiota composition in diabetic patients.	[Liu, Yangyang; Wang, Chaorui; Li, Jinshan; Li, Tiantian; Zhang, Yong; Liang, Yunxiang; Mei, Yuxia] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Mei, Yuxia] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Huazhong Agricultural University; University of California System; University of California Davis	Mei, YX (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.	mei@mail.hzau.edu.cn	Li, Jinshan/AAQ-9461-2020	Li, Jinshan/0000-0003-3109-5092	State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University; Fundamental Research Funds for the Central Universities of China [2662019PY066, 2662016PY132]; China Scholarship Council [201706765055]	State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); China Scholarship Council(China Scholarship Council)	This study was supported by funds from the State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Fundamental Research Funds for the Central Universities of China (grant No. 2662019PY066, No. 2662016PY132), and a special grant from China Scholarship Council (No. 201706765055). The authors are grateful to Dr. S. Anderson for English editing of the manuscript.	Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen H, 2016, FITOTERAPIA, V113, P6, DOI 10.1016/j.fitote.2016.06.009; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; de Assis AM, 2009, EXP BIOL MED, V234, P1296, DOI 10.3181/0904-RM-126; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Ding QA, 2017, FOOD HYDROCOLLOID, V63, P646, DOI 10.1016/j.foodhyd.2016.10.018; Duan YH, 2019, FASEB J, V33, P10019, DOI 10.1096/fj.201900665RR; Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Feng H, 2018, CARBOHYD POLYM, V200, P144, DOI 10.1016/j.carbpol.2018.07.086; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Hehemann JH, 2019, ISME J, V13, P1883, DOI 10.1038/s41396-019-0406-z; Hernandez JB, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8216, 10.1038/ncomms8489]; Hu T, 2018, CARBOHYD POLYM, V200, P487, DOI 10.1016/j.carbpol.2018.08.021; Hwang HJ, 2008, KOREAN J CHEM ENG, V25, P308, DOI 10.1007/s11814-008-0054-x; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Jayachandran M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091934; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kieler IN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41195-0; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Liu YY, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020296; Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012; Martel J, 2017, NAT REV ENDOCRINOL, V13, P149, DOI 10.1038/nrendo.2016.142; Martens EC, 2018, NAT REV MICROBIOL, V16, P457, DOI 10.1038/s41579-018-0036-x; Mei YX, 2015, CARBOHYD POLYM, V124, P90, DOI 10.1016/j.carbpol.2015.02.009; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Palacio J C, 1990, Nutr Clin Pract, V5, P99, DOI 10.1177/011542659000500399; Puddu Alessandra, 2014, Mediators Inflamm, V2014, P162021, DOI 10.1155/2014/162021; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ravachol J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22770; Scott TA, 2017, CELL, V169, P442, DOI 10.1016/j.cell.2017.03.040; Singh A, 2019, FASEB J, V33, P6748, DOI 10.1096/fj.201801627RRR; Solano-Aguilar GI, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111721; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Tian Y, 2018, J FUNCT FOODS, V45, P223, DOI 10.1016/j.jff.2018.04.008; Uyanoglu M, 2014, INT J FOOD SCI NUTR, V65, P482, DOI 10.3109/09637486.2013.869796; Vanegas SM, 2017, AM J CLIN NUTR, V105, P635, DOI 10.3945/ajcn.116.146928; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wan Y, 2019, GUT, V68, P1417, DOI 10.1136/gutjnl-2018-317609; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wu TR, 2019, GUT, V68, P248, DOI 10.1136/gutjnl-2017-315458; Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8; Yang WY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205784; You YM, 2015, FOOD FUNCT, V6, P3144, DOI 10.1039/c5fo00432b; Zhang BW, 2018, J FUNCT FOODS, V46, P256, DOI 10.1016/j.jff.2018.04.070; Zhao C, 2014, J FOOD SCI, V79, pH1002, DOI 10.1111/1750-3841.12464; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhou D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01751-y	55	34	37	4	71	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1065	1078		10.1096/fj.201901943RR	http://dx.doi.org/10.1096/fj.201901943RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914668				2022-12-28	WOS:000507308900072
J	Ricci, A; Galluzzi, L; Magnani, M; Menotta, M				Ricci, Anastasia; Galluzzi, Luca; Magnani, Mauro; Menotta, Michele			DDIT4 gene expression is switched on by a new HDAC4 function in ataxia telangiectasia	FASEB JOURNAL			English	Article						ataxia telangiectasia; DDIT4; dexamethasone; HDAC4	HISTONE DEACETYLASE 4; NEUROLOGICAL SYMPTOMS; LOADING CONTROL; ATM DEFICIENCY; CELL-GROWTH; DNA-DAMAGE; MTOR; DEXAMETHASONE; LC3; BETAMETHASONE	Ataxia telangiectasia (AT) is a rare, severe, and ineluctably progressive multisystemic neurodegenerative disease. Histone deacetylase 4 (HDAC4) nuclear accumulation has been related to neurodegeneration in AT. Since treatment with glucocorticoid analogues has been shown to improve the neurological symptoms that characterize this syndrome, the effects of dexamethasone on HDAC4 were investigated. In this paper, we describe a novel nonepigenetic function of HDAC4 induced by dexamethasone, through which it can directly modulate HIF-1a activity and promote the upregulation of the DDIT4 gene and protein expression. This new HDAC4 transcription regulation mechanism leads to a positive effect on autophagic flux, an AT-compromised biological pathway. This signaling was specifically induced by dexamethasone only in AT cell lines and can contribute in explaining the positive effects of dexamethasone observed in AT-treated patients.	[Ricci, Anastasia; Galluzzi, Luca; Magnani, Mauro; Menotta, Michele] Univ Urbino Carlo Bo, Dept Biomol Sci, Via Saffi 2, I-61029 Urbino, Italy	University of Urbino	Ricci, A (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Via Saffi 2, I-61029 Urbino, Italy.	anastasia.ricci@uniurb.it	Magnani, Mauro/A-1919-2008; Galluzzi, Luca/G-3969-2012	Galluzzi, Luca/0000-0002-1747-526X; Magnani, Mauro/0000-0001-6456-6626	EC | Horizon 2020 (EU Framework Programme for Research and Innovation) [667946]; FanoAteneo	EC | Horizon 2020 (EU Framework Programme for Research and Innovation); FanoAteneo	EC | Horizon 2020 (EU Framework Programme for Research and Innovation), Grant/Award Number: 667946; FanoAteneo	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Alexander A, 2010, AUTOPHAGY, V6, P672, DOI 10.4161/auto.6.5.12509; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Biagiotti S, 2016, FEBS J, V283, P3962, DOI 10.1111/febs.13901; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Broccoletti T, 2008, EUR J NEUROL, V15, P223, DOI 10.1111/j.1468-1331.2008.02060.x; Broccoletti T, 2011, EUR J NEUROL, V18, P564, DOI 10.1111/j.1468-1331.2010.03203.x; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buoni S, 2006, ARCH NEUROL-CHICAGO, V63, P1479, DOI 10.1001/archneur.63.10.1479; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chessa L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-5; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Cirillo E, 2018, EUR J NEUROL, V25, P833, DOI 10.1111/ene.13606; D'Assante R, 2017, CLIN IMMUNOL, V175, P16, DOI 10.1016/j.clim.2016.11.015; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Dennis MD, 2013, CELL SIGNAL, V25, P2709, DOI 10.1016/j.cellsig.2013.08.038; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Di Giorgio E, 2016, EPIGENOMICS-UK, V8, P251, DOI 10.2217/epi.15.106; Du F, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0315-y; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Flynn P, 2000, CURR BIOL, V10, P1439, DOI 10.1016/S0960-9822(00)00801-0; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Leuzzi V, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000098; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Mani M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8394; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Menotta M, 2017, MOL CELL BIOCHEM, V12, P126, DOI DOI 10.1186/S13023-017-0669-2; Menotta M, 2018, MOL CELL BIOCHEM, V438, P153, DOI 10.1007/s11010-017-3122-x; Menotta M, 2017, CELL BIOCHEM BIOPHYS, V75, P95, DOI 10.1007/s12013-016-0775-0; Menotta M, 2012, J BIOL CHEM, V287, P41352, DOI 10.1074/jbc.M112.344473; Menotta M, 2010, BIOSENS BIOELECTRON, V25, P2490, DOI 10.1016/j.bios.2010.04.022; Mielcarek M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00042; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molitoris JK, 2011, J BIOL CHEM, V286, P30181, DOI 10.1074/jbc.M111.245423; Napione L, 2012, BLOOD, V119, P5599, DOI 10.1182/blood-2011-11-390666; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Peng C, 2012, J BIOL CHEM, V287, P32861, DOI 10.1074/jbc.M112.384305; Polman JAE, 2012, ENDOCRINOLOGY, V153, P4317, DOI 10.1210/en.2012-1255; Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Russo I, 2009, EUR J NEUROL, V16, P755, DOI 10.1111/j.1468-1331.2009.02600.x; Rybak JN, 2004, PROTEOMICS, V4, P2296, DOI 10.1002/pmic.200300780; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Sharma NK, 2014, DNA REPAIR, V13, P22, DOI 10.1016/j.dnarep.2013.11.002; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Tang YF, 2016, ONCOTARGET, V7, P15854, DOI 10.18632/oncotarget.7493; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Wolff NC, 2014, MOL CANCER RES, V12, P867, DOI 10.1158/1541-7786.MCR-13-0625; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Zannolli R, 2012, MOVEMENT DISORD, V27, P1312, DOI 10.1002/mds.25126	87	6	6	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1802	1818		10.1096/fj.201902039R	http://dx.doi.org/10.1096/fj.201902039R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914654	hybrid, Green Published			2022-12-28	WOS:000507308900119
J	Wang, C; Feng, YP; Zhang, CY; Cheng, D; Wu, RY; Yang, YQ; Sargsyan, D; Kumar, D; Kong, AN				Wang, Chao; Feng, Yaping; Zhang, Chengyue; Cheng, David; Wu, Renyi; Yang, Yuqing; Sargsyan, Davit; Kumar, Dibyendu; Kong, Ah-Ng			PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer	FASEB JOURNAL			English	Article						CXCL1; DNA methylation; prostate cancer; PTEN; transcriptome	TUMOR-SUPPRESSOR; MICROSATELLITE INSTABILITY; EPIGENETIC REACTIVATION; PROMOTER METHYLATION; INFLAMMATION; CXCL1; GENE; INACTIVATION; EXPRESSION; BREAST	Phosphatase and tensin homolog located on chromosome 10 (PTEN) is a tumor suppressor gene and one of the most frequently mutated/deleted genes in human prostate cancer (PCa). However, how PTEN deletion would impact the epigenome and transcriptome alterations remain unknown. This hypothesis was tested in a prostate-specific PTEN-/- (KO) mouse prostatic adenocarcinoma model through DNA methyl-Seq and RNA-Seq analyses. Examination of cancer genomic datasets revealed that PTEN is expressed at lower levels in PTEN-deleted tumor samples than in normal solid tissue samples. Methylome and transcriptome profiling identified several inflammatory responses and immune response signaling pathways, including NF-kB signaling, IL-6 signaling, LPS/IL-1-mediated inhibition of RXR Function, PI3K in B lymphocytes, iCOS-iCOSL in T helper cells, and the role of NFAT in regulating the immune response, were affected by PTEN deletion. Importantly, a small subset of genes that showed DNA hypermethylation or hypomethylation was correlated with decreased or increased gene expression including CXCL1. quantitative polymerase chain reaction analyses of representative genes validated the RNA-Seq results. Histopathological examinations showed that the severity of prostatic intraepithelial neoplasia and inflammation development gradually increased as PTEN null mice aged. Collectively, these findings suggest that loss of PTEN drives global changes in DNA CpG methylation and transcriptomic gene expression and highly associated with several inflammatory and immune molecular pathways during PCa development. These biomarkers could be valuable molecular targets for cancer drug discovery and development against PCa.	[Wang, Chao; Zhang, Chengyue; Cheng, David; Wu, Renyi; Yang, Yuqing; Sargsyan, Davit; Kong, Ah-Ng] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ USA; [Wang, Chao; Zhang, Chengyue; Cheng, David; Wu, Renyi; Yang, Yuqing; Sargsyan, Davit; Kong, Ah-Ng] Rutgers State Univ, Ernest Mario Sch Pharm, Ctr Phytochem Epigenome Studies, Piscataway, NJ USA; [Feng, Yaping; Kumar, Dibyendu] Rutgers State Univ, Waksman Inst Microbiol, Genom Core Facil, Piscataway, NJ USA; [Cheng, David; Sargsyan, Davit] Rutgers State Univ, Ernest Mario Sch Pharm, Grad Program Pharmaceut Sci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kong, AN (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Ctr Phytochem Epigenome Studies, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	KongT@pharmacy.rutgers.edu	Sargsyan, Davit/AHB-2158-2022; Kong, Ah-Ng Tony/AAX-2828-2020	Sargsyan, Davit/0000-0003-1594-6715	HHS \ NIH \ National Center for Complementary and Integrative Health (NCCIH) [AT009152, R01AT007065]; HHS \ NIH \ National Cancer Institute (NCI) [CA200129]	HHS \ NIH \ National Center for Complementary and Integrative Health (NCCIH); HHS \ NIH \ National Cancer Institute (NCI)	HHS vertical bar NIH vertical bar National Center for Complementary and Integrative Health (NCCIH), Grant/Award Number: AT009152 and R01AT007065; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: CA200129	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Birbach A, 2011, NEOPLASIA, V13, P692, DOI 10.1593/neo.11524; Boyanapalli SSS, 2016, PHARMACOL RES, V114, P175, DOI 10.1016/j.phrs.2016.10.021; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clegg NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017449; Cooke J, 2012, INFLAMM BOWEL DIS, V18, P2128, DOI 10.1002/ibd.22942; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Dluzniewski PJ, 2012, CANCER EPIDEM BIOMAR, V21, P1774, DOI 10.1158/1055-9965.EPI-12-0458; Dugue PA, 2018, PROSTATE, V78, P962, DOI 10.1002/pros.23654; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; Garcia AJ, 2014, MOL CELL BIOL, V34, P2017, DOI 10.1128/MCB.00090-14; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Geybels MS, 2017, ONCOTARGET, V8, P84338, DOI 10.18632/oncotarget.20940; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Graca I, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0264-8; Guo Y, 2017, BIOCHEM PHARMACOL, V135, P22, DOI 10.1016/j.bcp.2017.02.021; Hartnett L, 2012, CARCINOGENESIS, V33, P723, DOI 10.1093/carcin/bgs006; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hsi LC, 2005, MOL CANCER THER, V4, P1740, DOI 10.1158/1535-7163.MCT-05-0218; Huang FY, 2013, EUR J CANCER, V49, P2760, DOI 10.1016/j.ejca.2013.03.031; Huidobro C, 2012, EUR J CANCER, V48, P2270, DOI 10.1016/j.ejca.2011.12.019; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100; Khor TO, 2014, CANCER PREV RES, V7, P1186, DOI 10.1158/1940-6207.CAPR-14-0127; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kozuka T, 2011, J IMMUNOL, V187, P5974, DOI 10.4049/jimmunol.1100550; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Lopez J, 2009, BRIT J CANCER, V100, P571, DOI 10.1038/sj.bjc.6604930; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maxwell PJ, 2013, EUR UROL, V64, P177, DOI 10.1016/j.eururo.2012.08.032; Miyake M, 2019, THERANOSTICS, V9, P853, DOI 10.7150/thno.29553; Miyake M, 2014, PATHOL RES PRACT, V210, P74, DOI 10.1016/j.prp.2013.08.013; Piras G, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-16; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodriguez-Berriguete G, 2013, CYTOKINE, V64, P555, DOI 10.1016/j.cyto.2013.09.003; Roh MR, 2016, J INVEST DERMATOL, V136, P1002, DOI 10.1016/j.jid.2016.01.024; Salvesen HB, 2001, INT J CANCER, V91, P22, DOI 10.1002/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S; Song EY, 2010, CANCER RES, V70, P4394, DOI 10.1158/0008-5472.CAN-10-0427; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Su ZY, 2013, CHEM RES TOXICOL, V26, P477, DOI 10.1021/tx300524p; Tommasi S, 2005, CANCER RES, V65, P92; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Ueda S, 2006, CANCER RES, V66, P5346, DOI 10.1158/0008-5472.CAN-05-3684; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; Wang N, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0876-3; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Wu Y, 2016, EPIGENETICS-US, V11, P247, DOI 10.1080/15592294.2016.1148867; Yu SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008579; Zysman MA, 2002, AM J PATHOL, V160, P795, DOI 10.1016/S0002-9440(10)64902-4	57	13	14	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1304	1318		10.1096/fj.201901205RR	http://dx.doi.org/10.1096/fj.201901205RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914691	Green Accepted			2022-12-28	WOS:000507308900087
J	Choi, EK; Aring, L; Das, NK; Solanki, S; Inohara, N; Iwase, S; Samuelson, LC; Shah, YM; Seo, YA				Choi, Eun-Kyung; Aring, Luisa; Das, Nupur K.; Solanki, Sumeet; Inohara, Naohiro; Iwase, Shigeki; Samuelson, Linda C.; Shah, Yatrik M.; Seo, Young Ah			Impact of dietary manganese on experimental colitis in mice	FASEB JOURNAL			English	Article						colitis; gut microbiota; inflammatory bowel disease; manganese; tight junction	INFLAMMATORY-BOWEL-DISEASE; OXIDATIVE DNA-DAMAGE; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; DEXTRAN SULFATE; GUT MICROBIOTA; NUTRITION; HOMEOSTASIS; BIOMARKER; ELEMENTS	Diet plays a significant role in the pathogenesis of inflammatory bowel disease (IBD). A recent epidemiological study has shown an inverse relationship between nutritional manganese (Mn) status and IBD patients. Mn is an essential micronutrient required for normal cell function and physiological processes. To date, the roles of Mn in intestinal homeostasis remain unknown and the contribution of Mn to IBD has yet to be explored. Here, we provide evidence that Mn is critical for the maintenance of the intestinal barrier and that Mn deficiency exacerbates dextran sulfate sodium (DSS)-induced colitis in mice. Specifically, when treated with DSS, Mn-deficient mice showed increased morbidity, weight loss, and colon injury, with a concomitant increase in inflammatory cytokine levels and oxidative and DNA damage. Even without DSS treatment, dietary Mn deficiency alone increased intestinal permeability by impairing intestinal tight junctions. In contrast, mice fed a Mn-supplemented diet showed slightly increased tolerance to DSS-induced experimental colitis, as judged by the colon length. Despite the well-appreciated roles of intestinal microbiota in driving inflammation in IBD, the gut microbiome composition was not altered by changes in dietary Mn. We conclude that Mn is necessary for proper maintenance of the intestinal barrier and provides protection against DSS-induced colon injury.	[Choi, Eun-Kyung; Aring, Luisa; Seo, Young Ah] Univ Michigan, Dept Nutr Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Das, Nupur K.; Solanki, Sumeet; Samuelson, Linda C.; Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Inohara, Naohiro] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Iwase, Shigeki] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Seo, YA (corresponding author), Univ Michigan, Dept Nutr Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA.	youngseo@umich.edu	Seo, Young Ah/AAT-5022-2020; Iwase, Shigeki/J-8294-2019; Das, Nupur/AAK-7877-2020	Seo, Young Ah/0000-0003-3884-0665; Iwase, Shigeki/0000-0003-2280-7422; Das, Nupur/0000-0002-5652-1134; Aring, Luisa/0000-0002-0437-4785	HHS \ National Institutes of Health (NIH) [R00 ES024340, R01 DK095201, R01 DK118023, R01 NS089896]; Crohn's and Colitis Foundation; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5P30DK034933]	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R00 ES024340, R01 DK095201, R01 DK118023 and R01 NS089896; Crohn's and Colitis Foundation (Crohn's & Colitis Foundation); HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: 5P30DK034933	Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Association CN, 2001, CHIN DIET REF INT; Barrett CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067845; Caruso R, 2019, CELL REP, V27, P3401, DOI 10.1016/j.celrep.2019.05.042; Cho JM, 2018, BIOL TRACE ELEM RES, V185, P20, DOI 10.1007/s12011-017-1225-6; Choi EK, 2019, FASEB J, V33, P2228, DOI 10.1096/fj.201800831R; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Colombel JF, 2017, GASTROENTEROLOGY, V152, P309, DOI 10.1053/j.gastro.2016.12.004; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Egan SK, 2002, FOOD ADDIT CONTAM A, V19, P103, DOI 10.1080/02652030110071354; Eichele DD, 2017, WORLD J GASTROENTERO, V23, P6016, DOI 10.3748/wjg.v23.i33.6016; Finley JW, 2003, J NUTR, V133, P2849, DOI 10.1093/jn/133.9.2849; Freeland-Graves JH, 2016, J TRACE ELEM MED BIO, V38, P24, DOI 10.1016/j.jtemb.2016.05.004; Gilca-Blanariu GE, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1813047; HALLFRISCH J, 1987, J NUTR, V117, P48, DOI 10.1093/jn/117.1.48; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; IJssennagger N, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043260, 10.1371/journal.pone.0049868]; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Jiang J, 2015, J FOOD COMPOS ANAL, V39, P1, DOI 10.1016/j.jfca.2014.10.012; Kang M, 2014, EUR J CLIN NUTR, V68, P804, DOI 10.1038/ejcn.2014.77; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Khalili H, 2018, NAT REV GASTRO HEPAT, V15, P525, DOI 10.1038/s41575-018-0022-9; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Kim Eun-Young, 2008, Nutr Res Pract, V2, P22, DOI 10.4162/nrp.2008.2.1.22; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Konig J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.54; Kudva AK, 2015, AM J PHYSIOL-GASTR L, V309, pG71, DOI 10.1152/ajpgi.00379.2014; Lechuga S, 2017, BBA-MOL CELL RES, V1864, P1183, DOI 10.1016/j.bbamcr.2017.03.007; Lomer MCE, 2019, ANN NUTR METAB, V74, P18, DOI 10.1159/000495214; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Penagini F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060334; Rapozo DCM, 2017, WORLD J GASTROENTERO, V23, P2124, DOI 10.3748/wjg.v23.i12.2124; Reddavide Rosa, 2018, Acta Biomed, V89, P60, DOI 10.23750/abm.v89i9-S.7952; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Seo YA, 2016, BIOMETALS, V29, P147, DOI 10.1007/s10534-015-9904-2; Seo YA, 2015, FASEB J, V29, P2726, DOI 10.1096/fj.14-262592; Stein J, 2013, ANN GASTROENTEROL, V26, P104; Suwendi E, 2012, BIOMED RES-TOKYO, V33, P329, DOI 10.2220/biomedres.33.329; Trivedi PP, 2013, CHEM-BIOL INTERACT, V201, P19, DOI 10.1016/j.cbi.2012.12.004; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; van't Erve TJ, 2016, FREE RADICAL BIO MED, V95, P65, DOI 10.1016/j.freeradbiomed.2016.03.001; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Yahia D, 2016, ENVIRON TOXICOL, V31, P192, DOI 10.1002/tox.22034; Zanello G, 2014, NESTLE NUTR WORKS SE, V79, P41, DOI 10.1159/000360676; Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247	52	20	20	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2929	2943		10.1096/fj.201902396R	http://dx.doi.org/10.1096/fj.201902396R		DEC 2019	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908045	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000504854200001
J	Machado, MG; Tavares, LP; Souza, GVS; Queiroz, CM; Ascencao, FR; Lopes, ME; Garcia, CC; Menezes, GB; Perretti, M; Russo, RC; Teixeira, MM; Sousa, LP				Machado, Marina Gomes; Tavares, Luciana Padua; Souza, Geovanna V. Santos; Queiroz-Junior, Celso M.; Ascencao, Fernando Roque; Lopes, Mateus Eustaquio; Garcia, Cristiana Couto; Menezes, Gustavo Batista; Perretti, Mauro; Russo, Remo Castro; Teixeira, Mauro Martins; Sousa, Lirlandia Pires			The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia	FASEB JOURNAL			English	Article						inflammation; pro-resolving mediator; resolution; Streptococcus pneumoniae	ANTIINFLAMMATORY DRUGS; NEUTROPHIL RECRUITMENT; GENE-EXPRESSION; RESOLUTION; INFECTION; DEXAMETHASONE; MACROPHAGES; MODULATION; MECHANISMS; MEDIATORS	Streptococcus pneumoniae is a major cause of community-acquired pneumonia leading to high mortality rates. Inflammation triggered by pneumococcal infection is necessary for bacterial clearance but must be spatially and temporally regulated to prevent further tissue damage and bacterial dissemination. Annexin A1 (AnxA1) mainly acts through Formyl Peptide Receptor 2 (FPR2) inducing the resolution of inflammation. Here, we have evaluated the role of AnxA1 and FPR2 during pneumococcal pneumonia in mice. For that, AnxA1, Fpr2/3 knockout (KO) mice and wild-type (WT) controls were infected intranasally with S pneumoniae. AnxA1 and Fpr2/3 KO mice were highly susceptible to infection, displaying uncontrolled inflammation, increased bacterial dissemination, and pulmonary dysfunction compared to WT animals. Mechanistically, the absence of AnxA1 resulted in the loss of lung barrier integrity and increased neutrophil activation upon S pneumoniae stimulation. Importantly, treatment of WT or AnxA1 KO-infected mice with Ac2-26 decreased inflammation, lung damage, and bacterial burden in the airways by increasing macrophage phagocytosis. Conversely, Ac2-26 peptide was ineffective to afford protection in Fpr2/3 KO mice during infection. Altogether, these findings show that AnxA1, via FPR2, controls inflammation and bacterial dissemination during pneumococcal pneumonia by promoting host defenses, suggesting AnxA1-based peptides as a novel therapeutic strategy to control pneumococcal pneumonia.	[Machado, Marina Gomes; Souza, Geovanna V. Santos; Sousa, Lirlandia Pires] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Lab Sinalizacao Inflamacao, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil; [Machado, Marina Gomes; Tavares, Luciana Padua; Souza, Geovanna V. Santos; Ascencao, Fernando Roque; Teixeira, Mauro Martins; Sousa, Lirlandia Pires] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil; [Queiroz-Junior, Celso M.; Lopes, Mateus Eustaquio; Menezes, Gustavo Batista] Univ Fed Minas Gerais, ICB, Dept Morfol, Belo Horizonte, MG, Brazil; [Garcia, Cristiana Couto] Inst Oswaldo Cruz Fiocruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil; [Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Russo, Remo Castro] Univ Fed Minas Gerais, ICB, Dept Fisiol & Biofis, Lab Imunol & Mecan Pulm, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; University of London; Queen Mary University London; Universidade Federal de Minas Gerais	Sousa, LP (corresponding author), Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Lab Sinalizacao Inflamacao, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Teixeira, MM (corresponding author), Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	mmtex.ufmg@gmail.com; lipsousa72@gmail.com	Garcia, Cristiana Couto/AAE-4290-2022; Menezes, Gustavo B/B-3350-2013; Teixeira, Mauro M/A-4587-2008; Russo, Remo Castro/O-8980-2019; Eustaquio de Moura Lopes, Mateus/T-3145-2017	Garcia, Cristiana Couto/0000-0002-4400-9141; Teixeira, Mauro M/0000-0002-6944-3008; Russo, Remo Castro/0000-0002-1715-3834; Padua Tavares, Luciana/0000-0002-5319-0210; Gomes Machado, Marina/0000-0002-8996-613X; Eustaquio de Moura Lopes, Mateus/0000-0001-8730-7336	William Harvey Research Foundation; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-03221-18]; Instituto Nacional de Ciencia e Tecnologia de Investigacao em Imunologia (INCT-iii) [465425/2014-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [465425, 2014-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	William Harvey Research Foundation; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia de Investigacao em Imunologia (INCT-iii); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	William Harvey Research Foundation; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Grant/Award Number: APQ-03221-18; Instituto Nacional de Ciencia e Tecnologia de Investigacao em Imunologia (INCT-iii), Grant/Award Number: 465425/2014-3; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Grant/Award Number: 465425 and 2014-3; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Choi EH, 2016, CLIN VACCINE IMMUNOL, V23, P162, DOI 10.1128/CVI.00591-15; Cooray Sadani N, 2013, Proc Natl Acad Sci U S A, V110, P18232, DOI 10.1073/pnas.1308253110; Corminboeuf O, 2015, J MED CHEM, V58, P537, DOI 10.1021/jm501051x; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Cristante E, 2013, P NATL ACAD SCI USA, V110, P832, DOI 10.1073/pnas.1209362110; Dalli J, 2017, MOL ASPECTS MED, V58, P12, DOI 10.1016/j.mam.2017.03.007; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; Dockrell DH, 2012, CHEST, V142, P482, DOI 10.1378/chest.12-0210; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Fica A, 2014, BRAZ J INFECT DIS, V18, P115, DOI 10.1016/j.bjid.2013.06.001; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Galvao I, 2017, EUR J IMMUNOL, V47, P585, DOI 10.1002/eji.201646551; Garcia CC, 2010, DISCOV MED, V10, P479; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; LaFemina MJ, 2014, AM J RESP CELL MOL, V51, P550, DOI 10.1165/rcmb.2013-0456OC; Lastrucci C, 2015, FASEB J, V29, P1914, DOI 10.1096/fj.14-259341; Leoni G, 2016, BIOL CHEM, V397, P971, DOI 10.1515/hsz-2016-0180; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li Y, 2011, ONCOGENE, V30, P3887, DOI 10.1038/onc.2011.112; Liao WI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081771; Light R B, 1999, Semin Respir Infect, V14, P218; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Marriott HM, 2008, AM J RESP CRIT CARE, V177, P887, DOI 10.1164/rccm.200707-990OC; Martens P, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-21; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; Meduri GU, 2002, CRIT CARE, V6, P24, DOI 10.1186/cc1450; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; Patel DM, 2011, J CELL SCI, V124, P578, DOI 10.1242/jcs.076208; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Perretti M, 2004, BIOCHEM SOC T, V32, P507, DOI 10.1042/BST0320507; Scalerandi MV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01980; Schloer S, 2019, FASEB J, V33, P12188, DOI 10.1096/fj.201901265R; Senthilkumaran C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-24; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Steel HC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/490346; Sugimoto MA, 2019, TRENDS IMMUNOL, V40, P212, DOI 10.1016/j.it.2019.01.007; Tavares LP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01799; Tavares LP, 2016, AM J RESP CELL MOL, V55, P24, DOI 10.1165/rcmb.2015-0083OC; Trentin PG, 2015, BRIT J PHARMACOL, V172, P3058, DOI 10.1111/bph.13109; Vago JP, 2012, J LEUKOCYTE BIOL, V92, P249, DOI 10.1189/jlb.0112008; vanderPoll T, 1996, J INFECT DIS, V174, P994, DOI 10.1093/infdis/174.5.994; Vanessa KHQ, 2015, IMMUNOBIOLOGY, V220, P614, DOI 10.1016/j.imbio.2014.12.001; Wang H, 2017, CLIN SCI, V131, P2347, DOI 10.1042/CS20171006; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Yona S, 2006, BRIT J PHARMACOL, V148, P469, DOI 10.1038/sj.bjp.0706730; Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204	57	39	41	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2749	2764		10.1096/fj.201902172R	http://dx.doi.org/10.1096/fj.201902172R		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908042	Bronze			2022-12-28	WOS:000504667700001
J	Tang, JQ; Goldschmeding, R; Samarakoon, R; Higgins, PJ				Tang, Jiaqi; Goldschmeding, Roel; Samarakoon, Rohan; Higgins, Paul J.			Protein phosphatase Mg2+/Mn2+ dependent-1A and PTEN deregulation in renal fibrosis: Novel mechanisms and co-dependency of expression	FASEB JOURNAL			English	Article						CCN2; CTGF; CKD; epithelial dysfunction; PAI-1; TGF-beta 1	CHRONIC KIDNEY-DISEASE; ARISTOLOCHIC ACID NEPHROPATHY; TGF-BETA; MOUSE FIBROBLASTS; DOWN-REGULATION; TARGETING PTEN; TGF-BETA-1; GENES; DEGRADATION; ACTIVATION	PPM1A and PTEN emerged as novel suppressors of chronic kidney disease (CKD). Since loss of PPM1A and PTEN in the tubulointerstitium promotes fibrogenesis, defining molecular events underlying PPM1A/PTEN deregulation is necessary to develop expression rescue as novel therapeutic strategies. Here we identify TGF-beta 1 as a principle repressor of PPM1A, as conditional renal tubular-specific induction of TGF-beta 1 in mice dramatically downregulates kidney PPM1A expression. TGF-beta 1 similarly attenuates PPM1A and PTEN expression in human renal epithelial cells and fibroblasts, via a protein degradation mechanism by promoting their ubiquitination. A proteasome inhibitor MG132 rescues PPM1A and PTEN expression, even in the presence of TGF-beta 1, along with decreased fibrogenesis. Restoration of PPM1A or PTEN similarly limits SMAD3 phosphorylation and the activation of TGF-beta 1-induced fibrotic genes. Concurrent loss of PPM1A and PTEN levels in aristolochic acid nephropathy further suggests crosstalk between these repressors. PPM1A silencing in renal fibroblasts, moreover, results in PTEN loss, while PTEN stable depletion decreases PPM1A expression with acquisition of a fibroproliferative phenotype in each case. Transient PPM1A expression, conversely, elevates cellular PTEN levels while lentiviral PTEN introduction increases PPM1A expression. PPM1A and PTEN, therefore, co-regulate each other's relative abundance, identifying a previously unknown pathological link between TGF-beta 1 repressors, contributing to CKD.	[Tang, Jiaqi; Samarakoon, Rohan; Higgins, Paul J.] Albany Med Ctr, Dept Regenerat & Canc Cell Biol, Albany, NY USA; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Albany Medical College; Utrecht University; Utrecht University Medical Center	Samarakoon, R; Higgins, PJ (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, 47 New Scotland Ave, Albany, NY 12208 USA.	samarar@amc.edu; higginp@amc.edu		Tang, Jiaqi/0000-0002-3544-3456	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [GM057242]; A Capital Region Medical Institute Grant; Graver Family Endowment; Friedman Family Fund; Butler Family Foundation; Roach Family Foundation	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); A Capital Region Medical Institute Grant; Graver Family Endowment; Friedman Family Fund; Butler Family Foundation; Roach Family Foundation	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM057242; A Capital Region Medical Institute Grant; The Graver Family Endowment; The Friedman Family Fund; The Butler Family Foundation; The Roach Family Foundation	Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Bera A, 2017, AM J PHYSIOL-CELL PH, V313, pC430, DOI 10.1152/ajpcell.00081.2017; Bhatt K, 2015, J AM SOC NEPHROL, V26, P1588, DOI 10.1681/ASN.2014050463; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Chen JK, 2015, J CLIN INVEST, V125, P2429, DOI 10.1172/JCI78945; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Fukasawa H, 2006, KIDNEY INT, V69, P1733, DOI 10.1038/sj.ki.5000261; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Higgins DF, 2017, BBA-MOL BASIS DIS, V1863, P3095, DOI 10.1016/j.bbadis.2017.09.011; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lan RP, 2012, AM J PHYSIOL-RENAL, V302, pF1210, DOI 10.1152/ajprenal.00660.2011; Lee YR, 2018, NAT REV MOL CELL BIO, V19, P547, DOI 10.1038/s41580-018-0015-0; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu SX, 2013, ARTHRITIS RHEUM-US, V65, P2940, DOI 10.1002/art.38121; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Macconi D, 2014, KIDNEY INT SUPPL, V4, P58, DOI 10.1038/kisup.2014.11; McClelland AD, 2015, CLIN SCI, V129, P1237, DOI 10.1042/CS20150427; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Parapuram SK, 2015, MATRIX BIOL, V43, P35, DOI 10.1016/j.matbio.2015.01.017; Parapuram SK, 2011, J INVEST DERMATOL, V131, P1996, DOI 10.1038/jid.2011.156; Patel S, 2019, FASEB J, V33, P9797, DOI 10.1096/fj.201802489RR; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; Samarakoon R, 2016, FASEB J, V30, P3308, DOI 10.1096/fj.201500105R; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Tang JQ, 2018, CANCERS, V10, DOI 10.3390/cancers10060159; Yang JW, 2003, J AM SOC NEPHROL, V14, P3167, DOI 10.1097/01.ASN.0000099373.33259.B2; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Zeniya M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13486-x; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Zhou Y, 2013, AM J PATHOL, V183, P1183, DOI 10.1016/j.ajpath.2013.06.032	44	8	8	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2641	2656		10.1096/fj.201902015RR	http://dx.doi.org/10.1096/fj.201902015RR		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909517				2022-12-28	WOS:000504067500001
J	Ma, XD; Wang, QQ; Li, YW; Tan, P; Wu, HY; Wang, PR; Dong, X; Hong, L; Meng, GY				Ma, Xiaodan; Wang, Qianqian; Li, Yuwen; Tan, Pan; Wu, Haiyan; Wang, Pengran; Dong, Xue; Hong, Liang; Meng, Guoyu			How BamA recruits OMP substrates via poly-POTRAs domain	FASEB JOURNAL			English	Article						beta-barrel assembly machinery; OMP recruitment; lipopartners; fishing mechanism	OUTER-MEMBRANE PROTEINS; BARREL ASSEMBLY MACHINERY; CRYSTAL-STRUCTURE; ESSENTIAL COMPONENT; ESCHERICHIA-COLI; YAET COMPLEX; BIOGENESIS; DYNAMICS; ANTIGEN; TRANSLOCATION	Almost all the outer membrane proteins (OMPs) fold into an invariant beta-barrel fold via the polypeptide-transport-associated (POTRA) motif and beta-barrel assembly machinery (BAM). However, whether and how poly-POTRAs interact with OMPs remain largely unknown. Here, we have characterized the structures of Haemophilus influenzae poly-POTRAs via X-ray crystallography, small angle X-ray scattering, and molecular dynamics simulation. Unexpectedly, crystal packing reveals a putative OMP travel pathway spiraled by the conserved alpha 2-beta 2 edges in poly-POTRAs. Supportively, the structure-based mutations targeting the OMP binding sites significantly disrupt OMP biogenesis, resulting in severe cell growth defects. Another notable feature in H. influenzae POTRA structures is flexibility. As characterized by ELISA assays, poly-POTRAs could recruit OMP substrates in a step-wise manner. More importantly, the restriction of POTRA-POTRA linkage and flexibility significantly impairs the BamA function and causes cell growth defect. Altogether, these results suggest that the beta-strand augmentations and intrinsic flexibility are important factors for BamA-OMP recruitment.	[Ma, Xiaodan; Wang, Qianqian; Li, Yuwen; Wu, Haiyan; Wang, Pengran; Dong, Xue; Meng, Guoyu] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China; [Wang, Pengran] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Inst Translat Med, Shanghai, Peoples R China; [Tan, Pan; Hong, Liang] Shanghai Jiao Tong Univ, Sch Phys & Astron, Inst Translat Med, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Meng, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.	guoyumeng@shsmu.edu.cn	li, yuwen/HGU-6435-2022; Li, yu/HHZ-5236-2022	Tan, Pan/0000-0003-2086-0940; Meng (meng), Guoyu (guo yu)/0000-0001-7904-2382	National Scientific Foundation of China [81970132, 81770142, 81800144, 31800642, 81370620, 81570120]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20152504]; Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institute of Higher Learning	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institute of Higher Learning	The authors thank the personnel of Beamlines BL17U1/18U1/19U1/19U2 Shanghai Synchrotron Radiation Facility/National Center for Protein Science Shanghai (SSRF/NCPSS) for help during data collection. The authors also thank Drs. Thomas J. Silhavy (Princeton University, Princeton, NJ, USA), Joseph W. St Geme III (University of Pennsylvania, Philadel-phia, PA, USA), and Yihua Huang (Institute of Biophysics, Chinese Academy of Sciences, Beijing, China) for their kind sharing of JCM166 cells. This work was supported by research Grants 81970132, 81770142, 81800144, 31800642, 81370620, and 81570120 from National Scientific Foundation of China, research Grant 20152504 from Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support, and the Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institute of Higher Learning. The authors declare no conflicts of interest.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold T, 2010, J BIOL CHEM, V285, P18003, DOI 10.1074/jbc.M110.112516; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Delattre AS, 2011, MOL MICROBIOL, V81, P99, DOI 10.1111/j.1365-2958.2011.07680.x; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Garnett JA, 2012, CURR PROTEIN PEPT SC, V13, P739; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Grass S, 2015, J BACTERIOL, V197, P1769, DOI 10.1128/JB.00039-15; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Heinz E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00370; Heras B, 2014, P NATL ACAD SCI USA, V111, P457, DOI 10.1073/pnas.1311592111; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koenig P, 2010, J BIOL CHEM, V285, P18016, DOI 10.1074/jbc.M110.112649; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Loosmore SM, 1997, INFECT IMMUN, V65, P3701, DOI 10.1128/IAI.65.9.3701-3707.1997; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maier T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8452; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; MELCHIONNA S, 1993, MOL PHYS, V78, P533, DOI 10.1080/00268979300100371; Meng GY, 2011, EMBO J, V30, P3864, DOI 10.1038/emboj.2011.279; Meng G, 2008, J MOL BIOL, V384, P824, DOI 10.1016/j.jmb.2008.09.085; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Noinaj N, 2015, METHODS MOL BIOL, V1329, P51, DOI 10.1007/978-1-4939-2871-2_4; Noinaj N, 2015, CURR OPIN STRUC BIOL, V31, P35, DOI 10.1016/j.sbi.2015.02.012; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; O'Neil PK, 2017, P NATL ACAD SCI USA, V114, pE4868, DOI 10.1073/pnas.1621179114; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Simmerman RF, 2014, INT REV CEL MOL BIO, V308, P1, DOI 10.1016/B978-0-12-800097-7.00001-4; Sinnige T, 2015, STRUCTURE, V23, P1317, DOI 10.1016/j.str.2015.04.014; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; THOMAS WR, 1990, INFECT IMMUN, V58, P1909, DOI 10.1128/IAI.58.6.1909-1913.1990; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vo JL, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600431; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yang YP, 1998, INFECT IMMUN, V66, P3349, DOI 10.1128/IAI.66.7.3349-3354.1998; Zavialov A, 2007, FEMS MICROBIOL REV, V31, P478, DOI 10.1111/j.1574-6976.2007.00075.x; Zeng LH, 2017, ELIFE, V6, DOI 10.7554/eLife.28619	67	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14690	14702		10.1096/fj.201900681RR	http://dx.doi.org/10.1096/fj.201900681RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31702961	Bronze			2022-12-28	WOS:000507466100125
J	Su, WH; Cheng, CY				Su, Wenhui; Cheng, C. Yan			Cdc42 is involved in NC1 peptide-regulated BTB dynamics through actin and microtubule cytoskeletal reorganization	FASEB JOURNAL			English	Article						testis; spermatogenesis; noncollagenous domain 1; collagen alpha 3(IV) chain; F-actin	BLOOD-TESTIS BARRIER; EXTRACELLULAR-MATRIX COMPONENTS; SERTOLI-CELLS; IV COLLAGEN; ECTOPLASMIC SPECIALIZATION; F-ACTIN; ORGANIZATION; EXPRESSION; TUBULIN; GROWTH	Noncollagenous domain 1 (NC1)-peptide is a biologically active peptide derived from the C-terminal region of collagen alpha 3(IV) chain, a structural constituent protein at the basement membrane in the rat testis, likely via proteolytic cleavage of matrix metalloproteinase 9. Studies have shown that this NC1 peptide regulates testis function by inducing Sertoli cell blood-testis barrier (BTB) remodeling and is also capable of inducing elongate spermatid exfoliation through its disruptive effects on the organization of actin- and microtubule (MT)-based cytoskeletons at these cell adhesion sites. However, the underlying molecular mechanism remains unknown. NC1 peptide was found to exert its biologic effects through an activation of small GTPase cell division control protein 42 homolog (Cdc42) because cooverexpression of the dominant negative mutant of Cdc42 [namely, Cdc42-T17N (via a single mutation of amino acid residue 17 from the N terminus from Thr to Asn by site-directed mutagenesis, making it constitutively inactive)] and NC1 peptide was able to block the NC1 peptide-induced Sertoli cell tight junction-permeability barrier disruption. Their cooverexpression also blocked the NC1 peptide-induced misdistribution of BTB-associated proteins at the cell-cell interface and also disruptive cytoskeletal organization of F-actin and MTs through changes in spatial expression of the corresponding actin and MT regulatory proteins. Interestingly, NC1 peptide was also found to induce an up-regulation of phosphorylated (p)-ribosomal protein S6 (rpS6) (namely, p-rpS6-5235/5236) and a concomitant down-regulation of p Akt1/2 (namely, p-Akt1-5473 and p-Akt2-5474), but these changes could not be blocked by overexpression of Cdc42-T17N. More importantly, NC1 peptide-induced Cdc42 activation was effectively blocked by treatment of Sertoli cell epithelium with a p-Akt1/2 activator SC79, which is also capable of blocking NC1 peptide-induced down-regulation of p-Akt1-5473 and p-Akt2/5474, but not p-rpS6-S235/S236 up-regulation. In summary, these findings illustrate that Cdc42 is working downstream of the mammalian target of rapamycin complex 1/rpS6/Akt1/2 signaling pathway to support NC1 peptide-mediated effects on Sertoli cell function in the testis using the rat as an animal model.	[Su, Wenhui; Cheng, C. Yan] Rockefeller Univ, Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA; [Su, Wenhui] China Med Univ, Dept Biochem & Mol Biol, Shenyang, Peoples R China	Population Council; Rockefeller University; China Medical University	Cheng, CY (corresponding author), Rockefeller Univ, Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu		Cheng, C Yan/0000-0003-3117-3791	U.S. National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) [R01 HD056034]; National Natural Science Foundation of China [81971442]; China Scholarship Council [201608210374]	U.S. National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by grants from the U.S. National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD; R01 HD056034 to C.Y.C.) and the National Natural Science Foundation of China (81971442 to W.S.). W.S. was supported by a Fellowship from the China Scholarship Council (201608210374). The authors declare no conflicts of interest.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Assadin S, 2008, EXPERT OPIN BIOL TH, V8, P941, DOI [10.1517/14712590802184482, 10.1517/14712598.8.7.941 ]; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Boyer A, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.115.138016; Brouhard GJ, 2018, NAT REV MOL CELL BIO, V19, P451, DOI 10.1038/s41580-018-0009-y; BYERS SW, 1986, J ANDROL, V7, P59; Chen HQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15671-4; Chen HQ, 2017, FASEB J, V31, P3587, DOI 10.1096/fj.201700052R; Chin YR, 2010, FEBS LETT, V584, P4769, DOI 10.1016/j.febslet.2010.10.056; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Cho HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01823; DAVIS CM, 1990, BIOL REPROD, V43, P860, DOI 10.1095/biolreprod43.5.860; Du M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104851; DYM M, 1994, ENDOCR REV, V15, P102, DOI 10.1210/er.15.1.102; ENDERS GC, 1995, BIOL REPROD, V53, P1489, DOI 10.1095/biolreprod53.6.1489; Frojdman K, 1998, DIFFERENTIATION, V63, P125, DOI 10.1046/j.1432-0436.1998.6330125.x; Gao Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01016-8; Gao Y, 2017, ENDOCRINOLOGY, V158, P963, DOI 10.1210/en.2016-1630; Gao Y, 2017, FASEB J, V31, P584, DOI 10.1096/fj.201600870R; Gao Y, 2016, ONCOTARGET, V7, P64203, DOI 10.18632/oncotarget.11887; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P409, DOI 10.1002/jemt.20786; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; JANECKI A, 1992, TOXICOL APPL PHARM, V112, P51, DOI 10.1016/0041-008X(92)90278-Z; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; Li SYT, 2018, AM J PHYSIOL-ENDOC M, V314, pE174, DOI 10.1152/ajpendo.00263.2017; Lie PPY, 2010, P NATL ACAD SCI USA, V107, P11411, DOI 10.1073/pnas.1001823107; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; Ma HJ, 2006, CELL BIOL INT, V30, P999, DOI 10.1016/j.cellbi.2006.07.007; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Rindone GM, 2018, REPRODUCTION, V156, P93, DOI 10.1530/REP-18-0233; Meyuhas O, 2015, INT REV CEL MOL BIO, V320, P41, DOI 10.1016/bs.ircmb.2015.07.006; Mok KW, 2015, ENDOCRINOLOGY, V156, P1900, DOI 10.1210/en.2014-1791; Mok KW, 2014, J CELL SCI, V127, P4870, DOI 10.1242/jcs.152231; Mok KW, 2012, ENDOCRINOLOGY, V153, P5036, DOI 10.1210/en.2012-1665; Monboisse JC, 2014, BBA-GEN SUBJECTS, V1840, P2589, DOI 10.1016/j.bbagen.2013.12.029; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Ngok SP, 2014, J CELL SCI, V127, P3205, DOI 10.1242/jcs.153197; Nicholls PK, 2009, ENDOCRINOLOGY, V150, P2481, DOI 10.1210/en.2008-1048; Okada M, 2019, J PHARMACOL SCI, V139, P59, DOI 10.1016/j.jphs.2018.12.001; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Pizarro-Cerda J, 2017, TRENDS CELL BIOL, V27, P93, DOI 10.1016/j.tcb.2016.08.001; Qian XJ, 2013, ENDOCRINOLOGY, V154, P1907, DOI 10.1210/en.2012-2269; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Su LL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2171; Sudhakar A, 2008, PHARM RES-DORD, V25, P2731, DOI 10.1007/s11095-008-9634-z; Tang EI, 2015, ENDOCRINOLOGY, V156, P680, DOI 10.1210/en.2014-1720; Tang Elizabeth I, 2012, Spermatogenesis, V2, P117; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; Wen Q, 2018, AM J PHYSIOL-ENDOC M, V315, pE924, DOI 10.1152/ajpendo.00114.2018; Wen Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0201-6; Wong EWP, 2010, P NATL ACAD SCI USA, V107, P11399, DOI 10.1073/pnas.1001077107; Wu YJ, 2017, CURR TOP DEV BIOL, V123, P365, DOI 10.1016/bs.ctdb.2016.11.001; Xiong Z, 2018, BIOL REPROD, V99, P1289, DOI 10.1093/biolre/ioy144; Yan HHN, 2008, P NATL ACAD SCI USA, V105, P8950, DOI 10.1073/pnas.0711264105; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/ncomms14542, 10.1038/s41467-017-00321-0, 10.1038/s41467-017-01968-5]	73	13	14	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14461	14478		10.1096/fj.201900991R	http://dx.doi.org/10.1096/fj.201900991R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31682474	Green Published, Bronze			2022-12-28	WOS:000507466100108
J	Che, H; Wang, YQ; Li, H; Li, Y; Sahil, A; Lv, J; Liu, YN; Yang, ZY; Dong, RX; Xue, HR; Wang, LH				Che, Hui; Wang, Yueqiu; Li, Hui; Li, Yang; Sahil, Abbas; Lv, Jie; Liu, Yining; Yang, Zhenyu; Dong, Ruixue; Xue, Hongru; Wang, Lihong			Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-beta 1/Smads signaling in diabetic cardiomyopathy	FASEB JOURNAL			English	Article						diabetic cardiomyopathy; lncRNA MALAT1; melatonin; microRNA-141; NLRP3 inflammasome; TGF-beta 1; Smads	NONCODING RNA MALAT1; NEUROPEPTIDE-Y; RAT-HEART; PATHOGENESIS; ACTIVATION; EXPRESSION; PROTECTS; PATHWAY; INJURY	Melatonin is a hormone produced by the pineal gland, and it has extensive beneficial effects on various tissue and organs; however, whether melatonin has any effect on cardiac fibrosis in the pathogenesis of diabetic cardiomyopathy (DCM) is still unknown. Herein, we found that melatonin administration significantly ameliorated cardiac dysfunction and reduced collagen production by inhibiting TGF-beta 1/Smads signaling and NLRP3 inflammasome activation, as manifested by downregulating the expression of TGF-beta 1, p-Smad2, p-Smad3, NLRP3, ASC, cleaved caspase-1, mature IL-1 beta, and IL-18 in the heart of melatonin-treated mice with diabetes mellitus (DM). Similar beneficial effects of melatonin were consistently observed in high glucose (HG)-treated cardiac fibroblasts (CFs). Moreover, we also found that lncRNA MALAT1 (lncR-MALAT1) was increased along with concomitant decrease in microRNA-141 (miR-141) in DM mice and HG-treated CFs. Furthermore, we established NLRP3 and TGF-beta 1 as target genes of miR-141 and lncR-MALAT1 as an endogenous sponge or ceRNA to limit the functional availability of miR-141. Finally, we observed that knockdown of miR-141 abrogated anti-fibrosis action of melatonin in HG-treated CFs. Our findings indicate that melatonin produces an antifibrotic effect via inhibiting lncR-MALAT1/miR-141-mediated NLRP3 inflammasome activation and TGF-beta 1/Smads signaling, and it might be considered a potential agent for the treatment of DCM.	[Che, Hui; Wang, Yueqiu; Li, Hui; Li, Yang; Sahil, Abbas; Lv, Jie; Wang, Lihong] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin 150001, Heilongjiang, Peoples R China; [Liu, Yining; Yang, Zhenyu; Dong, Ruixue; Xue, Hongru] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Res, Dept Pharmacol,Minist Educ,Coll Pharm, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Che, H; Wang, LH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin 150001, Heilongjiang, Peoples R China.	chehui1203@163.com; nd6688@163.com			National Natural Science Foundation of China (NSFC) [81770809, 81600935]; China Postdoctoral Science Foundation [2017M621308]; Natural Science Foundation of Heilongjiang Province [QC2017108]; Graduate research and practice innovation project of Harbin medical university [YJSKYCX2018-52HYD]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Graduate research and practice innovation project of Harbin medical university	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770809 and 81600935; China Postdoctoral Science Foundation, Grant/Award Number: 2017M621308; Natural Science Foundation of Heilongjiang Province, Grant/Award Number: QC2017108; Graduate research and practice innovation project of Harbin medical university, Grant/Award Number: YJSKYCX2018-52HYD	Abdulle LE, 2019, INT J MED SCI, V16, P548, DOI 10.7150/ijms.30097; Alonso N, 2018, ADV EXP MED BIOL, V1067, P197, DOI 10.1007/5584_2017_105; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amin AH, 2015, EUR J PHARMACOL, V747, P166, DOI 10.1016/j.ejphar.2014.12.002; Artlett Carol M, 2012, Open Rheumatol J, V6, P80, DOI 10.2174/1874312901206010080; Artlett CM, 2011, ARTHRITIS RHEUM-US, V63, P3563, DOI 10.1002/art.30568; Aydin M, 2008, REGUL PEPTIDES, V146, P197, DOI 10.1016/j.regpep.2007.09.009; Bujak M, 2007, CIRCULATION, V116, P2127, DOI 10.1161/CIRCULATIONAHA.107.704197; Chaudhuri V, 2007, J CUTAN PATHOL, V34, P146, DOI 10.1111/j.1600-0560.2006.00584.x; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Chen XY, 2015, INT J BIOCHEM CELL B, V69, P52, DOI 10.1016/j.biocel.2015.10.012; Ding MG, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12491; Dong PH, 2018, PHARMACOLOGY, V102, P272, DOI 10.1159/000492576; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dvorakova MC, 2008, NEUROSCIENCE, V151, P1016, DOI 10.1016/j.neuroscience.2007.07.069; Esmaiel EM, 2019, PAK J PHARM SCI, V32, P1453; Fowlkes V, 2013, LIFE SCI, V92, P669, DOI 10.1016/j.lfs.2013.01.003; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goldsmith EC, 2014, J MOL CELL CARDIOL, V70, P92, DOI 10.1016/j.yjmcc.2014.01.008; He B, 2016, J PINEAL RES, V60, P313, DOI 10.1111/jpi.12312; Hu W, 2016, J PINEAL RES, V60, P121, DOI 10.1111/jpi.12302; Huang YH, 2015, INT J MOL MED, V35, P311, DOI 10.3892/ijmm.2014.2008; Hutchinson KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072080; Prado NJ, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0842-6; Kandemir YB, 2019, ADV CLIN EXP MED, V28, P1171, DOI 10.17219/acem/103799; Kandemir YB, 2018, CELL MOL BIOL, V64, P47, DOI 10.14715/cmb/2018.64.14.8; Khorsand M, 2019, J DIABETES METAB DIS, V18, P543, DOI 10.1007/s40200-019-00445-8; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Laflamme AK, 1998, AM J HYPERTENS, V11, P219, DOI 10.1016/S0895-7061(97)00401-9; Li X, 2017, EXP CELL RES, V350, P327, DOI 10.1016/j.yexcr.2016.12.006; Li XL, 2019, BIOCHEM BIOPH RES CO, V514, P1, DOI 10.1016/j.bbrc.2019.04.110; Luo BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104771; Luo BB, 2014, CARDIOVASC DRUG THER, V28, P33, DOI 10.1007/s10557-013-6498-1; Luo DD, 2009, NEPHROL DIAL TRANSPL, V24, P2655, DOI 10.1093/ndt/gfp208; Nishiyama K, 2001, Am Heart J, V141, pE9, DOI 10.1067/mhj.2001.114368; Pan XC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020360; Pechanova O, 2014, INT J MOL SCI, V15, P17920, DOI 10.3390/ijms151017920; Russo I, 2016, J MOL CELL CARDIOL, V90, P84, DOI 10.1016/j.yjmcc.2015.12.011; Sedgwick B, 2014, CARDIOVASC PATHOL, V23, P204, DOI 10.1016/j.carpath.2014.03.004; Shi Y, 2018, J ALZHEIMERS DIS, V63, P911, DOI 10.3233/JAD-171178; Shieh JM, 2009, J PINEAL RES, V47, P339, DOI 10.1111/j.1600-079X.2009.00720.x; Simko F, 2016, J PINEAL RES, V61, P127, DOI 10.1111/jpi.12348; Stehle JH, 2011, J PINEAL RES, V51, P17, DOI 10.1111/j.1600-079X.2011.00856.x; Suetomi T, 2018, CIRCULATION, V138, P2530, DOI 10.1161/CIRCULATIONAHA.118.034621; SUNDKVIST G, 1992, DIABETES RES CLIN PR, V15, P219, DOI 10.1016/0168-8227(92)90028-P; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Wang SJ, 2018, J CELL MOL MED, V22, P5132, DOI 10.1111/jcmm.13802; Wang ZV, 2015, CIRCULATION, V131, P771, DOI 10.1161/CIRCULATIONAHA.115.015357; Xiong FY, 2018, MOL MED REP, V17, P374, DOI 10.3892/mmr.2017.7841; Yu LM, 2018, BBA-MOL BASIS DIS, V1864, P563, DOI 10.1016/j.bbadis.2017.11.023; Zhang MY, 2016, INT J CARDIOL, V203, P214, DOI 10.1016/j.ijcard.2015.10.136; Zhang MY, 2016, INT J CARDIOL, V202, P753, DOI 10.1016/j.ijcard.2015.10.019; Zhang MM, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12418; Zhang PF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09482-6; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12449; Zhao G, 2016, FEBS LETT, V590, P2884, DOI 10.1002/1873-3468.12315; Zhou H, 2018, CELL SIGNAL, V47, P88, DOI 10.1016/j.cellsig.2018.03.012; Zhou WY, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5702103; Zuo GF, 2019, J CELL PHYSIOL, V234, P1925, DOI 10.1002/jcp.27070	60	60	65	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5282	5298		10.1096/fj.201902692R	http://dx.doi.org/10.1096/fj.201902692R		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067273				2022-12-28	WOS:000515247200001
J	Gose, T; Shafi, T; Fukuda, Y; Das, S; Wang, Y; Allcock, A; McHarg, AG; Lynch, J; Chen, TS; Tamai, I; Shelat, A; Ford, RC; Schuetz, JD				Gose, Tomoka; Shafi, Talha; Fukuda, Yu; Das, Sourav; Wang, Yao; Allcock, Alice; Gavan McHarg, Ailsa; Lynch, John; Chen, Taosheng; Tamai, Ikumi; Shelat, Anang; Ford, Robert C.; Schuetz, John D.			ABCG2 requires a single aromatic amino acid to "clamp" substrates and inhibitors into the binding pocket	FASEB JOURNAL			English	Article						BCRP; cancer; CETSA; drug; thermal shift assay; kinase inhibitor; transporter	DRUG TARGET ENGAGEMENT; THERMAL SHIFT ASSAY; STEM-CELLS; IN-VITRO; EXPRESSION; TRANSPORTERS; ANALOG	ATP-binding cassette sub-family G member 2 (ABCG2) is a homodimeric ATP-binding cassette (ABC) transporter that not only has a key role in helping cancer cells to evade the cytotoxic effects of chemotherapy, but also in protecting organisms from multiple xeno- and endobiotics. Structural studies indicate that substrate and inhibitor (ligands) binding to ABCG2 can be differentiated quantitatively by the number of amino acid contacts, with inhibitors displaying more contacts. Although binding is the obligate initial step in the transport cycle, there is no empirical evidence for one amino acid being primarily responsible for ligand binding. By mutagenesis and biochemical studies, we demonstrated that the phylogenetically conserved amino acid residue, F439, was critical for both transport and the binding of multiple substrates and inhibitors. Structural modeling implied that the pi-pi interactions from each F439 monomer mediated the binding of a surprisingly diverse array of structurally unrelated substrates and inhibitors and that this symmetrical pi-pi interaction "clamps" the ligand into the binding pocket. Key molecular features of diverse ABCG2 ligands using the pi-pi clamp along with structural studies created a pharmacophore model. These novel findings have important therapeutic implications because key properties of ligands interacting with ABCG2 have been disovered. Furthermore, mechanistic insights have been revealed by demonstrating that for ABCG2 a single amino acid is essential for engaging and initiating transport of multiple drugs and xenobiotics.	[Gose, Tomoka; Fukuda, Yu; Wang, Yao; Allcock, Alice; Gavan McHarg, Ailsa; Lynch, John; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Shafi, Talha; Ford, Robert C.] Univ Manchester, Sch Biol Sci, Manchester, Lancs, England; [Das, Sourav; Chen, Taosheng; Shelat, Anang] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tamai, Ikumi] Kanazawa Univ, Dept Pharmaceut Sci, Kanazawa, Ishikawa, Japan	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Manchester; St Jude Children's Research Hospital; Kanazawa University	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	john.schuetz@stjude.org	Gose, Tomoka/AGX-9986-2022; Chen, Taosheng/I-6351-2013; Fukuda, Yu/GLT-1434-2022; Shelat, Anang/J-4995-2013	Gose, Tomoka/0000-0003-2388-8885; Chen, Taosheng/0000-0001-6420-3809; Das, Sourav/0000-0003-1759-0345; Shelat, Anang/0000-0002-6266-2910; Allcock, Alice/0000-0002-2574-5880	NIH, ALSAC [R01CA194057, R35-GM118041, P30CA21745, CA21865, CA96832]	NIH, ALSAC	NIH, ALSAC, Grant/Award Number: R01CA194057, R35-GM118041, P30CA21745, CA21865, CA96832	Allen JD, 2002, MOL CANCER THER, V1, P417; Ashok Y, 2015, PROTEIN ENG DES SEL, V28, P539, DOI 10.1093/protein/gzv049; Clark R, 2006, BRIT J PHARMACOL, V149, P506, DOI 10.1038/sj.bjp.0706904; Cox MH, 2018, BIOCHEM J, V105, P877; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Elkins CA, 2007, ANTIMICROB AGENTS CH, V51, P923, DOI 10.1128/AAC.01048-06; Enokizono J, 2008, DRUG METAB DISPOS, V36, P995, DOI 10.1124/dmd.107.019257; Ferreira RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15452-z; Fukuda Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92409; Fukuda Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12353; Fukuda Y, 2012, BIOCHEM PHARMACOL, V83, P1073, DOI 10.1016/j.bcp.2011.12.042; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Haider AJ, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150150; Hosomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030456; Hussaarts KGAM, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835918818347; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Jackson SM, 2018, NAT STRUCT MOL BIOL, V25, P333, DOI 10.1038/s41594-018-0049-1; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Khunweeraphong N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11794-w; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Manolaridis I, 2018, NATURE, V563, P426, DOI 10.1038/s41586-018-0680-3; Matsuo H, 2009, SCI TRANSL MED, V120, P1791; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Morfouace M, 2015, CANCER RES, V75, P3879, DOI 10.1158/0008-5472.CAN-15-0030; Nagai S, 2011, CANCER RES, V71, P1781, DOI 10.1158/0008-5472.CAN-10-1919; Pal A, 2007, J PHARMACOL EXP THER, V321, P1085, DOI 10.1124/jpet.106.119289; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Robey RW, 2018, NAT REV CANCER, V18, P452, DOI 10.1038/s41568-018-0005-8; Robey RW, 2004, CANCER RES, V64, P1242, DOI 10.1158/0008-5472.CAN-03-3298; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shukla S, 2014, MOL PHARMACEUT, V11, P2313, DOI 10.1021/mp400762h; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Takenaka K, 2007, CANCER RES, V67, P6965, DOI 10.1158/0008-5472.CAN-06-4720; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; Vaidehi N, 2016, TRENDS PHARMACOL SCI, V37, P37, DOI 10.1016/j.tips.2015.09.005; Wang Z, 2017, ELIFE, V6, DOI 10.7554/eLife.24905; Wijaya J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122544; Yasuda K, 2018, DRUG METAB DISPOS, V46, P1725, DOI 10.1124/dmd.118.083584; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	41	20	19	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4890	4903		10.1096/fj.201902338RR	http://dx.doi.org/10.1096/fj.201902338RR		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067270	Green Accepted			2022-12-28	WOS:000515246800001
J	Wu, H; Wei, SS; Huang, YL; Chen, LT; Wang, YR; Wu, XL; Zhang, ZD; Pei, YC; Wang, DY				Wu, Hao; Wei, Shuangshuang; Huang, Yonglin; Chen, Lintao; Wang, Yuerong; Wu, Xinli; Zhang, Zhuandan; Pei, Yechun; Wang, Dayong			A beta monomer induces phosphorylation of Tau at Ser-214 through beta 2AR-PKA-JNK signaling pathway	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid beta peptide; JNK; monomer; Tau	AMYLOID PRECURSOR PROTEIN; MILD COGNITIVE IMPAIRMENT; N-TERMINAL KINASE; ALZHEIMERS-DISEASE; MITOCHONDRIAL DYSFUNCTION; ADRENERGIC-RECEPTOR; INSULIN-RESISTANCE; PATHOGENESIS; EXPRESSION; ETIOLOGY	Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with synaptic dysfunction, pathological accumulation of beta-amyloid peptide 1-42 (A beta(1-42)), and neuronal loss. The self-association of A beta(1-42) monomers (A beta-M) into soluble oligomers seems to be crucial for the development of neurotoxicity. Previous publications have shown that A beta oligomers and dimers might play key roles in inducing AD. The role of A beta-M was rarely investigated and still unclear in AD. To understand the effects of A beta-M on neurons and other cell types in the brain could be the key to understand its function. In our study, we found that A beta-M expression slowly induced cell apoptosis within 48 hours after transfection, beta 2 adrenergic receptor (beta 2AR) interacted with A beta-M in the pull-down and the yeast two-hybrid assays, and A beta-M played a major role in inducing phosphorylation of Tau at Ser-214, c-Jun N-terminal kinase (JNK) at Thr-183/Tyr-185, p70 ribosomal protein S6 kinase (p70S6K) at Thr-389. We also discovered that beta 2AR, G protein-coupled receptor kinase 2 (GRK2), and protein kinase A (PKA) mediated the phosphorylation of Tau and JNK. A beta-M induced phosphorylation of Tau at Ser-214 through both beta 2AR-cAMP/PKA-JNK and beta 2AR-GRK signaling pathways. Mitogen-activated protein kinase kinase (MEK) mediated the phosphorylation of p70S6K induced by A beta-M.	[Wu, Hao; Wei, Shuangshuang; Huang, Yonglin; Chen, Lintao; Wang, Yuerong; Wu, Xinli; Zhang, Zhuandan; Wang, Dayong] Hainan Univ, Hainan Prov Key Lab Sustainable Utilizat Trop Bio, Haikou, Hainan, Peoples R China; [Wu, Hao; Wei, Shuangshuang; Huang, Yonglin; Chen, Lintao; Wang, Yuerong; Wu, Xinli; Zhang, Zhuandan; Wang, Dayong] Hainan Univ, Sch Life & Pharmaceut Sci, Lab Biotechnol & Mol Pharmacol, Haikou, Hainan, Peoples R China; [Pei, Yechun] Hainan Univ, Dept Vet Sci, Coll Anim Sci, Haikou, Hainan, Peoples R China	Hainan University; Hainan University; Hainan University	Wang, DY (corresponding author), Hainan Univ, Dept Biosci, 58 Peoples Rd, Haikou 570228, Hainan, Peoples R China.; Pei, YC (corresponding author), Hainan Univ, Dept Vet Sci, 58 Peoples Rd, Haikou 570228, Hainan, Peoples R China.	ycpei@hainanu.edu.cn; wangdy@hainanu.edu.cn			National Natural Science Foundation of China [31460226, 31760246]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31460226 and 31760246	Ahmed S, 2015, NEUROL SCI, V36, P1; Alzheimer A, 1995, Clin Anat, V8, P429; Beyreuther K, 1991, BRAIN PATHOL, V1, P241, DOI 10.1111/j.1750-3639.1991.tb00667.x; Chami B, 2016, METAB BRAIN DIS, V31, P497, DOI 10.1007/s11011-016-9806-1; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Combs CK, 2001, J NEUROSCI, V21, P1179; de la Monte SM, 2014, EUR NEUROPSYCHOPHARM, V24, P1954, DOI 10.1016/j.euroneuro.2014.06.008; Diniz BSO, 2008, WORLD J BIOL PSYCHIA, V9, P172, DOI 10.1080/15622970701535502; Freude S, 2009, CURR ALZHEIMER RES, V6, P213, DOI 10.2174/156720509788486527; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1987, J NEURAL TRANSM, P23; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hashimoto Y, 2003, J NEUROCHEM, V84, P864, DOI 10.1046/j.1471-4159.2003.01585.x; Igbavboa U, 2006, NEUROSCIENCE, V142, P655, DOI 10.1016/j.neuroscience.2006.06.056; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kar S, 2004, J PSYCHIATR NEUROSCI, V29, P427; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635; Manassero G, 2016, AGING CELL, V15, P914, DOI 10.1111/acel.12500; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Mitsuyama F, 2009, ALZHEIMERS DEMENTI S, V5, P109; Mitsuyama F, 2012, INT J ALZHEIMERS DIS, V2012; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Pei JJ, 2006, FEBS LETT, V580, P107, DOI 10.1016/j.febslet.2005.11.059; Rad SK, 2018, DRUG DES DEV THER, V12, P3999, DOI 10.2147/DDDT.S173970; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tamagno E, 2018, J ALZHEIMERS DIS, V62, P1241, DOI 10.3233/JAD-170581; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Wang D., 2015, J IND MICROBIOL BIOT, V42, P1; Wang DY, 2013, J BIOL CHEM, V288, P10298, DOI 10.1074/jbc.M112.415141; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhou XW, 2008, FEBS LETT, V582, P159, DOI 10.1016/j.febslet.2007.11.078; Zimbone S, 2018, AGING CELL, V17, DOI 10.1111/acel.12684	40	9	9	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5092	5105		10.1096/fj.201902230RR	http://dx.doi.org/10.1096/fj.201902230RR		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067279				2022-12-28	WOS:000515247700001
J	Cai, Y; Ying, F; Liu, H; Ge, L; Song, EF; Wang, L; Zhang, DW; Tang, EHC; Xia, ZY; Irwin, MG				Cai, Yin; Ying, Fan; Liu, Hao; Ge, Liang; Song, Erfei; Wang, Lin; Zhang, Dengwen; Tang, Eva Hoi Ching; Xia, Zhengyuan; Irwin, Michael G.			Deletion of Rap1 protects against myocardial ischemia/reperfusion injury through suppressing cell apoptosis via activation of STAT3 signaling	FASEB JOURNAL			English	Article						cardiomyocytes; ischemic heart disease; stattic; telomere	NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; ISCHAEMIA/REPERFUSION INJURY; DIABETIC-RATS; CARDIOPROTECTION; TRANSDUCER; HEART; MICE; TRANSCRIPTION-3; INHIBITION	Ischemic heart disease is a leading cause of morbidity and mortality. Repressor activator protein 1 (Rap1), an established telomere-associated protein, is a novel modulator of hypoxia-induced apoptosis. This study aimed to explore the potential direct role of Rap1 in myocardial ischemia/reperfusion injury (I/RI) and to determine the underlying molecular mechanism. In a mouse model of myocardial I/RI (30-min of left descending coronary artery ligation followed by 2-h reperfusion), Rap1 deficiency significantly reduced myocardial infarct size (IS) and improved cardiac systolic/diastolic function. This was associated with a reduction in apoptosis in the post-ischemic myocardium. In H9C2 and primary cardiomyocytes, Rap1 knockdown or knockout significantly suppressed hypoxia/reoxygenation (H/R)-induced cell injury and apoptosis through increasing the phosphorylation/activation of STAT3 at site Ser(727) and translocation of STAT3 to the nucleus. We surmise this since Stattic (selective STAT3 inhibitor) pretreatment canceled the abovementioned protective effect. Furthermore, co-immunoprecipitation assay revealed a direct interaction between Rap1 and STAT3, but not JAK2, suggesting that the association of Rap1 with STAT3 may contribute to the reduced activity of STAT3 (Ser(727)) upon H/R stimulation. In conclusion, Rap1 deficiency protects the heart from ischemic damage through STAT3-dependent reduction of cardiomyocyte apoptosis, which may yield viable target for pharmacological intervention in ischemic heart disease.	[Cai, Yin; Ying, Fan; Liu, Hao; Wang, Lin; Xia, Zhengyuan; Irwin, Michael G.] Univ Hong Kong, Dept Anaesthesiol, Hong Kong, Peoples R China; [Liu, Hao] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Dept Cardiol, Affiliated Hosp 2, Guangzhou, Peoples R China; [Ge, Liang] Jilin Univ, Hosp 1, Dept Anesthesiol, Changchun, Peoples R China; [Song, Erfei] Jinan Univ, Affiliated Hosp 1, Guangzhou, Peoples R China; [Zhang, Dengwen] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Cardiovasc Inst, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Tang, Eva Hoi Ching] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Peoples R China; [Tang, Eva Hoi Ching] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China	University of Hong Kong; Guangzhou Medical University; Jilin University; Jinan University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Hong Kong; University of Hong Kong	Irwin, MG (corresponding author), Univ Hong Kong, Dept Anaesthesiol, Li Ka Shing Fac Med, 102 Pokfulam Rd, Hong Kong, Peoples R China.	mgirwin@hku.hk	Irwin, Michael Garnet/GLR-9714-2022; Irwin, Michael Garnet/C-4286-2009	Irwin, Michael Garnet/0000-0001-5801-274X; Irwin, Michael Garnet/0000-0001-5801-274X; Cai, Yin/0000-0002-7763-0612	Health and Medical Research Fund (Hong Kong) [04151816]; General Research Fund (Research Grants Council of Hong Kong) [17123718, 17118619, 17117217]	Health and Medical Research Fund (Hong Kong); General Research Fund (Research Grants Council of Hong Kong)(Hong Kong Research Grants Council)	The authors' research was supported by the Health and Medical Research Fund (grant number 04151816 to Y. Cai, Hong Kong) and General Research Fund (grant numbers 17123718 and 17118619 to Z. Xia and 17117217 to MG Irwin, Research Grants Council of Hong Kong).	Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Cai Y, 2017, CELL CYCLE, V16, P1765, DOI 10.1080/15384101.2017.1371886; Cai Y, 2015, CELL CYCLE, V14, P3580, DOI 10.1080/15384101.2015.1100771; Cai Y, 2015, FASEB J, V29, P4924, DOI 10.1096/fj.15-274597; Cai Y, 2015, EUR J PHARMACOL, V747, P18, DOI 10.1016/j.ejphar.2014.11.036; Choi HJ, 2009, EXP MOL MED, V41, P94, DOI 10.3858/emm.2009.41.2.012; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dhingra R, 2010, J CARDIOVASC TRANSL, V3, P344, DOI 10.1007/s12265-010-9195-5; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Gao SM, 2017, CELL PHYSIOL BIOCHEM, V43, P1140, DOI 10.1159/000481755; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Kabir S, 2010, CELL CYCLE, V9, P4061, DOI 10.4161/cc.9.20.13579; Knight Richard A, 2012, JAKSTAT, V1, P111, DOI 10.4161/jkst.20078; Kosuru R, 2018, CELL PHYSIOL BIOCHEM, V46, P1381, DOI 10.1159/000489154; Le Page S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164066; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Li CX, 2016, ONCOTARGET, V7, P27711, DOI 10.18632/oncotarget.8509; Li HB, 2016, DIABETES, V65, P942, DOI 10.2337/db15-0782; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068949; Martinez P, 2016, AGING CELL, V15, P1113, DOI 10.1111/acel.12517; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; O'Sullivan KE, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0543-8; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pang L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3453059; Pang L, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1324347; PIPICZ M, 2018, INT J MOL SCI, V12, P19; Poon MW, 2015, INVEST OPHTH VIS SCI, V56, P711, DOI 10.1167/iovs.14-15268; Qian MY, 2020, ONCOGENE, V39, P428, DOI 10.1038/s41388-019-0996-y; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Teo HL, 2010, NAT CELL BIOL, V12, P758, DOI 10.1038/ncb2080; Teringova E, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1191-y; Wang CY, 2018, CELL PHYSIOL BIOCHEM, V45, P2107, DOI 10.1159/000488047; Wang TT, 2013, FREE RADICAL BIO MED, V63, P291, DOI 10.1016/j.freeradbiomed.2013.05.043; Wang YM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-32; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wong KHK, 2018, J MOL CELL CARDIOL, V115, P1, DOI 10.1016/j.yjmcc.2017.12.009; Xia P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9583268; Xue R, 2016, CLIN SCI, V130, P377, DOI 10.1042/CS20150496; Yada M, 2004, J THORAC CARDIOV SUR, V128, P588, DOI 10.1016/j.jtcvs.2004.02.007; Ye XD, 2018, ACTA PHARMACOL SIN, V39, P1155, DOI 10.1038/aps.2018.37; Zhang Y, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.7; Zhou M, 2015, CLIN SCI, V129, P547, DOI 10.1042/CS20150073; Zouein Fouad A, 2015, Front Cardiovasc Med, V2, P36, DOI 10.3389/fcvm.2015.00036	53	14	18	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4482	4496		10.1096/fj.201901592RR	http://dx.doi.org/10.1096/fj.201901592RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32020680				2022-12-28	WOS:000512308900001
J	Tao, LC; Huang, XL; Xu, M; Yang, L; Hua, F				Tao, Lichan; Huang, Xiaoli; Xu, Min; Yang, Ling; Hua, Fei			MiR-144 protects the heart from hyperglycemia-induced injury by regulating mitochondrial biogenesis and cardiomyocyte apoptosis	FASEB JOURNAL			English	Article						cardiac function; hyperglycemia; miR-144; mitochondrial biogenesis	DIABETIC CARDIOMYOPATHY; ENDOTHELIAL-CELLS; TRANSCRIPTIONAL CONTROL; OXIDATIVE STRESS; GLUCOSE-UPTAKE; ACTIVATION; MITOPHAGY; RAC1; ANGIOGENESIS; DYSFUNCTION	Several lines of evidence have revealed the potential of microRNAs (miRNAs, miRs) as biomarkers for detecting diabetic cardiomyopathy, although their functions in hyperglycemic cardiac dysfunction are still lacking. In this study, mitochondrial biogenesis was markedly impaired induced by high glucose (HG), as evidenced by dysregulated mitochondrial structure, reduced mitochondrial DNA contents, and biogenesis-related mRNA levels, accompanied by increased cell apoptosis. MiR-144 was identified to be decreased in HG-induced cardiomyocytes and in streptozotocin (STZ)-challenged heart samples. Forced miR-144 expression enhanced mitochondrial biogenesis and suppressed cell apoptosis, while miR-144 inhibition exhibited the opposite results. Rac-1 was identified as a target gene of miR-144. Decreased Rac-1 levels activated AMPK phosphorylation and PGC-1 alpha deacetylation, leading to increased mitochondrial biogenesis and reduced cell apoptosis. Importantly, the systemic neutralization of miR-144 attenuated mitochondrial disorder and ventricular dysfunction following STZ treatment. Additionally, plasma miR-144 decreased markedly in diabetic patients with cardiac dysfunction. The receiver-operator characteristic curve showed that plasma miR-144 could specifically predict diabetic patients developing cardiac dysfunction. In conclusion, this study provides strong evidence suggesting that miR-144 protects heart from hyperglycemia-induced injury by improving mitochondrial biogenesis and decreasing cell apoptosis via targeting Rac-1. Forced miR-144 expression might, thus, be a protective strategy for treating hyperglycemia-induced cardiac dysfunction.	[Tao, Lichan; Yang, Ling] Soochow Univ, Affiliated Hosp 3, Dept Cardiol, Changzhou, Jiangsu, Peoples R China; [Huang, Xiaoli; Hua, Fei] Soochow Univ, Affiliated Hosp 3, Dept Endocrinol, Changzhou 213003, Jiangsu, Peoples R China; [Xu, Min] Soochow Univ, Affiliated Hosp 3, Dept Echocardiog, Changzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Hua, F (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Endocrinol, Changzhou 213003, Jiangsu, Peoples R China.	huafei1970@suda.edu.cn	TAO, Li/HIR-4254-2022; min, xu/AGJ-0451-2022	min, xu/0000-0002-0576-497X				Anderson EJ, 2009, J AM COLL CARDIOL, V54, P1891, DOI 10.1016/j.jacc.2009.07.031; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Battiprolu Pavan K, 2010, Drug Discov Today Dis Mech, V7, pe135; Battiprolu PK, 2013, LIFE SCI, V92, P609, DOI 10.1016/j.lfs.2012.10.011; Battogtokh G, 2018, ACTA PHARM SIN B, V8, P862, DOI 10.1016/j.apsb.2018.05.006; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Carrizzo A, 2014, CURR DRUG TARGETS, V15, P1231, DOI 10.2174/1389450115666141027110156; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Dai BB, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0767-z; Dingreville F, 2019, DIABETES, V68, P1778, DOI 10.2337/db18-1112; Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Feng B, 2017, J MOL CELL CARDIOL, V105, P70, DOI 10.1016/j.yjmcc.2017.03.002; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Jang WB, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4528184; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Liang C, 2019, LIFE SCI, V224, P12, DOI 10.1016/j.lfs.2019.02.059; Liao XD, 2015, J CLIN INVEST, V125, P3461, DOI 10.1172/JCI79964; Liu N, 2017, J CELL MOL MED, V21, P3190, DOI 10.1111/jcmm.13223; Liu YQ, 2016, MOL PHARMACOL, V89, P313, DOI 10.1124/mol.115.102004; Lynn EG, 2010, J MOL CELL CARDIOL, V49, P693, DOI 10.1016/j.yjmcc.2010.06.008; Ma S, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4602715; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nandi SS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01275; Nandi SS, 2018, ADV EXP MED BIOL, V1056, P47, DOI 10.1007/978-3-319-74470-4_4; Ni R, 2016, DIABETES, V65, P255, DOI 10.2337/db15-0963; Oclon E, 2016, J ENDOCRINOL, V229, P259, DOI 10.1530/JOE-15-0495; Olson EN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009008; Palomer X, 2018, TRENDS PHARMACOL SCI, V39, P452, DOI 10.1016/j.tips.2018.02.010; Piccoli MT, 2015, J MOL CELL CARDIOL, V89, P59, DOI 10.1016/j.yjmcc.2015.02.002; Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820; Rabinovich-Nikitin I, 2019, CIRC RES, V124, P1288, DOI 10.1161/CIRCRESAHA.119.314967; Raut SK, 2016, MOL CELL BIOCHEM, V417, P191, DOI 10.1007/s11010-016-2729-7; Rawal S, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0814-4; Reaven PD, 2019, NEW ENGL J MED, V380, P2215, DOI 10.1056/NEJMoa1806802; Riehle C, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-018-0711-0; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Schiattarella GG, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007322; Shen E, 2009, DIABETES, V58, P2386, DOI 10.2337/db08-0617; Singh GB, 2017, MOL CELL BIOCHEM, V424, P1, DOI 10.1007/s11010-016-2838-3; Sylow L, 2013, DIABETES, V62, P1139, DOI 10.2337/db12-0491; Tao LC, 2019, MOL CELL ENDOCRINOL, V481, P95, DOI 10.1016/j.mce.2018.11.015; Tao LC, 2018, METHODS MOL BIOL, V1733, P203, DOI 10.1007/978-1-4939-7601-0_17; Tong MM, 2019, CIRC RES, V124, P1360, DOI 10.1161/CIRCRESAHA.118.314607; van der Pluijm I, 2018, CARDIOVASC RES, V114, P1776, DOI 10.1093/cvr/cvy150; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wang XH, 2016, DIABETES, V65, P3111, DOI 10.2337/db15-1563; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Wang YH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.193; Wu SN, 2019, CIRCULATION, V139, P1913, DOI 10.1161/CIRCULATIONAHA.118.033552; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Yao GH, 2016, EUR HEART J-CARD IMG, V17, P512, DOI 10.1093/ehjci/jev330; Yin ZW, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0811-7; Yu ML, 2015, CARDIOVASC PATHOL, V24, P375, DOI 10.1016/j.carpath.2015.06.003; Zhu JH, 2013, AUTOPHAGY, V9, P1663, DOI 10.4161/auto.24135	67	18	19	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2173	2197		10.1096/fj.201901838R	http://dx.doi.org/10.1096/fj.201901838R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907983	hybrid			2022-12-28	WOS:000514663600018
J	Sousa, DM; Martins, PS; Leitao, L; Alves, CJ; Gomez-Lazaro, M; Neto, E; Conceicao, F; Herzog, H; Lamghari, M				Sousa, Daniela M.; Martins, Pedro S.; Leitao, Luis; Alves, Cecilia J.; Gomez-Lazaro, Maria; Neto, Estrela; Conceicao, Francisco; Herzog, Herbert; Lamghari, Meriem			The lack of neuropeptide Y-Y-1 receptor signaling modulates the chemical and mechanical properties of bone matrix	FASEB JOURNAL			English	Article						biomechanical properties; bone quality; bone strength; Y-1 receptor	Y1 RECEPTORS; DIFFERENTIATION; OSTEOCYTES; GUIDELINES; INCREASES; QUALITY	Genetic and pharmacological functional studies have provided evidence that the lack of Neuropeptide Y-Y-1 receptor (Y1R) signaling pathway induces a high bone mass phenotype in mice. However, clinical observations have shown that drug or genetic mediated improvement of bone mass might be associated to alterations to bone extracellular matrix (ECM) properties, leading to bone fragility. Hence, in this study we propose to characterize the physical, chemical and biomechanical properties of mature bone ECM of germline NPY-Y1R knockout (Y1R-/-) mice, and compare to their wild-type (WT) littermates. Our results demonstrated that the high bone mass phenotype observed in Y1R-/- mice involves alterations in Y(1)R(-/- )bone ECM ultrastructure, as a result of accelerated deposition of organic and mineral fractions. In addition, Y1R-/- bone ECM displays enhanced matrix maturation characterized by greater number of mature/highly packed collagen fibers without pathological accumulation of immature/mature collagen crosslinks nor compromise of mineral crystallinity. These unique features of Y1R-/- bone ECM improved the biochemical properties of Y(1)R(-/- )bones, reflected by mechanically robust bones with diminished propensity to fracture, contributing to greater bone strength. These findings support the future usage of drugs targeting Y1R signaling as a promising therapeutic strategy to treat bone loss-related pathologies.	[Sousa, Daniela M.; Leitao, Luis; Alves, Cecilia J.; Gomez-Lazaro, Maria; Neto, Estrela; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal; [Sousa, Daniela M.; Leitao, Luis; Alves, Cecilia J.; Gomez-Lazaro, Maria; Neto, Estrela; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, INEB Inst Engn Biomed, Porto, Portugal; [Martins, Pedro S.] Univ Porto, Fac Engn, INEGI Inst Ciencia & Inovacao Engn Mecan & Engn I, Porto, Portugal; [Leitao, Luis; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, ICBAS, Porto, Portugal; [Herzog, Herbert] St Vincents Hosp, Garvan Inst Med Res, Neurosci Res Program, Darlinghurst, NSW, Australia	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Lamghari, M (corresponding author), Univ Porto, i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal.	lamghari@ineb.up.pt	Lazaro, Maria Gomez/J-5931-2018; Conceição, Francisco/HCI-8740-2022; Martins, Pedro A.L.S./H-4313-2011; Martins, Pedro/GWC-7702-2022; Neto, Estrela C/M-2561-2013; Sousa, Daniela/C-1485-2014; Lamghari, Meriem/K-2159-2013	Lazaro, Maria Gomez/0000-0002-8836-396X; Martins, Pedro A.L.S./0000-0001-9732-4498; Neto, Estrela C/0000-0003-2334-2292; Sousa, Daniela/0000-0001-8498-0664; Lamghari, Meriem/0000-0002-2500-4548; Conceicao, Francisco/0000-0003-4587-2470	FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 -Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT/MCTES [POCI-01-0145-FEDER-030158, PTDC/MED-PAT/30158/2017]; i3S Scientific Platforms Bioimaging [PPBI-POCI-01-0145-FEDER-022122]; HEMS (Histology and Electron Microscopy Services) [PPBI-POCI-01-0145-FEDER-022122];  [SFRH/BPD/115341/2016];  [SFRH/BD/109686/2015];  [SFRH/BD/128771/2017]	FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 -Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020; Portuguese funds through FCT/MCTES; i3S Scientific Platforms Bioimaging; HEMS (Histology and Electron Microscopy Services); ; ; 	This work was financed by FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 -Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT/MCTES in the framework of the project "SproutOC" (POCI-01-0145-FEDER-030158, PTDC/MED-PAT/30158/2017). DMS is a recipient of a Post-Doc fellowship (SFRH/BPD/115341/2016). LL and FC are recipients of Ph.D. fellowships (SFRH/BD/109686/2015 and SFRH/BD/128771/2017, respectively). The authors would like to acknowledge Claudia Machado for helping with histology analysis and Carla Oliveira for the help with linear regression analysis. The authors acknowledge the support of the i3S Scientific Platforms Bioimaging and HEMS (Histology and Electron Microscopy Services), members of the national infrastructure PPBI - Portuguese Platform of Bioimaging (PPBI-POCI-01-0145-FEDER-022122).	Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; Allison SJ, 2009, J BONE MINER RES, V24, P294, DOI [10.1359/jbmr.081013, 10.1359/JBMR.081013]; Alves CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165465; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Bhan Arti, 2018, Bone Rep, V8, P125, DOI 10.1016/j.bonr.2018.03.005; Bi XH, 2011, J BIOMECH, V44, P297, DOI 10.1016/j.jbiomech.2010.10.009; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boskey AL., 2013, OSTEOPOROSIS, P235, DOI [10.1016/B978-0-12-415853-5.00011-X, DOI 10.1016/B978-0-12-415853-5.00011-X]; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Compston Juliet, 2006, Arq Bras Endocrinol Metab, V50, P579, DOI 10.1590/S0004-27302006000400003; Dole NS, 2017, CELL REP, V21, P2585, DOI 10.1016/j.celrep.2017.10.115; Donnelly E, 2011, CLIN ORTHOP RELAT R, V469, P2128, DOI 10.1007/s11999-010-1702-0; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Franquinho F, 2010, FEBS J, V277, P3664, DOI 10.1111/j.1742-4658.2010.07774.x; Fuchs RK, 2019, WOODH PUBL SER BIOM, P15, DOI 10.1016/B978-0-08-102451-5.00002-0; Goodyear SR, 2019, METHODS MOL BIOL, V1914, P651, DOI 10.1007/978-1-4939-8997-3_35; Grassel S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0485-1; Igwe JC, 2009, J CELL BIOCHEM, V108, P621, DOI 10.1002/jcb.22294; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Jin A, 2017, BONE JOINT RES, V6, P602, DOI 10.1302/2046-3758.610.BJR-2016-0321.R1; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; Kremer R, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00190; Lee NJ, 2011, BONE, V48, P461, DOI 10.1016/j.bone.2010.10.174; Lee NJ, 2010, J BONE MINER RES, V25, P1736, DOI 10.1002/jbmr.61; Leitao L, 2019, FASEB J, V33, P8697, DOI 10.1096/fj.201900454R; Licata A, 2009, CLEV CLIN J MED, V76, P331, DOI 10.3949/ccjm.76a.08041; Mandair GS, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2014.115; McNally EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029258; Mertz EL, 2016, MATRIX BIOL, V52-54, P29, DOI 10.1016/j.matbio.2016.03.005; Oest ME, 2016, BONE, V86, P91, DOI 10.1016/j.bone.2016.03.003; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; Schwarcz HP, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00039; Sousa DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33470; Sousa DM, 2013, J ORTHOP RES, V31, P1570, DOI 10.1002/jor.22400; Sousa DM, 2012, BONE, V51, P8, DOI 10.1016/j.bone.2012.03.020; Stark Z, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-5; Teixeira L, 2009, J CELL BIOCHEM, V107, P908, DOI 10.1002/jcb.22194; Treager C, 2017, ORTHOPEDIC SURG CLER, P743; Vijayan V, 2017, J ENDOCRINOL, V233, P243, DOI 10.1530/JOE-16-0562; Zengin A, 2010, TRENDS ENDOCRIN MET, V21, P411, DOI 10.1016/j.tem.2010.02.004; Zhang L, 2010, INT J OBESITY, V34, P357, DOI 10.1038/ijo.2009.232	42	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4163	4177		10.1096/fj.201902796R	http://dx.doi.org/10.1096/fj.201902796R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31960508				2022-12-28	WOS:000508661500001
J	Forstner, P; Knoll, B				Foerstner, Philip; Knoell, Bernd			Interference of neuronal activity-mediated gene expression through serum response factor deletion enhances mortality and hyperactivity after traumatic brain injury	FASEB JOURNAL			English	Article						c-Fos; Egr; hematoma; hyperactivity; immediate early gene; transcription	CLOSED-HEAD INJURY; TRANSCRIPTION FACTORS; SYNAPSE DEVELOPMENT; C-JUN; ACTIVATION; SRF; RECEPTORS; MEMORY; CREB; NEUROINFLAMMATION	Traumatic brain injury (TBI) is one of the most frequent causes of brain injury and mortality in young adults with detrimental sequelae such as cognitive impairments, epilepsy, and attention-deficit hyperactivity disorder. TBI modulates the neuronal excitability resulting in propagation of a neuronal activity-driven gene expression program. However, the impact of such neuronal activity mediated gene expression in TBI has been poorly studied. In this study we analyzed mouse mutants of the prototypical neuronal activity-dependent transcription factor SRF (serum response factor) in a weight-drop TBI model. Neuron-restricted SRF deletion elevated TBI inflicted mortality suggesting a neuroprotective SRF function during TBI. Behavioral inspection uncovered elevated locomotor activity in Srf mutant mice after TBI in contrast to hypoactivity observed in wild-type littermates. This indicates an SRF role in modulation of TBI-associated alterations in locomotor activity. Finally, induction of a neuronal activity induced gene expression program composed of immediate early genes (IEGs) such as Egr1, Egr2, Egr3, Npas4, Atf3, Arc, Ptgs2, and neuronal pentraxins (Nptx2) was compromised upon SRF depletion. Overall, our data show a role of neuronal activity-mediated gene transcription during TBI and suggest a molecular link between TBI and such post-TBI neurological comorbidities involving hyperactivity phenotypes.	[Foerstner, Philip; Knoell, Bernd] Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany	Ulm University	Knoll, B (corresponding author), Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	bernd.knoell@uni-ulm.de			Deutsche Forschungsgemeinschaft (DFG) [SFB1149]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB1149	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Aid S, 2011, BIOCHIMIE, V93, P46, DOI 10.1016/j.biochi.2010.09.009; Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Anastasiadou S, 2016, EXP NEUROL, V279, P243, DOI 10.1016/j.expneurol.2016.03.012; Anastasiadou S, 2015, GLIA, V63, P958, DOI 10.1002/glia.22794; Benito E, 2015, MOL NEUROBIOL, V51, P1071, DOI 10.1007/s12035-014-8772-z; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Gallo FT, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00079; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Heuvel FO, 2019, BRAIN BEHAV IMMUN, V81, P228, DOI 10.1016/j.bbi.2019.06.019; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Kim S, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0025-1; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Kuzniewska B, 2016, MOL NEUROBIOL, V53, P1478, DOI 10.1007/s12035-014-9089-7; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Losing P, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0310-2; Luckow KS, 2015, EURASIP J EMBED SYST, DOI 10.1186/s13639-015-0020-8; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Mokalled MH, 2010, DEVELOPMENT, V137, P2365, DOI 10.1242/dev.047605; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nader K, 2019, BRAIN STRUCT FUNCT; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Ohnishi YN, 2011, BIOL PSYCHIAT, V70, P487, DOI 10.1016/j.biopsych.2011.04.021; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pacchioni AM, 2009, J PHARMACOL EXP THER, V328, P183, DOI 10.1124/jpet.108.143115; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Parkitna JR, 2010, FASEB J, V24, P2427, DOI 10.1096/fj.09-151423; Patel TP, 2014, J NEUROSCI, V34, P4200, DOI 10.1523/JNEUROSCI.4172-13.2014; Pelkey KA, 2015, NEURON, V85, P1257, DOI 10.1016/j.neuron.2015.02.020; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Schaukowitch K, 2017, CELL REP, V18, P1512, DOI 10.1016/j.celrep.2017.01.033; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Stern S, 2013, J NEUROSCI, V33, P18836, DOI 10.1523/JNEUROSCI.3029-13.2013; Stern S, 2012, J NEUROINFLAMM, V9, DOI [10.1186/1742-2094-9-79, 10.1186/1742-2094-9-78]; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Tomasevic G, 2010, J NEUROSCI RES, V88, P3414, DOI 10.1002/jnr.22491; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Wang MY, 2018, MOL MED REP, V17, P4925, DOI 10.3892/mmr.2018.8525; Whitfield PC, 2000, NEUROL RES, V22, P138, DOI 10.1080/01616412.2000.11741050; Wong CT, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12506; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Zimmermann AM, 2015, BIOL PSYCHIAT, V78, P95, DOI 10.1016/j.biopsych.2014.03.011; Zimprich A, 2017, MOL NEUROBIOL, V54, P8242, DOI 10.1007/s12035-016-0300-x; Zimprich A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00125	74	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3855	3873		10.1096/fj.201902257RR	http://dx.doi.org/10.1096/fj.201902257RR		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930559	Green Published, hybrid			2022-12-28	WOS:000507880600001
J	Kioka, H; Kato, H; Fujita, T; Asano, Y; Shintani, Y; Yamazaki, S; Tsukamoto, O; Imamura, H; Kogo, M; Kitakaze, M; Sakata, Y; Takashima, S				Kioka, Hidetaka; Kato, Hisakazu; Fujita, Takeshi; Asano, Yoshihiro; Shintani, Yasunori; Yamazaki, Satoru; Tsukamoto, Osamu; Imamura, Hiromi; Kogo, Mikihiko; Kitakaze, Masafumi; Sakata, Yasushi; Takashima, Seiji			In vivo real-time ATP imaging in zebrafish hearts reveals G0s2 induces ischemic tolerance	FASEB JOURNAL			English	Article						ATP; energy metabolism; FRET; in vivo imaging; ischemic tolerance	SWITCH GENE 2; OXIDATIVE-PHOSPHORYLATION; POSITIVE REGULATOR; ENERGY-METABOLISM; HYPOXIA; VISUALIZATION; ADAPTATION; KINASE; MICE	Most eukaryotic cells generate adenosine triphosphate (ATP) through the oxidative phosphorylation system (OXPHOS) to support cellular activities. In cultured cell-based experiments, we recently identified the hypoxia-inducible protein G0/G1 switch gene 2 (G0s2) as a positive regulator of OXPHOS, and showed that G0s2 protects cultured cardiomyocytes from hypoxia. In this study, we examined the in vivo protective role of G0s2 against hypoxia by generating both loss-of-function and gain-of-function models of g0s2 in zebrafish. Zebrafish harboring transcription activator-like effector nuclease (TALEN)-mediated knockout of g0s2 lost hypoxic tolerance. Conversely, cardiomyocyte-specific transgenic zebrafish hearts exhibited strong tolerance against hypoxia. To clarify the mechanism by which G0s2 protects cardiac function under hypoxia, we introduced a mitochondrially targeted FRET-based ATP biosensor into zebrafish heart to visualize ATP dynamics in in vivo beating hearts. In addition, we employed a mosaic overexpression model of g0s2 to compare the contraction and ATP dynamics between g0s2-expressing and non-expressing cardiomyocytes, side-by-side within the same heart. These techniques revealed that g0s2-expressing cardiomyocyte populations exhibited preserved contractility coupled with maintained intra-mitochondrial ATP concentrations even under hypoxic condition. Collectively, these results demonstrate that G0s2 provides ischemic tolerance in vivo by maintaining ATP production, and therefore represents a promising therapeutic target for hypoxia-related diseases.	[Kioka, Hidetaka; Fujita, Takeshi; Asano, Yoshihiro; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Kato, Hisakazu; Tsukamoto, Osamu; Takashima, Seiji] Osaka Univ, Grad Sch Med Frontier Biosci, Dept Med Biochem, Suita, Osaka, Japan; [Fujita, Takeshi; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Shintani, Yasunori; Yamazaki, Satoru] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Pharmacol, Suita, Osaka, Japan; [Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Clin Res & Dev, Suita, Osaka, Japan; [Takashima, Seiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Osaka University; Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Japan Science & Technology Agency (JST)	Kioka, H; Asano, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kioka@cardiology.med.osaka-u.ac.jp; asano@cardiology.med.osaka-u.ac.jp	Kogo, Mikihiko/ABD-7080-2020	Kogo, Mikihiko/0000-0002-4556-2491; Tsukamoto, Osamu/0000-0002-9504-8001; Shintani, Yasunori/0000-0001-9579-0727; Kato, Hisakazu/0000-0003-4619-3680; Sakata, Yasushi/0000-0002-5618-4721	JSPS KAKENHI [JP16K09501, JP19K08581]; AMED [JP19ek0109412h0001]; JST CREST [JPMJCR14M2]; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Research Promotion Society for Cardiovascular Diseases; Japan Medical Association; Takeda Science Foundation; Takeda Medical Research Foundation; Heart Foundation/Novartis; Naito Foundation; Banyu Foundation; Nakatani Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Research Promotion Society for Cardiovascular Diseases; Japan Medical Association; Takeda Science Foundation(Takeda Science Foundation (TSF)); Takeda Medical Research Foundation; Heart Foundation/Novartis; Naito Foundation(Naito Memorial Foundation); Banyu Foundation; Nakatani Foundation	This research was supported by JSPS KAKENHI Grant Number JP16K09501 and JP19K08581 (to H. Kioka), AMED under Grant Number JP19ek0109412h0001 (to H. Kioka), and JST CREST Grant Number JPMJCR14M2 (to S.T). This research was also supported by grants from the Japan Heart Foundation, Japan Cardiovascular Research Foundation, Japan Research Promotion Society for Cardiovascular Diseases, Japan Medical Association, Takeda Science Foundation, Takeda Medical Research Foundation, Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology, Naito Foundation, Banyu Foundation, and Nakatani Foundation. We thank K. Kawakami, R. Fukuda, and National BioResource Project from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for providing plasmid constructs and crucial lines of zebrafish. We thank T. Yoshida and H. Miyagi (Olympus Corporation) for technical advice regarding microscope; S. Ikezawa and M. Kishimoto for technical assistance; Y. Okada, Y. Kurokawa, and H. Kawasaki for secretarial support.	Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; BARBOUR RL, 1984, BIOCHEMISTRY-US, V23, P6053, DOI 10.1021/bi00320a024; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Heckmann BL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88735; Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Heier C, 2015, J BIOL CHEM, V290, P26141, DOI 10.1074/jbc.M115.671842; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Kobara M, 1996, J MOL CELL CARDIOL, V28, P417, DOI 10.1006/jmcc.1996.0038; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nagao T, 2020, FASEB J, V34, P1859, DOI 10.1096/fj.201800389R; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Picard MH, 2011, J AM SOC ECHOCARDIOG, V24, P1, DOI 10.1016/j.echo.2010.11.006; Ritterhoff J, 2017, CARDIOVASC RES, V113, P411, DOI 10.1093/cvr/cvx017; SCHAPER J, 1985, CIRC RES, V56, P377, DOI 10.1161/01.RES.56.3.377; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sicari R, 2017, CARDIOVASC ULTRASOUN, V15, DOI 10.1186/s12947-017-0099-2; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Turner DA, 2007, TRENDS NEUROSCI, V30, P390, DOI 10.1016/j.tins.2007.06.001; Yoshida T, 2017, METHODS MOL BIOL, V1567, P231, DOI 10.1007/978-1-4939-6824-4_14	33	4	4	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2041	2054		10.1096/fj.201901686R	http://dx.doi.org/10.1096/fj.201901686R		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916304	Bronze			2022-12-28	WOS:000506440400001
J	Kitamura, N; Shindo, M; Ohtsuka, J; Nakamura, A; Tanokura, M; Hiroi, T; Kaminuma, O				Kitamura, Noriko; Shindo, Mayumi; Ohtsuka, Jun; Nakamura, Akira; Tanokura, Masaru; Hiroi, Takachika; Kaminuma, Osamu			Identification of novel interacting regions involving calcineurin and nuclear factor of activated T cells	FASEB JOURNAL			English	Article						calcineurin-binding region; cytokine; immunosuppressant; nuclear translocation	CYCLOSPORINE-A; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NFAT; PEPTIDE; GROWTH; INHIBITION; MECHANISMS; DEFICIENT; RESPONSES	Nuclear factor of activated T cells (NFAT) leads to the transcription of diverse inducible genes involved in many biological processes; therefore, aberrant NFAT expression is responsible for the development and exacerbation of various disorders. Since five isoforms of NFAT (NFATc1-c4, NFAT5) exhibit distinct and overlapping functions, selective control of a part, but not all, of NFAT family members is desirable. By comparing the binding activity of each NFATc1-c4 with its regulatory enzyme, calcineurin (CN), using a quantitative immunoprecipitation assay, we found a new CN-binding region (CNBR) selectively functioning in NFATc1 and NFATc4. This region, termed CNBR3, is located between two preexisting CNBR1 and CNBR2, within the Ca2+ regulatory domain. The nuclear translocation of NFATc1 but not NFATc2 in T cells was suppressed by ectopic expression of CNBR3 and, accordingly, NFATc1-dependent cytokine expression was downregulated. Through competition assays using NFATc1-derived partial peptides and mass spectrometry with photoaffinity technology, we identified 18 amino acids in NFATc1 (Arg(258) to Pro(275)) and 13 amino acids in CN catalytic subunit (CNA) (Asn(77) to Gly(89)) responsible for CNA/CNBR3 binding in which Cys(263) and Asp(82), respectively, played crucial roles. The possible selective regulation of NFAT-mediated biological processes by targeting this new CN/NFAT-binding region is suggested.	[Kitamura, Noriko; Hiroi, Takachika; Kaminuma, Osamu] Tokyo Metropolitan Inst Med Sci, Allergy & Immunol Project, Tokyo, Japan; [Shindo, Mayumi] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo, Japan; [Ohtsuka, Jun; Nakamura, Akira; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Nakamura, Akira] Gakushuin Univ, Dept Life Sci, Fac Sci, Tokyo, Japan; [Kaminuma, Osamu] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Gakushuin University; Hiroshima University	Kaminuma, O (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	okami@hiroshima-u.ac.jp	; Nakamura, Akira/C-1658-2016	Tanokura, Masaru/0000-0001-5072-2480; Nakamura, Akira/0000-0001-7733-4007	MEXT | Japan Society for the Promotion of Science (JSPS) [24590107, 21590086]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 24590107 and 21590086	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baumgart S, 2012, GASTROENTEROLOGY, V142, P388, DOI 10.1053/j.gastro.2011.11.001; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chen Zhao-Li, 2011, Chin J Cancer, V30, P62; Choi JM, 2012, IMMUNOL LETT, V143, P170, DOI 10.1016/j.imlet.2012.01.016; Erb KJ, 2003, INFECT IMMUN, V71, P6641, DOI 10.1128/IAI.71.11.6641-6647.2003; Fougere M, 2010, ONCOGENE, V29, P2292, DOI 10.1038/onc.2009.499; Gal M, 2014, STRUCTURE, V22, P1016, DOI 10.1016/j.str.2014.05.006; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Im SH, 2004, MOL CELLS, V18, P1; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Kaminuma O, 2018, J IMMUNOL, V200, P92, DOI 10.4049/jimmunol.1602113; Kaminuma O, 2012, INT ARCH ALLERGY IMM, V158, P30, DOI 10.1159/000337757; Koch S, 2015, CLIN EXP ALLERGY, V45, P1356, DOI 10.1111/cea.12493; Kwon HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19453; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Liu J, 2001, J IMMUNOL, V167, P2677, DOI 10.4049/jimmunol.167.5.2677; LUNN CA, 1984, J BIOL CHEM, V259, P469; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Park S, 2000, P NATL ACAD SCI USA, V97, P7130, DOI 10.1073/pnas.97.13.7130; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Quang CT, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.14; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Rojanathammanee L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0255-2; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Tripathi MK, 2014, CANCER RES, V74, P6947, DOI 10.1158/0008-5472.CAN-14-1592; Vihma H, 2016, J NEUROCHEM, V137, P394, DOI 10.1111/jnc.13568; Woo M, 1997, BONE MARROW TRANSPL, V20, P1095, DOI 10.1038/sj.bmt.1701027; Yu HX, 2012, CIRC RES, V110, P200, DOI 10.1161/CIRCRESAHA.111.240895; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhang L, 2013, BRIT J PHARMACOL, V170, P426, DOI 10.1111/bph.12292	42	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3197	3208		10.1096/fj.201902229	http://dx.doi.org/10.1096/fj.201902229		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909857	Bronze			2022-12-28	WOS:000505940000001
J	Andrade-Souza, VA; Ghiarone, T; Sansonio, A; Silva, KAS; Tomazini, F; Arcoverde, L; Fyfe, J; Perri, E; Saner, N; Kuang, JJ; Bertuzzi, R; Leandro, CG; Bishop, DJ; Lima-Silva, AE				Andrade-Souza, Victor Amorim; Ghiarone, Thaysa; Sansonio, Andre; Santos Silva, Kleiton Augusto; Tomazini, Fabiano; Arcoverde, Lucyana; Fyfe, Jackson; Perri, Enrico; Saner, Nicholas; Kuang, Jujiao; Bertuzzi, Romulo; Leandro, Carol Gois; Bishop, David John; Lima-Silva, Adriano Eduardo			Exercise twice-a-day potentiates markers of mitochondrial biogenesis in men	FASEB JOURNAL			English	Article						high-intensity exercise; mitochondrial biogenesis; molecular signaling; muscle glycogen; transcription factor	HUMAN SKELETAL-MUSCLE; REDUCED CARBOHYDRATE AVAILABILITY; TRANSCRIPTIONAL REGULATION; GLYCOGEN DEPLETION; INTERVAL EXERCISE; GENE-EXPRESSION; ENZYME-ACTIVITY; PCR DATA; ADAPTATIONS; INTENSITY	Endurance exercise begun with reduced muscle glycogen stores seems to potentiate skeletal muscle protein abundance and gene expression. However, it is unknown whether this greater signaling responses is due to performing two exercise sessions in close proximity-as a first exercise session is necessary to reduce the muscle glycogen stores. In the present study, we manipulated the recovery duration between a first muscle glycogen-depleting exercise and a second exercise session, such that the second exercise session started with reduced muscle glycogen in both approaches but was performed either 2 or 15 hours after the first exercise session (so-called "twice-a-day" and "once-daily" approaches, respectively). We found that exercise twice-a-day increased the nuclear abundance of transcription factor EB (TFEB) and nuclear factor of activated T cells (NFAT) and potentiated the transcription of peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1 alpha), peroxisome proliferator-activated receptor-alpha (PPAR alpha), and peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) genes, in comparison with the once-daily exercise. These results suggest that part of the elevated molecular signaling reported with previous "train-low" approaches might be attributed to performing two exercise sessions in close proximity. The twice-a-day approach might be an effective strategy to induce adaptations related to mitochondrial biogenesis and fat oxidation.	[Andrade-Souza, Victor Amorim; Ghiarone, Thaysa; Sansonio, Andre; Santos Silva, Kleiton Augusto; Tomazini, Fabiano; Arcoverde, Lucyana; Leandro, Carol Gois; Lima-Silva, Adriano Eduardo] Univ Fed Pernambuco, Acad Ctr Vitoria, Dept Phys Educ & Sports Sci, Vitoria De Santo Antao, PE, Brazil; [Santos Silva, Kleiton Augusto] Univ Missouri, Sch Med, Dept Med, Columbiaville, MI USA; [Fyfe, Jackson] Deakin Univ, Fac Hlth, Sch Exercise & Nutr Sci, Burwood, Vic, Australia; [Perri, Enrico; Saner, Nicholas; Kuang, Jujiao; Bishop, David John] Victoria Univ, Inst Hlth & Sport, POB 14428, Melbourne, Vic 8001, Australia; [Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp, Sao Paulo, SP, Brazil; [Bishop, David John] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia; [Lima-Silva, Adriano Eduardo] Technol Fed Univ Parana, Acad Dept Phys Educ, Human Performance Res Grp, Curitiba, Parana, Brazil	Universidade Federal de Pernambuco; University of Missouri System; University of Missouri Columbia; Deakin University; Victoria University; Universidade de Sao Paulo; Edith Cowan University; Universidade Tecnologica Federal do Parana	Bishop, DJ (corresponding author), Victoria Univ, Inst Hlth & Sport, POB 14428, Melbourne, Vic 8001, Australia.	David.Bishop@vu.edu.au	Leandro, Carol Virgínia Góis/ABH-6614-2020; Bertuzzi, Romulo/E-7048-2012; Lima-Silva, Adriano Eduardo/C-2800-2013; Lima-Silva, Adriano/Y-2404-2019; Bishop, David John/X-9826-2019; Perri, enrico/AAE-1092-2020	Lima-Silva, Adriano Eduardo/0000-0002-0613-5104; Lima-Silva, Adriano/0000-0002-0613-5104; Bishop, David John/0000-0002-6956-9188; Perri, enrico/0000-0002-7869-6365; Saner, Nicholas/0000-0002-6011-7126; Kuang, Jujiao/0000-0002-1366-0089; Fyfe, Jackson/0000-0002-9541-2336; Silva, Kleiton/0000-0001-8230-0012	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [406201/2013-7]; Australian Research Council [DP140104165]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Australian Research Council(Australian Research Council)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant/Award Number: 406201/2013-7; Australian Research Council, Grant/Award Number: DP140104165	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baar K, 2008, EUR J SPORT SCI, V8, P97, DOI 10.1080/17461390801919094; Baar K, 2014, SPORTS MED, V44, P5, DOI 10.1007/s40279-014-0146-1; Bartlett JD, 2015, EUR J SPORT SCI, V15, P3, DOI 10.1080/17461391.2014.920926; Bartlett JD, 2013, AM J PHYSIOL-REG I, V304, pR450, DOI 10.1152/ajpregu.00498.2012; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; Bishop D, 1998, MED SCI SPORT EXER, V30, P1270, DOI 10.1097/00005768-199808000-00014; Bishop DJ, 2019, PHYSIOLOGY, V34, P56, DOI 10.1152/physiol.00038.2018; Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; Burke LM, 2010, SCAND J MED SCI SPOR, V20, P48, DOI 10.1111/j.1600-0838.2010.01185.x; Chan MHS, 2004, FASEB J, V18, P1785, DOI 10.1096/fj.03-1039fje; Cochran AJR, 2015, INT J SPORT NUTR EXE, V25, P463, DOI 10.1123/ijsnem.2014-0263; Cochran AJR, 2010, J APPL PHYSIOL, V108, P628, DOI 10.1152/japplphysiol.00659.2009; Edge J, 2006, J APPL PHYSIOL, V101, P918, DOI 10.1152/japplphysiol.01534.2005; EVANS WJ, 1982, MED SCI SPORT EXER, V14, P101; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gejl KD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13847; Gejl KD, 2017, MED SCI SPORT EXER, V49, P2486, DOI 10.1249/MSS.0000000000001377; Ghiarone T, 2019, J APPL PHYSIOL, V127, P713, DOI 10.1152/japplphysiol.00060.2019; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; Granata C, 2018, SPORTS MED, V48, P1541, DOI 10.1007/s40279-018-0894-4; Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y; Granata C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44227; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Granata C, 2016, FASEB J, V30, P3413, DOI 10.1096/fj.201500100R; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hansen AK, 1985, J APPL PHYSIOL, V98, P93; HARRIS RC, 1974, SCAND J CLIN LAB INV, V33, P109; Hawley JA, 2010, EXERC SPORT SCI REV, V38, P152, DOI 10.1097/JES.0b013e3181f44dd9; Hearris MA, 2019, J APPL PHYSIOL, V126, P1587, DOI 10.1152/japplphysiol.00913.2018; HEIGENHAUSER GJF, 1983, J APPL PHYSIOL, V54, P470, DOI 10.1152/jappl.1983.54.2.470; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009; Hulston CJ, 2010, MED SCI SPORT EXER, V42, P2046, DOI 10.1249/MSS.0b013e3181dd5070; Impey SG, 2018, SPORTS MED, V48, P1031, DOI 10.1007/s40279-018-0867-7; Islam H, 2018, METABOLISM, V79, P42, DOI 10.1016/j.metabol.2017.11.001; Kessen U, 1999, J BIOL CHEM, V274, P37821, DOI 10.1074/jbc.274.53.37821; Knuiman P, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0055-9; Kuang JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196438; Lane S. C., 2015, J APPL PHYSIOL, V119, P643; Lima-Silva AE, 2013, APPL PHYSIOL NUTR ME, V38, P928, DOI 10.1139/apnm-2012-0467; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Marchenko ND, 2010, CELL DEATH DIFFER, V17, P255, DOI 10.1038/cdd.2009.173; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McGinley C, 2016, EXP PHYSIOL, V101, P1565, DOI 10.1113/EP085921; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Millay DP, 2013, CELL METAB, V17, P3, DOI 10.1016/j.cmet.2012.12.008; Morton JP, 2009, J APPL PHYSIOL, V106, P1513, DOI 10.1152/japplphysiol.00003.2009; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Philp A, 2011, NESTLE NUTR WORKS SE, V69, P19, DOI 10.1159/000329279; Pilegaard H, 2005, METABOLISM, V54, P1048, DOI 10.1016/j.metabol.2005.03.008; Pilegaard H, 2002, J PHYSIOL-LONDON, V541, P261, DOI 10.1113/jphysiol.2002.016832; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Psilander N, 2013, EUR J APPL PHYSIOL, V113, P951, DOI 10.1007/s00421-012-2504-8; Russell AP, 2005, FASEB J, V19, P986, DOI 10.1096/fj.04-3168fje; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Steinberg GR, 2006, APPL PHYSIOL NUTR ME, V31, P302, DOI 10.1139/H06-003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yeo WK, 2008, J APPL PHYSIOL, V105, P1462, DOI 10.1152/japplphysiol.90882.2008; Yeo WK, 2010, EXP PHYSIOL, V95, P351, DOI 10.1113/expphysiol.2009.049353	71	21	21	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1602	1619		10.1096/fj.201901207RR	http://dx.doi.org/10.1096/fj.201901207RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914620	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000507308900106
J	Huang, Y; Li, D; Zhang, PF; Liu, M; Liang, X; Yang, X; Jiang, L; Zhang, LF; Zhou, WL; Su, JH; Gong, YL; Gou, HF; Wei, YQ; Wang, W				Huang, Yong; Li, Dan; Zhang, Peng-Fei; Liu, Mei; Liang, Xiao; Yang, Xiao; Jiang, Lin; Zhang, Li-Feng; Zhou, Wei-Lin; Su, Jin-Hua; Gong, You-Ling; Gou, Hong-Feng; Wei, Yu-Quan; Wang, Wei			IL-18R-dependent and independent pathways account for IL-18-enhanced antitumor ability of CAR-T cells	FASEB JOURNAL			English	Article						CAR-T; IL-18; IL-18 receptor; cancer immunotherapy	ADOPTIVE TRANSFER; IFN-GAMMA; MEMORY; CD8(+); LYMPHOCYTES; PROMOTES; CANCER; IL-12; IMMUNOTHERAPY; ACTIVATION	Interleukin-18 (IL-18) has been demonstrated to augment the antitumor capacity of chimeric antigen receptor-T cells (CAR-T) but the underlying mechanisms are largely unknown. Here we explored the effects and mechanisms of exogenous IL-18 on the antitumor response of CAR-T cells. IL-18 boosted the cytotoxicity of human epidermal growth factor receptor-2 (HER2)-specific CAR-T cells ex vivo and enhanced the antitumor efficacy of the CAR-T cells in immunodeficient mice, moreover, IL-18 improved the antitumor capacity of OVA-specific T cells in immunocompetent mice, indicating the universal enhancing function of IL-18 for adoptive cell therapy. To address the roles of IL-18 receptor (IL-18R) in the enhancing function, we evaluated the effects of IL-18R knockout (IL-18R(-/-)) condition in immunocompetent host and CAR-T cells on the IL-18-enhanced antitumor activities. Interestingly, IL-18 persisted to improve the antitumor ability of IL-18R intact CAR-T cells in IL-18R(-/-) mice. For IL-18R(-/-) CAR-T cells, however, IL-18 still holds the enhancing ability to boost the antitumor efficacy in IL-18R(-/-) mice, albeit the ex vivo tumor-killing ability was lower than that of IL-18R intact CAR-T cells, indicating that IL-18R-independent pathway is involved in the enhancement. Furthermore, tagged IL-18 binded to the membrane of IL-18R(-/-) splenic and lymph node cells and IL-18R intact and IL-18R(-/-) CAR-T cells showed distinct transcriptomic profiles when stimulated by IL-18. These data demonstrate that IL-18R-independent pathways contribute to functions of IL-18.	[Huang, Yong; Li, Dan; Liu, Mei; Liang, Xiao; Yang, Xiao; Jiang, Lin; Zhang, Li-Feng; Zhou, Wei-Lin; Su, Jin-Hua; Wei, Yu-Quan; Wang, Wei] Sichuan Univ, West China Hosp, Dept Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Huang, Yong; Li, Dan; Liu, Mei; Liang, Xiao; Yang, Xiao; Jiang, Lin; Zhang, Li-Feng; Zhou, Wei-Lin; Su, Jin-Hua; Wei, Yu-Quan; Wang, Wei] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China; [Huang, Yong; Li, Dan; Zhang, Peng-Fei; Liu, Mei; Liang, Xiao; Yang, Xiao; Jiang, Lin; Zhang, Li-Feng; Zhou, Wei-Lin; Su, Jin-Hua; Gou, Hong-Feng; Wei, Yu-Quan; Wang, Wei] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China; [Zhang, Peng-Fei; Liang, Xiao; Gou, Hong-Feng; Wei, Yu-Quan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Med Oncol,Canc Ctr, Chengdu, Peoples R China; [Gong, You-Ling; Wei, Yu-Quan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Thorac Oncol,Canc Ctr, Chengdu, Peoples R China; [Zhang, Li-Feng] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wang, W (corresponding author), Sichuan Univ, West China Hosp, Dept Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.; Wang, W (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China.; Wang, W (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China.	weiwang@scu.edu.cn		liang, xiao/0000-0003-0330-7027	National Key Research and Development [2016YFC1303403]; National Natural and Scientific Foundation of China [81572981/H1611, 81672397/H1617]; National High-tech RD [2014AA020704]; Science and Technology Major Project in Sichuan Province of China [2017SZDZX0012]	National Key Research and Development; National Natural and Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RD; Science and Technology Major Project in Sichuan Province of China	National Key Research and Development, Grant/Award Number: 2016YFC1303403; National Natural and Scientific Foundation of China, Grant/Award Number: 81572981/H1611 and 81672397/H1617; National High-tech R&D, Grant/Award Number: 2014AA020704; Science and Technology Major Project in Sichuan Province of China, Grant/Award Number: 2017SZDZX0012	Abken H, 2017, HUM GENE THER, V28, P1047, DOI 10.1089/hum.2017.115; Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Avanzi MP, 2018, CELL REP, V23, P2130, DOI 10.1016/j.celrep.2018.04.051; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cerignoli F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193498; Chen N, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1273302; Chinnasamy D, 2012, CLIN CANCER RES, V18, P1672, DOI 10.1158/1078-0432.CCR-11-3050; Chmielewski M, 2017, CELL REP, V21, P3205, DOI 10.1016/j.celrep.2017.11.063; Chmielewski M, 2011, CANCER RES, V71, P5697, DOI 10.1158/0008-5472.CAN-11-0103; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Fan HT, 2002, CYTOKINE, V19, P126, DOI 10.1006/cyto.2002.1958; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hashimoto W, 1999, J IMMUNOL, V163, P583; Hege KM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0222-9; Hoyos V, 2010, LEUKEMIA, V24, P1160, DOI 10.1038/leu.2010.75; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Hu BL, 2017, CELL REP, V20, P3025, DOI 10.1016/j.celrep.2017.09.002; Hurton LV, 2016, P NATL ACAD SCI USA, V113, pE7788, DOI 10.1073/pnas.1610544113; Kaartinen T, 2017, CYTOTHERAPY, V19, P689, DOI 10.1016/j.jcyt.2017.03.067; Kerkar SP, 2011, J IMMUNOTHER, V34, P343, DOI 10.1097/CJI.0b013e3182187600; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Li J, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0568-6; Micallef MJ, 1997, CANCER RES, V57, P4557; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Osaki T, 1998, J IMMUNOL, V160, P1742; Palma G, 2013, BBA-REV CANCER, V1836, P296, DOI 10.1016/j.bbcan.2013.09.001; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Perna SK, 2014, CLIN CANCER RES, V20, P131, DOI 10.1158/1078-0432.CCR-13-1016; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Robertson MJ, 2008, CLIN CANCER RES, V14, P3462, DOI 10.1158/1078-0432.CCR-07-4740; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Shum T, 2017, CANCER DISCOV, V7, P1238, DOI 10.1158/2159-8290.CD-17-0538; Slovin SF, 2013, J CLIN ONCOL S, V31; Tanyi JL, 2017, J IMMUNOTHER, V40, P104, DOI 10.1097/CJI.0000000000000160; Tanyi JL, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-CT105; Tarhini AA, 2009, CANCER-AM CANCER SOC, V115, P859, DOI 10.1002/cncr.24100; Tsutsumi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6340; Wang RF, 2017, CELL RES, V27, P11, DOI 10.1038/cr.2016.155; Yang SC, 2011, CANCER IMMUNOL IMMUN, V60, P739, DOI 10.1007/s00262-011-0977-7; Yang YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1209	49	7	8	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1768	1782		10.1096/fj.201901809R	http://dx.doi.org/10.1096/fj.201901809R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914650	Bronze			2022-12-28	WOS:000507308900117
J	Nagao, T; Shintani, Y; Hayashi, T; Kioka, H; Kato, H; Nishida, Y; Yamazaki, S; Tsukamoto, O; Yashirogi, S; Yazawa, I; Asano, Y; Shinzawa-Itoh, K; Imamura, H; Suzuki, T; Suzuki, T; Goto, Y; Takashima, S				Nagao, Takemasa; Shintani, Yasunori; Hayashi, Takaharu; Kioka, Hidetaka; Kato, Hisakazu; Nishida, Yuya; Yamazaki, Satoru; Tsukamoto, Osamu; Yashirogi, Shohei; Yazawa, Issei; Asano, Yoshihiro; Shinzawa-Itoh, Kyoko; Imamura, Hiromi; Suzuki, Takeo; Suzuki, Tsutomu; Goto, Yu-ichi; Takashima, Seiji			Higd1a improves respiratory function in the models of mitochondrial disorder	FASEB JOURNAL			English	Article						cytochrome c oxidase; hypoxia; mitochondria; respiratory chain	POSITIVE REGULATOR; ATP LEVELS; CELLS; DYSFUNCTION; EXPRESSION; MUTATION; DISEASES; OXIDASE; PROTEIN; MICE	The respiratory chain (RC) transports electrons to form a proton motive force that is required for ATP synthesis in the mitochondria. RC disorders cause mitochondrial diseases that have few effective treatments; therefore, novel therapeutic strategies are critically needed. We previously identified Higd1a as a positive regulator of cytochrome c oxidase (CcO) in the RC. Here, we test that Higd1a has a beneficial effect by increasing CcO activity in the models of mitochondrial dysfunction. We first demonstrated the tissue-protective effects of Higd1a via in situ measurement of mitochondrial ATP concentrations ([ATP](mito)) in a zebrafish hypoxia model. Heart-specific Higd1a overexpression mitigated the decline in [ATP](mito) under hypoxia and preserved cardiac function in zebrafish. Based on the in vivo results, we examined the effects of exogenous HIGD1A on three cellular models of mitochondrial disease; notably, HIGD1A improved respiratory function that was coupled with increased ATP synthesis and demonstrated cellular protection in all three models. Finally, enzyme kinetic analysis revealed that Higd1a significantly increased the maximal velocity of the reaction between CcO and cytochrome c without changing the affinity between them, indicating that Higd1a is a positive modulator of CcO. These results corroborate that Higd1a, or its mimic, provides therapeutic options for the treatment of mitochondrial diseases.	[Nagao, Takemasa; Shintani, Yasunori; Kato, Hisakazu; Nishida, Yuya; Tsukamoto, Osamu; Yashirogi, Shohei; Yazawa, Issei; Takashima, Seiji] Osaka Univ, Grad Sch Frontier Biol Sci, Dept Med Biochem, Suita, Osaka 5650871, Japan; [Hayashi, Takaharu; Kioka, Hidetaka; Asano, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Nishida, Yuya; Takashima, Seiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Japan; [Yamazaki, Satoru] Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Suita, Osaka, Japan; [Shinzawa-Itoh, Kyoko] Univ Hyogo, Dept Life Sci, Kobe, Hyogo, Japan; [Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Suzuki, Takeo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Goto, Yu-ichi] Natl Ctr Hosp Neurol & Psychiat NCNP, Dept Child Neurol, Kodaira, Tokyo, Japan; [Shintani, Yasunori; Nishida, Yuya; Yamazaki, Satoru; Yazawa, Issei] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Suita, Osaka, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); National Cerebral & Cardiovascular Center - Japan; University of Hyogo; Kyoto University; University of Tokyo; National Cerebral & Cardiovascular Center - Japan	Shintani, Y (corresponding author), Osaka Univ, Grad Sch Frontier Biol Sci, Dept Med Biochem, Suita, Osaka 5650871, Japan.	yshintani@medbio.med.osaka-u.ac.jp	; Suzuki, Tsutomu/J-1776-2015	Tsukamoto, Osamu/0000-0002-9504-8001; nishida, yuya/0000-0002-1994-0807; Shintani, Yasunori/0000-0001-9579-0727; Suzuki, Tsutomu/0000-0002-9731-1731; Kato, Hisakazu/0000-0003-4619-3680	Japan Society for the Promotion of Science (JSPS); Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Takeda Science Foundation; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Intractable Diseases Research Foundation; Japan Foundation of Applied Enzymology; Japan Medical Association; Uehara Memorial Foundation; Mochida Memorial Foundation; Osaka Medical Research Foundation for intractable diseases; Ichiro Kanehara Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Intractable Diseases Research Foundation; Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology); Japan Medical Association; Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation; Osaka Medical Research Foundation for intractable diseases; Ichiro Kanehara Foundation	This research was supported by the Japan Society for the Promotion of Science (JSPS), grants-in-aid from the Ministry of Health, Labor, and Welfare, Japan, and grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This research was also supported by grants from Takeda Science Foundation, Japan Heart Foundation, Japan Cardiovascular Research Foundation, Japan Intractable Diseases Research Foundation, Japan Foundation of Applied Enzymology, Japan Medical Association, Uehara Memorial Foundation, Mochida Memorial Foundation, Osaka Medical Research Foundation for intractable diseases, and Ichiro Kanehara Foundation. We appreciated Drs. Tomitake Tsukihara and Shinya Yoshikawa for insightful discussions and continuing support. We thank S. Gion, E. Takada, K. Shingu, M. Kishimoto, M. Nishizawa, and Y Ishizuka for technical assistance; Y. Okada for secretarial support; and all Takashima Labo members for discussion.	Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809; An HJ, 2013, P NATL ACAD SCI USA, V110, P13014, DOI 10.1073/pnas.1307170110; Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Denko N, 2000, CLIN CANCER RES, V6, P480; Ferrari M, 2017, P NATL ACAD SCI USA, V241, P201621511; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Guo, 2015, NONLINEAR DYNAM, V2015, P1; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Kioka H, 2020, FASEB J, V34, P2041, DOI 10.1096/fj.201901686R; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI [10.1038/NCHEMBIO.2099, 10.1038/nchembio.2099]; Pfeffer G, 2012, COCHRANE DB SYST REV, V45, P1193; Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Torraco A, 2015, MITOCHONDRION, V21, P76, DOI 10.1016/j.mito.2015.01.009; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002	31	8	8	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1859	1871		10.1096/fj.201800389R	http://dx.doi.org/10.1096/fj.201800389R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914602				2022-12-28	WOS:000507308900123
J	Burgraff, NJ; Neumueller, SE; Buchholz, KJ; LeClaire, J; Hodges, MR; Pan, L; Forster, HV				Burgraff, Nicholas J.; Neumueller, Suzanne E.; Buchholz, Kirstyn J.; LeClaire, John; Hodges, Matthew R.; Pan, Lawrence; Forster, Hubert V.			Brainstem serotonergic, catecholaminergic, and inflammatory adaptations during chronic hypercapnia in goats	FASEB JOURNAL			English	Article						plasticity; catecholamines; serotonin; inflammation	NUCLEUS-TRACTUS-SOLITARIUS; CARBON-DIOXIDE; LOCUS-COERULEUS; NEURONS; VENTILATION; HYPOXEMIA; RESPONSES; MEDULLA; DISEASE; CO2	Despite the prevalence of CO2 retention in human disease, little is known about the adaptive neurobiological effects of chronic hypercapnia. We have recently shown 30-d exposure to increased inspired CO2 (InCO2) leads to a steady-state ventilation that exceeds the level predicted by the sustained acidosis and the acute CO2/H+ chemoreflex, suggesting plasticity within respiratory control centers. Based on data showing brainstem changes in aminergic and inflammatory signaling during carotid body denervation-induced hypercapnia, we hypothesized chronic hypercapnia per se will lead to similar changes. We found that: 1) increased InCO2 increased IL-1 beta in the medullary raphe (MR), ventral respiratory column, and cuneate nucleus after 24 h, but not after 30 d of hypercapnia; 2) the number of serotonergic and total neurons were reduced within the MR and ventrolateral medulla following 30 d of increased InCO2; 3) markers of tryptophan metabolism were altered following 24 h, but not 30 d of InCO2; and 4) there were few changes in brainstem amine levels following 24 h or 30 d of increased InCO2. We conclude that these changes may contribute to initiating or maintaining respiratory neuroplasticity during chronic hypercapnia but alone do not account for ventilatory acclimatization to chronic increased InCO2.	[Burgraff, Nicholas J.; Neumueller, Suzanne E.; Buchholz, Kirstyn J.; LeClaire, John; Hodges, Matthew R.; Forster, Hubert V.] Med Coll Wisconsin, Dept Physiol, Wauwatosa, WI USA; [Hodges, Matthew R.; Forster, Hubert V.] Med Coll Wisconsin, Neurosci Res Ctr, Wauwatosa, WI USA; [Pan, Lawrence] Marquette Univ, Dept Phys Therapy, Milwaukee, WI 53233 USA; [Forster, Hubert V.] Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Marquette University	Forster, HV (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd,BSB 503, Milwaukee, WI 53226 USA.	bforster@mcw.edu	Hodges, Matthew/GZB-0433-2022		U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL-007852]; U.S. Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007852] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant HL-007852) and the U.S. Department of Veterans Affairs. Funding sources were not involved in the preparation of this manuscript, experimental design or data collection, data analysis or interpretation, writing of the report, or decision to submit this manuscript for publication. All experiments were performed at the Medical College of Wisconsin. The authors declare no conflicts of interest.	Ahmadi Z, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-30; Burgraff NJ, 2018, J PHYSIOL-LONDON, V596, P5343, DOI 10.1113/JP276666; Burgraff NJ, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14035; Calverley PM, 2003, EUR RESPIR J, V47, p26s; Costello R, 1997, AM J MED, V102, P239, DOI 10.1016/S0002-9343(97)00017-X; Cream C, 2002, RESP PHYSIOL NEUROBI, V130, P121, DOI 10.1016/S0034-5687(01)00338-3; Dean C, 1999, J APPL PHYSIOL, V87, P1220, DOI 10.1152/jappl.1999.87.3.1220; Garcia de Yebenes Prous J, 1977, Naunyn Schmiedebergs Arch Pharmacol, V301, P11; Gargaglioni LH, 2010, RESP PHYSIOL NEUROBI, V173, P264, DOI 10.1016/j.resp.2010.04.024; Hochstrasser T, 2011, NEUROSCIENCE, V184, P128, DOI 10.1016/j.neuroscience.2011.03.070; Hodges MR, 2010, RESP PHYSIOL NEUROBI, V173, P256, DOI 10.1016/j.resp.2010.03.006; Hodges MR, 2010, J APPL PHYSIOL, V108, P1425, DOI 10.1152/japplphysiol.01270.2009; Hoehe M. R., 2007, DIALOGUES CLIN NEURO, V9, P471; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kent BD, 2011, INT J CHRONIC OBSTR, V6, P199, DOI 10.2147/COPD.S10611; Miller JR, 2014, J APPL PHYSIOL, V116, P1531, DOI 10.1152/japplphysiol.00216.2014; Miller JR, 2013, J APPL PHYSIOL, V115, P1088, DOI 10.1152/japplphysiol.00293.2013; Morinaga R, 2019, NEUROSCI RES, V143, P20, DOI 10.1016/j.neures.2018.05.004; Nichols NL, 2008, ADV EXP MED BIOL, V605, P348; Nin N, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.01.09; Pierson D J, 2000, Respir Care, V45, P39; Popa D, 2011, RESP PHYSIOL NEUROBI, V178, P381, DOI 10.1016/j.resp.2011.03.024; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; ROSE CE, 1983, AM J PHYSIOL, V245, pH924, DOI 10.1152/ajpheart.1983.245.6.H924; SCHAEFER KE, 1976, J APPL PHYSIOL, V41, P67, DOI 10.1152/jappl.1976.41.1.67; SCHOFIELD SPM, 1981, J ANAT, V132, P391; SCHOFIELD SPM, 1982, J ANAT, V134, P315; Slenter RHJ, 2013, RESPIRATION, V85, P15, DOI 10.1159/000342036; STONE EA, 1983, N-S ARCH PHARMACOL, V324, P313, DOI 10.1007/BF00502629; Thom SR, 2017, J APPL PHYSIOL, V123, P297, DOI 10.1152/japplphysiol.00343.2017; Thom SR, 2017, FREE RADICAL BIO MED, V106, P406, DOI 10.1016/j.freeradbiomed.2017.03.005; THOR KB, 1989, J CHEM NEUROANAT, V2, P139; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027	33	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14491	14505		10.1096/fj.201901288RR	http://dx.doi.org/10.1096/fj.201901288RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31670983	Green Published, Bronze			2022-12-28	WOS:000507466100110
J	Cimmino, I; Perruolo, G; Prisco, F; Paciello, O; D'Esposito, V; Spinelli, R; Ferraro, G; Miele, C; Beguinot, F; Formisano, P; Oriente, F				Cimmino, I.; Perruolo, G.; Prisco, F.; Paciello, O.; D'Esposito, V.; Spinelli, R.; Ferraro, G.; Miele, C.; Beguinot, F.; Formisano, P.; Oriente, F.			Prep1 regulates angiogenesis through a PGC-1 alpha-mediated mechanism	DIABETOLOGIA			English	Meeting Abstract	55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)	SEP 16-20, 2019	Barcelona, SPAIN	European Assoc Study Diabet					[Cimmino, I.; Perruolo, G.; D'Esposito, V.; Spinelli, R.; Ferraro, G.; Miele, C.; Beguinot, F.; Formisano, P.; Oriente, F.] Univ Naples Federico II, CNR, IEOS, Dept Translat Med, Naples, Italy; [Cimmino, I.; Perruolo, G.; D'Esposito, V.; Spinelli, R.; Ferraro, G.; Miele, C.; Beguinot, F.; Formisano, P.; Oriente, F.] URT, Naples, Italy; [Prisco, F.; Paciello, O.] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II			D'Esposito, Vittoria/K-7633-2016	D'Esposito, Vittoria/0000-0002-3675-8062; Perruolo, Giuseppe/0000-0003-0479-8729					0	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	SEP	2019	62			1	SI	1155	S555	S556						2	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism	IW9HI	31618597	Bronze			2022-12-28	WOS:000485303805008
J	Kotarska, A; Fernandes, L; Kleene, R; Schachner, ML				Kotarska, Agnieszka; Fernandes, Luciana; Kleene, Ralf; Schachner, Melitta			Cell adhesion molecule close homolog of L1 binds to the dopamine receptor D2 and inhibits the internalization of its short isoform	FASEB JOURNAL			English	Article						monoaminergic receptors; neurotransmission; postsynaptic compartment; presynaptic compartment; striatum	INVERSE AGONIST ACTION; LOW-AFFINITY STATES; MICE DEFICIENT; CALL GENE; IMMUNOGLOBULIN SUPERFAMILY; DISPLAY ALTERATIONS; IN-VIVO; CHL1; LONG; RELEASE	Cell adhesion molecule close homolog of L1 (CHL1) and the dopamine receptor D2 (DRD2) are associated with psychiatric and mental disorders. We here show that DRD2 interacts with CHL1 in mouse brain, as evidenced by co-immunostaining, proximity ligation assay, co-immunoprecipitation, and pull-down assay with recombinant extracellular CHL1 domain fused to Fc (CHL1-Fc). Direct binding of CHL1-Fc to the first extracellular loop of DRD2 was shown by ELISA. Using HEK cells transfected to co-express CHL1 and the short (DRD2-S) or long (DRD2-L) DRD2 isoforms, co-localization of CHL1 and both isoforms was observed by immunostaining and proximity ligation assay. Moreover, CHL1 inhibited agonist-triggered internalization of DRD2-S. Proximity ligation assay showed close interaction between CHL1 and DRD2 in neurons expressing dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP32) or tyrosine hydroxylase (TH) in tissue sections of adult mouse striatum. In cultures of striatum or ventral midbrain, CHL1 was also closely associated with DRD2 in DARPP32- or TH-immunopositive cells, respectively. In the dorsal striatum of CHL1-deficient mice, lower levels of DRD2 and phosphorylated TH were observed, when compared to wild-type littermates. In the ventral striatum of CHL1-deficient mice, levels of phosphorylated DARPP32 were reduced. We propose that CHL1 regulates DRD2-dependent presynaptic and postsynaptic functions.	[Kotarska, Agnieszka; Fernandes, Luciana; Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Schachner, Melitta] Shantou Univ, Ctr Neurosci, Coll Med, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Shantou University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, ML (corresponding author), Shantou Univ, Ctr Neurosci, Coll Med, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China.	schachner@stu.edu.cn			Li-Kashing Foundation	Li-Kashing Foundation	Li-Kashing Foundation	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Alsanie WF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09599-y; Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Angeloni D, 1999, PSYCHIATR GENET, V9, P165, DOI 10.1097/00041444-199909000-00011; Anzalone A, 2012, J NEUROSCI, V32, P9023, DOI 10.1523/JNEUROSCI.0918-12.2012; Arias-Carrion O, 2007, ACTA NEUROBIOL EXP, V67, P481; Arreola R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3160486; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Belujon P, 2017, INT J NEUROPSYCHOPH, V20, P1036, DOI 10.1093/ijnp/pyx056; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Bullock CM, 2001, PROG NEURO-PSYCHOPH, V25, P1387, DOI 10.1016/S0278-5846(01)00198-1; Bye CR, 2015, P NATL ACAD SCI USA, V112, pE1946, DOI 10.1073/pnas.1501989112; CASTRO SW, 1993, J NEUROCHEM, V60, P372, DOI 10.1111/j.1471-4159.1993.tb05863.x; Centonze D, 2002, NEUROPSYCHOPHARMACOL, V27, P723, DOI 10.1016/S0893-133X(02)00367-6; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Choi Won-Seok, 2013, Methods Mol Biol, V1018, P61, DOI 10.1007/978-1-62703-444-9_6; Chong TTJ, 2016, PROG BRAIN RES, V229, P389, DOI 10.1016/bs.pbr.2016.05.007; Chu TT, 2010, J HUM GENET, V55, P285, DOI 10.1038/jhg.2010.24; Cuoco C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-12; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; DAVID C, 1991, BIOCHEM BIOPH RES CO, V179, P824, DOI 10.1016/0006-291X(91)91891-F; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gomes Ivone, 2016, Curr Protoc Pharmacol, V75, DOI 10.1002/cpph.15; Goto Y, 2007, INT REV NEUROBIOL, V78, P41, DOI 10.1016/S0074-7742(06)78002-3; Guo NN, 2010, NEUROPSYCHOPHARMACOL, V35, P806, DOI 10.1038/npp.2009.189; Hall DA, 1997, BRIT J PHARMACOL, V121, P731, DOI 10.1038/sj.bjp.0701196; Holm J, 1996, EUR J NEUROSCI, V8, P1613, DOI 10.1111/j.1460-9568.1996.tb01306.x; Irintchev A, 2004, BRAIN RES, V1029, P131, DOI 10.1016/j.brainres.2004.09.042; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jomphe C, 2006, NEUROPHARMACOLOGY, V50, P595, DOI 10.1016/j.neuropharm.2005.11.010; Joseph JD, 2002, NEUROSCIENCE, V112, P39, DOI 10.1016/S0306-4522(02)00067-2; Kessler RM, 2009, BIOL PSYCHIAT, V65, P1024, DOI 10.1016/j.biopsych.2008.12.029; Khan ZU, 1998, P NATL ACAD SCI USA, V95, P7731, DOI 10.1073/pnas.95.13.7731; Kleene R, 2015, J CELL SCI, V128, P4642, DOI 10.1242/jcs.176941; Klein MO, 2019, CELL MOL NEUROBIOL, V39, P31, DOI 10.1007/s10571-018-0632-3; Ko F, 2002, NEUROREPORT, V13, P1017, DOI 10.1097/00001756-200206120-00007; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P11465, DOI 10.1073/pnas.0402028101; Kozell LB, 1997, MOL PHARMACOL, V52, P1137, DOI 10.1124/mol.52.6.1137; L'hirondel M, 1998, BRAIN RES, V792, P253, DOI 10.1016/S0006-8993(98)00146-2; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; LEYSEN JE, 1993, PSYCHOPHARMACOLOGY, V110, P27, DOI 10.1007/BF02246947; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; Mailman Richard B, 2007, Handb Clin Neurol, V83, P77, DOI 10.1016/S0072-9752(07)83004-1; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Montag-Sallaz M, 2003, J NEUROBIOL, V57, P67, DOI 10.1002/neu.10254; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; Morellini F, 2007, MOL CELL NEUROSCI, V34, P121, DOI 10.1016/j.mcn.2006.10.006; Neve KA, 2013, NEUROSCIENCE, V248, P479, DOI 10.1016/j.neuroscience.2013.06.035; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nikonenko AG, 2006, EUR J NEUROSCI, V23, P1839, DOI 10.1111/j.1460-9568.2006.04710.x; Pratte M, 2003, BEHAV BRAIN RES, V147, P31, DOI 10.1016/S0166-4328(03)00114-1; Pratte M, 2009, PHYSIOL BEHAV, V97, P394, DOI 10.1016/j.physbeh.2009.03.009; Roberts DJ, 2005, BRIT J PHARMACOL, V145, P34, DOI 10.1038/sj.bjp.0706073; Roberts DJ, 2004, MOL PHARMACOL, V66, P1573, DOI 10.1124/mol.104.004077; Roberts DJ, 2004, BIOCHEM PHARMACOL, V67, P1657, DOI 10.1016/j.bcp.2003.12.030; Robinson BG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04728-z; Rolf B, 2003, J NEUROSCI RES, V71, P835, DOI 10.1002/jnr.10533; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Salamone JD, 2016, CURR TOP BEHAV NEURO, V27, P231, DOI 10.1007/7854_2015_383; Salyakina D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026049; Sander CY, 2016, NEUROPSYCHOPHARMACOL, V41, P1427, DOI 10.1038/npp.2015.296; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Schock SC, 2010, HISTOCHEM CELL BIOL, V134, P1, DOI 10.1007/s00418-010-0707-9; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Seeman P, 2006, EXPERT OPIN THER TAR, V10, P515, DOI 10.1517/14728222.10.4.515; Senogles SE, 2004, J BIOL CHEM, V279, P1601, DOI 10.1074/jbc.M309792200; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Shi L, 2001, BIOCHEMISTRY-US, V40, P12339, DOI 10.1021/bi011204a; Shoukier M, 2013, NEUROPEDIATRICS, V44, P268, DOI 10.1055/s-0033-1333874; SIBLEY DR, 1982, J BIOL CHEM, V257, P6351; Sierra M, 2015, J PARKINSON DIS, V5, P625, DOI 10.3233/JPD-150535; Skinbjerg M, 2012, BIOCHEM PHARMACOL, V83, P193, DOI 10.1016/j.bcp.2011.09.008; Strange PE, 1999, CLIN EXP PHARMACOL P, V26, pS3; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Wang S, 2018, NATURE, V555, P269, DOI 10.1038/nature25758; Wang YY, 2000, J NEUROSCI, V20, P8305, DOI 10.1523/JNEUROSCI.20-22-08305.2000; Weinstein JJ, 2018, MOL PSYCHIATR, V23, P1506, DOI 10.1038/mp.2017.107; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; WREGGETT KA, 1984, MOL PHARMACOL, V25, P10; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Zhang Boyang, 2014, Adv Pharmacol, V70, P175, DOI 10.1016/B978-0-12-417197-8.00007-9; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	93	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4832	4851		10.1096/fj.201900577RRRR	http://dx.doi.org/10.1096/fj.201900577RRRR		FEB 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052901				2022-12-28	WOS:000513849400001
J	LeBleu, VS; Neilson, EG				LeBleu, Valerie S.; Neilson, Eric G.			Origin and functional heterogeneity of fibroblasts	FASEB JOURNAL			English	Review						cancer; endothelial-to-mesenchymal transition; epithelial-to-mesenchymal transition; fibroblasts; fibrosis; mesenchymal state	TO-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; ANTIGEN-PRESENTING CELLS; SMOOTH-MUSCLE-CELLS; LIVER FIBROSIS; PULMONARY-FIBROSIS; DNA METHYLATION; GENE-EXPRESSION; FIBROTIC LIVER; RENAL FIBROSIS	The inherent plasticity and resiliency of fibroblasts make this cell type a conventional tool for basic research. But where do they come from, are all fibroblasts the same, and how do they function in disease? The first fibroblast lineages in mammalian development emerge from the ooze of primary mesenchyme during gastrulation. They are cells that efficiently create and negotiate the extracellular matrix of the mesoderm in order to migrate and meet their developmental fate. Mature fibroblasts in epithelial tissues live in the interstitial spaces between basement membranes that spatially delimit complex organ structures. While the function of resident fibroblasts in healthy tissues is largely conjecture, the accumulation of fibroblasts in pathologic lesions offers insight into biologic mechanisms that control their function; fibroblasts are poised to coordinate fibrogenesis in tissue injury, neoplasia, and aging. Here, we examine the developmental origin and plasticity of fibroblasts, their molecular and functional definitions, the epigenetic control underlying their identity and activation, and the evolution of their immune regulatory functions. These topics are reviewed through the lens of fate mapping using genetically engineered mouse models and from the perspective of single-cell RNA sequencing. Recent observations suggest dynamic and heterogeneous functions for fibroblasts that underscore their complex molecular signatures and utility in injured tissues.	[Neilson, Eric G.] Northwestern Univ, Feinberg Sch Med, Dept Med, Rubloff Bldg 12-109,420 E Super St, Chicago, IL 60611 USA; [LeBleu, Valerie S.; Neilson, Eric G.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Dev Biol, Rubloff Bldg 12-109,420 E Super St, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Neilson, EG (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Rubloff Bldg 12-109,420 E Super St, Chicago, IL 60611 USA.; Neilson, EG (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Dev Biol, Rubloff Bldg 12-109,420 E Super St, Chicago, IL 60611 USA.	egneilson@northwestern.edu						Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Agorku DJ, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00716; Alex L, 2018, CIRC RES, V122, P540, DOI 10.1161/CIRCRESAHA.118.312654; Bautista-Hernandez LA, 2017, EUR J MICROBIOL IMMU, V7, P151, DOI 10.1556/1886.2017.00009; Avery D, 2018, MATRIX BIOL, V67, P90, DOI 10.1016/j.matbio.2017.12.003; Baglieri J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071723; Barron L, 2016, AM J PATHOL, V186, P2519, DOI 10.1016/j.ajpath.2016.07.004; Bartis D, 2014, THORAX, V69, P760, DOI 10.1136/thoraxjnl-2013-204608; Bartoschek M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07582-3; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bergmann C, 2017, EPIGENOMICS-UK, V9, P463, DOI 10.2217/epi-2016-0150; Bochet L, 2013, CANCER RES, V73, P5657, DOI 10.1158/0008-5472.CAN-13-0530; Bolender D L, 1979, Scan Electron Microsc, P313; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Buchtler S, 2018, J AM SOC NEPHROL, V29, P1859, DOI 10.1681/ASN.2018020138; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen GB, 2018, EUR J IMMUNOL, V48, P1522, DOI 10.1002/eji.201847583; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; Chuai M, 2009, CURR OPIN GENET DEV, V19, P343, DOI 10.1016/j.gde.2009.06.007; Clifford RL, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0464-5; Compton LA, 2006, DEV DYNAM, V235, P82, DOI 10.1002/dvdy.20629; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Costa-Almeida R, 2018, J TISSUE ENG REGEN M, V12, P240, DOI 10.1002/term.2405; Cruz-Solbes AS, 2017, RESULTS PROBL CELL D, V60, P345, DOI 10.1007/978-3-319-51436-9_13; Der E, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93009; Di Carlo SE, 2018, J CLIN INVEST, V128, P54, DOI 10.1172/JCI93558; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Du YN, 2015, THORAX, V70, P1092, DOI 10.1136/thoraxjnl-2015-207035; Duband JL, 1995, ACTA ANAT, V154, P63; Ebmeier S, 2015, CURR OPIN RHEUMATOL, V27, P555, DOI 10.1097/BOR.0000000000000217; Eissa MG, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010023; El Agha E, 2017, CELL STEM CELL, V20, P261, DOI 10.1016/j.stem.2016.10.004; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; Foote AG, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5682-5; Galichon P, 2013, CANCER LETT, V341, P24, DOI 10.1016/j.canlet.2013.04.018; Geng Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125326; Gladka MM, 2018, CIRCULATION, V138, P166, DOI 10.1161/CIRCULATIONAHA.117.030742; Gomez IG, 2016, AM J PHYSIOL-RENAL, V310, pP931, DOI 10.1152/ajprenal.00523.2015; Green J, 2016, AM J RESP CELL MOL, V54, P532, DOI 10.1165/rcmb.2015-0095OC; GRIFFITH CM, 1992, DEVELOPMENT, V116, P1087; Guerrero-Juarez CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08247-x; Habiel DM, 2017, CURR PATHOBIOL REP, V5, P101, DOI 10.1007/s40139-017-0134-x; Haensel D, 2018, DEV DYNAM, V247, P473, DOI 10.1002/dvdy.24561; Hajarnis S, 2018, J AM SOC NEPHROL, V29, P518, DOI 10.1681/ASN.2017030334; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hausmann C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39770-6; Haviv I, 2009, CELL CYCLE, V8, P589, DOI 10.4161/cc.8.4.7669; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hong WM, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9013124; Hosein AN, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129212; Hu MS, 2018, J INVEST DERMATOL, V138, P729, DOI 10.1016/j.jid.2017.10.012; Huang SZ, 2016, TRENDS MOL MED, V22, P4, DOI 10.1016/j.molmed.2015.11.009; Huang XY, 2019, J BIOL CHEM, V294, P8894, DOI 10.1074/jbc.RA118.006994; Hulshoff MS, 2018, ARTERIOSCL THROM VAS, V38, P1986, DOI 10.1161/ATVBAHA.118.311276; Ivanov NA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005819; Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111; Jing H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1605-2; Jolly MK, 2018, DEV DYNAM, V247, P346, DOI 10.1002/dvdy.24541; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Karouzakis E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24240-2; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352; Kramann R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99561; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; Kurashige M, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0137-0; Kuwabara JT, 2017, ARTERIOSCL THROM VAS, V37, P1598, DOI 10.1161/ATVBAHA.117.308199; Lago JC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219165; LAWSON KA, 1991, DEVELOPMENT, V113, P891; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; LeBleu VS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.029447; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee JU, 2019, DNA CELL BIOL, V38, P905, DOI 10.1089/dna.2018.4557; Lee SJ, 2014, WORLD J HEPATOL, V6, P207, DOI 10.4254/wjh.v6.i4.207; Liebau S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0461; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lua I, 2016, J HEPATOL, V64, P1137, DOI 10.1016/j.jhep.2016.01.010; Lynch MD, 2018, J CLIN INVEST, V128, P26, DOI 10.1172/JCI93555; Marangoni RG, 2015, ARTHRITIS RHEUMATOL, V67, P1062, DOI 10.1002/art.38990; Marsh T, 2013, BBA-MOL BASIS DIS, V1832, P1070, DOI 10.1016/j.bbadis.2012.10.013; McGowan SE, 2019, AM J PHYSIOL-LUNG C, V316, pL869, DOI 10.1152/ajplung.00109.2019; Mescher AL, 2017, REGENERATION, V4, P39, DOI 10.1002/reg2.77; Miao CG, 2018, EXP LUNG RES, V44, P178, DOI 10.1080/01902148.2018.1455927; Micallef L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S5; Monteran L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01835; Moore-Morris T, 2018, CIRC RES, V122, P583, DOI 10.1161/CIRCRESAHA.117.311490; Munker S, 2017, WORLD J GASTROENTERO, V23, P4661, DOI 10.3748/wjg.v23.i26.4661; Nakamura M, 2011, J DERMATOL SCI, V61, P7, DOI 10.1016/j.jdermsci.2010.11.015; Nefzger CM, 2017, CELL REP, V21, P2649, DOI 10.1016/j.celrep.2017.11.029; Neilson EG, 2007, J AM SOC NEPHROL, V18, P1995, DOI 10.1681/ASN.2007040457; NEWGREEN DF, 1995, DEV BIOL, V170, P91, DOI 10.1006/dbio.1995.1198; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Ning XX, 2018, J CELL MOL MED, V22, P1383, DOI 10.1111/jcmm.13465; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Ohyama H, 2002, CYTOKINE, V17, P175, DOI 10.1006/cyto.2001.0976; Onuora Sarah, 2015, Nat Rev Rheumatol, V11, P63, DOI 10.1038/nrrheum.2014.223; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; POTTS JD, 1991, P NATL ACAD SCI USA, V88, P1516, DOI 10.1073/pnas.88.4.1516; Pure E, 2018, ONCOGENE, V37, P4343, DOI 10.1038/s41388-018-0275-3; Raab S, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/768391; Raz Y, 2018, J EXP MED, V215, P3075, DOI 10.1084/jem.20180818; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rodriguez-Romo R, 2015, NEPHROLOGY, V20, P736, DOI 10.1111/nep.12521; Rognoni E, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178174; Rosa FF, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau4292; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Sacco AM, 2019, J CELL MOL MED, V23, P4256, DOI 10.1111/jcmm.14316; Sanchez-Duffhues G, 2016, J PATHOL, V238, P378, DOI 10.1002/path.4653; Saraswati S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10965-9; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schoepp M, 2017, CANCERS, V9, DOI 10.3390/cancers9060054; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sheng GJ, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0094-5; Shook BA, 2018, SCIENCE, V362, P909, DOI 10.1126/science.aar2971; Shrishrimal S, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4278658; SHULER C F, 1991, International Journal of Developmental Biology, V35, P463; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Soare A, 2020, ARTHRITIS RHEUMATOL, V72, P137, DOI 10.1002/art.41058; Sontake V, 2015, J IMMUNOL, V195, P3978, DOI 10.4049/jimmunol.1500963; Soundararajan M, 2018, J CELL PHYSIOL, V233, P9099, DOI 10.1002/jcp.26860; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; SPRENT J, 1995, CURR BIOL, V5, P1095, DOI 10.1016/S0960-9822(95)00219-3; Sriyastava SP, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00904; Stone RC, 2016, CELL TISSUE RES, V365, P495, DOI 10.1007/s00441-016-2464-0; Stratton MS, 2019, CIRC RES, V125, P662, DOI 10.1161/CIRCRESAHA.119.315125; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sun YBY, 2016, DIFFERENTIATION, V92, P102, DOI 10.1016/j.diff.2016.05.008; Tabib T, 2018, J INVEST DERMATOL, V138, P802, DOI 10.1016/j.jid.2017.09.045; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Tigges J, 2014, MECH AGEING DEV, V138, P26, DOI 10.1016/j.mad.2014.03.004; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; UMETSU DT, 1986, J IMMUNOL, V136, P440; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Van Linthout S, 2014, CARDIOVASC RES, V102, P258, DOI 10.1093/cvr/cvu062; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; Wells RG, 2010, HEPATOLOGY, V51, P737, DOI 10.1002/hep.23529; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yang X, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00356; Yoshitomi H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01395; Yu WL, 2009, EXP BIOL MED, V234, P483, DOI 10.3181/0812-MR-365; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2013, J PATHOL, V229, P264, DOI 10.1002/path.4120; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang XY, 2013, INT J MOL SCI, V14, P19605, DOI 10.3390/ijms141019605; Ziani L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00414; Zolak JS, 2013, AM J PATHOL, V182, P1239, DOI 10.1016/j.ajpath.2012.12.030	189	78	78	4	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3519	3536		10.1096/fj.201903188R	http://dx.doi.org/10.1096/fj.201903188R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32037627	Bronze			2022-12-28	WOS:000512568100001
J	Li, X; Bi, ZH; Sun, YD; Li, C; Li, YX; Liu, ZY				Li, Xiang; Bi, Zhenghong; Sun, Yidi; Li, Chao; Li, Yixue; Liu, Zhiyong			In vivo ectopic Ngn1 and Neurod1 convert neonatal cochlear glial cells into spiral ganglion neurons	FASEB JOURNAL			English	Article						cochlea; glial cells; inner ear; Neurog1; Neurod1; regeneration; spiral ganglion neurons	INNER-EAR; NERVE DEGENERATION; SENSORY EPITHELIA; GENE-EXPRESSION; MULLER GLIA; GENERATION; INJURY; MODEL	Damage or degeneration of inner ear spiral ganglion neurons (SGNs) causes hearing impairment. Previous in vitro studies indicate that cochlear glial cells can be reprogrammed into SGNs, however, it remains unknown whether this can occur in vivo. Here, we show that glial cells can be converted, in vivo, into SGNs (defined as new SGNs) by simultaneous induction of Neurog1 (Ngn1) and Neurod1. New SGNs express SGN markers, Tuj1, Map2, Prox1, Mafb and Gata3, and reduce glial cell marker Sox10 and Scn7a. The heterogeneity within new SGNs is illustrated by immunostaining and transcriptomic assays. Transcriptomes analysis indicates that well reprogrammed SGNs are similar to type I SGNs. In addition, reprogramming efficiency is positively correlated with the dosage of Ngn1 and Neurod1, but declined with aging. Taken together, our in vivo data demonstrates the plasticity of cochlear glial cells and the capacity of Ngn1 and Neurod1 to reprogram glial cells into SGNs. Looking ahead, we expect that combination of Neurog1 and Neurod1 along with other factors will further boost the percentage of fully converted (Mafb+/Gata3+) new SGNs.	[Li, Xiang; Bi, Zhenghong; Li, Chao; Liu, Zhiyong] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China; [Sun, Yidi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, CAS Key Lab Syst Biol,CAS Ctr Excellence Mol Cell, Shanghai, Peoples R China; [Sun, Yidi; Li, Yixue] Univ Chinese Acad Sci, Shanghai, Peoples R China; [Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Nutr & Hlth, Biomed Big Data Ctr,Key Lab Computat Biol,CAS MPG, Shanghai, Peoples R China; [Liu, Zhiyong] Shanghai Ctr Brain Sci & Brain Inspired Intellige, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Liu, ZY (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China.	Zhiyongliu@ion.ac.cn		Bi, Zhenghong/0000-0002-7811-8012; Li, Xiang/0000-0002-0098-9133	Ministry of Science and Technology of the People's Republic of China (MOST) [2017YFA0103901]; Chinese Academy of Sciences (CAS) [XDB32060100]; National Natural Science Foundation of China (NSFC) [81771012]; Science and Technology Commission of Shanghai Municipality (STCSM) [2018SHZDZX05]; Boehringer Ingelheim [DE811138149]	Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM)); Boehringer Ingelheim(Boehringer Ingelheim)	Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2017YFA0103901; Chinese Academy of Sciences (CAS), Grant/Award Number: XDB32060100; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81771012; Science and Technology Commission of Shanghai Municipality (STCSM), Grant/Award Number: 2018SHZDZX05; Boehringer Ingelheim, Grant/Award Number: DE811138149	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barclay M, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-33; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Cox BC, 2012, JARO-J ASSOC RES OTO, V13, P295, DOI 10.1007/s10162-012-0324-5; Deng M, 2014, GENE EXPR PATTERNS, V15, P31, DOI 10.1016/j.gep.2014.03.001; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Froud KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8115; Gomez-Casati ME, 2010, JARO-J ASSOC RES OTO, V11, P19, DOI 10.1007/s10162-009-0191-x; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Jen HI, 2019, ELIFE, V8, DOI 10.7554/eLife.44328; Jorstad NL, 2017, NATURE, V548, P103, DOI 10.1038/nature23283; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Knipper M, 1998, DEVELOPMENT, V125, P3709; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lang H, 2005, JARO-J ASSOC RES OTO, V6, P63, DOI 10.1007/s10162-004-5021-6; Lang HN, 2011, JARO-J ASSOC RES OTO, V12, P151, DOI 10.1007/s10162-010-0244-1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li C, 2018, HEARING RES, V364, P12, DOI 10.1016/j.heares.2018.04.006; Li XN, 2018, P NATL ACAD SCI USA, V115, P415, DOI 10.1073/pnas.1703601115; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086273; Liu ZY, 2010, DEV DYNAM, V239, P1674, DOI 10.1002/dvdy.22302; Loffler K, 2015, GLIA, V63, P1809, DOI 10.1002/glia.22846; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Nishimura K, 2014, NEUROSCIENCE, V275, P125, DOI 10.1016/j.neuroscience.2014.05.067; Nishimura K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170568; Nishimura K, 2012, CELL TRANSPLANT, V21, P763, DOI 10.3727/096368911X623907; Noda T, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00016; Pataskar A, 2016, EMBO J, V35, P24, DOI 10.15252/embj.201591206; Petitpre C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06033-3; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Schmiedt RA, 2002, JARO, V3, P223, DOI 10.1007/s1016200220017; Sherrill HE, 2019, J NEUROSCI, V39, P5284, DOI 10.1523/JNEUROSCI.2728-18.2019; Shrestha BR, 2018, CELL, V174, P1229, DOI 10.1016/j.cell.2018.07.007; Song ZC, 2017, STEM CELL REP, V9, P1516, DOI 10.1016/j.stemcr.2017.09.011; Sun SH, 2018, CELL, V174, P1247, DOI 10.1016/j.cell.2018.07.008; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Wan GQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14487; Wise AK, 2011, HEARING RES, V278, P69, DOI 10.1016/j.heares.2011.04.010; Xing YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034500; Yao K, 2018, NATURE, V560, P484, DOI 10.1038/s41586-018-0425-3; Yu WM, 2013, ELIFE, V2, DOI 10.7554/eLife.01341; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	46	8	8	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4764	4782		10.1096/fj.201902118R	http://dx.doi.org/10.1096/fj.201902118R		FEB 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32027432				2022-12-28	WOS:000512074600001
J	Klingler, C; Ashley, J; Shi, K; Stiefvater, A; Kyba, M; Sinnreich, M; Aihara, H; Kinter, J				Klingler, Christian; Ashley, Jon; Shi, Ke; Stiefvater, Adeline; Kyba, Michael; Sinnreich, Michael; Aihara, Hideki; Kinter, Jochen			DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD	FASEB JOURNAL			English	Article						bulge loop; decoy; PAX7; PROP1; transcription factor	FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; OPEN-ACCESS DATABASE; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; CANDIDATE GENE; BULGE LOOP; STEM-CELL; RNA; EXPRESSION; BINDING	Aberrant expression of the transcription factor double homeobox protein 4 (DUX4) can lead to a number of diseases including facio-scapulo-humeral muscular dystrophy (FSHD), acute lymphoblastic leukemia, and sarcomas. Inhibition of DUX4 may represent a therapeutic strategy for these diseases. By applying Systematic Evolution of Ligands by EXponential Enrichment (SELEX), we identified aptamers against DUX4 with specific secondary structural elements conveying high affinity to DUX4 as assessed by fluorescence resonance energy transfer and fluorescence polarization techniques. Sequences analysis of these aptamers revealed the presence of two consensus DUX4 motifs in a reverse complementary fashion forming hairpins interspersed with bulge loops at distinct positions that enlarged the binding surface with the DUX4 protein, as determined by crystal structure analysis. We demonstrate that insertion of specific structural elements into transcription factor binding oligonucleotides can enhance specificity and affinity.	[Klingler, Christian; Ashley, Jon; Stiefvater, Adeline; Sinnreich, Michael; Kinter, Jochen] Univ Hosp Basel, Dept Neurol, Neuromuscular Res Grp, CH-4031 Basel, Switzerland; [Klingler, Christian; Ashley, Jon; Stiefvater, Adeline; Sinnreich, Michael; Kinter, Jochen] Univ Hosp Basel, Dept Biomed, Neuromuscular Res Grp, Basel, Switzerland; [Ashley, Jon] Tech Univ Denmark, Dept Hlth Technol, Lyngby, Denmark; [Shi, Ke; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	University of Basel; University of Basel; Technical University of Denmark; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sinnreich, M (corresponding author), Univ Hosp Basel, Dept Neurol, Neuromuscular Res Grp, CH-4031 Basel, Switzerland.	michael.sinnreich@unibas.ch	Ashley, Jon/H-5064-2016	Ashley, Jon/0000-0002-7062-1019; , Ke/0000-0003-4175-3714; Sinnreich, Michael/0000-0002-9835-1276; Kyba, Michael/0000-0002-5579-7534	US Department of Energy (DOE) [DE-AC02-06CH11357]; National Institutes of Health [GM118047, S10OD021527, P30 GM124165]; CSL Behring	US Department of Energy (DOE)(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSL Behring	US Department of Energy (DOE), Grant/Award Number: DE-AC02-06CH11357; National Institutes of Health, Grant/Award Number: GM118047, S10OD021527 and P30 GM124165; CSL Behring	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bae ON, 2012, ARCH PHARM RES, V35, P1693, DOI 10.1007/s12272-012-1000-3; Banerji CRS, 2019, HUM MOL GENET, V28, P2224, DOI 10.1093/hmg/ddz043; Banerji CRS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01200-4; Bevilacqua PC, 2016, ANNU REV GENET, V50, P235, DOI 10.1146/annurev-genet-120215-035034; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bing T, 2010, BIOORGAN MED CHEM, V18, P1798, DOI 10.1016/j.bmc.2010.01.054; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Bosnakovski D, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw7781; Bosnakovski D, 2017, J CELL SCI, V130, P3685, DOI 10.1242/jcs.205427; Bosnakovski D, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-4; Chen JCJ, 2016, MOL THER, V24, P1405, DOI 10.1038/mt.2016.111; Chen ZY, 2019, NAT GENET, V51, P947, DOI 10.1038/s41588-019-0418-7; Chew GL, 2019, DEV CELL, V50, P658, DOI 10.1016/j.devcel.2019.06.011; Chiu TP, 2016, BIOINFORMATICS, V32, P1211, DOI 10.1093/bioinformatics/btv735; Choi SH, 2016, J BIOMOL SCREEN, V21, P680, DOI 10.1177/1087057116651868; Choi SH, 2016, NUCLEIC ACIDS RES, V44, P5161, DOI 10.1093/nar/gkw141; Correa FA, 2019, ARCH ENDOCRIN METAB, V63, P167, DOI 10.20945/2359-3997000000139; Cruz JM, 2018, J BIOL CHEM, V293, P11837, DOI 10.1074/jbc.RA118.002633; Corona ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075614; Das S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160022; Davis SW, 2013, CURR TOP DEV BIOL, V106, P1, DOI 10.1016/B978-0-12-416021-7.00001-8; De Iaco A, 2017, NAT GENET, V49, P941, DOI 10.1038/ng.3858; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; Degtyareva N, 2001, J BIOL CHEM, V276, P8778, DOI 10.1074/jbc.M006795200; Dib C, 2019, TRENDS CANCER, V5, P268, DOI 10.1016/j.trecan.2019.03.001; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dornberger U, 1999, BIOCHEMISTRY-US, V38, P12860, DOI 10.1021/bi9906874; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Gollmick FA, 2002, NUCLEIC ACIDS RES, V30, P2669, DOI 10.1093/nar/gkf375; Haynes P, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0130-1; Hecker M, 2017, BIOCHEM PHARMACOL, V144, P29, DOI 10.1016/j.bcp.2017.06.122; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Himeda CL, 2019, ANNU REV GENOM HUM G, V20, P265, DOI 10.1146/annurev-genom-083118-014933; Himeda CL, 2016, MOL THER, V24, P527, DOI 10.1038/mt.2015.200; Hoinka J, 2018, MOL THER-NUCL ACIDS, V11, P515, DOI 10.1016/j.omtn.2018.04.006; Hosoya T, 1999, FEBS LETT, V461, P136, DOI 10.1016/S0014-5793(99)01450-7; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaur H, 2018, THERANOSTICS, V8, P4016, DOI 10.7150/thno.25958; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Ku TH, 2015, SENSORS-BASEL, V15, P16281, DOI 10.3390/s150716281; Lee JK, 2018, CELL REP, V25, P2955, DOI 10.1016/j.celrep.2018.11.060; Lee SW, 1997, NAT BIOTECHNOL, V15, P41, DOI 10.1038/nbt0197-41; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li YY, 2018, BIOCHEM BIOPH RES CO, V505, P1161, DOI 10.1016/j.bbrc.2018.10.056; Lilljebjorn H, 2017, BLOOD, V130, P1395, DOI 10.1182/blood-2017-05-742643; Lilljebjorn H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11790; Liu YF, 2016, EBIOMEDICINE, V8, P173, DOI 10.1016/j.ebiom.2016.04.038; Lu JR, 2019, INTRACTABLE RARE DIS, V8, P9, DOI 10.5582/irdr.2019.01016; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menne J, 2017, NEPHROL DIAL TRANSPL, V32, P307, DOI 10.1093/ndt/gfv459; Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088; Mitsuhashi H, 2018, BIOL OPEN, V7, DOI 10.1242/bio.033977; Mitsuhashi H, 2013, HUM MOL GENET, V22, P568, DOI 10.1093/hmg/dds467; Mul Karlien, 2016, Pract Neurol, V16, P201, DOI 10.1136/practneurol-2015-001353; Nakayama M, 2009, MOL CELL ENDOCRINOL, V307, P36, DOI 10.1016/j.mce.2009.03.010; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Osako MK, 2007, J GENE MED, V9, P812, DOI 10.1002/jgm.1077; Pfeiffer F, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00025; Poolsup S, 2017, CURR OPIN BIOTECH, V48, P180, DOI 10.1016/j.copbio.2017.05.004; Rickard AM, 2015, HUM MOL GENET, V24, P5901, DOI 10.1093/hmg/ddv315; Ritz C, 2005, J STAT SOFTW, V12, P1; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schreck JS, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4917199; Sen M, 2012, CANCER DISCOV, V2, P694, DOI 10.1158/2159-8290.CD-12-0191; Siddiqui MAA, 2005, DRUGS, V65, P1571, DOI 10.2165/00003495-200565110-00010; Sirvent N, 2009, CANCER GENET CYTOGEN, V195, P12, DOI 10.1016/j.cancergencyto.2009.06.011; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Specht K, 2014, GENE CHROMOSOME CANC, V53, P622, DOI 10.1002/gcc.22172; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van den Boogaard ML, 2016, AM J HUM GENET, V98, P1020, DOI 10.1016/j.ajhg.2016.03.013; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VARANI G, 1995, ANNU REV BIOPH BIOM, V24, P379, DOI 10.1146/annurev.biophys.24.1.379; Volker J, 2014, BIOPOLYMERS, V101, P1, DOI 10.1002/bip.22236; von Maltzahn J, 2013, P NATL ACAD SCI USA, V110, P16474, DOI 10.1073/pnas.1307680110; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; Yasuda T, 2016, NAT GENET, V48, P569, DOI 10.1038/ng.3535; Yoon S, 2016, MOL THER, V24, P1106, DOI 10.1038/mt.2016.60; Yoshimoto T, 2017, CANCER RES, V77, P2927, DOI 10.1158/0008-5472.CAN-16-3351; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Zboralski D, 2017, CANCER IMMUNOL RES, V5, P950, DOI 10.1158/2326-6066.CIR-16-0303; Zhang JH, 2016, NAT GENET, V48, P1481, DOI 10.1038/ng.3691; Zhang Y, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0080-z; Zhang YZ, 2017, MOL BIOTECHNOL, V59, P159, DOI 10.1007/s12033-017-9998-6	101	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4573	4590		10.1096/fj.201902696	http://dx.doi.org/10.1096/fj.201902696		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32020675	Green Published, hybrid			2022-12-28	WOS:000512309200001
J	Talamonti, E; Sasso, V; To, H; Haslam, RP; Napier, JA; Ulfhake, B; Pernold, K; Asadi, A; Hessa, T; Jacobsson, A; Chiurchiu, V; Viscomi, MT				Talamonti, Emanuela; Sasso, Valeria; To, Hoi; Haslam, Richard P.; Napier, Johnathan A.; Ulfhake, Brun; Pernold, Karin; Asadi, Abolfazl; Hessa, Tara; Jacobsson, Anders; Chiurchiu, Valerio; Viscomi, Maria Teresa			Impairment of DHA synthesis alters the expression of neuronal plasticity markers and the brain inflammatory status in mice	FASEB JOURNAL			English	Article						anti-inflammatory molecules; brain plasticity; microglia; omega-3; PUFA	POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; SYSTEMIC DHA; DEFICIENCY; MOUSE; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; DEPRIVATION; MICROGLIA; BEHAVIOR	Docosahexaenoic acid (DHA) is a omega-3 fatty acid typically obtained from the diet or endogenously synthesized through the action of elongases (ELOVLs) and desaturases. DHA is a key central nervous system constituent and the precursor of several molecules that regulate the resolution of inflammation. In the present study, we questioned whether the impaired synthesis of DHA affected neural plasticity and inflammatory status in the adult brain. To address this question, we investigated neural and inflammatory markers from mice deficient for ELOVL2 (Elovl2(-/-)), the key enzyme in DHA synthesis. From our findings, Elovl2(-/-) mice showed an altered expression of markers involved in synaptic plasticity, learning, and memory formation such as Egr-1, Arc1, and BDNF specifically in the cerebral cortex, impacting behavioral functions only marginally. In parallel, we also found that DHA-deficient mice were characterized by an increased expression of pro-inflammatory molecules, namely TNF, IL-1 beta, iNOS, caspase-1 as well as the activation and morphologic changes of microglia in the absence of any brain injury or disease. Reintroducing DHA in the diet of Elovl2(-/-) mice reversed such alterations in brain plasticity and inflammation. Hence, impairment of systemic DHA synthesis can modify the brain inflammatory and neural plasticity status, supporting the view that DHA is an essential fatty acid with an important role in keeping inflammation within its physiologic boundary and in shaping neuronal functions in the central nervous system.	[Talamonti, Emanuela; To, Hoi; Hessa, Tara] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Talamonti, Emanuela; Asadi, Abolfazl; Jacobsson, Anders] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Sasso, Valeria] IRCCS Santa Lucia Fdn, Lab Expt Neurorehabil, Rome, Italy; [Haslam, Richard P.; Napier, Johnathan A.] Rothamsted Res, Dept Plant Sci, Harpenden, Herts, England; [Ulfhake, Brun; Pernold, Karin] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Chiurchiu, Valerio] Campus Biomed Univ Rome, Dept Med, Rome, Italy; [Chiurchiu, Valerio] IRCCS Santa Lucia Fdn, Lab Resolut Neuroinflammat, Rome, Italy; [Viscomi, Maria Teresa] Univ Cattolica S Cuore, Ist Istol & Embriol, Rome, Italy	Stockholm University; Stockholm University; IRCCS Santa Lucia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Karolinska Institutet; University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Talamonti, E (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.; Chiurchiu, V (corresponding author), Univ Campus Biomed, Dept Med, Via Alvaro del Portillo 21, I-00123 Rome, Italy.; Viscomi, MT (corresponding author), Univ Cattolica Sacro Cuore, Ist Istol & Embriol, Largo Francesco Vito 1, I-00168 Rome, Italy.	emanuela.talamonti@su.se; v.chiurchiu@unicampus.it; mariateresa.viscomi@unicatt.it	Viscomi, Maria Teresa/AAL-6625-2021; Viscomi, Maria Teresa/AAB-9412-2022; Chiurchiu, Valerio/G-6227-2011	Viscomi, Maria Teresa/0000-0002-9096-4967; Haslam, Richard/0000-0001-6226-5643; Napier, Johnathan/0000-0003-3580-3607; Chiurchiu, Valerio/0000-0002-0316-7311	BBSRC [BBS/E/C/000I0420] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/000I0420] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Belkind-Gerson J, 2008, J PEDIATR GASTR NUTR, V47, pS7, DOI 10.1097/MPG.0b013e3181818e3f; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bisicchia E, 2018, MOL NEUROBIOL, V55, P6894, DOI 10.1007/s12035-018-0889-z; Brand A, 2008, J NEUROCHEM, V105, P1325, DOI 10.1111/j.1471-4159.2008.05234.x; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483; Ciappolino V, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040769; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; CRAWFORD MA, 1976, COMP BIOCHEM PHYS B, V54, P395, DOI 10.1016/0305-0491(76)90264-9; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Duclot F, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00035; Echeverria F, 2017, PROSTAG LEUKOTR ESS, V124, P1, DOI 10.1016/j.plefa.2017.08.001; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fahlstrom A, 2012, AGE, V34, P1435, DOI 10.1007/s11357-011-9320-7; Farkas T, 2000, P NATL ACAD SCI USA, V97, P6362, DOI 10.1073/pnas.120157297; Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Ji AL, 2012, NEUROTOXICOLOGY, V33, P780, DOI 10.1016/j.neuro.2012.02.018; Kempuraj D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00216; Khairova RA, 2009, INT J NEUROPSYCHOPH, V12, P561, DOI 10.1017/S1461145709009924; Kim HY, 2014, MIL MED, V179, P106, DOI 10.7205/MILMED-D-14-00162; Kitajka K, 2004, P NATL ACAD SCI USA, V101, P10931, DOI 10.1073/pnas.0402342101; Krashia P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11928-w; Labrousse VF, 2018, BRAIN BEHAV IMMUN, V73, P427, DOI 10.1016/j.bbi.2018.06.004; Labrousse VF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036861; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Larrieu T, 2012, J PHYSIOL BIOCHEM, V68, P671, DOI 10.1007/s13105-012-0179-6; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Leuti A, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8107265; Levin SG, 2017, BIOCHEMISTRY-MOSCOW+, V82, P264, DOI 10.1134/S000629791703004X; Lo Iacono L, 2018, BIOL PSYCHIAT, V84, P905, DOI 10.1016/j.biopsych.2018.05.022; Lorente-Cebrian S, 2015, J PHYSIOL BIOCHEM, V71, P341, DOI 10.1007/s13105-015-0395-y; Luchtman DW, 2013, NEUROPHARMACOLOGY, V64, P550, DOI 10.1016/j.neuropharm.2012.07.019; Madore C, 2014, BRAIN BEHAV IMMUN, V41, P22, DOI 10.1016/j.bbi.2014.03.021; Mamik MK, 2017, BRAIN, V140, P2273, DOI 10.1093/brain/awx133; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Moranis A, 2012, BRAIN BEHAV IMMUN, V26, P721, DOI 10.1016/j.bbi.2011.11.001; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Mottahedin A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00190; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Oster T, 2010, BBA-MOL CELL BIOL L, V1801, P791, DOI 10.1016/j.bbalip.2010.02.011; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pauter AM, 2017, J LIPID RES, V58, P111, DOI 10.1194/jlr.M070862; Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Rao JS, 2007, MOL PSYCHIATR, V12, P36, DOI 10.1038/sj.mp.4001888; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Sheets KG, 2013, MOL VIS, V19, P1747; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Sidhu VK, 2011, J PROTEOME RES, V10, P5472, DOI 10.1021/pr2007285; Solas M, 2017, CURR OPIN PHARMACOL, V37, P87, DOI 10.1016/j.coph.2017.10.005; Talamonti E, 2017, CELL MOL LIFE SCI, V74, P2815, DOI 10.1007/s00018-017-2498-9; Tamminga CA, 2007, AM J PSYCHIAT, V164, P1790, DOI 10.1176/appi.ajp.2007.07101634; Tanaka K, 2012, BIOMOL THER, V20, P152, DOI 10.4062/biomolther.2012.20.2.152; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Viscomi MT, 2008, NEUROSCIENCE, V154, P1267, DOI 10.1016/j.neuroscience.2008.04.024; Wohleb ES, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00544; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346; Zhang YP, 2018, J NEUROL NEUROSUR PS, V89, P382, DOI 10.1136/jnnp-2017-316176	68	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2024	2040		10.1096/fj.201901890RR	http://dx.doi.org/10.1096/fj.201901890RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909582	Green Published, hybrid			2022-12-28	WOS:000514663600009
J	Walter, LM; Franz, P; Lindner, R; Tsiavaliaris, G; Hensel, N; Claus, P				Walter, Lisa Marie; Franz, Peter; Lindner, Robert; Tsiavaliaris, Georgios; Hensel, Niko; Claus, Peter			Profilin2a-phosphorylation as a regulatory mechanism for actin dynamics	FASEB JOURNAL			English	Article						actin binding; actin polymerization; phosphatidylinositol; poly-L-proline; protein phosphorylation	L-PROLINE-BINDING; PROFILIN II; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; STRUCTURAL-ANALYSIS; PROTEIN SMN; IN-VITRO; PHOSPHORYLATION; SITE; OLIGOMERIZATION; POLYMERIZATION	Profilin is a major regulator of actin dynamics in multiple specific processes localized in different cellular compartments. This specificity is not only meditated by its binding to actin but also its interaction with phospholipids such as phosphatidylinositol (4,5)-bisphosphate (PIP2) at the membrane and a plethora of proteins containing poly-L-proline (PLP) stretches. These interactions are fine-tuned by posttranslational modifications such as phosphorylation. Several phospho-sites have already been identified for profilin1, the ubiquitously expressed isoform. However, little is known about the phosphorylation of profilin2a. Profilin2a is a neuronal isoform important for synapse function. Here, we identified several putative profilin2a phospho-sites in silico and tested recombinant phospho-mimetics with regard to their actin-, PLP-, and PIP2-binding properties. Moreover, we assessed their impact on actin dynamics employing a pyrene-actin polymerization assay. Results indicate that distinct phospho-sites modulate specific profilin2a functions. We could identify a molecular switch site at serine residue 71 which completely abrogated actin binding-as well as other sites important for fine-tuning of different functions, for example, tyrosine 29 for PLP binding. Our findings suggest that differential profilin2a phosphorylation is a sensitive mechanism for regulating its neuronal functions. Moreover, the dysregulation of profilin2a phosphorylation may contribute to neurodegeneration.	[Walter, Lisa Marie; Lindner, Robert; Hensel, Niko; Claus, Peter] Inst Neuroanat, Hannover Med Sch, Cell Biol, Hannover, Germany; [Walter, Lisa Marie; Hensel, Niko; Claus, Peter] Ctr Syst Neuroscience, Hannover, Germany; [Franz, Peter; Tsiavaliaris, Georgios] Inst Cellular BioPhys, Hannover Med Sch, Hannover, Germany; Inst Neuroanat, Hannover Med Sch, Peter Claus, Cell Biol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Claus, P (corresponding author), Inst Neuroanat, Hannover Med Sch, Cell Biol, Hannover, Germany.	claus.peter@mh-hannover.de	Claus, Peter/A-7978-2008; Lindner, Robert/AAO-9538-2020	Claus, Peter/0000-0003-3824-9445; Lindner, Robert/0000-0002-6421-5778; Franz, Peter/0000-0001-9770-743X				ARCHER SJ, 1994, FEBS LETT, V337, P145, DOI 10.1016/0014-5793(94)80262-9; BJORKEGREN C, 1993, FEBS LETT, V333, P123, DOI 10.1016/0014-5793(93)80388-B; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; CARLSSON L, 1976, J MOL BIOL, V105, P353, DOI 10.1016/0022-2836(76)90098-X; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Courtemanche N, 2013, BIOCHEMISTRY-US, V52, P6456, DOI 10.1021/bi400682n; D'Ambrosi N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00279; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Fan Y, 2012, NAT CELL BIOL, V14, P1046, DOI 10.1038/ncb2580; FEDOROV AA, 1994, P NATL ACAD SCI USA, V91, P8636, DOI 10.1073/pnas.91.18.8636; Fil D, 2017, HUM MOL GENET, V26, P686, DOI 10.1093/hmg/ddw429; Freischmidt A, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0214-y; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; Gau D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156313; Gibbon BC, 1997, BIOCHEM J, V327, P909; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; HAARER BK, 1993, MOL CELL BIOL, V13, P7864, DOI 10.1128/MCB.13.12.7864; Hensel N, 2018, NEUROSCIENTIST, V24, P54, DOI 10.1177/1073858417705059; HONORE B, 1993, FEBS LETT, V330, P151, DOI 10.1016/0014-5793(93)80262-S; Jonckheere V, 1999, FEBS LETT, V447, P257, DOI 10.1016/S0014-5793(99)00293-8; Kaiser DA, 1999, J CELL SCI, V112, P3779; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kiaei M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31199-7; Korupolu RV, 2009, INT J BIOL MACROMOL, V45, P265, DOI 10.1016/j.ijbiomac.2009.06.001; Krishnan Kannan, 2009, Biophys Rev, V1, P71, DOI 10.1007/s12551-009-0010-y; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lambrechts A, 2000, MOL CELL BIOL, V20, P8209, DOI 10.1128/MCB.20.21.8209-8219.2000; Lambrechts A, 1997, EMBO J, V16, P484, DOI 10.1093/emboj/16.3.484; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; METZLER WJ, 1994, J BIOL CHEM, V269, P4620; Michaelsen-Preusse K, 2016, P NATL ACAD SCI USA, V113, P3365, DOI 10.1073/pnas.1516697113; Minde DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046147; Mittermann I, 1998, SEX PLANT REPROD, V11, P183, DOI 10.1007/s004970050140; Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; Nyman T, 2002, J BIOL CHEM, V277, P15828, DOI 10.1074/jbc.M112195200; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; POLLARD TD, 1981, J CELL BIOL, V88, P654, DOI 10.1083/jcb.88.3.654; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; SOHN RH, 1995, J BIOL CHEM, V270, P21114, DOI 10.1074/jbc.270.36.21114; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; Topf A, 2017, BIOTECHNIQUES, V63, P187, DOI 10.2144/000114599; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yang CX, 2016, P NATL ACAD SCI USA, V113, pE6209, DOI 10.1073/pnas.1605964113	62	7	7	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2147	2160		10.1096/fj.201901883R	http://dx.doi.org/10.1096/fj.201901883R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908005	hybrid			2022-12-28	WOS:000514663600016
J	Goetzl, EJ; Yaffe, K; Peltz, CB; Ledreux, A; Gorgens, K; Davidson, B; Granholm, AC; Mustapic, M; Kapogiannis, D; Tweedie, D; Greig, NH				Goetzl, Edward J.; Yaffe, Kristine; Peltz, Carrie B.; Ledreux, Aurelie; Gorgens, Kim; Davidson, Bradley; Granholm, Ann-Charlotte; Mustapic, Maja; Kapogiannis, Dimitrios; Tweedie, David; Greig, Nigel H.			Traumatic brain injury increases plasma astrocyte-derived exosome levels of neurotoxic complement proteins	FASEB JOURNAL			English	Article						extracellular vesicles; neurodegeneration; neuroinflammation	IDENTIFICATION; ATTACK	Possible involvement of complement (C) systems in the pathogenesis of traumatic brain injury (TBI) was investigated by quantifying Cproteins in plasma astrocyte-derived exosomes (ADEs) of subjects with sports-related TBI (sTBI) and TBI in military veterans (mtTBI) without cognitive impairment. All sTBI subjects (n = 24) had mild injuries, whereas eight of the mtTBI subjects had moderate, and 17 had mild injuries. Plasma levels of ADEs were decreased after acute sTBI and returned to normal within months. Cprotein levels in ADEs were from 12- to 35-fold higher than the corresponding levels in neuron-derived exosomes. CD81 exosome marker-normalized ADE levels of classical pathway C4b, alternative pathway factor D and Bb, lectin pathway mannose-binding lectin (MBL), and shared neurotoxic effectors C3b and C5b-9 terminal C complex were significantly higher and those of C regulatory proteins CR1 and CD59 were lower in the first week of acute sTBI (n = 12) than in controls (n = 12). Most C abnormalities were no longer detected in chronic sTBI at 3-12 months after acute sTBI, except for elevated levels of factor D, Bb, and MBL. In contrast, significant elevations of ADE levels of C4b, factor D, Bb, MBL, C3b and C5b-9 terminal C complex, and depressions of CR1 and CD59 relative to those of controls were observed after 1-4 years in early chronic mtTBI (n = 10) and persisted for decades except for normalization of Bb, MBL, and CD59 in late chronic mtTBI (n = 15). Complement inhibitors may be useful therapeutically in acute TBI and post-concussion syndrome.	[Goetzl, Edward J.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Med Ctr, Neurol Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine; Peltz, Carrie B.] San Francisco VA Med Ctr, Dept Psychiat, San Francisco, CA USA; [Peltz, Carrie B.] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Ledreux, Aurelie; Granholm, Ann-Charlotte] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO USA; [Gorgens, Kim] Univ Denver, Grad Sch Profess Psychol, Denver, CO USA; [Davidson, Bradley] Univ Denver, Dept Mech & Mat Engn, Denver, CO USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Lab Clin Invest, Baltimore, MD 21224 USA; [Tweedie, David; Greig, Nigel H.] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Northern California Institute for Research & Education; University of Denver; University of Denver; University of Denver; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Goetzl, EJ (corresponding author), UCSF, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Mustapic, Maja/AAV-3212-2020; Kapogiannis, Dimitrios/AAW-4934-2020; Ledreux, Aurelie/M-3967-2018	Kapogiannis, Dimitrios/0000-0003-2181-3118; Gorgens, Kim/0000-0003-4413-0600; Ledreux, Aurelie/0000-0001-6232-7672; Mustapic, Maja/0000-0003-0511-2047	U.S. Department of Defense (DOD) [WB1XWH-14-2-0137]; University of Denver (DU) [999]; HHS \ NIH \ National Institute on Aging (NIA)	U.S. Department of Defense (DOD)(United States Department of Defense); University of Denver (DU); HHS \ NIH \ National Institute on Aging (NIA)	U.S. Department of Defense (DOD), Grant/Award Number: WB1XWH-14-2-0137; University of Denver (DU), Grant/Award Number: 999; HHS vertical bar NIH vertical bar National Institute on Aging (NIA)	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Carpanini SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00362; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Choi SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097093; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Goetzl EJ, 2020, J NEUROTRAUM, V37, P382, DOI 10.1089/neu.2019.6711; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Goetzl EJ, 2017, FASEB J, V31, P1792, DOI 10.1096/fj.201601221R; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harris ME, 2002, J CLIN EXP NEUROPSYC, V24, P214, DOI 10.1076/jcen.24.2.214.995; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Ivnik RJ, 2000, NEUROPSYCHOLOGY, V14, P163, DOI 10.1037/0894-4105.14.2.163; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Winston CN, 2019, ALZH DEMENT-DADM, V11, P61, DOI 10.1016/j.dadm.2018.11.002; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	33	30	31	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3359	3366		10.1096/fj.201902842R	http://dx.doi.org/10.1096/fj.201902842R		JAN 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916313	hybrid, Green Accepted			2022-12-28	WOS:000506440100001
J	Carmicheal, J; Atri, P; Sharma, S; Kumar, S; Venkata, RC; Kulkarni, P; Salgia, R; Ghersi, D; Kaur, S; Batra, SK				Carmicheal, Joseph; Atri, Pranita; Sharma, Sunandini; Kumar, Sushil; Chirravuri Venkata, Ramakanth; Kulkarni, Prakash; Salgia, Ravi; Ghersi, Dario; Kaur, Sukhwinder; Batra, Surinder K.			Presence and structure-activity relationship of intrinsically disordered regions across mucins	FASEB JOURNAL			English	Article						intrinsically disordered protein; glycoprotein; protein-protein interaction; protein structure	MOLECULAR RECOGNITION FEATURES; PROTEIN-PROTEIN INTERACTION; PANCREATIC-CANCER; GENE ONTOLOGY; WEB SERVER; SEA DOMAIN; CELL; SEQUENCE; GLYCOSYLATION; PROMISCUITY	Many members of the mucin family are evolutionarily conserved and are often aberrantly expressed and glycosylated in various benign and malignant pathologies leading to tumor invasion, metastasis, and immune evasion. The large size and extensive glycosylation present challenges to study the mucin structure using traditional methods, including crystallography. We offer the hypothesis that the functional versatility of mucins may be attributed to the presence of intrinsically disordered regions (IDRs) that provide dynamism and flexibility and that the IDRs offer potential therapeutic targets. Herein, we examined the links between the mucin structure and function based on IDRs, posttranslational modifications (PTMs), and potential impact on their interactome. Using sequence-based bioinformatics tools, we observed that mucins are predicted to be moderately (20%-40%) to highly (>40%) disordered and many conserved mucin domains could be disordered. Phosphorylation sites overlap with IDRs throughout the mucin sequences. Additionally, the majority of predicted O- and N- glycosylation sites in the tandem repeat regions occur within IDRs and these IDRs contain a large number of functional motifs, that is, molecular recognition features (MoRFs), which directly influence protein-protein interactions (PPIs). This investigation provides a novel perspective and offers an insight into the complexity and dynamic nature of mucins.	[Carmicheal, Joseph; Atri, Pranita; Sharma, Sunandini; Kumar, Sushil; Chirravuri Venkata, Ramakanth; Kaur, Sukhwinder; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Kumar, Sushil; Kaur, Sukhwinder; Batra, Surinder K.] Univ Nebraska Med Ctr, Buffett Canc Ctr, Omaha, NE USA; [Kulkarni, Prakash; Salgia, Ravi] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA; [Ghersi, Dario] Univ Nebraska Omaha, Sch Interdisciplinary Informat, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; City of Hope; University of Nebraska System; University of Nebraska Omaha	Ghersi, D (corresponding author), Univ Nebraska Omaha, Sch Interdisciplinary Informat, Omaha, NE 68182 USA.; Kaur, S; Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Eppley Inst Res Canc & Allied Dis, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	dghersi@unomaha.edu; skaur@unmc.edu; sbatra@unmc.edu			National Institutes of Health [R01 CA183459, RO1 CA195586, RO1 CA210637, UO1 CA200466, UO1 CA210240, P01 CA217798, R44CA224619]; Nebraska Department of Health and Human Services [LB595]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Department of Health and Human Services	National Institutes of Health, Grant/Award Number: R01 CA183459, RO1 CA195586, RO1 CA210637, UO1 CA200466, UO1 CA210240, P01 CA217798, R44CA224619 and UO1 CA210240; Nebraska Department of Health and Human Services, Grant/Award Number: LB595	Aithal A, 2018, EXPERT OPIN THER TAR, V22, P675, DOI 10.1080/14728222.2018.1498845; Ambadipudi S, 2016, EXPERT OPIN DRUG DIS, V11, P65, DOI 10.1517/17460441.2016.1107041; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Astro V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3312; Baert T, 2018, GYNECOL ONCOL, V150, P31, DOI 10.1016/j.ygyno.2018.05.004; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Basile W, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007186; Bauer AK, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120941; Boomsma W, 2016, PEERJ, V4, DOI 10.7717/peerj.1725; Boze H, 2010, BIOPHYS J, V99, P656, DOI 10.1016/j.bpj.2010.04.050; Burgi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158594; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Charon J, 2018, MOL BIOL EVOL, V35, P38, DOI 10.1093/molbev/msx249; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Chen SH, 2012, FASEB J, V26, P1349, DOI 10.1096/fj.11-195669; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Chuang GY, 2012, BIOINFORMATICS, V28, P2249, DOI 10.1093/bioinformatics/bts426; Das S, 2015, ONCOTARGET, V6, P5772, DOI 10.18632/oncotarget.3308; Dong GQ, 2017, J MED CHEM, V60, P7965, DOI 10.1021/acs.jmedchem.7b00467; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Edwards YJK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r50; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Goyal S, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S5-S8; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Guharoy M, 2013, CYTOSKELETON, V70, P550, DOI 10.1002/cm.21118; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hale ML, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2960-9; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hoshi H, 2013, INT J ONCOL, V42, P887, DOI 10.3892/ijo.2013.1760; Hu G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122761; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jung KY, 2015, J MED CHEM, V58, P3002, DOI 10.1021/jm501440q; Kaur S, 2017, AM J GASTROENTEROL, V112, P172, DOI 10.1038/ajg.2016.482; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Kjaergaard M, 2017, CELL MOL LIFE SCI, V74, P3205, DOI 10.1007/s00018-017-2562-5; Krishn SR, 2016, CANCER LETT, V374, P304, DOI 10.1016/j.canlet.2016.02.016; Kurotani A, 2015, INT J MOL SCI, V16, P19812, DOI 10.3390/ijms160819812; Lakshmanan I, 2017, CLIN CANCER RES, V23, P3906, DOI 10.1158/1078-0432.CCR-16-2530; Lakshmanan I, 2015, ONCOTARGET, V6, P21085, DOI 10.18632/oncotarget.3912; Lang TG, 2016, MOL BIOL EVOL, V33, P1921, DOI 10.1093/molbev/msw066; Larion M., 2015, INTRINSICALLY DISORD, V3, P1; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Lise S, 2005, PROTEINS, V58, P144, DOI 10.1002/prot.20279; Lo PW, 2018, P NATL ACAD SCI USA, V115, P7302, DOI 10.1073/pnas.1801850115; Machkalyan G, 2016, CELL SIGNAL, V28, P401, DOI 10.1016/j.cellsig.2016.02.002; Maeda T, 2004, J BIOL CHEM, V279, P13174, DOI 10.1074/jbc.M309417200; Malaney P, 2015, METHODS, V77-78, P69, DOI 10.1016/j.ymeth.2014.10.005; Malhis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141603; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marcotte EM, 2009, CELL, V138, P16, DOI 10.1016/j.cell.2009.06.024; Merino F, 2017, ANGEW CHEM INT EDIT, V56, P2846, DOI 10.1002/anie.201608432; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Mitrea DM, 2012, BIOL CHEM, V393, P259, DOI 10.1515/hsz-2011-0254; Muniyan Sakthivel, 2016, Genes Cancer, V7, P110, DOI 10.18632/genesandcancer.104; Neira JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39732; Niv Y, 2019, J CLIN GASTROENTEROL, V53, P434, DOI 10.1097/MCG.0000000000001050; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Pai P, 2016, CARCINOGENESIS, V37, P223, DOI 10.1093/carcin/bgw005; Pan S, 2014, J PROTEOME RES, V13, P1293, DOI 10.1021/pr4010184; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Pelaseyed T, 2013, FEBS J, V280, P1491, DOI 10.1111/febs.12144; Pentony MM, 2010, PROTEINS, V78, P212, DOI 10.1002/prot.22504; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Pryor EE, 2014, BIOPHYS J, V106, P1638, DOI 10.1016/j.bpj.2014.02.025; Quin RJ, 2000, INT J CANCER, V87, P499, DOI 10.1002/1097-0215(20000815)87:4<499::AID-IJC6>3.0.CO;2-9; Raina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135156; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; Ridley C, 2018, BIOCHEM SOC T, V46, P1099, DOI 10.1042/BST20170402; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Salgia R, 2018, J CLIN MED, V7, DOI 10.3390/jcm7060156; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Shammas SL, 2017, CURR OPIN STRUC BIOL, V42, P155, DOI 10.1016/j.sbi.2017.02.003; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Silverman HS, 2001, GLYCOBIOLOGY, V11, P459, DOI 10.1093/glycob/11.6.459; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tamarozzi ER, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010198; Tarakhovsky A, 2018, J EXP MED, V215, P1777, DOI 10.1084/jem.20180099; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsafou K, 2018, J MOL BIOL, V430, P2321, DOI 10.1016/j.jmb.2018.04.008; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111874; Uversky VN, 2014, CHEM REV, V114, P6844, DOI 10.1021/cr400713r; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; van Putten JPM, 2017, J INNATE IMMUN, V9, P281, DOI 10.1159/000453594; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Verkhivker GM, 2018, METHODS MOL BIOL, V1709, P253, DOI 10.1007/978-1-4939-7477-1_19; Walsh I, 2015, BIOINFORMATICS, V31, P201, DOI 10.1093/bioinformatics/btu625; Wang RY, 2013, GASTROENTEROLOGY, V145, P1436, DOI 10.1053/j.gastro.2013.08.009; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Wojcik S, 2018, METHOD ENZYMOL, V611, P703, DOI 10.1016/bs.mie.2018.09.036; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2012, MOL BIOSYST, V8, P134, DOI 10.1039/c1mb05163f; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yadav LR, 2015, J BIOMOL STRUCT DYN, V33, P2469, DOI 10.1080/07391102.2014.1000973; Yamashita MSD, 2018, CELL TISSUE RES, V374, P455, DOI 10.1007/s00441-018-2916-9; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Yu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22298; Zhou JH, 2018, J MOL BIOL, V430, P2342, DOI 10.1016/j.jmb.2018.03.028	116	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1939	1957		10.1096/fj.201901898RR	http://dx.doi.org/10.1096/fj.201901898RR		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908009	Green Accepted, Bronze			2022-12-28	WOS:000505692800001
J	Shi, MJ; Maique, J; Shaffer, J; Davidson, T; Sebti, S; Fernandez, AF; Zou, ZJ; Yan, S; Levine, B; Moe, OW; Hu, MC				Shi, Mingjun; Maique, Jenny; Shaffer, Joy; Davidson, Taylor; Sebti, Salwa; Fernandez, Alvaro F.; Zou, Zhongju; Yan, Shirley; Levine, Beth; Moe, Orson W.; Hu, Ming Chang			The tripartite interaction of phosphate, autophagy, and alpha Klotho in health maintenance	FASEB JOURNAL			English	Article						aging; autophagy; BCL2; beclin 1; fertility; longevity; NaPi cotransporter; phosphorus; phosphotoxicity; alpha Klotho	CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; VASCULAR CALCIFICATION; DIETARY PHOSPHORUS; GENETIC-EVIDENCE; MICE; PROGRESSION; DEFICIENCY; MECHANISMS; INHIBITION	Aging-related organ degeneration is driven by multiple factors including the cell maintenance mechanisms of autophagy, the cytoprotective protein alpha Klotho, and the lesser known effects of excess phosphate (Pi), or phosphotoxicity. To examine the interplay between Pi, autophagy, and alpha Klotho, we used the BK/BK mouse (homozygous for mutant Becn1(F121A)) with increased autophagic flux, and alpha Klotho-hypomorphic mouse (kl/kl) with impaired urinary Pi excretion, low autophagy, and premature organ dysfunction. BK/BK mice live longer than WT littermates, and have heightened phosphaturia from downregulation of two key NaPi cotransporters in the kidney. The multi-organ failure in kl/kl mice was rescued in the double-mutant BK/BK;kl/kl mice exhibiting lower plasma Pi, improved weight gain, restored plasma and renal alpha Klotho levels, decreased pathology of multiple organs, and improved fertility compared to kl/kl mice. The beneficial effects of heightened autophagy from Becn1(F121A) was abolished by chronic high-Pi diet which also shortened life span in the BK/BK;kl/kl mice. Pi promoted beclin 1 binding to its negative regulator BCL2, which impairs autophagy flux. Pi downregulated alpha Klotho, which also independently impaired autophagy. In conclusion, Pi, alpha Klotho, and autophagy interact intricately to affect each other. Both autophagy and alpha Klotho antagonizes phosphotoxicity. In concert, this tripartite system jointly determines longevity and life span.	[Shi, Mingjun; Maique, Jenny; Shaffer, Joy; Moe, Orson W.; Hu, Ming Chang] Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Davidson, Taylor; Sebti, Salwa; Fernandez, Alvaro F.; Levine, Beth; Moe, Orson W.; Hu, Ming Chang] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sebti, Salwa; Fernandez, Alvaro F.; Zou, Zhongju; Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Zou, Zhongju; Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yan, Shirley] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Moe, Orson W.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Moe, OW; Hu, MC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	orson.moe@utsouthwestern.edu; ming-chang.hu@utsouthwestern.edu	Fernández, Álvaro F./A-7375-2019; Sebti, Salwa/AAB-3188-2020	Fernández, Álvaro F./0000-0002-7704-4285; Sebti, Salwa/0000-0003-4327-1129	NIH [R01-CA109618, R01-DK091392, R01-DK092461]; UT Southwestern Medical Center O'Brien Kidney Research Center [P30DK07938, U19AI199725]; Fondation Leducq [15CBD04]; Simmons Family Foundation; Pak Center Innovative Research; Pak-Seldin Center for Metabolic Research; Endowed Professors Collaborative Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Southwestern Medical Center O'Brien Kidney Research Center; Fondation Leducq(Leducq Foundation); Simmons Family Foundation; Pak Center Innovative Research; Pak-Seldin Center for Metabolic Research; Endowed Professors Collaborative Research	NIH, Grant/Award Number: R01-CA109618 (BL), R01-, DK091392 and R01-DK092461; UT Southwestern Medical Center O'Brien Kidney Research Center, Grant/Award Number: P30DK07938 and U19AI199725; Fondation Leducq, Grant/Award Number: 15CBD04; Simmons Family Foundation; Pak Center Innovative Research; Endowed Professors Collaborative Research; Pak-Seldin Center for Metabolic Research	AlGhatrif M, 2017, MED CLIN N AM, V101, P81, DOI 10.1016/j.mcna.2016.08.006; Barker SL, 2015, NEPHROL DIAL TRANSPL, V30, P223, DOI 10.1093/ndt/gfu291; Bian A, 2014, J ENDOCRINOL INVEST, V37, P1121, DOI 10.1007/s40618-014-0158-6; Bian A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181848; Biber J, 2009, PFLUG ARCH EUR J PHY, V458, P39, DOI 10.1007/s00424-008-0580-8; Biber J, 2013, ANNU REV PHYSIOL, V75, P535, DOI 10.1146/annurev-physiol-030212-183748; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Chang AR, 2014, AM J CLIN NUTR, V99, P320, DOI 10.3945/ajcn.113.073148; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451; Chen TH, 2013, EUR J PHARMACOL, V698, P67, DOI 10.1016/j.ejphar.2012.09.032; Cherqui S, 2017, NAT REV NEPHROL, V13, P115, DOI 10.1038/nrneph.2016.182; Crawford NM, 2015, OBSTET GYN CLIN N AM, V42, P15, DOI 10.1016/j.ogc.2014.09.005; Dai XY, 2013, KIDNEY INT, V83, P1042, DOI 10.1038/ki.2012.482; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Eren M, 2014, P NATL ACAD SCI USA, V111, P7090, DOI 10.1073/pnas.1321942111; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fernandez AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Garcia-Sanz P, 2018, AUTOPHAGY, V14, P717, DOI 10.1080/15548627.2018.1427396; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Grieco G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32389-z; Haller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039229; Hansen M, 2018, NAT REV MOL CELL BIO, V19, P579, DOI 10.1038/s41580-018-0033-y; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hoorn EJ, 2017, KIDNEY INT, V91, P1003, DOI 10.1016/j.kint.2017.01.033; Hsu YJ, 2015, J VASC SURG, V62, P210, DOI 10.1016/j.jvs.2014.02.040; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Hu MC, 2019, PFLUG ARCH EUR J PHY, V471, P99, DOI 10.1007/s00424-018-2238-5; Hu MC, 2017, KIDNEY INT, V91, P1104, DOI 10.1016/j.kint.2016.10.034; Hu MC, 2016, J AM SOC NEPHROL, V27, P79, DOI 10.1681/ASN.2014101030; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Hu MC, 2014, CURR OPIN NEPHROL HY, V23, P331, DOI 10.1097/01.mnh.0000447024.97464.a3; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Kawai M, 2016, J AM SOC NEPHROL, V27, P2810, DOI 10.1681/ASN.2015040446; Kempe DS, 2010, NEPHROL DIAL TRANSPL, V25, P2938, DOI 10.1093/ndt/gfq172; Khositseth S, 2017, KIDNEY INT, V91, P1070, DOI 10.1016/j.kint.2016.12.005; Khositseth S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18311; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Kuro-o M, 2019, NAT REV NEPHROL, V15, P27, DOI 10.1038/s41581-018-0078-3; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lanning NJ, 2018, AM J PHYSIOL-RENAL, V315, pF1465, DOI 10.1152/ajprenal.00009.2018; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Lu X, 2017, KIDNEY DIS-BASEL, V3, P15, DOI 10.1159/000452880; McGovern AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074996; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Neyra JA, 2017, BONE, V100, P41, DOI 10.1016/j.bone.2017.01.017; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814; Osuka S, 2012, J BONE MINER METAB, V30, P10, DOI 10.1007/s00774-011-0343-z; Peraro L, 2017, J AM CHEM SOC, V139, P7792, DOI 10.1021/jacs.7b01698; Pletcher SD, 2002, CURR BIOL, V12, pR328, DOI 10.1016/S0960-9822(02)00832-1; Pous C, 2011, NAT CELL BIOL, V13, P342, DOI 10.1038/ncb0411-342; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ritter CS, 2016, CLIN J AM SOC NEPHRO, V11, P1088, DOI 10.2215/CJN.11901115; Rocchi A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006962; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Scanni R, 2014, J AM SOC NEPHROL, V25, P2730, DOI 10.1681/ASN.2013101076; SCHMITZ G, 1991, J LIPID RES, V32, P1539; Schwarz C, 2001, NEPHROL DIAL TRANSPL, V16, P378, DOI 10.1093/ndt/16.2.378; Scialla JJ, 2014, NAT REV NEPHROL, V10, P268, DOI 10.1038/nrneph.2014.49; Shanahan CM, 2013, KIDNEY INT, V83, P984, DOI 10.1038/ki.2013.75; Shi M, 2017, AM J PHYSIOL-RENAL, V314, pF501; Shi MJ, 2018, LAB INVEST, V98, P1105, DOI 10.1038/s41374-018-0063-2; Shi MJ, 2016, J AM SOC NEPHROL, V27, P2331, DOI 10.1681/ASN.2015060613; Shiraki-Iida T, 2000, J GENE MED, V2, P233, DOI 10.1002/1521-2254(200007/08)2:4<233::AID-JGM110>3.0.CO;2-5; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vega-Rubin-de-Celis S, 2018, P NATL ACAD SCI USA, V115, P4176, DOI 10.1073/pnas.1717800115; Wagner CA, 2019, PEDIATR NEPHROL, V34, P549, DOI 10.1007/s00467-017-3873-3; Watanabe R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07341-2; Wei W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18427-2; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XL, 2016, AUTOPHAGY, V12, P1954, DOI 10.1080/15548627.2016.1212787; Zhang YY, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0836-2	87	11	11	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3129	3150		10.1096/fj.201902127R	http://dx.doi.org/10.1096/fj.201902127R		JAN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908069	Bronze, Green Accepted			2022-12-28	WOS:000505692500001
J	Buscetta, M; Di Vincenzo, S; Miele, M; Badami, E; Pace, E; Cipollina, C				Buscetta, Marco; Di Vincenzo, Serena; Miele, Monica; Badami, Ester; Pace, Elisabetta; Cipollina, Chiara			Cigarette smoke inhibits the NLRP3 inflammasome and leads to caspase-1 activation via the TLR4-TRIF-caspase-8 axis in human macrophages	FASEB JOURNAL			English	Article						caspase-8; inflammation; IL-1 beta; IL-18; metabolism; smoking	NF-KAPPA-B; AEROBIC GLYCOLYSIS; IL-1-BETA; CELLS; DYSFUNCTION; DOWNSTREAM; RELEASE; PROTEIN	The NLRP3 inflammasome is formed by the sensor NLRP3, the adaptor ASC, and pro-caspase-1. Assembly and activation of the inflammasome trigger caspase-1-dependent cleavage of pro-IL-1 beta and pro-IL-18 into their secreted forms. Cigarette smoke is a risk factor for chronic inflammatory diseases and is associated with macrophage dysfunction. The impact of cigarette smoke on NLRP3-dependent responses in macrophages is largely unknown. Herein, we investigated the effects of cigarette smoke extract (CSE) on the NLRP3 inflammasome in human monocyte-derived macrophages (MDMs) and THP-1 cells stimulated with lipopolysaccharide (LPS) and LPS plus the NLRP3 inflammasome activator ATP. We found that CSE inhibited the release of IL-1 beta and IL-18 as well as the expression of NLRP3 acting mainly at the transcriptional level. Interestingly, we found that CSE increased the caspase-1 activity via an NLRP3-independent and TLR4-TRIF-caspase-8-dependent pathway. Activation of caspase-1 by CSE led to a reduction of the basal glycolytic flux and impaired glycolytic burst in response to LPS. Overall, our findings unveil novel pathways leading to immune-metabolic alterations in human macrophages exposed to cigarette smoke. These mechanisms may contribute to macrophage dysfunction and increased risk of infection in smokers.	[Buscetta, Marco; Miele, Monica; Badami, Ester; Cipollina, Chiara] Fdn Ri MED, Palermo, Italy; [Di Vincenzo, Serena; Pace, Elisabetta; Cipollina, Chiara] CNR, Ist Ric Innovaz Biomed, Via Ugo La Malfa 153, I-90146 Palermo, Italy; [Miele, Monica; Badami, Ester] Ist Mediterraneo Trapianti & Terapie Ad Alta Spec, Dept Lab Med & Adv Biotechnol, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Ricerca l'Innovazione Biomedica (IRIB-CNR); IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Cipollina, C (corresponding author), CNR, Ist Ric Innovaz Biomed, Via Ugo La Malfa 153, I-90146 Palermo, Italy.	ccipollina@fondazionerimed.com	Di Vincenzo, Serena/K-3330-2018; Pace, Elisabetta/AAL-2537-2020; Di Vincenzo, Serena/Q-7852-2019	Di Vincenzo, Serena/0000-0003-1695-9307; Pace, Elisabetta/0000-0003-1141-9010; Buscetta, Marco/0000-0001-8313-2647; Badami, Ester/0000-0002-0154-6270; Miele, Monica/0000-0002-1606-651X	Sicilian Region; Programme Cohesion Development Fund 2014/2020Grant "Patto per il Sud"-Project CheMiST [CUP G77B17000110001]; Fondazione Ri.MED	Sicilian Region; Programme Cohesion Development Fund 2014/2020Grant "Patto per il Sud"-Project CheMiST; Fondazione Ri.MED	Sicilian Region; Programme Cohesion Development Fund 2014/2020Grant "Patto per il Sud"-Project CheMiST, Grant/Award Number: CUP G77B17000110001; Fondazione Ri.MED	Aghapour M, 2018, AM J RESP CELL MOL, V58, P157, DOI 10.1165/rcmb.2017-0200TR; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Berenson CS, 2014, THORAX, V69, P811, DOI 10.1136/thoraxjnl-2013-203669; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Chen L, 2016, AM J RESP CELL MOL, V55, P815, DOI 10.1165/rcmb.2016-0051OC; Cipollina C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37625; Di Stefano A, 2014, THORAX, V69, P516, DOI 10.1136/thoraxjnl-2012-203062; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Faner R, 2016, ERJ OPEN RES, V2; Ferraro M, 2019, EXP GERONTOL, V118, P78, DOI 10.1016/j.exger.2019.01.016; Finucane OM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40619-1; Gaidt MM, 2017, CURR OPIN IMMUNOL, V44, P7, DOI 10.1016/j.coi.2016.10.007; Gleeson LE, 2018, AM J RESP CELL MOL, V59, P572, DOI 10.1165/rcmb.2018-0162OC; Gleeson LE, 2016, J IMMUNOL, V196, P2444, DOI 10.4049/jimmunol.1501612; Han S, 2017, RESP RES, V18, DOI 10.1186/s12931-016-0485-6; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hiemstra Pieter S, 2013, Ann Am Thorac Soc, V10 Suppl, pS180, DOI 10.1513/AnnalsATS.201305-123AW; Jaccard G, 2019, TOXICOL REP, V6, P222, DOI 10.1016/j.toxrep.2019.02.009; Kang MJ, 2015, J CLIN INVEST, V125, P2458, DOI 10.1172/JCI71747; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim YH, 2018, ENV HLTH TOXICOL, V33, pe2018010; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Metcalfe HJ, 2014, CLIN EXP IMMUNOL, V176, P461, DOI 10.1111/cei.12289; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Moon JS, 2015, CELL REP, V12, P102, DOI 10.1016/j.celrep.2015.05.046; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Brien M, 2017, J IMMUNOL METHODS, V447, P1, DOI 10.1016/j.jim.2017.03.004; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Park JW, 2008, J IMMUNOL, V180, P4668, DOI 10.4049/jimmunol.180.7.4668; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pinkerton JW, 2017, MOL IMMUNOL, V86, P44, DOI 10.1016/j.molimm.2017.01.014; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thorley Andrew J, 2007, Int J Chron Obstruct Pulmon Dis, V2, P409; Tsai M, 2018, AM J RESP CRIT CARE, V197; Wang HY, 2018, INFLAMMATION, V41, P1321, DOI 10.1007/s10753-018-0780-0; Wiegman CH, 2015, J ALLERGY CLIN IMMUN, V136, P769, DOI 10.1016/j.jaci.2015.01.046; Xie M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13280; Yang DQ, 2016, FEBS LETT, V590, P3179, DOI 10.1002/1873-3468.12360; Yang WL, 2015, INT J CLIN EXP PATHO, V8, P13209; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Yi G, 2018, INFLAMM RES, V67, P539, DOI 10.1007/s00011-018-1145-8; Zhu QF, 2017, J IMMUNOL, V198, P4210, DOI 10.4049/jimmunol.1700352	50	29	29	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1819	1832		10.1096/fj.201901239R	http://dx.doi.org/10.1096/fj.201901239R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914643	Green Published, hybrid			2022-12-28	WOS:000507308900120
J	Chakraborty, D; Strayve, DG; Makia, MS; Conley, SM; Kakahel, M; Al-Ubaidi, MR; Naash, MI				Chakraborty, Dibyendu; Strayve, Daniel G.; Makia, Mustafa S.; Conley, Shannon M.; Kakahel, Mashal; Al-Ubaidi, Muayyad R.; Naash, Muna I.			Novel molecular mechanisms for Prph2-associated pattern dystrophy	FASEB JOURNAL			English	Article						butterfly pattern dystrophy; C213Y knockin; disulfide linkages; extracellular loop; retinitis pigmentosa; retinal degeneration slow (RDS); tetraspanin	ACID-RICH PROTEINS; OF-FUNCTION PHENOTYPE; PERIPHERIN RDS GENE; RETINITIS-PIGMENTOSA; OUTER SEGMENTS; MEMBRANE-PROTEINS; TRANSGENIC MICE; R172W MUTATION; MOUSE MODEL; ROD	Mutations in peripherin 2 (PRPH2) have been associated with retinitis pigmentosa (RP) and macular/pattern dystrophies, but the origin of this phenotypic variability is unclear. The majority of Prph2 mutations are located in the large intradiscal loop (D2), a region that contains seven cysteines involved in intra- and intermolecular disulfide bonding and protein folding. A mutation at cysteine 213, which is engaged in an intramolecular disulfide bond, leads to butterfly-shaped pattern dystrophy in humans, in sharp contrast to mutations in the adjacent cysteine at position 214 which result in RP. To help understand this unexpected phenotypic variability, we generated a knockin mouse line carrying the C213Y disease mutation. The mutant Prph2 protein lost the ability to oligomerize with rod outer segment membrane protein 1 (Rom1), but retained the ability to form homotetramers. C213Y heterozygotes had significantly decreased overall Prph2 levels as well as decreased rod and cone function. Critically, supplementation with extra wild-type Prph2 protein elicited improvements in Prph2 protein levels and rod outer segment structure, but not functional rescue in rods or cones. These findings suggest that not all interruptions of D2 loop intramolecular disulfide bonding lead to haploinsufficiency-related RP, but rather that more subtle changes can lead to mutant proteins stable enough to exert gain-of-function defects in rods and cones. This outcome highlights the difficulty in targeting Prph2-associated gain-of-function disease and suggests that elimination of the mutant protein will be a pre-requisite for any curative therapeutic strategy.	[Chakraborty, Dibyendu; Strayve, Daniel G.; Makia, Mustafa S.; Kakahel, Mashal; Al-Ubaidi, Muayyad R.; Naash, Muna I.] Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd SERC 2009, Houston, TX 77204 USA; [Chakraborty, Dibyendu; Conley, Shannon M.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Chakraborty, Dibyendu] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA	University of Houston System; University of Houston; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Alabama System; University of Alabama Birmingham	Al-Ubaidi, MR; Naash, MI (corresponding author), Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd SERC 2009, Houston, TX 77204 USA.	malubaid@Central.UH.EDU; mnaash@central.uh.edu		kakakhel, mashal/0000-0001-9516-8161	NEI/NIH [EY010609]	NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NEI/NIH, Grant/Award Number: EY010609	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Becirovic E, 2014, HUM MOL GENET, V23, P5989, DOI 10.1093/hmg/ddu323; Bhattacharya S, 2017, INVEST OPHTH VIS SCI, V58, P2366, DOI 10.1167/iovs.16-21162; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2016, HUM MOL GENET, V25, P3500, DOI 10.1093/hmg/ddw193; Chakraborty D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098939; Chakraborty D, 2013, FEBS J, V280, P127, DOI 10.1111/febs.12055; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Conley SM, 2017, HUM MOL GENET, V26, P509, DOI 10.1093/hmg/ddw408; Conley SM, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017376; Conley SM, 2014, HUM MOL GENET, V23, P3102, DOI 10.1093/hmg/ddu014; Conley SM, 2012, CELL MOL LIFE SCI, V69, P1035, DOI 10.1007/s00018-011-0736-0; Ding XQ, 2005, BIOCHEMISTRY-US, V44, P4897, DOI 10.1021/bi048414i; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Fossarello M, 1996, ARCH OPHTHALMOL-CHIC, V114, P448, DOI 10.1001/archopht.1996.01100130444016; Francis PJ, 2005, BRIT J OPHTHALMOL, V89, P1115, DOI 10.1136/bjo.2004.062695; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; Katagiri S, 2018, OPHTHALMIC GENET, V39, P357, DOI 10.1080/13816810.2018.1459737; Kedzierski W, 1997, INVEST OPHTH VIS SCI, V38, P498; Kedzierski W, 1999, J BIOL CHEM, V274, P29181, DOI 10.1074/jbc.274.41.29181; Koirala A, 2013, HUM MOL GENET, V22, P1632, DOI 10.1093/hmg/ddt013; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Manes G, 2015, AM J OPHTHALMOL, V159, P302, DOI 10.1016/j.ajo.2014.10.033; Nguyen ONP, 2016, HUM MOL GENET, V25, P2367, DOI 10.1093/hmg/ddw103; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Nour M, 2008, ADV EXP MED BIOL, V613, P129, DOI 10.1007/978-0-387-74904-4_14; Pentia DC, 2006, J BIOL CHEM, V281, P5500, DOI 10.1074/jbc.M507488200; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Poloschek CM, 2010, INVEST OPHTH VIS SCI, V51, P4253, DOI 10.1167/iovs.09-4655; Ritter LM, 2011, J NEUROSCI, V31, P11231, DOI 10.1523/JNEUROSCI.2875-11.2011; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; SAGA M, 1993, HUM GENET, V92, P519, DOI 10.1007/BF00216463; Salinas RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054292; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shankar SP, 2016, INVEST OPHTH VIS SCI, V57, P349, DOI 10.1167/iovs.15-16965; Souied EH, 1998, EUR J OPHTHALMOL, V8, P98, DOI 10.1177/112067219800800208; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Stuck MW, 2016, PROG RETIN EYE RES, V52, P47, DOI 10.1016/j.preteyeres.2015.12.002; Stuck MW, 2015, J BIOL CHEM, V290, P27901, DOI 10.1074/jbc.M115.683698; Stuck MW, 2014, HUM MOL GENET, V23, P6260, DOI 10.1093/hmg/ddu345; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Vaclavik V, 2012, RETINA-J RET VIT DIS, V32, P1942, DOI 10.1097/IAE.0b013e31824b32e4; Villaverde Cristina, 2007, Hum Genet, V122, P555; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; Zhang K, 2002, ARCH OPHTHALMOL-CHIC, V120, P485; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhang T, 2015, HUM MOL GENET, V24, P1755, DOI 10.1093/hmg/ddu588; Zulliger R, 2018, HUM MOL GENET, V27, P3507, DOI 10.1093/hmg/ddy240	62	13	13	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1211	1230		10.1096/fj.201901888R	http://dx.doi.org/10.1096/fj.201901888R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914632	Green Accepted			2022-12-28	WOS:000507308900082
J	Liu, ZQ; Shan, HH; Chen, SY; Chen, M; Song, YN; Lai, LX; Li, ZJ				Liu, Zhiquan; Shan, Huanhuan; Chen, Siyu; Chen, Mao; Song, Yuning; Lai, Liangxue; Li, Zhanjun			Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits	FASEB JOURNAL			English	Article						base editor; CRISPR; Cas9; NG PAMs; rabbit	GENOMIC DNA; HAIR; MUTATION; FGF5; IDENTIFICATION; DELETION; LONG	Base editors, composed of a cytidine deaminase or an evolved adenine deaminase fused to Cas9 nickase, enable efficient C-to-T or A-to-G conversion in various organisms. However, the NGG protospacer adjacent motif (PAM) requirement of Streptococcus pyogenes Cas9 (SpCas9) substantially limits the target sites suitable for base editing. Quite recently, a new engineered SpCas9-NG variant, which can recognize minimal NG PAMs more efficiently than the present xCas9 variant. Here, we investigated the efficiency and PAM compatibility of SpCas9-NG-assisted cytidine base editors (CBEs) and adenine base editors (ABEs) in rabbits. In this study, we showed that NG-BE4max and NG-ABEmax systems can achieve a targeted mutation efficiency of 75%-100% and 80%-100% with excellent PAM compatibility of NGN PAMs in rabbit embryos, respectively. In addition, both base editors were successfully applied to create new rabbit models with precise point mutations, demonstrating their high efficiency and expanded genome-targeting scope in rabbits. Meanwhile, NG-ABEmax can be used to precisely mimic human Hoxc13 p.Q271R missense mutation in Founder (F0) rabbits, which is arduous for conventional ABEs to achieve due to a NGA PAM requirement. Collectively, NG-BE4max and NG-ABEmax systems provide promising tools to perform efficient base editing with expanded targeting scope in rabbits and enhances its capacity to model human diseases.	[Liu, Zhiquan; Shan, Huanhuan; Chen, Siyu; Chen, Mao; Song, Yuning; Lai, Liangxue; Li, Zhanjun] Jilin Univ, Coll Anim Sci, Key Lab Zoonosis Res, Minist Educ, Changchun 130062, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, CAS Key Lab Regenerat Biol,Guangzhou Inst Biomed, Guangzhou, Peoples R China; [Lai, Liangxue] GRMH GDL, Guangzhou, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Chinese Academy of Sciences	Lai, LX; Li, ZJ (corresponding author), Jilin Univ, Coll Anim Sci, Key Lab Zoonosis Res, Minist Educ, Changchun 130062, Peoples R China.	lai_liangxue@gibh.ac.cn; lizj_1998@jlu.edu.cn		li, zhanjun/0000-0001-6914-8589; Liu, Zhiquan/0000-0001-5433-5656	National Key Research and Development Program of China Stem Cell and Translational Research [2017YFA0105101]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_16R32]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16030501, XDA16030503]; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110104004]	National Key Research and Development Program of China Stem Cell and Translational Research; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory	This study was financially supported by the National Key Research and Development Program of China Stem Cell and Translational Research (2017YFA0105101). The Program for Changjiang Scholars and Innovative Research Team in University (No.IRT_16R32). The Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16030501, XDA16030503), Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110104004).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Chatterjee P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau0766; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Edraki A, 2019, MOL CELL, V73, P714, DOI 10.1016/j.molcel.2018.12.003; Endo M, 2019, NAT PLANTS, V5, P14, DOI 10.1038/s41477-018-0321-8; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Grunewald J, 2019, NATURE, V569, P433, DOI 10.1038/s41586-019-1161-z; Higgins CA, 2014, P NATL ACAD SCI USA, V111, P10648, DOI 10.1073/pnas.1402862111; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Hua K, 2019, MOL PLANT, V12, P1003, DOI 10.1016/j.molp.2019.03.009; Huang TP, 2019, NAT BIOTECHNOL, V37, P626, DOI 10.1038/s41587-019-0134-y; Jin S, 2019, SCIENCE, V364, P292, DOI 10.1126/science.aaw7166; Ki CS, 2002, J HUM GENET, V47, P225, DOI 10.1007/s100380200029; Kim D, 2019, NAT BIOTECHNOL, V37, P430, DOI 10.1038/s41587-019-0050-1; Kluesner MG, 2018, CRISPR J, V1, P239, DOI 10.1089/crispr.2018.0014; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Koblan LW, 2018, NAT BIOTECHNOL, V36, P843, DOI 10.1038/nbt.4172; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kostrzewa M, 1996, HUM GENET, V98, P48, DOI 10.1007/s004390050157; Li XS, 2018, NAT BIOTECHNOL, V36, P324, DOI 10.1038/nbt.4102; Li XX, 2017, PEDIATR DERMATOL, V34, P172, DOI 10.1111/pde.13074; Liu XY, 2019, MOL THER-NUCL ACIDS, V17, P626, DOI 10.1016/j.omtn.2019.06.024; Liu ZQ, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0099-5; Liu ZQ, 2019, CELL MOL LIFE SCI, V76, P4155, DOI 10.1007/s00018-019-03110-8; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Ren B, 2019, MOL PLANT, V12, P1015, DOI 10.1016/j.molp.2019.03.010; Ryu SM, 2018, NAT BIOTECHNOL, V36, P536, DOI 10.1038/nbt.4148; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Thuronyi BW, 2019, NAT BIOTECHNOL, V37, P1070, DOI 10.1038/s41587-019-0193-0; Villiger L, 2018, NAT MED, V24, P1519, DOI 10.1038/s41591-018-0209-1; Wang JJ, 2019, PLANT BIOTECHNOL J, V17, P709, DOI 10.1111/pbi.13053; Wang X, 2018, NAT BIOTECHNOL, V36, P946, DOI 10.1038/nbt.4198; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Yoshizawa Y, 2015, MAMM GENOME, V26, P630, DOI 10.1007/s00335-015-9608-5; Zhong ZH, 2019, MOL PLANT, V12, P1027, DOI 10.1016/j.molp.2019.03.011; Zhou CY, 2019, NATURE, V571, P275, DOI 10.1038/s41586-019-1314-0; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	43	12	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					588	596		10.1096/fj.201901587R	http://dx.doi.org/10.1096/fj.201901587R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914687	Bronze			2022-12-28	WOS:000507308900040
J	Konieczny, P; Artero, R				Konieczny, Piotr; Artero, Ruben			Drosophila SMN2 minigene reporter model identifies moxifloxacin as a candidate therapy for SMA	FASEB JOURNAL			English	Article						drug repurposing; SMA; SMN2; splicing	SPINAL MUSCULAR-ATROPHY; EXONIC SPLICING ENHANCER; KAPPA-OPIOID-RECEPTOR; PRE-MESSENGER-RNA; SINGLE NUCLEOTIDE; POTENTIAL THERAPY; VALPROIC ACID; SMN2 GENE; PROTEIN; SURVIVAL	Spinal muscular atrophy is a rare and fatal neuromuscular disorder caused by the loss of alpha motor neurons. The affected individuals have mutated the ubiquitously expressed SMN1 gene resulting in the loss or reduction in the survival motor neuron (SMN) protein levels. However, an almost identical paralog exists in humans: SMN2. Pharmacological activation of SMN2 exon 7 inclusion by small molecules or modified antisense oligonucleotides is a valid approach to treat SMA. Here we describe an in vivo SMN2 minigene reporter system in Drosophila motor neurons that serves as a cost-effective, feasible, and stringent primary screening model for identifying chemicals capable of crossing the conserved Drosophila blood-brain barrier and modulating exon 7 inclusion. The model was used for the screening of 1100 drugs from the Prestwick Chemical Library, resulting in 2.45% hit rate. The most promising candidate drugs were validated in patient-derived fibroblasts where they proved to increase SMN protein levels. Among them, moxifloxacin modulated SMN2 splicing by promoting exon 7 inclusion. The recovery of SMN protein levels was confirmed by increased colocalization of nuclear gems with Cajal Bodies. Thus, a Drosophila-based drug screen allowed the discovery of an FDA-approved small molecule with the potential to become a novel therapy for SMA.	[Konieczny, Piotr; Artero, Ruben] Univ Valencia, Interdisciplinary Res Struct Biotechnol & Biomed, Valencia, Spain; [Konieczny, Piotr; Artero, Ruben] Incliva Hlth Res Inst, Translat Genom Grp, Valencia, Spain; [Konieczny, Piotr; Artero, Ruben] Incliva CIPF Joint Unit, Valencia, Spain	University of Valencia	Artero, R (corresponding author), Univ Valencia, ERI Biotecmed, C Doctor Moliner 50, E-46100 Burjassot, Spain.	ruben.artero@uv.es	Artero, Ruben/K-6815-2014	Artero, Ruben/0000-0003-1596-047X; Konieczny, Piotr/0000-0003-2644-5502	SMA Europe, FundAME [19243]; AFM-Telethon [22346]	SMA Europe, FundAME; AFM-Telethon(Association Francaise contre les Myopathies)	SMA Europe, FundAME, Grant/Award Number: 19243; AFM-Telethon, Grant/Award Number: 22346	Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Angelozzi C, 2008, J MED GENET, V45, P29, DOI 10.1136/jmg.2007.051177; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bowerman M, 2009, MOL CELL NEUROSCI, V42, P66, DOI 10.1016/j.mcn.2009.05.009; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Clermont O, 1995, LANCET, V346, P1712, DOI 10.1016/S0140-6736(95)92881-2; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Dimitriadi M, 2013, J NEUROSCI, V33, P6557, DOI 10.1523/JNEUROSCI.1536-12.2013; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Fabian I, 2006, BRIT J CANCER, V95, P1038, DOI 10.1038/sj.bjc.6603355; Farrelly-Rosch A, 2017, NEUROCHEM INT, V108, P213, DOI 10.1016/j.neuint.2017.02.016; Fayzullina S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093329; Garcia-Lopez A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04110-1; Golembe TJ, 2005, MOL CELL BIOL, V25, P10989, DOI 10.1128/MCB.25.24.10989-11004.2005; Grzeschik SM, 2005, ANN NEUROL, V58, P194, DOI 10.1002/ana.20548; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hao LT, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-28; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hindle SJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00414; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1356-9597.2004.00709.x; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lemos JC, 2011, METHODS MOL BIOL, V717, P197, DOI 10.1007/978-1-61779-024-9_11; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Martinez-Hernandez R, 2014, J NEUROPATH EXP NEUR, V73, P559, DOI 10.1097/NEN.0000000000000078; Mascarenhas JB, 2018, AM J RESP CELL MOL, V58, P604, DOI 10.1165/rcmb.2017-0141OC; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Pinard E, 2017, J MED CHEM, V60, P4444, DOI 10.1021/acs.jmedchem.7b00406; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Reuveni D, 2010, INT J ONCOL, V37, P463, DOI 10.3892/ijo_00000695; Salemi S, 2005, BIOCHEM BIOPH RES CO, V338, P1012, DOI 10.1016/j.bbrc.2005.10.072; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2015, ANN NY ACAD SCI, V1341, P176, DOI 10.1111/nyas.12727; Singh NN, 2011, MOL CELL BIOL, V31, P935, DOI 10.1128/MCB.00945-10; Singh RN, 2018, ADV NEUROBIOL, V20, P31, DOI 10.1007/978-3-319-89689-2_2; Solier S, 2004, MOL CANCER RES, V2, P53; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Talukdar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027869; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Wang JX, 2018, P NATL ACAD SCI USA, V115, pE4604, DOI 10.1073/pnas.1800260115; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550	61	9	9	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3021	3036		10.1096/fj.201802554RRR	http://dx.doi.org/10.1096/fj.201802554RRR		DEC 2019	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31909520				2022-12-28	WOS:000505012200001
J	Wu, HT; Chen, SC; Fan, KC; Kuo, CH; Lin, SY; Wang, SH; Chang, CJ; Li, HY				Wu, Hung-Tsung; Chen, Szu-Chi; Fan, Kang-Chih; Kuo, Chun-Heng; Lin, Shin-Yu; Wang, Shu-Huei; Chang, Chih-Jen; Li, Hung-Yuan			Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity	FASEB JOURNAL			English	Article						adipogenesis; adipokine; fibrinogen-like protein-1; hepassocin; obesity	ALL-CAUSE MORTALITY; BODY-MASS INDEX; HUMAN HEPASSOCIN; INSULIN; PROLIFERATION; OVERWEIGHT; EXPRESSION; DELTA	Fibrinogen-like-protein 1 (FGL1) is a novel hepatokine that plays an important role in hepatic steatosis and insulin resistance. Although FGL1 expression can be detected in adipose tissues, the functions of FGL1 in adipose tissues are still unknown. In this study, 356 participants with (body mass index (BMI) >= 25 kg/m(2); n = 134) or without obesity (BMI <25 kg/m(2); n = 222) were recruited, and we found that the plasma FGL1 concentrations were significantly higher in obese group than those of in the normal weight group, and were positively correlated with age, BMI, waist circumference, fat content, plasma glucose at 2 hours during an oral glucose tolerance test, and the insulin sensitivity index. In univariate analyses, BMI, waist circumference, total fat, visceral fat, and subcutaneous fat areas were positively correlated with FGL1 levels. After adjusting for age and gender, obesity indices, including the BMI and different fat areas, remained significantly associated with FGL1 levels. In order to investigate the causal relationship between FGL1 and obesity, animal and cell models were used. Overexpression of FGL1 in epididymal adipose tissue by lentiviral vector encoding FGL1 increased the fat pad size, whereas FGL1-knockdown by lentiviral vector encoding short-hairpin RNA targeted to FGL1 decreased high-fat diet-induced adiposity. In addition, 3T3-L1 adipocytes were used to clarify the possible mechanism of FGL1-induced adipogenesis. FGL1 induced adipogenesis through an ERK1/2-C/EBP beta-dependent pathway in 3T3-L1 adipocytes. These findings highlight the pathophysiological role of FGL1 in obesity, and FGL1 might be a novel therapeutic target to combat obesity.	[Wu, Hung-Tsung] Taipei Med Univ, Grad Inst Metab & Obes Sci, Taipei, Taiwan; [Chen, Szu-Chi] Cardinal Tien Hosp, Div Endocrinol, Dept Internal Med, Xindian, Taiwan; [Fan, Kang-Chih] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Kuo, Chun-Heng] Fu Jen Catholic Univ, Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan; [Lin, Shin-Yu] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Wang, Shu-Huei] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan, Taiwan; [Li, Hung-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, 7 Zhongshan South Rd, Taipei 100, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; Fu Jen Catholic University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University Hospital	Li, HY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, 7 Zhongshan South Rd, Taipei 100, Taiwan.	larsli@ntuh.gov.tw	Fan, Kang-Chih/AAH-1425-2021; Kuo, Chun-Heng/AGT-3969-2022	LIN, SHIN-YU/0000-0002-0753-2793; WANG, SHU-HUEI/0000-0002-9208-3135; Li, Hung-Yuan/0000-0001-9644-2855; FAN, KANG-CHIH/0000-0002-6993-4528	Ministry of Science and Technology, Taiwan (MOST) [MOST107-2314-B-038 -112, 107-2314-B-002-178-MY3, 104-2314-B-006 -029-MY2]; National Cheng Kung University Hospital (NCKU) [NCKUH-10804038]; Ministry of Science and Technology; National Cheng Kung University Hospital	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital (NCKU); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Cheng Kung University Hospital	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST107-2314-B-038 -112, 107-2314-B-002-178-MY3 and 104-2314-B-006 -029-MY2; National Cheng Kung University Hospital (NCKU), Grant/Award Number: NCKUH-10804038; Ministry of Science and Technology; National Cheng Kung University Hospital	Abdelmoemen G, 2019, ENDOCR METAB IMMUNE, V19, P185, DOI 10.2174/1871530318666180716100543; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Balkow Aileen, 2016, J Biol Methods, V3, pe48, DOI 10.14440/jbm.2016.123; Belmonte N, 2001, MOL ENDOCRINOL, V15, P2037, DOI 10.1210/me.15.11.2037; Chen MX, 2017, OBES RES CLIN PRACT, V11, P227, DOI 10.1016/j.orcp.2016.07.004; Choi HY, 2013, DIABETES METAB J, V37, P63, DOI 10.4093/dmj.2013.37.1.63; Demchev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058084; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gao M, 2015, BIOCHEM BIOPH RES CO, V463, P466, DOI 10.1016/j.bbrc.2015.05.121; Gao M, 2014, CELL SIGNAL, V26, P2161, DOI 10.1016/j.cellsig.2014.04.013; Giralt M, 2015, MOL CELL ENDOCRINOL, V418, P66, DOI 10.1016/j.mce.2015.09.018; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Hara H, 2001, BBA-GENE STRUCT EXPR, V1520, P45, DOI 10.1016/S0167-4781(01)00249-4; Hishida T, 2009, BIOCHIMIE, V91, P654, DOI 10.1016/j.biochi.2009.02.002; Hung CS, 2011, CLIN ENDOCRINOL, V75, P780, DOI 10.1111/j.1365-2265.2011.04129.x; Hung CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112355; Iroz A, 2015, DIABETOLOGIA, V58, P1699, DOI 10.1007/s00125-015-3634-4; Jung TW, 2018, MOL CELL ENDOCRINOL, V470, P26, DOI 10.1016/j.mce.2017.10.014; Kuo C-H, 2005, INT J OBESITY, V2019, P512; Li CY, 2010, GUT, V59, P817, DOI 10.1136/gut.2008.171124; Ma WY, 2013, DIABETES CARE, V36, P1660, DOI 10.2337/dc12-1452; Oh KJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010008; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Ou HY, 2017, J CLIN ENDOCR METAB, V102, P2407, DOI 10.1210/jc.2016-3287; Rosen ED, 2000, GENE DEV, V14, P1293; Thakkinstian A, 2014, CLIN ENDOCRINOL, V81, P197, DOI 10.1111/cen.12303; TREPANOWSKI JF, 2015, INT J OBESITY, V39, P734, DOI DOI 10.1038/IJO.2014.203; Wu HT, 2016, DIABETOLOGIA, V59, P1732, DOI 10.1007/s00125-016-3991-7; Wu HT, 2013, J HEPATOL, V59, P1065, DOI 10.1016/j.jhep.2013.06.004; Zheng Y, 2017, JAMA-J AM MED ASSOC, V318, P255, DOI 10.1001/jama.2017.7092	32	19	19	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2958	2967		10.1096/fj.201901925R	http://dx.doi.org/10.1096/fj.201901925R		DEC 2019	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908014	Bronze			2022-12-28	WOS:000504676600001
J	Li, L; Tian, FY; Yuan, Y; Zhang, T; Yang, WB; Kong, R; Wang, G; Chen, H; Chen, HZ; Hu, JS; Zhang, GQ; Zhao, ZJ; Wang, XL; Li, GQ; Sun, B				Li, Le; Tian, Feng-Yu; Yuan, Yue; Zhang, Tao; Yang, Wen-Bo; Kong, Rui; Wang, Gang; Chen, Hua; Chen, Hong-Ze; Hu, Ji-Sheng; Zhang, Guang-Quan; Zhao, Zhong-Jie; Wang, Xin-Long; Li, Guan-Qun; Sun, Bei			HYAL-1-induced autophagy facilitates pancreatic fistula for patients who underwent pancreaticoduodenectomy	FASEB JOURNAL			English	Article						autophagy; fibrosis; HYAL-1; pancreaticoduodenectomy; pancreatic fistula	ACTIVATED PROTEIN-KINASE; HYALURONIDASE 1; CANCER; STAT3; AMPK; METABOLISM; PREDICTION; HYAL-1; CELLS; PHOSPHORYLATION	The main mechanism of hyaluronidase 1(HYAL-1) in the development of postoperative pancreatic fistula (POPF) after pancreatoduodenectomy (PD) was unknown. In this study, a comprehensive inventory of pre-, intra-, and postoperative clinical and biological data of two cohorts (62 pancreatic cancer [PCa] and 111 pancreatic ductal adenocarcinoma [PDAC]) which could induce POPF were retrospectively analyzed. Then, a total of 7644 genes correlated with HYAL-1 was predicted in PDAC tissues and the enriched pathway, kinase targets and biological process of those correlated genes were evaluated. Finally, a mouse pancreatic fistula (PF) model was first built and in vitro studies were performed to investigate the effects of HYAL-1 on PF progression. Our data indicated that preoperative serum HYAL-1 level, pancreatic fibrosis score, and pancreatic duct size were valuable factors for detecting POPF of Grade B and C. The serum HYAL-1 level of 2.07 mg/ml and pancreatic fibrosis score of 2.5 were proposed as the cutoff values for indicating POPF. The bioinformatic analysis and in vitro and in vivo studies demonstrated that HYAL-1 facilitates pancreatic acinar cell autophagy via the dephosphorylation of adenosine 5'-monophosphate-activated protein kinase (AMPK) and signal transducers and activators of transcription 3 (STAT3) signaling pathways, which exacerbate pancreatic secretion and inflammation. In summary, the preoperative serum HYAL-1 was a significant predictor for POPF in patients who underwent PD. Tumor-induced HYAL-1 is one of core risk in accelerating PF and then promoting pancreatic secretion and acute inflammation response through the AMPK and STAT3-induced autophagy.	[Li, Le; Tian, Feng-Yu; Zhang, Tao; Yang, Wen-Bo; Kong, Rui; Wang, Gang; Chen, Hua; Chen, Hong-Ze; Hu, Ji-Sheng; Zhang, Guang-Quan; Zhao, Zhong-Jie; Wang, Xin-Long; Li, Guan-Qun; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Heilongjiang, Peoples R China; [Yuan, Yue] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Kong, Rui; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Minist Educ, Key Lab Hepatosplen Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Sun, B (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Key Lab Hepatosplen Surg,Minist Educ, 23 Youzheng St, Harbin 150001, Heilongjiang, Peoples R China.	sunbei70@tom.com	Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Wang, Xin/0000-0002-4457-7376; 	National Natural Science Foundation of China [81800572, 81670583, 81871974, 81770639]; China Postdoctoral Science Foundation [2017M621300, 2018T110316]; Heilongjiang Providence Postdoctoral Science Foundation [LBH-Z17179, LBH-TZ17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Providence Postdoctoral Science Foundation	This work was supported by The National Natural Science Foundation of China (81800572, 81670583, 81871974, 81770639). The China Postdoctoral Science Foundation (2017M621300, 2018T110316) and The Heilongjiang Providence Postdoctoral Science Foundation (LBH-Z17179, LBH-TZ17).	Bassi C, 2017, SURGERY, V161, P584, DOI 10.1016/j.surg.2016.11.014; Benitez A, 2011, CANCER RES, V71, P4085, DOI 10.1158/0008-5472.CAN-10-4610; Biczo G, 2018, GASTROENTEROLOGY, V154, P689, DOI 10.1053/j.gastro.2017.10.012; Deng Y, 2018, J GASTROINTEST SURG, V22, P438, DOI 10.1007/s11605-017-3660-2; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Dogne S, 2016, DIABETES, V65, P2742, DOI 10.2337/db15-1662; Dumaresq-Doiron K, 2012, J CELL PHYSIOL, V227, P1911, DOI 10.1002/jcp.22919; Gayral F, 2009, ANN SURG, V250, P872, DOI 10.1097/SLA.0b013e3181b2489f; Gilardini Montani MS, 2019, AUTOPHAGY, V15, P652, DOI 10.1080/15548627.2018.1536530; Goyert N, 2017, ANN SURG, V265, P2, DOI 10.1097/SLA.0000000000001889; Guo XJ, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0534-4; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; He CY, 2013, DIABETES, V62, P1270, DOI 10.2337/db12-0533; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hogg ME, 2016, ANN SURG, V264, P482, DOI 10.1097/SLA.0000000000001862; Hsu P, 2015, J IMMUNOL, V195, P3665, DOI 10.4049/jimmunol.1402898; Hu JS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0839-8; Hu W, 2018, PROG LIPID RES, V70, P17, DOI 10.1016/j.plipres.2018.04.002; Inata Y, 2018, FASEB J, V32, P728, DOI 10.1096/fj.201700576R; Ji L, 2016, J CELL MOL MED, V20, P2349, DOI 10.1111/jcmm.12928; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Kang JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177052; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kiyochi H, 2015, WORLD J SURG, V39, P2967, DOI 10.1007/s00268-015-3211-5; Kosaka H, 2014, J HEPATO-BIL-PAN SCI, V21, P128, DOI 10.1002/jhbp.11; Kosztelnik M, 2019, FASEB J, V33, P2372, DOI 10.1096/fj.201800565RR; Kramer MW, 2011, CANCER-AM CANCER SOC, V117, P1197, DOI 10.1002/cncr.25565; Li L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0980-4; Li L, 2016, MOL CANCER THER, V15, P2232, DOI 10.1158/1535-7163.MCT-16-0008; Lokeshwar VB, 2008, J BIOL CHEM, V283, P29215, DOI 10.1074/jbc.M801101200; Ma LW, 2017, ANN SURG, V265, P11, DOI 10.1097/SLA.0000000000001892; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Maggino L, 2019, ANN SURG, V269, P1146, DOI 10.1097/SLA.0000000000002673; Mathur A, 2007, ANN SURG, V246, P1058, DOI 10.1097/SLA.0b013e31814a6906; Mazzaferro V, 2019, ANN SURG, V270, P791, DOI 10.1097/SLA.0000000000003514; McMillan MT, 2017, JAMA SURG, V152, P327, DOI 10.1001/jamasurg.2016.4755; Neoptolemos JP, 2018, NAT REV GASTRO HEPAT, V15, P332, DOI 10.1038/s41575-018-0005-x; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Ohgi K, 2020, HPB, V22, P67, DOI 10.1016/j.hpb.2019.05.008; Partelli S, 2017, HPB, V19, P580, DOI 10.1016/j.hpb.2017.03.001; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Poves I, 2018, ANN SURG, V268, P731, DOI 10.1097/SLA.0000000000002893; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Qi YL, 2014, CANCER RES, V74, P3740, DOI 10.1158/0008-5472.CAN-13-3182; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Smits FJ, 2017, JAMA SURG, V152, P540, DOI 10.1001/jamasurg.2016.5708; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Sugimoto M, 2017, J GASTROINTEST SURG, V21, P846, DOI 10.1007/s11605-017-3356-7; Sun LH, 2017, AUTOPHAGY, V13, P703, DOI 10.1080/15548627.2017.1280217; Tanaka T, 2013, J GASTROENTEROL, V48, P1081, DOI 10.1007/s00535-012-0706-9; Van Buren G, 2014, ANN SURG, V259, P605, DOI 10.1097/SLA.0000000000000460; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; Witzel I, 2017, BREAST CANCER RES TR, V162, P427, DOI 10.1007/s10549-017-4135-6; Yamashita S, 2018, ANN SURG, V267, P989; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; You LK, 2015, AUTOPHAGY, V11, P729, DOI 10.1080/15548627.2015.1017192; Zhao YX, 2015, ACTA OCEANOL SIN, V34, P1, DOI 10.1007/s13131-015-0736-2	57	1	1	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2524	2540		10.1096/fj.201901583R	http://dx.doi.org/10.1096/fj.201901583R		DEC 2019	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908026				2022-12-28	WOS:000503399000001
J	Sun, M; Luong, G; Plastikwala, F; Sun, Y				Sun, Ming; Luong, Gary; Plastikwala, Faiz; Sun, Yue			Control of Rab7a activity and localization through endosomal type Igamma PIP 5-kinase is required for endosome maturation and lysosome function	FASEB JOURNAL			English	Article						autophagy; endosome maturation; lysosome; PIPKI gamma i5; Rab7a	PHOSPHATIDYLINOSITOL-PHOSPHATE KINASE; COMPLEX; AUTOPHAGY; PROTEINS; CELLS; PROGRESSION; TRAFFICKING; ASSOCIATION; RECEPTORS; TRANSPORT	The small GTPase Ras-related protein Rab-7a (Rab7a) serves as a key organizer of the endosomal-lysosomal system. However, molecular mechanisms controlling Rab7a activation levels and subcellular translocation are still poorly defined. Here, we demonstrate that type Igamma phosphatidylinositol phosphate 5-kinase i5 (PIPKI gamma i5), an endosome-localized enzyme that produces phosphatidylinositol 4,5-bisphosphate, directly interacts with Rab7a and plays critical roles in the control of the endosomal-lysosomal system. The loss of PIPKI gamma i5 blocks Rab7a recruitment to early endosomes, which prevents the maturation of early to late endosomes. PIPKI gamma i5 loss disturbs retromer complex connection with Rab7a, which blocks the retrograde sorting of Cation-independent Mannose 6-Phosphate Receptor from late endosomes. This leads to the decreased sorting of hydrolases to lysosomes and reduces the autophagic degradation. By modulating the retromer-Rab7a connection, PIPKI gamma i5 is also required for the recruitment of the GTPase-activating protein TBC1 domain family member 5 to late endosomes, which controls the conversion of Rab7a from the active state to the inactive state. Thus, PIPKI gamma i5 is critical for the modulation of Rab7a activity, localization, and function in the endosomal-lysosomal system.	[Sun, Ming; Luong, Gary; Plastikwala, Faiz; Sun, Yue] Virginia Commonwealth Univ, Sch Dent, Philips Inst Oral Hlth Res, Richmond, VA 23298 USA; [Sun, Ming; Luong, Gary; Plastikwala, Faiz; Sun, Yue] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Sun, Y (corresponding author), Virginia Commonwealth Univ, Sch Dent, Philips Inst Oral Hlth Res, Richmond, VA 23298 USA.; Sun, Y (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA.	ysun4@vcu.edu			HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR) [R03DE025893]; American Cancer Society (ACS) [RSG-17-064-01-TBE]	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR); American Cancer Society (ACS)(American Cancer Society)	HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: R03DE025893; American Cancer Society (ACS), Grant/Award Number: RSG-17-064-01-TBE	Baba T, 2019, EMBO J, V38, DOI 10.15252/embj.2018100312; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Choi SY, 2015, BBA-MOL CELL BIOL L, V1851, P711, DOI 10.1016/j.bbalip.2015.01.009; Choy CH, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213587; Cullen PJ, 2018, NAT REV MOL CELL BIO, V19, P679, DOI 10.1038/s41580-018-0053-7; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Durchfort N, 2012, TRAFFIC, V13, P108, DOI 10.1111/j.1600-0854.2011.01300.x; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldenring JR, 2015, CURR OPIN CELL BIOL, V35, P117, DOI 10.1016/j.ceb.2015.04.018; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hasanagic M, 2015, INT REV CEL MOL BIO, V320, P75, DOI 10.1016/bs.ircmb.2015.07.008; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Jacobi AM, 2017, METHODS, V121, P16, DOI 10.1016/j.ymeth.2017.03.021; Jia D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13305; Jimenez-Orgaz A, 2018, EMBO J, V37, P235, DOI 10.15252/embj.201797128; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972; Kim S, 2006, FASEB J, V20, P2399, DOI 10.1096/fj.05-4621fje; Kvainickas A, 2017, J CELL BIOL, V216, P3677, DOI 10.1083/jcb.201702137; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Langemeyer L, 2018, TRENDS CELL BIOL, V28, P957, DOI 10.1016/j.tcb.2018.06.007; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Liu K, 2017, J CELL BIOL, V216, P3307, DOI 10.1083/jcb.201705151; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; Luzio JP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016840; Luzio JP, 2000, J CELL SCI, V113, P1515; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; McNally KE, 2018, TRENDS CELL BIOL, V28, P807, DOI 10.1016/j.tcb.2018.06.005; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Neefjes J, 2014, TRENDS NEUROSCI, V37, P66, DOI 10.1016/j.tins.2013.11.006; Podinovskaia M, 2018, PROG MOL SUBCELL BIO, V57, P1, DOI 10.1007/978-3-319-96704-2_1; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sleat DE, 2005, PROTEOMICS, V5, P1520, DOI 10.1002/pmic.200401054; Soori M, 2016, J PHARMACOL EXP THER, V356, P375, DOI 10.1124/jpet.115.229229; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Sun Jim, 2009, V531, P57, DOI 10.1007/978-1-59745-396-7_5; Sun M, 2016, J BIOL CHEM, V291, P21461, DOI 10.1074/jbc.M116.736041; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Tan XJ, 2016, P NATL ACAD SCI USA, V113, P10896, DOI 10.1073/pnas.1523145113; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Xia Y, 2011, BIOCHEM BIOPH RES CO, V411, P416, DOI 10.1016/j.bbrc.2011.06.168; Xiong XH, 2012, MOL BIOL CELL, V23, P87, DOI 10.1091/mbc.E11-05-0449; Yang MJ, 2004, BIOCHEM BIOPH RES CO, V318, P792, DOI 10.1016/j.bbrc.2004.04.115; Zhan LX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.330	69	8	8	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2730	2748		10.1096/fj.201901830R	http://dx.doi.org/10.1096/fj.201901830R		DEC 2019	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908013	Green Accepted			2022-12-28	WOS:000503397700001
J	Soldner, ELB; Hartz, AMS; Akanuma, SI; Pekcec, A; Doods, H; Kryscio, RJ; Hosoya, KI; Bauer, B				Soldner, Emma L. B.; Hartz, Anika M. S.; Akanuma, Shin-Ichi; Pekcec, Anton; Doods, Henri; Kryscio, Richard J.; Hosoya, Ken-Ichi; Bauer, Bjorn			Inhibition of human microsomal PGE2 synthase-1 reduces seizure-induced increases of P-glycoprotein expression and activity at the blood-brain barrier	FASEB JOURNAL			English	Article						epilepsy; neurovasculature; ABCB1/MDR1	PROSTAGLANDIN-E SYNTHASE-1; NECROSIS-FACTOR-ALPHA; INDUCED UP-REGULATION; TRANSPORT ACTIVITY; RAT MODEL; EPILEPSY; E-2; CYCLOOXYGENASE-2; RESISTANCE; RECEPTORS	The cause of antiseizure drug (ASD) resistance in epilepsy is poorly understood. Here, we focus on the transporter P-glycoprotein (P-gp) that is partly responsible for limited ASD brain uptake, which is thought to contribute to ASD resistance. We previously demonstrated that cyclooxygenase-2 (COX-2) and the prostaglandin E receptor, prostanoid E receptor subtype 1, are involved in seizure-mediated P-gp up-regulation. Thus, we hypothesized that inhibiting microsomal prostaglandin E-2 (PGE2) synthase-1 (mPGES-1), the enzyme generating PGE2, prevents blood-brain barrier P-gp up-regulation after status epilepticus (SE). To test our hypothesis, we exposed isolated brain capillaries to glutamate ex vivo and used a combined in vivo ex vivo approach by isolating brain capillaries from humanized mPGES-1 mice to study P-gp levels. We demonstrate that glutamate signaling through the NMDA receptor, cytosolic phospholipase A2, COX-2, and mPGES-1 increases P-gp protein expression and transport activity levels. We show that mPGES-1 is expressed in human, rat, and mouse brain capillaries. We show that BI1029539, an mPGES-1 inhibitor, prevented up-regulation of P-gp expression and transport activity in capillaries exposed to glutamate and in capillaries from humanized mPGES-1 mice after SE. Our data provide key signaling steps underlying seizure-induced P-gp up-regulation and suggest that mPGES-1 inhibitors could potentially prevent P-gp up-regulation in epilepsy.	[Soldner, Emma L. B.] Univ Minnesota, Coll Pharm, Dept Pharm Practice & Pharmaceut Sci, Duluth, MN 55812 USA; [Hartz, Anika M. S.; Kryscio, Richard J.] Univ Kentucky, Sanders Brown Ctr Aging, Coll Pharm, Lexington, KY 40536 USA; [Hartz, Anika M. S.] Univ Kentucky, Coll Pharm, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Akanuma, Shin-Ichi; Bauer, Bjorn] Univ Kentucky, Dept Pharmaceut Sci, Coll Pharm, Lexington, KY USA; [Kryscio, Richard J.] Univ Kentucky, Dept Stat, Lexington, KY USA; [Bauer, Bjorn] Univ Kentucky, Epilepsy Ctr, Lexington, KY USA; [Akanuma, Shin-Ichi; Hosoya, Ken-Ichi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut, Toyama, Japan; [Pekcec, Anton; Doods, Henri] Boehringer Ingelheim Pharma GmbH & Co KG, Res Borders, Biberach, Germany	University of Minnesota System; University of Minnesota Duluth; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Toyama; Boehringer Ingelheim	Bauer, B (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Sanders Brown Ctr Aging 333, 800 S Limestone, Lexington, KY 40536 USA.	bjoern.bauer@uky.edu			Boehringer Ingelheim Pharma (Biberach, Germany); U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) [1R01NS079507]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079507] Funding Source: NIH RePORTER	Boehringer Ingelheim Pharma (Biberach, Germany)(Boehringer Ingelheim); U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank members of the B.B. and A.M.S.H. laboratories for proofreading the manuscript. The authors acknowledge Dr. Marion Bankstahl and Dr. Wolfgang Loscher (both from the University of Veterinary Medicine Hannover, Hannover, Germany) for help with the kainic acid mouse status epilepticus model. This project was supported by funding from Boehringer Ingelheim Pharma (Biberach, Germany), and by U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) Grant 1R01NS079507 (to B.B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the NIH. The authors declare no conflicts of interest.	Akanuma S, 2014, DRUG METAB PHARMACOK, V29, P387, DOI 10.2133/dmpk.DMPK-14-RG-004; Bauer B, 2004, MOL PHARMACOL, V66, P413; Bauer B, 2008, MOL PHARMACOL, V73, P1444, DOI 10.1124/mol.107.041210; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Brandt C, 2006, NEUROBIOL DIS, V24, P202, DOI 10.1016/j.nbd.2006.06.014; Chen SH, 2018, MOL NEUROBIOL, V55, P8001, DOI 10.1007/s12035-018-0965-4; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Desjardins P, 2003, NEUROCHEM INT, V42, P299, DOI 10.1016/S0197-0186(02)00101-8; Ding L, 2007, J CLIN NEUROPHYSIOL, V24, P130, DOI 10.1097/WNP.0b013e318038fd52; Eskilsson A, 2014, J COMP NEUROL, V522, P3229, DOI 10.1002/cne.23593; Fellin T, 2006, J NEUROSCI, V26, P9312, DOI 10.1523/JNEUROSCI.2836-06.2006; Guan YF, 2001, AM J PHYSIOL-RENAL, V281, pF1173, DOI 10.1152/ajprenal.0116.2001; Gurusamy M, 2016, RESPIROLOGY, V21, P67; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Hartz AMS, 2004, MOL PHARMACOL, V66, P387, DOI 10.1124/mol.104.001503; Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997; Hartz AMS, 2017, MOL PHARMACEUT, V14, P999, DOI 10.1021/acs.molpharmaceut.6b00770; Hartz AMS, 2010, MOL PHARMACOL, V77, P715, DOI 10.1124/mol.109.061754; Hellier JL, 2005, CURR PROTOC NEUROSCI, V9, P9, DOI DOI 10.1002/0471142301.ns0919s31; Ikeda-Matsuo Y, 2010, BRIT J PHARMACOL, V159, P1174, DOI 10.1111/j.1476-5381.2009.00595.x; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kelley KA, 1999, AM J PATHOL, V155, P995, DOI 10.1016/S0002-9440(10)65199-1; Kobayashi T, 2002, PROSTAG OTH LIPID M, V68-9, P557, DOI 10.1016/S0090-6980(02)00055-2; Kojima F, 2003, ARTHRITIS RHEUM, V48, P2819, DOI 10.1002/art.11261; Lazarus M, 2004, PROSTAG LEUKOTR ESS, V71, P233, DOI 10.1016/j.plefa.2004.03.018; Loscher W, 2002, EPILEPSY RES, V50, P3, DOI 10.1016/S0920-1211(02)00063-3; Luna-Tortos C, 2008, NEUROPHARMACOLOGY, V55, P1364, DOI 10.1016/j.neuropharm.2008.08.032; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Minghetti L, 2000, J NEUROPATH EXP NEUR, V59, P866, DOI 10.1093/jnen/59.10.866; NAVARRO E, 1989, J CEREBR BLOOD F MET, V9, P180, DOI 10.1038/jcbfm.1989.27; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P1136, DOI 10.1097/nen.0b013e31815c5efb; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Oliveira MS, 2008, EPILEPSY RES, V79, P14, DOI 10.1016/j.eplepsyres.2007.12.008; Ozen G, 2017, BRIT J PHARMACOL, V174, P4087, DOI 10.1111/bph.13939; Pekcec A, 2009, EPILEPSY RES, V83, P144, DOI 10.1016/j.eplepsyres.2008.10.010; Pekcec A, 2009, J PHARMACOL EXP THER, V330, P939, DOI 10.1124/jpet.109.152520; Priepke H., 2012, Patent No. [WO2012022792, 2012022792]; Rizzi M, 2002, J NEUROSCI, V22, P5833, DOI 10.1523/jneurosci.22-14-05833.2002; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Schlichtiger J, 2010, BRIT J PHARMACOL, V160, P1062, DOI 10.1111/j.1476-5381.2010.00765.x; SCHRAMM U, 1995, AM J PHYSIOL-RENAL, V268, pF46, DOI 10.1152/ajprenal.1995.268.1.F46; Seegers U, 2002, EPILEPSIA, V43, P675, DOI 10.1046/j.1528-1157.2002.33101.x; Tachikawa M, 2012, J NEUROCHEM, V123, P750, DOI 10.1111/jnc.12018; Takemiya T, 2003, PROSTAG OTH LIPID M, V71, P205, DOI 10.1016/S1098-8823(03)00040-6; Takemiya T, 2006, NEUROSCI RES, V56, P103, DOI 10.1016/j.neures.2006.06.003; Takemiya T, 2011, NEUROCHEM INT, V58, P489, DOI 10.1016/j.neuint.2011.01.003; Takemiya T, 2010, J NEUROSCI RES, V88, P381, DOI 10.1002/jnr.22195; Tang F, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00301; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; van Vliet EA, 2010, NEUROPHARMACOLOGY, V58, P404, DOI 10.1016/j.neuropharm.2009.09.012; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Volk HA, 2004, EPILEPSY RES, V58, P67, DOI 10.1016/j.eplepsyres.2003.12.009; Volk HA, 2005, BRAIN, V128, P1358, DOI 10.1093/brain/awh437; Xu DG, 2008, J PHARMACOL EXP THER, V326, P754, DOI 10.1124/jpet.108.138776; Yucel-Lindberg T, 2006, CELL SIGNAL, V18, P2131, DOI 10.1016/j.cellsig.2006.04.003; Zibell G, 2009, NEUROPHARMACOLOGY, V56, P849, DOI 10.1016/j.neuropharm.2009.01.009	56	12	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13966	13981		10.1096/fj.201901460RR	http://dx.doi.org/10.1096/fj.201901460RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31638830	Green Published, Bronze			2022-12-28	WOS:000507466100070
J	Wang, RZ; Xu, C; Zhong, HJ; Hu, B; Wei, LX; Liu, N; Zhang, YZ; Shi, QH; Wang, C; Qi, M; Gu, YF; Shen, XL; Tian, Y; Liu, Y; Cao, P; Chen, HJ; Yuan, W				Wang, Ruizhe; Xu, Chen; Zhong, Huajian; Hu, Bo; Wei, Leixin; Liu, Ning; Zhang, Yizhi; Shi, Qianghui; Wang, Chen; Qi, Min; Gu, Yifei; Shen, Xiaolong; Tian, Ye; Liu, Yang; Cao, Peng; Chen, Huajiang; Yuan, Wen			Inflammatory-sensitive CHI3L1 protects nucleus pulposus via AKT3 signaling during intervertebral disc degeneration	FASEB JOURNAL			English	Article						AKT3; intervertebral disc degeneration; nucleus pulposus	HUMAN CARTILAGE GP-39; SYNOVIAL-CELLS; YKL-40; EXPRESSION; PROLIFERATION; INHIBITION; IL-1-BETA; APOPTOSIS; RESPONSES; THERAPY	Intervertebral disc degeneration (IDD) is the main cause of low back pain and the mechanism of which is far from fully revealed. Although inflammation directed nucleus pulposus (NP) extracellular matrix metabolism dysregulation is known to be the main cause of the degeneration process, few is known about the protective factors. Using high-throughput label-free proteomics, we found that inflammation-related autocrine factor Chitinase-3-like protein 1 (CHI3L1, or YKL-40) is highly expressed in the NP cells during degeneration. Immunohistochemical analysis show that the expression of CHI3L1 is NP tissue specific, and increase significantly during degeneration. Overexpression of CHI3L1 significantly decrease the catabolism, and increase the anabolism of extracellular matrix. Knockdown of CHI3L1 using siRNAs show the opposite results, which imply that the protective role of CHI3L1 in IDD. Using high-throughput RNA sequencing and functional analyses, we find that AKT3 expression and its phosphorylation is mainly regulated by CHI3L1. And lastly, the mechanism of which is also validated using human and mouse degenerated NP tissues. In summary, our findings show that the inflammation-related autocrine factor CHI3L1 is NP specific, and it protects IDD by promoting the AKT3 signaling, which may serve as a potential therapeutic target in intervertebral disc degeneration.	[Wang, Ruizhe; Xu, Chen; Zhong, Huajian; Hu, Bo; Wei, Leixin; Liu, Ning; Zhang, Yizhi; Shi, Qianghui; Wang, Chen; Qi, Min; Gu, Yifei; Shen, Xiaolong; Tian, Ye; Liu, Yang; Cao, Peng; Chen, Huajiang; Yuan, Wen] Second Mil Med Univ, Changzheng Hosp, Spine Ctr, Dept Orthoped, 415th Feng Yang Rd, Shanghai 200003, Peoples R China	Naval Medical University	Cao, P; Chen, HJ; Yuan, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, Spine Ctr, Dept Orthoped, 415th Feng Yang Rd, Shanghai 200003, Peoples R China.	pinocao@163.com; chen.huajiang@163.com; yuanwenspine@smmu.edu.cn	Xu, Chen/AAQ-5514-2020	Xu, Chen/0000-0001-8068-2109				Bigg HF, 2006, J BIOL CHEM, V281, P21082, DOI 10.1074/jbc.M601153200; Blanquer SBG, 2015, ADV DRUG DELIVER REV, V84, P172, DOI 10.1016/j.addr.2014.10.024; Choi H, 2018, MATRIX BIOL, V70, P102, DOI 10.1016/j.matbio.2018.03.019; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Deutschmann C, 2019, CLIN IMMUNOL, V199, P12, DOI 10.1016/j.clim.2018.12.005; Ebner F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01868; Gullbrand SE, 2017, OSTEOARTHR CARTILAGE, V25, P146, DOI 10.1016/j.joca.2016.08.006; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Hu B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21190; Hu B, 2015, CELL PHYSIOL BIOCHEM, V37, P793, DOI 10.1159/000430396; Huang K, 2009, J INT MED RES, V37, P18, DOI 10.1177/147323000903700102; Ji ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07360-1; JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949; Kao TH, 2014, J NEUROSURG-SPINE, V21, P653, DOI 10.3171/2014.6.SPINE13756; Kognole AA, 2017, J BIOL CHEM, V292, P2624, DOI 10.1074/jbc.M116.764985; Lee CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12752; Lee DH, 2019, MOL THER-NUCL ACIDS, V16, P63, DOI 10.1016/j.omtn.2019.02.007; Li Y, 2016, BIOCHEM BIOPH RES CO, V469, P507, DOI 10.1016/j.bbrc.2015.12.020; Lin HP, 2015, ONCOTARGET, V6, P27097, DOI 10.18632/oncotarget.4553; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; MELCHERS LS, 1994, PLANT J, V5, P469, DOI 10.1046/j.1365-313X.1994.5040469.x; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mo XM, 2016, MOL MED REP, V13, P1961, DOI 10.3892/mmr.2016.4760; Molinos M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1191; Moriya C, 2011, J INVEST DERMATOL, V131, P655, DOI 10.1038/jid.2010.361; Mouser VHM, 2019, J ORTHOP RES, V37, P1110, DOI 10.1002/jor.24268; Nakazawa KR, 2018, SPINE J, V18, P343, DOI 10.1016/j.spinee.2017.09.018; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Pasku D, 2011, EUR SPINE J, V20, P1676, DOI 10.1007/s00586-011-1841-3; Pozzuoli A, 2007, CLIN EXP RHEUMATOL, V25, P453; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Rutges JPHJ, 2008, J PATHOL, V214, P523, DOI 10.1002/path.2317; Sakai D, 2015, ADV DRUG DELIVER REV, V84, P159, DOI 10.1016/j.addr.2014.06.009; Shen JL, 2016, PAIN PHYSICIAN, V19, pE215; Studer RK, 2008, J ORTHOP RES, V26, P991, DOI 10.1002/jor.20604; Sun DD, 2015, J CELL MOL MED, V19, P1296, DOI 10.1111/jcmm.12501; Tang P, 2018, FREE RADICAL BIO MED, V120, P368, DOI 10.1016/j.freeradbiomed.2018.04.008; Tian Y, 2016, MATRIX BIOL, V50, P39, DOI 10.1016/j.matbio.2015.11.008; Wang F, 2016, OSTEOARTHR CARTILAGE, V24, P398, DOI 10.1016/j.joca.2015.09.019; Wu XH, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2016.107; Zhang MM, 2015, APOPTOSIS, V20, P1150, DOI 10.1007/s10495-015-1148-7; Zhang Y, 2018, MATRIX BIOL, V70, P123, DOI 10.1016/j.matbio.2018.03.024; Zhou Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007096	47	8	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3554	3569		10.1096/fj.201902096R	http://dx.doi.org/10.1096/fj.201902096R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31997395	hybrid			2022-12-28	WOS:000519218400009
J	Carmona, R; Barrena, S; Gambero, AJL; Rojas, A; Munoz-Chapuli, R				Carmona, Rita; Barrena, Silvia; Lopez Gambero, Antonio Jesus; Rojas, Anabel; Munoz-Chapuli, Ramon			Epicardial cell lineages and the origin of the coronary endothelium	FASEB JOURNAL			English	Article						cardiac development; cell tracing; coronary endothelium; epicardium; Wilms' tumor suppressor gene	LYMPHATIC VASCULATURE; LATERAL MESODERM; PROGENITOR CELLS; WT1 EXPRESSION; SINUS VENOSUS; CONTRIBUTE; ARTERIES; ADULT; FORM; ANGIOGENESIS	The embryonic epicardium generates a population of epicardial-derived mesenchymal cells (EPDC) whose contribution to the coronary endothelium is minor or, according to some reports, negligible. We have compared four murine cell-tracing models related to the EPDC in order to elucidate this contribution. Cre recombinase was expressed under control of the promoters of the Wilms' tumor suppressor (Wt1), the cardiac troponin (cTnT), and the GATA5 genes, activating expression of the R26R(EYFP) reporter. We have also used the G2 enhancer of the GATA4 gene as a driver due to its activation in the proepicardium. Recombination was found in most of the epicardium/EPDC in all cases. The contribution of these lineages to the cardiac endothelium was analyzed using confocal microscopy and flow cytometry. G2-GATA4 lineage cells are the most frequent in the endothelium, probably due to the recruitment of circulating endothelial progenitors. The contribution of the WT1 cell lineage increases along gestation due to further endothelial expression of WT1. GATA5 and cTnT lineages represent 4% of the cardiac endothelial cells throughout the gestation, probably standing for the actual EPDC contribution to the coronary endothelium. These results suggest caution when using a sole cell-tracing model to study the fate of the EPDC.	[Carmona, Rita; Barrena, Silvia; Lopez Gambero, Antonio Jesus; Munoz-Chapuli, Ramon] Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain; [Carmona, Rita; Barrena, Silvia; Lopez Gambero, Antonio Jesus; Munoz-Chapuli, Ramon] Andalusian Ctr Nanomed & Biotechnol BIONAND, Malaga, Spain; [Carmona, Rita; Barrena, Silvia; Lopez Gambero, Antonio Jesus; Munoz-Chapuli, Ramon] Inst Biomed Res Malaga IBIMA, Malaga, Spain; [Rojas, Anabel] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Rojas, Anabel] Ctr Biomed Res Diabet & Associated Metab Disorder, Seville, Spain; [Lopez Gambero, Antonio Jesus] Reg Hosp Malaga, Inst Biomed Res Malaga IBIMA, Malaga, Spain	Universidad de Malaga; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Universidad de Malaga	Munoz-Chapuli, R (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain.	chapuli@uma.es		Lopez Gambero, Antonio Jesus/0000-0001-7716-9056; Barrena Garcia, Silvia/0000-0002-0859-3969	Spanish Ministry of Science, Innovation and Universities [BFU201783907-P, BFU2017-82497-P]; Instituto de Salud Carlos III-TERCEL network [RD16/0011/0034, RD16/0011/0030]; Consejeria de Salud, Junta de Andalucia [PC00662017]; Instituto de Salud Carlos III [IFI18/00042]	Spanish Ministry of Science, Innovation and Universities; Instituto de Salud Carlos III-TERCEL network; Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Spanish Ministry of Science, Innovation and Universities under grants BFU201783907-P and BFU2017-82497-P; Instituto de Salud Carlos III-TERCEL network under grant RD16/0011/0034 and RD16/0011/0030; and Consejeria de Salud, Junta de Andalucia under grant PC00662017. AJLG is the recipient of a i-PFIS contract from Instituto de Salud Carlos III (IFI18/00042)	Bani D, 2010, J CELL MOL MED, V14, P2531, DOI 10.1111/j.1582-4934.2010.01119.x; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Canete A, 2017, HAEMATOLOGICA, V102, P647, DOI 10.3324/haematol.2016.155812; Cano E, 2016, P NATL ACAD SCI USA, V113, P656, DOI 10.1073/pnas.1509834113; Cano E, 2013, AM J PHYSIOL-LUNG C, V305, pL322, DOI 10.1152/ajplung.00424.2012; Casanova JC, 2013, GENESIS, V51, P32, DOI 10.1002/dvg.22353; Chen HI, 2014, DEVELOPMENT, V141, P4500, DOI 10.1242/dev.113639; Cossette S, 2011, DEV DYNAM, V240, P2344, DOI 10.1002/dvdy.22724; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; Delgado I, 2014, HEPATOLOGY, V59, P2358, DOI 10.1002/hep.27005; Duim SN, 2015, J MOL CELL CARDIOL, V81, P127, DOI 10.1016/j.yjmcc.2015.02.007; Eley L, 2018, ELIFE, V7, DOI 10.7554/eLife.34110; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Ikeda N, 2017, BIOMED RES-TOKYO, V38, P228; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Kamimura T, 2018, DEV GROWTH DIFFER, V60, P97, DOI 10.1111/dgd.12422; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Lee WS, 1998, CIRC RES, V82, P845; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mifflin JJ, 2018, DEV DYNAM, V247, P1005, DOI [10.1002/DVDY.24641, 10.1002/dvdy.24641]; Norman S, 2016, CLIN ANAT, V29, P305, DOI 10.1002/ca.22638; Palmquist-Gomes P, 2018, DEV DYNAM, V247, P686, DOI 10.1002/dvdy.24610; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Plein A, 2018, NATURE, V562, P223, DOI 10.1038/s41586-018-0552-x; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; Sharma B, 2017, ANNU REV PHYSIOL, V79, P1, DOI 10.1146/annurev-physiol-022516-033953; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Wood HB, 1997, BLOOD, V90, P2300; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Yin YJ, 2004, ARTERIOSCL THROM VAS, V24, P691, DOI 10.1161/01.ATV.0000120375.51196.73; Zhang H, 2016, CIRC RES, V118, P1880, DOI 10.1161/CIRCRESAHA.116.308749; Zhao WN, 2016, METABOLISM, V65, P1755, DOI 10.1016/j.metabol.2016.09.007	39	10	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5223	5239		10.1096/fj.201902249RR	http://dx.doi.org/10.1096/fj.201902249RR		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32068311				2022-12-28	WOS:000515253600001
J	Gupta, G; Gliga, A; Hedberg, J; Serra, A; Greco, D; Wallinder, IO; Fadeel, B				Gupta, Govind; Gliga, Anda; Hedberg, Jonas; Serra, Angela; Greco, Dario; Odnevall Wallinder, Inger; Fadeel, Bengt			Cobalt nanoparticles trigger ferroptosis-like cell death (oxytosis) in neuronal cells: Potential implications for neurodegenerative disease	FASEB JOURNAL			English	Article						cobalt; ferroptosis; hard metal; nanoparticles; neurodegeneration; oxytosis	OXIDATIVE STRESS; INDUCED CYTOTOXICITY; TOXICITY; GLUTATHIONE; MECHANISM; HEALTH; METAL; PARTICLES; BIOLOGY; FORM	The neurotoxicity of hard metal-based nanoparticles (NPs) remains poorly understood. Here, we deployed the human neuroblastoma cell line SH-SY5Y differentiated or not into dopaminergic- and cholinergic-like neurons to study the impact of tungsten carbide (WC) NPs, WC NPs sintered with cobalt (Co), or Co NPs versus soluble CoCl2. Co NPs and Co salt triggered a dose-dependent cytotoxicity with an increase in cytosolic calcium, lipid peroxidation, and depletion of glutathione (GSH). Co NPs and Co salt also suppressed glutathione peroxidase 4 (GPX4) mRNA and protein expression. Co-exposed cells were rescued by N-acetylcysteine (NAC), a precursor of GSH, and partially by liproxstatin-1, an inhibitor of lipid peroxidation. Furthermore, in silico analyses predicted a significant correlation, based on similarities in gene expression profiles, between Co-containing NPs and Parkinson's disease, and changes in the expression of selected genes were validated by RT-PCR. Finally, experiments using primary human dopaminergic neurons demonstrated cytotoxicity and GSH depletion in response to Co NPs and CoCl2 with loss of axonal integrity. Overall, these data point to a marked neurotoxic potential of Co-based but not WC NPs and show that neuronal cell death may occur through a ferroptosis-like mechanism.	[Gupta, Govind; Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Unit Mol Toxicol, Nobels Vag 13, S-17177 Stockholm, Sweden; [Gliga, Anda] Karolinska Inst, Inst Environm Med, Unit Met & Hlth, Stockholm, Sweden; [Hedberg, Jonas; Odnevall Wallinder, Inger] Royal Inst Technol, Div Surface & Corros Sci, Dept Chem, Stockholm, Sweden; [Serra, Angela; Greco, Dario] Univ Tampere, Inst Biosci & Med Technol, Tampere, Finland; [Serra, Angela; Greco, Dario] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology; Tampere University; University of Helsinki	Fadeel, B (corresponding author), Karolinska Inst, Inst Environm Med, Unit Mol Toxicol, Nobels Vag 13, S-17177 Stockholm, Sweden.	bengt.fadeel@ki.se	Gupta, Govind/AAU-5965-2020; Wallinder, Inger Odnevall/Q-6875-2017	Greco, Dario/0000-0001-9195-9003; Odnevall, Inger/0000-0003-2206-0082; Gupta, Govind/0000-0003-4703-418X	Swedish Foundation for Strategic Environmental Research	Swedish Foundation for Strategic Environmental Research(Swedish Foundation for Strategic Research)	Swedish Foundation for Strategic Environmental Research	Abdalkader M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00466; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Bastian S, 2009, ENVIRON HEALTH PERSP, V117, P530, DOI 10.1289/ehp.0800121; Bhattacharya K, 2017, NANOTOXICOLOGY, V11, P809, DOI 10.1080/17435390.2017.1363309; Cao JY, 2019, CELL REP, V26, P1544, DOI 10.1016/j.celrep.2019.01.043; Catalani S, 2012, HUM EXP TOXICOL, V31, P421, DOI 10.1177/0960327111414280; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Di Bucchianico S, 2018, PART FIBRE TOXICOL, V15, DOI 10.1186/s12989-018-0268-y; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Estey MMP, 2013, CLIN CHEM, V59, P880, DOI 10.1373/clinchem.2012.193037; Fenoglio I, 2008, FREE RADICAL RES, V42, P737, DOI 10.1080/10715760802350904; Furberg A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081774; Gallud A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40579-6; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; Hedberg YS, 2017, ENVIRON POLLUT, V224, P275, DOI 10.1016/j.envpol.2017.02.006; Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI [10.1080/10408440701845534, 10.1080/10408440701845534 ]; Kloditz K, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0146-x; Kong LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068414; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Lewerenz J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00214; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Leyssens L, 2017, TOXICOLOGY, V387, P43, DOI 10.1016/j.tox.2017.05.015; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; LISON D, 1992, TOXICOL LETT, V60, P203, DOI 10.1016/0378-4274(92)90275-O; LISON D, 1995, CHEM RES TOXICOL, V8, P600, DOI 10.1021/tx00046a015; Lison D, 1996, CRIT REV TOXICOL, V26, P585, DOI 10.3109/10408449609037478; LISON D, 1990, ENVIRON RES, V52, P187, DOI 10.1016/S0013-9351(05)80253-1; LISON D, 1994, ARCH TOXICOL, V68, P528, DOI 10.1007/s002040050108; Lison D, 2015, HANDBOOK ON THE TOXICOLOGY OF METALS, VOL I & II, 4TH EDITION, P743, DOI 10.1016/B978-0-444-59453-2.00034-2; LLOBET JM, 1986, ARCH TOXICOL, V58, P278, DOI 10.1007/BF00297121; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Neitemeier S, 2017, REDOX BIOL, V12, P558, DOI 10.1016/j.redox.2017.03.007; Nyga A, 2015, NANOTOXICOLOGY, V9, P905, DOI 10.3109/17435390.2014.991430; Onate M, 2020, CELL DEATH DIFFER, V27, P1169, DOI 10.1038/s41418-019-0408-4; Paustenbach DJ, 2013, CRIT REV TOXICOL, V43, P316, DOI 10.3109/10408444.2013.779633; Rizzetti MC, 2009, LANCET, V373, P1052, DOI 10.1016/S0140-6736(09)60490-6; ROY S, 1969, J PATHOL, V99, P39, DOI 10.1002/path.1710990106; Scharf B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05729; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Serra A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37411-y; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tan SL, 1998, J NEUROCHEM, V71, P95; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; Woelber Erik, 2016, JBJS Case Connect, V6, pe45, DOI 10.2106/JBJS.CC.15.00063; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029; Zheng FL, 2019, TOXICOL APPL PHARM, V369, P90, DOI 10.1016/j.taap.2019.03.003; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028	50	26	26	7	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5262	5281		10.1096/fj.201902191RR	http://dx.doi.org/10.1096/fj.201902191RR		FEB 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32060981	Green Published			2022-12-28	WOS:000515245900001
J	Cordaro, M; Scuto, M; Siracusa, R; D'amico, R; Peritore, AF; Gugliandolo, E; Fusco, R; Crupi, R; Impellizzeri, D; Pozzebon, M; Alfonsi, D; Mattei, N; Marcolongo, G; Evangelista, M; Cuzzocrea, S; Di Paola, R				Cordaro, Marika; Scuto, Maria; Siracusa, Rosalba; D'amico, Ramona; Peritore, Alessio Filippo; Gugliandolo, Enrico; Fusco, Roberta; Crupi, Rosalia; Impellizzeri, Daniela; Pozzebon, Michele; Alfonsi, Daniele; Mattei, Nicolo; Marcolongo, Gabriele; Evangelista, Maurizio; Cuzzocrea, Salvatore; Di Paola, Rosanna			Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease	FASEB JOURNAL			English	Article						comorbidity; DSS; gut-brain-axis; N-palmitoylethanolamine-oxazoline	DEXTRAN SULFATE SODIUM; INDUCED COLITIS; MAST-CELLS; GASTROINTESTINAL TRANSIT; ULCERATIVE-COLITIS; TIGHT JUNCTION; RAT MODEL; BRAIN; GUT; STRESS	Inflammatory bowel disease (IBD) is a chronic disorder characterized by inflammation of the gastrointestinal (GI) tract, and it is associated with different neurological disorders. Recent evidence has demonstrated that the gut-brain-axis has a central function in the perpetuation of IBS, and for this reason, it can be considered a possible therapeutic target. N-Palmitoylethanolamine-oxazoline (PEA-OXA) possesses anti-inflammatory and potent neuroprotective effects. Although recent studies have explained the neuroprotective properties of PEA-OXA, nothing is known about its effects on the gut-brain axis during colitis. The aim of this study is to explore the mechanism and the effect of PEA-OXA on the gut-brain axis in rats subjected to experimental colitis induced by intracolonic administration of dextran sulfate sodium (DSS). Daily oral administration of PEA-OXA (10 mg/kg daily o.s.) was able to decrease the body weight loss, macroscopic damage, colon length, histological alteration, and inflammation after DSS induction. Additionally, PEA-OXA administration enhanced neurotrophic growth factor release and decreased the astroglial and microglial activation induced by DSS. Moreover, PEA-OXA restored intestinal permeability and tight junctions (TJs) as well as reduced apoptosis in the colon and brain. In our work, we demonstrated, for the first time, the action of PEA-OXA on the gut-brain axis in a model of DSS-induced colitis and its implication on the "secondary" effects associated with colonic disturbance.	[Cordaro, Marika; Siracusa, Rosalba; D'amico, Ramona; Peritore, Alessio Filippo; Gugliandolo, Enrico; Fusco, Roberta; Crupi, Rosalia; Impellizzeri, Daniela; Cuzzocrea, Salvatore; Di Paola, Rosanna] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy; [Scuto, Maria] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Pozzebon, Michele] dtoLABS Srl Analyt Excellence Ctr, Resana, Italy; [Alfonsi, Daniele; Mattei, Nicolo; Marcolongo, Gabriele] Epitech Grp SpA, Milan, Italy; [Evangelista, Maurizio] Univ Cattolica Sacro Cuore, Inst Anaesthesiol & Reanimat, Rome, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; University of Catania; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Saint Louis University	Cuzzocrea, S; Di Paola, R (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	salvator@unime.it; dipaolar@unime.it	Peritore, Alessio/HGB-1327-2022; Siracusa, Rosalba/AAC-3110-2022; Gugliandolo, Enrico/AAB-9972-2019; evangelista, maurizio/G-6820-2012; FUSCO, Roberta/AAC-1745-2019; Cordaro, Marika/K-7329-2016; di paola, rosanna/U-4356-2019; D'Amico, Ramona/AAC-9061-2019	Siracusa, Rosalba/0000-0001-7868-2505; Gugliandolo, Enrico/0000-0001-6840-3154; FUSCO, Roberta/0000-0003-0223-1403; Cordaro, Marika/0000-0002-3980-0043; di paola, rosanna/0000-0001-6725-8581; Crupi, Rosalia/0000-0002-7629-3132; D'Amico, Ramona/0000-0003-0389-3871; Impellizzeri, Daniela/0000-0001-9492-3161; peritore, alessio filippo/0000-0001-8545-990X				Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Balaha M, 2016, LIFE SCI, V146, P40, DOI 10.1016/j.lfs.2016.01.012; Bassotti G, 2014, WORLD J GASTROENTERO, V20, P37, DOI 10.3748/wjg.v20.i1.37; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; BJARNASON I, 1994, GUT, V35, pS18, DOI 10.1136/gut.35.1_Suppl.S18; Cordaro M, 2018, MOL NEUROBIOL, V55, P9251, DOI 10.1007/s12035-018-1064-2; Cordaro M, 2016, MOL PHARMACOL, V90, P549, DOI 10.1124/mol.116.105668; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Dalziel JE, 2017, AM J PHYSIOL-GASTR L, V313, pG62, DOI 10.1152/ajpgi.00008.2017; Dalziel JE, 2016, NEUROGASTROENT MOTIL, V28, P1241, DOI 10.1111/nmo.12824; Dalziel JE, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121351; De Winter BY, 2012, BBA-MOL BASIS DIS, V1822, P66, DOI 10.1016/j.bbadis.2011.03.016; Do J, 2018, CLIN PSYCHOPHARM NEU, V16, P422, DOI 10.9758/cpn.2018.16.4.422; Elsheikh W, 2012, J PHYSIOL PHARMACOL, V63, P463; Emge JR, 2016, AM J PHYSIOL-GASTR L, V310, pG989, DOI 10.1152/ajpgi.00086.2016; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Goodhand JR, 2012, INFLAMM BOWEL DIS, V18, P2301, DOI 10.1002/ibd.22916; Gugliandolo E, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1303-5; Halpin SJ, 2012, AM J GASTROENTEROL, V107, P1474, DOI 10.1038/ajg.2012.260; Han Y, 2018, NEUROSCI BULL, V34, P1058, DOI 10.1007/s12264-018-0288-5; Hathaway CA, 1999, AM J PHYSIOL-GASTR L, V276, pG1174, DOI 10.1152/ajpgi.1999.276.5.G1174; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Iba Y, 2003, INT IMMUNOPHARMACOL, V3, P485, DOI 10.1016/S1567-5769(02)00299-0; Impellizzeri D, 2019, NEUROBIOL DIS, V125, P77, DOI 10.1016/j.nbd.2019.01.007; Impellizzeri D, 2017, J NEUROTRAUM, V34, P2609, DOI 10.1089/neu.2016.4808; Impellizzeri D, 2016, PHARMACOL RES, V108, P23, DOI 10.1016/j.phrs.2016.04.007; Jain P, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00177; Khan Waliul I, 2013, Gastroenterol Hepatol (N Y), V9, P259; Kim MW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072025; Kim YR, 2017, J CELL MOL MED, V21, P3565, DOI 10.1111/jcmm.13267; Kishimoto Y, 2019, NEUROMOL MED, V21, P239, DOI 10.1007/s12017-019-08539-5; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li YH, 2018, INT IMMUNOPHARMACOL, V60, P194, DOI 10.1016/j.intimp.2018.05.001; Liu JT., 2015, NEUROL-NEUROIMMUNOL, V2, P131, DOI DOI 10.4103/2347-8659.156980; Mawdsley JE, 2006, NEUROIMMUNOMODULAT, V13, P327, DOI 10.1159/000104861; Painsipp E, 2011, BRIT J PHARMACOL, V163, P1302, DOI 10.1111/j.1476-5381.2011.01326.x; Park Yo Han, 2015, J Cancer Prev, V20, P260, DOI 10.15430/JCP.2015.20.4.260; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Petrosino S, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00308; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Sanchez-Fidalgo S, 2015, MOL NUTR FOOD RES, V59, P284, DOI 10.1002/mnfr.201400518; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Shalev Hadar, 2009, Cardiovasc Psychiatry Neurol, V2009, P278531, DOI 10.1155/2009/278531; Taniguchi T, 1998, J GASTROEN HEPATOL, V13, P945, DOI 10.1111/j.1440-1746.1998.tb00766.x; Tyagi A, 2012, BRIT J NUTR, V108, P1612, DOI 10.1017/S0007114511007197; Vidal A, 2008, INFLAMM BOWEL DIS, V14, P977, DOI 10.1002/ibd.20388; Villaran RF, 2010, J NEUROCHEM, V114, P1687, DOI 10.1111/j.1471-4159.2010.06879.x; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wan MX, 2002, BRIT J PHARMACOL, V135, P1749, DOI 10.1038/sj.bjp.0704638; Wei L, 2018, NEUROMOL MED, V20, P252, DOI 10.1007/s12017-018-8489-7; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Xia XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027282; Zhao L, 2017, MOLECULES, V22, DOI 10.3390/molecules22071218; Zhao Q, 2018, INFLAMM RES, V67, P663, DOI 10.1007/s00011-018-1155-6; Zhong F, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00776; Zhu CH, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0252-y; Zhu CZ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00442	61	15	15	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4085	4106		10.1096/fj.201901584RR	http://dx.doi.org/10.1096/fj.201901584RR		JAN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31950563	Bronze			2022-12-28	WOS:000507916300001
J	Park, EJ; Jung, HJ; Choi, HJ; Jang, HJ; Park, HJ; Nejsum, LN; Kwon, TH				Park, Eui-Jung; Jung, Hyun Jun; Choi, Hyo-Jung; Jang, Hyo-Ju; Park, Hye-Jeong; Nejsum, Lene N.; Kwon, Tae-Hwan			Exosomes co-expressing AQP5-targeting miRNAs and IL-4 receptor-binding peptide inhibit the migration of human breast cancer cells	FASEB JOURNAL			English	Article						aquaporin-5; breast cancer; cell migration; exosome; miRNA	INTERLEUKIN-4 RECEPTOR; TARGETED DELIVERY; AQUAPORIN-5; KIDNEY; SUPPRESSION; BIOGENESIS; SURVIVAL; GROWTH; SIRNA; AQP5	Aquaporin-5 (AQP5) plays a role in breast cancer cell migration. This study aimed to identify AQP5-targeting miRNAs and examine their effects on breast cancer cell migration through exosome-mediated delivery. Bioinformatic analyses identified miR-1226-3p, miR-19a-3p, and miR-19b-3p as putative regulators of AQP5 mRNA. Immunoblotting revealed a decrease of AQP5 protein abundance when each of these miRNAs was transfected into human breast cancer MDA-MB-231 cells. Quantitative real-time PCR demonstrated the reduction of AQP5 mRNA expression by the transfection of miR-1226-3p and a luciferase reporter assay revealed the reduction of AQP5 translation after the transfection of miR-19b-3p in MDA-MB-231 cells. Consistently, the transfection of each miRNA impeded cell migration. Pathway enrichment analyses showed that these three miRNAs regulate target genes, which were predominantly enriched in the gap junction pathway. For the efficient delivery of AQP5-targeting miRNAs to breast cancer cells, exosomes expressing both miRNAs and a peptide targeting interleukin-4 receptor, which is highly expressed in breast cancer cells, were bioengineered and their inhibitory effects on AQP5 protein expression and cell migration were demonstrated in MDA-MB-231 cells. Taken together, AQP5-regulating miRNAs are identified, which could be exploited for the inhibition of breast cancer cell migration via the exosome-mediated delivery.	[Park, Eui-Jung; Choi, Hyo-Jung; Jang, Hyo-Ju; Park, Hye-Jeong; Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Dongin Dong 101, Taegu 41944, South Korea; [Park, Eui-Jung; Jang, Hyo-Ju; Park, Hye-Jeong; Kwon, Tae-Hwan] Kyungpook Natl Univ, BK21 Plus KNU Biomed Convergence Program, Dept Biomed Sci, Sch Med, Taegu, South Korea; [Jung, Hyun Jun] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Nejsum, Lene N.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark	Kyungpook National University; Kyungpook National University; Johns Hopkins University; Aarhus University	Kwon, TH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Dongin Dong 101, Taegu 41944, South Korea.	thkwon@knu.ac.kr	Kwon, Tae-Hwan/ABA-1981-2020	Nejsum, Lene Niemann/0000-0003-4368-8821; Jung, Hyun Jun/0000-0003-0519-5858	National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology, Korea [2014R1A5A2009242, 2017R1D1A3B03036044]	National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology, Korea	This study was supported by the grant from the National Research Foundation of Korea (NRF), which is funded by the Ministry of Science, Information and Communication Technology, Korea (2014R1A5A2009242 and 2017R1D1A3B03036044).	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Benovic JL, 2004, CANCER CELL, V6, P429, DOI 10.1016/j.ccr.2004.10.017; Burt BM, 2012, CLIN CANCER RES, V18, P1568, DOI 10.1158/1078-0432.CCR-11-1808; Conlan RS, 2017, TRENDS MOL MED, V23, P636, DOI 10.1016/j.molmed.2017.05.003; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Delporte Christine, 2009, Handb Exp Pharmacol, P185, DOI 10.1007/978-3-540-79885-9_9; Donnarumma E, 2017, ONCOTARGET, V8, P19592, DOI 10.18632/oncotarget.14752; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Eitan E, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26373; Garcia-Manrique P, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2017.1422676; Guruprasath P, 2017, BIOMATERIALS, V142, P101, DOI 10.1016/j.biomaterials.2017.07.024; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jensen HH, 2017, BIOCHEM BIOPH RES CO, V493, P1210, DOI 10.1016/j.bbrc.2017.09.125; Jensen HH, 2016, INT J BIOCHEM CELL B, V79, P271, DOI 10.1016/j.biocel.2016.09.005; Jiang BF, 2014, J GASTROENTEROL, V49, P1011, DOI 10.1007/s00535-013-0851-9; Jin CN, 2010, INT J ONCOL, V37, P61, DOI 10.3892/ijo_00000653; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kang SK, 2008, AM J PATHOL, V173, P518, DOI 10.2353/ajpath.2008.071198; Kawakami K, 2002, CANCER RES, V62, P3575; Kawakami M, 2002, CLIN CANCER RES, V8, P3503; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kim JE, 2015, AM J PHYSIOL-RENAL, V308, pF749, DOI 10.1152/ajprenal.00334.2014; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kooijmans SAA, 2012, INT J NANOMED, V7, P1525, DOI 10.2147/IJN.S29661; Kowal EJK, 2017, METHODS MOL BIOL, V1660, P143, DOI 10.1007/978-1-4939-7253-1_12; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lee SJ, 2014, ANN SURG ONCOL, V21, P375, DOI 10.1245/s10434-013-3317-7; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu Y, 2016, CANCER LETT, V370, P125, DOI 10.1016/j.canlet.2015.10.011; Login FH, 2019, FASEB J, V33, P6980, DOI 10.1096/fj.201802068RR; Marlar S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102106; McKelvey Kelly J, 2015, J Circ Biomark, V4, P7, DOI 10.5772/61186; Meldolesi J, 2018, CURR BIOL, V28, pR435, DOI 10.1016/j.cub.2018.01.059; Momen-Heravi F, 2014, NANOMED-NANOTECHNOL, V10, P1517, DOI 10.1016/j.nano.2014.03.014; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; OBIRI NI, 1994, CLIN EXP IMMUNOL, V95, P148; OBIRI NI, 1993, J CLIN INVEST, V91, P88, DOI 10.1172/JCI116205; Oh SH, 2019, FASEB J, V33, P7301, DOI 10.1096/fj.201802415RR; Ohno S, 2016, METHODS MOL BIOL, V1448, P261, DOI 10.1007/978-1-4939-3753-0_19; Oklinski MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122050; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Park EJ, 2018, AM J PHYSIOL-RENAL, V314, pF329, DOI 10.1152/ajprenal.00358.2017; Promeneur D, 2000, AM J PHYSIOL-RENAL, V279, pF370, DOI 10.1152/ajprenal.2000.279.2.F370; Ribatti D, 2014, BBA-GEN SUBJECTS, V1840, P1550, DOI 10.1016/j.bbagen.2013.09.025; Rodriguez GV, 2017, CANCER IMMUNOL RES, V5, P234, DOI 10.1158/2326-6066.CIR-16-0150; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shahabipour F, 2017, J CELL PHYSIOL, V232, P1660, DOI 10.1002/jcp.25766; Skandalis SS, 2014, MATRIX BIOL, V35, P182, DOI 10.1016/j.matbio.2013.09.002; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Thomson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055214; Vadevoo MP, 2017, MOL CANCER THER, V16, P2803, DOI 10.1158/1535-7163.MCT-17-0339; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang H, 2016, ONCOL REP, V36, P2079, DOI 10.3892/or.2016.5029; Yin RT, 2018, INT J BIOCHEM CELL B, V97, P43, DOI 10.1016/j.biocel.2018.02.005; Yu G, 2013, MOL CELL BIOCHEM, V380, P239, DOI 10.1007/s11010-013-1679-6; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30; Zhu ZC, 2018, ONCOL LETT, V16, P2661, DOI 10.3892/ol.2018.8955	63	27	27	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3379	3398		10.1096/fj.201902434R	http://dx.doi.org/10.1096/fj.201902434R		JAN 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31922312				2022-12-28	WOS:000506612000001
J	Kim, JH; Ahn, JB; Kim, DH; Kim, S; Ma, HW; Che, X; Seo, DH; Kim, TI; Kim, WH; Cheon, JH; Kim, SW				Kim, Jae Hyeon; Ahn, Jae Bum; Kim, Da Hye; Kim, Soochan; Ma, Hyun Woo; Che, Xiumei; Seo, Dong Hyuk; Kim, Tae Il; Kim, Won Ho; Cheon, Jae Hee; Kim, Seung Won			Glutathione S-transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22	FASEB JOURNAL			English	Article						dimerization; glutathione S-transferase theta 1; goblet cell; inflammatory bowel disease; interleukin 22	INFLAMMATORY-BOWEL-DISEASE; OXIDATIVE STRESS; NULL GENOTYPE; GSTT1; POLYMORPHISMS; METAANALYSIS; HOMEOSTASIS; GSTM1; STAT3; SUSCEPTIBILITY	The enzyme glutathione S-transferase theta 1 (GSTT1) is involved in detoxifying chemicals, including reactive oxygen species (ROS). Here, we provide a significant insight into the role of GSTT1 in inflammatory bowel disease (IBD). We identified decreased expression of GSTT1 in inflamed colons from IBD patients compared to controls. We intrarectally or intraperitoneally delivered Gstt1 gene to mice with dextran sodium sulfate (DSS)-induced colitis and noted attenuation of colitis through gene transfer of Gstt1 via an IL-22 dependent pathway. Downregulation of GSTT1 by pathogen-associated molecular patterns (PAMPs) of microbes reduced innate defense responses and goblet cell differentiation. The GSTT1 mutation in intestinal epithelial cells (IECs) and IBD patients decreased its dimerization, which was connected to insufficient phosphorylation of signal transducer and activator of transcription-3 and p38/mitogen-activated protein kinase by their common activator, IL-22. GSTT1 ameliorated colitis and contributed as a modulator of goblet cells through sensing pathogens and host immune responses. Its mutations are linked to chronic intestinal inflammation due to its insufficient dimerization. Our results provide new insights into GSTT1 mutations that are linked to chronic intestinal inflammation due to its insufficient dimerization and their functional consequences in IBDs.	[Kim, Jae Hyeon; Kim, Da Hye; Kim, Soochan; Ma, Hyun Woo; Che, Xiumei; Seo, Dong Hyuk; Kim, Tae Il; Kim, Won Ho; Cheon, Jae Hee; Kim, Seung Won] Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Kim, Jae Hyeon; Kim, Da Hye; Kim, Soochan; Ma, Hyun Woo; Che, Xiumei; Seo, Dong Hyuk; Kim, Tae Il; Kim, Won Ho; Cheon, Jae Hee; Kim, Seung Won] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Kim, Jae Hyeon; Ma, Hyun Woo; Che, Xiumei; Seo, Dong Hyuk; Cheon, Jae Hee; Kim, Seung Won] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Ahn, Jae Bum] Yonsei Univ, Coll Med, Dept Med, Seoul, South Korea; [Cheon, Jae Hee; Kim, Seung Won] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cheon, JH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Kim, SW (corresponding author), Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea.	GENIUSHEE@yuhs.ac; swk21c@hanmail.net	Cheon, Jae Hee/B-4523-2015	Cheon, Jae Hee/0000-0002-2282-8904; Kim, Seung Won/0000-0002-1692-1192; Kim, Soochan/0000-0002-2577-2969; Kim, Won Ho/0000-0002-5682-9972; Kim, Tae Il/0000-0003-4807-890X; KIM, JAEHYEON/0000-0003-0064-6656	Ministry of Sicence, ICT, amp; Future Planning [NRF-2014R1A1A1008096, NRF-2017R1A1A1A05001011]; Korean government (MSIP) [NRF-2017R1A2B4001848]	Ministry of Sicence, ICT, amp; Future Planning; Korean government (MSIP)	The Ministry of Sicence, ICT, & Future Planning, Grant/Award Number: NRF-2014R1A1A1008096 and NRF-2017R1A1A1A05001011; the Korean government (MSIP), Grant/Award Number: NRF-2017R1A2B4001848	Ardesjo B, 2008, J AUTOIMMUN, V30, P273, DOI 10.1016/j.jaut.2007.11.008; ARNOLD JW, 1993, CELL IMMUNOL, V151, P336, DOI 10.1006/cimm.1993.1243; Aviello G, 2017, BRIT J PHARMACOL, V174, P1704, DOI 10.1111/bph.13428; Booth C., 2002, CULTURE EPITHELIAL C, P303, DOI DOI 10.1002/0471221201.CH10; Boutouja F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010018; Broekman MMTJ, 2014, J HUM GENET, V59, P575, DOI 10.1038/jhg.2014.77; BURDON RH, 1989, FREE RADICAL RES COM, V7, P149, DOI 10.3109/10715768909087937; Butturini E, 2014, ACS CHEM BIOL, V9, P1885, DOI 10.1021/cb500407d; Butturini E, 2013, FREE RADICAL BIO MED, V65, P1322, DOI 10.1016/j.freeradbiomed.2013.09.015; Cobo ER, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00905-16; Deakin M, 1996, CARCINOGENESIS, V17, P881, DOI 10.1093/carcin/17.4.881; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Ebert MN, 2001, NUTR CANCER, V41, P156, DOI 10.1207/S15327914NC41-1&amp;2_22; Friedrich M, 2019, IMMUNITY, V50, P992, DOI 10.1016/j.immuni.2019.03.017; Garama DJ, 2015, MOL CELL BIOL, V35, P3646, DOI 10.1128/MCB.00541-15; Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hu SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159758; Ito M, 2011, AGING-US, V3, P1213, DOI 10.18632/aging.100418; Juronen E, 1996, BIOCHEM MOL BIOL INT, V39, P21; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; King SJ, 2019, INTEST RES, V17, P177, DOI 10.5217/ir.2018.00170; Liang SQ, 2013, RESPIROLOGY, V18, P774, DOI 10.1111/resp.12097; Luo Z, 2019, AM J PHYSIOL-CELL PH, V316, pC198, DOI 10.1152/ajpcell.00256.2018; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marcos M, 2011, ALIMENT PHARM THER, V34, P1159, DOI 10.1111/j.1365-2036.2011.04862.x; Masoodi TA, 2012, GENOMICS, V99, P330, DOI 10.1016/j.ygeno.2012.04.006; Menon D, 2014, FREE RADICAL BIO MED, V73, P318, DOI 10.1016/j.freeradbiomed.2014.05.020; Miner-Williams WM, 2016, NUTR RES REV, V29, P40, DOI 10.1017/S0954422416000019; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Qian J, 2017, CELL PHYSIOL BIOCHEM, V41, P2545, DOI 10.1159/000475978; Ren HT, 2018, J SURG RES, V222, P39, DOI 10.1016/j.jss.2017.09.041; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; Sovran B, 2015, INFLAMM BOWEL DIS, V21, P531, DOI 10.1097/MIB.0000000000000319; Turner JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003698; Wang LR, 2016, CELL HOST MICROBE, V19, P227, DOI 10.1016/j.chom.2016.01.003; Wells JM, 2017, AM J PHYSIOL-GASTR L, V312, pG171, DOI 10.1152/ajpgi.00048.2015; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089302; Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087749, 10.1371/journal.pone.0100677, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.588	51	9	9	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3289	3304		10.1096/fj.201902421R	http://dx.doi.org/10.1096/fj.201902421R		JAN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916636				2022-12-28	WOS:000506442800001
J	Liang, S; Fuchs, S; Mymrikov, EV; Stulz, A; Kaiser, M; Heerklotz, H; Hunte, C				Liang, Shuo; Fuchs, Simon; Mymrikov, Evgeny V.; Stulz, Anja; Kaiser, Michael; Heerklotz, Heiko; Hunte, Carola			Calcium affects CHP1 and CHP2 conformation and their interaction with sodium/proton exchanger 1	FASEB JOURNAL			English	Article						calcineurin B homologous proteins; Ca2+ signaling; EF-hand Ca2+-binding proteins; NHE1; protein-protein interaction	CALCINEURIN HOMOLOGOUS PROTEIN; CA2+-BINDING PROTEIN; NA+/H+ EXCHANGER; CYTOPLASMIC REGION; ESSENTIAL COFACTOR; BINDING; MEMBRANE; P22; ORGANIZATION; CALMODULIN	Calcineurin B homologous proteins (CHPs) belong to the EF-hand Ca2+-binding protein (EFCaBP) family. They have multiple important functions including the regulation of the Na+/H+ exchanger 1 (NHE1). The human isoforms CHP1 and CHP2 share high sequence similarity, but have distinct expression profiles with CHP2 levels for instance increased in malignant cells. These CHPs bind Ca2+ with high affinity. Biochemical data indicated that Ca2+ can regulate their functions. Experimental evidence for Ca2+-modulated structural changes was lacking. With a newly established fluorescent probe hydrophobicity (FPH) assay, we detected Ca2+-induced conformational changes in both CHPs. These changes are in line with an opening of their hydrophobic pocket that binds the CHP-binding region (CBD) of NHE1. Whereas the pocket is closed in the absence of Ca2+ in CHP2, it is still accessible for the dye in CHP1. Both CHPs interacted with CBD in the presence and absence of Ca2+. Isothermal titration calorimetry (ITC) analysis revealed high binding affinity for both CHPs to CBD with equilibrium dissociation constants (K(D)s) in the nanomolar range. The K-D for CHP1:CBD was not affected by Ca2+, whereas Ca2+-depletion increased the K-D 7-fold for CHP2:CBD showing a decreased affinity. The data indicate an isoform specific regulatory interaction of CHP1 and CHP2 with NHE1.	[Liang, Shuo; Fuchs, Simon; Mymrikov, Evgeny V.; Hunte, Carola] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, Fac Med, Freiburg, Germany; [Liang, Shuo; Fuchs, Simon] Univ Freiburg, Fac Biol, Freiburg, Germany; [Mymrikov, Evgeny V.; Heerklotz, Heiko; Hunte, Carola] Univ Freiburg, CIBSS, Freiburg, Germany; [Stulz, Anja; Kaiser, Michael; Heerklotz, Heiko] Univ Freiburg, Dept Pharmaceut Technol & Biopharm, Freiburg, Germany; [Heerklotz, Heiko] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Heerklotz, Heiko; Hunte, Carola] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Toronto; University of Freiburg	Hunte, C (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Fac Med, ZBMZ,CIBSS, Stefan Meier Str 17, D-79104 Freiburg, Germany.	carola.hunte@biochemie.uni-freiburg.de		Heerklotz, Heiko/0000-0003-4615-7022; Hunte, Carola/0000-0002-0826-3986; Mymrikov, Evgeny/0000-0003-4817-6278	Deutsche Forschungsgemeinschaft (DFG) under Germanys Excellence Initiative [SFB 746, 403222702/SFB 1381, 278002225/RTG 2202, BIOSS - EXC294]; Deutsche Forschungsgemeinschaft (DFG) under Germanys Excellence Strategy [CIBSS - EXC-2189, 390939984]	Deutsche Forschungsgemeinschaft (DFG) under Germanys Excellence Initiative(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG) under Germanys Excellence Strategy(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB 746, Project-ID 403222702/SFB 1381, Project-ID 278002225/RTG 2202, under Germanys Excellence Initiative, BIOSS - EXC294 and under Germanys Excellence Strategy,CIBSS - EXC-2189 - Project-ID 390939984	Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Battey N H, 1992, Methods Mol Biol, V11, P73, DOI 10.1385/0-89603-213-2:73; Ben Ammar Y, 2005, ACTA CRYSTALLOGR F, V61, P956, DOI [10.1107/S1744309105030836, 10.1107/s1744309105030836]; Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Chazin WJ, 2011, ACCOUNTS CHEM RES, V44, P171, DOI 10.1021/ar100110d; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cornish-Bowden A, 2002, J BIOSCIENCES, V27, P121, DOI 10.1007/BF02703768; Di Sole F, 2012, AM J PHYSIOL-RENAL, V303, pF165, DOI 10.1152/ajprenal.00628.2011; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Elbers D, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00355; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Fuchs S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33096-5; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; GILL SJ, 1976, P NATL ACAD SCI USA, V73, P2955, DOI 10.1073/pnas.73.9.2955; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Guissart C, 2015, HUM MOL GENET, V24, P463, DOI 10.1093/hmg/ddu461; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Iwama K, 2018, J HUM GENET, V63, P1049, DOI 10.1038/s10038-018-0488-x; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kroeger T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177024; Kuwahara H, 2003, J BIOCHEM, V134, P245, DOI 10.1093/jb/mvg137; Li GD, 2008, J BIOL CHEM, V283, P32660, DOI 10.1074/jbc.M806684200; Li QH, 2011, GENES CELLS, V16, P416, DOI 10.1111/j.1365-2443.2011.01497.x; Liu Y, 2013, J NEUROSCI, V33, P12656, DOI 10.1523/JNEUROSCI.0406-13.2013; Mailander J, 2001, FEBS LETT, V507, P331, DOI 10.1016/S0014-5793(01)02986-6; Majorek KA, 2014, PROTEIN SCI, V23, P1359, DOI 10.1002/pro.2520; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Mendoza-Ferreira N, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000209; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Nakamura N, 2002, J BIOCHEM, V132, P483, DOI 10.1093/oxfordjournals.jbchem.a003246; Naoe Y, 2005, J BIOL CHEM, V280, P32372, DOI 10.1074/jbc.M503390200; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; ROCHETTEEGLY C, 1984, ELECTROPHORESIS, V5, P285, DOI 10.1002/elps.1150050508; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017	46	1	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3253	3266		10.1096/fj.201902093R	http://dx.doi.org/10.1096/fj.201902093R		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31912575	hybrid			2022-12-28	WOS:000506147000001
J	Kim, GD; Ng, HP; Chan, ER; Mahabeleshwar, GH				Kim, Gun-Dong; Ng, Hang Pong; Chan, E. Ricky; Mahabeleshwar, Ganapati H.			Kruppel-like factor 6 promotes macrophage inflammatory and hypoxia response	FASEB JOURNAL			English	Article						glycolysis; inflammation; KLF6; macrophage; metabolism	TRANSCRIPTIONAL REGULATION; CANDIDA-ALBICANS; LIPOPOLYSACCHARIDE; RECOGNITION; HIF-1-ALPHA; LEUKOCYTES	Macrophages are the professional phagocytes that protect the host from infection or injury. Tissue microenvironment at the site of injury and inflammation is characterized by low oxygen concentration and poor supply of nutrients. The responding macrophages have to advance against oxygen and nutrient gradients to reach the site of inflammation to perform host protection, and tissue repair functions. Thus, evolution has fashioned macrophages to orchestrate a coordinated inflammatory and hypoxic gene program to mount an effective immune response. Here, we discovered that Kruppel-like factor 6 (KLF6) governs macrophage functions by promoting inflammatory and hypoxic response gene programming. Our in vivo studies revealed that myeloid-KLF6-deficient mice were highly resistant to endotoxin-induced systemic inflammatory response syndrome symptomatology and mortality. Using complementary gain- and loss-of-function studies, we observed that KLF6 overexpression elevate and KLF6 deficiency attenuate inducible HIF1 alpha expression in macrophages. Our integrated transcriptomics and gene set enrichment analysis studies uncovered that KLF6 deficiency attenuates broad inflammatory and glycolytic gene expression in macrophages. More importantly, overexpression of oxygen stable HIF1 alpha reversed attenuated proinflammatory and glycolytic gene expression in KLF6-deficient macrophages. Collectively, our studies uncovered that KLF6 govern inflammatory and hypoxic response by regulating HIF1 alpha expression in macrophage.	[Kim, Gun-Dong; Ng, Hang Pong; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA; [Chan, E. Ricky] Case Western Reserve Univ, Sch Med, Cleveland Inst Computat Biol, Cleveland, OH USA; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Cardiovasc Res Inst, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA.	ghm4@case.edu		Chan, Ernest/0000-0001-9277-5329	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL141423, HL126626]; Crohn's and Colitis Foundation of America (CCFA) [421904]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); Crohn's and Colitis Foundation of America (CCFA)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL126626; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL141423; Crohn's and Colitis Foundation of America (CCFA), Grant/Award Number: 421904	Backer V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190074; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bartels K, 2013, P NATL ACAD SCI USA, V110, P18351, DOI 10.1073/pnas.1318345110; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Das A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00022; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; De Graeve F, 2003, GENE, V314, P55, DOI 10.1016/S0378-1119(03)00720-0; Goodman WA, 2016, MUCOSAL IMMUNOL, V9, P1250, DOI 10.1038/mi.2016.1; Kanarek N, 2018, NATURE, V559, P632, DOI 10.1038/s41586-018-0316-7; Kim GD, 2019, FASEB J, V33, P10902, DOI 10.1096/fj.201900867RR; Kim GD, 2016, J BIOL CHEM, V291, P21271, DOI 10.1074/jbc.M116.738617; Levene PA, 1912, J BIOL CHEM, V11, P361; Levene PA, 1912, J BIOL CHEM, V12, P265; Lin N, 2016, J CLIN INVEST, V126, P3661, DOI 10.1172/JCI84426; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Saadi S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0690hyp; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Syafruddin SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09116-x; Takikawa A, 2016, DIABETES, V65, P3649, DOI 10.2337/db16-0012; Weber U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096933; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Zheng NX, 2015, VIRULENCE, V6, P347, DOI 10.1080/21505594.2015.1014270	33	15	17	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3209	3223		10.1096/fj.201902221R	http://dx.doi.org/10.1096/fj.201902221R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908054	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000505939400001
J	Northeast, RC; Chrobok, L; Hughes, ATL; Petit, C; Piggins, HD				Northeast, Rebecca C.; Chrobok, Lukasz; Hughes, Alun T. L.; Petit, Cheryl; Piggins, Hugh D.			Keeping time in the lamina terminalis: Novel oscillator properties of forebrain sensory circumventricular organs	FASEB JOURNAL			English	Article						circadian; circumventricular organ; fluid balance; OVLT; SFO; suprachiasmatic	SUBFORNICAL ORGAN; SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; SODIUM APPETITE; MOUSE; CLOCK; BRAIN; EXPRESSION; BEHAVIOR; THIRST	Drinking behavior and osmotic regulatory mechanisms exhibit clear daily variation which is necessary for achieving the homeostatic osmolality. In mammals, the master clock in the brain's suprachiasmatic nuclei has long been held as the main driver of circadian (24 h) rhythms in physiology and behavior. However, rhythmic clock gene expression in other brain sites raises the possibility of local circadian control of neural activity and function. The subfornical organ (SFO) and the organum vasculosum laminae terminalis (OVLT) are two sensory circumventricular organs (sCVOs) that play key roles in the central control of thirst and water homeostasis, but the extent to which they are subject to intrinsic circadian control remains undefined. Using a combination of ex vivo bioluminescence and in vivo gene expression, we report for the first time that the SFO contains an unexpectedly robust autonomous clock with unusual spatiotemporal characteristics in core and noncore clock gene expression. Furthermore, putative single-cell oscillators in the SFO and OVLT are strongly rhythmic and require action potential-dependent communication to maintain synchrony. Our results reveal that these thirst-controlling sCVOs possess intrinsic circadian timekeeping properties and raise the possibility that these contribute to daily regulation of drinking behavior.	[Northeast, Rebecca C.; Chrobok, Lukasz; Hughes, Alun T. L.; Petit, Cheryl; Piggins, Hugh D.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Piggins, Hugh D.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Chrobok, Lukasz] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Neurophysiol & Chronobiol, Gronostajowa St 9, PL-30387 Krakow, Poland; [Hughes, Alun T. L.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England	University of Manchester; University of Bristol; Jagiellonian University; Liverpool John Moores University	Piggins, HD (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	hugh.piggins@bristol.ac.uk	Hughes, Alun/HCI-2220-2022	Hughes, Alun/0000-0001-7460-3216	Biotechnology and Biological Sciences Research Council [BB/M02329X, BB/090223]; Medical Research Council; University of Manchester; BBSRC [BB/R019223/1, BB/M02329X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Manchester; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council, Grant/Award Number: BB/M02329X and BB/090223; Medical Research Council; University of Manchester	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Brancaccio M, 2019, SCIENCE, V363, P187, DOI 10.1126/science.aat4104; Brancaccio M, 2017, NEURON, V93, P1420, DOI 10.1016/j.neuron.2017.02.030; Cheng HYM, 2009, HUM MOL GENET, V18, P3110, DOI 10.1093/hmg/ddp252; Cottrell GT, 2004, J NEUROSCI, V24, P2375, DOI 10.1523/JNEUROSCI.5187-03.2004; Ferguson AV, 2013, NEUROBIOLOGY BODY FL, P1; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gizowski C, 2016, NATURE, V537, P685, DOI 10.1038/nature19756; Gizowski C, 2018, NAT REV NEPHROL, V14, P11, DOI 10.1038/nrneph.2017.149; Guido ME, 1999, J BIOL RHYTHM, V14, P275, DOI 10.1177/074873099129000687; Guilding C, 2010, NEUROSCIENCE, V169, P1630, DOI 10.1016/j.neuroscience.2010.06.015; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Hastings MH, 2018, NAT REV NEUROSCI, V19, P453, DOI 10.1038/s41583-018-0026-z; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Landgraf D, 2016, EUR J NEUROSCI, V43, P1309, DOI 10.1111/ejn.13085; Langlet F, 2013, J COMP NEUROL, V521, P3389, DOI 10.1002/cne.23355; Lima HRC, 2004, AN ACAD BRAS CIENC, V76, P85, DOI 10.1590/S0001-37652004000100008; Lucas RJ, 2012, PROG BRAIN RES, V199, P1, DOI 10.1016/B978-0-444-59427-3.00001-0; Masri S, 2018, NAT MED, V24, P1795, DOI 10.1038/s41591-018-0271-8; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; Miller JEK, 2014, J NEUROSCI, V34, P6040, DOI 10.1523/JNEUROSCI.4713-13.2014; MISELIS RR, 1981, BRAIN RES, V230, P1, DOI 10.1016/0006-8993(81)90388-7; MISELIS RR, 1979, SCIENCE, V205, P1022, DOI 10.1126/science.472723; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Myung J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03507-2; Nishinaga H, 2009, BIOMED RES-TOKYO, V30, P87, DOI 10.2220/biomedres.30.87; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Paul JR, 2019, EUR J NEUROSCI; Pavlovski I, 2018, NEUROSCIENCE, V393, P175, DOI 10.1016/j.neuroscience.2018.10.009; Pocsai K, 2015, J HISTOCHEM CYTOCHEM, V63, P367, DOI 10.1369/0022155415575027; RAMSAY DJ, 1983, PROG BRAIN RES, V60, P91; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Riddle M, 2017, EUR J NEUROSCI, V45, P1357, DOI 10.1111/ejn.13441; ROUAHROSILIO M, 1994, PHYSIOL BEHAV, V55, P811, DOI 10.1016/0031-9384(94)90064-7; Sakhi K, 2014, J PHYSIOL-LONDON, V592, P5025, DOI 10.1113/jphysiol.2014.280065; Sakhi K, 2014, J PHYSIOL-LONDON, V592, P587, DOI 10.1113/jphysiol.2013.263319; Shan ZL, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4641; Smith PM, 1997, NEUROENDOCRINOLOGY, V66, P130, DOI 10.1159/000127230; SPITERI NJ, 1982, PHYSIOL BEHAV, V28, P139, DOI 10.1016/0031-9384(82)90115-9; Sujino M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19224-1; SWANSON LW, 1986, BRAIN RES, V379, P399, DOI 10.1016/0006-8993(86)90799-7; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Tao WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15212; Timothy JWS, 2018, BIOL PSYCHIAT, V84, P827, DOI 10.1016/j.biopsych.2017.04.018; Tso CF, 2017, CURR BIOL, V27, P1055, DOI 10.1016/j.cub.2017.02.037; Washburn DLS, 1999, NEUROSCIENCE, V93, P349, DOI 10.1016/S0306-4522(99)00125-6; Webb AB, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002787; Wefers J, 2018, P NATL ACAD SCI USA, V115, P7789, DOI 10.1073/pnas.1722295115; Wegner S, 2017, J NEUROSCI, V37, P7824, DOI 10.1523/JNEUROSCI.0691-17.2017; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yan L, 2007, COLD SPRING HARB SYM, V72, P527, DOI 10.1101/sqb.2007.72.037; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zimmerman CA, 2017, NAT REV NEUROSCI, V18, P459, DOI 10.1038/nrn.2017.71; Zimmerman CA, 2016, NATURE, V537, P680, DOI 10.1038/nature18950	62	7	7	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					974	987		10.1096/fj.201901111R	http://dx.doi.org/10.1096/fj.201901111R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914667	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000507308900066
J	Rapa, SF; Waltenberger, B; Di Paola, R; Adesso, S; Siracusa, R; Peritore, AF; D'Amico, R; Autore, G; Cuzzocrea, S; Stuppner, H; Marzocco, S				Rapa, Shara F.; Waltenberger, Birgit; Di Paola, Rosanna; Adesso, Simona; Siracusa, Rosalba; Peritore, Alessio F.; D'Amico, Ramona; Autore, Giuseppina; Cuzzocrea, Salvatore; Stuppner, Hermann; Marzocco, Stefania			Plumericin prevents intestinal inflammation and oxidative stress in vitro and in vivo	FASEB JOURNAL			English	Article						plumericin; intestinal epithelial cells; DNBS-induced colitis; inflammation; oxidative stress	BOWEL-DISEASE; EPITHELIAL-CELLS; PATHOGENESIS; ACTIVATION; MANAGEMENT; FUMARATE; THERAPY; COLITIS; SULFATE	Inflammatory bowel diseases (IBDs) are characterized by an inflammatory and oxidative stress condition in the intestinal tissue. In this study, we evaluated the effect of plumericin, one of the main bioactive components of Himatanthus sucuuba (Woodson) bark, on intestinal inflammation and oxidative stress, both in vitro and in vivo. The effect of plumericin (0.5-2 mu M) in vitro was evaluated in rat intestinal epithelial cells (IEC-6) treated with lipopolysaccharides from E. coli (10 mu g/mL) plus interferon-gamma (10 U/mL). Moreover, a 2,4,6-dinitrobenzene sulfonic acid (DNBS)-induced colitis model was used to evaluate the anti-inflammatory and antioxidant activity of plumericin (3 mg/kg) in vivo. The results showed that plumericin significantly reduces intestinal inflammatory factors such as tumor necrosis factor-alpha, cyclooxygenase-2 and inducible nitric oxide synthase expression, and nitrotyrosine formation. Plumericin also inhibited nuclear factor-kappa B translocation, reactive oxygen species (ROS) release, and inflammasome activation. Moreover, plumericin activated the nuclear factor erythroid-derived 2 pathway in IEC-6. Using the DNBS-induced colitis model, a significant reduction in the weight loss and in the development of the macroscopic and histologic signs of colon injury, together with a reduced inflammatory and oxidative stress state, were observed in plumericin-treated mice. These results indicate that plumericin exerts a strong anti-inflammatory and antioxidant activity. Thus, it might be a candidate for the development of a new pharmacologic approach for IBDs treatment.	[Rapa, Shara F.; Adesso, Simona; Autore, Giuseppina; Marzocco, Stefania] Univ Salerno, Dept Pharm, Via Giovanni Paolo II 132, I-84084 Fisciano, Salerno, Italy; [Waltenberger, Birgit; Stuppner, Hermann] Univ Innsbruck, Inst Pharm Pharmacognosy, Innsbruck, Austria; [Waltenberger, Birgit; Stuppner, Hermann] Univ Innsbruck, CMBI, Innsbruck, Austria; [Di Paola, Rosanna; Siracusa, Rosalba; Peritore, Alessio F.; D'Amico, Ramona; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy	University of Salerno; University of Innsbruck; University of Innsbruck; University of Messina	Marzocco, S (corresponding author), Univ Salerno, Dept Pharm, Via Giovanni Paolo II 132, I-84084 Fisciano, Salerno, Italy.	smarzocco@unisa.it	Marzocco, Stefania/AAI-1493-2020; Peritore, Alessio/HGB-1327-2022; Siracusa, Rosalba/AAC-3110-2022; D'Amico, Ramona/AAC-9061-2019; di paola, rosanna/U-4356-2019	Siracusa, Rosalba/0000-0001-7868-2505; peritore, alessio filippo/0000-0001-8545-990X; D'Amico, Ramona/0000-0003-0389-3871; di paola, rosanna/0000-0001-6725-8581	University of Salerno [FARB 2018-ORSA180779]	University of Salerno	University of Salerno, Grant/Award Number: FARB 2018-ORSA180779	Adesso S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092280; Adesso S, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100365; Adesso S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030800; Adesso S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121343; Adesso S, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00370; Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335; Amaral A. C. F., 2007, Pharmacognosy Reviews, V1, P305; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Basilicata MG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071955; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Bryant RV, 2015, SCAND J GASTROENTERO, V50, P90, DOI 10.3109/00365521.2014.968864; Burge K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081912; Casili G, 2016, J CROHNS COLITIS, V10, P472, DOI 10.1093/ecco-jcc/jjv231; Chudy-Onwugaje KO, 2019, INFLAMM BOWEL DIS, V25, P820, DOI 10.1093/ibd/izy327; Cuzzocrea S, 2004, LAB INVEST, V84, P1643, DOI 10.1038/labinvest.3700185; da Silva VC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124016; Fakhrudin N, 2014, BRIT J PHARMACOL, V171, P1676, DOI 10.1111/bph.12558; Farzaei MH, 2015, CURR PHARM BIOTECHNO, V16, P196, DOI 10.2174/1389201016666150118131704; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Guan G., 2018, BIOMED RES INT, V2018, P1; Han KH, 2017, GUT LIVER, V11, P655, DOI 10.5009/gnl16496; He Y, 2015, MOLECULES, V20, P9183, DOI 10.3390/molecules20059183; Heiss EH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20771; Impellizzeri D, 2015, CLIN NUTR, V34, P1146, DOI 10.1016/j.clnu.2014.11.012; Kang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061411; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Khan SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39501; Kuigoua GM, 2010, PLANTA MED, V76, P620, DOI 10.1055/s-0029-1240611; Lei-Leston AC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01168; Li L, 2018, BIOMED PHARMACOTHER, V104, P622, DOI 10.1016/j.biopha.2018.05.072; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; Marzocco S., 2017, DORONICUM AUSTRIACUM, V22, P1003; McDaniel DK, 2016, INFLAMM BOWEL DIS, V22, P2265, DOI 10.1097/MIB.0000000000000858; Moldoveanu AC, 2015, ROM J INTERN MED, V53, P118, DOI 10.1515/rjim-2015-0016; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pepe G, 2016, J FUNCT FOODS, V26, P494, DOI 10.1016/j.jff.2016.08.021; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Ranneh Y, 2017, APPL BIOL CHEM, V60, P327, DOI 10.1007/s13765-017-0285-9; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; RIEDER F, 2015, AM J PHYSIOL-GASTR L, V303, pG786; Seidel P, 2009, AM J PHYSIOL-LUNG C, V297, pL326, DOI 10.1152/ajplung.90624.2008; Sharma Umakant, 2011, Indian J Med Res, V134, P709, DOI 10.4103/0971-5916.91005; Singh D, 2011, NAT PROD COMMUN, V6, P1567; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Waltenberger B, 2011, ACTA CRYSTALLOGR C, V67, pO409, DOI 10.1107/S0108270111035761; Yasukawa K, 2012, FREE RADICAL RES, V46, P1427, DOI 10.3109/10715762.2012.732698; Zhang J, 2015, BIOORG MED CHEM LETT, V25, P3661, DOI 10.1016/j.bmcl.2015.06.046	52	17	17	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1576	1590		10.1096/fj.201902040R	http://dx.doi.org/10.1096/fj.201902040R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914614	Bronze			2022-12-28	WOS:000507308900104
J	Roberston, MJ; Raghunathan, S; Potaman, VN; Zhang, F; Stewart, MD; McConnell, BK; Schwartz, RJ				Roberston, Matthew J.; Raghunathan, Suchi; Potaman, Vladimir N.; Zhang, Fan; Stewart, M. David; McConnell, Bradley K.; Schwartz, Robert J.			CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression	FASEB JOURNAL			English	Article						gene regulation; insulin-like growth factor 1; muscle atrophy	GROWTH-FACTOR; SATELLITE CELLS; ATROPHY; HYPERTROPHY; APOPTOSIS; PROGRAM	Muscle wasting, or muscle atrophy, can occur with age, injury, and disease; it affects the quality of life and complicates treatment. Insulin-like growth factor 1 (IGF1) is a key positive regulator of muscle mass. The IGF1/Igf1 gene encodes multiple protein isoforms that differ in tissue expression, potency, and function, particularly in cellular proliferation and differentiation, as well as in systemic versus localized signaling. Genome engineering is a novel strategy for increasing gene expression and has the potential to recapitulate the diverse biology seen in IGF1 signaling through the overexpression of multiple IGF1 isoforms. Using a CRISPR-Cas9 gene activation approach, we showed that the expression of multiple IGF1 or Igf1 mRNA variants can be increased in human and mouse skeletal muscle myoblast cell lines using a single-guide RNA (sgRNA). We found increased IGF1 protein levels in the cell culture media and increased cellular phosphorylation of AKT1, the main effector of IGF1 signaling. We also showed that the expression of Class 1 or Class 2 mRNA variants can be selectively increased by changing the sgRNA target location. The expression of multiple IGF1 or Igf1 mRNA transcript variants in human and mouse skeletal muscle myoblasts promoted myotube differentiation and prevented dexamethasone-induced atrophy in myotubes in vitro. Our findings suggest that this novel approach for enhancing IGF1 signaling has potential therapeutic applications for treating skeletal muscle atrophy.	[Roberston, Matthew J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Adv Technol Core, Alkek Ctr Mol Discovery, Houston, TX 77030 USA; [Roberston, Matthew J.; Potaman, Vladimir N.; Schwartz, Robert J.] Texas Heart Inst, Stem Cell Lab, Houston, TX 77025 USA; [Raghunathan, Suchi; Zhang, Fan; McConnell, Bradley K.] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, 4849 Calhoun Rd,Hlth 2 H2 Bldg,Room 5024, Houston, TX 77204 USA; [Stewart, M. David; Schwartz, Robert J.] Univ Houston, Dept Biol & Biochem, Coll Nat Sci & Math, 3455 Cullen Blvd,Room 4004, Houston, TX 77204 USA	Baylor College of Medicine; Texas Heart Institute; University of Houston System; University of Houston; University of Houston System; University of Houston	McConnell, BK (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, 4849 Calhoun Rd,Hlth 2 H2 Bldg,Room 5024, Houston, TX 77204 USA.; Schwartz, RJ (corresponding author), Univ Houston, Dept Biol & Biochem, Coll Nat Sci & Math, 3455 Cullen Blvd,Room 4004, Houston, TX 77204 USA.	bkmcconn@central.uh.edu; rjschwartz@uh.edu			Center for the Advancement of Science in Space; National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) [R15 HL141963, R15 HL124458]; American Heart Association (AHA) [18AIREA 33960175]; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation	Center for the Advancement of Science in Space; National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association); Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation	The research reported in this manuscript was supported in part by a grant from the Center for the Advancement of Science in Space (R.J.S). Research was also supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) under Award Number R15 HL141963 to (B.K.M.), R15 HL124458 to (B.K.M.), American Heart Association (AHA) under Award Number 18AIREA 33960175 (B.K.M.), and a grant from Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (B.K.M.). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Apel PJ, 2010, MUSCLE NERVE, V41, P335, DOI 10.1002/mus.21485; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; Barton ER, 2006, J APPL PHYSIOL, V100, P1778, DOI 10.1152/japplphysiol.01405.2005; Bioinformatics B, 2011, FASTQC QUALITY CONTR; Brisson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045588; Cen YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154941; Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200; Chakravarthy MV, 2001, MECH AGEING DEV, V122, P1303, DOI 10.1016/S0047-6374(01)00263-9; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Demonbreun AR, 2017, CURR OPIN PHARMACOL, V34, P7, DOI 10.1016/j.coph.2017.03.008; Dobrucki LW, 2010, J MOL CELL CARDIOL, V48, P1071, DOI 10.1016/j.yjmcc.2009.10.008; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Gallego-Colon E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/484357; Goldspink G, 2006, INT J BIOCHEM CELL B, V38, P480, DOI 10.1016/j.biocel.2005.10.013; Holmes B, 2012, CELL SIGNAL, V24, P309, DOI 10.1016/j.cellsig.2011.09.015; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee WS, 2018, BBA-MOL BASIS DIS, V1864, P1931, DOI 10.1016/j.bbadis.2017.08.029; Li JL, 2007, J BIOL CHEM, V282, P34984, DOI 10.1074/jbc.M703513200; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lok C, 2015, NATURE, V528, P182, DOI 10.1038/528182a; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Oberbauer A., 2013, FRONT ENDOCRINOL, V4, P1, DOI DOI 10.3389/FENDO.2013.0003923533068; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Philippou A, 2014, GROWTH HORM IGF RES, V24, P157, DOI 10.1016/j.ghir.2014.06.003; Rabinovsky ED, 2002, FASEB J, V16, P53, DOI 10.1096/fj.02-0183fje; Rae FK, 2012, GROWTH HORM IGF RES, V22, P6, DOI 10.1016/j.ghir.2011.11.002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shavlakadze T, 2005, GROWTH HORM IGF RES, V15, P4, DOI 10.1016/j.ghir.2004.11.001; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607	41	6	6	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					555	570		10.1096/fj.201901107RR	http://dx.doi.org/10.1096/fj.201901107RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914652	Green Accepted			2022-12-28	WOS:000507308900038
J	Roberts, MWG; Sui, GP; Wu, R; Rong, WF; Wildman, S; Montgomery, B; Ali, A; Langley, S; Ruggieri, MR; Wu, CH				Roberts, Max W. G.; Sui, Guiping; Wu, Rui; Rong, Weifang; Wildman, Scott; Montgomery, Bruce; Ali, Ahmed; Langley, Steve; Ruggieri, Michael R., Sr.; Wu, Changhao			TRPV4 receptor as a functional sensory molecule in bladder urothelium: Stretch-independent, tissue-specific actions and pathological implications	FASEB JOURNAL			English	Article						aging; ATP release; overactive bladders; TRPV4 receptor; urothelium	CATION CHANNEL TRPV4; INTRACELLULAR CA2+ REGULATION; HEAT-EVOKED ACTIVATION; URINARY-BLADDER; ATP RELEASE; VANILLOID RECEPTOR; POTENTIAL VANILLOID-4; AFFERENT-FIBERS; EXPRESSION; CELLS	The newly recognized sensory role of bladder urothelium has generated intense interest in identifying its novel sensory molecules. Sensory receptor TRPV4 may serve such function. However, specific and physiologically relevant tissue actions of TRPV4, stretch-independent responses, and underlying mechanisms are unknown and its role in human conditions has not been examined. Here we showed TRPV4 expression in guinea-pig urothelium, suburothelium, and bladder smooth muscle, with urothelial predominance. Selective TRPV4 activation without stretch evoked significant ATP release-key urothelial sensory process, from live mucosa tissue, full-thickness bladder but not smooth muscle, and sustained muscle contractions. ATP release was mediated by Ca2+-dependent, pannexin/connexin-conductive pathway involving protein tyrosine kinase, but independent from vesicular transport and chloride channels. TRPV4 activation generated greater Ca2+ rise than purinergic activation in urothelial cells. There was intrinsic TRPV4 activity without exogeneous stimulus, causing ATP release. TRPV4 contributed to 50% stretch-induced ATP release. TRPV4 activation also triggered superoxide release. TRPV4 expression was increased with aging. Human bladder mucosa presented similarities to guinea pigs. Overactive bladders exhibited greater TRPV4-induced ATP release with age dependence. These data provide the first evidence in humans for the key functional role of TRPV4 in urothelium with specific mechanisms and identify TRPV4 up-regulation in aging and overactive bladders.	[Roberts, Max W. G.; Wu, Changhao] Univ Surrey, Sch Biosci & Med, Guildford GU2 7XH, Surrey, England; [Sui, Guiping] Guys & St Thomas Hosp NHS Trust, London, England; [Wu, Rui] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [Rong, Weifang] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai, Peoples R China; [Wildman, Scott] Univ Kent, Sch Pharm, Chatham, Kent, England; [Montgomery, Bruce; Ali, Ahmed] Frimley Hlth NHS Trust, Frimley, England; [Langley, Steve] Royal Surrey Cty NHS Trust, Guildford, Surrey, England; [Ruggieri, Michael R., Sr.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA	University of Surrey; University of Warwick; Shanghai Jiao Tong University; University of Kent; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wu, CH (corresponding author), Univ Surrey, Sch Biosci & Med, Guildford GU2 7XH, Surrey, England.	c.wu@surrey.ac.uk		Rong, Weifang/0000-0003-4934-5715	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/P004695/1]; HHS | NIH | National Institute on Aging (NIA) [1R01AG04932101A1]; Age UK Henry -Smith Charity [RiA 373]; BBSRC [BB/P004695/1] Funding Source: UKRI	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC); HHS | NIH | National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Age UK Henry -Smith Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/P004695/1; HHS | NIH | National Institute on Aging (NIA), Grant/Award Number: 1R01AG04932101A1; Age UK Henry -Smith Charity, Grant/Award Number: RiA 373	Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Alexander R, 2013, BRIT J PHARMACOL, V168, P761, DOI 10.1111/j.1476-5381.2012.02186.x; Avelino A, 2006, N-S ARCH PHARMACOL, V373, P287, DOI 10.1007/s00210-006-0073-2; Beckel JM, 2006, AM J PHYSIOL-RENAL, V290, pF103, DOI 10.1152/ajprenal.00098.2005; Beckel JM, 2015, J PHYSIOL-LONDON, V593, P1857, DOI 10.1113/jphysiol.2014.283119; Birder LA, 2012, NEUROUROL URODYNAM, V31, P293, DOI 10.1002/nau.22195; Birder LA, 2004, AM J PHYSIOL-RENAL, V287, pF1084, DOI 10.1152/ajprenal.00118.2004; Birder LA, 2003, AM J PHYSIOL-RENAL, V285, pF423, DOI 10.1152/ajprenal.00056.2003; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Birder L, 2007, J PHARMACOL EXP THER, V323, P227, DOI 10.1124/jpet.107.125435; Birder LA, 2006, VASC PHARMACOL, V45, P221, DOI 10.1016/j.vph.2005.08.027; Birder LA, 2010, AUTON NEUROSCI-BASIC, V153, P33, DOI 10.1016/j.autneu.2009.07.005; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Burnstock G, 1999, J ANAT, V194, P335, DOI 10.1046/j.1469-7580.1999.19430335.x; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Chien CT, 2003, AM J PHYSIOL-RENAL, V284, pF840, DOI 10.1152/ajprenal.00187.2002; Chopra B, 2005, J PHYSIOL-LONDON, V562, P859, DOI 10.1113/jphysiol.2004.071159; Chopra B, 2008, AM J PHYSIOL-RENAL, V294, pF821, DOI 10.1152/ajprenal.00321.2006; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Contreras-Sanz A, 2016, AM J PHYSIOL-RENAL, V311, pF805, DOI 10.1152/ajprenal.00339.2015; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cross WR, 2005, AM J PHYSIOL-RENAL, V289, pF459, DOI 10.1152/ajprenal.00040.2005; Deruyver Y, 2018, EUR UROL, V74, P336, DOI 10.1016/j.eururo.2018.05.020; Du SQ, 2007, UROLOGY, V69, P590, DOI 10.1016/j.urology.2007.01.039; Everaerts W, 2009, NEUROUROL URODYNAM, V28, P701; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fini M, 2008, BIOMED PHARMACOTHER, V62, P709, DOI 10.1016/j.biopha.2007.03.001; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Gomez-Pinilla PJ, 2007, J UROLOGY, V177, P1558, DOI 10.1016/j.juro.2006.11.071; Guler AD, 2002, J NEUROSCI, V22, P6408; HABLER HJ, 1990, J PHYSIOL-LONDON, V425, P545; HORSFALL DJ, 1994, LAB INVEST, V70, P753; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Isogai A, 2016, PFLUG ARCH EUR J PHY, V468, P1573, DOI 10.1007/s00424-016-1863-0; Janssen DAW, 2011, J UROLOGY, V186, P1121, DOI 10.1016/j.juro.2011.04.107; Jones SA, 2004, J PHYSIOL-LONDON, V560, P429, DOI 10.1113/jphysiol.2004.072108; Kanai A, 2007, AM J PHYSIOL-RENAL, V292, pF1065, DOI 10.1152/ajprenal.00229.2006; KARIM OMA, 1992, J CELL BIOCHEM, V48, P373, DOI 10.1002/jcb.240480406; Kullmann FA, 2009, AM J PHYSIOL-RENAL, V296, pF892, DOI 10.1152/ajprenal.90718.2008; Kumar V, 2007, J UROLOGY, V178, P1533, DOI 10.1016/j.juro.2007.05.116; Lee H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12561-7; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Malecot CO, 1998, BRIT J PHARMACOL, V124, P465, DOI 10.1038/sj.bjp.0701854; Masuda H, 2008, BJU INT, V101, P775, DOI 10.1111/j.1464-410X.2007.07310.x; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Pierre MS, 2009, EXP BRAIN RES, V196, P31, DOI 10.1007/s00221-009-1808-3; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Rong W, 2002, J PHYSIOL-LONDON, V541, P591, DOI 10.1113/jphysiol.2001.013469; Schwartzberg PL, 1998, ONCOGENE, V17, P1463, DOI 10.1038/sj.onc.1202176; Shen CH, 2014, BIOMARK GENOM MED, V6, P37, DOI 10.1016/j.bgm.2014.01.004; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Sui GP, 2008, AM J PHYSIOL-RENAL, V295, pF688, DOI 10.1152/ajprenal.00133.2008; Sui GP, 2014, AM J PHYSIOL-RENAL, V306, pF286, DOI 10.1152/ajprenal.00291.2013; Sun Y, 2006, AM J PHYSIOL-CELL PH, V290, pC27, DOI 10.1152/ajpcell.00552.2004; Takaoka E, 2018, NEUROUROL URODYNAM, V37, P2527, DOI 10.1002/nau.23790; Taylor AH, 2000, J MOL ENDOCRINOL, V24, P145, DOI 10.1677/jme.0.0240145; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wu C, 1998, J PHYSIOL-LONDON, V508, P131, DOI 10.1111/j.1469-7793.1998.131br.x; Wu C, 2011, CELL CALCIUM, V49, P395, DOI 10.1016/j.ceca.2011.03.008; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Yamada T, 2009, J HISTOCHEM CYTOCHEM, V57, P277, DOI 10.1369/jhc.2008.951962; Young JS, 2013, BJU INT, V111, P355, DOI 10.1111/j.1464-410X.2012.11300.x; Yu WQ, 2006, AM J PHYSIOL-CELL PH, V291, pC254, DOI 10.1152/ajpcell.00025.2006	80	18	18	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					263	286		10.1096/fj.201900961RR	http://dx.doi.org/10.1096/fj.201900961RR			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914645	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000507308900020
J	Taniguchi, K; Kawai, T; Kitawaki, J; Tomikawa, J; Nakabayashi, K; Okamura, K; Sago, H; Hata, K				Taniguchi, Kosuke; Kawai, Tomoko; Kitawaki, Jo; Tomikawa, Junko; Nakabayashi, Kazuhiko; Okamura, Kohji; Sago, Haruhiko; Hata, Kenichiro			Epitranscriptomic profiling in human placenta: N6-methyladenosine modification at the 5 '-untranslated region is related to fetal growth and preeclampsia	FASEB JOURNAL			English	Article						6-methyladenosine; epitranscriptome; fetal growth; preeclampsia; post-transcriptional regulation	MESSENGER-RNA METHYLATION; M(6)A RNA; GENE-EXPRESSION; CELL; MOUSE; RESTRICTION; REVEALS; N-6-METHYLADENOSINE; METABOLISM; BINDING	Intracellular mRNA levels are not always proportional to their respective protein levels, especially in the placenta. This discrepancy may be attributed to various factors including post-transcriptional regulation, such as mRNA methylation (N6-methyladenosine: m(6)A). Here, we conducted a comprehensive m(6)A analysis of human placental tissue from neonates with various birth weights to clarify the involvement of m(6)A in placental biology. The augmented m(6)A levels at the 5'-untranslated region (UTR) in mRNAs of small-for-date placenta samples were dominant compared to reduction of m(6)A levels, whereas a decrease in m(6)A in the vicinity of stop codons was common in heavy-for-date placenta samples. Notably, most of these genes showed similar expression levels between the different birth weight categories. In particular, preeclampsia placenta samples showed consistently upregulated SMPD1 protein levels and increased m(6)A at 5'-UTR but did not show increased mRNA levels. Mutagenesis of adenosines at 5'-UTR of SMPD1 mRNAs actually decreased protein levels in luciferase assay. Collectively, our findings suggest that m(6)A both at the 5'-UTR and in the vicinity of stop codon in placental mRNA may play important roles in fetal growth and disease.	[Taniguchi, Kosuke; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan; [Taniguchi, Kosuke; Kawai, Tomoko; Tomikawa, Junko; Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Okamura, Kohji] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Tokyo, Japan; [Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan	Kyoto Prefectural University of Medicine; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Kawai, T; Hata, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	kawai-tm@ncchd.go.jp; hata-k@ncchd.go.jp		Tomikawa, Junko/0000-0002-6149-1400; Kawai, Tomoko/0000-0001-8137-0334	AMED [17gk0110013h0002, 17gk0110018s0602]; KAKENHI [26560076, 16K00898, 18K15737]; NCCHD of Japan [26-47, 26-13]	AMED; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NCCHD of Japan	AMED, Grant/Award Number: 17gk0110013h0002 and 17gk0110018s0602; KAKENHI, Grant/Award Number: 26560076, 16K00898 and 18K15737; NCCHD of Japan, Grant/Award Number: 26-47 and 26-13	Barton SJ, 2016, PLACENTA, V38, P100, DOI 10.1016/j.placenta.2015.12.015; Bassols J, 2010, INT J OBESITY, V34, P1365, DOI 10.1038/ijo.2010.62; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Bertero A, 2018, NATURE, V555, P256, DOI 10.1038/nature25784; Bokar JA, 1997, RNA, V3, P1233; Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Coots RA, 2017, MOL CELL, V68, P504, DOI 10.1016/j.molcel.2017.10.002; Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; CUI X, 2016, BIOMED RES INT, V2016; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dobierzewska A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175118; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Ewing AC, 2017, MATERN CHILD HLTH J, V21, P786, DOI 10.1007/s10995-016-2165-z; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fry NJ, 2017, RNA, V23, P1444, DOI 10.1261/rna.061044.117; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levin HI, 2017, PLACENTA, V55, P5, DOI 10.1016/j.placenta.2017.04.014; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Lian IA, 2011, PLACENTA, V32, P823, DOI 10.1016/j.placenta.2011.08.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CH, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1435-z; Mayhew TM, 2007, PLACENTA, V28, P233, DOI 10.1016/j.placenta.2006.02.011; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Motomura K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177994; Muy-Rivera M, 2004, AM J HYPERTENS, V17, P334, DOI 10.1016/j.amjhyper.2003.12.010; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roignant JY, 2017, TRENDS GENET, V33, P380, DOI 10.1016/j.tig.2017.04.003; Sabri A, 2014, FETAL DIAGN THER, V36, P173, DOI 10.1159/000360535; Schneider D, 2015, PLACENTA, V36, P552, DOI 10.1016/j.placenta.2015.02.003; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Sober S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13336; Sui LL, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.124248; Tian FJ, 2016, J PATHOL, V239, P36, DOI 10.1002/path.4694; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsang JCH, 2017, P NATL ACAD SCI USA, V114, pE7786, DOI 10.1073/pnas.1710470114; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/293271; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Zhang CX, 2017, NATURE, V549, P273, DOI 10.1038/nature23883; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	63	9	10	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					494	512		10.1096/fj.201900619RR	http://dx.doi.org/10.1096/fj.201900619RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914637	Green Published, hybrid			2022-12-28	WOS:000507308900034
J	Liu, B; Wu, XZ; Zeng, RH; Yin, YH; Guo, TT; Xu, YN; Zhang, YZ; Leng, J; Ge, JH; Yu, G; Guo, JW; Zhou, YB				Liu, Bin; Wu, Xiangzhong; Zeng, Ruhui; Yin, Yehu; Guo, Tingting; Xu, Yineng; Zhang, Yingzhan; Leng, Jing; Ge, Jiahui; Yu, Gang; Guo, Jinwei; Zhou, Yingbi			Prostaglandin E-2 sequentially activates E-prostanoid receptor-3 and thromboxane prostanoid receptor to evoke contraction and increase in resistance of the mouse renal vasculature	FASEB JOURNAL			English	Article						EP3; gene deficiency; PGE(2); renal vasoconstriction; TP	CYCLOOXYGENASE-1-MEDIATED PROSTACYCLIN SYNTHESIS; ENDOTHELIUM-DEPENDENT CONTRACTION; VASOCONSTRICTOR ACTIVITY; EP4 RECEPTORS; ARTERIES; AORTA	Although recognized to have an in vivo vasodepressor effect blunted by the vasoconstrictor effect of E-prostanoid receptor-3 (EP3), prostaglandin E-2 (PGE(2)) evokes contractions of many vascular beds that are sensitive to antagonizing the thromboxane prostanoid receptor (TP). This study aimed to determine the direct effect of PGE(2) on renal arteries and/or the whole renal vasculature and how each of these two receptors is involved in the responses. Experiments were performed on isolated vessels and perfused kidneys of wild-type mice and/or mice with deficiency in TP (TP-/-), EP3 (EP3(-/-)), or both TP and EP3 (TP-/-/EP3(-/-)). Here we show that PGE(2) (0.001-30 mu M) evoked not only contraction of main renal arteries, but also a decrease of flow in perfused kidneys. EP3(-/-) diminished the response to 0.001-0.3 mu M PGE(2), while TP-/- reduced that to the prostanoid of higher concentrations. In TP-/-/EP3(-/-) vessels and perfused kidneys, PGE(2) did not evoke contraction but instead resulted in vasodilator responses. These results demonstrate that PGE(2) functions as an overall direct vasoconstrictor of the mouse renal vasculature with an effect reflecting the vasoconstrictor activities outweighing that of dilation. Also, our results suggest that EP3 dominates the vasoconstrictor effect of PGE(2) of low concentrations (<= 0.001-0.3 mu M), but its effect is further added by that of TP, which has a higher efficacy, although activated by higher concentrations (from 0.01 mu M) of the same prostanoid PGE(2).	[Liu, Bin; Wu, Xiangzhong; Zeng, Ruhui; Yin, Yehu; Guo, Tingting; Xu, Yineng; Zhang, Yingzhan; Leng, Jing; Ge, Jiahui; Yu, Gang; Guo, Jinwei; Zhou, Yingbi] Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou, Peoples R China; [Zeng, Ruhui] Shantou Univ, Dept Gynaecol & Obstet, Affiliated Hosp 1, Med Coll, Shantou, Peoples R China	Shantou University; Shantou University	Zhou, YB (corresponding author), Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou, Peoples R China.	yz_sumc@163.com			National Natural Science Foundation of China (NSFC) [31771272, 81970433, 81770678]; Major Research Program for Universities of Guangdong province [2017KZDXM037]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Research Program for Universities of Guangdong province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771272, 81970433 and 81770678; the Major Research Program for Universities of Guangdong province, Grant/Award Number: 2017KZDXM037	ARMSTRONG JM, 1976, EUR J PHARMACOL, V39, P251, DOI 10.1016/0014-2999(76)90133-3; Audoly LP, 2001, AM J PHYSIOL-HEART C, V280, pH327, DOI 10.1152/ajpheart.2001.280.1.H327; Audoly LP, 1999, AM J PHYSIOL-HEART C, V277, pH924, DOI 10.1152/ajpheart.1999.277.3.H924; BAER PG, 1973, KIDNEY INT, V4, P12, DOI 10.1038/ki.1973.75; Chen LH, 2012, ARTERIOSCL THROM VAS, V32, P3024, DOI 10.1161/ATVBAHA.112.254052; DUNN MJ, 1985, ADV PROSTAG THROMB L, V13, P179; Eskildsen MP, 2014, HYPERTENSION, V64, P551, DOI 10.1161/HYPERTENSIONAHA.113.03051; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Hockel G M, 1980, Adv Prostaglandin Thromboxane Res, V7, P1061; HOCKEL GM, 1980, HYPERTENSION, V2, P529, DOI 10.1161/01.HYP.2.4.529; Hristovska AM, 2007, HYPERTENSION, V50, P525, DOI 10.1161/HYPERTENSIONAHA.107.088948; Hu CJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01247; INSCHO EW, 1990, AM J PHYSIOL, V259, pF157, DOI 10.1152/ajprenal.1990.259.1.F157; Ishida K, 2012, PFLUG ARCH EUR J PHY, V463, P593, DOI 10.1007/s00424-012-1088-9; Jin J, 2017, LIFE SCI, V174, P68, DOI 10.1016/j.lfs.2017.03.001; Kennedy CRJ, 1999, NAT MED, V5, P217, DOI 10.1038/5583; Kida T, 2014, HEART VESSELS, V29, P390, DOI 10.1007/s00380-013-0374-6; Li SS, 2016, CLIN EXP PHARMACOL P, V43, P67, DOI 10.1111/1440-1681.12501; Li Z, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.17; Liu B, 2019, FASEB J, V33, P2451, DOI 10.1096/fj.201801064RR; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09288-w; Liu B, 2013, AM J PHYSIOL-RENAL, V305, pF1315, DOI 10.1152/ajprenal.00332.2013; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Longrois D, 2012, EUR J PHARMACOL, V681, P55, DOI 10.1016/j.ejphar.2012.01.041; Luo WH, 2016, EUR J PHARMACOL, V780, P148, DOI 10.1016/j.ejphar.2016.03.043; MARTINEAU A, 1984, HYPERTENSION, V6, pI161, DOI 10.1161/01.HYP.6.2_Pt_2.I161; MCGIFF JC, 1976, FED PROC, V35, P2382; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nasjletti A, 1998, HYPERTENSION, V31, P194, DOI 10.1161/01.HYP.31.1.194; Purdy KE, 2000, AM J PHYSIOL-RENAL, V279, pF755, DOI 10.1152/ajprenal.2000.279.4.F755; Rifkind JM, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00492; Schweda F, 2004, AM J PHYSIOL-RENAL, V287, pF427, DOI 10.1152/ajprenal.00072.2004; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; TAN SY, 1978, PROSTAG OTH LIPID M, V15, P139, DOI 10.1016/S0090-6980(78)80012-4; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Thibodeau JF, 2016, ANTIOXID REDOX SIGN, V25, P642, DOI 10.1089/ars.2015.6592; van Rodijnen WF, 2007, AM J PHYSIOL-RENAL, V292, pF1094, DOI 10.1152/ajprenal.00351.2005; Vanhoutte PM, 2011, HYPERTENSION, V57, P526, DOI 10.1161/HYPERTENSIONAHA.110.165100; WATABE A, 1993, J BIOL CHEM, V268, P20175; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005; Zhu NX, 2014, AM J PHYSIOL-HEART C, V307, pH319, DOI 10.1152/ajpheart.00022.2014	44	8	8	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2568	2578		10.1096/fj.201901611R	http://dx.doi.org/10.1096/fj.201901611R		DEC 2019	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908041	Bronze			2022-12-28	WOS:000503400200001
J	Cao, XY; Chen, JN; Li, D; Xie, PP; Xu, MY; Lin, WZ; Li, SQ; Pan, GP; Tang, Y; Xu, J; Olkkonen, VM; Yan, DG; Zhong, WB				Cao, Xiuye; Chen, Jianuo; Li, Dan; Xie, Peipei; Xu, Mengyang; Lin, Weize; Li, Shiqian; Pan, Guoping; Tang, Yong; Xu, Jun; Olkkonen, Vesa M.; Yan, Daoguang; Zhong, Wenbin			ORP4L couples IP3 to ITPR1 in control of endoplasmic reticulum calcium release	FASEB JOURNAL			English	Article						Ca2+ signaling; bioenergetics; T-ALL cells	OXYSTEROL-BINDING; PLASMA-MEMBRANE; CONTACT SITES; PROTEIN; ACTIVATION; OSCILLATIONS; INHIBITION; RECEPTORS; APOPTOSIS; DOMAIN	Oxysterol-binding protein related protein (ORP) 4L acts as a scaffold protein assembling CD3-epsilon, G-alpha(q/11), and PLC-beta 3 into a complex at the plasma membrane that mediates inositol (1,4,5)-trisphosphate (IP3) induced endoplasmic reticulum (ER) Ca2+ release and oxidative phosphorylation in T-cell acute lymphoblastic leukemia cells. Here, we offer new evidence that ORP4L interacts with the carboxyl terminus of the IP3 receptor type 1 (ITPR1) in Jurkat T cells. ORP4L enables IP3 binding to ITPR1; a truncated construct that lacks the ITPR1-binding region retains the ability to increase IP3 production but fails to mediate IP3 and ITPR1 binding. In association with this ability of ORP4L, it enhances Ca2+ release from the ER and subsequent cytosolic and mitochondrial parallel Ca2+ spike oscillations that stimulate mitochondrial energetics and thus maintains cell survival. These data support a novel model in which ORP4L is a cofactor of ITPR1, which increases ITPR1 sensitivity to IP3 and enables ER Ca2+ release.	[Cao, Xiuye; Chen, Jianuo; Li, Dan; Xie, Peipei; Xu, Mengyang; Lin, Weize; Li, Shiqian; Pan, Guoping; Tang, Yong; Yan, Daoguang; Zhong, Wenbin] Jinan Univ, Dept Biol, 601 Huangpu Ave, Guangzhou 510632, Peoples R China; [Xu, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Res Ctr Drug Discovery, Guangzhou, Peoples R China; [Olkkonen, Vesa M.] Minerva Fdn, Biomedicum Helsinki 2U, Helsinki, Finland	Jinan University; Sun Yat Sen University; University of Helsinki	Zhong, WB (corresponding author), Jinan Univ, Dept Biol, 601 Huangpu Ave, Guangzhou 510632, Peoples R China.	tzhongwb@jnu.edu.cn	Li, Shiqian/ABH-2154-2021		National Natural Science Foundation of China (NSFC) [81770438, 91439122, 30971104]; Major Research Program of Guangdong Science and Technology [2017A030308002]; Academy of Finland [285223, 322647]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Research Program of Guangdong Science and Technology; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation	This work was supported by the National Natural Science Foundation of China (NSFC) (Grants 81770438, 91439122, and 30971104 to D.Y.), the Major Research Program of Guangdong Science and Technology (Grant 2017A030308002 to D.Y.), the Academy of Finland (Grants 285223 and 322647), the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, and the Magnus Ehrnrooth Foundation (to V.M.O.). The authors declare no conflicts of interest.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Bagur R, 2017, MOL CELL, V66, P780, DOI 10.1016/j.molcel.2017.05.028; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bhanumathy C, 2012, J BIOL CHEM, V287, P43674, DOI 10.1074/jbc.M112.415786; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Cardenas C, 2016, CELL REP, V15, P219, DOI 10.1016/j.celrep.2016.03.045; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Dickinson GD, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aag1625; Dong JQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08791-0; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; Foskett JK, 2015, J MOL CELL CARDIOL, V78, P3, DOI 10.1016/j.yjmcc.2014.11.015; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Harrington JL, 2015, J MOL CELL CARDIOL, V78, P46, DOI 10.1016/j.yjmcc.2014.10.013; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Jamecna D, 2019, DEV CELL, V49, P220, DOI 10.1016/j.devcel.2019.02.021; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kuchay S, 2017, NATURE, V546, P554, DOI 10.1038/nature22965; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pan GP, 2018, J BIOL CHEM, V293, P17430, DOI 10.1074/jbc.RA118.005437; Patel S, 1997, P NATL ACAD SCI USA, V94, P11627, DOI 10.1073/pnas.94.21.11627; Pietrangelo A, 2018, CELL MOL LIFE SCI, V75, P3079, DOI 10.1007/s00018-018-2795-y; Prole DL, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a035063; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Taylor CW, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6029; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Wang LW, 2017, J BIOL CHEM, V292, P11714, DOI 10.1074/jbc.M117.789917; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Zhong WB, 2019, CELL REP, V26, P2166, DOI 10.1016/j.celrep.2019.01.082; Zhong WB, 2016, CIRC RES, V119, P1296, DOI 10.1161/CIRCRESAHA.116.309603; Zhong WB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12702; Zhong WB, 2011, EXP CELL RES, V317, P2353, DOI 10.1016/j.yexcr.2011.05.028	51	9	10	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13852	13865		10.1096/fj.201900933RR	http://dx.doi.org/10.1096/fj.201900933RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31648575	Bronze			2022-12-28	WOS:000507466100062
J	Yeo, TW; Bush, PA; Chen, YW; Young, SP; Zhang, HY; Millington, DS; Granger, DL; Mwaikambo, ED; Anstey, NM; Weinberg, JB				Yeo, Tsin W.; Bush, Peggy A.; Chen, Youwei; Young, Sarah P.; Zhang, Haoyue; Millington, David S.; Granger, Donald L.; Mwaikambo, Esther D.; Anstey, Nicholas M.; Weinberg, J. Brice			Glycocalyx breakdown is increased in African children with cerebral and uncomplicated falciparum malaria	FASEB JOURNAL			English	Article						Plasmodium falciparum; cerebral malaria; nitric oxide; endothelial glycocalyx	NITRIC-OXIDE BIOAVAILABILITY; ENDOTHELIAL GLYCOCALYX; MICROVASCULAR FUNCTION; OXYGEN-CONSUMPTION; HEPARAN-SULFATE; L-ARGININE; CREATININE; INJURY; URINE; NORMALIZATION	Cerebral malaria (CM) from Plasmodium falciparum infection is associated with endothelial dysfunction and parasite sequestration. The glycocalyx (GCX), a carbohydrate-rich layer lining the endothelium, is crucial in vascular homeostasis. To evaluate the role of its loss in the pathogenesis of pediatric CM, we measured GCX degradation in Tanzanian children with World Health Organization defined CM (n = 55), uncomplicated malaria (UM; n = 20), and healthy controls (HCs; n = 25). Urine GCX breakdown products [glycosaminoglycans (GAGs)] were quantified using dimethylmethylene blue (DMMB) and liquid chromatography tandem mass spectrometry assays. DMMB-GAG and mass spectrometry (MS)-GAG (g/mol creatinine) were increased in CM and UM compared with HCs (P < 0.001), with no differences in DMMB-GAG and MS-GAG between CM and UM children or between those with and without a fatal outcome. In CM survivors, urinary GCX DMMB-GAG normalized by d 3. After adjusting for disease severity, DMMB-GAG was significantly associated with parasitemia [partial correlation coefficient (P-corr = 0.34; P = 0.01] and plasma TNF (P-corr = 0.26; P = 0.04) and inversely with plasma and urine NO oxidation products [P-corr = 0.31 (P = 0.01) and P-corr = 0.26 (P = 0.03), respectively]. GCX breakdown is increased in children with falciparum malaria, with similar elevations in CM and UM. Endothelial GCX degradation may impair endothelial NO production, exacerbate adhesion-molecule expression, exposure, and parasite sequestration, and contribute to malaria pathogenesis.	[Yeo, Tsin W.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Yeo, Tsin W.] Tan Tock Seng Hosp, Natl Ctr Infect Dis, Singapore, Singapore; [Yeo, Tsin W.; Anstey, Nicholas M.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Bush, Peggy A.; Chen, Youwei; Young, Sarah P.; Zhang, Haoyue; Millington, David S.; Weinberg, J. Brice] Duke Univ, VA Med Ctr, 508 Fulton St Room E1001, Durham, NC 27705 USA; [Granger, Donald L.] Univ Utah, VA Med Ctr, Salt Lake City, UT USA; [Mwaikambo, Esther D.] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Centre for Infectious Diseases Singapore; Tan Tock Seng Hospital; Charles Darwin University; Menzies School of Health Research; Duke University; Utah System of Higher Education; University of Utah	Weinberg, JB (corresponding author), Duke Univ, VA Med Ctr, 508 Fulton St Room E1001, Durham, NC 27705 USA.	brice@duke.edu	Zhang, Haoyue/GRF-0485-2022	Bush, Margaret/0000-0003-1937-2640	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL130763-01]; National Health and Medical Research Council of Australia [1132975, 1098334, 1135820]; Durham and Salt Lake City Veterans Affairs (VA) Medical Centers; Singapore National Medical Research Council (CSA INV) [15nov007]; American Society of Tropical Medicine and Hygiene; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130763] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Durham and Salt Lake City Veterans Affairs (VA) Medical Centers; Singapore National Medical Research Council (CSA INV); American Society of Tropical Medicine and Hygiene; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank all patients and their families for participation in this research and the staff at the Duke-Muhimbili Clinical Research Laboratory and the Muhimbili Medical Center. This study was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant R01 HL130763-01), the National Health and Medical Research Council of Australia (Grants 1132975, 1098334, and Fellowship 1135820 to N.M.A.), the Durham and Salt Lake City Veterans Affairs (VA) Medical Centers (to J.B.W. and D.L.G.), the Singapore National Medical Research Council (CSA INV 15nov007 to T.W.Y.), and a fellowship from the American Society of Tropical Medicine and Hygiene (to N.M.A.). The authors declare no conflicts of interest.	[Anonymous], 1996, METHODS NITRIC OXIDE; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Ashley EA, 2018, LANCET, V391, P1608, DOI 10.1016/S0140-6736(18)30324-6; Auray-Blais C, 2011, MOL GENET METAB, V102, P49, DOI 10.1016/j.ymgme.2010.09.003; Chappell D, 2014, EUR J ANAESTH, V31, P474, DOI 10.1097/EJA.0000000000000085; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Embery G, 2003, CONNECT TISSUE RES, V44, P41, DOI 10.1080/03008200390152070; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Goldstein SL, 2010, KIDNEY INT, V78, P433, DOI 10.1038/ki.2010.200; Granger DL, 1996, METHOD ENZYMOL, V268, P142; Hempel C, 2019, FASEB J, V33, P2058, DOI 10.1096/fj.201800657R; Hempel C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1844-6; Hempel C, 2016, TRENDS MOL MED, V22, P453, DOI 10.1016/j.molmed.2016.04.004; Hempel C, 2014, J CEREBR BLOOD F MET, V34, P1107, DOI 10.1038/jcbfm.2014.79; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; HUSDAN H, 1968, CLIN CHEM, V14, P222; Introini V, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0773; Lopansri BK, 2003, LANCET, V361, P676, DOI 10.1016/S0140-6736(03)12564-0; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lukasz A, 2017, CARDIOVASC RES, V113, P671, DOI 10.1093/cvr/cvx023; Manjurano A, 2015, J INFECT DIS, V212, P1129, DOI 10.1093/infdis/jiv192; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Remer T, 2014, CLIN BIOCHEM, V47, P307, DOI 10.1016/j.clinbiochem.2014.09.009; Rubach MP, 2019, INFECT IMMUN, V87, DOI [10.1128/IAI.00655-18, 10.1128/iai.00655-18]; Rubach MP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004655; Schmidt EP, 2016, AM J RESP CRIT CARE, V194, P439, DOI 10.1164/rccm.201511-2281OC; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; SCHWARTZ GJ, 1976, J PEDIATR-US, V88, P828, DOI 10.1016/S0022-3476(76)81125-0; Song JW, 2018, NEPHROL DIAL TRANSPL, V33, P203, DOI 10.1093/ndt/gfx076; Sun XJ, 2015, ANAL CHEM, V87, P6220, DOI 10.1021/acs.analchem.5b00913; Tang KWA, 2015, SINGAP MED J, V56, P7, DOI 10.11622/smedj.2015003; Tang THC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46191; Tarbell JM, 2016, J INTERN MED, V280, P97, DOI 10.1111/joim.12465; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Waikar SS, 2012, J AM SOC NEPHROL, V23, P13, DOI 10.1681/ASN.2010111124; Wang JJ, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2035-8; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Weinberg JB, 2008, CURR OPIN INFECT DIS, V21, P468, DOI 10.1097/QCO.0b013e32830ef5cf; Weinberg JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep29151; Weinberg JB, 2014, J INFECT DIS, V210, P913, DOI 10.1093/infdis/jiu156; World Health Organization, 2018, WORLD MAL REP 2018; Yen WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117133; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2008, J INFECT DIS, V198, P602, DOI 10.1086/590209; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx079; Yeo TW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004667; Yeo TW, 2014, J INFECT DIS, V210, P1627, DOI 10.1093/infdis/jiu308; Yeo TW, 2013, J INFECT DIS, V207, P528, DOI 10.1093/infdis/jis692; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641; Yeo TW, 2019, CLIN INFECT DIS; Zhang HY, 2015, MOL GENET METAB, V114, P123, DOI 10.1016/j.ymgme.2014.09.009; Zullo JA, 2016, AM J PATHOL, V186, P248, DOI 10.1016/j.ajpath.2015.10.001	59	13	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14185	14193		10.1096/fj.201901048RR	http://dx.doi.org/10.1096/fj.201901048RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31658834	Green Published			2022-12-28	WOS:000507466100087
J	Zhu, Q; Dong, H; Bukhari, AAS; Zhao, AR; Li, M; Sun, YF; Zhang, X; Cao, CC; Su, DM; Liang, XB				Zhu, Qian; Dong, Hao; Bukhari, Ashfaq-Ahmad-Shah; Zhao, Anran; Li, Min; Sun, Yifei; Zhang, Xue; Cao, Changchun; Su, Dongming; Liang, Xiubin			HUWE1 promotes EGFR ubiquitination and degradation to protect against renal tubulointerstitial fibrosis	FASEB JOURNAL			English	Article						EGFR; HUWE1; protein-protein interaction; renal tubulointerstitial fibrosis; ubiquitination	GROWTH-FACTOR RECEPTOR; CHRONIC KIDNEY-DISEASE; ANGIOTENSIN-II; ACTIVATION; PROGRESSION; MECHANISMS; THERAPY; CANCER; BETA	Injury of renal tubular epithelial cells is a key feature of the pathogenicity associated with tubulointerstitial fibrosis and other kidney diseases. HUWE1, an E3 ubiquitin ligase, acts by participating in ubiquitination and degradation of its target proteins. However, the detailed mechanisms by which HUWE1 might regulate fibrosis in renal tubular epithelial cells have not been established. Here, the possible regulation of renal tubulointerstitial fibrosis by HUWE1 was investigated by examining the expression of HUWE1 and EGFR in unilateral ureteral obstruction (UUO) mice. Markedly consistent reciprocal changes in HUWE1 and EGFR expression were observed at the protein and mRNA levels in the kidney after UUO injury. Expression of HUWE1 inhibited TGF-beta-induced injury to HK-2 cells, while HUWE1 overexpression decreased the expression of EGFR. Further analysis indicated that HUWE1 physically interacted with EGFR and promoted its ubiquitination and degradation. HUWE1 expression also showed clinical relevance in renal disease, as it notably decreased in multiple types of clinical nephropathy, while EGFR expression significantly increased when compared to the normal kidney. Therefore, this study demonstrated that HUWE1, which serves as an E3 ubiquitin ligase specific for EGFR, promotes EGFR ubiquitination and degradation, thereby regulating EGFR expression and providing protection against kidney injury.	[Zhu, Qian; Dong, Hao; Bukhari, Ashfaq-Ahmad-Shah; Zhao, Anran; Sun, Yifei; Zhang, Xue; Liang, Xiubin] Nanjing Med Univ, Dept Pathophysiol, Nanjing 211166, Jiangsu, Peoples R China; [Li, Min; Su, Dongming] Nanjing Med Univ, Dept Pathol, Nanjing, Peoples R China; [Cao, Changchun; Liang, Xiubin] Nanjing Med Univ, Dept Nephrol, Affiliated Sir Run Run Hosp, Nanjing, Peoples R China; [Su, Dongming] Nanjing Med Univ, Ctr Pathol & Clin Lab, Affiliated Sir Run Run Hosp, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liang, XB (corresponding author), Nanjing Med Univ, Dept Pathophysiol, Nanjing 211166, Jiangsu, Peoples R China.	liangxiubin@njmu.edu.cn			National Natural Science Foundation of China (NSFC) [81870467, 81670619, 81570779]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870467, 81670619 and 81570779	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Appenroth D, 2001, EXP TOXICOL PATHOL, V53, P316, DOI 10.1078/0940-2993-00197; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; Cappuzzo F, 2006, NEW ENGL J MED, V354, P2619, DOI 10.1056/NEJMc060020; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; ElNahas AM, 1997, INT J BIOCHEM CELL B, V29, P55, DOI 10.1016/S1357-2725(96)00119-7; Fogo AB, 2001, KIDNEY INT, V59, P804, DOI 10.1046/j.1523-1755.2001.059002804.x; Gagliardini E, 2006, CYTOKINE GROWTH F R, V17, P89, DOI 10.1016/j.cytogfr.2005.09.005; Gao CL, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/918396; Harskamp LR, 2016, NAT REV NEPHROL, V12, P496, DOI 10.1038/nrneph.2016.91; Huang YJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0002-y; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Izzedine H, 2017, NEPHROL DIAL TRANSPL, V32, P1089, DOI 10.1093/ndt/gfw467; Jiang L, 2013, J AM SOC NEPHROL, V24, P1114, DOI 10.1681/ASN.2012050476; Kao SH, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0470-0; Klahr S, 2000, KIDNEY INT, V57, pS7, DOI 10.1046/j.1523-1755.2000.07509.x; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Li YA, 2010, AM J PHYSIOL-HEART C, V299, pH1959, DOI 10.1152/ajpheart.00526.2010; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Melenhorst WBWH, 2008, HYPERTENSION, V52, P987, DOI 10.1161/HYPERTENSIONAHA.108.113860; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Rego RL, 2010, BRIT J CANCER, V102, P165, DOI 10.1038/sj.bjc.6605473; Rosell R, 2008, ANN ONCOL, V19, P362, DOI 10.1093/annonc/mdm474; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Swanton C, 2006, CLIN CANCER RES, V12, p4377S, DOI 10.1158/1078-0432.CCR-06-0115; Tang JH, 2013, AM J PATHOL, V183, P160, DOI 10.1016/j.ajpath.2013.04.005; Tang JH, 2013, KIDNEY INT, V83, P804, DOI 10.1038/ki.2012.435; Tong JF, 2014, MOL CELL PROTEOMICS, V13, P1644, DOI 10.1074/mcp.M114.038596; Wang X, 2016, BIOCHEM PHARMACOL, V116, P200, DOI 10.1016/j.bcp.2016.07.017; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; You H, 2017, J CELL SCI, V130, P1027, DOI 10.1242/jcs.198242; ZHUANG S, 2011, KIDNEY INT S, V4, P70	38	11	12	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4591	4601		10.1096/fj.201902751R	http://dx.doi.org/10.1096/fj.201902751R		FEB 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32017279				2022-12-28	WOS:000511114300001
J	Erickson, SL; Alston, L; Nieves, K; Chang, TKH; Mani, S; Flannigan, KL; Hirota, SA				Erickson, Sarah L.; Alston, Laurie; Nieves, Kristoff; Chang, Thomas K. H.; Mani, Sridhar; Flannigan, Kyle L.; Hirota, Simon A.			The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins	FASEB JOURNAL			English	Article						Clostridioides difficile; eosinophils; neutrophils; Nr1i2; pregnane X receptor; toxin	NF-KAPPA-B; NEUTROPHIL RECRUITMENT; INTESTINAL INFLAMMATION; COLONIC INFLAMMATION; BARRIER FUNCTION; INFECTION; ACTIVATION; EOSINOPHILS; EXPRESSION; CELLS	Clostridioides difficile (formerly Clostridium difficile; C difficile), the leading cause of nosocomial antibiotic-associated colitis and diarrhea in the industrialized world, triggers colonic disease through the release two toxins, toxin A (TcdA) and toxin B (TcdB), glucosyltransferases that modulate monomeric G-protein function and alter cytoskeletal function. The initial degree of the host immune response to C difficile and its pathogenic toxins is a common indicator of disease severity and infection recurrence. Thus, targeting the intestinal inflammatory response during infection could significantly decrease disease morbidity and mortality. In the current study, we sought to interrogate the influence of the pregnane X receptor (PXR), a modulator of xenobiotic and detoxification responses, which can sense and respond to microbial metabolites and modulates inflammatory activity, during exposure to TcdA and TcdB. Following intrarectal exposure to TcdA/B, PXR-deficient mice (Nr1i2(-/-)) exhibited reduced survival, an effect that was associated with increased levels of innate immune cell influx. This exacerbated response was associated with a twofold increase in the expression of Tlr4. Furthermore, while broad-spectrum antibiotic treatment (to deplete the intestinal microbiota) did not alter the responses in Nr1i2(-/-) mice, blocking TLR4 signaling significantly reduced TcdA/B-induced disease severity and immune responses in these mice. Lastly, to assess the therapeutic potential of targeting the PXR, we activated the PXR with pregnenolone 16 alpha-carbonitrile (PCN) in wild-type mice, which greatly reduced the severity of TcdA/B-induced damage and intestinal inflammation. Taken together, these data suggest that the PXR plays a role in the host's response to TcdA/B and may provide a novel target to dampen the inflammatory tissue damage in C difficile infections.	[Erickson, Sarah L.; Alston, Laurie; Nieves, Kristoff; Flannigan, Kyle L.; Hirota, Simon A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Chang, Thomas K. H.] Univ British Columbia, Fac Pharmaceut Sciences, Vancouver, BC, Canada; [Mani, Sridhar] Albert Einstein Coll Med, Dept Med, Bronx, NY USA; [Hirota, Simon A.] Univ Calgary, Dept MicroBiol, Immunol, Infect Dis, Calgary, AB, Canada; Univ Calgary, Calgary, AB T2N 4N1, Canada	University of Calgary; University of British Columbia; Yeshiva University; Albert Einstein College of Medicine; University of Calgary; University of Calgary	Flannigan, KL; Hirota, SA (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Hirota, SA (corresponding author), Univ Calgary, Dept MicroBiol, Immunol, Infect Dis, Calgary, AB, Canada.	kyle.flannigan1@ucalgary.ca; shirota@ucalgary.ca		, Thomas/0000-0003-2167-5165	NCI NIH HHS [R01 CA222469] Funding Source: Medline; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [CA161879, CA222469] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)		Abt MC, 2016, NAT REV MICROBIOL, V14, P609, DOI 10.1038/nrmicro.2016.108; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Buonomo EL, 2016, CELL REP, V16, P432, DOI 10.1016/j.celrep.2016.06.007; Castagliuolo I, 1998, J IMMUNOL, V160, P6039; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Darkoh C, 2014, CLIN VACCINE IMMUNOL, V21, P509, DOI 10.1128/CVI.00770-13; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dheer R, 2016, INFECT IMMUN, V84, P798, DOI 10.1128/IAI.01374-15; El Feghaly RE, 2013, CLIN INFECT DIS, V56, P1713, DOI 10.1093/cid/cit147; Esposito G, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00120; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Flannigan KL, 2017, MUCOSAL IMMUNOL, V10, P673, DOI 10.1038/mi.2016.80; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; Garg A, 2016, J PHARMACOL EXP THER, V359, P91, DOI 10.1124/jpet.116.234096; Gerding DN, 2015, INFECT DIS CLIN N AM, V29, P37, DOI 10.1016/j.idc.2014.11.004; Ghose C, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.62; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Hirota SA, 2012, INFECT IMMUN, V80, P4474, DOI 10.1128/IAI.00933-12; Hirota SA, 2010, GASTROENTEROLOGY, V139, P259, DOI 10.1053/j.gastro.2010.03.045; Huang KZ, 2018, PEDIATR RES, V83, P1031, DOI 10.1038/pr.2018.14; Hudson GM, 2017, BRIT J PHARMACOL, V174, P1857, DOI 10.1111/bph.13787; Hung YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069577; Hunt JJ, 2013, MICROBIOL MOL BIOL R, V77, P567, DOI 10.1128/MMBR.00017-13; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Jefferson KK, 1999, J IMMUNOL, V163, P5183; Jose S, 2016, ANAEROBE, V41, P85, DOI 10.1016/j.anaerobe.2016.04.001; KELLY CP, 1994, J CLIN INVEST, V93, P1257, DOI 10.1172/JCI117080; Kim JM, 2006, SCAND J IMMUNOL, V63, P453, DOI 10.1111/j.1365-3083.2006.001756.x; Kim J, 2017, ANN LAB MED, V37, P53, DOI 10.3343/alm.2017.37.1.53; Lamas B, 2018, MUCOSAL IMMUNOL, V11, P1024, DOI 10.1038/s41385-018-0019-2; Lee JY, 2007, J MOL MED-JMM, V85, P1393, DOI 10.1007/s00109-007-0237-7; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; LYERLY DM, 1982, INFECT IMMUN, V35, P1147, DOI 10.1128/IAI.35.3.1147-1150.1982; Maltby S, 2010, AM J PATHOL, V177, P1244, DOI 10.2353/ajpath.2010.100191; McAlees JW, 2015, MUCOSAL IMMUNOL, V8, P863, DOI 10.1038/mi.2014.117; McDermott AJ, 2017, IMMUNOLOGY, V150, P468, DOI 10.1111/imm.12700; Miller KA, 2019, P NATL ACAD SCI USA, V116, P5955, DOI 10.1073/pnas.1814047116; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; Pawlowski SW, 2010, J INFECT DIS, V202, P1708, DOI 10.1086/657086; Peretz A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1618-8; Qiu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31936; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ranhotra H.S, 2016, NUCL RECEPTOR RES, V3; Rao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092578; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG1114, DOI 10.1152/ajpgi.00528.2006; Terc J, 2014, EUR J PHARM SCI, V55, P12, DOI 10.1016/j.ejps.2014.01.007; van Beurden YH, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.07.025; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Vieira AT, 2009, AM J PATHOL, V175, P2382, DOI 10.2353/ajpath.2009.090093; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2000, J CLIN INVEST, V105, P1147, DOI 10.1172/JCI7545; Weller PF, 2017, NAT REV IMMUNOL, V17, P746, DOI 10.1038/nri.2017.95; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	63	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2198	2212		10.1096/fj.201902083RR	http://dx.doi.org/10.1096/fj.201902083RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907988	Green Published, hybrid			2022-12-28	WOS:000514663600019
J	Kashiwagi, S				Kashiwagi, Satoshi			Laser adjuvant for vaccination	FASEB JOURNAL			English	Review						adjuvant; laser; skin; vaccine	XCR1(+) DENDRITIC CELLS; INTRADERMAL DELIVERY; TRANSCUTANEOUS VACCINATION; EPICUTANEOUS IMMUNOTHERAPY; SKIN VACCINATION; IMMUNITY; VACCINES; PHOTOIMMUNOTHERAPY; IMMUNIZATION; RESPONSES	The use of an immunologic adjuvant to augment the immune response is essential for modern vaccines which are relatively ineffective on their own. In the past decade, researchers have been consistently reporting that skin treatment with a physical parameter, namely laser light, augments the immune response to vaccine and functions as an immunologic adjuvant. This "laser adjuvant" has numerous advantages over the conventional chemical or biological agents; it is free from cold chain storage, hypodermic needles, biohazardous sharp waste, irreversible formulation with vaccine antigen, undesirable biodistribution in vital organs, or unknown long-term toxicity. Since vaccine formulations are given to healthy populations, these characteristics render the "laser adjuvant" significant advantages for clinical use and open a new developmental path for a safe and effective vaccine. In addition, laser technology has been used in the clinic for more than three decades and is therefore technically matured and has been proved to be safe. Currently, four classes of laser adjuvant have been reported; ultrashort pulsed, non-pulsed, non-ablative fractional, and ablative fractional lasers. Since each class of the laser adjuvant shows a distinct mechanism of action, a proper choice is necessary to craft an effective vaccine formulation toward a desired clinical benefit for a clinical vaccine to maximize protection. In addition, data also suggest that further improvement in the efficacy is possible when a laser adjuvant is combined with chemical or biological adjuvant(s). To realize these goals, further efforts to uncover the molecular mechanisms of action of the laser adjuvants is warranted. This review provides a summary and comments of the recent updates in the laser adjuvant technology.	[Kashiwagi, Satoshi] Massachusetts Gen Hosp, Dept Radiol, Gordon Ctr Med Imaging, 149 13th St, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Kashiwagi, S (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Gordon Ctr Med Imaging, 149 13th St, Charlestown, MA 02129 USA.	skashiwagi@mgh.harvard.edu	Kashiwagi, Satoshi/T-2420-2019		National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI105131, R21AI144103]; Massachusetts General Hospital Executive Committee On Research (ECOR)	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Massachusetts General Hospital Executive Committee On Research (ECOR)	This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI105131 (SK) and R21AI144103 (SK) and Massachusetts General Hospital Executive Committee On Research (ECOR) Interim Support Funding (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ackroyd R, 2001, PHOTOCHEM PHOTOBIOL, V74, P656, DOI 10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO;2; Alexandre YO, 2016, J EXP MED, V213, P75, DOI 10.1084/jem.20142350; Bachhav YG, 2010, J CONTROL RELEASE, V146, P31, DOI 10.1016/j.jconrel.2010.05.025; Batista-Duharte A, 2013, INT IMMUNOPHARMACOL, V17, P526, DOI 10.1016/j.intimp.2013.07.025; Batista-Duharte A, 2011, TOXICOL LETT, V203, P97, DOI 10.1016/j.toxlet.2011.03.001; Bergmann-Leitner ES, 2014, VACCINES-BASEL, V2, P252, DOI 10.3390/vaccines2020252; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Bonam SR, 2017, TRENDS PHARMACOL SCI, V38, P771, DOI 10.1016/j.tips.2017.06.002; Chen WR, 1997, CANCER LETT, V115, P25, DOI 10.1016/S0304-3835(97)04707-1; Chen XW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008598; Chen XY, 2014, J CONTROL RELEASE, V192, P310, DOI 10.1016/j.jconrel.2014.08.006; Chen XY, 2012, VACCINE, V31, P159, DOI 10.1016/j.vaccine.2012.10.069; Chen XY, 2012, CLIN CANCER RES, V18, P2240, DOI 10.1158/1078-0432.CCR-11-2654; Chen XY, 2012, J CONTROL RELEASE, V159, P43, DOI 10.1016/j.jconrel.2012.01.002; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Combadiere B, 2011, HUM VACCINES, V7, P811, DOI 10.4161/hv.7.8.16274; Del Giudice G, 2018, SEMIN IMMUNOL, V39, P14, DOI 10.1016/j.smim.2018.05.001; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Fehres CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00157; Garcon N, 2011, VACCINE, V29, P4453, DOI 10.1016/j.vaccine.2011.04.046; Gavillet BM, 2015, VACCINE, V33, P3450, DOI 10.1016/j.vaccine.2015.05.089; Gelfand JA, 2019, FASEB J, V33, P3074, DOI 10.1096/fj.201801095R; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Globinska A, 2018, ANN ALLERG ASTHMA IM, V121, P306, DOI 10.1016/j.anai.2018.06.026; Grzybowski A, 2012, CLIN DERMATOL, V30, P451, DOI 10.1016/j.clindermatol.2011.11.019; Gudjonsson A, 2017, J IMMUNOL, V198, P2785, DOI 10.4049/jimmunol.1601881; Gupta R K, 1995, Pharm Biotechnol, V6, P229; Gutowska-Owsiak D, 2012, J INVEST DERMATOL, V132, P940, DOI 10.1038/jid.2011.398; Haedersdal M, 2010, LASER SURG MED, V42, P113, DOI 10.1002/lsm.20860; Hanna E, 2016, INT J DERMATOL, V55, P831, DOI 10.1111/ijd.13235; Herve PL, 2019, J CONTROL RELEASE, V298, P12, DOI 10.1016/j.jconrel.2019.02.004; Herve PL, 2016, J CONTROL RELEASE, V243, P146, DOI 10.1016/j.jconrel.2016.10.003; Hessenberger M, 2013, VACCINE, V31, P3427, DOI 10.1016/j.vaccine.2012.09.086; Joubert IA, 2020, VACCINE, V38, P1015, DOI 10.1016/j.vaccine.2019.11.051; Kashiwagi Satoshi, 2016, J Vaccines Vaccin, V7; Kashiwagi S, 2014, HUM VACC IMMUNOTHER, V10, P1892, DOI 10.4161/hv.28840; Kashiwagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082899; Kim DH, 2012, EXP DERMATOL, V21, P99, DOI 10.1111/j.1600-0625.2011.01399.x; Kim KS, 2016, ADV FUNCT MATER, V26, P2512, DOI 10.1002/adfm.201504879; Kimizuka Y, 2018, J IMMUNOL, V201, P3587, DOI 10.4049/jimmunol.1701687; Kimizuka Y, 2017, VACCINE, V35, P2404, DOI 10.1016/j.vaccine.2017.03.036; Kitano M, 2016, P NATL ACAD SCI USA, V113, P1044, DOI 10.1073/pnas.1513607113; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kumar MNK, 2016, J CONTROL RELEASE, V235, P82, DOI 10.1016/j.jconrel.2016.05.057; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; Larange A, 2016, ANNU REV IMMUNOL, V34, P369, DOI 10.1146/annurev-immunol-041015-055427; Lee S, 2015, IMMUNE NETW, V15, P51, DOI 10.4110/in.2015.15.2.51; Li PY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02570; Lopes PP, 2018, J VIROL, V92, DOI 10.1128/JVI.02156-17; Luo M, 2018, INT J HYPERTHER, V34, P1337, DOI 10.1080/02656736.2018.1446221; Machado Y, 2017, J CONTROL RELEASE, V266, P87, DOI 10.1016/j.jconrel.2017.09.020; MEW D, 1983, J IMMUNOL, V130, P1473; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Mondoulet L, 2010, CLIN EXP ALLERGY, V40, P659, DOI 10.1111/j.1365-2222.2009.03430.x; Morse K, 2017, J IMMUNOL, V199, P1319, DOI 10.4049/jimmunol.1601873; Naylor MF, 2017, J BIOPHOTONICS, V10, P618, DOI 10.1002/jbio.201600271; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Nirschl CJ, 2016, HUM VACC IMMUNOTHER, V12, P104, DOI 10.1080/21645515.2015.1066050; Onikienko S. B., 2007, DONOSOLOGIYA ST PETE, V1, P32; Preissig Jason, 2012, Semin Plast Surg, V26, P109, DOI 10.1055/s-0032-1329413; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Saedi N, 2011, CLIN PLAST SURG, V38, P449, DOI 10.1016/j.cps.2011.02.008; Scheiblhofer S, 2017, VACCINE, V35, P1802, DOI 10.1016/j.vaccine.2016.11.105; Schijns VEJC, 2011, EXPERT REV VACCINES, V10, P539, DOI [10.1586/erv.11.21, 10.1586/ERV.11.21]; Shi L, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800149; Sticchi L, 2010, J Prev Med Hyg, V51, P7; Tan A U, 2018, Int J Womens Dermatol, V4, P56, DOI 10.1016/j.ijwd.2017.10.006; Terhorst D, 2015, J IMMUNOL, V194, P5895, DOI 10.4049/jimmunol.1500564; Teunissen MBM, 2015, VACCINE, V33, P4659, DOI 10.1016/j.vaccine.2015.07.079; Tian XY, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.01683, 10.3389/fimmu.2018.00473]; Wang J, 2015, P NATL ACAD SCI USA, V112, P5005, DOI 10.1073/pnas.1500408112; Wang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5447; Weiss R, 2012, J CONTROL RELEASE, V162, P391, DOI 10.1016/j.jconrel.2012.06.031; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884; Wu SN, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804923; Wu SA, 2014, ANTIOXID REDOX SIGN, V20, P733, DOI 10.1089/ars.2013.5229; Wu SN, 2009, J CELL PHYSIOL, V218, P603, DOI 10.1002/jcp.21636; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798; Zehrung D, 2013, VACCINE, V31, P3392, DOI 10.1016/j.vaccine.2012.11.021; Zhou C, 2015, J CONTROL RELEASE, V204, P30, DOI 10.1016/j.jconrel.2015.02.031; Zhou FF, 2018, CLIN CANCER RES, V24, P5335, DOI 10.1158/1078-0432.CCR-18-1126; Zhou FF, 2016, J INNOV OPT HEAL SCI, V9, DOI 10.1142/S1793545816300019; Zhou FF, 2013, J INNOV OPT HEAL SCI, V6, DOI 10.1142/S1793545813500399	84	12	13	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3485	3500		10.1096/fj.201902164R	http://dx.doi.org/10.1096/fj.201902164R		JAN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31994227	Green Accepted			2022-12-28	WOS:000509934000001
J	Shaul, ME; Eyal, O; Guglietta, S; Aloni, P; Zlotnik, A; Forkosh, E; Levy, L; Weber, LM; Levin, Y; Pomerantz, A; Nechushtan, L; Eruslanov, E; Singhal, S; Robinson, MD; Krieg, C; Fridlender, ZG				Shaul, Merav E.; Eyal, Ophir; Guglietta, Silvia; Aloni, Pazzit; Zlotnik, Asaf; Forkosh, Ester; Levy, Liran; Weber, Lukas M.; Levin, Yonathan; Pomerantz, Alon; Nechushtan, Lovav; Eruslanov, Evgeniy; Singhal, Sunil; Robinson, Mark D.; Krieg, Carsten; Fridlender, Zvi G.			Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis	FASEB JOURNAL			English	Article						lung cancer; mass cytometry; neutrophils; phenotypic modulation	TO-LYMPHOCYTE RATIO; POOR-PROGNOSIS; CELLS; PLASTICITY; PHENOTYPE; FUNCTIONALITY; GRANULOCYTES; CHEMOTHERAPY; INDICATOR	The accumulation of circulating low-density neutrophils (LDN) has been described in cancer patients and associated with tumor-supportive properties, as opposed to the high-density neutrophils (HDN). Here we aimed to evaluate the clinical significance of circulating LDN in lung cancer patients, and further assessed its diagnostic vs prognostic value. Using mass cytometry (CyTOF), we identified major subpopulations within the circulating LDN/HDN subsets and determined phenotypic modulations of these subsets along tumor progression. LDN were highly enriched in the low-density (LD) fraction of advanced lung cancer patients (median 7.0%; range 0.2%-80%, n = 64), but not in early stage patients (0.7%; 0.05%-6%; n = 35), healthy individuals (0.8%; 0%-3.5%; n = 15), or stable chronic obstructive pulmonary disease (COPD) patients (1.2%; 0.3%-7.4%, n = 13). Elevated LDN (>10%) remarkably related with poorer prognosis in late stage patients. We identified three main neutrophil subsets which proportions are markedly modified in cancer patients, with CD66b(+)/CD10(low)/CXCR4(+)/PDL1(inter) subset almost exclusively found in advanced lung cancer patients. We found substantial variability in subsets between patients, and demonstrated that HDN and LDN retain a degree of inherent spontaneous plasticity. Deep phenotypic characterization of cancer-related circulating neutrophils and their modulation along tumor progression is an important advancement in understanding the role of myeloid cells in lung cancer.	[Shaul, Merav E.; Eyal, Ophir; Aloni, Pazzit; Zlotnik, Asaf; Forkosh, Ester; Levy, Liran; Levin, Yonathan; Pomerantz, Alon; Fridlender, Zvi G.] Hadassah Hebrew Univ Hosp, Inst Pulm Med, Jerusalem, Israel; [Guglietta, Silvia; Krieg, Carsten] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Guglietta, Silvia; Krieg, Carsten] Med Univ South Carolina, Dept Dermatol, Charleston, SC 29425 USA; [Weber, Lukas M.; Robinson, Mark D.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Weber, Lukas M.; Robinson, Mark D.] Univ Zurich, SIB, Zurich, Switzerland; [Nechushtan, Lovav] Hadassah Hebrew Univ Hosp, Sharrett Inst Oncol, Jerusalem, Israel; [Eruslanov, Evgeniy; Singhal, Sunil] Univ Penn, Thorac Oncol Res Lab, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Medical University of South Carolina; Medical University of South Carolina; University of Zurich; Swiss Institute of Bioinformatics; University of Zurich; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Pennsylvania	Fridlender, ZG (corresponding author), Hadassah Hebrew Univ Hosp, Hadassah Med Ctr, Inst Pulm Med, POB 12000, IL-91120 Jerusalem, Israel.	fridlender@hadassah.org.il	Robinson, Mark D./O-2254-2019; Eruslanov, Evgeniy/AAS-1277-2020	Robinson, Mark D./0000-0002-3048-5518; Levy, Liran/0000-0001-6368-8015; Krieg, Carsten/0000-0002-5145-7591; Guglietta, Silvia/0000-0001-9998-5716	Israel Cancer Research Fund; Israel Science Foundation; Israel Lung Association; Hebrew University; Hadassah Medical Center; COST Action [BM1404]; EU	Israel Cancer Research Fund; Israel Science Foundation(Israel Science Foundation); Israel Lung Association; Hebrew University; Hadassah Medical Center; COST Action(European Cooperation in Science and Technology (COST)); EU(European Commission)	This work was supported by a grant from the Israel Cancer Research Fund, by the Israel Science Foundation, the Israel Lung Association and by a grant from the Joint Research Fund of the Hebrew University and Hadassah Medical Center. This work was kindly backed by the COST Action BM1404 Mye-EUNITER (http://www.myeeuniter.eu).COST is supported by the EU Framework Program Horizon 2020.	[Anonymous], 2010, R LANG ENV STAT COMP; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Carmona-Rivera C, 2013, SEMIN IMMUNOPATHOL, V35, P455, DOI 10.1007/s00281-013-0375-7; Cassatella MA, 2017, BLOOD, V129, P1895, DOI 10.1182/blood-2017-02-767574; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Chevrier S, 2018, CELL SYST, V6, P612, DOI 10.1016/j.cels.2018.02.010; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Demers M, 2014, SEMIN THROMB HEMOST, V40, P277, DOI 10.1055/s-0034-1370765; Elliott LA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00086; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gershkovitz M, 2018, CANCER RES, V78, P2680, DOI 10.1158/0008-5472.CAN-17-3614; Granot Z, 2015, CANCER RES, V75, P4441, DOI 10.1158/0008-5472.CAN-15-1502; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hsu BE, 2019, CELL REP, V27, P3902, DOI 10.1016/j.celrep.2019.05.091; Jeong J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01817; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Lalani AKA, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0315-0; Lang S, 2018, CLIN CANCER RES, V24, P4834, DOI 10.1158/1078-0432.CCR-17-3726; Lecot P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02155; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Liu D, 2018, CELL PHYSIOL BIOCHEM, V46, P1595, DOI 10.1159/000489207; Liu S, 2018, MOL MED REP, V17, P699, DOI 10.3892/mmr.2017.7970; Ma PW, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01401; Marini O, 2017, BLOOD, V129, P1343, DOI 10.1182/blood-2016-04-713206; Matsushima H, 2013, BLOOD, V121, P1677, DOI 10.1182/blood-2012-07-445189; Mhaonaigh AU, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02603; Mitchell P, 2015, ANN ONCOL, V26, P1134, DOI 10.1093/annonc/mdv104; Najjar YG, 2017, CLIN CANCER RES, V23, P2346, DOI 10.1158/1078-0432.CCR-15-1823; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Park YH, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-243; Patel S, 2018, NAT IMMUNOL, V19, P1236, DOI 10.1038/s41590-018-0229-5; Peng B, 2015, INT J CLIN EXP MED, V8, P3098; Piccard H, 2012, CRIT REV ONCOL HEMAT, V82, P296, DOI 10.1016/j.critrevonc.2011.06.004; Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Schmielau J, 2001, CANCER RES, V61, P4756; Shao N, 2015, CLIN TRANSL ONCOL, V17, P772, DOI 10.1007/s12094-015-1289-8; Shaul ME, 2017, J LEUKOCYTE BIOL, V102, P343, DOI 10.1189/jlb.5MR1216-508R; Shaul ME, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232221; Singhal S, 2016, CANCER CELL, V30, P120, DOI 10.1016/j.ccell.2016.06.001; Ssemaganda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085696; Tabaries S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0558-3; Takashima A, 2015, J LEUKOCYTE BIOL, V98, P489, DOI 10.1189/jlb.1MR1014-502R; Takeda T, 2018, THORAC CANCER, V9, P1291, DOI 10.1111/1759-7714.12838; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Vono M, 2017, BLOOD, V129, P1991, DOI 10.1182/blood-2016-10-744441; Weber LM, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0415-5; Weber LM, 2016, CYTOM PART A, V89A, P1084, DOI 10.1002/cyto.a.23030; Wu LY, 2019, CANCERS, V11, DOI 10.3390/cancers11040564; Yamauchi Y, 2018, AM J RESP CRIT CARE, V198, P777, DOI 10.1164/rccm.201708-1707OC; Yang PQ, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/8016254; Yu Y, 2017, MOL CLIN ONCOL, V7, P498, DOI 10.3892/mco.2017.1342	58	37	37	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4204	4218		10.1096/fj.201902467R	http://dx.doi.org/10.1096/fj.201902467R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957112				2022-12-28	WOS:000508135500001
J	Elsayed, R; Kurago, Z; Cutler, CW; Arce, R; Gerber, J; Celis, E; Sultan, H; Elashiry, M; Meghil, M; Sun, C; Auersvald, CM; Elsayed, R; Elshikh, MEM; Isales, C; Elsalanty, ME; Zeitoun, R; Awad, ME				Elsayed, Ranya; Kurago, Zoya; Cutler, Christopher W.; Arce, Roger; Gerber, Jennifer; Celis, Esteban; Sultan, Hussein; Elashiry, Mahmoud; Meghil, Mohamed; Sun, Christina; Auersvald, Caroline M.; Elsayed, Riham; Elshikh, Mohey Eldin M.; Isales, Carlos; Elsalanty, Mohammed E.; Zeitoun, Rana; Awad, Mohamed E.			Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw	FASEB JOURNAL			English	Article						alveolar bone healing; dendritic cells; osteonecrosis	MEDICATION-RELATED OSTEONECROSIS; ZOLEDRONIC ACID; PROGENITOR CELLS; POSITION PAPER; BONE; BISPHOSPHONATES; MONOCYTES; ASSOCIATION; REMOVAL; LIGAND	Dendritic cells are an important link between innate and adaptive immune response. The role of dendritic cells in bone homeostasis, however, is not understood. Osteoporosis medications that inhibit osteoclasts have been associated with osteonecrosis, a condition limited to the jawbone, thus called medication-related osteonecrosis of the jaw. We propose that disruption of the local immune response renders the oral microenvironment conducive to osteonecrosis. We tested whether zoledronate (Zol) treatment impaired dendritic cell (DC) functions and increased bacterial load in alveolar bone in vivo and whether DC inhibition alone predisposed the animals to osteonecrosis. We also analyzed the role of Zol in impairment of differentiation and function of migratory and tissue-resident DCs, promoting disruption of T-cell activation in vitro. Results demonstrated a Zol induced impairment in DC functions and an increased bacterial load in the oral cavity. DC-deficient mice were predisposed to osteonecrosis following dental extraction. Zol treatment of DCs in vitro caused an impairment in immune functions including differentiation, maturation, migration, antigen presentation, and T-cell activation. We conclude that the mechanism of Zol-induced osteonecrosis of the jaw involves disruption of DC immune functions required to clear bacterial infection and activate T cell effector response.	[Elsayed, Ranya; Kurago, Zoya; Gerber, Jennifer; Elashiry, Mahmoud; Meghil, Mohamed; Sun, Christina; Auersvald, Caroline M.; Elsalanty, Mohammed E.; Zeitoun, Rana; Awad, Mohamed E.] Augusta Univ, Dent Coll Georgia, Dept Oral Biol & Diagnost Sci, Augusta, GA 30904 USA; [Kurago, Zoya; Celis, Esteban] Augusta Univ, Med Coll Georgia, Biochem & Mol Biol, Georgia Canc Ctr, Augusta, GA USA; [Cutler, Christopher W.; Arce, Roger; Elashiry, Mahmoud; Meghil, Mohamed] Augusta Univ, Dent Coll Georgia, Dept Periodont, Augusta, GA 30904 USA; [Sultan, Hussein] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Elsayed, Riham; Elshikh, Mohey Eldin M.] Barts & London Queen Marys Sch Med & Dent, Ctr Expt Med & Rheumatol, William Harvey Res Inst, London, England; [Isales, Carlos] Augusta Univ, Dept Neurosci & Regenerat Med, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Washington University (WUSTL); University of London; Queen Mary University London; University System of Georgia; Augusta University	Elsalanty, ME (corresponding author), Augusta Univ, Dent Coll Georgia, Dept Oral Biol & Diagnost Sci, Augusta, GA 30904 USA.	melsalanty@augusta.edu	Meghil, Mohamed M./I-4851-2019; Awad, Mohamed E./ABC-8407-2020; Sultan, Hussein/AAQ-5261-2020; Isales, Carlos/J-9902-2013; Arce, Roger M./E-6768-2011	Meghil, Mohamed M./0000-0003-2344-3579; Isales, Carlos/0000-0002-4480-3484; El Sayed, Riham/0000-0002-8634-5872; Arce, Roger M./0000-0002-4721-4722; Celis, Esteban/0000-0001-8299-4480	National Institute of Dental and Craniofacial Research [2R15DE025134-02]; National Institute of Health [1-S10 OD025177-01]; National Institute of Aging [2P01AG036675-06A1]	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by the National Institute of Dental and Craniofacial Research award number 2R15DE025134-02, National Institute of Health award number 1-S10 OD025177-01, and the National Institute of Aging award number 2P01AG036675-06A1	Abbasi J, 2018, JAMA-J AM MED ASSOC, V319, P2464, DOI 10.1001/jama.2018.7097; Alnaeeli M, 2007, J BONE MINER RES, V22, P775, DOI 10.1359/JBMR.070314; Arizon M, 2012, P NATL ACAD SCI USA, V109, P7043, DOI 10.1073/pnas.1116770109; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bringmann A, 2007, LEUKEMIA, V21, P732, DOI 10.1038/sj.leu.2404556; Cheng ML, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00329; Cutler CW, 2006, J DENT RES, V85, P678, DOI 10.1177/154405910608500801; Cutler CW, 2007, PERIODONTOL 2000, V45, P35, DOI 10.1111/j.1600-0757.2007.00222.x; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Elsayed R, 2018, BONE, V110, P141, DOI 10.1016/j.bone.2018.01.030; Failli A, 2014, HUM VACC IMMUNOTHER, V10, P3375, DOI 10.4161/hv.29416; Ferrari-Lacraz S, 2011, OSTEOPOROSIS INT, V22, P435, DOI 10.1007/s00198-010-1326-y; Howie RN, 2015, ARCH ORAL BIOL, V60, P1699, DOI 10.1016/j.archoralbio.2015.09.001; Howie RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132520; Kalyan S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0568-z; Khosla S, 2016, J BONE MINER RES, V31, P1485, DOI 10.1002/jbmr.2888; Kozloff KM, 2010, J BONE MINER RES, V25, P1748, DOI 10.1002/jbmr.66; Kyrgidis A, 2017, OSTEOPOROSIS INT, V28, P991, DOI 10.1007/s00198-016-3807-0; Lam-Ubol A, 2010, INFLAMMATION, V33, P207, DOI 10.1007/s10753-009-9175-6; Liu ZF, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.701:300319, 10.3389/fmicb.2015.00319]; Lombard T, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8768162; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Moutsopoulos NM, 2018, TRENDS IMMUNOL, V39, P276, DOI 10.1016/j.it.2017.08.005; Muccioli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2785; Muratsu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067906; Nudel I, 2011, J IMMUNOL, V186, P891, DOI 10.4049/jimmunol.1002943; Orsini G, 2011, EXP BIOL MED, V236, P1420, DOI 10.1258/ebm.2011.011168; Palani Chithra Devi, 2018, Oncotarget, V9, P6814, DOI 10.18632/oncotarget.23784; Papapoulos SE, 2007, NEW ENGL J MED, V356, P1075, DOI 10.1056/NEJMc062792; Pazianas M, 2011, JNCI-J NATL CANCER I, V103, P232, DOI 10.1093/jnci/djq516; Pushalkar S, 2014, INT J ORAL SCI, V6, P219, DOI 10.1038/ijos.2014.46; Rocha-Perugini V, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00202-17; Roelofs AJ, 2010, CURR PHARM DESIGN, V16, P2950; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Rosella D, 2016, J INT SOC PREV COMMU, V6, P97, DOI 10.4103/2231-0762.178742; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Santiago-Schwarz F, 2001, J IMMUNOL, V167, P1758, DOI 10.4049/jimmunol.167.3.1758; Santini D, 2009, CANCER IMMUNOL IMMUN, V58, P31, DOI 10.1007/s00262-008-0521-6; Sedghizadeh PP, 2008, J ORAL MAXIL SURG, V66, P767, DOI 10.1016/j.joms.2007.11.035; Siegert I, 2014, METHODS MOL BIOL, V1121, P111, DOI 10.1007/978-1-4614-9632-8_9; Stadler AF, 2017, J IMMUNOL METHODS, V449, P7, DOI 10.1016/j.jim.2017.06.007; Svejda B, 2016, WIEN MED WOCHENSCHR, V166, P68, DOI 10.1007/s10354-016-0437-2; Unternaehrer JJ, 2007, P NATL ACAD SCI USA, V104, P234, DOI 10.1073/pnas.0609665104; van Blijswijk J, 2013, EUR J IMMUNOL, V43, P22, DOI 10.1002/eji.201243022; Wilensky A, 2014, ORAL DIS, V20, P119, DOI 10.1111/odi.12122; Wolf AM, 2006, HAEMATOLOGICA, V91, P1165; Wu RQ, 2014, INT J ORAL SCI, V6, P125, DOI 10.1038/ijos.2014.48	49	14	14	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2595	2608		10.1096/fj.201901819RR	http://dx.doi.org/10.1096/fj.201901819RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31919918	Green Accepted			2022-12-28	WOS:000506587800001
J	Hatta, D; Shirotani, K; Hori, Y; Kurotaki, N; Iwata, N				Hatta, Daisuke; Shirotani, Keiro; Hori, Yuma; Kurotaki, Naohiro; Iwata, Nobuhisa			Activity-dependent cleavage of dyskinesia-related proline-rich transmembrane protein 2 (PRRT2) by calpain in mouse primary cortical neurons	FASEB JOURNAL			English	Article						calcium signaling; glutamate; neuronal excitation; NMDA receptor; proteolysis	PAROXYSMAL KINESIGENIC DYSKINESIA; MUTATIONS; DYSFUNCTION; CHANNELS	Mutations of PRRT2 (proline-rich transmembrane protein 2) cause several neurological disorders, represented by paroxysmal kinesigenic dyskinesia (PKD), which is characterized by attacks of involuntary movements triggered by sudden voluntary movements. PRRT2 is reported to suppress neuronal excitation, but it is unclear how the function of PRRT2 is modulated during neuronal excitation. We found that PRRT2 is processed to a 12 kDa carboxy-terminal fragment (12K-CTF) by calpain, a calcium-activated cysteine protease, in a neuronal activity-dependent manner, predominantly via NMDA receptors or voltage-gated calcium channels. Furthermore, we clarified that 12K-CTF is generated by sequential cleavages at Q220 and S244. The amino-terminal fragment (NTF) of PRRT2, which corresponds to PKD-related truncated mutants, is not detected, probably due to rapid cleavage at multiple positions. Given that 12K-CTF lacks most of the proline-rich domain, this cleavage might be involved in the activity-dependent enhancement of neuronal excitation perhaps through transient retraction of PRRT2's function. Therefore, PRRT2 might serve as a buffer for neuronal excitation, and lack of this function in PKD patients might cause neuronal hyperexcitability in their motor circuits.	[Hatta, Daisuke; Shirotani, Keiro; Hori, Yuma; Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Genome Based Drug Discovery, 1-14 Bunkyo Machi, Nagasaki, Nagasaki 8528521, Japan; [Kurotaki, Naohiro] Kagawa Univ, Grad Sch Med, Dept Clin Psychiat, Takamatsu, Kagawa, Japan	Nagasaki University; Kagawa University	Iwata, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Genome Based Drug Discovery, 1-14 Bunkyo Machi, Nagasaki, Nagasaki 8528521, Japan.	iwata-n@nagasaki-u.ac.jp			Program for Intractable Diseases Research, Japan Agency for Medical Research and Development (AMED) [JP16ek0109119h]; Japan Society for the Promotion of Science (JSPS) [18H02720]	Program for Intractable Diseases Research, Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Program for Intractable Diseases Research, Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP16ek0109119h; Grants-in-Aid for Scientific Research (KAKENHI), Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18H02720	Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Amini M, 2013, J NEUROSCI, V33, P5773, DOI 10.1523/JNEUROSCI.4247-12.2013; Atlas D, 2014, TRENDS BIOCHEM SCI, V39, P45, DOI 10.1016/j.tibs.2013.12.005; Budisantoso T, 2013, J PHYSIOL-LONDON, V591, P219, DOI 10.1113/jphysiol.2012.241398; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Choi SM, 2016, J MOV DISORD, V9, P80, DOI 10.14802/jmd.16004; Coleman J, 2018, CELL REP, V22, P820, DOI 10.1016/j.celrep.2017.12.056; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Duflocq A, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-66; duVerle David, 2010, V22, P202; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Ebrahimi-Fakhari D, 2015, BRAIN, V138, P3476, DOI 10.1093/brain/awv317; EDMUNDS T, 1991, BIOCHIM BIOPHYS ACTA, V1077, P197, DOI 10.1016/0167-4838(91)90059-9; Fairless R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058260; Friedman LK, 2003, NEUROCHEM INT, V43, P179, DOI 10.1016/S0197-0186(03)00005-6; Fruscione F, 2018, BRAIN, V141, P1000, DOI 10.1093/brain/awy051; Gardiner AR, 2015, BRAIN, V138, P3567, DOI 10.1093/brain/awv310; Gardiner AR, 2012, NEUROLOGY, V79, P2115, DOI 10.1212/WNL.0b013e3182752c5a; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; Itoh M, 2006, BIOTECHNIQUES, V41, P44, DOI 10.2144/000112209; Jackman SL, 2016, NATURE, V529, P88, DOI 10.1038/nature16507; Ji ZS, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-146; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kita M, 2017, MOV DISORD CLIN PRAC, V4, P625, DOI 10.1002/mdc3.12500; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li M, 2015, INT J MOL SCI, V16, P9134, DOI 10.3390/ijms16059134; Liu YT, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00831; Liu YT, 2016, ONCOTARGET, V7, P39184, DOI 10.18632/oncotarget.9258; Ma HY, 2018, EPILEPSIA, V59, P1621, DOI 10.1111/epi.14511; Marini C, 2012, NEUROLOGY, V79, P2109, DOI 10.1212/WNL.0b013e3182752ca2; Michetti C, 2017, NEUROBIOL DIS, V99, P66, DOI 10.1016/j.nbd.2016.12.018; Mo J, 2019, NEUROBIOL DIS, V121, P274, DOI 10.1016/j.nbd.2018.10.011; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Ono S, 2012, J HUM GENET, V57, P338, DOI 10.1038/jhg.2012.23; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Otsuki T, 2005, DNA RES, V12, P117, DOI 10.1093/dnares/12.2.117; Rossi P, 2016, J BIOL CHEM, V291, P6111, DOI 10.1074/jbc.M115.683888; Scholzke MN, 2003, EUR J NEUROSCI, V18, P3305, DOI 10.1111/j.1460-9568.2003.03079.x; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shinkai-Ouchi F, 2016, MOL CELL PROTEOMICS, V15, P1262, DOI 10.1074/mcp.M115.053413; Tan GH, 2018, CELL RES, V28, P90, DOI 10.1038/cr.2017.128; Valente P, 2018, CEREB CORTEX, P1; Valente P, 2016, CELL REP, V15, P117, DOI 10.1016/j.celrep.2016.03.005; Wu D, 2017, NATURE, V544, P316, DOI 10.1038/nature21720; Wu L, 2014, PARKINSONISM RELAT D, V20, P1399, DOI 10.1016/j.parkreldis.2014.10.012; Yan M, 2016, MOL MED REP, V13, P2499, DOI 10.3892/mmr.2016.4819	50	2	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					180	191		10.1096/fj.201902148R	http://dx.doi.org/10.1096/fj.201902148R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914621	Green Submitted, Bronze			2022-12-28	WOS:000507308900014
J	Leite, DM; Baskovic, BZ; Civita, P; Neto, C; Gumbleton, M; Pilkington, GJ				Leite, Diana M.; Zvar Baskovic, Barbara; Civita, Prospero; Neto, Catia; Gumbleton, Mark; Pilkington, Geoffrey J.			A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics	FASEB JOURNAL			English	Article						3D co-culture; drug resistance; human serum; hyaluronic acid hydrogel	CANCER-CELLS; GLIOMA; PROLIFERATION; MATRIX; HYALURONAN; TEMOZOLOMIDE; EXPRESSION; PHENOTYPE; CULTURE; TARGET	Despite the importance of the tumor microenvironment in regulating tumor progression, few in vitro models have been developed to understand the effects of non-neoplastic cells and extracellular matrix (ECM) on drug resistance in glioblastoma (GBM) cells. Using CellTrace-labeled human GBM and microglial (MG) cells, we established a 2D co-culture including various ratios of the two cell types. Viability, proliferation, migration, and drug response assays were carried out to assess the role of MG. A 3D model was then established using a hyaluronic acid-gelatin hydrogel to culture a mixture of GBM and MG and evaluate drug resistance. A contact co-culture of fluorescently labeled GBM and MG demonstrated that MG cells modestly promoted tumor cell proliferation (17%-30% increase) and greater migration of GBM cells (>1.5-fold increase). Notably, the presence of MG elicited drug resistance even when in a low ratio (10%-20%) relative to co-cultured tumor cells. The protective effect of MG on GBM was greater in the 3D model (>100% survival of GBM when challenged with cytotoxics). This new 3D human model demonstrated the influence of non-neoplastic cells and matrix on chemoresistance of GBM cells to three agents with different mechanisms of action suggesting that such sophisticated in vitro approaches may facilitate improved preclinical testing.	[Leite, Diana M.; Civita, Prospero; Pilkington, Geoffrey J.] Univ Portsmouth, Sch Pharm & Biomed Sci, Brain Tumour Res Ctr, IBBS, White Swan Rd, Portsmouth PO1 2DT, Hants, England; [Zvar Baskovic, Barbara] Univ Ljubljana, Biotehn Fak, Ljubljana, Slovenia; [Civita, Prospero] Fdn Pisana Sci ONLUS, Genom Sect, Pisa, Italy; [Neto, Catia; Gumbleton, Mark] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, S Glam, Wales; [Leite, Diana M.] UCL, Dept Chem, London, England	University of Portsmouth; University of Ljubljana; Cardiff University; University of London; University College London	Pilkington, GJ (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Brain Tumour Res Ctr, IBBS, White Swan Rd, Portsmouth PO1 2DT, Hants, England.	geoff.pilkington@port.ac.uk	Civita, Prospero/AAU-6170-2020; Neto, Catia/CAH-0167-2022; Leite, Diana Moreira/Z-1844-2018; Gumbleton, Mark/J-3861-2014	Neto, Catia/0000-0002-4693-3960; Leite, Diana Moreira/0000-0002-6017-6433; Civita, Prospero/0000-0002-8313-1094; Gumbleton, Mark/0000-0002-7386-311X	Jake McCarthy Foundation; Brain Tumour Research	Jake McCarthy Foundation; Brain Tumour Research	Jake McCarthy Foundation, Grant/Award Number: N/A; Brain Tumour Research, Grant/Award Number: N/A	An Q, 2014, NEURO-ONCOLOGY, V16, P265, DOI 10.1093/neuonc/not202; Beaney RP, 2005, J CLIN ONCOL, V23, p122S; Begum J, 2013, CYTOM PART A, V83, P1085, DOI 10.1002/cyto.a.22403; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bettinger I, 2002, ACTA NEUROPATHOL, V103, P351, DOI 10.1007/s00401-001-0472-x; Bolteus A J, 2001, Curr Neurol Neurosci Rep, V1, P225, DOI 10.1007/s11910-001-0022-x; Boyle FM, 2004, NEURO-ONCOLOGY, V6, P300, DOI 10.1215/S1152851703000516; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chen W, 2015, MED ONCOL, V32, P1; da Fonseca ACC, 2012, NEUROSCIENCE, V200, P130, DOI 10.1016/j.neuroscience.2011.10.025; Daley E, 2005, BIOCHEM BIOPH RES CO, V328, P623, DOI 10.1016/j.bbrc.2005.01.028; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; EMERMAN JT, 1987, IN VITRO CELL DEV B, V23, P134, DOI 10.1007/BF02623594; Gomez-Roman N, 2017, NEURO-ONCOLOGY, V19, P229, DOI 10.1093/neuonc/now164; Graeber MB, 2002, GLIA, V40, P252, DOI 10.1002/glia.10147; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Herrera-Perez RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194183; Higgins SC, 2016, NEURO-ONCOLOGY, V18, P54; Hill R, 2016, RESIST TARGET ANTI-C, V11, P107, DOI 10.1007/978-3-319-46505-0_6; Howarth A, 2019, BRAIN PATHOL, P1; Ivanov DP, 2015, J BIOTECHNOL, V205, P3, DOI 10.1016/j.jbiotec.2015.01.002; Jadin L, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.04.07; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jassam SA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071474; Jassam SA, 2016, NEURO-ONCOLOGY, V18, P679, DOI 10.1093/neuonc/nov248; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Koh I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22681-3; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Leiss L, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3109-8; Lisi L, 2014, ASN NEURO, V6, DOI 10.1042/AN20130045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons AB, 1999, IMMUNOL CELL BIOL, V77, P509, DOI 10.1046/j.1440-1711.1999.00864.x; Maherally Z, 2018, FASEB J, V32, P168, DOI 10.1096/fj.201700162R; Meredith EJ, 2005, FASEB J, V19, P1187, DOI 10.1096/fj.04-3477fje; Murray SA, 2010, SIGNIFICANCE SERUM S; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Papapetrou EP, 2016, NAT MED, V22, P1392, DOI 10.1038/nm.4238; Parker K., 2006, RADIOL ONCOL, V40, P87; Pedron S, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700529; Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024; Pilkington G.J., 2006, RADIOL ONCOL, V40, P73; Pilkington GJ, 2008, SEMIN CANCER BIOL, V18, P226, DOI 10.1016/j.semcancer.2007.12.006; PLOWMAN J, 1994, CANCER RES, V54, P3793; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; Rape A, 2014, ADV DRUG DELIVER REV, V79-80, P172, DOI 10.1016/j.addr.2014.08.012; Rolon-Reyes K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131059; Shchors K, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.012; Smith RC, 2019, CELL STEM CELL, V24, P12, DOI 10.1016/j.stem.2018.11.012; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang C, 2014, MOL PHARMACEUT, V11, P2115, DOI 10.1021/mp5000828; Xiao WK, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2016-0094; Yang N, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0278-y; Yoo KC, 2018, ONCOGENE, V37, P3317, DOI 10.1038/s41388-018-0199-y; Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117; Zhu W, 2016, CARCINOGENESIS, V37, P839, DOI 10.1093/carcin/bgw068	60	30	30	7	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1710	1727		10.1096/fj.201901858RR	http://dx.doi.org/10.1096/fj.201901858RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914660	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000507308900113
J	Ma, ZY; Guo, XJ; Liu, JP				Ma, Zongyuan; Guo, Xiaojiao; Liu, Jipeng			Translocator protein mediates olfactory repulsion	FASEB JOURNAL			English	Article						attraction; GPCR; migratory locusts; olfaction; tyramine receptor	18 KDA TSPO; PERIPHERAL BENZODIAZEPINE-RECEPTOR; COUPLED RECEPTOR; BINDING; LOCALIZATION; EXPRESSION; ALZHEIMERS; LOCUST; ACTIVATION; LIGANDS	Translocator protein (TSPO, 18kDa), which was previously known as a peripheral-type benzodiazepine receptor, is associated with psychiatric disorders and acts as a neuroimaging biomarker. However, its function and mechanism in modulating behaviors are less well-known. Herein, we found that TSPO in migratory locusts shows conserved protein traits and is expressed at high levels in the brains. The expression levels of tspo mRNA and protein were higher in brains of solitary locusts than those in gregarious locusts, whereas the mRNA and protein expression levels remained stable during crowding and isolation, suggesting that the expression level of TSPO is potentially associated with behavioral phenotype of solitary locusts. Moreover, tspo RNAi knockdown in the brains of solitary locusts decreased their olfactory repulsion. After RNAi knockdown of tyramine receptor (TyR) in the brains of solitary locusts, RNA-seq analysis identified that a functional class of receptors, which included tspo, was downregulated significantly. Moreover, tspo mRNA and protein expression levels were downregulated and upregulated after TyR RNAi knockdown and activation, respectively. tspo RNAi knockdown in the brains of solitary locusts induced the attractive response and inhibited the function of tyramine (TA)-TyR in inducing olfactory repulsion. In gregarious locusts, tspo RNAi knockdown inhibited the function of TA-TyR inducing olfactory repulsion. This study confirms that TSPO acts as a crucial effector protein in TA-TyR signaling to modulate olfactory repulsion. Furthermore, this study provides a novel mechanism by which TSPO functionally connects a G-protein-coupled receptor and a mitochondria membrane protein in modulating olfactory repulsion.	[Ma, Zongyuan; Guo, Xiaojiao; Liu, Jipeng] Chinese Acad Sci, Beijing Inst Life Sci, Beichen West Rd, Beijing 100101, Peoples R China	Chinese Academy of Sciences	Ma, ZY (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Beichen West Rd, Beijing 100101, Peoples R China.	mazy@biols.ac.cn			National nature science foundation of China [31772537,31472040,31522054]; Strategic priority Research Program of the Chinese Academy of Sciences [XDB11010700]	National nature science foundation of China(National Natural Science Foundation of China (NSFC)); Strategic priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	National nature science foundation of China, Grant/Award Number: 31772537,31472040,31522054; Strategic priority Research Program of the Chinese Academy of Sciences, Grant/Award Number: XDB11010700	ANHOLT RRH, 1984, J NEUROSCI, V4, P593; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Batoko H, 2015, TRENDS BIOCHEM SCI, V40, P497, DOI 10.1016/j.tibs.2015.07.001; Betlazar C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092707; BOLGER GT, 1984, EUR J PHARMACOL, V105, P143, DOI 10.1016/0014-2999(84)90658-7; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; Chelli B, 2008, EUR NEUROPSYCHOPHARM, V18, P249, DOI 10.1016/j.euroneuro.2007.10.003; Collett D, 2002, MODELING BINARY DATA; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Culty M, 1999, J STEROID BIOCHEM, V69, P123, DOI 10.1016/S0960-0760(99)00056-4; de Lima CB, 2012, BIOCHEM BIOPH RES CO, V417, P918, DOI 10.1016/j.bbrc.2011.12.078; Diotel N, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00084; GARNIER M, 1993, ENDOCRINOLOGY, V132, P444, DOI 10.1210/en.132.1.444; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GAVISH M, 1992, J NEUROCHEM, V58, P1589, DOI 10.1111/j.1471-4159.1992.tb10030.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Guo XJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03437-z; Hernstadt H, 2009, BRAIN RES, V1286, P42, DOI 10.1016/j.brainres.2009.06.043; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; Kupa LDK, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00766; Kim K, 2018, GENOMICS, V110, P43, DOI 10.1016/j.ygeno.2017.08.004; Li DM, 2016, PSYCHIAT RES, V245, P141, DOI 10.1016/j.psychres.2016.02.068; Li F, 2016, BIOCHEMISTRY-US, V55, P2821, DOI 10.1021/acs.biochem.6b00142; Li HD, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0921-7; Ma Z, 2016, TRACE AMINES AND NEUROLOGICAL DISORDERS: POTENTIAL MECHANISMS AND RISK FACTORS, P221; Ma ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08036; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Mirzaei N, 2016, GLIA, V64, P993, DOI 10.1002/glia.22978; Notter T, 2018, MOL PSYCHIATR, V23, P323, DOI 10.1038/mp.2016.248; Ohhara Y, 2015, P NATL ACAD SCI USA, V112, P1452, DOI 10.1073/pnas.1414966112; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Qiu ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep37345; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Simoes PMV, 2012, J EXP BIOL, V215, P1711, DOI 10.1242/jeb.068106; Sokal RR, 1998, BIOMETRY PRINCIPLES; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trapani A, 2013, BIOCONJUGATE CHEM, V24, P1415, DOI 10.1021/bc300666f; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wang XH, 2014, ANNU REV ENTOMOL, V59, P225, DOI 10.1146/annurev-ento-011613-162019; Wang ZF, 2015, CELL MOL LIFE SCI, V72, P4429, DOI 10.1007/s00018-015-2009-9; Xu L, 2017, INSECT MOL BIOL, V26, P1, DOI 10.1111/imb.12266; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021	47	2	2	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					513	524		10.1096/fj.201900528RR	http://dx.doi.org/10.1096/fj.201900528RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914587	Bronze			2022-12-28	WOS:000507308900035
J	Molla, G; Chaves-Sanjuan, A; Savinelli, A; Nardini, M; Pollegioni, L				Molla, Gianluca; Chaves-Sanjuan, Antonio; Savinelli, Antonio; Nardini, Marco; Pollegioni, Loredano			Structure and kinetic properties of human d-aspartate oxidase, the enzyme-controlling d-aspartate levels in brain	FASEB JOURNAL			English	Article						d-aspartate; d-aspartate oxidase; flavoprotein; NMDA receptor; structure-function relationships	AMINO-ACID OXIDASE; RHODOTORULA-GRACILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SERINE RACEMASE; BEEF KIDNEY; RAT; MECHANISM; SUBSTRATE; MODEL	d-Amino acids are the "wrong" enantiomers of amino acids as they are not used in proteins synthesis but evolved in selected functions. On this side, d-aspartate (d-Asp) plays several significant roles in mammals, especially as an agonist of N-methyl-d-aspartate receptors (NMDAR), and is involved in relevant diseases, such as schizophrenia and Alzheimer's disease. In vivo modulation of d-Asp levels represents an intriguing task to cope with such pathological states. As little is known about d-Asp synthesis, the only option for modulating the levels is via degradation, which is due to the flavoenzyme d-aspartate oxidase (DASPO). Here we present the first three-dimensional structure of a DASPO enzyme (from human) which belongs to the d-amino acid oxidase family. Notably, human DASPO differs from human d-amino acid oxidase (attributed to d-serine degradation, the main coagonist of NMDAR) showing peculiar structural features (a specific active site charge distribution), oligomeric state and kinetic mechanism, and a higher FAD affinity and activity. These results provide useful insights into the structure-function relationships of human DASPO: modulating its activity represents now a feasible novel therapeutic target.	[Molla, Gianluca; Savinelli, Antonio; Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy; [Chaves-Sanjuan, Antonio; Nardini, Marco] Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy	University of Insubria; University of Milan	Pollegioni, L (corresponding author), Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy.; Nardini, M (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.	marco.nardini@unimi.it; loredano.pollegioni@uninsubria.it	Chaves-Sanjuan, Antonio/GLR-8353-2022; Chaves-Sanjuan, Antonio/AAA-7172-2019	Chaves-Sanjuan, Antonio/0000-0003-3287-9024; Chaves-Sanjuan, Antonio/0000-0003-3287-9024; POLLEGIONI, LOREDANO/0000-0003-1733-7243				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aliashkevich A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00683; Caldinelli L, 2010, PROTEIN SCI, V19, P1500, DOI 10.1002/pro.429; Caldinelli L, 2009, PROTEIN SCI, V18, P801, DOI 10.1002/pro.86; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cristino L, 2015, NEUROBIOL AGING, V36, P1890, DOI 10.1016/j.neurobiolaging.2015.02.003; D'Aniello A, 2017, NEUROSCI LETT, V651, P151, DOI 10.1016/j.neulet.2017.04.041; D'Aniello S, 2011, FASEB J, V25, P1014, DOI 10.1096/fj.10-168492; DALZIEL K, 1969, BIOCHEM J, V114, P547, DOI 10.1042/bj1140547; de Rosa V, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809278; DECKER LE, 1954, J NUTR, V53, P303; Di Fiore MM, 2014, AMINO ACIDS, V46, P1805, DOI 10.1007/s00726-014-1759-2; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errico F, 2008, MOL CELL NEUROSCI, V37, P236, DOI 10.1016/j.mcn.2007.09.012; Errico F, 2013, J PSYCHIATR RES, V47, P1432, DOI 10.1016/j.jpsychires.2013.06.013; Errico F, 2012, AMINO ACIDS, V43, P1861, DOI 10.1007/s00726-012-1356-1; Errico F, 2011, NEUROBIOL AGING, V32, P2229, DOI 10.1016/j.neurobiolaging.2010.01.002; Errico F, 2009, REV NEUROSCIENCE, V20, P429; Ferraris D, 2008, J MED CHEM, V51, P3357, DOI 10.1021/jm800200u; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Frattini LF, 2011, FEBS J, V278, P4362, DOI 10.1111/j.1742-4658.2011.08354.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Guercio GD, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00014; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; HASHIMOTO A, 1993, J NEUROCHEM, V61, P348, DOI 10.1111/j.1471-4159.1993.tb03575.x; Hefti MH, 2003, EUR J BIOCHEM, V270, P4227, DOI 10.1046/j.1432-1033.2003.03802.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito T, 2016, J BIOCHEM, V160, P345, DOI 10.1093/jb/mvw043; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katane M, 2008, AMINO ACIDS, V35, P75, DOI 10.1007/s00726-007-0627-8; Katane M, 2018, BBA-PROTEINS PROTEOM, V1866, P806, DOI 10.1016/j.bbapap.2017.12.009; Katane M, 2017, BBA-PROTEINS PROTEOM, V1865, P1129, DOI 10.1016/j.bbapap.2017.06.010; Katane M, 2015, J MED CHEM, V58, P7328, DOI 10.1021/acs.jmedchem.5b00871; Katane M, 2015, BIOL PHARM BULL, V38, P298, DOI 10.1248/bpb.b14-00690; Katane M, 2010, CHEM BIODIVERS, V7, P1435, DOI 10.1002/cbdv.200900250; Kawazoe T, 2006, PROTEIN SCI, V15, P2708, DOI 10.1110/ps.062421606; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496; Molinaro G, 2010, NEUROSCI LETT, V478, P128, DOI 10.1016/j.neulet.2010.04.077; Molla G, 2006, FEBS LETT, V580, P2358, DOI 10.1016/j.febslet.2006.03.045; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; NEGRI A, 1987, J BIOL CHEM, V262, P10026; NEGRI A, 1988, J BIOL CHEM, V263, P13557; Ota N, 2012, AMINO ACIDS, V43, P1873, DOI 10.1007/s00726-012-1364-1; Palazzo E, 2016, AMINO ACIDS, V48, P1553, DOI 10.1007/s00726-016-2205-4; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Pollegioni L, 1997, J BIOTECHNOL, V58, P115, DOI 10.1016/S0168-1656(97)00142-9; Pollegioni L, 2002, J MOL BIOL, V324, P535, DOI 10.1016/S0022-2836(02)01062-8; POLLEGIONI L, 1993, J BIOL CHEM, V268, P13850; Pollegioni L, 2010, CELL MOL LIFE SCI, V67, P2387, DOI 10.1007/s00018-010-0307-9; Sacchi S, 2016, CELL MOL LIFE SCI, V73, P2029, DOI 10.1007/s00018-016-2165-6; Sacchi S, 2013, CURR PHARM DESIGN, V19, P2499, DOI 10.2174/1381612811319140002; Sacchi S, 2011, MOL CELL NEUROSCI, V48, P20, DOI 10.1016/j.mcn.2011.06.001; Sasabe J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00933; Schell MJ, 1997, P NATL ACAD SCI USA, V94, P2013, DOI 10.1073/pnas.94.5.2013; Senda M, 2012, ACTA CRYSTALLOGR F, V68, P644, DOI 10.1107/S1744309112013243; Setoyama C, 1997, J BIOCHEM-TOKYO, V121, P798; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Takahashi S, 2004, J BIOCHEM, V135, P533, DOI 10.1093/jb/mvh068; Tickle IJ, 2018, 2010 STARANISO; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; VANVELDHOVEN PP, 1991, BIOCHIM BIOPHYS ACTA, V1073, P203, DOI 10.1016/0304-4165(91)90203-S; Weil ZM, 2006, BEHAV BRAIN RES, V171, P295, DOI 10.1016/j.bbr.2006.04.008; Wolosker H, 2000, NEUROSCIENCE, V100, P183, DOI 10.1016/S0306-4522(00)00321-3; Wolosker H, 2011, BBA-PROTEINS PROTEOM, V1814, P1558, DOI 10.1016/j.bbapap.2011.01.001; Zaar K, 2002, J COMP NEUROL, V450, P272, DOI 10.1002/cne.10320	69	14	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1182	1197		10.1096/fj.201901703R	http://dx.doi.org/10.1096/fj.201901703R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914658	Green Submitted			2022-12-28	WOS:000507308900080
J	Soroush, F; Tang, Y; Mustafa, O; Sun, S; Yang, QL; Kilpatrick, LE; Kiani, MF				Soroush, Fariborz; Tang, Yuan; Mustafa, Omar; Sun, Shuang; Yang, Qingliang; Kilpatrick, Laurie E.; Kiani, Mohammad F.			Neutrophil-endothelial interactions of murine cells is not a good predictor of their interactions in human cells	FASEB JOURNAL			English	Article						biomimetic; endothelial cells; inflammation; microfluidics; mouse model	PROTEIN-KINASE-C; IN-VITRO; DELTA-PKC; ADHESION MOLECULES; MICROFLUIDIC ASSAY; ICAM-1 EXPRESSION; SEVERE SEPSIS; SEPTIC SHOCK; LUNG INJURY; MOUSE	All drugs recently developed in rodent models to treat inflammatory disease have failed in clinical trials. We therefore used our novel biomimetic microfluidic assay (bMFA) to determine whether the response of murine cells to inflammatory activation or anti-inflammatory treatment is predictive of the response in human cells. Under physiologically relevant flow conditions, permeability and transendothelial electrical resistance (TEER) of human or mouse lung microvascular endothelial cells (HLMVEC or MLMVEC), and neutrophil-endothelial cell interaction was measured. The differential impact of a protein kinase C-delta TAT peptide inhibitor (PKC delta-i) was also quantified. Permeability of HLMVEC and MLMVEC was similar under control conditions but tumor necrosis factor alpha (TNF-alpha) and PKC delta-i had a significantly higher impact on permeability of HLMVEC. TEER across HLMVEC was significantly higher than MLMVEC, but PKC delta-i returned TEER to background levels only in human cells. The kinetics of N-formylmethionyl-leucyl-phenylalanine (fMLP)-mediated neutrophil migration was significantly different between the two species and PKC delta-i was significantly more effective in attenuating human neutrophil migration. However, human and mouse neutrophil adhesion patterns to microvascular endothelium were not significantly different. Surprisingly, while intercellular adhesion molecule 1 (ICAM-1) was significantly upregulated on activated HLMVEC, it was not significantly upregulated on activated MLMVEC. Responses to activation and anti-inflammatory treatment in mice may not always be predictive of their response in humans.	[Soroush, Fariborz; Yang, Qingliang; Kiani, Mohammad F.] Temple Univ, Dept Mech Engn, Coll Engn, Philadelphia, PA 19122 USA; [Tang, Yuan] Univ Toledo, Coll Engn, Dept Bioengn, 2801 W Bancroft St, Toledo, OH 43606 USA; [Mustafa, Omar] Temple Univ, Dept Bioengn, Coll Engn, Philadelphia, PA 19122 USA; [Sun, Shuang; Kilpatrick, Laurie E.] Temple Univ, Ctr Inflammat Clin & Translat Lung Res, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Kiani, Mohammad F.] Temple Univ, Dept Radiat Oncol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kiani, MF (corresponding author), Temple Univ, Dept Mech Engn, Coll Engn, Philadelphia, PA 19122 USA.	mkiani@temple.edu	Yang, Qingliang/GRY-1981-2022; Tang, Yuan/ABG-7928-2020	Tang, Yuan/0000-0003-0450-3222; Yang, Qingliang/0000-0002-4094-9662	American Heart Association [16PRE29860006, 16GRNT29980001]; National Institutes of Health [GM114359, GM134701, HL111552]; Defense Threat Reduction Agency [HDTRA11910012]	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	American Heart Association, Grant/Award Number: 16PRE29860006 and 16GRNT29980001; National Institutes of Health, Grant/Award Number: GM114359, GM134701 and HL111552; Defense Threat Reduction Agency, Grant/Award Number: HDTRA11910012	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bailey KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08417-9; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; BURNS AR, 1994, J IMMUNOL, V153, P3189; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Deosarkar SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142725; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Doerschuk CM, 2000, AM J RESP CELL MOL, V23, P133, DOI 10.1165/ajrcmb.23.2.f193; Drake AC, 2013, CELL MOL IMMUNOL, V10, P284, DOI 10.1038/cmi.2013.21; Efron PA, 2015, J LEUKOCYTE BIOL, V98, P945, DOI 10.1189/jlb.5MR0315-127R; FABRY Z, 1992, J NEUROIMMUNOL, V36, P1, DOI 10.1016/0165-5728(92)90026-H; Fink MP, 2014, NAT REV DRUG DISCOV, V13, P741, DOI 10.1038/nrd4368; Ghosh Subrata, 2010, Therap Adv Gastroenterol, V3, P239, DOI 10.1177/1756283X10373176; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Guo RF, 2006, J IMMUNOL, V177, P1306, DOI 10.4049/jimmunol.177.2.1306; Hagai T, 2018, NATURE, V563, P197, DOI 10.1038/s41586-018-0657-2; Hattori Y, 2017, PHARMACOL THERAPEUT, V177, P56, DOI 10.1016/j.pharmthera.2017.02.040; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Jugg BJA, 2011, PHILOS T R SOC B, V366, P306, DOI 10.1098/rstb.2010.0235; Khakpour S, 2015, INNATE IMMUN-LONDON, V21, P827, DOI 10.1177/1753425915606525; Kiani MF, 2002, PHARM RES-DORDR, V19, P1317, DOI 10.1023/A:1020350708672; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Lamberti G, 2015, MICROVASC RES, V99, P19, DOI 10.1016/j.mvr.2015.02.004; Lamberti G, 2014, ANAL CHEM, V86, P8344, DOI 10.1021/ac5018716; Lamberti G, 2013, MICROVASC RES, V89, P107, DOI 10.1016/j.mvr.2013.03.007; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Ley K, 2006, Handb Exp Pharmacol, P97; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liverani E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195379; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Mondrinos MJ, 2015, J PHARMACOL EXP THER, V355, P86, DOI 10.1124/jpet.115.224832; Mondrinos MJ, 2014, AM J PATHOL, V184, P200, DOI 10.1016/j.ajpath.2013.09.010; Mondrinos MJ, 2013, SHOCK, V39, P467, DOI 10.1097/SHK.0b013e318294f85a; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Perlman H, 2013, AM J RESP CRIT CARE, V187, P898, DOI 10.1164/rccm.201303-0489ED; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Prabhakarpandian B, 2008, BIOMED MICRODEVICES, V10, P585, DOI 10.1007/s10544-008-9170-y; Prabhakarpandian B, 2011, MICROVASC RES, V82, P210, DOI 10.1016/j.mvr.2011.06.013; Prabhakarpandian B, 2011, MICROCIRCULATION, V18, P380, DOI 10.1111/j.1549-8719.2011.00099.x; Predescu SA, 2001, MOL BIOL CELL, V12, P1019, DOI 10.1091/mbc.12.4.1019; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Reutershan J, 2007, AM J RESP CRIT CARE, V175, P1027, DOI 10.1164/rccm.200612-1822OC; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rosano JM, 2009, BIOMED MICRODEVICES, V11, P1051, DOI 10.1007/s10544-009-9322-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Seynhaeve ALB, 2006, CELL BIOCHEM BIOPHYS, V44, P157, DOI 10.1385/CBB:44:1:157; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Soroush F, 2016, J LEUKOCYTE BIOL, V100, P1027, DOI 10.1189/jlb.3MA0216-087R; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356; Tang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09815-9; Vogel SM, 2012, COMPR PHYSIOL, V2, P449, DOI 10.1002/cphy.c100006; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Ye M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04681; Zucco F, 2005, ATLA-ALTERN LAB ANIM, V33, P603, DOI 10.1177/026119290503300618	71	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2691	2702		10.1096/fj.201900048R	http://dx.doi.org/10.1096/fj.201900048R		DEC 2019	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908006	Bronze, Green Accepted			2022-12-28	WOS:000504095400001
J	Murphy, B; Bhattacharya, R; Mukherjee, P				Murphy, Brennah; Bhattacharya, Resham; Mukherjee, Priyabrata			Hydrogen sulfide signaling in mitochondria and disease	FASEB JOURNAL			English	Review						H2S; metabolism; ROS; apoptosis; persulfidation	CYSTATHIONINE-BETA-SYNTHASE; STIMULATES CELLULAR BIOENERGETICS; ISCHEMIA-REPERFUSION INJURY; CYTOCHROME-C-OXIDASE; TAG-SWITCH METHOD; GAMMA-LYASE; S-SULFHYDRATION; INSULIN-SECRETION; OXIDATIVE STRESS; ENDOTHELIAL-CELLS	Hydrogen sulfide can signal through 3 distinct mechanisms: 1) reduction and/or direct binding of metalloprotein heme centers, 2) serving as a potent antioxidant through reactive oxygen species/reactive nitrogen species scavenging, or 3) post-translational modification of proteins by addition of a thiol (-SH) group onto reactive cysteine residues: a process known as persulfidation. Below toxic levels, hydrogen sulfide promotes mitochondrial biogenesis and function, thereby conferring protection against cellular stress. For these reasons, increases in hydrogen sulfide and hydrogen sulfide-producing enzymes have been implicated in several human disease states. This review will first summarize our current understanding of hydrogen sulfide production and metabolism, as well as its signaling mechanisms; second, this work will detail the known mechanisms of hydrogen sulfide in the mitochondria and the implications of its mitochondrial-specific impacts in several pathologic conditions.	[Murphy, Brennah; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Bhattacharya, Resham; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Mukherjee, P (corresponding author), Univ Oklahoma, Hlth Sci Ctr, BRC, 975 NE 10th St,Room 1409a, Oklahoma City, OK 73104 USA.	priyabrata-mukherjee@ouhsc.edu			U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) [2R01CA136494, CA213278]; NIH National Heart, Lung, and Blood Institute [HL120585]; NCI Cancer Center Support Grant [P30CA225520]; NATIONAL CANCER INSTITUTE [R01CA136494, R01CA213278, P30CA225520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120585] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grants 2R01CA136494, CA213278, and NIH National Heart, Lung, and Blood Institute Grant HL120585. Preparation of this publication was supported, in part, by NCI Cancer Center Support Grant P30CA225520 awarded to The University of Oklahoma Stephenson Cancer Center through the use of services provided by the Office of Cancer Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Abe K, 1996, J NEUROSCI, V16, P1066; Adhikari S, 2008, J CELL MOL MED, V12, P1374, DOI 10.1111/j.1582-4934.2008.00318.x; Agrawal N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004032; Ahmad A, 2016, PHARMACOL RES, V113, P348, DOI 10.1016/j.phrs.2016.09.013; Ahmad A, 2016, SHOCK, V45, P88, DOI 10.1097/SHK.0000000000000478; Ahmad FUD, 2014, RENAL FAILURE, V36, P598, DOI 10.3109/0886022X.2014.882218; Ali MY, 2007, J ENDOCRINOL, V195, P105, DOI 10.1677/JOE-07-0184; Alvorcem LD, 2019, MITOCHONDRION, V47, P141, DOI 10.1016/j.mito.2018.11.001; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Araujo-Alvarez JM, 2002, SALUD PUBLICA MEXICO, V44, P362, DOI 10.1590/S0036-36342002000400010; Aravindhan N, 2000, ANESTHESIOLOGY, V93, P883, DOI 10.1097/00000542-200009000-00040; Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Badiei A, 2016, J BIOSCIENCES, V41, P87, DOI 10.1007/s12038-016-9598-9; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; BARTHOLOMEW TC, 1980, BIOCHEM PHARMACOL, V29, P2431, DOI 10.1016/0006-2952(80)90346-9; Baskar R, 2007, FASEB J, V21, P247, DOI 10.1096/fj.06-6255com; Bearden SE, 2010, AM J PHYSIOL-HEART C, V299, pH1568, DOI 10.1152/ajpheart.00555.2010; Beltowski J., 2016, MOLECULES, V22, pE63; Beltowski J, 2018, BIOCHEM PHARMACOL, V149, P60, DOI 10.1016/j.bcp.2018.01.004; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P7366; BERZOFSKY JA, 1972, J BIOL CHEM, V247, P3774; Bhattacharyya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079167; Bianca RDD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31491; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Bostelaar T, 2016, J AM CHEM SOC, V138, P8476, DOI 10.1021/jacs.6b03456; CARRICO RJ, 1978, J BIOL CHEM, V253, P7212; Chakraborty PK, 2015, ONCOTARGET, V6, P37367, DOI 10.18632/oncotarget.5424; Chakraborty PK, 2018, FASEB J, V32, P4145, DOI 10.1096/fj.201701095R; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Cheung SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194176; Collman J, 2009, P NATL ACAD SCI USA, V106, P22090, DOI 10.1073/pnas.0904082106; Cuevasanta E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034562; CURTIS CG, 1972, BIOCHEM PHARMACOL, V21, P2313, DOI 10.1016/0006-2952(72)90382-6; Davoli A, 2015, ANN NEUROL, V77, P697, DOI 10.1002/ana.24372; DeLeon ER, 2012, ANAL BIOCHEM, V421, P203, DOI 10.1016/j.ab.2011.10.016; Doka E, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500968; Dominy JE, 2004, NUTR REV, V62, P348, DOI 10.1301/nr.2004.sept.348-353; Donnarumma E, 2017, COMPR PHYSIOL, V7, P583, DOI 10.1002/cphy.c160023; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Eto K, 2002, BIOCHEM BIOPH RES CO, V293, P1485, DOI 10.1016/S0006-291X(02)00422-9; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Filipovic MR, 2015, HANDB EXP PHARMACOL, V230, P29, DOI 10.1007/978-3-319-18144-8_2; Filipovic MR, 2012, J AM CHEM SOC, V134, P12016, DOI 10.1021/ja3009693; Filipovic MR, 2012, BIOCHEM J, V441, P609, DOI 10.1042/BJ20111389; FINCH CA, 1948, NEW ENGL J MED, V239, P470, DOI 10.1056/NEJM194809232391305; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; Frasdorf B, 2014, J BIOL CHEM, V289, P34543, DOI 10.1074/jbc.M114.605733; Francoleon NE, 2011, ARCH BIOCHEM BIOPHYS, V516, P146, DOI 10.1016/j.abb.2011.09.015; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Fukuto JM, 2009, FREE RADICAL BIO MED, V47, P1318, DOI 10.1016/j.freeradbiomed.2009.06.014; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gambari L, 2017, J CELL PHYSIOL, V232, P3574, DOI 10.1002/jcp.25825; Gao J, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020025; Gemici B, 2015, METHOD ENZYMOL, V555, P169, DOI 10.1016/bs.mie.2014.11.034; Geng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073892; George L, 2019, IMMUNOL INVEST, V48, P451, DOI 10.1080/08820139.2019.1566355; Gero D, 2016, PHARMACOL RES, V113, P186, DOI 10.1016/j.phrs.2016.08.019; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Giuffre A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6290931; Go YM, 2015, FREE RADICAL BIO MED, V84, P227, DOI 10.1016/j.freeradbiomed.2015.03.022; Gonzalez-Franquesa A, 2017, ADV EXP MED BIOL, V982, P465, DOI 10.1007/978-3-319-55330-6_25; GOODWIN LR, 1989, J ANAL TOXICOL, V13, P105, DOI 10.1093/jat/13.2.105; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Greiner R, 2013, ANTIOXID REDOX SIGN, V19, P1749, DOI 10.1089/ars.2012.5041; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hassan MI, 2012, BRIT J PHARMACOL, V166, P2231, DOI 10.1111/j.1476-5381.2012.01949.x; He XL, 2016, PHARMACOL REP, V68, P975, DOI 10.1016/j.pharep.2016.05.006; Hellmich MR, 2015, HANDB EXP PHARMACOL, V230, P233, DOI 10.1007/978-3-319-18144-8_12; Hellmich MR, 2015, ANTIOXID REDOX SIGN, V22, P424, DOI 10.1089/ars.2014.5933; HILL BC, 1984, BIOCHEM J, V224, P591, DOI 10.1042/bj2240591; Hine C, 2017, CELL METAB, V25, P1320, DOI 10.1016/j.cmet.2017.05.003; Hodgson N, 2013, J ALZHEIMERS DIS, V36, P197, DOI 10.3233/JAD-130101; Hourihan JM, 2013, ANTIOXID REDOX SIGN, V19, P465, DOI 10.1089/ars.2012.4944; Hu LF, 2010, AGING CELL, V9, P135, DOI 10.1111/j.1474-9726.2009.00543.x; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang P, 2015, NITRIC OXIDE-BIOL CH, V46, P192, DOI 10.1016/j.niox.2015.01.004; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Ikeda K, 2015, NITRIC OXIDE-BIOL CH, V49, P90, DOI 10.1016/j.niox.2015.05.001; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jain SK, 2014, METAB SYNDR RELAT D, V12, P299, DOI 10.1089/met.2014.0022; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jeney V, 2009, FREE RADICAL BIO MED, V46, P616, DOI 10.1016/j.freeradbiomed.2008.11.018; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016; Kabil O, 2006, BIOCHEMISTRY-US, V45, P13528, DOI 10.1021/bi0615644; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kanagy NL, 2017, AM J PHYSIOL-CELL PH, V312, pC537, DOI 10.1152/ajpcell.00329.2016; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Kaneko Y, 2009, FEBS LETT, V583, P377, DOI 10.1016/j.febslet.2008.12.026; Karwi QG, 2017, BRIT J PHARMACOL, V174, P287, DOI 10.1111/bph.13688; Kashatus DF, 2018, BIOCHEM BIOPH RES CO, V500, P9, DOI 10.1016/j.bbrc.2017.06.192; Kida K, 2015, HANDB EXP PHARMACOL, V230, P181, DOI 10.1007/978-3-319-18144-8_9; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Kimura H, 2017, ANTIOXID REDOX SIGN, V27, P619, DOI 10.1089/ars.2017.7076; Kimura H, 2015, ANTIOXID REDOX SIGN, V22, P362, DOI 10.1089/ars.2014.5869; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kimura Y, 2013, FASEB J, V27, P2451, DOI 10.1096/fj.12-226415; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Koenitzer Jeffrey R, 2007, Am J Physiol Heart Circ Physiol, V292, pH1953; Kong B, 2014, J BIOL CHEM, V289, P27134, DOI 10.1074/jbc.M114.594812; Konukoglu D, 2017, ADV EXP MED BIOL, V956, P511, DOI 10.1007/5584_2016_90; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Kruger WD, 2017, MOL GENET METAB, V121, P199, DOI 10.1016/j.ymgme.2017.05.011; Kuo Maggie M, 2016, Am J Physiol Heart Circ Physiol, V310, pH71, DOI 10.1152/ajpheart.00574.2014; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; Leschelle X, 2005, BBA-GEN SUBJECTS, V1725, P201, DOI 10.1016/j.bbagen.2005.06.002; Li SS, 2015, ANTIOXID REDOX SIGN, V23, P630, DOI 10.1089/ars.2014.6186; Liang R, 2006, CHINESE MED J-PEKING, V119, P1877, DOI 10.1097/00029330-200611020-00006; Libiad M, 2019, J BIOL CHEM, V294, P12077, DOI 10.1074/jbc.RA119.009442; Liu N, 2017, J CELL MOL MED, V21, P3190, DOI 10.1111/jcmm.13223; Liu Xiang-qin, 2008, Zhonghua Yi Xue Za Zhi, V88, P2246; Liu Y, 2014, CELL STEM CELL, V15, P66, DOI 10.1016/j.stem.2014.03.005; Liu YG, 2016, PHARMACOL BIOCHEM BE, V150, P207, DOI 10.1016/j.pbb.2016.11.002; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; LU Y, 1992, BIOCHEM BIOPH RES CO, V189, P749, DOI 10.1016/0006-291X(92)92265-Y; Lv M, 2014, MOL MED REP, V10, P341, DOI 10.3892/mmr.2014.2161; Ma L, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1055433; Ma SN, 2017, CELL PHYSIOL BIOCHEM, V41, P1838, DOI 10.1159/000471932; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Majtan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105290; Martin JA, 2007, CELL MOL BIOL, V53, pOL1010, DOI 10.1170/115; Matsuzawa A, 2017, ARCH BIOCHEM BIOPHYS, V617, P101, DOI 10.1016/j.abb.2016.09.011; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Meng GL, 2018, BRIT J PHARMACOL, V175, P1126, DOI 10.1111/bph.13861; Meng GL, 2015, BRIT J PHARMACOL, V172, P5501, DOI 10.1111/bph.12900; Meram AT, 2018, ANTICANCER RES, V38, P3843, DOI 10.21873/anticanres.12668; Miao L, 2016, ANTIOXID REDOX SIGN, V25, P268, DOI 10.1089/ars.2015.6577; MINTEL R, 1966, J BIOL CHEM, V241, P3381; Miyamoto R, 2015, NEUROSCI RES, V97, P52, DOI 10.1016/j.neures.2015.03.003; Modis K, 2016, PHARMACOL RES, V113, P116, DOI 10.1016/j.phrs.2016.08.023; Modis K, 2014, NITRIC OXIDE-BIOL CH, V41, P146, DOI 10.1016/j.niox.2014.03.001; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Morrison LD, 1996, J NEUROCHEM, V67, P1328; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muellner MK, 2009, BIOCHEM J, V420, P277, DOI 10.1042/BJ20082421; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Nagahara N, 2006, CURR MED CHEM, V13, P1219, DOI 10.2174/092986706776360914; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; Nagahara N, 2004, BBA-GENE STRUCT EXPR, V1680, P176, DOI 10.1016/j.bbaexp.2004.09.007; Nagahara N, 2007, J BIOL CHEM, V282, P1561, DOI 10.1074/jbc.M605931200; Nagahara N, 2018, BRIT J PHARMACOL, V175, P577, DOI 10.1111/bph.14100; Nagy P, 2015, METHOD ENZYMOL, V554, P3, DOI 10.1016/bs.mie.2014.11.036; Nagy P, 2010, CHEM RES TOXICOL, V23, P1541, DOI 10.1021/tx100266a; Naik JS, 2016, AM J PHYSIOL-HEART C, V311, pH1437, DOI 10.1152/ajpheart.00465.2016; Nandi SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03776-9; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Nicholls P, 2013, BIOCHEM SOC T, V41, P1312, DOI 10.1042/BST20130070; Nicholson CK, 2013, ARTERIOSCL THROM VAS, V33, P744, DOI 10.1161/ATVBAHA.112.300484; Niu WN, 2015, ANTIOXID REDOX SIGN, V22, P350, DOI 10.1089/ars.2014.5891; Niu WN, 2018, J BIOL CHEM, V293, P2523, DOI 10.1074/jbc.RA117.000103; Pan H, 2014, EUR J PHARMACOL, V741, P74, DOI 10.1016/j.ejphar.2014.07.037; Pan J, 2013, ACS CHEM BIOL, V8, P1110, DOI 10.1021/cb4001052; Park CM, 2015, METHOD ENZYMOL, V555, P39, DOI 10.1016/bs.mie.2014.11.033; Parsanathan R, 2018, FREE RADICAL RES, V52, P288, DOI 10.1080/10715762.2018.1431626; Patel MA, 2010, J YOUNG PHARM, V2, P148, DOI 10.4103/0975-1483.63156; Patterson SE, 2016, ANN NY ACAD SCI, V1374, P202, DOI 10.1111/nyas.13114; Paul BD, 2018, BIOCHEM PHARMACOL, V149, P101, DOI 10.1016/j.bcp.2017.11.019; Paul BD, 2015, METHOD ENZYMOL, V555, P79, DOI 10.1016/bs.mie.2014.11.021; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; Phillips CM, 2017, CANCER RES, V77, P5741, DOI 10.1158/0008-5472.CAN-16-3480; Pietri R, 2011, ANTIOXID REDOX SIGN, V15, P393, DOI 10.1089/ars.2010.3698; Potor L, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3812568; Powell CR, 2018, BIOCHEM PHARMACOL, V149, P110, DOI 10.1016/j.bcp.2017.11.014; Pun PBL, 2010, MITOCHONDRION, V10, P83, DOI 10.1016/j.mito.2009.12.142; Qiao PF, 2017, MOL MED REP, V16, P971, DOI 10.3892/mmr.2017.6627; Renga B, 2015, AM J PHYSIOL-HEART C, V309, pH114, DOI 10.1152/ajpheart.00087.2015; Renga B, 2009, WORLD J GASTROENTERO, V15, P2097, DOI 10.3748/wjg.15.2097; Rios-Gonzalez BB, 2014, J INORG BIOCHEM, V133, P78, DOI 10.1016/j.jinorgbio.2014.01.013; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; Rose P, 2017, CELL MOL LIFE SCI, V74, P1391, DOI 10.1007/s00018-016-2406-8; Roy A, 2012, AM J HYPERTENS, V25, P74, DOI 10.1038/ajh.2011.149; Ruetz M, 2017, J BIOL CHEM, V292, P6512, DOI 10.1074/jbc.M116.770370; Saha S, 2016, FASEB J, V30, P441, DOI 10.1096/fj.15-278648; Salloum FN, 2015, PHARMACOL THERAPEUT, V152, P11, DOI 10.1016/j.pharmthera.2015.04.004; Santel A, 2001, J CELL SCI, V114, P867; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; SAVAGE JC, 1990, J CHROMATOGR-BIOMED, V526, P540, DOI 10.1016/S0378-4347(00)82537-2; Sbodio JI, 2019, BRIT J PHARMACOL, V176, P583, DOI 10.1111/bph.14446; Sbodio JI, 2016, P NATL ACAD SCI USA, V113, P8843, DOI 10.1073/pnas.1608264113; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Sen S, 2015, FREE RADICAL BIO MED, V86, P228, DOI 10.1016/j.freeradbiomed.2015.05.024; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shen XG, 2013, FREE RADICAL BIO MED, V60, P195, DOI 10.1016/j.freeradbiomed.2013.02.024; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Shimizu Y, 2018, J MOL CELL CARDIOL, V116, P29, DOI 10.1016/j.yjmcc.2018.01.011; Sikora M, 2014, PHARMACOL REP, V66, P751, DOI 10.1016/j.pharep.2014.04.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Snijder PM, 2015, MOL MED, V21, P758, DOI 10.2119/molmed.2015.00221; Spindel ON, 2012, ANTIOXID REDOX SIGN, V16, P587, DOI 10.1089/ars.2011.4137; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Sun LL, 2014, MOL MED, V20, P503, DOI 10.2119/molmed.2013.00096; Sun Ning-ling, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P1145; Sun QX, 2009, J BIOL CHEM, V284, P3076, DOI 10.1074/jbc.M805459200; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Szabo C, 2018, BIOCHEM PHARMACOL, V149, P5, DOI 10.1016/j.bcp.2017.09.010; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Szczesny B, 2016, SCI REP-UK, V6, DOI 10.1038/srep36125; Szczesny B, 2014, NITRIC OXIDE-BIOL CH, V41, P120, DOI 10.1016/j.niox.2014.04.008; Takahashi N, 2017, NUCLEIC ACIDS RES, V45, P435, DOI 10.1093/nar/gkw745; Talipov MR, 2013, J PHYS CHEM B, V117, P1827, DOI 10.1021/jp310664z; Tang G, 2013, DIABETOLOGIA, V56, P533, DOI 10.1007/s00125-012-2806-8; Taniguchi S, 2011, BRIT J PHARMACOL, V162, P1171, DOI 10.1111/j.1476-5381.2010.01119.x; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Theissen U, 2008, FEBS J, V275, P1131, DOI 10.1111/j.1742-4658.2008.06273.x; Tian DY, 2017, FREE RADICAL BIO MED, V110, P291, DOI 10.1016/j.freeradbiomed.2017.06.016; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; Turbat-Herrera EA, 2018, ANTICANCER RES, V38, P6085, DOI 10.21873/anticanres.12958; Untereiner AA, 2018, BIOCHEM PHARMACOL, V149, P174, DOI 10.1016/j.bcp.2017.10.007; Untereiner AA, 2017, BIOCHEM PHARMACOL, V136, P86, DOI 10.1016/j.bcp.2017.03.025; Untereiner AA, 2016, NITRIC OXIDE-BIOL CH, V58, P67, DOI 10.1016/j.niox.2016.06.005; Untereiner AA, 2016, ANTIOXID REDOX SIGN, V24, P129, DOI 10.1089/ars.2015.6369; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Vellecco V, 2016, CLIN SCI, V130, P35, DOI 10.1042/CS20150521; Vicente JB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8940321; Vigneron A, 2018, ISME J, V12, P2096, DOI 10.1038/s41396-018-0155-4; Vitvitsky V, 2018, ACS CHEM BIOL, V13, P2300, DOI 10.1021/acschembio.8b00463; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Volkel S, 1996, EUR J BIOCHEM, V235, P231, DOI 10.1111/j.1432-1033.1996.00231.x; Wang B, 2017, CAN J PHYSIOL PHARM, V95, P667, DOI 10.1139/cjpp-2016-0611; Wang CN, 2018, MOL CELL ENDOCRINOL, V474, P65, DOI 10.1016/j.mce.2018.02.011; Wang J, 2018, ANTIOXID REDOX SIGN, V28, P1447, DOI 10.1089/ars.2016.6968; Wang ZJ, 2017, CELL PHYSIOL BIOCHEM, V42, P859, DOI 10.1159/000478628; WARENYCIA MW, 1989, BIOCHEM PHARMACOL, V38, P973, DOI 10.1016/0006-2952(89)90288-8; Wedmann R, 2016, CHEM SCI, V7, P3414, DOI 10.1039/c5sc04818d; Wedmann R, 2014, NITRIC OXIDE-BIOL CH, V41, P85, DOI 10.1016/j.niox.2014.06.003; Wen YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053147; Wright DJ, 2016, HUM MOL GENET, V25, P2923, DOI 10.1093/hmg/ddw144; Wu DD, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/186908; Wu LY, 2009, LAB INVEST, V89, P59, DOI 10.1038/labinvest.2008.109; Xie LP, 2016, DIABETES, V65, P3171, DOI 10.2337/db16-0020; Xie YH, 2014, MOL MED REP, V10, P1907, DOI 10.3892/mmr.2014.2391; Xie ZZ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6043038; Xu MT, 2019, EXP DERMATOL, V28, P776, DOI 10.1111/exd.13930; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yamasaki H, 2016, NITRIC OXIDE-BIOL CH, V55-56, P91, DOI 10.1016/j.niox.2016.04.002; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang GD, 2011, J BIOL CHEM, V286, P26450, DOI 10.1074/jbc.M111.266643; Yang J, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0431-5; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5776; Yang W, 2005, J PHYSIOL-LONDON, V569, P519, DOI 10.1113/jphysiol.2005.097642; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yin WL, 2017, NEUROSCI LETT, V657, P45, DOI 10.1016/j.neulet.2017.07.019; Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271; Yuan S, 2017, ANTIOXID REDOX SIGN, V27, P634, DOI 10.1089/ars.2017.7096; Zhai YK, 2019, J CELL PHYSIOL, V234, P18602, DOI 10.1002/jcp.28498; Zhang DH, 2014, ANGEW CHEM INT EDIT, V53, P575, DOI 10.1002/anie.201305876; Zhang JY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9396089; Zhang L, 2011, DIABETOLOGIA, V54, P2615, DOI 10.1007/s00125-011-2187-4; Zhang L, 2013, ENDOCRINOLOGY, V154, P114, DOI 10.1210/en.2012-1658; Zhao FL, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8360738; Zhao KX, 2014, J BIOL CHEM, V289, P20824, DOI 10.1074/jbc.M114.559518; Zhao KX, 2014, EMBO REP, V15, P792, DOI 10.1002/embr.201338213; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao X, 2008, HYPERTENS RES, V31, P1619, DOI 10.1291/hypres.31.1619; Zhao ZZ, 2011, EXP BIOL MED, V236, P169, DOI 10.1258/ebm.2010.010308; Zong YF, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/754670; Zou W, 2017, ONCOTARGET, V8, P64203, DOI 10.18632/oncotarget.19448	275	63	68	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13098	13125		10.1096/fj.201901304R	http://dx.doi.org/10.1096/fj.201901304R			28	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31648556	Bronze, Green Published			2022-12-28	WOS:000507466100007
J	Lepa, C; Moeller-Kerutt, A; Stoelting, M; Picciotto, C; Eddy, ML; Butt, E; Kerjaschki, D; Korb-Pap, A; Vollenbroeker, B; Weide, T; George, B; Kremerskothen, J; Pavenstaedt, H				Lepa, Carolin; Moeller-Kerutt, Annika; Stoelting, Miriam; Picciotto, Cara; Eddy, Mee-Ling; Butt, Elke; Kerjaschki, Dontscho; Korb-Pap, Adelheid; Vollenbroeker, Beate; Weide, Thomas; George, Britta; Kremerskothen, Joachim; Pavenstaedt, Hermann			LIM and SH3 protein 1 (LASP-1): A novel link between the slit membrane and actin cytoskeleton dynamics in podocytes	FASEB JOURNAL			English	Article						actin cytoskeleton; angiotensin; CD2AP; nephrocyte; slit membrane	NUCLEAR-LOCALIZATION; DIAPHRAGM; CD2AP; PHOSPHORYLATION; OVEREXPRESSION; SYSTEM; BINDS; CELL	The foot processes of podocytes exhibit a dynamic actin cytoskeleton, which maintains their complex cell structure and antagonizes the elastic forces of the glomerular capillary. Interdigitating secondary foot processes form a highly selective filter for proteins in the kidney, the slit membrane. Knockdown of slit membrane components such as Nephrin or Neph1 and cytoskeletal adaptor proteins such as CD2AP in mice leads to breakdown of the filtration barrier with foot process effacement, proteinuria, and early death of the mice. Less is known about the crosstalk between the slit membrane-associated proteins and cytoskeletal components inside the podocyte foot processes. Our study shows that LASP-1, an actin-binding protein, is highly expressed in podocytes. Electron microscopy studies demonstrate that LASP-1 is found at the slit membrane suggesting a role in anchoring slit membrane components to the actin cytoskeleton. Live cell imaging experiments with transfected podocytes reveal that LASP-1 is either part of a highly dynamic granular complex or a static, actin cytoskeleton-bound protein. We identify CD2AP as a novel LASP-1 binding partner that regulates its association with the actin cytoskeleton. Activation of the renin-angiotensin-aldosterone system, which is crucial for podocyte function, leads to phosphorylation and altered localization of LASP-1. In vivo studies using the Drosophila nephrocyte model indicate that Lasp is necessary for the slit membrane integrity and functional filtration.	[Lepa, Carolin; Moeller-Kerutt, Annika; Stoelting, Miriam; Picciotto, Cara; Eddy, Mee-Ling; Vollenbroeker, Beate; Weide, Thomas; George, Britta; Kremerskothen, Joachim; Pavenstaedt, Hermann] Univ Klinikum Munster, Med Klin & Poliklin D, Munster, Germany; [Butt, Elke] Klinikum Julius Maximilians Univ Wurzburg, Inst Expt Biomed 2, Wurzburg, Germany; [Kerjaschki, Dontscho] Med Univ Wien, Klin Inst Pathol, Vienna, Austria; [Korb-Pap, Adelheid] Univ Klinikum Munster, Inst Expt Muskuloskelettale Med, Munster, Germany	University of Munster; University of Wurzburg; Medical University of Vienna; University of Munster	Kremerskothen, J (corresponding author), Univ Hosp Munster, Dept Mol Nephrol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	kremers@uni-muenster.de	George, Britta/AAL-2031-2021	George, Britta/0000-0001-5430-5086				Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Butt E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00391; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Duvall-Noelle N, 2016, ONCOGENE, V35, P1122, DOI 10.1038/onc.2015.166; Frietsch JJ, 2010, BRIT J CANCER, V102, P1645, DOI 10.1038/sj.bjc.6605685; Fu YL, 2017, HUM MOL GENET, V26, P768, DOI 10.1093/hmg/ddw428; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Helmstadter M, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00262; Hochapfel F, 2017, CELL MOL LIFE SCI, V74, P4573, DOI 10.1007/s00018-017-2593-y; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Marquez E, 2015, AM J PHYSIOL-RENAL, V308, P1; Mihlan S, 2013, ONCOGENE, V32, P2107, DOI 10.1038/onc.2012.216; Orth MF, 2015, ONCOTARGET, V6, P26, DOI 10.18632/oncotarget.3083; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Ruggieri V, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705757; Schenk LK, 2017, FASEB J, V31, P5019, DOI 10.1096/fj.201700142R; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Tossidou I, 2007, J BIOL CHEM, V282, P7457, DOI 10.1074/jbc.M608519200; Viney RL, 2007, PROTEOMICS, V7, P804, DOI 10.1002/pmic.200600666; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Welsch T, 2005, AM J PHYSIOL-RENAL, V289, pF1134, DOI 10.1152/ajprenal.00178.2005; Wennmann DO, 2012, SEMIN NEPHROL, V32, P377, DOI 10.1016/j.semnephrol.2012.06.009; Yu SMW, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00221	29	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5453	5464		10.1096/fj.201901443R	http://dx.doi.org/10.1096/fj.201901443R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086849	Green Published, hybrid			2022-12-28	WOS:000530242100041
J	Zhou, JR; Wang, Y; Fan, QJ; Liu, YH; Liu, H; Yan, JY; Li, M; Dong, WJ; Li, WZ				Zhou, Jiaorui; Wang, Yue; Fan, Qingjie; Liu, Yinhui; Liu, He; Yan, Jingyu; Li, Ming; Dong, Weijie; Li, Wenzhe			High levels of fucosylation and sialylation of milk N-glycans from mothers with gestational diabetes mellitus alter the offspring gut microbiome and immune balance in mice	FASEB JOURNAL			English	Article						Bacteroides; gestational diabetes mellitus; gut microbiome; immune balance; milk N-glycans	REGULATORY T-CELLS; ORAL TOLERANCE; OLIGOSACCHARIDES; CHILDREN; DISEASE; WOMEN; ASSOCIATION; BACTEROIDES; IMBALANCE; MECHANISM	Gestational diabetes mellitus (GDM) is significantly associated with allergen sensitization in early childhood, and this may influence the gut microbiome and immune system of the children. In addition to mother-to-child transmission of microbes, milk glycans play a pivotal role in shaping the gut microbiome of infants. A previous study has demonstrated alterations in the major milk N-glycans of mothers with GDM. However, the impact of these changes on the gut microbiome and immune response of the neonates has yet to be studied. Here, we aimed to compare the glycosylation levels of various milk glycans between normal and GDM mice, and to characterize the intestinal microbiome and immune responses of the offspring after weaning. We found that GDM mouse milk contained significantly higher concentrations of fucosylated and sialylated N-glycans than control mice, but there was no difference in the concentration of milk oligosaccharides between the groups. The differences in milk N-glycans had direct effects on the intestinal microbiome of the offspring, which in turn affected their immune response upon challenge with ovalbumin (OVA), with disruptions in the Th1/Th2 and Th17/Treg cell balances. This study lays the foundation for further research and development of specific nutritional care for the offspring of GDM mothers.	[Zhou, Jiaorui; Fan, Qingjie; Liu, Yinhui; Liu, He; Li, Ming] Dalian Med Univ, Coll Basic Med Sci, Dept Microecol, Dalian 116044, Peoples R China; [Wang, Yue; Dong, Weijie; Li, Wenzhe] Dalian Med Univ, Coll Basic Med Sci, Dept Biochem, Dalian 116044, Peoples R China; [Yan, Jingyu] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Li, M (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Dept Microecol, Dalian 116044, Peoples R China.; Dong, WJ; Li, WZ (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Dept Biochem, Dalian 116044, Peoples R China.	vivianmarat@163.com; wjdong@dlmedu.edu.cn; liwenzhe@dlmedu.edu.cn	fan, qingjie/AAB-8624-2022	fan, qingjie/0000-0001-8281-1218	National Nature Science Fundation of China [31770859, 31900920]; Guangzhou Biostime Institute of Nutrition Care [2018BINCMCF39, 2016BINCMCF1102, 2019BINCMCF02]	National Nature Science Fundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Biostime Institute of Nutrition Care	National Nature Science Fundation of China, Grant/Award Number: 31770859 and 31900920; Guangzhou Biostime Institute of Nutrition & Care, Grant/Award Number: 2018BINCMCF39, 2016BINCMCF1102 and 2019BINCMCF02	ADLERBERTH I, 1991, ACTA PAEDIATR SCAND, V80, P602, DOI 10.1111/j.1651-2227.1991.tb11917.x; Allhorn M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001413; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Boerschmann H, 2010, DIABETES CARE, V33, P1845, DOI 10.2337/dc10-0139; Briliute J, 2019, NAT MICROBIOL, V4, P1571, DOI 10.1038/s41564-019-0466-x; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cregan, 2007, BREASTFEEDING REV, V15, P5; Damm P, 2015, NAT REV ENDOCRINOL, V11, DOI 10.1038/nrendo.2015.54; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Hadar E, 2009, NUTR METAB CARDIOVAS, V19, P75, DOI 10.1016/j.numecd.2008.11.007; Huang CJ, 2018, MOL MED REP, V17, P6293, DOI 10.3892/mmr.2018.8683; Ji XL, 2019, INT J BIOL MACROMOL, V131, P1067, DOI 10.1016/j.ijbiomac.2019.03.175; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Johnson CC, 2016, EXPERT REV CLIN IMMU, V12, P379, DOI 10.1586/1744666X.2016.1139452; Kim SY, 2012, CURR OPIN OBSTET GYN, V24, P376, DOI 10.1097/GCO.0b013e328359f0f4; Kim WG, 2019, BENEF MICROBES, V10, P55, DOI 10.3920/BM2017.0146; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kumar R, 2009, J ALLERGY CLIN IMMUN, V124, P1031, DOI 10.1016/j.jaci.2009.06.052; Kwon MS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01905; Li CC, 2018, J ASTHMA, V55, P1, DOI 10.1080/02770903.2016.1266494; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Li M, 2019, MBIO, V10, DOI [10.1128/mBio.00128-19, 10.1128/mbio.00128-19]; Madan JC, 2016, JAMA PEDIATR, V170, P212, DOI 10.1001/jamapediatrics.2015.3732; Meng SS, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0430-8; Nakayama J, 2011, FEMS IMMUNOL MED MIC, V63, P397, DOI 10.1111/j.1574-695X.2011.00872.x; Ravcheev DA, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00111; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Sakaguchi S, 2011, J IMMUNOL, V186, P3808; SALYERS AA, 1984, ANNU REV MICROBIOL, V38, P293, DOI 10.1146/annurev.mi.38.100184.001453; Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706; Sifnaios E, 2019, IN VIVO, V33, P31, DOI 10.21873/invivo.11435; Smilowitz JT, 2013, J NUTR, V143, P1906, DOI 10.3945/jn.113.180695; Sofi MH, 2019, DIABETES, V68, P1975, DOI 10.2337/db19-0211; Su ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205695; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Tao BH, 2015, IRAN J ALLERGY ASTHM, V14, P273; TESTI R, 1990, J EXP MED, V172, P701, DOI 10.1084/jem.172.3.701; Thurl S, 2017, NUTR REV, V75, P920, DOI 10.1093/nutrit/nux044; Vaarasmaki M, 2009, AM J EPIDEMIOL, V169, P1209, DOI 10.1093/aje/kwp020; Wang J, 2014, J ETHNOPHARMACOL, V154, P131, DOI 10.1016/j.jep.2014.03.041; Wang JF, 2018, GUT, V67, P1614, DOI 10.1136/gutjnl-2018-315988; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Warner BB, 2016, LANCET, V387, P1928, DOI 10.1016/S0140-6736(16)00081-7; Wu LC, 2014, NAT REV IMMUNOL, V14, P247, DOI 10.1038/nri3632; Wu SY, 2018, EUR J PHARMACOL, V831, P38, DOI 10.1016/j.ejphar.2018.04.028; Xu J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43039-3; Yanagibashi T, 2013, IMMUNOBIOLOGY, V218, P645, DOI 10.1016/j.imbio.2012.07.033; Ye GY, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/6081248; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138; Zhang YB, 2004, AM J MED GENET B, V129B, P16, DOI 10.1002/ajmg.b.30076; Zhu WW, 2013, DIABETES CARE, V36, P586, DOI 10.2337/dc12-1157; Zimmermann P, 2019, J ALLERGY CLIN IMMUN, V143, P467, DOI 10.1016/j.jaci.2018.09.025; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	65	11	12	5	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3715	3731		10.1096/fj.201901674R	http://dx.doi.org/10.1096/fj.201901674R		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944389				2022-12-28	WOS:000507592900001
J	Chu, CH; Chen, JS; Chuang, PC; Su, CH; Chan, YL; Yang, YJ; Chiang, YT; Su, YY; Gean, PW; Sun, HS				Chu, Chun-Hsien; Chen, Jia-Shing; Chuang, Pei-Chin; Su, Chia-Hao; Chan, Ya-Ling; Yang, Ying-Ju; Chiang, Yu-Ting; Su, Yu-Ya; Gean, Po-Wu; Sun, H. Sunny			TIAM2S as a novel regulator for serotonin level enhances brain plasticity and locomotion behavior	FASEB JOURNAL			English	Article						guanine nucleotide exchange factor (GEF); hyperlocomotion; neuroplasticity; serotonergic fiber; serotonin (5-HT); TIAM2	HYPERACTIVITY DISORDER ADHD; CELL LYMPHOMA INVASION; METASTASIS 2 TIAM2; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; 5-HT7 RECEPTORS; RAC1; PROTEIN; GENE; OVEREXPRESSION	TIAM2S, the short form of human T-cell lymphoma invasion and metastasis 2, can have oncogenic effects when aberrantly expressed in the liver or lungs. However, it is also abundant in healthy, non-neoplastic brain tissue, in which its primary function is still unknown. Here, we examined the neurobiological and behavioral significance of human TIAM2S using the human brain protein panels, a human NT2/D1-derived neuronal cell line model (NT2/N), and transgenic mice that overexpress human TIAM2S (TIAM2S-TG). Our data reveal that TIAM2S exists primarily in neurons of the restricted brain areas around the limbic system and in well-differentiated NT2/N cells. Functional studies revealed that TIAM2S has no guanine nucleotide exchange factor (GEF) activity and is mainly located in the nucleus. Furthermore, whole-transcriptome and enrichment analysis with total RNA sequencing revealed that TIAM2S-knockdown (TIAM2S-KD) was strongly associated with the cellular processes of the brain structural development and differentiation, serotonin-related signaling, and the diseases markers representing neurobehavioral developmental disorders. Moreover, TIAM2S-KD cells display decreased neurite outgrowth and reduced serotonin levels. Moreover, TIAM2S overexpressing TG mice show increased number and length of serotonergic fibers at early postnatal stage, results in higher serotonin levels at both the serum and brain regions, and higher neuroplasticity and hyperlocomotion in latter adulthood. Taken together, our results illustrate the non-oncogenic functions of human TIAM2S and demonstrate that TIAM2S is a novel regulator of serotonin level, brain neuroplasticity, and locomotion behavior.	[Chu, Chun-Hsien; Yang, Ying-Ju; Chiang, Yu-Ting; Su, Yu-Ya; Sun, H. Sunny] Natl Cheng Kung Univ, Inst Mol Med, Coll Med, 1 Univ Rd, Tainan 70101, Taiwan; [Chen, Jia-Shing; Gean, Po-Wu; Sun, H. Sunny] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan, Taiwan; [Chuang, Pei-Chin] Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chuang, Pei-Chin] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Su, Chia-Hao] Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung, Taiwan; [Chan, Ya-Ling; Gean, Po-Wu] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Coll Biosci & Biotechnol, Tainan, Taiwan; [Gean, Po-Wu] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; Chang Gung Memorial Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; National Cheng Kung University; National Cheng Kung University	Sun, HS (corresponding author), Natl Cheng Kung Univ, Inst Mol Med, Coll Med, 1 Univ Rd, Tainan 70101, Taiwan.	hssun@mail.ncku.edu.tw		Sun, Sunny/0000-0002-3661-4448; Chen, Jia-Shing/0000-0002-5256-2123; Chan, Ya-Ling/0000-0002-9721-6718	Ministry of Science and Technology, Taiwan (MOST) [MOST 104-2811-B-006-004, MOST 1042811-B-006-065, MOST 105-2320-B-006056-MY2, MOST 105-2320-B-006046-MY3]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 104-2811-B-006-004, MOST 1042811-B-006-065, MOST 105-2320-B-006056-MY2 and MOST 105-2320-B-006046-MY3	Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Barreiro-Iglesias A, 2015, CELL REP, V13, P924, DOI 10.1016/j.celrep.2015.09.050; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bonetto A, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.101; Brandler WM, 2016, AM J HUM GENET, V98, P667, DOI 10.1016/j.ajhg.2016.02.018; Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Cabaj AM, 2017, J PHYSIOL-LONDON, V595, P301, DOI 10.1113/JP272271; Caubit X, 2016, NAT GENET, V48, P1359, DOI 10.1038/ng.3681; Chahdi A, 2013, J BIOL CHEM, V288, P34019, DOI 10.1074/jbc.M113.480103; Chen JS, 2012, INT J CANCER, V130, P1302, DOI 10.1002/ijc.26117; Chiu CY, 1999, GENOMICS, V61, P66, DOI 10.1006/geno.1999.5936; Christakis DA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00546; Chu CH, 2016, BRAIN BEHAV IMMUN, V55, P260, DOI 10.1016/j.bbi.2016.04.015; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Dayer A, 2014, DIALOGUES CLIN NEURO, V16, P29; Ding Y, 2014, ONCOL REP, V32, P607, DOI 10.3892/or.2014.3241; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Gabriel JP, 2009, J NEUROSCI, V29, P10387, DOI 10.1523/JNEUROSCI.1978-09.2009; Goto A, 2011, MOL BIOL CELL, V22, P1780, DOI 10.1091/mbc.E10-09-0783; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Huang J, 2013, INT J CANCER, V132, P90, DOI 10.1002/ijc.27627; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Ito H, 2003, J NEUROSCI RES, V71, P648, DOI 10.1002/jnr.10532; Jin H, 2011, HUM PATHOL, V42, P541, DOI 10.1016/j.humpath.2010.08.013; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kent L, 2002, MOL PSYCHIATR, V7, P908, DOI 10.1038/sj.mp.4001100; Kiser D, 2012, NEUROSCI BIOBEHAV R, V36, P786, DOI 10.1016/j.neubiorev.2011.12.009; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Levitan RD, 2002, J AFFECT DISORDERS, V71, P229, DOI 10.1016/S0165-0327(01)00372-X; Li J, 2012, ONCOL REP, V27, P1835, DOI 10.3892/or.2012.1744; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Lin YMJ, 2007, ARCH GEN PSYCHIAT, V64, P1015, DOI 10.1001/archpsyc.64.9.1015; Lo SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18335; Maddaloni G, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00202; Matsuo N, 2003, MOL CELL NEUROSCI, V24, P69, DOI 10.1016/S1044-7431(03)00122-2; Miller MB, 2013, NEUROSCIENTIST, V19, P255, DOI 10.1177/1073858413475486; Mogensen J, 2003, PHARMACOL BIOCHEM BE, V75, P381, DOI 10.1016/S0091-3057(03)00107-2; Narboux-Neme N, 2013, ACS CHEM NEUROSCI, V4, P171, DOI 10.1021/cn300165x; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; Quist JF, 2000, MOL PSYCHIATR, V5, P537, DOI 10.1038/sj.mp.4000779; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rojas PS, 2014, J NEUROSCI RES, V92, P1000, DOI 10.1002/jnr.23390; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Serre A, 2012, STEM CELLS DEV, V21, P539, DOI 10.1089/scd.2011.0079; Slawinska U, 2014, ACTA NEUROBIOL EXP, V74, P172; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551; Su CH, 2016, THERANOSTICS, V6, P837, DOI 10.7150/thno.14837; Subramanian N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070422; Tang LTH, 2019, ELIFE, V8, DOI 10.7554/eLife.38949; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Thomas J, 2015, PHARM BIOL, V53, P1539, DOI 10.3109/13880209.2014.991837; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tsai CY, 2013, NEUROIMAGE, V82, P190, DOI 10.1016/j.neuroimage.2013.05.124; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wang S, 2015, ONCOL REP, V33, P1807, DOI 10.3892/or.2015.3785; Wong RWJ, 2017, BLOOD, V130, P2326, DOI 10.1182/blood-2017-06-792184; Wu JB, 2015, NEUROPHARMACOLOGY, V97, P220, DOI 10.1016/j.neuropharm.2015.04.035; Yokoi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024539; Yoo S, 2012, MOL CELLS, V34, P103, DOI 10.1007/s10059-012-0119-x; Zhao ZY, 2013, ASIAN PAC J CANCER P, V14, P6305, DOI 10.7314/APJCP.2013.14.11.6305; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	70	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3267	3288		10.1096/fj.201901323R	http://dx.doi.org/10.1096/fj.201901323R		JAN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908036				2022-12-28	WOS:000505951500001
J	Ahmetaj-Shala, B; Kawai, R; Marei, I; Nikolakopoulou, Z; Shih, CC; Konain, B; Reed, DM; Mongey, R; Kirkby, NS; Mitchell, JA				Ahmetaj-Shala, Blerina; Kawai, Ryota; Marei, Isra; Nikolakopoulou, Zacharoula; Shih, Chih-Chin; Konain, Bhatti; Reed, Daniel M.; Mongey, Roisin; Kirkby, Nicholas S.; Mitchell, Jane A.			A bioassay system of autologous human endothelial, smooth muscle cells, and leukocytes for use in drug discovery, phenotyping, and tissue engineering	FASEB JOURNAL			English	Article						blood vessel; cytokine response; stem cells	PERIPHERAL-BLOOD; PROGENITOR CELLS; DIABETES-MELLITUS; CYTOKINE STORM; KAPPA-B; OUTGROWTH; TARGET; INTERFERON; RELEASE; DISEASE	Blood vessels are comprised of endothelial and smooth muscle cells. Obtaining both types of cells from vessels of living donors is not possible without invasive surgery. To address this, we have devised a strategy whereby human endothelial and smooth muscle cells derived from blood progenitors from the same donor could be cultured with autologous leukocytes to generate a same donor "vessel in a dish" bioassay. Autologous sets of blood outgrowth endothelial cells (BOECs), smooth muscle cells (BO-SMCs), and leukocytes were obtained from four donors. Cells were treated in monoculture and cumulative coculture conditions. The endothelial specific mediator endothelin-1 along with interleukin (IL)-6, IL-8, tumor necrosis factor alpha, and interferon gamma-induced protein 10 were measured under control culture conditions and after stimulation with cytokines. Cocultures remained viable throughout. The profile of individual mediators released from cells was consistent with what we know of endothelial and smooth muscle cells cultured from blood vessels. For the first time, we report a proof of concept study where autologous blood outgrowth "vascular" cells and leukocytes were studied alone and in coculture. This novel bioassay has usefulness in vascular biology research, patient phenotyping, drug testing, and tissue engineering.	[Ahmetaj-Shala, Blerina; Kawai, Ryota; Marei, Isra; Nikolakopoulou, Zacharoula; Konain, Bhatti; Reed, Daniel M.; Mongey, Roisin; Kirkby, Nicholas S.; Mitchell, Jane A.] Imperial Coll London, Natl Heart & Lung Inst, Cardiothorac Pharmacol, Dovehouse St, London SW3 6LY, England; [Kawai, Ryota] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Tokyo, Japan; [Marei, Isra] Qatar Fdn, Div Res & Dev, Doha, Qatar; [Nikolakopoulou, Zacharoula] Imperial Coll London, Ctr Haematol, Fac Med, London, England; [Shih, Chih-Chin] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan	Imperial College London; Daiichi Sankyo Company Limited; Qatar Foundation (QF); Imperial College London; National Defense Medical Center	Ahmetaj-Shala, B; Mitchell, JA (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Cardiothorac Pharmacol, Dovehouse St, London SW3 6LY, England.	b.ahmetaj@imperial.ac.uk; j.a.mitchell@ic.ac.uk	Marei, Isra/AAG-2598-2021; marei, Isra/GPW-6811-2022	Kirkby, Nicholas/0000-0003-3509-8549	British Heart Foundation Project Grant [PG/16/83/32467]; British Heart Foundation [FS/16/1/31699]; Daiichi-Sankyo Co.Ltd; Qatar Foundation	British Heart Foundation Project Grant(British Heart Foundation); British Heart Foundation(British Heart Foundation); Daiichi-Sankyo Co.Ltd(Daiichi Sankyo Company Limited); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	British Heart Foundation Project Grant, Grant/Award Number: PG/16/83/32467; British Heart Foundation Intermediate Fellow, Grant/Award Number: FS/16/1/31699; Daiichi-Sankyo Co.Ltd; Qatar Foundation Research Fellow	Badiger R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046779; Boersema M, 2015, IMMUNOBIOLOGY, V220, P673, DOI 10.1016/j.imbio.2014.11.011; Brisset AC, 2007, CIRC RES, V100, P1055, DOI 10.1161/01.RES.0000262654.84810.6c; Daniel JM, 2011, J MOL CELL CARDIOL, V50, P273, DOI 10.1016/j.yjmcc.2010.10.030; Deb A, 2004, CIRCULATION, V110, P2673, DOI 10.1161/01.CIR.0000139842.15651.B2; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; George PM, 2014, CIRC RES, V114, P677, DOI 10.1161/CIRCRESAHA.114.302221; Joo HJ, 2014, BIOCHEM BIOPH RES CO, V449, P405, DOI 10.1016/j.bbrc.2014.05.061; Kang HS, 2014, J NEUROSURG, V120, P415, DOI 10.3171/2013.9.JNS131000; Kirkby NS, 2008, BRIT J PHARMACOL, V153, P1105, DOI 10.1038/sj.bjp.0707516; Kolster M, 2017, J TISSUE ENG, V8, DOI 10.1177/2041731417698852; Kusuyama T, 2006, J PHARMACOL SCI, V102, P96, DOI 10.1254/jphs.FP0060256; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Medina RJ, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/346735; Merkulova-Rainon T, 2012, CARDIOVASC RES, V95, P205, DOI 10.1093/cvr/cvs097; Metharom P, 2008, ATHEROSCLEROSIS, V198, P29, DOI 10.1016/j.atherosclerosis.2007.09.020; Mitchell JA, 2019, BRIT J PHARMACOL, V176, P1038, DOI 10.1111/bph.14167; Phi JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169714; Reed DM, 2015, FASEB J, V29, P2595, DOI 10.1096/fj.14-268144; Reed DM, 2014, BIOCHEM BIOPH RES CO, V455, P172, DOI 10.1016/j.bbrc.2014.10.140; Reed DM, 2013, BRIT J CLIN PHARMACO, V75, P897, DOI 10.1111/j.1365-2125.2012.04361.x; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Stanford SJ, 2000, ARTERIOSCL THROM VAS, V20, P677, DOI 10.1161/01.ATV.20.3.677; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Subramanian M, 2014, SEMIN IMMUNOPATHOL, V36, P93, DOI 10.1007/s00281-013-0400-x; Sugiyama S, 2006, ATHEROSCLEROSIS, V187, P351, DOI 10.1016/j.atherosclerosis.2005.09.014; van Ark J, 2012, DIABETOLOGIA, V55, P2501, DOI 10.1007/s00125-012-2590-5; Wang CH, 2012, ARTERIOSCL THROM VAS, V32, P1875, DOI 10.1161/ATVBAHA.112.245852; WARNER SJC, 1989, J IMMUNOL, V142, P100; Woods M, 1998, J CARDIOVASC PHARM, V31, pS348, DOI 10.1097/00005344-199800001-00097; Woods M, 2003, MOL PHARMACOL, V64, P923, DOI 10.1124/mol.64.4.923; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Xie SZ, 2008, J ZHEJIANG UNIV-SC B, V9, P923, DOI 10.1631/jzus.B0820257; Yang Z, 2008, J VASC SURG, V47, P432, DOI 10.1016/j.jvs.2007.10.039; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692	37	3	3	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1745	1754		10.1096/fj.201901379RR	http://dx.doi.org/10.1096/fj.201901379RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914612	Green Published, hybrid			2022-12-28	WOS:000507308900115
J	Chu, AN; Wang, D; Guo, QQ; Lv, Z; Yuan, Y; Gong, YH				Chu, Aining; Wang, Dan; Guo, Qianqian; Lv, Zhi; Yuan, Yuan; Gong, Yuehua			Molecular detection of H. pylori antibiotic-resistant genes and molecular docking analysis	FASEB JOURNAL			English	Article						23SrRNA; antibiotic resistance; gyrA; rdxA; H; pylori	23S RIBOSOMAL-RNA; HELICOBACTER-PYLORI; CLARITHROMYCIN RESISTANCE; METRONIDAZOLE RESISTANCE; ANTIMICROBIAL SUSCEPTIBILITY; CONFERRING RESISTANCE; T2182C MUTATION; GYRA; FLUOROQUINOLONE; THERAPY	To explore the mutation characteristics of H. pylori resistance-related genes to antibiotics of clarithromycin (CAM), levofloxacin (LVX) and metronidazole, 23SrRNA, gyrA, gyrB, rdxA, and frxA genes were amplified and sequenced, respectively. Molecular docking study was performed to explore molecular interactions between chemotherapeutic agents and target proteins. In the CAM-resistant strains, the mutation rate in site A2143G was 74.2% (n = 23). The interactions in sites of G1949A, C1953T, and G2211T with CAM were weaker after mutation. In the LVX-resistant strains, the mutation rates in 87 (N to K/I) and 91 (D to N/Y/G) of gyrA were 28.6% (n = 16) and 12.5% (n = 7), respectively. We could infer by docking studies that N87 K/I, D91Y/G/N, D99N, and D143E mutations in GyrA protein all had weakened interaction with LVX. The mutation types of RdxA protein consisted of protein truncation caused by premature stop codons (n = 26, 33.3%), frameshift mutations (n = 8, 10.3%), FMN-binding sites (n = 16, 20.5%), and the others (n = 11, 14.1%). Docking analysis showed that some mutations in those four types of RdxA protein could reduce interaction with MNZ, and play a significant role in antibiotic resistance. What's more, we performed natural transformation with some of these mutated DNA fragments to see if they really impact susceptibility to antibiotics. Our study suggested that in addition to the reported mutation sites, H. pylori antibiotic resistance in this region may also be associated with changes in some new sites. Our study provides novel ideas and methods for the identification of H. pylori resistance-related mutations, and also clues and basis for further investigation on specific molecular mechanism.	[Chu, Aining; Wang, Dan; Guo, Qianqian; Lv, Zhi; Yuan, Yuan; Gong, Yuehua] China Med Univ, Hosp 1, Tumor Etiol & Screening Dept Canc Inst & Gen Surg, 155 Nanjing Bei St, Shenyang 110001, Liaoning, Peoples R China; [Chu, Aining; Wang, Dan; Guo, Qianqian; Lv, Zhi; Yuan, Yuan; Gong, Yuehua] China Med Univ, Hosp 1, Dept Educ, Key Lab Canc Etiol & Prevent Liaoning, Shenyang, Peoples R China; [Chu, Aining; Wang, Dan; Guo, Qianqian; Lv, Zhi; Yuan, Yuan; Gong, Yuehua] China Med Univ, Hosp 1, Key Lab GI Canc Etiol & Prevent Liaoning Prov, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Yuan, Y; Gong, YH (corresponding author), China Med Univ, Hosp 1, Tumor Etiol & Screening Dept Canc Inst & Gen Surg, 155 Nanjing Bei St, Shenyang 110001, Liaoning, Peoples R China.	yuanyuan@cmu.edu.cn; yhgong@cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key R&D Program of China [2017YFC0907402]; National Natural Science Foundation [81970501]	National Key R&D Program of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	National Key R&D Program of China, Grant/Award Number: 2017YFC0907402; National Natural Science Foundation, Grant/Award Number: 81970501	Burucoa C, 2005, ANTIMICROB AGENTS CH, V49, P868, DOI 10.1128/AAC.49.2.868-870.2005; Chung JW, 2012, J GASTROEN HEPATOL, V27, P493, DOI 10.1111/j.1440-1746.2011.06874.x; De Palma GZ, 2017, MICROB DRUG RESIST, V23, P351, DOI 10.1089/mdr.2015.0361; Garcia M, 2012, ANTIMICROB AGENTS CH, V56, P550, DOI 10.1128/AAC.05243-11; Ge Z, 1997, Methods Mol Med, V8, P145, DOI 10.1385/0-89603-381-3:145; Goh KL, 2011, HELICOBACTER, V16, P241, DOI 10.1111/j.1523-5378.2011.00841.x; Gong YH, 2005, WORLD J GASTROENTERO, V11, P3523, DOI 10.3748/wjg.v11.i23.3523; Gong YH, 2018, CRIT REV MICROBIOL, V44, P371, DOI 10.1080/1040841X.2017.1418285; Hirata K, 2010, J GASTROEN HEPATOL, V25, pS75, DOI 10.1111/j.1440-1746.2009.06220.x; Jeong JY, 2000, J BACTERIOL, V182, P5082, DOI 10.1128/JB.182.18.5082-5090.2000; Kaneko F, 2004, ALIMENT PHARM THER, V20, P62, DOI 10.1111/j.1365-2036.2004.01993.x; Khan R, 2004, ANTIMICROB AGENTS CH, V48, P3567, DOI 10.1128/AAC.48.9.3567-3569.2004; Khashei R, 2016, APMIS, V124, P787, DOI 10.1111/apm.12567; Klesiewicz K, 2014, ACTA BIOCHIM POL, V61, P311; Kwon DH, 2000, J ANTIMICROB CHEMOTH, V46, P793, DOI 10.1093/jac/46.5.793; Lee JW, 2011, HELICOBACTER, V16, P301, DOI 10.1111/j.1523-5378.2011.00840.x; Matsuzaki J, 2012, ANTIMICROB AGENTS CH, V56, P1643, DOI 10.1128/AAC.05941-11; Matsuzaki J, 2010, J GASTROEN HEPATOL, V25, pS7, DOI 10.1111/j.1440-1746.2010.06245.x; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Miftahussurur M, 2017, AM J TROP MED HYG, V96, P1050, DOI 10.4269/ajtmh.16-0729; Miftahussurur M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166199; Mori H, 2018, UNITED EUR GASTROENT, V6, P391, DOI 10.1177/2050640617737215; Mori H, 2017, UNITED EUR GASTROENT, V5, P796, DOI 10.1177/2050640616688995; Mori H, 2016, HELICOBACTER, V21, P286, DOI 10.1111/hel.12286; Nishizawa T, 2006, ANTIMICROB AGENTS CH, V50, P1538, DOI 10.1128/AAC.50.4.1538-1540.2006; Nishizawa T, 2007, J CLIN MICROBIOL, V45, P303, DOI 10.1128/JCM.01997-06; Osaki T, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12396; Pagadala Nataraj S, 2017, Biophys Rev, V9, P91, DOI 10.1007/s12551-016-0247-1; Acosta CP, 2017, BIOMEDICA, V37, P191, DOI 10.7705/biomedica.v37i2.3007; Rasheed F, 2014, HELICOBACTER, V19, P387, DOI 10.1111/hel.12142; Sanches BS, 2016, WORLD J GASTROENTERO, V22, P7587, DOI 10.3748/wjg.v22.i33.7587; Seck A, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-3; Secka O, 2013, ANTIMICROB AGENTS CH, V57, P1231, DOI 10.1128/AAC.00517-12; Sohretoglu D, 2018, INT J BIOL MACROMOL, V108, P81, DOI 10.1016/j.ijbiomac.2017.11.151; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; Suzuki H, 2009, ANTIMICROB AGENTS CH, V53, P1720, DOI 10.1128/AAC.00049-09; Suzuki RB, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-164; Take S, 2015, J GASTROENTEROL, V50, P638, DOI 10.1007/s00535-014-1004-5; Teh X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101481; Thung I, 2016, ALIMENT PHARM THER, V43, P514, DOI 10.1111/apt.13497; Binh TT, 2015, ANTIMICROB AGENTS CH, V59, P2343, DOI 10.1128/AAC.04852-14; Binh TT, 2014, J ANTIMICROB CHEMOTH, V69, P1796, DOI 10.1093/jac/dku050; Tsugawa H, 2011, BIOCHEM BIOPH RES CO, V404, P656, DOI 10.1016/j.bbrc.2010.12.034; Tsugawa H, 2011, ANTIOXID REDOX SIGN, V14, P15, DOI 10.1089/ars.2010.3146; Tu IF, 2014, HELICOBACTER, V19, P356, DOI 10.1111/hel.12140; Wang D, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1517-4; WANG Y, 1993, J GEN MICROBIOL, V139, P2485, DOI 10.1099/00221287-139-10-2485; Zhao LJ, 2014, WORLD J GASTROENTERO, V20, P4761, DOI 10.3748/wjg.v20.i16.4761	48	7	7	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					610	618		10.1096/fj.201900774R	http://dx.doi.org/10.1096/fj.201900774R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914672	Bronze			2022-12-28	WOS:000507308900042
J	Neal, ML; Fleming, SM; Budge, KM; Boyle, AM; Kim, C; Alam, G; Beier, EE; Wu, LJ; Richardson, JR				Neal, Matthew L.; Fleming, Sheila M.; Budge, Kevin M.; Boyle, Alexa M.; Kim, Chunki; Alam, Gelareh; Beier, Eric E.; Wu, Long-Jun; Richardson, Jason R.			Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration	FASEB JOURNAL			English	Article						microglia; neuroprotection; Parkinson's disease; proliferation	COLONY-STIMULATING FACTOR; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; GENE-EXPRESSION; RECEPTOR; PROGRESSION; NEURON; CELLS; CSF-1; MICE	Increased pro-inflammatory cytokine levels and proliferation of activated microglia have been found in Parkinson's disease (PD) patients and animal models of PD, suggesting that targeting of the microglial inflammatory response may result in neuroprotection in PD. Microglial proliferation is regulated by many factors, but colony stimulating factor-1 receptor (CSF1R) has emerged as a primary factor. Using data mining techniques on existing microarray data, we found that mRNA expression of the CSF1R ligand, CSF-1, is increased in the brain of PD patients compared to controls. In two different neurotoxic mouse models of PD, acute MPTP and sub-chronic LPS treatment, mRNA and protein levels of CSF1R and CSF-1 were significantly increased. Treatment with the CSF1R inhibitor GW2580 significantly attenuated MPTP-induced CSF1R activation and Iba1-positive cell proliferation, without a reduction of the basal Iba1-positive population in the substantia nigra. GW2580 treatment also significantly decreased mRNA levels of pro-inflammatory factors, without alteration of anti-inflammatory mediators, and significantly attenuated the MPTP-induced loss of dopamine neurons and motor behavioral deficits. Importantly, these effects were observed in the absence of overt microglial depletion, suggesting that targeting CSF1R signaling may be a viable neuroprotective strategy in PD that disrupts pro-inflammatory signaling, but maintains the beneficial effects of microglia.	[Neal, Matthew L.; Kim, Chunki; Richardson, Jason R.] Florida Int Univ, Robert Stempel Sch Publ Hlth & Social Work, Dept Environm Hlth, 11200 SW 8th St AHC5-515, Miami, FL 33199 USA; [Neal, Matthew L.; Fleming, Sheila M.; Boyle, Alexa M.; Alam, Gelareh; Richardson, Jason R.] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Rootstown, OH USA; [Neal, Matthew L.; Fleming, Sheila M.; Boyle, Alexa M.; Alam, Gelareh; Richardson, Jason R.] Northeast Ohio Med Univ, Ctr Neurodegenerat Dis & Aging, Rootstown, OH USA; [Budge, Kevin M.; Boyle, Alexa M.] Kent State Univ, Dept Biomed Sci, Kent, OH 44242 USA; [Beier, Eric E.; Richardson, Jason R.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA; [Wu, Long-Jun] Mayo Clin, Dept Neurol, Rochester, MN USA	State University System of Florida; Florida International University; Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Rutgers State University New Brunswick; Mayo Clinic	Richardson, JR (corresponding author), Florida Int Univ, Robert Stempel Sch Publ Hlth & Social Work, Dept Environm Hlth, 11200 SW 8th St AHC5-515, Miami, FL 33199 USA.	jarichar@fiu.edu	Wu, Long-Jun/AAK-7113-2020; Richardson, Jason/AAG-5281-2019	Wu, Long-Jun/0000-0001-8019-3380; Richardson, Jason/0000-0001-6521-610X; Kim, Chunki/0000-0003-2410-9118	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [R01ES021800]; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [R01NS088627]	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS); HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: R01ES021800; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS088627	Alam G, 2017, NEUROTOXICOLOGY, V60, P99, DOI 10.1016/j.neuro.2017.03.008; Beier EE, 2017, NEUROBIOL DIS, V108, P115, DOI 10.1016/j.nbd.2017.08.009; Boulakirba S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18433-4; Cannarile MA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0257-y; Conway JG, 2008, J PHARMACOL EXP THER, V326, P41, DOI 10.1124/jpet.107.129429; Dammeijer F, 2017, CANCER IMMUNOL RES, V5, P535, DOI 10.1158/2326-6066.CIR-16-0309; De I, 2014, GLIA, V62, P1955, DOI 10.1002/glia.22717; Duke DC, 2006, NEUROGENETICS, V7, P139, DOI 10.1007/s10048-006-0033-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elmore MRP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122912; Eyo UB, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/456857; Fleming SM, 2018, NEUROTOXICOLOGY, V64, P256, DOI 10.1016/j.neuro.2017.06.005; Fleming SM, 2011, MOL CELL NEUROSCI, V46, P597, DOI 10.1016/j.mcn.2010.12.011; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Fornai F, 1997, J PHARMACOL EXP THER, V283, P100; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; FREI K, 1992, J NEUROIMMUNOL, V40, P189, DOI 10.1016/0165-5728(92)90133-6; Frost JL, 2016, TRENDS CELL BIOL, V26, P587, DOI 10.1016/j.tcb.2016.02.006; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Garcia S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0973-6; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Klinkert K, 2017, EUR SURG RES, V58, P109, DOI 10.1159/000451078; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Kondo Y, 2009, J NEUROSCI RES, V87, P2686, DOI 10.1002/jnr.22096; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Leblond AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137515; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Martinez-Muriana A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25663; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; Mitrasinovic OM, 2001, J BIOL CHEM, V276, P30142, DOI 10.1074/jbc.M104265200; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Moreno M, 2014, J NEUROSCI, V34, P8175, DOI 10.1523/JNEUROSCI.1137-14.2014; Nakamichi Y, 2013, J BONE MINER METAB, V31, P486, DOI 10.1007/s00774-013-0476-3; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Neal ML, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1100-1; Noelker C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01393; Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Parillaud VR, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0830-9; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Smith CC, 2015, CANCER DISCOV, V5, P668, DOI 10.1158/2159-8290.CD-15-0060; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Takeuchi A, 2001, J NEUROSCI RES, V65, P38, DOI 10.1002/jnr.1125; Wake H, 2011, NEURON GLIA BIOL, V7, P47, DOI 10.1017/S1740925X12000063; Walker DG, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00244; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Whitton PS, 2010, CURR OPIN INVEST DR, V11, P788; Yang XX, 2018, FASEB J, V32, P3336, DOI 10.1096/fj.201700833RR; Zhang QS, 2017, TOXICOL LETT, V265, P30, DOI 10.1016/j.toxlet.2016.11.002; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	61	37	37	4	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1679	1694		10.1096/fj.201900567RR	http://dx.doi.org/10.1096/fj.201900567RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914683	Green Accepted			2022-12-28	WOS:000507308900111
J	Wu, YC; Gong, YH; Luan, YX; Li, Y; Liu, JX; Yue, ZT; Yuan, BY; Sun, JX; Xie, CX; Li, LJ; Zhen, JL; Jin, XX; Zheng, Y; Wang, XM; Xie, LW; Wang, W				Wu, Yancheng; Gong, Yuhong; Luan, Yongxin; Li, Yang; Liu, Juxiong; Yue, Zitong; Yuan, Boyu; Sun, Jingxuan; Xie, Changxin; Li, Lijuan; Zhen, Junli; Jin, Xinxin; Zheng, Yan; Wang, Xiaomin; Xie, Liwei; Wang, Wei			BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						5XFAD mice; Alzheimer's disease; BHBA; inflammation; microglia; beta-amyloid	AMYLOID PRECURSOR PROTEIN; BETA-HYDROXYBUTYRATE; KETOGENIC DIET; KETONE ESTER; MICROGLIA; EXPRESSION; ENERGY; INFLAMMASOME; IMPAIRMENT; METABOLISM	Accumulation of amyloid beta (A beta) peptide, inflammation, and oxidative stress contribute to Alzheimer's disease (AD) and trigger complex pathogenesis. The ketone body beta-hydroxybutyrate (BHBA) is an endogenous metabolic intermediate that protects against stroke and neurodegenerative diseases, but the underlying mechanisms are unclear. The present study aims to elucidate the protective effects of BHBA in the early stage of AD model and investigate the underlying molecular mechanisms. Three-and-half-month-old double-transgenic mice (5XFAD) overexpressing beta-amyloid precursor protein (APP) and presenilin-1 (PS1) were used as the AD model. The 5XFAD mice received 1.5 mmol/kg/d BHBA subcutaneously for 28 days. Morris water maze test, nest construction, and passive avoidance experiments were performed to assess the therapeutic effects on AD prevention in vivo, and brain pathology of 5XFAD mice including amyloid plaque deposition and microglia activation were assessed. Gene expression profiles in the cortexes of 5XFAD- and BHBA-treated 5XFAD mice were performed with high-throughput sequencing and bioinformatic analysis. Mouse HT22 cells were treated with 2 mM BHBA to explore its in vitro protective effects of BHBA on hippocampal neurons against A beta oligomer toxicity, ATP production, ROS generation, and mitochondrial aerobic respiratory function. APP, BACE1, and neprilysin (NEP) expression levels were evaluated in HT22 cells following treatment with BHBA by measuring the presence or absence of G protein-coupled receptor 109A (GPR109A). BHBA improved cognitive function of 5XFAD mice in Morris water maze test, nesting construction and passive avoidance experiments, and attenuated A beta accumulation and microglia overactivation in the brain. BHBA also enhanced mitochondrial respiratory function of hippocampal neurons and protected it from A beta toxicity. The enzymes, APP and NEP were regulated by BHBA via G-protein-coupled receptor 109A (GPR109A). Furthermore, RNA sequencing revealed that BHBA-regulated genes mainly annotated in aging, immune system, nervous system, and neurodegenerative diseases. Our data suggested that BHBA confers protection against the AD-like pathological events in the AD mouse model by targeting multiple aspects of AD and it may become a promising candidate for the prevention and treatment of AD.	[Wu, Yancheng; Wang, Wei] Zhongkai Univ Agr & Engn, Coll Anim Sci & Technol, Key Lab Waterfowl Hlth Breeding Guangdong Prov, Innovat Inst Anim Hlth Breeding, Guangzhou 510225, Peoples R China; [Wu, Yancheng; Gong, Yuhong; Liu, Juxiong; Yuan, Boyu; Sun, Jingxuan; Xie, Changxin; Jin, Xinxin; Wang, Wei] Jilin Univ, Coll Vet Med, Changchun, Peoples R China; [Luan, Yongxin] First Hosp Jilin Univ, Dept Neurosurg, Changchun, Peoples R China; [Li, Yang; Li, Lijuan; Zhen, Junli; Zheng, Yan; Wang, Xiaomin; Wang, Wei] Capital Med Univ, Minist Educ, Dept Neurobiol, Key Lab Neurodegenerat Disorders, Beijing 100069, Peoples R China; [Yue, Zitong] Changchun Jida Middle Sch Expt Sch, Changchun, Peoples R China; [Li, Lijuan] Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China; [Xie, Liwei] Guangdong Inst Microbiol, Guangdong Open Lab Appl Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou 510070, Peoples R China	Zhongkai University of Agriculture & Engineering; Jilin University; Jilin University; Capital Medical University; Hebei Medical University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Wang, W (corresponding author), Zhongkai Univ Agr & Engn, Coll Anim Sci & Technol, Key Lab Waterfowl Hlth Breeding Guangdong Prov, Innovat Inst Anim Hlth Breeding, Guangzhou 510225, Peoples R China.; Zheng, Y; Wang, XM (corresponding author), Capital Med Univ, Minist Educ, Dept Neurobiol, Key Lab Neurodegenerat Disorders, Beijing 100069, Peoples R China.; Xie, LW (corresponding author), Guangdong Inst Microbiol, Guangdong Open Lab Appl Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou 510070, Peoples R China.	zhengyan@ccmu.edu.cn; xmwang@ccmu.edu.cn; xielw@gdim.cn; wang_wei99@jlu.edu.cn	jin, xin/GQZ-5811-2022; Yuan, Boyu/HCI-9190-2022	Sun, Jingxuan/0000-0002-2502-6157; yuan, yuan bo yu/0000-0003-3150-5346	National Natural Science Foundation of China [31572479, 31872442]; Program for JLU Science and Technology Innovative Research Team [2017TD-30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for JLU Science and Technology Innovative Research Team	This work was funded by the National Natural Science Foundation of China (31572479, 31872442) and Program for JLU Science and Technology Innovative Research Team (2017TD-30)	Ambrosi G, 2014, BBA-MOL BASIS DIS, V1842, P1385, DOI 10.1016/j.bbadis.2014.05.008; Aso E, 2013, CURR ALZHEIMER RES, V10, P290, DOI 10.2174/15672050112099990128; Augustin K, 2018, LANCET NEUROL, V17, P84, DOI 10.1016/S1474-4422(17)30408-8; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Boza-Serrano A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19699-y; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brownlow ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075713; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; Cross Helen, 2015, BMJ Clin Evid, V2015; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Feng WQ, 2018, CELL PHYSIOL BIOCHEM, V47, P1617, DOI 10.1159/000490981; Fu SP, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0230-3; Fu SP, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/983401; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Julio-Amilpas A, 2015, J CEREBR BLOOD F MET, V35, P851, DOI 10.1038/jcbfm.2015.1; Kadakkuzha BM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00063; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kossoff EH, 2009, NEUROTHERAPEUTICS, V6, P406, DOI 10.1016/j.nurt.2009.01.005; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024620; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Mamelak M, 2017, NEUROSCI BIOBEHAV R, V75, P297, DOI 10.1016/j.neubiorev.2017.02.001; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marosi K, 2016, J NEUROCHEM, V139, P769, DOI 10.1111/jnc.13868; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nakamura K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020206; Nei M, 2014, SEIZURE-EUR J EPILEP, V23, P439, DOI 10.1016/j.seizure.2014.02.015; Newport MT, 2015, ALZHEIMERS DEMENT, V11, P99, DOI 10.1016/j.jalz.2014.01.006; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Orre M, 2013, BRAIN, V136, P1415, DOI 10.1093/brain/awt083; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Ringheim GE, 1998, MOL BRAIN RES, V55, P35, DOI 10.1016/S0169-328X(97)00356-2; Rothman SM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1265-7; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Shadfar S, 2015, ARCH PHARM RES, V38, P2106, DOI 10.1007/s12272-015-0648-x; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Q, 2014, DIS MODEL MECH, V7, P1385, DOI 10.1242/dmm.018218; Wesson DW, 2011, BEHAV BRAIN RES, V216, P408, DOI 10.1016/j.bbr.2010.08.033; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Yamanashi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08055-1; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6; Yin JX, 2016, NEUROBIOL AGING, V39, P25, DOI 10.1016/j.neurobiolaging.2015.11.018; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641	63	29	31	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1412	1429		10.1096/fj.201901984R	http://dx.doi.org/10.1096/fj.201901984R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914599	hybrid			2022-12-28	WOS:000507308900094
J	Njavro, JR; Klotz, J; Dislich, B; Wanngren, J; Shmueli, MD; Herber, J; Kuhn, PH; Kumar, R; Koeglsperger, T; Conrad, M; Wurst, W; Feederle, R; Vlachos, A; Michalakis, S; Jedlicka, P; Muller, SA; Lichtenthaler, SF				Rudan Njavro, Jasenka; Klotz, Jakob; Dislich, Bastian; Wanngren, Johanna; Shmueli, Merav D.; Herber, Julia; Kuhn, Peer-Hendrik; Kumar, Rohit; Koeglsperger, Thomas; Conrad, Marcus; Wurst, Wolfgang; Feederle, Regina; Vlachos, Andreas; Michalakis, Stylianos; Jedlicka, Peter; Mueller, Stephan A.; Lichtenthaler, Stefan F.			Mouse brain proteomics establishes MDGA1 and CACHD1 as in vivo substrates of the Alzheimer protease BACE1	FASEB JOURNAL			English	Article						gamma-secretase; inhibitory synapse; retina; secretase; SILAC	AMYLOID PRECURSOR PROTEIN; HUMAN INSULIN-RECEPTOR; GATED SODIUM-CHANNELS; CLEAVING ENZYME BACE1; BETA-SECRETASE; MEMORY DEFICITS; GAMMA-SECRETASE; RANDOMIZED-TRIAL; KNOCKOUT MICE; MIGRATION	The protease beta-site APP cleaving enzyme 1 (BACE1) has fundamental functions in the nervous system. Its inhibition is a major therapeutic approach in Alzheimer's disease, because BACE1 cleaves the amyloid precursor protein (APP), thereby catalyzing the first step in the generation of the pathogenic amyloid beta (A beta) peptide. Yet, BACE1 cleaves numerous additional membrane proteins besides APP. Most of these substrates have been identified in vitro, but only few were further validated or characterized in vivo. To identify BACE1 substrates with in vivo relevance, we used isotope label-based quantitative proteomics of wild type and BACE1-deficient (BACE1 KO) mouse brains. This approach identified known BACE1 substrates, including Close homolog of L1 and contactin-2, which were found to be enriched in the membrane fraction of BACE1 KO brains. VWFA and cache domain-containing protein 1 (CACHD)1 and MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (MDGA1), which have functions in synaptic transmission, were identified and validated as new BACE1 substrates in vivo by immunoblots using primary neurons and mouse brains. Inhibition or deletion of BACE1 from primary neurons resulted in a pronounced inhibition of substrate cleavage and a concomitant increase in full-length protein levels of CACHD1 and MDGA1. The BACE1 cleavage site in both proteins was determined to be located within the juxtamembrane domain. In summary, this study identifies and validates CACHD1 and MDGA1 as novel in vivo substrates for BACE1, suggesting that cleavage of both proteins may contribute to the numerous functions of BACE1 in the nervous system.	[Rudan Njavro, Jasenka; Klotz, Jakob; Dislich, Bastian; Shmueli, Merav D.; Herber, Julia; Kumar, Rohit; Koeglsperger, Thomas; Mueller, Stephan A.; Lichtenthaler, Stefan F.] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Rudan Njavro, Jasenka; Klotz, Jakob; Shmueli, Merav D.; Herber, Julia; Mueller, Stephan A.; Lichtenthaler, Stefan F.] Tech Univ Munich, Sch Med, Neuroprote, Klinikum Rechts Isar, Munich, Germany; [Dislich, Bastian] Univ Bern, Inst Pathol, Bern, Switzerland; [Wanngren, Johanna] Karolinska Inst, Div Neurogeriatr, Dept NVS, Ctr Alzheimer Res, Stockholm, Sweden; [Shmueli, Merav D.] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Kuhn, Peer-Hendrik] Tech Univ Munich, Inst Pathol, Munich, Germany; [Kumar, Rohit] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Munich, Germany; [Kumar, Rohit; Koeglsperger, Thomas] Ludwig Maximilian Univ Munich, Dept Neurol, Munich, Germany; [Conrad, Marcus; Wurst, Wolfgang] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Wurst, Wolfgang] German Ctr Neurodegenerat Dis DZNE, Genome Engn, Munich, Germany; [Wurst, Wolfgang] Tech Univ Munich, Sch Life Sci Weihenstephan, Dev Genet, Freising Weihenstephan, Germany; [Wurst, Wolfgang; Feederle, Regina; Lichtenthaler, Stefan F.] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Feederle, Regina] Helmholtz Zentrum Munchen, Inst Diabet & Obes, German Res Ctr Environm Hlth, Monoclonal Antibody Core Facil, Neuherberg, Germany; [Feederle, Regina] German Ctr Neurodegenerat Dis DZNE, Core Facil Monoclonal Antibodies, Munich, Germany; [Vlachos, Andreas] Univ Freiburg, Inst Anat & Cell Biol, Dept Neuroanat, Fac Med, Freiburg, Germany; [Vlachos, Andreas] Univ Freiburg, Ctr Basics Neuromodulat NeuroModulBasics, Fac Med, Freiburg, Germany; [Michalakis, Stylianos] Ludwig Maximilian Univ Munich, Dept Ophthalmol, Munich, Germany; [Jedlicka, Peter] Justus Liebig Univ, ICAR3R Interdisciplinary Ctr 3Rs Anim Res, Fac Med, Giessen, Germany; [Jedlicka, Peter] Goethe Univ, Inst Clin Neuroanat, Neurosci Ctr, Frankfurt, Germany; [Jedlicka, Peter] Frankfurt Inst Adv Studies, Frankfurt, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Bern; Karolinska Institutet; Weizmann Institute of Science; Technical University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Freiburg; University of Freiburg; University of Munich; Justus Liebig University Giessen; Goethe University Frankfurt	Lichtenthaler, SF (corresponding author), German Ctr Neurodegenerat Dis DZNE, Munich, Germany.	Stefan.Lichtenthaler@dzne.de	Michalakis, Stylianos/M-4677-2019; Kumar, Rohit/GYV-2433-2022; Jedlicka, Peter/AAW-4207-2020; Shmueli, Merav/HDM-9859-2022; Lichtenthaler, Stefan/B-6587-2016; Conrad, Marcus/E-8792-2015	Michalakis, Stylianos/0000-0001-5092-9238; Kumar, Rohit/0000-0001-9490-2387; Jedlicka, Peter/0000-0001-6571-5742; Shmueli, Merav/0000-0002-9196-7633; Lichtenthaler, Stefan/0000-0003-2211-2575; Conrad, Marcus/0000-0003-1140-5612; Wurst, Wolfgang/0000-0003-4422-7410; Feederle, Regina/0000-0002-3981-367X	Deutsche Forschungsgemeinschaft (DFG) [EXC 2145 SyNergy, 390857198, JE 528/6-1, FOR 2290]; BMBF Bundesministerium fur Bildung und Forschung [CLINSPECT-M]; Swedish Society of Medical Research [123]; Alzheimer Forschung Initiative (AFI) [15038]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BMBF Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Swedish Society of Medical Research; Alzheimer Forschung Initiative (AFI)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: EXC 2145 SyNergy, project ID 390857198, JE 528/6-1 and FOR 2290; BMBF Bundesministerium fur Bildung und Forschung, Grant/Award Number: CLINSPECT-M; Swedish Society of Medical Research, Grant/Award Number: 123; Alzheimer Forschung Initiative (AFI), Grant/Award Number: 15038	Barao S, 2016, TRENDS NEUROSCI, V39, P158, DOI 10.1016/j.tins.2016.01.003; Brummer T, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809695; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; Cheret C, 2013, EMBO J, V32, P2015, DOI 10.1038/emboj.2013.146; Colombo A, 2018, EMBO J, V37, DOI 10.15252/embj.201797390; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; Connor SA, 2019, CURR OPIN NEUROBIOL, V57, P71, DOI 10.1016/j.conb.2019.01.002; Connor SA, 2017, CELL REP, V21, P3637, DOI 10.1016/j.celrep.2017.11.109; Cottrell GS, 2018, J NEUROSCI, V38, P9186, DOI 10.1523/JNEUROSCI.3572-15.2018; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dahimene S, 2018, CELL REP, V25, P1610, DOI 10.1016/j.celrep.2018.10.033; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; Dislich B, 2015, MOL CELL PROTEOMICS, V14, P2550, DOI 10.1074/mcp.M114.041533; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Egan MF, 2019, NEW ENGL J MED, V380, P1408, DOI 10.1056/NEJMoa1812840; Egan MF, 2018, NEW ENGL J MED, V378, P1691, DOI 10.1056/NEJMoa1706441; Freeman M, 2014, ANNU REV CELL DEV BI, V30, P235, DOI 10.1146/annurev-cellbio-100913-012944; Gangwar SP, 2017, NEURON, V94, P1132, DOI 10.1016/j.neuron.2017.06.009; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Henley D, 2019, NEW ENGL J MED, V380, P1483, DOI 10.1056/NEJMc1813435; Herber J, 2018, MOL CELL PROTEOMICS, V17, P1487, DOI 10.1074/mcp.RA118.000608; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Hogl S, 2013, PROTEOMICS, V13, P1519, DOI 10.1002/pmic.201200582; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2013, CELL REP, V4, P40, DOI 10.1016/j.celrep.2013.06.005; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Ishikawa T, 2011, DEV DYNAM, V240, P96, DOI 10.1002/dvdy.22496; JAY SD, 1991, J BIOL CHEM, V266, P3287; Johnson N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07556-3; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim JA, 2017, NEURON, V94, P1121, DOI 10.1016/j.neuron.2017.05.034; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2015, MOL CELL PROTEOMICS, V14, P1584, DOI 10.1074/mcp.M115.048298; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lee K, 2013, P NATL ACAD SCI USA, V110, P336, DOI 10.1073/pnas.1219987110; Lemberg MK, 2013, TRENDS CELL BIOL, V23, P210, DOI 10.1016/j.tcb.2013.01.002; Li JY, 2011, SCHIZOPHR RES, V125, P194, DOI 10.1016/j.schres.2010.11.002; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Martin-Murphy BV, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103352, 10.1371/journal.pone.0080949, 10.1371/journal.pone.0109166]; May PC, 2015, J NEUROSCI, V35, P1199, DOI 10.1523/JNEUROSCI.4129-14.2015; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; Nguyen QA, 2016, ELIFE, V5, DOI 10.7554/eLife.19236; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Oikawa N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030209; Ou-Yang MH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5620; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Pettem KL, 2013, J CELL BIOL, V200, P321, DOI 10.1083/jcb.201206028; Pigoni M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0134-z; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stutzer I, 2013, J BIOL CHEM, V288, P10536, DOI 10.1074/jbc.M112.444703; Takeuchi A, 2006, J NEUROSCI, V26, P4460, DOI 10.1523/JNEUROSCI.4935-05.2006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Vassar R, 2019, JPAD-J PREV ALZHEIM, V6, P78, DOI 10.14283/jpad.2019.3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vlachos A, 2013, P NATL ACAD SCI USA, V110, P8242, DOI 10.1073/pnas.1213677110; Vnencak M, 2019, BRAIN STRUCT FUNCT, V224, P1279, DOI 10.1007/s00429-019-01836-6; Volloch Vladimir, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6020045; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Voytyuk I, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800026; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465; Zhu KC, 2018, BIOL PSYCHIAT, V83, P428, DOI 10.1016/j.biopsych.2016.12.023; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	92	14	14	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2465	2482		10.1096/fj.201902347R	http://dx.doi.org/10.1096/fj.201902347R		DEC 2019	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908000	Green Published, hybrid			2022-12-28	WOS:000504676900001
J	Day, J; Passecker, A; Beck, HP; Vakonakis, I				Day, Jemma; Passecker, Armin; Beck, Hans-Peter; Vakonakis, Ioannis			The Plasmodium falciparum Hsp70-x chaperone assists the heat stress response of the malaria parasite	FASEB JOURNAL			English	Article						PfHsp70-x; protein structure; chaperone-cochaperone interactions; chaperone inhibition	NUCLEOTIDE-BINDING DOMAIN; HEAT-SHOCK-PROTEIN-70 HSP70; J-PROTEINS; EVOLUTION; ROLES; INHIBITOR; MKT-077; HSP40	Plasmodium falciparum is the most lethal of human-infective malaria parasites. A hallmark of P. falciparum malaria is extensive remodeling of host erythrocytes by the parasite, which facilitates the development of virulence properties such as host cell adhesion to the endothelial lining of the microvasculature. Host remodeling is mediated by a large complement of parasite proteins exported to the erythrocyte; among them is a single heat shock protein (Hsp)70-class protein chaperone, P. falciparum Hsp70-x (PfHsp70-x). PfHsp70-x was previously shown to assist the development of virulent cytoadherence characteristics. Here, we show that PfHsp70-x also supports parasite growth under elevated temperature conditions that simulate febrile episodes, especially at the beginning of the parasite life cycle when most of host cell remodeling takes place. Biochemical and biophysical analyses of PfHsp70-x, including crystallographic structures of its catalytic domain and the J-domain of its stimulatory Hsp40 cochaperone, suggest that PfHsp70-x is highly similar to human Hsp70 chaperones endogenous to the erythrocyte. Nevertheless, our results indicate that selective inhibition of PfHsp70-x function using small molecules may be possible and highlight specific sites of its catalytic domain as potentially of high interest. We discuss the likely roles of PfHsp70-x and human chaperones in P. falciparum biology and how specific inhibitors may assist us in disentangling their relative contributions.	[Day, Jemma; Vakonakis, Ioannis] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England; [Passecker, Armin; Beck, Hans-Peter] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Passecker, Armin; Beck, Hans-Peter] Univ Basel, Basel, Switzerland	University of Oxford; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk			Medical Research Council UK [MR/N009274/1]; Swiss National Science Foundation [SNF 31003A_169347]; Wellcome Trust; Wellcome Institutional Strategic Support Fund; Edward Penley Abraham Cephalosporin Trust; John Fell Oxford University Press (OUP) Research Fund; Wellcome Trust [094872/Z/10/Z]; MRC [MR/N009274/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome Trust); Wellcome Institutional Strategic Support Fund; Edward Penley Abraham Cephalosporin Trust; John Fell Oxford University Press (OUP) Research Fund; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Nick Soffe and Christina Redfield (University of Oxford) for maintenance of the solution NMR facility, Edward Lowe (University of Oxford) for supporting the crystallization facility of Oxford Biochemistry, and Dr. Vasant Muralidharan (University of Georgia, Athens, GA, USA) for providing the PfHsp70-xglmS parasite clone. The authors thank the Medical Research Council UK (MR/N009274/1) for support to I.V., and the Swiss National Science Foundation (SNF 31003A_169347) for support to H.-P.B. J.D. was funded by a Ph.D. studentship from the Wellcome Trust. The Oxford Biochemistry NMR facility was supported by the Wellcome Trust (094872/Z/10/Z), the Wellcome Institutional Strategic Support Fund, the Edward Penley Abraham Cephalosporin Trust, and the John Fell Oxford University Press (OUP) Research Fund. The authors declare no conflicts of interest.	Acharya P, 2007, MOL BIOCHEM PARASIT, V153, P85, DOI 10.1016/j.molbiopara.2007.01.009; Amick J, 2014, PROTEIN SCI, V23, P833, DOI 10.1002/pro.2466; Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Bryk AH, 2017, J PROTEOME RES, V16, P2752, DOI 10.1021/acs.jproteome.7b00025; Charnaud SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181656; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28608-2; Cobb DW, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00363-17, 10.1128/msphere.00363-17]; Cockburn IL, 2014, BIOL CHEM, V395, P1353, DOI 10.1515/hsz-2014-0138; Craig AG, 2012, MALAYS J MED SCI, V19, P5; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Daniyan MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148517; de Koning-Ward TF, 2016, NAT REV MICROBIOL, V14, P494, DOI 10.1038/nrmicro.2016.79; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dicko Alassane, 2018, Lancet Infect Dis, V18, P627, DOI 10.1016/S1473-3099(18)30044-6; Dondorp Arjen M, 2011, N Engl J Med, V365, P1073, DOI 10.1056/NEJMp1108322; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enserink M, 2010, SCIENCE, V328, P844, DOI 10.1126/science.328.5980.844; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Fuxreiter M, 2018, J MOL BIOL, V430, P2278, DOI 10.1016/j.jmb.2018.02.015; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Hempelmann E, 2007, PARASITOL RES, V100, P671, DOI 10.1007/s00436-006-0313-x; Hussein HA, 2015, NUCLEIC ACIDS RES, V43, pW436, DOI 10.1093/nar/gkv462; Hviid L, 2015, ADV PARASIT, V88, P51, DOI 10.1016/bs.apar.2015.02.004; Johansson KE, 2018, CURR OPIN STRUC BIOL, V48, P157, DOI 10.1016/j.sbi.2018.01.010; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Keul ND, 2018, NATURE, V563, P584, DOI 10.1038/s41586-018-0699-5; Kirchgatter K, 2005, AN ACAD BRAS CIENC, V77, P455, DOI 10.1590/S0001-37652005000300008; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kneller, 2003, SPARKY 3; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; KWIATKOWSKI D, 1989, J EXP MED, V169, P357, DOI 10.1084/jem.169.1.357; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Loy DE, 2017, INT J PARASITOL, V47, P87, DOI 10.1016/j.ijpara.2016.05.008; Lu G, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1045-3; Mabate B, 2018, PROTEINS, V86, P1189, DOI 10.1002/prot.25600; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Moll K., 2013, METHODS MALARIA RES, V6th, DOI DOI 10.1007/S00436-008-0981-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Pesce ER, 2014, PARASITOLOGY, V141, P1167, DOI 10.1017/S003118201300228X; Pettinger J, 2017, ANGEW CHEM INT EDIT, V56, P3536, DOI 10.1002/anie.201611907; POLOGE LG, 1988, CELL, V55, P869, DOI 10.1016/0092-8674(88)90142-0; Proellocks NI, 2016, ADV PARASIT, V91, P1, DOI 10.1016/bs.apar.2015.09.002; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Rogala KB, 2015, ELIFE, V4, DOI 10.7554/eLife.07410; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Sinha S, 2014, PARASITE, V21, DOI 10.1051/parasite/2014059; Smith JD, 2013, CELL MICROBIOL, V15, P1976, DOI 10.1111/cmi.12183; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Vial H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-396; Warncke JD, 2016, MICROBIOL MOL BIOL R, V80, P905, DOI 10.1128/MMBR.00014-16; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WERNSDORFER WH, 1991, PARASITOL TODAY, V7, P297, DOI 10.1016/0169-4758(91)90262-M; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; World Health Organization, 2018, WORLD MAL REP 2018; Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhang ZM, 2015, BIOCHIMIE, V108, P186, DOI 10.1016/j.biochi.2014.11.012; Zoungrana A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001630; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	77	24	24	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14611	14624		10.1096/fj.201901741R	http://dx.doi.org/10.1096/fj.201901741R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690116	Green Published, hybrid			2022-12-28	WOS:000507466100119
J	Mroueh, FM; Noureldein, M; Zeidan, YH; Boutary, S; Irani, SA; Eid, S; Haddad, M; Barakat, R; Harb, F; Costantine, J; Kanj, R; Sauleau, EA; Ouhtit, A; Azar, ST; Eid, AH; Eid, AA				Mroueh, Fatima Mohsen; Noureldein, Mohamed; Zeidan, Youssef H.; Boutary, Suzan; Irani, Sara Abou Merhi; Eid, Stephanie; Haddad, Mary; Barakat, Rasha; Harb, Frederic; Costantine, Joseph; Kanj, Rouwaida; Sauleau, Erik-Andre; Ouhtit, Allal; Azar, Sami T.; Eid, Ali H.; Eid, Assaad A.			Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer	FASEB JOURNAL			English	Article						colorectal cancer; NADPH oxidases; mTORC1; DNA damage	ACTIVATED PROTEIN-KINASE; EXCISION-REPAIR PATHWAY; COLORECTAL ADENOMA RISK; MAMMALIAN TARGET; CELL-PROLIFERATION; PODOCYTE DEPLETION; INSULIN THERAPY; DNA-DAMAGE; MELLITUS; AMPK	Cancer was recently annexed to diabetic complications. Furthermore, recent studies suggest that cancer can increase the risk of diabetes. Consequently, diabetes and cancer share many risk factors, but the cellular and molecular pathways correlating diabetes and colon and rectal cancer (CRC) remain far from understood. In this study, we assess the effect of hyperglycemia on cancer cell aggressiveness in human colon epithelial adenocarcinoma cells in vitro and in an experimental animal model of CRC. Our results show that Nox (NADPH oxidase enzyme) 4 induced reactive oxygen species (ROS) production is deregulated in both diabetes and CRC. This is paralleled by inactivation of the AMPK and activation of the mammalian target of rapamycin (mTOR) C1 signaling pathways, resulting in 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) accumulation, induction of DNA damage, and exacerbation of cancer cell aggressiveness, thus contributing to the genomic instability and predisposition to increased tumorigenesis in the diabetic milieu. Pharmacologic activation of AMPK, inhibition of mTORC1, or blockade of Nox4 reduce ROS production, restore the homeostatic signaling of 8-oxoguanine DNA glycosylase/8-oxodG, and lessen the progression of CRC malignancy in a diabetic milieu. Taken together, our results identify the AMPK/mTORC1/Nox4 signaling axis as a molecular switch correlating diabetes and CRC. Modulating this pathway may be a strategic target of therapeutic potential aimed at reversing or slowing the progression of CRC in patients with or without diabetes.	[Mroueh, Fatima Mohsen; Noureldein, Mohamed; Zeidan, Youssef H.; Boutary, Suzan; Irani, Sara Abou Merhi; Eid, Stephanie; Haddad, Mary; Barakat, Rasha; Eid, Assaad A.] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Bliss St,Hamra 11-0236, Beirut 2020, Lebanon; [Mroueh, Fatima Mohsen; Noureldein, Mohamed; Zeidan, Youssef H.; Boutary, Suzan; Irani, Sara Abou Merhi; Eid, Stephanie; Haddad, Mary; Barakat, Rasha; Azar, Sami T.; Eid, Assaad A.] Amer Univ Beirut, Med Ctr, Bliss St,Hamra 11-0236, Beirut 2020, Lebanon; [Zeidan, Youssef H.] Amer Univ Beirut, Dept Radiat Oncol, Fac Med, Beirut, Lebanon; [Costantine, Joseph; Kanj, Rouwaida] Amer Univ Beirut, Dept Elect & Comp Engn, Maroun Semaan Fac Engn & Architecture, Beirut, Lebanon; [Azar, Sami T.] Amer Univ Beirut, Fac Med, Dept Internal Med, Beirut, Lebanon; [Azar, Sami T.; Eid, Assaad A.] Amer Univ Beirut, Med Ctr, Amer Univ Beirut AUB Diabet, Beirut, Lebanon; [Eid, Ali H.] Amer Univ Beirut, Fac Med, Dept Pharmacol & Toxicol, Beirut, Lebanon; [Harb, Frederic] Lebanese Univ, Fac Sci, Dept Life & Earth Sci, Fanar, Lebanon; [Sauleau, Erik-Andre] Univ Strasbourg, CNRS, Dept Biostat, ICube,Unite Mixte Rech UMR 7357, Strasbourg, France; [Ouhtit, Allal; Eid, Ali H.] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; Lebanese University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Qatar University	Eid, AA (corresponding author), Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Bliss St,Hamra 11-0236, Beirut 2020, Lebanon.; Eid, AA (corresponding author), Amer Univ Beirut, Med Ctr, Bliss St,Hamra 11-0236, Beirut 2020, Lebanon.	ae49@aub.edu.lb	Eid, Ali Hussein/ABD-6291-2021; Costantine, Joseph/ABD-7022-2021; Harb, Frederic/O-4587-2019	Eid, Ali Hussein/0000-0003-3004-5675; Costantine, Joseph/0000-0003-3423-5425; Eid, Stephanie/0000-0003-3775-7544; Harb, Frederic/0000-0001-5882-1619; Barakat, Rasha/0000-0003-2371-9109	National Priority Research Programs (NPRP) grant from the Qatar National Research Foundation (QNRF) [5-409-3-112]	National Priority Research Programs (NPRP) grant from the Qatar National Research Foundation (QNRF)	The authors thank the American University of Beirut Animal Care Facility staff for their help in taking care of the animals used in this study. This work was funded by a National Priority Research Programs (NPRP) grant from the Qatar National Research Foundation (QNRF; 5-409-3-112 to A.O., A.H.E., and A.A.E.). The authors declare no conflicts of interest.	Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3231, DOI 10.1167/iovs.08-1754; Arbiser JL, 2002, J AM ACAD DERMATOL, V46, P376, DOI 10.1067/mjd.2002.120530; Bauer TM, 2015, PHARMACOL THERAPEUT, V146, P53, DOI 10.1016/j.pharmthera.2014.09.006; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Cadet J, 2014, ARCH BIOCHEM BIOPHYS, V557, P47, DOI 10.1016/j.abb.2014.05.001; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Chew SH, 2015, FREE RADICAL BIO MED, V86, P166, DOI 10.1016/j.freeradbiomed.2015.05.002; Chung YW, 2008, DIS COLON RECTUM, V51, P593, DOI 10.1007/s10350-007-9184-1; Das S, 2016, AIP ADV, V5, P1; De Bruijn KMJ, 2015, ANN SURG, V261, P854, DOI 10.1097/SLA.0000000000000819; Dizdaroglu M, 2012, FREE RADICAL RES, V46, P382, DOI 10.3109/10715762.2011.653969; Duan WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035970; Dziaman T, 2014, INT J CANCER, V134, P376, DOI 10.1002/ijc.28374; Eid AA, 2013, MOL CELL BIOL, V33, P3439, DOI 10.1128/MCB.00217-13; Eid AA, 2013, DIABETES, V62, P2935, DOI 10.2337/db12-1504; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Eid S, 2016, ANTIOXID REDOX SIGN, V25, P703, DOI 10.1089/ars.2015.6562; Elwing JE, 2006, AM J GASTROENTEROL, V101, P1866, DOI 10.1111/j.1572-0241.2006.00651.x; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Filla LA, 2016, MOL BIOSYST, V12, P1090, DOI 10.1039/c6mb00014b; Fitzgerald JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030712; Fujishita T, 2017, ONCOGENE, V36, P6480, DOI 10.1038/onc.2017.242; Furman BL, 2015, CURR PROTOCOLS PHARM, V70, DOI [10.1002/0471141755.ph0547s70, 10.1002/0471141755.ph0547-70, DOI 10.1002/0471141755.PH0547-70, 10.1002/cpz1.78, DOI 10.1002/0471141755.PH0547S70]; Giouleme O, 2011, WORLD J GASTROENTERO, V17, P444, DOI 10.3748/wjg.v17.i4.444; Guo W, 2014, ONCOGENE, V33, P537, DOI 10.1038/onc.2013.260; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Holmes HM, 2014, EUR J INTERN MED, V25, P374, DOI 10.1016/j.ejim.2013.12.003; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Hwangbo Y, 2018, JAMA ONCOL, V4, P1099, DOI 10.1001/jamaoncol.2018.1684; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Jeon SM, 2015, ARCH PHARM RES, V38, P346, DOI 10.1007/s12272-015-0549-z; Kim JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.115; Limburg PJ, 2006, AM J GASTROENTEROL, V101, P1872, DOI 10.1111/j.1572-0241.2006.00725.x; Lipscombe LL, 2013, DIABETOLOGIA, V56, P476, DOI 10.1007/s00125-012-2793-9; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Loft S, 2008, BIOCHEM SOC T, V36, P1071, DOI 10.1042/BST0361071; Maalouf RM, 2012, AM J PHYSIOL-CELL PH, V302, pC597, DOI 10.1152/ajpcell.00331.2011; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; MOSER AR, 1995, EUR J CANCER, V31A, P1061, DOI 10.1016/0959-8049(95)00181-H; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nagel JM, 2006, Z GASTROENTEROL, V44, P1153, DOI 10.1055/s-2006-927132; Nozawa H, 2007, CANCER LETT, V251, P105, DOI 10.1016/j.canlet.2006.11.008; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Oh SW, 2008, DIS COLON RECTUM, V51, P56, DOI 10.1007/s10350-007-9083-5; Pan HZ, 2008, BRIT J OPHTHALMOL, V92, P548, DOI 10.1136/bjo.2007.130542; Park IJ, 2006, ANN NY ACAD SCI, V1091, P102, DOI 10.1196/annals.1378.059; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Ren X, 2009, PUBLIC HEALTH, V123, P540, DOI 10.1016/j.puhe.2009.06.019; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Rodriguez Luis G, 2005, Methods Mol Biol, V294, P23; Rodriguez Y, 2015, DNA REPAIR, V32, P113, DOI 10.1016/j.dnarep.2015.04.021; Rojas A, 2008, CURR VASC PHARMACOL, V6, P44, DOI 10.2174/157016108783331312; Roszkowski K, 2012, CANCER EPIDEM BIOMAR, V21, P629, DOI 10.1158/1055-9965.EPI-11-0981; Saito N, 2008, MOL MED REP, V1, P77; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sedeek M, 2012, J CARDIOVASC TRANSL, V5, P509, DOI 10.1007/s12265-012-9387-2; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shin DW, 2010, CANCER CAUSE CONTROL, V21, P919, DOI 10.1007/s10552-010-9521-x; Siddiqui AA, 2008, DIGEST DIS SCI, V53, P2486, DOI 10.1007/s10620-008-0264-4; Singh S, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv402; Slattery ML, 2010, CARCINOGENESIS, V31, P1604, DOI 10.1093/carcin/bgq142; Srivastava A, 2009, ANN SURG ONCOL, V16, P1695, DOI 10.1245/s10434-009-0354-3; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Suchanek S, 2016, WORLD J GASTROENTERO, V22, P8103, DOI 10.3748/wjg.v22.i36.8103; Sugiyama M, 2009, INT J ONCOL, V34, P339, DOI 10.3892/ijo_00000156; Szablewski L, 2014, DIABETES-METAB RES, V30, P543, DOI 10.1002/dmrr.2573; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Thallas-Bonke V, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12192; Thallas-Bonke V, 2015, CURR OPIN NEPHROL HY, V24, P74, DOI 10.1097/MNH.0000000000000082; Tomimoto A, 2008, CANCER SCI, V99, P2136, DOI 10.1111/j.1349-7006.2008.00933.x; Tsilidis KK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7607; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Vasconcelos-dos-Santos A, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.2; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xia P, 2016, ONCOTARGET, V7, P45538, DOI 10.18632/oncotarget.9998; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang YX, 2005, CLIN GASTROENTEROL H, V3, P587, DOI 10.1016/S1542-3565(05)00152-7; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; Yellen P, 2011, CELL CYCLE, V10, P3948, DOI 10.4161/cc.10.22.18124; Yue W, 2014, CANCER PREV RES, V7, P388, DOI 10.1158/1940-6207.CAPR-13-0337; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105; Zhang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065742; Zhang Shuai, 2015, Huanjing Kexue, V36, P661, DOI 10.13227/j.hjkx.2015.02.038	93	14	15	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14051	14066		10.1096/fj.201900396RR	http://dx.doi.org/10.1096/fj.201900396RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31661292	Green Submitted, Bronze			2022-12-28	WOS:000507466100076
J	Yin, C; Ke, XX; Zhang, R; Hou, JB; Dong, Z; Wang, F; Zhang, K; Zhong, X; Yang, LQ; Cui, HJ				Yin, Chao; Ke, Xiaoxue; Zhang, Rui; Hou, Jianbing; Dong, Zhen; Wang, Feng; Zhang, Kui; Zhong, Xi; Yang, Liqun; Cui, Hongjuan			G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR	FASEB JOURNAL			English	Article							INHIBITION; PROTECTS; TRANSCRIPTION; METHYLATION; EXPRESSION; APOPTOSIS; SURVIVAL	As an important methyltransferase, G9a has been reported to be abnormally expressed in various human cancers and plays essential roles in tumorigenesis. However, the biologic functions and molecular mechanisms of G9a in gastric cancer (GC) remain unclear. GC is the fifth most frequent cancer around the world and seriously threatens human health, especially in developing countries. Here, our results showed that high expression of G9a was intensively correlated with poor prognosis and more advanced stages of GCs. Knockdown of G9a or treatment with its inhibitor, BIX01294, significantly reduced cell growth by cell cycle arrest and autophagy. In addition, the mechanistic target of rapamycin (mTOR) was evidently decreased after G9a silencing or inhibition, and mTOR activation partially rescued the effects of cell proliferation inhibition and autophagy induced by G9a knockdown or inhibition. Down-regulation of G9a effectively inhibited mTOR expression and tumor growth in the xenograft tumor model of GC cells. We also showed that G9a regulates mTOR and cell proliferation and autophagy depending on its histone methylase activity. Using chromatin immunoprecipitation analysis, we found that mTOR expression was associated with promoter methylation and an enrichment for mono- and dimethylated histone 3 lys 9 (H3K9). G9a knockdown revealed an apparent decrease in H3K9 monomethylation levels, but no apparent change in H3K9 dimethylation levels at the mTOR promoter. These results indicate that G9a is a novel and promising therapeutic target for GC treatment.	[Yin, Chao; Ke, Xiaoxue; Zhang, Rui; Hou, Jianbing; Dong, Zhen; Wang, Feng; Zhang, Kui; Zhong, Xi; Yang, Liqun; Cui, Hongjuan] Southwest Univ, State Key Lab Silkworm Genome Biol, Inst Sericulture & Syst Biol, 2 Tiansheng Rd, Chongqing 400716, Peoples R China; [Yin, Chao; Ke, Xiaoxue; Zhang, Rui; Hou, Jianbing; Dong, Zhen; Wang, Feng; Zhang, Kui; Zhong, Xi; Yang, Liqun; Cui, Hongjuan] Southwest Univ, Med Res Inst, Ctr Canc, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Yang, LQ; Cui, HJ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Inst Sericulture & Syst Biol, 2 Tiansheng Rd, Chongqing 400716, Peoples R China.	cysylq@swu.edu.cn; hongjuan.cui@gmail.com	Zhang, Kui/AAE-9324-2022; Dong, Zhen/AAJ-7172-2020	Zhang, Kui/0000-0001-9618-610X; Dong, Zhen/0000-0003-3108-0245	National Key Research and Development Program of China [2016YFC1302204, 2017YFC1308601]; National Natural Science Foundation of China [81672502, 81872071, 31672496, 81201551, 31802142]; Key Projects of Special Funds for Basic Scientific Research Operating Expenses of Central Universities [XDJK2013B020]; Discipline Team with Special Funds for Basic Scientific Research Operating Expenses of Central Universities [2362015XK09]; Basic Scientific Research Operating Expenses of Central Universities Southwest University Nature Foundation [20120524]; Chongqing Research Program of Basic Research and Frontier Technology [cstc2016jcyjA0425]; China Postdoctoral Science Foundation [2017M620408]; Graduate Scientific Research Foundation of Chongqing [CYB18104]; Chongqing Special Postdoctoral Science Foundation [XmT2018080]; Fundamental Research Funds for the Central Universities [XDJK2019C013]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects of Special Funds for Basic Scientific Research Operating Expenses of Central Universities; Discipline Team with Special Funds for Basic Scientific Research Operating Expenses of Central Universities; Basic Scientific Research Operating Expenses of Central Universities Southwest University Nature Foundation; Chongqing Research Program of Basic Research and Frontier Technology; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Graduate Scientific Research Foundation of Chongqing; Chongqing Special Postdoctoral Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Research and Development Program of China (2016YFC1302204 and 2017YFC1308601), the National Natural Science Foundation of China (81672502 and 81872071), the National Natural Science Foundation of China (31672496, 81201551, and 31802142), the Key Projects of Special Funds for Basic Scientific Research Operating Expenses of Central Universities (XDJK2013B020), Discipline Team with Special Funds for Basic Scientific Research Operating Expenses of Central Universities (2362015XK09), the Basic Scientific Research Operating Expenses of Central Universities Southwest University Nature Foundation (20120524), the Chongqing Research Program of Basic Research and Frontier Technology (cstc2016jcyjA0425), China Postdoctoral Science Foundation (2017M620408), the Graduate Scientific Research Foundation of Chongqing (CYB18104), the Project Funded by Chongqing Special Postdoctoral Science Foundation (XmT2018080), and the Fundamental Research Funds for the Central Universities (XDJK2019C013). The authors declare no conflicts of interest.	Abbas M, 2017, BIOMED PHARMACOTHER, V95, P1082, DOI 10.1016/j.biopha.2017.09.032; Ahmad F, 2016, INT J BIOCHEM CELL B, V78, P87, DOI 10.1016/j.biocel.2016.07.009; Auclair G, 2016, GENOME RES, V26, P192, DOI 10.1101/gr.198291.115; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Casciello F, 2017, P NATL ACAD SCI USA, V114, P7077, DOI 10.1073/pnas.1618706114; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Cen WJ, 2018, J CELL PHYSIOL, V233, P6779, DOI 10.1002/jcp.26405; Chatterjee A, 2015, CANCER LETT, V360, P134, DOI 10.1016/j.canlet.2015.01.043; Cheng CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182149; Chi LJ, 2017, DEVELOPMENT, V144, P1976, DOI 10.1242/dev.148916; Deng Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1082-z; Ding J, 2013, CELL METAB, V18, P896, DOI 10.1016/j.cmet.2013.11.004; Dong Z, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010004; Dong Z, 2019, SEMIN CANCER BIOL, V57, P45, DOI 10.1016/j.semcancer.2018.09.002; Fan B, 2016, MOL MED REP, V13, P3771, DOI 10.3892/mmr.2016.5011; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Hsiao SM, 2015, ANN SURG ONCOL, V22, pS1556, DOI 10.1245/s10434-015-4379-5; Hu LH, 2018, PROCEEDINGS OF 2018 INTERNATIONAL CONFERENCE ON COMPUTING AND ARTIFICIAL INTELLIGENCE (ICCAI 2018), P9, DOI 10.1145/3194452.3194455; Huang TH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.65; Kamiunten T, 2017, EXP CELL RES, V357, P202, DOI 10.1016/j.yexcr.2017.05.016; Ke XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106962; Kim KB, 2015, NUCLEIC ACIDS RES, V43, P3509, DOI 10.1093/nar/gkv183; Kim TW, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0930-1; Lee HJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081043; Li A, 2017, J CELL MOL MED, V21, P1619, DOI 10.1111/jcmm.13091; Li F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138390; Lin XL, 2016, ONCOL REP, V35, P3041, DOI 10.3892/or.2016.4692; Liu WY, 2017, CELL MOL NEUROBIOL, V37, P1195, DOI 10.1007/s10571-016-0449-x; Nebbioso A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007362; Oh ST, 2014, FEBS LETT, V588, P685, DOI 10.1016/j.febslet.2014.01.039; Park SE, 2016, ONCOTARGET, V7, P39796, DOI 10.18632/oncotarget.9290; Poulard C, 2017, EMBO REP, V18, P1442, DOI 10.15252/embr.201744060; Rao VK, 2016, NUCLEIC ACIDS RES, V44, P8129, DOI 10.1093/nar/gkw483; Ren AS, 2015, BIOCHEM BIOPH RES CO, V459, P10, DOI 10.1016/j.bbrc.2015.01.068; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Wang LF, 2013, EMBO J, V32, P45, DOI 10.1038/emboj.2012.306; Wang YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14173; Wei FZ, 2015, AUTOPHAGY, V11, P2309, DOI 10.1080/15548627.2015.1117734; White E, 2015, CLIN CANCER RES, V21, P5037, DOI 10.1158/1078-0432.CCR-15-0490; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Xuan F, 2016, NEURO-ONCOLOGY, V18, P819, DOI 10.1093/neuonc/nov281; Yang F, 2017, CELL PHYSIOL BIOCHEM, V43, P1168, DOI 10.1159/000481758; Yang QY, 2017, P NATL ACAD SCI USA, V114, pE6054, DOI 10.1073/pnas.1700694114; Yuan Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.191; Zhang J, 2015, ONCOTARGET, V6, P2917, DOI 10.18632/oncotarget.2784; Zhao EH, 2016, CELL REP, V14, P506, DOI 10.1016/j.celrep.2015.12.053; Zhao W, 2019, FASEB J, V33, P1151, DOI 10.1096/fj.201800408R; Zhu SQ, 2019, SEMIN CANCER BIOL, V57, P59, DOI 10.1016/j.semcancer.2018.11.003	52	20	20	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14036	14050		10.1096/fj.201900233RR	http://dx.doi.org/10.1096/fj.201900233RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31647887	Bronze			2022-12-28	WOS:000507466100075
J	Sinha, A; Israeli, R; Cirigliano, A; Gihaz, S; Trabelcy, B; Braus, GH; Gerchman, Y; Fishman, A; Negri, R; Rinaldi, T; Pick, E				Sinha, Abhishek; Israeli, Ran; Cirigliano, Angela; Gihaz, Shalev; Trabelcy, Beny; Braus, Gerhard H.; Gerchman, Yoram; Fishman, Ayelet; Negri, Rodolfo; Rinaldi, Teresa; Pick, Elah			The COP9 signalosome mediates the Spt23 regulated fatty acid desaturation and ergosterol biosynthesis	FASEB JOURNAL			English	Article						Csn5; COP9 signalosome; Ergosterol; NEDD8; Ole1; Rub1; Spt23; S; cerevisiae	UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; UBIQUITIN LIGASE; PCI COMPLEXES; GTPASE YPT7; YEAST; PROTEASOME; STRESS	The COP9 signalosome (CSN) is a conserved eukaryotic complex, essential for vitality in all multicellular organisms and critical for the turnover of key cellular proteins through catalytic and non-catalytic activities. Saccharomyces cerevisiae is a powerful model organism for studying fundamental aspects of the CSN complex, since it includes a conserved enzymatic core but lacks non-catalytic activities, probably explaining its non-essentiality for life. A previous transcriptomic analysis of an S. cerevisiae strain deleted in the CSN5/RRI1 gene, encoding to the CSN catalytic subunit, revealed a downregulation of genes involved in lipid metabolism. We now show that the S. cerevisiae CSN holocomplex is essential for cellular lipid homeostasis. Defects in CSN assembly or activity lead to decreased quantities of ergosterol and unsaturated fatty acids (UFA); vacuole defects; diminished lipid droplets (LDs) size; and to accumulation of endoplasmic reticulum (ER) stress. The molecular mechanism behind these findings depends on CSN involvement in upregulating mRNA expression of SPT23. Spt23 is a novel activator of lipid desaturation and ergosterol biosynthesis. Our data reveal for the first time a functional link between the CSN holocomplex and Spt23. Moreover, CSN-dependent upregulation of SPT23 transcription is necessary for the fine-tuning of lipid homeostasis and for cellular health.	[Sinha, Abhishek; Israeli, Ran; Trabelcy, Beny; Gerchman, Yoram; Pick, Elah] Univ Haifa, Dept Biol & Environm, Fac Nat Sci, IL-3600600 Oranim, Tivon, Israel; [Cirigliano, Angela; Negri, Rodolfo; Rinaldi, Teresa] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Gihaz, Shalev; Fishman, Ayelet] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel; [Braus, Gerhard H.] Univ Goettingen, Dept Mol Microbiol & Genet, Inst Microbiol & Genet, Goettingen Ctr Mol Biosci GZMB, Gottingen, Germany	University of Haifa; Sapienza University Rome; Technion Israel Institute of Technology; University of Gottingen	Pick, E (corresponding author), Univ Haifa, Dept Biol & Environm, Fac Nat Sci, IL-3600600 Oranim, Tivon, Israel.	elahpic@research.haifa.ac.il	Braus, Gerhard H/G-3999-2012; Gerchman, Yoram/F-5226-2015; Rinaldi, Teresa/AAC-9710-2020	Braus, Gerhard H/0000-0002-3117-5626; Gerchman, Yoram/0000-0002-8637-9589; Rinaldi, Teresa/0000-0001-6291-245X; Gihaz, Shalev/0000-0001-7292-0808; Sinha, Abhishek/0000-0003-1831-5513	Ministry of Science and Technology [3-9022]; Ministry of Foreign Affairs; Israel Science Foundation [162/17]; Council for Higher Education	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy)); Israel Science Foundation(Israel Science Foundation); Council for Higher Education	Ministry of Science and Technology, Grant/Award Number: 3-9022; Ministry of Foreign Affairs; Israel Science Foundation 162/17; Council for Higher Education	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Auld KL, 2006, CELL CYCLE, V5, P1503, DOI 10.4161/cc.5.14.2979; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Balderhaar HJK, 2010, J CELL SCI, V123, P4085, DOI 10.1242/jcs.071977; Ballweg S, 2017, BIOL CHEM, V398, P215, DOI 10.1515/hsz-2016-0277; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Brachmann CB, 1998, YEAST, V14, P115; Bramasole L, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090449; BREIVIK ON, 1957, J AGR FOOD CHEM, V5, P360, DOI 10.1021/jf60075a005; Busch S, 2003, MOL MICROBIOL, V49, P717, DOI 10.1046/j.1365-2958.2003.03612.x; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Catlett NL, 2000, J CELL BIOL, V150, P513, DOI 10.1083/jcb.150.3.513; Cavadini S, 2016, NATURE, V531, P598, DOI 10.1038/nature17416; Chamovitz DA, 2009, EMBO REP, V10, P352, DOI 10.1038/embor.2009.33; Chemler JA, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-20; Christmann M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003275; Cirigliano A, 2019, BBA-MOL CELL BIOL L, V1864, P290, DOI 10.1016/j.bbalip.2018.12.002; Cirigliano A, 2016, J ENZYM INHIB MED CH, V31, P1632, DOI 10.3109/14756366.2016.1160901; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covino R, 2016, MOL CELL, V63, P49, DOI 10.1016/j.molcel.2016.05.015; Davies BSJ, 2006, GENETICS, V174, P191, DOI 10.1534/genetics.106.059964; De Angelis L, 2016, MICROBIOL-SGM, V162, P1435, DOI 10.1099/mic.0.000315; Deguil J, 2011, TRAFFIC, V12, P349, DOI 10.1111/j.1600-0854.2010.01150.x; Di Mambro T, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00080; Dror A, 2014, APPL ENVIRON MICROB, V80, P1515, DOI 10.1128/AEM.03371-13; Dubiel D, 2017, BBA-MOL CELL RES, V1864, P1405, DOI 10.1016/j.bbamcr.2017.05.009; Dubiel D, 2015, FEBS LETT, V589, P2507, DOI 10.1016/j.febslet.2015.06.007; Eisenberg-Bord M, 2018, J CELL BIOL, V217, P269, DOI 10.1083/jcb.201704122; ENCHEV RI, 2012, CELL REP, V16, P30; Fabris M, 2014, NEW PHYTOL, V204, P521, DOI 10.1111/nph.12917; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jiang YD, 2001, MOL CELL BIOL, V21, P6161, DOI 10.1128/MCB.21.18.6161-6169.2001; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Kaliszewski P, 2008, BBA-MOL CELL BIOL L, V1781, P627, DOI 10.1016/j.bbalip.2008.07.011; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; KNITTELFELDER OL, 2017, COLD SPRING HARB PRO; Kolawa N, 2013, MOL CELL PROTEOMICS, V12, P2791, DOI 10.1074/mcp.M113.030163; Krogerus K, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0679-8; KUPKE IR, 1978, J CHROMATOGR, V146, P261, DOI 10.1016/S0378-4347(00)81892-7; Lee MH, 2011, CELL CYCLE, V10; Licursi V, 2014, FEBS J, V281, P175, DOI 10.1111/febs.12584; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Liu C, 2013, J BIOL CHEM, V288, P20443, DOI 10.1074/jbc.M113.468959; Liu SF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147991; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Matheson K, 2017, G3-GENES GENOM GENET, V7, P2219, DOI 10.1534/g3.117.040022; Maytal-Kivity V, 2002, EMBO REP, V3, P1215, DOI 10.1093/embo-reports/kvf235; Maytal-Kivity V, 2003, INT J BIOCHEM CELL B, V35, P706, DOI 10.1016/S1357-2725(02)00378-3; Menon Suchithra, 2008, BMC Biochemistry, V9, P1, DOI 10.1186/1471-2091-9-1; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Mosadeghi R, 2016, ELIFE, V5, DOI 10.7554/eLife.12102; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Munn AL, 1999, MOL BIOL CELL, V10, P3943, DOI 10.1091/mbc.10.11.3943; Nahlik K, 2010, MOL MICROBIOL, V78, P964, DOI 10.1111/j.1365-2958.2010.07384.x; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Nezames CD, 2012, PLANT PHYSIOL, V160, P38, DOI 10.1104/pp.112.198879; Numrich J, 2015, J CELL SCI, V128, P2278, DOI 10.1242/jcs.164905; Oh CS, 2006, J BIOL CHEM, V281, P7030, DOI 10.1074/jbc.M510746200; Oron E, 2002, DEVELOPMENT, V129, P4399; Oron E, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100150; Ottaviano D, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov028; PEREIRA L, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/93195622291708; Pick E, 2014, BIOCHEM SOC T, V42, P1786, DOI 10.1042/BST20140227; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Rabut G, 2011, MOL CELL, V43, P488, DOI 10.1016/j.molcel.2011.05.032; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rice C, 2010, BIOCHEM BIOPH RES CO, V403, P293, DOI 10.1016/j.bbrc.2010.11.020; Rispal D, 2011, RNA, V17, P1213, DOI 10.1261/rna.2697111; Rosel D, 2006, EUR J CELL BIOL, V85, P1023, DOI 10.1016/j.ejcb.2006.04.006; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Schlierf A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13166; Schmaler T, 2010, SUBCELL BIOCHEM, V54, P57, DOI 10.1007/978-1-4419-6676-6_5; Schwechheimer C, 2010, EUR J CELL BIOL, V89, P157, DOI 10.1016/j.ejcb.2009.11.021; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schweitzer K, 2010, BIOCHEM SOC T, V38, P156, DOI 10.1042/BST0380156; Serratore ND, 2018, GENETICS, V208, P1037, DOI 10.1534/genetics.117.300554; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Siepe D, 2009, NAT CELL BIOL, V11, P967, DOI 10.1038/ncb1908; Soares JR, 2017, BBA-GEN SUBJECTS, V1861, P3429, DOI 10.1016/j.bbagen.2016.09.005; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Su HB, 2013, CIRC-HEART FAIL, V6, P1049, DOI 10.1161/CIRCHEARTFAILURE.113.000338; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Tamura KI, 2004, J BIOSCI BIOENG, V98, P159, DOI 10.1016/S1389-1723(04)00260-9; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wang JY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001232; Wang RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048020; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; WEI N, 1992, PLANT CELL, V4, P1507, DOI 10.1105/tpc.4.12.1507; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Weindling E, 2015, BIOCHEM BIOPH RES CO, V457, P473, DOI 10.1016/j.bbrc.2015.01.021; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; YOSHIDA A, 2013, SCI REP UK, V3; Yu ZL, 2011, MOL BIOL CELL, V22, P911, DOI 10.1091/mbc.E10-08-0655; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zhang SR, 1999, GENETICS, V151, P473; Zhang SR, 1997, MOL CELL BIOL, V17, P4718, DOI 10.1128/MCB.17.8.4718; Zhou ZP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002712; Zuleta IA, 2014, NAT METHODS, V11, P443, DOI 10.1038/nmeth.2879	123	6	6	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4870	4889		10.1096/fj.201902487R	http://dx.doi.org/10.1096/fj.201902487R		FEB 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32077151				2022-12-28	WOS:000515255600001
J	Hernandez, DM; Kang, JH; Choudhury, M; Andrianifahanana, M; Yin, XQ; Limper, AH; Leof, EB				Hernandez, Danielle M.; Kang, Jeong-Han; Choudhury, Malay; Andrianifahanana, Mahefatiana; Yin, Xueqian; Limper, Andrew H.; Leof, Edward B.			IPF pathogenesis is dependent upon TGF beta induction of IGF-1	FASEB JOURNAL			English	Article						fibroblast; promoter; signaling; transcription	GROWTH-FACTOR-I; IDIOPATHIC PULMONARY-FIBROSIS; INDUCED LUNG INJURY; MAMMALIAN TARGET; GENE-EXPRESSION; INSULIN; RECEPTOR; MECHANISMS; ACTIVATION; BLEOMYCIN	Pathogenic fibrotic diseases, including idiopathic pulmonary fibrosis (IPF), have some of the worst prognoses and affect millions of people worldwide. With unclear etiology and minimally effective therapies, two-thirds of IPF patients die within 2-5 years from this progressive interstitial lung disease. Transforming Growth Factor Beta (TGF beta) and insulin-like growth factor-1 (IGF-1) are known to promote fibrosis; however, myofibroblast specific upregulation of IGF-1 in the initiation and progression of TGF beta-induced fibrogenesis and IPF have remained unexplored. To address this, the current study (1) documents the upregulation of IGF-1 via TGF beta in myofibroblasts and fibrotic lung tissue, as well as its correlation with decreased pulmonary function in advanced IPF; (2) identifies IGF-1's C1 promoter as mediating the increase in IGF-1 transcription by TGF beta in pulmonary fibroblasts; (3) determines that SMAD2 and mTOR signaling are required for TGF beta-dependent Igf-1 expression in myofibroblasts; (4) demonstrates IGF-1R activation is essential to support TGF beta-driven profibrotic myofibroblast functions and excessive wound healing; and (5) establishes the effectiveness of slowing the progression of murine lung fibrosis with the IGF-1R inhibitor OSI-906. These findings expand our knowledge of IGF-1's role as a novel fibrotic-switch, bringing us one step closer to understanding the complex biological mechanisms responsible for fibrotic diseases and developing effective therapies.	[Hernandez, Danielle M.] Mayo Clin, Coll Med & Sci, Grad Sch Biomed Sci, Biochem & Mol Biol Dept, Rochester, MN USA; [Hernandez, Danielle M.; Kang, Jeong-Han; Choudhury, Malay; Andrianifahanana, Mahefatiana; Yin, Xueqian; Limper, Andrew H.; Leof, Edward B.] Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Dept Med,Coll Med, 200 Second St SW, Rochester, MN 55905 USA; [Hernandez, Danielle M.] Univ Minnesota Twin Cities, Masonic Canc Ctr, Dept Neurosurg, Minneapolis, MN USA; [Kang, Jeong-Han] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Yin, Xueqian] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic	Limper, AH; Leof, EB (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Dept Med,Coll Med, 200 Second St SW, Rochester, MN 55905 USA.	limper.andrew@mayo.edu; leof.edward@mayo.edu	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Hernandez, Danielle M./0000-0003-0867-4950; Choudhury, Malay/0000-0003-3051-9084	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R01-GM054200, R37-GM055816]; Caerus Foundation [91736058]; Hurvis Accelerate the Cure for IPF [91736063]	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Caerus Foundation; Hurvis Accelerate the Cure for IPF	HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01-GM054200 and R37-GM055816; Caerus Foundation, Grant/Award Number: 91736058; Hurvis Accelerate the Cure for IPF, Grant/Award Number: 91736063	Ahamed K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-31; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Allen JT, 2000, NEUROPEPTIDES, V34, P98, DOI 10.1054/npep.2000.0802; Andonegui G, 2012, AM J PHYSIOL-LUNG C, V303, pL788, DOI 10.1152/ajplung.00008.2012; Andrianifahanana M, 2016, FASEB J, V30, P3733, DOI 10.1096/fj.201600428R; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Andrianifahanana M, 2010, CANCER RES, V70, P7421, DOI 10.1158/0008-5472.CAN-10-0232; Antoniou KM, 2010, CONNECT TISSUE RES, V51, P71, DOI 10.3109/03008200903056150; ATKISON PR, 1980, ENDOCRINOLOGY, V106, P2006, DOI 10.1210/endo-106-6-2006; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartholmai B, 2006, INSIGHT J; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloor CA, 2001, AM J RESP CRIT CARE, V164, P265, DOI 10.1164/ajrccm.164.2.2003114; Brisson Becky K, 2013, Front Endocrinol (Lausanne), V4, P42, DOI 10.3389/fendo.2013.00042; Brown GC, 2015, EMBO REP, V16, P137, DOI 10.15252/embr.201439518; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Cai WK, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00417-7, 10.1038/ncomms14892]; Camelo A, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00173; Chetty A, 1999, EXP LUNG RES, V25, P701; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Choi JE, 2009, AM J RESP CRIT CARE, V179, P212, DOI 10.1164/rccm.200802-228OC; CLEMMONS DR, 1981, J CLIN INVEST, V67, P10, DOI 10.1172/JCI110001; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Della Latta V, 2015, PHARMACOL RES, V97, P122, DOI 10.1016/j.phrs.2015.04.012; Divo MJ, 2014, EUR RESPIR J, V44, P1055, DOI 10.1183/09031936.00059814; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esnault S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170207; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Frankel SK, 2005, AM J PHYSIOL-LUNG C, V288, pL805, DOI 10.1152/ajplung.00420.2004; George PM, 2019, LANCET RESP MED, V7, P271, DOI 10.1016/S2213-2600(18)30502-2; GOLDSTEIN RH, 1989, ENDOCRINOLOGY, V124, P964, DOI 10.1210/endo-124-2-964; Gyorfi AH, 2018, MATRIX BIOL, V68-69, P8, DOI 10.1016/j.matbio.2017.12.016; Hecker L, 2018, AM J PHYSIOL-LUNG C, V314, P1642, DOI 10.1152/ajplung.00275.2017; Hewlett JC, 2018, MATRIX BIOL, V71-72, P112, DOI 10.1016/j.matbio.2018.03.021; Honeyman L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-16; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Hung CF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-102; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Jung MY, 2018, FASEB J, V32, P3803, DOI 10.1096/fj.201701187R; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kang JH, 2017, J CLIN INVEST, V127, P2541, DOI 10.1172/JCI88696; Kasprzak A, 2013, INT J ONCOL, V42, P305, DOI 10.3892/ijo.2012.1706; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; KIAMINSKI N, 2015, LUNG DIS WEEK ATS PU; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Kim TH, 2012, AM J RESP CELL MOL, V47, P372, DOI 10.1165/rcmb.2012-0085OC; Koczorowska MM, 2011, EXP THER MED, V2, P149, DOI 10.3892/etm.2010.174; Kotarkonda LK, 2017, EXP MOL PATHOL, V102, P86, DOI 10.1016/j.yexmp.2017.01.004; Kottmann RM, 2009, RESPIROLOGY, V14, P917, DOI 10.1111/j.1440-1843.2009.01624.x; Laron Zvi, 2004, Novartis Found Symp, V262, P56; Leger C, 2010, AM J PHYSIOL-LUNG C, V298, pL492, DOI 10.1152/ajplung.00310.2009; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacNee W, 2014, EUR RESPIR J, V44, P1332, DOI 10.1183/09031936.00134014; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Mukhopadhyay S, 2016, MOL CANCER THER, V15, P347, DOI 10.1158/1535-7163.MCT-15-0720; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; NATIONS U, 2019, WORLD POP PROSP 2019; O'Dwyer DN, 2017, SCI REP-UK, V7, DOI 10.1038/srep46560; Oberbauer A M, 2013, Front Endocrinol (Lausanne), V4, P39, DOI 10.3389/fendo.2013.00039; Pala L, 2001, J ENDOCRINOL INVEST, V24, P856, DOI 10.1007/BF03343942; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Pineiro-Hermida S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04561-4; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Puche JE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-224; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; REISER KM, 1986, EXP LUNG RES, V10, P331, DOI 10.3109/01902148609058286; Ryu JH, 2014, MAYO CLIN PROC, V89, P1130, DOI 10.1016/j.mayocp.2014.03.016; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; STILES AD, 1989, AM J RESP CELL MOL, V1, P21, DOI 10.1165/ajrcmb/1.1.21; STILES AD, 1990, AM J RESP CELL MOL, V3, P93, DOI 10.1165/ajrcmb/3.2.93; Tao Y, 2007, NAT CLIN PRACT ONCOL, V4, P591, DOI 10.1038/ncponc0934; TORRY DJ, 1994, J CLIN INVEST, V93, P1525, DOI 10.1172/JCI117131; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; UN, 2013, ESAPWP228 UN; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassilakos G, 2014, HORM-INT J ENDOCRINO, V13, P182, DOI 10.1007/BF03401333; Walton KL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00461; Wang Z, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6057589; Warnken M, 2010, N-S ARCH PHARMACOL, V382, P511, DOI 10.1007/s00210-010-0561-2; Wu YL, 1996, J CELL PHYSIOL, V168, P499, DOI 10.1002/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K; Zank DC, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00010; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	94	18	20	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5363	5388		10.1096/fj.201901719RR	http://dx.doi.org/10.1096/fj.201901719RR		FEB 2020	26	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067272	Green Accepted			2022-12-28	WOS:000515249700001
J	Chen, L; Xiong, Y; Yan, CC; Zhou, W; Endo, Y; Xue, H; Hu, YQ; Hu, LC; Leng, XZ; Liu, J; Lin, Z; Mi, BB; Liu, GH				Chen, Lang; Xiong, Yuan; Yan, Chenchen; Zhou, Wu; Endo, Yori; Xue, Hang; Hu, Yiqiang; Hu, Liangcong; Leng, Xingzhu; Liu, Jing; Lin, Ze; Mi, Bobin; Liu, Guohui			LncRNA KCNQ1OT1 accelerates fracture healing via modulating miR-701-3p/FGFR3 axis	FASEB JOURNAL			English	Article						apoptosis; FGFR3; lncRNA; migration; miRNA; osteoblast proliferation	ENDOCHONDRAL OSSIFICATION; FGFR3; RNA; MOUSE	Emerging evidence highlights the role of the long noncoding RNA (lncRNA) KCNQ1OT1 in fracture healing. Osteoblast proliferation, migration, and survival are pivotal during this process. In this study, we aimed to improve our understanding of the regulatory role of lncRNA KCNQ1OT1 during osteoblast proliferation, migration, and survival. We searched the gene expression omnibus databases and LncBase Experimental V.2 to identify key microRNAs (miRNAs) targets of KCNQ1OT1. MiR-701-3p was selected as a differentially expressed miRNA and RNA immunoprecipitation assays were performed to verify its interaction with KCNQ1OT1. Fibroblast growth factor receptor 3 (FGFR3) was also identified as a target of miR-701-3p. We further identified KCNQ1OT1 as a competing endogenous RNA of miR-701-3p that could influence osteoblast proliferation, migration, and apoptosis in vitro and in vivo. Taken together, our results indicate that the KCNQ1OT1/miR-701-3p/FGFR3 axis is an important regulator of osteoblast proliferation, migration, and apoptosis, and provide a new therapeutic avenue for fracture healing.	[Chen, Lang; Xiong, Yuan; Yan, Chenchen; Zhou, Wu; Xue, Hang; Hu, Yiqiang; Hu, Liangcong; Liu, Jing; Lin, Ze; Mi, Bobin; Liu, Guohui] Huazhong Univ Sci & Technol, Union Hosp, Dept Orthoped, Tongji Med Coll, Wuhan, Peoples R China; [Endo, Yori] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA; [Leng, Xingzhu] Univ Utrecht, Dept Biomed Sci, UMC Utrecht, Utrecht, Netherlands	Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utrecht University	Mi, BB; Liu, GH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.	mibobin@hust.edu.cn; liuguohui@hust.edu.cn	Endo, Yori/AAY-8962-2020; Xiong, Yuan/AAQ-3642-2021	Endo, Yori/0000-0002-9282-8811; Xiong, Yuan/0000-0003-1090-9288	National Natural Science Foundation of China [81772345, 81606934]; Health and Family Planning Commission of Hubei Province [WJ2019Z009]; Department of Science and Technology, Hubei Provincial People's Government [2016CFB424]; National Health and Family Planning Commission of the People's Republic of China [ZX-01-C2016024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Hubei Province; Department of Science and Technology, Hubei Provincial People's Government(Department of Science & Technology (DOST), Philippines); National Health and Family Planning Commission of the People's Republic of China	National Natural Science Foundation of China, Grant/Award Number: 81772345 and 81606934; Health and Family Planning Commission of Hubei Province, Grant/Award Number: WJ2019Z009; Department of Science and Technology, Hubei Provincial People's Government, Grant/Award Number: 2016CFB424; National Health and Family Planning Commission of the People's Republic of China, Grant/Award Number: ZX-01-C2016024	Chen GH, 2019, PRION, V13, P106, DOI 10.1080/19336896.2019.1607464; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Dong ZW, 2019, J CELL PHYSIOL, V234, P11304, DOI 10.1002/jcp.27788; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Foldynova-Trantirkova S, 2012, HUM MUTAT, V33, P29, DOI 10.1002/humu.21636; Gao XR, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0216-4; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Giganti MG, 2014, FRONT BIOSCI-LANDMRK, V19, P1162, DOI 10.2741/4273; Huang YH, 2015, 2015 12TH WEB INFORMATION SYSTEM AND APPLICATION CONFERENCE (WISA), P3, DOI [10.1109/WISA.2015.16, 10.1109/PPC.2015.7296864]; Huch K, 2003, HISTOCHEM CELL BIOL, V119, P281, DOI 10.1007/s00418-003-0519-2; Jing PY, 2018, CANCER LETT, V427, P38, DOI 10.1016/j.canlet.2018.04.019; Liang TT, 2018, FASEB J, V32, P377, DOI 10.1096/fj.201700560RR; Lin P, 2018, CELL PHYSIOL BIOCHEM, V48, P1953, DOI 10.1159/000492519; Liu XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0677-8; Mao WP, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1136-9; Niyibizi C, 2000, EXPERT OPIN INV DRUG, V9, P1573, DOI 10.1517/13543784.9.7.1573; Osawa Y, 2017, BONE, V105, P42, DOI 10.1016/j.bone.2017.05.016; Rashid F, 2016, GENOM PROTEOM BIOINF, V14, P73, DOI 10.1016/j.gpb.2016.03.005; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Shao J, 2019, J CELL PHYSIOL, V234, P17269, DOI 10.1002/jcp.28344; Shi ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168691; Wang CG, 2019, EXP MOL PATHOL, V107, P77, DOI 10.1016/j.yexmp.2019.01.012; Wang XN, 2017, EUR REV MED PHARMACO, V21, P4771; Wang XF, 2015, AUTOPHAGY, V11, P1998, DOI 10.1080/15548627.2015.1091551; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Wu Q., 2019, J CELL PHYSL; Xian D, 2019, J CELL MOL MED, V23, P3808, DOI 10.1111/jcmm.14071; Xiong Y, 2019, MOL THER-NUCL ACIDS, V17, P223, DOI 10.1016/j.omtn.2019.06.001; Xu HJ, 2019, FASEB J, V33, P8055, DOI 10.1096/fj.201801618RRR; Yang CL, 2019, FASEB J, V33, P10490, DOI 10.1096/fj.201802543RR; Yu SJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12940	32	15	17	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5208	5222		10.1096/fj.201901864RR	http://dx.doi.org/10.1096/fj.201901864RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32060985				2022-12-28	WOS:000515245500001
J	Castro, CM; Corciulo, C; Solesio, ME; Liang, FX; Pavlov, EV; Cronstein, BN				Castro, Cristina M.; Corciulo, Carmen; Solesio, Maria E.; Liang, Fengxia; Pavlov, Evgeny V.; Cronstein, Bruce N.			Adenosine A2A receptor (A2AR) stimulation enhances mitochondrial metabolism and mitigates reactive oxygen species-mediated mitochondrial injury	FASEB JOURNAL			English	Article						adenosine receptor; ATP; chondrocytes; mitochondria; osteoarthritis	PHOSPHORYLATION; DYSFUNCTION; CARTILAGE; RESPONSES; STRESS; ALPHA; A(2A); SHAPE; OPA1	In OA chondrocytes, there is diminished mitochondrial production of ATP and diminished extracellular adenosine resulting in diminished adenosine A2A receptor (A2AR) stimulation and altered chondrocyte homeostasis which contributes to the pathogenesis of OA. We tested the hypothesis that A2AR stimulation maintains or enhances mitochondrial function in chondrocytes. The effect of A2AR signaling on mitochondrial health and function was determined in primary murine chondrocytes, a human chondrocytic cell line (T/C-28a2), primary human chondrocytes, and a murine model of OA by transmission electron microscopy analysis, mitochondrial stress testing, confocal live imaging for mitochondrial inner membrane polarity, and immunohistochemistry. In primary murine chondrocytes from A2AR(-/-) null mice, which develop spontaneous OA by 16 weeks, there is mitochondrial swelling, dysfunction, and reduced mitochondrial content with increased reactive oxygen species (ROS) burden and diminished mitophagy, as compared to chondrocytes from WT animals. IL-1-stimulated T/C-28a2 cells treated with an A2AR agonist had reduced ROS burden with increased mitochondrial dynamic stability and function, findings which were recapitulated in primary human chondrocytes. In an obesity-induced OA mouse model, there was a marked increase in mitochondrial oxidized material which was markedly improved after intraarticular injections of liposomal A2AR agonist. These results are consistent with the hypothesis that A2AR ligation is mitoprotective in OA.	[Castro, Cristina M.] NYU, Grossman Sch Med, Skirball Inst Grad Biomol Sci, Immunol & Inflammat Training Program, New York, NY USA; [Castro, Cristina M.; Corciulo, Carmen; Cronstein, Bruce N.] NYU, Grossman Sch Med, Div Translat Med, 550 First Ave, New York, NY 10016 USA; [Solesio, Maria E.; Pavlov, Evgeny V.] NYU, Coll Dent, New York, NY USA; [Liang, Fengxia] NYU Langone Hlth, DART Microscopy Lab, New York, NY USA; [Cronstein, Bruce N.] NYU, Dept Med, Grossman Sch Med, Div Rheumatol, 550 1St Ave, New York, NY 10016 USA; [Solesio, Maria E.] Rutgers State Univ, Dept Biol, New Brunswick, NJ USA	New York University; New York University; New York University; NYU Langone Medical Center; New York University; Rutgers State University New Brunswick	Cronstein, BN (corresponding author), NYU, Grossman Sch Med, Div Translat Med, 550 First Ave, New York, NY 10016 USA.	bruce.cronstein@nyulangone.org		Liang, Fengxia/0000-0003-0037-4590; Solesio Torregrosa, Maria de la Encarnacion/0000-0002-8105-1701; CORCIULO, CARMEN/0000-0002-1865-3494; Cronstein, Bruce/0000-0002-4295-7383	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [RO1-AR054897, RO1-AR056672]; Arthritis Foundation (AF); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [T32GM007308]; NYU-HHC Clinical and Translational Science Institute [UL1-TR000038]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Arthritis Foundation (AF); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); NYU-HHC Clinical and Translational Science Institute	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: RO1-AR054897 and RO1-AR056672; Arthritis Foundation (AF); HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: T32GM007308; NYU-HHC Clinical and Translational Science Institute, Grant/Award Number: UL1-TR000038	Ahmad Aamir, 2009, Curr Aging Sci, V2, P174; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Ansari MY, 2018, OSTEOARTHR CARTILAGE, V26, P1087, DOI 10.1016/j.joca.2017.07.020; Anson RM, 2000, J AM AGING ASSOC, V23, P199, DOI 10.1007/s11357-000-0020-y; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34; Chen JF, 2001, P NATL ACAD SCI USA, V98, P1970, DOI 10.1073/pnas.98.4.1970; Cillero-Pastor B, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-235; Cillero-Pastor B, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-42; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; CORCIULO C, 2019, OSTEOARTHR CARTIL S1, V27, pS174; Corciulo C, 2017, AM COLL RHEUM ANN M, V69; Corciulo C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15019; Corciulo C, 2016, PURINERG SIGNAL, V12, P537, DOI 10.1007/s11302-016-9519-2; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cronstein BN, 2017, NAT REV RHEUMATOL, V13, P41, DOI 10.1038/nrrheum.2016.178; D'Lima D, 2006, ARTHRITIS RHEUM-US, V54, P1814, DOI 10.1002/art.21874; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; Delco ML, 2018, J ORTHOP RES, V36, P739, DOI 10.1002/jor.23651; Demontiero O, 2012, THER ADV MUSCULOSKEL, V4, P61, DOI 10.1177/1759720X11430858; Gibon E, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0300-9; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Goutas A, 2018, FREE RADICAL BIO MED, V126, P122, DOI 10.1016/j.freeradbiomed.2018.08.003; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Guasti L, 2012, STEM CELL TRANSL MED, V1, P384, DOI 10.5966/sctm.2012-0009; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; Higuchi-Sanabria R, 2018, DEV CELL, V44, P139, DOI 10.1016/j.devcel.2017.12.020; Inoue K, 2001, Tanpakushitsu Kakusan Koso, V46, P829; Johnson K, 2000, ARTHRITIS RHEUM-US, V43, P1560, DOI 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.3.CO;2-J; Khoa ND, 2006, MOL PHARMACOL, V69, P1311, DOI 10.1124/mol.105.016857; Khoa ND, 2003, J IMMUNOL, V171, P3991, DOI 10.4049/jimmunol.171.8.3991; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Kurz B, 2004, ARTHRITIS RHEUM, V50, P123, DOI 10.1002/art.11438; Laforge M, 2016, CELL DEATH DIFFER, V23, P89, DOI 10.1038/cdd.2015.42; Lizana L, 2008, P NATL ACAD SCI USA, V105, P4099, DOI 10.1073/pnas.0709932105; Loeser Richard F, 2017, Trans Am Clin Climatol Assoc, V128, P44; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; McElroy GS, 2017, EXP CELL RES, V356, P217, DOI 10.1016/j.yexcr.2017.03.034; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Mendez AS, 2015, ELIFE, V4, DOI 10.7554/eLife.05434; Oh CK, 2017, CELL REP, V21, P2171, DOI 10.1016/j.celrep.2017.10.068; Quintana-Cabrera R, 2018, BIOCHEM BIOPH RES CO, V500, P94, DOI 10.1016/j.bbrc.2017.04.088; Quintana-Cabrera R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05655-x; Rampelt H, 2017, BBA-MOL CELL RES, V1864, P737, DOI 10.1016/j.bbamcr.2016.05.020; Ren ZL, 2019, ACTA PHARMACOL SIN, V40, P441, DOI 10.1038/s41401-018-0077-8; Soto-Hermida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112735; Terkeltaub R, 2002, MITOCHONDRION, V1, P301, DOI 10.1016/S1567-7249(01)00037-X; Thomas WD, 2000, J IMMUNOL, V165, P5612, DOI 10.4049/jimmunol.165.10.5612; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003	53	20	20	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5027	5045		10.1096/fj.201902459R	http://dx.doi.org/10.1096/fj.201902459R		FEB 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052890	Green Accepted			2022-12-28	WOS:000513850200001
J	Cilleros-Mane, V; Just-Borras, L; Tomas, M; Garcia, N; Tomas, JM; Lanuza, MA				Cilleros-Mane, Victor; Just-Borras, Laia; Tomas, Marta; Garcia, Neus; Tomas, Josep Maria; Lanuza, Maria Angel			The M-2 muscarinic receptor, in association to M-1, regulates the neuromuscular PKA molecular dynamics	FASEB JOURNAL			English	Article						muscarinic receptors; neuromuscular junction; PKA; SNAP-25	PROTEIN-KINASE-C; SPONTANEOUS ACETYLCHOLINE-RELEASE; SYNAPTOSOME-ASSOCIATED PROTEIN; MODULATE TRANSMITTER RELEASE; ADENYLATE-CYCLASE ACTIVITY; LONG-TERM POTENTIATION; HIGH-AFFINITY BINDING; CATALYTIC SUBUNIT; NEUROTRANSMITTER RELEASE; GENE-EXPRESSION	Muscarinic acetylcholine receptor 1 subtype (M-1) and muscarinic acetylcholine receptor 2 subtype (M-2) presynaptic muscarinic receptor subtypes increase and decrease, respectively, neurotransmitter release at neuromuscular junctions. M-2 involves protein kinase A (PKA), although the muscarinic regulation to form and inactivate the PKA holoenzyme is unknown. Here, we show that M-2 signaling inhibits PKA by downregulating C beta subunit, upregulating RII alpha/beta and liberating RI beta and RII alpha to the cytosol. This promotes PKA holoenzyme formation and reduces the phosphorylation of the transmitter release target synaptosome-associated protein 25 and the gene regulator cAMP response element binding. Instead, M-1 signaling, which is downregulated by M-2, opposes to M-2 by recruiting R subunits to the membrane. The M-1 and M-2 reciprocal actions are performed through the anchoring protein A kinase anchor protein 150 as a common node. Interestingly, M-2 modulation on protein expression needs M-1 signaling. Altogether, these results describe the dynamics of PKA subunits upon M-2 muscarinic signaling in basal and under presynaptic nerve activity, uncover a specific involvement of the M-1 receptor and reveal the M-1/M-2 balance to activate PKA to regulate neurotransmission. This provides a molecular mechanism to the PKA holoenzyme formation and inactivation which could be general to other synapses and cellular models.	[Cilleros-Mane, Victor; Just-Borras, Laia; Tomas, Marta; Garcia, Neus; Tomas, Josep Maria; Lanuza, Maria Angel] Univ Rovira & Virgili, Dept Ciencies Med Basiques, Unitat Histol & Neurobiol UHNEUROB, C St Llorenc 21, E-43201 Reus, Spain	Universitat Rovira i Virgili	Tomas, JM; Lanuza, MA (corresponding author), Univ Rovira & Virgili, Dept Ciencies Med Basiques, Unitat Histol & Neurobiol UHNEUROB, C St Llorenc 21, E-43201 Reus, Spain.	josepmaria.tomas@urv.cat; mariaangel.lanuza@urv.cat	Lanuza, Maria A/I-3236-2017; Cilleros-Mañé, Víctor/G-5251-2018	Lanuza, Maria A/0000-0003-4795-4103; Cilleros-Mañé, Víctor/0000-0001-5690-9932; Just Borras, Laia/0000-0003-0473-3730; Tomas, Josep/0000-0002-0406-0006	Universitat Rovira i Virgili (ES) [2014PFR-URV-B2-83, 2017PFRURV-B2-85]; European Social Fund (ESF); Iniciativa de Empleo Juvenil (IEJ) [LE1511314-2014PEJ-04]; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES) [SAF2015-67143-P]; Generalitat de Catalunya (ES) [2014SGR344, 2017SGR704]; Sistema Nacional de Garantia Juvenil (ES)	Universitat Rovira i Virgili (ES); European Social Fund (ESF)(European Social Fund (ESF)); Iniciativa de Empleo Juvenil (IEJ); Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES); Generalitat de Catalunya (ES)(Generalitat de Catalunya); Sistema Nacional de Garantia Juvenil (ES)	Universitat Rovira i Virgili (ES), Grant/Award Number: 2014PFR-URV-B2-83 and 2017PFRURV-B2-85; Sistema Nacional de Garantia Juvenil (ES), the European Social Fund (ESF) and the Iniciativa de Empleo Juvenil (IEJ), Grant/Award Number: LE1511314-2014PEJ-04; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES), Grant/Award Number: SAF2015-67143-P; Generalitat de Catalunya (ES), Grant/Award Number: 2014SGR344 and 2017SGR704	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; BARNES SJ, 1993, ENDOCRINOLOGY, V133, P2756, DOI 10.1210/en.133.6.2756; Beavo J A, 1975, Adv Cyclic Nucleotide Res, V5, P241; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Beguin P, 1996, AM J PHYSIOL-CELL PH, V270, pC131, DOI 10.1152/ajpcell.1996.270.1.C131; Besalduch N, 2010, J COMP NEUROL, V518, P211, DOI 10.1002/cne.22220; Boczan J, 2004, J BIOL CHEM, V279, P18911, DOI 10.1074/jbc.M400496200; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Brazhnik E, 2004, J NEUROSCI, V24, P9313, DOI 10.1523/JNEUROSCI.1618-04.2004; Burford NT, 1996, BIOCHEM J, V315, P883, DOI 10.1042/bj3150883; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CADD GG, 1990, J BIOL CHEM, V265, P19502; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; Choi RCY, 2013, CHEM-BIOL INTERACT, V203, P282, DOI 10.1016/j.cbi.2012.10.025; Chou WH, 2010, J NEUROSCI, V30, P13955, DOI 10.1523/JNEUROSCI.0270-10.2010; Constantinescu A, 2002, J BIOL CHEM, V277, P18810, DOI 10.1074/jbc.M112107200; CRONIN MJ, 1986, PEPTIDES, V7, P935, DOI 10.1016/0196-9781(86)90114-2; Curia G, 2007, BRIT J PHARMACOL, V150, P792, DOI 10.1038/sj.bjp.0707144; de Jong APH, 2016, P NATL ACAD SCI USA, V113, P5095, DOI 10.1073/pnas.1522927113; Dell Ralph B, 2002, ILAR J, V43, P207; DIXON D, 1989, J NEUROSCI, V9, P4246; Enns LC, 2009, J GERONTOL A-BIOL, V64, P1221, DOI 10.1093/gerona/glp133; Nguyen E, 2013, MOL PHARMACOL, V83, P1057, DOI 10.1124/mol.112.081034; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Favreau P, 1999, Acta Physiol Pharmacol Ther Latinoam, V49, P257; Funderud A, 2009, CELL SIGNAL, V21, P274, DOI 10.1016/j.cellsig.2008.10.013; Furlan I, 2005, BRIT J PHARMACOL, V146, P389, DOI 10.1038/sj.bjp.0706329; Garcia N, 2005, HISTOL HISTOPATHOL, V20, P733, DOI 10.14670/HH-20.733; GARREL G, 1995, NEUROENDOCRINOLOGY, V62, P514, DOI 10.1159/000127042; GARREL G, 1993, ENDOCRINOLOGY, V133, P1010, DOI 10.1210/en.133.3.1010; Gervasi N, 2007, J NEUROSCI, V27, P2744, DOI 10.1523/JNEUROSCI.5352-06.2007; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; Hao W, 2005, NEUROSCI LETT, V383, P121, DOI 10.1016/j.neulet.2005.03.062; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; Hoover F, 2002, MOL CELL NEUROSCI, V19, P125, DOI 10.1006/mcne.2001.1053; Hurtado E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00147; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Kaplan AP, 2017, ACS CHEM NEUROSCI, V8, P2746, DOI 10.1021/acschemneuro.7b00282; KELLAR KJ, 1985, J NEUROSCI, V5, P1577, DOI 10.1523/jneurosci.05-06-01577.1985; Keryer G, 1999, EXP CELL RES, V249, P131, DOI 10.1006/excr.1999.4447; KLEIN M, 1994, NEURON, V13, P159, DOI 10.1016/0896-6273(94)90466-9; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Lanuza MA, 2006, J NEUROSCI RES, V83, P1407, DOI 10.1002/jnr.20848; Lanuza MA, 2007, J NEUROSCI RES, V85, P748, DOI 10.1002/jnr.21192; Lanuza MA, 2010, EXP NEUROL, V225, P183, DOI 10.1016/j.expneurol.2010.06.014; Leenders AGM, 2005, PHARMACOL THERAPEUT, V105, P69, DOI 10.1016/j.pharmthera.2004.10.012; Li L, 2017, CARDIOVASC RES, V113, P147, DOI 10.1093/cvr/cvw221; Li MX, 2002, J NEUROBIOL, V52, P241, DOI 10.1002/neu.10089; Li MX, 2001, NAT NEUROSCI, V4, P871, DOI 10.1038/nn0901-871; Liu TP, 2002, AUTON NEUROSCI-BASIC, V96, P113, DOI 10.1016/S1566-0702(01)00396-4; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Lonart G, 1998, J NEUROSCI, V18, P634; Losavio A, 1997, AM J PHYSIOL-CELL PH, V273, pC1835, DOI 10.1152/ajpcell.1997.273.6.C1835; Losavio A, 2000, LIFE SCI, V66, P2543, DOI 10.1016/S0024-3205(00)00588-9; Mantilla CB, 2014, J APPL PHYSIOL, V117, P910, DOI 10.1152/japplphysiol.01386.2013; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; Minic J, 2002, EUR J NEUROSCI, V15, P439, DOI 10.1046/j.0953-816x.2001.01875.x; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Nadal L, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00024; Nadal L, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0248-9; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Nagy G, 2002, J NEUROSCI, V22, P9278; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Nomura S, 2002, BIOCHEM BIOPH RES CO, V295, P236, DOI 10.1016/S0006-291X(02)00664-2; Obis T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0171-5; Obis T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0098-x; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Perkins GA, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-17; Perrino C, 2017, CARDIOVASC RES, V113, P115, DOI 10.1093/cvr/cvw254; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Pontier SM, 2006, EMBO J, V25, P2698, DOI 10.1038/sj.emboj.7601157; Poppinga WJ, 2015, AM J PHYSIOL-LUNG C, V308, pL766, DOI 10.1152/ajplung.00301.2014; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; Reinitz CA, 1997, ARCH BIOCHEM BIOPHYS, V348, P391, DOI 10.1006/abbi.1997.0401; Reinton N, 1998, GENOMICS, V49, P290, DOI 10.1006/geno.1998.5240; Reyes R, 1996, ARCH BIOCHEM BIOPHYS, V331, P41, DOI 10.1006/abbi.1996.0280; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; Rudolf R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00290; Santafe MM, 2007, NEUROSCIENCE, V148, P432, DOI 10.1016/j.neuroscience.2007.06.017; Santafe MM, 2009, J NEUROSCI RES, V87, P683, DOI 10.1002/jnr.21885; Santafe MM, 2006, EUR J NEUROSCI, V23, P2048, DOI 10.1111/j.1460-9568.2006.04753.x; Santafe MM, 2004, NEUROSCIENCE, V123, P61, DOI 10.1016/j.neuroscience.2003.09.012; Santafe MM, 2003, EUR J NEUROSCI, V17, P119, DOI 10.1046/j.1460-9568.2003.02428.x; Santafe MM, 2001, NEUROSCIENCE, V102, P697, DOI 10.1016/S0306-4522(00)00507-8; SCHERER NM, 1990, BIOCHEMISTRY-US, V29, P8475, DOI 10.1021/bi00488a039; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Simo A, 2019, MOL NEUROBIOL, V56, P5346, DOI 10.1007/s12035-018-1462-5; Simo A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00207; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Slutsky I, 1999, J PHYSIOL-LONDON, V514, P769, DOI 10.1111/j.1469-7793.1999.769ad.x; Slutsky I, 2001, J PHYSIOL-LONDON, V536, P717, DOI 10.1111/j.1469-7793.2001.00717.x; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SPAULDING SW, 1993, ENDOCR REV, V14, P632, DOI 10.1210/er.14.5.632; SPENCER DG, 1986, BRAIN RES, V380, P59, DOI 10.1016/0006-8993(86)91429-0; Stakkestad O, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-7; Stefan E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1605; SUMMERS ST, 1986, BIOCHEM BIOPH RES CO, V135, P276, DOI 10.1016/0006-291X(86)90973-3; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Tan ZY, 2014, FEBS LETT, V588, P3964, DOI 10.1016/j.febslet.2014.09.011; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Tillo SE, 2017, CELL REP, V19, P617, DOI 10.1016/j.celrep.2017.03.070; Tomas J, 2018, PATHWAYS, V9, P1, DOI DOI 10.3389/fphar.2018.00397; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; WALSH DA, 1968, J BIOL CHEM, V243, P3763; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wright MC, 2009, J NEUROSCI, V29, P14942, DOI 10.1523/JNEUROSCI.2276-09.2009; Xu ZR, 2017, J CACHEXIA SARCOPENI, V8, P808, DOI 10.1002/jcsm.12204; YAN C, 1994, J NEUROSCI, V14, P973; Zeng C, 2014, AM J PHYSIOL-ENDOC M, V307, pE384, DOI 10.1152/ajpendo.00175.2014	125	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4934	4955		10.1096/fj.201902113R	http://dx.doi.org/10.1096/fj.201902113R		FEB 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052889				2022-12-28	WOS:000513849800001
J	Li, Y; Liu, Y; Huang, YH; Yang, K; Xiao, TL; Xiong, JC; Wang, KL; Liu, C; He, T; Yu, YL; Han, WH; Wang, Y; Bi, XJ; Zhang, JB; Huang, YJ; Zhang, B; Zhao, JH				Li, Yan; Liu, Yong; Huang, Yinghui; Yang, Ke; Xiao, Tangli; Xiong, Jiachuan; Wang, Kailong; Liu, Chi; He, Ting; Yu, Yanlin; Han, Wenhao; Wang, Yue; Bi, Xianjin; Zhang, Jingbo; Huang, Yunjian; Zhang, Bo; Zhao, Jinghong			IRF-1 promotes renal fibrosis by downregulation of Klotho	FASEB JOURNAL			English	Article						chronic kidney disease; IRF; Klotho; renal fibrosis; TNF-alpha	NF-KAPPA-B; SIGNALING PATHWAY; EPITHELIAL-CELLS; KIDNEY INJURY; EXPRESSION; INFLAMMATION; CONTRIBUTES; FACTOR-1; MECHANISMS; TRANSITION	Although the key role of renal fibrosis in the progression of chronic kidney disease (CKD) is well known, the causes of renal fibrosis are not fully clarified. In this study, interferon regulatory factor 1 (IRF-1), a mammalian transcription factor, was highly expressed in fibrotic kidney of CKD patients. Concordantly, the expression level of IRF-1 was significantly elevated in the kidney of unilateral ureteral obstruction (UUO) and Adriamycin nephropathy (ADR) mice. In tubular epithelial cells, overexpression of IRF-1 could induce profibrotic markers expression, which accompanied by dramatic downregulation of Klotho, an important inhibitor of renal fibrosis. Luciferase reporter analysis and ChIP assay revealed that IRF-1 repressed Klotho expression by downregulation of C/EBP-beta, which regulates Klotho gene transcription via directly binding to its promoter. Further investigation showed that tumor necrosis factor-alpha may be an important inducement for the increase of IRF-1 in tubular epithelial cells after UUO and genetic deletion of IRF-1 attenuated renal fibrosis in UUO mice. Hence, these findings demonstrate that IRF-1 contributes to the pathogenesis of renal fibrosis by downregulation of Klotho, and suppresses IRF-1 may be a potential therapeutic target for CKD.	[Li, Yan; Liu, Yong; Huang, Yinghui; Yang, Ke; Xiao, Tangli; Xiong, Jiachuan; Wang, Kailong; Liu, Chi; He, Ting; Yu, Yanlin; Han, Wenhao; Wang, Yue; Bi, Xianjin; Zhang, Jingbo; Huang, Yunjian; Zhang, Bo; Zhao, Jinghong] Third Mil Med Univ, Army Med Univ, Xinqiao Hosp, Kidney Ctr PLA,Dept Nephrol,Key Lab Prevent & Tre, Chongqing 400037, Peoples R China	Army Medical University	Zhao, JH (corresponding author), Third Mil Med Univ, Army Med Univ, Xinqiao Hosp, Kidney Ctr PLA,Dept Nephrol,Key Lab Prevent & Tre, Chongqing 400037, Peoples R China.	zhaojh@tmmu.edu.cn			Nature Science Foundation of China [81873605, 81500544, 81700379, 81800621, 81500561, 81800640]; Personal training Program for Clinical Medicine Research of Army Medical University [2018XLC1007]; Frontier specific projects of Xinqiao Hospital [2018YQYLY004]; Program for Clinical Medicine Research of Army Medical University [2018XLC1007]; Xinqiao Hospital [2018YQYLY004]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Personal training Program for Clinical Medicine Research of Army Medical University; Frontier specific projects of Xinqiao Hospital; Program for Clinical Medicine Research of Army Medical University; Xinqiao Hospital	the Nature Science Foundation of China, Grant/Award Number: 81873605, 81500544, 81700379, 81800621, 81500561 and 81800640; Personal training Program for Clinical Medicine Research of Army Medical University, Grant/Award Number: 2018XLC1007; Frontier specific projects of Xinqiao Hospital, Grant/Award Number: 2018YQYLY004; Program for Clinical Medicine Research of Army Medical University, Grant/Award Number: 2018XLC1007; Xinqiao Hospital, Grant/Award Number: 2018YQYLY004	Adachi T, 2015, BIOCHEM BIOPH RES CO, V467, P63, DOI 10.1016/j.bbrc.2015.09.121; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chen FF, 2012, TUMOR BIOL, V33, P2217, DOI 10.1007/s13277-012-0483-3; Chen TH, 2013, EUR J PHARMACOL, V698, P67, DOI 10.1016/j.ejphar.2012.09.032; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Ding H, 2018, ANTIOXID REDOX SIGN, V29, P637, DOI 10.1089/ars.2017.7041; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Dong YJ, 2016, J IMMUNOL, V196, P1874, DOI 10.4049/jimmunol.1501232; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Guan X, 2014, J PATHOL, V234, P560, DOI 10.1002/path.4420; Gun SY, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12819; Hara H, 2014, BIOL PHARM BULL, V37, P1042, DOI 10.1248/bpb.b14-00116; He LY, 2017, KIDNEY INT, V92, P1071, DOI 10.1016/j.kint.2017.06.030; Huang JS, 2014, MOL CELL ENDOCRINOL, V390, P45, DOI 10.1016/j.mce.2014.04.001; Ide N, 2016, KIDNEY INT, V90, P348, DOI 10.1016/j.kint.2016.04.009; Irifuku T, 2016, KIDNEY INT, V89, P147, DOI 10.1038/ki.2015.291; Jiang DS, 2014, HYPERTENSION, V64, P77, DOI 10.1161/HYPERTENSIONAHA.114.03229; Jiang L, 2013, EXP CELL RES, V319, P2254, DOI 10.1016/j.yexcr.2013.06.007; Jin MH, 2017, BIOCHEM BIOPH RES CO, V486, P451, DOI 10.1016/j.bbrc.2017.03.061; Kang SJ, 2011, ARCH PHARM RES, V34, P829, DOI 10.1007/s12272-011-0517-1; Kassiri Z, 2009, J AM SOC NEPHROL, V20, P1223, DOI 10.1681/ASN.2008050492; Khan SB, 2005, KIDNEY INT, V67, P1812, DOI 10.1111/j.1523-1755.2005.00279.x; Klahr S, 2003, KIDNEY INT, V64, pS105, DOI 10.1046/j.1523-1755.64.s87.16.x; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Li BH, 2017, TRANSL RES, V180, P103, DOI 10.1016/j.trsl.2016.08.006; Ling L, 2019, AM J TRANSL RES, V11, P131; Liu QF, 2017, INT UROL NEPHROL, V49, P345, DOI 10.1007/s11255-016-1439-0; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Remoli AL, 2016, MBIO, V7, DOI 10.1128/mBio.01528-16; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Sanchez-Nino MD, 2013, J AM SOC NEPHROL, V24, P687, DOI 10.1681/ASN.2013030294; Satoh M, 2012, AM J PHYSIOL-RENAL, V303, pF1641, DOI 10.1152/ajprenal.00460.2012; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Silverstein DM, 2003, KIDNEY INT, V64, P25, DOI 10.1046/j.1523-1755.2003.00067.x; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Sun QZ, 2019, J IMMUNOL, V202, P37, DOI 10.4049/jimmunol.1800782; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Thurston RD, 2010, GASTROENTEROLOGY, V138, P1384, DOI 10.1053/j.gastro.2009.12.002; Tie YY, 2018, J CELL MOL MED, V22, P1475, DOI 10.1111/jcmm.13406; Umbach AT, 2015, KIDNEY INT, V87, P728, DOI 10.1038/ki.2014.371; Wang HD, 2019, MOL THER, V27, P571, DOI 10.1016/j.ymthe.2019.01.008; Wang YX, 2009, J AM SOC NEPHROL, V20, P1544, DOI 10.1681/ASN.2008080843; Wen Y, 2019, J AM SOC NEPHROL, V30, P1925, DOI 10.1681/ASN.2019020111; Wu YL, 2017, KIDNEY INT, V91, P830, DOI 10.1016/j.kint.2016.09.039; Xiao L, 2014, DIABETES, V63, P1366, DOI 10.2337/db13-1412; Xie P, 2009, J AM SOC NEPHROL, V20, P807, DOI 10.1681/ASN.2008091007; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yan R, 2017, J INNATE IMMUN, V9, P546, DOI 10.1159/000477211; Yang RH, 2017, SCI REP-UK, V7, DOI 10.1038/srep43409; Yu QL, 2009, AM J PHYSIOL-HEART C, V297, pH76, DOI 10.1152/ajpheart.01285.2008; Zeng Y, 2016, AGING CLIN EXP RES, V28, P69, DOI 10.1007/s40520-015-0371-y; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhao J, 2015, J MOL NEUROSCI, V57, P595, DOI 10.1007/s12031-015-0642-2; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262; Zhou D, 2016, NAT REV NEPHROL, V12, P68, DOI 10.1038/nrneph.2015.215; Zhou LL, 2015, AM J PATHOL, V185, P3211, DOI 10.1016/j.ajpath.2015.08.004; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zhou XJ, 2014, J PHARMACOL SCI, V126, P344, DOI 10.1254/jphs.14173FP	62	5	5	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4415	4429		10.1096/fj.201902446R	http://dx.doi.org/10.1096/fj.201902446R		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31965641	Bronze			2022-12-28	WOS:000508585400001
J	Brown, E; Rowan, C; Strowitzki, MJ; Fagundes, RR; Faber, KN; Guntsch, A; Halligan, DN; Kugler, J; Jones, F; Lee, CT; Doherty, G; Taylor, CT				Brown, Eric; Rowan, Catherine; Strowitzki, Moritz J.; Fagundes, Raphael R.; Faber, Klaas Nico; Guentsch, Annemarie; Halligan, Doug N.; Kugler, Julia; Jones, Fiona; Lee, Chee T.; Doherty, Glen; Taylor, Cormac T.			Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1 alpha response in ulcerative colitis patients	FASEB JOURNAL			English	Article						colitis; epithelium; hypoxia; inflammation; PHD1	BINDING-PROTEIN ISOFORMS; GENE-EXPRESSION; HYPOXIA; ACTIVATION; PATHWAY; MODEL	The HIF hydroxylase enzymes (PHD1-3 and FIH) are cellular oxygen-sensors which confer hypoxic-sensitivity upon the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha. Microenvironmental hypoxia has a strong influence on the epithelial and immune cell function through HIF-dependent gene expression and consequently impacts upon the course of disease progression in ulcerative colitis (UC), with HIF-1 alpha being protective while HIF-2 alpha promotes disease. However, little is known about how inflammation regulates hypoxia-responsive pathways in UC patients. Here we demonstrate that hypoxia is a prominent microenvironmental feature of the mucosa in UC patients with active inflammatory disease. Furthermore, we found that inflammation drives transcriptional programming of the HIF pathway including downregulation of PHD1 thereby increasing the tissue responsiveness to hypoxia and skewing this response toward protective HIF-1 over detrimental HIF-2 activation. We identified CEBP alpha as a transcriptional regulator of PHD1 mRNA expression which is downregulated in both inflamed tissue derived from patients and in cultured intestinal epithelial cells treated with inflammatory cytokines. In summary, we propose that PHD1 downregulation skews the hypoxic response toward enhanced protective HIF-1 alpha stabilization in the inflamed mucosa of UC patients.	[Brown, Eric; Strowitzki, Moritz J.; Fagundes, Raphael R.; Guentsch, Annemarie; Halligan, Doug N.; Kugler, Julia; Lee, Chee T.; Doherty, Glen; Taylor, Cormac T.] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Brown, Eric; Strowitzki, Moritz J.; Fagundes, Raphael R.; Guentsch, Annemarie; Halligan, Doug N.; Kugler, Julia; Lee, Chee T.; Doherty, Glen; Taylor, Cormac T.] Univ Coll Dublin, Conway Inst, Dublin, Ireland; [Rowan, Catherine; Jones, Fiona; Doherty, Glen] St Vincents Univ Hosp, Ctr Colorectal Dis, Elm Pk, Dublin, Ireland; [Fagundes, Raphael R.; Faber, Klaas Nico] Univ Groningen, Univ Med Ctr Groningen, Dept Hepatol & Gastroenterol, Groningen, Netherlands	University College Dublin; University College Dublin; University College Dublin; Saint Vincent's University Hospital; University of Groningen	Taylor, CT (corresponding author), Univ Coll Dublin, UCD Conway Inst, Dublin 4, Ireland.	cormac.taylor@ucd.ie		Lee, Chee Teik/0000-0002-9769-9422; Doherty, Glen/0000-0003-4384-5049; Strowitzki, Moritz J./0000-0001-6967-9283; Fagundes, Raphael/0000-0003-1571-0374	European Commission (EC) [15/ERA-CSM/32/67]; Science Foundation Ireland	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	European Commission (EC), Grant/Award Number: 15/ERA-CSM/32/67; Science Foundation Ireland	Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2017, MICROBES INFECT, V19, P210, DOI 10.1016/j.micinf.2016.09.004; Evans SM, 2000, CANCER RES, V60, P2018; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Giatromanolaki A, 2003, J CLIN PATHOL, V56, P209, DOI 10.1136/jcp.56.3.209; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; Higashiyama M, 2012, J LEUKOCYTE BIOL, V91, P901, DOI 10.1189/jlb.1011518; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Jain R, 1999, BIOCHEM J, V338, P737, DOI 10.1042/0264-6021:3380737; Kalra J, 2018, N-S ARCH PHARMACOL, V391, P285, DOI 10.1007/s00210-017-1455-3; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Lin X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-48; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchal-Bressenot A, 2017, GUT, V66, P43, DOI 10.1136/gutjnl-2015-310187; McDonnell M, SINGLE ASCENDING DOS; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Palmieri O, 2015, INFLAMM BOWEL DIS, V21, P1260, DOI 10.1097/MIB.0000000000000370; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Scholz CC, 2013, CURR OPIN PHARMACOL, V13, P646, DOI 10.1016/j.coph.2013.04.009; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Taylor CT, 2017, NAT REV IMMUNOL, V17, P774, DOI 10.1038/nri.2017.103; Tengku-Muhammad TS, 2000, CYTOKINE, V12, P1430, DOI 10.1006/cyto.2000.0711; Thompson AAR, 2014, BLOOD, V123, P366, DOI 10.1182/blood-2013-05-500207; Van Welden S, 2017, NAT REV GASTRO HEPAT, V14, P596, DOI 10.1038/nrgastro.2017.101; Xu CM, 2016, EXP THER MED, V11, P1330, DOI 10.3892/etm.2016.3030; Xue X, 2014, AM J PHYSIOL-GASTR L, V307, pG187, DOI 10.1152/ajpgi.00112.2014; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Yin M, 1996, J BIOL CHEM, V271, P17974, DOI 10.1074/jbc.271.30.17974; Zhou KR, 2017, NUCLEIC ACIDS RES, V45, pD43, DOI 10.1093/nar/gkw965	34	10	11	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3732	3742		10.1096/fj.201902103R	http://dx.doi.org/10.1096/fj.201902103R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944416	Green Published, Bronze			2022-12-28	WOS:000507596600001
J	Bhattachan, P; Rae, J; Yu, HY; Jung, W; Wei, JK; Parton, RG; Dong, B				Bhattachan, Punit; Rae, James; Yu, Haiyan; Jung, WooRam; Wei, Jiankai; Parton, Robert G.; Dong, Bo			Ascidian caveolin induces membrane curvature and protects tissue integrity and morphology during embryogenesis	FASEB JOURNAL			English	Article						caveolin; Ciona spp; null; lumen formation; membrane curvature; morphogenesis	CIONA-INTESTINALIS; LUMEN EXPANSION; SHOW EVIDENCE; CELL BIOLOGY; MICE SHOW; NULL MICE; NOTOCHORD; PROTEINS; MUSCLE; INVASION	Cell morphology and tissue integrity are essential for embryogenesis. Caveolins are membrane proteins that induce the formation of surface pits called caveolae that serve as membrane reservoirs for cell and tissue protection during development. In vertebrates, caveolin 1 (Cav1) and caveolin 3 (Cav3) are required for caveola formation. However, the formation of caveola and the function of caveolins in invertebrates are largely unknown. In this study, three caveolins, Cav-a, Cav-b, and CavY, are identified in the genome of the invertebrate chordate Ciona spp. Based on phylogenetic analysis, Cav-a is found to be closely related to the vertebrate Cav1 and Cav3. In situ hybridization shows that Cav-a is expressed in Ciona embryonic notochord and muscle. Cell-free experiments, model cell culture systems, and in vivo experiments demonstrate that Ciona Cav-a has the ability to induce membrane curvature at the plasma membrane. Knockdown of Cav-a in Ciona embryos causes loss of invaginations in the plasma membrane and results in the failure of notochord elongation and lumenogenesis. Expression of a dominant-negative Cav-a point mutation causes cells to change shape and become displaced from the muscle and notochord to disrupt tissue integrity. Furthermore, we demonstrate that Cav-a vesicles show polarized trafficking and localize at the luminal membrane during notochord lumenogenesis. Taken together, these results show that the invertebrate chordate caveolin from Ciona plays crucial roles in tissue integrity and morphology by inducing membrane curvature and intracellular vesicle trafficking during embryogenesis.	[Bhattachan, Punit; Yu, Haiyan; Wei, Jiankai; Dong, Bo] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China; [Bhattachan, Punit; Yu, Haiyan; Wei, Jiankai; Dong, Bo] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China; [Bhattachan, Punit; Wei, Jiankai; Dong, Bo] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Shandong, Peoples R China; [Rae, James; Jung, WooRam; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Jung, WooRam] NCI, Ctr Canc Res, Frederick, MD 21701 USA	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Ocean University of China; University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dong, B (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.; Parton, RG (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	r.parton@imb.uq.edu.au; bodong@ouc.edu.cn	Jung, Wooram/D-3874-2017	Jung, Wooram/0000-0001-5748-5473; Dong, Bo/0000-0003-1616-5363	National Natural Science Foundation of China (NSFC) [31572352, 31771649]; Australian National health and Medical Research Council [APP569452, APP1150083]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Australian National health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31572352 and 31771649; Australian National health and Medical Research Council, Grant/Award Number: APP569452 and APP1150083	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Cheng JPX, 2015, J CELL BIOL, V211, P53, DOI 10.1083/jcb.201504042; Christiaen L., 2009, COLD SPRING HARB PRO, V2009, DOI 10.1101/pdb.prot5344; Corbo JC, 1997, DEVELOPMENT, V124, P589; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Deng W, 2013, P NATL ACAD SCI USA, V110, P14972, DOI 10.1073/pnas.1220884110; Denker E, 2015, DEVELOPMENT, V142, P1639, DOI 10.1242/dev.117150; Di Gregorio A, 2002, DEV BIOL, V244, P385, DOI 10.1006/dbio.2002.0582; Dong B, 2009, DEV BIOL, V330, P237, DOI 10.1016/j.ydbio.2009.03.015; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Garcia J, 2017, CURR BIOL, V27, P1982, DOI 10.1016/j.cub.2017.05.035; Goehring NW, 2011, J CELL BIOL, V193, P583, DOI 10.1083/jcb.201011094; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hayashi K, 2001, CANCER RES, V61, P2361; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Jung W, 2018, J CELL BIOL, V217, P2141, DOI 10.1083/jcb.201707004; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Lim YW, 2017, CURR BIOL, V27, P1968, DOI 10.1016/j.cub.2017.05.067; Ludwig A, 2016, J CELL SCI, V129, P3077, DOI 10.1242/jcs.191262; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Minetti C, 2002, AM J PATHOL, V160, P265, DOI 10.1016/S0002-9440(10)64370-2; Mizotani Y, 2018, P NATL ACAD SCI USA, V115, pE8873, DOI 10.1073/pnas.1808756115; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2001, J BIOL CHEM, V276, P38121; Rieth MD, 2012, BIOCHEMISTRY-US, V51, P3911, DOI 10.1021/bi3001853; Roitenberg N, 2018, EMBO REP, V19, DOI 10.15252/embr.201745673; Shatz M, 2010, EXP CELL RES, V316, P1748, DOI 10.1016/j.yexcr.2010.02.006; Shi DB, 2016, MECH DEVELOP, V141, P78, DOI 10.1016/j.mod.2016.05.002; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sohn J, 2016, BIRTH DEFECTS RES C, V108, P45, DOI 10.1002/bdrc.21121; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoeber M, 2016, P NATL ACAD SCI USA, V113, pE8069, DOI 10.1073/pnas.1616838113; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; WADA S, 1995, MECH DEVELOP, V51, P115, DOI 10.1016/0925-4773(95)00359-9; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	54	12	12	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1345	1361		10.1096/fj.201901281R	http://dx.doi.org/10.1096/fj.201901281R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914618	hybrid, Green Published			2022-12-28	WOS:000507308900090
J	Jung, E; Choi, TI; Lee, JE; Kim, CH; Kim, J				Jung, Eunji; Choi, Tae-Ik; Lee, Ji-Eun; Kim, Cheol-Hee; Kim, Joon			ESCRT subunit CHMP4B localizes to primary cilia and is required for the structural integrity of the ciliary membrane	FASEB JOURNAL			English	Article						ciliopathy phenotype; endosomal sorting complex; membrane curvature	CILIOGENESIS; COMPLEX; MACHINERY; PATHWAYS; REVEALS; TUBULIN; CP110	Proteins specialized in the detection, generation, or stabilization of membrane curvature play important roles in establishing various morphologies of cells and cellular organelles. Primary cilia are cellular organelles that protrude from the cell surface using a microtubule-based cytoskeleton called the axoneme as a structural support. It is unclear whether the integrity of the high curvature of the ciliary membrane depends on membrane curvature-related proteins. Charged Multivesicular Body Protein 4B (CHMP4B), a subunit of the endosomal sorting complexes required for transport (ESCRT), can stabilize membrane curvature. Here we show that CHMP4B is involved in the assembly and maintenance of primary cilia. CHMP4B was localized to primary cilia in mammalian cells. Knockdown of CHMP4B interfered with cilium assembly and also caused fragmentation of preexisting cilia. By contrast, cilium formation was unaffected by the interruption of the ESCRT-dependent endocytic degradation pathway. Morpholino (MO)-mediated CHMP4B depletion in zebrafish embryos induced characteristic phenotypes of ciliary defects such as curved body axis, hydrocephalus, otolith malformation, and kidney cyst. Our study reveals a new role for the multifunctional protein CHMP4B as a key factor in maintaining the structural integrity of primary cilia.	[Jung, Eunji; Kim, Joon] Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon, South Korea; [Choi, Tae-Ik; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, 99 Daehak Ro, Daejeon 34134, South Korea; [Lee, Ji-Eun] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Kim, Joon] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Sungkyunkwan University (SKKU); Korea Advanced Institute of Science & Technology (KAIST)	Kim, CH (corresponding author), Chungnam Natl Univ, Dept Biol, 99 Daehak Ro, Daejeon 34134, South Korea.; Kim, J (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea.	zebrakim@cnu.ac.kr; joonkim@kaist.ac.kr	Kim, Joon/C-1833-2011		Korean Ministry of Science and ICT [2017R1A2B3005208, 2018M3A9B8021980]; Korean Ministry of Health Welfare [HI18C0013]	Korean Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); Korean Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	Korean Ministry of Science and ICT, Grant/Award Number: 2017R1A2B3005208 and 2018M3A9B8021980; Korean Ministry of Health & Welfare, Grant/Award Number: HI18C0013	Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Benmerah A, 2013, CURR OPIN CELL BIOL, V25, P78, DOI 10.1016/j.ceb.2012.10.011; Cajanek L, 2014, P NATL ACAD SCI USA, V111, pE2841, DOI 10.1073/pnas.1401777111; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Carter SP, 2019, CURR OPIN CELL BIOL, V59, P133, DOI 10.1016/j.ceb.2019.04.007; Christ L, 2016, J CELL BIOL, V212, P499, DOI 10.1083/jcb.201507009; Dema A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.209080; Diener DR, 2015, CURR BIOL, V25, P379, DOI 10.1016/j.cub.2014.11.066; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Dorn KV, 2012, DEV CELL, V23, P823, DOI 10.1016/j.devcel.2012.07.004; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Fremont S, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms14528; Garcia G, 2018, CURR BIOL, V28, pR421, DOI 10.1016/j.cub.2018.03.010; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hu JH, 2007, MOL BIOL CELL, V18, P3277, DOI 10.1091/mbc.E07-03-0239; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Insinna C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08192-9; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kuhns S, 2013, J CELL BIOL, V200, P505, DOI 10.1083/jcb.201206013; Lee IH, 2015, P NATL ACAD SCI USA, V112, P15892, DOI 10.1073/pnas.1518765113; Lee SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27284; Lee S, 2018, J CELL BIOL, V217, P2831, DOI 10.1083/jcb.201711104; Long H, 2016, CURR BIOL, V26, P3327, DOI 10.1016/j.cub.2016.09.055; MacDonald E, 2018, J CELL BIOL, V217, P2549, DOI 10.1083/jcb.201710051; Madhivanan K, 2016, RES REP BIOL, V7, P15, DOI 10.2147/RRB.S62510; Mamiska A., 2016, SCI SIGNAL, V9, pra8, DOI 10.1126/scisignal.aad0848; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Mirvis M, 2018, BIOCHEM J, V475, P2329, DOI 10.1042/BCJ20170453; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Nachury MV, 2019, NAT REV MOL CELL BIO, V20, P389, DOI 10.1038/s41580-019-0116-4; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Ott C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21491-x; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Roosing S, 2015, ELIFE, V4, DOI 10.7554/eLife.06602; Saito M, 2017, EMBO REP, V18, P1460, DOI 10.15252/embr.201744204; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Shiels A, 2007, AM J HUM GENET, V81, P596, DOI 10.1086/519980; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Smith KP, 2011, CYTOSKELETON, V68, P112, DOI 10.1002/cm.20498; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Szymanska Katarzyna, 2012, Cilia, V1, P10, DOI 10.1186/2046-2530-1-10; Tang SG, 2016, ELIFE, V5, DOI 10.7554/eLife.15507; Tang SG, 2015, ELIFE, V4, DOI 10.7554/eLife.12548; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Wenzel EM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05345-8; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073	55	7	7	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1331	1344		10.1096/fj.201901778R	http://dx.doi.org/10.1096/fj.201901778R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914703				2022-12-28	WOS:000507308900089
J	Larpin, Y; Besancon, H; Iacovache, MI; Babiychuk, VS; Babiychuk, EB; Zuber, B; Draeger, A; Koffel, R				Larpin, Yu; Besancon, Herve; Iacovache, Mircea-Ioan; Babiychuk, Victoriia S.; Babiychuk, Eduard B.; Zuber, Benoit; Draeger, Annette; Koffel, Rene			Bacterial pore-forming toxin pneumolysin: Cell membrane structure and microvesicle shedding capacity determines differential survival of cell types	FASEB JOURNAL			English	Article						bacterial pore-forming toxins; host-defense; lymphoid immune cells; myeloid immune cells; plasma membrane repair	REPAIR; CHOLESTEROL; PROTEIN; BINDING; RAFTS	Bacterial infectious diseases can lead to death or to serious illnesses. These outcomes are partly the consequence of pore-forming toxins, which are secreted by the pathogenic bacteria (eg, pneumolysin of Streptococcus pneumoniae). Pneumolysin binds to cholesterol within the plasma membrane of host cells and assembles to form trans-membrane pores, which can lead to Ca2+ influx and cell death. Membrane repair mechanisms exist that limit the extent of damage. Immune cells which are essential to fight bacterial infections critically rely on survival mechanisms after detrimental pneumolysin attacks. This study investigated the susceptibility of different immune cell types to pneumolysin. As a model system, we used the lymphoid T-cell line Jurkat, and myeloid cell lines U937 and THP-1. We show that Jurkat T cells are highly susceptible to pneumolysin attack. In contrast, myeloid THP-1 and U937 cells are less susceptible to pneumolysin. In line with these findings, human primary T cells are shown to be more susceptible to pneumolysin attack than monocytes. Differences in susceptibility to pneumolysin are due to (I) preferential binding of pneumolysin to Jurkat T cells and (II) cell type specific plasma membrane repair capacity. Myeloid cell survival is mostly dependent on Ca2+ induced expelling of damaged plasma membrane areas as microvesicles. Thus, in myeloid cells, first-line defense cells in bacterial infections, a potent cellular repair machinery ensures cell survival after pneumolysin attack. In lymphoid cells, which are important at later stages of infections, less efficient repair mechanisms and enhanced toxin binding renders the cells more sensitive to pneumolysin.	[Larpin, Yu; Besancon, Herve; Babiychuk, Victoriia S.; Babiychuk, Eduard B.; Draeger, Annette; Koffel, Rene] Univ Bern, Inst Anat, Dept Cell Biol, Baltzerstr 2, CH-3012 Bern, Switzerland; [Iacovache, Mircea-Ioan; Zuber, Benoit] Univ Bern, Inst Anat, Lab Expt Morphol, Bern, Switzerland	University of Bern; University of Bern	Koffel, R (corresponding author), Univ Bern, Inst Anat, Dept Cell Biol, Baltzerstr 2, CH-3012 Bern, Switzerland.	rene.koeffel@ana.unibe.ch	Babiychuk, Eduard/AAV-7223-2021; Köffel, René/ABI-2028-2020	Köffel, René/0000-0001-9477-4282; Zuber, Benoit/0000-0001-7725-5579; iacovache, ioan/0000-0001-8470-5056; Besancon, Herve/0000-0002-1426-1901; Larpin, Yu/0000-0002-4313-5509; Babiychuk, Eduard/0000-0003-1786-0085	Gebert-Ruf Foundation [GRS-073/14]	Gebert-Ruf Foundation	Gebert-Ruf Foundation, Grant/Award Number: GRS-073/14	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Baumgartner U, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0781-5; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Draeger A, 2014, BIOCHIMIE, V107, P66, DOI 10.1016/j.biochi.2014.08.008; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Drucker P, 2018, BBA-MOL CELL BIOL L, V1863, P795, DOI 10.1016/j.bbalip.2018.04.010; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Etxaniz A, 2018, TOXINS, V10, DOI 10.3390/toxins10060234; Henry BD, 2015, NAT BIOTECHNOL, V33, P81, DOI 10.1038/nbt.3037; Iacovache I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12062; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Koffel R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01688; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Maekawa M, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030504; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; MORGAN BP, 1987, J IMMUNOL, V138, P246; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; Romero M, 2017, CELL DEATH DIFFER, V24, P798, DOI 10.1038/cdd.2017.11; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SKOAAJ M, 2014, PLOS ONE, V0009; Tan JMJ, 2018, NAT MICROBIOL, V3, P1472, DOI 10.1038/s41564-018-0293-5; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Wolfmeier H, 2016, BBA-GEN SUBJECTS, V1860, P2498, DOI 10.1016/j.bbagen.2016.07.022; Wolfmeier H, 2015, BBA-MOL CELL RES, V1853, P2045, DOI 10.1016/j.bbamcr.2014.09.005; Yoo IH, 2010, FEMS IMMUNOL MED MIC, V60, P28, DOI 10.1111/j.1574-695X.2010.00699.x	31	17	17	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1665	1678		10.1096/fj.201901737RR	http://dx.doi.org/10.1096/fj.201901737RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914676				2022-12-28	WOS:000507308900110
J	San Segundo, PM; Terni, B; Burgueno, J; Monroy, X; Dordal, A; Merlos, M; Llobet, A				Martinez San Segundo, Pablo; Terni, Beatrice; Burgueno, Javier; Monroy, Xavier; Dordal, Albert; Merlos, Manuel; Llobet, Artur			Outside-in regulation of the readily releasable pool of synaptic vesicles by alpha 2 delta-1	FASEB JOURNAL			English	Article						i +/- 2i '-1; gabapentinoids; neurotransmission; presynaptic terminal; readily releasable pool; synaptic vesicle	RAT SYMPATHETIC NEURONS; CALCIUM-CHANNELS; FAST EXOCYTOSIS; CA2+ CHANNELS; UP-REGULATION; GABAPENTIN; EXPRESSION; SUBUNIT; BINDING; TRANSMISSION	The readily releasable pool (RRP) of synaptic vesicles is a key determinant of phasic neurotransmission. Although the size of the RRP is tightly regulated by intracellular factors, there is little evidence for its modification by extracellular signals. By studying the homogeneous population of synapses present in autaptic microcultures, we show that pregabalin, a prototypical gabapentinoid, decreases the effective RRP size. Simultaneous imaging of presynaptic calcium influx and recording of postsynaptic responses shows that the effect is not related to a reduction of calcium entry. The main cause is the impairment of the functional coupling among N-type calcium channels and the RRP, resembling an increase of intracellular mobile calcium buffers. The ectodomain of neurexin-1 alpha shows a similar action to pregabalin, acting as an endogenous ligand of alpha 2 delta-1 that reduces the RRP size without affecting presynaptic calcium influx. The regulatory actions described for pregabalin and the ectodomain of neurexin-1 alpha are mutually exclusive. The overexpression of alpha 2 delta-1 enhances the effect of pregabalin and the ectodomain of neurexin-1 alpha on neurotransmission by decreasing their effective concentration. In contrast, knockdown of alpha 2 delta-1 causes a profound inhibition of synaptic transmission. These observations prompt to consider alpha 2 delta-1 as an outside-in signaling platform that binds exogenous and endogenous cues for regulating the coupling of voltage-gated calcium channels to synaptic vesicles.	[Martinez San Segundo, Pablo; Terni, Beatrice; Llobet, Artur] Bellvitge Biomed Res Inst IDIBELL, Lab Neurobiol, Barcelona, Spain; [Martinez San Segundo, Pablo; Terni, Beatrice; Llobet, Artur] Univ Barcelona, Inst Neurosci, Sch Med, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Burgueno, Javier; Monroy, Xavier; Dordal, Albert; Merlos, Manuel] ESTEVE, Dept Pharmacol Drug Discovery & Preclin Dev, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Esteve	Llobet, A (corresponding author), Univ Barcelona, Sch Med, Lab Neurobiol, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08907, Spain.	allobet@ub.edu	Llobet, Artur/D-4339-2014; Merlos, Manuel/AAC-3064-2021	Llobet, Artur/0000-0001-5797-6782; Merlos, Manuel/0000-0002-8423-3033; Martinez San Segundo, Pablo/0000-0001-8719-5186	Spanish government (MICINN) [RTI2018-096948-B-100]; European Regional Development Fund (ERDF)	Spanish government (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund (ERDF)(European Commission)	Spanish government (MICINN), Grant/Award Number: RTI2018-096948-B-100; European Regional Development Fund (ERDF)	Albrecht D, 2012, MOL CELL NEUROSCI, V49, P364, DOI 10.1016/j.mcn.2012.01.005; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Beaumont V, 2005, P NATL ACAD SCI USA, V102, P10700, DOI 10.1073/pnas.0501961102; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Biederer T, 2017, NEURON, V96, P680, DOI 10.1016/j.neuron.2017.10.006; Brockhaus J, 2018, J NEUROSCI, V38, P8277, DOI 10.1523/JNEUROSCI.0511-18.2018; Brown JP, 1998, ANAL BIOCHEM, V255, P236, DOI 10.1006/abio.1997.2447; Brown JT, 2005, SYNAPSE, V55, P262, DOI 10.1002/syn.20115; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; Chai ZY, 2017, NEURON, V96, P1317, DOI 10.1016/j.neuron.2017.10.028; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; CURRIE PJ, 1995, LIFE SCI, V57, P1911, DOI 10.1016/0024-3205(95)02178-L; de Arce KP, 2015, NEURON, V88, P1165, DOI 10.1016/j.neuron.2015.11.011; de Jong APH, 2016, P NATL ACAD SCI USA, V113, P5095, DOI 10.1073/pnas.1522927113; Delvendahl I, 2015, P NATL ACAD SCI USA, V112, pE3075, DOI 10.1073/pnas.1508419112; Di Guilmi MN, 2011, J PHARMACOL EXP THER, V336, P973, DOI 10.1124/jpet.110.172171; Dolphin AC, 2018, F1000RES, V7; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Fell B, 2016, J NEUROSCI, V36, P11024, DOI 10.1523/JNEUROSCI.3468-14.2016; Feng MHR, 2001, EUR J DRUG METAB PH, V26, P123, DOI 10.1007/BF03190385; FURSHPAN EJ, 1986, J NEUROSCI, V6, P1061; Glebov OO, 2017, CELL REP, V18, P2715, DOI 10.1016/j.celrep.2017.02.064; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Hernandez-Vivanco A, 2012, J PHARMACOL EXP THER, V342, P263, DOI 10.1124/jpet.111.190652; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Kaeser PS, 2017, CURR OPIN NEUROBIOL, V43, P63, DOI 10.1016/j.conb.2016.12.012; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kaeser PS, 2012, P NATL ACAD SCI USA, V109, P11830, DOI 10.1073/pnas.1209318109; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Lopez-Murcia FJ, 2015, P NATL ACAD SCI USA, V112, P13366, DOI 10.1073/pnas.1512202112; Lopez-Murcia FJ, 2014, J NEUROSCI, V34, P8618, DOI 10.1523/JNEUROSCI.5081-13.2014; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Micheva KD, 2006, MOL PHARMACOL, V70, P467, DOI 10.1124/mol.106.023309; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nieto-Rostro M, 2018, P NATL ACAD SCI USA, V115, pE12043, DOI 10.1073/pnas.1811212115; Old EA, 2015, HANDB EXP PHARMACOL, V227, P145, DOI 10.1007/978-3-662-46450-2_8; Patel MK, 2000, BRIT J PHARMACOL, V130, P1731, DOI 10.1038/sj.bjp.0703530; Perez-Gonzalez AP, 2008, J PHYSIOL-LONDON, V586, P4675, DOI 10.1113/jphysiol.2008.160044; Quinn DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42920; Sakaba T, 2002, NEUROSCI RES, V44, P343, DOI 10.1016/S0168-0102(02)00174-8; Schreiner D, 2015, ELIFE, V4, DOI 10.7554/eLife.07794; Scott MB, 2017, CHANNELS, V11, P555, DOI 10.1080/19336950.2017.1356954; Smillie KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3394; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; SUMANCHAUHAN N, 1993, EUR J PHARM-MOLEC PH, V244, P293, DOI 10.1016/0922-4106(93)90155-3; Thanawala MS, 2016, J NEUROSCI METH, V264, P136, DOI 10.1016/j.jneumeth.2016.02.021; THURLOW RJ, 1993, EUR J PHARM-MOLEC PH, V247, P341, DOI 10.1016/0922-4106(93)90204-M; Tong XJ, 2017, NEURON, V95, P326, DOI 10.1016/j.neuron.2017.06.018; Wang TT, 2016, CELL REP, V16, P2875, DOI 10.1016/j.celrep.2016.08.030; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Wu MM, 2009, J PHYSIOL-LONDON, V587, P5377, DOI 10.1113/jphysiol.2009.176065; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	60	3	3	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1362	1377		10.1096/fj.201901551R	http://dx.doi.org/10.1096/fj.201901551R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914622				2022-12-28	WOS:000507308900091
J	Shi, YH; Wang, HA; Zheng, MJ; Xu, W; Yang, Y; Shi, FS				Shi, Yuhua; Wang, Huanan; Zheng, Mengjie; Xu, Wei; Yang, Yang; Shi, Fushan			Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly	FASEB JOURNAL			English	Article						anti-inflammation; ginsenoside Rg3; inflammasome; NLRP3 inflammasome	NALP3 INFLAMMASOME; IL-1-BETA; INNATE; MECHANISM; IMMUNITY; RECEPTOR; CELLS; NEK7	Ginsenoside Rg3 is one of the main constituents of Panax ginseng. Compelling evidence has demonstrated that ginsenoside Rg3 is capable of inhibiting inflammation. However, the mechanism mediating its anti-inflammatory effects remain unclear. Here we show that ginsenoside Rg3 blocks IL-1 beta secretion and caspase-1 activation through inhibiting LPS priming and the NLRP3 inflammasome activation in human and mouse macrophages. Rg3 specifically inhibits activation of NLRP3 but not the NLRC4 or AIM2 inflammasomes. In addition, Rg3 has no effect on upstream regulation of NLRP3 inflammasome, such as K+ efflux, ROS production, or mitochondrial membrane potential. Mechanistically, Rg3 abrogates NEK7-NLRP3 interaction, and subsequently inhibits NLRP3-ASC interaction, ASC oligomerization, and speckle formation. More importantly, Rg3 can reduce IL-1 beta secretion induced by LPS in mice and protect mice from lethal endotoxic shock. Thus, our findings reveal an anti-inflammatory mechanism for Rg3 and suggest its potential use in NLRP3-driven diseases.	[Shi, Yuhua; Wang, Huanan; Zheng, Mengjie; Xu, Wei; Shi, Fushan] Zhejiang Univ, Coll Anim Sci, Dept Vet Med, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Yang] Zhejiang A&F Univ, Zhejiang Prov Engn Lab Anim Hlth Inspect & Intern, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Coll Anim Sci & Technol, Hangzhou 311300, Zhejiang, Peoples R China; [Shi, Fushan] Zhejiang Univ, Zhejiang Prov Key Lab Prevent Vet Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang A&F University; Zhejiang University	Shi, FS (corresponding author), Zhejiang Univ, Coll Anim Sci, Dept Vet Med, Hangzhou 310058, Zhejiang, Peoples R China.; Yang, Y (corresponding author), Zhejiang A&F Univ, Zhejiang Prov Engn Lab Anim Hlth Inspect & Intern, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Coll Anim Sci & Technol, Hangzhou 311300, Zhejiang, Peoples R China.	yyang@zafu.edu.cn; sfs@zju.edu.cn	Xu, Wei/AED-3066-2022; yanyan, zheng/ABF-1123-2020	Xu, Wei/0000-0002-1287-4552; 	Zhejiang Provincial Natural Science Foundation [LY18C180001, LQ15C180002]; National Natural Science Foundation of China [31502034]; Fundamental Research Funds for the Central Universities [2018QNA6032]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Zhejiang Provincial Natural Science Foundation, Grant/Award Number: LY18C180001 and LQ15C180002; National Natural Science Foundation of China, Grant/Award Number: 31502034; Fundamental Research Funds for the Central Universities, Grant/Award Number: 2018QNA6032	Chen J, 2019, LIFE SCI, V216, P1, DOI 10.1016/j.lfs.2018.11.022; Cheng ZQ, 2016, INT IMMUNOPHARMACOL, V34, P53, DOI 10.1016/j.intimp.2016.02.011; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI, V69, P4215, DOI 10.1007/s00018-012-1140-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He HB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04947-6; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Huang Y, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708689; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Jia L, 2009, CURR MED CHEM, V16, P2924, DOI 10.2174/092986709788803204; Jiang H, 2017, J EXP MED, V214, P3219, DOI 10.1084/jem.20171419; Kim J, 2014, IMMUNOL LETT, V158, P143, DOI 10.1016/j.imlet.2013.12.017; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Marchetti C, 2018, P NATL ACAD SCI USA, V115, pE1530, DOI 10.1073/pnas.1716095115; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McGonagle D, 2007, ANN RHEUM DIS, V66, P1683, DOI 10.1136/ard.2007.073759; Min JK, 2006, BIOCHEM BIOPH RES CO, V349, P987, DOI 10.1016/j.bbrc.2006.08.129; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Sun MY, 2017, INT J MOL MED, V39, P507, DOI 10.3892/ijmm.2017.2857; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tsuchiya K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09753-2; Wang JJ, 2018, CANCER LETT, V415, P73, DOI 10.1016/j.canlet.2017.11.037; Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3; Wang WB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006123; Wang XJ, 2019, EUR J PHARMACOL, V850, P141, DOI 10.1016/j.ejphar.2019.02.023; Wei XJ, 2012, FITOTERAPIA, V83, P636, DOI 10.1016/j.fitote.2012.01.006; Yang J, 2017, CELL MOL IMMUNOL, V14, P65, DOI 10.1038/cmi.2016.29; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Yoon SJ, 2015, BIOCHEM BIOPH RES CO, V463, P1184, DOI 10.1016/j.bbrc.2015.06.080; Zheng X, 2017, BIOMED PHARMACOTHER, V85, P620, DOI 10.1016/j.biopha.2016.11.072; Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347	43	30	30	7	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					208	221		10.1096/fj.201901537R	http://dx.doi.org/10.1096/fj.201901537R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914640				2022-12-28	WOS:000507308900016
J	Wei, L; Surma, M; Yang, Y; Tersey, S; Shi, JJ				Wei, Lei; Surma, Michelle; Yang, Yang; Tersey, Sarah; Shi, Jianjian			ROCK2 inhibition enhances the thermogenic program in white and brown fat tissue in mice	FASEB JOURNAL			English	Article						beige adipogenesis; energy expenditure; obesity; ROCK2; ROCK2-selective inhibitor	RHO-ASSOCIATED-KINASE; ADIPOSE-TISSUE; INSULIN-RESISTANCE; TARGETED DISRUPTION; MOUSE; BEIGE; CELL; DELETION; OBESITY; ACTIVATION	The RhoA/ROCK-mediated actin cytoskeleton dynamics have been implicated in adipogenesis. The two ROCK isoforms, ROCK1 and ROCK2, are highly homologous. The contribution of ROCK2 to adipogenesis in vivo has not been elucidated. The present study aimed at the in vivo and in vitro roles of ROCK2 in the regulation of adipogenesis and the development of obesity. We performed molecular, histological, and metabolic analyses in ROCK2(+/-) and ROCK2(+/KD) mouse models, the latter harboring an allele with a kinase-dead (KD) mutation. Both ROCK2(+/-) and ROCK2(+/KD) mouse models showed a lean body mass phenotype during aging, associated with increased amounts of beige cells in subcutaneous white adipose tissue (sWAT) and increased thermogenic gene expression in all fat depots. ROCK2(+/-) mice on a high-fat diet showed increased energy expenditure accompanying by reduced obesity, and improved insulin sensitivity. In vitro differentiated ROCK2(+/-) stromal-vascular (SV) cells revealed increased beige adipogenesis associated with increased thermogenic gene expressions. Treatment with a selective ROCK2 inhibitor, KD025, to inhibit ROCK2 activity in differentiated SV cells reproduced the pro-beige phenotype of ROCK2(+/-) SV cells. In conclusion, ROCK2 activity-mediated actin cytoskeleton dynamics contribute to the inhibition of beige adipogenesis in WAT, and also promotes age-related and diet-induced fat mass gain and insulin resistance.	[Wei, Lei; Surma, Michelle; Yang, Yang; Tersey, Sarah; Shi, Jianjian] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, 1044 West Walnut St,R4-240, Indianapolis, IN 46202 USA; [Wei, Lei; Tersey, Sarah] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA; [Wei, Lei] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wei, L; Shi, JJ (corresponding author), Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, 1044 West Walnut St,R4-240, Indianapolis, IN 46202 USA.	lewei@iu.edu; jishi@iu.edu		Tersey, Sarah/0000-0003-0667-2361	School of Medicine, Indiana University (IUSM) [2286128, 2286118]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL107537, HL134599]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30 DK097512]	School of Medicine, Indiana University (IUSM); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	School of Medicine, Indiana University (IUSM), Grant/Award Number: 2286128; School of Medicine, Indiana University (IUSM), Grant/Award Number: 2286118; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL107537; HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: P30 DK097512; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL134599	Akhter M, 2018, ANN CLIN TRANSL NEUR, V5, P769, DOI 10.1002/acn3.569; [Anonymous], 2019, FACT SHEET OB OV; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; Berry DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10184; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Boerma M, 2008, BLOOD COAGUL FIBRIN, V19, P709, DOI 10.1097/MBC.0b013e32830b2891; Chang YJ, 2015, ELIFE, V4, DOI 10.7554/eLife.06011; Chun KH, 2012, ENDOCRINOLOGY, V153, P1649, DOI 10.1210/en.2011-1036; Chun KH, 2011, AM J PHYSIOL-ENDOC M, V300, pE536, DOI 10.1152/ajpendo.00538.2010; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Defert O, 2017, EXPERT OPIN THER PAT, V27, P507, DOI 10.1080/13543776.2017.1272579; Dorn T, 2018, EMBO J, V37, DOI 10.15252/embj.201798133; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Diep DTV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20821-3; Feng YB, 2016, J MED CHEM, V59, P2269, DOI 10.1021/acs.jmedchem.5b00683; Flynn R, 2016, BLOOD, V127, P2144, DOI 10.1182/blood-2015-10-678706; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Hara Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001227; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Huang H, 2018, J CLIN INVEST, V128, P5335, DOI 10.1172/JCI63562; Inoue Y, 2018, CURR OBES REP, V7, P276, DOI 10.1007/s13679-018-0317-8; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jahani V, 2018, BIOMED PHARMACOTHER, V106, P1024, DOI 10.1016/j.biopha.2018.07.060; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Lee DH, 2009, J BIOL CHEM, V284, P11776, DOI 10.1074/jbc.C900014200; Lee JH, 2014, ANN CLIN TRANSL NEUR, V1, P2, DOI 10.1002/acn3.19; Lee SH, 2014, AM J PHYSIOL-ENDOC M, V306, pE332, DOI 10.1152/ajpendo.00619.2013; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JZ, 2016, ADIPOCYTE, V5, P130, DOI 10.1080/21623945.2016.1140708; Liu L, 2016, CLIN CHIM ACTA, V462, P107, DOI 10.1016/j.cca.2016.09.003; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Munoz VR, 2018, J GERONTOL A-BIOL, P1, DOI [10.1093/gerona/gly293, DOI 10.1093/GER0NA/GLY293]; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nedergaard J, 2005, EMBO REP, V6, P917, DOI 10.1038/sj.embor.7400532; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Noda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110446; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Sadeghian H, 2018, ANN NEUROL, V84, P409, DOI 10.1002/ana.25298; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shi JJ, 2008, J MOL CELL CARDIOL, V44, P551, DOI 10.1016/j.yjmcc.2007.11.018; Shi JJ, 2019, FASEB J, V33, P7348, DOI 10.1096/fj.201802510R; Shi Jianjian, 2018, Oncotarget, V9, P12995, DOI 10.18632/oncotarget.24457; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shi JJ, 2012, AM J PHYSIOL-HEART C, V302, pH1603, DOI 10.1152/ajpheart.00844.2011; Shi JJ, 2010, J MOL CELL CARDIOL, V49, P819, DOI 10.1016/j.yjmcc.2010.08.008; Sim CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174761; Soliman H, 2016, INT J OBESITY, V40, P1435, DOI 10.1038/ijo.2016.89; Soliman H, 2015, AM J PHYSIOL-HEART C, V309, pH70, DOI 10.1152/ajpheart.00664.2014; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Surma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090758; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Weiss JM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8953; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zanin-Zhorov A, 2017, J IMMUNOL, V198, P3809, DOI 10.4049/jimmunol.1602142; Zanin-Zhorov Alexandra, 2016, Small GTPases, V7, P173, DOI 10.1080/21541248.2016.1181698; Zanin-Zhorov A, 2014, P NATL ACAD SCI USA, V111, P16814, DOI 10.1073/pnas.1414189111; Zhou XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29669	67	7	7	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					474	493		10.1096/fj.201901174RR	http://dx.doi.org/10.1096/fj.201901174RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914704	Green Accepted, Green Submitted			2022-12-28	WOS:000507308900033
J	Zhang, HX; Zhang, H; Wang, CJ; Wang, YH; Zou, RY; Shi, CX; Guan, BC; Gamper, N; Xu, YF				Zhang, Hongxue; Zhang, Hua; Wang, Chanjuan; Wang, Yuhong; Zou, Ruya; Shi, Chenxia; Guan, Bingcai; Gamper, Nikita; Xu, Yanfang			Auxiliary subunits control biophysical properties and response to compound NS5806 of the Kv4 potassium channel complex	FASEB JOURNAL			English	Article						cardiomyocyte; dipeptidyl peptidase-like protein; K+ channel-interacting protein; transient outward K+ current	OUTWARD K+ CURRENT; PROTEIN DPPX; I-TO; ACTIVATOR; MODULATION; EXPRESSION; CURRENTS; REPOLARIZATION; MECHANISMS; INSIGHTS	Kv4 pore-forming subunits co-assemble with beta-subunits including KChIP2 and DPP6 and the resultant complexes conduct cardiac transient outward K+ current (I-to). Compound NS5806 has been shown to potentate I-to in canine cardiomyocytes; however, its effects on I-to in other species yet to be determined. We found that NS5806 inhibited native I-to in a concentration-dependent manner (0.1 similar to 30 mu M) in both mouse ventricular cardiomyocytes and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), but potentiated I-to in the canine cardiomyocytes. In HEK293 cells co-transfected with cloned Kv4.3 (or Kv4.2) and beta-subunit KChIP2, NS5806 significantly increased the peak current amplitude and slowed the inactivation. In contrast, NS5806 suppressed the current and accelerated inactivation of the channels when cells were co-transfected with Kv4.3 (or Kv4.2), KChIP2 and another beta-subunit, DPP6-L (long isoform). Western blot analysis showed that DPP6-L was dominantly expressed in both mouse ventricular myocardium and hiPSC-CMs, while it was almost undetectable in canine ventricular myocardium. In addition, low level of DPP6-S expression was found in canine heart, whereas levels of KChIP2 expression were comparable among all three species. siRNA knockdown of DPP6 antagonized the I-to inhibition by NS5806 in hiPSC-CMs. Molecular docking simulation suggested that DPP6-L may associate with KChIP2 subunits. Mutations of putative KChIP2-interacting residues of DPP6-L reversed the inhibitory effect of NS5806 into potentiation of the current. We conclude that a pharmacological modulator can elicit opposite regulatory effects on Kv4 channel complex among different species, depending on the presence of distinct beta-subunits. These findings provide novel insight into the molecular design and regulation of cardiac I-to. Since I-to is a potential therapeutic target for treatment of multiple cardiovascular diseases, our data will facilitate the development of new therapeutic I-to modulators.	[Zhang, Hongxue; Zhang, Hua; Wang, Chanjuan; Zou, Ruya; Shi, Chenxia; Guan, Bingcai; Gamper, Nikita; Xu, Yanfang] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Hongxue; Zhang, Hua; Wang, Chanjuan; Zou, Ruya; Shi, Chenxia; Guan, Bingcai; Xu, Yanfang] Minist Educ, Key Lab New Drug Pharmacol & Toxicol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Hongxue; Zhang, Hua; Wang, Chanjuan; Zou, Ruya; Shi, Chenxia; Guan, Bingcai; Xu, Yanfang] Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang, Hebei, Peoples R China; [Wang, Yuhong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Masteria Med, Beijing, Peoples R China; [Gamper, Nikita] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England	Hebei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Leeds	Gamper, N; Xu, YF (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China.; Gamper, N (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England.	n.gamper@leeds.ac.uk; yanfangxu@hebmu.edu.cn	Wang, Yu/GZL-9655-2022	Gamper, Nikita/0000-0001-5806-0207	National Natural Science Foundation of China (NSFC) [31771259]; Science and Technology Foundation of Hebei Province [17274803D]; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/R003068/1, BB/R02104X/1]; BBSRC [BB/R003068/1, BB/R02104X/1] Funding Source: UKRI; MRC [G0700966] Funding Source: UKRI	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Hebei Province; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771259; Science and Technology Foundation of Hebei Province, Grant/Award Number: 17274803D; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/R003068/1 and BB/R02104X/1	Akar FG, 2004, AM J PHYSIOL-HEART C, V286, pH602, DOI 10.1152/ajpheart.00673.2003; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Calloe K, 2011, J CARDIOVASC ELECTR, V22, P1057, DOI 10.1111/j.1540-8167.2011.02053.x; Calloe K, 2010, J MOL CELL CARDIOL, V48, P191, DOI 10.1016/j.yjmcc.2009.07.017; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Cheng HW, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13172; Cheng Hsien C., 2006, Journal of Pharmacological and Toxicological Methods, V54, P278, DOI 10.1016/j.vascn.2006.01.002; Chiamvimonvat N, 2017, J PHYSIOL-LONDON, V595, P2229, DOI 10.1113/JP272883; Cordeiro JM, 2004, AM J PHYSIOL-HEART C, V286, pH1471, DOI 10.1152/ajpheart.00748.2003; Cordeiro JM, 2013, J MOL CELL CARDIOL, V60, P36, DOI 10.1016/j.yjmcc.2013.03.014; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Gonzalez WG, 2014, J BIOL CHEM, V289, P32201, DOI 10.1074/jbc.M114.577528; Kassiri Z, 2002, J MOL MED, V80, P351, DOI 10.1007/s00109-002-0325-7; Kin Y, 2001, J BIOCHEM-TOKYO, V129, P289, DOI 10.1093/oxfordjournals.jbchem.a002856; Lei M, 2018, CIRCULATION, V138, P1879, DOI 10.1161/CIRCULATIONAHA.118.035455; Liang P, 2009, J BIOL CHEM, V284, P4960, DOI 10.1074/jbc.M807704200; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133274; Lundby A, 2010, BRIT J PHARMACOL, V160, P2028, DOI 10.1111/j.1476-5381.2010.00859.x; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nerbonne Jeanne M, 2016, Card Electrophysiol Clin, V8, P257, DOI 10.1016/j.ccep.2016.01.001; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Radicke S, 2009, N-S ARCH PHARMACOL, V379, P617, DOI 10.1007/s00210-008-0389-1; Shi C, 2013, ACTA PHYSIOL, V208, P95, DOI 10.1111/apha.12071; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; Witzel K, 2012, NEUROPHARMACOLOGY, V63, P1389, DOI 10.1016/j.neuropharm.2012.08.017; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Xu YF, 2005, J PHYSIOL-LONDON, V562, P745, DOI 10.1113/jphysiol.2004.076216; Yang KC, 2016, TRENDS CARDIOVAS MED, V26, P209, DOI 10.1016/j.tcm.2015.07.002	35	4	4	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					807	821		10.1096/fj.201902010RR	http://dx.doi.org/10.1096/fj.201902010RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914636	Green Published, hybrid			2022-12-28	WOS:000507308900055
J	Zhang, WD; Sakoda, H; Nakazato, M				Zhang, Weidong; Sakoda, Hideyuki; Nakazato, Masamitsu			Neuromedin U suppresses insulin secretion by triggering mitochondrial dysfunction and endoplasmic reticulum stress in pancreatic beta-cells	FASEB JOURNAL			English	Article						beta-cell; diabetes; insulin secretion; mitochondria; NMU	OXIDATIVE STRESS; ER-STRESS; EXPRESSION; PEPTIDE; ENERGY; GENERATION; RESISTANCE; CAPACITY; ROLES	Neuromedin U (NMU), a highly conserved peptide in mammals, is involved in a wide variety of physiological processes. NMU, which is synthesized in beta-cells and co-localizes with insulin, directly acts on beta-cells via NMU receptor 1 (NMUR1) to suppress glucose-stimulated insulin secretion (GSIS). The mechanism underlying this insulinostatic effect has yet to be elucidated. We observed that NMU caused mitochondrial dysfunction by impairing mitochondrial biogenesis, respiration, and mitochondrial Ca2+ uptake in beta-cell-derived MIN6-K8 cells. NMU administration induced the endoplasmic reticulum (ER) stress, as reflected by the activation of ER stress signaling pathways involving ATF6, XBP-1s, and PERK-ATF4-CHOP. Nmu knockdown in MIN6-K8 cells increased the number of insulin granules and improved mitochondrial biogenesis and function. NMU was upregulated in both the islets of db/db mice and palmitate-treated MIN6-K8 cells. Our results highlight the crucial role of NMU in the maintenance of beta-cell function and glucose metabolism through regulation of mitochondria dysfunction and ER stress. In pathological stages that develop into diabetes, upregulation of NMU could suppress the insulin secretion by inducing mitochondrial dysfunction and ER stress, which may contribute to subsequent beta-cell dysfunction.	[Zhang, Weidong; Sakoda, Hideyuki; Nakazato, Masamitsu] Univ Miyazaki, Div Neurol Respirol Endocrinol & Metab, Dept Internal Med, Fac Med, Kihara 5200, Miyazaki 8891692, Japan; [Nakazato, Masamitsu] Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	University of Miyazaki	Nakazato, M (corresponding author), Univ Miyazaki, Div Neurol Respirol Endocrinol & Metab, Dept Internal Med, Fac Med, Kihara 5200, Miyazaki 8891692, Japan.	nakazato@med.miyazaki-u.ac.jp			Japan Agency for Medical Research and Development (AMED) [JP19gm0610016]; MEXT | Japan Society for the Promotion of Science (JSPS) [16H05333]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm0610016; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16H05333	Al-Amily IM, 2019, PFLUG ARCH EUR J PHY, V471, P633, DOI 10.1007/s00424-019-02262-7; Alfa RW, 2015, CELL METAB, V21, P323, DOI 10.1016/j.cmet.2015.01.006; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Atanes P, 2018, CELL MOL LIFE SCI, V75, P3039, DOI 10.1007/s00018-018-2778-z; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Braun M, 2012, DIABETES OBES METAB, V14, P143, DOI 10.1111/j.1463-1326.2012.01642.x; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Hoshino A, 2014, P NATL ACAD SCI USA, V111, P3116, DOI 10.1073/pnas.1318951111; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kaczmarek P, 2006, INT J MOL MED, V18, P951; Kaufman BA, 2015, MOL ASPECTS MED, V42, P91, DOI 10.1016/j.mam.2015.01.004; Keane KN, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/181643; Kowalski TJ, 2005, J ENDOCRINOL, V185, P151, DOI 10.1677/joe.1.05948; Kuhre RE, 2019, CELL METAB, V29, P719, DOI 10.1016/j.cmet.2018.10.008; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; MINAMINO N, 1988, BIOCHEM BIOPH RES CO, V156, P355, DOI 10.1016/S0006-291X(88)80848-9; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Mitchell JD, 2009, BRIT J PHARMACOL, V158, P87, DOI 10.1111/j.1476-5381.2009.00252.x; Mitchell JD, 2009, CARDIOVASC RES, V81, P353, DOI 10.1093/cvr/cvn302; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mnatsakanyan N, 2017, J BIOENERG BIOMEMBR, V49, P13, DOI 10.1007/s10863-016-9652-1; Moin ASM, 2012, BIOCHEM BIOPH RES CO, V428, P512, DOI 10.1016/j.bbrc.2012.10.073; Mukhuty A, 2017, BIOCHEM BIOPH RES CO, V491, P1118, DOI 10.1016/j.bbrc.2017.08.022; Nakazato M, 2000, BIOCHEM BIOPH RES CO, V277, P191, DOI 10.1006/bbrc.2000.3669; Newsholme P, 2012, J ENDOCRINOL, V214, P11, DOI 10.1530/JOE-12-0072; Newsholme P, 2009, DIABETOLOGIA, V52, P2489, DOI 10.1007/s00125-009-1536-z; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Peier AM, 2011, ENDOCRINOLOGY, V152, P2644, DOI 10.1210/en.2010-1463; Przygodzka P, 2016, BBA-GEN SUBJECTS, V1860, P2445, DOI 10.1016/j.bbagen.2016.07.012; Rieusset J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0416-1; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Santulli G, 2015, J CLIN INVEST, V125, P1968, DOI 10.1172/JCI79273; Sharma RB, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0492-2; Silvander JSG, 2017, FASEB J, V31, P4578, DOI 10.1096/fj.201700095R; Silzer TK, 2018, MITOCHONDRION, V43, P16, DOI 10.1016/j.mito.2018.04.004; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; Vernochet C, 2014, FASEB J, V28, P4408, DOI 10.1096/fj.14-253971; WAGONER PK, 1993, P NATL ACAD SCI USA, V90, P9145, DOI 10.1073/pnas.90.19.9145; Wang J, 2016, CELL SIGNAL, V28, P1099, DOI 10.1016/j.cellsig.2016.05.007; Zhang EM, 2019, CELL METAB, V29, P64, DOI 10.1016/j.cmet.2018.09.008; Zhang WD, 2017, BIOCHEM BIOPH RES CO, V493, P677, DOI 10.1016/j.bbrc.2017.08.132	50	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					133	147		10.1096/fj.201901743R	http://dx.doi.org/10.1096/fj.201901743R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914613	Bronze			2022-12-28	WOS:000507308900011
J	Khan, N; Kim, SK; Gagneux, P; Dugan, LL; Varki, A				Khan, Naazneen; Kim, Stuart K.; Gagneux, Pascal; Dugan, Laura L.; Varki, Ajit			Maximum reproductive lifespan correlates with CD33rSIGLEC gene number: Implications for NADPH oxidase-derived reactive oxygen species in aging	FASEB JOURNAL			English	Article						CD33rSIGLEC; NADPH-oxidase; prolonged post-reproductive lifespan; reactive oxygen species	EVOLUTION; MECHANISMS; SIGLEC-9; MITOCHONDRIA; NEUTROPHILS; ACTIVATION; LONGEVITY; RECEPTOR; DEATH; MENOPAUSE	Humans and orcas are among the very rare species that have a prolonged post-reproductive lifespan (PRLS), during which the aging process continues. Reactive oxygen species (ROS) derived from mitochondria and from the NADPH oxidase (NOX) enzymes of innate immune cells are known to contribute to aging, with the former thought to be dominant. CD33-related-Siglecs are immune receptors that recognize self-associated-molecular-patterns and modulate NOX-derived-ROS. We herewith demonstrate a strong correlation of lifespan with CD33rSIGLEC gene number in 26 species, independent of body weight or phylogeny. The correlation is stronger when considering total CD33rSIGLEC gene number rather than those encoding inhibitory and activating subsets, suggesting that lifetime balancing of ROS is important. Combining independent lines of evidence including the short half-life and spontaneous activation of neutrophils, we calculate that even without inter-current inflammation, a major source of lifetime ROS exposure may actually be neutrophil NOX-derived. However, genomes of human supercentenarians (>110 years) do not harbor a significantly higher number of functional CD33rSIGLEC genes. Instead, lifespan correlation with CD33rSIGLEC gene number was markedly strengthened by excluding the post-reproductive lifespan of humans and orcas (R-2 = 0.83; P < .0001). Thus, CD33rSIGLEC modulation of ROS likely contributes to maximum reproductive lifespan, but other unknown mechanisms could be important to PRLS.	[Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Ctr Acad Res & Training Anthropogeny, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Dept Pathol, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Dept Anthropol, La Jolla, CA USA; [Khan, Naazneen; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA USA; [Kim, Stuart K.] Stanford Univ, Dept Dev Biol, Med Ctr, Stanford, CA 94305 USA; [Dugan, Laura L.] Vanderbilt Univ, Med Ctr, Med Geriatr, Nashville, TN USA; [Dugan, Laura L.] VA Tennessee Valley Geriatr Res Educ & Clin Ctr G, Nashville, TN USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Ctr Acad Res & Training Anthropogeny, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Anthropol, La Jolla, CA USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA USA.; Varki, A (corresponding author), UCSD Sch Med, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	KHAN, NAAZNEEN/J-8868-2019	KHAN, NAAZNEEN/0000-0002-4386-1703	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R01GM32373]	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01GM32373	Adams OJ, 2018, GLYCOBIOLOGY, V28, P640, DOI 10.1093/glycob/cwx108; Alberts SC, 2013, P NATL ACAD SCI USA, V110, P13440, DOI 10.1073/pnas.1311857110; Ali SS, 2011, BRAIN RES, V1368, P65, DOI 10.1016/j.brainres.2010.11.009; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Angata T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02885; AUSTAD SN, 1994, EXP GERONTOL, V29, P255, DOI 10.1016/0531-5565(94)90005-1; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Bochner BS, 2015, J ALLERGY CLIN IMMUN, V135, P598, DOI 10.1016/j.jaci.2014.11.031; Bornhofft KF, 2018, DEV COMP IMMUNOL, V86, P219, DOI 10.1016/j.dci.2018.05.008; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; Cachat J, 2015, CLIN SCI, V128, P635, DOI 10.1042/CS20140635; Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Chang YC, 2014, GLYCOBIOLOGY, V24, P818, DOI 10.1093/glycob/cwu067; Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; Crocker P R, 1998, Glycobiology, V8, pv; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Croft DP, 2017, CURR BIOL, V27, P298, DOI 10.1016/j.cub.2016.12.015; Croft DP, 2015, TRENDS ECOL EVOL, V30, P407, DOI 10.1016/j.tree.2015.04.011; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049; Dugan Laura L, 2005, Sci Aging Knowledge Environ, V2005, ppe20, DOI 10.1126/sageke.2005.26.pe20; Ellis S, 2018, ECOL EVOL, V8, P2482, DOI 10.1002/ece3.3856; Favier B, 2016, IMMUNOL REV, V273, P140, DOI 10.1111/imr.12457; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2010, AGING CELL, V9, P519, DOI 10.1111/j.1474-9726.2010.00578.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gierman HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112430; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hawkes K, 2013, EVOL ANTHROPOL, V22, P294, DOI 10.1002/evan.21382; Hawkes K, 2009, AM J PHYS ANTHROPOL, V140, P173, DOI 10.1002/ajpa.21061; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Jha JC, 2017, CLIN SCI, V131, P981, DOI 10.1042/CS20160846; Kano G, 2013, J ALLERGY CLIN IMMUN, V132, P437, DOI 10.1016/j.jaci.2013.03.024; Karlstetter M, 2017, EMBO MOL MED, V9, P154, DOI 10.15252/emmm.201606627; Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017; Khan SS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1617; Lahdenpera M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27213; Lahdenpera M, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0054-0; Lahoz-Beneytez J, 2016, BLOOD, V127, P3431, DOI 10.1182/blood-2016-03-700336; Lizcano A, 2017, BLOOD, V129, P3100, DOI 10.1182/blood-2016-11-751636; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McMillan SJ, 2014, J BIOL CHEM, V289, P20370, DOI 10.1074/jbc.M114.574624; Mitra N, 2011, J BIOL CHEM, V286, P23003, DOI 10.1074/jbc.M111.244152; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Naviaux RK, 2012, J PHARMACOL EXP THER, V342, P608, DOI 10.1124/jpet.112.192120; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Newburger PE, 2013, SEMIN HEMATOL, V50, P198, DOI 10.1053/j.seminhematol.2013.06.010; Nutku-Bilir E, 2008, AM J RESP CELL MOL, V38, P121, DOI 10.1165/rcmb.2007-0154OC; Partridge L, 2014, TRENDS ENDOCRIN MET, V25, P555, DOI 10.1016/j.tem.2014.08.003; Patras KA, 2017, IMMUNOL CELL BIOL, V95, P960, DOI 10.1038/icb.2017.63; Photopoulou T, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0208-y; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; Ruby JG, 2018, ELIFE, V7, DOI 10.7554/eLife.31157; Satoh A, 2017, NAT REV NEUROSCI, V18, P362, DOI 10.1038/nrn.2017.42; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schwarz F, 2016, P NATL ACAD SCI USA, V113, P74, DOI 10.1073/pnas.1517951112; Schwarz F, 2015, ELIFE, V4, DOI 10.7554/eLife.06184; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Varki A, 2017, ESSENTIALS GLYCOBIOL, P450; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112; Walter RB, 2008, J LEUKOCYTE BIOL, V83, P200, DOI 10.1189/jlb.0607388; White L, 2017, HEMATOL ONCOL CLIN N, V31, P981, DOI 10.1016/j.hoc.2017.08.004; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yamanaka M, 2009, GLYCOBIOLOGY, V19, P841, DOI 10.1093/glycob/cwp052; Yang Q, 2018, FREE RADICAL BIO MED, V124, P466, DOI 10.1016/j.freeradbiomed.2018.06.042; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262	89	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1928	1938		10.1096/fj.201902116R	http://dx.doi.org/10.1096/fj.201902116R		DEC 2019	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907986	Bronze, Green Accepted			2022-12-28	WOS:000504269100001
J	Aranda, CJ; Arredondo-Amador, M; Ocon, B; Lavin, JL; Aransay, AM; Martinez-Augustin, O; de Medina, FS				Aranda, Carlos J.; Arredondo-Amador, Maria; Ocon, Borja; Luis Lavin, Jose; Maria Aransay, Ana; Martinez-Augustin, Olga; Sanchez de Medina, Fermin			Intestinal epithelial deletion of the glucocorticoid receptor NR3C1 alters expression of inflammatory mediators and barrier function	FASEB JOURNAL			English	Article						mucosal barrier function; epithelial homeostasis; mucus production; proliferation	ALKALINE-PHOSPHATASE; EXPERIMENTAL COLITIS; THERAPY; DISEASE; CELLS; CORTICOSTEROIDS; MECHANISMS; RESISTANCE; FREQUENCY; HEALTH	Glucocorticoids (GCs) are important hormones involved in the regulation of multiple physiologic functions. GCs are also widely used in anti-inflammatory/immunosuppressant drugs. GCs are synthesized by the adrenal cortex as part of the hypothalamus-pituitary-adrenal axis and also by intestinal epithelial cells, among other peripheral sites. GCs are one of the main therapy choices for the exacerbations of inflammatory bowel disease, but they are not useful to prolong remission, and development of tolerance with secondary treatment failure is frequent. Thus, GC actions at the intestinal epithelial level are of great importance, both physiologically and pharmacologically. We generated a tamoxifen-inducible nuclear receptor subfamily 3 group C member 1 (NR3C1)(Delta IEC) mouse model to study the effects of GCs on epithelial cells in vivo. Nr3c1 deletion in epithelial cells of the small intestine and colon was associated with limited colonic inflammation at 1 wk postdeletion, involving augmented epithelial proliferation and mucus production, plus local and systemic immune/inflammatory changes. This phenotype regressed substantially, but not completely, after 2 wk. The mechanism may involve augmented inflammatory signaling by epithelial cells or defective barrier function. We condude that the epithelial GC receptor plays a significant role in colonic homeostasis in basal conditions, but its deficiency can be compensated in the short term. Future studies are required to assess the impact of Nr3c1 deletion in other conditions such as experimental colitis.	[Aranda, Carlos J.; Martinez-Augustin, Olga] Univ Granada, Inst Invest Biosanitaria, Sch Pharm, CIBERehd,Dept Biochem & Mol Biol 2, Granada, Spain; [Arredondo-Amador, Maria; Ocon, Borja; Sanchez de Medina, Fermin] Univ Granada, Inst Invest Biosanitaria, Sch Pharm, CIBERehd,Dept Pharmacol, Granada, Spain; [Luis Lavin, Jose; Maria Aransay, Ana] CIBERehd, Ctr Cooperat Res Biosci CIC BioGUNE, Derio, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Martinez-Augustin, O (corresponding author), Univ Granada, Sch Pharm, CIBERehd, Dept Biochem & Mol Biol 2, Campus Cartuja S-N, E-18071 Granada, Spain.	omartine@ugr.es	Aransay, Ana M./F-8086-2011; JL, Lavín/J-7892-2013; Aranda, Carlos J/K-3842-2014; Augustin, Olga Martínez/K-6720-2014; de Medina, Fermin Sanchez/B-3782-2013	Aransay, Ana M./0000-0002-8271-612X; JL, Lavín/0000-0003-0914-3211; Aranda, Carlos J/0000-0001-6224-9352; Augustin, Olga Martínez/0000-0001-8291-3468; de Medina, Fermin Sanchez/0000-0002-4516-5824	Ministry of Economy and Competitivity; Fondo Europeo de Desarrollo Regional (FEDER) funds [BFU2014-57736-P, AGL2014-58883-R, SAF2017-88457-R, AGL2017-85270-R]; Junta de Andalucia [CTS235, CTS164]; Ministry of Education; Instituto de Salud Carlos III; Basque Department of Industry, Tourism, and Trade; Innovation Technology Department of Bizkaia County; CIBERehd Network; Spanish Ministry of Economy and Competitiveness (MINECO) Severo Ochoa Excellence Accreditation [SEV-2016-0644]; Amino Up Chemical; Pfizer; Hospira; Sanofi; Biosearch Life; Bioiberica; APC Europe	Ministry of Economy and Competitivity; Fondo Europeo de Desarrollo Regional (FEDER) funds(European Commission); Junta de Andalucia(Junta de Andalucia); Ministry of Education; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Basque Department of Industry, Tourism, and Trade; Innovation Technology Department of Bizkaia County; CIBERehd Network; Spanish Ministry of Economy and Competitiveness (MINECO) Severo Ochoa Excellence Accreditation; Amino Up Chemical; Pfizer(Pfizer); Hospira; Sanofi; Biosearch Life; Bioiberica; APC Europe	This work was supported by funds from the Ministry of Economy and Competitivity, partly with Fondo Europeo de Desarrollo Regional (FEDER) funds (BFU2014-57736-P, AGL2014-58883-R, SAF2017-88457-R, and AGL2017-85270-R), and by Junta de Andalucia (CTS235 and CTS164). B.O., C.J.A., and M.A.-A. were supported by fellowships from the Ministry of Education. Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by Instituto de Salud Carlos III. Center for Cooperative Research in Biosciences (CIC bioGUNE) support was provided by the Basque Department of Industry, Tourism, and Trade (Etortek and Elkartek Programs), the Innovation Technology Department of Bizkaia County, CIBERehd Network, and Spanish Ministry of Economy and Competitiveness (MINECO) Severo Ochoa Excellence Accreditation (SEV-2016-0644). The authors have received funds and/or support from Amino Up Chemical, Pfizer, Hospira, Sanofi, Biosearch Life, Bioiberica and APC Europe. The authors declare no conflicts of interest.	Bjorck S, 1997, DIGEST DIS SCI, V42, P824, DOI 10.1023/A:1018880501437; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Canny G, 2006, METH MOL B, V341, P17; Dubois-Camacho K, 2017, WORLD J GASTROENTERO, V23, P6628, DOI 10.3748/wjg.v23.i36.6628; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Finnie IA, 1996, CLIN SCI, V91, P359, DOI 10.1042/cs0910359; Fischer A, 2014, AM J PHYSIOL-GASTR L, V306, pG218, DOI 10.1152/ajpgi.00095.2013; Flynn BP, 2018, ANN ENDOCRINOL-PARIS, V79, P112, DOI 10.1016/j.ando.2018.03.003; Ford AC, 2011, AM J GASTROENTEROL, V106, P590, DOI 10.1038/ajg.2011.70; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lopez-Posadas R, 2011, INFLAMM BOWEL DIS, V17, P543, DOI 10.1002/ibd.21381; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Martinez-Augustin O, 2009, INFLAMM BOWEL DIS, V15, P114, DOI 10.1002/ibd.20579; Martinez-Moya P, 2012, PHARMACOL RES, V66, P144, DOI 10.1016/j.phrs.2012.04.006; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; MUNKHOLM P, 1994, GUT, V35, P360, DOI 10.1136/gut.35.3.360; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Ocon B, 2016, BIOCHEM PHARMACOL, V116, P73, DOI 10.1016/j.bcp.2016.07.010; Olivares-Villagomez D, 2018, TRENDS IMMUNOL, V39, P264, DOI 10.1016/j.it.2017.11.003; Ramamoorthy S, 2016, RHEUM DIS CLIN N AM, V42, P15, DOI 10.1016/j.rdc.2015.08.002; Reichardt SD, 2012, ENDOCRINOLOGY, V153, P1783, DOI 10.1210/en.2011-1747; Romero-Calvo I, 2018, PFLUG ARCH EUR J PHY, V470, P1705, DOI 10.1007/s00424-018-2187-z; Sales-Campos H, 2017, IMMUNOLOGY, V150, P115, DOI 10.1111/imm.12672; de Medina FS, 2014, INFLAMM BOWEL DIS, V20, P2394, DOI 10.1097/MIB.0000000000000204; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Talaber G, 2013, MOL CELL ENDOCRINOL, V380, P89, DOI 10.1016/j.mce.2013.05.007; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRUELOVE SC, 1978, LANCET, V2, P1086; Tung J, 2006, INFLAMM BOWEL DIS, V12, P1093, DOI 10.1097/01.mib.0000235835.32176.85; Tuzun A, 2004, J GASTROEN HEPATOL, V19, P429, DOI 10.1111/j.1440-1746.2003.03300.x; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; WELCH CL, 1983, CLIN CHEM, V29, P2022; Wu T, 2018, LIFE SCI, V192, P173, DOI 10.1016/j.lfs.2017.11.049; Zhang YZ, 2014, WORLD J GASTROENTERO, V20, P91, DOI 10.3748/wjg.v20.i1.91	40	9	9	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14067	14082		10.1096/fj.201900404RR	http://dx.doi.org/10.1096/fj.201900404RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31657630				2022-12-28	WOS:000507466100077
J	Ray, DA; Paulat, N; An, WF; Boissinot, S; Cordaux, R; Kaul, T; Freeman, B; Belancio, V				Ray, David A.; Paulat, Nicole; An, Wenfeng; Boissinot, Stephane; Cordaux, Richard; Kaul, Tiffany; Freeman, Ben; Belancio, Victoria			The 2019 FASEB Science Research Conference on The Mobile DNA Conference: 25 Years of Discussion and Research, June 23-28, Palm Springs, California, USA	FASEB JOURNAL			English	Editorial Material									[Ray, David A.; Paulat, Nicole] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [An, Wenfeng] South Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA; [Boissinot, Stephane] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates; [Cordaux, Richard] Univ Poitiers, CNRS, UMR 7267, Lab Ecol & Biol Interact, Poitiers, France; [Kaul, Tiffany] Tulane Univ, Tulane Canc Ctr, New Orleans, LA 70118 USA; [Freeman, Ben; Belancio, Victoria] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA	Texas Tech University System; Texas Tech University; South Dakota State University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Tulane University; Tulane University	Ray, DA (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	david.4.ray@gmail.com	An, Wenfeng/A-9816-2013	An, Wenfeng/0000-0002-5659-7120; Ray, David/0000-0002-3340-3987; Paulat, Nicole/0000-0002-6881-2588; Boissinot, Stephane/0000-0002-8760-1284					0	1	1	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11625	11628		10.1096/fj.201902390	http://dx.doi.org/10.1096/fj.201902390			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31671501	Bronze			2022-12-28	WOS:000507461600004
J	Kawashima, H; Ozawa, Y; Toda, E; Homma, K; Osada, H; Narimatsu, T; Nagai, N; Tsubota, K				Kawashima, Hirohiko; Ozawa, Yoko; Toda, Eriko; Homma, Kohei; Osada, Hideto; Narimatsu, Toshio; Nagai, Norihiro; Tsubota, Kazuo			Neuroprotective and vision-protective effect of preserving ATP levels by AMPK activator	FASEB JOURNAL			English	Article						AMPK; ATP; Neurodegeneration; photostress; retina	RETINAL-PIGMENT EPITHELIUM; STRAND BREAK REPAIR; OXIDATIVE-METABOLISM; PROTEIN-KINASE; LIGHT; RHODOPSIN; DNA; OVEREXPRESSION; DEGENERATION; RETINOPATHY	Progression of blinding diseases, such as age-related macular degeneration, is accelerated by light exposure. However, no particular intervention is applied to the photostress. Here, we report neuroprotective effects of the adenosine monophosphate (AMP)-activated protein kinase (AMPK) activator, 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR), on light-induced visual function impairment, photoreceptor disorders and death in mice. Increase in retinal ATP levels in response to photostress was transient, because oxygen consumption rate (OCR) and cytochrome c oxidase (CcO) activity were reduced under photostress. However, AICAR treatment preserved OCR, CcO activity, and high levels of retinal ATP after light exposure. AMPK knockdown in the photoreceptor-derived cell line revealed that AMPK targeted CcO activity. Further, our data indicated that photostress reduced mitochondrial respiratory function and ATP levels, while AICAR treatment promoted neuronal survival and retained visual function, stabilizing ATP levels through preserved CcO activity. The current study has provided proof of concept for providing cells with sufficient energy to promote cell survival in the presence of cellular stress. This is in contrast to the previous reports which primarily investigated therapeutic approaches to suppress stress signals. Hence, stabilization of the ATP supply may serve as a novel therapeutic approach to support tissue survival under stress and prevent neurodegeneration.	[Kawashima, Hirohiko; Ozawa, Yoko; Toda, Eriko; Homma, Kohei; Osada, Hideto; Narimatsu, Toshio; Nagai, Norihiro] Keio Univ, Lab Retinal Cell Biol, Sch Med, Tokyo, Japan; [Kawashima, Hirohiko; Ozawa, Yoko; Narimatsu, Toshio; Nagai, Norihiro; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan	Keio University; Keio University	Ozawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ozawa@a5.keio.jp	Ozawa, Yoko/AAH-9888-2020; Homma, Kohei/AAF-6716-2021; Tsubota, Kazuo/M-1915-2013	Homma, Kohei/0000-0002-6253-8047; Tsubota, Kazuo/0000-0002-8874-7111; Osada, Hideto/0000-0001-9971-8992; Ozawa, Yoko/0000-0003-4797-5705	Japan Society of the Promotion of Science [18K09422]; Keio | School of Medicine, Keio University (School of Medicine, Keio University)	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio | School of Medicine, Keio University (School of Medicine, Keio University)	Japan Society of the Promotion of Science, Grant/Award Number: 18K09422; Keio | School of Medicine, Keio University (School of Medicine, Keio University)	Ban N, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0017-8; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Choi SU, 2019, EYE, V33, P1540, DOI 10.1038/s41433-019-0439-6; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hopfner KP, 2014, BIOESSAYS, V36, P1170, DOI 10.1002/bies.201400102; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Iacovelli J, 2016, INVEST OPHTH VIS SCI, V57, P1038, DOI 10.1167/iovs.15-17758; Kamoshita M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30226; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16; Kooragayala K, 2015, INVEST OPHTH VIS SCI, V56, P8428, DOI 10.1167/iovs.15-17901; Kubota S, 2010, AM J PATHOL, V177, P1725, DOI 10.2353/ajpath.2010.100098; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Narimatsu T, 2015, EXP EYE RES, V132, P48, DOI 10.1016/j.exer.2015.01.003; Narimatsu T, 2014, CLIN EXP OPHTHALMOL, V42, P555, DOI 10.1111/ceo.12253; Narimatsu T, 2014, FREE RADICAL BIO MED, V71, P176, DOI 10.1016/j.freeradbiomed.2014.03.020; Narimatsu T, 2013, INVEST OPHTH VIS SCI, V54, P4555, DOI 10.1167/iovs.12-11572; Okamoto T, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.6.20; Okamoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146517; Osada H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178627; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Ozawa Y, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/506137; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Pobre KFR, 2019, J BIOL CHEM, V294, P2098, DOI 10.1074/jbc.REV118.002804; Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707; Reme CE, 1999, INVEST OPHTH VIS SCI, V40, P2398; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rojowska A, 2014, EMBO J, V33, P2847, DOI 10.15252/embj.201488889; Sasaki M, 2012, J NUTR BIOCHEM, V23, P423, DOI 10.1016/j.jnutbio.2011.01.006; Satish S, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9248640; Saydah S, 2019, MMWR-MORBID MORTAL W, V68, P453, DOI 10.15585/mmwr.mm6820a2; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xu L, 2018, P NATL ACAD SCI USA, V115, P10475, DOI 10.1073/pnas.1802724115; Zhang C, 2015, J ALZHEIMERS DIS, V44, P375, DOI 10.3233/JAD-141890	49	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5016	5026		10.1096/fj.201902387RR	http://dx.doi.org/10.1096/fj.201902387RR		FEB 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32090372	hybrid			2022-12-28	WOS:000515260900001
J	Shin, JH; Lee, G; Jeong, MG; Kim, HK; Won, HY; Choi, Y; Lee, JH; Nam, M; Choi, CS; Hwang, GS; Hwang, ES				Shin, Ji Hyun; Lee, Gibbeum; Jeong, Mi Gyeong; Kim, Hyo Kyeong; Won, Hee Yeon; Choi, Yujeong; Lee, Ji-Hyeok; Nam, Miso; Choi, Cheol Soo; Hwang, Geum-Sook; Hwang, Eun Sook			Transcriptional coactivator with PDZ-binding motif suppresses the expression of steroidogenic enzymes by nuclear receptor 4 A1 in Leydig cells	FASEB JOURNAL			English	Article						Leydig cell; mitochondrial dysfunction; steroidogenesis; TAZ; testosterone	3-BETA-HYDROXYSTEROID DEHYDROGENASE-DEFICIENCY; MYOGENIC DIFFERENTIATION; TAZ; CHOLESTEROL; GENE; BIOSYNTHESIS; ACTIVATION; TISSUE; RAT; PROLIFERATION	Transcriptional coactivator with PDZ-binding motif (TAZ) plays crucial role in maintaining testicular structure and function via regulation of senescence of spermatogenic cells. However, it remains unclear whether TAZ is involved in testosterone biosynthesis in testicular Leydig cells. We found that TAZ deficiency caused aberrant Leydig cell expansion and increased lipid droplet formation, which was significantly associated with increased lipogenic enzyme expression. Additionally, the expression of key steroidogenic enzymes, including steroidogenic acute regulatory protein, cytochrome P450 (CYP) 11A1, CYP17A1, and 3 beta-hydroxysteroid dehydrogenase, was greatly increased in TAZ-deficient testes and primary Leydig cells. Interestingly, the transcriptional activity of nuclear receptor 4 A1 (NR4A1) was dramatically suppressed by TAZ; however, the protein expression and the subcellular localization of NR4A1 were not affected by TAZ. TAZ directly associated with the N-terminal region of NR4A1 and substantially suppressed its DNA-binding and transcriptional activities. Stable expression of TAZ in the mouse Leydig TM3 cell line decreased the expression of key steroidogenic enzymes, whereas knockdown of endogenous TAZ in TM3 cells increased transcripts of steroidogenic genes induced by NR4A1. Consistently, testosterone production was enhanced within TAZ-deficient Leydig cells. However, TAZ deficiency resulted in decreased testosterone secretion caused by dysfunctional mitochondria and lysosomes. Therefore, TAZ plays essential role in NR4A1-induced steroidogenic enzyme expression and testosterone production in Leydig cells.	[Shin, Ji Hyun; Lee, Gibbeum; Jeong, Mi Gyeong; Kim, Hyo Kyeong; Won, Hee Yeon; Choi, Yujeong; Hwang, Eun Sook] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul, South Korea; [Lee, Ji-Hyeok; Choi, Cheol Soo] Gachon Univ, Sch Med, Lee Gil Ya Canc & Diabet Inst, Korea Mouse Metab Phenotyping Ctr, Incheon, South Korea; [Nam, Miso; Hwang, Geum-Sook] Korea Basic Sci Inst, Western Seoul Ctr, Integrated Metabol Res Grp, Seoul, South Korea	Ewha Womans University; Gachon University; Korea Basic Science Institute (KBSI)	Hwang, ES (corresponding author), Ewha Womans Univ, Coll Pharm, C206 Sci Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea.; Hwang, ES (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, C206 Sci Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea.	eshwang@ewha.ac.kr			National Research Foundation of Korea [2016R1D1A1B03935951, 2018R1A5A2025286, 2014M3A9D5A01073886]; Korea Basic Science Institute [C39531]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Basic Science Institute	National Research Foundation of Korea, Grant/Award Number: 2016R1D1A1B03935951, 2018R1A5A2025286 and 2014M3A9D5A01073886; Korea Basic Science Institute, Grant/Award Number: C39531	AZZIZ R, 1993, AM J OBSTET GYNECOL, V168, P889, DOI 10.1016/S0002-9378(12)90840-6; Di Palma T, 2009, EXP CELL RES, V315, P162, DOI 10.1016/j.yexcr.2008.10.016; DiMarino AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00201; Doran E, 2004, CHEM-BIOL INTERACT, V147, P141, DOI 10.1016/j.cbi.2003.12.002; Fan JJ, 2018, ENDOCRINOLOGY, V159, P1130, DOI 10.1210/en.2017-03065; Fukuda H, 1999, EUR J BIOCHEM, V260, P505, DOI 10.1046/j.1432-1327.1999.00183.x; HALL PF, 1991, J STEROID BIOCHEM, V40, P527, DOI 10.1016/0960-0760(91)90272-7; Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; HOU JW, 1990, ENDOCRINOLOGY, V127, P2047; Hwang JH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08287-x; Iida KT, 2002, FEBS LETT, V520, P177, DOI 10.1016/S0014-5793(02)02811-9; Jang EJ, 2012, MOL CELL BIOL, V32, P4925, DOI 10.1128/MCB.00392-12; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Jeong MG, 2017, AGING CELL, V16, P1035, DOI 10.1111/acel.12631; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kim AR, 2019, FASEB J, V33, P5914, DOI 10.1096/fj.201801256RR; Kim AR, 2017, BIOCHEM BIOPH RES CO, V486, P378, DOI 10.1016/j.bbrc.2017.03.049; Kim TH, 2017, ARCH PHARM RES, V40, P1336, DOI 10.1007/s12272-017-0965-3; Konishi T, 2018, AM J PHYSIOL-GASTR L, V314, pG471, DOI 10.1152/ajpgi.00153.2017; Lala DS, 1997, P NATL ACAD SCI USA, V94, P4895, DOI 10.1073/pnas.94.10.4895; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li F, 2019, ARTERIOSCL THROM VAS, V39, P850, DOI 10.1161/ATVBAHA.119.312136; Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205; Martin LJ, 2005, ENDOCRINOLOGY, V146, P861, DOI 10.1210/en.2004-0859; Martin LJ, 2010, BIOL REPROD, V83, P3, DOI 10.1095/biolreprod.110.083824; Miller WL, 2007, MOL ENDOCRINOL, V21, P589, DOI 10.1210/me.2006-0303; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; O'Donnell L, 2000, BIOL REPROD, V63, P99, DOI 10.1095/biolreprod63.1.99; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; PARDRIDGE WM, 1986, CLIN ENDOCRINOL META, V15, P259, DOI 10.1016/S0300-595X(86)80024-X; Park GH, 2014, BRIT J PHARMACOL, V171, P4051, DOI 10.1111/bph.12755; PAULA FJA, 1994, BRAZ J MED BIOL RES, V27, P1149; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PIGNATARO OP, 1983, MOL CELL ENDOCRINOL, V33, P53, DOI 10.1016/0303-7207(83)90056-4; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; SCHUMACHER M, 1978, FEBS LETT, V91, P333, DOI 10.1016/0014-5793(78)81204-6; Shea-Eaton WK, 2001, ENDOCRINOLOGY, V142, P1525, DOI 10.1210/en.142.4.1525; Sun J, 2011, J REPROD DEVELOP, V57, P433, DOI 10.1262/jrd.10-123N; TANABE Y, 1983, GEN COMP ENDOCR, V49, P144, DOI 10.1016/0016-6480(83)90018-7; Thelen AM, 2017, TRENDS CELL BIOL, V27, P843, DOI 10.1016/j.tcb.2017.07.006; Traish AM, 2011, HORM MOL BIOL CLIN I, V8, P431, DOI 10.1515/HMBCI.2011.132; van Rensburg HJJ, 2018, CANCER RES, V78, P1457, DOI 10.1158/0008-5472.CAN-17-3139; Wang ZJ, 2001, P NATL ACAD SCI USA, V98, P7988, DOI 10.1073/pnas.141543298; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wilhelm D, 2013, CURR TOP DEV BIOL, V106, P89, DOI 10.1016/B978-0-12-416021-7.00003-1; Won HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17073-y; Yui S, 2018, CELL STEM CELL, V22, P35, DOI 10.1016/j.stem.2017.11.001; Zhang PL, 1996, MOL ENDOCRINOL, V10, P147, DOI 10.1210/me.10.2.147; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zirkin BR, 2018, BIOL REPROD, V99, P101, DOI 10.1093/biolre/ioy059; ZIRKIN BR, 1980, ENDOCRINOLOGY, V107, P1867, DOI 10.1210/endo-107-6-1867	57	5	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5332	5347		10.1096/fj.201900695RRRR	http://dx.doi.org/10.1096/fj.201900695RRRR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067268				2022-12-28	WOS:000515248800001
J	Zhang, T; Liu, Y; Yan, JK; Cai, W				Zhang, Tian; Liu, Yang; Yan, Jun-Kai; Cai, Wei			Early downregulation of P-glycoprotein facilitates bacterial attachment to intestinal epithelial cells and thereby triggers barrier dysfunction in a rodent model of total parenteral nutrition	FASEB JOURNAL			English	Article						Escherichia coli; intestinal barrier function; Occludin; P-glycoprotein; total parenteral nutrition	ENTEROPATHOGENIC ESCHERICHIA-COLI; MOUSE MODEL; LIVER-DISEASE; CACO-2 CELLS; I INTERFERON; INFLAMMATION; PERMEABILITY; ACTIVATION; MICROBIOTA; EXPRESSION	Intestinal barrier dysfunction is a major complication of total parenteral nutrition (TPN). Our preliminary study revealed that intestinal P-glycoprotein (P-gp) was significantly downregulated under TPN treatment followed by disruption of barrier function, and thus the significance of early downregulation of P-gp needs to be addressed. Herein, we report a pivotal role of P-gp in the development of intestinal barrier dysfunction under TPN. Functional suppression of P-gp may facilitate bacterial attachment to intestinal epithelial cells (IECs) and thereby induce degradation of tight junctions to trigger barrier dysfunction. By using a rat model of TPN, we found early downregulation of P-gp function in ileum after 3-day TPN, followed by disruption of barrier function after 7-day TPN. By using Escherichia coli (E. coli) k88 and DH5 alpha as type strains, we found significantly increased bacterial attachment to IECs in TPN group compared to sham. By using Caco-2 cells as an IEC model in vitro, we found that functional suppression of P-gp remarkably facilitated bacterial attachment to Caco-2 cells, leading to subsequent disruption of intestinal barrier function. Of note, Occludin was significantly downregulated by bacterial attachment when P-gp was functionally suppressed. Mechanistically, changes on Occludin were attributed to enhanced protein degradation instead of suppressed protein translation. Despite the half-life of Occludin protein being unchanged by DH5 alpha treatment alone, it was decreased by about 40% when P-gp was simultaneously suppressed. Taken together, our findings revealed that early downregulation of intestinal P-gp under TPN may be a potential therapeutic target to prevent the development of barrier dysfunction.	[Zhang, Tian; Liu, Yang; Yan, Jun-Kai; Cai, Wei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai, Peoples R China; [Yan, Jun-Kai; Cai, Wei] Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University	Yan, JK; Cai, W (corresponding author), Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai 200092, Peoples R China.	yanjunkai@xinhuamed.com.cn; caiw204@sjtu.edu.cn			Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation) [20184Y0337]; National Natural Science Foundation of China (NSFC) [81630039, 81700787]; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [17DZ2272000]	Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition	Foundation of Shanghai Municipal Commission of Health and Family Planning (Shanghai Municipal Commission of Health and Family Planning Foundation), Grant/Award Number: 20184Y0337; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81630039 and 81700787; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Grant/Award Number: 17DZ2272000	Aluko K, 2017, ANIM NUTR, V3, P353, DOI 10.1016/j.aninu.2017.06.006; [Anonymous], 2017, NUTRIENTS, DOI [DOI 10.3390/nu9090987, DOI 10.3390/NU9090987]; Bielawska B, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050466; Bleier BS, 2016, INT FORUM ALLERGY RH, V6, P169, DOI 10.1002/alr.21566; Braga M, 2009, CLIN NUTR, V28, P378, DOI 10.1016/j.clnu.2009.04.002; Buyse M, 2005, BIOCHEM PHARMACOL, V69, P1745, DOI 10.1016/j.bcp.2005.03.025; Crowe A, 2012, EUR J PHARMACOL, V689, P204, DOI 10.1016/j.ejphar.2012.05.047; Crowe A, 2011, J CROHNS COLITIS, V5, P531, DOI 10.1016/j.crohns.2011.05.002; Demehri FR, 2015, NUTR CLIN PRACT, V30, P798, DOI 10.1177/0884533615609904; Didziapetris R, 2003, J DRUG TARGET, V11, P391, DOI 10.1080/10611860310001648248; Feng YJ, 2016, AM J PHYSIOL-GASTR L, V310, pG273, DOI 10.1152/ajpgi.00335.2015; Feng YJ, 2013, J PHYSIOL-LONDON, V591, P3709, DOI 10.1113/jphysiol.2013.253518; Freeman JJ, 2015, FASEB J, V29, P2943, DOI 10.1096/fj.14-269480; Glotfelty LG, 2014, CELL MICROBIOL, V16, P1767, DOI 10.1111/cmi.12323; Groschwitz KR, 2013, AM J PHYSIOL-GASTR L, V304, pG479, DOI 10.1152/ajpgi.00186.2012; Heneghan AF, 2013, ANN SURG, V258, P1065, DOI 10.1097/SLA.0b013e318277ea9e; Ho GT, 2003, GUT, V52, P759, DOI 10.1136/gut.52.5.759; Hodin CM, 2012, J NUTR, V142, P2141, DOI 10.3945/jn.112.162388; Huang YH, 2017, J GASTROEN HEPATOL, V32, P1949, DOI 10.1111/jgh.13806; Jirsova Z, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7084734; Kim J, 2012, GRAEF ARCH CLIN EXP, V250, P691, DOI 10.1007/s00417-011-1912-5; Lavallee CM, 2017, JPEN-PARENTER ENTER, V41, P1301, DOI 10.1177/0148607116662972; Lei QC, 2018, NUTR RES, V49, P56, DOI 10.1016/j.nutres.2017.10.007; Li QR, 2008, FEBS J, V275, P6022, DOI 10.1111/j.1742-4658.2008.06731.x; Lilja HE, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0084-7; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Long TM, 2014, INFECT IMMUN, V82, P2802, DOI 10.1128/IAI.00105-14; Lu A, 2013, NEUROSCIENCE, V253, P361, DOI 10.1016/j.neuroscience.2013.08.068; Mitra A, 2017, CLIN LIVER DIS, V21, P687, DOI 10.1016/j.cld.2017.06.008; Miyasaka EA, 2013, J IMMUNOL, V190, P6607, DOI 10.4049/jimmunol.1201746; Neudeck BL, 2004, INFECT IMMUN, V72, P3849, DOI 10.1128/IAI.72.7.3849-3854.2004; Parm U, 2015, NUTR RES, V35, P496, DOI 10.1016/j.nutres.2015.04.006; Parveen Z, 2011, MOL PHARMACOL, V79, P443, DOI 10.1124/mol.110.067611; Peralta-Ramirez J, 2008, INFECT IMMUN, V76, P3854, DOI 10.1128/IAI.00072-08; Ralls MW, 2014, JPEN-PARENTER ENTER, V38, P392, DOI 10.1177/0148607113486482; Roselli M, 2006, BRIT J NUTR, V95, P1177, DOI 10.1079/BJN20051681; Sigal N, 2015, INFECT IMMUN, V83, P2358, DOI 10.1128/IAI.00380-15; Szabady RL, 2018, J CLIN INVEST, V128, P4044, DOI 10.1172/JCI96817; Takizawa Y, 2013, INT J PHARMACEUT, V450, P31, DOI 10.1016/j.ijpharm.2013.04.026; Xiao WD, 2014, FASEB J, V28, P2073, DOI 10.1096/fj.13-238311; Yamada H, 2013, BIOCHEM PHARMACOL, V85, P1770, DOI 10.1016/j.bcp.2013.04.006; Yan JK, 2019, FASEB J, V33, P3378, DOI [10.1096/fj.201801695r, 10.1096/fj.201801695R]; Yan JK, 2018, J CELL MOL MED, V22, P1562, DOI 10.1111/jcmm.13430; Yan JK, 2017, CELL PHYSIOL BIOCHEM, V41, P711, DOI 10.1159/000458430; Yan JK, 2016, CELL PHYSIOL BIOCHEM, V39, P1581, DOI 10.1159/000447860	45	1	1	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4670	4683		10.1096/fj.201902513R	http://dx.doi.org/10.1096/fj.201902513R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32027421				2022-12-28	WOS:000520982300001
J	Tang, HY; Mao, JW; Ye, XJ; Zhang, FR; Kerr, WG; Zheng, T; Zhu, Z				Tang, Haiying; Mao, Jingwei; Ye, Xujun; Zhang, Fengrui; Kerr, William G.; Zheng, Tao; Zhu, Zhou			SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis	FASEB JOURNAL			English	Article						endothelial-mesenchymal transition; lung fibrosis; miR-155; phosphatase SHIP-1	MESENCHYMAL TRANSITION; PULMONARY-FIBROSIS; MICRORNAS; MYOFIBROBLASTS; PATHOGENESIS; INFLAMMATION; DEFICIENCY; PATHOLOGY; DISEASE; LEADS	Src Homology 2-containing Inositol Phosphatase-1 (SHIP-1) is a target of miR-155, a pro-inflammatory factor. Deletion of the SHIP-1 gene in mice caused spontaneous lung inflammation and fibrosis. However, the role and function of endothelial miR-155 and SHIP-1 in lung fibrosis remain unknown. Using whole-body miR-155 knockout mice and endothelial cell-specific conditional miR-155 (VEC-Cre-miR-155 or VEC-miR-155) or SHIP-1 (VEC-SHIP-1) knockout mice, we assessed endothelial-mesenchymal transition (EndoMT) and fibrotic responses in bleomycin (BLM) induced lung fibrosis models. Primary mouse lung endothelial cells (MLEC) and human umbilical vein endothelial cells (HUVEC) with SHIP-1 knockdown were analyzed in TGF-beta 1 or BLM, respectively, induced fibrotic responses. Fibrosis and EndoMT were significantly reduced in miR-155KO mice and changes in EndoMT markers in MLEC after TGF-beta 1 stimulation confirmed the in vivo findings. Furthermore, lung fibrosis and EndoMT responses were reduced in VEC-miR-155 mice but significantly enhanced in VEC-SHIP-1 mice after BLM challenge. SHIP-1 knockdown in HUVEC cells resulted in enhanced EndoMT induced by BLM. Meanwhile, these changes involved the PI3K/AKT, JAK/STAT3, and SMAD/STAT signaling pathways. These studies demonstrate that endothelial miR-155 plays an important role in fibrotic responses in the lung through EndoMT. Endothelial SHIP-1 is essential in controlling fibrotic responses and SHIP-1 is a target of miR-155. Endothelial cells are an integral part in lung fibrosis.	[Tang, Haiying; Mao, Jingwei; Ye, Xujun; Zhang, Fengrui; Zheng, Tao; Zhu, Zhou] Yale Univ Sch Med, Sect Allergy, Clin Immunol, New Haven, CT USA; [Tang, Haiying] Dalian Med Univ, Affiliated Hosp 1, Dept Pulm, Crit Care Med, Dalian, Peoples R China; [Mao, Jingwei] Dalian Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Dalian, Peoples R China; [Kerr, William G.] SUNY Upstate Med Univ, Dept MicroBiol, Immunol, Syracuse, NY USA; [Zheng, Tao; Zhu, Zhou] Brown Univ Warren Alpert Med Sch, Dept Mol MicroBiol, Immunol, Providence, RI USA; Brown Univ Warren Alpert Med Sch, Dept Mol MicroBiol & Immunol, Providence, RI USA	Yale University; Dalian Medical University; Dalian Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Zhu, Z (corresponding author), Yale Univ Sch Med, Sect Allergy, Clin Immunol, New Haven, CT USA.	zhou_zhu@brown.edu		Mao, Jingwei/0000-0003-1896-1988	NHLBI NIH HHS [P01 HL107151] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu El-Asrar AM, 2015, EXP EYE RES, V132, P179, DOI 10.1016/j.exer.2015.01.023; Ambrozova G, 2016, BBA-GEN SUBJECTS, V1860, P2428, DOI 10.1016/j.bbagen.2016.07.010; Artlett CM, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1331-z; Bacha NC, 2018, STEM CELL REV REP, V14, P223, DOI 10.1007/s12015-017-9778-5; Bagnato G, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0125-2016; Blaya D, 2018, HEPATOLOGY, V68, P691, DOI 10.1002/hep.29833; Cao ZW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8710; Pena-Philippides JC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0753-x; Cho JG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00294; Christmann RB, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1054-6; Csak T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129251; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Elich M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00931; Eramo MJ, 2016, BIOCHEM SOC T, V44, P240, DOI 10.1042/BST20150214; Evrard SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11853; Fernandes S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01100; Ferreira FU, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030458; Goodwin J, 2018, AM J RESP CELL MOL, V58, P216, DOI 10.1165/rcmb.2016-0186OC; Hartopo AB, 2018, PHYSIOL RES, V67, pS185, DOI 10.33549/physiolres.933812; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Jimenez SA, 2016, MATRIX BIOL, V51, P26, DOI 10.1016/j.matbio.2016.01.012; Johansson K, 2017, J ALLERGY CLIN IMMUN, V139, P1007, DOI 10.1016/j.jaci.2016.06.035; Kim J, 2018, BMB REP, V51, P65, DOI 10.5483/BMBRep.2018.51.2.011; Kurowska-Stolarska M, 2017, J ALLERGY CLIN IMMUN, V139, P1946, DOI 10.1016/j.jaci.2016.09.021; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Lehtonen ST, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0328-5; Li HM, 2016, ACTA PHARM SIN B, V6, P531, DOI 10.1016/j.apsb.2016.06.010; Li JH, 2010, DIABETES, V59, P2612, DOI 10.2337/db09-1631; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Lv Z, 2018, CRIT CARE MED, V46, pE49, DOI 10.1097/CCM.0000000000002799; Maxwell MJ, 2011, J IMMUNOL, V186, P7164, DOI 10.4049/jimmunol.1004185; Maxwelll MJ, 2014, GENES IMMUN, V15, P233, DOI 10.1038/gene.2014.9; Meadows Kafi N, 2009, J Angiogenes Res, V1, P2, DOI 10.1186/2040-2384-1-2; Musilova K, 2015, LEUKEMIA, V29, P1004, DOI 10.1038/leu.2014.351; Oh SY, 2007, J ALLERGY CLIN IMMUN, V119, P123, DOI 10.1016/j.jaci.2006.08.029; Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Stolzenburg LR, 2018, BIOL CHEM, V399, P219, DOI 10.1515/hsz-2017-0249; Tsantikos E, 2018, J CLIN INVEST, V128, P2406, DOI 10.1172/JCI98224; Van Roosbroeck K, 2017, CLIN CANCER RES, V23, P2891, DOI 10.1158/1078-0432.CCR-16-1025; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; Wang W, 2016, AM J PHYSIOL-LUNG C, V311, pL494, DOI 10.1152/ajplung.00001.2016; Waters DW, 2018, AM J PHYSIOL-LUNG C, V315, pL162, DOI 10.1152/ajplung.00037.2018; Yazdani S, 2017, ADV DRUG DELIVER REV, V121, P101, DOI 10.1016/j.addr.2017.07.010; Yin Q, 2018, J CELL PHYSIOL, V233, P2451, DOI 10.1002/jcp.26122; Yu XX, 2018, ONCOL LETT, V16, P5299, DOI 10.3892/ol.2018.9281	46	17	17	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2011	2023		10.1096/fj.201902063R	http://dx.doi.org/10.1096/fj.201902063R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907997	Bronze, Green Accepted			2022-12-28	WOS:000514663600008
J	Song, XH; Yu, Y; Shen, CJ; Wang, YB; Wang, N				Song, Xiaohan; Yu, Yi; Shen, Cangjie; Wang, Yubo; Wang, Nan			Dimerization/oligomerization of the extracellular domain of the GLP-1 receptor and the negative cooperativity in its ligand binding revealed by the improved NanoBiT	FASEB JOURNAL			English	Article						binding kinetics; exenatide; fragment complementation; GPCR; luminescence	GLUCAGON-LIKE PEPTIDE-1; PROTEIN-COUPLED SECRETIN; IN-VITRO; MEDIATED DIMERIZATION; HOMODIMERIZATION; EXPRESSION; STABILITY; MECHANISM; REPORTER; AFFINITY	The glucagon-like peptide-1 receptor (GLP-1R), a family B G-protein coupled receptor (GPCR), regulates the insulin secretion following stimulation by ligands. The transmembrane domain (TM) mediates GLP-1R homodimerization, which modulates its ligand binding and signaling. We investigated the possible involvement of the N-terminal extracellular domain (NTD) in dimerization/oligomerization and dimer-associated ligand binding by NanoLuc Binary Technology (NanoBiT). With improved NanoBiT detection using a decreasing substrate concentration, the negative cooperativity of ligand binding to the NTD was confirmed by accelerated dissociation and Scatchard analysis. The dimerization/oligomerization of the isolated NTD was observed by NanoBiT and validated by analytical ultracentrifugation, deriving the comparable dimerization affinity (10(5) M-1). The NTD was also involved in the dimerization/oligomerization of the full-length GLP-1R with mutated TM4 at the cellular level. In an analysis of the parameters of the NTD binding, the K-d for the probe GLP-1 (7-36, A8G) was similar (6-8 mu M) in both the 1:1 binding model and the receptor dimerization model. Compared with GLP-1 and dulaglutide, exenatide showed two-site binding with K-i values of 1.4 pM and 8.7 nM. Our study indicates the involvement of NTD in the GLP-1R dimerization/oligomerization and suggests that further investigations on the role in other family B GPCRs are needed.	[Song, Xiaohan; Yu, Yi; Shen, Cangjie; Wang, Yubo; Wang, Nan] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab New Drug Mech & Pharmacol Evaluat, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, N (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, 1st Xiannongtan St, Beijing, Peoples R China.	wangnan@imm.ac.cn		Wang, Nan/0000-0003-0330-8636	Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) [7162134]; Ministry of Science and Technology of the People's Republic of China (MOST) [2018ZX09711001-003-001]	Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation); Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China)	Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation), Grant/Award Number: No. 7162134; Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2018ZX09711001-003-001	Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Albizu L, 2006, MOL PHARMACOL, V70, P1783, DOI 10.1124/mol.106.025684; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Burcelin R, 1999, METABOLISM, V48, P252, DOI 10.1016/S0026-0495(99)90043-4; Casado-Anguera V, 2019, PHARMACOL RES, V139, P337, DOI 10.1016/j.phrs.2018.11.032; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; Deacon CF, 1998, DIABETOLOGIA, V41, P271, DOI 10.1007/s001250050903; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Deng LG, 2017, PROTEIN EXPRES PURIF, V138, P46, DOI 10.1016/j.pep.2017.06.019; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Durroux T, 2005, TRENDS PHARMACOL SCI, V26, P376, DOI 10.1016/j.tips.2005.05.006; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Haglin ER, 2017, BIOCHEMISTRY-US, V56, P5874, DOI 10.1021/acs.biochem.7b00698; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2017, ENDOCRINOLOGY, V158, P1685, DOI 10.1210/en.2017-00023; Harikumar KG, 2012, P NATL ACAD SCI USA, V109, P18607, DOI 10.1073/pnas.1205227109; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hu MJ, 2018, AMINO ACIDS, V50, P1111, DOI 10.1007/s00726-018-2588-5; Jimenez-Solem E, 2010, CURR OPIN MOL THER, V12, P790; Karageorgos V, 2018, HORM-INT J ENDOCRINO, V17, P45, DOI 10.1007/s42000-018-0009-5; Koole C, 2017, J BIOL CHEM, V292, P7131, DOI 10.1074/jbc.M117.779496; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laschet C, 2019, J BIOL CHEM, V294, P4079, DOI 10.1074/jbc.RA118.006231; Lee SP, 2003, BIOCHEMISTRY-US, V42, P11023, DOI 10.1021/bi0345539; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lisenbee CS, 2006, BIOCHEMISTRY-US, V45, P8216, DOI 10.1021/bi060494y; Maniatis T., 1983, ANAL BIOCHEM, V186, P182; Miller L J, 2014, Int J Obes Suppl, V4, pS9, DOI 10.1038/ijosup.2014.4; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Norisada J, 2018, MOL BIOTECHNOL, V60, P539, DOI 10.1007/s12033-018-0092-5; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Oh-hashi K, 2016, CELL BIOCHEM FUNCT, V34, P497, DOI 10.1002/cbf.3222; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; Pioszak AA, 2010, J BIOL CHEM, V285, P12435, DOI 10.1074/jbc.M109.093138; Roed Sarah Norklit, 2012, Front Endocrinol (Lausanne), V3, P62, DOI 10.3389/fendo.2012.00062; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schroder-Tittmann K, 2010, BIOCHEMISTRY-US, V49, P7956, DOI 10.1021/bi101159s; Surinya HH, 2002, J BIOL CHEM, V277, P16718, DOI 10.1074/bjc.M112014200; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Svendsen AM, 2008, MOL CELL ENDOCRINOL, V296, P10, DOI 10.1016/j.mce.2008.07.014; Taylor ES, 2017, PROTEINS, V85, P561, DOI 10.1002/prot.25220; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; van Zoelen EJJ, 1998, TRENDS PHARMACOL SCI, V19, P487, DOI 10.1016/S0165-6147(98)01250-4; VanEyll B, 1996, PEPTIDES, V17, P565, DOI 10.1016/0196-9781(96)00019-8; Ward RJ, 2017, BIOCHEM J, V474, P1879, DOI 10.1042/BCJ20170184; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051811; Yuan SJ, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-5	58	6	6	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4348	4368		10.1096/fj.201902007R	http://dx.doi.org/10.1096/fj.201902007R		JAN 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31970836				2022-12-28	WOS:000508879400001
J	Salvage, SC; Rees, JS; McStea, A; Hirsch, M; Wang, L; Tynan, CJ; Reed, MW; Irons, JR; Butler, R; Thompson, AJ; Martin-Fernandez, ML; Huang, CLH; Jackson, AP				Salvage, Samantha C.; Rees, Johanna S.; McStea, Alexandra; Hirsch, Michael; Wang, Lin; Tynan, Christopher J.; Reed, Matthew W.; Irons, Jennifer R.; Butler, Richard; Thompson, Andrew J.; Martin-Fernandez, Marisa L.; Huang, Christopher L-H; Jackson, Antony P.			Supramolecular clustering of the cardiac sodium channel Nav1.5 in HEK293F cells, with and without the auxiliary beta 3-subunit	FASEB JOURNAL			English	Article						beta 3-subunit; Hodgkin Huxley kinetics; super-resolution imaging; voltage-gated sodium channel Nav1; 5	NA+ CHANNEL; KINETICS; MUTATION; SCN5A; INACTIVATION; TRAFFICKING; NA(V)1.5; DOMAINS; COMPLEX	Voltage-gated sodium channels comprise an ion-selective alpha-subunit and one or more associated beta-subunits. The beta 3-subunit (encoded by the SCN3B gene) is an important physiological regulator of the heart-specific sodium channel, Nav1.5. We have previously shown that when expressed alone in HEK293F cells, the full-length beta 3-subunit forms trimers in the plasma membrane. We extend this result with biochemical assays and use the proximity ligation assay (PLA) to identify oligomeric beta 3-subunits, not just at the plasma membrane, but throughout the secretory pathway. We then investigate the corresponding clustering properties of the alpha-subunit and the effects upon these of the beta 3-subunits. The oligomeric status of the Nav1.5 alpha-subunit in vivo, with or without the beta 3-subunit, has not been previously investigated. Using super-resolution fluorescence imaging, we show that under conditions typically used in electrophysiological studies, the Nav1.5 alpha-subunit assembles on the plasma membrane of HEK293F cells into spatially localized clusters rather than individual and randomly dispersed molecules. Quantitative analysis indicates that the beta 3-subunit is not required for this clustering but beta 3 does significantly change the distribution of cluster sizes and nearest-neighbor distances between Nav1.5 alpha-subunits. However, when assayed by PLA, the beta 3-subunit increases the number of PLA-positive signals generated by anti-(Nav1.5 alpha-subunit) antibodies, mainly at the plasma membrane. Since PLA can be sensitive to the orientation of proteins within a cluster, we suggest that the beta 3-subunit introduces a significant change in the relative alignment of individual Nav1.5 alpha-subunits, but the clustering itself depends on other factors. We also show that these structural and higher-order changes induced by the beta 3-subunit do not alter the degree of electrophysiological gating cooperativity between Nav1.5 alpha-subunits. Our data provide new insights into the role of the beta 3-subunit and the supramolecular organization of sodium channels, in an important model cell system that is widely used to study Nav channel behavior.	[Salvage, Samantha C.; Rees, Johanna S.; Irons, Jennifer R.; Huang, Christopher L-H; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [McStea, Alexandra; Hirsch, Michael; Wang, Lin; Tynan, Christopher J.; Martin-Fernandez, Marisa L.] Rutherford Appleton Lab, Sci & Technol Facil Council, Cent Laser Facil, Res Complex Harwell, Oxford, England; [Reed, Matthew W.] Australian Natl Univ, Res Sch Phys & Engn, Dept Nucl Phys, Canberrra, ACT, Australia; [Butler, Richard] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; [Thompson, Andrew J.] Univ Cambridge, Dept Pharmacol, Cambridge, England; [Huang, Christopher L-H] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Australian National University; University of Cambridge; University of Cambridge; University of Cambridge	Salvage, SC; Jackson, AP (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England.	ss2148@cam.ac.uk; apj10@cam.ac.uk		Tynan, Christopher/0000-0002-4553-7018; Salvage, Samantha/0000-0002-5793-2349; Hirsch, Michael/0000-0001-6183-6256; Thompson, Andrew/0000-0002-7046-6792; martin-fernandez, marisa/0000-0001-5496-6300	British Heart Foundation [PG/14/79/31102]; Wellcome Trust [105727/Z/14/Z]; Medical Research Council (UK) [MR/K015591/1]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	British Heart Foundation, Grant/Award Number: PG/14/79/31102; Wellcome Trust, Grant/Award Number: 105727/Z/14/Z; Medical Research Council (UK), Grant/Award Number: MR/K015591/1	ADRIAN RH, 1969, J PHYSIOL-LONDON, V204, P207, DOI 10.1113/jphysiol.1969.sp008909; ADRIAN RH, 1978, ANNU REV BIOPHYS BIO, V7, P85, DOI 10.1146/annurev.bb.07.060178.000505; Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Alsemarz A., 2018, LTD SIGNIFICANCE SIT, DOI [10.1101/411355, DOI 10.1101/411355]; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Balse E, 2018, HANDB EXP PHARMACOL, V246, P73, DOI 10.1007/164_2017_45; CATTERALL WA, 1978, P NATL ACAD SCI USA, V75, P218, DOI 10.1073/pnas.75.1.218; Clatot J, 2018, AM J PHYSIOL-HEART C, V315, pH1250, DOI 10.1152/ajpheart.00721.2017; Clatot J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02262-0; Clatot J, 2012, CARDIOVASC RES, V96, P53, DOI 10.1093/cvr/cvs211; Corder G., 2014, NONPARAMETRIC STAT S, Vsecond; Cusdin FS, 2010, J BIOL CHEM, V285, P33404, DOI 10.1074/jbc.M110.114058; Durisic N, 2014, CURR OPIN CHEM BIOL, V20, P22, DOI 10.1016/j.cbpa.2014.04.005; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; Hakim P, 2010, ACTA PHYSIOL, V198, P47, DOI 10.1111/j.1748-1716.2009.02048.x; Hakim P, 2008, PROG BIOPHYS MOL BIO, V98, P251, DOI 10.1016/j.pbiomolbio.2009.01.005; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Ishikawa T, 2013, CIRC J, V77, P959, DOI 10.1253/circj.CJ-12-0995; Ko SH, 2005, PFLUG ARCH EUR J PHY, V449, P403, DOI 10.1007/s00424-004-1348-4; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Namadurai S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140192; Namadurai S, 2014, J BIOL CHEM, V289, P10797, DOI 10.1074/jbc.M113.527994; Pan XJ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2486; Poelzing S, 2006, CIRCULATION, V114, P368, DOI 10.1161/CIRCULATIONAHA.105.601294; Printsev I, 2017, J MEMBRANE BIOL, V250, P379, DOI 10.1007/s00232-016-9931-0; Roberts SK, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3096; Ruhlmann AH, 2019, UNCOUPLING SODIUM CH, DOI [10.1101/716654, DOI 10.1101/716654]; Saka SK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5509; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shen HZ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2596; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Shimizu H, 2017, J BIOL CHEM, V292, P13428, DOI 10.1074/jbc.M117.786509; Shimizu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26618; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Yereddi NR, 2013, FASEB J, V27, P568, DOI 10.1096/fj.12-209445; Yu EJ, 2005, BIOCHEM J, V392, P519, DOI 10.1042/BJ20050518; Zanetti-Domingues LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06632-0; Zhu WD, 2017, J GEN PHYSIOL, V149, P813, DOI 10.1085/jgp.201711802	43	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3537	3553		10.1096/fj.201701473RR	http://dx.doi.org/10.1096/fj.201701473RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31950564	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000507917000001
J	Jacques, M; Kuang, JJ; Bishop, DJ; Yan, X; Alvarez-Romero, J; Munson, F; Garnham, A; Papadimitriou, I; Voisin, S; Eynon, N				Jacques, Macsue; Kuang, Jujiao; Bishop, David J.; Yan, Xu; Alvarez-Romero, Javier; Munson, Fiona; Garnham, Andrew; Papadimitriou, Ioannis; Voisin, Sarah; Eynon, Nir			Mitochondrial respiration variability and simulations in human skeletal muscle: The Gene SMART study	FASEB JOURNAL			English	Article						exercise; intervention; mitochondria; OXPHOS; oxygen consumption	EXERCISE PERFORMANCE; AEROBIC PERFORMANCE; INTERVAL; IMPROVEMENTS; FIBERS; ADAPTATIONS; INCREASE; HYPOXIA; SPRINT	Mitochondrial respiration using the oxygraph-2k respirometer (Oroboros) is widely used to estimate mitochondrial capacity in human skeletal muscle. Here, we measured mitochondrial respiration variability, in a relatively large sample, and for the first time, using statistical simulations, we provide the sample size required to detect meaningful respiration changes following lifestyle intervention. Muscle biopsies were taken from healthy, young men from the Gene SMART cohort, at multiple time points. We utilized samples for each measurement with two technical repeats using two respirometer chambers (n = 160 pairs of same muscle after removal of low-quality samples). We measured the Technical Error of measurement (TEM) and the coefficient of variation (CV) for each mitochondrial complex. There was a high correlation between measurements from the two chambers (R > 0.7 P < .001) for all complexes, but the TEM was large (7.9-27 pmol s(-1) mg(-1); complex dependent), and the CV was >15% for all complexes. We performed statistical simulations of a range of effect sizes at 80% power and found that 75 participants (with duplicate measurements) are required to detect a 6% change in mitochondrial respiration after an intervention, while for interventions with 11% effect size, 24 participants are sufficient. The high variability in respiration suggests that the typical sample sizes in exercise studies may not be sufficient to capture exercise-induced changes.	[Jacques, Macsue; Kuang, Jujiao; Bishop, David J.; Yan, Xu; Alvarez-Romero, Javier; Munson, Fiona; Garnham, Andrew; Papadimitriou, Ioannis; Voisin, Sarah; Eynon, Nir] Victoria Univ, Inst Hlth & Sport iHeS, POB 14428, Melbourne, Vic 8001, Australia; [Eynon, Nir] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Victoria University; Murdoch Children's Research Institute	Eynon, N (corresponding author), Victoria Univ, Inst Hlth & Sport iHeS, POB 14428, Melbourne, Vic 8001, Australia.	Nir.Eynon@vu.edu.au	Bishop, David John/X-9826-2019	Bishop, David John/0000-0002-6956-9188; Kuang, Jujiao/0000-0002-1366-0089; Eynon, Nir/0000-0003-4046-8276; Jacques, Macsue/0000-0002-4337-7022; Voisin, Sarah/0000-0002-4074-7083; Yan, Xu/0000-0001-8547-4210	NHMRC CDF [APP1140644, APP115777321]	NHMRC CDF(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Nir Eynon, Grant/Award Number: NHMRC CDF#APP1140644; Sarah Voisin, Grant/Award Number: NHMRC CDF#APP115777321	Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Cardinale DA, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13611; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Christensen PM, 2016, J APPL PHYSIOL, V120, P1319, DOI 10.1152/japplphysiol.00115.2015; Brandao CFC, 2019, SCAND J MED SCI SPOR, V29, P1699, DOI 10.1111/sms.13514; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; De Lucas RD, 2014, J SPORT SCI, V32, P22, DOI 10.1080/02640414.2013.797098; DOERRIER C, 2018, HIGH RESOLUTION FLUO; Dohlmann TL, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13857; Gatterer H, 2018, J SPORT SCI MED, V17, P339; Goedecke JH, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.9098; Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Granata C, 2016, FASEB J, V30, P3413, DOI 10.1096/fj.201500100R; Hedges CP, 2019, J APPL PHYSIOL, V126, P454, DOI 10.1152/japplphysiol.00777.2018; Irving BA, 2015, J CLIN ENDOCR METAB, V100, P1654, DOI 10.1210/jc.2014-3081; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; Kitchen RR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-134; Konopka AR, 2019, AGING CELL, V18, DOI 10.1111/acel.12880; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Larsen FJ, 2016, FASEB J, V30, P417, DOI 10.1096/fj.15-276857; Larsen S, 2014, ANAL BIOCHEM, V446, P64, DOI 10.1016/j.ab.2013.10.023; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Leckey JJ, 2018, FASEB J, V32, P2979, DOI 10.1096/fj.201700993R; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2955, DOI 10.1113/JP272570; McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546; Montero D, 2015, J PHYSIOL-LONDON, V593, P4677, DOI 10.1113/JP270250; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Porter C, 2015, MED SCI SPORT EXER, V47, P1922, DOI 10.1249/MSS.0000000000000605; Robach P, 2014, MED SCI SPORT EXER, V46, P1936, DOI 10.1249/MSS.0000000000000321; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Tsai HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep35170; Vincent G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00051; Voisin S, 2019, EXERC SPORT SCI REV, V47, P37, DOI 10.1249/JES.0000000000000176; Walsh B, 2001, PFLUG ARCH EUR J PHY, V442, P420, DOI 10.1007/s004240100538; Whitham M, 2016, NAT REV DRUG DISCOV, V15, P719, DOI 10.1038/nrd.2016.153; WIBOM R, 1990, AM J PHYSIOL, V259, pE204, DOI 10.1152/ajpendo.1990.259.2.E204; Yan X, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4186-4	39	15	15	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2978	2986		10.1096/fj.201901997RR	http://dx.doi.org/10.1096/fj.201901997RR		JAN 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31919888	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000506588100001
J	Zhou, XD; Xia, N; Lv, BJ; Tang, TT; Nie, SF; Zhang, M; Jiao, J; Liu, JF; Xu, CJ; Hou, GF; Yang, XP; Hu, Y; Liao, YH; Cheng, X				Zhou, Xingdi; Xia, Ni; Lv, Bingjie; Tang, Tingting; Nie, Shaofang; Zhang, Min; Jiao, Jiao; Liu, Jianfeng; Xu, Chanjuan; Hou, Guofei; Yang, Xiangping; Hu, Yu; Liao, Yuhua; Cheng, Xiang			Interleukin 35 ameliorates myocardial ischemia-reperfusion injury by activating the gp130-STAT3 axis	FASEB JOURNAL			English	Article						apoptosis; cardiomyocyte; cytokine; heart	PANCREATIC DUCTAL ADENOCARCINOMA; HEART-FAILURE; IL-12 FAMILY; GROWTH-FACTORS; INFARCT SIZE; CYTOKINES; IL-35; MECHANISMS; RECEPTOR; COMMUNICATION	Myocardial ischemia-reperfusion injury (MIRI) is common clinical complication, which represents significant challenge in the treatment of acute myocardial infarction (AMI) diseases. Interleukin 35 (IL-35) exhibits anti-inflammatory properties via the engagement of the gp130, IL-12R beta 2 and IL-27R alpha receptors. However, whether IL-35 plays a beneficial role in the treatment of MIRI and potential underling mechanism are unclear. We showed that IL-35 conferred protection from MIRI as demonstrated by reduced infarct size and cardiac troponin T, improved cardiac function and decreased cardiomyocyte apoptosis in a mouse model. Despite activation of both STAT3 and STAT5 phosphorylation in the heart by IL-35, signal transducers and activators of transcription 3 (STAT3) was essential for mediating the IL-35-mediated protective effect on MIRI using cardiomyocyte-specific STAT3 deficient mice. Furthermore, gp130 was required for the STAT3 activation and cardio-protection induced by IL-35. Interestingly, IL-35 induced gp130 homodimer and gp130/IL-12R beta 2 heterodimers in cardiomyocyte. Our results indicate that IL-35 can execute a protective role against MIRI through a novel signaling pathway, IL-35-gp130-STAT3 pathway, in cardiomyocytes, which may be beneficial for the development of novel and effective therapeutic approaches to treat the MIRI.	[Zhou, Xingdi; Xia, Ni; Lv, Bingjie; Tang, Tingting; Nie, Shaofang; Zhang, Min; Jiao, Jiao; Liao, Yuhua; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Cardiol, Union Hosp, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Zhou, Xingdi; Xia, Ni; Lv, Bingjie; Tang, Tingting; Nie, Shaofang; Zhang, Min; Jiao, Jiao; Hu, Yu; Liao, Yuhua; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Educ Minist & Hubei Prov, Key Lab Biol Targeted Therapy,Union Hosp, Wuhan, Peoples R China; [Liu, Jianfeng; Xu, Chanjuan; Hou, Guofei] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Sino France Lab Cellular Signaling, Key Lab Mol Biophys,Minist Educ, Wuhan, Hubei, Peoples R China; [Liu, Jianfeng; Xu, Chanjuan; Hou, Guofei] Huazhong Univ Sci & Technol, Collaborat Innovat Ctr Genet & Dev, Wuhan, Hubei, Peoples R China; [Yang, Xiangping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Wuhan, Peoples R China; [Hu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Cardiol, Union Hosp, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	nathancx@hust.edu.cn	饭, 蔡/AAI-5850-2020	Yang, Xiang-Ping/0000-0001-9003-1772	National Natural Science Fund for Distinguished Young Scholars [81525003]; National Natural Science Foundation of China [81720108005, 91639301, 81770503, 81670361, 81500186, 81600187]	National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Fund for Distinguished Young Scholars, Grant/Award Number: 81525003; National Natural Science Foundation of China, Grant/Award Number: 81720108005, 91639301, 81770503, 81670361, 81500186 and 81600187	Bar-Natan M, 2012, LEUKEMIA, V26, P1407, DOI 10.1038/leu.2011.338; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Barry SP, 2007, TRENDS MOL MED, V13, P82, DOI 10.1016/j.molmed.2006.12.002; Behzadi P, 2016, ACTA MICROBIOL IMM H, V63, P1, DOI 10.1556/030.63.2016.1.1; Boag SE, 2017, ANTIOXID REDOX SIGN, V26, P660, DOI 10.1089/ars.2016.6940; Booz GW, 2002, J MOL CELL CARDIOL, V34, P1443, DOI 10.1006/jmcc.2002.2076; Bulluck H, 2016, HEART, V102, P341, DOI 10.1136/heartjnl-2015-307855; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Egwuagu CE, 2015, CYTOKINE GROWTH F R, V26, P587, DOI 10.1016/j.cytogfr.2015.07.013; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fischer P, 2008, BRIT J PHARMACOL, V153, pS414, DOI 10.1038/bjp.2008.1; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Haghikia A, 2014, CARDIOVASC RES, V102, P281, DOI 10.1093/cvr/cvu034; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hu YD, 2014, ARCH VIROL, V159, P2411, DOI 10.1007/s00705-014-2098-z; Huang CB, 2018, GASTROENTEROLOGY, V154, P675, DOI 10.1053/j.gastro.2017.09.039; Huang CB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14035; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Jia DL, 2019, CIRC RES, V124, P1323, DOI 10.1161/CIRCRESAHA.118.314569; Kempe S, 2009, AM J PATHOL, V175, P440, DOI 10.2353/ajpath.2009.080752; Kim SC, 2012, JOVE-J VIS EXP, DOI 10.3791/3896; Li X, 2017, CYTOKINE, VS1043-4666; Li YB, 2007, ULTRASOUND MED BIOL, V33, P894, DOI 10.1016/j.ultrasmedbio.2006.12.008; Liu H, 2015, IMMUNOL INVEST, V44, P566, DOI 10.3109/08820139.2015.1043671; Metzler B, 2001, CARDIOVASC RES, V49, P399, DOI 10.1016/S0008-6363(00)00261-3; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Pulkki KJ, 1997, ANN MED, V29, P339, DOI 10.3109/07853899708999358; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Roubille F, 2011, CIRCULATION, V124, P1330, DOI 10.1161/CIRCULATIONAHA.111.031864; Sha XJ, 2015, J BIOL CHEM, V290, P19307, DOI 10.1074/jbc.M115.663286; Shewchuk LJ, 2010, CAN J PHYSIOL PHARM, V88, P324, DOI 10.1139/Y09-131; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van der Heijden T, 2017, CYTOKINE; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Wang ZH, 2013, J IMMUNOL, V190, P2415, DOI 10.4049/jimmunol.1202535; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Xu C, 2018, NEUROCHEM RES, V43, P1454, DOI 10.1007/s11064-018-2560-5; Yang ZQ, 2008, AM J PHYSIOL-HEART C, V295, pH2328, DOI 10.1152/ajpheart.00091.2008; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	52	10	14	8	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3224	3238		10.1096/fj.201901718RR	http://dx.doi.org/10.1096/fj.201901718RR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31917470				2022-12-28	WOS:000506443100001
J	Bats, ML; Bougaran, P; Peghaire, C; Gueniot, F; Abelanet, A; Chan, H; Seguy, C; Jeanningros, S; Jaspard-Vinassa, B; Couffinhal, T; Duplaa, C; Dufourcq, P				Bats, Marie-Lise; Bougaran, Pauline; Peghaire, Claire; Gueniot, Florian; Abelanet, Alice; Chan, Helene; Seguy, Camille; Jeanningros, Sylvie; Jaspard-Vinassa, Beatrice; Couffinhal, Thierry; Duplaa, Cecile; Dufourcq, Pascale			Therapies targeting Frizzled-7/beta-catenin pathway prevent the development of pathological angiogenesis in an ischemic retinopathy model	FASEB JOURNAL			English	Article						Frizzled 7; Neovascularization; OIR; Retinopathy; therapeutic target; Wnt/Frizzled signaling	WNT PATHWAY; RETINAL ANGIOGENESIS; DIABETIC-RETINOPATHY; FRIZZLED 4; EXPRESSION; ANTIBODY; PREMATURITY; JAGGED1; GROWTH; CELLS	Retinopathies remain major causes of visual impairment in diabetic patients and premature infants. Introduction of anti-angiogenic drugs targeting vascular endothelial growth factor (VEGF) has transformed therapy for these proliferative retinopathies. However, limitations associated with anti-VEGF medications require to unravel new pathways of vessel growth to identify potential drug targets. Here, we investigated the role of Wnt/Frizzled-7 (Fzd7) pathway in a mouse model of oxygen-induced retinopathy (OIR). Using transgenic mice, which enabled endothelium-specific and time-specific Fzd7 deletion, we demonstrated that Fzd7 controls both vaso-obliteration and neovascular phases (NV). Deletion of Fzd7 at P12, after the ischemic phase of OIR, prevented formation of aberrant neovessels into the vitreous by suppressing proliferation of endothelial cells (EC) in tufts. Next we validated in vitro two Frd7 blocking strategies: a monoclonal antibody (mAbFzd7) against Fzd7 and a soluble Fzd7 receptor (CRD). In vivo a single intravitreal microinjection of mAbFzd7 or CRD significantly attenuated retinal neovascularization (NV) in mice with OIR. Molecular analysis revealed that Fzd7 may act through the activation of Wnt/beta-catenin and Jagged1 expression to control EC proliferation in extra-retinal neovessels. We identified Fzd7/beta-catenin signaling as new regulator of pathological retinal NV. Fzd7 appears to be a potent pharmacological target to prevent or treat aberrant angiogenesis of ischemic retinopathies.	[Bats, Marie-Lise; Bougaran, Pauline; Peghaire, Claire; Gueniot, Florian; Abelanet, Alice; Chan, Helene; Seguy, Camille; Jeanningros, Sylvie; Jaspard-Vinassa, Beatrice; Couffinhal, Thierry; Duplaa, Cecile; Dufourcq, Pascale] Inserm, U1034, Biol Cardiovasc Dis, 1 Ave Magellan, F-33600 Pessac, France; [Bats, Marie-Lise; Bougaran, Pauline; Gueniot, Florian; Abelanet, Alice; Jaspard-Vinassa, Beatrice; Couffinhal, Thierry; Duplaa, Cecile; Dufourcq, Pascale] Univ Bordeaux, U1034, Biol Cardiovasc Dis, Bordeaux, France; [Bats, Marie-Lise] CHU Bordeaux, Serv Biochim Clin, Bordeaux, France; [Peghaire, Claire] Imperial Coll London, NHLI Vasc Sci, London, England; [Couffinhal, Thierry] CHU Bordeaux, Serv Malad Cardiaques & Vasc, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Imperial College London; CHU Bordeaux	Dufourcq, P (corresponding author), Inserm, U1034, Biol Cardiovasc Dis, 1 Ave Magellan, F-33600 Pessac, France.	pascale.dufourcq@u-bordeaux.fr	Peghaire, Claire/AAD-8112-2022; Duplàa, cecile/GLU-6264-2022; Dufourcq, Pascale/ABH-6412-2020; Couffinhal, Thierry/M-6857-2014	Peghaire, Claire/0000-0003-3304-3018; Duplàa, cecile/0000-0001-8003-3969; Dufourcq, Pascale/0000-0002-9244-1879; Bougaran, Pauline/0000-0002-4064-2388; Bats, Marie-Lise/0000-0002-8359-4662; Abelanet, Alice/0000-0001-5526-9515; Couffinhal, Thierry/0000-0002-9217-2533; Jaspard-Vinassa, Beatrice/0000-0003-1623-7742	Fondation pour la Recherche Medicale (FRM) [FRM Vision DVS20131228623, FRM DEQ20170336719]; Agence Nationale de la Recherche (ANR) [ANR-16-CE17-0001-01]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	Fondation pour la Recherche Medicale (FRM), Grant/Award Number: FRM Vision DVS20131228623 and FRM DEQ20170336719; Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-16-CE17-0001-01	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Amadio M, 2016, PHARMACOL RES, V103, P253, DOI 10.1016/j.phrs.2015.11.027; Bucher F, 2017, CIRCULATION, V136, P180, DOI 10.1161/CIRCULATIONAHA.116.025604; Cavallaro G, 2014, ACTA OPHTHALMOL, V92, P2, DOI 10.1111/aos.12049; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Chen Q, 2017, VISION RES, V139, P47, DOI 10.1016/j.visres.2017.02.007; Chen X, 2010, ONCOTARGET, V1, P210, DOI 10.18632/oncotarget.127; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Descamps B, 2012, CIRC RES, V110, P47, DOI 10.1161/CIRCRESAHA.111.250936; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Fischer MM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700090; Franco CA, 2016, ELIFE, V5, DOI 10.7554/eLife.07727; Franco CA, 2013, DEVELOPMENT, V140, P2321, DOI 10.1242/dev.091074; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kilani B, 2019, J THROMB HAEMOST, V17, P827, DOI 10.1111/jth.14417; King TD, 2012, CELL SIGNAL, V24, P846, DOI 10.1016/j.cellsig.2011.12.009; Kirikoshi H, 2001, INT J ONCOL, V19, P767; Lee K, 2012, DIABETES, V61, P2948, DOI 10.2337/db11-0300; Lobo CL, 2004, J CATARACT REFR SURG, V30, P752, DOI 10.1016/S0886-3350(03)00582-0; Messersmith W, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw371.69; Nickho H, 2017, BIOENGINEERED, V8, P501, DOI 10.1080/21655979.2016.1255383; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Peghaire C, 2016, ARTERIOSCL THROM VAS, V36, P2369, DOI 10.1161/ATVBAHA.116.307926; Phesse T, 2016, CANCERS, V8, DOI 10.3390/cancers8050050; Pode-Shakked N, 2011, ONCOGENE, V30, P1664, DOI 10.1038/onc.2010.549; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Riley RS, 2017, SMALL, V13, DOI 10.1002/smll.201700544; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Sagara N, 1998, BIOCHEM BIOPH RES CO, V252, P117, DOI 10.1006/bbrc.1998.9607; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Schulenburg WE, 2004, BRIT J OPHTHALMOL, V88, P1500, DOI 10.1136/bjo.2004.044669; Sewduth RN, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag3209; Sewduth RN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5832; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2010, AM J PATHOL, V177, P2715, DOI 10.2353/ajpath.2010.100526; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Takahashi Y, 2015, FEBS LETT, V589, P1143, DOI 10.1016/j.febslet.2015.03.010; Tanaka S, 1998, P NATL ACAD SCI USA, V95, P10164, DOI 10.1073/pnas.95.17.10164; Tojais NF, 2014, CARDIOVASC RES, V103, P291, DOI 10.1093/cvr/cvu133; Tripathi S, 2017, SCI REP-UK, V7, P1, DOI [10.26700/shuri.2017.04.7.1.1, 10.1038/srep43056]; Vincan E, 2007, ONCOGENE, V26, P2340, DOI 10.1038/sj.onc.1210026; Wei W, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-16; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yoon CH, 2016, CIRCULATION, V134, P233, DOI 10.1161/CIRCULATIONAHA.116.014411; Yoon CH, 2014, J MOL CELL CARDIOL, V69, P52, DOI 10.1016/j.yjmcc.2013.12.006; Zeng CM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051543; Zhou T, 2012, DIABETOLOGIA, V55, P255, DOI 10.1007/s00125-011-2314-2	59	8	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1288	1303		10.1096/fj.201901886R	http://dx.doi.org/10.1096/fj.201901886R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914666				2022-12-28	WOS:000507308900086
J	Cruces-Sande, M; Arcones, AC; Vila-Bedmar, R; Val-Blasco, A; Sharabi, K; Diaz-Rodriguez, D; Puigserver, P; Mayor, F; Murga, C				Cruces-Sande, Marta; Arcones, Alba C.; Vila-Bedmar, Rocio; Val-Blasco, Almudena; Sharabi, Kfir; Diaz-Rodriguez, Daniel; Puigserver, Pere; Mayor, Federico, Jr.; Murga, Cristina			Autophagy mediates hepatic GRK2 degradation to facilitate glucagon-induced metabolic adaptation to fasting	FASEB JOURNAL			English	Article						autophagy; calorie restriction; fasting; glucagon signaling; gluconeogenesis; GPCR; GRK2; intermittent fasting	RECEPTOR KINASE 2; EXOGENOUS GLUCAGON; LIVER AUTOPHAGY; RAT HEPATOCYTES; DAIRY-COWS; IN-VIVO; GLUCOSE; GLUCONEOGENESIS; INSULIN; GLUCOSE-6-PHOSPHATASE	The liver plays a key role during fasting to maintain energy homeostasis and euglycemia via metabolic processes mainly orchestrated by the insulin/glucagon ratio. We report here that fasting or calorie restriction protocols in C57BL6 mice promote a marked decrease in the hepatic protein levels of G protein-coupled receptor kinase 2 (GRK2), an important negative modulator of both G protein-coupled receptors (GPCRs) and insulin signaling. Such downregulation of GRK2 levels is liver-specific and can be rapidly reversed by refeeding. We find that autophagy, and not the proteasome, represents the main mechanism implicated in fasting-induced GRK2 degradation in the liver in vivo. Reducing GRK2 levels in murine primary hepatocytes facilitates glucagon-induced glucose production and enhances the expression of the key gluconeogenic enzyme Pck1. Conversely, preventing full downregulation of hepatic GRK2 during fasting using adenovirus-driven overexpression of this kinase in the liver leads to glycogen accumulation, decreased glycemia, and hampered glucagon-induced gluconeogenesis, thus preventing a proper and complete adaptation to nutrient deprivation. Overall, our data indicate that physiological fasting-induced downregulation of GRK2 in the liver is key for allowing complete glucagon-mediated responses and efficient metabolic adaptation to fasting in vivo.	[Cruces-Sande, Marta; Arcones, Alba C.; Val-Blasco, Almudena; Diaz-Rodriguez, Daniel; Mayor, Federico, Jr.; Murga, Cristina] Ctr Biol Mol Severo Ochoa UAM CSIC, Dept Biol Mol, Madrid, Spain; [Cruces-Sande, Marta; Arcones, Alba C.; Val-Blasco, Almudena; Mayor, Federico, Jr.; Murga, Cristina] Inst Invest Sanitaria La Princesa, Madrid, Spain; [Cruces-Sande, Marta; Arcones, Alba C.; Val-Blasco, Almudena; Mayor, Federico, Jr.; Murga, Cristina] ISCIII, CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain; [Vila-Bedmar, Rocio] URJC, Area Bioquim & Biol Mol, Dept Ciencias Basicas Salud, Madrid, Spain; [Sharabi, Kfir; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Sharabi, Kfir; Puigserver, Pere] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; Universidad Rey Juan Carlos; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Mayor, F; Murga, C (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	fmayor@cbm.csic.es; cristina.murga@uam.es	Arcones, Alba Concepción/ABH-8685-2020	Arcones, Alba Concepción/0000-0001-8182-4973; VAL BLASCO, ALMUDENA/0000-0001-7029-2895; Sharabi, Kfir/0000-0002-7810-6521	NIH [R01 DK089883]; MINECO [SAF2017-84125-R]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MINECO(Spanish Government)	NIH, Grant/Award Number: R01 DK089883; MINECO, Grant/Award Number: SAF2017-84125-R	BAND GC, 1980, FEBS LETT, V119, P190, DOI 10.1016/0014-5793(80)81028-3; Bobe G, 2007, ANIM REPROD SCI, V102, P194, DOI 10.1016/j.anireprosci.2006.11.003; Bobe G, 2003, J DAIRY SCI, V86, P2895, DOI 10.3168/jds.S0022-0302(03)73886-7; Charbonneau A, 2007, J PHYSIOL-LONDON, V579, P255, DOI 10.1113/jphysiol.2006.121954; Ciccarelli M, 2011, CIRCULATION, V123, P1953, DOI 10.1161/CIRCULATIONAHA.110.988642; Cipolletta E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061492; CIUDAD C, 1984, EUR J BIOCHEM, V142, P511, DOI 10.1111/j.1432-1033.1984.tb08315.x; Cruces-Sande M, 2018, BBA-MOL BASIS DIS, V1864, P3655, DOI 10.1016/j.bbadis.2018.09.027; DETER RL, 1967, J CELL BIOL, V35, pC11, DOI 10.1083/jcb.35.2.C11; Escobar KA, 2019, AGING CELL, V18, DOI 10.1111/acel.12876; Esteban-Martinez L, 2015, METHODS, V75, P79, DOI 10.1016/j.ymeth.2015.01.008; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Fang F, 2019, P NATL ACAD SCI USA, V116, P7449, DOI 10.1073/pnas.1901867116; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Krilov L, 2011, EXP CELL RES, V317, P2981, DOI 10.1016/j.yexcr.2011.10.001; Lombardi MS, 2002, MOL PHARMACOL, V62, P379, DOI 10.1124/mol.62.2.379; Lucas E, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0474-6; Lucas E, 2014, BBA-MOL BASIS DIS, V1842, P2448, DOI 10.1016/j.bbadis.2014.09.004; Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042; Mayor Jr F, 2018, CELL SIGNAL, V41, P7; Miller RA, 2016, DIABETOLOGIA, V59, P1376, DOI 10.1007/s00125-016-3955-y; MORTIMOR.GE, 1970, J BIOL CHEM, V245, P2375; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Moulis M, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020014; Murga C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00112; Nafikov RA, 2006, J DAIRY SCI, V89, P1533, DOI 10.3168/jds.S0022-0302(06)72221-4; Naito T, 2013, J BIOL CHEM, V288, P21074, DOI 10.1074/jbc.M113.456228; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Nogues L, 2016, EBIOMEDICINE, V13, P132, DOI 10.1016/j.ebiom.2016.09.030; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Penela P, 2010, P NATL ACAD SCI USA, V107, P1118, DOI 10.1073/pnas.0905778107; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Quinones M, 2019, EXPERT OPIN DRUG DIS, V14, P421, DOI 10.1080/17460441.2019.1583642; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211; Sharabi K, 2017, CELL, V169, P148, DOI 10.1016/j.cell.2017.03.001; Taguchi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08998-5; Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185; Valdecantos MP, 2017, HEPATOLOGY, V65, P950, DOI 10.1002/hep.28962; Vila-Bedmar R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa4374; Watari Kenji, 2014, J Mol Signal, V9, P1, DOI 10.1186/1750-2187-9-1; Westergaard N, 1999, ARCH BIOCHEM BIOPHYS, V366, P55, DOI 10.1006/abbi.1999.1181; Yi HQ, 2012, DIS MODEL MECH, V5, P804, DOI 10.1242/dmm.009712; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang L, 2015, J PHARMACOKINET PHAR, V42, P541, DOI 10.1007/s10928-015-9445-x; Zhu L, 2017, J CLIN INVEST, V127, P2941, DOI 10.1172/JCI92913	51	3	4	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					399	409		10.1096/fj.201901444R	http://dx.doi.org/10.1096/fj.201901444R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914606	Green Accepted, Green Published			2022-12-28	WOS:000507308900028
J	Huo, W; Li, HY; Zhang, Y; Li, H				Huo, Wei; Li, Hongyan; Zhang, Yun; Li, Hai			Epigenetic silencing of microRNA-874-3p implicates in erectile dysfunction in diabetic rats by activating the Nupr1/Chop-mediated pathway	FASEB JOURNAL			English	Article						Chop; diabetic erectile dysfunction; microRNA-874-3p; Nupr1	TRANSCRIPTION FACTORS; GLUCOSE-INTOLERANCE; DOWN-REGULATION; APOPTOSIS; MELLITUS; CELLS; NUPR1; PATHOGENESIS; METHYLATION; AUTOPHAGY	Diabetes is a global medical problem that causes many deaths every year. Complications caused by diabetes are serious and affect patients' quality of life. Diabetes mellitus erectile dysfunction (DMED) affects more than half of male diabetes patients. In this study, we determined the role of microRNA-874-3p (miR-874-3p) and nuclear protein-1 (Nupr1) in streptozocin-induced DMED rats. Control rats received equal amount of vehicle. These rats were also injected with lentiviral vector or agomir to silence or overexpress miR-874-3p or Nupr1. Apomorphine (100 mu g/kg, s.c.) was used to induce erection and time of erection was recorded. Intracavernosal and mean arterial pressure ratio (ICP/MAP) were also recorded. O2- level and concentration of thiobarbituric acid reactive substances (TBARs) were detected using lucigenin-derived chemiluminescence method and Colorimetry. Rat cavernosum tissues were collected for subsequent experiments. Cavernosum smooth muscle cells (CSMCs) were also used for in vitro experiments. Nupr1 was found highly expressed (by RT-qPCR and Western blot analysis) in cavernosum tissues from DMED rats. Nupr1 silencing improved the ICP/MAP ratio and erection time. Nupr1 silencing also reduced CSMC apoptosis (by TUNEL assay) as well as decreased O2- level and TBAR concentration. Nupr1 was targeted and inhibited by miR-874-3p (by luciferase activity and RNA immunoprecipitation assays), which was downregulated in DMED. miR-874-3p downregulation was due to increased methylation at the promoter region (methylation-specific PCR). miR-874-3p overexpression improved erection time and reduced apoptosis. In summary, miR-874-3p was downregulated which led to increased apoptosis and erectile dysfunction in DMED rats, through inhibition of Nupr1-mediated pathway. This study may also provide a new therapeutic direction for the treatment of DMED.	[Huo, Wei; Li, Hongyan; Zhang, Yun; Li, Hai] Jilin Univ, China Japan Union Hosp, Dept Urol, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China	Jilin University	Li, H (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Urol, 126 Xiantai St, Changchun 130033, Jilin, Peoples R China.	lihai@jlu.edu.cn						Aambo A, 2017, TIDSSKR NOR LAEGEFOR, V137; Al-awar A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9051426; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Baer C, 2013, CANCER RES, V73, P473, DOI 10.1158/0008-5472.CAN-12-3731; Barbosa-Sampaio HC, 2015, BBA-MOL BASIS DIS, V1852, P962, DOI 10.1016/j.bbadis.2015.01.013; Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x; Cai D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.67; Di Martino MT, 2015, ONCOTARGET, V6, P19132, DOI 10.18632/oncotarget.4302; Ding Y, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4080364; Gallo CBM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106409; Gandhi J, 2017, CURR DIABETES REV, V13, P573, DOI 10.2174/1573399813666161122124017; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Han Y, 2014, AM J CHINESE MED, V42, P1169, DOI 10.1142/S0192415X14500736; Hatzimouratidis K, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0545-6; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hill Michael D, 2014, Handb Clin Neurol, V126, P167, DOI 10.1016/B978-0-444-53480-4.00012-6; Hollern DP, 2014, MOL CELL BIOL, V34, P3229, DOI 10.1128/MCB.00737-14; Hu YG, 2017, ONCOTARGET, V8, P77219, DOI 10.18632/oncotarget.20431; Hu YY, 2017, ONCOTARGET, V8, P94554, DOI 10.18632/oncotarget.21791; Huang SY, 2015, AUTOPHAGY, V11, P2172, DOI 10.1080/15548627.2015.1106663; Jiang YZ, 2015, ARTERIOSCL THROM VAS, V35, P1317, DOI 10.1161/ATVBAHA.115.303427; Kamenov ZA, 2015, EXP CLIN ENDOCR DIAB, V123, P141, DOI 10.1055/s-0034-1394383; Kara M, 2014, MOL BIOL REP, V41, P8093, DOI 10.1007/s11033-014-3707-3; Kouidrat Y, 2017, DIABETIC MED, V34, P1185, DOI 10.1111/dme.13403; La Sala L, 2018, ACTA DIABETOL, V55, P989, DOI 10.1007/s00592-018-1149-4; LaPierre MP, 2017, MOL METAB, V6, P1010, DOI 10.1016/j.molmet.2017.06.020; Li DS, 2017, BIOMED PHARMACOTHER, V92, P888, DOI 10.1016/j.biopha.2017.05.071; Li YM, 2014, ACTA BIOCH BIOPH SIN, V46, P629, DOI 10.1093/abbs/gmu048; Li YY, 2012, BIO-MED MATER ENG, V22, P97, DOI 10.3233/BME-2012-0694; Ma JP, 2017, CLINICS, V72, P111, DOI 10.6061/clinics/2017(02)08; Maric-Bilkan C, 2017, CLIN SCI, V131, P833, DOI 10.1042/CS20160998; Marongiu F, 2011, HEPATOLOGY, V53, P1719, DOI 10.1002/hep.24255; Miao CG, 2018, CAN J PHYSIOL PHARM, V96, P103, DOI 10.1139/cjpp-2017-0452; Narzt MS, 2019, REDOX BIOL, V20, P467, DOI 10.1016/j.redox.2018.11.006; Pan F, 2016, MOL GENET GENOMICS, V291, P2215, DOI 10.1007/s00438-016-1250-8; Passaglia P, 2015, VASC PHARMACOL, V74, P49, DOI 10.1016/j.vph.2015.04.002; Patel DP, 2017, SEX MED REV, V5, P288, DOI 10.1016/j.sxmr.2017.04.003; Petersen KH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207867; Sebastiani G, 2017, J ENDOCRINOL INVEST, V40, P591, DOI 10.1007/s40618-017-0611-4; Shi Y, 2017, J DIABETES, V9, P434, DOI 10.1111/1753-0407.12521; Strycharz J, 2018, CURR MED CHEM, V25, P1002, DOI 10.2174/0929867324666171107103114; Sun ZW, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0178-y; Tao ZQ, 2015, CELL BIOCHEM BIOPHYS, V73, P181, DOI 10.1007/s12013-015-0598-4; Wang SM, 2017, EPIGENETICS-US, V12, P187, DOI 10.1080/15592294.2016.1273308; Wen Y, 2019, J CELL MOL MED, V23, P3257, DOI 10.1111/jcmm.14212; Xu X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00203; Yan YY, 2017, BIOMARK MED, V11, P761, DOI 10.2217/bmm-2017-0144; Zhang JJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/595742; Zhang Y, 2018, CELL PHYSIOL BIOCHEM, V48, P348, DOI 10.1159/000491741; Zhang Y, 2018, CELL PHYSIOL BIOCHEM, V45, P419, DOI 10.1159/000486919; Zhao J, 2018, EXP NEUROL, V302, P22, DOI 10.1016/j.expneurol.2017.12.015; Zhu SB, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12416	52	9	10	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1695	1709		10.1096/fj.201902086R	http://dx.doi.org/10.1096/fj.201902086R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914690	Bronze			2022-12-28	WOS:000507308900112
J	Pierre, WC; Legault, LM; Londono, I; McGraw, S; Lodygensky, GA				Pierre, Wyston C.; Legault, Lisa-Marie; Londono, Irene; McGraw, Serge; Lodygensky, Gregory A.			Alteration of the brain methylation landscape following postnatal inflammatory injury in rat pups	FASEB JOURNAL			English	Article						DNA methylation; epigenetics; lipopolysaccharide; periventricular leukomalacia	WHITE-MATTER INJURY; DNA METHYLATION; NEONATAL EXPOSURE; DEVELOPMENTAL ORIGINS; EPIGENETIC REGULATION; HIPPOCAMPAL INJURY; MEMORY IMPAIRMENT; PRETERM BIRTH; LIPOPOLYSACCHARIDE; ALPHA	Preterm infants are vulnerable to inflammation-induced white matter injury (WMI), which is associated with neurocognitive impairment and increased risk of neuropsychiatric diseases in adulthood. Epigenetic mechanisms, particularly DNA methylation, play a role in normal development and modulate the response to pathological challenges. Our aims were to determine how WMI triggered DNA methylation alterations in brains of neonatal rats and if such changes persisted over time. We used a robust model of WMI by injecting lipopolysaccharide (LPS) or sterile saline in the corpus callosum of 3-day-old (P3) rat pups. Brains were collected 24 hours (P4) and 21 days post-injection (P24). We extracted genomic DNA from the brain to establish genome-wide quantitative DNA methylation profiles using reduced representation bisulfite sequencing. Neonatal LPS exposure induced a persistent increased methylation of genes related to nervous system development and a reduced methylation of genes associated with inflammatory pathways. These findings suggest that early-life neuroinflammatory exposure impacts the cerebral methylation landscape with determining widespread epigenetic modifications especially in genes related to neurodevelopment.	[Pierre, Wyston C.; Londono, Irene; Lodygensky, Gregory A.] Univ Montreal, CHU St Justine, Res Ctr, Dept Pediat, Montreal, PQ, Canada; [Legault, Lisa-Marie; McGraw, Serge] Univ Montreal, CHU St Justine, Res Ctr, Dept Biochem & Mol Med, Montreal, PQ, Canada; [McGraw, Serge] Univ Montreal, CHU St Justine, Res Ctr, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Lodygensky, Gregory A.] Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Lodygensky, GA (corresponding author), St Justine Hosp & Res Ctr, NICU, Dept Pediat, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	ga.lodygensky@umontreal.ca	McGraw, Serge/AAN-4478-2020	McGraw, Serge/0000-0002-3504-8253; Pierre, Wyston Chadwick/0000-0002-5529-6983	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) [136908]; Centre de recherche du CHU Sainte-Justine (CHU Sainte-Justine Research Center); Fonds de Recherche du Quebec -Sante (FRQS); Institute of Human Development, Child and Youth Health	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Centre de recherche du CHU Sainte-Justine (CHU Sainte-Justine Research Center); Fonds de Recherche du Quebec -Sante (FRQS); Institute of Human Development, Child and Youth Health(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: 136908; Centre de recherche du CHU Sainte-Justine (CHU Sainte-Justine Research Center); Fonds de Recherche du Quebec -Sante (FRQS); Institute of Human Development, Child and Youth Health; Health Research	Akakpo L, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3793; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Allswede DM, 2016, SCHIZOPHR RES, V172, P41, DOI 10.1016/j.schres.2016.02.022; Back SA, 2014, GLIA, V62, P1790, DOI 10.1002/glia.22658; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Braun PR, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0376-y; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Ciccarone F, 2018, MECH AGEING DEV, V174, P3, DOI 10.1016/j.mad.2017.12.002; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Cruickshank MN, 2013, GENOME MED, V5, DOI 10.1186/gm500; Debnath M, 2015, NEUROSCI BIOBEHAV R, V49, P90, DOI 10.1016/j.neubiorev.2014.12.003; Degos V, 2013, ANN NEUROL, V73, P667, DOI 10.1002/ana.23868; Doherty TS, 2016, BEHAV BRAIN RES, V298, P55, DOI 10.1016/j.bbr.2015.05.028; Duke CG, 2017, LEARN MEMORY, V24, P278, DOI 10.1101/lm.045112.117; Everson TM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42654-4; Fan LW, 2008, EUR J NEUROSCI, V27, P1475, DOI 10.1111/j.1460-9568.2008.06121.x; Fan LW, 2011, BRAIN BEHAV IMMUN, V25, P286, DOI 10.1016/j.bbi.2010.09.020; Fan LW, 2009, EXP NEUROL, V220, P143, DOI 10.1016/j.expneurol.2009.08.003; Field AE, 2018, MOL CELL, V71, P882, DOI 10.1016/j.molcel.2018.08.008; Frost PS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1529-x; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Grova N, 2019, INT J GENOMICS, V2019, DOI 10.1155/2019/2085496; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guevara E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00358; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Halder R, 2016, NAT NEUROSCI, V19, P102, DOI 10.1038/nn.4194; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Heinonen K, 2015, PEDIATRICS, V135, pE818, DOI 10.1542/peds.2014-3556; Hodgson K, 2017, J NEUROSCI, V37, P4735, DOI 10.1523/JNEUROSCI.0177-17.2017; Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Ianov L, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00249; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Karlsson L, 2019, J ENDOCR SOC, V3, P250, DOI 10.1210/js.2018-00377; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kim-Ha J, 2016, BMB REP, V49, P671, DOI 10.5483/BMBRep.2016.49.12.184; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Lardenoije R, 2015, PROG NEUROBIOL, V131, P21, DOI 10.1016/j.pneurobio.2015.05.002; Leenen FAD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0256-8; Legault LM, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3171; Levine ME, 2015, AGING-US, V7, P1198, DOI 10.18632/aging.100864; Lister R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00252; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lodygensky GA, 2010, BRAIN BEHAV IMMUN, V24, P759, DOI 10.1016/j.bbi.2009.11.005; Lodygensky GA, 2005, PEDIATRICS, V116, P1, DOI 10.1542/peds.2004-1275; Lodygensky GA, 2014, PEDIATR RES, V75, P415, DOI 10.1038/pr.2013.242; Lussier AA, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00610; Magnus N, 2014, P NATL ACAD SCI USA, V111, P3544, DOI 10.1073/pnas.1314118111; McCoy CR, 2016, EUR J NEUROSCI, V44, P2829, DOI 10.1111/ejn.13404; McGraw S, 2015, NUCLEIC ACIDS RES, V43, P1485, DOI 10.1093/nar/gku1386; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Monson BB, 2016, JAMA PEDIATR, V170, P772, DOI 10.1001/jamapediatrics.2016.0781; Mottahedin A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00190; Neal M, 2018, BBA-MOL BASIS DIS, V1864, P432, DOI 10.1016/j.bbadis.2017.11.004; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Pierre WC, 2017, BRAIN BEHAV IMMUN, V59, P333, DOI 10.1016/j.bbi.2016.08.018; Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423; Rahimi S, 2019, HUM REPROD, V34, P851, DOI 10.1093/humrep/dez036; Ramachandra R., 2011, ATLAS NEONATAL RAT B; Rauscher GH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1777-9; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schlesinger F, 2013, GENOME RES, V23, P1601, DOI 10.1101/gr.157271.113; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shinozaki G, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00311; Smith AK, 2015, AM J MED GENET B, V168, P36, DOI 10.1002/ajmg.b.32278; Smith ZD, 2017, NATURE, V549, P543, DOI 10.1038/nature23891; Sparrow S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.210; Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8; Tan QH, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0518-8; Tartaglione AM, 2016, CURR TOP BEHAV NEURO, V29, P231, DOI 10.1007/7854_2015_416; Thompson DK, 2014, HUM BRAIN MAPP, V35, P4129, DOI 10.1002/hbm.22464; Thornton C, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/506320; Tien LT, 2013, TOXICOLOGY, V308, P96, DOI 10.1016/j.tox.2013.03.014; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; van Vliet EOG, 2013, JAMA PEDIATR, V167, P662, DOI 10.1001/jamapediatrics.2013.1199; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wang KC, 2013, NEUROSCIENCE, V234, P146, DOI 10.1016/j.neuroscience.2012.12.049; Weng YL, 2016, EPIGENOMICS-UK, V8, P1429, DOI 10.2217/epi-2016-0058; Whidden L, 2016, HUM MOL GENET, V25, P4649, DOI 10.1093/hmg/ddw293; Williamson LL, 2011, J NEUROSCI, V31, P15511, DOI 10.1523/JNEUROSCI.3688-11.2011; Wischhof L, 2015, PROG NEURO-PSYCHOPH, V57, P17, DOI 10.1016/j.pnpbp.2014.10.004; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xu XG, 2015, ONCOTARGET, V6, P13925, DOI 10.18632/oncotarget.4215; Yin P, 2013, EPILEPSY BEHAV, V27, P9, DOI 10.1016/j.yebeh.2012.12.015; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	94	10	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					432	445		10.1096/fj.201901461R	http://dx.doi.org/10.1096/fj.201901461R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914673	Green Published, hybrid			2022-12-28	WOS:000507308900030
J	Wang, K; Xu, FH; Campbell, SP; Hart, KD; Durham, T; Maylie, J; Xu, J				Wang, Kang; Xu, Fuhua; Campbell, Shawn P.; Hart, Kyle D.; Durham, Tyler; Maylie, James; Xu, Jing			Rapid actions of anti-Mullerian hormone in regulating synaptic transmission and long-term synaptic plasticity in the hippocampus	FASEB JOURNAL			English	Article						anti-Mullerian hormone receptor 2; cognitive development; cognitive function; electrophysiological recording; postsynaptic modulation	INHIBITING SUBSTANCE; POTENTIATION; EXCITABILITY; CONTRIBUTES; EXPRESSION; RECEPTORS; MECHANISM; DELIVERY; BRAIN; CA2+	Anti-Mullerian hormone (Amh) is a peptide factor that is known to regulate sexual differentiation and gonadal function in mammals. Although Amh is also suggested to be associated with cognitive development and function in the postnatal brain, little is known about its expression or direct effects on neuronal activities in the hippocampus. Therefore, we assessed Amh and its receptor expression in the hippocampus of male and female mice using PCR, Western blot, and immunofluorescence staining. While Amh-specific receptor expression was comparable between males and females, mRNA and protein levels of Amh were higher in females than those of males. Electrophysiological recordings on acute hippocampal slices showed that exogenous Amh protein addition increased synaptic transmission and long-term synaptic plasticity at the Cornu Ammonis (CA) 3-CA1 synapses. Amh exposure also increased the excitatory postsynaptic potential at CA1 synapses. Our findings support direct and rapid actions of Amh as a paracrine and/or autocrine factor in regulating hippocampal neuronal activities. Data provide functional evidence of Amh-mediated postsynaptic modulation of synaptic transmission and Amh-regulated long-term synaptic plasticity in the hippocampus. These results suggest a potential role of Amh in learning and memory, and a possible cause of the sex differences in cognitive development and function.	[Wang, Kang; Xu, Fuhua; Campbell, Shawn P.; Hart, Kyle D.; Maylie, James; Xu, Jing] Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Durham, Tyler; Xu, Jing] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Maylie, J (corresponding author), Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Xu, J (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mayliej@ohsu.edu; xujin@ohsu.edu	Wang, Kang/AAE-1168-2019; Jing, Xu/AAF-2502-2020	Wang, Kang/0000-0002-4563-7385; Xu, Jing/0000-0003-1116-6631	HHS | National Institutes of Health (NIH) [P51OD011092, R01HD082208]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: P51OD011092 and R01HD082208	Bedussi B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00861-x; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Cabrera-Socorro A, 2006, EUR J NEUROSCI, V23, P2109, DOI 10.1111/j.1460-9568.2006.04750.x; Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cimino I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10055; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; di Clemente N, 2003, MOL CELL ENDOCRINOL, V211, P9, DOI 10.1016/j.mce.2003.09.005; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Harden CL, 2016, EPILEPSY RES, V127, P66, DOI 10.1016/j.eplepsyres.2016.08.003; Hayata T, 2018, GENES CELLS, V23, P345, DOI 10.1111/gtc.12575; Josso N, 1998, MOL CELL ENDOCRINOL, V145, P3, DOI 10.1016/S0303-7207(98)00186-5; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Lebeurrier N, 2008, J CELL SCI, V121, P3357, DOI 10.1242/jcs.031872; Lee MM, 1996, J CLIN ENDOCR METAB, V81, P571, DOI 10.1210/jc.81.2.571; Lim NKH, 2018, JOVE-J VIS EXP, DOI 10.3791/56774; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lopez-Ramos JC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.005; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Morgan K, 2017, ENDOCRINE, V57, P528, DOI 10.1007/s12020-017-1333-2; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; Nelson SM, 2018, FERTIL STERIL, V110, pE106, DOI 10.1016/j.fertnstert.2018.07.321; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Pankhurst MW, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.72; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Renner MC, 2017, ELIFE, V6, DOI 10.7554/eLife.25462; Sweatt JD, 2004, PSYCHOPHARMACOLOGY, V174, P99, DOI 10.1007/s00213-004-1795-9; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835, DOI 10.1152/ajprenal.1984.246.6.F835; Tata B, 2018, NAT MED, V24, P834, DOI 10.1038/s41591-018-0035-5; Wang K, 2014, NEURON, V81, P379, DOI 10.1016/j.neuron.2013.11.004; Wang PY, 2009, P NATL ACAD SCI USA, V106, P7203, DOI 10.1073/pnas.0902253106; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xu J, 2005, MOL HUM REPROD, V11, P151, DOI 10.1093/molehr/gah157; Xu J, 2016, J ASSIST REPROD GEN, V33, P1665, DOI 10.1007/s10815-016-0804-3; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	38	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					706	719		10.1096/fj.201902217R	http://dx.doi.org/10.1096/fj.201902217R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914642	Green Accepted			2022-12-28	WOS:000507308900049
J	Jeon, SA; Kim, DW; Cho, JY				Jeon, Seon-Ae; Kim, Dong Wook; Cho, Je-Yoel			Neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) regulates hydrogen peroxide-induced cell proliferation and death through inhibition of Hippo signaling	FASEB JOURNAL			English	Article						hBMSCs; H2O2; NF-kappa B; YAP	KAPPA-B ACTIVATION; E3 LIGASE NEDD4-1; UP-REGULATION; YAP PATHWAY; PROTEIN; YAP/TAZ; DEGRADATION; HOMEOSTASIS; INDUCTION; APOPTOSIS	E3 ubiquitin ligases are involved in the regulation of oxidative stress-induced cell death. In this study, we investigated the role of neural precursor cell-expressed, developmentally down-regulated protein 4 (NEDD4) in regulation of hydrogen peroxide (H2O2)-induced cell proliferation and apoptosis in human bone marrow-derived stem cells (hBMSCs). Cell proliferation was increased in low doses of H2O2 (10(-4) to 10(-2) mu M), whereas sublethal concentrations of H2O2 (>200 mu M) induced apoptosis. A chromatin immunoprecipitation assay identified that recruitment of NF-kappa B onto the promoter region of NEDD4 mediated H2O2-induced NEDD4 expression. The increase of NEDD4 expression by H2O2 induced translocation of yes-associated protein (YAP) into the nucleus by decreasing the stability of large tumor suppressor kinase (LATS). Thus, the phosphorylation of serine 127 residue of YAP by LATS upstream kinase is decreased and thereby increased the transcriptional activity of YAP. The mRNA expression levels of catalase and manganese superoxide dismutase, which are well-known targets of YAP, were increased by H2O2 treatment but down-regulated by NEDD4 silencing using a specific small interfering RNA targeting NEDD4 (siNEDD4). H2O2-induced scavenging capacity of reactive oxygen species was also decreased by siNEDD4 in hBMSCs. Finally, hBMSC differentiation into osteoblast was decreased by siNEDD4 but reverted by reintroduction of the S127A mutant construction of YAP. Taken together, these results indicate that NEDD4 regulates H2O2-induced alteration of cell status through regulation of the Hippo signaling pathway.	[Jeon, Seon-Ae; Kim, Dong Wook; Cho, Je-Yoel] Seoul Natl Univ, Dept Vet Biochem, Sch Vet Med, BK21 Plus & Res Inst Vet Sci, Seoul, South Korea	Seoul National University (SNU)	Cho, JY (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Vet Biochem, 1 Gwanak Ro, Seoul 08826, South Korea.	jeycho@snu.ac.kr			National Research Foundation of Korea (NRF); Bio and Medical Technology Development Program - Ministry of Science, Information and Communications Technology (ICT), and Future Planning [2014M3A9D5A01073598, 2016M3A9B6026771]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Bio and Medical Technology Development Program - Ministry of Science, Information and Communications Technology (ICT), and Future Planning	The authors thank Dr. Jho's laboratory (Department of Life Science, University of Seoul, Seoul, South Korea) for the plasmid containing YAP and green fluorescent protein and Johannes Josephus Schabort (Department of Veterinary Biochemistry, Seoul National University) for English proofreading of the manuscript of this study. This research was supported by grants from the National Research Foundation of Korea (NRF) and the Bio and Medical Technology Development Program funded by the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (2014M3A9D5A01073598 and 2016M3A9B6026771). The authors declare no conflicts of interest.	Antunes F, 2017, REDOX BIOL, V13, P1, DOI 10.1016/j.redox.2017.04.039; Atashi F, 2015, STEM CELLS DEV, V24, P1150, DOI 10.1089/scd.2014.0484; Bae SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7314; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Choi JJ, 2007, FREE RADICAL RES, V41, P555, DOI 10.1080/10715760601173010; Cyrne L, 2013, METHOD ENZYMOL, V528, P173, DOI 10.1016/B978-0-12-405881-1.00010-0; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; Dupont S, 2016, EXP CELL RES, V343, P42, DOI 10.1016/j.yexcr.2015.10.034; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Harvey KF, 1998, J BIOL CHEM, V273, P13524, DOI 10.1074/jbc.273.22.13524; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hong SW, 2014, CELL DEATH DIFFER, V21, P146, DOI 10.1038/cdd.2013.141; Hsia Hung-En, 2015, Commun Integr Biol, V8, pe1017161, DOI 10.1080/19420889.2015.1017161; Jeon SA, 2018, BONE, V116, P248, DOI 10.1016/j.bone.2018.08.012; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Jung S, 2013, INT J ONCOL, V43, P1587, DOI 10.3892/ijo.2013.2064; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Lee D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0562-5; Lee EH, 2011, J CELL PHYSIOL, V226, P1676, DOI 10.1002/jcp.22498; Lee JH, 2010, BONE, V46, P1522, DOI 10.1016/j.bone.2010.02.013; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Liu J, 2014, ONCOTARGET, V5, P1026, DOI 10.18632/oncotarget.1675; Mao BB, 2015, ACTA BIOCH BIOPH SIN, V47, P2, DOI 10.1093/abbs/gmu109; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Pan JX, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0018-7; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Polytarchou C, 2005, J BIOL CHEM, V280, P40428, DOI 10.1074/jbc.M505120200; Salah Z, 2013, CELL CYCLE, V12, P3817, DOI 10.4161/cc.26672; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; Su JN, 2017, BIOCHEM PHARMACOL, V140, P28, DOI 10.1016/j.bcp.2017.05.014; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weng M, 2017, ONCOTARGET, V8, P20288, DOI 10.18632/oncotarget.15446; Xiong JH, 2018, BONE, V112, P1, DOI 10.1016/j.bone.2018.04.001; Xu C, 2015, ONCOGENE, V34, P342, DOI 10.1038/onc.2013.557; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Ye XT, 2014, CURR CANCER DRUG TAR, V14, P549, DOI 10.2174/1568009614666140725092430; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhou XX, 2011, J PHARMACOL EXP THER, V339, P218, DOI 10.1124/jpet.111.182352; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006	53	6	7	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14772	14783		10.1096/fj.201901404R	http://dx.doi.org/10.1096/fj.201901404R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690112	Bronze			2022-12-28	WOS:000507466100131
J	Tsai, CK; Huang, LC; Wu, YP; Kan, IY; Hueng, DY				Tsai, Chia-Kuang; Huang, Li-Chun; Wu, Yi-Ping; Kan, I-Ying; Hueng, Dueng-Yuan			SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down-regulation of MGMT	FASEB JOURNAL			English	Article						S-nitroso-N-acetylpenicillamine; NDRG1; apoptosis; HIF-1	NITRIC-OXIDE SYNTHASE; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; TUMOR-CELLS; POSTTRANSLATIONAL MODIFICATION; GENE-EXPRESSION; CANCER CELLS; P53; TRANSCRIPTION; PROMOTER; ACTIVATION	Glioblastoma multiforme (GBM) is the most frequently occurring and gravest primary tumor of the CNS in adults. The development of chemoresistance to temozolomide (TMZ), the first-line chemotherapy for GBM, is an important factor contributing to poor treatment outcomes. Down-regulation of O-6-methylguanine-DNA methyltransferase (MGMT) expression in GBM cells is an attractive strategy for overcoming TMZ resistance and improving outcomes. This study revealed that the nitric oxide (NO) donor S-nitroso-N-acetylpenicillamine (SNAP) exerts antitumorigenic effects on TMZ-sensitive and TMZ-resistant (TMZ-R) glioma cells. Pretreatment with SNAP not only induced apoptosis, mitochondrial dysfunction, and hypoxia-inducing factor 1, but also resensitized TMZ-R GBM cells to TMZ through down-regulation of MGMT expression. SNAP acted principally through posttranslational modification of p53, phosphorylated N-myc downstream regulated gene 1, and MGMT protein stability in TMZ-R GBM cells. Additionally, when applied together, SNAP and TMZ enhanced the inhibition of tumor growth in vitro and in vivo. This study sheds new light on a potential strategy to overcome TMZ resistance in GBM and thus possesses the potential for prolonging survival of patients with GBM.	[Tsai, Chia-Kuang] Triserv Gen Hosp, Dept Neurol, Taipei, Taiwan; [Huang, Li-Chun; Wu, Yi-Ping; Kan, I-Ying; Hueng, Dueng-Yuan] Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Hueng, Dueng-Yuan] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Hueng, Dueng-Yuan] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Hueng, Dueng-Yuan] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan	Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Hueng, DY (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, 325,Sec 2,Cheng Kung Rd, Taipei, Taiwan.	hondy2195@yahoo.com.tw	Tsai, Chia-Kuang/AAR-8144-2021; Hueng, Dueng-Yuan/AAM-7807-2021	Hueng, Dueng-Yuan/0000-0001-7868-3161; Tsai, Chia-Kuang/0000-0001-7693-1408	Ministry of Science and Technology [MOST 106-2314-B-016-012-MY3]; Tri-Service General Hospital [TSGH-2-C107-106-2314-B-016-012-MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tri-Service General Hospital	This work was supported, in part, by grants from the Ministry of Science and Technology (MOST 106-2314-B-016-012-MY3 to D.-Y.H.) and Tri-Service General Hospital (TSGH-2-C107-106-2314-B-016-012-MY3 to D.-Y.H). The authors declare no conflicts of interest.	Aranda E, 2012, CURR MOL MED, V12, P50, DOI 10.2174/156652412798376099; Binabaj MM, 2018, J CELL PHYSIOL, V233, P378, DOI 10.1002/jcp.25896; Bobustuc GC, 2010, NEURO-ONCOLOGY, V12, P917, DOI 10.1093/neuonc/noq044; Bocangel D, 2009, ANTICANCER RES, V29, P3741; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Brune B, 2003, TOXICOL LETT, V139, P119, DOI 10.1016/S0378-4274(02)00426-5; Cabrini G, 2015, INT J ONCOL, V47, P417, DOI 10.3892/ijo.2015.3026; Chang K, 2004, EXP MOL MED, V36, P311, DOI 10.1038/emm.2004.42; Chao JI, 2004, J BIOL CHEM, V279, P20267, DOI 10.1074/jbc.M312381200; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Ekmekcioglu S, 2006, INT J CANCER, V119, P861, DOI 10.1002/ijc.21767; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Garban HJ, 2001, J IMMUNOL, V167, P75, DOI 10.4049/jimmunol.167.1.75; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hara E, 1996, BIOCHEM BIOPH RES CO, V224, P153, DOI 10.1006/bbrc.1996.0999; HARRIS LC, 1991, NUCLEIC ACIDS RES, V19, P6163, DOI 10.1093/nar/19.22.6163; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hendrickson MD, 2015, RES REP BIOCHEM, V5, P147, DOI 10.2147/RRBC.S58280; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Huang SM, 2001, ONCOGENE, V20, P2134, DOI 10.1038/sj.onc.1204298; Jahani-Asl A, 2013, CURR MOL MED, V13, P1241, DOI 10.2174/1566524011313080002; Janssens MY, 1999, BRIT J CANCER, V79, P1085, DOI 10.1038/sj.bjc.6690173; Kang KB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-66; Kim RK, 2013, CANCER SCI, V104, P1172, DOI 10.1111/cas.12207; Kitagaki J, 2009, ONCOGENE, V28, P619, DOI 10.1038/onc.2008.401; Kitamura Y, 1998, NEUROCHEM INT, V32, P93, DOI 10.1016/S0197-0186(97)00029-6; Leung EL, 2008, BRIT J CANCER, V98, P1803, DOI 10.1038/sj.bjc.6604375; Loibl S, 2005, EUR J CANCER, V41, P265, DOI 10.1016/j.ejca.2004.07.010; Matsumoto H, 2007, CANCER RES, V67, P8574, DOI 10.1158/0008-5472.CAN-07-1913; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; MONCADA S, 1991, PHARMACOL REV, V43, P109; Natsume A, 2008, CANCER CHEMOTH PHARM, V61, P653, DOI 10.1007/s00280-007-0520-x; Ookawa S, 2018, WORLD NEUROSURG, V111, pE783, DOI 10.1016/j.wneu.2017.12.166; Riganti C, 2005, CANCER RES, V65, P516; Rizi BS, 2017, TRENDS CANCER, V3, P659, DOI 10.1016/j.trecan.2017.07.005; Schneiderhan N, 2003, ONCOGENE, V22, P2857, DOI 10.1038/sj.onc.1206431; Singh S, 2011, CANCER CHEMOTH PHARM, V67, P1211, DOI 10.1007/s00280-011-1654-4; Srivenugopal KS, 2001, CLIN CANCER RES, V7, P1398; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Su L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7287; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tsai Chia-Kuang, 2018, Oncotarget, V9, P15705, DOI 10.18632/oncotarget.24594; VAN MEIR EG, 1994, CANCER RES, V54, P649; Vieira H, 2003, IUBMB LIFE, V55, P613, DOI 10.1080/15216540310001639652; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Weiler M, 2014, P NATL ACAD SCI USA, V111, P409, DOI 10.1073/pnas.1314469111; Xu S, 2013, NEURO-ONCOLOGY, V15, P1160, DOI 10.1093/neuonc/not067	50	14	14	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14171	14184		10.1096/fj.201901021RR	http://dx.doi.org/10.1096/fj.201901021RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31725331	Bronze			2022-12-28	WOS:000507466100086
J	Cheung, K; Barter, MJ; Falk, J; Proctor, CJ; Reynard, LN; Young, DA				Cheung, Kathleen; Barter, Matthew J.; Falk, Julia; Proctor, Carole J.; Reynard, Louise N.; Young, David A.			Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity	FASEB JOURNAL			English	Article						cartilage; chondrocyte development; chromatin	IN-VITRO CHONDROGENESIS; MARROW STEM-CELLS; DNA METHYLATION; TRANSCRIPTION FACTORS; CHONDROCYTE HYPERTROPHY; GENOME-WIDE; FUNCTIONAL-CHARACTERIZATION; ARTICULAR CHONDROCYTES; EPIGENETIC REGULATION; GENE-REGULATION	Epigenetic mechanisms are known to regulate gene expression during chondrogenesis. In this study, we have characterized the epigenome during the in vitro differentiation of human mesenchymal stem cells (hMSCs) into chondrocytes. Chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) was used to assess a range of N-terminal posttranscriptional modifications (marks) to histone H3 lysines (H3K4me3, H3K4me1, H3K27ac, H3K27me3, and H3K36me3) in both hMSCs and differentiated chondrocytes. Chromatin states were characterized using histone ChIP-seq and cis-regulatory elements were identified in chondrocytes. Chondrocyte enhancers were associated with chondrogenesis-related gene ontology (GO) terms. In silico analysis and integration of DNA methylation data with chondrogenesis chromatin states revealed that enhancers marked by histone marks H3K4me1 and H3K27ac were de-methylated during in vitro chondrogenesis. Similarity analysis between hMSC and chondrocyte chromatin states defined in this study with epigenomes of cell-types defined by the Roadmap Epigenomics project revealed that enhancers are more distinct between cell-types compared to other chromatin states. Motif analysis revealed that the transcription factor SOX9 is enriched in chondrocyte enhancers. Luciferase reporter assays confirmed that chondrocyte enhancers characterized in this study exhibited enhancer activity which may be modulated by DNA methylation and SOX9 overexpression. Altogether, these integrated data illustrate the cross-talk between different epigenetic mechanisms during chondrocyte differentiation.	[Cheung, Kathleen; Barter, Matthew J.; Falk, Julia; Proctor, Carole J.; Reynard, Louise N.; Young, David A.] Newcastle Univ, Inst Med Genet, Skeletal Res Grp, Cent Pkwy, Newcastle Upon Tyne, Tyne & Wear, England; [Cheung, Kathleen] Newcastle Univ, Fac Med Sci, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Cheung, K; Young, DA (corresponding author), Newcastle Univ, Inst Med Genet, Skeletal Res Grp, Cent Pkwy, Newcastle Upon Tyne, Tyne & Wear, England.	kat.cheung@ncl.ac.uk; david.young@ncl.ac.uk	Young, David/GOV-5677-2022	Young, David/0000-0002-7078-6745; Cheung, Kathleen/0000-0002-6449-7517; Reynard, Louise/0000-0002-6613-1797	MRC [MR/P020941/1] Funding Source: UKRI; Arthritis Research UK [19424, 18746] Funding Source: Medline; Medical Research Council [MR/P020941/1] Funding Source: Medline; The Dunhill Medical Trust [R476/0516] Funding Source: Medline; Versus Arthritis [18746, 19424] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Dunhill Medical Trust(Dunhill Medical Trust); Versus Arthritis(Versus Arthritis); Department of Health		Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Alvarez-Garcia O, 2016, ARTHRITIS RHEUMATOL, V68, P1876, DOI 10.1002/art.39643; Baker M, 2011, NAT METHODS, V2011, P89; Barter MJ, 2017, DEVELOPMENT, V144, P4510, DOI 10.1242/dev.152504; Barter MJ, 2015, STEM CELLS, V33, P3266, DOI 10.1002/stem.2093; Barter MJ, 2020, SCI REP, P625954; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bell RE, 2016, GENOME RES, V26, P601, DOI 10.1101/gr.197194.115; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Capellini TD, 2017, NAT GENET, V49, P1202, DOI 10.1038/ng.3911; Cayami FK, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.823; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Cremazy F, 1998, FEBS LETT, V438, P311, DOI 10.1016/S0014-5793(98)01294-0; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Ealy M, 2008, HEARING RES, V240, P80, DOI 10.1016/j.heares.2008.03.001; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Ferguson GB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05573-y; Furumatsu T, 2010, ACTA MED OKAYAMA, V64, P155; Grossman SR, 2018, P NATL ACAD SCI USA, V115, pE7222, DOI 10.1073/pnas.1804663115; Haller R, 2012, CELL DEATH DIFFER, V19, P461, DOI 10.1038/cdd.2011.114; Hata K, 2015, JPN DENT SCI REV, V51, P105, DOI 10.1016/j.jdsr.2015.05.001; He XJ, 2016, DEVELOPMENT, V143, P3012, DOI 10.1242/dev.134502; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Herlofsen SR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-105; Heyn H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0879-2; Hissnauer TN, 2010, OSTEOARTHR CARTILAGE, V18, P1630, DOI 10.1016/j.joca.2010.10.002; Huynh NPT, 2019, FASEB J, V33, P358, DOI 10.1096/fj.201800534R; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; Keller RB, 2018, GENET MED, V20, P411, DOI 10.1038/gim.2017.115; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kokabu S, 2014, FEBS LETT, V588, P614, DOI 10.1016/j.febslet.2013.12.031; Kozhemyakina E, 2015, ARTHRITIS RHEUMATOL, V67, P1261, DOI 10.1002/art.39030; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee WJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8932583; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Li CR, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0039-9; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Li IMH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19186-4; Lian CJ, 2019, BONE RES, V7, DOI 10.1038/s41413-019-0046-y; Liu CF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164459; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Liu Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33779-z; Liu Y, 2017, ENGINEERING-PRC, V3, P28, DOI 10.1016/J.ENG.2017.01.010; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lovkvist C, 2016, NUCLEIC ACIDS RES, V44, P5123, DOI 10.1093/nar/gkw124; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Malfait F, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-78; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Mokuda S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10177-1; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Murdoch AD, 2016, MATRIX BIOL, V50, P16, DOI 10.1016/j.matbio.2015.10.003; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Otero M, 2017, CONNECT TISSUE RES, V58, P15, DOI 10.1080/03008207.2016.1200566; Otero M, 2012, J BIOL CHEM, V287, P3559, DOI 10.1074/jbc.M111.265744; Palstra Robert-Jan, 2012, Frontiers in Genetics, V3, DOI 10.3389/fgene.2012.00195; Pask AJ, 2002, GENESIS, V33, P131, DOI 10.1002/gene.10096; Pasumarthy KK, 2017, STEM CELL REP, V9, P999, DOI 10.1016/j.stemcr.2017.07.018; Petell CJ, 2016, NUCLEIC ACIDS RES, V44, P7605, DOI 10.1093/nar/gkw426; Qu Y, 2017, BLOOD, V129, pE13, DOI [10.1182/blood-2016-07726877, 10.1182/blood-2016-07-726877]; Reynard LN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159024; Rutkowski TP, 2016, J CELL SCI, V129, P2145, DOI 10.1242/jcs.181271; Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663; Sharifi-Zarchi A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4353-7; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shin Y, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4466; Smith EM, 2016, AM J HUM GENET, V98, P185, DOI 10.1016/j.ajhg.2015.12.002; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Tew SR, 2011, OSTEOARTHR CARTILAGE, V19, P1036, DOI 10.1016/j.joca.2011.04.015; Tew SR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2311; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tian Y, 2016, LIFE SCI, V148, P220, DOI 10.1016/j.lfs.2016.02.031; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; Vandel J, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5408-0; Watts AE, 2013, TISSUE ENG PT A, V19, P2275, DOI [10.1089/ten.tea.2012.0479, 10.1089/ten.TEA.2012.0479]; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Whitney GA, 2012, BIORESEARCH OPEN ACC, V1, P157, DOI 10.1089/biores.2012.0231; Wondimu EB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24695-3; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; Yamasaki S, 2014, CARTILAGE, V5, P196, DOI 10.1177/1947603514534681; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yasuda H, 2017, J BIOL CHEM, V292, P528, DOI 10.1074/jbc.M116.758425; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893; Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x; Zhang Y, 2016, OSTEOARTHR CARTILAGE, V24, P835, DOI 10.1016/j.joca.2015.12.013; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	103	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5317	5331		10.1096/fj.201902061RR	http://dx.doi.org/10.1096/fj.201902061RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32058623	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000530242100033
J	Menarim, BC; Gillis, KH; Oliver, A; Mason, C; Werre, SR; Luo, X; Byron, CR; Kalbfleisch, TS; MacLeod, JN; Dahlgren, LA				Menarim, Bruno C.; Gillis, Kiersten H.; Oliver, Andrea; Mason, Caitlin; Werre, Stephen R.; Luo, Xin; Byron, Christopher R.; Kalbfleisch, Theodore S.; MacLeod, James N.; Dahlgren, Linda A.			Inflamed synovial fluid induces a homeostatic response in bone marrow mononuclear cells in vitro: Implications for joint therapy	FASEB JOURNAL			English	Article						cell therapy; homeostasis; joint; macrophage; osteoarthritis	EXPERIMENTALLY-INDUCED ARTHRITIS; PRORESOLVING LIPID MEDIATORS; AUTOLOGOUS CONDITIONED SERUM; MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; MACROPHAGE DEPLETION; ARTICULAR-CARTILAGE; CD14 EXPRESSION	Synovial inflammation is a central feature of osteoarthritis (OA), elicited when local regulatory macrophages (M2-like) become overwhelmed, activating an inflammatory response (M1-like). Bone marrow mononuclear cells (BMNC) are a source of naive macrophages capable of reducing joint inflammation and producing molecules essential for cartilage metabolism. This study investigated the response of BMNC to normal (SF) and inflamed synovial fluid (ISF). Equine BMNC cultured in autologous SF or ISF (n = 8 horses) developed into macrophage-rich cultures with phenotypes similar to cells native to normal SF and became more confluent in ISF (similar to 100%) than SF (similar to 25%). BMNC cultured in SF or ISF were neither M1- nor M2-like, but exhibited aspects of both phenotypes and a regulatory immune response, characterized by increasing counts of IL-10(+) macrophages, decreasing IL-1 beta concentrations and progressively increasing IL-10 and IGF-1 concentrations. Changes were more marked in ISF and suggest that homeostatic mechanisms were preserved over time and were potentially favored by progressive cell proliferation. Collectively, our data suggest that intra-articular BMNC could increase synovial macrophage counts, potentiating the macrophage- and IL-10-associated mechanisms of joint homeostasis lost during the progression of OA, preserving the production of cytokines involved in tissue repair (PGE(2), IL-10) generally impaired by frequently used corticosteroids.	[Menarim, Bruno C.; Gillis, Kiersten H.; Oliver, Andrea; Mason, Caitlin; Byron, Christopher R.; Dahlgren, Linda A.] Virginia Tech, Dept Large Anim Clin Sci, Virginia Maryland Coll Vet Med, 205 Duck Pond Dr, Blacksburg, VA 24061 USA; [Werre, Stephen R.] Virginia Tech, Lab Study Design & Stat Anal, Virginia Maryland Coll Vet Med, Blacksburg, VA 24061 USA; [Luo, Xin] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll Vet Med, Blacksburg, VA 24061 USA; [Kalbfleisch, Theodore S.; MacLeod, James N.] Univ Kentucky, Coll Agr & Vet Sci, Maxwell Gluck Equine Res Ctr, Lexington, KY USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Kentucky	Dahlgren, LA (corresponding author), Virginia Tech, Dept Large Anim Clin Sci, Virginia Maryland Coll Vet Med, 205 Duck Pond Dr, Blacksburg, VA 24061 USA.	lad11@vt.edu	Luo, Xin M/J-6544-2016; Kalbfleisch, Theodore/AAN-5407-2021	Luo, Xin M/0000-0002-2809-5836; Kalbfleisch, Theodore/0000-0002-2370-8189; Menarim, Bruno/0000-0003-1829-4978	Grayson-Jockey Club Research Foundation	Grayson-Jockey Club Research Foundation	Grayson-Jockey Club Research Foundation	Abramson SB, 2004, J RHEUMATOL, V31, P70, DOI 10.1097/BOR.0b013e328349c2b1; Agadi S, 2015, STEM CELLS, V33, P2093, DOI 10.1002/stem.2029; Amin AR, 2014, DNA CELL BIOL, V33, P550, DOI 10.1089/dna.2013.2198; [Anonymous], 2016, BRAZ ARCH BIOL TECHN; Barrera P, 2000, ARTHRITIS RHEUM-US, V43, P1951, DOI 10.1002/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K; Barussi FCM, 2016, RESP PHYSIOL NEUROBI, V232, P35, DOI 10.1016/j.resp.2016.07.002; Baxter GT, 1999, J BIOL CHEM, V274, P9539, DOI 10.1074/jbc.274.14.9539; Behrendt P, 2018, OSTEOARTHR CARTILAGE, V26, P264, DOI 10.1016/j.joca.2017.11.007; Bekkers JEJ, 2013, OSTEOARTHR CARTILAGE, V21, P950, DOI 10.1016/j.joca.2013.03.015; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Bruyere O, 2016, SEMIN ARTHRITIS RHEU, V45, pS3, DOI 10.1016/j.semarthrit.2015.11.010; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Caron JP, 2019, PROSTAG OTH LIPID M, V142, P1, DOI 10.1016/j.prostaglandins.2019.02.007; Chan MWY, 2019, CYTOTHERAPY, V21, P393, DOI 10.1016/j.jcyt.2019.02.002; Chang KV, 2014, ARCH PHYS MED REHAB, V95, P562, DOI 10.1016/j.apmr.2013.11.006; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Cruz FF, 2016, STEM CELL TRANSL MED, V5, P488, DOI 10.5966/sctm.2015-0141; Cuende N, 2012, STEM CELL TRANSL MED, V1, P403, DOI 10.5966/sctm.2011-0064; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; Daniel B, 2018, NUCLEIC ACIDS RES, V46, P4425, DOI 10.1093/nar/gky157; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; de Grauw JC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2640; Elhage R, 2001, ATHEROSCLEROSIS, V156, P315, DOI 10.1016/S0021-9150(00)00682-1; Fahy N, 2014, OSTEOARTHR CARTILAGE, V22, P1167, DOI 10.1016/j.joca.2014.05.021; Feehan KT, 2019, TRENDS MOL MED, V25, P198, DOI 10.1016/j.molmed.2019.01.006; Fendl B, 2019, BIOCHEM BIOPH RES CO, V517, P709, DOI 10.1016/j.bbrc.2019.07.120; Fichadiya A, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0120-9; Filardo G, 2015, Knee Surg Sports Traumatol Arthrosc, V23, P2459, DOI 10.1007/s00167-013-2743-1; Finnegan A, 2012, AUTOIMMUNITY, V45, P353, DOI 10.3109/08916934.2012.665526; Flaminio MJBF, 2007, VET IMMUNOL IMMUNOP, V119, P92, DOI 10.1016/j.vetimm.2007.06.035; Fortier LA, 1999, J ORTHOP RES, V17, P467, DOI 10.1002/jor.1100170403; Freeman SA, 2018, CELL, V172, P305, DOI 10.1016/j.cell.2017.12.023; Frisbie DD, 2007, AM J VET RES, V68, P290, DOI 10.2460/ajvr.68.3.290; Fuster JJ, 2014, EMBO J, V33, P1425, DOI 10.15252/embj.201488856; Giraldi-Guimaraes A, 2012, BRAIN RES, V1452, P173, DOI 10.1016/j.brainres.2012.03.002; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; GOLDRING MB, 1990, ANN NY ACAD SCI, V580, P536, DOI 10.1111/j.1749-6632.1990.tb17983.x; Goncars V, 2019, CARTILAGE, V10, P26, DOI 10.1177/1947603517746721; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Iannone F, 2001, CLIN EXP RHEUMATOL, V19, P139; Ibrahim S, 2007, VET IMMUNOL IMMUNOP, V119, P63, DOI 10.1016/j.vetimm.2007.06.034; Ibrahim S, 2012, VET IMMUNOL IMMUNOP, V145, P7, DOI 10.1016/j.vetimm.2011.07.021; Iijima H, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0041-8; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jain S, 2015, BIOMATERIALS, V61, P162, DOI 10.1016/j.biomaterials.2015.05.028; Jansen NWD, 2008, BRIT J HAEMATOL, V142, P953, DOI 10.1111/j.1365-2141.2008.07278.x; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kabithe E, 2010, VET IMMUNOL IMMUNOP, V138, P149, DOI 10.1016/j.vetimm.2010.07.003; Kadri N, 2007, IMMUNOL LETT, V108, P129, DOI 10.1016/j.imlet.2006.11.007; Kalbfleisch TS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0199-z; Karagianni AE, 2017, EQUINE VET J, V49, P375, DOI 10.1111/evj.12584; Kay AT, 2008, AM J VET RES, V69, P1646, DOI 10.2460/ajvr.69.12.1646; King A, 2014, ADV WOUND CARE, V3, P315, DOI 10.1089/wound.2013.0461; Lasarzik J, 2018, J EQUINE VET SCI, V60, P35, DOI 10.1016/j.jevs.2016.09.014; Laudy ABM, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094036; Leveque M, 2017, FASEB J, V31, P1891, DOI 10.1096/fj.201600772R; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; MALEFYT RD, 1991, J EXP MED, V174, P1209; Manferdini C, 2017, OSTEOARTHR CARTILAGE, V25, P1161, DOI 10.1016/j.joca.2017.01.011; Manferdini C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0983-4; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; McIlwraith CW, 2012, BONE JOINT RES, V1, P297, DOI 10.1302/2046-3758.111.2000132; McIlwraith CW, 2011, CARTILAGE, V2, P317, DOI 10.1177/1947603511406531; MCILWRAITH CW, 1979, AM J VET RES, V40, P11; MCILWRAITH CW, 1981, AM J VET RES, V42, P209; Menarim BC, 2019, FASEB J, V33, P14337, DOI 10.1096/fj.201901684RR; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morin J, 2003, CLIN EXP IMMUNOL, V134, P388, DOI 10.1111/j.1365-2249.2003.02308.x; MORRIS EA, 1994, AM J VET RES, V55, P138; MORRIS EA, 1990, AM J VET RES, V51, P59; Morton AJ, 2005, RES VET SCI, V78, P189, DOI 10.1016/j.rvsc.2004.07.006; Murphy LB, 2018, ARTHRIT CARE RES, V70, P869, DOI 10.1002/acr.23425; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nawaz A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00231-1; Liem NT, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0992-x; Odobasic D, 2008, IMMUNOLOGY, V124, P503, DOI 10.1111/j.1365-2567.2007.02802.x; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Ortved KF, 2012, EQUINE VET J, V44, P606, DOI 10.1111/j.2042-3306.2011.00510.x; PALMER JL, 1994, EQUINE VET J, V26, P492, DOI 10.1111/j.2042-3306.1994.tb04056.x; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Peffers MJ, 2015, OSTEOARTHR CARTILAGE, V23, P1204, DOI 10.1016/j.joca.2015.03.019; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Poulsen RC, 2008, AM J HEMATOL, V83, P437, DOI 10.1002/ajh.21170; Rannou F, 2014, ATLAS OSTEOARTHRITIS, P37; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Riyazi N, 2005, ARTHRITIS RHEUM-US, V52, P1443, DOI 10.1002/art.21014; Ross TN, 2012, OSTEOARTHR CARTILAGE, V20, P1583, DOI 10.1016/j.joca.2012.08.008; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Ryncarz RE, 1998, BLOOD, V91, P3892, DOI 10.1182/blood.V91.10.3892.3892_3892_3900; Safi W, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.11; Saw KY, 2009, ARTHROSCOPY, V25, P1391, DOI 10.1016/j.arthro.2009.07.011; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Shizhu J, 2012, TURK J GASTROENTEROL, V23, P344, DOI 10.4318/tjg.2012.0344; St Clair EW, 1999, ANN RHEUM DIS, V58, P99; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; SUZUKI Y, 2018, SCI REP UK, V8; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Todhunter PG, 1996, AM J VET RES, V57, P1080; Trombetta AC, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0891-z; Tsubosaka Y, 2019, FASEB J, V33, P6829, DOI 10.1096/fj.201802153R; TYLER JA, 1989, BIOCHEM J, V260, P543, DOI 10.1042/bj2600543; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; van de Water E, 2017, EQUINE VET J, V49, P532, DOI 10.1111/evj.12629; van den Berg WB, 2000, ANN RHEUM DIS, V59, P81, DOI 10.1136/ard.59.suppl_1.i81; van Loon JPAM, 2013, VET J, V196, P40, DOI 10.1016/j.tvjl.2012.07.030; VANLENT PLEM, 1993, AM J PATHOL, V143, P1226; Verde CK, 2001, J VET PHARMACOL THER, V24, P179, DOI 10.1046/j.1365-2885.2001.00336.x; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Wagner B, 2008, VET IMMUNOL IMMUNOP, V122, P57, DOI 10.1016/j.vetimm.2007.10.012; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Williams LB, 2016, EQUINE VET J, V48, P619, DOI 10.1111/evj.12477; Wu CL, 2017, ARTHRITIS RHEUMATOL, V69, P1772, DOI 10.1002/art.40161; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zamani F, 2013, ADV PHARM BULL, V3, P329, DOI 10.5681/apb.2013.053; ZHANG DE, 1994, J IMMUNOL, V153, P3276; Zhou YD, 2017, MOL MED REP, V15, P3949, DOI 10.3892/mmr.2017.6491	128	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4430	4444		10.1096/fj.201902698R	http://dx.doi.org/10.1096/fj.201902698R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32030831	Bronze			2022-12-28	WOS:000512333500001
J	Hait, NC; Maiti, A; Xu, P; Qi, QY; Kawaguchi, T; Okano, M; Takabe, K; Yan, L; Luo, C				Hait, Nitai C.; Maiti, Aparna; Xu, Pan; Qi, Qianya; Kawaguchi, Tsutomu; Okano, Maiko; Takabe, Kazuaki; Yan, Li; Luo, Cheng			Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate	FASEB JOURNAL			English	Article						hypoxia-inducible factors; sphingosine-1-phosphate; sphingosine kinase 2; triple-negative breast cancer	SPHINGOSINE KINASE 2; BREAST-CANCER; HISTONE ACETYLATION; EXPRESSION; PROTEIN; SPHK2; GROWTH; ACID; CHEMORESISTANCE; OVEREXPRESSION	Sphingosine kinase 2 (SphK2) is known to phosphorylate the nuclear sphingolipid metabolite to generate sphingosine-1-phosphate (S1P). Nuclear S1P is involved in epigenetic regulation of gene expression; however, the underlying mechanisms are not well understood. In this work, we have identified the role of nuclear S1P and SphK2 in regulating hypoxia-responsive master transcription factors hypoxia-inducible factor (HIF)-1 alpha/2 alpha, and their functions in breast cancer, with a focus on triple-negative breast cancer (TNBC). We have shown SphK2 is associated with HIF-1 alpha in protein complexes, and is enriched at the promoters of HIF target genes, including vascular endothelial growth factor (VEGF), where it enhances local histone H3 acetylation and transcription. S1P specifically binds to the PAS domains of HIF-1 alpha. SphK2, and HIF-1 alpha expression levels are elevated in metastatic estrogen receptor-positive (ER+) and TNBC clinical tissue specimens compared to healthy breast tissue samples. To determine if S1P formation in the nucleus by SphK2 is a key regulator of HIF functions, we found using a preclinical TNBC xenograft mouse model, and an existing selective SphK2 inhibitor K-145, that nuclear S1P, histone acetylation, HIF-1 alpha expression, and TNBC tumor growth were all reduced in vivo. Our results suggest that S1P and SphK2 in the nucleus are linked to the regulation of HIF-1 alpha/2 alpha functions associated with breast cancer progression, and may provide potential therapeutic targets.	[Hait, Nitai C.; Maiti, Aparna; Kawaguchi, Tsutomu; Okano, Maiko; Takabe, Kazuaki] Roswell Park Comprehens Canc Ctr, Div Breast Surg, Buffalo, NY USA; [Hait, Nitai C.; Maiti, Aparna; Kawaguchi, Tsutomu; Okano, Maiko; Takabe, Kazuaki] Roswell Park Comprehens Canc Ctr, Dept Surg Oncol, Buffalo, NY USA; [Hait, Nitai C.; Maiti, Aparna] Roswell Park Comprehens Canc Ctr, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA; [Xu, Pan; Luo, Cheng] Chinese Acad Sci, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai, Peoples R China; [Xu, Pan; Luo, Cheng] Univ Chinese Acad Sci, Sch Pharm, Beijing, Peoples R China; [Qi, Qianya; Yan, Li] Roswell Park Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hait, NC (corresponding author), Roswell Park Comprehens Canc Ctr, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA.; Hait, NC (corresponding author), Roswell Park Comprehens Canc Ctr, Div Breast Surg, Dept Surg Oncol, Elm & Carlton St, Buffalo, NY 14263 USA.	nitai.hait@roswellpark.org			Roswell Park Cancer Institute (RPCI) [714084-01]	Roswell Park Cancer Institute (RPCI)	Roswell Park Cancer Institute (RPCI), Grant/Award Number: 714084-01	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Antoon JW, 2011, CANCER BIOL THER, V11, P678, DOI 10.4161/cbt.11.7.14903; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Asby DJ, 2014, MOL BIOSYST, V10, P2505, DOI 10.1039/c4mb00351a; Bouquerel P, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.13; Britten CD, 2017, CLIN CANCER RES, V23, P4642, DOI 10.1158/1078-0432.CCR-16-2363; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chu JH, 2014, BIOMED PHARMACOTHER, V68, P1089, DOI 10.1016/j.biopha.2014.10.001; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeRose Yoko S, 2013, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1423s60; Downes NL, 2018, MOL THER, V26, P1735, DOI 10.1016/j.ymthe.2018.05.004; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Gangavarapu KJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt343; Gates LA, 2017, J BIOL CHEM, V292, P14456, DOI 10.1074/jbc.M117.802074; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/FON.13.92, 10.2217/fon.13.92]; Guan SH, 2016, BIOCHEM BIOPH RES CO, V476, P230, DOI 10.1016/j.bbrc.2016.05.102; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hait NC, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.16; Hait NC, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4806541; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hashimoto T, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00033; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hohenberger P, 1998, BREAST CANCER RES TR, V48, P97, DOI 10.1023/A:1005921513083; Hutt DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106224; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Jung JE, 2007, CARCINOGENESIS, V28, P1780, DOI 10.1093/carcin/bgm130; Kawaguchi T, 2017, J MAMMARY GLAND BIOL, V22, P131, DOI 10.1007/s10911-017-9378-7; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Khaitan D, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-12; Kim SH, 2007, ONCOL REP, V17, P647; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; LeBlanc M, 2002, STAT METHODS MED RES, V11, P247, DOI 10.1191/0962280202sm286ra; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin Q, 2011, MOL CANCER RES, V9, P757, DOI 10.1158/1541-7786.MCR-11-0053; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056471; Liu W, 2016, TUMOR BIOL, V37, P6331, DOI 10.1007/s13277-015-4480-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maiti A, 2019, INT J ONCOL, V55, P116, DOI 10.3892/ijo.2019.4796; Maiti A, 2017, CELL SIGNAL, V32, P85, DOI 10.1016/j.cellsig.2017.01.021; Mendonca Daniela B, 2013, Methods Mol Biol, V977, P323, DOI 10.1007/978-1-62703-284-1_26; Mendonca DBS, 2011, BIOCHEM BIOPH RES CO, V404, P997, DOI 10.1016/j.bbrc.2010.12.098; Nagahashi M, 2018, CANCER RES, V78, P1713, DOI 10.1158/0008-5472.CAN-17-1423; Nagahashi M, 2015, HEPATOLOGY, V61, P1216, DOI 10.1002/hep.27592; Neubauer HA, 2016, ONCOTARGET, V7, P64886, DOI 10.18632/oncotarget.11714; Newton J, 2017, FASEB J, V31, P1719, DOI 10.1096/fj.201601041R; Nguyen-Tran DH, 2014, DIS MODEL MECH, V7, P41, DOI 10.1242/dmm.013631; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Poljakova J, 2014, ONCOL REP, V31, P1928, DOI 10.3892/or.2014.2999; Qiu WW, 2016, ONCOTARGET, V7, P39907, DOI 10.18632/oncotarget.9530; Rex K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068328; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sengupta T, 2011, MOL CELL BIOL, V31, P3885, DOI 10.1128/MCB.05089-11; Shi WN, 2017, ONCOTARGET, V8, P39605, DOI 10.18632/oncotarget.17174; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Sun E, 2016, TUMOR BIOL, V37, P473, DOI 10.1007/s13277-015-3818-z; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Wainwright EN, 2017, TRENDS CANCER, V3, P372, DOI 10.1016/j.trecan.2017.04.004; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wallington-Beddoe CT, 2014, CANCER RES, V74, P2803, DOI 10.1158/0008-5472.CAN-13-2732; Wang QS, 2014, TUMOR BIOL, V35, P363, DOI 10.1007/s13277-013-1051-1; Wang W, 2014, CLIN CHIM ACTA, V428, P32, DOI 10.1016/j.cca.2013.10.018; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wu DL, 2015, NATURE, V524, P303, DOI 10.1038/nature14883; Xun C, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0205-y; Zhang C, 2017, ONCOTARGET, V8, P56110, DOI 10.18632/oncotarget.18125; Zhang Xiaomei, 2013, Curr Protoc Mouse Biol, V3, P21, DOI 10.1002/9780470942390.mo120140	83	15	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4293	4310		10.1096/fj.201901734RR	http://dx.doi.org/10.1096/fj.201901734RR		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	32017264				2022-12-28	WOS:000511114000001
J	Kaplan, N; Dong, Y; Wang, SJ; Yang, WD; Park, JK; Wang, JY; Fiolek, E; White, BP; Chandel, NS; Peng, H; Lavker, RM				Kaplan, Nihal; Dong, Ying; Wang, Sijia; Yang, Wending; Park, Jong Kook; Wang, Junyi; Fiolek, Elaina; Perez White, Bethany; Chandel, Navdeep S.; Peng, Han; Lavker, Robert M.			FIH-1 engages novel binding partners to positively influence epithelial proliferation via p63	FASEB JOURNAL			English	Article						ASPP2; epidermis; GADD45 alpha; limbal and corneal epithelia	STEM-CELL; ASPARAGINYL HYDROXYLATION; UNINVOLVED SKIN; DIFFERENTIATION; EXPRESSION; HYPOXIA; APOPTOSIS; PROTEIN; KERATINOCYTES; KINASE	Whereas much is known about the genes regulated by Delta Np63 alpha in keratinocytes, how Delta Np63 alpha is regulated is less clear. During studies with the hydroxylase, factor inhibiting hypoxia-inducible factor 1 (FIH-1), we observed increases in epidermal Delta Np63 alpha expression along with proliferative capacity in a conditional FIH-1 transgenic mouse. Conversely, loss of FIH-1 in vivo and in vitro attenuated Delta Np63 alpha expression. To elucidate the FIH-1/p63 relationship, BioID proteomics assays identified FIH-1 binding partners that had the potential to regulate p63 expression. FIH-1 interacts with two previously unknown partners, Plectin1 and signal transducer and activator of transcription 1 (STAT1) leading to the regulation of Delta Np63 alpha expression. Two known interactors of FIH-1, apoptosis-stimulating of P53 protein 2 (ASPP2) and histone deacetylase 1 (HDAC1), were also identified. Knockdown of ASPP2 upregulated Delta Np63 alpha and reversed the decrease in Delta Np63 alpha by FIH-1 depletion. Additionally, FIH-1 regulates growth arrest and DNA damage-45 alpha (GADD45 alpha), a negative regulator of Delta Np63 alpha by interacting with HDAC1. GADD45 alpha knockdown rescued reduction in Delta Np63 alpha by FIH-1 depletion. Collectively, our data reveal that FIH-1 positively regulates Delta Np63 alpha in keratinocytes via variety of signaling partners: (a) Plectin1/STAT1, (b) ASPP2, and (c) HDAC1/GADD45 alpha signaling pathways.	[Kaplan, Nihal; Dong, Ying; Wang, Sijia; Yang, Wending; Park, Jong Kook; Wang, Junyi; Fiolek, Elaina; Perez White, Bethany; Peng, Han; Lavker, Robert M.] Northwestern Univ, Dept Dermatol, 303 E Chicago Ave Ward 9-124, Chicago, IL 60611 USA; [Dong, Ying; Wang, Junyi] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Ophthalmol, Beijing, Peoples R China; [Wang, Sijia] Southern Med Univ, Nanfang Hosp, Dept Dermatol, Guangzhou, Peoples R China; [Park, Jong Kook] Hallym Univ, Dept Biomed Sci, Coll Nat Sci 8403, Chunchon, South Korea; [Chandel, Navdeep S.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA	Northwestern University; Chinese People's Liberation Army General Hospital; Southern Medical University - China; Hallym University; Northwestern University	Peng, H; Lavker, RM (corresponding author), Northwestern Univ, Dept Dermatol, 303 E Chicago Ave Ward 9-124, Chicago, IL 60611 USA.	han.peng@northwestern.edu; r-lavker@northwestern.edu	wang, junyi/GYA-3213-2022; White, Bethany E. Perez/AAF-7256-2020	Perez White, Bethany/0000-0002-5594-0599; Park, Jong Kook/0000-0002-3946-5687	HHS \ NIH \ National Eye Institute (NEI) [EY06769, EY017539, EY019463]; NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [31300814]; Deramatology Foundation Career Development Award; Eversight Research Grant; HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01AR072773]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057216]; Comprehensive Cancer Center; National Institutes of Health [EY019463, 31300814]; National Natural Science Foundation of China; Dermatology Foundation; Core	HHS \ NIH \ National Eye Institute (NEI); NSFC \ National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); Deramatology Foundation Career Development Award; Eversight Research Grant; HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dermatology Foundation; Core(Luxembourg National Research Fund)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY06769, EY017539 and EY019463; NSFC vertical bar National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 31300814; Deramatology Foundation Career Development Award; Eversight Research Grant; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: K01AR072773; National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Number: AR057216; Core; Comprehensive Cancer Center; National Institutes of Health, Grant/Award Number: EY019463 and 31300814; National Natural Science Foundation of China; Dermatology Foundation	Arcidiacono P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03470-y; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Beretta C, 2005, CELL CYCLE, V4, P1625, DOI 10.4161/cc.4.11.2135; Bin BH, 2017, P NATL ACAD SCI USA, V114, P12243, DOI 10.1073/pnas.1710726114; Cable CJ, 2019, METHOD MOL BIOL, P1; Cervo PRD, 2012, P NATL ACAD SCI USA, V109, P1133, DOI 10.1073/pnas.1112257109; Chakravarti D, 2014, P NATL ACAD SCI USA, V111, pE572, DOI 10.1073/pnas.1319743111; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Danilov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026815; DEBOER OJ, 1994, ARCH DERMATOL RES, V286, P304, DOI 10.1007/BF00402220; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; FORSTER S, 1983, BRIT J DERMATOL, V108, P103, DOI 10.1111/j.1365-2133.1983.tb04585.x; FRAKI JE, 1982, SCIENCE, V215, P685, DOI 10.1126/science.7036342; Hamanaka RB, 2017, J INVEST DERMATOL, V137, P1267, DOI 10.1016/j.jid.2016.12.020; Helton ES, 2008, ONCOGENE, V27, P2843, DOI 10.1038/sj.onc.1210948; Hildesheim J, 2004, ONCOGENE, V23, P1829, DOI 10.1038/sj.onc.1207301; Hojlund K, 2008, MOL CELL PROTEOMICS, V7, P257, DOI 10.1074/mcp.M700304-MCP200; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Janke K, 2013, J CELL SCI, V126, P2629, DOI 10.1242/jcs.117564; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Kouwenhoven EN, 2015, BBA-GENE REGUL MECH, V1849, P590, DOI 10.1016/j.bbagrm.2015.03.003; KRUEGER GG, 1981, J CLIN INVEST, V68, P1548, DOI 10.1172/JCI110409; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Li CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175721; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Matheny KE, 2003, LARYNGOSCOPE, V113, P936, DOI 10.1097/00005537-200306000-00004; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mehrazarin S, 2015, J BIOL CHEM, V290, P19999, DOI 10.1074/jbc.M115.659144; Meissl K, 2017, CYTOKINE, V89, P12, DOI 10.1016/j.cyto.2015.11.011; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; Park JK, 2016, J CELL BIOL, V215, P667, DOI 10.1083/jcb.201604032; Park MA, 2008, NUCLEIC ACIDS RES, V36, P263, DOI 10.1093/nar/gkm969; Peng H, 2015, STEM CELLS, V33, P1642, DOI 10.1002/stem.1962; Peng H, 2014, AM J PATHOL, V184, P3262, DOI 10.1016/j.ajpath.2014.08.014; Peng H, 2013, INVEST OPHTH VIS SCI, V54, P2781, DOI 10.1167/iovs.12-11512; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; de Sousa FLP, 2017, REPROD BIOL, V17, P218, DOI 10.1016/j.repbio.2017.05.005; Riemondy K, 2014, WIRES RNA, V5, P849, DOI 10.1002/wrna.1250; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shen CS, 2005, J DERMATOL, V32, P236, DOI 10.1111/j.1346-8138.2005.tb00755.x; Shin SJ, 2013, P NATL ACAD SCI USA, V110, P19414, DOI 10.1073/pnas.1309720110; Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tordella L, 2013, P NATL ACAD SCI USA, V110, P17969, DOI 10.1073/pnas.1309362110; Turnquist C, 2014, P NATL ACAD SCI USA, V111, P9834, DOI 10.1073/pnas.1407898111; Wang H, 2010, CELL SIGNAL, V22, P1717, DOI 10.1016/j.cellsig.2010.06.012; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; White BEP, 2017, J CELL SCI, V130, P111, DOI 10.1242/jcs.188169; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	60	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					525	539		10.1096/fj.201901512R	http://dx.doi.org/10.1096/fj.201901512R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914679	Green Accepted			2022-12-28	WOS:000507308900036
J	Kong, QR; Yang, X; Zhang, H; Liu, SC; Zhao, JC; Zhang, JM; Weng, XG; Jin, JX; Liu, ZH				Kong, Qingran; Yang, Xu; Zhang, Heng; Liu, Shichao; Zhao, Jianchao; Zhang, Jiaming; Weng, Xiaogang; Jin, Junxue; Liu, Zhonghua			Lineage specification and pluripotency revealed by transcriptome analysis from oocyte to blastocyst in pig	FASEB JOURNAL			English	Article						mammals; pig; preimplantation embryonic development; single-cell RNA-seq; transcriptome	STEM-CELLS; NAIVE; EXPRESSION; ESTABLISHMENT	The inner cell mass (ICM) in blastocyst is the origin of all somatic and germ cells in mammals and pluripotent stem cells (PSCs) in vitro. As the conserved principles between pig and human, here we performed comprehensive single-cell RNA-seq for porcine early embryos from oocyte to early blastocyst (EB). We show the specification of the ICM and trophectoderm in morula and the molecular signature of the precursors. We demonstrate the existence of naive pluripotency signature in morula and ICM of EB, and the specific pluripotent genes and the activity of signalling pathways highlight the characteristics of the naive pluripotency. We observe the absence of dosage compensation with respect to X-chromosome (XC) in morula, and incomplete dosage compensation in the EB. However, the dynamics of dosage compensation may be independent of the expression of XIST induced XC inactivation. Our study describes molecular landmarks of embryogenesis in pig that will provide a better strategy for derivation of porcine PSCs and improve research in regenerative medicine.	[Kong, Qingran; Yang, Xu; Zhang, Heng; Liu, Shichao; Zhao, Jianchao; Zhang, Jiaming; Weng, Xiaogang; Jin, Junxue; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin, Peoples R China; [Zhang, Heng] Westlake Univ, Inst Biol, Hangzhou, Peoples R China	Northeast Agricultural University - China; Westlake University	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin, Peoples R China.	Liuzhonghua@neau.edu.cn	Liu, Shichao/J-2954-2019	Liu, Shichao/0000-0002-4156-3876	Northeast Agricultural University (NEAU)	Northeast Agricultural University (NEAU)	Northeast Agricultural University (NEAU)	Ashida Y, 2017, GENES CELLS, V22, P189, DOI 10.1111/gtc.12467; Bou G, 2017, DEVELOPMENT, V144, P1296, DOI 10.1242/dev.141085; Chen KF, 2015, NAT GENET, V47, P1149, DOI 10.1038/ng.3385; Chiu YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19227; Collier AJ, 2017, CELL STEM CELL, V20, P874, DOI 10.1016/j.stem.2017.02.014; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gong HX, 2016, STEM CELL REP, V7, P1050, DOI 10.1016/j.stemcr.2016.10.006; Heemskerk I, 2016, DEV DYNAM, V245, P976, DOI [10.1002/DVDY.24432, 10.1002/dvdy.24432]; Ho L, 2015, CELL STEM CELL, V17, P435, DOI 10.1016/j.stem.2015.08.010; Holm IE, 2016, J PATHOL, V238, P267, DOI 10.1002/path.4654; Hryhorowicz M, 2017, MOL BIOTECHNOL, V59, P435, DOI 10.1007/s12033-017-0024-9; Hwang JY, 2015, MECH DEVELOP, V138, P246, DOI 10.1016/j.mod.2015.10.005; Hwang KC, 2005, MOL REPROD DEV, V70, P314, DOI 10.1002/mrd.20204; Kubaczka C, 2017, CELL RES, V27, P961, DOI 10.1038/cr.2017.61; Kugler J, 2017, EXPERT OPIN DRUG MET, V13, P833, DOI 10.1080/17425255.2017.1351548; Li YQ, 2017, DNA CELL BIOL, V36, P725, DOI 10.1089/dna.2017.3780; Lingel A, 2017, J MED CHEM, V60, P415, DOI 10.1021/acs.jmedchem.6b01473; Liu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173047; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; de Mello JCM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11044-z; Mzoughi S, 2017, NAT GENET, V49, P1354, DOI 10.1038/ng.3922; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Posfai E, 2017, ELIFE, V6, DOI 10.7554/eLife.22906; Qi W, 2017, NAT CHEM BIOL, V13, P381, DOI 10.1038/nchembio.2304; Ramos-Ibeas P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08387-8; Suman Pankaj, 2013, JAKSTAT, V2, pe25155, DOI 10.4161/jkst.25155; Takahashi S, 2018, CELL MOL LIFE SCI, V75, P1191, DOI 10.1007/s00018-017-2703-x; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Magana GV, 2014, DEV BIOL, V387, P15, DOI 10.1016/j.ydbio.2014.01.008; Wang JQ, 2018, CELL, V175, P1887, DOI 10.1016/j.cell.2018.11.039; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wei QQ, 2017, BIOL REPROD, V97, P5, DOI 10.1093/biolre/iox071; Yang J, 2017, NATURE, V550, P393, DOI 10.1038/nature24052; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhou LQ, 2017, DEVELOPMENT, V144, P519, DOI 10.1242/dev.141390	41	29	30	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					691	705		10.1096/fj.201901818RR	http://dx.doi.org/10.1096/fj.201901818RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914626	Bronze			2022-12-28	WOS:000507308900048
J	Lee, BR; Rengaraj, D; Choi, HJ; Han, JY				Lee, Bo Ram; Rengaraj, Deivendran; Choi, Hee Jung; Han, Jae Yong			A novel F-box domain containing cyclin F like gene is required for maintaining the genome stability and survival of chicken primordial germ cells	FASEB JOURNAL			English	Article						gene expression; gene identification; gene regulation	MEDIATED DEGRADATION; GENOTOXIC STRESS; MESSENGER-RNA; IN-VITRO; EXPRESSION; DNA; APOPTOSIS; HOMOLOG; INTEGRITY; OVEREXPRESSION	The stability and survival of germ cells are controlled by the germline-specific genes, however, such genes are less known in the avian species. Using a microarray-based the National Center for Biotechnology Information Gene Expression Omnibus dataset, we found an unigene (Gga.9721) that upregulated in the chicken primordial germ cells (PGCs). The unigene showed 97% identities with an uncharacterized chicken cyclin F like gene. The predicted chicken cyclin F like gene was further characterized through expression and regulation in the chicken PGCs. The sequence analysis revealed that the gene shows identities with cyclin F gene and contains an F-box domain. The expression of chicken cyclin F like was detected specifically in the gonads, PGCs, and germline cells. The knockdown of cyclin F like gene resulted in DNA damage and apoptosis in the PGCs. The genes related to stemness and germness were downregulated, whereas, genes related to apoptosis and DNA damage response were increased in the PGCs after the knockdown of chicken cyclin F like. We further observed that the Nanog homeobox controlled the transcriptional activity of chicken cyclin F like gene in PGCs. Collectively, the chicken cyclin F like gene, which is not reported in any other species, is required for maintaining the genome stability of germ cells.	[Lee, Bo Ram; Rengaraj, Deivendran; Choi, Hee Jung; Han, Jae Yong] Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea; [Lee, Bo Ram; Rengaraj, Deivendran; Choi, Hee Jung; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Lee, Bo Ram] Rural Dev Adm, Natl Inst Anim Sci, Anim Biotechnol Div, Wanju Gun, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Han, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr	Rengaraj, Deivendran/C-5593-2015	Rengaraj, Deivendran/0000-0001-9274-9921; Lee, Bo Ram/0000-0002-0537-6205	National Research Foundation of Korea (NRF) [NRF-2015R1A3A2033826]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2017R1D1A1B03029512; National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2015R1A3A2033826	Aramaki S, 2007, CELL TISSUE RES, V330, P45, DOI 10.1007/s00441-007-0435-1; Awwad SW, 2015, BIOL OPEN, V4, P498, DOI 10.1242/bio.201410991; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; Bailly Aymeric, 2013, Adv Exp Med Biol, V757, P249, DOI 10.1007/978-1-4614-4015-4_9; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Choi HJ, 2018, FASEB J, V32, P2563, DOI 10.1096/fj.201700924RR; Choi HJ, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.127365; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Dankert JF, 2016, MOL CELL, V64, P507, DOI 10.1016/j.molcel.2016.09.010; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; De Felici M, 2015, INT J DEV BIOL, V59, P41, DOI 10.1387/ijdb.150064md; Deshmukh RS, 2018, CANCER RES, V78, P6386, DOI 10.1158/0008-5472.CAN-18-1772; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Ge C, 2009, BIOL REPROD, V80, P528, DOI 10.1095/biolreprod.108.072728; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Gong J, 2018, ONCOL LETT, V15, P8891, DOI 10.3892/ol.2018.8500; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Han JY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-220; Han JY, 2018, INT J DEV BIOL, V62, P341, DOI 10.1387/ijdb.170255jh; Han JY, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0246-0; Han JY, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0234-4; Han JY, 2017, METHODS MOL BIOL, V1650, P229, DOI 10.1007/978-1-4939-7216-6_15; Han JY, 2017, METHODS MOL BIOL, V1630, P153, DOI 10.1007/978-1-4939-7128-2_13; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Helle F, 2012, CANCER GENE THER, V19, P299, DOI 10.1038/cgt.2012.1; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Hsia KT, 2003, DEVELOPMENT, V130, P369, DOI 10.1242/dev.00221; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jin SD, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-016-0133-5; Jung HG, 2018, STEM CELLS DEV, V27, P1215, DOI 10.1089/scd.2018.0059; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim H, 2006, GENOMICS, V88, P252, DOI 10.1016/j.ygeno.2006.03.015; Kim JN, 2010, BIOL REPROD, V82, P257, DOI 10.1095/biolreprod.109.079723; Kim JN, 2004, MOL REPROD DEV, V68, P81, DOI 10.1002/mrd.20051; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kost GC, 2012, MUTAT RES-FUND MOL M, V735, P51, DOI 10.1016/j.mrfmmm.2012.05.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Lee BR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-60; Lee HC, 2016, STEM CELLS DEV, V25, P68, DOI 10.1089/scd.2015.0208; Lee SI, 2011, P NATL ACAD SCI USA, V108, P10426, DOI 10.1073/pnas.1106141108; Li WG, 2012, GERONTOLOGY, V58, P129, DOI 10.1159/000334368; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Maheshwari A, 2009, FEBS J, V276, P870, DOI 10.1111/j.1742-4658.2008.06831.x; McAnuff MA, 2007, J PHARM SCI-US, V96, P2922, DOI 10.1002/jps.20968; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Murakami K, 2016, NATURE, V529, P403, DOI 10.1038/nature16480; Naito Mitsuru, 2007, Journal of Poultry Science, V44, P416, DOI 10.2141/jpsa.44.416; Olsen AK, 2001, NUCLEIC ACIDS RES, V29, P1781, DOI 10.1093/nar/29.8.1781; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Rengaraj D, 2012, POULTRY SCI, V91, P3167, DOI 10.3382/ps.2012-02279; Rengaraj D, 2010, THERIOGENOLOGY, V74, P765, DOI 10.1016/j.theriogenology.2010.04.001; Rengaraj D, 2008, ASIAN J ANDROL, V10, P503, DOI 10.1111/j.1745-7262.2008.00360.x; Rengaraj D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-757; Rengaraj D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019524; Rengaraj D, 2011, DEV DYNAM, V240, P850, DOI 10.1002/dvdy.22575; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Shaha C, 2010, PHILOS T R SOC B, V365, P1501, DOI 10.1098/rstb.2009.0124; Shen J, 2017, ONCOTARGET, V8, P110650; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Skandalis A, 2016, MUTAT RES-FUND MOL M, V784, P34, DOI 10.1016/j.mrfmmm.2016.01.002; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Strome S, 2015, NAT REV MOL CELL BIO, V16, P406, DOI 10.1038/nrm4009; Tagami T, 2017, ADV EXP MED BIOL, V1001, P1, DOI 10.1007/978-981-10-3975-1_1; Tang WWC, 2016, NAT REV GENET, V17, P585, DOI 10.1038/nrg.2016.88; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Yamamoto Y, 2007, BIOL REPROD, V77, P115, DOI 10.1095/biolreprod.107.061200; Yang SY, 2018, POULTRY SCI, V97, P650, DOI 10.3382/ps/pex316; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Yu ML, 2011, AMINO ACIDS, V40, P933, DOI 10.1007/s00726-010-0717-x; Zheng YH, 2009, REPRODUCTION, V138, P483, DOI 10.1530/REP-09-0163	81	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1001	1017		10.1096/fj.201901294R	http://dx.doi.org/10.1096/fj.201901294R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914591				2022-12-28	WOS:000507308900068
J	Pedraz, L; Blanco-Cabra, N; Torrents, E				Pedraz, Lucas; Blanco-Cabra, Nuria; Torrents, Eduard			Gradual adaptation of facultative anaerobic pathogens to microaerobic and anaerobic conditions	FASEB JOURNAL			English	Article						biofilm; Escherichia; oxygen; Pseudomonas; ribonucleotide	PSEUDOMONAS-AERUGINOSA PAO1; REGULATED GENE-EXPRESSION; ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASE; PHYSIOLOGICAL HETEROGENEITY; TRANSCRIPTIONAL REGULATOR; OXYGEN CONCENTRATION; CLASS-II; FNR; NITRATE	Many notable human pathogens are facultative anaerobes. These pathogens exhibit redundant metabolic pathways and a whole array of regulatory systems to adapt to changing oxygen levels. However, our knowledge of facultative anaerobic pathogens is mostly based on fully aerobic or anaerobic cultures, which does not reflect real infection conditions, while the microaerobic range remains understudied. Here, we examine the behavior of pathogenic and nonpathogenic strains of two facultative anaerobes, Escherichia coli and Pseudomonas aeruginosa, during the aerobic-anaerobic transition. To do so, we introduce a new technique named AnaeroTrans, in which we allow self-consumption of oxygen by steady-state cultures and monitor the system by measuring the gas-phase oxygen concentration. We explore the different behavior of the studied species toward oxygen and examine how this behavior is associated with the targeted infection sites. As a model, we characterize the adaptation profile of the ribonucleotide reductase network, a complex oxygen-dependent enzymatic system responsible for the generation of the deoxyribonucleotides. We also explore the actions of the most important anaerobic regulators and how these regulators influence bacterial fitness. Our results allow us to classify the different elements that compose the aerobic-anaerobic transition into reproducible stages, thus showing the different adaptation mechanisms of the studied species.	[Pedraz, Lucas; Blanco-Cabra, Nuria; Torrents, Eduard] BIST, Inst Bioengn Catalonia IBEC, Bacterial Infect Antimicrobial Therapies Grp, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Pedraz, L; Torrents, E (corresponding author), BIST, Inst Bioengn Catalonia IBEC, Bacterial Infect Antimicrobial Therapies Grp, Barcelona, Spain.	lpedraz@ibecbarcelona.eu; etorrents@ibecbarcelona.eu	Blanco-Cabra, Nuria/AAT-9770-2021; Pedraz, Lucas/T-1731-2019; Torrents, Eduard/C-7184-2008	Blanco-Cabra, Nuria/0000-0002-4784-1072; Pedraz, Lucas/0000-0003-3666-3343; Torrents, Eduard/0000-0002-3010-1609	Ministerio de Ciencia, Innovacion y Universidades (MCIU)-Agencia Estatal de Investigacion (AEI)-Fondo Europea de Desarrollo Regional (FEDER) [BIO2015-63557-R, RTI2018-098573-B-100]; Generalitat de Catalunya/CERCA Program [2017 SGR1079]; La Caixa Foundation; Catalan Cystic Fibrosis foundation; FI-DGR program [2015-FI-B-00817]; Spanish Cystic Fibrosis foundation	Ministerio de Ciencia, Innovacion y Universidades (MCIU)-Agencia Estatal de Investigacion (AEI)-Fondo Europea de Desarrollo Regional (FEDER); Generalitat de Catalunya/CERCA Program; La Caixa Foundation(La Caixa Foundation); Catalan Cystic Fibrosis foundation; FI-DGR program; Spanish Cystic Fibrosis foundation	Ministerio de Ciencia, Innovacion y Universidades (MCIU)-Agencia Estatal de Investigacion (AEI)-Fondo Europea de Desarrollo Regional (FEDER), Grant/Award Number: BIO2015-63557-R and RTI2018-098573-B-100; Generalitat de Catalunya/CERCA Program, Grant/Award Number: 2017 SGR1079; La Caixa Foundation, and Catalan and Spanish Cystic Fibrosis foundations; FI-DGR program, Grant/Award Number: 2015-FI-B-00817	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Becker S, 1996, J BACTERIOL, V178, P4515, DOI 10.1128/jb.178.15.4515-4521.1996; Becker S, 1997, ARCH MICROBIOL, V168, P290, DOI 10.1007/s002030050501; Bettenbrock K, 2014, ADV MICROB PHYSIOL, V64, P65, DOI 10.1016/B978-0-12-800143-1.00002-6; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Boston T, 2003, J BACTERIOL, V185, P5310, DOI 10.1128/JB.185.17.5310-5313.2003; Chen F, 2006, BIOTECHNOL BIOENG, V93, P1069, DOI 10.1002/bit.20812; Crespo A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14051-2; Crespo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00688; Crespo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123571; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; Cendra MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046350; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Filiatrault MJ, 2005, INFECT IMMUN, V73, P3764, DOI 10.1128/IAI.73.6.3764-3772.2005; GALIMAND M, 1991, J BACTERIOL, V173, P1598, DOI 10.1128/jb.173.5.1598-1606.1991; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; GUEST JR, 1992, J GEN MICROBIOL, V138, P2253, DOI 10.1099/00221287-138-11-2253; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hong CS, 2004, J BIOSCI BIOENG, V97, P184, DOI 10.1263/jbb.97.184; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; McKethan BL, 2013, MOL MICROBIOL, V90, P278, DOI 10.1111/mmi.12364; Mettert EL, 2007, J BACTERIOL, V189, P3036, DOI 10.1128/JB.00052-07; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Poole AM, 2002, J MOL EVOL, V55, P180, DOI 10.1007/s00239-002-2315-3; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; Roca I, 2008, INT MICROBIOL, V11, P49, DOI 10.2436/20.1501.01.44; Rolfe MD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120091; Sabra W, 2002, MICROBIOL-SGM, V148, P3195, DOI 10.1099/00221287-148-10-3195; SAWERS RG, 1991, MOL MICROBIOL, V5, P1469, DOI 10.1111/j.1365-2958.1991.tb00793.x; Schiessl KT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08733-w; Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007; Shalel-Levanon S, 2005, BIOTECHNOL BIOENG, V92, P147, DOI 10.1002/bit.20583; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Tata M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147811; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; TUGGLE CK, 1986, EMBO J, V5, P1077, DOI 10.1002/j.1460-2075.1986.tb04325.x; UNDEN G, 1994, ANTON LEEUW INT J G, V66, P3, DOI 10.1007/BF00871629; UNDEN G, 1995, ARCH MICROBIOL, V164, P81; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	64	9	9	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2912	2928		10.1096/fj.201902861R	http://dx.doi.org/10.1096/fj.201902861R		DEC 2019	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908067	Bronze			2022-12-28	WOS:000504676700001
J	Hilliard, KA; Blaho, VA; Jackson, CD; Brown, CR				Hilliard, Kinsey A.; Blaho, Victoria A.; Jackson, Christa D.; Brown, Charles R.			Leukotriene B4 receptor BLT1 signaling is critical for neutrophil apoptosis and resolution of experimental Lyme arthritis	FASEB JOURNAL			English	Article						BLT1; efferocytosis; Lyme arthritis; resolution	COLLAGEN-INDUCED ARTHRITIS; BORRELIA-BURGDORFERI; B-4 RECEPTORS; ALVEOLAR MACROPHAGES; LIPID MEDIATORS; SYNOVIAL-FLUID; HOST-DEFENSE; IN-VITRO; PHAGOCYTOSIS; INFLAMMATION	Eicosanoids are powerful mediators of inflammation and are known to drive both the progression and regression of arthritis. We previously reported the infection of C3H 5-lipoxygenase (LO)-deficient mice with Borrelia burgdorferi results in prolonged nonresolving Lyme arthritis. Here we define the role of the 5-LO metabolite leukotriene (LT)B-4 and its high-affinity receptor, BLT1, in this response. C3H and C3H BLT1(-/-) mice were infected with B. burgdorferi and arthritis progression was monitored by ankle swelling over time. Similar to 5-LO-/- mice, BLT1(-/-) mice developed nonresolving Lyme arthritis characterized by increased neutrophils in the joint at later time points than WT mice, but with fewer apoptotic (caspase-3(+)) neutrophils. In vitro, BLT1(-/-) neutrophils were defective in their ability to undergo apoptosis due to the lack of LTB4-mediated down-regulation of cAMP, subsequent failure to induce Death-Inducing Signaling Complex (DISC) components, and decreased FasL and CD36 expression. Inhibition of adenylyl cyclase with SQ 22,536 restored BLT1(-/-) BMN apoptosis, FasL and CD36 expression, and clearance by macrophages. We conclude that LTB4/BLT1 signaling has an unexpected critical role in mediating neutrophil apoptosis via the down-regulation of cAMP. Loss of BLT1 signaling led to defective clearance of neutrophils from the inflamed joint and failed arthritis resolution.	[Hilliard, Kinsey A.; Jackson, Christa D.; Brown, Charles R.] Univ Missouri, Coll Vet Med, Dept Pathobiol, Columbia, MO USA; [Blaho, Victoria A.] Sanford Burnham Prebys Med Discovery Inst, Immun & Pathogenesis Program, San Diego, CA USA	University of Missouri System; University of Missouri Columbia; Sanford Burnham Prebys Medical Discovery Institute	Brown, CR (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, 315 Connaway Hall, Columbia, MO 65211 USA.	BrownChar@missouri.edu		Brown, Charles/0000-0002-1914-9601; Jackson, Christa/0000-0002-4152-2222	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR052748]; UM System Research Board; MU CVM Committee on Research; MU Department of Veterinary Pathobiology	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); UM System Research Board; MU CVM Committee on Research; MU Department of Veterinary Pathobiology	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR052748; UM System Research Board; MU CVM Committee on Research; MU Department of Veterinary Pathobiology	AHMADZADEH N, 1991, INFLAMMATION, V15, P497, DOI 10.1007/BF00923346; BARTHOLD SW, 1995, J INFECT DIS, V172, P778, DOI 10.1093/infdis/172.3.778; Barthold SW, 1996, LAB INVEST, V74, P57; Bhattacharjee R, 2012, BIOCHEM BIOPH RES CO, V423, P85, DOI 10.1016/j.bbrc.2012.05.087; Blaho VA, 2008, ARTHRITIS RHEUM-US, V58, P1485, DOI 10.1002/art.23371; Blaho VA, 2011, J IMMUNOL, V186, P3076, DOI 10.4049/jimmunol.1003473; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Brandt SL, 2017, SEMIN IMMUNOL, V33, P37, DOI 10.1016/j.smim.2017.08.006; Brown CR, 2006, J INTERF CYTOK RES, V26, P390, DOI 10.1089/jir.2006.26.390; Brown CR, 2003, J IMMUNOL, V171, P893, DOI 10.4049/jimmunol.171.2.893; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Carroll JA, 2003, MICROBIOL-SGM, V149, P1819, DOI 10.1099/mic.0.26165-0; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Dasgupta Y, 2016, BLOOD, V127, P2131, DOI 10.1182/blood-2015-11-681171; DeLeon-Pennell KY, 2016, CIRC-CARDIOVASC GENE, V9, P14, DOI 10.1161/CIRCGENETICS.115.001249; Diaz-Gonzalez F, 2007, ANN RHEUM DIS, V66, P628, DOI 10.1136/ard.2006.062554; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Gheorghe KR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2717; Griffiths RJ, 1997, J EXP MED, V185, P1123, DOI 10.1084/jem.185.6.1123; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Hashimoto A, 2003, J RHEUMATOL, V30, P1712; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Kuwabara K, 2000, EUR J PHARMACOL, V402, P275, DOI 10.1016/S0014-2999(00)00518-5; Lasky CE, 2015, INFECT IMMUN, V83, P2627, DOI 10.1128/IAI.00369-15; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; Lokuta Mary A., 2007, V412, P211, DOI 10.1007/978-1-59745-467-4_14; Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200; Mathis SP, 2010, J IMMUNOL, V185, P3049, DOI 10.4049/jimmunol.1001031; MAYATEPEK E, 1993, MEDIAT INFLAMM, V2, P225, DOI 10.1155/S0962935193000304; Miyabe Y, 2017, SEMIN IMMUNOL, V33, P52, DOI 10.1016/j.smim.2017.09.009; Nagatake T, 2019, MUCOSAL IMMUNOL, V12, P1082, DOI 10.1038/s41385-019-0175-z; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Sasaki F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185133; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SCHAIBLE UE, 1989, J EXP MED, V170, P1427, DOI 10.1084/jem.170.4.1427; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shao WH, 2006, J IMMUNOL, V176, P6254, DOI 10.4049/jimmunol.176.10.6254; Silva MT, 2010, J LEUKOCYTE BIOL, V88, P885, DOI 10.1189/jlb.0410205; Soares EM, 2013, J IMMUNOL, V190, P1614, DOI 10.4049/jimmunol.1202932; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; WEINBLATT ME, 1992, J RHEUMATOL, V19, P1537; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wooten RM, 2001, CURR OPIN MICROBIOL, V4, P274, DOI 10.1016/S1369-5274(00)00202-2; Xu SH, 2010, RHEUMATOL INT, V30, P1183, DOI 10.1007/s00296-009-1125-y; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2015, J BIOCHEM, V157, P65, DOI 10.1093/jb/mvu078; Zhang M, 2011, INVEST OPHTH VIS SCI, V52, P1800, DOI 10.1167/iovs.10-6904; Zhang Y, 2017, J LIPID RES, V58, P494, DOI 10.1194/jlr.M068882	55	4	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2840	2852		10.1096/fj.201902014R	http://dx.doi.org/10.1096/fj.201902014R		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908031	Bronze			2022-12-28	WOS:000504270500001
J	Tavera-Montanez, C; Hainer, SJ; Cangussu, D; Gordon, SJV; Xiao, Y; Reyes-Gutierrez, P; Imbalzano, AN; Navea, JG; Fazzio, TG; Padilla-Benavides, T				Tavera-Montanez, Cristina; Hainer, Sarah J.; Cangussu, Daniella; Gordon, Shellaina J. V.; Xiao, Yao; Reyes-Gutierrez, Pablo; Imbalzano, Anthony N.; Navea, Juan G.; Fazzio, Thomas G.; Padilla-Benavides, Teresita			The classic metal-sensing transcription factor MTF1 promotes myogenesis in response to copper	FASEB JOURNAL			English	Article						myogenic differentiation 1; ChIP-Seq; copper binding	PLACENTA GROWTH-FACTOR; FACTOR-I MTF-1; NF-KAPPA-B; METALLOTHIONEIN-I; GENE-EXPRESSION; TRANSPORTING ATPASES; MITOCHONDRIAL BIOGENESIS; MUSCLE DIFFERENTIATION; REGULATORY ELEMENTS; CYSTEINE CLUSTER	Metal-regulatory transcription factor 1 (MTF1) is a conserved metal-binding transcription factor in eukaryotes that binds to conserved DNA sequence motifs, termed metal response elements. MTF1 responds to both metal excess and deprivation, protects cells from oxidative and hypoxic stresses, and is required for embryonic development in vertebrates. To examine the role for MTF1 in cell differentiation, we use multiple experimental strategies [including gene knockdown (KD) mediated by small hairpin RNA and clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9), immunofluorescence, chromatin immunopreciptation sequencing, subcellular fractionation, and atomic absorbance spectroscopy] and report a previously unappreciated role for MTF1 and copper (Cu) in cell differentiation. Upon initiation of myogenesis from primary myoblasts, both MTF1 expression and nuclear localization increased. Mtf1 KD impaired differentiation, whereas addition of nontoxic concentrations of Cu+-enhanced MTF1 expression and promoted myogenesis. Furthermore, we observed that Cu+ binds stoichiometrically to a C terminus tetra-cysteine of MTF1. MTF1 bound to chromatin at the promoter regions of myogenic genes, and Cu addition stimulated this binding. Of note, MTF1 formed a complex with myogenic differentiation (MYOD)1, the master transcriptional regulator of the myogenic lineage, at myogenic promoters. These findings uncover unexpected mechanisms by which Cu and MTF1 regulate gene expression during myoblast differentiation.	[Tavera-Montanez, Cristina; Cangussu, Daniella; Gordon, Shellaina J. V.; Reyes-Gutierrez, Pablo; Imbalzano, Anthony N.; Padilla-Benavides, Teresita] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA; [Hainer, Sarah J.; Fazzio, Thomas G.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA; [Xiao, Yao; Navea, Juan G.] Skidmore Coll, Dept Chem, Saratoga Springs, NY 12866 USA; [Hainer, Sarah J.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Skidmore College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Padilla-Benavides, T (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA.	teresita.padilla@umassmed.edu	Padilla-Benavides, Teresita/K-1968-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822; Hainer, Sarah/0000-0003-0503-1183	University of Massachusetts Medical School; U.S. National Institute of Health [NIH] (National Institute of General Medical Sciences) [R01GM56244]; U.S. National Institute of Health [NIH] (Eunice Kennedy Shriver National Institute of Child Health and Human Development) [R01HD072122]; University of Massachusetts Medical School funding for the Summer Undergraduate Research Experience Program [NIH] (National Heart, Lung, and Blood Institute) [2R25HL092610]; National Science Foundation [Division of Biological Infrastructure (DBI)] [0959476]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	University of Massachusetts Medical School; U.S. National Institute of Health [NIH] (National Institute of General Medical Sciences); U.S. National Institute of Health [NIH] (Eunice Kennedy Shriver National Institute of Child Health and Human Development); University of Massachusetts Medical School funding for the Summer Undergraduate Research Experience Program [NIH] (National Heart, Lung, and Blood Institute); National Science Foundation [Division of Biological Infrastructure (DBI)](National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Courtney McCann, Dr. Sabriya Syed, Dr. Hanna Witwicka, and members of the T.P.-B. laboratory for insightful discussions regarding this manuscript. This work was supported by the Faculty Diversity Scholars Award from the University of Massachusetts Medical School to T.P.-B. Funding from the U.S. National Institute of Health [NIH; Grants R01GM56244 (National Institute of General Medical Sciences) to A.N.I. and R01HD072122 (Eunice Kennedy Shriver National Institute of Child Health and Human Development) to T.G.F.). S.J.V.G was supported by the University of Massachusetts Medical School funding for the Summer Undergraduate Research Experience Program [NIH Grant 2R25HL092610 (National Heart, Lung, and Blood Institute)]. Funding from the National Science Foundation [Division of Biological Infrastructure (DBI) 0959476 to J.G.N.]. S.J.H. is a Special Fellow of the Leukemia and Lymphoma Society. The authors declare no conflicts of interest.	Andeol Y, 2018, BIOCHEM CELL BIOL, V96, P726, DOI 10.1139/bcb-2018-0073; Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Balamurugan K, 2004, BIOL CHEM, V385, P597, DOI 10.1515/BC.2004.074; Banci L, 2010, CELL MOL LIFE SCI, V67, P2563, DOI 10.1007/s00018-010-0330-x; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bittel D, 1998, J BIOL CHEM, V273, P7127, DOI 10.1074/jbc.273.12.7127; Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Chen XH, 2004, J BIOL CHEM, V279, P4515, DOI 10.1074/jbc.M308924200; Chen XH, 2008, NUCLEIC ACIDS RES, V36, P3128, DOI 10.1093/nar/gkn103; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; Cramer M, 2005, BIOL CHEM, V386, P865, DOI 10.1515/BC.2005.101; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; Ferenci P, 2004, ALIMENT PHARM THER, V19, P157, DOI 10.1046/j.1365-2036.2003.01813.x; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; FUJISAWASEHARA A, 1993, BIOCHEM BIOPH RES CO, V191, P351, DOI 10.1006/bbrc.1993.1224; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Gilmour J, 2014, DEVELOPMENT, V141, P2391, DOI 10.1242/dev.106054; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Goel HL, 2002, CELL PROLIFERAT, V35, P131, DOI 10.1046/j.1365-2184.2002.00232.x; Gordon S. J. V., 2019, JOVE-J VIS EXP, V157; Gordon SJV, 2019, METALLOMICS, V11, P1140, DOI 10.1039/c8mt00348c; Green CJ, 2001, CANCER RES, V61, P2696; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Gunther V, 2012, BBA-MOL CELL RES, V1823, P476, DOI 10.1016/j.bbamcr.2011.10.006; Gunther V, 2012, INT J BIOCHEM CELL B, V44, P404, DOI 10.1016/j.biocel.2011.11.016; Guidi CJ, 2004, J BIOL CHEM, V279, P4180, DOI 10.1074/jbc.M312043200; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; He XQ, 2009, J BIOL CHEM, V284, P12609, DOI 10.1074/jbc.M901204200; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Himeda CL, 2010, MOL CELL BIOL, V30, P3430, DOI 10.1128/MCB.00302-10; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Jeney V, 2005, CIRC RES, V96, P723, DOI 10.1161/01.RES.0000162001.57896.66; Kaler SG, 1998, AM J CLIN NUTR, V67, p1029S, DOI 10.1093/ajcn/67.5.1029S; Karunadharma PP, 2015, FASEB J, V29, P3582, DOI 10.1096/fj.15-272666; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KERN SR, 1981, TOXICOL APPL PHARM, V59, P346, DOI 10.1016/0041-008X(81)90206-4; Kodama H, 1999, PEDIATR INT, V41, P423, DOI 10.1046/j.1442-200x.1999.01095.x; Kodama K, 1999, PEDIATR INT, V41, P430, DOI 10.1046/j.1442-200x.1999.01091.x; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; LaRochelle O, 2001, BIOCHEM J, V353, P591, DOI 10.1042/0264-6021:3530591; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Li Y, 2006, MOL CELL BIOL, V26, P5580, DOI 10.1128/MCB.00471-06; Lichten LA, 2009, AM J PHYSIOL-GASTR L, V296, pG860, DOI 10.1152/ajpgi.90676.2008; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; Linder MC, 1996, AM J CLIN NUTR, V63, P797; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Liu YY, 2010, BIOCHEMISTRY-US, V49, P10006, DOI 10.1021/bi101423j; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Lutsenko S, 2016, METALLOMICS, V8, P840, DOI [10.1039/c6mt00176a, 10.1039/C6MT00176A]; Lynes MA, 2007, ANN NY ACAD SCI, V1113, P159, DOI 10.1196/annals.1391.010; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Merry TL, 2010, AM J PHYSIOL-ENDOC M, V298, pE577, DOI 10.1152/ajpendo.00239.2009; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Miles AT, 2000, CRIT REV BIOCHEM MOL, V35, P35, DOI 10.1080/10409230091169168; Mitchell DL, 2010, MOL BIOL CELL, V21, P2780, DOI 10.1091/mbc.E10-04-0290; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Muller PAJ, 2009, INT J BIOCHEM CELL B, V41, P1233, DOI 10.1016/j.biocel.2008.08.001; Murata M, 1999, J CELL PHYSIOL, V180, P105, DOI 10.1002/(SICI)1097-4652(199907)180:1<105::AID-JCP12>3.0.CO;2-5; Murphy BJ, 1999, CANCER RES, V59, P1315; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nasipak BT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8441; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; OUELLETTE AJ, 1982, DEV BIOL, V92, P240, DOI 10.1016/0012-1606(82)90168-3; Padilla-Benavides T, 2017, J BIOL CHEM, V292, P18592, DOI 10.1074/jbc.M117.799676; Padilla-Benavides T, 2016, METHODS MOL BIOL, V1377, P267, DOI 10.1007/978-1-4939-3179-8_24; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Paskavitz AL, 2018, J TRACE ELEM MED BIO, V49, P27, DOI 10.1016/j.jtemb.2018.04.024; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Potter BM, 2005, J BIOL CHEM, V280, P28529, DOI 10.1074/jbc.M505217200; QUAIFE C, 1986, DEV BIOL, V118, P549, DOI 10.1016/0012-1606(86)90025-4; Raimunda D, 2014, MOL MICROBIOL, V91, P185, DOI 10.1111/mmi.12454; Raimunda D, 2013, METALLOMICS, V5, P144, DOI 10.1039/c2mt20191g; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Saydam N, 2003, J BIOL CHEM, V278, P31879, DOI 10.1074/jbc.M302138200; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Seo SJ, 1996, GENE, V178, P177, DOI 10.1016/0378-1119(96)00383-6; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Siebert X, 2005, BIOPHYS J, V89, P3312, DOI 10.1529/biophysj.105.066100; Sims HI, 2012, P NATL ACAD SCI USA, V109, P16516, DOI 10.1073/pnas.1207737109; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Uno H, 1987, Am J Med Genet Suppl, V3, P367; VANWASSENAERVANHALL HN, 1995, AM J NEURORADIOL, V16, P2021; vanWassenaervanHall HN, 1997, METAB BRAIN DIS, V12, P1; Vendelboe TV, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500980; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Vest KE, 2018, METALLOMICS, V10, P309, DOI 10.1039/c7mt00324b; Wang Y, 2004, FASEB J, V18, P1071, DOI 10.1096/fj.03-1282com; Yokoyama S, 2011, CELL MOL LIFE SCI, V68, P1843, DOI 10.1007/s00018-011-0629-2; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Yuan SM, 2017, METALLOMICS, V9, P1169, DOI 10.1039/c7mt00184c; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001	140	20	20	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14556	14574		10.1096/fj.201901606R	http://dx.doi.org/10.1096/fj.201901606R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690123	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000507466100115
J	Kurahashi, M; Kito, Y; Baker, SA; Jennings, LK; Dowers, JGR; Koh, SD; Sanders, KM				Kurahashi, Masaaki; Kito, Yoshihiko; Baker, Salah A.; Jennings, Libby K.; Dowers, James G. R.; Koh, Sang Don; Sanders, Kenton M.			A novel postsynaptic signal pathway of sympathetic neural regulation of murine colonic motility	FASEB JOURNAL			English	Article						colonic motility; PDGFR alpha(+) cells; sympathetic neural regulation; alpha 1 adrenoceptor	ALPHA-POSITIVE CELLS; IRRITABLE-BOWEL-SYNDROME; SMOOTH-MUSCLE-CELLS; INTERSTITIAL-CELLS; GASTROINTESTINAL MOTILITY; NERVOUS-SYSTEM; RECEPTOR; INNERVATION; INSIGHTS; MECHANISMS	Transcriptome data revealed alpha 1 adrenoceptors (ARs) expression in platelet-derived growth factor receptor alpha(+) cells (PDGFR alpha(+) cells) in murine colonic musculature. The role of PDGFR alpha(+) cells in sympathetic neural regulation of murine colonic motility was investigated. Norepinephrine (NE), via alpha 1A ARs, activated a small conductance Ca2+-activated K+ (SK) conductance, evoked outward currents and hyperpolarized PDGFR alpha(+) cells (the alpha 1A AR-SK channel signal pathway). alpha 1 AR agonists increased intracellular Ca2+ transients in PDGFR alpha(+) cells and inhibited spontaneous phasic contractions (SPCs) of colonic muscle through activation of a SK conductance. Sympathetic nerve stimulation inhibited both contractions of distal colon and propulsive contractions represented by the colonic migrating motor complexes (CMMCs) via the alpha 1A AR-SK channel signal pathway. Postsynaptic signaling through alpha 1A ARs in PDGFR alpha(+) cells is a novel mechanism that conveys part of stress responses in the colon. PDGFR alpha(+) cells appear to be a primary effector of sympathetic neural regulation of murine colonic motility.	[Kurahashi, Masaaki; Baker, Salah A.; Jennings, Libby K.; Dowers, James G. R.; Koh, Sang Don; Sanders, Kenton M.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Anderson Med Bldg MS352, Reno, NV 89557 USA; [Kito, Yoshihiko] Saga Univ, Dept Pharmacol, Saga, Japan	Nevada System of Higher Education (NSHE); University of Nevada Reno; Saga University	Kurahashi, M (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Anderson Med Bldg MS352, Reno, NV 89557 USA.	mkurahashi@med.unr.edu	Dowers, James/GYU-7830-2022	BAKER, SAL/0000-0002-1514-6876	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK-091336]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01-DK-091336	AGGARWAL A, 1994, GASTROENTEROLOGY, V106, P945, DOI 10.1016/0016-5085(94)90753-6; Anderson G, 2007, EXP NEUROL, V207, P4, DOI 10.1016/j.expneurol.2007.05.010; Baker SA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0080-18.2018; Baker SA, 2016, J PHYSIOL-LONDON, V594, P3317, DOI 10.1113/JP271699; Baker SA, 2015, J PHYSIOL-LONDON, V593, P1945, DOI 10.1113/jphysiol.2014.287599; Baker SA, 2013, J PHYSIOL-LONDON, V591, P6193, DOI 10.1113/jphysiol.2013.264747; Berman S, 2012, NEUROIMAGE, V63, P1854, DOI 10.1016/j.neuroimage.2012.08.028; BURNSTOCK G, 1973, GASTROENTEROLOGY, V64, P141; Chhatriwala M, 2004, J PHARMACOL EXP THER, V311, P1038, DOI 10.1124/jpet.104.068650; DePonti F, 1996, PHARMACOL THERAPEUT, V69, P59, DOI 10.1016/0163-7258(95)02031-4; Ford AC, 2017, NEW ENGL J MED, V376, P2566, DOI 10.1056/NEJMra1607547; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; GAGNON DJ, 1972, GUT, V13, P654, DOI 10.1136/gut.13.8.654; Gallego D, 2006, AM J PHYSIOL-GASTR L, V291, pG584, DOI 10.1152/ajpgi.00474.2005; GONELLA J, 1987, PHYSIOL REV, V67, P902, DOI 10.1152/physrev.1987.67.3.902; Ha SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182265; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hwang SJ, 2012, J PHYSIOL-LONDON, V590, P1957, DOI 10.1113/jphysiol.2011.224634; Iino S, 2009, HISTOCHEM CELL BIOL, V131, P691, DOI 10.1007/s00418-009-0580-6; KOH SD, 1997, AM J PHYSIOL-CELL PH, V273; Komuro T, 1999, ARCH HISTOL CYTOL, V62, P295, DOI 10.1679/aohc.62.295; Kurahashi M, 2014, AM J PHYSIOL-CELL PH, V307, pC561, DOI 10.1152/ajpcell.00080.2014; Kurahashi M, 2012, J CELL MOL MED, V16, P1397, DOI 10.1111/j.1582-4934.2011.01510.x; Kurahashi M, 2011, J PHYSIOL-LONDON, V589, P697, DOI 10.1113/jphysiol.2010.201129; Lee MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176031; Lee MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133751; Lomax AE, 2010, NEUROGASTROENT MOTIL, V22, P7, DOI 10.1111/j.1365-2982.2009.01381.x; MANBER L, 1979, AM J PHYSIOL, V236, pE738, DOI 10.1152/ajpendo.1979.236.6.E738; McAllen RM, 1997, CLIN EXP PHARMACOL P, V24, P791, DOI 10.1111/j.1440-1681.1997.tb02693.x; NORBERG K, 1966, PHARMACOL REV, V18, P743; Peri LE, 2013, NEUROGASTROENT MOTIL, V25, pE609, DOI 10.1111/nmo.12174; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Posserud I, 2004, GUT, V53, P1102, DOI 10.1136/gut.2003.017962; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; Sanders KM, 2016, PHYSIOLOGY, V31, P316, DOI 10.1152/physiol.00006.2016; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Smith TK, 2017, AM J PHYSIOL-GASTR L, V312, pG1, DOI 10.1152/ajpgi.00337.2016; Spencer NJ, 2016, J PHYSIOL-LONDON, V594, P4099, DOI 10.1113/JP271919; Spencer NJ, 1998, NEUROGASTROENT MOTIL, V10, P543; Walter GC, 2016, J COMP NEUROL, V524, P2577, DOI 10.1002/cne.23978; Williams TJ, 1999, BRIT J PHARMACOL, V127, P252, DOI 10.1038/sj.bjp.0702541	41	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5563	5577		10.1096/fj.201903134R	http://dx.doi.org/10.1096/fj.201903134R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086857	Bronze, Green Accepted			2022-12-28	WOS:000515258400001
J	Pederson, T				Pederson, Thoru			The double helix: "Photo 51" revisited	FASEB JOURNAL			English	Editorial Material									[Pederson, Thoru] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Pederson, T (corresponding author), Univ Massachusetts, Med Sch, 364 Plantat St, Worcester, MA 01605 USA.	thoru.pederson@umassmed.edu						FRANKLIN RE, 1950, ACTA CRYSTALLOGR, V3, P107, DOI 10.1107/S0365110X50000264; FRANKLIN RE, 1951, PROC R SOC LON SER-A, V209, P196, DOI 10.1098/rspa.1951.0197; FRANKLIN RE, 1949, T FARADAY SOC, V45, P274, DOI 10.1039/tf9494500274; FRANKLIN RE, 1949, T FARADAY SOC, V45, P668, DOI 10.1039/tf9494500668; FRANKLIN RE, 1950, NATURE, V165, P71, DOI 10.1038/165071a0; FRANKLIN RE, 1951, ACTA CRYSTALLOGR, V4, P253, DOI 10.1107/S0365110X51000842; FRANKLIN RE, 1950, ACTA CRYSTALLOGR, V3, P158, DOI 10.1107/S0365110X50000343; JUDSON HF, 1980, MINERVA, V18, P369, DOI 10.1007/BF01096950; Keilin David, 1937, M PERUTZ SECRET LIFE, V122, P298; MADDOX B., 2002, R FRANKLIN DARK LADY; Olby R, 1974, PATH DOUBLE HELIX DI; Pederson T., 2003, J STRUCT BIOL, V141, P5; PERUTZ MF, 1969, SCIENCE, V164, P1537, DOI 10.1126/science.164.3887.1537; Perutz MF, 1969, SCI AM, V221, P8; WILKINS M., 2003, 3 MAN DOUBLE HELIX	15	4	4	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1923	1927		10.1096/fj.202000119	http://dx.doi.org/10.1096/fj.202000119			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	32046470	Bronze			2022-12-28	WOS:000514663600001
J	Reyes, M; Pena-Oyarzun, D; Silva, P; Venegas, S; Criollo, A; Torres, VA				Reyes, Montserrat; Pena-Oyarzun, Daniel; Silva, Patricio; Venegas, Sebastian; Criollo, Alfredo; Torres, Vicente A.			Nuclear accumulation of beta-catenin is associated with endosomal sequestration of the destruction complex and increased activation of Rab5 in oral dysplasia	FASEB JOURNAL			English	Article						cell signaling; destruction complex; endosome; keratinocyte; oral cancer; oral dysplasia; Rab5; beta-catenin	POTENTIALLY MALIGNANT DISORDERS; EPITHELIAL DYSPLASIA; EXPRESSION; LOCALIZATION; PROGRESSION; CLASSIFICATION; TRANSFORMATION; ENDOCYTOSIS; CARCINOMA; MIGRATION	Potentially malignant lesions, commonly referred to as dysplasia, are associated with malignant transformation by mechanisms that remain unclear. We recently reported that increased Wnt secretion promotes the nuclear accumulation of beta-catenin and expression of target genes in oral dysplasia. However, the mechanisms accounting for nuclear re-localization of beta-catenin in oral dysplasia remain unclear. In this study, we show that endosomal sequestration of the beta-catenin destruction complex allows nuclear accumulation of beta-catenin in oral dysplasia, and that these events depended on the endocytic protein Rab5. Tissue immunofluorescence analysis showed aberrant accumulation of enlarged early endosomes in oral dysplasia biopsies, when compared with healthy oral mucosa. These observations were confirmed in cell culture models, by comparing dysplastic oral keratinocytes (DOK) and non-dysplastic oral keratinocytes (OKF6). Intriguingly, DOK depicted higher levels of active Rab5, a critical regulator of early endosomes, when compared with OKF6. Increased Rab5 activity in DOK was necessary for nuclear localization of beta-catenin and Tcf/Lef-dependent transcription, as shown by expression of dominant negative and constitutively active mutants of Rab5, along with immunofluorescence, subcellular fractionation, transcription, and protease protection assays. Mechanistically, elevated Rab5 activity in DOK accounted for endosomal sequestration of components of the destruction complex, including GSK3 beta, Axin, and adenomatous polyposis coli (APC), as observed in Rab5 dominant negative experiments. In agreement with these in vitro observations, tissue immunofluorescence analysis showed increased co-localization of GSK3 beta, APC, and Axin, with early endosome antigen 1- and Rab5-positive early endosomes in clinical samples of oral dysplasia. Collectively, these data indicate that increased Rab5 activity and endosomal sequestration of the beta-catenin destruction complex leads to stabilization and nuclear accumulation of beta-catenin in oral dysplasia.	[Reyes, Montserrat; Pena-Oyarzun, Daniel; Silva, Patricio; Venegas, Sebastian; Criollo, Alfredo; Torres, Vicente A.] Univ Chile, Fac Dent, Inst Res Dent Sci, Calle Sergio Livingstone 943, Santiago, Chile; [Reyes, Montserrat; Pena-Oyarzun, Daniel; Silva, Patricio; Venegas, Sebastian; Criollo, Alfredo; Torres, Vicente A.] Univ Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Reyes, Montserrat] Univ Chile, Fac Dent, Dept Pathol & Oral Med, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Torres, VA (corresponding author), Univ Chile, Fac Dent, Inst Res Dent Sci, Calle Sergio Livingstone 943, Santiago, Chile.	vatorres@odontologia.uchile.cl	Reyes, Montserrat/O-6843-2019	Reyes, Montserrat/0000-0002-4116-4074; Torres, Vicente A/0000-0002-5973-7248	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1180495, 1171075, 3170660]; MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [15130011]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Grant/Award Number: 1180495, 1171075 and 3170660; MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Grant/Award Number: 15130011	Angiero F, 2008, ANTICANCER RES, V28, P2535; Arriagada C, 2019, J BIOL CHEM, V294, P12836, DOI 10.1074/jbc.RA119.008667; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; da Silva SD, 2015, ONCOTARGET, V6, P21950, DOI 10.18632/oncotarget.4277; Diaz J, 2014, J CELL SCI, V127, P2401, DOI 10.1242/jcs.141689; Dost F, 2014, OR SURG OR MED OR PA, V117, P343, DOI 10.1016/j.oooo.2013.09.017; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Fukui K, 2007, HEPATOL RES, V37, P957, DOI 10.1111/j.1872-034X.2007.00143.x; Gonzalez-Moles MA, 2010, ORAL ONCOL, V46, P525, DOI 10.1016/j.oraloncology.2010.03.020; He S, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0052-4; Igarashi T, 2017, ONCOTARGET, V8, P12290, DOI 10.18632/oncotarget.14703; Ishida K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-62; Johnson IRD, 2015, ONCOTARGET, V6, P37919, DOI 10.18632/oncotarget.6114; Jung YS, 2018, NAT CELL BIOL, V20, P1421, DOI 10.1038/s41556-018-0219-8; Li Y, 1999, CLIN EXP METASTAS, V17, P213, DOI 10.1023/A:1006617016451; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Palamidessi A, 2013, CURR BIOL, V23, P2355, DOI 10.1016/j.cub.2013.09.060; Polanska H, 2014, ORAL ONCOL, V50, P168, DOI 10.1016/j.oraloncology.2013.12.008; Prasad CP, 2018, CANCER METAST REV, V37, P767, DOI 10.1007/s10555-018-9760-y; Qin XY, 2017, DRUG DISCOV TODAY, V22, P1139, DOI 10.1016/j.drudis.2017.03.012; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reyes M, 2019, ORAL ONCOL, V94, P58, DOI 10.1016/j.oraloncology.2019.05.010; Reyes M, 2015, MED ORAL PATOL ORAL, V20, pE540, DOI 10.4317/medoral.20341; Saito-Diaz K, 2018, DEV CELL, V44, P566, DOI 10.1016/j.devcel.2018.02.013; Sato K, 2002, ORAL ONCOL, V38, P772, DOI 10.1016/S1368-8375(02)00044-1; Silva P, 2016, ONCOTARGET, V7, P29548, DOI 10.18632/oncotarget.8794; Silva P, 2015, BIOCHEM BIOPH RES CO, V464, P642, DOI 10.1016/j.bbrc.2015.06.176; Speight PM, 2007, HEAD NECK PATHOL, V1, P61, DOI 10.1007/s12105-007-0014-5; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; van der Waal I, 2014, MED ORAL PATOL ORAL, V19, pE386, DOI 10.4317/medoral.20205; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Warnakulasuriya S, 2008, J ORAL PATHOL MED, V37, P127, DOI 10.1111/j.1600-0714.2007.00584.x; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zhao Z, 2010, CANCER SCI, V101, P1454, DOI 10.1111/j.1349-7006.2010.01558.x	43	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4009	4025		10.1096/fj.201902345RR	http://dx.doi.org/10.1096/fj.201902345RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31990106				2022-12-28	WOS:000510650600001
J	Wen, SH; Li, X; Ling, YH; Chen, SQ; Deng, QW; Yang, L; Li, Y; Shen, JT; Qiu, YX; Zhan, YQ; Lai, HJ; Zhang, XY; Ke, ZF; Huang, WQ				Wen, Shihong; Li, Xiang; Ling, Yihong; Chen, Shaoqian; Deng, Qiwen; Yang, Lu; Li, Ying; Shen, Jiantong; Qiu, Yuxin; Zhan, Yaqing; Lai, Hanjin; Zhang, Xuyu; Ke, Zunfu; Huang, Wenqi			HMGB1-associated necroptosis and Kupffer cells M1 polarization underlies remote liver injury induced by intestinal ischemia/reperfusion in rats	FASEB JOURNAL			English	Article						cell death; gut-liver axis; high-mobility group box-1; inflammation	MOBILITY GROUP BOX-1; ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY RESPONSE; REACTIVE OXYGEN; PROTECTS; GUT; ACTIVATION; DEPLETION; RECEPTOR; STRESS	Reperfusion of the ischemic intestine often leads to drive distant organ injury, especially injuries associated with hepatocellular dysfunction. The precise molecular mechanisms and effective multiple organ protection strategies remain to be developed. In the current study, significant remote liver dysfunction was found after 6 hours of reperfusion according to increased histopathological scores, serum lactate dehydrogenase (LDH), alanine aminotransferase (ALT)/aspartate aminotransferase (AST) levels, as well as enhanced bacterial translocation in a rat intestinal ischemia/reperfusion (I/R) injury model. Moreover, receptor-interacting protein kinase 1/3 (RIP1/3) and phosphorylated-MLKL expressions in tissue were greatly elevated, indicating that necroptosis occurred and resulted in acute remote liver function impairment. Inhibiting the necroptotic pathway attenuated HMGB1 cytoplasm translocation and tissue damage. Meanwhile, macrophage-depletion study demonstrated that Kupffer cells (KCs) are responsible for liver damage. Blocking HMGB1 partially restored the liver function via suppressed hepatocyte necroptosis, tissue inflammation, hepatic KCs, and circulating macrophages M1 polarization. What's more, HMGB1 neutralization further protects against intestinal I/R-associated liver damage in microbiota-depleted rats. Therefore, intestinal I/R is likely associated with acute liver damage due to hepatocyte necroptosis, and which could be ameliorated by Nec-1 administration and HMGB1 inhibition with the neutralizing antibody and inhibitor. Necroptosis inhibition and HMGB1 neutralization/inhibition, may emerge as effective pharmacological therapies to minimize intestinal I/R-induced acute remote organ dysfunction.	[Wen, Shihong; Deng, Qiwen; Yang, Lu; Shen, Jiantong; Qiu, Yuxin; Zhan, Yaqing; Zhang, Xuyu; Huang, Wenqi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Peoples R China; [Li, Xiang] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Anesthesiol, Shanghai, Peoples R China; [Ling, Yihong] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China; [Ling, Yihong] Sun Yat Sen Univ, Canc Ctr, Dept Pathol, Guangzhou, Peoples R China; [Chen, Shaoqian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Lab, Guangzhou, Peoples R China; [Li, Ying] State Key Lab Appl Microbiol Southern China, Guangzhou, Peoples R China; [Li, Ying] Guangdong Acad Sci, Guangdong Inst Microbiol, Guangzhou, Peoples R China; [Lai, Hanjin] Sun Yat Sen Univ, Affiliated Hosp 1, Surg Intens Care Unit, Guangzhou, Peoples R China; [Ke, Zunfu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China	Sun Yat Sen University; Shanghai Jiao Tong University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Sun Yat Sen University; Sun Yat Sen University	Huang, WQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Peoples R China.; Ke, ZF (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China.	kezunfu@mail.sysu.edu.cn; scorpiosslove@aliyun.com	Wen, Shihong/T-5246-2019; Wen, shihong/GWC-7753-2022; huang, wen/GXW-0661-2022	Wen, Shihong/0000-0003-3433-2938; Li, Ying/0000-0003-4012-6954	National Natural Science Foundation of China [81772116, 81801895, 81770619]; Natural Science Foundation of Guangdong Province, China [2017A030313572]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from National Natural Science Foundation of China (No. 81772116, No. 81801895 and No. 81770619), and grant from Natural Science Foundation of Guangdong Province, China (No. 2017A030313572).	Acosta S, 2010, SEMIN VASC SURG, V23, P4, DOI 10.1053/j.semvascsurg.2009.12.001; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Beaumont M, 2018, FASEB J, V32, P6681, DOI 10.1096/fj.201800544; Boulter L, 2015, J CLIN INVEST, V125, P1269, DOI 10.1172/JCI76452; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; de Couto G, 2015, J CLIN INVEST, V125, P3147, DOI 10.1172/JCI81321; Degos V, 2013, ANESTHESIOLOGY, V118, P527, DOI 10.1097/ALN.0b013e3182834d94; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Eckhoff DE, 2002, SURGERY, V132, P302, DOI 10.1067/msy.2002.125718; Emal D, 2017, J AM SOC NEPHROL, V28, P1450, DOI 10.1681/ASN.2016030255; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Feng D, 2017, 5TH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER SCIENCE APPLICATIONS AND TECHNOLOGIES (ACSAT 2017), P1, DOI 10.23977/acsat.2017.1001; Ferenbach DA, 2012, KIDNEY INT, V82, P928, DOI 10.1038/ki.2012.207; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Horie Y, 1997, J CLIN INVEST, V99, P781, DOI 10.1172/JCI119224; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Kalimeris K, 2016, J SURG RES, V206, P263, DOI 10.1016/j.jss.2016.08.049; Kanou T, 2018, J HEART LUNG TRANSPL, V37, P1261, DOI 10.1016/j.healun.2018.04.005; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Lei CY, 2015, STROKE, V46, P500, DOI 10.1161/STROKEAHA.114.006825; Li L, 2018, CELL PHYSIOL BIOCHEM, V51, P557, DOI 10.1159/000495276; Li X, 2018, J SURG RES, V225, P108, DOI 10.1016/j.jss.2018.01.007; Linkermann A, 2013, AM J TRANSPLANT, V13, P2797, DOI 10.1111/ajt.12448; Liu JP, 2014, INT J MED SCI, V11, P626, DOI 10.7150/ijms.8228; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Matsuo S, 2018, AM J PHYSIOL-GASTR L, V315, pG283, DOI 10.1152/ajpgi.00024.2018; Meng M, 2017, CURR OPIN CRIT CARE, V23, P143, DOI 10.1097/MCC.0000000000000386; Michael SL, 1999, HEPATOLOGY, V30, P186, DOI 10.1002/hep.510300104; Mihm S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103104; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Oami T, 2018, SHOCK, V50, P427, DOI 10.1097/SHK.0000000000001040; Pavlosky A, 2014, AM J TRANSPLANT, V14, P1778, DOI 10.1111/ajt.12779; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rao J, 2014, AM J TRANSPLANT, V14, P1552, DOI 10.1111/ajt.12711; Rao ZQ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01299; Shafik AN, 2013, DIGEST DIS SCI, V58, P650, DOI 10.1007/s10620-012-2391-1; Shukla PK, 2018, FASEB J, V32, P6274, DOI 10.1096/fj.201800351R; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sturm E, 2005, J HEPATOL, V42, P102, DOI 10.1016/j.jhep.2004.09.019; Sureshbabu A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98411; Takemoto K, 2014, FEBS OPEN BIO, V4, P777, DOI 10.1016/j.fob.2014.08.007; Van Hauwermeiren F, 2015, MUCOSAL IMMUNOL, V8, P828, DOI 10.1038/mi.2014.112; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang Q, 2009, ANESTHESIOLOGY, V110, P1279, DOI 10.1097/ALN.0b013e3181a160d6; Wang XF, 2013, HEPATOLOGY, V57, P373, DOI 10.1002/hep.25982; Wen SH, 2013, SURGERY, V153, P555, DOI 10.1016/j.surg.2012.09.017; Wen SH, 2017, J CELL MOL MED, V21, P432, DOI 10.1111/jcmm.12987; Wiest R, 2014, J HEPATOL, V60, P197, DOI 10.1016/j.jhep.2013.07.044; Yamagishi Y, 2002, AM J PHYSIOL-GASTR L, V282, pG640, DOI 10.1152/ajpgi.00171.2001; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yasuda T, 2006, PANCREAS, V33, P359, DOI 10.1097/01.mpa.0000236741.15477.8b; Yokoi T, 2018, SURGERY, V163, P270, DOI 10.1016/j.surg.2017.08.025; Zelic M, 2018, J CLIN INVEST, V128, P2064, DOI 10.1172/JCI96147; Zhao HL, 2018, AM J TRANSPLANT, V18, P1890, DOI 10.1111/ajt.14699; Zhao HL, 2015, KIDNEY INT, V87, P738, DOI 10.1038/ki.2014.388; Zhou S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00948	66	39	42	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4384	4402		10.1096/fj.201900817R	http://dx.doi.org/10.1096/fj.201900817R		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31961020	hybrid			2022-12-28	WOS:000508840200001
J	de Laffolie, J; Sheridan, D; Reinshagen, K; Wessel, L; Zimmermann, C; Stricker, S; Lerch, MM; Weigel, M; Hain, T; Domann, E; Rudloff, S; Nichols, BL; Naim, HY; Zimmer, KP				de Laffolie, Jan; Sheridan, Diana; Reinshagen, Konrad; Wessel, Lucas; Zimmermann, Christian; Stricker, Sebastian; Lerch, Markus M.; Weigel, Markus; Hain, Torsten; Domann, Eugen; Rudloff, Silvia; Nichols, Buford L.; Naim, Hassan Y.; Zimmer, Klaus-Peter			Digestive enzyme expression in the large intestine of children with short bowel syndrome in a late stage of adaptation	FASEB JOURNAL			English	Article						enteral nutrition; microbiota; parenteral nutrition; pediatric intestinal failure; pediatric short bowel syndrome; prognostic factors	MICROBIOTA SIGNATURES; ADULT PATIENTS; RAT MODEL; RESECTION; COLON; GROWTH; FEATURES; STARCH	Background and aims: Intestinal adaptation in short bowel syndrome (SBS) includes morphologic processes and functional mechanisms. This study investigated whether digestive enzyme expression in the duodenum and colon is upregulated in SBS patients. Method: Sucrase-isomaltase (SI), lactase-phlorizin hydrolase (LPH), and neutral Aminopeptidase N (ApN) were analyzed in duodenal and colonic biopsies from nine SBS patients in a late stage of adaptation as well as healthy and disease controls by immunoelectron microscopy (IEM), Western blots, and enzyme activities. Furthermore, proliferation rates and intestinal microbiota were analyzed in the mucosal specimen. Results: We found significantly increased amounts of SI, LPH, and ApN in colonocytes in most SBS patients with large variation and strongest effect for SI and ApN. Digestive enzyme expression was only partially elevated in duodenal enterocytes due to a low proliferation level measured by Ki-67 staining. Microbiome analysis revealed high amounts of Lactobacillus resp. low amounts of Proteobacteria in SBS patients with preservation of colon and ileocecal valve. Colonic expression was associated with a better clinical course in single cases. Conclusion: In SBS patients disaccharidases and peptidases can be upregulated in the colon. Stimulation of this colonic intestinalization process by drugs, nutrients, and pre- or probiotics might offer better therapeutic approaches.	[de Laffolie, Jan; Zimmermann, Christian; Stricker, Sebastian; Rudloff, Silvia; Zimmer, Klaus-Peter] Justus Liebig Univ Giessen, Dept Paediat, Giessen, Germany; [Sheridan, Diana] Justus Liebig Univ Giessen, Dept Pathol, Giessen, Germany; [Reinshagen, Konrad] UKE Univ Hosp Eppendorf, Altona Childrens Hosp, Dept Pediat Surg, Hamburg, Germany; [Wessel, Lucas] Heidelberg Univ, Med Fac Mannheim, Dept Pediat Surg, Mannheim, Germany; [Lerch, Markus M.] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med A, Greifswald, Germany; [Weigel, Markus; Hain, Torsten; Domann, Eugen] Justus Liebig Univ Giessen, Inst Med Microbiol, Giessen, Germany; [Weigel, Markus; Hain, Torsten; Domann, Eugen] Justus Liebig Univ Giessen, German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Giessen, Germany; [Nichols, Buford L.] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Ernst Moritz Arndt Universitat Greifswald; Justus Liebig University Giessen; German Center for Infection Research; Justus Liebig University Giessen; Baylor College of Medicine; University of Veterinary Medicine Hannover, Foundation	de Laffolie, J (corresponding author), Univ Giessen, Dept Gen Pediat & Neonatol, Feulgenstr 12, D-35392 Giessen, Germany.	jan.delaffolie@paediat.med.uni-giessen.de	Zimmer, Klaus-Peter/AAY-9261-2020; Lerch, Markus M./E-2206-2016; Zimmer, Klaus-Peter/AAY-9351-2020; de Laffolie, Jan/K-2215-2019	Lerch, Markus M./0000-0002-9643-8263; de Laffolie, Jan/0000-0003-1023-7442; Weigel, Markus/0000-0002-3140-3174	German Research Foundation (DFG) [SFB621]; Justus Liebig University Giessen	German Research Foundation (DFG)(German Research Foundation (DFG)); Justus Liebig University Giessen	German Research Foundation (DFG) (SFB621, to HYN); intramural funding from Justus Liebig University Giessen	Buccigrossi V, 2013, J PEDIATR GASTR NUTR, V56, P40, DOI 10.1097/MPG.0b013e318268a9a4; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Davidovics ZH, 2016, JPEN-PARENTER ENTER, V40, P1106, DOI 10.1177/0148607115591216; Domann E, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00747-16; Dou Y, 2002, NEUROGASTROENT MOTIL, V14, P43, DOI 10.1046/j.1365-2982.2002.00301.x; Dunn JCY, 1997, J SURG RES, V67, P90, DOI 10.1006/jsre.1996.4959; Engelstad HJ, 2018, J AM COLL SURGEONS, V227, P439, DOI 10.1016/j.jamcollsurg.2018.07.657; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1047, DOI 10.1152/ajpgi.1992.262.6.G1047; Fouhse JM, 2015, J NUTR, V145, P2464, DOI 10.3945/jn.115.214353; Gao S, 2018, NAT CELL BIOL, V20, DOI 10.1038/s41556-018-0105-4; Gillard L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00224; GRIFFITHS G, 1986, J HISTOCHEM CYTOCHEM, V34, P1389, DOI 10.1177/34.11.3534077; Huang YH, 2017, J GASTROEN HEPATOL, V32, P1949, DOI 10.1111/jgh.13806; Jiang HP, 2011, WORLD J GASTROENTERO, V17, P2572, DOI 10.3748/wjg.v17.i20.2572; Joly F, 2009, AM J PHYSIOL-GASTR L, V297, pG116, DOI 10.1152/ajpgi.90657.2008; King DR, 1996, AUST NZ J SURG, V66, P543, DOI 10.1111/j.1445-2197.1996.tb00806.x; Korpela K, 2017, JPEN-PARENTER ENTER, V41, P238, DOI 10.1177/0148607115584388; Kouti V, 2011, FUND CLIN PHARMACOL, V25, P734, DOI 10.1111/j.1472-8206.2010.00901.x; Li GP, 2015, J MICROBIOL BIOTECHN, V25, P1136, DOI 10.4014/jmb.1412.12047; Lilja HE, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0084-7; Liu XW, 2006, AM J CLIN NUTR, V84, P1142, DOI 10.1093/ajcn/84.5.1142; Maldonado-Gomez MX, 2016, CELL HOST MICROBE, V20, P515, DOI 10.1016/j.chom.2016.09.001; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Mayeur C, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4010016; MENARD D, 1987, J PEDIATR GASTR NUTR, V6, P509, DOI 10.1097/00005176-198707000-00003; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; Musch MW, 2002, AM J PHYSIOL-GASTR L, V283, pG975, DOI 10.1152/ajpgi.00528.2001; Neelis E, 2019, JPEN-PARENTER ENTER, V43, P194, DOI 10.1002/jpen.1423; NIGHTINGALE JMD, 1992, GUT, V33, P1493, DOI 10.1136/gut.33.11.1493; Norsa L, 2019, AM J CLIN NUTR, V109, P1112, DOI 10.1093/ajcn/nqy367; Pereira-Fantini PM, 2011, HISTOCHEM CELL BIOL, V135, P195, DOI 10.1007/s00418-011-0778-2; Piper HG, 2017, JPEN-PARENTER ENTER, V41, P1202, DOI 10.1177/0148607116658762; Rossi L, 2007, J PEDIATR GASTR NUTR, V45, P213, DOI 10.1097/MPG.0b013e31803c75e8; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Sigalet DL, 2006, DIGEST DIS SCI, V51, P1557, DOI 10.1007/s10620-006-9077-5; Sukhotnik I, 2004, PEDIATR SURG INT, V20, P185, DOI 10.1007/s00383-004-1143-5; Sukhotnik I, 2012, AM J PHYSIOL-GASTR L, V302, pG1274, DOI 10.1152/ajpgi.00532.2011; Thiesen A, 2003, BEST PRACT RES CL GA, V17, P981, DOI 10.1016/S1521-6918(03)00097-0; Topping DL, 1997, J NUTR, V127, P615, DOI 10.1093/jn/127.4.615; Tremblay E, 2011, J PEDIATR GASTR NUTR, V52, P670, DOI 10.1097/MPG.0b013e3182078370; Turner JM, 2011, J PEDIATR GASTR NUTR, V52, P9, DOI 10.1097/MPG.0b013e3181f18ca0; VANDERHOOF JA, 1992, GASTROENTEROLOGY, V102, P1949, DOI 10.1016/0016-5085(92)90318-S; Vegge A, 2013, AM J PHYSIOL-GASTR L, V305, pG277, DOI 10.1152/ajpgi.00064.2013; Wang WS, 2012, PEDIATR SURG INT, V28, P533, DOI 10.1007/s00383-012-3075-9; Wetzel G, 2009, BIOL CHEM, V390, P545, DOI 10.1515/BC.2009.077; Yang Q, 2010, J PEDIATR GASTR NUTR, V50, P16, DOI 10.1097/MPG.0b013e3181c2c2af; Zeichner SL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215351; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007; Ziegler TR, 2002, AM J CLIN NUTR, V75, P922, DOI 10.1093/ajcn/75.5.922; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656; ZWEIBAUM A, 1984, INT J CANCER, V34, P591, DOI 10.1002/ijc.2910340502	51	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3983	3995		10.1096/fj.201901758RR	http://dx.doi.org/10.1096/fj.201901758RR		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31957074	hybrid			2022-12-28	WOS:000508135700001
J	Lyozin, GT; Brunelli, L				Lyozin, George T.; Brunelli, Luca			Live-cell PCR and one-step purification streamline DNA engineering	FASEB JOURNAL			English	Article						colony PCR; DNA gap repair; DNA purification; melting curve analysis	ESCHERICHIA-COLI	In vivo DNA engineering such as recombineering (recombination-mediated genetic engineering) and DNA gap repair typically involve growing Escherichia coli (E coli) containing plasmids, followed by plasmid DNA extraction and purification prior to downstream PCR-mediated DNA modifications and DNA sequencing. We previously demonstrated that crude cell lysates could be used for some limited downstream DNA applications. Here, we show how live E coli cell PCR and one-step LiCl-isopropanol purification can streamline DNA engineering. In DNA gap repair, live-cell PCR allowed the convenient elimination of clones containing background plasmids prior to DNA sequencing. Live-cell PCR also enabled the generation of specific DNA sequences for DNA engineering up to 11 kilo base pairs in length and with up to 80 base pair terminal non-homology. Using gel electrophoresis and DNA melting curve analysis, we showed that LiCl-isopropanol DNA precipitation removed primers and small, nonspecific PCR products from live-cell PCR products in only similar to 10-minutes. DNA sequencing of purified products yielded Phred quality scores values of similar to 55%. These data indicate that live-cell PCR and LiCl-isopropanol DNA precipitation are ideal to prepare DNA for sequencing and other downstream DNA applications, and might therefore accelerate high-throughput DNA engineering pipelines.	[Lyozin, George T.; Brunelli, Luca] Univ Nebraska Med Ctr, Dept Pediat, DRC 2,Rm 4034,601 S Saddle Creek Rd, Omaha, NE 68106 USA; [Lyozin, George T.; Brunelli, Luca] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68106 USA; [Brunelli, Luca] Univ Utah, Dept Pediat Neonatol, Salt Lake City, UT USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Utah System of Higher Education; University of Utah	Brunelli, L (corresponding author), Univ Nebraska Med Ctr, Dept Pediat, DRC 2,Rm 4034,601 S Saddle Creek Rd, Omaha, NE 68106 USA.	Luca.Brunelli@hsc.utah.edu			Department of Pediatrics, University of Nebraska	Department of Pediatrics, University of Nebraska	Department of Pediatrics, University of Nebraska intramural funds	BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flock S, 1996, BIOPHYS J, V70, P1456, DOI 10.1016/S0006-3495(96)79705-9; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Freitas SS, 2006, BIOTECHNOL PROGR, V22, P1179, DOI 10.1021/bp060052d; Gasperini M, 2016, NAT PROTOC, V11, P1782, DOI 10.1038/nprot.2016.135; Green MR, 2012, MOL CLONING LAB MANU, V1; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Lezin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023457; Lezin G, 2011, BIOTECHNOL BIOENG, V108, P1872, DOI 10.1002/bit.23116; Lyozin George T, 2017, Curr Protoc Mol Biol, V118, DOI 10.1002/cpmb.34; Lyozin GT, 2014, NAT METHODS, V11, P966, DOI [10.1038/NMETH.3030, 10.1038/nmeth.3030]; Lyozin GT, 2019, 313155 BIORXIV, P313155; MANDECKI W, 1986, P NATL ACAD SCI USA, V83, P7177, DOI 10.1073/pnas.83.19.7177; Miura M, 2013, REV INST MED TROP SP, V55, P401, DOI 10.1590/S0036-46652013000600005; SANDHU GS, 1989, BIOTECHNIQUES, V7, P689; SEMANCIK JS, 1983, ANAL BIOCHEM, V135, P275, DOI 10.1016/0003-2697(83)90683-8; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; Wei XM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004819; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Zeugin JA Hartley JL., 1985, FOCUS, V7, P1, DOI DOI 10.1108/EB015969	24	2	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3448	3460		10.1096/fj.201902261R	http://dx.doi.org/10.1096/fj.201902261R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944382	Bronze			2022-12-28	WOS:000507593300001
J	Baster, Z; Li, LQ; Kukkurainen, S; Chen, J; Pentikainen, O; Gyorffy, B; Hytonen, VP; Zhu, HN; Rajfur, Z; Huang, C				Baster, Zbigniew; Li, Liqing; Kukkurainen, Sampo; Chen, Jing; Pentikainen, Olli; Gyorffy, Balazs; Hytonen, Vesa P.; Zhu, Haining; Rajfur, Zenon; Huang, Cai			Cyanidin-3-glucoside binds to talin and modulates colon cancer cell adhesions and 3D growth	FASEB JOURNAL			English	Article						adhesion; cancer prevention; cyanidin-3-glucoside; drug discovery; molecular docking; talin1; talin2; beta-integrin	PROTEIN-LIGAND DOCKING; INTEGRIN; ANTHOCYANINS; VINCULIN; INVASION; SITES; PHOSPHORYLATION; INFLAMMATION; FIBRONECTIN; REVEALS	Cyanidin-3-glucoside (C3G) is a natural pigment, found in many colorful fruits and vegetables. It has many health benefits, including anti-inflammation, cancer prevention, and anti-diabetes. Although C3G is assumed to be an antioxidant, it has been reported to affect cell-matrix adhesions. However, the underlying molecular mechanism is unknown. Here, we show that the expression of talin1, a key regulator of integrins and cell adhesions, negatively correlated with the survival rate of colon cancer patients and that depletion of talin1 inhibited 3D spheroid growth in colon cancer cells. Interestingly, C3G bound to talin and promoted the interaction of talin with beta 1A-integrin. Molecular docking analysis shows that C3G binds to the interface of the talin-beta-integrin complex, acting as an allosteric regulator and altering the interaction between talin and integrin. Moreover, C3G promoted colon cancer cell attachment to fibronectin. While C3G had no significant effect on colon cancer cell proliferation, it significantly inhibited 3D spheroid growth in fibrin gel assays. Since C3G has no or very low toxicity, it could be potentially used for colon cancer prevention or therapy.	[Baster, Zbigniew; Li, Liqing; Huang, Cai] Univ Kentucky, Dept Pharmacol & Nutr Sci, Markey Canc Ctr, Todd Bldg,Room 551,789 South Limestone St, Lexington, KY 40536 USA; [Baster, Zbigniew; Rajfur, Zenon] Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Inst Phys, Krakow, Poland; [Kukkurainen, Sampo; Hytonen, Vesa P.] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Chen, Jing; Zhu, Haining] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA; [Pentikainen, Olli] Univ Turku, Inst Biomed Integrat Physiol & Pharmacol, Turku, Finland; [Gyorffy, Balazs] Hungarian Acad Sci, Inst Enzymol, MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland; [Huang, Cai] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA	University of Kentucky; Jagiellonian University; Tampere University; University of Kentucky; University of Turku; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Kentucky	Huang, C (corresponding author), Univ Kentucky, Dept Pharmacol & Nutr Sci, Markey Canc Ctr, Todd Bldg,Room 551,789 South Limestone St, Lexington, KY 40536 USA.; Rajfur, Z (corresponding author), Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Inst Phys, Krakow, Poland.	zenon.rajfur@uj.edu.pl; cai-huang@uky.edu	LI, LI/GVS-5344-2022; Hytonen, Vesa P./E-8855-2013; LI, LI QING/GRR-8855-2022; li, li/AAT-2097-2020; Baster, Zbigniew/L-5174-2013; li, li/GPX-3938-2022; li, li/HII-4157-2022; Gyorffy, Balazs/AAA-9135-2021; Li, Li/AEM-3636-2022	Hytonen, Vesa P./0000-0002-9357-1480; Baster, Zbigniew/0000-0002-5987-5712; Gyorffy, Balazs/0000-0002-5772-3766; Kukkurainen, Sampo/0000-0002-0635-784X	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R01 GM122994]; Faculty of Physics, Astronomy, and Applied Computer Science of Jagiellonian University [N17/MNS/000006]; BRATNIAK Jagiellonian University Students and Graduates Foundation	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); Faculty of Physics, Astronomy, and Applied Computer Science of Jagiellonian University; BRATNIAK Jagiellonian University Students and Graduates Foundation	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01 GM122994; Faculty of Physics, Astronomy, and Applied Computer Science of Jagiellonian University, Grant/Award Number: N17/MNS/000006; BRATNIAK Jagiellonian University Students and Graduates Foundation	Aguilar F, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3145; Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arnaout M Amin, 2016, F1000Res, V5; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bru A, 2003, BIOPHYS J, V85, P2948, DOI 10.1016/S0006-3495(03)74715-8; BURRIDGE K, 1983, CELL MOTIL CYTOSKEL, V3, P405, DOI 10.1002/cm.970030509; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chen PN, 2006, CHEM-BIOL INTERACT, V163, P218, DOI 10.1016/j.cbi.2006.08.003; Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033; Chung J, 2008, MICROSC RES TECHNIQ, V71, P380, DOI 10.1002/jemt.20566; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Ding M, 2006, J BIOL CHEM, V281, P17359, DOI 10.1074/jbc.M600861200; Feral CC, 2008, DIABETES, V57, P1842, DOI 10.2337/db07-1751; Ferrari D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3454023; Galvano Fabio, 2007, Ann Ist Super Sanita, V43, P382; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Guo HH, 2008, BIOCHEM PHARMACOL, V75, P1393, DOI 10.1016/j.bcp.2007.11.016; Heida NM, 2010, ARTERIOSCL THROM VAS, V30, P200, DOI 10.1161/ATVBAHA.109.192807; Hemmings L, 1996, J CELL SCI, V109, P2715; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Jayaprakasam B, 2005, J AGR FOOD CHEM, V53, P28, DOI 10.1021/jf049018+; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Kourtzelis I, 2017, J LEUKOCYTE BIOL, V102, P677, DOI 10.1189/jlb.3MR0117-024R; Lee JS, 2015, INT J MOL MED, V35, P405, DOI 10.3892/ijmm.2014.2013; Li LQ, 2017, ONCOTARGET, V8, P106876, DOI 10.18632/oncotarget.22449; Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/NMAT3361, 10.1038/nmat3361]; Lohachoompol V, 2004, J BIOMED BIOTECHNOL, P248; Ma X, 2019, PHYTOTHER RES, V33, P81, DOI 10.1002/ptr.6201; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Pace E, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7020024; Pantan R, 2016, EXP CELL RES, V342, P104, DOI 10.1016/j.yexcr.2016.02.017; Petrovic MG, 2003, J HUM GENET, V48, P457, DOI 10.1007/s10038-003-0060-0; Prior RL, 2003, AM J CLIN NUTR, V78, p570S, DOI 10.1093/ajcn/78.3.570S; Qi L, 2018, CURR PROTEIN PEPT SC, V19, P1071, DOI 10.2174/1389203719666180809094731; Qi L, 2016, J CELL SCI, V129, P3661, DOI 10.1242/jcs.185959; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Reis JF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1076-5; ROTH T, 1993, P NATL ACAD SCI USA, V90, P9640, DOI 10.1073/pnas.90.20.9640; Rozanska D, 2018, ADV CLIN EXP MED, V27, P135, DOI 10.17219/acem/64983; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Rupasinghe HPV, 2018, J FUNCT FOODS, V44, P24, DOI 10.1016/j.jff.2018.02.023; Sztupinszki Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep37169; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; ten Brink T, 2009, J CHEM INF MODEL, V49, P1535, DOI 10.1021/ci800420z; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Warner EF, 2017, MOL NUTR FOOD RES, V61, DOI [10.1002/mnfr.201600053, 10.1002/mnfr.201700053]; Xu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-285; YANG XD, 1994, P NATL ACAD SCI USA, V91, P12604, DOI 10.1073/pnas.91.26.12604; You YL, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700261; Yuan YX, 2017, SCI REP-UK, V7, DOI 10.1038/srep41989; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	56	9	9	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2227	2237		10.1096/fj.201900945R	http://dx.doi.org/10.1096/fj.201900945R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916632				2022-12-28	WOS:000506442100001
J	Zhao, HJ; Klausen, C; Zhu, H; Chang, HM; Li, Y; Leung, PCK				Zhao, Hong-Jin; Klausen, Christian; Zhu, Hua; Chang, Hsun-Ming; Li, Yan; Leung, Peter C. K.			Bone morphogenetic protein 2 promotes human trophoblast cell invasion and endothelial-like tube formation through ID1-mediated upregulation of IGF binding protein-3	FASEB JOURNAL			English	Article						BMP2; ID1; IGFBP3; trophoblast invasion; tube formation	GROWTH-FACTOR; EMBRYO IMPLANTATION; SIGNALING PATHWAYS; OVER-EXPRESSION; ID-1 EXPRESSION; GENE-EXPRESSION; ACTIVIN-A; ANGIOGENESIS; DIFFERENTIATION; IGFBP-3	Extravillous cytotrophoblasts (EVTs) invade into the uterine wall and remodel spiral arteries for proper placentation. Studies from us and others have demonstrated that the transforming growth factor-beta superfamily member bone morphogenetic protein 2 (BMP2) plays important roles in endometrial decidualization and trophoblast cell invasion. However, BMP2 has also been shown to regulate endothelial cell migration and capillary-like tube formation, as has its downstream signaling molecule inhibitor of DNA binding 1 (ID1). Interestingly, insulin-like growth factor binding protein 3 (IGFBP3) also promotes cell migration and angiogenesis in endothelial precursor cell. Moreover, Id1 has a regulatory effect on Igfbp3 expression in rat prostate epithelial cells. However, whether ID1 and IGFBP3 are integrated in BMP2 signaling and involved in the regulation of trophoblast invasive and endovascular differentiation remains unknown. The objective of our study was to examine the effects of BMP2 on ID1 and IGFBP3 expression and their roles in BMP2-regulated human trophoblast invasion and endothelial-like tube formation. Primary and immortalized (HTR8/SVneo) cultures of human trophoblast cells were employed as study models. BMP2 treatment increased ID1 and IGFBP3 mRNA and protein levels in HTR8/SVneo and primary human EVT cells. Intriguingly, ID1 was essential for BMP2-induced IGFBP3 upregulation in both study models, and BMP2-induced trophoblast invasion was attenuated by knockdown of either ID1 or IGFBP3. In addition, BMP2 significantly increased endothelial-like tube formation and knockdown of ID1 and IGFBP3 reduced basal and BMP2-induced tube formation in HTR8/SVneo cells. Similarly, BMP2 increased placenta growth factor (PlGF) production in HTR8/SVneo cells and these effects were attenuated by knockdown of ID1 or IGFBP3. Our results reveal that BMP2 promotes trophoblast cell invasion and endothelial-like tube formation by ID1-mediated IGFBP3 upregulation.	[Zhao, Hong-Jin] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China; [Zhao, Hong-Jin; Klausen, Christian; Zhu, Hua; Chang, Hsun-Ming; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Li, Yan] Shandong Univ, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Li, Yan] Shandong Univ, Ctr Reprod Med, Jinan, Shandong, Peoples R China; [Li, Yan] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Shandong, Peoples R China; [Li, Yan] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of British Columbia; Shandong University; Shandong University	Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.; Li, Y (corresponding author), Shandong Univ, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	yanli.sdu@gmail.com; peter.leung@ubc.ca	Chang, Hsun-Ming/M-8584-2018; Li, Yan/AAK-5719-2020	Li, Yan/0000-0003-1813-8115; Zhao, Hong-Jin/0000-0001-5296-2293; Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research [FDN-143317]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a Foundation grant (FDN-143317) from the Canadian Institutes of Health Research to PCKL	Ahn S, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12722; Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Barucker C, 2015, J ALZHEIMERS DIS, V44, P613, DOI 10.3233/JAD-141902; Biadasiewicz K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115279; Burrows C, 2006, ENDOCRINOLOGY, V147, P3484, DOI 10.1210/en.2006-0005; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Darby S, 2008, J PATHOL, V214, P394, DOI 10.1002/path.2292; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Forootan SS, 2007, HUM PATHOL, V38, P1321, DOI 10.1016/j.humpath.2007.02.011; Gangopahyay A, 2011, J BIOL CHEM, V286, P33134, DOI 10.1074/jbc.M111.274100; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Han JY, 2006, MOL CELLS, V22, P168; Han VKM, 1996, J CLIN ENDOCR METAB, V81, P2680, DOI 10.1210/jcem.81.7.8675597; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Highet AR, 2015, EUR J CELL BIOL, V94, P589, DOI 10.1016/j.ejcb.2015.10.004; Hu Y, 2010, PLACENTA, V31, P213, DOI 10.1016/j.placenta.2009.12.011; IruelaArispe ML, 1997, J CLIN INVEST, V99, P2057, DOI 10.1172/JCI119374; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Li B, 2016, CLIN CANCER RES, V22, P1243, DOI 10.1158/1078-0432.CCR-15-1196; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li Y, 2015, ENDOCRINOLOGY, V156, P4257, DOI 10.1210/en.2015-1228; Li Y, 2014, J CLIN ENDOCR METAB, V99, pE2216, DOI 10.1210/jc.2014-2118; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Lim KH, 1997, AM J PATHOL, V151, P1809; Ling F, 2014, CURR TOP DEV BIOL, V110, P189, DOI 10.1016/B978-0-12-405943-6.00005-1; Ling MT, 2002, BBA-GEN SUBJECTS, V1570, P145, DOI 10.1016/S0304-4165(02)00189-7; Luo RC, 2014, HYPERTENSION, V64, P839, DOI 10.1161/HYPERTENSIONAHA.114.03530; Mark EB, 2006, ARCH DERMATOL RES, V297, P459, DOI 10.1007/s00403-006-0649-1; Marrony S, 2003, BONE, V33, P426, DOI 10.1016/S8756-3282(03)00195-9; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mayo JC, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12373; Natsuizaka M, 2010, CARCINOGENESIS, V31, P1344, DOI 10.1093/carcin/bgq108; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Paria BC, 2001, P NATL ACAD SCI USA, V98, P1047, DOI 10.1073/pnas.98.3.1047; Pijnenborg R, 2011, BEST PRACT RES CL OB, V25, P273, DOI 10.1016/j.bpobgyn.2010.10.009; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Renaud SJ, 2015, P NATL ACAD SCI USA, V112, pE6175, DOI 10.1073/pnas.1507397112; Ryan DH, 2018, PREGNANCY HYPERTENS, V14, P260, DOI 10.1016/j.preghy.2018.03.003; Schmidt M, 2010, CELL MOL BIOL LETT, V15, P272, DOI 10.2478/s11658-010-0007-3; Sharma S, 2016, AM J REPROD IMMUNOL, V75, P341, DOI 10.1111/aji.12466; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Soncin F, 2015, CELL MOL LIFE SCI, V72, P1291, DOI 10.1007/s00018-014-1794-x; Suman P, 2013, FERTIL STERIL, V99, P533, DOI 10.1016/j.fertnstert.2012.10.004; Terracciano D, 2012, PROSTATE, V72, P100, DOI 10.1002/pros.21411; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Xu WW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14399; Xue WC, 2005, HISTOPATHOLOGY, V47, P303, DOI 10.1111/j.1365-2559.2005.02190.x; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zhang QL, 2015, INT J MOL SCI, V16, P17734, DOI 10.3390/ijms160817734; Zhao HJ, 2018, ENDOCRINOLOGY, V159, P2815, DOI 10.1210/en.2018-00301; Zhao HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0230-1; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387; Zuo WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37499	69	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3151	3164		10.1096/fj.201902168RR	http://dx.doi.org/10.1096/fj.201902168RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31908038	Bronze			2022-12-28	WOS:000505525800001
J	Hong, CJ; Yeon, J; Yeo, BK; Woo, H; An, HK; Heo, W; Kim, K; Yu, SW				Hong, Caroline Jeeyeon; Yeon, Jihye; Yeo, Bo Kyoung; Woo, Hanwoong; An, Hyun-Kyu; Heo, Woojung; Kim, Kyuhyung; Yu, Seong-Woon			Fas-apoptotic inhibitory molecule 2 localizes to the lysosome and facilitates autophagosome-lysosome fusion through the LC3 interaction region motif-dependent interaction with LC3	FASEB JOURNAL			English	Article						autolysosome; autophagosome maturation; FAIM2; LIR; MAP1LC3B; xbx-6	PROTEIN; ACIDIFICATION; DEGRADATION; ATPASE; MODULATION; MATURATION; SYNTHASE; GENES; FAIM2; TMBIM	Fas-apoptotic inhibitory molecule 2 (FAIM2) is a member of the transmembrane BAX inhibitor motif-containing (TMBIM) family. TMBIM family is comprised of six anti-apoptotic proteins that suppress cell death by regulating endoplasmic reticulum Ca2+ homeostasis. Recent studies have implicated two TMBIM proteins, GRINA and BAX Inhibitor-1, in mediating cytoprotection via autophagy. However, whether FAIM2 plays a role in autophagy has been unknown. Here we show that FAIM2 localizes to the lysosomes at basal state and facilitates autophagy through interaction with microtubule-associated protein 1 light chain 3 proteins in human neuroblastoma SH-SY5Y cells. FAIM2 overexpression increased autophagy flux, while autophagy flux was impaired in shRNA-mediated knockdown (shFAIM2) cells, and the impairment was more evident in the presence of rapamycin. In shFAIM2 cells, autophagosome maturation through fusion with lysosomes was impaired, leading to accumulation of autophagosomes. A functional LC3-interacting region motif within FAIM2 was essential for the interaction with LC3 and rescue of autophagy flux in shFAIM2 cells while LC3-binding property of FAIM2 was dispensable for the anti-apoptotic function in response to Fas receptor-mediated apoptosis. Suppression of autophagosome maturation was also observed in a null mutant of Caenorhabditis elegans lacking xbx-6, the ortholog of FAIM2. Our study suggests that FAIM2 is a novel regulator of autophagy mediating autophagosome maturation through the interaction with LC3.	[Hong, Caroline Jeeyeon; Yeon, Jihye; Yeo, Bo Kyoung; Woo, Hanwoong; An, Hyun-Kyu; Heo, Woojung; Kim, Kyuhyung; Yu, Seong-Woon] Daegu Gyeongbuk Inst Sci & Technol DGIST, Dept Brain & Cognit Sci, 333 Techno Jungang Daero, Dalseong Gun 42988, Daegu, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Yu, SW (corresponding author), Daegu Gyeongbuk Inst Sci & Technol DGIST, Dept Brain & Cognit Sci, 333 Techno Jungang Daero, Dalseong Gun 42988, Daegu, South Korea.	yusw@dgist.ac.kr			National Research Foundation of Korea (NRF) [2018M3C7A1056275]; DGIST Convergence Science Center Program [19-BD-0402]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); DGIST Convergence Science Center Program	National Research Foundation of Korea (NRF), Grant/Award Number: 2018M3C7A1056275; DGIST Convergence Science Center Program, Grant/Award Number: 19-BD-0402	Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bagh MB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14612; Besirli CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046664; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BRENNER S, 1974, GENETICS, V77, P71; Chang JT, 2017, ELIFE, V6, DOI 10.7554/eLife.18459; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gauthier T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128701; Gomez NM, 2018, FASEB J, V32, P782, DOI 10.1096/fj.201700220RR; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Lisak DA, 2015, BBA-MOL CELL RES, V1853, P2104, DOI 10.1016/j.bbamcr.2015.03.002; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Park H, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00046; Pawar M, 2017, CELL DEATH DIFFER, V24, P1799, DOI 10.1038/cdd.2017.109; Planells-Ferrer L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.356; Popelka H, 2015, AUTOPHAGY, V11, P2153, DOI 10.1080/15548627.2015.1111503; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reich A, 2011, J NEUROSCI, V31, P225, DOI 10.1523/JNEUROSCI.2188-10.2011; Reimers K, 2006, INT J MOL MED, V18, P729; Rogov VV, 2017, EMBO REP, V18, P1382, DOI 10.15252/embr.201643587; Schaaf MBE, 2016, FASEB J, V30, P3961, DOI 10.1096/fj.201600698R; Schweitzer B, 2002, MOL BRAIN RES, V107, P47, DOI 10.1016/S0169-328X(02)00445-X; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Tauber SC, 2014, J NEUROPATH EXP NEUR, V73, P2, DOI 10.1097/NEN.0000000000000020; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Urresti J, 2016, J BIOL CHEM, V291, P1221, DOI 10.1074/jbc.M115.677682; Wang L, 2007, APOPTOSIS, V12, P1489, DOI 10.1007/s10495-007-0073-9; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yadav RK, 2015, AUTOPHAGY, V11, P1760, DOI 10.1080/15548627.2015.1082021; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Zhang H, 2015, AUTOPHAGY, V11, P9, DOI 10.1080/15548627.2014.1003478; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	47	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					161	179		10.1096/fj.201901626R	http://dx.doi.org/10.1096/fj.201901626R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914609				2022-12-28	WOS:000507308900013
J	Kautzmann, MAI; Gordon, WC; Jun, B; Do, KV; Matherne, BJ; Fang, ZD; Bazan, NG				Kautzmann, Marie-Audrey I.; Gordon, William C.; Jun, Bokkyoo; Do, Khanh V.; Matherne, Blake J.; Fang, Zhide; Bazan, Nicolas G.			Membrane-type frizzled-related protein regulates lipidome and transcription for photoreceptor function	FASEB JOURNAL			English	Article						Adipor1; inflammatory signaling; matrix-assisted laser desorption; ionization imaging mass spectrometry (MALDI IMS); retinal degenerations; RPE cell; VLC-PUFAs	POLYENOIC FATTY-ACIDS; LONG-CHAIN PUFAS; DOCOSAHEXAENOIC ACID; MACULAR DEGENERATION; MOUSE MODEL; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; GENE-THERAPY; MUTATION; MFRP	Molecular decision-makers of photoreceptor (PRC) membrane organization and gene regulation are critical to understanding sight and retinal degenerations that lead to blindness. Using Mfrp(rd6) mice, which develop PRC degeneration, we uncovered that membrane-type frizzled-related protein (MFRP) participates in docosahexaenoic acid (DHA, 22:6) enrichment in a manner similar to adiponectin receptor 1 (AdipoR1). Untargeted imaging mass spectrometry demonstrates cell-specific reduction of phospholipids containing 22:6 and very long-chain polyunsaturated fatty acids (VLC-PUFAs) in Adipor1(-/-) and Mfrp(rd6 )retinas. Gene expression of pro-inflammatory signaling pathways is increased and gene-encoding proteins for PRC function decrease in both mutants. Thus, we propose that both proteins are necessary for retinal lipidome membrane organization, visual function, and to the understanding of the early pathology of retinal degenerative diseases.	[Kautzmann, Marie-Audrey I.; Gordon, William C.; Jun, Bokkyoo; Do, Khanh V.; Matherne, Blake J.; Bazan, Nicolas G.] Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, New Orleans, LA USA; [Fang, Zhide] Louisiana State Univ Hlth New Orleans, Sch Publ Hlth, Biostat, New Orleans, LA USA; [Matherne, Blake J.] Louisiana State Univ Hlth New Orleans, Sch Med, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bazan, NG (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444; DO, KHANH/0000-0001-7834-3781	National Institutes of Health; National Eye Institute; National Institute of General Medical Sciences; Research to Prevent Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	National Institutes of Health; National Eye Institute; National Institute of General Medical Sciences; Research to Prevent Blindness	Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; AVELDANO MI, 1987, J BIOL CHEM, V262, P1172; Ayala-Ramirez R, 2006, MOL VIS, V12, P1483; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bazan NG, 2018, MOL ASPECTS MED, V64, P18, DOI 10.1016/j.mam.2018.09.003; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Cameron DJ, 2007, INT J BIOL SCI, V3, P111; Collery RF, 2016, INVEST OPHTH VIS SCI, V57, P6805, DOI 10.1167/iovs.16-19593; DETURCO EBR, 1991, J NEUROSCI, V11, P3667; Dinculescu A, 2014, ADV EXP MED BIOL, V801, P711, DOI 10.1007/978-1-4614-3209-8_89; Ferguson LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067265; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fogerty J, 2014, ADV EXP MED BIOL, V801, P355, DOI 10.1007/978-1-4614-3209-8_45; Fogerty J, 2011, INVEST OPHTH VIS SCI, V52, P7256, DOI 10.1167/iovs.11-8112; Genetics Home Reference, 2019, NATL LIB MED; Hankin JA, 2007, J AM SOC MASS SPECTR, V18, P1646, DOI 10.1016/j.jasms.2007.06.010; Hawes NL, 2000, INVEST OPHTH VIS SCI, V41, P3149; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Sanchez-Martin MJ, 2013, CHEMBIOCHEM, V14, P639, DOI 10.1002/cbic.201200687; Jun B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05433-7; Kaarniranta K, 2012, NEUROSCI LETT, V513, P233, DOI 10.1016/j.neulet.2012.02.050; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kameya S, 2002, HUM MOL GENET, V11, P1879, DOI 10.1093/hmg/11.16.1879; Katoh M, 2001, BIOCHEM BIOPH RES CO, V282, P116, DOI 10.1006/bbrc.2001.4551; Krill AE, 1977, HEREDITARY RETINAL C, VII, P739; Lagali PS, 2003, INVEST OPHTH VIS SCI, V44, P2841, DOI 10.1167/iovs.02-0991; Li Y, 2014, MOL THER, V22, P1688, DOI 10.1038/mt.2014.100; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Litman BJ, 2001, J MOL NEUROSCI, V16, P237, DOI 10.1385/JMN:16:2-3:237; Liu AH, 2010, J LIPID RES, V51, P3217, DOI 10.1194/jlr.M007518; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5505, DOI 10.1167/iovs.06-0312; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5514, DOI 10.1167/iovs.06-0449; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Metherel AH, 2019, J NUTR, V149, P586, DOI 10.1093/jn/nxy282; Mitchell DC, 2003, LIPIDS, V38, P437, DOI 10.1007/s11745-003-1081-1; Oresti GM, 2010, J LIPID RES, V51, P2600, DOI 10.1194/jlr.M006395; Rice DS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7228; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Sluch VM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32579-9; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; Suh M, 2005, CURR EYE RES, V30, P959, DOI 10.1080/02713680500246957; Tu XY, 2014, J STRUCT BIOL, V186, P86, DOI 10.1016/j.jsb.2014.02.001; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Velez G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16275-8; Wassall SR, 2018, BBA-BIOMEMBRANES, V1860, P1985, DOI 10.1016/j.bbamem.2018.04.016; Won J, 2008, VISUAL NEUROSCI, V25, P563, DOI 10.1017/S0952523808080723; Xu M, 2016, ACTA PHARMACOL SIN, V37, P246, DOI 10.1038/aps.2015.125; Yu M, 2012, J LIPID RES, V53, P494, DOI 10.1194/jlr.M021386; Zhang JL, 2016, HUM GENET, V135, P1375, DOI 10.1007/s00439-016-1730-2	55	10	10	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					912	929		10.1096/fj.201902359R	http://dx.doi.org/10.1096/fj.201902359R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914617	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000507308900062
J	Patil, MJ; Salas, M; Bialuhin, S; Boyd, JT; Jeske, NA; Akopian, AN				Patil, Mayur J.; Salas, Margaux; Bialuhin, Siarhei; Boyd, Jacob T.; Jeske, Nathaniel A.; Akopian, Armen N.			Sensitization of small-diameter sensory neurons is controlled by TRPV1 and TRPA1 association	FASEB JOURNAL			English	Article						pain; sensitization; sensory neurons; TRPA1; TRPV1	ROOT GANGLION NEURONS; ION-CHANNEL TRPA1; VANILLOID 1; SIGNALING PATHWAY; PAIN SENSATION; RECEPTOR; RAT; ACTIVATION; RESPONSES; PHOSPHORYLATION	Unique features of sensory neuron subtypes are manifest by their distinct physiological and pathophysiological functions. Using patch-clamp electrophysiology, Ca2+ imaging, calcitonin gene-related peptide release assay from tissues, protein biochemistry approaches, and behavioral physiology on pain models, this study demonstrates the diversity of sensory neuron pathophysiology is due in part to subtype-dependent sensitization of TRPV1 and TRPA1. Differential sensitization is influenced by distinct expression of inflammatory mediators, such as prostaglandin E-2 (PGE(2)), bradykinin (BK), and nerve growth factor (NGF) as well as multiple kinases, including protein kinase A (PKA) and C (PKC). However, the co-expression and interaction of TRPA1 with TRPV1 proved to be the most critical for differential sensitization of sensory neurons. We identified N- and C-terminal domains on TRPV1 responsible for TRPA1-TRPV1 (A1-V1) complex formation. Ablation of A1-V1 complex with dominant-negative peptides against these domains substantially reduced the sensitization of TRPA1, as well as BK- and CFA-induced hypersensitivity. These data indicate that often occurring TRP channel complexes regulate diversity in neuronal sensitization and may provide a therapeutic target for many neuroinflammatory pain conditions.	[Patil, Mayur J.; Salas, Margaux; Bialuhin, Siarhei; Boyd, Jacob T.; Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Patil, Mayur J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Salas, Margaux] US Army Inst Surg Res, Air Force 59th Med Wing, San Antonio, TX USA; [Boyd, Jacob T.; Jeske, Nathaniel A.; Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Johns Hopkins University; United States Department of Defense; United States Army; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Akopian, AN (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Akopian@UTHSCSA.edu	Belugin, Sergei/L-5005-2013	Belugin, Sergei/0000-0001-9006-7732	NIH/NINDS [NS102161]; NIH/NIGMS [GM112747]	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NINDS, Grant/Award Number: NS102161; NIH/NIGMS, Grant/Award Number: GM112747	ABBADIE C, 1994, J NEUROSCI, V14, P5865; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Akopian AN, 2009, TRENDS PHARMACOL SCI, V30, P79, DOI 10.1016/j.tips.2008.10.008; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Arcourt A, 2017, NEURON, V93, P179, DOI 10.1016/j.neuron.2016.11.027; Bai L, 2015, CELL, V163, P1783, DOI 10.1016/j.cell.2015.11.060; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Brackley AD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01999-4; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Fang D, 2015, PAIN, V156, P1124, DOI 10.1097/j.pain.0000000000000158; Feketa Viktor V, 2015, Temperature (Austin), V2, P244, DOI 10.1080/23328940.2015.1024383; Fischer MJM, 2014, PFLUG ARCH EUR J PHY, V466, P2229, DOI 10.1007/s00424-014-1497-z; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Gavva NR, 2008, TRENDS PHARMACOL SCI, V29, P550, DOI 10.1016/j.tips.2008.08.003; Green DP, 2016, MOL PAIN, V12, DOI 10.1177/1744806916661725; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han ZT, 2017, AM J TRANSL RES, V9, P2567; Jankowski MP, 2010, TRANSLATIONAL PAIN R; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Jeske NA, 2011, J NEUROSCI, V31, P8681, DOI 10.1523/JNEUROSCI.0020-11.2011; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LaMotte RH, 2007, J NEUROPHYSIOL, V97, P1, DOI 10.1152/jn.01021.2006; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2015, HANDB EXP PHARMACOL, V226, P71, DOI 10.1007/978-3-662-44605-8_5; Megat S, 2019, J NEUROSCI, V39, P393, DOI 10.1523/JNEUROSCI.2661-18.2018; Mizuta K., 2016, ETIOLOGY MORPHOGENES; Nielsen TA, 2018, PAIN, V159, P1989, DOI 10.1097/j.pain.0000000000001298; Patil MJ, 2013, NEUROSCIENCE, V253, P132, DOI 10.1016/j.neuroscience.2013.08.035; Patil MJ, 2010, NEUROSCIENCE, V171, P1109, DOI 10.1016/j.neuroscience.2010.09.031; Patil MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198601; Por ED, 2012, J BIOL CHEM, V287, P37552, DOI 10.1074/jbc.M112.391847; Ray P, 2018, PAIN, V159, P1325, DOI 10.1097/j.pain.0000000000001217; Reynders A, 2015, CELL REP, V10, P1007, DOI 10.1016/j.celrep.2015.01.022; Rouwette T, 2016, MOL CELL PROTEOMICS, V15, P2152, DOI 10.1074/mcp.M116.058966; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Sadofsky LR, 2014, CELLS-BASEL, V3, P616, DOI 10.3390/cells3020616; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Smith JAM, 2000, EUR J NEUROSCI, V12, P3250, DOI 10.1046/j.1460-9568.2000.00218.x; Song YB, 2018, SOMATOSENS MOT RES, V35, P11, DOI 10.1080/08990220.2018.1439000; Souza GR, 2013, P NATL ACAD SCI USA, V110, P11193, DOI 10.1073/pnas.1307445110; Spahn V, 2014, MOL PHARMACOL, V85, P335, DOI 10.1124/mol.113.088997; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sun SH, 2017, NEURON, V93, P840, DOI 10.1016/j.neuron.2017.01.012; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Tomlinson RE, 2017, P NATL ACAD SCI USA, V114, pE3632, DOI 10.1073/pnas.1701054114; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vellani V, 2006, J NEUROSCI, V26, P5109, DOI 10.1523/JNEUROSCI.3870-05.2006; Vermeulen W, 2013, EUR J PHARMACOL, V698, P404, DOI 10.1016/j.ejphar.2012.10.014; Wang CM, 2019, FASEB J, V33, P1360, DOI 10.1096/fj.201800615RR; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Weyer AD, 2015, J NEUROSCI, V35, P9456, DOI 10.1523/JNEUROSCI.0549-15.2015; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhang J, 2016, NEURON, V92, P461, DOI 10.1016/j.neuron.2016.09.014; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	68	25	26	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					287	302		10.1096/fj.201902026R	http://dx.doi.org/10.1096/fj.201902026R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914619	Green Accepted			2022-12-28	WOS:000507308900021
J	Peters-Hall, JR; Min, J; Tedone, E; Sho, S; Siteni, S; Mender, I; Shay, JW				Peters-Hall, Jennifer R.; Min, Jaewon; Tedone, Enzo; Sho, Sei; Siteni, Silvia; Mender, Ilgen; Shay, Jerry W.			Proliferation of adult human bronchial epithelial cells without a telomere maintenance mechanism for over 200 population doublings	FASEB JOURNAL			English	Article						conditional reprogramming; low oxygen; ROCK inhibitor; senescence; telomerase	LIFE-SPAN; STEM-CELLS; PULMONARY-FIBROSIS; CYSTIC-FIBROSIS; CULTURE; OXYGEN; DIFFERENTIATION; IMMORTALIZATION; SENESCENCE; MUTATIONS	To date, there is no direct evidence of telomerase activity in adult lung epithelial cells, but typical culture conditions only support cell proliferation for 30-40 population doublings (PD), a point at which telomeres remain relatively long. Here we report that in in vitro low stress culture conditions consisting of a fibroblast feeder layer, rho-associated coiled coil protein kinase inhibitor (ROCKi), and low oxygen (2%), normal human bronchial epithelial basal progenitor cells (HBECs) divide for over 200 PD without engaging a telomere maintenance mechanism (almost four times the "Hayflick limit"). HBECs exhibit critically short telomeres at 200 PD and the population of cells start to undergo replicative senescence. Subcloning these late passage cells to clonal density, to mimic lung injury in vivo, selects for rare subsets of HBECs that activate low levels of telomerase activity to maintain short telomeres. CRISPR/Cas9 knockout of human telomerase reverse transcriptase or treatment with the telomerase-mediated telomere targeting agent 6-thio-2 ' deoxyguanosine abrogates colony growth in these late passage cultures (>200 PD) but not in early passage cultures (<200 PD). To our knowledge, this is the first study to report such long-term growth of HBECs without a telomere maintenance mechanism. This report also provides direct evidence of telomerase activation in HBECs near senescence when telomeres are critically short. This novel cell culture system provides an experimental model to understand how telomerase is regulated in normal adult tissues.	[Peters-Hall, Jennifer R.; Min, Jaewon; Tedone, Enzo; Sho, Sei; Siteni, Silvia; Mender, Ilgen; Shay, Jerry W.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Shay, JW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jerry.shay@utsouthwestern.edu			National Cancer Institute T32 training grant [CA124334]; Cystic Fibrosis Foundation (CFF) [PETERS15F0]; CFF grant [SHAY17GO]; Harold Simmons National Cancer Institute Designated Comprehensive Cancer Center Support Grant [CA142543]; NCI SPORE [P50CA70907]; NIH [C06 RR30414]	National Cancer Institute T32 training grant; Cystic Fibrosis Foundation (CFF); CFF grant; Harold Simmons National Cancer Institute Designated Comprehensive Cancer Center Support Grant; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was initially supported by a National Cancer Institute T32 training grant (CA124334) and later by a Cystic Fibrosis Foundation (CFF) Postdoctoral Fellowship to JRP (PETERS15F0); and a CFF grant (SHAY17GO) to JWS. We also acknowledge the Harold Simmons National Cancer Institute Designated Comprehensive Cancer Center Support Grant [CA142543] and NCI SPORE P50CA70907. This work was performed in laboratories constructed with support from NIH grant C06 RR30414. JWS holds the distinguished Southland Financial Corporation Distinguished Chair in Geriatrics Research.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Fulcher ML, 2009, AM J PHYSIOL-LUNG C, V296, pL82, DOI 10.1152/ajplung.90314.2008; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hazawa M, 2018, EMBO REP, V19, P73, DOI 10.15252/embr.201744523; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hiyama E, 1996, INT J ONCOL, V9, P453; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Holohan B, 2014, J CELL BIOL, V205, P289, DOI 10.1083/jcb.201401012; Huang E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05174-7; Kim W, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000016; Lai TP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01291-z; Lai TP, 2016, BIOTECHNIQUES, V60, P306, DOI 10.2144/000114427; Lebkowski JS, 2001, CANCER J, V7, pS83; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439; Mender I, 2015, CANCER DISCOV, V5, P82, DOI 10.1158/2159-8290.CD-14-0609; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Peters-Hall JR, 2018, AM J PHYSIOL-LUNG C, V315, pL313, DOI 10.1152/ajplung.00355.2017; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ramirez RD, 1997, J INVEST DERMATOL, V108, P113, DOI 10.1111/1523-1747.ep12285654; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Rubin H, 1998, NAT BIOTECHNOL, V16, P396, DOI 10.1038/nbt0598-396; Ryu JH, 2014, MAYO CLIN PROC, V89, P1130, DOI 10.1016/j.mayocp.2014.03.016; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Wright WE, 1996, DEV GENET, V18, P173; Yasumoto S, 1996, ONCOGENE, V13, P433; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	55	9	9	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					386	398		10.1096/fj.201902376R	http://dx.doi.org/10.1096/fj.201902376R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914653	Green Accepted			2022-12-28	WOS:000507308900027
J	Watson, EL; Baker, LA; Wilkinson, TJ; Gould, DW; Graham-Brown, MPM; Major, RW; Ashford, RU; Philp, A; Smith, AC				Watson, Emma L.; Baker, Luke A.; Wilkinson, Thomas J.; Gould, Douglas W.; Graham-Brown, Matthew P. M.; Major, Rupert W.; Ashford, Robert U.; Philp, Andrew; Smith, Alice C.			Reductions in skeletal muscle mitochondrial mass are not restored following exercise training in patients with chronic kidney disease	FASEB JOURNAL			English	Article						chronic kidney disease; exercise; mitochondria; skeletal muscle	ALL-CAUSE MORTALITY; PHYSICAL FUNCTION; PROTEIN-METABOLISM; DYSFUNCTION; CKD; ACTIVATION; RESISTANCE; PGC-1-ALPHA; BIOGENESIS; CAPACITY	Patients with chronic kidney disease (CKD) exhibit reduced exercise capacity, poor physical function and symptoms of fatigue. The mechanisms that contribute to this are not clearly defined but may involve reductions in mitochondrial function, mass and biogenesis. Here we report on the effect of non-dialysis dependent CKD (NDD-CKD) on mitochondrial mass and basal expression of transcription factors involved in mitochondrial biogenesis compared to a healthy control cohort (HC). In addition, we sought to investigate the effect of a 12-week exercise-training programme on these aspects of mitochondrial dysfunction in a NDD-CKD cohort.For the comparison between NDD-CKD and HC populations, skeletal muscle biopsies were collected from the vastus lateralis (VL) of n=16 non-dialysis dependent CKD patient's stage 3b-5 (NDD-CKD) and n=16 healthy controls matched for age, gender and physical activity (HC). To investigate the effect of exercise training, VL biopsies were collected from n=17 NDD-CKD patients before and after a 12-week exercise intervention that was comprised of aerobic exercise (AE) or a combination of aerobic exercise and resistance training (CE). Mitochondrial mass was analysed by citrate synthase activity and mitochondrial protein content by Porin expression, whilst the expression of transcription factors involved in mitochondrial biogenesis were quantified by real-time qPCR. NDD-CKD patients exhibited a significant reduction in mitochondrial mass when compared to HC, coupled to a reduction in PGC-1 alpha, NRF-1, Nrf2, TFam, mfn2 and SOD1/2 gene expression. 12-weeks of exercise training resulted in a significant increase in PGC-1 alpha expression in both groups, with no further changes seen across indicators of mitochondrial biogenesis. No significant changes in mitochondrial mass were observed in response to either exercise programme. NDD-CKD patients exhibit reduced skeletal muscle mitochondrial mass and gene expression of transcription factors involved in mitochondrial biogenesis compared to HC. These reductions were not restored following 12-weeks of exercise training implying exercise resistance in this cohort. The reasons for this lack of improvement are currently unknown and require further investigation, as reversing the dysregulation of these processes in NDD-CKD may provide a therapeutic opportunity to improve muscle fatigue and dysfunction in this population.	[Watson, Emma L.; Gould, Douglas W.; Graham-Brown, Matthew P. M.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Baker, Luke A.; Wilkinson, Thomas J.; Major, Rupert W.; Smith, Alice C.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Gould, Douglas W.] Intens Care Natl Audit & Res Ctr, London, England; [Graham-Brown, Matthew P. M.; Major, Rupert W.; Smith, Alice C.] Univ Hosp Leicester NHS Trust, John Walls Renal Unit, Leicester, Leics, England; [Graham-Brown, Matthew P. M.] Loughborough Univ, Natl Ctr Sport & Exercise Med, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Ashford, Robert U.] Univ Hosp Leicester, Leicester Orthopaed, Leicester, Leics, England; [Ashford, Robert U.] Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England; [Philp, Andrew] Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Philp, Andrew] UNSW Sydney, UNSW Med, Sydney, NSW, Australia	University of Leicester; University of Leicester; Intensive Care National Audit & Research Centre; University Hospitals of Leicester NHS Trust; University of Leicester; Loughborough University; University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; Garvan Institute of Medical Research; University of New South Wales Sydney	Watson, EL (corresponding author), Univ Leicester, Leicester Kidney Lifestyle Team, Dept Cardiovasc Sci, Med Sci Bldg, Leicester LE1 9HN, Leics, England.	emma.watson@le.ac.uk	Ashford, Robert U./AAT-2468-2021; Graham-Brown, Matthew/ABB-5400-2020	Ashford, Robert U./0000-0002-8246-2334; Baker, Luke/0000-0003-2111-3832; Gould, Doug/0000-0003-4148-3312; Major, Rupert/0000-0003-4920-623X; Philp, Andrew/0000-0003-3860-4136; Graham-Brown, Matthew/0000-0002-6197-180X	Kidney Research UK [PDF2/2015, TF2/2015]	Kidney Research UK(Kidney Research UK (KRUK))	Kidney Research UK, Grant/Award Number: PDF2/2015 and TF2/2015	Adams GR, 2005, MED SCI SPORT EXER, V37, P557, DOI 10.1249/01.MSS.0000159006.87769.67; Baar K., 2014, MOL EXERCISE PHYSIOL, P79; Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209; Baria F, 2014, NEPHROL DIAL TRANSPL, V29, P857, DOI 10.1093/ndt/gft529; Boushel R, 2014, EXERC SPORT SCI REV, V42, P169, DOI 10.1249/JES.0000000000000025; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [10.1080/07303084.1993.10606684, DOI 10.1080/07303084.1993.10606684]; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Craig DM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00296; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Enoki Y, 2017, J CACHEXIA SARCOPENI, V8, P735, DOI 10.1002/jcsm.12202; Gamboa JL, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12780; Golbidi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/941868; Gonzalez-Freire M, 2018, J CACHEXIA SARCOPENI, V9, P435, DOI 10.1002/jcsm.12313; Gonzalez-Freire M, 2018, AGING CELL, V17, DOI 10.1111/acel.12725; Gould DW, 2019, J CACHEXIA SARCOPENI, V10, P748, DOI 10.1002/jcsm.12429; Groennebaek T, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00713; Hayot M, 2005, EUR RESPIR J, V25, P431, DOI 10.1183/09031936.05.00053404; Hedges CP, 2019, J APPL PHYSIOL, V126, P454, DOI 10.1152/japplphysiol.00777.2018; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Hiraki K, 2013, CLIN EXP NEPHROL, V17, P225, DOI 10.1007/s10157-012-0681-8; Hollander J, 2001, PFLUG ARCH EUR J PHY, V442, P426, DOI 10.1007/s004240100539; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Irving BA, 2015, J CLIN ENDOCR METAB, V100, P1654, DOI 10.1210/jc.2014-3081; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Johansen KL, 1999, ADV RENAL REPLACE TH, V6, P141, DOI 10.1016/S1073-4449(99)70032-4; Joseph AM, 2016, J PHYSIOL-LONDON, V594, P5105, DOI 10.1113/JP270659; Kemp GJ, 2004, NEPHROL DIAL TRANSPL, V19, P1520, DOI 10.1093/ndt/gfh189; Kosmadakis GC, 2010, NEPHRON CLIN PRACT, V115, pE7, DOI 10.1159/000286344; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lawler JM, 2016, J PHYSIOL-LONDON, V594, P5161, DOI 10.1113/JP270656; Leehey DJ, 2016, AM J NEPHROL, V44, P54, DOI 10.1159/000447703; Lim PS, 2002, J BIOMED SCI, V9, P549, DOI 10.1007/BF02254982; MacKinnon HJ, 2018, THER ADV CHRONIC DIS, V9, P209, DOI 10.1177/2040622318785575; MAY RC, 1987, J CLIN INVEST, V79, P1099, DOI 10.1172/JCI112924; Morishita S, 2017, HEMODIAL INT, V21, P483, DOI 10.1111/hdi.12564; Nishikawa M, 2015, NEPHROL DIAL TRANSPL, V30, P934, DOI 10.1093/ndt/gfv103; O'Sullivan TF, 2018, CLIN KIDNEY J, V11, P810, DOI 10.1093/ckj/sfy052; Perez-Schindler J, 2015, CLIN SCI, V129, P589, DOI 10.1042/CS20150246; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; PRICE SR, 1994, AM J PHYSIOL-CELL PH, V267, pC955, DOI 10.1152/ajpcell.1994.267.4.C955; Puthucheary ZA, 2018, THORAX, V73, P926, DOI 10.1136/thoraxjnl-2017-211073; Rao M, 2018, CURR OPIN NEPHROL HY, V27, P113, DOI 10.1097/MNH.0000000000000393; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; Robinson KA, 2020, NEPHROL DIAL TRANSPL, V35, P1469, DOI 10.1093/ndt/gfz193; Roshanravan B, 2017, AM J KIDNEY DIS, V69, P837, DOI 10.1053/j.ajkd.2017.01.051; Roshanravan B, 2016, AM J KIDNEY DIS, V68, P658, DOI 10.1053/j.ajkd.2016.05.011; Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702; Smiles WJ, 2015, J PHYSIOL-LONDON, V593, P2115, DOI 10.1113/JP270177; Stocks B, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00941; Su Z, 2017, AM J PHYSIOL-RENAL, V312, pF1128, DOI 10.1152/ajprenal.00600.2016; Sung CC, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/301982; Tamaki M, 2014, KIDNEY INT, V85, P1330, DOI 10.1038/ki.2013.473; Thomas SS, 2013, KIDNEY INT, V84, P308, DOI 10.1038/ki.2013.97; Tsai YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183642; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; Wang DT, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/684965; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; Watson EL, 2018, AM J PHYSIOL-RENAL, V314, pF1188, DOI 10.1152/ajprenal.00012.2018; Watson EL, 2015, AM J KIDNEY DIS, V66, P249, DOI 10.1053/j.ajkd.2014.10.019; Wilkinson TJ, 2019, NEPHROL DIAL TRANSPL, V34, P1344, DOI 10.1093/ndt/gfy139; Xu J, 2012, KIDNEY INT, V82, P401, DOI 10.1038/ki.2012.84; Yazdi PG, 2013, INT J CLIN EXP MED, V6, P532; Zaza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077847; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	70	30	30	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1755	1767		10.1096/fj.201901936RR	http://dx.doi.org/10.1096/fj.201901936RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914685	Bronze			2022-12-28	WOS:000507308900116
J	Zhu, JJ; Liu, X; Cai, XL; Ouyang, G; Fan, SJ; Wang, J; Xiao, WH				Zhu, Junji; Liu, Xing; Cai, Xiaolian; Ouyang, Gang; Fan, Sijia; Wang, Jing; Xiao, Wuhan			Zebrafish prmt7 negatively regulates antiviral responses by suppressing the retinoic acid-inducible gene-I-like receptor signaling	FASEB JOURNAL			English	Article						GCRV; irf3; Prmt7; SVCV; zebrafish	PROTEIN ARGININE METHYLTRANSFERASE; GRASS CARP REOVIRUS; SPRING VIREMIA; 7 PRMT7; RECOGNITION; METHYLATION; RNA; METASTASIS; INDUCTION; CELLS	Arginine methylation is a post-translational modification in histone and nonhistone proteins that can affect numerous cellular activities. Protein arginine methyltransferase 7 (Prmt7), a type III arginine methyltransferase, catalyzes the formation of stable monomethylarginines of histones. The role of PRMT7 in virus-induced innate immunity signaling, however, remains largely unknown. We demonstrate that zebrafish prmt7 could be inhibited by spring viremia of carp virus (SVCV) and grass carp reovirus (GCRV) infection. The overexpression of prmt7 suppresses cellular antiviral responses that are partially dependent on the arginine methyltransferase activity of prmt7. Consistently, prmt7-null zebrafish were more resistant to SVCV or GCRV infection, exhibiting enhanced expression of key antiviral genes and fewer necrotic cells in the liver and kidney upon viral infection. Furthermore, we established a zebrafish model to investigate grass carp hemorrhagic disease. Our findings suggest that by suppressing the RIG-I-like receptors signaling, zebrafish prmt7 negatively regulates antiviral responses, indicating the vital role of prmt7 and its arginine methyltransferase activity in innate immunity.	[Zhu, Junji; Liu, Xing; Cai, Xiaolian; Ouyang, Gang; Fan, Sijia; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Zhu, Junji; Cai, Xiaolian; Fan, Sijia; Xiao, Wuhan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Xing; Ouyang, Gang; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Minist Agr, Key Lab Aquaculture Dis Control, Wuhan, Peoples R China; [Liu, Xing; Ouyang, Gang; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Innovat Seed Design, Wuhan, Peoples R China; [Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Zhu, Junji/AGG-9650-2022; Xiao, Wuhan/GLU-7352-2022; Zhu, Junji/GPF-8726-2022	Zhu, Junji/0000-0003-2968-180X	National Natural Science Foundation of China (NSFC) [31830101, 31721005, 31631102, 31671315]; National Key R & D Program of China [2018YFD0900602]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R & D Program of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31830101, 31721005, 31631102 and 31671315; National Key R & D Program of China, Grant/Award Number: 2018YFD0900602	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Ahne W, 2002, DIS AQUAT ORGAN, V52, P261, DOI 10.3354/dao052261; Baldwin RM, 2015, ONCOTARGET, V6, P3013, DOI 10.18632/oncotarget.3072; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Blanc RS, 2016, CELL REP, V14, P1528, DOI 10.1016/j.celrep.2016.01.022; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Cheng DZ, 2018, ONCOTARGETS THER, V11, P4869, DOI 10.2147/OTT.S166412; Feng H, 2015, J IMMUNOL, V194, P1225, DOI 10.4049/jimmunol.1402415; Feng Y, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609271; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Greenblatt SM, 2016, EXP HEMATOL, V44, P435, DOI 10.1016/j.exphem.2016.03.009; Ji JF, 2018, J IMMUNOL, V200, P573, DOI 10.4049/jimmunol.1701149; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6058147; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Liang HR, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-178; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu X, 2016, J IMMUNOL, V197, P4736, DOI 10.4049/jimmunol.1601187; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Rao YL, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/670437; ROY P, 1978, J VIROL, V25, P912, DOI 10.1128/JVI.25.3.912-916.1978; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wesche J, 2017, CELL MOL LIFE SCI, V74, P3305, DOI 10.1007/s00018-017-2515-z; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Ying ZZ, 2015, J IMMUNOL, V195, P1538, DOI 10.4049/jimmunol.1500224; Yu GQ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01432; Zhang HQ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030364; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	41	19	20	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					988	1000		10.1096/fj.201902219R	http://dx.doi.org/10.1096/fj.201902219R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914680				2022-12-28	WOS:000507308900067
J	Kelm, M; Lehoux, S; Azcutia, V; Cummings, RD; Nusrat, A; Parkos, CA; Brazil, JC				Kelm, Matthias; Lehoux, Sylvain; Azcutia, Veronica; Cummings, Richard D.; Nusrat, Asma; Parkos, Charles A.; Brazil, Jennifer C.			Regulation of neutrophil function by selective targeting of glycan epitopes expressed on the integrin CD11b/CD18	FASEB JOURNAL			English	Article						colitis; glycans; inflammation; neutrophil	MANNOSE TYPE OLIGOSACCHARIDE; INTESTINAL EPITHELIUM; TYROSINE KINASE; PEANUT LECTIN; SIALYL-LEWIS; ADHESION; BINDING; MAC-1; APOPTOSIS; PHAGOCYTOSIS	Polymorphonuclear neutrophils (PMNs) play a critical role in the innate immune response to invading pathogens. However, dysregulated mucosal trafficking of PMNs and associated epithelial tissue damage is a pathological hallmark of numerous inflammatory conditions including inflammatory bowel disease. The glycoprotein CD11b/CD18 plays a well-described role in regulating PMN transepithelial migration and PMN inflammatory functions. Previous studies have demonstrated that targeting of the N-linked glycan Lewis X on CD11b blocks PMN transepithelial migration (TEpM). Given evidence of glycosylation-dependent regulation of CD11b/CD18 function, we performed MALDI TOF Mass Spectrometry (MS) analyses on CD11b/CD18 purified from human PMNs. Unusual glycan epitopes identified on CD11b/CD18 included high Mannose oligosaccharides recognized by the Galanthus Nivalis lectin and biantennary galactosylated N-glycans recognized by the Phaseolus Vulgaris erythroagglutinin lectin. Importantly, we show that selective targeting of glycans on CD11b with such lectins results in altered intracellular signaling events that inhibit TEpM and differentially affect key PMN inflammatory functions including phagocytosis, superoxide release and apoptosis. Taken together, these data demonstrate that discrete glycan motifs expressed on CD11b/CD18 such as biantennary galactose could represent novel targets for selective manipulation of CD11b function and reduction of PMN-associated tissue damage in chronic inflammatory diseases.	[Kelm, Matthias; Azcutia, Veronica; Nusrat, Asma; Parkos, Charles A.; Brazil, Jennifer C.] Univ Michigan, Dept Pathol, 109 Zina Pitcher Pl,BSRB Rm 4620, Ann Arbor, MI 48109 USA; [Lehoux, Sylvain; Cummings, Richard D.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Brazil, JC (corresponding author), Univ Michigan, Dept Pathol, 109 Zina Pitcher Pl,BSRB Rm 4620, Ann Arbor, MI 48109 USA.	brazilj@med.umich.edu	; Azcutia, Veronica/A-7704-2017	Brazil, Jennifer/0000-0002-5013-5291; Azcutia, Veronica/0000-0003-2160-5175	NIH [DK072564, DK079392, DK061379, DK59888, DK55679]; Crohn's and Colitis Foundation (Crohn's & Colitis Foundation) [544596]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation (Crohn's & Colitis Foundation)	NIH, Grant/Award Number: DK072564, DK079392, DK061379, DK59888 and DK55679; Crohn's and Colitis Foundation (Crohn's & Colitis Foundation), Grant/Award Number: SRA #544596	ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; ARNAOUT MA, 1990, BLOOD, V75, P1037; ARNAOUT MA, 1985, FED PROC, V44, P2664; Balsam LB, 1998, J IMMUNOL, V160, P5058; BATEMAN J, 1993, CELL BIOCHEM FUNCT, V11, P87, DOI 10.1002/cbf.290110203; Becker DJ, 1999, BBA-MOL BASIS DIS, V1455, P193, DOI 10.1016/S0925-4439(99)00071-X; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; Brazil JC, 2017, J LEUKOCYTE BIOL, V102, P753, DOI 10.1189/jlb.1MA0117-013R; Brazil JC, 2016, AM J PATHOL, V186, P297, DOI 10.1016/j.ajpath.2015.10.015; Brazil JC, 2013, J IMMUNOL, V191, P4804, DOI 10.4049/jimmunol.1301307; Brazil JC, 2010, J IMMUNOL, V185, P7026, DOI 10.4049/jimmunol.1001293; Bressenot A, 2015, GUT, V64, P1412, DOI 10.1136/gutjnl-2014-307477; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; CLARK MA, 1995, CELL TISSUE RES, V282, P455, DOI 10.1007/BF00318877; Conejeros I, 2011, VET IMMUNOL IMMUNOP, V139, P308, DOI 10.1016/j.vetimm.2010.10.021; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Dong GY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01088; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; Girao DKFB, 2015, J MOL RECOGNIT, V28, P285, DOI 10.1002/jmr.2441; Flemming S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99722; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Futosi K, 2016, IMMUNOL REV, V273, P121, DOI 10.1111/imr.12455; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; GRAHAM IL, 1989, J IMMUNOL, V142, P2352; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; HAJTO T, 1989, CANCER RES, V49, P4803; Hsu MJ, 2003, BRIT J PHARMACOL, V139, P289, DOI 10.1038/sj.bjp.0705243; Jondle CN, 2016, J IMMUNOL, V196, P3088, DOI 10.4049/jimmunol.1501790; JUTILA MA, 1989, J IMMUNOL, V143, P3318; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Karlsson A, 1999, INFECT IMMUN, V67, P3461, DOI 10.1128/IAI.67.7.3461-3468.1999; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; KUEHN C, 1980, INFECT IMMUN, V29, P600; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin J, 2017, INT IMMUNOPHARMACOL, V52, P101, DOI 10.1016/j.intimp.2017.08.006; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Liu Y, 2004, J IMMUNOL, V172, P2578, DOI 10.4049/jimmunol.172.4.2578; LOCK R, 1988, ANAL BIOCHEM, V173, P450, DOI 10.1016/0003-2697(88)90213-8; Louis NA, 2005, FASEB J, V19, P950, DOI 10.1096/fj.04-3251com; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Mandell KJ, 2004, J BIOL CHEM, V279, P16254, DOI 10.1074/jbc.M309483200; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McEver RP, 1997, J CLIN INVEST, V100, pS97; MILLER LJ, 1987, J IMMUNOL, V139, P842; MILLER LJ, 1987, J IMMUNOL, V138, P2381; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Morishima S, 2003, J ENDOCRINOL, V176, P285, DOI 10.1677/joe.0.1760285; Nagae M, 2014, GLYCOBIOLOGY, V24, P368, DOI 10.1093/glycob/cwu004; Oki T, 1999, J ANTIBIOT, V52, P449, DOI 10.7164/antibiotics.52.449; PARKOS CA, 1995, AM J PHYSIOL-CELL PH, V268, pC472, DOI 10.1152/ajpcell.1995.268.2.C472; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; Rhodes JM, 1996, LANCET, V347, P40, DOI 10.1016/S0140-6736(96)91563-9; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; RYDER SD, 1994, GASTROENTEROLOGY, V106, P117, DOI 10.1016/S0016-5085(94)94775-9; SASTRE L, 1986, J IMMUNOL, V137, P1060; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schymeinsky J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001132; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Sheth K, 2001, SURGERY, V130, P242, DOI 10.1067/msy.2001.115902; SHIBUYA N, 1988, J BIOL CHEM, V263, P728; Simpson JL, 2009, PHARMACOL THERAPEUT, V124, P86, DOI 10.1016/j.pharmthera.2009.06.004; SPRINGER TA, 1985, NATURE, V314, P540, DOI 10.1038/314540a0; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Sumagin R, 2014, MUCOSAL IMMUNOL, V7, P905, DOI 10.1038/mi.2013.106; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Thornton BP, 1996, J IMMUNOL, V156, P1235; Tsikitis VL, 2004, SURGERY, V136, P384, DOI 10.1016/j.surg.2004.05.014; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang Q, 1998, LANCET, V352, P1831, DOI 10.1016/S0140-6736(05)79894-9; Wang X, 2017, P NATL ACAD SCI USA, V114, P4483, DOI 10.1073/pnas.1616752114; Watanabe K, 1997, J CLIN PERIODONTOL, V24, P814, DOI 10.1111/j.1600-051X.1997.tb01195.x; Werner Lael, 2013, J Crohns Colitis, V7, pe522, DOI 10.1016/j.crohns.2013.03.009; Zen K, 2002, J IMMUNOL, V169, P5270, DOI 10.4049/jimmunol.169.9.5270; Zerfaoui M, 2000, EUR J BIOCHEM, V267, P53, DOI 10.1046/j.1432-1327.2000.00958.x; Zhou XM, 2005, AM J PHYSIOL-LUNG C, V288, pL655, DOI 10.1152/ajplung.00327.2004; Zou WY, 2019, METHODS MOL BIOL, V1576, P229, DOI 10.1007/7651_2017_1	83	14	16	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2326	2343		10.1096/fj.201902542R	http://dx.doi.org/10.1096/fj.201902542R		DEC 2019	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907993	Green Accepted			2022-12-28	WOS:000504094800001
J	Wu, ZY; Liu, H; Xu, LS; Chen, HF; Feng, Y				Wu, Zhiyun; Liu, Hao; Xu, Lishi; Chen, Hai-Feng; Feng, Yan			Algorithm-based coevolution network identification reveals key functional residues of the alpha/beta hydrolase subfamilies	FASEB JOURNAL			English	Article						algorithm optimization; enzyme; mutant library; protein engineering; statistical coupling analysis	ANTARCTICA LIPASE-B; CANDIDA-ANTARCTICA; MOLECULAR-DYNAMICS; INACTIVATION; RESOLUTION; EVOLUTION; SEQUENCE; MOTIONS; DESIGN; SITE	Covariant residues identified by computational algorithms have provided new insights into enzyme evolutionary routes. However, the reliability and accuracy of routine statistical coupling analysis (SCA) are unable to satisfy the needs of protein engineering because SCA depends only on sequence information. Here, we set up a new SCA algorithm, SCA.SIM, by integrating structure information and MD simulation data. The more reliable covariant residues with high-quality scores are obtained from sequence alignment weighted by residual movement for eight related subfamilies, belonging to alpha/beta hydrolase family, with Candida antarctica lipase B (CALB). The 38 predicted covariant residues are tested for function by high-throughput quantitative evaluation in combination with activity and thermostability assays of a mutant library and deep sequencing. Based on the landscapes of both activity and thermostability, most mutants play key roles in catalysis, and some mutants gain 2.4- to 6-fold increase in half-life at 50 degrees C and 9- to 12-fold improvement in catalytic efficiency. The activity of double mutants for A225F/T103A is higher than those of A225F and T103A which means that SCA.SIM method might be useful for identifying the allosteric coupling. The SCA.SIM algorithm can be used for protein coevolution and enzyme engineering research.	[Wu, Zhiyun; Liu, Hao; Xu, Lishi; Chen, Hai-Feng; Feng, Yan] Shanghai Jiao Tong Univ, Natl Expt Teaching Ctr Life Sci & Biotechnol, Joint Int Res Lab Metab & Dev Sci, State Key Lab Microbial Metab,Sch Life Sci & Biot, Shanghai 200240, Peoples R China; [Chen, Hai-Feng] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences	Chen, HF; Feng, Y (corresponding author), Shanghai Jiao Tong Univ, Natl Expt Teaching Ctr Life Sci & Biotechnol, Joint Int Res Lab Metab & Dev Sci, State Key Lab Microbial Metab,Sch Life Sci & Biot, Shanghai 200240, Peoples R China.	haifengchen@sjtu.edu.cn; haifengchen@sjtu.edu.cn	Liu, Hao/AAJ-4404-2021; Chen, Haifeng/AAT-7444-2020	Liu, Hao/0000-0003-0994-6284; 	National Natural Science Foundation of China (NSFC) [31770771, 31620103901]; Research and Development [31770771, 31620103901, 2017YFE0103300, YG2017MS08]; Shanghai Jiao Tong University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research and Development; Shanghai Jiao Tong University	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31770771 and 31620103901; Research and Development, Grant/Award Number: 2017YFE0103300, 31770771, 31620103901 and YG2017MS08; Shanghai Jiao Tong University	Adkar BV, 2012, STRUCTURE, V20, P371, DOI 10.1016/j.str.2011.11.021; Anishchenko I, 2017, P NATL ACAD SCI USA, V114, P9122, DOI 10.1073/pnas.1702664114; Bai F, 2016, P NATL ACAD SCI USA, V113, pE8051, DOI 10.1073/pnas.1615932113; Case D., 2015, AMBER, V14; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Engstrom K, 2011, ORG BIOMOL CHEM, V9, P81, DOI 10.1039/c0ob00748j; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Fuentes G, 2004, PROTEIN SCI, V13, P3092, DOI 10.1110/ps.04724504; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hamberg A, 2012, CHEM COMMUN, V48, P10013, DOI 10.1039/c2cc34684b; Hong SY, 2013, APPL BIOCHEM BIOTECH, V170, P925, DOI 10.1007/s12010-013-0237-8; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Irani M, 2013, BIOCHEMISTRY-US, V52, P1280, DOI 10.1021/bi301298m; Jacob E, 2015, ELIFE, V4, DOI 10.7554/eLife.08932; Juhl PB, 2010, J BIOTECHNOL, V150, P474, DOI 10.1016/j.jbiotec.2010.09.951; Jung SY, 2008, BIOTECHNOL LETT, V30, P717, DOI 10.1007/s10529-007-9591-3; Kim SJ, 2010, BIOTECHNOL PROGR, V26, P1038, DOI 10.1002/btpr.408; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Kuipers RK, 2010, PROTEINS, V78, P2101, DOI 10.1002/prot.22725; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Linder M, 2011, J MOL MODEL, V17, P833, DOI 10.1007/s00894-010-0775-8; Liu DN, 2010, CHEMBIOCHEM, V11, P789, DOI 10.1002/cbic.200900776; Liu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24117; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Park CG, 2011, BIOTECHNOL PROGR, V27, P47, DOI 10.1002/btpr.532; Park HJ, 2013, J BIOTECHNOL, V163, P346, DOI 10.1016/j.jbiotec.2012.11.006; Peng XQ, 2013, APPL BIOCHEM BIOTECH, V169, P351, DOI 10.1007/s12010-012-9954-7; Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Rotticci D, 2001, CHEMBIOCHEM, V2, P766, DOI 10.1002/1439-7633(20011001)2:10<766::AID-CBIC766>3.0.CO;2-K; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salinas VH, 2018, ELIFE, V7, DOI 10.7554/eLife.34300; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skjot M, 2009, CHEMBIOCHEM, V10, P520, DOI 10.1002/cbic.200800668; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Stone J., 2012, DYNAMICAL NETWORK AN; Sun ZT, 2019, CHEM REV, V119, P1626, DOI 10.1021/acs.chemrev.8b00290; Tai K, 2001, BIOPHYS J, V81, P715, DOI 10.1016/S0006-3495(01)75736-0; Tanino T, 2007, APPL MICROBIOL BIOT, V75, P1319, DOI 10.1007/s00253-007-0959-z; Tosco P, 2011, J MOL MODEL, V17, P201, DOI 10.1007/s00894-010-0684-x; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Vallin M, 2010, CHEMBIOCHEM, V11, P411, DOI 10.1002/cbic.200900635; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wu Q, 2013, J AM CHEM SOC, V135, P1872, DOI 10.1021/ja310455t; Xie Y, 2014, J BIOL CHEM, V289, P7994, DOI 10.1074/jbc.M113.536045; Yi ZL, 2011, BIORESOURCE TECHNOL, V102, P3636, DOI 10.1016/j.biortech.2010.11.043; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zhang NY, 2003, PROTEIN ENG, V16, P599, DOI 10.1093/protein/gzg074	57	3	4	1	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					1983	1995		10.1096/fj.201900948RR	http://dx.doi.org/10.1096/fj.201900948RR		DEC 2019	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31907985	Bronze			2022-12-28	WOS:000504091600001
J	Venegas, C; Heneka, MT				Venegas, Carmen; Heneka, Michael T.			Inflammasome-mediated innate immunity in Alzheimer's disease	FASEB JOURNAL			English	Review						neuroinflammation; DAMP; ASC specks	AMYLOID-BETA-PEPTIDE; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; OXIDATIVE STRESS; INTERLEUKIN-1-BETA PRODUCTION; BACTERIAL FLAGELLIN; MOLECULAR PLATFORM; CHROMOGRANIN-A; FAMILY-MEMBER; UP-REGULATION	Historically neurodegenerative diseases, Alzheimer's disease (AD) in particular, have been viewed to be primarily caused and driven by neuronal mechanisms. Very recently, due to experimental, genetic, and epidemiologic evidence, immune mechanisms have entered the central stage and are now believed to contribute significantly to risk, onset, and disease progression of this class of disorders. Although immune activation of microglial cells may over time engage various signal transduction pathways, inflammasome activation, which represents a canonical and initiating pathway, seems to be one of the first responses to extracellular beta-amyloid (A beta) accumulation. Here we review the current understanding of inflammasome activation in AD.	[Venegas, Carmen; Heneka, Michael T.] Univ Bonn, Med Ctr, Dept Neurodegenerat Dis & Geriatr Psychiat, Bonn, Germany; [Heneka, Michael T.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Heneka, Michael T.] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA USA	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Massachusetts System; University of Massachusetts Worcester	Heneka, MT (corresponding author), Univ Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Sigmund Freud Str 25, D-53127 Bonn, Germany.	michael.heneka@ukbonn.de	Venegas, Carmen/HIK-2268-2022; Heneka, Michael/E-8072-2015	Venegas, Carmen/0000-0002-8902-4986; Heneka, Michael/0000-0003-4996-1630				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Angulo E, 2004, J NEUROCHEM, V91, P547, DOI 10.1111/j.1471-4159.2004.02771.x; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Bieberich E, 2012, NEUROCHEM RES, V37, P1208, DOI 10.1007/s11064-011-0698-5; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Buxbaum JN, 2019, FASEB J, V33, P9701, DOI 10.1096/fj.201901895; Buxbaum JN, 2017, FASEB J, V31, P2, DOI 10.1096/fj.201601179; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Ferwerda G, 2008, EUR J IMMUNOL, V38, P184, DOI 10.1002/eji.200737103; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Frank MG, 2016, BRAIN BEHAV IMMUN, V55, P215, DOI 10.1016/j.bbi.2015.10.009; Galimberti Daniela, 2008, Curr Aging Sci, V1, P30; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heneka MT, 2017, BRAIN PATHOL, V27, P220, DOI 10.1111/bpa.12483; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Jembrek MJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/346783; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kaushal V, 2015, CELL DEATH DIFFER, V22, P1676, DOI 10.1038/cdd.2015.16; Kreisl WC, 2013, BRAIN, V136, P2228, DOI 10.1093/brain/awt145; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lamkanfi M, 2007, J IMMUNOL, V178, P8022, DOI 10.4049/jimmunol.178.12.8022; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matsuoka Y, 2001, NEUROSCIENCE, V104, P609, DOI 10.1016/S0306-4522(01)00115-4; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, J CLIN IMMUNOL, V30, P502, DOI 10.1007/s10875-010-9386-5; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ojala J, 2009, NEUROBIOL AGING, V30, P198, DOI 10.1016/j.neurobiolaging.2007.06.006; Pannaccione A, 2007, MOL PHARMACOL, V72, P665, DOI 10.1124/mol.107.034868; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Radi E, 2014, J ALZHEIMERS DIS, V42, pS125, DOI 10.3233/JAD-132738; Rangon CM, 2003, NEUROREPORT, V14, P755, DOI 10.1097/00001756-200304150-00019; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Salminen A, 2008, J CELL MOL MED, V12, P2255, DOI 10.1111/j.1582-4934.2008.00496.x; Scheiblich H, 2017, J NEUROCHEM, V143, P534, DOI 10.1111/jnc.14225; Schuitemaker A, 2013, NEUROBIOL AGING, V34, P128, DOI 10.1016/j.neurobiolaging.2012.04.021; Shao W, 2017, J CLIN NEUROSCI, V45, P1, DOI 10.1016/j.jocn.2017.06.074; Sivananthan SN, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.74; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Tamboli IY, 2011, AUTOPHAGY, V7, P643, DOI 10.4161/auto.7.6.15122; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tzeng TC, 2018, P NATL ACAD SCI USA, V115, P9002, DOI 10.1073/pnas.1801802115; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Venegas C, 2017, J LEUKOCYTE BIOL, V101, P87, DOI 10.1189/jlb.3MR0416-204R; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wu Z, 2013, NEUROBIOL AGING, V34, P2715, DOI 10.1016/j.neurobiolaging.2013.05.018; YASUHARA O, 1994, NEUROSCI LETT, V170, P13, DOI 10.1016/0304-3940(94)90227-5; Yokokura M, 2011, EUR J NUCL MED MOL I, V38, P343, DOI 10.1007/s00259-010-1612-0; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	104	25	25	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13075	13084		10.1096/fj.201900439	http://dx.doi.org/10.1096/fj.201900439			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31702392	Bronze			2022-12-28	WOS:000507466100005
J	Yang, L; Liu, XF; Song, LS; Su, GH; Di, AQ; Bai, CL; Wei, ZY; Li, GP				Yang, Lei; Liu, Xuefei; Song, Lishuang; Su, Guanghua; Di, Anqi; Bai, Chunling; Wei, Zhuying; Li, Guangpeng			Inhibiting repressive epigenetic modification promotes telomere rejuvenation in somatic cell reprogramming	FASEB JOURNAL			English	Article						SCNT; melatonin; ROS	NUCLEAR TRANSFER EFFICIENCY; GENOMIC STABILITY; LENGTH; EXPRESSION; MELATONIN; EMBRYOS; ANTIOXIDANT; ELONGATION; LANDSCAPE; REVEALS	The efficiency of somatic cell nuclear transfer (SCNT) reprogramming is extremely low in terms of production of cloned animals. Here, we found that telomere rejuvenation is a critical event for SCNT reprogramming. Through small-molecule screening, we identified that melatonin significantly improved the in vitro and in vivo developmental competence of SCNT-derived embryos. Through use of embryonic biopsy, single-cell RNA sequencing, and quantitative FISH experiments, we revealed that melatonin not only attenuated the zygotic genome activation defect but also facilitated telomere elongation in the SCNT embryos. Further investigation indicated that melatonin inhibited heterochromatic epigenetic modification related to gene silencing including DNA methylation and histone H3 lysine 9 trimethylation. In addition, melatonin could increase the level of activation markers such as acetylated histone H3. This is the first study to characterize melatonin-treatment and telomere rejuvenation in SCNT-mediated reprogramming. Moreover, combinational use of melatonin-treated donor embryos and pseudopregnant recipients achieved synergistic enhancement of the production of cloned animals.	[Yang, Lei; Liu, Xuefei; Song, Lishuang; Su, Guanghua; Di, Anqi; Bai, Chunling; Wei, Zhuying; Li, Guangpeng] Inner Mongolia Univ, State Key Lab Reprod Regulat & Breeding Grassland, Hohhot, Peoples R China; [Song, Lishuang; Su, Guanghua; Di, Anqi; Bai, Chunling; Wei, Zhuying; Li, Guangpeng] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China	Inner Mongolia University; Inner Mongolia University	Li, GP (corresponding author), Inner Mongolia Univ, 24 Zhaojun Rd, Hohhot 010070, Peoples R China.	gpengli@imu.edu.cn	Song, Lishuang/AAW-9572-2020	Yang, Lei/0000-0002-9767-9026	Genetically Modified Organisms Breeding Major Projects [2016ZX08007-002]; opening project of the State Key Laboratory of R2BGL; Inner Mongolia University Chief Scientist Program; Inner Mongolia Autonomous Region Basic Research Project	Genetically Modified Organisms Breeding Major Projects; opening project of the State Key Laboratory of R2BGL; Inner Mongolia University Chief Scientist Program; Inner Mongolia Autonomous Region Basic Research Project	The authors thank Prof. Shaorong Gao (Tongji University, Shanghai, China), Prof. Zhiming Han (Chinese Academy of Sciences, Beijing, China), and Prof. Qing Xia (Peking University, Beijing China) for technical assistance. The authors also thank Prof. Yi Zhang (Harvard Medical School, Boston, MA, USA) for sharing the list of reprogramming resistant regions (RRRs). This study was supported by the Genetically Modified Organisms Breeding Major Projects (2016ZX08007-002), the opening project of the State Key Laboratory of R2BGL (to L.Y.), the Inner Mongolia University Chief Scientist Program (to G.L.), and the Inner Mongolia Autonomous Region Basic Research Project (to G.L.). The authors declare no conflicts of interest.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Burgstaller JP, 2017, GERONTOLOGY, V63, P417, DOI 10.1159/000452444; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Cubiles MD, 2018, NUCLEIC ACIDS RES, V46, P2347, DOI 10.1093/nar/gky006; Fojtova M, 2014, CYTOGENET GENOME RES, V143, P125, DOI 10.1159/000360775; Fu B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030790; Gao R, 2018, CELL STEM CELL, V23, P426, DOI 10.1016/j.stem.2018.07.017; Gao YW, 2017, CELL REP, V21, P3957, DOI 10.1016/j.celrep.2017.11.111; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; Hormanseder E, 2017, CELL STEM CELL, V21, P135, DOI 10.1016/j.stem.2017.03.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Keefer CL, 2015, P NATL ACAD SCI USA, V112, P8874, DOI 10.1073/pnas.1501718112; Korkmaz A, 2008, J PINEAL RES, V44, P41, DOI 10.1111/j.1600-079X.2007.00509.x; Le RR, 2014, CELL STEM CELL, V14, P27, DOI 10.1016/j.stem.2013.11.005; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Liu L, 2017, TRENDS GENET, V33, P16, DOI 10.1016/j.tig.2016.10.007; Liu WQ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.10; Liu WQ, 2014, CELL REP, V6, P1008, DOI 10.1016/j.celrep.2014.02.018; Liu XL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165092; Lu FL, 2015, NATL SCI REV, V2, P217, DOI 10.1093/nsr/nwv009; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Matoba S, 2018, CELL STEM CELL, V23, P471, DOI 10.1016/j.stem.2018.06.018; Matoba S, 2018, CELL STEM CELL, V23, P343, DOI 10.1016/j.stem.2018.06.008; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Ozturk S, 2014, MOL HUM REPROD, V20, P15, DOI 10.1093/molehr/gat055; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Saito S, 2019, CELL MOL LIFE SCI, V76, P45, DOI 10.1007/s00018-018-2924-7; Schmidt JC, 2015, GENE DEV, V29, P1095, DOI 10.1101/gad.263863.115; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Siderakis M, 2007, CHROMOSOME RES, V15, P667, DOI 10.1007/s10577-007-1149-7; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tian XZ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050988; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaquero-Sedas MI, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks730; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wang F, 2013, P NATL ACAD SCI USA, V110, pE1906, DOI 10.1073/pnas.1306639110; Wang LB, 2017, CELL RES, V27, P815, DOI 10.1038/cr.2017.58; Wang YQ, 2017, CURR OPIN STRUC BIOL, V47, P77, DOI 10.1016/j.sbi.2017.06.010; Whitworth KM, 2010, MOL REPROD DEV, V77, P1001, DOI 10.1002/mrd.21242; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu HB, 2017, FASEB J, V31, P1731, DOI [10.1096/fj.201601085R, 10.1096/fj.201601085r]; Yang J, 2016, CELL REP, V15, P1809, DOI 10.1016/j.celrep.2016.04.058; Yang L, 2018, EMBO REP, V19, DOI 10.15252/embr.201846240; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhou C, 2019, FASEB J, V33, P4638, DOI 10.1096/fj.201801887R	58	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13982	13997		10.1096/fj.201901486RR	http://dx.doi.org/10.1096/fj.201901486RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31645134				2022-12-28	WOS:000507466100071
J	Yu, W; Shin, MR; Sesti, F				Yu, Wei; Shin, Mi Ryung; Sesti, Federico			Complexes formed with integrin-alpha 5 and KCNB1 potassium channel wild type or epilepsy-susceptibility variants modulate cellular plasticity via Ras and Akt signaling	FASEB JOURNAL			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIN CYTOSKELETON; LARGE-CONDUCTANCE; PROTEIN-SYNTHESIS; SURVIVAL SIGNALS; DENDRITIC SPINE; BKCA CHANNELS; HIPPOCAMPAL; ACTIVATION; FILAMENTS	Voltage-gated potassium (K+) channel subfamily B member 1 (KCNB1, Kv2.1) and integrin-alpha 5 form macromolecular complexes-named integrin-alpha 5-KCNB1 complexes (IKCs)-in the human brain, but their function was poorly understood. Here we report that membrane depolarization triggered IKC intracellular signals mediated by small GTPases of the Ras subfamily and protein kinase B (Akt) to advance the development of filopodia and lamellipodia in Chinese hamster ovary cells, stimulate their motility, and enhance neurite outgrowth in mouse neuroblastoma Neuro2a cells. Five KCNB1 mutants (L211P, R312H G379R, G381R, and F416L) linked to severe infancy or early-onset epileptic encephalopathy exhibited markedly defective conduction. However, although L211P, G379R, and G381R normally engaged Ras/Akt and stimulated cell migration, R312H and F416L failed to activate Ras/Akt signaling and did not enhance cell migration. Taken together, these data suggest that IKCs modulate cellular plasticity via Ras and Akt signaling. As such, defective IKCs may cause epilepsy through mechanisms other than dysregulated excitability such as, for example, abnormal neuronal development and resulting synaptic connectivity.	[Yu, Wei; Shin, Mi Ryung; Sesti, Federico] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sesti, F (corresponding author), Rutgers Robert Wood Johnson Med Sch, 683 Hoes Lane, Piscataway, NJ 08854 USA.	federico.sesti@rutgers.edu			National Science Foundation (NSF) [1456675]; U.S. National Institute of Health (NIH) (National Institute on Aging) [R01AG060919]; U.S. National Institute of Health (NIH) (National Institute of Neurological Disorders and Stroke) [R21NS0966]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); U.S. National Institute of Health (NIH) (National Institute on Aging); U.S. National Institute of Health (NIH) (National Institute of Neurological Disorders and Stroke)	The authors thank Drs. Mladen-Roko Rasin and Huaye Zhang (Robert Wood Johnson Medical School, Rutgers University) for help with the confocal microscope and Drs. Kiram Madura and Li Chen (Robert Wood Johnson Medical School, Rutgers University) for help with the plate reader. The Lifeact-GFP construct was provided by the Addgene repository. This work was supported by National Science Foundation (NSF) Grant 1456675 and U.S. National Institutes of Health (NIH) Grants R01AG060919 (National Institute on Aging) and R21NS0966 (National Institute of Neurological Disorders and Stroke) to F.S. The authors declare no conflicts of interest.	Akama KT, 2003, J NEUROSCI, V23, P2333; Becchetti A, 2010, INT REV CEL MOL BIO, V279, P135, DOI 10.1016/S1937-6448(10)79005-5; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Brady Peter A., 1996, American Journal of Physiology, V271, pH2710; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Cai SQ, 2009, EMBO J, V28, P1601, DOI 10.1038/emboj.2009.112; Calhoun JD, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000198; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; D'Adamo MC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00134; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Kovel CGF, 2017, JAMA NEUROL, V74, P1228, DOI 10.1001/jamaneurol.2017.1714; de Kovel CGF, 2016, MOL GENET GENOM MED, V4, P568, DOI 10.1002/mgg3.235; Delgado-Ramirez M, 2019, J PHYSIOL SCI, V69, P513, DOI 10.1007/s12576-019-00671-y; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Ehrhardt AG, 1996, J PHYSIOL-LONDON, V496, P663, DOI 10.1113/jphysiol.1996.sp021717; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Furukawa T, 1996, PFLUG ARCH EUR J PHY, V431, P504, DOI 10.1007/s004240050028; GREENGARD P, 1994, ADV SEC MESS PHOSPH, V29, P31; He K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129498; Huang H, 2002, NEUROSCI LETT, V332, P141, DOI 10.1016/S0304-3940(02)00836-4; Hwang JU, 1997, PLANT PHYSIOL, V115, P335, DOI 10.1104/pp.115.2.335; Ilic D, 1998, J CELL BIOL, V143, P547; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Kim EY, 2010, AM J PHYSIOL-RENAL, V299, pF594, DOI 10.1152/ajprenal.00206.2010; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Latypova X, 2017, J HUM GENET, V62, P569, DOI 10.1038/jhg.2016.154; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Leung YM, 2011, J CELL PHYSIOL, V226, P1090, DOI 10.1002/jcp.22430; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Malin SA, 2002, J NEUROSCI, V22, P10094; Marini C, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000206; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Nakahira K, 1998, J MOL NEUROSCI, V11, P199, DOI 10.1385/JMN:11:3:199; O'Malley D, 2005, FASEB J, V19, P1917, DOI 10.1096/fj.05-4166fje; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Parent JM, 1997, J NEUROSCI, V17, P3727; Piao L, 2003, PFLUG ARCH EUR J PHY, V446, P523, DOI 10.1007/s00424-003-1079-y; Piwkowska A, 2015, BBA-MOL BASIS DIS, V1852, P1599, DOI 10.1016/j.bbadis.2015.04.024; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rubboli G, 2019, ANN CLIN TRANSL NEUR, V6, P386, DOI 10.1002/acn3.708; Saitsu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15199; Scott BW, 2000, EXP NEUROL, V165, P231, DOI 10.1006/exnr.2000.7458; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Thiffault I, 2015, J GEN PHYSIOL, V146, P399, DOI 10.1085/jgp.201511444; Torkamani A, 2014, ANN NEUROL, V76, P529, DOI 10.1002/ana.24263; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Webb DJ, 2007, J BIOL CHEM, V282, P6929, DOI 10.1074/jbc.M610981200; Wei JF, 2008, J CELL PHYSIOL, V217, P544, DOI 10.1002/jcp.21530; Wei Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0886-1; Wu XL, 2013, J BIOL CHEM, V288, P4128, DOI 10.1074/jbc.M112.440933; Yokoshiki H, 1997, PFLUG ARCH EUR J PHY, V434, P203, DOI 10.1007/s004240050384; Yu W, 2019, BIOCHEM BIOPH RES CO, V512, P665, DOI 10.1016/j.bbrc.2019.03.130; Yu W, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.160; Yu W, 2016, J NEUROSCI, V36, P11084, DOI 10.1523/JNEUROSCI.2273-16.2016; Zhang Y, 2016, CELL, V165, P434, DOI 10.1016/j.cell.2016.02.009	71	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14680	14689		10.1096/fj.201901792R	http://dx.doi.org/10.1096/fj.201901792R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31682765	Bronze, Green Published			2022-12-28	WOS:000507466100124
